<SEC-DOCUMENT>0001140361-20-018789.txt : 20200820
<SEC-HEADER>0001140361-20-018789.hdr.sgml : 20200820
<ACCEPTANCE-DATETIME>20200820102609
ACCESSION NUMBER:		0001140361-20-018789
CONFORMED SUBMISSION TYPE:	F-1/A
PUBLIC DOCUMENT COUNT:		13
FILED AS OF DATE:		20200820
DATE AS OF CHANGE:		20200820

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nano-X Imaging Ltd.
		CENTRAL INDEX KEY:			0001795251
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-240209
		FILM NUMBER:		201119117

	BUSINESS ADDRESS:	
		STREET 1:		COMMUNICATIONS CENTER
		CITY:			NEVE ILAN
		STATE:			L3
		ZIP:			9085000
		BUSINESS PHONE:		972 02 995 0506

	MAIL ADDRESS:	
		STREET 1:		COMMUNICATIONS CENTER
		CITY:			NEVE ILAN
		STATE:			L3
		ZIP:			9085000
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-1/A
<SEQUENCE>1
<FILENAME>nt10006151x14_f1a.htm
<DESCRIPTION>F-1/A
<TEXT>
<html><head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.1.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head><body style=" color: #000000;">
<!--Begin Page 1-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 540pt;"><a name="nt10006151x14_f1a_100-regcov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 540pt; margin-left: 0pt;"> <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 27pt; text-align: center;">As filed with the U.S. Securities and Exchange Commission on August&#160;20, 2020 </div> <div class="regno" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: right;">Registration No. 333-240209 </div></div></div><div class="block-frill" style="width: 540pt; margin-left: 0pt;"><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div><div class="block-main" style="width: 540pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 8pt; text-align: center;">UNITED STATES <br>SECURITIES AND EXCHANGE COMMISSION <br><font style="font-size: 10pt;">Washington, D.C. 20549</font><font style="font-size: 10pt;"> </font></div> <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 3pt; text-align: center;">Amendment No. 2 to<br>Form F-1</div> <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 1pt; text-align: center;">REGISTRATION STATEMENT</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: -1pt; text-align: center;">UNDER <br>THE SECURITIES ACT OF 1933 </div><div><div class="rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 3.75pt;"> </div></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 1pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-size: 9pt;">(Exact Name of Registrant as Specified in its Charter)</font></div><div><div class="rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 4.75pt;"> </div></div><table cellspacing="0" cellpadding="0" class="txttab" align="center" style="margin-top: 3.05pt; border-collapse: collapse; width: 540pt; margin-left: 0pt;"><tr><td style="width: 31.85%; text-align: center; vertical-align: top; padding-top: 6pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">State of Israel</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 31.85%; text-align: center; vertical-align: top; padding-top: 6pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">3844</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 31.85%; text-align: center; vertical-align: top; padding-top: 6pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Not Applicable</div></td></tr><tr><td style="width: 31.85%; text-align: center; vertical-align: top; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">(State or Other Jurisdiction of <br>Incorporation or Organization)</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td style="width: 31.85%; text-align: center; vertical-align: top; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Primary Standard Industrial <br>Classification Code Number)</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td style="width: 31.85%; text-align: center; vertical-align: top; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">(I.R.S. Employer Identification No. )</div></td></tr></table><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 14pt; text-align: center;">Communications Center,<br>Neve Ilan, Israel 9085000<br>+972 02 995 0506 <br>(Address, including zip code, and telephone number, including<br>area code, of Registrant&#8217;s principal executive offices)</div><div><div class="rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 4.74pt;"> </div></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">CT Corporation System<br>28 Liberty Street<br>New York, NY 10005<br>(212) 894-8940 </div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 2.5pt; text-align: center;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</div><div><div class="rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 4.75pt;"> </div></div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-style: italic; font-weight: bold; margin-top: 4.5pt; text-align: center;">Copies to:</div><table cellspacing="0" cellpadding="0" class="txttab" align="center" style="border-collapse: collapse; width: 540pt; margin-left: 0pt;"><tr><td style="width: 28.89%; text-align: center; vertical-align: top; padding-top: 6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Andrea L. Nicol&#225;s<br>Yossi Vebman<br>Skadden, Arps, Slate, Meagher &amp;<br>Flom LLP<br>One Manhattan West<br>New York, New York 10001<br>Tel: +1-212-735-3000<br>Fax: +1-212-735-2000</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt;">&#8203;</td><td style="width: 21.48%; text-align: center; vertical-align: top; padding-top: 6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Ian Rostowsky<br>Amit, Pollak, Matalon &amp; Co.<br>APM House, 18 Raoul <br>Wallenberg St.<br>Building D.<br>Ramat Hachayal<br>Tel Aviv 6971915, Israel<br>Tel: +972-3-568-9000<br>Fax: +972-73-297-8645</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt;">&#8203;</td><td style="width: 21.48%; text-align: center; vertical-align: top; padding-top: 6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Peter N. Handrinos<br>Wesley C. Holmes<br>Latham &amp; Watkins LLP<br>200 Clarendon Street<br>Boston, Massachusetts 02116<br>Tel: +1-617-948-6000<br>Fax: +1-617-948-6001<br></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt;">&#8203;</td><td style="width: 21.48%; text-align: center; vertical-align: top; padding-top: 6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Chaim Friedland<br>Ari Fried<br>Gornitzky &amp; Co.<br>Zion House<br>45 Rothschild Blvd.<br>Tel Aviv 6578403, Israel<br>Tel. +972-3-710-9191<br>Fax: +972-3-560-6555</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 4.75pt;"> </div></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 3pt; margin-left: 20pt; text-align: left;">Approximate date of commencement of proposed sale to the public:<font style="font-weight: normal;"> As soon as practicable after effectiveness of this registration statement.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 1pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. <font style="font-size: 1pt;">&#8201;</font>&#x2610;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 1pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font>&#x2610;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 1pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font>&#x2610;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 1pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font>&#x2610;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 1pt; margin-left: 20pt; text-align: left;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 1pt; margin-left: 20pt; text-align: left;">Emerging growth company &#x2612;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 1pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#x2612;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 1pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8224; The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April&#160;5, 2012. </div><div><div class="rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 0.75pt;"> </div></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 4.5pt; text-align: center;">CALCULATION OF REGISTRATION FEE</div><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 2pt; margin-left: auto; margin-right: auto;"> </div></div> <table cellspacing="0" cellpadding="0" class="regtab" align="center" style="margin-top: 1.5pt; border-collapse: collapse; width: 540pt; margin-left: 0pt; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000;"><tr class="header"><td style="width: 40%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Title of each Class of Securities to be Registered</div></td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 13.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount to be <br>Registered<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 13.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Proposed Maximum <br>Offering Price <br>Per Share<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div></td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 13.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Proposed Maximum <br>Aggregate Offering <br>Price<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(2)</sup></div></td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.56%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 13.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount of <br>Registration Fee<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div></td></tr><tr><td style="width: 40%; text-align: left; vertical-align: bottom; padding-top: 4.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Ordinary shares, par value NIS 0.01 per share<font style="padding-left: 4.18pt;"></font></div></td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt;">&#8203;</td><td style="width: 13.89%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 0pt; margin-left: 19.05pt; text-align: left;">10,147,059</div></td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt;">&#8203;</td><td style="width: 13.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 0pt; margin-left: 26.23pt; text-align: left;">$18.00</div></td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt;">&#8203;</td><td style="width: 13.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 0pt; margin-left: 14.95pt; text-align: left;">$182,647,062</div></td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt;">&#8203;</td><td style="width: 13.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt;"><div class="calc" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; margin-top: 0pt; margin-left: 19.05pt; text-align: left;">$23,707.59</div></td></tr></table> <div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 3pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes ordinary shares that the underwriters may purchase pursuant to their option to purchase additional ordinary shares </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 1pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 1pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Of this amount, $16,225 has previously been paid. </div></td></tr></table> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.2pt; font-weight: bold; margin-top: 2pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Securities and Exchange Commission acting pursuant to said Section 8(a), may determine.</div></div><div class="block-frill" style="width: 540pt; margin-top: 12pt; margin-left: 0pt;"><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div></div>
<!--End Page 1-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 2-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 456pt;"><a name="nt10006151x14_f1a_101-cov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 456pt; margin-left: 0pt;"> <div class="h2" style="color: #FC0014; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><div style="font-family: Arial, Helvetica, sans-serif; text-align: left; margin-bottom: 12pt;">Information contained herein is subject to completion or amendment. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This prospectus shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any State in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such State. </div>SUBJECT TO COMPLETION DATED <font style="text-transform: uppercase;">August</font> 20, 2020 </div> <div class="h2" style="color: #FC0014; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">PRELIMINARY PROSPECTUS</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 19.5pt; text-align: center;">NANO-X IMAGING LTD</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 13.25pt; text-align: center;"><img style="height: 55px; width: 225px;" src="logo_nanox2.jpg"><br>&#8201;</div> <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 20.5pt; text-align: center;">8,823,530 ORDINARY SHARES</div> <div><div class="rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 13.25pt;"> </div></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">This is an initial public offering of ordinary shares of NANO-X IMAGING LTD. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">No public market currently exists for our ordinary shares. The initial public offering price is expected to be between $16.00 and $18.00 per ordinary share. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">We have applied to list our ordinary shares on The Nasdaq Global Market under the symbol &#8220;NNOX.&#8221;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We are an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 and will be subject to reduced public company reporting requirements. See &#8220;Prospectus Summary&#8212;Implications of Being an Emerging Growth Company and a Foreign Private Issuer.&#8221; </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">Investing in our ordinary shares involves a high degree of risk. See &#8220;Risk Factors&#8221; beginning on page&#160;<a href="#tRF">10</a> of this prospectus for a discussion of information that should be considered in connection with an investment in our ordinary shares<font style="font-weight: normal;">. </font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 456pt; margin-left: 0pt;"><tr class="header"><td style="width: 73.68%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.47%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.22%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Per share</div></td><td class="gutter" style="width: 2.47%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.47%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.22%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div></td></tr><tr><td style="width: 73.68%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Initial public offering price<font style="padding-left: 2.61pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$&#8199;&#8199;&#8199;&#8201;&#8199;&#8199;&#8199;</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$&#8199;&#8199;&#8199;&#8201;&#8199;&#8199;&#8199;</div></td></tr><tr><td style="width: 73.68%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Underwriting discounts and commissions<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 1.47pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$</div></td></tr><tr><td style="width: 73.68%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Proceeds to us (before expenses)<font style="padding-left: 4.13pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Refer to &#8220;Underwriting&#8221; for additional information regarding underwriting compensation. </div></td></tr></table> <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We have granted a 30-day option to the underwriters to purchase up to 1,323,529 additional ordinary shares solely to cover over-allotments, if any. The underwriters expect to deliver the shares to purchasers in the offering on or about&#8195;&#8195;&#8195;&#8195; , 2020.</div> <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Certain of our existing investors and their affiliated entities, including Yozma Group Korea (&#8220;Yozma&#8221;), SK Telecom TMT Investment Corp. (&#8220;SKT&#8221;), Jin Ji Full Investment Holding Co., Ltd., an affiliate of Foxconn Singapore Pte Ltd (&#8220;JJFIHC&#8221;) and iA Financial Group, an affiliate of Industrial Alliance Investment Management Inc. (&#8220;iA&#8221;), and certain other investors have indicated an interest in purchasing an aggregate of up to approximately $80 million of our ordinary shares in this offering at the initial public offering price. However, because indications of interest are not binding agreements or commitments to purchase, these entities may determine to purchase fewer shares than they indicate an interest in purchasing or to not purchase any shares in this offering. It is also possible that these entities could indicate an interest in purchasing more of our ordinary shares. In addition, the underwriters could determine to sell fewer shares to any of these entities than the entities indicate an interest in purchasing or to not sell any shares to these entities. The underwriters will receive the same underwriting discount on any shares purchased by these entities as they will on any other shares sold to the public in this offering. </div><table cellspacing="0" cellpadding="0" class="txttab" align="center" style="margin-top: 17.25pt; border-collapse: collapse; width: 456pt; margin-left: 0pt;"><tr><td style="width: 11.84%; text-align: left; vertical-align: top; padding-top: 6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cantor</div></td><td class="gutter" style="width: 2.79%; border-bottom: none; font-size: 2pt; padding-top: 6pt;">&#8203;</td><td class="gutter" style="width: 2.79%; border-bottom: none; font-size: 2pt; padding-top: 6pt;">&#8203;</td><td style="width: 27.14%; text-align: left; vertical-align: top; padding-top: 6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Oppenheimer &amp; Co.</div></td><td class="gutter" style="width: 2.79%; border-bottom: none; font-size: 2pt; padding-top: 6pt;">&#8203;</td><td class="gutter" style="width: 2.79%; border-bottom: none; font-size: 2pt; padding-top: 6pt;">&#8203;</td><td style="width: 13.75%; text-align: left; vertical-align: top; padding-top: 6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Berenberg</div></td><td class="gutter" style="width: 2.79%; border-bottom: none; font-size: 2pt; padding-top: 6pt;">&#8203;</td><td class="gutter" style="width: 2.79%; border-bottom: none; font-size: 2pt; padding-top: 6pt;">&#8203;</td><td style="width: 30.52%; text-align: left; vertical-align: top; padding-top: 6pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CIBC Capital Markets</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; text-align: center;">National Securities Corporation</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 19pt; text-align: center;">&#8195;&#8195;&#8195;, 2020</div></div></div></div>
<!--End Page 2-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 3-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 613.35pt;"><a name="nt10006151x14_f1a_101a-cov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 613.35pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; text-align: center;"><img style="height: 963px; width: 720px;" src="nt10006151x14_cov001.jpg"><br>&#8201;</div></div></div></div>
<!--End Page 3-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 4-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_102-toc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">TABLE OF CONTENTS</div><a name="TOC"><!--Anchor--></a><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 10.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.09%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 3.51%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page </div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPRS">PROSPECTUS SUMMARY<font style="padding-left: 2.84pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tPRS"><font style="padding-left: 10pt;">1</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tTO">THE OFFERING<font style="padding-left: 2.85pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tTO"><font style="padding-left: 10pt;">7</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSCF">SUMMARY CONSOLIDATED FINANCIAL DATA<font style="padding-left: 3.32pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tSCF"><font style="padding-left: 10pt;">9</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF">RISK FACTORS<font style="padding-left: 4.32pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tRF"><font style="padding-left: 5pt;">10</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSN">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS<font style="padding-left: 0.19pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tSN"><font style="padding-left: 5pt;">55</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUP">USE OF PROCEEDS<font style="padding-left: 0.07pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tUP"><font style="padding-left: 5pt;">57</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDP">DIVIDEND POLICY<font style="padding-left: 1.2pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tDP"><font style="padding-left: 5pt;">59</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tC">CAPITALIZATION<font style="padding-left: 3.66pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tC"><font style="padding-left: 5pt;">60</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tD">DILUTION<font style="padding-left: 1.74pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tD"><font style="padding-left: 5pt;">62</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSC">SELECTED CONSOLIDATED FINANCIAL DATA<font style="padding-left: 4.06pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tSC"><font style="padding-left: 5pt;">65</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tMDA">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS<font style="padding-left: 2.3pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tMDA"><font style="padding-left: 5pt;">66</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tB">BUSINESS<font style="padding-left: 2.28pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tB"><font style="padding-left: 5pt;">79</font></a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tM">MANAGEMENT<font style="padding-left: 2.3pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tM">106</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPS">PRINCIPAL SHAREHOLDERS<font style="padding-left: 1.93pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tPS">127</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCR">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS<font style="padding-left: 2.48pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tCR">130</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDS">DESCRIPTION OF SHARE CAPITAL<font style="padding-left: 2.56pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tDS">134</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSE">SHARES ELIGIBLE FOR FUTURE SALE<font style="padding-left: 4.54pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tSE">141</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tMT">MATERIAL TAX CONSIDERATIONS<font style="padding-left: 2.56pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tMT">143</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tU">UNDERWRITING<font style="padding-left: 2.3pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tU">153</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tER">EXPENSES RELATED TO OFFERING<font style="padding-left: 3.78pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tER">159</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">LEGAL MATTERS<font style="padding-left: 3.22pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tLM">160</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tE">EXPERTS<font style="padding-left: 1.77pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tE">160</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tEC">ENFORCEABILITY OF CIVIL LIABILITIES<font style="padding-left: 3.08pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tEC">161</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tWY">WHERE YOU CAN FIND ADDITIONAL INFORMATION<font style="padding-left: 1.45pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tWY">162</a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tIC">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS<font style="padding-left: 4.44pt;"></font></a></div></td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.09%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 3.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.72pt; text-align: left;"><a href="#tIC"><font style="padding-left: 1.11pt;">F-</font>1</a></div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 13.25pt;"> </div></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Through and including&#8195;&#8195;&#8195;&#8195;&#8195;, 2020 (the 25<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer&#8217;s obligation to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">i<br></div></div></div>
<!--End Page 4-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 5-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_102-toc_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">You should rely only on the information contained in this prospectus and any related free-writing prospectus that we authorize to be distributed to you. We have not authorized any person, including any underwriter, to provide you with information different from that contained in this prospectus or any related free-writing prospectus that we authorize to be distributed to you. This prospectus is not an offer to sell, nor is it seeking an offer to buy, our ordinary shares in any state or jurisdiction where such offer or sale is not permitted. The information in this prospectus speaks only as of the date of this prospectus unless the information specifically indicates that another date applies, regardless of the time of delivery of this prospectus or of any sale of the ordinary shares offered hereby. Our business, financial condition, results of operations, and prospects may have changed since that date. We do not take any responsibility for, nor do we provide any assurance as to the reliability of, any information other than the information in this prospectus and any free writing prospectus prepared by us or on our behalf. Neither the delivery of this prospectus nor the sale of our ordinary shares means that information contained in this prospectus is correct after the date of this prospectus.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">You may lose all of your investment in our ordinary shares. If you are uncertain as to our business and operations or you are not prepared to lose all of your investment in our ordinary shares, we strongly urge you not to purchase any of our ordinary shares. We recommend that you consult legal, financial, tax and other professional advisors or experts for further guidance before participating in the offering of our ordinary shares as further detailed in this prospectus.<font style="font-weight: normal;"> </font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We do not recommend that you purchase our ordinary shares unless you have prior experience with investments in capital markets, and basic knowledge of the healthcare and medical imaging industry, and unless you have received independent professional advice.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tMA"><!--Anchor--></a>Market and Industry Data</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">This prospectus includes statistics and other data relating to markets, market sizes and other industry data pertaining to our business that we have obtained from industry publications and surveys and other information available to us. Industry publications and surveys generally state that the information contained therein has been obtained from sources believed to be reliable. We have not independently verified any of the data from third-party sources nor have we ascertained the underlying economic assumptions relied upon therein. Market data and statistics are inherently predictive and speculative and are not necessarily reflective of actual market conditions. Such statistics are based on market research, which itself is based on sampling and subjective judgments by both the researchers and the respondents, including judgments about what types of products and transactions should be included in the relevant market. In addition, the value of comparisons of statistics for different markets is limited by many factors, including that (i)&#160;the markets are defined differently, (ii)&#160;the underlying information was gathered by different methods, and (iii)&#160;different assumptions were applied in compiling the data. Accordingly, the market statistics included in this prospectus should be viewed with caution. We believe that information from these industry publications included in this prospectus is reliable.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tTS"><!--Anchor--></a>Trademarks, Service Marks and Trade Names</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Solely for convenience, the trademarks, service marks, and trade names referred to in this prospectus are without the &#174; and &#8482; symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks and trade names. This prospectus contains additional trademarks, service marks and trade names of others, which are the property of their respective owners. We do not intend our use or display of other companies&#8217; trademarks, service marks or trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Basis of Presentation</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We were incorporated under the laws of the State of Israel under the name &#8220;NANO-X IMAGING LTD&#8221; on December&#160;20, 2018. We commenced our operations on September 3, 2019. Substantially all of our assets were acquired or assigned (the &#8220;Asset Purchase&#8221;) from our predecessor company, Nanox Imaging PLC (&#8220;Nanox Gibraltar&#8221;), a Gibraltar public company, pursuant to an asset purchase agreement (the &#8220;Asset Purchase Agreement&#8221;), dated as of September&#160;3, 2019 and as amended on December&#160;3, 2019 and December 31, 2019, between Nanox Gibraltar and us. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of September&#160;3, 2019, we and Nanox Gibraltar had the same shareholders and therefore the transaction was treated as a transaction under common control for accounting purposes. For periods and at dates prior to the </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">ii<br></div></div></div>
<!--End Page 5-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 6-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_102-toc_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Asset Purchase, the financial statements prior to September&#160;3, 2019 included in this prospectus were prepared based on the historical financial statements of Nanox Gibraltar, which were adjusted to reflect (a) only the net assets that were transferred in the transaction according to the Asset Purchase Agreement, (b) that no interests of Nanox Japan, Inc., a wholly owned subsidiary of Nanox Gibraltar (&#8220;Nanox Japan (predecessor)&#8221;) were transferred under the Asset Purchase, and the fact that the consolidated statement of operations at Nano-X Imaging Ltd includes the costs incurred for services provided by Nanox Japan (predecessor) to Nanox Gibraltar, (c) the consideration in the Asset Purchase as if it was recorded at the beginning of the earliest period presented, against a decrease in the shareholders&#8217; equity, with the exception of the cash consideration that was received by Nanox Gibraltar from its equity financing activities in 2019, which was recorded in 2019, and (d)&#160;all of the share-related information as the share information of Nano-X Imaging Ltd.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Unless derived from our financial statements or otherwise noted, the terms &#8220;shekels&#8221; and &#8220;NIS&#8221; refer to New Israeli Shekels, the lawful currency of the State of Israel, the terms &#8220;dollar&#8221; or &#8220;$&#8221; refer to U.S. dollars, the lawful currency of the United States, and &#8220;Yen&#8221; refers to Japanese Yen, the lawful currency of Japan. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">iii<br></div></div></div>
<!--End Page 6-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 7-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10006151x14_f1a_103-sum_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="block-main" style="width: 468pt; margin-left: 12pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPRS"><!--Anchor--></a>PROSPECTUS SUMMARY</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">This summary highlights selected information contained elsewhere in this prospectus. Because it is only a summary, it does not contain all of the information you should consider before making your investment decision. Before investing in our ordinary shares, you should carefully read this entire prospectus, including our financial statements and the related notes thereto and the information set forth under &#8220;Risk Factors,&#8221; &#8220;Selected Consolidated Financial Data,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Business.&#8221; Unless the context otherwise requires, all references to &#8220;Nanox,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; and similar designations refer to NANO-X IMAGING LTD, an Israeli company, and its wholly-owned Japanese subsidiary, or, where applicable, our predecessor company, Nanox Imaging PLC, a Gibraltar public limited company, and its wholly-owned Japanese subsidiary.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; text-align: center;">Overview</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Early detection saves lives&#8212;and we at Nanox are focused on applying our proprietary medical imaging technology to make diagnostic medicine more accessible and affordable across the globe. Our vision is to increase early detection of medical conditions that are discoverable by X-ray, which we believe is key to increasing early treatment, improving health outcomes and, ultimately, saving lives. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As a first step to producing a new class of affordable medical imaging systems, we have focused on identifying and developing a novel X-ray source. Our X-ray source is based on a novel digital microelectromechanical system (&#8220;MEMs&#8221;) semiconductor cathode that we believe can achieve the same functionalities as legacy X-ray analog cathodes, while allowing for lower-cost production than existing medical imaging systems. We developed this technology over eight years to reach commercial applicability. This novel digital X-ray source is the basis of core technology in the Nanox.ARC, the imaging system we are developing, and we believe it also has the potential to replace the legacy X-ray source in other existing imaging systems. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our solution, which we refer to as the Nanox System, has two integrated components&#8212;hardware (Nanox.ARC) and software (Nanox.CLOUD). We have developed a prototype of the Nanox.ARC, a medical imaging system incorporating our novel digital X-ray source. Subject to receiving regulatory clearance, the first version of the Nanox.ARC that we expect to introduce to the market will be a three-dimensional (&#8220;3D&#8221;) tomosynthesis imaging system. Tomosynthesis is an imaging technique widely used for early detection, that is designed to produce a high-resolution, 3D&#160;X-ray image reconstruction of the scanned human body part for review by a professional diagnostics expert. In parallel, we have developed a prototype of the Nanox.CLOUD, a companion cloud-based software that is designed to provide an end-to-end medical imaging service, including services such as image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence (&#8220;AI&#8221;) systems, billing and reporting. The Nanox System is designed to enable medical screening as a service (&#8220;MSaaS&#8221;) to improve accessibility and affordability of early-detection services worldwide. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If cleared, we plan to market and deploy the Nanox System globally at a substantially lower cost than currently available medical imaging systems, such as computed tomography (&#8220;CT&#8221;), because our digital X-ray source will allow the Nanox.ARC to have a simpler structure without the costly cooling equipment or the complex rotating mechanism used in legacy CT devices. See &#8220;Business&#8212;Our Technology&#8212;The Nanox System.&#8221; We believe that the Nanox System could increase the accessibility and affordability of early-detection medical imaging systems worldwide.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As we continue to develop the Nanox.ARC, we expect to take a multi-step approach to the regulatory clearance process. As a first step, we submitted a 510(k) application for a single-source version of the Nanox.ARC to an accredited Review Organization under the U.S. Food and Drug Administration&#8217;s (the &#8220;FDA&#8221;) 510(k) Third Party Review Program (the &#8220;Third Party Review Program&#8221;) in January 2020. As part of the review process, in March 2020, we received an additional information request, referred to as a major deficiency letter, from the Review Organization which, among other things, required us to provide additional data and other information to complete the application and to address certain deficiencies highlighted by the reviewer, including the results of certain performance tests. In response to the feedback we received from the Review Organization, we have conducted additional product testing and expect to submit the results from these tests, along with our response, to the Review Organization, in the third quarter of 2020. Our original timeline for completing the application was delayed due to the impact of COVID-19 on the external labs we work with to complete our product testing. We will continue to optimize and develop further features of the Nanox.ARC, and plan to submit an additional 510(k) application under the Third Party Review Program with </div></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">1<br></div></div></div>
<!--End Page 7-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 8-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10006151x14_f1a_103-sum_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="block-main" style="width: 468pt; margin-left: 12pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">respect to the multiple-source Nanox.ARC during the fourth quarter of 2020, which, if approved, will be our commercial imaging system. We believe that neither our novel digital X-ray source nor the Nanox.CLOUD will require regulatory approval or clearance. However, to date, we have not obtained feedback from the FDA regarding our regulatory strategy. We introduced a working prototype of the Nanox.ARC in February&#160;2020 and, if cleared, we plan to deploy the first Nanox.ARC in the first half of 2021. If cleared, we are targeting a minimum installed base of at least 1,000 Nanox Systems in the second half of 2021 with the goal to finalize deployment of the initial 15,000 Nanox Systems by 2024.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; text-align: center;">Limitation of Current Medical Imaging Systems and Our Market Opportunity</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The main categories of current medical imaging systems that use X-ray sources include CT, mammography, fluoroscopy, angiogram and dental. The analog X-ray source used by these systems produces X-rays by accelerating electrons to high energies, causing them to hit a metal target from which the X-rays are emitted. This requires a significant amount of electrical energy to be transferred to the X-ray tube. Due to the heat generated by this process, one of the most complex mechanical challenges is cooling the analog X-ray source. In addition, for CTs, the mechanical structure is even more complex because the analog X-ray source needs to rotate in a heavy gantry at high speed. We believe these are key factors leading to the high cost and complexity of existing medical imaging systems, which in turn significantly limits the availability of medical imaging for early detection globally. According to a report from the Pan-American Health Organization and the World Health Organization (&#8220;WHO&#8221;) in 2012, approximately two-thirds of the world population did not have access to medical imaging, while many people with access to medical imaging face substantial wait times for scanning. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, most market participants, including medical imaging manufacturing companies, medical imaging providers and radiologists, among others, have not provided the same level of end-to-end medical imaging services. One of the reasons is that the scanning process is currently not integrated with the diagnostics process, which contributes to extended wait times for image diagnostics by experts. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We estimate that the total annual capital expenditures on existing X-ray-based medical imaging systems, not including support, maintenance, insurance and ancillary services, will reach approximately $21 billion by 2021, which we believe represents a significant market opportunity for the Nanox System.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; text-align: center;">Our Solution </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 20pt; text-align: left;">We believe the Nanox System addresses the limitations of existing medical imaging systems on three levels:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">D</font><font style="font-weight: bold;">igital X-ray source</font><font style="font-weight: bold;"> with the potential to significantly reduce the costs of medical imaging </font><font style="font-weight: bold;">systems</font><font style="font-weight: bold;">.</font> We believe our digital X-ray source technology will allow us to manufacture the Nanox.ARC, if cleared, at substantially lower costs compared to medical imaging systems that use a legacy analog X-ray source without sacrificing imaging quality. A lower cost device has the potential to substantially increase medical imaging availability and improve accessibility of early-detection services broadly across the globe. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Technology</font><font style="font-weight: bold;"> designed to improve</font><font style="font-weight: bold;"> upon the industry standard with integrated</font><font style="font-weight: bold;"> radiology diagnostics </font><font style="font-weight: bold;">via a cloud-based </font><font style="font-weight: bold;">M</font><font style="font-weight: bold;">SaaS platform.</font> The Nanox.ARC employs our novel digital X-ray source that is designed to be energy-efficient, smaller and can be more precisely controlled compared to existing X-ray source. By integrating the Nanox.CLOUD, we believe the Nanox System could provide a streamlined process where each scanned image is uploaded automatically to the cloud system and matched to a human radiology expert and decision assistive AI algorithms to provide scan reviews and diagnostics in a significantly shorter time frame than current diagnostics, which could substantially reduce wait-times for imaging results and increase early detection rates compared to currently employed imaging process protocols. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Business model designed to increase the availability of</font><font style="font-weight: bold;"> medical imaging</font><font style="font-weight: bold;">.</font> Our primary business model is based on a pay-per-scan pricing structure as opposed to the capital expenditure-based business model currently used by medical imaging manufacturing companies. We believe our business model will significantly reduce the price per scan compared to the current global average cost of $300 per scan, and has the potential to commoditize medical imaging services at prices that are affordable to a greater number of people. We believe our MSaaS business model has the potential to expand the total size of the X-ray-based medical imaging market. </div></td></tr></table></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">2<br></div></div></div>
<!--End Page 8-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 9-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10006151x14_f1a_103-sum_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="block-main" style="width: 468pt; margin-left: 12pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">Our Strategy</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Secure regulatory </font><font style="font-weight: bold;">clearance</font><font style="font-weight: bold;"> for </font><font style="font-weight: bold;">our medical imaging system</font><font style="font-weight: bold;">. </font>We expect to take a multi-step approach to the regulatory clearance process. As a first step, we submitted a 510(k) application for a single-source version of the Nanox.ARC to an accredited Review Organization under the Third Party Review Program in January 2020. As part of the review process, in March 2020, we received an additional information request, referred to as a major deficiency letter, from the Review Organization which, among other things, required us to provide additional data and other information to complete the application and to address certain deficiencies highlighted by the reviewer, including the results of certain performance tests. In response to the feedback we received from the Review Organization, we have conducted additional product testing and expect to submit the results from these tests, along with our response, to the Review Organization, in the third quarter of 2020. Our original timeline for completing the application was delayed due to the impact of COVID-19 on the external labs we work with to complete our product testing. We will continue to optimize and develop further features of the Nanox.ARC, and plan to submit an additional 510(k) application under the Third Party Review Program with respect to the multiple-source Nanox.ARC during the fourth quarter of 2020, which, if cleared, will be our commercial imaging system. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Jumpstart the </font><font style="font-weight: bold;">MSaa</font><font style="font-weight: bold;">S-based </font><font style="font-weight: bold;">medical imaging market with strategic partnerships. </font>We plan to produce and deploy an initial wave of approximately 15,000 Nanox.ARC units over the next three to four years to jumpstart the MSaaS-based medical imaging market. We have entered into a contract manufacturing agreement with a subsidiary of Foxconn for the commercial production and assembly of the Nanox.ARC and we have entered into commercial agreements with strategic regional partners for the deployment, operation and marketing of the Nanox System broadly across the globe, including in the United States and certain countries in Asia, Europe, Africa and South America. We plan to work with these partners to achieve local integrations into health maintenance organizations, electronic health record systems, payment methods and insurance coverage companies. In addition, we have entered into collaboration agreements with AI partners and are actively seeking collaboration opportunities, as we anticipate an industry shift to a digital and cloud-based subscription model will bring more digital healthcare disruptors into the market. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Maximize the commercial potential</font><font style="font-weight: bold;"> of our technology</font><font style="font-weight: bold;"> with </font><font style="font-weight: bold;">simultaneous</font><font style="font-weight: bold;"> </font><font style="font-weight: bold;">business models</font><font style="font-weight: bold;">. </font>We plan to commercialize our novel X-ray source technology by pursuing three simultaneous business models, which we believe will provide us the flexibility and long-term sustainability to monetize our technology. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic;">Subscription Model</font><font style="font-style: italic;">:</font> In certain countries, if permitted by the laws in the applicable jurisdiction, our primary sales strategy will be based on a pay-per-scan pricing structure, where we expect to sell the Nanox System at low cost or at no cost, with a suggested retail price per scan that is substantially lower than the current global average charge, and receive a portion of the proceeds from each scan as the right-to-use licensing fee and fees for usage of the Nanox.CLOUD, artificial intelligence capability and maintenance support. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic;">Sales Model:</font> In certain countries, to accommodate specific local regulatory requirements, we expect to sell the Nanox.ARC for a one-time charge at a price that is substantially less than current market offerings. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic;">Licensing Model</font><font style="font-style: italic;">:</font> For certain medical imaging market participants, we plan to tailor our X-ray source technology to their specific imaging systems to replace the legacy X-ray source or to license our X-ray source technology to them to develop new types of imaging systems. We expect to charge a one-time licensing fee upfront and receive recurring royalty payments for each system sold. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Leverage </font><font style="font-weight: bold;">the Nanox System to bring added value to our collaborators.</font> We expect that the Nanox System will enable us to accumulate a significant number of medical images, which have the potential to be used by collaborators, such as medical AI-analytics companies, through machine learning algorithms to increase the probability of early disease detection. </div></td></tr></table></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">3<br></div></div></div>
<!--End Page 9-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 10-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10006151x14_f1a_103-sum_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="block-main" style="width: 468pt; margin-left: 12pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">Recent Developments</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From December 2019 through August 2020, we entered into share purchase agreements with certain investors (together, the &#8220;Investors&#8221;), under which we sold an aggregate of 6,812,000 ordinary shares to the Investors, at a price per share of $16.00, for an aggregate purchase price, before fees and expenses, of approximately $109&#160;million (the &#8220;Private Placement&#8221;). As part of the Private Placement, we sold 312,500&#160;ordinary shares to Foxconn Singapore Pte Ltd. for an aggregate purchase price of approximately $5 million, 1,250,000 ordinary shares to SKT for an aggregate purchase price of $20 million, 375,000 ordinary shares to certain funds affiliated with Industrial Alliance Investment Management Inc., a Canadian-based financial institution, for an aggregate purchase price of approximately $6 million, and 2,512,000 ordinary shares to Yozma for an aggregate purchase price of $40.2 million, in each case before fees and expenses. In addition, we entered into a share purchase agreement with Asia Beam Limited pursuant to which we will sell 1,875,000 ordinary shares for a purchase price, before fees and expenses, of approximately $30 million. The sale is expected to close prior to the closing of this offering.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In December 2019, June 2020 and July 2020, we issued warrants to A-Labs Advisory &amp; Finance Ltd. (&#8220;A-Labs&#8221;) for their consulting services in connection with certain investments in the Private Placement that qualified as Triggering Events (as defined below). See &#8220;Business&#8212;Letter Agreement with A-Labs.&#8221; The warrants are exercisable for 9,375 ordinary shares, 63,582 ordinary shares and 50,469 ordinary shares, respectively, each at an exercise price of $16.00 per ordinary share.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In connection with SKT&#8217;s investment, we have entered into a collaboration agreement with SKT Telecom Co., Ltd. (&#8220;SK Telecom&#8221;), under which we and SK Telecom will further explore and engage in good faith to develop a definitive agreement for the deployment of 2,500 Nanox Systems in South Korea and Vietnam, and we will use commercially reasonable efforts to establish a wholly-owned subsidiary in South Korea with the support of SK Telecom for the purpose of manufacturing MEMs X-ray chips for the Nanox.ARC. See &#8220;Certain Relationships and Related Party Transactions&#8212;Relationship with SKT.&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In connection with the Private Placement, we also entered into an investor rights agreement with each of the Investors. Under the investor rights agreements, so long as such Investor holds at least 4% of our outstanding shares or is otherwise deemed an affiliate of us under Rule 144 of the Securities Act, it shall be entitled to the same piggyback registration rights as the most favorable registration rights that we have provided to any of our current shareholders or provide to future shareholders, and shall be made a party to any investor rights agreement or registration rights agreement that we thereafter enter into. The rights under the investor rights agreements will terminate upon the closing of this offering, but each of SKT, Asia Beam Limited and Yozma is expected to become party to the Registration Rights Agreement (as defined below) prior to the closing of this offering. See &#8220;Description of Share Capital&#8212;Registration Rights&#8221; for detailed description of the registration rights. In addition, we entered into an amended investor rights agreement with SKT that grants SKT the right to appoint Mr.&#160;Jung Ho Park (or another person designated by SKT) as a director for a term of three years and certain pre-emptive rights to participate in any issuance of new securities by us until the closing of an initial public offering. See &#8220;Certain Relationships and Related Party Transactions&#8212;Relationship with SKT.&#8221; </div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; text-align: center;">Risks Associated with our Business</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Investing in our ordinary shares involves risks. You should carefully consider the risks described in &#8220;Risk Factors&#8221; before making a decision to invest in our ordinary shares. If any of these risks actually occurs, our business, financial condition or results of operations could be materially and adversely affected. In such case, the trading price of our ordinary shares would likely decline, and you may lose all or part of your investment. The following is a summary of some of the principal risks we face: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we are a development-stage company with limited operating history. We may never be able to effectuate our business plan or achieve any revenue or profitability. Therefore, at this stage of our business, potential investors have a high probability of losing their entire investment; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our efforts may never demonstrate the feasibility of our X-ray source technology for commercial applications;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we are highly dependent on the successful development, marketing and sale of our X-ray source technology and the related products and services;</div></td></tr></table></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">4<br></div></div></div>
<!--End Page 10-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 11-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10006151x14_f1a_103-sum_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="block-main" style="width: 468pt; margin-left: 12pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our business models depend on the successful commercial application of Nanox.CLOUD, which is subject to numerous risks and uncertainties;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">business interruptions resulting from the COVID-19 pandemic or similar public health crises could cause a disruption of the development, deployment or regulatory clearance of the Nanox System and adversely impact our business; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">products utilizing our technology may need to be approved or cleared by the FDA and similar regulatory agencies worldwide. We may not receive, or may be delayed in receiving, the necessary approval or clearance for our future products, which would adversely affect business, financial condition, results of operations and products; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we may not be successful in implementing our business models; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we expect to depend on third parties to manufacture the Nanox.ARC and to supply certain component parts;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">it is difficult and costly to protect our intellectual property and our proprietary technologies, and we may not be able to ensure their protection;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">patent terms may be inadequate to protect our competitive position on our future products for an adequate amount of time;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our product candidates and operations are subject to extensive government regulation and oversight both in the United States and abroad, and our failure to comply with applicable requirements could harm our business;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">under applicable employment laws, we may not be able to enforce covenants not to compete and therefore may be unable to prevent our competitors from benefiting from the expertise of some of our former employees; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">conditions in Israel could materially and adversely affect our business.</div></td></tr></table><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;">Corporate Information</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We were incorporated under the laws of the State of Israel under the name &#8220;NANO-X IMAGING LTD&#8221; on December&#160;20, 2018 and we commenced our operations on September 3, 2019. Substantially all of our assets at the time of commencement of our operations were acquired or assigned (the &#8220;Asset Purchase&#8221;) from our predecessor company, Nanox Imaging PLC (&#8220;Nanox Gibraltar&#8221;), a Gibraltar public company, under an Asset Purchase Agreement, dated as of September&#160;3, 2019 and as amended on December&#160;3, 2019 and December 31, 2019, between Nanox Gibraltar and us. Our principal executive offices are located at Communications Center, Neve Ilan, Israel 9085000, and our telephone number is +972 02 995 0506. Our website address is <u>http://www.nanox.vision</u>. The information contained therein or connected thereto shall not be deemed to be incorporated into this prospectus or the registration statement of which it forms a part. Our agent for service of process in the United States is CT Corporation System.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; text-align: center;">Implications of Being an Emerging Growth Company and a Foreign Private Issuer</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As a company with less than $1.07 billion in revenue during our most recently completed fiscal year, we qualify as an &#8220;emerging growth company&#8221; as that term is defined in Section 2(a) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS&#160;Act&#8221;). As an emerging growth company, we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to U.S. public companies that are not emerging growth companies. These provisions include:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the option to include in an initial public offering registration statement only two years of audited financial statements and selected financial data and only two years of related disclosure;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reduced executive compensation disclosure; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an exemption from the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;) in the assessment of our internal control over financial reporting.</div></td></tr></table></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">5<br></div></div></div>
<!--End Page 11-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 12-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10006151x14_f1a_103-sum_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="block-main" style="width: 468pt; margin-left: 12pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The JOBS Act also permits an emerging growth company such as us to delay adopting new or revised accounting standards until such time as those standards are applicable to private companies. We have elected to &#8220;opt out&#8221; of this provision, and as a result, we will comply with new or revised accounting standards as required when they are adopted for public companies. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">We will remain an emerging growth company until the earliest of:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the last day of our fiscal year during which we have total annual revenue of at least $1.07&#160;billion;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the last day of our fiscal year following the fifth anniversary of the closing of this offering;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the date on which we have, during the previous three-year period, issued more than $1.0&#160;billion in non-convertible debt securities; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which, among other things, would occur if the market value of our ordinary shares that are held by non-affiliates exceeds $700&#160;million as of the last business day of our most recently completed second fiscal quarter.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have taken advantage of reduced reporting requirements in this prospectus. Accordingly, the information contained herein may be different than the information you receive from other public companies. References to an &#8220;emerging growth company&#8221; in this prospectus shall have the meaning associated with that term in the JOBS&#160;Act.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, upon closing of this offering, we will report under the Exchange Act as a &#8220;foreign private issuer.&#8221; As a foreign private issuer, we may take advantage of certain provisions under the rules that allow us to follow Israeli law for certain corporate governance matters. Even after we no longer qualify as an emerging growth company, as long as we qualify as a foreign private issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the sections of the Exchange Act requiring insiders to file public reports of their share ownership and trading activities and liability for insiders who profit from trades made in a short period of time; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the rules under the Exchange Act requiring the filing with the Securities and Exchange Commission (the &#8220;SEC&#8221;) of quarterly reports on Form 10-Q containing unaudited financial and other specified information, or current reports on Form 8-K, upon the occurrence of specified significant events; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Regulation Fair Disclosure (&#8220;Regulation FD&#8221;), which regulates selective disclosures of material information by issuers. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Foreign private issuers, like emerging growth companies, are also exempt from certain more stringent executive compensation disclosure rules. Thus, if we remain a foreign private issuer, even if we no longer qualify as an emerging growth company, we will continue to be exempt from the more stringent compensation disclosures required of public companies that are neither an emerging growth company nor a foreign private issuer. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We may take advantage of these exemptions until such time as we are no longer a foreign private issuer. We are required to determine our status as a foreign private issuer on an annual basis at the end of our second fiscal quarter. We would cease to be a foreign private issuer at such time as more than 50% of our outstanding voting securities are held by U.S. residents and any of the following three circumstances applies:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the majority of our executive officers or directors are U.S. citizens or residents;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">more than 50% of our assets are located in the United States; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our business is administered principally in the United States.</div></td></tr></table></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">6<br></div></div></div>
<!--End Page 12-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 13-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10006151x14_f1a_103-sum_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="block-main" style="width: 468pt; margin-left: 12pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tTO"><!--Anchor--></a>THE OFFERING</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 7pt; margin-left: 0pt; text-align: left;">Ordinary shares offered by us<font style="font-weight: normal; padding-left: 4.24pt;"></font></div> <div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">8,823,530 ordinary shares (or 10,147,059 ordinary shares if the underwriters exercise their option to purchase additional ordinary shares in full).</div> <div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 6pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Ordinary shares to be outstanding after this offering<font style="font-weight: normal; padding-left: 1.63pt;"></font></div> <div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">44,393,910 ordinary shares (or 45,717,439 ordinary shares if the underwriters exercise their option to purchase additional ordinary shares in full).</div> <div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Option to purchase additional ordinary shares<font style="font-weight: normal; padding-left: 5.68pt;"></font></div> <div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">We have granted the underwriters an option to purchase up to 1,323,529 additional ordinary shares from us within 30 days of the date of this prospectus.</div> <div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Use of proceeds<font style="font-weight: normal; padding-left: 1.38pt;"></font></div> <div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">We estimate that we will receive net proceeds from this offering of approximately $133.2 million, or approximately $153.6 million if the underwriters exercise their option to purchase additional ordinary shares in full, based on an assumed initial public offering price of&#8201; $17.00 per ordinary share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering expenses, including the fees payable to A-Labs, payable by us.<br>&#8195;<br>We intend to use the net proceeds from this offering, together with cash on hand, cash equivalents, and short-term investments, for (i) the manufacturing of the initial wave of Nanox.ARC units planned for global deployment and investment in manufacturing capacities, (ii) shipping, installation and deployment costs of the Nanox System, (iii) continued research and development of the Nanox.ARC, the development of the Nanox.CLOUD and regulatory clearance in various regions and (iv) sales and marketing expenses, general and administrative expenses and other general corporate purposes. See &#8220;Use of Proceeds&#8221; for additional information. </div> <div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Risk factors<font style="font-weight: normal; padding-left: 5.3pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 240pt; text-align: left;">See &#8220;Risk Factors&#8221; and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in our ordinary shares.</div><div class="sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 216pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Proposed Nasdaq Global Market symbol<font style="font-weight: normal; padding-left: 0.5pt;"></font></div><div class="sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -10pt; margin-left: 240pt; text-align: left;">&#8220;NNOX&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The number of ordinary shares to be outstanding after this offering is based on 35,570,380 ordinary shares outstanding as of August 13, 2020 after giving effect to certain adjustments listed below, and excludes:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">4,928,769 ordinary shares issuable upon the exercise of options to purchase ordinary shares outstanding under the NANO-X Imaging Ltd 2019 Equity Incentive Plan (the &#8220;2019 Equity Incentive Plan&#8221;) as of August 13, 2020, at a weighted average exercise price of $4.18 per share; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">3,113,167 additional ordinary shares reserved for future issuance under our 2019 Equity Incentive Plan as of August 13, 2020;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">4,536,901 ordinary shares issuable upon the exercise of warrants to purchase ordinary shares as of August 13, 2020, at a weighted average exercise price of $11.54 per share, which warrants shall not expire upon the closing of this offering if not exercised; and </div></td></tr></table></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">7<br></div></div></div>
<!--End Page 13-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 14-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10006151x14_f1a_103-sum_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="block-main" style="width: 468pt; margin-left: 12pt;"> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">220,588 ordinary shares issuable upon the exercise of warrants to purchase ordinary shares to be granted to A-Labs, which provided certain consulting services for this offering, at the closing of this offering, at an exercise price equal to the price per ordinary share in this offering. See &#8220;Business&#8212;Letter Agreement with A-Labs.&#8221;</div></td></tr></table> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Unless otherwise indicated, all information in this prospectus is based on 35,570,380 ordinary shares outstanding as of August 13, 2020 after giving effect to:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the assumed issuance of 1,875,000 ordinary shares to Asia Beam Limited for an aggregate purchase price, before fees and expenses, of approximately $30.0 million on August 13, 2020 (see &#8220;&#8212;Recent Developments&#8221;);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the assumed exercise on a cashless basis immediately prior to the closing of this offering of outstanding warrants to purchase 553,506 ordinary shares that shall otherwise expire upon such closing, at a weighted average exercise price of $2.72 per share, with the fair market value of the ordinary shares determined based on an assumed initial public offering price of&#8201; $17.00 per ordinary share, which is the midpoint of the price range set forth on the cover page of this prospectus;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the exercise on a cashless basis of warrants prior to the closing of this offering to purchase 99,507 ordinary shares that shall not expire upon such closing, at a price of $2.21 per share;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">no exercise of the outstanding share options or warrants (other than as described above) after August 13, 2020;</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">no exercise by the underwriters of their option to purchase up to 1,323,529 additional ordinary shares from us; and</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the adoption and effectiveness of our amended and restated articles of association, which will occur immediately prior to the closing of this offering.</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Certain of our existing investors and their affiliated entities, including Yozma, SKT, JJFIHC and iA, and certain other investors have indicated an interest in purchasing an aggregate of up to approximately $80 million of our ordinary shares in this offering at the initial public offering price. However, because indications of interest are not binding agreements or commitments to purchase, these entities may determine to purchase fewer shares than they indicate an interest in purchasing or to not purchase any shares in this offering. It is also possible that these entities could indicate an interest in purchasing more of our ordinary shares. In addition, the underwriters could determine to sell fewer shares to any of these entities than the entities indicate an interest in purchasing or to not sell any shares to these entities. The underwriters will receive the same underwriting discount on any shares purchased by these entities as they will on any other shares sold to the public in this offering.</div></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">8<br></div></div></div>
<!--End Page 14-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 15-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 492pt;"><a name="nt10006151x14_f1a_103-sum_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="block-main" style="width: 468pt; margin-left: 12pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSCF"><!--Anchor--></a>SUMMARY CONSOLIDATED FINANCIAL DATA</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following tables present our summary consolidated statement of operations, balance sheet data and other data for the periods or as of the dates indicated. The summary statement of operations data for the years ended December&#160;31, 2019 and 2018 and the summary balance sheet data as of December 31, 2019 have been derived from our audited consolidated financial statements included elsewhere in this prospectus. The summary statement of operations data for the six months ended June&#160;30, 2019 and 2020 and the summary balance sheet data as of June&#160;30, 2020 have been derived from our unaudited consolidated financial statements included elsewhere in this prospectus and have been prepared on the same basis as the audited financial statements. We prepare our financial statements in accordance with U.S.&#160;GAAP. For periods and at dates prior to the Asset Purchase, our financial statements were prepared based on the historical financial statements of Nanox Gibraltar, with certain adjustments as described under &#8220;Basis of Presentation.&#8221; Our historical results are not necessarily indicative of results to be expected in any future periods. You should read this summary consolidated financial data section together with &#8220;Selected Consolidated Financial Data,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our audited consolidated financial statements and related notes included elsewhere in this prospectus.</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 5.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 23.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six months ended June 30,</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 23.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December&#160;31,</div></td></tr><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.9%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.9%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.9%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.9%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td colspan="10" style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands, except <br>per share data)</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consolidated Statement of Operations Data:<br></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development expenses<font style="padding-left: 3.68pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;">$<font style="padding-left: 8.33pt;">4,152</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;">$<font style="padding-left: 12.5pt;">340</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;">$<font style="padding-left: 8.33pt;">2,717</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;">$<font style="padding-left: 12.5pt;">672</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketing expenses<font style="padding-left: 1.42pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="padding-left: 13.33pt;">1,745</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 17.5pt;">242</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="padding-left: 13.33pt;">1,556</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 17.5pt;">209</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative expenses<font style="padding-left: 3.12pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000;">7,903</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000;">1,079</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000;">1</font><font style="border-bottom: 1pt solid #000000;">8,298</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000;">1,</font><font style="border-bottom: 1pt solid #000000;">023</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating loss<font style="padding-left: 3.63pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="padding-left: 5pt;">(13,800)</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 6.67pt;">(1,661)</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="padding-left: 5pt;">(22,571)</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 6.67pt;">(</font>1,904)</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Financial (income) expenses, net<font style="padding-left: 3.39pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000;">(14</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000;">14</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 1pt solid #000000;">(8</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 1pt solid #000000;">5</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss for the year<font style="padding-left: 3.11pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$(13,786</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 1.67pt; border-bottom: 1pt solid #000000;">(1,675</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="border-bottom: 1pt solid #000000;">(22,563</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 3.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 1.67pt; border-bottom: 1pt solid #000000;">(1,909</font>)</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Basic and diluted loss per ordinary share<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 1.05pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$</font><font style="padding-left: 10pt; border-bottom: 3pt double #000000;">(0.47</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$</font><font style="padding-left: 6.67pt; border-bottom: 3pt double #000000;">(0.07</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$</font><font style="padding-left: 10pt; border-bottom: 3pt double #000000;">(0.90</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$</font><font style="padding-left: 6.67pt; border-bottom: 3pt double #000000;">(0.09</font>)</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Weighted average number of ordinary shares outstanding&#8201;&#8211;&#8201;basic and diluted<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 2.67pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000;">29,273</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 3pt double #000000;">23,452</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000;">25,18</font><font style="border-bottom: 3pt double #000000;">1</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 3pt double #000000;">20,79</font><font style="border-bottom: 3pt double #000000;">3</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pro forma basic and diluted loss per ordinary share<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="padding-left: 3.3pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$</font><font style="padding-left: 10pt; border-bottom: 3pt double #000000;">&#8203;</font><font style="border-bottom: 3pt double #000000;">(0.40</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 3pt double #000000;">&#8199;&#8201;&#8199;&#8201;&#8201;&#8201;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$</font><font style="padding-left: 10pt; border-bottom: 3pt double #000000;">&#8203;</font><font style="border-bottom: 3pt double #000000;">(0.7</font><font style="border-bottom: 3pt double #000000;">5</font><font style="border-bottom: 3pt double #000000;"></font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 3pt double #000000;">&#8199;&#8201;&#8199;&#8201;&#8201;&#8201;</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro forma weighted average number of ordinary shares outstanding &#8211; basic and diluted<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="padding-left: 1.01pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000;">34,</font><font style="border-bottom: 3pt double #000000;">163</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 3pt double #000000;">&#8199;&#8201;&#8199;&#8201;&#8201;&#8201;</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000;">30,</font><font style="border-bottom: 3pt double #000000;">071</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.25pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 3pt double #000000;">&#8199;&#8201;&#8199;&#8201;&#8201;&#8201;</font></div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">See Note 7 to our unaudited condensed consolidated financial statements and Note 11 to our audited consolidated financial statements appearing at the end of this prospectus for further details on the calculation of basic and diluted net loss per share.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Pro forma loss per ordinary share is calculated by dividing loss for the period by the pro forma weighted average number of ordinary shares outstanding during the period, which gives effect to the Transactions (as defined and further described under &#8220;Capitalization&#8221;), as if the Transactions were consummated as of January 1, 2019. </div></td></tr></table> <table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 3.75pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 11.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Actual </div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 11.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pro forma<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 11.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pro forma, <br>as adjusted<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 37.18%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.75pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">As of June&#160;30, 2020</div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;">&#8203;</td><td colspan="7" style="width: 37.18%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands)</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consolidated Balance Sheet Data:<br></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 2.77pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.09pt; text-align: left;">$<font style="padding-left: 3.33pt;">&#8203;</font>39,524</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.25pt; text-align: left;">$103,290</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.25pt; text-align: left;">$236,521</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Working capital<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 2.02pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.09pt; text-align: left;"><font style="padding-left: 8.33pt;">37</font>,846</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.25pt; text-align: left;"><font style="padding-left: 5pt;">101,</font>612</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.25pt; text-align: left;"><font style="padding-left: 5pt;">234,843</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total assets<font style="padding-left: 3.44pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.09pt; text-align: left;"><font style="padding-left: 8.33pt;">43</font>,581</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.25pt; text-align: left;"><font style="padding-left: 5pt;">107,</font>347</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.25pt; text-align: left;"><font style="padding-left: 5pt;">240,578</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total liabilities<font style="padding-left: 4.55pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.09pt; text-align: left;"><font style="padding-left: 13.33pt;">3</font>,222</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.25pt; text-align: left;"><font style="padding-left: 15pt;">3,222</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.25pt; text-align: left;"><font style="padding-left: 15pt;">3,222</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated deficit<font style="padding-left: 3.31pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.09pt; text-align: left;"><font style="padding-left: 5pt;">(</font>54,387)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.25pt; text-align: left;"><font style="padding-left: 6.67pt;">(54,387)</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.25pt; text-align: left;"><font style="padding-left: 6.67pt;">(54,387)</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total shareholders&#8217; equity<font style="padding-left: 0.31pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.09pt; text-align: left;"><font style="padding-left: 8.33pt;">40</font>,359</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.25pt; text-align: left;"><font style="padding-left: 5pt;">104,</font>125</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 11.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.25pt; text-align: left;"><font style="padding-left: 5pt;">237,</font>356</div></td></tr></table> <div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">We define working capital as current assets less current liabilities.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The summary pro forma balance sheet data gives effect to the Transactions (as defined and further described under &#8220;Capitalization&#8221;). </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The summary pro forma as adjusted balance sheet data gives effect to (i)&#160;the Transactions (as defined and further described under &#8220;Capitalization&#8221;), and (ii) the issuance of 8,823,530 ordinary shares in this offering, at an assumed initial public offering price of $17.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering expenses, including the fees payable to A-Labs, payable by us.</div></td></tr></table> </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">9<br></div></div></div>
<!--End Page 15-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 16-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tRF"><!--Anchor--></a>RISK FACTORS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We are subject to various risks that may materially harm our business, financial condition, results of operations and prospects. An investment in our ordinary shares is speculative and involves a high degree of risk. In evaluating an investment, and before deciding whether to invest, in our ordinary shares, you should carefully consider the risks and uncertainties described below, together with all the other information included in this prospectus, including our consolidated financial statements and the related notes included elsewhere in this prospectus and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8217;&#8217;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If any of the events described in the following risk factors actually occurs, or if additional risks and uncertainties that are not presently known to us or that we currently deem immaterial later materialize, then our business, financial condition, results of operations and prospects could be materially adversely affected, the trading price of our ordinary shares could very likely decline, and you may lose all or part of your investment in our shares. The risks and uncertainties described below are not the only ones we face. In addition, the risks discussed below include forward-looking statements, and our actual results may differ substantially from those discussed in these forward-looking statements.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Risks Related to Our Business</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">We are a development-stage company with limited operating history. We may never be able to effectuate our business plan or achieve any revenue or reach profitability. Therefore, at this stage of our business, potential investors have a high probability of losing their entire investment. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We are a development-stage company, and are subject to all of the risks inherent in the establishment of a new business enterprise. We have a limited operating history and only a preliminary and unproven business plan upon which investors may evaluate our prospects. We have not yet demonstrated the feasibility of our digital X-ray source technology for commercial applications. Although we have produced a working prototype of the Nanox.ARC and developed a prototype of the Nanox.CLOUD, we have not produced any of the approximately 15,000 Nanox.ARC units planned for the initial global deployment under the contract manufacturing agreement with FoxSemicon Integrated Technology, Inc., a subsidiary of Foxconn (&#8220;FITI&#8221;). Even if we are able to do so, we may not be able to manufacture the Nanox.ARC at the low costs needed to support our business models, including the Subscription Model, which is our primary business model. We may not receive, or may be delayed in receiving, the necessary approval or clearance for the Nanox.ARC or our future products. We also have not entered into any commercial arrangement for the licensing of our X-ray source under the Licensing Model. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Furthermore, even if our technology becomes commercially viable, our business models may not generate sufficient revenue necessary to support our business. We estimate that effectively stimulating market interest in our Nanox System will require deploying at least 5,000 to 10,000 Nanox.ARC units. In addition, we estimate that a minimum installed base of at least 1,000 Nanox.ARC units will be needed to support our business during the initial deployment, assuming we enter into at least one licensing agreement on commercially reasonable terms. We may never achieve any of these thresholds for units deployed in the near-to-mid-term at any level or at all, which may cause our business to fail. The Subscription Model is based on selling the Nanox System at low cost or no cost using a pay-per-scan pricing structure, which is pioneering for medical imaging companies and is subject to numerous risks. The medical imaging industry is also highly competitive and our technology, products, services or business models may not achieve widespread market acceptance. If we are unable to address any issues mentioned above, or encounter other problems, expenses, difficulties, complications, and delays in connection with the starting and expansion of our business, our entire business may fail, in which case you may lose your entire investment.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have a history of net losses and negative cash flow from operations since inception and we expect such losses and negative cash flows from operations to continue in the foreseeable future. As of June&#160;30, 2020 and December&#160;31, 2019, we had working capital of approximately $37.8 million and $(10.6) million, respectively, and shareholders&#8217; equity (deficit) of approximately $40.4 million and $(8.8) million, respectively. For the six months ended June 30, 2020 and 2019 and the years ended December&#160;31, 2019 and 2018, we incurred net losses of approximately $13.8 million, $1.7&#160;million, $22.6 million and $1.9&#160;million, respectively. As of June&#160;30, 2020 and December&#160;31, 2019, we had an accumulated deficit of approximately $54.4&#160;million and $40.6 million, respectively, and negative cash flow from operations of $4.7&#160;million, $1.1&#160;million, $5.5&#160;million and $3.7&#160;million for the six months ended June&#160;30, 2020 and 2019 and the years ended December&#160;31, 2019 and 2018, respectively. We anticipate our losses will continue to increase from current levels because we expect to incur </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">10<br></div></div></div>
<!--End Page 16-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 17-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">additional costs related to developing our business, including research and development costs, manufacturing costs, employee-related costs, costs of complying with government regulations, intellectual property development and prosecution costs, marketing and promotion costs, capital expenditures, general and administrative expenses, and costs associated with operating as a public company. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our ability to generate revenue from our operations and, ultimately, achieve profitability will depend on, among others, whether we can complete the development and commercialization of our technology, our future products and our services, including our X-ray source technology, the Nanox.ARC and the Nanox.CLOUD, whether we can manufacture the Nanox.ARC on a commercial scale in such amounts and at such costs as we anticipate, and whether we can achieve market acceptance of our products, services and business models. We may never generate any revenue or operate on a profitable basis. Even if we achieve profitability, we may not be able to sustain it. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Our efforts may never demonstrate the feasibility of our digital X-ray source technology for commercial applications.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have developed our X-ray source technology and a prototype of the Nanox.ARC. Even though we believe our X-ray source has achieved commercial applicability, our technology has not been tested over extended periods of time and therefore no meaningful data exists regarding the durability, safety and effectiveness of our X-ray source over extended periods. Although we have produced a working prototype of the Nanox.ARC, we may not be able to successfully integrate our X-ray source into the Nanox.ARC or any medical imaging system. In addition, there is no precedent for commercialization of technology like ours. Even with a fully functional prototype, the commercial scale production and deployment of Nanox.ARC will require significant additional development, sales and marketing efforts, and we may not be able to ensure the effectiveness, accuracy, consistency and safety of the Nanox.ARC in commercial settings. Any unanticipated technical or other problems and the possible insufficiency of funds and other resources needed to complete the development and commercialization of our X-ray source, the Nanox.ARC or the Nanox.CLOUD may result in delays and cause us to incur additional expenses that would increase our losses. If our X-ray source is not commercially feasible now or in the long term, our business may fail. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Two of our business models depend on the successful commercial application of the Nanox.CLOUD, which is subject to numerous risks and uncertainties.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition to the Nanox.ARC, we are also developing the Nanox.CLOUD, a companion cloud software designed to deliver MSaaS. We have developed a prototype of the Nanox.CLOUD. The development and commercialization of the Nanox.CLOUD has a number of risks, including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Nanox.CLOUD requires a considerable investment of technical, financial, and legal resources, which may not be available to us;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">it may require separate regulatory clearances or approvals;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">it may not be technically viable to integrate the Nanox.CLOUD with the businesses of our potential customers and collaborators, such as local operators, radiologists, cloud storage providers, medical AI software providers and others;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">market acceptance of the MSaaS model is affected by a variety of factors, including security, reliability, scalability, customization, performance, customer preference, patients&#8217; concerns with entrusting a third party to store and manage their health data, public concerns regarding privacy and compliance with restrictive laws or regulations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our cloud-based service may raise concerns among our customer base, including concerns regarding changes to pricing over time, service availability, information security of a cloud-based solution and access to medical images while offline;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Nanox.CLOUD may be subject to computer system failures, cyber-attacks or other security breaches; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">incorrect or improper implementation or use of the Nanox.CLOUD by third-party cloud-service providers under our Sales Model could result in customer dissatisfaction and harm our business and reputation;</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">11<br></div></div></div>
<!--End Page 17-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 18-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">undetected software errors or flaws in the Nanox.CLOUD could harm our reputation or decrease market acceptance of the MSaaS model; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we may incur higher costs than we expected as we expand our cloud-based services. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If we are unable to successfully develop and commercialize the Nanox.CLOUD, our business, financial condition, results of operations and prospects could be negatively impacted.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">We are highly dependent on the successful development, marketing and sale of our X-ray source technology and the related products and services.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our core digital X-ray source technology is the basis of our business. The Nanox.ARC currently under development is being designed to integrate our X-ray source technology into a medical imaging device for commercial use. As a result, the success of our business plan is highly dependent on our ability to develop, manufacture and commercialize our X-ray source technology and related products and services, such as the Nanox.ARC and the Nanox.CLOUD, and our failure to do so could cause our business to fail. Successful commercialization of medical imaging devices is a complex and uncertain process, dependent on the efforts of management, manufacturers, local operators, integrators, medical professionals, third-party payors, as well as general economic conditions, among other factors. Any factor that adversely impacts the development and commercialization of our X-ray source technology or related products and services, including the Nanox.ARC, the Nanox.CLOUD and the Nanox System, will have a negative impact on our business, financial condition, results of operations and prospects. Some potential factors include:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to achieve sufficient market acceptance by hospitals and clinics, providers of medical imaging services, medical professionals such as radiologists, third-party payors and others in the medical community;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to compete with existing medical imaging technology companies;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to establish, maintain and expand our sales, marketing and distribution networks; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to obtain and/or maintain necessary regulatory approvals; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to effectively protect our intellectual property. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our inability to successfully obtain clearance or approval for and subsequently commercialize our X-ray source technology or related products and services, and/or successfully develop and commercialize additional products or any enhancements to the products which we may develop would have a material adverse effect on our business, financial condition, results of operations and prospects. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Products utilizing our technology may need to be approved or cleared by the FDA and similar regulatory agencies worldwide. We may not receive, or may be delayed in receiving, the necessary approval or clearance for our future products, which would adversely affect business, financial condition, results of operations and prospects. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We expect to take a multi-step approach to the regulatory clearance process. As a first step, we submitted a 510(k) application to an accredited Review Organization under the Third Party Review Program for a single-source version of the Nanox.ARC in January 2020. As part of the review process, in March 2020, we received an additional information request, referred to as a major deficiency letter, from the Review Organization, which among other things, required us to provide additional data and other information to complete the application and to address certain deficiencies highlighted by the reviewer, including the results of certain performance tests. In response to the feedback we received from the Review Organization, we have conducted additional product testing and expect to submit the results from these tests, along with our response, to the Review Organization, in the third quarter of 2020. Our original timeline for completing the pplication was delayed due to the impact of COVID-19 on the external labs we work with to complete our product testing. We believe that we will be able to successfully resolve the deficiencies identified in the letter and ultimately obtain FDA clearance of the single-source version of the Nanox.ARC. However, the review process is an iterative process and our initial response may result in further feedback from the Review Organization. As a result, the review process may be more costly and time consuming than we expect and we may not ultimately be successful in completing the review process and our 510(k) application may not be cleared by the FDA in a timely manner or at all. We will continue to optimize and develop further features of the Nanox.ARC, and plan to submit an </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">12<br></div></div></div>
<!--End Page 18-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 19-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">additional 510(k) application under the Third Party Review Program with respect to the multiple-source Nanox.ARC during the fourth quarter of 2020, which, if cleared, will be our commercial imaging system. We may also need to seek approval from foreign regulatory authorities. With respect to our X-ray source technology and the Nanox.CLOUD, although we believe that they do not require regulatory approval or clearance, regulatory agencies may not agree. To date, we have not had any discussion with the FDA or other regulatory authorities regarding the regulatory pathways for our product candidates. Efforts to achieve required governmental clearances and approvals could be costly and time consuming, and we may not be able to obtain any such required approvals in accordance with our anticipated timeline or in a cost-efficient manner. Any delay or failure to obtain necessary regulatory clearances or approvals could have a material negative impact on our ability to generate revenues. Even if the products containing our technology receive the required regulatory clearance or approval, such products will remain subject to extensive regulatory requirements. If we fail to comply with the regulatory requirements of the FDA and other applicable U.S. and foreign regulatory authorities, or previously unknown problems with any approved commercial products, manufacturers or manufacturing processes are discovered, we could be subject to administrative or judicially imposed sanctions. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, the cost of compliance with new laws or regulations governing our technology or future products could adversely affect our business, financial condition, results of operations and prospects. New laws or regulations may impose restrictions or obligations on us that could force us to redesign our technology or other future products or services, and may impose restrictions that are not possible or practicable to comply with, which could cause our business to fail. See &#8220;&#8212;Risks Related to Government Regulation.&#8221; </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">We will need to obtain additional financing to fund our future operations. If we are unable to obtain such financing, we may be unable to complete the development and commercialization of our technology and our products and services.</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our operations have consumed substantial amounts of cash since inception. Our net losses were $13.8 million, $1.7&#160;million, $22.6 million and $1.9 million for the six months ended June&#160;30, 2020 and 2019 and the years ended December&#160;31, 2019 and 2018, respectively. In addition, significant resources were invested in the development of our X-ray source technology prior to us acquiring the technology. We anticipate that our future cash requirements will continue to be significant. From December 2019 through July 2020, we entered into share purchase agreements in connection with the Private Placement with certain Investors, including Asia Beam Limited, for an aggregate purchase price, before fees and expenses, of approximately $109 million. The sale of our ordinary shares to Asia Beam Limited has not closed as of the date of this prospectus, and is expected to close prior to the closing of this offering. To the extent the sale to Asia Beam Limited is not closed, we will have $30 million less cash, before fees and expenses, than we expect, which may have a negative impact on our business and financial condition. We will need to obtain additional financing, including the proceeds from this offering, to implement our business plan as described in this prospectus. Specifically, we may need to raise additional funds to complete the manufacture, shipping, installation and deployment of the initial wave of approximately 15,000 Nanox.ARC units, as well as to support the continued research and development of the Nanox.ARC and the development of the Nanox.CLOUD, including in the case of unforeseen events. Such financings could include equity financing, which may be dilutive to shareholders, or debt financing, which would likely restrict our ability to borrow from other sources. In addition, such securities may contain rights, preferences or privileges senior to those of the rights of our current shareholders. Additional funds may not be available when we need them, on terms attractive to us, or at all. If adequate funds are not available on a timely basis, we may be required to curtail the development of our technology, products or services, or materially delay, curtail, reduce or terminate our research and development and commercialization activities. We could be forced to sell or dispose of our rights or assets. Any inability to raise adequate funds on commercially reasonable terms could have a material adverse effect on our business, financial condition, results of operation and prospects, including the possibility that a lack of funds could cause our business to fail and liquidate with little or no return to investors. </div> <div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">The success of our primary business model, the Subscription Model, is subject to numerous risks and uncertainties. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We expect the Subscription Model to be our primary business model and the key to achieving our vision of increasing early-detection of medical conditions that are discoverable by X-ray. Even if we are able to successfully implement our Sales Model and/or our Licensing Model, the sustainability of our general business plan depends substantially on the sustainability of our Subscription Model. We believe that effectively stimulating market interest in our Nanox System will require deploying 5,000 to 10,000 Nanox.ARC units. In addition, we </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">13<br></div></div></div>
<!--End Page 19-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 20-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">estimate that a minimum installed base of at least 1,000 Nanox.ARC units will be needed to support our business during the initial deployment, assuming we enter into at least one licensing agreement on commercially reasonable terms. The success of our Subscription Model will also depend on each device, once deployed, performing a sufficient number of scans per day to be fully utilized. We may not be successful in achieving these goals for various reasons, including: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the process of manufacturing and deploying the Nanox System is a complex, multi-step process that depends on factors outside our control, and could cause us to expend significant time and resources prior to earning associated revenues;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the manufacturing cost of the Nanox.ARC may be higher than we expect, may increase significantly, or may increase at a higher rate than anticipated, and we may not be able to set or timely adjust our pay-per-scan pricing to compensate for any increased costs;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the manufacturing of the Nanox.ARC may take longer than we expected, and we may have insufficient manufacturing capacity and experience delays in the manufacturing and deployment of the Nanox System, which would have a negative impact on the timing of our revenues; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">deployment and full utilization of the Nanox System may not be achieved or may take substantially longer than we expect, and we may not be able to deploy a sufficient number of units of the Nanox System to support our business or to effectively stimulate market interest; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a Nanox System may perform fewer scans per day than our estimates due to a number of factors, including low market acceptance rate, technical failures and downtime, service disruptions, outages or other performance problems, which would have a negative impact on our revenues and our ability to recover costs;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the implementation, integration and testing of the Nanox.CLOUD with our potential customers and collaborators can be complex, time-consuming and expensive for them, which may have a negative impact on the timing of our revenues;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">as part of the Subscription Model, we will be responsible for maintenance of the Nanox System units we deploy, which may be more costly and time-consuming than we expect;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our customers may not be able to find or retain a sufficient number of radiologists to review the images generated by the Nanox System, especially as we deploy additional Nanox Systems and the volume of scans increases;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the portion of our pay-per-scan pricing allocated to our collaborators may not be acceptable to them, either now or in the future, and pricing negotiations with such collaborators may be a complex and time-consuming process;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our pay-per-scan pricing may not be sufficient to recover our costs and may not be adjusted in a timely manner, which could negatively affect our revenues or cause our revenues and results of operations to vary significantly from period to period;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we may be unsuccessful in maintaining our target price per scan because we do not control the price charged by local operators and higher prices may adversely affect market acceptance of the Nanox System; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulatory authorities may challenge our Subscription Model altogether, and impose significant civil, criminal, and administrative penalties, damages, fines, and/or exclusion from government funded healthcare programs, which could adversely affect our revenues and results of operations. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Any of the above factors may negatively affect the implementation of our Subscription Model, or cause our Subscription Model to fail. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">We may not be successful in tailoring our X-ray source to the specific systems of other medical imaging companies under our Licensing Model, and/or entering into licensing agreements on terms favorable to us.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under our proposed Licensing Model, we expect to be engaged to tailor our X-ray source to other medical imaging companies&#8217; specific systems to replace the legacy X-ray source or to license our X-ray source technology to them to develop new types of imaging systems, and we expect to receive a one-time, non-recurring </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">14<br></div></div></div>
<!--End Page 20-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 21-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">licensing fee upfront, as well as recurring royalty payments for each imaging system sold by such companies. We expect customization to be a complex and multi-step process that varies for each project, which will require significant research and testing activities. We may also not be able to demonstrate the feasibility, functionality or safety of our technology in other medical imaging systems, meet the potential licensees&#8217; design and manufacturing requirements, or satisfy their marketing and product needs. In addition, we may not be successful in entering into licensing agreements with favorable terms as a result of a numbers of factors, many of which are outside of our control, including willingness of, and the resources available to, other medical imaging companies to in-license our novel X-ray source technology, our ability to agree with a potential partner on the value of our technology, or on the related terms, as well as the availability of other technologies at lower cost or other alternative technologies at the time. We have not entered into any licensing agreements; however, we are in negotiations regarding a commercial arrangement with FUJIFILM Corporation for the licensing of our Nanox System. Any of the above factors may negatively affect the implementation of our Licensing Model, or cause our Licensing Model to fail. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">To the extent that we license our X-ray source technology to other medical imaging companies, the products integrating our technology may need to be approved or cleared by the FDA or similar regulatory agencies.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The FDA may require products developed by other medical imaging companies under the Licensing Model to go through lengthier or more rigorous processes than we expected. These products may also be subject to regulations by governmental agencies in other jurisdictions, or regulation by other federal, state and local agencies. In addition, we may not have control with respect to any such further regulatory approval strategies or process. If such products do not receive, or are delayed in receiving, the necessary clearances or approvals, or if the performance of one or more clinical trials are required in connection with such clearances or approvals, the prospects of our Licensing Model may be materially affected, which could have a material adverse impact on our business and our revenues. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">A pandemic, epidemic or outbreak of an infectious disease, such as COVID-19, may materially and adversely affect our business and our financial results and could cause a disruption to the development or deployment of the Nanox System.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Public health crises such as pandemics or similar outbreaks could adversely impact our business. Recently, a novel strain of a virus named SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), or coronavirus, which causes COVID-19 has spread to most countries across the world, including Israel, Japan and all 50 states within the U.S. The COVID-19 pandemic is evolving, and to date has led to the implementation of various responses, including government-imposed quarantines, travel restrictions and other public health safety measures. The COVID-19 pandemic has adversely impacted our operations in various ways. For example, our engineers are unable to make work-related trips to Korea or Israel to test and optimize the Nanox.ARC or to begin development of MEMs X-ray chip manufacturing in Korea. Our potential business partners are unable to make on-site visits to our facilities or attend industry conferences and meetings to experience the Nanox.ARC, which has negatively impacted our business development and deployment activities. The external labs we work with have also been affected by COVID-19, resulting in delays in our timeline for obtaining regulatory approval. COVID-19 has also caused shutdowns or disruptions of business for our manufactures and suppliers.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The extent to which the COVID-19 pandemic impacts our operations or those of our third-party partners will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information that will emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others. The continued spread of COVID-19 globally could adversely impact our development, manufacture or deployment of the Nanox System, which could adversely affect our ability to obtain regulatory approval for and to commercialize the Nanox System, increase our operating expenses and have a material adverse effect on our financial results.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">These and other factors arising from the COVID-19 pandemic could worsen in countries that are already afflicted with the coronavirus or could continue to spread to additional countries. Any of these factors, and other factors related to any such disruptions that are unforeseen, could have a material adverse effect on our business and our results of operations and financial condition. Further, uncertainty around these and related issues could lead to adverse effects on the economy of the United States and other economies, which could impact our ability to raise the necessary capital needed to develop and commercialize the Nanox System. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">15<br></div></div></div>
<!--End Page 21-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 22-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Our industry is highly competitive and is subject to technological change, which may result in new products or solutions that are superior to our technology or other future products we may bring to market from time to time. If we are unable to anticipate or keep pace with changes in the marketplace and the direction of technological innovation and customer demands, our technology may become less useful or obsolete and our operating results will suffer.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The medical imaging industry is rapidly evolving and subject to intense and increasing competition. To compete successfully and to be able to establish and maintain a competitive position in current and future technologies, we will need to demonstrate the advantages of our technology over well-established alternative solutions, products and technologies, such as CT, as well as newer methods of medical imaging and early detection. We believe that effectively stimulating market interest for the Nanox System will require deploying 5,000 to 10,000 Nanox.ARC units. To achieve this, we will need to raise or develop financial resources, technical expertise, marketing, distribution or support capabilities and we may not be successful in doing so. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Also, companies offering traditional medical imaging systems, such as General Electric, Siemens, Philips, Hologic, Varian, Fuji, Toshiba and Hitachi, may be better established in the market than we are, have greater corporate, financial, operational, sales and marketing resources than we do, or have more experience in research and development than we have. In particular, the field emission technology has been used by a wide range of leading market players in an attempt to create an alternative digital source of X-ray, the most well-known attempt being the use of carbon nano tubes as the base materials for a potential field emission-based solution. In addition, early-detection technologies developed by other companies, such as blood testing and DNA screening, may also reduce the attractiveness of our technology for early detection or render it obsolete. Successful developments of these or other technologies by competitors resulting in new approaches for medical imaging, including technologies, products or services that are more effective or commercially attractive, could make our technology less useful or obsolete. We may also face opposition from certain industry leaders, who may have political influence and the ability to delay deployment of the Nanox System in certain geographical areas.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Furthermore, as the market expands, we expect the entry of additional competitors, such as cloud computing companies or leading IT companies, who may have longer operating histories, more extensive international operations, greater name recognition, and/or substantially greater technical, marketing and financial resources.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">Our competitive position also depends on our ability to: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">generate widespread awareness, acceptance and adoption of our technology and future products or services; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">develop new or enhanced technologies or features that improve the convenience, efficiency, safety or perceived safety, and productivity of our technology and future products or services; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">properly identify customer needs and deliver new products or services or product enhancements to address those needs; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">limit the time required from prototype development to commercial production; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">limit the timing and cost of regulatory approvals; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">attract and retain qualified personnel and collaborators; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">protect our inventions with patents or otherwise develop proprietary products and processes; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">secure sufficient capital resources to expand both our continued research and development, and sales and marketing efforts. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If our technology is not, or our future products or services are not, competitive based on these or other factors, our business would be harmed.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">We expect to depend on third parties to manufacture the Nanox.ARC and to supply certain component parts. Our reliance on third-party manufacturers and suppliers involve certain risks that may result in, among others, increased costs, quality or compliance issues, or failure to timely manufacture the Nanox.ARC, any of which could materially harm our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If cleared, we expect to rely on third-party manufacturers and suppliers for the commercial production of the Nanox.ARC. We have entered into a contract manufacturing agreement with FITI to manufacture the Nanox.ARC, with a goal to enable the commercial production of the initial approximately 15,000 units planned </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">16<br></div></div></div>
<!--End Page 22-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 23-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">for global deployment over the next three to four years. In addition, although we currently use our own equipment to manufacture the MEMs X-ray chip and we have entered into arrangements with a manufacturer for the production of our X-ray tubes, under the contract manufacturing agreement with FITI, FITI will negotiate and contract with other parties for the supply of the various other components of the Nanox.ARC in accordance with the pre-approved supplier list and on the terms to be agreed upon by both parties. Our dependence on such third-party manufacturers and suppliers involves a number of risks, including: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">insufficient capacity or delays in meeting our demand;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">inadequate manufacturing yields, inferior quality and excessive costs;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">inability to manufacture products that meet the agreed upon specifications;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">inability to obtain an adequate supply of materials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">inability to comply with the relevant regulatory requirements for the manufacturing process;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">limited warranties on products supplied to us;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">inability to comply with our contractual obligations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">potential increases in prices; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">increased exposure to potential misappropriation of our intellectual property. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We currently expect to engage only one general manufacturer for the manufacture of the Nanox.ARC. We also expect to manufacture a small number of Nanox.ARC units in Israel that will be used for the acceptance tests under our MSaaS agreements. As we further expand our business in connection with the commercialization of our technology, we expect to seek to engage alternative manufacturers of the Nanox.ARC. If any of our manufacturers or suppliers breach their agreements, are unable to meet their contractual or quality requirements, or become unwilling to perform for any reason, we may be unable, or may be unable in a timely manner, to locate alternative acceptable manufacturers or suppliers and enter into favorable agreements with them. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As mentioned above, we currently manufacture the MEMs X-ray chips in the clean rooms located in Tokyo, Japan. While we expect to expand our manufacturing capacity, including through the establishment of a wholly-owned subsidiary in Korea with the support of SKT, to meet our currently anticipated needs, we may not have sufficient capacity to manufacture the MEMs X-ray chips as our business expands. In addition, we rely on third parties to supply the raw materials and certain component parts. Disruptions of our relationships with such suppliers could negatively impact our production for an extended period of time. Any inability to acquire sufficient quantities of any raw materials or components in a timely manner from these third-party suppliers could have a material negative impact on our business. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, if we are required to change the manufacturer of a critical component of our products, we will be required to verify that the new manufacturer maintains facilities, procedures and operations that comply with our quality and applicable regulatory requirements, which could further impede our ability to manufacture our products in a timely manner. Transitioning to a new supplier could be time-consuming and expensive, may result in interruptions in our operations and product delivery, could affect the performance specifications of our products or could require that we modify the design of those systems. If the change in manufacturer results in a significant change to any product, a new 510(k) clearance or approval from the FDA or similar international regulatory authorization may be necessary before we implement the change, which could cause substantial delays. The occurrence of any of these events could harm our ability to meet the demand for our products in a timely or cost-effective manner. See &#8220;&#8212;Risks Related to Government Regulation.&#8221; </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">We may experience development or manufacturing problems and higher costs, or delays that could limit our revenue, if any, or increase our losses. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Developing manufacturing procedures for new products requires developing specific production processes for those products. Developing such processes could be time consuming, and any unexpected difficulty in doing so can delay the introduction of the Nanox.ARC. Moreover, difficulties associated with adapting our technology and product design to the proprietary process technology and design rules of outside manufacturers can lead to reduced yields. Since low yields may result from either design or process technology failures, yield problems may not be effectively determined or resolved until an actual product exists that can be analyzed and tested to identify process sensitivities relating to the design rules that are used. As a result, yield problems may not be </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">17<br></div></div></div>
<!--End Page 23-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 24-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">identified until well into the production process, and resolution of yield problems may require cooperation between our manufacturers and us. This risk could be compounded by the offshore location of our manufacturers, increasing the effort and time required to identify, communicate and resolve manufacturing yield problems. Manufacturing defects that we do not discover during the manufacturing or testing process may lead to costly product recalls. These risks may lead to increased costs or delayed product delivery, which would harm our profitability and customer relationships. Furthermore, our, our manufacturers&#8217; or our suppliers&#8217; production processes and assembly methods may have to change to accommodate any significant, future expansion of our manufacturing capacity, which may increase the manufacturing costs, delay production of our products, reduce our product margin, require supplemental filings with the FDA or other regulatory authorities, any of which may adversely impact our business. If we are unable to keep up with demand for our products by successfully manufacturing and shipping our products in a timely manner, our revenue could be impaired, and market acceptance for our products could be adversely affected. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">We may not be able to successfully execute our business models.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We are pursuing three simultaneous business models to maximize the commercial potential of our X-ray source technology, each of which requires significant time and resources, in particular, our primary business model, the Subscription Model. We are a company with limited operating history and we may not have the necessary resources, expertise and experience to successfully execute any of our business models on a global scale, such as obtaining the necessary approvals or clearances from the regulatory agencies of our target markets. Our ability to execute our models is dependent on a number of factors, including the ability of our senior management team to execute our models, our ability to engage local operators and integrators in different geographic regions, our ability to begin or maintain our pace of product development, manufacturing and commercialization, our ability to meet the changing needs of the medical imaging market, and the ability of our employees to perform at a high-level. If we are unable to execute our models, if our models do not drive the growth that we anticipate, or if our market opportunity is not as large as we have estimated, it could adversely affect our business and our prospects. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">We have a limited operating history. If we successfully commercially launch the Nanox.ARC or the Nanox.CLOUD, and they do not achieve widespread market acceptance, we will not be able to generate the revenue necessary to support our business. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have a limited operating history and have no history of marketing our X-ray source technology, the Nanox.ARC, the Nanox.CLOUD or any other product using our technology. We may fail to generate significant interest in our X-ray source technology, the Nanox.ARC, the Nanox.CLOUD or the imaging products using our technology, or any other product we may develop. These and other factors, including the following, may affect the rate and level of market acceptance:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">effectiveness of the sales and marketing efforts of us, and our partners such as the local partners;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">perception by medical professionals and patients of the convenience, safety, efficiency and benefits of the Nanox.ARC, the Nanox.CLOUD or products using our technology, compared to competing methods of medical imaging;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">opposition from certain industry leaders, which may limit our ability to promote the Nanox.ARC or the Nanox.CLOUD and to penetrate into the medical imaging market in certain geographical areas;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the existence of established medical imaging technology; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">willingness of market participants to accept the MSaaS model;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the changing and volatile U.S. and global economic environments, including as a result of the COVID-19 pandemic; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">timing of market introduction of competing products, and the sales and marketing initiatives of such products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">press and blog coverage, social media coverage, and other publicity and public relations factors by others; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">lack of financing or other resources to successfully develop and commercialize our technology and implement our business plan; </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">18<br></div></div></div>
<!--End Page 24-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 25-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the level of commitment and support that we receive from our partners, such as local operators, cloud storage providers and medical AI software providers, as well as medical professionals such as radiologists; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">coverage determinations and reimbursement levels of third party payors.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If cleared or approved for marketing by the FDA or other regulatory agencies, depending on the approved clinical indication, the Nanox.ARC will be competing with existing and future imaging products and similar offerings. The technology underlying our X-ray source and the Nanox.ARC may be perceived as inferior or inaccurate and patients may be unwilling to undergo medical screening using the Nanox.ARC or other products using our technology. Moreover, patients and medical professionals may be unwilling to depart from the current medical imaging technology. Medical professionals tend to be slow to change their medical diagnostic practices because of perceived liability risks arising from the use of new technology or products, and they may not recommend medical imaging using the Nanox.ARC or other products using our technology until there is long-term clinical evidence to convince them to alter or modify their existing imaging methods. Our efforts to educate patients, radiologists and other members of the medical community on the benefits of our products require significant resources and may not be successful. Our efforts to educate the marketplace may require more resources than are required by conventional technologies marketed by our competitors. In particular, gaining market acceptance for our products in nascent markets, such as China, India, and certain countries in Latin America, could be challenging. Moreover, in the event that the Nanox.ARC or other products using our technology are the subject of guidelines, clinical studies or scientific publications that are unfavorable or damaging, or otherwise call into question their benefits, we may have difficulty in convincing market participants to adopt our products. In addition, medical professionals, patients, providers of medical imaging services and third-party payors may not adopt or reimburse the use of the Nanox.ARC in the near term or at all. If we are unable to achieve or maintain an adequate level of market acceptance, we may not generate significant revenue or become profitable and our business, financial condition, results of operations and prospects would be significantly harmed. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">We plan to do business globally, including in certain countries where we might have limited resources and would be subject to additional regulatory burdens and other risks and uncertainties.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We expect to do business globally, including in North America and certain countries in Asia, Europe, Africa and South America. Commercialization of our X-ray source technology, the Nanox.ARC or the Nanox System in foreign markets, either directly or through third parties, is subject to additional risks and uncertainties, including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reimbursement and insurance coverage;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our inability to find agencies, dealers or distributors in specific countries or regions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our inability to directly control commercial activities of third parties;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">limited resources to be deployed to a specific jurisdiction;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the burden of complying with complex and changing regulatory, tax, accounting and legal requirements;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">different medical imaging practice and customs in foreign countries affecting acceptance in the marketplace;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">import or export licensing and other requirements;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">longer accounts receivable collection times;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">longer lead times for shipping;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">language barriers for technical training;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reduced protection of intellectual property rights in some foreign countries;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">foreign currency exchange rate fluctuations; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">interpretations of contractual provisions governed by foreign laws in the event of a contract dispute.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Sales of the Nanox.ARC, the Nanox.CLOUD or the Nanox System in foreign markets could also be adversely affected by the imposition of governmental controls, political and economic instability, trade restrictions and changes in tariffs, any of which may adversely affect our business, financial condition, results of operations and prospects. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">19<br></div></div></div>
<!--End Page 25-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 26-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Because the Nanox System is still in the development stage, it is not yet approved for third-party payor coverage or reimbursement. If in the future we are approved for and are otherwise able to commercialize it, but are unable to obtain adequate reimbursement or insurance coverage from third-party payors, we may not be able to generate significant revenue, in which case we may need to obtain additional financing.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Because the Nanox System is still in the development stage, it is not yet approved for third-party payor coverage or reimbursement. Coding and coverage determinations as well as reimbursement levels and conditions are important to the commercial success of an imaging product or offering. The future availability of insurance coverage and reimbursement for newly approved medical devices is highly uncertain, and our future business will be greatly impacted by the level of reimbursement provided by third-party payors. In the United States, third-party payors decide which imaging products and services they will cover, how much they will pay and whether they will continue reimbursement. Third-party payors may not cover or provide adequate reimbursement for the Nanox System or the imaging services using the Nanox System, assuming we are able to fully develop and obtain all regulatory approvals and clearances to market it in the United States or other geographies. To date, we have not had any discussions with any third-party payors, including any regulatory agencies administering any government funded healthcare programs, regarding the coding, coverage or reimbursement for imaging services using the Nanox System. Accordingly, unless government and other third-party payors provide coverage and reimbursement for our services, patients may not use them, which would cause investors to lose their entire investment. A primary trend in the United States healthcare industry and elsewhere is cost containment. Government authorities and other third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular products and services. Reimbursement may not be available, or continue to be available, for the Nanox System or the imaging services using the Nanox System, other products or systems using our X-ray source technology or any other products we may develop in the future, or even if reimbursement is available, such reimbursement may not be adequate. We also will be subject to foreign reimbursement policies in the international markets we expect to enter. Decisions by health insurers or other third-party payors in these markets not to cover, or to discontinue reimbursing, our products could materially and adversely affect our business. If such decisions are made, they could also have a negative impact on our ability to generate revenues, in which case we may need to obtain additional financing. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Recent changes in the United States related to payment policies for imaging procedures could have a negative impact on the utilization of our imaging services.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In the United States, over the past several years, the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), the federal agency responsible for administering the Medicare program, has implemented numerous changes to payment policies for imaging procedures in both the hospital setting and non-hospital settings, which include physician offices and freestanding imaging facilities. Some of these changes have had a negative impact on utilization of imaging services. Examples of these changes include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">limiting payments for imaging services in physician offices and free-standing imaging facility settings based upon rates paid to hospital outpatient departments; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reducing payments for certain imaging procedures when performed together with other imaging procedures in the same family of procedures on the same patient on the same day in the physician office and free-standing imaging facility setting; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">making significant revisions to the methodology for determining the practice expense component of the Medicare payment applicable to the physician office and free-standing imaging facility setting which results in a reduction in payment; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">revising payment policies and reducing payment amounts for imaging procedures performed in the hospital outpatient setting. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We also expect increased regulation and oversight of advanced diagnostic testing. One provision in the Protecting Access to Medicare Act requires CMS to develop appropriate use criteria (&#8220;AUC&#8221;) that professionals must consult when ordering advanced diagnostic imaging services (which include magnetic resonance imaging (&#8220;MRI&#8221;), CT, nuclear medicine (including position emission tomography) and other advanced diagnostic imaging services that the Secretary of the Department of Health and Human Services (&#8220;HHS&#8221;) may specify). Beginning in 2020, payment will be made to the furnishing professional for an applicable advanced diagnostic imaging service only if the claim indicates that the ordering professional consulted a qualified clinical decision support mechanism, as identified by HHS, as to whether the ordered service adheres to the applicable AUC. To the </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">20<br></div></div></div>
<!--End Page 26-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 27-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">extent that these types of changes have the effect of reducing the aggregate number of diagnostic medical imaging procedures performed in the United States, our business, results of operations, financial condition and cash flows would be adversely affected. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Billing complexities associated with obtaining payment or reimbursement may negatively affect our revenue, cash flow and profitability.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Billing for imaging services is complex. Payment is provided by individual patients and from a variety of payors, such as commercial insurance carriers, managed care organizations and governmental programs. Each payor typically has different billing requirements, and the billing requirements of many payors have become increasingly stringent.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Among the factors complicating our customers&#8217; ability to bill and receive reimbursement from third-party payors are:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disputes among payors as to which party is responsible for payment;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disparity in coverage among various payors;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disparity in information and billing requirements among payors; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">incorrect or missing billing information, which is required to be provided by the ordering physician.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, we may be required to seek new billing codes for imaging services using the Nanox System, and regulatory authorities may not approve the creation of separate codes. Additionally, even if we are successful, these billing codes or the payment amounts associated with such codes may change in the future.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The impact of these factors may be compounded by our use of the novel Subscription Model. These billing complexities, and the related uncertainty in obtaining payment for our products, could negatively affect our revenue, cash flow and profitability. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Any collaborative arrangements that we have established or may establish in the future may not be successful or we may otherwise not realize the anticipated benefits from these collaborations. We do not control third parties with whom we have or may have collaborative arrangements, and we will rely on them to achieve results which may be significant to us. In addition, any current or future collaborative arrangements may place the development and commercialization of our technology outside our control, may require us to relinquish important rights or may otherwise be on terms unfavorable to us.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have entered into certain, and expect to enter into additional, collaborative arrangements with respect to the research, development, manufacture and commercialization of our technology with different relevant industry participants, including, among others, local operators, integrators, radiologists, cloud storage providers and medical AI software providers and third-party payors. See &#8220;Business&#8212;Commercial Agreements.&#8221; Any future potential collaborative arrangements may require us to rely on external consultants, advisors, and experts for assistance in several key functions, including research and development, manufacturing, regulatory and intellectual property. We cannot and will not control these third parties, but we may rely on them to achieve results, which may be significant to us. Relying upon these collaborative arrangements for our technology subjects us to a number of risks, including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we may not be able to control the amount and timing of resources that our collaborators may devote to our technology;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">should a collaborator fail to comply with applicable laws, rules or regulations when performing services for us, we could be held liable for such violations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our collaborators may have a shortage of qualified personnel, particularly radiologists who can review the medical images generated by the Nanox System, especially as we deploy additional Nanox Systems and the volume of scans increases;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we may be required to relinquish important rights, such as marketing and distribution rights;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">business combinations or significant changes in a collaborator&#8217;s business strategy may adversely affect a collaborator&#8217;s willingness or ability to complete its obligations under any arrangement;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">under certain circumstances, a collaborator could move forward with a competing product developed either independently or in collaboration with others, including our competitors;</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">21<br></div></div></div>
<!--End Page 27-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 28-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our current or future collaborators may utilize our proprietary information in a way that could expose us to competitive harm;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our collaborators could obtain ownership or other control over intellectual property that is material to our business; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborative arrangements are often terminated or allowed to expire, which could delay the ability to commercialize our technology. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, if disputes arise between us and any of our collaborators, it could result in the delay or termination of the development, manufacturing or commercialization of products containing our technology, lead to protracted and costly legal proceedings, or cause collaborators to act in their own interest, which may not be in our interest. As a result, the collaborative arrangements that we may enter into, may not achieve their intended goals.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If any of these scenarios materialize, they could have a material adverse effect on our business, financial condition, results of operations and prospects.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We also may have other future products where it is desirable or essential to enter into agreements with a collaborator who has greater financial resources or different expertise than us, but for which we are unable to find an appropriate collaborator or are unable to do so on favorable terms. If we fail to enter into such collaborative agreements on favorable terms, it could materially delay or impair our ability to develop and commercialize, and increase the costs of development and commercialization of, our technology. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">We could become subject to product liability claims, product recalls, and warranty claims that could be expensive, divert management&#8217;s attention and harm our business reputation and financial results.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our business exposes us to potential liability risks that are inherent in the marketing and sale of products used in patient care. We may be held liable if the Nanox System or if any other product that integrates our X-ray source technology causes injury or death or is found otherwise unsuitable during usage. The Nanox System currently under development incorporates sophisticated components and computer software. Complex software can contain errors, particularly when first introduced. In addition, new products or enhancements may contain undetected errors or performance problems that, despite testing, are discovered only after installation. Patients could allege or possibly prove defects of our products or other products that integrate our technology. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A product liability claim, regardless of its merit or eventual outcome, could result in significant legal defense costs and divert management&#8217;s attention. Regardless of merit or eventual outcome, liability claims may result in:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">decreased demand for the Nanox System;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">injury to our reputation;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">costs of related litigation;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">substantial monetary awards to patients and others;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">loss of revenue; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the inability to commercialize future products.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Any of these outcomes may have an adverse effect on our business, financial condition and results of operations, and may increase the volatility of our share price.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The coverage limits of our insurance policies we may choose to purchase to cover related risks may not be sufficient to cover future claims. If sales of the Nanox System or other products integrating our technology increase or we suffer future product liability claims, we may be unable to maintain product liability insurance at satisfactory rates or with adequate amounts or at all. A product liability claim, any product recalls or excessive warranty claims, whether arising from defects in design or manufacture or otherwise, could negatively affect our sales or require a change in the design or manufacturing process, any of which could harm our relationship with our customers and partners, and have a material adverse impact on our reputation and business, financial condition, results of operations and prospects.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">22<br></div></div></div>
<!--End Page 28-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 29-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, if the Nanox System or other products integrating our technology are defective, we, our future customers or partners may be required to notify regulatory authorities and/or to recall the products. See &#8220;&#8212;Risks Related to Government Regulation&#8212;Our products may cause or contribute to adverse medical events or be subject to failures or malfunctions that we are required to report to the FDA, and if we fail to do so, we would be subject to sanctions that could harm our reputation, business, financial condition and results of operations. The discovery of serious safety issues with our products, or a recall of our products either voluntarily or at the direction of the FDA or another governmental authority, could have a negative impact on us.&#8221; Any recall would divert management&#8217;s attention and financial resources and harm our reputation with customers, patients, medical professionals and third-party payors. A recall involving the Nanox System would be particularly harmful to our business. The adverse publicity resulting from any of these actions could adversely affect the perception of our customers or partners. These investigations or recalls, especially if accompanied by unfavorable publicity, could result in our incurring substantial costs, losing revenues and damaging our reputation, each of which would harm our business, financial condition, results of operations and prospects.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">We are highly dependent on key members of our executive management team. Our inability to retain these individuals could impede our business plan and growth strategies, which could have a negative impact on our business and the value of your investment.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our ability to implement our business plan depends on the continued services of key members of our senior management. In particular, and to a critical extent, we are dependent on the continued efforts and services of the members of management named in the &#8220;Management&#8221; section. If we lose the services of such key members of our management team, we would likely be forced to expend significant time and money in the pursuit of replacement individuals, which may result in a delay in the implementation of our business plan and plan of operations. We may not be able to find satisfactory replacements on terms that would not be unduly expensive or burdensome to us. We do not currently carry a key-man life insurance policy that would assist us in recouping our costs in the event of the death or disability of a member of our management team. The loss of members of our management team, or our inability to attract or retain other qualified individuals, could have a material adverse effect on our business, results of operations and financial condition. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">The mishandling or the perceived mishandling of sensitive information, or the occurrence of data security breaches, could harm our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We expect that the Nanox System will enable us to accumulate a significant amount of highly sensitive and/or confidential information, including medical images and other medical information. These images could be received by our customers or collaborators, such as medical AI-analytics companies, to increase the probability of early disease detection. While employee contracts generally contain standard confidentiality provisions, our employees, customers or collaborators may not properly handle or process sensitive or confidential data. The improper handling of sensitive or confidential data, or even the perception of such mishandling (whether or not valid), or other security lapses by us, our customers or collaborators, could reduce demand for such products or otherwise expose us to financial or reputational harm or legal liability.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, any security breach, including personal data breaches, or incident, including cybersecurity incidents, that we experience could result in unauthorized access to, misuse of, or unauthorized acquisition of the sensitive or confidential information and data (including medical information), the loss, corruption, or alteration of this data, interruptions in our operations, or damage to our systems. Any such incidents could expose us to claims, litigation, regulatory or other governmental investigations, administrative fines and potential liability. An increasing number of digital platforms have disclosed breaches of their security, some of which have involved sophisticated and highly targeted attacks on portions of their services. Because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and often are not foreseeable or recognized until launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. If an actual or perceived breach of our security occurs, public perception of the effectiveness of our security measures and brand could be harmed and our results of operations could be negatively affected. Data security breaches and other incidents may also result from non-technical means (e.g., actions by employees or contractors). Any compromise of our security could result in a violation of applicable security, privacy or data protection, consumer and other laws, regulatory or other governmental </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">23<br></div></div></div>
<!--End Page 29-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 30-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">investigations, enforcement actions, and legal and financial exposure, including potential contractual liability. Any such compromise could also result in damage to our reputation and a loss of confidence in our security and privacy or data protection measures. Any of these effects could materially and adversely affect our business, financial condition and results of operations.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Our business and operations would suffer in the event of computer system failures, cyber-attacks or deficiencies in our cyber-security.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our ability to execute our business strategy depends, in part, on the continued and uninterrupted performance of our IT systems, which support our operations. Despite the implementation of security measures, our internal computer systems, and those of third parties on which we rely, are vulnerable to damage from, among others, computer viruses, malware, natural disasters, terrorism, war, telecommunication and electrical failures, cyber-attacks or cyber-intrusions over the internet, attachments to emails, persons inside our organization, or persons with access to systems inside our organization or similar disruptive problems. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusion, including by computer hackers, foreign governments, and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. If such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our product development programs. Any such security breach may compromise information stored on our networks and may result in significant data losses or theft of personally identifiable information. A cybersecurity breach could also hurt our reputation by adversely affecting the patients&#8217; perception of the security of their information. A number of proposed and enacted federal, state and international laws and regulations obligate companies to notify individuals of security breaches involving particular personally identifiable information, which could result from breaches experienced by us or by third parties, including collaborators, vendors, contractors or other organizations with which we expect to form strategic relationships. In addition, a cybersecurity attack could result in other negative consequences, including disruption of our internal operations, increased cyber security protection costs, lost revenue, regulatory actions or litigations.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Exchange rate fluctuations between the U.S. dollar, Japanese Yen and the New Israeli Shekel and inflation may negatively affect our results of operations, and we may not be able to hedge our currency exchange risks successfully.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The U.S. dollar is our functional and reporting currency. However, a portion of our operating expenses, including personnel and facilities related expenses, are incurred in NIS and Yen. As a result, we are exposed to the risks that the NIS and Yen may appreciate relative to the U.S. dollar, or, if the NIS or Yen instead devalues relative to the U.S. dollar, that the inflation rate in Israel may exceed such rate of devaluation of the NIS or Yen, or that the timing of such devaluation may lag behind inflation in Israel. In any such event, the dollar cost of our operations in Israel would increase and our dollar-denominated results of operations would be adversely affected. Given our general lack of currency hedging arrangements to protect us from fluctuations in the exchange rates of the NIS and Yen and other foreign currencies in relation to the U.S. dollar (and/or from inflation of such foreign currencies), we may be exposed to material adverse effects from such movements. Our exchange rate exposure may change over time as our business evolves and could result in increased costs or reduced revenue and could affect our actual cash flow. Changes in the relative values of currencies occur regularly and, in some instances, may have a significant impact on our operating results. The rate of inflation in Israel or in currency exchange rates may materially change and we might not be able to effectively mitigate these risks.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">If significant tariffs or other restrictions related to &#8220;trade wars&#8221; are placed on Chinese imports or any related counter-measures are taken by China, our revenue and results of operations may be materially harmed.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have, and expect to enter into, agreements with manufacturers and/or suppliers in China for the production of our X-ray tube, the Nanox.ARC and some of their respective components. If significant tariffs or other restrictions are placed by the United States government on Chinese imports or any related counter-measures are taken by China, our business, financial condition and results of operations may be materially harmed. In July 2018, the Trump Administration announced a list of thousands of categories of goods that could face tariffs. If these duties or any other forms of duties or tariffs are imposed on the Nanox.ARC, our X-ray tube or their components, we may be required to charge higher prices in the United States than we expect, which may result in fewer customers and harm our operating performance. Alternatively, we may seek to shift production outside of China, resulting in significant costs and disruption to our operations and business. Additionally, the Trump </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">24<br></div></div></div>
<!--End Page 30-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 31-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Administration continues to signal that it may alter trade agreements and terms between China and the United States, including limiting trade with China, and may impose additional tariffs on imports from China. Our business could also be impacted by retaliatory trade measures taken by China or other countries in response to existing or future tariffs, causing us to raise prices or make changes to our operations, any of which could materially harm our business, financial condition and results of operations.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;">Our business may be impacted by changes in general economic conditions.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our business is subject to risks arising from changes in domestic and global economic conditions, including adverse economic conditions in markets in which we operate, which may harm our business. For example, the current COVID-19 pandemic has caused significant volatility and uncertainty in U.S. and international markets. If our future customers significantly reduce spending in areas in which our technology and products are utilized, or prioritize other expenditures over our technology and products, our business, financial condition, results of operations and prospects would be materially adversely affected.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Disruption to the global economy could also result in a number of follow-on effects on our business, including a possible slow-down resulting from lower customer expenditures; inability of customers to pay for products, solutions or services on time, if at all; more restrictive export regulations which could limit our potential customer base; negative impact on our liquidity, financial condition and share price, which may impact our ability to raise capital in the market, obtain financing and secure other sources of funding in the future on terms favorable to us.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, the occurrence of catastrophic events, such as hurricanes, storms, earthquakes, tsunamis, floods, medical epidemics and other catastrophes that adversely affect the business climate in any of our markets could have a material adverse effect on our business, financial condition and results of operations. Some of our operations are located in areas that have been in the past, and may be in the future, susceptible to such occurrences.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">The outcome of any future claims and litigation could have a material adverse impact on our business, financial condition and results of operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We may, from time to time, be subject to claims and may become party to litigation in the normal course of business, including class action lawsuits. Such claims and litigation proceedings may be brought by third parties, including our customers, competitors, advisors, service providers, partners or collaborators, employees, and governmental or regulatory bodies. The final outcome of these claims and litigation, including any settlements, may be significant and may differ substantially from our expectations. We may not be able to determine the amount of any potential losses and other costs we may incur due to the inherent uncertainties of litigation and settlement negotiations. In the event we are required or decide to pay amounts in connection with any claims or lawsuits, such amounts could be significant and could have a material adverse impact on our liquidity, business, financial condition and results of operations. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">We do not expect to carry any business interruption insurance or any other insurance (except for director and officer, property and product liability insurance). As a result, we may incur uninsured losses, increasing the possibility that you would lose your entire investment in our company.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our products and services are in the medical imaging field and so may be subject to claims. We are not immune from product liability or other product claim risks, and we may not be able to maintain insurance on acceptable terms against such risks or that such insurance will be sufficient to protect us against potential claims or that insurance will be available in the future in amounts sufficient to protect us. A product liability claim or other claim, as well as any claims for uninsured liabilities or in excess of insured liabilities, could have a material adverse effect on our business, financial condition, results of operations and prospects. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;">Certain of our directors and/or officers may have interests that compete with ours.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Certain of our directors currently own, operate and manage other entities, which may have similar or different objectives than ours. Such activities could detract from the time these people have to allocate to our affairs. We had previously entered into a consulting agreement and a service agreement with an entity owned by Ran Poliakine, and we are currently party to a service agreement with an entity of which Onn Fenig and Ran Poliakine each serves as a director and Ran Poliakine is a significant shareholder. Furthermore, Ran Poliakine is </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">25<br></div></div></div>
<!--End Page 31-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 32-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">a director and Onn Fenig manages the operations of such entity&#8217;s controlled subsidiary. See &#8220;Certain Relationships and Related Party Transactions&#8212;Agreements With Directors and Officers&#8212;Relationship With Six-Eye Interactive Ltd.&#8221; and &#8220; &#8212;Relationship with SixAI Ltd.&#8221; Additionally, we lease office space to an entity of which Ran Poliakine serves as a member of senior management, Richard Stone serves as a director and Anat Kaphan serves as a consultant. Each of Ran Poliakine and Richard Stone is also a significant shareholder. See &#8220;Certain Relationships and Related Party Transactions&#8212;Agreements With Directors and Officers&#8212;Relationship with Illumigyn, Ltd.&#8221; The terms of such agreements may not be as favorable to us as those that could be obtained from a third party. Moreover, certain of our directors and officers are affiliated with our current shareholders, and may have different interests than other shareholders. For additional information regarding related party transactions and potential conflicts of interest, see &#8220;Certain Relationships and Related Party Transactions.&#8221; Under the Israeli Companies Law, 5759-1999 (the &#8220;Companies Law&#8221;), office holders must promptly disclose to us any direct or indirect personal interest that he or she may have and all related material information or documents known to him or her relating to any existing or proposed transaction by us. See &#8220;Fiduciary Duties and Approval of Specified Related Party Transactions and Compensation Under Israeli Law&#8212;Disclosure of Personal Interests of an Office Holder and Approval of Certain Transactions.&#8221; In addition, on the closing of this offering, we will adopt a code of ethics and conduct that will require our employees, officers and directors to disclose any situation that reasonably would be expected to give rise to a conflict of interest.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;">Our management team has limited experience managing a public company. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Most members of our management team have limited experience managing a publicly traded company, interacting with public company investors and complying with the increasingly complex laws pertaining to public companies in the United States. Our management team may not successfully or efficiently manage our transition to being a public company subject to significant regulatory oversight and reporting obligations under the U.S. federal securities laws and the continuous scrutiny of securities analysts and investors. These new obligations and constituents will require significant attention from our senior management and could divert their attention away from the day-to-day management of our business, which could adversely affect our business, financial condition, results of operations and prospects.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;">Risks Related to Our Intellectual Property</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">It is difficult and costly to protect our intellectual property and our proprietary technologies, and we may not be able to ensure their protection.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We rely upon a combination of patents and trade secrets to protect the intellectual property related to our proprietary technologies. Our success depends significantly on our ability to obtain and maintain intellectual property protection with respect to our technology and products. Patents and other proprietary rights provide uncertain protections, and we may be unable to protect our intellectual property for reasons including those that result from complex factual and legal issues such as those that create uncertainty as to the validity, scope and enforceability of any particular patent that we hold or for which we have applied. As a result, we may be unsuccessful in defending our patents and other proprietary rights against third-party challenges, which could have a material adverse effect on our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Although we are attempting to obtain patent coverage for our technology where available and where we believe appropriate, there are aspects of the technology for which patent coverage may never be sought or received. Additionally, we have obtained, and may in the future obtain, certain intellectual property related to our technology from third parties, and we cannot be certain that such third parties took the necessary actions to maintain such rights or that the transfer of such rights to us was proper and effective. We may, as a result, be subject to claims challenging the ownership or enforceability of such rights. Furthermore, we may not possess the resources to, or for other reasons may not choose to, pursue patent protection on every invention or in any or every country where we may eventually decide to sell our future products. Our ability to prevent others from making or selling duplicate or similar technologies will be impaired for those technologies with respect to which, and in those countries where, we have no patent protection. In addition, there is no assurance that all potentially relevant prior art relating to our patents and patent applications has been found, which can prevent a patent from issuing from a pending patent application or later invalidate or narrow the scope of an issued patent. Even if patents do successfully issue and even if such patents cover our technology, third parties may challenge their validity, enforceability or scope, which may result in such patents being narrowed, invalidated, or held </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">26<br></div></div></div>
<!--End Page 32-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 33-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">unenforceable. Any successful challenge to these patents or any other patents owned by or licensed to us could deprive us of rights necessary for the successful commercialization of our technology.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, for patents that do issue based on our applications or future applications, any issued patents may not provide us with any competitive advantages. Competitors may be able to design around our patents and develop products that provide outcomes comparable or superior to ours. Any changes we make to our product or any future products, including designs that may be required for commercialization or that cause them to have what we view as more advantageous properties, may not be covered by patents and patent applications we have licensed or own, and we may be required to file new applications and/or seek other forms of protection for any such altered products if any such protection is available. In addition, the patent prosecution process is expensive, time-consuming and complicated, and we and our current or future licensors, licensees or collaborators may not be able to prepare, file, prosecute and maintain all necessary or desirable patents or patent applications at a reasonable cost or in a timely manner. It is also possible that we or our current or future licensors, licensees or collaborators will fail to identify patentable aspects of inventions before it is too late to obtain patent protection for them. In addition, if we choose to and are able to secure patent protection in countries outside the U.S., the laws of some foreign countries may not protect our intellectual property rights to the same extent as do the laws of the United States. For instance, the legal systems of some countries, including India, China and other developing countries, do not favor the enforcement of patents and other intellectual property rights. This could make it difficult for us to stop the infringement of our patents or the misappropriation of our other intellectual property rights. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Some countries also have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, some countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we or any of our licensors is forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Changes in either the patent laws or their interpretation in the United States and other countries may diminish our ability to protect our inventions and enforce our intellectual property rights, and more generally could affect the value of our intellectual property. Our efforts to seek patent protection for our technology could be negatively impacted by any such changes, which could have a material adverse effect on our existing patent rights and our ability to protect and enforce our intellectual property in the future. In particular, our ability to stop third parties from making, using, selling, offering to sell or importing products that infringe our intellectual property will depend in part on our success in obtaining and enforcing patent claims that cover our technology, inventions and improvements.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We may come to believe that third parties are infringing on, or otherwise violating, our patents or other proprietary rights. To prevent infringement or unauthorized use, we may need to file infringement and/or misappropriation suits, which are very expensive and time-consuming, could result in meritorious counterclaims against us and would distract management&#8217;s attention. Also, in an infringement or misappropriation proceeding, a court may decide that one or more of our patents is invalid, unenforceable, or both, in which case third parties may be able to use our technology without paying license fees or royalties. Even if the validity of our patents is upheld, a court may refuse to stop the other party from using the technology at issue on the grounds that the other party&#8217;s activities are not covered by our patents. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition to patents, we rely on trade secrets to protect our technology; however, the policies we use to protect our trade secrets may not be effective in preventing misappropriation of our trade secrets by others. In addition, confidentiality agreements executed by our employees, consultants and advisors may not be enforceable or may not provide meaningful protection for our trade secrets or other proprietary information in the event of unauthorized use or disclosure. Litigating a trade secret claim is expensive and time consuming, and the outcome may be unexpected. In addition, courts outside the United States are sometimes less willing to protect trade secrets. Moreover, our competitors may independently develop knowledge, methods and know-how that allow them to create substantially similar products or services without misappropriating our trade secrets. If we are unable to protect our trade secrets, we may be unable to prevent competitors from using our own inventions and intellectual property to compete against us, and our business may be harmed.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">27<br></div></div></div>
<!--End Page 33-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 34-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Patent terms may be inadequate to protect our competitive position on our future products for an adequate amount of time.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20&#160;years from its earliest U.S. non-provisional filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our future products are obtained, once the patent life has expired, we may be open to competition from competitive products.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Given the amount of time required for the development, testing and regulatory review of new products, patents protecting our future products might expire before or shortly after we or our future partners commercialize those products. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours for a sufficient amount of time, and, as a result, we may not be able to obtain adequate protection from our patent portfolio against competition, in spite of the time and effort invested in the commercialization of our future products. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Claims that our technology or our future products or the sale or use of our future products infringe the patents or other intellectual property rights of third parties could result in costly litigation or could require substantial time and money to resolve, even if litigation is avoided.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Because our industry is characterized by competing intellectual property, we may be subject to legal actions for violating the intellectual property rights of others, including claims that former employees, collaborators or third parties have an interest in our patents, trade secrets or other intellectual property. For example, we may have inventorship or ownership disputes arising from conflicting obligations of employees, consultants or others who are involved in developing our technology or our products. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We also may be required to participate in interference, derivation or opposition proceedings that concern disputes regarding priority of inventions disclosed in our patents. Determining whether a product infringes a patent, as well as priority of inventions and other patent-related disputes, involves complex legal and factual issues and the outcome is often uncertain. We have not conducted any significant search of patents issued to third parties, and third-party patents containing claims covering our technology or methods that predate our patents may exist. Because of the number of patents issued and patent applications filed in our technical areas or fields (including some pertaining specifically to medical imaging technologies), our competitors or other third parties may assert that our technology and the methods we employ in the use of products incorporating our technology are covered by United States or foreign patents held by them. In addition, because patent applications can take many years to issue and because publication schedules for pending applications vary by jurisdiction, there may be applications now pending of which we are unaware, and which may result in issued patents that our technology or other future products would infringe. Also, because the claims of published patent applications can change between publication and patent grant, there may be published patent applications that may ultimately issue with claims that we infringe. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As the number of competitors in the market for medical imaging technologies increases, and as the number of patents issued in this area grows, the possibility of patent infringement claims against us increases. Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can, including if they have substantially greater resources. Defending against such litigation is costly and time consuming, and would distract our management from our business. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In the event that we become subject to a patent infringement or other intellectual property lawsuit and if the relevant patents or other intellectual property were upheld as valid and enforceable and we were found to infringe or violate those rights or the terms of a license to which we are a party, we could be prevented from selling any infringing products of ours unless we could obtain a license or were able to redesign the product to avoid infringement. If we were unable to obtain a license or successfully redesign, we might be prevented from selling our technology or other future products. If we are able to redesign, we may need to invest substantial resources in the redesign process. If there is an allegation or determination that we have infringed the intellectual </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">28<br></div></div></div>
<!--End Page 34-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 35-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">property rights of a competitor or other person, we may be required to pay damages, or a settlement or ongoing royalties, or we may be required to enter into cross-licenses with our competitors. In any of these circumstances, we may be unable to sell our products at competitive prices or at all, and our business, financial condition, results of operations and prospects could be harmed.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, we may be required to indemnify our customers and distributors against claims relating to the infringement of intellectual property rights of third parties related to our products. Third parties may assert infringement claims against our customers or distributors. These claims may require us to initiate or defend protracted and costly litigation on behalf of our customers or distributors, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of our customers or distributors, or may be required to obtain licenses for the products or services they use. If we cannot obtain all necessary licenses on commercially reasonable terms, our distributors may be forced to stop distributing our products or services, and our customers may be forced to stop using our products or services. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during discovery. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments, which could have a material adverse effect on the price of our ordinary shares. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our ordinary shares.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated if we or our future licensors do not comply with these requirements.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Periodic maintenance fees, renewal fees, annuity fees and various other government fees on a patent and patent application are due to be paid to the patent offices and agencies in several stages over the lifetime of the patent and patent application. The U.S. Patent and Trademark Office and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In certain circumstances, we may be required to rely on our licensing partners to take the necessary action to comply with these requirements with respect to patents or other intellectual property they have licensed to us. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance, which could include failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents, can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, our competitors may be able to enter the market and compete with our products, which would have a material adverse effect on our business.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">We may be subject to claims that our employees, consultants or advisers have wrongfully used or disclosed alleged trade secrets of their former employers or claims asserting ownership of what we regard as our own intellectual property.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Many of our employees, consultants and advisers, including our senior management, were previously employed at other companies that may have proprietary rights related to our business. Some of these employees, consultants and advisers, including members of our senior management, executed proprietary rights, non-disclosure and non-competition agreements in connection with such previous employment. Although we try to ensure that such individuals do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or these employees have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#8217;s former employer. We are not aware of any such disclosures, or threatened or pending claims related to these matters, but in the future, litigation may be necessary to defend against such claims. If we fail in defending any such claims, we may lose valuable intellectual property rights or personnel, in addition to possibly paying monetary damages and being enjoined from conducting our business as contemplated. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Additionally, a licensor, collaborator, employee, consultant, adviser or other third party may dispute our or our licensor&#8217;s ownership of certain intellectual property rights. We seek to address these concerns in our </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">29<br></div></div></div>
<!--End Page 35-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 36-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">contractual agreements; however, we may not have contractual arrangements with the party in question and/or such provisions may not be effective. If these provisions prove to be ineffective, we may not be able to achieve our business objectives. If we or our licensors fail in defending any such claims, we may have to pay monetary damages and may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property, which could adversely impact our business, financial condition and results of operations. </div><div class="risk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our unregistered trademarks or trade names are valuable assets and may be challenged, infringed, circumvented or declared generic or determined to infringe third party&#8217;s marks. We may not be able to protect our rights to these trademarks and trade names, which may be necessary to build name recognition among potential collaborators or customers in our markets of interest. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other trademarks or trademarks that incorporate variations of our unregistered trademarks or trade names. We have not conducted any registrability studies for possible future trademarks to assess whether such marks would be successfully registered. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. In addition, we may license our trademarks and trade names to third parties, such as distributors. Though these license agreements may provide guidelines for how our trademarks and trade names may be used, a breach of these agreements or misuse of our trademarks and tradenames by our licensees may jeopardize our rights in or diminish the goodwill associated with our trademarks and trade names. Our efforts to enforce or protect our proprietary rights related to trademarks, trade names, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and adversely affect our competitive position, business, financial condition, results of operations and prospects.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Our rights to develop and commercialize our products may be subject to the terms and conditions of licenses and sublicenses granted to us by third parties.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We rely on licenses and sublicenses to certain patent rights and other intellectual property from third parties that are important or necessary to the development of our products, including the software modules that we expect to integrate into the Nanox.CLOUD. These and other licenses may not provide exclusive rights to use such intellectual property in all relevant fields of use and in all territories in which we may wish to develop or commercialize our products and the underlying patents may fail to provide the intended exclusivity. As a result, we may not be able to prevent competitors from developing and commercializing competitive products in the markets that we hope to address. Moreover, we would not own at least some of the underlying intellectual property rights related to these products, and as a result our rights would be subject to the continuation and compliance with the terms of those agreements. If such in-licenses were terminated, competitors would have the freedom to develop, seek regulatory approval of, and to market, products similar or identical to ours.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, these license agreements may not grant us the right to control the preparation, filing, prosecution or maintenance of patents and patent applications covering our products. Therefore, we cannot be certain that these patents and patent applications will be prepared, filed, prosecuted or maintained in a manner consistent with the best interests of our business. If our current or future licensing partners fail to file, prosecute or maintain such patents, including the payment of applicable fees, or otherwise lose rights to those patents or patent applications, the intellectual property we have licensed or exclusivity we have been granted may be reduced or eliminated, and our right to develop and commercialize any of our future products that are subject of such licensed rights, and our ability to prevent competitors from developing or commercializing such products, could be adversely affected. In addition, even where we have the right to control patent prosecution and maintenance of patents and patent applications we have licensed from third parties, we may still be adversely affected or prejudiced by actions or inactions of our licensees, our licensors and their counsel that took place prior to the date upon which we assumed control over patent prosecution.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to the terms of such license agreements, the licensors may also have the right to control enforcement of our licensed patents or defense of any claims asserting the invalidity or unenforceability of these patents. Even if we are permitted to pursue the enforcement or defense of our licensed patents, we may require the cooperation of our future licensors or collaboration partners and any other applicable patent owners and we </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">30<br></div></div></div>
<!--End Page 36-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 37-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">cannot be certain that such cooperation will be provided to us. We also cannot be certain that our licensors will allocate sufficient resources or prioritize their or our enforcement of such patents or defense of such claims to protect our interests in the licensed patents. Even if we are not a party to these legal actions, an adverse outcome could harm our business because it might prevent us from continuing to license intellectual property that we may need to operate our business. If we lose any of our licensed intellectual property, our right to develop and commercialize any of our products that are subject of such licensed rights could be adversely affected.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, our future licensors may rely on third-party consultants or collaborators or on funds from third parties such that our licensors are not the sole and exclusive owners of the patents we in-license. If other third parties have ownership rights to our in-licensed patents, they may be able to license such patents to our competitors, and our competitors could market competing products and technologies. In addition, if our licensors have not obtained adequate rights from these third parties, we may need to obtain additional rights from these third parties or we could be prevented from developing and commercializing the related products. This could have a material adverse effect on our competitive position, business, financial conditions, results of operations and prospects.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In spite of our best efforts, our licensors might conclude that we have materially breached our license agreements and might therefore terminate the license agreements, in which event we may have to cease developing, manufacturing or marketing any product covered by these agreements and we may face other additional penalties or be required to grant our licensors additional rights. In addition, we may seek to obtain additional licenses from our licensors and, in connection with obtaining such licenses, we may agree to amend our existing licenses in a manner that may be more favorable to the licensors, including by agreeing to terms that could enable third parties (potentially including our competitors) to receive licenses to a portion of the intellectual property that is subject to our existing licenses. Any of these events could have a material adverse effect on our competitive position, business, financial conditions, results of operations and prospects.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">We may be required to pay certain milestones and royalties and fulfill other obligations under our license agreements with third-party licensors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We may be required to pay milestones and royalties related to our development or commercialization activities of our products utilizing the technologies licensed or sublicensed from third parties under license agreements we may enter into with them. These payments could adversely affect our overall profitability related to any future products that we may seek to develop or commercialize. In order to maintain our license rights under our license agreements, we may need to meet certain specified milestones or fulfill certain obligations, including to devote a certain amount of resources, in the development of our products. Failure to satisfy such obligations could result in the termination of our rights under such agreements.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">If we choose to license our technology to third parties, this could result in disputes or otherwise limit our future operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We may also in the future, as one of our strategies, deploy our technology into the market and license patents and other intellectual proprietary rights to third parties. Disputes with our licensees may arise, including regarding the scope and content of these licenses. Additionally, a licensee may use our intellectual property without our permission, dispute our ownership of certain intellectual property rights or argue that our intellectual property does not cover our product. Regardless of whether we pursue legal action to enforce any such dispute, a dispute with a licensee or customer over intellectual property rights may damage our relationship with that licensee or customer and may also harm our reputation in the industry. Our ability to expand into additional fields with our technologies also may be restricted by licenses or other rights we may grant to third parties in the future, including if the licenses are exclusive, the licensee is assigned ownership of intellectual property that we develop or rights of first negotiation or refusal are granted. For instance, pursuant to the Right of First Negotiation Agreement with FUJIFILM Corporation, dated May 21, 2019, we granted FUJIFILM Corporation a right of first negotiation to obtain an exclusive license to certain of our intellectual property for use in the field of mammography. See &#8220;Business&#8212;Our Business Model&#8212;The Licensing Model&#8221; for a description of the terms of such agreement. While we do not currently plan to use this intellectual property in this field, if we chose to do so in the future, our ability would be limited by these rights and any related rights granted in the future to FUJIFILM Corporation.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">31<br></div></div></div>
<!--End Page 37-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 38-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Risks Related to Government Regulation</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our product candidates and operations are subject to extensive government regulation and oversight both in the United States and abroad, and our failure to comply with applicable requirements could harm our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We expect the Nanox.ARC and other future products we develop to be regulated by the FDA as medical devices. Our product candidate is subject to extensive regulation in the United States and elsewhere, including by the FDA and its foreign counterparts, the U.S. Department of Justice (the &#8220;DOJ&#8221;) and the U.S. Health and Human Services-Office of the Inspector General (&#8220;HHS&#8221;). The FDA and foreign regulatory agencies regulate, among other things, with respect to medical devices: design, development and manufacturing; testing, labeling, content and language of instructions for use and storage; clinical trials; product safety; establishment registration and device listing; marketing, sales and distribution; pre-market clearance and approval; conformity assessment procedures; record keeping procedures; advertising and promotion; recalls and field safety corrective actions; post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to occur, could lead to death or serious injury; post-market approval studies; and product import and export.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The regulations our product candidate is subject to are complex and have tended to become more stringent over time. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated sales for any approved product. Failure to comply with applicable regulations could jeopardize our ability to sell our future products, if cleared or approved, and result in enforcement actions such as: warning or untitled letters; fines; injunctions; consent decrees; civil penalties; customer notifications; termination of distribution; recalls or seizures of products; administrative detention of medical devices believed to be adulterated or misbranded; delays in the introduction of products into the market; operating restrictions; total or partial suspension of production; refusal to grant future clearances or approvals for new products, new intended uses or modifications to our products; withdrawals or suspensions of current approvals, resulting in prohibitions on sales of our products; and in the most serious cases, criminal prosecution or penalties. The occurrence of any of these events would have a material adverse effect on our business, financial condition and results of operations and could result in shareholders losing their entire investment.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">We may not receive, or may be delayed in receiving, the necessary clearances or approvals for our future products, and failure to timely obtain necessary clearances or approvals for our future products would adversely affect our ability to grow our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In the United States, before we can market a new medical device, or a new use of, new claim for or significant modification to an existing product, we must first receive either clearance under Section 510(k) of the Federal Food, Drug, and Cosmetic Act (the &#8220;FDCA&#8221;) or approval of a pre-market approval application (a &#8220;PMA&#8221;) from the FDA, unless an exemption applies. In the 510(k) clearance process, before a device may be marketed, the FDA must determine that a proposed device is &#8220;substantially equivalent&#8221; to a legally-marketed &#8220;predicate&#8221; device, which includes a device that has been previously cleared through the 510(k) process, a device that was legally marketed prior to May&#160;28, 1976 (pre-amendments device), a device that was originally on the U.S. market pursuant to an approved PMA and later down-classified, or a 510(k)-exempt device. To be &#8220;substantially equivalent,&#8221; the proposed device must have the same intended use as the predicate device, and either have the same technological characteristics as the predicate device or have different technological characteristics and not raise different questions of safety or effectiveness than the predicate device. Clinical data are sometimes required to support substantial equivalence. In the process of obtaining PMA approval, the FDA must determine that a proposed device is safe and effective for its intended use based, in part, on extensive data, including, but not limited to, technical, pre-clinical, clinical trial, manufacturing and labeling data. The PMA process is typically required for devices that are deemed to pose the greatest risk, such as life-sustaining, life-supporting or implantable devices. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Modifications to products that are approved through a PMA application generally require FDA approval. Similarly, certain modifications made to products cleared through a 510(k) may require a new 510(k) clearance. Both the PMA approval and the 510(k) clearance process can be expensive, lengthy and uncertain. The FDA&#8217;s 510(k) clearance process usually takes from three to 12 months, but can last longer. The process of obtaining a PMA is much more costly and uncertain than the 510(k) clearance process and generally takes from one to three years, or even longer, from the time the application is submitted to the FDA. In addition, a PMA generally requires the performance of one or more clinical trials. Despite the time, effort and cost, a device may not be </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">32<br></div></div></div>
<!--End Page 38-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 39-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">approved or cleared by the FDA. Any delay or failure to obtain necessary regulatory clearances or approvals could harm our business. Furthermore, even if we are granted regulatory clearances or approvals, they may include significant limitations on the indicated uses for the device or other restrictions or requirements, which may limit the market for the device.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In the United States, we expect to take a multi-step approach to the regulatory clearance process. As a first step, we submitted a 510(k) application for a single-source version of the Nanox.ARC to an accredited Review Organization under the Third Party Review Program in January 2020. As part of the review process, in March&#160;2020, we received an additional information request, referred to as a major deficiency letter, from the Review Organization, which among other things, required us to provide additional data and other information to complete the application and to address certain deficiencies highlighted by the reviewer, including the results of certain performance tests. In response to the feedback we received from the Review Organization, we have conducted additional product testing and expect to submit the results from these tests, along with our response, to the Review Organization, in the third quarter of 2020. Our original timeline for completing the application was delayed due to the impact of COVID-19 on the external labs we work with to complete our product testing. We believe that we will be able to successfully resolve the deficiencies identified in the letter and ultimately obtain FDA clearance of the single-source version of the Nanox.ARC. However, the review process is an iterative process and our initial response may result in further feedback from the Review Organization. As a result, the review process may be more costly and time consuming than we expect and we may not ultimately be successful in completing the review process and our 510(k) application may not be cleared by the FDA in a timely manner or at all. We will continue to optimize and develop further features of the Nanox.ARC, and plan to submit an additional 510(k) application under the Third Party Review Program with respect to the multiple-source Nanox.ARC during the fourth quarter of 2020, which, if cleared, will be our commercial imaging system. If cleared, any modification to these systems that has not been previously cleared may require us to submit a new 510(k) premarket notification and obtain clearance, or submit a PMA and obtain FDA approval prior to implementing the change. Specifically, any modification to a 510(k)-cleared device that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, design or manufacture, requires a new 510(k) clearance or, possibly, approval of a PMA. The FDA requires every manufacturer to make this determination in the first instance, but the FDA may review any manufacturer&#8217;s decision. The FDA may not agree with our decisions regarding whether new clearances or approvals are necessary. We may make modifications or add additional features in the future that we believe do not require a new 510(k) clearance or approval of a PMA. If the FDA disagrees with our determination and requires us to submit new 510(k) notifications or PMA applications for modifications to our previously cleared products for which we have concluded that new clearances or approvals are unnecessary, we may be required to cease marketing or to recall the modified product until we obtain clearance or approval, and we may be subject to significant regulatory fines or penalties. If the FDA requires us to go through a lengthier, more rigorous examination for future products or modifications to existing products than we had expected, product introductions or modifications could be delayed or canceled, which could adversely affect our ability to grow our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">The FDA can delay, limit or deny clearance or approval of a medical device for many reasons, including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our inability to demonstrate to the satisfaction of the FDA or the applicable regulatory entity or notified body that our product candidates are safe or effective for their intended uses;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the disagreement of the FDA or the applicable foreign regulatory body with the design or implementation of our clinical trials or the interpretation of data from pre-clinical studies or clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">serious and unexpected adverse effects experienced by participants in our clinical trials;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the data from our pre-clinical studies and clinical trials may be insufficient to support clearance or approval, where required;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our inability to demonstrate that the clinical and other benefits of the device outweigh the risks;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the manufacturing process or facilities we use may not meet applicable requirements; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the potential for approval policies or regulations of the FDA or applicable foreign regulatory bodies to change significantly in a manner rendering our clinical data or regulatory filings insufficient for clearance or approval.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">33<br></div></div></div>
<!--End Page 39-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 40-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In order to sell our products in member countries of the European Economic Area (&#8220;EEA&#8221;), our products must comply with the essential requirements of the EU Medical Devices Directive (Council Directive 93/42/EEC). Compliance with these requirements is a prerequisite to be able to affix the Conformit&#233; Europ&#233;ene (&#8220;CE&#8221;) mark to our products, without which they cannot be sold or marketed in the EEA. To demonstrate compliance with the essential requirements we must undergo a conformity assessment procedure, which varies according to the type of medical device and its classification. Except for low-risk medical devices (Class&#160;I non-sterile, non-measuring devices), where the manufacturer can issue a European Community (&#8220;EC&#8221;) Declaration of Conformity based on a self-assessment of the conformity of its products with the essential requirements of the EU Medical Devices Directive, a conformity assessment procedure requires the intervention of an organization accredited by a member state of the EEA to conduct conformity assessments, or a Notified Body. Depending on the relevant conformity assessment procedure, the Notified Body would typically audit and examine the technical file and the quality system for the manufacture, design and final inspection of our devices. The Notified Body issues a certificate of conformity following successful completion of a conformity assessment procedure conducted in relation to the medical device and its manufacturer and their conformity with the essential requirements. This certificate entitles the manufacturer to affix the CE mark to its medical devices after having prepared and signed a related EC Declaration of Conformity.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As a general rule, demonstration of conformity of medical devices and their manufacturers with the essential requirements must be based, among other things, on the evaluation of clinical data supporting the safety and performance of the products during normal conditions of use. Specifically, a manufacturer must demonstrate that the device achieves its intended performance during normal conditions of use, that the known and foreseeable risks, and any adverse events, are minimized and acceptable when weighed against the benefits of its intended performance, and that any claims made about the performance and safety of the device are supported by suitable evidence. If we fail to remain in compliance with applicable European laws and directives, we would be unable to continue to affix the CE mark to our products, which would prevent us from selling them within the EEA.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Failure to comply with post-marketing regulatory requirements could subject us to enforcement actions, including substantial penalties, and might require us to recall or withdraw a product from the market.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If we receive regulatory clearance or approval of the Nanox.ARC or other future products, we will remain subject to ongoing and pervasive regulatory requirements governing, among other things, the manufacture, marketing, advertising, medical device reporting, sale, promotion, import, export, registration, and listing of devices. For example, we will be required to submit periodic reports to the FDA as a condition of 510(k)&#160;clearance. These reports include information about failures and certain adverse events associated with the device after its clearance. Failure to submit such reports, or failure to submit the reports in a timely manner, could result in enforcement action by the FDA. Following its review of the periodic reports, the FDA might ask for additional information or initiate further investigation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The regulations to which we are subject are complex and have become more stringent over time. Regulatory changes could result in restrictions on our ability to continue or expand our operations, higher than anticipated costs, or lower than anticipated sales. Even after we have obtained the proper regulatory clearance to market a device, we have ongoing responsibilities under FDA regulations and applicable foreign laws and regulations. The FDA, state and foreign regulatory authorities have broad enforcement powers. Our failure to comply with applicable regulatory requirements could result in enforcement action by the FDA, state or foreign regulatory authorities, which may include any of the following sanctions:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">untitled letters or warning letters;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">fines, injunctions, consent decrees and civil penalties;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">recalls, termination of distribution, administrative detention, or seizure of our products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">customer notifications or repair, replacement or refunds;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">operating restrictions or partial suspension or total shutdown of production;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">delays in or refusal to grant our requests for future clearances or approvals or foreign marketing authorizations of new products, new intended uses, or modifications to existing products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">withdrawals or suspensions of product clearances or approvals, resulting in prohibitions on sales of our products;</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">34<br></div></div></div>
<!--End Page 40-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 41-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">FDA refusal to issue certificates to foreign governments needed to export products for sale in other countries; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">criminal prosecution.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Any of these sanctions could result in higher than anticipated costs or lower than anticipated sales and have a material adverse effect on our reputation, business, financial condition and results of operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, the FDA or state or foreign authorities may change their clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions, which may prevent or delay clearance or approval of our future products under development on a timely basis. Such policy or regulatory changes could impose additional requirements upon us that could delay our ability to obtain new clearances or approvals, increase the costs of compliance or restrict our ability to maintain any approvals we are able to obtain. For example, the FDA recently announced forthcoming steps that the FDA intends to take to modernize the premarket notification pathway under Section 510(k) of the FDCA. For more information, see &#8220;&#8212;Legislative or regulatory reforms in the United States or the EU may make it more difficult and costly for us to obtain regulatory clearances or approvals for our products or to manufacture, market or distribute our products after clearance or approval is obtained.&#8221; </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Our products must be manufactured in accordance with federal, state and foreign regulations, and we could be forced to recall our devices or terminate production if we fail to comply with these regulations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The methods used in, and the facilities used for, the manufacture of our products must comply with the Quality System Regulation (&#8220;QSR&#8221;), which is a complex regulatory scheme that covers the procedures and documentation of the design, testing, production, process controls, quality assurance, labeling, packaging, handling, storage, distribution, installation, servicing and shipping of medical devices. As manufacturers of electron radiation-emitting products, we are also responsible for compliance with the radiological health regulations and certain radiation safety performance standards.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Furthermore, we are required to verify that our suppliers maintain facilities, procedures and operations that comply with our quality standards and applicable regulatory requirements. The FDA enforces the QSR through periodic announced or unannounced inspections of medical device manufacturing facilities, which may include the facilities of subcontractors. Our products are also subject to similar state regulations and various laws and regulations of foreign countries governing manufacturing.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our third-party manufacturers may not take the necessary steps to comply with applicable regulations, which could cause delays in the delivery of our products. In addition, failure to comply with applicable FDA or state or foreign requirements or later discovery of previously unknown problems with our products or manufacturing processes could result in, among other things: warning letters or untitled letters; fines, injunctions or civil penalties; suspension or withdrawal of approvals; seizures or recalls of our products; total or partial suspension of production or distribution; administrative or judicially imposed sanctions; the FDA&#8217;s refusal to grant pending or future clearances or approvals for our products; clinical holds; refusal to permit the import or export of our products; and criminal prosecution of us, our suppliers or our employees.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Any of these actions could significantly and negatively affect supply of our products. If any of these events occurs, our reputation could be harmed, we could be exposed to product liability claims and we could lose customers and experience reduced sales and increased costs.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">The misuse or off-label use of our products may harm our reputation in the marketplace, result in injuries that lead to product liability suits or result in costly investigations, fines or sanctions by regulatory bodies if we are deemed to have engaged in the promotion of these uses, any of which could be costly to our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Advertising and promotion of our future products that obtains approval in the United States may be heavily scrutinized by the FDA, the DOJ, HHS, state attorneys general, members of Congress, and the public. In addition, advertising and promotion of any future product that obtains approval outside of the United States will be heavily scrutinized by comparable foreign regulatory authorities.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We expect that, if cleared or approved, our products, including the Nanox.ARC, will be cleared by the requisite regulatory authorities for specific indications. We expect to train our marketing personnel and direct sales force to not promote our devices for uses outside of the FDA-approved indications for use, known as </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">35<br></div></div></div>
<!--End Page 41-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 42-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">&#8220;off-label uses.&#8221; We cannot, however, prevent a physician from using our devices off-label, when in the physician&#8217;s independent professional medical judgment he or she deems it appropriate. There may be increased risk of injury to patients if physicians attempt to use our devices off-label. Furthermore, the use of our devices for indications other than those approved by the FDA or approved by any foreign regulatory body may not effectively treat such conditions, which could harm our reputation in the marketplace among healthcare providers and patients.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If the FDA or any state or foreign regulatory body determines that our promotional materials or training constitute promotion of an off-label use, it could request that we modify our training or promotional materials or subject us to regulatory or enforcement actions, including the issuance or imposition of an untitled letter, which is used for violators that do not necessitate a warning letter, injunction, seizure, civil fine or criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action under other regulatory authority, such as false claims laws, if they consider our business activities to constitute promotion of an off-label use, which could result in significant penalties, including, but not limited to, criminal, civil and administrative penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs and the curtailment of our operations. We may become subject to such actions and, if we are not successful in defending against such actions, those actions may have a material adverse effect on our business, financial condition and results of operations. Equivalent laws and potential consequences exist in foreign jurisdictions.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, if our products are cleared or approved, healthcare providers may misuse our products or use improper techniques if they are not adequately trained, potentially leading to injury and an increased risk of product liability. If our devices are misused or used with improper technique, we may become subject to costly litigation by our customers or their patients. As described above, product liability claims could divert management&#8217;s attention from our core business, be expensive to defend and result in sizeable damage awards against us that may not be covered by insurance. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Our products may cause or contribute to adverse medical events or be subject to failures or malfunctions that we are required to report to the FDA, and if we fail to do so, we would be subject to sanctions that could harm our reputation, business, financial condition and results of operations. The discovery of serious safety issues with our products, or a recall of our products either voluntarily or at the direction of the FDA or another governmental authority, could have a negative impact on us.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If the Nanox.ARC or our other future products receive clearance or approval, we will be subject to the FDA&#8217;s medical device reporting regulations and similar foreign regulations, which require us to report to the FDA when we receive or become aware of information that reasonably suggests that one or more of our products may have caused or contributed to a death or serious injury or malfunctioned in a way that, if the malfunction were to recur, could cause or contribute to a death or serious injury. The timing of our obligation to report is triggered by the date we become aware of the adverse event as well as the nature of the event. We may fail to report adverse events of which we become aware within the prescribed timeframe. We may also fail to recognize that we have become aware of a reportable adverse event, especially if it is not reported to us as an adverse event or if it is an adverse event that is unexpected or removed in time from the use of the product. If we fail to comply with our reporting obligations, the FDA or other regulatory bodies could take action, including warning letters, untitled letters, administrative actions, criminal prosecution, imposition of civil monetary penalties, revocation of our device clearance or approval, seizure of our products or delay in clearance or approval of future products.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The FDA and foreign regulatory bodies have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture of a product or in the event that a product poses an unacceptable risk to health. The FDA&#8217;s authority to require a recall must be based on a finding that there is reasonable probability that the device could cause serious injury or death. We may also choose to voluntarily recall a product if any material deficiency is found. A government-mandated or voluntary recall by us could occur as a result of an unacceptable risk to health, component failures, malfunctions, manufacturing defects, labeling or design deficiencies, packaging defects or other deficiencies or failures to comply with applicable regulations. Product defects or other errors may occur in the future.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Depending on the corrective action we take to redress a product&#8217;s deficiencies or defects, the FDA may require, or we may decide, that we will need to obtain new clearances or approvals for the device before we may market or distribute the corrected device. Seeking such clearances or approvals may delay our ability to replace </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">36<br></div></div></div>
<!--End Page 42-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 43-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg28"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">the recalled devices in a timely manner. Moreover, if we do not adequately address problems associated with our devices, we may face additional regulatory enforcement action, including FDA warning letters, product seizure, injunctions, administrative penalties or civil or criminal fines.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Companies are required to maintain certain records of recalls and corrections, even if they are not reportable to the FDA. We may initiate voluntary withdrawals or corrections for our products in the future that we determine do not require notification of the FDA. If the FDA disagrees with our determinations, it could require us to report those actions as recalls and we may be subject to enforcement action. A future recall announcement could harm our reputation with customers, potentially lead to product liability claims against us and negatively affect our sales. Any corrective action, whether voluntary or involuntary, as well as defending ourselves in a lawsuit, will require the dedication of our time and capital, distract management from operating our business and may harm our reputation and financial results.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Our relationships with customers and third-party payors will be subject to applicable anti-kickback, fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future earnings.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Physicians, other healthcare providers, and third-party payors will play a primary role with respect to any future products for which we obtain marketing approval. Our arrangements with third-party payors and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business or financial arrangements and relationships through which we market, sell and distribute our product. Restrictions under applicable federal and state healthcare laws and regulations include the following:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The U.S. federal healthcare program Anti-Kickback Statute prohibits, among other things, persons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made, in whole or in part, under federal healthcare programs such as Medicare and Medicaid. Although there are a number of statutory exemptions and regulatory safe harbors protecting certain common activities from prosecution, the exemptions and safe harbors are drawn narrowly and practices that involve remuneration to those who prescribe, purchase, or recommend medical devices, including certain discounts, or engaging consultants as speakers or consultants, may be subject to scrutiny if they do not fit squarely within the exemption or safe harbor. Our practices may not in all cases meet all of the criteria for safe harbor protection from anti-kickback liability. Moreover, there are no safe harbors for many common practices, such as educational and research grants. Liability may be established without a person or entity having actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act. Due to the breadth of these laws, the narrowness of statutory exceptions and regulatory safe harbors available, and the range of interpretations to which they are subject, it is possible that some of our current or future practices might be challenged under one or more of these laws, including, without limitation, our proposed Subscription Model, and our advisory, consulting and royalty agreements with certain physicians who receive compensation, in part, in the form of stock or stock options.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The federal civil False Claims Act prohibits, among other things, any person from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment of government funds, or knowingly making, using, or causing to be made or used, a false record or statement material to an obligation to pay money to the government or knowingly concealing or knowingly and improperly avoiding, decreasing, or concealing an obligation to pay money to the federal government. In recent years, several healthcare companies have faced enforcement actions under the federal False Claims Act for, among other things, allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product or causing false claims to be submitted because of the company&#8217;s marketing the product for unapproved, and thus non-reimbursable, uses. False Claims Act liability is potentially significant in the healthcare industry because the statute provides for treble damages and mandatory penalties of tens of thousands of dollars per false claim or statement. Healthcare companies also are subject to other federal false claims laws, including, among others, federal criminal healthcare fraud and false statement statutes that extend to non-government health benefit programs.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">37<br></div></div></div>
<!--End Page 43-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 44-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg29"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), imposes criminal and civil liability for knowingly and willfully executing a scheme to defraud any healthcare benefit program, or knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement in connection with the delivery of or payment for healthcare benefits, items or services. In addition, HIPAA, as amended by HITECH, and their respective implementing regulations impose obligations, including mandatory contractual terms, on covered healthcare providers, health plans, as well as their business associates, with respect to safeguarding the privacy, security and transmission of individually identifiable health information.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Physician Payment Sunshine Act, implemented as the Open Payments program, requires manufacturers of certain products reimbursed by Medicare, Medicaid, or the Children&#8217;s Health Insurance Program to track and report to the federal government payments and transfers of value that they make to physicians and teaching hospitals, certain other healthcare professionals beginning in 2022, group purchasing organizations, and ownership interests held by physicians and their families, and provides for public disclosures of these data. Manufacturers are required to submit annual reports to the government and failure to do so may result in civil monetary penalties for all payments, transfers of value and ownership or investment interests not reported in an annual submission, and may result in liability under other federal laws and regulations. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Many states have adopted laws and regulations analogous to the federal laws cited above, including state anti-kickback and false claims laws, which may apply to items or services reimbursed under Medicaid and other state programs or, in several states, regardless of the payer. Several states have enacted legislation requiring medical device companies to, among other things, establish marketing compliance programs; file periodic reports with the state, including reports on gifts and payments to individual health care providers; make periodic public disclosures on sales, marketing, pricing, clinical trials and other activities; and/or register their sales representatives. Some states prohibit specified sales and marketing practices, including the provision of gifts, meals, or other items to certain health care providers. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations involve substantial costs. Additionally, it is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, exclusion from government funded healthcare programs, such as Medicare and Medicaid, and the curtailment or restructuring of our operations. Exclusion, suspension and debarment from government funded healthcare programs would significantly impact our ability to commercialize, sell or distribute any product. If any of the physicians or other providers or entities with whom we expect to do business are found not to be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Changes in laws or regulations relating to data protection, or any actual or perceived failure by us to comply with such laws and regulations or our privacy policies, could materially and adversely affect our business or could lead to government enforcement actions and significant penalties against us, and adversely impact our operating results.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We expect to receive health information and other highly sensitive or confidential information and data of patients and other third parties (e.g., healthcare providers who refer patients for scans), which we expect to compile and analyze. Collection and use of this data might raise privacy and data protection concerns, which could negatively impact our business. There are numerous federal, state and international laws and regulations regarding privacy, data protection, information security, and the collection, storing, sharing, use, processing, transfer, disclosure, and protection of personal information and other data, and the scope of such laws and regulations may change, be subject to differing interpretations, and may be inconsistent among countries and regions we intend to operate in (e.g., the United States, the European Union and Israel), or conflict with other laws and regulations. The regulatory framework for privacy and data protection worldwide is, and is likely to remain for the foreseeable future, uncertain and complex, and this or other actual or alleged obligations may be </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">38<br></div></div></div>
<!--End Page 44-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 45-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg30"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">interpreted and applied in a manner that we may not anticipate or that is inconsistent from one jurisdiction to another and may conflict with other rules or practices including ours. Further, any significant change to applicable laws, regulations, or industry practices regarding the collection, use, retention, security, or disclosure of data, or their interpretation, or any changes regarding the manner in which the consent of relevant users for the collection, use, retention, or disclosure of such data must be obtained, could increase our costs and require us to modify our services and candidate products, possibly in a material manner, which we may be unable to complete, and may limit our ability to store and process patients&#8217; data or develop new services and features.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In particular, we will be subject to U.S. data protection laws and regulations (i.e., laws and regulations that address privacy and data security) at both the federal and state levels. The legislative and regulatory landscape for data protection continues to evolve, and in recent years there has been an increasing focus on privacy and data security issues. Numerous federal and state laws, including state data breach notification laws, state health information privacy laws, and federal and state consumer protection laws, govern the collection, use, and disclosure of health-related and other personal information. Failure to comply with such laws and regulations could result in government enforcement actions and create liability for us (including the imposition of significant civil or criminal penalties), private litigation and/or adverse publicity that could negatively affect our business. For instance, California enacted the California Consumer Privacy Act (CCPA) on June 28, 2018, which took effect on January 1, 2020. The CCPA creates individual privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal data. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. The CCPA may increase our compliance costs and potential liability, and many similar laws have been proposed at the federal level and in other states.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, we expect to obtain health information that is subject to privacy and security requirements under HITECH and its implementing regulations. The Privacy Standards and Security Standards under HIPAA establish a set of standards for the protection of individually identifiable health information by health plans, health care clearinghouses and certain health care providers, referred to as Covered Entities, and the business associates with whom Covered Entities enter into service relationships pursuant to which individually identifiable health information may be exchanged. Notably, whereas HIPAA previously directly regulated only Covered Entities, HITECH makes certain of HIPAA&#8217;s privacy and security standards also directly applicable to Covered Entities&#8217; business associates. As a result, both Covered Entities and business associates are now subject to significant civil and criminal penalties for failure to comply with Privacy Standards and Security Standards. As part of our normal operations, we expect to collect, process and retain personal identifying information regarding patients, including as a business associate of Covered Entities, so we expect to be subject to HIPAA, including changes implemented through HITECH, and we could be subject to criminal penalties if we knowingly obtain or disclose individually identifiable health information in a manner that is not authorized or permitted by HIPAA. A data breach affecting sensitive personal information, including health information, also could result in significant legal and financial exposure and reputational damages that could potentially have an adverse effect on our business. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">HIPAA requires Covered Entities (like many of our potential customers) and business associates, like us, to develop and maintain policies and procedures with respect to protected health information that is used or disclosed, including the adoption of administrative, physical and technical safeguards to protect such information. HITECH expands the notification requirement for breaches of patient-identifiable health information, restricts certain disclosures and sales of patient-identifiable health information and provides for civil monetary penalties for HIPAA violations. HITECH also increased the civil and criminal penalties that may be imposed against Covered Entities and business associates and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and its implementing regulations and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions. Additionally, certain states have adopted comparable privacy and security laws and regulations, some of which may be more stringent than HIPAA.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Internationally, many jurisdictions have or are considering enacting privacy or data protection laws or regulations relating to the collection, use, storage, transfer, disclosure and/or other processing of personal data, as well as certification requirements for the hosting of health data specifically. Such laws and regulations may include data hosting, data residency or data localization requirements (which generally require that certain types of data collected within a certain country be stored and processed within that country), data export restrictions, international transfer laws (which prohibit or impose conditions upon the transfer of such data from one country to another), or may require companies to implement privacy or data protection and security policies, enable users </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">39<br></div></div></div>
<!--End Page 45-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 46-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg31"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">to access, correct and delete personal data stored or maintained by such companies, inform individuals of security breaches that affect their personal data or obtain individuals&#8217; consent to use their personal data. For example, European legislators adopted the European Union&#8217;s General Data Protection Regulation (2016/679) (&#8220;GDPR&#8221;), which became effective on May 25, 2018, and are now in the process of finalizing the ePrivacy Regulation to replace the European ePrivacy Directive (Directive 2002/58/EC as amended by Directive&#160;2009/136/EC). The GDPR, supplemented by national laws and further implemented through binding guidance from the European Data Protection Board, imposes more stringent European Union data protection requirements and provides for significant penalties for noncompliance. Further, the United Kingdom&#8217;s initiating a process to leave the European Union has created uncertainty with regard to the regulation of data protection in the United Kingdom. In particular, the United Kingdom has brought the GDPR into domestic law with the Data Protection Act 2018 which will remain in force, even if and when the United Kingdom leaves the European Union. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Virtually every jurisdiction in which we expect to operate has established its own data security and privacy legal framework with which we must, and our target customers will need to, comply, including the rules and regulation mentioned above. We may also need to comply with varying and possibly conflicting privacy laws and regulations in other jurisdictions. As a result, we could face regulatory actions, including significant fines or penalties, adverse publicity and possible loss of business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">While we are preparing to implement various measures intended to enable us to comply with applicable privacy or data protection laws, regulations and contractual obligations, these measures may not always be effective and do not guarantee compliance. Any failure or perceived failure by us to comply with our contractual or legal obligations or regulatory requirements relating to privacy, data protection, or information security may result in governmental investigations or enforcement actions, litigation, claims, or public statements against us by consumer advocacy groups or others and could result in significant liability, cause our customers, partners or patients to lose trust in us, and otherwise materially and adversely affect our reputation and business. Furthermore, the costs of compliance with, and other burdens imposed by, the laws, regulations, and policies that are applicable to the businesses of our customers or partners may limit the adoption and use of, and reduce the overall demand for, our products and services. Additionally, if third parties we work with violate applicable laws, regulations, or agreements, such violations may put the data we have received at risk, could result in governmental investigations or enforcement actions, fines, litigation, claims, or public statements against us by consumer advocacy groups or others and could result in significant liability, cause our customers, partners or patients to lose trust in us, and otherwise materially and adversely affect our reputation and business. Further, public scrutiny of, or complaints about, technology companies or their data handling or data protection practices, even if unrelated to our business, industry or operations, may lead to increased scrutiny of technology companies, including us, and may cause government agencies to enact additional regulatory requirements, or to modify their enforcement or investigation activities, which may increase our costs and risks.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">If we do not obtain and maintain international regulatory registrations, clearances or approvals for our products, we will be unable to market and sell our products outside of the United States.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Sales of our products outside of the United States are subject to foreign regulatory requirements that vary widely from country to country. Approval procedures vary among countries and can involve additional testing. The time required to obtain approval outside of the United States may differ substantially from that required to obtain FDA approval. In addition, the FDA regulates exports of medical devices from the United States. While the regulations of some countries may not impose barriers to marketing and selling our products or only require notification, others require that we obtain the clearance or approval of a specified regulatory body. Complying with foreign regulatory requirements, including obtaining registrations, clearances or approvals, can be expensive and time-consuming, and we may not receive regulatory clearances or approvals in each country in which we plan to market our products or we may be unable to do so on a timely basis. The time required to obtain registrations, clearances or approvals, if required by other countries, may be longer than that required for FDA clearance or approval, and requirements for such registrations, clearances or approvals may significantly differ from FDA requirements. If we modify our products, we may need to apply for additional regulatory clearances or approvals before we are permitted to sell the modified product. In addition, we may not continue to meet the quality and safety standards required to maintain the authorizations that we have received. If we are unable to maintain our authorizations in a particular country, we will no longer be able to sell the applicable product in that country.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">40<br></div></div></div>
<!--End Page 46-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 47-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg32"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Regulatory clearance or approval by the FDA does not ensure registration, clearance or approval by regulatory authorities in other countries, and registration, clearance or approval by one or more foreign regulatory authorities does not ensure registration, clearance or approval by regulatory authorities in other foreign countries or by the FDA. However, a failure or delay in obtaining registration or regulatory clearance or approval in one country may have a negative effect on the regulatory process in others.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Legislative or regulatory reforms in the United States or the EU may make it more difficult and costly for us to obtain regulatory clearances or approvals for our products or to manufacture, market or distribute our products after clearance or approval is obtained.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From time to time, legislation is drafted and introduced in Congress that could significantly change the statutory provisions governing the regulation of medical devices. In addition, the FDA may change its clearance and approval policies, adopt additional regulations or revise existing regulations, or take other actions, which may prevent or delay approval or clearance of our future products under development or impact our ability to modify our currently cleared products on a timely basis. Over the last several years, the FDA has proposed reforms to its 510(k) clearance process, and such proposals could include increased requirements for clinical data and a longer review period, or could make it more difficult for manufacturers to utilize the 510(k) clearance process for their products. For example, in November 2018, FDA officials announced forthcoming steps that the FDA intends to take to modernize the premarket notification pathway under Section 510(k) of the FDCA. Among other things, the FDA announced that it planned to develop proposals to drive manufacturers utilizing the 510(k)&#160;pathway toward the use of newer predicates. These proposals included plans to potentially sunset certain older devices that were used as predicates under the 510(k) clearance pathway, and to potentially publish a list of devices that have been cleared on the basis of demonstrated substantial equivalence to predicate devices that are more than 10&#160;years old. In May 2019, the FDA solicited public feedback on these proposals. The FDA requested public feedback on whether it should consider certain actions that might require new authority, such as whether to sunset certain older devices that were used as predicates under the 510(k) clearance pathway. These proposals have not yet been finalized or adopted, and the FDA may work with Congress to implement such proposals through legislation. Accordingly, it is unclear the extent to which any proposals, if adopted, could impose additional regulatory requirements on us that could delay our ability to obtain new 510(k) clearances, increase the costs of compliance, or restrict our ability to maintain our current clearances, or otherwise create competition that may negatively affect our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">More recently, in September 2019, the FDA finalized guidance describing an optional &#8220;safety and performance based&#8221; premarket review pathway for manufacturers of &#8220;certain, well-understood device types&#8221; to demonstrate substantial equivalence under the 510(k) clearance pathway by showing that such device meets objective safety and performance criteria established by the FDA, thereby obviating the need for manufacturers to compare the safety and performance of their medical devices to specific predicate devices in the clearance process. The FDA intends to develop and maintain a list device types appropriate for the &#8220;safety and performance based&#8221; pathway and will continue to develop product-specific guidance documents that identify the performance criteria for each such device type, as well as the testing methods recommended in the guidance documents, where feasible. The FDA may establish performance criteria for classes of devices for which we or our competitors seek or currently have received clearance, and it is unclear the extent to which such performance standards, if established, could impact our ability to obtain new 510(k) clearances or otherwise create competition that may negatively affect our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, FDA regulations and guidance are often revised or reinterpreted by the FDA in ways that may significantly affect our business and our products. Any new statutes, regulations or revisions or reinterpretations of existing regulations may impose additional costs or lengthen review times of any future products or make it more difficult to obtain clearance or approval for, manufacture, market or distribute our products. We cannot determine what effect changes in regulations, statutes, legal interpretation or policies, when and if promulgated, enacted or adopted may have on our business in the future. Such changes could, among other things, require: additional testing prior to obtaining clearance or approval; changes to manufacturing methods; recall, replacement or discontinuance of our products; or additional record keeping.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional government regulations may be promulgated that could prevent, limit or delay regulatory clearance or approval of our future products. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. For example, certain policies of the Trump </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">41<br></div></div></div>
<!--End Page 47-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 48-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg33"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">administration may impact our business and industry. Namely, the Trump administration has taken several executive actions, including the issuance of a number of Executive Orders, that could impose significant burdens on, or otherwise materially delay, FDA&#8217;s ability to engage in routine oversight activities such as implementing statutes through rulemaking, issuance of guidance, and review and approval of marketing applications. It is difficult to predict how these executive actions will be implemented, and the extent to which they will impact the FDA&#8217;s ability to exercise its regulatory authority. If these executive actions impose restrictions on the FDA&#8217;s ability to engage in oversight and implementation activities in the normal course, our business may be negatively impacted. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval or clearance that we may have obtained and we may not achieve or sustain profitability.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On April&#160;5, 2017, the European Parliament passed the Medical Devices Regulation (Regulation 2017/745), which repeals and replaces the EU Medical Devices Directive. Unlike directives, which must be implemented into the national laws of the EEA member states, the regulations would be directly applicable, i.e., without the need for adoption of EEA member state laws implementing them, in all EEA member states and are intended to eliminate current differences in the regulation of medical devices among EEA member States. The Medical Devices Regulation, among other things, is intended to establish a uniform, transparent, predictable and sustainable regulatory framework across the EEA for medical devices and ensure a high level of safety and health while supporting innovation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Medical Devices Regulation will, however, only become applicable three years after publication (in&#160;2020). Once applicable, the new regulations will, among other things:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">strengthen the rules on placing devices on the market and reinforce surveillance once they are available;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">establish explicit provisions on manufacturers&#8217; responsibilities for follow-up regarding the quality, performance and safety of devices placed on the market;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">improve the traceability of medical devices throughout the supply chain to the end-user or patient through a unique identification number;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">set up a central database to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">strengthened rules for the assessment of certain high-risk devices, which may have to undergo an additional check by experts before they are placed on the market.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">These modifications may have an effect on the way we conduct our business in the EEA.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Healthcare reform laws could adversely affect our products and financial condition.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the past several years, the U.S. healthcare industry has been subject to an increase in governmental regulation at both the federal and state levels. Efforts to control healthcare costs, including limiting access to care, alternative delivery models and changes in the methods used to determine reimbursement scenarios and rates, are ongoing at the federal and state government levels. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In March 2010, former President Obama signed into law the Patient Protection and Affordable Care Act, and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;), which included measures that significantly changed the way healthcare is financed by both governmental and private insurers. While a primary goal of these healthcare reform efforts was to expand coverage to more individuals, it also involved additional regulatory mandates and other measures designed to constrain medical costs. The ACA significantly impacts the medical device industry. Among other things, the ACA:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Imposes an annual excise tax of 2.3% on any entity that manufactures or imports medical devices offered for sale in the United States, which, through a series of legislative amendments, was suspended, effective January&#160;1, 2016 and subsequently repealed altogether on December&#160;20, 2019;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Establishes a new Patient-Centered Outcomes Research Institute to oversee and identify priorities in comparative clinical effectiveness research in an effort to coordinate and develop such research; and</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">42<br></div></div></div>
<!--End Page 48-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 49-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg34"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Implements Medicare payment system reforms including a national pilot program on payment bundling to encourage hospitals, physicians and other providers to improve the coordination, quality and efficiency of certain healthcare services through bundled payment models.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, the ACA and related healthcare reform laws, regulations and initiatives have significantly increased regulation of managed care plans and decreased reimbursement under Medicare managed care. Moreover, to alleviate budget shortfalls, states have reduced or frozen payments to Medicaid managed care plans. We cannot accurately predict the complete impact of these healthcare reform initiatives, but they could lead to a decreased demand for medical devices and other outcomes that could adversely impact our business and financial results.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Some of the provisions of the ACA have yet to be fully implemented, and certain provisions have been subject to judicial and Congressional challenges. In addition, there have been efforts by the Trump administration to repeal or replace certain aspects of the ACA and to alter the implementation of the ACA and related laws. For example, the Tax Cuts and Jobs Act enacted on December&#160;22, 2017, or TCJA, eliminated the shared responsibility payment for individuals who fail to maintain minimum essential coverage under section 5000A of the Internal Revenue Code of 1986, commonly referred to as the &#8220;individual mandate,&#8221; effective January&#160;1, 2019. On December 14, 2018, a U.S. District Court Judge in the Northern District of Texas, or the Texas District Court Judge, ruled that the individual mandate is a critical and inseverable feature of the ACA, and therefore, because it was repealed as part of the Tax Cuts and Jobs Act, the remaining provisions of the ACA are invalid as well. This decision was subsequently appealed, and on December 18, 2019, the U.S. Court of Appeals for the Fifth Circuit affirmed the decision of the district court that the individual mandate, as amended by the TCJA, was unconstitutional. The Fifth Circuit remanded the case to the district court to consider a remedy, including to consider and explain which provisions of the ACA are inseverable and invalid. It is unclear how this litigation, including all future hearings and appeals, and other efforts to challenge, repeal or replace the ACA, or portions thereof, will affect our future products or our business. It is possible that the ACA, as currently enacted or as it may be amended in the future, and other healthcare reform measures that may be adopted in the future, could have an adverse effect on our industry generally and on our ability to commercialize our future products and achieve profitability.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Disruptions at the FDA and other government agencies caused by funding shortages or global health concerns could hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed, cleared or approved or commercialized in a timely manner or at all, which could negatively impact our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The ability of the FDA to review and clear or approve new products can be affected by a variety of factors, including government budget and funding levels, statutory, regulatory, and policy changes, the FDA&#8217;s ability to hire and retain key personnel and accept the payment of user fees, and other events that may otherwise affect the FDA&#8217;s ability to perform routine functions. Average review times at the FDA have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Disruptions at the FDA and other agencies may also slow the time necessary for new medical devices or modifications to cleared or approved medical devices to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, including for 35&#160;days beginning on December&#160;22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical FDA employees and stop critical activities.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Separately, in response to the COVID-19 pandemic, on March&#160;10, 2020 the FDA announced its intention to postpone most inspections of foreign manufacturing facilities, and on March&#160;18, 2020, the FDA temporarily postponed routine surveillance inspections of domestic manufacturing facilities. Subsequently, on July&#160;10, 2020 the FDA announced its intention to resume certain on-site inspections of domestic manufacturing facilities subject to a risk-based prioritization system. The FDA intends to use this risk-based assessment system to identify the categories of regulatory activity that can occur within a given geographic area, ranging from mission critical inspections to resumption of all regulatory activities. Regulatory authorities outside the United States may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic. If a prolonged government shutdown occurs, or if global health concerns continue to prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA or other regulatory authorities to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">43<br></div></div></div>
<!--End Page 49-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 50-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg35"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Risks Related to Employee Matters</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">Under applicable employment laws, we may not be able to enforce covenants not to compete and therefore may be unable to prevent our competitors from benefiting from the expertise of some of our former employees. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our employment agreements generally include covenants not to compete. These agreements prohibit our employees, if they cease working for us, from competing directly with us or working for our competitors for a limited period. We may be unable to enforce these agreements under the laws of the jurisdictions in which our employees work at all or for a sufficient duration of time to prevent members of our management team from competing with us. For example, Israeli courts have required employers seeking to enforce covenants not to compete to demonstrate that the competitive activities of a former employee will harm one of a limited number of material interests of the employer, such as the secrecy of a company&#8217;s confidential commercial information or the protection of its intellectual property. In Israel, if we cannot demonstrate that such an interest will be harmed, we may be unable to prevent our competitors from benefiting from the expertise of our former employees or consultants and our competitiveness may be diminished. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">We may not be able to attract and retain the highly skilled employees we need to support our planned growth. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">To continue to execute our business and our growth plan, we must attract and retain highly qualified personnel. Competition for these personnel is intense. We may not be successful in attracting and retaining qualified personnel. If we fail to attract new personnel or fail to retain and motivate our current personnel, our business, financial condition, results of operations and future growth prospects could be severely harmed.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Risks Related to this Offering and Owning Our Ordinary Shares</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Our share price may be volatile, and you may lose all or part of your investment.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The initial public offering price for our shares will be determined by negotiations between us and representatives of the underwriters based on several factors. This price may vary from the market price of our shares after this offering and the price of our ordinary shares may decline. You may be unable to sell your shares at or above the initial offering price. The market price for our shares may be volatile and subject to wide fluctuations in response to factors including the following:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">actual or anticipated fluctuations in results of operations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">actual or anticipated changes in our growth rate relative to our competitors, as well as announcements by us or our competitors of significant business developments, changes in relationships with our target customers, manufacturers or suppliers, acquisitions or expansion plans;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure to meet or exceed financial estimates and projections of the investment community or that we provide to the public, as well as variance in our financial performance from the expectations of market analysts;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">issuance of new or updated research or reports by securities analysts;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">share price and volume fluctuations attributable to inconsistent trading volume levels of our shares;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">additions or departures of key management or other personnel;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our involvement in litigation;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disputes or other developments related to proprietary rights, including patents, litigation matters, and our ability to obtain patent protection for our technology;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">announcement or expectation of additional debt or equity financing efforts;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">sales of our ordinary shares or other securities by us, our insiders or our other shareholders, or the perception that these sales may occur in the future; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the trading volume of our ordinary shares;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">market conditions in our industry; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in the estimation of the future size and growth rate of our markets; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">general economic, market or political conditions in the United States or elsewhere.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">44<br></div></div></div>
<!--End Page 50-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 51-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg36"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In particular, the market prices of pre-commercial-stage companies like ours have been highly volatile due to factors, including, but not limited to:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to develop and commercialize our technology and future products or services;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">developments or disputes concerning our product&#8217;s intellectual property rights;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our or our competitors&#8217; technological innovations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">fluctuations in the valuation of companies perceived by investors to be comparable to us;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">announcements by us or our competitors of significant contracts, acquisitions, strategic partnerships, joint ventures, capital commitments, new technologies or patents;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure to complete significant transactions or collaborate with vendors in manufacturing our product; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">proposals for legislation that would place restrictions on the price of medical therapies.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">These and other market and industry factors may cause the market price and demand for our ordinary shares to fluctuate substantially, regardless of our actual operating performance, which may limit or prevent investors from readily selling their ordinary shares and may otherwise negatively affect the liquidity of our ordinary shares. In addition, the stock market in general, and Nasdaq Global Market and emerging growth companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Such broad market fluctuations, and other factors (such as variations in quarterly and yearly operating results, general trends in the medical imaging industry, and changes in state, federal or other applicable regulations affecting us and our industry) may adversely affect the market price of our ordinary shares, if a market for them develops. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In the past, when the market price of shares has been volatile, holders of those shares have instituted securities class action litigation against the company that issued the shares. If any of our shareholders brought a lawsuit against us, we could incur substantial costs defending the lawsuit. Such a lawsuit could also divert resources and the time and attention of our management.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Prior to the completion of our initial public offering, there was no public trading market for our ordinary shares.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The offering under this prospectus is an initial public offering of our ordinary shares. Prior to the closing of the offering, there was no public market for our ordinary shares. While we plan to list our ordinary shares on the Nasdaq Global Market, our listing application may not be approved. If our application to the Nasdaq Global Market is not approved or we otherwise determine that we will not be able to secure the listing of the ordinary shares on the Nasdaq Global Market, we will not complete the offering. In addition, an active trading market may not develop following the closing of this offering or, if developed, may not be sustained. The lack of an active market may impair your ability to sell your shares at the time you wish to sell them or at a price that you consider reasonable. An inactive market may also impair our ability to raise capital by selling ordinary shares and may impair our ability to acquire other companies by using our shares as consideration. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">We are an &#8220;emerging growth company&#8221; under the JOBS Act and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our ordinary shares less attractive to investors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, and for so long as we continue to be an &#8220;emerging growth company&#8221; we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies&#8221; including, but not limited to, not being required to comply with the auditor attestation requirements of section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. In addition, under the JOBS Act, emerging growth companies can delay adopting new or revised financial accounting standards until such time as those standards apply to private companies. We have elected to &#8220;opt out&#8221; of this provision and, as a result, we will comply with new or revised accounting standards as required when they are adopted for public companies. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">45<br></div></div></div>
<!--End Page 51-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 52-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg37"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Our status as an &#8220;emerging growth company&#8221; under the JOBS Act may make it more difficult to raise capital as and when we need it.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Because of the exemptions from various reporting requirements provided to us as an &#8220;emerging growth company,&#8221; we may be less attractive to investors and it may be difficult for us to raise additional capital as and when we need it. Investors may be unable to compare our business with other companies in our industry if they believe that our reporting is not as transparent as the reporting of other companies in our industry. If we are unable to raise additional capital as and when we need it, our financial condition and results of operations may be materially and adversely affected.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We will remain an emerging growth company until the earliest of: (i)&#160;the last day of our fiscal year during which we have total annual gross revenue of at least $1.07&#160;billion; (ii)&#160;the last day of our fiscal year following the fifth anniversary of the completion of this offering; (iii)&#160;the date on which we have, during the previous three-year period, issued more than $1.0&#160;billion in non-convertible debt; or (iv)&#160;the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the Exchange Act. Once we cease to be an emerging growth company, we will not be entitled to the exemptions provided to emerging growth companies under the JOBS Act.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">As a foreign private issuer, we are exempt from certain requirements that apply to domestic issuers and we are permitted to follow certain home country corporate governance practices instead of applicable SEC and Nasdaq requirements, which may result in less protection than is accorded to shareholders under rules applicable to domestic issuers.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Upon the closing of this offering, we will report under the Exchange Act as a non-U.S. company with foreign private issuer status. Because we qualify as a foreign private issuer under the Exchange Act, we are exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including (1) the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act, (2) the sections of the Exchange Act requiring insiders to file public reports of their share ownership and trading activities and liability for insiders who profit from trades made in a short period of time and (3) the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information, although we intend to furnish comparable quarterly information on Form 6-K. In addition, foreign private issuers are not required to file their annual report on Form 20-F until 120 days after the end of each fiscal year, while U.S. domestic issuers that are accelerated filers are required to file their annual report on Form 10-K within 75 days after the end of each fiscal year and U.S. domestic issuers that are large accelerated filers are required to file their annual report on Form&#160;10-K within 60 days after the end of each fiscal year. Foreign private issuers are also exempt from Regulation FD, which is intended to prevent issuers from making selective disclosures of material information.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, as a foreign private issuer, we will be permitted to follow certain home country corporate governance practices instead of those otherwise required under the listing rules of the Nasdaq Stock Market for domestic issuers. For instance, we may follow home country practice in Israel with regard to, among other things, composition of the board of directors, director nomination procedure, approval of compensation of officers, and quorum at shareholders&#8217; meetings. For example, under Israeli law, as currently applicable to us, there is no requirement for a majority of our directors to be independent. In addition, we may follow our home country law, instead of the listing rules of the Nasdaq Stock Market, which require that we obtain shareholder approval for certain dilutive events, such as for the establishment or amendment of certain equity based compensation plans, an issuance that will result in a change of control of the company, certain transactions other than a public offering involving issuances of a 20% or more interest in the company and certain acquisitions of the stock or assets of another company. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As a result of all of the above, you may not have the same protections afforded to shareholders of a company that is not a foreign private issuer.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">We may lose our foreign private issuer status which would then require us to comply with the Exchange Act&#8217;s domestic reporting regime and cause us to incur significant legal, accounting and other expenses.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As discussed above, we are a foreign private issuer and therefore we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers. We will remain a foreign private issuer until our board determines that we no longer meet the </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">46<br></div></div></div>
<!--End Page 52-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 53-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg38"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">qualification set forth in Securities Act Rule 405 and Exchange Act Rule 3b-4, with such determinations to be made on an annual basis as of the end of our second fiscal quarter. In order to maintain our current status as a foreign private issuer, either (a) a majority of our ordinary shares must be either directly or indirectly owned of record by non-residents of the United States or (b)(i)&#160;a majority of our executive officers or directors must not be U.S. citizens or residents, (ii)&#160;more than 50 percent of our assets cannot be located in the United States and (iii)&#160;our business must be administered principally outside the United States. If we lose this status, we would be required to comply with the Exchange Act reporting and other requirements applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We may also be required to make changes in our corporate governance practices in accordance with various SEC and Nasdaq rules. The regulatory and compliance costs to us under U.S. securities laws if we are required to comply with the reporting requirements applicable to a U.S. domestic issuer may be significantly higher than the costs we would incur as a foreign private issuer. As a result, we expect that a loss of foreign private issuer status would increase our legal and financial compliance costs and would make some activities highly time consuming and costly. We also expect that if we were required to comply with the rules and regulations applicable to U.S. domestic issuers, it would make it more difficult and expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These rules and regulations could also make it more difficult for us to attract and retain qualified members of our board of directors.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">We have not paid dividends in the past and have no immediate plans to pay dividends.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We plan to reinvest all of our future earnings, to the extent we have earnings, in order to develop and commercialize our technology and products and to cover operating costs, finance operations and to otherwise become and remain competitive. We have never declared or paid any dividends on our ordinary shares and we do not plan to pay any cash dividends with respect to our securities in the foreseeable future. As we are a development-stage company with limited operating history, we may not be able to generate, at any time, sufficient surplus cash that would be available for distribution to the holders of our ordinary shares as a dividend. Therefore, you should not expect to receive cash dividends on the ordinary shares we are offering. Consequently, investors may need to rely on sales of their ordinary shares after price appreciation, which may never occur, as the only way to realize any future gains on their investment. In addition, the Companies Law imposes restrictions on our ability to declare and pay dividends. See &#8220;Description of Share Capital&#8212;Dividend and Liquidation Rights&#8221; for additional information.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">We will incur significant increased costs as a result of becoming a public company that reports to the Securities and Exchange Commission and our management will be required to devote substantial time to meet compliance obligations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As a public company reporting to the SEC, we will incur significant legal, insurance, director compensation, accounting and other expenses that we did not incur as a private company. We will be subject to reporting requirements of the Exchange Act and the Sarbanes-Oxley Act, as well as rules subsequently implemented by the SEC that impose significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. In addition, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the &#8220;Dodd-Frank Act&#8221;) impose various other requirements on public companies. There are significant corporate governance and executive compensation-related provisions in the Dodd-Frank Act that are expected to increase our legal and financial compliance costs, make some activities more difficult, time-consuming or costly and may also place undue strain on our personnel, systems and resources. Our management and other personnel will need to devote a substantial amount of time to these new compliance initiatives. In addition, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult and expensive for us to attract and retain qualified people to serve on our board of directors, our board committees or as executive officers.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We also anticipate that we will incur costs associated with corporate governance requirements, including requirements under rules implemented by the SEC and the Nasdaq Global Market, and provisions of Israeli corporate law applicable to public companies. We expect that these rules and regulations will increase our legal and financial compliance costs, introduce new costs such as investor relations and stock exchange listing fees, </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">47<br></div></div></div>
<!--End Page 53-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 54-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg39"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">and will make some activities more time-consuming and costly. Our board and other personnel will need to devote a substantial amount of time to these initiatives. We are currently evaluating and monitoring developments with respect to these rules, and we cannot estimate the amount of additional costs we may incur or the timing of such costs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, we may take advantage of certain temporary exemptions from various reporting requirements, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act (and the rules and regulations of the SEC thereunder). When these exemptions cease to apply, we expect to incur additional expenses and devote increased management effort toward ensuring compliance with them. We cannot estimate the amount of additional costs we may incur as a result of becoming a public company or the timing of such costs.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to Section 404 of the Sarbanes-Oxley Act and the related rules adopted by the SEC and the Public Company Accounting Oversight Board, starting with the second annual report that we file with the SEC after the closing of this offering, our management will be required to report on the effectiveness of our internal control over financial reporting. In addition, once we no longer qualify as an &#8220;emerging growth company&#8221; under the JOBS Act and lose the ability to rely on the exemptions related thereto discussed above and depending on our status as per Rule 12b-2 of the Exchange Act, our independent registered public accounting firm may also need to attest to the effectiveness of our internal control over financial reporting under Section 404. We have not yet commenced the process of determining whether our existing internal controls over financial reporting systems are compliant with Section 404. This process will require the investment of substantial time and resources, including by our chief financial officer and other members of our senior management. As a result, this process may divert internal resources and take a significant amount of time and effort to complete. In addition, the outcome of this determination may be unexpected and we may need to implement remedial actions in order to implement effective controls over financial reporting. The determination and any remedial actions required could result in us incurring additional costs that we did not anticipate, including the hiring of outside consultants. Irrespective of compliance with Section 404, any failure of our internal controls could have a material adverse effect on our stated results of operations and harm our reputation. As a result, we may experience higher than anticipated operating expenses, as well as higher independent auditor fees during and after the implementation of these changes. If we are unable to implement any of the required changes to our internal control over financial reporting effectively or efficiently or are required to do so earlier than anticipated, it could adversely affect our operations, financial reporting and/or results of operations and could result in an adverse opinion on internal controls from our independent auditors.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Assuming a market for our ordinary shares develops, shares eligible for future sale may adversely affect the market for our ordinary shares. </div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From time to time after we have been subject to the reporting requirements of section 13 or section 15(d) of the Exchange Act for at least 90 days, certain of our shareholders may be eligible to sell all or some of their ordinary shares by means of ordinary brokerage transactions in the open market pursuant to Rule 144, promulgated under the Securities Act, subject to certain limitations. In general, pursuant to Rule 144, non-affiliate shareholders may sell freely after six months subject only to the current public information requirement (which disappears after one year). Of the 44,393,910 ordinary shares expected to be outstanding following completion of the offering, after giving effect to the Transactions, approximately 36,637,050 shares will be held by &#8220;non-affiliates&#8221; and will be freely tradable without restriction pursuant to Rule 144, although a substantial majority of such shares will be subject to a 180-day lock-up. In addition, certain shareholders will have the ability to cause us to register the resale of their shares under the Registration Rights Agreement or the terms of certain warrants. See &#8220;Description of Share Capital&#8212;Registration Rights&#8221; for a description of the registration rights.</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Any substantial sale of our ordinary shares pursuant to Rule 144 or pursuant to any resale prospectus (including sales by investors of securities acquired in connection with this offering) may have a material adverse effect on the market price of our ordinary shares.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">48<br></div></div></div>
<!--End Page 54-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 55-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg40"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">We may allocate the net proceeds from this offering in ways that differ from the estimates discussed in the section titled &#8220;Use of Proceeds&#8221; and with which you may not agree.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The allocation of net proceeds of the offering set forth in the &#8220;Use of Proceeds&#8221; section below represents our estimates based upon our current plans and assumptions regarding industry and general economic conditions, and our future revenues and expenditures. The amounts and timing of our actual expenditures will depend on numerous factors, including market conditions, cash generated by our operations, business developments and rate of growth. Management has broad discretion over the use of proceeds of this offering and we may find it necessary or advisable to use all or portions of the proceeds from this offering for other purposes. Circumstances that may give rise to a change in the use of proceeds and the alternate purposes for which the proceeds may be used are discussed in the section entitled &#8220;Use of Proceeds.&#8221; You may not have an opportunity to evaluate the economic, financial or other information on which we base our decisions on how to use our proceeds. As a result, you and other shareholders may not agree with our decisions. Our failure to apply these funds effectively could have a material adverse effect on our business, financial condition, results of operations and prospects. Pending their use, we may invest the net proceeds from this offering in a manner that does not produce income or preserve value. See &#8220;Use of Proceeds&#8221; for additional information.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Participation in this offering by our existing shareholders or their affiliates, including Yozma, SKT, JJFIHC and iA, and certain other investors could reduce the public float for our ordinary shares. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Certain of our existing investors and their affiliated entities, including Yozma, SKT, JJFIHC and iA, and certain other investors have indicated an interest in purchasing an aggregate of up to approximately $80 million of our ordinary shares in this offering at the initial public offering price. However, because indications of interest are not binding agreements or commitments to purchase, these entities may determine to purchase fewer shares than they indicate an interest in purchasing or to not purchase any shares in this offering. It is also possible that these entities could indicate an interest in purchasing more of our ordinary shares. In addition, the underwriters could determine to sell fewer shares to any of these entities than the entities indicate an interest in purchasing or to not sell any shares to these entities.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If our existing shareholders or their affiliates, including Yozma, SKT, JJFIHC and iA, and certain other investors are allocated all or a portion of the shares in which these entities have indicated an interest in this offering or more, and purchase any such shares, such purchase could reduce the available public float for our shares if these entities hold these shares long term. These entities have agreed not to sell or transfer any of our ordinary shares that they purchase during the 180-day period commencing from the consummation of this offering, subject to limited exceptions.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">You will experience immediate dilution in the book value per share of the ordinary shares you purchase.</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Because the price per share of our ordinary shares being offered is substantially higher than the net tangible book value per share of our ordinary shares, you will experience substantial dilution in the pro forma as adjusted net tangible book value of the ordinary shares you purchase in this offering. Based on the assumed initial public offering price of $17.00 per share, the midpoint of the range set forth on the cover page of this prospectus, if you purchase ordinary shares in this offering, you will experience immediate and substantial dilution of $11.65 per share based on the pro forma as adjusted net tangible book value of the ordinary shares as of June&#160;30, 2020. See &#8220;Dilution&#8221; for a more detailed discussion of the dilution you will incur if you purchase ordinary shares in this offering. Moreover, we expect, in the future, to issue additional options to purchase our ordinary shares to compensate employees, consultants and directors and may issue additional shares to raise capital, to pay for services, or for other corporate purposes. To the extent our outstanding options or warrants are exercised or ordinary shares are issued at a price below net tangible book value per share, there will be additional dilution to our then-shareholders.</div> <div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">The purchase price of the ordinary shares may not reflect our actual value.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The purchase price of the ordinary shares is and will be determined through negotiations between us and representatives of the underwriters. The price of our ordinary shares may not be indicative of our actual value or any future market price for our securities. This price may not accurately reflect the value of the ordinary shares or the value that potential investors will realize upon their disposition of ordinary shares. The price does not necessarily bear any relationship to our assets, earnings, book value per share or other generally accepted criteria of value.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">49<br></div></div></div>
<!--End Page 55-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 56-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg41"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">If equity research analysts do not publish research or reports about us or our business or if they issue unfavorable commentary or downgrade our ordinary shares, the price of our ordinary shares could decline.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The trading market for our ordinary shares will rely in part on the research and reports that equity research analysts publish about us and our business. The analysts&#8217; estimates are based upon their own opinions and are often different from our estimates or expectations. If our results of operations are below the estimates or expectations of public market analysts and investors, the price of our ordinary shares could decline. Moreover, the price of our ordinary shares could decline if one or more securities analysts downgrade our ordinary shares or if those analysts issue other unfavorable commentary or cease publishing reports about us or our business.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">We have identified material weaknesses in our internal control over financial reporting that could, if not remediated, result in material misstatements in our financial statements. If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, shareholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our ordinary shares. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures are designed to prevent fraud. Our management will be required to assess the effectiveness of our internal controls and procedures and disclose changes in these controls on an annual basis. However, for as long as we are an &#8220;emerging growth company&#8221; under the JOBS Act, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to Section 404. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our ordinary shares. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have identified a material weakness in our internal control over financial reporting in connection with the audit of our financial statements as of and for the years ended December 31, 2018 and 2019. As defined in Regulation 12b-2 under the Exchange Act, a &#8220;material weakness&#8221; is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual financial statements will not be prevented, or detected on a timely basis. Specifically, we determined that the material weakness is related to having an insufficient number of financial reporting personnel with an appropriate level of knowledge, experience and training in application of U.S. GAAP and SEC rules and regulations commensurate with our reporting requirements. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have taken action toward remediating this material weakness by hiring additional qualified personnel with U.S. GAAP accounting and reporting experience, and intend to provide enhanced training to existing financial and accounting employees on related U.S. GAAP issues. In addition, to remediate this material weakness, we are implementing measures including the following:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we have hired a corporate controller with U.S. GAAP and SEC reporting experience and are continuing to seek additional financial professionals to increase the number of qualified financial reporting personnel;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we are selecting and implementing a new enterprise resource planning system;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we are developing, communicating and implementing an accounting policy manual for our financial reporting personnel for recurring transactions and period-end closing processes; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we are establishing monitoring and oversight controls for non-recurring and complex transactions to ensure the accuracy and completeness of our consolidated financial statements and related disclosures.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">However, the implementation of these initiatives may not fully address any material weakness or other deficiencies that we may have in our internal control over financial reporting.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">50<br></div></div></div>
<!--End Page 56-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 57-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg42"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Furthermore, we have not yet commenced the process of determining whether our existing internal control over financial reporting systems are compliant with Section 404 and whether there are any other material weaknesses or significant deficiencies in our existing internal controls. These controls and other procedures are designed to ensure that information required to be disclosed by us in the reports that we file with the SEC is disclosed accurately and is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Even if we develop effective internal control over financial reporting, these controls may become inadequate because of changes in conditions or the degree of compliance with these policies or procedures may deteriorate, and material weaknesses and deficiencies may be discovered in them. We are working with our legal, independent accounting and financial advisors to identify those areas in which changes should be made to our financial and management control systems to manage our growth and our obligations as a public company. These areas include corporate governance, corporate control, disclosure controls and procedures and financial reporting. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have made, and will continue to make, changes in these and other areas. In any event, the process of determining whether our existing internal controls are compliant with Section 404 and sufficiently effective will require the investment of substantial time and resources, including by our chief financial officer and other members of our senior management. As a result, this process may divert internal resources and take a significant amount of time and effort to complete, even more so after we are no longer an &#8220;Emerging Growth Company.&#8221; In addition, we cannot predict the outcome of this process and whether we will need to implement remedial actions in order to implement effective controls over financial reporting. The determination of whether or not our internal controls are sufficient and any remedial actions required could result in us incurring additional costs that we did not anticipate, including the hiring of outside consultants. We may also fail to complete our evaluation, testing and any required remediation needed to comply with Section 404 in a timely fashion. Irrespective of compliance with Section 404, any additional failure of our internal controls could have a material adverse effect on our stated results of operations and harm our reputation. As a result, we may experience higher than anticipated operating expenses, as well as higher independent auditor fees during and after the implementation of these changes. If we are unable to implement any of the required changes to our internal control over financial reporting effectively or efficiently or are required to do so earlier than anticipated, it could adversely affect our operations, financial reporting or results of operations and could result in an adverse opinion on internal controls from our independent auditors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Furthermore, if we are unable to certify that our internal control over financial reporting is effective and in compliance with Section 404, we may be subject to sanctions or investigations by regulatory authorities, such as the SEC or stock exchanges, and we could lose investor confidence in the accuracy and completeness of our financial reports, which could hurt our business, the price of our ordinary shares and our ability to access the capital markets.</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">It is likely that we will be classified as a passive foreign investment company, or PFIC, for U.S. federal income tax purposes for the current taxable year and possibly for future taxable years, which could result in adverse U.S. federal income tax consequences to U.S. Holders of our ordinary shares. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A non-U.S. corporation will be a PFIC for any taxable year if either (1) at least 75% of its gross income for such year consists of certain types of passive income; or (2) at least 50% of the value of its assets (generally determined based on an average of the quarterly values of the assets) during such year is attributable to assets that produce passive income or are held for the production of passive income. For this purpose, cash and assets readily convertible into cash are categorized as passive assets and our goodwill and other unbooked intangibles will generally be taken into account in determining our asset value. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A non-U.S. corporation&#8217;s PFIC status is a factual determination made annually after the close of each taxable year. Based upon our current and projected income and assets (including goodwill and taking into account our cash balances, including the anticipated proceeds from this offering) and the anticipated market price of our ordinary shares in this offering, it is likely that we will be classified as a PFIC for the current and future taxable years at least until we start generating a substantial amount of active revenue. In addition, it is possible that any subsidiary that we own would also be classified as a PFIC for such taxable years. Accordingly, prospective investors should be willing to assume the risks of investing in a PFIC.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If we were to be, or become, classified as a PFIC for any taxable year during which a U.S. Holder (as defined in the section headed &#8220;Material Tax Considerations&#8212;U.S. Federal Income Tax Considerations&#8221;) holds </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">51<br></div></div></div>
<!--End Page 57-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 58-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg43"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">our ordinary shares, certain adverse U.S. federal income tax consequences could apply to such U.S. Holder. See &#8220;Material Tax Considerations&#8212;U.S. Federal Income Tax Considerations.&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">You are strongly urged to consult your tax advisors regarding the impact of our being a PFIC in any taxable year on your investment in our ordinary shares as well as the application of the PFIC rules.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Risks Related to Our Operations in Israel</div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Conditions in Israel could materially and adversely affect our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our executive offices are located in Neve Ilan, Israel. In addition, a number of our officers and directors are residents of Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region may directly affect our business and operations. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its neighboring countries, as well as terrorist acts committed within Israel by hostile elements. During the last decade, there have been extended hostilities in 2009, 2012 through 2014, with additional small flare-ups as recently as 2018 and 2019. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Since February 2011, Egypt has experienced political turbulence and an increase in terrorist activity in the Sinai Peninsula. Such political turbulence and violence may damage peaceful and diplomatic relations between Israel and Egypt, and could affect the region as a whole. Similar civil unrest and political turbulence has occurred in other countries in the region, including Syria, which shares a common border with Israel, and is affecting the political stability of those countries. Since April 2011, internal conflict in Syria has escalated and chemical weapons have been used in the region. Foreign actors have intervened and may continue to intervene in Syria. This instability and any intervention may lead to deterioration of the political and economic relationships that exist between the State of Israel and some of these countries and may lead to additional conflicts in the region. In addition, Iran has threatened to attack Israel and may be developing nuclear weapons. Iran also has a strong influence among extremist groups in the region, including Hamas in Gaza, Hezbollah in Lebanon and various rebel militia groups in Syria. These situations have escalated at various points in recent years and may escalate in the future to more violent events, which may affect Israel and us. Any armed conflicts, terrorist activities or political instability in the region could adversely affect business conditions and could harm our results of operations and could make it more difficult for us to raise capital. In addition, the political and security situation in Israel may result in parties with whom we have agreements involving performance in Israel claiming that they are not obligated to perform their commitments under those agreements pursuant to force majeure provisions in such agreements. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We currently do not, and we do not expect to, carry any commercial insurance that covers losses resulting from events associated with war and terrorism. Although the Israeli government currently covers the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot be assured that this government coverage will be maintained or, if maintained, that it will be sufficient to compensate us fully for damages incurred and the government may cease providing such coverage or the coverage might not suffice to cover potential damages. Any losses or damages incurred by us could have a material adverse effect on our business. Any armed conflicts or political instability in the region would likely negatively affect business conditions and could harm our results of operations. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Further, in the past, the State of Israel and Israeli companies have been subjected to economic boycotts. Several countries still restrict business with the State of Israel and with Israeli companies. These restrictive laws and policies may have an adverse impact on our operating results, financial condition or the expansion of our business. A campaign of boycotts, divestment and sanctions has been undertaken against Israel, which could also adversely impact our business. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, many Israeli citizens are obligated to perform several days, and in some cases more, of annual military reserve duty each year until they reach the age of 40 (or older for certain reservists) and, in the event of a military conflict, may be called to active duty. In response to increases in terrorist activity, there have been periods of significant call-ups of military reservists. It is possible that there will be military reserve duty call-ups in the future. Our operations could be disrupted by such call-ups, which may include the call-up of members of our management. Such disruption could materially adversely affect our business, prospects, financial condition and results of operations. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">52<br></div></div></div>
<!--End Page 58-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 59-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg44"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">The termination or reduction of tax and other incentives that the Israeli government provides to Israeli companies may increase our costs and taxes.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Israeli government currently provides tax and capital investment incentives to Israeli companies, as well as grant and loan programs relating to research and development and marketing and export activities (see &#8220;Material Tax Considerations&#8212;Israeli Tax Considerations and Government Programs&#8221;). In recent years, the Israeli government has reduced the benefits available under these programs and the Israeli governmental authorities may in the future further reduce or eliminate the benefits of these programs. We may take advantage of these benefits and programs in the future; however, there can be no assurance that such benefits and programs will be available to us. If we qualify for such benefits and programs and fail to meet the conditions thereof, the benefits could be canceled and we could be required to refund any benefits we might already have enjoyed and become subject to penalties. Additionally, if we qualify for such benefits and programs and they are subsequently terminated or reduced, it could have an adverse effect on our financial condition and results of operations. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">It may be difficult to enforce a U.S. judgment against us, our officers and directors named in this prospectus in Israel or the United States, or to assert U.S. securities laws claims in Israel or serve process on our officers and directors. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Many of our directors and officers are not residents of the United States and a significant portion of their and our assets are located outside the United States. Service of process upon us or our non-U.S. resident directors and officers may be difficult to obtain within the United States. We have been informed by our legal counsel in Israel that it may be difficult to assert claims under U.S. securities laws in original actions instituted in Israel or obtain a judgment based on the civil liability provisions of U.S. federal securities laws. Israeli courts may refuse to hear a claim based on a violation of U.S. securities laws against us or our directors and officers because Israel may not be the most appropriate forum to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proved as a fact, which can be a time-consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding case law in Israel addressing the matters described above. Additionally, Israeli courts might not enforce judgments obtained in the United States against us or our directors and officers, which may make it difficult to collect on judgments rendered against us or our directors and officers. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Moreover, an Israeli court will not enforce a non-Israeli judgment if it was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases), if its enforcement is likely to prejudice the sovereignty or security of the State of Israel, if it was obtained by fraud or in the absence of due process, if it is at variance with another valid judgment that was given in the same matter between the same parties, or if a suit in the same matter between the same parties was pending before a court or tribunal in Israel at the time the foreign action was brought. For more information, see &#8220;Enforceability of civil liabilities.&#8221; </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Your rights and responsibilities as our shareholder will be governed by Israeli law, which may differ in some respects from the rights and responsibilities of shareholders of U.S. corporations. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We are incorporated under Israeli law. The rights and responsibilities of holders of our ordinary shares are governed by our amended and restated articles of association to be effective immediately prior to the closing of this offering and the Companies Law. These rights and responsibilities differ in some respects from the rights and responsibilities of shareholders in typical U.S. corporations. In particular, pursuant to the Companies Law, each shareholder of an Israeli company has to act in good faith and in a customary manner in exercising his or her rights and fulfilling his or her obligations toward the company and other shareholders and to refrain from abusing his or her power in the company, including, among other things, in voting at the general meeting of shareholders on amendments to a company&#8217;s articles of association, increases in a company&#8217;s authorized share capital, mergers and certain transactions requiring shareholders&#8217; approval under the Companies Law. In addition, under Israeli law, a controlling shareholder of an Israeli company or a shareholder who knows that it possesses the power to determine the outcome of a shareholder vote or who has the power to appoint or prevent the appointment of a director or officer in the company or has other powers toward the company has a duty of fairness toward the company. However, Israeli law does not define the substance of this duty of fairness. There is little case law available in Israel to assist in understanding the implications of these provisions that govern shareholder behavior. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">53<br></div></div></div>
<!--End Page 59-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 60-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_104-risk_pg45"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Our amended and restated articles of association will contain exclusive forum provisions for certain claims, which could limit our shareholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our amended and restated articles of association will provide that the federal district courts of the United States of America will, to the fullest extent permitted by law, be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act (the &#8220;Federal Forum Provision&#8221;). Our decision to adopt a Federal Forum Provision followed a decision by the Supreme Court of the State of Delaware holding that such provisions are facially valid under Delaware law. While there can be no assurance that U.S. federal or state courts or Israeli courts will follow the holding of the Delaware Supreme Court or determine that the Federal Forum Provision should be enforced in a particular case, application of the Federal Forum Provision means that suits brought by our shareholders to enforce any duty or liability created by the Securities Act must be brought in federal court and cannot be brought in state court. Section&#160;27 of the Exchange Act creates exclusive federal jurisdiction over all claims brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder and the Federal Forum Provision does not apply to suits brought to enforce any duty or liability created by the Exchange Act. Accordingly, actions by our shareholders to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder must also be brought in federal court. Our shareholders will not be deemed to have waived our compliance with the federal securities laws and the regulations promulgated thereunder.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Any person or entity purchasing or otherwise acquiring or holding any interest in any of our securities shall be deemed to have notice of and consented to the Federal Forum Provision. This provision may limit our shareholders&#8217; ability to bring a claim in a judicial forum they find favorable for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. Alternatively, if a court were to find the choice of forum provision contained in our amended and restated articles of association to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, operating results and financial condition. </div><div class="frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Provisions of our amended and restated articles of association and Israeli law and tax considerations may delay, prevent or make difficult an acquisition of us, which could prevent a change of control and negatively affect the price of our ordinary shares. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Israeli corporate law regulates mergers, requires tender offers for acquisitions of shares if such acquisitions cause the acquirer to hold more than specified thresholds, requires special approvals for certain transactions involving directors, officers or significant shareholders and regulates other matters that may be relevant to these types of transactions. For example, under Israeli law, a merger may not be consummated unless at least 50 days have passed from the date that a merger proposal was filed by each merging company with the Israel Registrar of Companies and at least 30 days have passed from the date that the shareholders of both merging companies approved the merger. See &#8220;Description of Share Capital&#8212;Acquisitions under Israeli Law.&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Furthermore, Israeli tax considerations may make potential transactions unappealing to us or to our shareholders, especially for those shareholders whose country of residence for tax purposes does not have a tax treaty with Israel which exempts such shareholders from Israeli tax. For example, Israeli tax law does not recognize tax-free share exchanges to the same extent as U.S. tax law. With respect to mergers, Israeli tax law allows for tax deferral in certain circumstances but makes the deferral contingent on the fulfillment of a number of conditions, including, in some cases, a holding period of two years from the date of the transaction during which sales and dispositions of shares of the participating companies are subject to certain restrictions. Moreover, with respect to certain share swap transactions, the tax deferral is limited in time, and when such time expires, the tax becomes payable even if no disposition of the shares has occurred. In order to benefit from the tax deferral, a pre-ruling from the Israeli Tax Authority may be required.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">These provisions of Israeli law and Israeli tax laws may delay, prevent or make difficult a merger with, or an acquisition of us, or all or a significant portion of our assets, which could prevent a change of control and may make it more difficult for a third party to acquire us, even if doing so would be beneficial to our shareholders. These provisions may limit the price that investors may be willing to pay in the future for our ordinary shares and therefore depress the price of our shares.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our amended and restated articles of association provide that our directors (other than external directors) are elected on a staggered basis, such that a potential acquirer cannot readily replace our entire board of directors at a single annual general shareholders meeting. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">54<br></div></div></div>
<!--End Page 60-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 61-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_105-special_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSN"><!--Anchor--></a>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">This prospectus contains forward-looking statements that are subject to risks and uncertainties. All statements that are not historical facts contained in this prospectus are forward-looking statements. These forward-looking statements include information about possible or assumed future results of our business, financial condition, results of operations, prospects, liquidity, plans and objectives. In some cases, you can identify forward-looking statements by terminology such as &#8220;can,&#8221; &#8220;might,&#8221; &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; or the negative of these terms or other similar expressions. Forward-looking statements are based on information we have when those statements are made or our management&#8217;s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Forward-looking statements include, but are not limited to, statements concerning: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The initiation, timing, progress and results of our research and development, manufacturing and commercialization activities with respect to our X-ray source technology, the Nanox.ARC, the Nanox.CLOUD and the Nanox System;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to successfully demonstrate the feasibility of our technology for commercial applications;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our expectations regarding the necessity of, timing of filing for, and receipt of, regulatory clearances or approvals regarding our technology, the Nanox.ARC and the Nanox.CLOUD;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to secure and maintain required FDA clearance and similar approvals from regulatory agencies worldwide and comply with applicable quality standards and regulatory requirements;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to manufacture the Nanox.ARC, if cleared, at substantially lower costs compared to medical imaging systems that use a legacy analog X-ray source;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to manufacture, market and deploy approximately 15,000 Nanox.ARC units within the contemplated timeframe;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to meet our planned deployment schedule for the Nanox System units within the contemplated timeframe;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the pricing structure of our products and services, if such products and services receive regulatory clearance or approval;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the implementation of our business models;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our expectations regarding collaborations with third-parties and their potential benefits;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to enter into and maintain our arrangements with third-party manufacturers and suppliers;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to conduct business globally;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our expectations regarding when certain patents may be issued and the protection and enforcement of our intellectual property rights;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to operate our business without infringing the intellectual property rights and propriety technology of third parties;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulatory developments in the United States and other jurisdictions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">estimates of our expenses, future revenues, capital requirements and our needs for additional financing;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the rate and degree of market acceptance of our technology and our products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">development relating to our competitors and the medical imaging industry;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our estimates of the adoption of the MSaaS-based model by market participants;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our estimates regarding the market opportunities for our technology and our products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to attract, motivate and retain key executive managers;</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">55<br></div></div></div>
<!--End Page 61-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 62-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_105-special_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to comply with data protection laws, regulations and similar rules and to establish and maintain adequate cyber-security and data protection;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to obtain third-party payor coverage or reimbursement of our Nanox System;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our expectation regarding the maintenance of our foreign private issuer and emerging growth company status;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our expectations regarding the use of proceeds from this offering; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our expectations regarding the closing of issuance and sale of our ordinary shares to Asia Beam Limited in the Private Placement;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the effect of the COVID-19 pandemic, including mitigation efforts and economic effects, on any of the foregoing or other aspects of our business operations, including but not limited to the development, deployment and regulatory clearance of the Nanox Systems; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our success at managing other risks and uncertainties, including those listed under &#8220;Risk Factors.&#8221; </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Many important factors, in addition to the factors described above and in other sections of this prospectus, could adversely impact our business and financial performance. The forward-looking statements contained in this prospectus speak only as of the date of this prospectus and are subject to a number of known and unknown risks, uncertainties and assumptions, including those described under the sections in this prospectus entitled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in this prospectus. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. Moreover, we operate in an evolving environment. New risks and uncertainties emerge from time to time, and it is not possible for our management to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from estimates or forward-looking statements. We qualify all of our forward-looking statements by these cautionary statements. Except as required by law, we undertake no obligation to update publicly any forward-looking statements after the date of this prospectus to conform these statements to actual results or to changes in our expectations.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">56<br></div></div></div>
<!--End Page 62-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 63-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_105-special_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tUP"><!--Anchor--></a>USE OF PROCEEDS</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We expect that we will receive net proceeds from this offering of approximately $133.2 million, based on an assumed initial public offering price of $17.00 per share, the mid-point of the estimated range of the initial public offering price shown on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering expenses, including the fees payable to A-Labs, payable by us. If the underwriters exercise their option to purchase additional ordinary shares in full, our net proceeds will be approximately $153.6 million after deducting the estimated underwriting discounts and commissions and estimated offering expenses, including the fees payable to A-Labs, payable by us. </div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We intend to use the net proceeds from our sale of ordinary shares in this offering, together with cash on hand, cash equivalents and short-term investments, as follows:</div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">between $144 million to $194 million will be used to manufacture the initial wave of Nanox.ARC units planned for global deployment and investment in manufacturing capacities; to the extent the cost-per-unit of the Nanox.ARC is higher than we expected or the amount of proceeds we receive is lower than we expected, we plan to reduce the number of units to be manufactured with such proceeds accordingly;</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">between $18 million to $30 million will be used for the shipping, installation and deployment costs of the Nanox System; to the extent the number of units of the Nanox.ARC to be manufactured is reduced for the reasons described above, the amount of proceeds to be used for shipping, installation and deployment will be reduced accordingly;</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">between $5 million to $9 million will be used for the continued research and development of the Nanox.ARC, the development of the Nanox.CLOUD and for regulatory clearance in various regions, which we expect will be sufficient for obtaining the 510(k) medical device clearance with respect to the Nanox.ARC with the FDA; and</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the remaining funds, if any, to be used for sales and marketing expenses, general and administrative expenses and general corporate purposes.</div></td></tr></table> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pending such use of the net proceeds from this offering, we intend to hold some amounts as cash and to invest the remaining net proceeds in a variety of capital preservation investments, including short-term, investment-grade, interest-bearing instruments denominated in currencies and with maturities that match our contracted expenditures and financial plans.</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The amounts and timing of our actual expenditures will depend on numerous factors, including market conditions, results from our research and development efforts, business developments and opportunities and customer facing and product support activities. Accordingly, our management will have broad discretion in the application of the net proceeds, and investors will be relying on the judgment of our management regarding the application of the proceeds from this offering. We may find it necessary or advisable to use portions of the proceeds from this offering for other purposes. Circumstances that may give rise to a change in the use of proceeds and the alternate purposes for which the proceeds may be used include:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the existence of unforeseen or other opportunities or the need to take advantage of changes in timing of our existing activities;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the need or desire on our part to accelerate, increase, reduce or eliminate one or more existing initiatives due to, among other things, changing market conditions or competitive developments or interim results of research and development efforts;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">results from our business development and marketing efforts;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the effect of federal, state, and local regulation on our business; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the presentation of strategic opportunities of which we are not currently aware (including acquisitions, joint ventures, licensing and other similar transactions).</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From time to time, we evaluate these and other factors and we anticipate continuing to make such evaluations to determine if the existing allocation of resources, including the proceeds of this offering, is being optimized.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">57<br></div></div></div>
<!--End Page 63-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 64-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_105-special_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A $1.00 increase or decrease in the assumed initial public offering price of $17.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, the net proceeds to us from this offering by approximately $8.0 million, assuming the number of shares offered by us remains the same as set forth on the cover page of this prospectus and after deducting the estimated underwriting discounts and commissions and estimated offering expenses, including the fees payable to A-Labs, payable by us.</div> </div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">58<br></div></div></div>
<!--End Page 64-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 65-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_105-special_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDP"><!--Anchor--></a>DIVIDEND POLICY</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have never declared or paid any cash dividends on our ordinary shares and we anticipate that, for the foreseeable future, we will retain any future earnings to support operations and to finance the growth and development of our business. Therefore, we do not expect to pay cash dividends for at least the next several years.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The distribution of dividends may also be limited by the Companies Law, which permits the distribution of dividends only out of retained earnings or earnings derived over the two most recent fiscal years, whichever is higher, provided that there is no reasonable concern that payment of a dividend will prevent a company from satisfying its existing and foreseeable obligations as they become due. Our amended and restated articles of association provide that dividends will be paid at the discretion of, and upon resolution by, our board of directors, subject to the provision of the Companies Law. See &#8220;Description of Share Capital&#8212;Dividend and Liquidation Rights.&#8221;</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">59<br></div></div></div>
<!--End Page 65-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 66-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_105-special_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tC"><!--Anchor--></a>CAPITALIZATION</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table sets forth our cash and cash equivalents and total capitalization as of June&#160;30, 2020. Our capitalization is presented on:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an actual basis;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a pro forma basis to give effect to (i)&#160;the receipt of approximately $66.1 million, before fees and expenses, and the issuance of 4,131,250 ordinary shares to certain investors after June&#160;30, 2020 in connection with the Private Placement, (ii) the issuance of 653,013 ordinary shares immediately prior to the closing of this offering as a result of the assumed and actual exercises of warrants on a cashless basis held by certain of our shareholders and (iii) the issuance of 106,152 ordinary shares prior to the closing of this offering as a result of the exercise of warrants on a cash basis held by certain of our shareholders with aggregate proceeds of $0.2 million (collectively, the &#8220;Transactions&#8221;); and</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">on a pro forma as adjusted basis to give further effect to the issuance and sale of 8,823,530 ordinary shares by us in this offering at an assumed initial public offering price of $17.00 per share, the midpoint of the price range set forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering expenses, including the fees payable to A-Labs, payable by us.</div></td></tr></table> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">You should read this table in conjunction with our audited consolidated financial statements and related notes as appearing elsewhere in this prospectus and the sections of this prospectus titled &#8220;Selected Consolidated Financial Data,&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included elsewhere in this prospectus.</div> <table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 1.17%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 30.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">As of June&#160;30, 2020</div></td></tr><tr class="header"><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 1.17%; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Actual</div></td><td class="gutter" style="width: 1.17%; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.17%; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pro Forma</div></td><td class="gutter" style="width: 1.17%; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.17%; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.51%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pro Forma <br>As Adjusted<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td></tr><tr class="header"><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt;">&#8203;</td><td colspan="7" style="width: 30.99%; text-align: center; vertical-align: bottom; padding-top: 4pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands, except share and <br>per share amounts)</div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 1.77pt;"></font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 3.33pt;">&#8203;</font>39,524</div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;">$103,290</div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.85pt; text-align: left;">$236,521</div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Shareholders&#8217; equity: <br></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Ordinary Shares, par value NIS 0.01 per share; 40,000,000 shares authorized, actual; 100,000,000 shares authorized, pro forma and pro forma as adjusted; 30,679,965 shares issued and outstanding, actual; 35,570,380 shares issued and outstanding, pro forma; 44,393,910 shares issued and outstanding, pro forma as adjusted<font style="padding-left: 2.07pt;"></font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.83pt;">85</font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;"><font style="padding-left: 27.5pt;">99</font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.85pt; text-align: left;"><font style="padding-left: 22.5pt;">124</font></div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Additional paid-in capital <br></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">94,661</font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;"><font style="padding-left: 5pt;">158,</font>414</div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;">&#8203;</td><td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.85pt; text-align: left;"><font style="padding-left: 5pt;">291,619</font></div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated deficit <br></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(54,387)</font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;"><font style="padding-left: 6.67pt;">(54,387)</font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.85pt; text-align: left;"><font style="padding-left: 6.67pt;">(54,387)</font></div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total shareholders&#8217; equity <font style="padding-left: 0.98pt;"></font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000;">40,359</font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">104,</font><font style="border-bottom: 1pt solid #000000;">125</font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;">&#8203;</td><td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 4pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.85pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">237,356</font></div></td></tr><tr><td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total capitalization<font style="padding-left: 1.89pt;"></font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$</font><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000;">&#8203;</font><font style="border-bottom: 3pt double #000000;">40,359</font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$</font><font style="border-bottom: 3pt double #000000;">104,</font><font style="border-bottom: 3pt double #000000;">125</font></div></td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.17%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.85pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$</font><font style="border-bottom: 3pt double #000000;">237,356</font></div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Each $1.00 increase or decrease in the assumed initial public offering price of&#8201; $17.00 per share (which is the midpoint of the price range set forth on the cover page of this prospectus) would increase or decrease the amount of each of cash and cash equivalents, additional paid-in capital, total shareholders&#8217; equity and total capitalization on a pro forma as adjusted basis by approximately $8.0 million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and commissions and estimated offering expenses, including the fees payable to A-Labs, payable by us. Each increase or decrease of 1.0&#160;million in the number of ordinary shares we are offering would increase or decrease the pro forma as adjusted amount of each of cash and cash equivalents, additional paid-in capital, total shareholders&#8217; equity and total capitalization by approximately $15.4 million, assuming no change in the assumed initial public offering price and after deducting the estimated underwriting discounts and commissions and estimated offering expenses, including the fees payable to A-Labs, payable by us.</div></td></tr></table> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">As of June&#160;30, 2020, we did not have any indebtedness. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">The table above excludes:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">4,586,424 ordinary shares issuable upon the exercise of options to purchase ordinary shares outstanding under the 2019 Equity Incentive Plan as of June&#160;30, 2020, at a weighted average exercise price of $3.70 per share;</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">60<br></div></div></div>
<!--End Page 66-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 67-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_105-special_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">3,455,512 additional ordinary shares reserved for future issuance under our 2019 Equity Incentive Plan as of June&#160;30, 2020; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">4,536,901 ordinary shares issuable upon the exercise of warrants to purchase ordinary shares as of June&#160;30, 2020, at a weighted average exercise price of $11.54 per share, which warrants shall not expire upon the closing of this offering if not exercised; and</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">220,588 ordinary shares issuable upon the exercise of warrants to purchase ordinary shares to be granted to A-Labs, which provided certain consulting services for this offering, at the closing of this offering, at an exercise price equal to the price per ordinary share in this offering.</div></td></tr></table> </div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">61<br></div></div></div>
<!--End Page 67-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 68-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_105-special_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tD"><!--Anchor--></a>DILUTION </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If you invest in our ordinary shares in this offering, your ownership interest will be immediately diluted to the extent of the difference between the initial public offering price per share and the pro forma as adjusted net tangible book value per share after this offering. Our historical net tangible book value as of June&#160;30, 2020 was $1.31 per share.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">Historical net tangible book value per share was calculated by:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">subtracting our liabilities from our tangible assets as of June&#160;30, 2020; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">dividing the difference by the number of ordinary shares outstanding as of June 30, 2020. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our pro forma net tangible book value as of June&#160;30, 2020 was $2.93 per share. Pro forma net tangible book value per share gives further effect to the Transactions (as defined and further described under&#160;&#8220;Capitalization&#8221;).</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">After giving effect to the sale of 8,823,530 ordinary shares that we are offering at an assumed initial public offering price of $17.00 per share (which is the midpoint of the price range set forth on the cover page of this prospectus), after deducting the estimated underwriting discounts and commissions and estimated offering expenses, including the fees payable to A-Labs, payable by us, our pro forma as adjusted net tangible book value as of June&#160;30, 2020 would have been $5.35 per share. This amount represents an immediate increase in pro forma net tangible book value of $1.62 per share to our existing shareholders and an immediate dilution in pro forma net tangible book value of $11.65 per share to new investors purchasing ordinary shares in this offering. We determine dilution by subtracting the pro forma as adjusted net tangible book value per share after this offering from the initial public offering price per share paid by new investors in this offering. </div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">The following table illustrates this dilution on a per share basis:</div> <table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assumed initial public offering price per share<font style="padding-left: 1.1pt;"></font></div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$17.00</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Historical net tangible book value per share as of June&#160;30, 2020<font style="padding-left: 4pt;"></font></div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1.31</div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Increase per share attributable to the Transactions<font style="padding-left: 4.24pt;"></font></div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5.78pt;">1.</font>62</div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Pro forma net tangible book value (deficit) per share as of June&#160;30, 2020<font style="padding-left: 1.11pt;"></font></div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5.78pt;">2.9</font>3</div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Increase per share attributable to this offering<font style="padding-left: 4.97pt;"></font></div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5.78pt; border-bottom: 1pt solid #000000;">2.42</font></div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pro forma as adjusted net tangible book value per share after this offering<font style="padding-left: 3.08pt;"></font></div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 4.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 5.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 5.98pt; border-bottom: 1pt solid #000000;">&#8203;</font><font style="border-bottom: 1pt solid #000000;">5.35</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dilution per share to new investors in this offering<font style="padding-left: 4.07pt;"></font></div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 1.55pt; border-bottom: 1pt solid #000000;">&#8203;</font><font style="border-bottom: 1pt solid #000000;">11.65</font></div></td></tr></table> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A $1.00 increase or decrease in the assumed initial public offering price of $17.00 per share (which is the midpoint of the price range set forth on the cover page of this prospectus) would increase or decrease the dilution to new investors by approximately $0.18 per share, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and commissions and estimated offering expenses, including the fees payable to A-Labs, payable by us. Each increase or decrease of 1.0 million shares in the number of shares offered by us would increase or decrease our pro forma as adjusted net tangible book value per share after this offering by $0.22 per share and decrease or increase the dilution to new investors by $0.22 per share, assuming that the assumed initial public offering price remains the same, and after deducting the estimated underwriting discounts and commissions and the estimated offering expenses, including the fees payable to A-Labs, payable by us. </div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If the underwriters exercise their option to purchase additional ordinary shares in full in this offering, the pro forma as adjusted net tangible book value after the offering would be $5.64 per share, the increase in net tangible book value per share to existing shareholders prior to such option exercise would be $0.29 per share and the dilution in net tangible book value per share to new investors would be $0.29 per share, in each case assuming an initial public offering price of $17.00 per share (which is the midpoint of the price range set forth on the cover page of this prospectus). </div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes, on a pro forma as adjusted basis, as of June&#160;30, 2020, the differences between the number of shares purchased from us, the total consideration paid to us, and the average price per share that existing shareholders paid during the past five years, on the one hand, and the average price per share that new </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">62<br></div></div></div>
<!--End Page 68-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 69-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_105-special_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">investors are paying in this offering at the assumed initial public offering price of $17.00 per share (which is the midpoint of the price range set forth on the cover page of this prospectus), after deducting the estimated underwriting discounts and commissions and estimated offering expenses, including the fees payable to A-Labs, payable by us, on the other hand. </div> <table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 5.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.11%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Ordinary Shares Purchased</div></td><td class="gutter" style="width: 1.11%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.11%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.39%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total Consideration</div></td><td class="gutter" style="width: 1.11%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.11%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 10.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average Price <br>Per Share</div></td></tr><tr class="header"><td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.11%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 12.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number</div></td><td class="gutter" style="width: 1.11%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.11%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.47%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">%</div></td><td class="gutter" style="width: 1.11%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.11%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 13.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td class="gutter" style="width: 1.11%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.11%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 4.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">%</div></td><td class="gutter" style="width: 1.11%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Existing shareholders<font style="padding-left: 2.31pt;"></font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 12.88%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.65pt; text-align: left;">35,570,380</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.65pt; text-align: left;"><font style="padding-left: 5pt;">80</font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 13.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 10pt;">158,</font>512,491</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10pt;">54</font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.39pt; text-align: left;">$<font style="padding-left: 15pt;">4.</font>50</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">New investors<font style="padding-left: 1.19pt;"></font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 12.88%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.65pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">8,823,530</font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 6.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.65pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">20</font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 13.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">&#8195;</font><font style="border-bottom: 1pt solid #000000;">133,230,543</font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 4.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">&#8195;</font><font style="border-bottom: 1pt solid #000000;">46</font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.39pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">&#8195;</font><font style="border-bottom: 1pt solid #000000;">15.10</font></div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 4.09pt;"></font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 12.88%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.65pt; text-align: left;">44,393,910</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.65pt; text-align: left;">100%</div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 13.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15pt;">291,743,034</font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 5pt;">100%</font></div></td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr></table> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A $1.00&#160;increase or decrease in the assumed initial public offering price of $17.00 per share (which is the midpoint of the price range set forth on the cover page of this prospectus) would increase or decrease the total consideration paid by new investors by $8.0 million and, in the case of an increase, would increase the percentage of total consideration paid by new investors by 1.4 percentage points and, in the case of a decrease, would decrease the percentage of total consideration paid by new investors by 1.4 percentage points, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same. An increase or decrease of 1.0&#160;million shares in the number of shares offered by us, as set forth on the cover page of this prospectus, would increase or decrease the total consideration paid by new investors by $15.4&#160;million and, in the case of an increase, would increase the percentage of total consideration paid by new investors by 2.7 percentage points and, in the case of a decrease, would decrease the percentage of total consideration paid by new investors by 2.7 percentage points, assuming no change in the assumed initial public offering price.</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">If the underwriters exercise their option to purchase additional ordinary shares in full:</div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the percentage of ordinary shares held by existing shareholders prior to such option exercise will decrease to approximately 78% of the total number of our ordinary shares outstanding after this offering; and</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the number of shares held by new investors will increase to 10.147,059, or approximately 22% of the total number of our ordinary shares outstanding after this offering. </div></td></tr></table> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The pro forma and pro forma as adjusted information discussed above is illustrative only. Our actual net tangible book value following the completion of this offering is subject to adjustment based on the actual initial public offering price of our ordinary shares and other terms of this offering determined at pricing.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of these securities may result in further dilution to new investors participating in this offering.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The number of our ordinary shares outstanding after this offering is based on 30,679,965 ordinary shares outstanding as of June&#160;30, 2020 and excludes:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">4,586,424 ordinary shares issuable upon the exercise of options to purchase ordinary shares outstanding under the 2019 Equity Incentive Plan as of June&#160;30, 2020, at a weighted average exercise price of $3.70 per share;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">3,455,512 additional ordinary shares reserved for future issuance under our 2019 Equity Incentive Plan as of June&#160;30, 2020;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">4,536,901 ordinary shares issuable upon the exercise of warrants to purchase ordinary shares as of June&#160;30, 2020, at a weighted average exercise price of $11.54 per share, which warrants shall not expire upon the closing of this offering if not exercised; and</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">220,588 ordinary shares issuable upon the exercise of warrants to purchase ordinary shares to be granted to A-Labs, which provided certain consulting services for this offering, at the closing of this offering, at an exercise price equal to the price per ordinary share in this offering.</div></td></tr></table> </div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">63<br></div></div></div>
<!--End Page 69-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 70-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_105-special_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">To the extent any of these outstanding options or warrants are exercised, there will be further dilution to new investors. To the extent all of such outstanding options and warrants had been exercised as of June&#160;30, 2020, the pro forma as adjusted net tangible book value per share after this offering would be $5.76, and total dilution per share to new investors would be $11.24.</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Certain of our existing investors and their affiliated entities, including Yozma, SKT, JJFIHC and iA, and certain other investors have indicated an interest in purchasing an aggregate of up to approximately $80 million of our ordinary shares in this offering at the initial public offering price. However, because indications of interest are not binding agreements or commitments to purchase, these entities may determine to purchase fewer shares than they indicate an interest in purchasing or to not purchase any shares in this offering. It is also possible that these entities could indicate an interest in purchasing more of our ordinary shares. In addition, the underwriters could determine to sell fewer shares to any of these entities than the entities indicate an interest in purchasing or to not sell any shares to these entities. The underwriters will receive the same underwriting discount on any shares purchased by these entities as they will on any other shares sold to the public in this offering.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">64<br></div></div></div>
<!--End Page 70-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 71-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_105-special_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSC"><!--Anchor--></a>SELECTED CONSOLIDATED FINANCIAL DATA</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following tables set forth our selected consolidated historical financial data which is derived from our audited financial statements, which have been prepared in accordance with U.S. GAAP. The selected statement of operations and balance sheet data for the years ended or as of December&#160;31, 2019 and 2018 have been derived from our audited consolidated financial statements included elsewhere in this prospectus. The selected statement of operations data for the six&#160;months ended June&#160;30, 2020 and 2019 and the selected balance sheet data as of June&#160;30, 2020 have been derived from our unaudited consolidated financial statements included elsewhere in this prospectus and have been prepared on the same basis as the audited financial statements. For periods and at dates prior to the Asset Purchase, our financial statements were prepared based on the historical financial statements of Nanox Gibraltar, with certain adjustments as described under &#8220;Basis of Presentation.&#8221; You should read this selected consolidated financial data section in conjunction with, and it is qualified in its entirety by, reference to our historical financial information and other information provided in this prospectus including &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our audited consolidated financial statements and related notes included elsewhere in this prospectus. The historical results set forth below are not necessarily indicative of the results to be expected in future periods.</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 17.95%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six months ended <br>June 30,</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 17.95%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December&#160;31,</div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td colspan="10" style="width: 37.18%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands, except <br>per share data)</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consolidated Statement of Operations Data:<br></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development expenses<font style="padding-left: 1.68pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;">$<font style="padding-left: 8.33pt;">4,152</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;">$<font style="padding-left: 12.5pt;">340</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;">$<font style="padding-left: 8.33pt;">&#8203;</font>2,717</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;">$<font style="padding-left: 12.5pt;">672</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketing expenses<font style="padding-left: 4.42pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;"><font style="padding-left: 13.33pt;">1,745</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="padding-left: 17.5pt;">242</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;"><font style="padding-left: 13.33pt;">1,556</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="padding-left: 17.5pt;">209</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative expenses<font style="padding-left: 1.12pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000;">7,903</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000;">1,079</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000;">1</font><font style="border-bottom: 1pt solid #000000;">8,298</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000;">1,</font><font style="border-bottom: 1pt solid #000000;">023</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating loss<font style="padding-left: 1.63pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;"><font style="padding-left: 5pt;">(13,800)</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="padding-left: 6.67pt;">(1,661)</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;"><font style="padding-left: 5pt;">(22,571)</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="padding-left: 6.67pt;">(</font>1,904)</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Financial (income) expenses, net<font style="padding-left: 1.39pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000;">(14</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000;">14</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 1pt solid #000000;">(8</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 1pt solid #000000;">5</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss for the year<font style="padding-left: 1.11pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: justify;"><font style="border-bottom: 1pt solid #000000;">$(13,78</font><font style="border-bottom: 1pt solid #000000;">6</font><font style="border-bottom: 1pt solid #000000;"></font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 1.67pt; border-bottom: 1pt solid #000000;">(1,675</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: justify;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="border-bottom: 1pt solid #000000;">(22,563</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 1.67pt; border-bottom: 1pt solid #000000;">(1,909</font>)</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Basic and diluted loss per ordinary share<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 4.05pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000;">(0.47</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="padding-left: 11.67pt; border-bottom: 1pt solid #000000;">(0.07</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 10pt; border-bottom: 1pt solid #000000;">(0.90</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000;">(0.09</font>)</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Weighted average number of ordinary shares outstanding&#8201;&#8211;&#8201;basic and diluted<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 1.21pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000;">29,273</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">23</font><font style="border-bottom: 1pt solid #000000;">,</font><font style="border-bottom: 1pt solid #000000;">452</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.59pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000;">25,18</font><font style="border-bottom: 1pt solid #000000;">1</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.25pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">20,79</font><font style="border-bottom: 1pt solid #000000;">3</font></div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Basic loss per share and diluted loss per share are the same because outstanding options would be anti-dilutive due to our net losses in these periods. See Note 7 to our unaudited condensed consolidated financial statements and Note 11 to our audited consolidated financial statements appearing at the end of this prospectus for further details on the calculation of basic and diluted net loss per share attributable to our ordinary shareholders.</div></td></tr></table><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 9.75pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">As of June 30,</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 22.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">As of December&#160;31,</div></td></tr><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td colspan="7" style="width: 34.62%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands)</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consolidated Balance Sheet Data:<br></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 4.77pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;">$<font style="padding-left: 3.33pt;">39,524</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;">$<font style="padding-left: 8.33pt;">&#8203;</font>8,072</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;">$<font style="padding-left: 25.83pt;">5</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Working capital<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 4.02pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 8.33pt;">37,846</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 5pt;">(10,627)</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 10pt;">(6,540)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total assets <font style="padding-left: 2.11pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 8.33pt;">43,581</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 8.7pt;">11,871</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 13.33pt;">1,855</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total liabilities<font style="padding-left: 1.55pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 13.33pt;">3,222</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 8.33pt;">20,649</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 13.33pt;">8,239</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated deficit <font style="padding-left: 1.98pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 5pt;">(54,387</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 5pt;">(40,601)</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 5pt;">(18,038)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total shareholders&#8217; equity (deficit)<font style="padding-left: 1.78pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 8.33pt;">40,359</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 10pt;">(8,778)</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 10pt;">(6,384)</font></div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">We define working capital as current assets less current liabilities.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">65<br></div></div></div>
<!--End Page 71-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 72-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tMDA"><!--Anchor--></a>MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION <br>AND RESULTS OF OPERATIONS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">You should read the following discussion and analysis of our financial condition and results of operations together with the &#8220;Selected Consolidated Financial Data&#8221; section of this prospectus and our consolidated financial statements and the related notes included elsewhere in this prospectus. Some of the information contained in this discussion and analysis or set forth elsewhere in this prospectus, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the &#8220;Risk Factors&#8221; section of this prospectus, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Overview</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Early detection saves lives&#8212;and we at Nanox are focused on applying our proprietary medical imaging technology to make diagnostic medicine more accessible and affordable across the globe. Our vision is to increase early detection of medical conditions that are discoverable by X-ray, which we believe is key to increasing early treatment, improving health outcomes and, ultimately, saving lives. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">To further our vision, we have developed a prototype of the Nanox.ARC, a medical imaging system incorporating our novel X-ray source, and we have developed a prototype of the Nanox.CLOUD, a companion cloud software. If cleared, we plan to market and deploy the Nanox System broadly across the globe at a substantially lower cost compared to currently available medical imaging systems, such as CT. We believe that, if cleared, our technology&#8217;s relatively low cost will enable us to increase accessibility and affordability of early-detection medical imaging systems globally.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Since our inception, we have devoted substantially all of our financial resources to acquiring the base technology for our X-ray source and related know-how, conducting research and development activities, organizing and staffing our company, developing our business plan, securing related intellectual property rights and raising capital. We do not have any product approved for sale and have not generated any revenue from product sales. We have funded our operations to date primarily with proceeds from the sale of our ordinary shares and warrants (after September&#160;3, 2019) and those of our predecessor company (prior to September&#160;3, 2019). During the six months ended June&#160;30, 2020 and 2019 and the years ended December 31, 2019 and 2018, we received net cash proceeds of $37.2&#160;million, $9.3&#160;million, $14.0 million and $3.7 million, respectively, from the sales of our and our predecessor&#8217;s ordinary shares.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have incurred significant operating losses since our inception. Our ability to achieve profitability depends on the successful development and commercialization of our technology and our products. We incurred net losses of $13.8&#160;million, $1.7&#160;million, $22.6 million and $1.9 million for the six months ended June&#160;30, 2020 and 2019 and the years ended December&#160;31, 2019 and 2018, respectively. As of June&#160;30, 2020 and December&#160;31, 2019, we had an accumulated deficit of $54.4 million and $40.6&#160;million, respectively. We expect to continue to incur significant expenses for at least the next several years as we advance the Nanox System through further development and regulatory approval. If we obtain marketing approval for the Nanox.ARC, we expect to incur significant commercialization expenses related to product manufacturing, marketing, sales and distribution. In addition, upon the closing of this offering, we expect to incur additional costs associated with operating as a public company, including significant legal, accounting, investor relations and other expenses that we did not incur as a private company.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We plan to jumpstart the MSaaS-based medical imaging market by producing and deploying an initial wave of approximately 15,000 Nanox.ARC units. We estimate that effectively stimulating market interest in our Nanox System will require deploying at least 5,000 to 10,000 Nanox.ARC units. In addition, we believe that a minimum installed base of at least 1,000 Nanox.ARC units will be required to support our business during the initial wave of deployment, assuming we enter into at least one licensing agreement on commercially reasonable terms. We expect to incur significant expenses for the manufacture, installation, deployment and maintenance of the Nanox System. As a result, we need substantial funding to support our continuing operations and pursue our business strategy before we can generate significant revenues. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through the sale of equity, debt financings or other capital sources, including collaborations, strategic partnerships or marketing, distribution or licensing arrangements with third parties. We may be unable to raise additional funds or enter into such other agreements </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">66<br></div></div></div>
<!--End Page 72-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 73-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as and when needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more of our products or delay our pursuit of potential in-licenses or acquisitions.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of June&#160;30, 2020, we had cash and cash equivalents of $39.5 million. We believe that the anticipated net proceeds from this offering, together with our cash on hand, cash equivalents and short-term investments, will enable us to fund our operating expenses and capital expenditure requirements for at least the next twelve months. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our capital resources sooner than we expect. See &#8220;&#8212;Liquidity and Capital Resources.&#8221; </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Asset Purchase</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company (NANO-X IMAGING LTD), an Israeli limited liability company, was formed on December 20, 2018. Pursuant to the Asset Purchase Agreement, as amended on December 3, 2019 and December 31, 2019, substantially all of the assets of Nanox Gibraltar, including all patents, patent applications and all other intellectual property rights, but not including the shares of Nanox Japan, Inc., a wholly owned subsidiary of Nanox Gibraltar (&#8220;Nanox Japan (predecessor)&#8221;), were sold to the Company for an aggregate consideration of $13.3 million, reflecting the fair market value of the transferred assets, which was estimated to be $6.1 million (excluding cash) based on an independent valuation report, plus the cash balance less $200,000, which cash amount totaled $7.2 million as of the date of the Asset Purchase Agreement. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the terms of the Asset Purchase Agreement, the consideration for the transferred assets will be paid only on the occurrence of one of the following events: (a) the closing of a transaction involving the sale of all or substantially all of the Company&#8217;s assets; (b) the acquisition of the Company by, or the merger of the Company with, another entity, consolidation, reorganization, recapitalization, sale, assignment or disposal by the Company of all or substantially all of the issued and outstanding shares of the Company; (c) the transfer, sale, lease, grant or other disposition of or the grant of an exclusive license over all or substantially all of Company&#8217;s assets, including, but not limited to, intellectual property, with the same economic effect to that of a sale and/or cessation of its business; (d) any other transaction, except for a financing round, following which the shareholders of the Company prior to the closing of such transaction own, directly or indirectly, less than 50% of the voting power of the surviving entity; (e) the closing of the first underwritten public offering of the Company pursuant to a registration statement under the Securities Act or the Israeli Securities Law, 5728-1968, as amended (or under equivalent securities law of another jurisdiction) or any other securities laws world-wide with the same effects and results; and (f) an equity financing of the Company at a minimum pre-money valuation of $100.0 million, with proceeds to the Company of at least $30.0&#160;million. In the events of (e) or (f) above, the Company will have the option to pay the consideration in cash or by the issuance to Nanox Gibraltar of the Company&#8217;s securities of the same series to be issued upon such event, in an amount reflecting a 25% discount on the price per share to be determined in connection with (e) and (f) above. If the Company elects to pay such consideration in cash, Nanox Gibraltar will have the right, at its sole discretion and in good faith, to reject such payment in cash, and require that the Company pay such consideration in the form of the Company&#8217;s securities in such amount and with such discount described above. In connection with this, the Company recorded a related party liability in an amount of $17.8 million in its financial statements as of and for the year ended December 31, 2019. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In January 2020, the board of directors of the Company and the board of directors and shareholders of Nanox Gibraltar approved the issuance of shares in accordance with the terms of the Asset Purchase Agreement described above. As a result, 1,109,245 of the Company&#8217;s ordinary shares were issued to Nanox Gibraltar, representing an aggregate consideration of approximately $17.8 that reflects a 25% discount on the price per share received in the Private Placement, and the Company has no further obligations to Nanox Gibraltar under the Asset Purchase Agreement. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Components of Our Results of Operations</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Revenue</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">As of the date of this prospectus, we have not generated any revenue from product sales or otherwise. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">67<br></div></div></div>
<!--End Page 73-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 74-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Operating Expenses</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Research and Development Expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Research and development expenses consist primarily of costs incurred in connection with the research and development of our products. These expenses include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">expenses incurred in connection with the development of our products, including payments made pursuant to agreements with third parties, such as outside consultants related to process development and manufacturing activities, as well as patent registrations;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">costs of components and materials, including payments made pursuant to agreements with third parties;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">costs of laboratory supplies incurred for each program;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">facilities, depreciation and other expenses, including direct or allocated expenses for rent and maintenance of facilities, as well as insurance costs; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">costs related to compliance with regulatory requirements; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">employee-related expenses, including salaries, related benefits and share-based compensation expenses for employees engaged in research and development activities.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We recognize external development costs based on an evaluation of the progress to completion of specific tasks using information provided to us by our suppliers and service providers. Upfront payments, milestone payments (other than those deemed contingent consideration in a business combination) and annual maintenance fees under license agreements are expensed in the period in which they are incurred.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Research and development activities are central to our business. We expect that our research and development expenses will increase substantially over the next several years as we continue development of the Nanox System. We expect to continue to devote a substantial portion of our resources to the Nanox.ARC hardware, the Nanox.CLOUD software and our underlying technology for the foreseeable future.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The successful development and commercialization of our products are highly uncertain. At this time, we cannot reasonably estimate or know the nature, timing and costs of the efforts that will be necessary to complete the development of any of our products. This uncertainty is due to the numerous risks and uncertainties associated with product development and commercialization, including the uncertainty of:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the timing and progress of development activities;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to maintain our current research and development programs and to establish new ones;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the receipt of regulatory approvals from applicable regulatory authorities without the need for independent clinical trials or validation;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the timing, receipt and terms of any marketing approvals from applicable regulatory authorities;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to establish new licensing or collaboration arrangements;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the performance of our future collaborators, if any;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">establishing commercial manufacturing capabilities or making arrangements with third-party manufacturers;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining, maintaining, defending and enforcing patent claims and other intellectual property rights;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">launching commercial sales of our products, including the Nanox.ARC hardware and Nanox.CLOUD software, whether alone or in collaboration with others; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">maintaining a continued acceptable safety profile of the products following approval.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Any changes in the outcome of any of these variables with respect to the development of our products could result in a significant change in the costs and timing associated with the development of these products. For example, if the FDA or another regulatory authority were to require us to conduct clinical trials or other testing beyond what we currently expect, we could be required to expend significant additional financial resources and time to complete development of our products. We may never obtain regulatory approval for any of our products and third parties may never obtain regulatory approvals for any products containing our technology.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">68<br></div></div></div>
<!--End Page 74-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 75-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Marketing, General and Administrative Expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Marketing expenses consist of public relations and general marketing expenses. General and administrative expenses consist primarily of salaries, related benefits and share-based compensation expense for personnel in executive, finance and administrative functions. General and administrative expenses also include facilities, depreciation and other expenses, which include direct or allocated expenses for rent and maintenance of facilities and insurance, as well as professional fees for legal, patent, consulting, investor and public relations, accounting and audit services. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We anticipate that our marketing, general and administrative expenses will increase as we increase our headcount to support our continued research activities and development of our products. Following the completion of this offering, we also anticipate that we will incur increased accounting, audit, legal, regulatory, compliance, director and officer insurance and investor and public relations costs associated with being a public company.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Results of Operations </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Comparison of the six months ended June&#160;30, 2020 and 2019 </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The table below summarizes the results of operations for the six months ended June&#160;30, 2020 and 2019, respectively, together with the changes in those items in dollars: </div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 22.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six months ended June 30,</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td></tr><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020 </div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019 </div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change </div></td></tr><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 34.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands) </div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses<br></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Research and development<font style="padding-left: 3.1pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;">$<font style="padding-left: 8.33pt;">4,152</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.59pt; text-align: left;">$<font style="padding-left: 10.83pt;">340</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;">$<font style="padding-left: 8.33pt;">3,812</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Marketing<font style="padding-left: 0.85pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 13.33pt;">1,745</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.59pt; text-align: left;"><font style="padding-left: 15.83pt;">242</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 13.33pt;">1,503</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<font style="padding-left: 2.55pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 13.33pt;">7,903</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.59pt; text-align: left;"><font style="padding-left: 8.33pt;">1,079</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 13.33pt;">6,824</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating loss<font style="padding-left: 3.63pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 5pt;">(13,800)</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.59pt; text-align: left;"><font style="padding-left: 5pt;">(1,661)</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 5pt;">(12,139)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Financial (income) expenses, net<font style="padding-left: 3.39pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000;">(14</font>) </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.59pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000;">14</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000;">(28</font>)</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 4.18pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="border-bottom: 1pt solid #000000;">(13,786</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.59pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="border-bottom: 1pt solid #000000;">(1,675</font>)</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.09pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 0.74pt; border-bottom: 1pt solid #000000;">(12,111</font>)</div></td></tr></table><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Research and Development Expenses </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">The table below summarizes our research and development expenses incurred during the periods presented:</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six months ended June 30, </div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020 </div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019 </div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands) </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and Development Expenses:<br></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">R&amp;D - salaries and wages<font style="padding-left: 4.78pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;">$<font style="padding-left: 7.5pt;">723</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14pt; text-align: left;">$151 </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Share-based compensation<font style="padding-left: 4.76pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 5pt;">1,917</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14pt; text-align: left;"><font style="padding-left: 15pt;">0</font> </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">R&amp;D - professional services<font style="padding-left: 1.45pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 5pt;">1,497</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14pt; text-align: left;"><font style="padding-left: 5pt;">157</font> </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other<font style="padding-left: 4.73pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000;">15</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000;">32</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 2.09pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="border-bottom: 1pt solid #000000;">4,152</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="border-bottom: 1pt solid #000000;">340</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Research and development expenses increased by $3.8&#160;million to $4.1&#160;million for the six months ended June&#160;30, 2020 from $0.3&#160;million for the six&#160;months ended June&#160;30, 2019. The increase in research and development expenses was primarily attributable to increases in salaries and wages, share-based compensation and professional services as we continue to expand our research and development activities relating to the Nanox System.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">69<br></div></div></div>
<!--End Page 75-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 76-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Marketing, General and Administrative Expenses </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">The table below summarizes our marketing expenses incurred during the periods presented: </div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six months ended June 30, </div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020 </div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019 </div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands) </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketing Expenses:<br></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketing &#8211; salaries and wages<font style="padding-left: 3.12pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;">$<font style="padding-left: 7.5pt;">246</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14pt; text-align: left;">$<font style="padding-left: 10pt;">8</font> </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketing and business development<font style="padding-left: 0.88pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 12.5pt;">855</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14pt; text-align: left;"><font style="padding-left: 5pt;">234</font> </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Share-based compensation<font style="padding-left: 4.76pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000;">644</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000;">0</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 2.09pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="border-bottom: 1pt solid #000000;">1,745</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="border-bottom: 1pt solid #000000;">242</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Marketing expenses increased by $1.5&#160;million to $1.7&#160;million for the six&#160;months ended June&#160;30, 2020 from $0.2&#160;million for the six&#160;months ended June&#160;30, 2019. The increase in marketing expenses was primarily attributable to increases in share-based compensation and professional services as we continue to expand our business and to build management infrastructure to move toward the commercial stage of our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">The table below summarizes our general and administrative expenses incurred during the periods presented: </div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six months ended June 30, </div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020 </div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019 </div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands) </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and Administrative Expenses:<br></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">G&amp;A &#8211; salaries and wages<font style="padding-left: 3.11pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;">$<font style="padding-left: 7.5pt;">783</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;">$<font style="padding-left: 12.5pt;">26</font> </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Share-based compensation<font style="padding-left: 4.76pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 5pt;">5,786</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 22.5pt;">0</font> </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Management fee<font style="padding-left: 4.76pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 17.5pt;">77</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 12.5pt;">278</font> </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">G&amp;A &#8211; professional services<font style="padding-left: 4.77pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 12.5pt;">765</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 12.5pt;">524</font> </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Legal fees<font style="padding-left: 0.3pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 12.5pt;">103</font> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 12.5pt;">149</font> </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Rent and Maintenance<font style="padding-left: 0.87pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 12.5pt;">233</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 17.5pt;">58</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other<font style="padding-left: 4.73pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000;">156</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000;">44</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 2.09pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="border-bottom: 1pt solid #000000;">7,903</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.25pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="border-bottom: 1pt solid #000000;">1,079</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">General and administrative expenses increased by $6.8&#160;million to $7.9&#160;million for the six&#160;months ended June&#160;30, 2020, from $1.1&#160;million for the six&#160;months ended June&#160;30, 2019. The increase in marketing, general and administrative expenses was primarily attributable to increases in share-based compensation and professional services as we continue to expand our business and to build management infrastructure to move toward the commercial stage of our business. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Comparison of the years ended December 31, 2019 and 2018 </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The table below summarizes the results of operations for the years ended December 31, 2019 and 2018, respectively, together with the changes in those items in dollars: </div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.2%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December 31,</div></td><td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 7.65%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td></tr><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td><td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td></tr><tr class="header"><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 32.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands)</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses<br></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Research and development<font style="padding-left: 3.1pt;"></font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.02pt; text-align: left;">$<font style="padding-left: 8.33pt;">2,717</font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;">$<font style="padding-left: 10.83pt;">672 </font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 8.33pt;">2,045</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Marketing<font style="padding-left: 0.85pt;"></font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.02pt; text-align: left;"><font style="padding-left: 13.33pt;">1,556</font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><font style="padding-left: 15.83pt;">209</font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt;">1,347</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<font style="padding-left: 2.55pt;"></font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.02pt; text-align: left;"><font style="padding-left: 8.33pt;">1</font>8,298</div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><font style="padding-left: 8.33pt;">1,</font>023 </div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">1</font>7,275</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating loss<font style="padding-left: 3.63pt;"></font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.02pt; text-align: left;"><font style="padding-left: 5pt;">(22,571)</font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><font style="padding-left: 5pt;">(1,904) </font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(20,667)</font></div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Financial (income) expenses, net<font style="padding-left: 3.39pt;"></font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.02pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 1pt solid #000000;">(8</font>)</div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000;">5</font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000;">(13</font>)</div></td></tr><tr><td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss <font style="padding-left: 0.85pt;"></font></div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.02pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$(22,563</font>)</div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$(1,909</font>)</div></td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$(20,654</font>)</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">70<br></div></div></div>
<!--End Page 76-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 77-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Research and Development Expenses </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">The table below summarizes our research and development expenses incurred during the periods presented:</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.5pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December&#160;31,</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3.5pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.64%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.5pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.04%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.5pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3.5pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt;">&#8203;</td><td colspan="4" style="width: 20.38%; text-align: center; vertical-align: bottom; padding-top: 3.5pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3.5pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and Development Expenses:<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.5pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.5pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">R&amp;D - salaries and wages <font style="padding-left: 1.45pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.81pt; text-align: left;">$<font style="padding-left: 7.5pt;">437</font> </div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.81pt; text-align: left;">$131 </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Share-based compensation <font style="padding-left: 1.43pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.81pt; text-align: left;"><font style="padding-left: 12.5pt;">661</font> </div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.81pt; text-align: left;"><font style="padding-left: 10pt;">&#8212;</font> </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">R&amp;D - professional services<font style="padding-left: 1.45pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.81pt; text-align: left;"><font style="padding-left: 5pt;">1,450</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.81pt; text-align: left;"><font style="padding-left: 5pt;">519</font> </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 3.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other<font style="padding-left: 4.73pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 3.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.81pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000;">16</font><font style="border-bottom: 1pt solid #000000;">9</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 3.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.81pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000;">22</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3.5pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total <font style="padding-left: 3.76pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 1.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 1.25pt;">&#8203;</td><td style="width: 9.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.81pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$2,71</font><font style="border-bottom: 1pt solid #000000;">7</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 1.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 1.25pt;">&#8203;</td><td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.5pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.81pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$672</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Research and development expenses increased by $2.0&#160;million to $2.7&#160;million for the year ended December&#160;31, 2019 from $0.7 million for the year ended December&#160;31, 2018. The increase in research and development expenses was primarily attributable to increases in salaries and wages, share-based compensation and professional services as we continue to expand our research and development activities relating to the Nanox System.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Marketing, General and Administrative Expenses </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">The table below summarizes our marketing expenses incurred during the periods presented: </div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December 31,</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.11%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketing Expenses:<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketing &#8211; salaries and wages<font style="padding-left: 3.12pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.31pt; text-align: left;">$<font style="padding-left: 7.5pt;">200</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.31pt; text-align: left;">$<font style="padding-left: 15pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketing and business development<font style="padding-left: 0.88pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.31pt; text-align: left;">$<font style="padding-left: 7.5pt;">&#8203;</font>439 </div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.31pt; text-align: left;">$&#8194;&#8195;59 </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Share-based compensation<font style="padding-left: 4.76pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.31pt; text-align: left;"><font style="padding-left: 12.5pt;">617</font> </div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.31pt; text-align: left;"><font style="padding-left: 20pt;">&#8212;</font> </div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other<font style="padding-left: 4.73pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.31pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000;">300</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.31pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000;">150</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 2.09pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt;">&#8203;</td><td style="width: 8.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.31pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$1,556</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt;">&#8203;</td><td style="width: 9.11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.31pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 10pt; border-bottom: 1pt solid #000000;">209</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Marketing expenses increased by $1.35 million to $1.56 million for the year ended December 31, 2019 from $0.21 million for the year ended December 31, 2018. The increase in marketing expenses was primarily attributable to increases in share-based compensation and professional services as we continue to expand our business and to build management infrastructure to move toward the commercial stage of our business.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">The table below summarizes our general and administrative expenses incurred during the periods presented: </div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December 31,</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and Administrative Expenses:<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">G&amp;A &#8211; salaries and wages<font style="padding-left: 3.11pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;">$<font style="padding-left: 12.5pt;">461</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;">$<font style="padding-left: 12.5pt;">88</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Share-based compensation<font style="padding-left: 4.76pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;"><font style="padding-left: 5pt;">14,</font>967</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;"><font style="padding-left: 12.87pt;">115</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Management fee<font style="padding-left: 4.76pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;"><font style="padding-left: 17.5pt;">534</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;"><font style="padding-left: 12.5pt;">429</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">G&amp;A &#8211; professional services<font style="padding-left: 4.77pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;"><font style="padding-left: 10pt;">1,470</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;"><font style="padding-left: 17.5pt;">84</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Legal fees<font style="padding-left: 0.3pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;"><font style="padding-left: 17.5pt;">417</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;"><font style="padding-left: 12.5pt;">165</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other<font style="padding-left: 4.73pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000;">449</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000;">142</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total <font style="padding-left: 3.76pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt;">&#8203;</td><td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="border-bottom: 1pt solid #000000;">18,298</font><font style="border-bottom: 1pt solid #000000;"> </font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt;">&#8203;</td><td style="width: 8.31%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.69pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="border-bottom: 1pt solid #000000;">1,023</font></div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">General and administrative expenses increased by $17.3 million to $18.3 million for the year ended December&#160;31, 2019 from $1.0 million for the year ended December&#160;31, 2018. The increase in general and administrative expenses was primarily attributable to increases in share-based compensation and professional services as we continue to expand our business and to build management infrastructure to move toward the commercial stage of our business. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">71<br></div></div></div>
<!--End Page 77-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 78-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Liquidity and Capital Resources</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Since our inception, we have not generated any revenue from product sales or otherwise, and have incurred significant operating losses and negative cash flows from our operations. We have not yet commercialized any products or technologies, and we do not expect to generate revenue from sales of any products in the near term, if at all. We have funded our operations to date primarily with proceeds from the sale of our and our predecessor company&#8217;s ordinary shares.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;">Cash Flows</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 20pt; text-align: left;">The following table provides information regarding our cash flows for the periods presented:</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 8.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt;">&#8203;</td><td class="gutter" style="width: 0.9%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six months ended June 30,</div></td><td class="gutter" style="width: 0.9%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.9%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 19.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December&#160;31,</div></td></tr><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;">&#8203;</td><td class="gutter" style="width: 0.9%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.53%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.75pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 0.9%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.9%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.17%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.75pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 0.9%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.9%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.02%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.75pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 0.9%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.9%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.75pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;">&#8203;</td><td colspan="10" style="width: 41.79%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands)</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash used in operating activities<font style="padding-left: 2.68pt;"></font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.53%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.05pt; text-align: left;">$<font style="padding-left: 1.67pt;">(4,738)</font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.17%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.05pt; text-align: left;">$(1,060)</div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.02%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.86pt; text-align: left;">$<font style="padding-left: 1.67pt;">&#8203;</font>(5,524)</div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.86pt; text-align: left;">$(3,671)</div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash used in investing activities<font style="padding-left: 3.78pt;"></font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.53%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.05pt; text-align: left;"><font style="padding-left: 14.17pt;">(244)</font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.17%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.05pt; text-align: left;"><font style="padding-left: 17.5pt;">(80)</font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 9.02%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.86pt; text-align: left;"><font style="padding-left: 14.17pt;">(125)</font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;">&#8203;</td><td style="width: 8.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.86pt; text-align: left;"><font style="padding-left: 17.5pt;">(73)</font> </div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash provided by financing activities<font style="padding-left: 3.23pt;"></font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.53%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.05pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">36,481</font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.17%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.05pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000;">9,264</font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.02%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.86pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">13,861</font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.86pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000;">3,684</font></div></td></tr><tr><td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net change in cash and cash equivalents and restricted cash<font style="padding-left: 1.07pt;"></font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 1.25pt;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 1.25pt;">&#8203;</td><td style="width: 9.53%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.05pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$31,499</font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 1.25pt;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 1.25pt;">&#8203;</td><td style="width: 9.17%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.05pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000;">8,124</font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 1.25pt;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 1.25pt;">&#8203;</td><td style="width: 9.02%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.86pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">&#8203;</font><font style="border-bottom: 1pt solid #000000;">8,212</font></div></td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 1.25pt;">&#8203;</td><td class="gutter" style="width: 0.9%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 1.25pt;">&#8203;</td><td style="width: 8.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 1.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.86pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000;">(60</font>)</div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Net Cash Provided by Operating Activities</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the six months ended June&#160;30, 2020 and 2019, net cash used in operating activities was $4.7&#160;million and $1.1&#160;million, respectively, resulting from our net loss of $13.8&#160;million and $1.7&#160;million, respectively, adjusted for stock-based compensation changes of $8.3&#160;million and changes in components of working capital of $0.7&#160;million for the six months ended June&#160;30, 2020 and $0&#160;million and $0.6&#160;million for the six months ended June&#160;30, 2019. The increase in cash used in operating activities was primarily due to activities related to our business expansion. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December&#160;31, 2019 and 2018, net cash used in operating activities was $5.5 million and $3.7&#160;million, respectively, resulting from our net loss of $22.6&#160;million and $1.9&#160;million, respectively, adjusted for non-cash charges and changes in components of working capital of $17.0 million and $1.8 million, respectively. The increase in cash used in operating activities was primarily due to activities related to our business expansion. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Net Cash used in Investing Activities</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the six months ended June&#160;30, 2020 and 2019, net cash used in investment activities was $0.2&#160;million and $0.1&#160;million, respectively, primarily due to purchases of property and equipment. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December&#160;31, 2019 and 2018, net cash used in investment activities was $0.1&#160;million and $0.1&#160;million, respectively, without significant change.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Net Cash provided by Financing Activities</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the six months ended June&#160;30, 2020 and 2019, net cash provided by financing activities was $36.5&#160;million and $9.3&#160;million, respectively, primarily due to proceeds from the issuance of ordinary shares and warrants, net of issuance costs. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December 31, 2019 and 2018, net cash provided by financing activities was $13.9&#160;million and $3.7 million, respectively, primarily due to proceeds from the issuance of ordinary shares and warrants, net of issuance costs.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Funding Requirements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We expect our expenses to increase in connection with our ongoing activities, particularly as we continue the research and development of the Nanox System and seek marketing approval for this product. In addition, upon the closing of this offering, we expect to incur additional costs associated with operating as a public company. Our expenses will also increase if, and as, we:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">seek regulatory approvals for any additional products;</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">72<br></div></div></div>
<!--End Page 78-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 79-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">seek to discover and develop additional products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">establish a manufacturing, sales, marketing, medical affairs and distribution infrastructure to commercialize the Nanox System for which we may obtain marketing approval and intend to commercialize on our own or jointly;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">hire additional quality control and scientific personnel;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">expand our operational, financial and management systems and increase personnel, including personnel to support our clinical development, manufacturing and commercialization efforts and our operations as a public company;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">maintain, expand and protect our intellectual property portfolio; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">acquire or in-license other products and technologies.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We believe that the anticipated net proceeds from this offering, together with our cash on hand, cash equivalents and short-term investments, will enable us to fund our operating expenses and capital expenditure requirements for at least the next twelve months. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Because of the numerous risks and uncertainties associated with manufacture, research, development and commercialization of products, we are unable to estimate the exact amount of our working capital requirements. Our future funding requirements will depend on, and could increase significantly as a result of, many factors, including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the scope, progress, results and costs of researching and developing the Nanox System;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the costs, timing and outcome of regulatory review of the Nanox.ARC;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the costs of future activities, including product sales, medical affairs, marketing, manufacturing and distribution, for the Nanox System for which we receive marketing approval;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">commercial manufacturing, shipping, installation and deployment of the Nanox System and sufficient inventory to support commercial launch;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the revenue, if any, received from commercial sale of the Nanox System, should the Nanox.ARC receive marketing approval;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the cost and timing of hiring new employees to support our continued growth;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the ability to establish and maintain collaborations on favorable terms, if at all; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the timing, receipt and amount of sales of the Nanox System, if any.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A change in any of these or other variables with respect to the development of any of our products could significantly change the costs and timing associated with the development of that product. Further, our operating plans may change in the future, and we may need additional funds to meet operational needs and capital requirements associated with such operating plans. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Until such time, if ever, as we can generate substantial product revenue, we expect to finance our cash needs through a combination of public or private equity offerings, debt financings, collaborations, strategic partnerships or marketing, distribution or licensing arrangements with third parties. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest may be materially diluted, and the terms of such securities could include liquidation or other preferences that adversely affect your rights as an ordinary shareholder. Debt financing and preferred equity financing, if available, may involve agreements that include restrictive covenants that limit our ability to take specified actions, such as incurring additional debt, making capital expenditures or declaring dividends. In addition, debt financing would result in increased fixed payment obligations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If we raise funds through collaborations, strategic partnerships or marketing, distribution or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or products or grant licenses on terms that may not be favorable to us.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">73<br></div></div></div>
<!--End Page 79-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 80-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If we are unable to raise additional funds when needed, we may be required to delay, reduce or eliminate our product development or future commercialization efforts, or grant rights to develop and market products that we would otherwise prefer to develop and market ourselves.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Contractual Obligations and Commitments</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes our contractual obligations as of December&#160;31, 2019 and the effects that such obligations are expected to have on our liquidity and cash flows in future periods:</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="13" style="width: 45.52%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Payment due by period</div></td></tr><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="13" style="width: 45.52%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($ in thousands)</div></td></tr><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Contractual Obligations</div></td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 4.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div></td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Less than<br>1&#160;year</div></td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.74%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">1-3&#160;years</div></td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.74%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">3-5&#160;years</div></td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.6%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">More than<br>5&#160;years</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Capital (Finance) Lease Obligations<font style="padding-left: 0.34pt;"></font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.66pt; text-align: left;"><font style="padding-left: 10pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.74%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.78pt; text-align: left;"><font style="padding-left: 10pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.74%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;">&#8212;</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.37pt; text-align: left;">&#8212;</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating Lease Obligations<font style="padding-left: 0.88pt;"></font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$526</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.66pt; text-align: left;">$140</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.74%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.78pt; text-align: left;">$386</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.74%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;">&#8212;</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.37pt; text-align: left;">&#8212;</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Purchase Obligations<font style="padding-left: 1.42pt;"></font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.66pt; text-align: left;"><font style="padding-left: 10pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.74%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.78pt; text-align: left;"><font style="padding-left: 10pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.74%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;">&#8212;</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.37pt; text-align: left;">&#8212;</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 2.09pt;"></font></div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 4.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$526</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 7.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.66pt; text-align: left;">$140</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 6.74%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.78pt; text-align: left;">$386</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 6.74%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;">&#8212;</div></td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.6%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 7.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.37pt; text-align: left;">&#8212;</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have entered into contracts in the normal course of business with third parties. These contracts do not contain any minimum purchase commitments and are cancelable by us upon prior notice and, as a result, are not included in the table of contractual obligations and commitments above. Payments due upon cancellation consist only of payments for services provided and expenses incurred, including non-cancelable obligations of our service providers, up to the date of cancellation. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Critical Accounting Policies and Significant Judgments and Estimates</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">While our significant accounting policies are described in more detail in Note 2 to our unaudited condensed consolidated financial statements and Note 2 to our audited consolidated financial statements appearing elsewhere in this prospectus, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated financial statements.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Use of Estimates in the Preparation of Financial Statements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates and such differences may have a material impact on our consolidated financial statements. As applicable to the consolidated financial statements, the most significant estimates relate to fair value of share-based payments and the fair value of the liability to related party.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Functional Currency</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The U.S. dollar is the currency of the primary economic environment in which our operations is conducted. A substantial portion of the operational costs are denominated in U.S. dollars. Accordingly, our functional currency is the U.S. dollar (&#8220;primary currency&#8221;). </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Foreign currency assets and liabilities are translated into the primary currency using the exchange rates in effect on the consolidated balance sheet date. Equity accounts are translated at historical rates, except for the </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">74<br></div></div></div>
<!--End Page 80-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 81-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">change in accumulated deficit during the year, which is the result of the income statement translation process. Expense accounts are translated using the weighted average exchange rate during the period. Currency transaction gains and losses are presented in financial income and expenses. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Statement of Cash Flows </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of January 1, 2018, we adopted ASU 2016-18 &#8220;Statement of Cash Flows (Topic 230): Restricted Cash,&#8221; which requires companies to include amounts generally described as restricted cash and restricted cash equivalents in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the statement of cash flows. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Cash and Cash Equivalents</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We consider all short-term, highly liquid investments as cash equivalents, which include short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Restricted Cash</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of June&#160;30, 2020 and December 31, 2019, our restricted cash consisted of a bank deposit that was denominated in New Israeli Shekel. Restricted deposit is presented at cost including accrued interest. This bank deposit is used as security for credit card use. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Property and Equipment, Net</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated on a straight-line basis over the following estimated useful lives:</div><table cellspacing="0" cellpadding="0" class="fintab" align="60" style="margin-top: 11.25pt; border-collapse: collapse; width: 348pt; margin-left: 60pt;"><tr class="header"><td style="width: 89.66%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.82%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.82%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.7%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">%</div></td></tr><tr><td style="width: 89.66%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Computers<font style="padding-left: 0.62pt;"></font></div></td><td class="gutter" style="width: 1.82%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.82%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">10-33</div></td></tr><tr><td style="width: 89.66%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Office furniture and lab equipment<font style="padding-left: 1.96pt;"></font></div></td><td class="gutter" style="width: 1.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.82%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 6.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">10-20</div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Impairment of Long-Lived Assets </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We test long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. Recoverability of long-lived assets is measured by comparing the carrying amount of the long-lived asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the sum of the expected undiscounted cash flow is less than the carrying amount of the asset, we recognize an impairment loss, which is the excess of the carrying amount over the fair value of the asset, using the expected future discounted cash flows.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For the six months ended June&#160;30, 2020 and 2019 and the years ended December 31, 2019 and 2018, we did not recognize an impairment loss on our long-lived assets. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Severance Pay</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Israeli labor law generally requires severance pay be granted upon dismissal of an employee or upon termination of employment under certain other circumstances. Pursuant to Section 14 of the Severance Compensation Act, 1963 (&#8220;Section 14&#8221;), all of our employees in Israel are entitled to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Payments under Section 14 relieve us from any future severance payment obligation with respect to those employees and, as such, we may only utilize the insurance policies for the purpose of disbursement of severance pay. As a result, we do not recognize an asset nor liability for these employees.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">In 2019 and 2020, all of our employees in Israel were subject to Section 14. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Legal and Other Contingencies</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Certain conditions, such as legal proceedings, may exist as of the date that the consolidated financial statements are issued and may result in a loss to us, but that will only be resolved when one or more future events occur or fail to occur. In assessing loss contingencies related to legal proceedings that are pending against </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">75<br></div></div></div>
<!--End Page 81-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 82-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">us or unasserted claims that may result in such proceedings, our management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought. Such assessment inherently involves an exercise of judgment. Legal fees are expensed as incurred.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our management applies the guidance in ASC 450-20-25 when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss would be incurred and the amount of the liability can be estimated, then we record an accrued expense in our consolidated financial statements based on its best estimate. Loss contingencies considered to be remote by management are generally not disclosed unless material. We are currently not a party to any material legal proceedings and are not aware of any material pending or threatened material legal proceedings against us.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Research and Development Expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Research and development expenses are charged to the statement of operations as incurred and consist primarily of personnel, materials and supplies for research and development activities.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Marketing Expenses</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Marketing expenses consist primarily of marketing campaigns and business development expenses. Marketing expenses are charged to the statement of operations, as incurred. Marketing expenses for the six months ended June&#160;30, 2020 and 2019 and the years ended December 31, 2019 and 2018, amounted to $1.7&#160;million, $0.2&#160;million, $1.6&#160;million and $0.2 million, respectively. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Income Tax </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We account for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. We provide a valuation allowance, if necessary, to reduce deferred tax assets to the assets&#8217; estimated realizable value if it is more likely than not that a portion or all of the deferred tax assets will not be realized, based on the weight of available positive and negative evidence. Deferred tax liabilities and assets are classified as non-current in accordance with ASU 2015-17.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Taxes that would apply in the event of disposal of investments in our foreign subsidiary have not been taken into account in computing the deferred income taxes, as it is our intent and ability to hold these investments.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We account for uncertain tax positions in accordance with ASC 740-10. ASC 740-10 contains a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative probability) likely to be realized upon ultimate settlement. We accrue interest and penalties related to unrecognized tax benefits under taxes on income (tax benefit). </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Share-Based Compensation</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We account for share-based compensation under ASC 718, &#8220;Compensation&#8212;Stock Compensation,&#8221; which requires the measurement and recognition of compensation expense based on estimated fair values for all share-based payment awards made to non-employees, employees, officers and directors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant. The Company uses the Black-Scholes-Merton option-pricing model as part of such estimation. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Prior to the adoption of ASU 2018-07, warrants issued to consultants and other non-employees, as compensation for services provided to us, were accounted for based upon the fair value of the warrants. The fair value of the warrants granted was measured on a final basis at the end of the related service period and was recognized over the related service period using the straight line method. After the adoption of ASU 2018-07, the </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">76<br></div></div></div>
<!--End Page 82-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 83-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">measurement date for non-employee awards is the date of the grant. The compensation expense for non-employees is recognized without changes in the fair value of the award, over the requisite service period, which is the vesting period of the respective award using the straight line method. We adopted ASU 2018-07 as of January 1, 2019 with no impact on our consolidated financial statements as all of our awards were fully vested at the adoption date. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Loss per Share</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Basic earnings per share are computed by dividing net income (loss) attributable to our ordinary shareholders by the weighted average number of ordinary shares outstanding for each reporting period. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In computing our diluted earnings per share, the denominator for diluted earnings per share is a computation of the weighted-average number of ordinary shares and the potential dilutive ordinary shares outstanding during the period. Potential dilutive ordinary shares outstanding include the dilutive effect of in-the-money options using the treasury stock method. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We did not take into account any dilutive instruments, such as share-based payments, since their effect, on a fully diluted basis, is anti-dilutive.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Fair Value Measurement</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Fair value is based on the price that would be received from the sale of an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 40pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Level 1:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 40pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Level 2:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Observable prices that are based on inputs not quoted on active markets, but corroborated by market data. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 40pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Level 3:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and considers counterparty credit risk in its assessment of fair value. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Deferred Offering Costs </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Deferred offering costs directly relating to this offering are capitalized. No amounts were capitalized as of December&#160;31, 2018. As of June&#160;30, 2020 and December&#160;31, 2019, we capitalized $1,469&#160;thousand and $1,197 thousand, respectively, of deferred offering costs on the consolidated balance sheet. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">JOBS Act</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The JOBS Act permits an &#8220;emerging growth company&#8221; such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected to &#8220;opt out&#8221; of such extended transition period and, as a result, we will comply with new or revised accounting standards as required when they are adopted for public companies. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Internal Control Over Financial Reporting</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In connection with the audit of our financial statements as of and for the years ended December 31, 2019 and 2018, we identified a material weakness in our internal control over financial reporting. The material weakness is related to having an insufficient number of financial reporting personnel with an appropriate level of knowledge, experience and training in application of U.S. GAAP and SEC rules and regulations commensurate with our reporting requirements.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">77<br></div></div></div>
<!--End Page 83-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 84-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_106-mda_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have taken action toward remediating this material weakness by hiring additional qualified personnel with U.S. GAAP accounting and reporting experience, and intend to provide enhanced training to existing financial and accounting employees on related U.S. GAAP issues. However, the measures we have taken to date and are continuing to implement may not be sufficient to remediate the material weakness we have identified or avoid potential future material weaknesses. If the steps we take do not correct the material weakness in a timely manner, we will be unable to conclude that we maintain effective internal control over financial reporting. Accordingly, there could continue to be a reasonable possibility that a material misstatement of our financial statements would not be prevented or detected on a timely basis. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Off-Balance Sheet Arrangements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements, as defined in the rules and regulations of the SEC.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Recently Issued Accounting Pronouncements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note 2 to our unaudited condensed consolidated financial statements and Note 2 to our audited consolidated financial statements, included elsewhere in this prospectus.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Quantitative and Qualitative Disclosures About Market Risks</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Interest Rate Risk</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of June&#160;30, 2020, we had cash equivalents consisting primarily of U.S. Dollar bank deposits. Our primary exposure to market risk is interest income sensitivity, which is affected by changes in the general level of U.S. interest rates. Consequently, changes in market interest rates would not have a material impact on our financial position or results of operations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of June&#160;30, 2020, we had no debt outstanding and are therefore not exposed to interest rate risk with respect to the cost of servicing and repaying debt.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Inflation-related Risks</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We do not believe that the rate of inflation in Israel has had a material impact on our business to date, however, our costs in Israel will increase if the inflation rate in Israel exceeds the devaluation of the NIS against the U.S. dollar or if the timing of such devaluation lags behind inflation in Israel.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Foreign Currency Exchange Risk</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our statements of operations and cash flows could be adversely affected in the future due to changes in foreign exchange rates. We expect to have cash and cash equivalents denominated in U.S. Dollars. As a result, changes in foreign currency exchange rates would not have a material impact on our financial position or results of operations. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">78<br></div></div></div>
<!--End Page 84-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 85-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tB"><!--Anchor--></a>BUSINESS</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Overview </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Early detection saves lives&#8212;and we at Nanox are focused on applying our proprietary medical imaging technology to make diagnostic medicine more accessible and affordable across the globe. Our vision is to increase early detection of medical conditions that are discoverable by X-ray, which we believe is key to increasing early treatment, improving health outcomes and, ultimately, saving lives.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As a first step to producing a new class of affordable medical imaging systems, we have focused on identifying and developing a novel X-ray source. Our X-ray source is based on a novel digital MEMs semiconductor cathode that we believe can achieve the same functionalities as legacy X-ray analog cathodes, while allowing for lower-cost production than existing medical imaging systems. We developed this technology over eight years to reach commercial applicability. This novel digital X-ray source is the basis of core technology in the Nanox.ARC, the imaging system we are developing, and we believe it also has the potential to replace the legacy X-ray source in other existing imaging systems.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our solution, which we refer to as the Nanox System, has two integrated components&#8212;hardware (Nanox.ARC) and software (Nanox.CLOUD). We have developed a prototype of the Nanox.ARC, a medical imaging system incorporating our novel digital X-ray source. Subject to receiving regulatory clearance, the first version of the Nanox.ARC that we expect to introduce to the market will be a 3D tomosynthesis imaging system. Tomosynthesis is an imaging technique widely used for early detection, that is designed to produce a high-resolution, 3D X-ray image reconstruction of the scanned human body part for review by a professional diagnostics expert. In parallel, we have developed a prototype of the Nanox.CLOUD, a companion cloud-based software that is designed to provide an end-to-end medical imaging service, including services such as image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive AI systems, billing and reporting. The Nanox System is designed to enable MSaaS to improve accessibility and affordability of early-detection services worldwide.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If cleared, we plan to market and deploy the Nanox System globally at a substantially lower cost than currently available medical imaging systems, such as CT, because our digital X-ray source will allow the Nanox.ARC to have a simpler structure without the costly cooling equipment or the complex rotating mechanism used in legacy CT devices. See &#8220;&#8212;Our Technology&#8212;The Nanox System.&#8221; We believe that the Nanox System could increase the accessibility and affordability of early-detection medical imaging systems worldwide.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As we continue to develop the Nanox.ARC, we expect to take a multi-step approach to the regulatory clearance process. As a first step, we submitted a 510(k) application for a single-source version of the Nanox.ARC to an accredited Review Organization under the Third Party Review Program in January 2020. As part of the review process, in March 2020, we received an additional information request, referred to as a major deficiency letter, from the Review Organization which, among other things, required us to provide additional data and other information to complete the application and to address certain deficiencies highlighted by the reviewer, including the results of certain performance tests. In response to the feedback we received from the Review Organization, we have conducted additional product testing and expect to submit the results of these tests, along with our response, to the Review Organization, in the third quarter of 2020. Our original timeline for completing the application was delayed due to the impact of COVID-19 on the external labs we work with to complete our product testing. We will continue to optimize and develop further features of the Nanox.ARC, and plan to submit an additional 510(k) application under the Third Party Review Program with respect to the multiple-source Nanox.ARC during the fourth quarter of 2020, which, if cleared, will be our commercial imaging system. We believe that neither our novel digital X-ray source nor the Nanox.CLOUD will require regulatory approval or clearance. However, to date, we have not obtained feedback from the FDA regarding our regulatory strategy. We introduced a working prototype of the Nanox.ARC in February&#160;2020 and, if cleared, we plan to deploy the first Nanox.ARC in the first half of 2021. If cleared, we are targeting a minimum installed base of at least 1,000 Nanox Systems in the second half of 2021, with the goal to finalize deployment of the initial 15,000 Nanox Systems by 2024. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Limitation of Current Medical Imaging Systems and Our Market Opportunity</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The main categories of current medical imaging systems that use X-ray sources include CT, mammography, fluoroscopy, angiogram and dental. The analog X-ray source used by these systems produces X-rays by accelerating electrons to high energies, causing them to hit a metal target from which the X-rays are emitted. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">79<br></div></div></div>
<!--End Page 85-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 86-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">This requires a significant amount of electrical energy to be transferred to the X-ray tube. Due to the heat generated by this process, one of the most complex mechanical challenges is cooling the analog X-ray source. In addition, for CTs, the mechanical structure is even more complex because the analog X-ray source needs to rotate in a heavy gantry at high speed. We believe these are key factors leading to the high cost and complexity of existing medical imaging systems, which in turn significantly limits the availability of medical imaging for early detection globally. According to a report from the Pan-American Health Organization and WHO in 2012, approximately two-thirds of the world population did not have access to medical imaging, while many people with access to medical imaging face substantial wait times for scanning.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, most market participants, including medical imaging manufacturing companies, medical imaging providers and radiologists, among others, have not provided the same level of end-to-end medical imaging services. One of the reasons is that the scanning process is currently not integrated with the diagnostics process, which contributes to extended wait times for image diagnostics by experts.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We estimate that the total annual capital expenditures on existing X-ray-based medical imaging systems, not including support, maintenance, insurance and ancillary services, will reach approximately $21 billion by 2021, which we believe represents a significant market opportunity for the Nanox System. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Our Solution </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 20pt; text-align: left;">We believe the Nanox System addresses the limitations of existing medical imaging systems on three levels:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Digital X-ray source with the potential to significantly reduce the costs of medical imaging </font><font style="font-weight: bold;">systems</font>. We believe our digital X-ray source technology will allow us to manufacture the Nanox.ARC, if cleared, at substantially lower costs compared to medical imaging systems that use a legacy analog X-ray source without sacrificing imaging quality. A lower cost device has the potential to substantially increase medical imaging availability and improve accessibility of early-detection services broadly across the globe.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Technology designed to improve upon the industry standard with integrated radiology diagnostics </font><font style="font-weight: bold;">via a cloud-based MSaaS platform</font>. The Nanox.ARC employs our novel digital X-ray source that is designed to be energy-efficient, smaller and can be more precisely controlled compared to existing X-ray source. By integrating the Nanox.CLOUD, we believe the Nanox System could provide a streamlined process where each scanned image is uploaded automatically to the cloud system and matched to a human radiology expert and decision assistive AI algorithms to provide scan reviews and diagnostics in a significantly shorter time frame than current diagnostics, which could substantially reduce wait-times for imaging results and increase early detection rates compared to currently employed imaging process protocols.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Business model designed to increase the availability of medical imaging</font>. Our primary business model is based on a pay-per-scan pricing structure as opposed to the capital expenditure-based business model currently used by medical imaging manufacturing companies. We believe our business model will significantly reduce the price per scan compared to the current global average cost of $300 per scan, and has the potential to commoditize medical imaging services at prices that are affordable to a greater number of people. We believe our MSaaS business model has the potential to expand the total size of the X-ray-based medical imaging market. </div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Our Strategy </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Secure regulatory clearance for </font><font style="font-weight: bold;">our medical imaging system</font>. We expect to take a multi-step approach to the regulatory clearance process. As a first step, we submitted a 510(k) application for a single-source version of the Nanox.ARC to an accredited Review Organization under the Third Party Review Program in January 2020. As part of the review process, in March 2020, we received an additional information request, referred to as a major deficiency letter, from the Review Organization which, among other things, required us to provide additional data and other information to complete the application and to address certain deficiencies highlighted by the reviewer, including the results of certain performance tests. In response to the feedback we received from the Review Organization, we have conducted additional product testing and expect to submit the results from these tests, along with our response, to the Review Organization, in the third quarter of 2020. Our original timeline for </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">80<br></div></div></div>
<!--End Page 86-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 87-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;">completing the application was delayed due to the impact of COVID-19 on the external labs we work with to complete our product testing. We will continue to optimize and develop further features of the Nanox.ARC, and plan to submit an additional 510(k) application under the Third Party Review Program with respect to the multiple-source Nanox.ARC during the fourth quarter of 2020, which, if cleared, will be our commercial imaging system. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Jumpstart the MSaaS-based medical imaging market with strategic partnerships</font>. We plan to produce and deploy an initial wave of approximately 15,000 Nanox.ARC units over the next three to four years to jumpstart the MSaaS-based medical imaging market. We have entered into a contract manufacturing agreement with FITI, a subsidiary of Foxconn for the commercial production and assembly of the Nanox.ARC and we have entered into commercial agreements with strategic regional partners for the deployment, operation and marketing of the Nanox System broadly across the globe, including in the United States and certain countries in Asia, Europe, Africa and South America. Specifically, we have entered into eight multi-year MSaaS agreements with partners for the deployment of Nanox Systems in various regions that we expect to be guaranteed by standby letters of credit for the amount of the agreed minimum annual fee. See &#8220;&#8212;Commercial Agreements&#8212;MSaaS Agreements.&#8221; In addition, we have entered into a collaboration agreement with USARAD Holdings (&#8220;USARAD&#8221;) for deploying and operating the Nanox System and establishing connections with the radiologist community in the United States. We plan to work with these partners to achieve local integrations into health maintenance organizations, electronic health record systems, payment methods and insurance coverage companies. In addition, we have entered into collaboration agreements with AI partners and are actively seeking collaboration opportunities, as we anticipate an industry shift to a digital and cloud-based subscription model will bring more digital healthcare disruptors into the market. See &#8220;&#8212;Commercial Agreements&#8212;Collaboration Agreements&#8212;Collaboration Agreements with our AI Partners.&#8221;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Maximize the commercial potential of our technology with simultaneous business models</font>. We plan to commercialize our novel X-ray source technology by pursuing three simultaneous business models, which we believe will provide us the flexibility and long-term sustainability to monetize our technology.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic;">Subscription Model:</font> In certain countries, if permitted by the laws in the applicable jurisdiction, our primary sales strategy will be based on a pay-per-scan pricing structure, where we expect to sell the Nanox System at low cost or at no cost, with a suggested retail price per scan that is substantially lower than the current global average charge, and receive a portion of the proceeds from each scan as the right-to-use licensing fee and fees for usage of the Nanox.CLOUD, artificial intelligence capability and maintenance support.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic;">Sales Model:</font> In certain countries, to accommodate specific local regulatory requirements, we expect to sell the Nanox.ARC for a one-time charge at a price that is substantially less than current market offerings.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic;">Licensing Model:</font> For certain medical imaging market participants, we plan to tailor our X-ray source technology to their specific imaging systems to replace the legacy X-ray source or to license our X-ray source technology to them to develop new types of imaging systems. We expect to charge a one-time licensing fee upfront and receive recurring royalty payments for each system sold.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-weight: bold;">Leverage the Nanox System to bring added value to our collaborators</font>. We expect that the Nanox System will enable us to accumulate a significant number of medical images, which have the potential to be used by collaborators, such as medical AI-analytics companies, through machine learning algorithms to increase the probability of early disease detection. </div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Our Technology</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Legacy Analog X-ray Source and Limitations of Existing Medical Imaging Systems</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The X-ray tube technology has essentially remained unchanged since its inception in 1895. For any type of imaging system to generate X-rays, the system must use X-ray tubes as a source for the X-rays. The X-ray tube converts electrical power into X-rays by accelerating electrons to high energies, causing them to hit a metal </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">81<br></div></div></div>
<!--End Page 87-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 88-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">target from which the X-rays are emitted. X-rays can only be produced if the X-ray tube is energized, which has historically required a significant amount of electrical energy to be transferred to the X-ray tube. However, only a small amount of the energy deposited into the X-ray tube is actually converted into X-rays; the majority of the energy turns into heat. This is called a thermionic (heat-based) mode of operation where a metal filament needs to be heated up to approximately 2,000&#176;C to generate the electron stream (a &#8220;cathode&#8221;) that will hit a metal target (an &#8220;anode&#8221;) to generate the photon-based X-ray stream resulting from that high-energy impact. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Heating the filament to approximately 2,000&#176;C requires the mechanical cathode support systems to withstand high temperatures within a high vacuum, high voltage environment. Tungsten was introduced into the X-ray tube in 1903 for its properties of a high melting point and ductility. The tungsten filaments still used today are critical components of X-ray tubes, but they limit the lifetime of the X-ray tube due to the progressive evaporation of filament material under these high temperatures. At temperatures of up to 2,000&#176;C, the filament evaporates in a hot spot close to the peak temperature location which over time can cause a catastrophic failure of the filament.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We believe that the use of the legacy analog X-ray source is one of the key factors for the high cost of existing medical imaging systems. The main categories of medical imaging systems that use X-ray sources include CT (3D&#160;cross-sectional 360&#176; &#8220;slicing&#8221; X-ray imaging), mammography (2D and 3D breast X-ray imaging), fluoroscopy (real-time X-ray video imaging), angiogram (blood vessels, contrast X-ray imaging) and dental (2D and panoramic X-ray imaging). CT scanners, for example, are complex diagnostic imaging systems that use X-rays to take pictures of a patient&#8217;s internal structures and organs. Due to the limitations of the analog X-ray source described above, general radiographic X-ray tubes are not well suited for use in a CT scanner. CT scanners instead use a specialized X-ray tube designed to withstand the excessive amount of heat produced by continuous energization. This X-ray tube is located in the gantry, which is the largest part of a CT scanner and consists of the X-ray detectors, the mechanical supports and the scanner housing. Due to the heat generated by this process, one of the most complex mechanical challenges is cooling the analog X-ray source while rotating it in a heavy gantry at high-speed. One solution used is the rotating anode, where a tungsten metal disk rotates at high revolutions per minute so the electron beam hits a different spot on the disk on a continuous basis to prevent the concentration of heat in one spot on the disk and reduce the likelihood of overheating or burning. In addition, CT scanners require a long continuous exposure time to create 3D photographs of the patient&#8217;s body using multiple X-ray images, which means that the X-ray tube must be continually energized and that patients are continuously exposed to radiation throughout that period. As a result of these complexities, most high-quality X-ray tubes for a CT scanner weigh between approximately 50 and 100 kilograms with the cooling mechanism and generally cost over $150,000 each.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Our Novel Digital X-ray Source</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Realizing that the X-ray tube technology has essentially not changed in more than 100 years and remains a significant source of complexity and cost-driver of existing X-ray-based medical imaging systems, we developed a novel digital X-ray source that we believe addresses these drawbacks and will enable a new class of medical imaging systems that can be produced at a significantly lower cost than the existing systems. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our technology has its roots in field emission display (&#8220;FED&#8221;) technology. FED technology was originally developed by Sony with other technology partners, for television screens and monitors, offering a novel way of lighting screen pixels compared to traditional cathode-ray tubes that were based on a one-source electron gun beam. The field emission display innovation used multiple nano-scale electron guns to achieve a much higher quality image with significantly reduced motion blur effects. In 2009, after having invested substantial resources in the development of this technology for over a decade including through a joint venture called Field Emission Technologies, Inc. (&#8220;FET&#8221;), Sony ceased development of the project.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In 2009, FET dissolved and transferred certain assets to FET Japan Inc. (&#8220;FETJ&#8221;). Scientists on our team, who worked at FETJ, applied their expertise to develop non-display related applications, including our X-ray source technology. In 2011, our predecessor company acquired certain non-display related know-how from FETJ and certain members of the FETJ technical team joined us.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">After acquiring the technology, we spent over eight years developing a digital X-ray source for the medical imaging industry that could be produced on a commercial scale. Our X-ray source is a MEMs-based semiconductor cathode that achieves electron emission by a non-thermionic low-voltage trigger to approximately 100 million nano-scale molybdenum cones that act as multiple electron &#8220;guns,&#8221; instead of a single heated filament. The cathode is housed in a customized X-ray tube. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">82<br></div></div></div>
<!--End Page 88-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 89-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">We believe our X-ray source has the following technological advantages over the analog X-ray source:</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Reduced duration of radiation exposure<font style="font-style: normal;">. Our X-ray source uses a digital chip that </font><font style="font-style: normal;">is designed to </font><font style="font-style: normal;">provide</font><font style="font-style: normal;"> </font><font style="font-style: normal;">better</font><font style="font-style: normal;"> </font><font style="font-style: normal;">control and </font><font style="font-style: normal;">enabl</font><font style="font-style: normal;">e</font><font style="font-style: normal;">s </font><font style="font-style: normal;">near-instantaneous</font><font style="font-style: normal;"> on/off toggling of the </font><font style="font-style: normal;">electron beam</font><font style="font-style: normal;">. </font><font style="font-style: normal;">This source control also enables a precise </font><font style="font-style: normal;">&#8220;stop and start&#8221; operation</font><font style="font-style: normal;">, which we believe </font><font style="font-style: normal;">can potentially</font><font style="font-style: normal;"> result in</font><font style="font-style: normal;"> significantly reduced </font><font style="font-style: normal;">duration of </font><font style="font-style: normal;">radiation </font><font style="font-style: normal;">exposure compared to an analog X-ray </font><font style="font-style: normal;">source</font><font style="font-style: normal;"> that exposes patients to continuous radiation exposure</font><font style="font-style: normal;">. </font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Multi-spectral imaging capacity using one X-ray source<font style="font-style: normal;">. Our X-ray source </font><font style="font-style: normal;">is designed to create</font><font style="font-style: normal;"> </font><font style="font-style: normal;">multi-spectral imaging using one X-ray source chip because there is </font><font style="font-style: normal;">complete independence and separation </font><font style="font-style: normal;">between the strength of X-ray penetration and the amount of photons for illumination (referred to as &#8220;KvP / </font><font style="font-style: normal;">MA&#8221;). KvP represents the speed of electrons that gives the X-ray its penetrating power, and higher KvP means </font><font style="font-style: normal;">the X-rays can penetrate higher density materials such as bones. MA represents the amount of photons or </font><font style="font-style: normal;">brightness levels of the X-ray image. For legacy X-ray sources, KvP / MA ratios were co</font><font style="font-style: normal;">dependent in a linear </font><font style="font-style: normal;">relationship and each X-ray </font><font style="font-style: normal;">source could only produce one set of KvP / MA combinations dedicated for a </font><font style="font-style: normal;">particular use (for example, either tissue images or bone images</font><font style="font-style: normal;">,</font><font style="font-style: normal;"> but not both simultaneously). </font><font style="font-style: normal;">W</font><font style="font-style: normal;">e believe </font><font style="font-style: normal;">our</font><font style="font-style: normal;"> </font><font style="font-style: normal;">X-ray source technology </font><font style="font-style: normal;">can </font><font style="font-style: normal;">produce</font><font style="font-style: normal;"> multi-spectral imaging from one X-ray source, which </font><font style="font-style: normal;">allows for</font><font style="font-style: normal;"> variable </font><font style="font-style: normal;">energy levels to be controlled during one scan. </font><font style="font-style: normal;">W</font><font style="font-style: normal;">ith</font><font style="font-style: normal;"> multi-spectral imaging, one source </font><font style="font-style: normal;">chip</font><font style="font-style: normal;"> can be used for </font><font style="font-style: normal;">multiple types of scans, such as head-scans, abdomen, mammography and angiograms, involving both soft and </font><font style="font-style: normal;">hard tissues at variable densities, simultaneously. </font><font style="font-style: normal;">We believe this multi-spectral imaging could </font><font style="font-style: normal;">also </font><font style="font-style: normal;">be applied to </font><font style="font-style: normal;">real-time video imaging.</font><font style="font-style: normal;"> The image below is a general illustration of the functionality </font><font style="font-style: normal;">and</font><font style="font-style: normal;"> </font><font style="font-style: normal;">capability</font><font style="font-style: normal;"> </font><font style="font-style: normal;">of </font><font style="font-style: normal;">multi-spectral imaging.</font><font style="font-style: normal;"> </font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15.25pt; text-align: center;"><img style="height: 334px; width: 598px;" src="nt10006151x14_graphic7.jpg"><br>&#8201;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Higher frequency use over a longer lifetime<font style="font-style: normal;">. Our X-ray source is based on a field of multiple electron guns</font><font style="font-style: normal;"> </font><font style="font-style: normal;">on our </font><font style="font-style: normal;">MEMs-based cathode</font><font style="font-style: normal;"> that spread the load of electron generation among many &#8220;producers&#8221; compared to a </font><font style="font-style: normal;">single filament that heats to a high temperature in the analog X-ray tube. </font><font style="font-style: normal;">As a result, our </font><font style="font-style: normal;">digital </font><font style="font-style: normal;">X-ray source </font><font style="font-style: normal;">is </font><font style="font-style: normal;">designed to</font><font style="font-style: normal;"> shoot an electron beam at different</font><font style="font-style: normal;"> lo</font><font style="font-style: normal;">cations on a stationary anode during each duty cycle without </font><font style="font-style: normal;">the need for the complex, high precision rotating mechanism.</font><font style="font-style: normal;"> </font><font style="font-style: normal;">In addition, the near instant on</font><font style="font-style: normal;">/off</font><font style="font-style: normal;"> tog</font><font style="font-style: normal;">gling feature</font><font style="font-style: normal;"> </font><font style="font-style: normal;">of our</font><font style="font-style: normal;"> digital</font><font style="font-style: normal;"> </font><font style="font-style: normal;">X-ray source </font><font style="font-style: normal;">is designed to allow</font><font style="font-style: normal;"> us to reduce the duration </font><font style="font-style: normal;">of</font><font style="font-style: normal;"> each operation. </font><font style="font-style: normal;">As a result, we </font><font style="font-style: normal;">believe our medical imaging system </font><font style="font-style: normal;">will have</font><font style="font-style: normal;"> higher stability</font><font style="font-style: normal;"> and</font><font style="font-style: normal;"> a longer lifetime</font><font style="font-style: normal;">,</font><font style="font-style: normal;"> with a </font><font style="font-style: normal;">longer</font><font style="font-style: normal;"> mean time </font><font style="font-style: normal;">between failures.</font><font style="font-style: normal;"> </font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Simplified hardware structure<font style="font-style: normal;">. Because our X-ray source is </font><font style="font-style: normal;">designed</font><font style="font-style: normal;"> to </font><font style="font-style: normal;">direct</font><font style="font-style: normal;"> an electron beam at different </font><font style="font-style: normal;">location</font><font style="font-style: normal;">s</font><font style="font-style: normal;"> </font><font style="font-style: normal;">for</font><font style="font-style: normal;"> </font><font style="font-style: normal;">e</font><font style="font-style: normal;">ach duty-cycle as described above, we are able to have multiple stationary tubes arranged around </font><font style="font-style: normal;">the patient as opposed to one tube </font><font style="font-style: normal;">that</font><font style="font-style: normal;"> rotate</font><font style="font-style: normal;">s</font><font style="font-style: normal;"> around the patient. </font><font style="font-style: normal;">We believe this </font><font style="font-style: normal;">could</font><font style="font-style: normal;"> reduce the complexity </font><font style="font-style: normal;">and cost of the Nanox.</font><font style="font-style: normal;">ARC</font><font style="font-style: normal;"> compared to l</font><font style="font-style: normal;">e</font><font style="font-style: normal;">gacy CT devices. In addition, the current approach to increase </font></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">83<br></div></div></div>
<!--End Page 89-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 90-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">durability of the tungsten anode in CT devices, the rotating anode mechanism discussed above, requires both a significant increase in tube size and cost to allow for the complex movements of the components. In contrast, we believe by using our X-ray source we will be able to significantly reduce the size of X-ray tubes and simplify the structure of our medical imaging system.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We believe our X-ray source has the potential to replace the legacy X-ray source in other existing imaging systems, as well as the X-ray source in systems used in other industries, such as security scanners. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Comparative Images from the Nanox.ARC and a Commercial Alternative</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have generated the images below with the Nanox.ARC using a single X-ray tube on an imaging phantom. An imaging phantom is a specially designed object that is scanned or imaged to evaluate and analyze the performance of an imaging device. The comparisons below show the X-ray images taken by our novel X-ray source (single tube) that is expected to be used in the Nanox.ARC and a commercial alternative, the DigitalDiagnost Rel. 3.x by Philips, Germany, each at the same source-to-image distance (100 cm), at the same source-detector angle (90<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#9702;</sup>) and with the same detector. &#8220;KvP&#8221; represents the penetrating power of the X-ray generated by the device. &#8220;mAs&#8221; represents the quantity of X-rays used during a given exposure time. The KvP and mAs numbers shown in the images below are based on the machine reading. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">84<br></div></div></div>
<!--End Page 90-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 91-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; text-align: center;"><img style="height: 699px; width: 351px;" src="nt10006151x14_graphic8.jpg"><br>&#8201; <br></div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">The Nanox System</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Nanox System has two integrated components &#8212; hardware (Nanox.ARC) and software (Nanox.CLOUD).</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have developed a prototype of the Nanox.ARC, a medical device that integrates our proprietary and novel X-ray source. Subject to receiving regulatory clearance, the first version of the Nanox.ARC that we expect to introduce to the market is expected to be a 3D tomosynthesis imaging system that produces a 3D reconstruction of the scanned human body part, as illustrated in the image below. The Nanox.ARC, using our X-ray source, is being designed to produce partial and full-body scans, with remote operation capability, and to have a full kVp/mA energy throughout range as per industry standards, multi-spectral imaging range, as well as quiet operation, cloud connectivity and standard compliance safety mechanisms. It is being designed for easy </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">85<br></div></div></div>
<!--End Page 91-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 92-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">setup and operation with multiple stationary X-ray tubes arranged around the patient. The substantial majority of operational software that we anticipate will be used to run the Nanox.ARC will be cloud-computing based and integrated with the Nanox.CLOUD, as further explained below.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15.25pt; text-align: center;"><img style="height: 213px; width: 388px;" src="nt10006151x14_graphic3.jpg"><br>&#8201;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition to the Nanox.ARC, we have developed a prototype of the Nanox.CLOUD, a companion cloud software that will allow for the delivery of medical screening as a service. With the Nanox.CLOUD, we anticipate that the high-cost components of existing medical imaging systems, such as analytics and computing software that are traditionally installed via multiple licenses on-premise and on a per-system basis, will become centralized through the cloud. We believe this will significantly reduce on-going software and IT licensing costs and enable a wide range of functionalities, such as per-body-part vertical analysis, multiple AI diagnostics and remote support. The Nanox.CLOUD is also expected to be able to provide an end-to-end medical imaging service, including services such as image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to medical imaging AI systems and billing and reporting. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A reliable and streamlined, post-scan imaging service is central to the delivery of effective clinical services. Today, even patients in developed countries experience delays of weeks and sometimes months for medical imaging and subsequent diagnostics results. For example, in Canada, access to medical imaging procedures is a growing problem with months of reported wait times for magnetic resonance imaging (&#8220;MRI&#8221;) and CT screening. Long wait times not only negatively impact patient outcomes but also add significant costs to the Canadian healthcare system each year due to delays in detection and treatment. Wait times for a CT scan can be longer than six weeks in Scotland, over 12 months in Ireland, and in the UK, tens of thousands of suspected cancer patients face month-long wait times to discover whether they have a particular illness due to delays in analyzing scans and X-rays. The Nanox System is designed to address such gaps and inefficiencies between completion of the scan and follow-on diagnostics.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">86<br></div></div></div>
<!--End Page 92-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 93-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We believe the Nanox System, if successfully developed, will streamline the entire medical screening process ranging from scanning to support diagnostics, and solve the bottleneck of imaging-to-diagnostics. The image below illustrates the potential interplay among the Nanox.ARC, the Nanox.CLOUD and third-party participants. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15.25pt; text-align: center;"><img style="height: 233px; width: 563px;" src="nt10006151x14_graphic6.jpg"><br>&#8201;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We also expect to be able to offer the Nanox System for a substantially lower cost than existing medical imaging systems, which we believe is key to achieving our goal of making early-detection medical imaging systems more accessible globally. We believe our novel X-ray source is crucial to our ability to substantially reduce the manufacturing cost of the Nanox.ARC. Our digital X-ray source generates X-ray radiation that is measurably identical in all key metrics to the X-ray radiation generated by existing analog X-ray sources, but without creating the high temperature that results from the filament used in the analog X-ray tube, thereby eliminating the need for the costly cooling equipment. In addition, our digital X-ray source is designed to enable the Nanox.ARC to have multiple stationary tubes arranged around the patient, which allows for a more simplified structure, as opposed to requiring the heavy, complex, high-precision rotating mechanisms used in legacy CT devices. We currently estimate the aggregate cost of purchasing and assembling the components of the Nanox.ARC will be approximately $8,000 to $12,000 per unit, assuming at least 15,000 Nanox.ARC units will be manufactured. We believe this will enable us to offer the Nanox System at a substantially lower cost than the cost of existing medical imaging systems based on analog X-ray sources. For example, a new high-end CT scanner sells for $1,350,000 to $2,100,000, with an additional $35,000 to $100,000 for cardiac software, $15,500 to $35,000 for lung software and approximately 10% to 14% of the capital expenditure cost for annual support and maintenance services, reaching a total cost of ownership in the millions of dollars. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our estimated manufacturing costs of the Nanox.ARC are subject to a number of assumptions and uncertainties and the actual cost per unit could vary significantly from our estimate, which would have a negative impact on our business. See &#8220;Risk Factors&#8212;We are a development-stage company with limited operating history. We may never be able to effectuate our business plan or achieve any revenue or reach profitability. Therefore, at this stage of our business, potential investors have a high probability of losing their entire investment,&#8221; &#8220;Risk Factors&#8212;The success of our primary business model, the Subscription Model, is subject to numerous risks and uncertainties,&#8221; &#8220;Risk Factors&#8212;We may experience development or manufacturing problems and higher costs, or delays that could limit our revenue, if any, or increase our losses&#8221; and &#8220;Risk Factors&#8212;We may not be able to successfully execute our business models.&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We do not believe that our novel digital X-ray source will require regulatory approval or clearance because we believe it falls within a category of radiology vacuum tubes converting electrical input power into X-rays that utilize the same energy levels, radiation types and throughputs as already existing and approved X-ray tubes applied in a wide range of radiology medical procedures. As a result, we expect that there will be no novel claim or methodology related to the X-ray radiation produced by the digital X-ray source. In addition, we do not believe that the Nanox.CLOUD will require regulatory approval or clearance because we expect that it will utilize software modules already cleared by the FDA for purposes of image transfer, upload, display and review. As we continue to develop the Nanox.ARC, we expect to take a multi-step approach to the regulatory clearance process. As a first step, we submitted a 510(k) application to an accredited Review Organization under the Third </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">87<br></div></div></div>
<!--End Page 93-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 94-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Party Review Program in January 2020 to seek clearance of a medical imaging system that incorporates a single digital X-ray source. The submission was based on a predicate filing for an equivalence claim to an existing FDA-approved X-ray imaging system by another market participant. Because our novel digital X-ray source incorporated into this system generates X-ray radiation that is measurably identical in all key characteristics to the X-ray radiation generated by the analog X-ray source incorporated into existing FDA-cleared X-ray imaging systems, we made no new claims as to the operation, image quality or functionality of this system versus the predicate device. As part of the review process, in March 2020, we received an additional information request, referred to as a major deficiency letter, from the Review Organization which, among other things, required us to provide additional data and other information to complete the application and to address certain deficiencies highlighted by the reviewer, including the results of certain performance tests. In response to the feedback we received from the Review Organization, we have conudcted additional product testing and expect to submit the results from these tests, along with our response, to the Review Organization, in the third quarter of 2020. Our original timeline for completing the application was delayed due to the impact of COVID-19 on the external labs we work with to complete our product testing. We will continue to optimize and develop further features of the Nanox.ARC, and plan to submit an additional 510(k) application under the Third Party Review Program with respect to the multiple-source Nanox.ARC during the fourth quarter of 2020, which, if cleared, will be our commercial imaging system. To date, we have not obtained feedback from the FDA regarding the regulatory pathways for any of our product candidates. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Our Business Model </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We plan to commercialize our X-ray source technology through three simultaneous business models: (i) the Subscription Model, (ii) the Sales Model and (iii) the Licensing Model. The chart below illustrates the various revenue streams we expect to derive from these three business models. We expect the Subscription Model to be our primary business model and the key vehicle to achieving our vision of increasing early-detection of medical conditions that are discoverable by X-ray. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.75pt; text-align: center;"><img style="height: 273px; width: 580px;" src="nt10006151x14_graphic2.jpg"><br>&#8201; <br></div><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 20pt; margin-top: 14.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">We expect to contract with third parties to provide maintenance and support services. </div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">The Subscription Model </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The foundation of the Subscription Model is our integrated offering of the Nanox.ARC and the Nanox.CLOUD, which we refer to as the &#8220;Nanox System.&#8221; Under the Subscription Model, we expect to sell the Nanox System, if cleared or approved by the requisite regulatory authorities, either at low cost or at no cost, and to receive a portion of the proceeds from each scan as the right-to-use licensing fee, and fees for usage of the Nanox.CLOUD, artificial intelligence capability and maintenance support, with the remaining amount allocated among our partners, including the local operators, radiologists, cloud storage providers, medical AI software providers and others, on a case by case basis. While the actual pricing charged by local operators may be greater </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">88<br></div></div></div>
<!--End Page 94-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 95-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">than our suggested retail price, the retail price per scan in all markets other than the United States is still expected to be substantially less than the global average of approximately $300. In the United States, we expect the retail price to represent a significant reduction compared to the $3,275 average cost of a CT&#160;scan. We expect the Nanox System will be operated by local operators independent from us, but we would contract with third parties to provide the day-to-day maintenance of the Nanox System. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">While we believe our novel X-ray source could provide existing market participants with the paradigm shift needed for preventive healthcare disruption, we also believe existing market participants are not likely to undertake the change-leadership route and will be slow to adopt the MSaaS model. Accordingly, we plan to produce and deploy approximately 15,000 Nanox.ARC units broadly across the globe over three to four years to jumpstart the MSaaS-based medical imaging market, including in the United States and certain countries in Asia, Europe, Africa and South America. We estimate that effectively stimulating market interest in our Nanox System will require deploying 5,000 to 10,000 Nanox.ARC units. We believe that this strategy will help initiate market disruption and accelerate the adoption of our novel X-ray source technology by traditional industry leaders.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">The Sales Model</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In certain countries, such as China, we intend to commercialize our technology using the Sales Model to accommodate specific local regulatory requirements. Under this model, we expect to sell the Nanox System, if cleared or approved by the requisite regulatory authorities, for a one-time charge. We expect this retail price to be higher than the upfront sales price under the Subscription Model but still substantially lower than the cost of existing medical imaging systems. We expect to enter into arrangements with third-party cloud vendors which will be responsible for providing the Nanox.CLOUD services, and be paid separately by the owner-operators of the Nanox Systems. In addition, we expect to contract with third-party service providers to provide maintenance services for the Nanox Systems at the owner-operators&#8217; own costs.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">The Licensing Model</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">While we believe the medical imaging industry will eventually migrate towards the recurring revenue-based MSaaS model, we expect certain leading market participants will be slower to adopt this model. For these market participants, we expect to provide an intermediate solution through which they will adopt our X-ray source technology for their existing systems. Under the Licensing Model, we would be engaged to tailor our X-ray source to the specific systems of medical imaging device manufacturers or to license our X-ray source technology to them to develop new types of imaging systems for a one-time licensing fee upfront for the X-ray source, as well as recurring royalty payments for each system sold. The licensees would be responsible for the operation of the medical imaging systems integrating our X-ray source. Although we expect to initially rely on the Licensing Model, in part, we view the Licensing Model as a transitional phase, aimed at maximizing the commercial value of our technology and strategic buy-in from market participants to our vision through partnership and commercial relationships.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">FUJIFILM Corporation was the first medical imaging device manufacturer to participate in our licensing model. On May 21, 2019, Nanox Gibraltar, our predecessor company, entered into a Right of First Negotiation Agreement with FUJIFILM Corporation. Under the terms of such agreement, the parties agreed to exclusively negotiate in good faith the terms and conditions of a potential commercial agreement until December 31, 2019. The terms of the commercial agreement are intended to cover the exclusive, worldwide licensing of certain patents and know-hows related to mammography medical devices and solutions owned by us to FUJIFILM Corporation to develop, manufacture, market, distribute, operate and use mammography equipment and services (the &#8220;field of use&#8221;). Under the Right of First Negotiation Agreement, if such commercial agreement was not entered into by December 31, 2019, and if we later become involved in any negotiation to enter into an agreement for the grant of license of the patents covered by the agreement in the field of use to any third party, FUJIFILM Corporation would have a right of first negotiation for six months with respect to such proposed transaction under terms and conditions no less favorable to us than those proposed or offered by or to such third party. In accordance with the terms of the Right of First Negotiation Agreement, we assumed all of Nanox Gibraltar&#8217;s obligations under such agreement upon the transfer of Nanox Gibraltar&#8217;s assets to us. We are currently discussing the terms of a potential commercial agreement with FUJIFILM Corporation.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">89<br></div></div></div>
<!--End Page 95-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 96-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Sales and Marketing</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We plan to commercialize our technology using the three simultaneous business models described above broadly across the globe by 2024, including in the United States and certain countries in Asia, Europe, Africa and South America. Our sales and marketing strategy varies depending on specific geographical regions, as different regions generally require different marketing approaches. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In most countries, other than the United States, we expect to primarily market through local partnerships with strong national branding and operational market participants in the target region. These local partners would be engaged in deploying and operating our medical imaging systems, training and recruiting a local medical professional workforce to operate the systems and providing medical imaging diagnostics for the systems&#8217; scan results. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In the United States, because we expect our systems will be relatively simple and cost effective to deploy compared to existing medical imaging systems, many urgent care units, outpatient clinics and retail locations could potentially become medical imaging service providers with the support of the appropriate partners and radiologists. We have already initiated discussions with some of the largest urgent care units, private clinic chains and retail locations for the potential deployment of thousands of units in the United States. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, we also expect to engage local value-added resellers or integrators in different geographic regions to facilitate the local integration of our systems with health maintenance organizations, electronic health record systems, payment methods and insurance coverage companies. We estimate that it will take approximately three to six months of integration and localization efforts before we can generate sales in a given region. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Manufacturing and Supply</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have optimized the MEMs proprietary manufacturing process and currently use our own equipment in the clean rooms located at the University of Tokyo to manufacture the MEMs X-ray chip, as shown in the picture below. As we further expand our business in connection with the commercialization of our technology, we expect to obtain access to other clean rooms provided by third parties. We plan to retain our core X-ray source technology production activities for the foreseeable future, and we expect to expand our manufacturing capacity, including through the establishment of a wholly-owned subsidiary in Korea with the support of SKT, to meet our currently anticipated needs.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.75pt; text-align: center;"><img style="height: 395px; width: 537px;" src="nt10006151x14_graphic5.jpg"><br>&#8201;</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">90<br></div></div></div>
<!--End Page 96-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 97-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have entered into direct arrangements with a manufacturer for the production of our X-ray tubes. We also expect to rely on third-party manufacturers for the commercial production of the other components of the Nanox.ARC, if cleared or approved by the requisite regulatory authorities. We also expect to manufacture a small number of Nanox.ARC units in Israel that will be used for the acceptance tests under our MSaaS agreements. We have entered into a contract manufacturing agreement with FITI to manufacture the Nanox.ARC, with a goal to enable the commercial production of approximately 15,000 Nanox.ARC units that we plan to deploy over the next three to four years. Under the contract manufacturing agreement, FITI will negotiate and subcontract with other third parties for the commercial supply of the components of the Nanox.ARC in accordance with the pre-approved supplier list and on the terms to be agreed upon by both parties, except for the MEMs X-ray chip and the X-ray tube. As we further expand our business in connection with the commercialization of our technology, we also expect to seek to engage alternative manufacturers of the Nanox.ARC. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On May 26, 2020, we entered into a Contract Manufacturing Agreement with FoxSemicon Integrated Technology, Inc. (&#8220;FITI&#8221;). Under the terms of the agreement, FITI agrees to manufacture, package, distribute and ship, and we agree to purchase, certain products and procurement and assembly services, including a minimum of 1,000 Nanox Systems per year. We agree to provide FITI with a rolling forecast of our estimated monthly purchases, which FITI will use to prepare its supply chain to cover the material and manufacturing needs. Subsequently, we will send purchase orders to FITI for certain products and services. Prices for the products will be agreed by the parties at least 90 days prior to the first expected delivery date. FITI will be entitled to order materials in accordance with an approved supplier list and on the terms that the parties agree upon on a quarterly basis, and FITI must obtain our prior written consent if it procures materials from other suppliers. FITI may also purchase materials from us to support orders pursuant to our requests. The parties also agree to enter into a quality agreement, which will set forth the manufacturing standards applicable to FITI. The agreement will be in effect for three years from the date of the agreement and is renewable for successive terms of one year unless or until either party notifies the other in writing of its intention not to renew with 90 days&#8217; prior notice. The agreement may be terminated by notice of the non-breaching party in case of a material breach of a party's material obligations, or by either party in case of the bankruptcy or insolvency of the other party.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have worked with a third party to develop the initial prototype of the Nanox.CLOUD and we plan to continue to develop the Nanox.CLOUD internally.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Commercial Agreements </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">MSaaS Agreements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have entered into eight MSaaS Agreements to deploy 4,520 Nanox Systems in eleven regions as described in the table below. Under the terms of each agreement, we grant the other party a limited, non-transferable, exclusive, sub-licensable right to access and operate the Nanox System in the region indicated for such party. We undertake to provide the specified number of Nanox Systems to each entity as indicated in the table below based on agreed shipment schedules, subject to local regulatory approval and material compliance with acceptance test protocol (the &#8220;conditions precedent&#8221;). The other party undertakes to deploy the systems to provide a minimum number of scans per year (based on 7 scans per day and 23 days per month) on a pay-per-scan basis at a minimum of $14 per scan, and to pay a minimum annual fee (including payments to our partners) in the amount indicated in the table below. The payments are expected to be guaranteed by a standby letter of credit in the amount equal to the minimum annual fee in favor of us after receipt of the conditions precedent. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Nanox Systems provided under each agreement will remain our property, and the other party will only have a limited license to use the Nanox Systems. In addition, we must approve in writing any sublicense granted under this agreement. We undertake to provide billing, radiology and maintenance services and to provide training for a local medical professional workforce to operate the Nanox.ARC.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">91<br></div></div></div>
<!--End Page 97-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 98-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Each agreement will be in effect for multiple years, ranging from three to six years from the date of the applicable agreement, and is renewable for an additional multi-year term with both parties&#8217; mutual consent as indicated in the table below. Each agreement may be terminated by notice of the non-breaching party in case of a material breach of a party's material obligations, or by either party in case of the bankruptcy or insolvency of the other party. </div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 25%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Entity</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Date of MSaaS<br>Agreement</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Region</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of<br>Nanox<br>Systems to <br>be Provided</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 19.87%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Minimum<br>Annual Fee<br>and Amount of <br>Letter of Credit<br>(approximate)</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Initial<br>Term</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Renewal<br>Term </div></td></tr><tr><td style="width: 25%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">The Gateway Group, Ltd.<font style="padding-left: 4.81pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 15.38%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">February 11, 2020</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Australia, New Zealand and Norway</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,000</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 19.87%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$58 million</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3 years</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3 years</div></td></tr><tr><td style="width: 25%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 9pt; text-indent: -9pt; text-align: left;">Golden Vine International Company, Ltd.<font style="padding-left: 1.34pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.38%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">May 28, 2020</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Taiwan and Singapore</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">500</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 19.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Up to $29 million</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">5 years</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">5 years*</div></td></tr><tr><td style="width: 25%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Promedica Bioelectronics s.r.l. <font style="padding-left: 0.7pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 15.38%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">May 29, 2020</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Italy</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">500</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 19.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$29 million</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4 years</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3 years</div></td></tr><tr><td style="width: 25%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">JSC Roel Group<font style="padding-left: 1.73pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.38%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">May 29, 2020</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Russian Federation</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">500</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 19.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$12.6 million</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">5 years</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">5 years</div></td></tr><tr><td style="width: 25%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 9pt; text-indent: -9pt; text-align: left;">Clarity Medical Solution, a division of &#8220;Grodnobioproduct&#8221; LLC<font style="padding-left: 3.52pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 15.38%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">June 4, 2020</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Belarus</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">100</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 19.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$3.7 million</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3 years</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4 years</div></td></tr><tr><td style="width: 25%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Gold Rush<font style="padding-left: 1.84pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.38%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">June 16, 2020</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">South Africa</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">500</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 19.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$15.5 million</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3 years</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3 years</div></td></tr><tr><td style="width: 25%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 9pt; text-indent: -9pt; text-align: left;">LATAM Business Development Group Ltd.<font style="padding-left: 1.78pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 15.38%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">July 6, 2020</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Brazil</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,000</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 19.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$4.8 million <br>(9 million Letter of <br>Credit) in Year 1<br>$14.5 million in <br>Year 2<br>$24.2 million in <br>Year 3***</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">6 years</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3 years</div></td></tr><tr><td style="width: 25%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">APR 1998 S.L. <font style="padding-left: 2.73pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.38%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">July 25, 2020</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Spain</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">420</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 19.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$11.4 million</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">5 years</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">5 years**</div></td></tr><tr><td style="width: 25%; text-align: left; vertical-align: top; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">TOTAL<font style="padding-left: 2.03pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 15.38%; text-align: left; vertical-align: top; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4,520</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 19.87%; text-align: left; vertical-align: top; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$163.8 million</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.01%; text-align: left; vertical-align: top; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt;">&#160;</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The MSaaS Agreement with Golden Vine International Company, Ltd. may also be terminated by either party upon notice stipulating that the notifying party has come to the conclusion, based on market evidence, that there is no business merit for the Nanox.ARC in Taiwan or Singapore.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">**<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The MSaaS Agreement with APR 1998 S.L. may also be terminated by the service provider at the end of a six-month trial period by sending within five days a formal notice to the Company if trial results are not satisfactory.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">***<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The enforceability of the standby letter of credit from LATAM Business Development Group Ltd. in our favor is also conditioned upon the parties finalizing within 90 days of the date of the agreement, in mutually agreed form, the terms and conditions of the statement of work, the system requirement specifications and the service level agreement.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have entered into certain business development agreements with finders to obtain MSaaS agreements in specified countries. Once the standby letter of credit has been issued in connection with each MSaaS agreement above, we will grant warrants to purchase our ordinary shares to the finder who caused such MSaaS agreement to be signed between the Company and the entity. The warrants will be granted in an amount equal to 30% of the amount of the standby letter of credit divided by 35.36 and have an exercise price equal to the fair market valueof our ordinary shares at the time of the grant. The finder will also be entitled to 5% of the gross amount that we receive from scans made by the Nanox Systems under the MSaaS agreement. If a finder causes an MSaaS agreement to be signed between us and an entity with a minimum of 23 scans per day at a minimum of $30 per scan, once the standby letter of credit has been issued, we will grant the finder warrants to purchase our ordinary shares in an amount equal to 5% of the amount of the standby letter of credit divided by the fair market value of the ordinary shares at the time of issuance of the warrant. If a finder causes a letter of intent to be signed with an entity that will cooperate to deploy Nanox Systems, we will grant the finder warrants to purchase our ordinary shares in an amount equal to $300,000 divided by the market price of our ordinary shares at the time of the closing of this offering.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">92<br></div></div></div>
<!--End Page 98-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 99-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We believe our MSaaS business model has the potential to expand the total size of the X-ray-based medical imaging market. We plan to measure the success of our MSaaS business model by annual capacity for Above-the-Line (&#8220;ATL&#8221;) scans which represent the increased capacity of imaging care we can provide to people that originally had no meaningful access to medical imaging. As we expand our operations and deploy more units of the Nanox Systems in an increasing number of countries using the MSaaS model, we expect our ATL scans metric to increase accordingly. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Collaboration Agreements</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Collaboration Agreement with Hadasit </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have entered into a Collaboration Agreement, dated September 8, 2019, with Hadasit Medical Research Services and Development Ltd. (&#8220;Hadasit&#8221;), a wholly owned subsidiary of the Hadassah Medical Organization (&#8220;HMO&#8221;). Under the terms of the agreement, the parties agreed to collaborate with respect to our medical imaging technology and resulting medical images devices (the &#8220;Company Products&#8221;), by way of (a) joint research and development projects (each, a &#8220;Research Project&#8221;); and (b) the provision by Hadasit of services in connection with Company Products, such as testing and consulting work, where no innovative research will be carried out (each, a &#8220;Service&#8221;). Each Research Project and Service will be rendered under a separate project agreement to be entered into between the parties in writing from time to time (collectively, the &#8220;Project Agreements&#8221;). Prior to entering into any Project Agreement, a joint steering committee to be established shall be responsible for determining whether such Project Agreement constitutes a Research Project or a Service. The parties envisage the collaboration to continue over a period of five years, unless extended in writing. Under this agreement, Hadasit has agreed to extend competitive prices comparable to prices that it offers to other commercial entities with respect to the Research Projects and Services. We made a non-refundable payment to Hadasit as an advance on account of the Research Projects and Services in the amount of $250,000, plus value-added tax, which amount will be credited against payments due from time to time to Hadasit under the Project Agreements. We have no obligation to enter into any Project Agreements with Hadasit that will cause us to pay Hadasit any payments in excess of the amount advanced, and we are not permitted to use funding from the Israel Innovation Authority for any Research Projects or Services.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under this agreement, Hadasit has granted us an exclusive, worldwide license, with the right to sublicense, under Hadasit's rights in proprietary information created within the framework of a Research Project (collectively, the &#8220;Collaboration Intellectual Property&#8221;), to develop, have developed, manufacture, have manufactured, use, market, offer for sale, sell, have sold, distribute, export and import Company Products. Notwithstanding the foregoing, Hadasit reserves for itself, HMO and other non-commercial third parties, rights to Collaboration Intellectual Property for teaching or academic research purposes.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In consideration for Hadasit's license to us, Hadasit is entitled to compensation, on a country-by-country basis, for all commercial scans (each, a &#8220;Scan&#8221;) carried out with the use of Covered Products (as defined below) throughout the applicable revenue sharing period at the rate of ten cents per Scan, which period commences upon the first Scan conducted in a country and ending on the later of: (i) the expiration of the last to expire valid claim of the applicable jointly owned patent; and (ii) 15 years from the date of the first Scan conducted in such country with a Covered Product after receipt of required regulatory approvals in such country. No royalty is due for Scans that are carried out with the use of Covered Products without consideration for internal, testing, training or demonstration purposes. &#8220;Covered Products&#8221; are those Company Products which (i) comprise, contain or incorporate, and/or use, in whole or in part, Collaboration Intellectual Property; (ii) the development, production and/or sale of which, is based on, or involves, in whole or in part, the use of the Collaboration Intellectual Property; or (iii) are produced or manufactured in whole or in part, using a process, method or system covered by, or included within the Collaboration Intellectual Property. If we, our affiliate or sublicensee challenges the validity, enforceability or scope of any patents jointly owned by us and Hadasit, Hadasit may terminate such license with respect to Covered Products covered by such patents and double the revenue sharing rate owed Hadasit under the agreement as described above.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, under this agreement, we have granted Hadasit a royalty-free, worldwide, non-exclusive license, with the right to sublicense only to permitted contractors, to use, copy, maintain, modify and prepare derivative works of our intellectual property as necessary to conduct the Research Projects and Services.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">93<br></div></div></div>
<!--End Page 99-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 100-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The term of the agreement will continue until the expiration of all payment obligations thereunder. The agreement may be terminated by mutual consent, by the non-breaching party in case of a material breach of a party's material obligations, or by either party in case of the bankruptcy or insolvency of the other party.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We also granted Hadasit a warrant to purchase 23,957 of our ordinary shares at a price of $20.87 per share with a total exercise price of $500,000. The warrant also includes a cashless exercise provision in case of an Exit Event (as defined below). The shares will be fully vested after two years, with one-third vested on September 8, 2019, another one-third to be vested on September 8, 2020 and the remainder after September 8, 2021. The terms of the warrant provide that the warrant may be exercised from the date of the Collaboration Agreement and until the earlier of (i) 48 months from the date of the full vesting of the shares and (ii) the closing of an &#8220;Exit Event,&#8221; which includes the consummation of this offering. However, we have agreed with Hadasit that the warrant can be exercised by September&#160;30, 2020, subject to the consummation of this offering. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 13pt; margin-left: 0pt; text-align: left;">Collaboration Agreement with USARAD</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We entered into a Non-Exclusive Collaboration Agreement, dated January&#160;22, 2020, with USARAD. Under the terms of the agreement, USARAD will use best efforts to contact official public health authorities of governments and/or medical center operators in the United States (&#8220;Medical System Operators&#8221;), to facilitate the closing of commercial agreements between us and the Medical System Operator for the deployment of 3,000&#160;Nanox Systems and to promote the Nanox.CLOUD services with radiologists for joining the Nanox diagnostics services platform. We must approve any engagement of a Medical System Operator that USARAD contacts. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We undertake to provide the deployed Nanox Systems on a pay-per-scan subscription basis using the Nanox.CLOUD. Subject to FDA clearance and a satisfactory Nanox System pilot testing by the Medical System Operator, USARAD undertakes to use best efforts to engage Medical System Operators that will undertake an annual subscription to a minimum number of scans per year. USARAD also undertakes to establish connections with the radiologist community in the United States. USARAD will receive a fee-per-scan, which will be subject to an upfront subscription commitment and fees. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We undertake to fully finance the cost of the Nanox Systems to be deployed in accordance with any commercial agreements between us and a Medical System Operator and their ongoing maintenance, as well as to provide training for the Nanox System operations. USARAD undertakes to make introductions to local maintenance contractors that are qualified to maintain medical equipment for the purpose of providing ongoing maintenance services for the Nanox Systems on our behalf.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The agreement will be in effect for 12 months from the date of the agreement and will be automatically renewed for additional 12-month periods. The agreement may be terminated by 90&#160;days&#8217; advance written notice by either party, by notice of the non-breaching party in case of a material breach of a party's material obligations, or by either party in case of the bankruptcy or insolvency of the other party. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 13pt; margin-left: 0pt; text-align: left;">Collaboration Agreement with SK Telecom</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On June 4, 2020, we entered into a collaboration agreement with SK Telecom, pursuant to which we and SK Telecom will further explore and engage in good faith to develop a definitive agreement within six months of the date of the agreement for the deployment of 2,500 Nanox Systems in South Korea and Vietnam, and we will use commercially reasonable efforts to establish a wholly-owned subsidiary in South Korea with the support of SK Telecom for the purpose of manufacturing MEMs X-ray chips for the Nanox.ARC. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">Collaboration Agreements with our AI Partners</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In 2019 and 2020, we entered into collaboration agreements with certain AI partners, including Brainomix Limited (&#8220;Brainomix&#8221;), CureMetrix, Inc. (&#8220;CureMetrix&#8221;), IMedis AI Ltd. (&#8220;IMedis&#8221;) and Qure.ai Technologies Pyt. Ltd. (&#8220;Qure.ai&#8221;). In 2020, we entered into non-binding agreements with Lunit Inc., (&#8220;Lunit&#8221;) and VUNO Inc. (&#8220;VUNO&#8221;). CureMetrix will support the development and testing of our technology together with medical imaging scans, in a diagnostic advisory capacity. Brainomix, IMedis and Qure.ai will each collaborate with us in the testing of the Nanox.ARC and the Nanox.CLOUD together with proprietary AI algorithms used for the analysis of brain damage caused by stroke, chest and abdomen X-rays, and chest and head X-rays, respectively, in medical imaging scans. Lunit and VUNO will each cooperate with us to jointly conduct research and development for commercializing medical AI solutions based on digital X-ray and CT technology. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">94<br></div></div></div>
<!--End Page 100-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 101-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Letter Agreement with A-Labs</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On January 29, 2019, Nanox Gibraltar and A-Labs entered into a Letter of Engagement. On October 18, 2019, we entered into an Amendment to the Letter of Engagement with A-Labs, in which we replaced and succeeded Nanox Gibraltar in all matters relating to the agreement. Under the terms of the agreement, A-Labs will provide consulting services to us in connection with various transactions, such as a private placement or this offering. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We agreed to pay A-Labs an advanced payment of $1 million within ten days of the signing of the amendment to the agreement, which will constitute the full and final payment for A-Labs&#8217; services under the agreement. In addition, if an initial public offering, a significant private placement or an M&amp;A event (a &#8220;Triggering Event&#8221;) occurs during the term of the agreement or within six months of its termination, A-Labs will be entitled to 1.5% in cash of all amounts that we receive as part of the Triggering Event. If we receive proceeds exceeding $150 million in the Triggering Event and have a pre-transaction valuation of at least $400 million, A-Labs will be entitled to 2.5% in cash of all amounts that we receive as part of the Triggering Event. The advanced payment and any fees received under the original agreement will be set off from any cash payment due to A-Labs as part of a Triggering Event.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, we will grant A-Labs an amount of warrants to purchase our ordinary shares equal to 2.5% of all shares issued in this offering, which warrants will be issued at the closing of this offering at an exercise price equal to the price per ordinary share in this offering. A-Labs has agreed not to sell or transfer any of our ordinary shares during the one-year period commencing from the closing of this offering.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The agreement will be in effect for 16 months from the date of the amendment to the agreement until December 31, 2020. The agreement may be terminated by 60 days&#8217; advance written notice by either party. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Competition</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Several large companies, such as General Electric, Siemens, Philips, Hologic, Varian, Fuji, Toshiba and Hitachi currently dominate the medical imaging market. High regulatory, distribution, manufacturing and service-related long-term contractual costs represent significant barriers to entry for any new player. We expect that the existing market participants will remain key players in the future and we aim to form alliances with several of these leading market participants, including through licensing.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Over time, we anticipate that the evolution in the industry will bring new players into the market. Digital healthcare disruptors such as cloud computing companies or leading IT companies may enter the industry and we believe that they may become strong partners through our Subscription Model. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">As a general matter, we view competition on two levels:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Competing digital X-ray sources with same or better attributes; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Competing enterprises operating an MSaaS business model.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In terms of digital X-ray sources, the field emission display technology is known and a wide range of industry leaders have used it to attempt to create an alternative, digital source of X-ray. We are not aware of any competing company that has achieved a commercial grade, stable digital X-ray source, either based on field emission display technology or otherwise. The most well-known attempt was the use of carbon nano tubes (&#8220;CNT&#8221;) as the base material for a potential field emission-based solution. To our knowledge, there are several companies currently in the process of developing this technology, including Carestream, XinRay Systems and Varex Imaging. Branded as a &#8220;cold cathode,&#8221; CNT solutions have been proven to be unstable and, to date, no commercially available solution has been implemented after significant investment.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">There are two main differences between our MEMs-based X-ray source and CNT-based X-ray sources. First, carbon, which is used in CNT-based X-ray sources, is much easier to burn than metal, which is used in our X-ray source. The carbon edges of CNT are extremely small. If these carbon edges are not controlled precisely, so that the maximum current is below their burn temperature, they burn out. Further, the edges of CNT are randomly positioned and cannot position nano-tubes in precise locations. Therefore, the edges burn first under high electric field voltage and cause a chain reaction of all edges burning, which renders the CNT useless. In contrast, we believe our molybdenum cones are a far more resistant base and our X-ray source positions metal cone edges in the precise location of the electric field using our MEMs with negligible positioning error deviation. Second, others have tried to prevent the deterioration of the CNT-based X-ray sources by using </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">95<br></div></div></div>
<!--End Page 101-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 102-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">&#8220;mesh&#8221; as an electric field to extract electrons. &#8220;Mesh&#8221; is a grid-electrode set a few millimeters above of CNTs. However, the distance between the metal edges and their gates is extremely large compared to our X-ray source, and it requires 1,000 volts to extract electrons, while our X-ray source only needs 50 volts. High voltage is costly and imprecise. Moreover, the mesh grid traps 50% of the electron emission, meaning the mesh-based solution is costly and extracts only a small number of electrons, many of which are wasted.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In terms of the MSaaS business model, we currently seek a first-mover advantage by introducing the Subscription Model, as the main pre-requisite for this model is the low cost of the X-ray source. However, the primary competition comes from established market participants. While in developing countries we are experiencing keen interest, the United States and other Western regions already have major market participants that are well entrenched in the market with strong political influence and the ability to delay deployment of our systems.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Intellectual Property </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of July&#160;8, 2020, we had three issued patents in the United States and eight provisional or pending U.S. patent applications. We also had three patents issued in each of Israel, Japan and China, three pending patent applications in the European Patent Office, three pending patent applications in Korea and six pending Patent Cooperation Treaty patent applications, which are the counterparts of our U.S. patent applications. Our issued patents expire between the years 2032 and 2034, and are directed to various features and combinations of features of the Nanox.ARC. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We intend to continue filing for patents on new technologies as they are developed and to actively pursue any infringement upon our patents. We believe that our know-how and trade secrets represent de facto barriers to potential competition.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Security and Data Privacy </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Nanox System is being designed and developed with personal privacy, data security and protection in mind as a top priority for all development parties. Medical imaging information and other health information is highly personal and sensitive and thus regarded as a prime target for hacks and malicious theft. As part of our normal operations, we expect to collect, process and retain personal identifying information regarding patients. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We believe we will likely be subject to U.S. rules and regulations governing data protection, including HIPAA. See &#8220;&#8212;Government Regulation&#8212;Healthcare Regulatory Laws&#8212;Data Privacy and Security.&#8221; </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, we believe we will likely be subject to the GDPR to the extent that our business involves personal data of persons within the EU. Data protection legislation, including the GDPR, regulates the manner in which we may hold and communicate personal data of our employees and patients (including, in our case, sensitive health data). We are likely to be defined as a &#8220;Data Controller&#8221; with respect to the personal data of patients that we intend to collect and are therefore likely to be subject to a number of key legal obligations under the GDPR. In addition to reflecting existing requirements that already existed under the old data protection regime, such as, among other things, requirements to provide users with a &#8220;fair processing notice&#8221; if we process their data, ensure that inaccurate data is corrected, only retain data for so long as is necessary and not transfer data outside the EEA to jurisdictions which do not ensure an adequate level of protection of personal data without taking certain safeguards, the GDPR also implemented new, more stringent operational and procedural requirements for our use of personal data. These include expanded prior information requirements in light of the transparency principle to tell patients how we may use their personal data, increased controls on profiling such persons, increased rights for patients to access, control and delete their personal data and mandatory data breach notification requirements. In addition, there are significantly increased administrative fines of the greater of &#8364;20 million and 4% of global turnover (as well as the right to compensation for financial or non-financial damages claimed by any individuals under Article 82 of the GDPR).</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Separate from, and in addition to, the GDPR requirements, certification requirements for the hosting of health data will vary by jurisdiction (and may or may not apply to hosts of health data). As the Nanox System is projected to operate in various EEA countries, we may be required to comply with other national healthcare regulations or regulatory requirements. For example, in France, there is a procedure as of April 1, 2018, for hosts of health data to obtain a prior certification with the competent certification body. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We are dedicated to making our systems and software both HIPAA and GDPR compliant. We intend to submit our systems to an independent external audit on a regular basis as required by HHS. We also intend to </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">96<br></div></div></div>
<!--End Page 102-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 103-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">develop our privacy protocols to comply with the GDPR. In addition, we are undertaking intendant measures to ensure a high-level of imaging data encryption, complete separation between the imaging data and personal information (anonymization) as well as three-factor authentication procedures during on-boarding and usage of the Nanox System. We also intend to undertake to perform periodic Pen-Tests by external cyber security professionals and publish the results of such audits publicly and without delay on our website and via public relations channels. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Government Regulation</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Nanox System and our operations will be subject to extensive regulation by the FDA, and other federal and state authorities in the United States, as well as comparable authorities in foreign jurisdictions. The Nanox.ARC will be subject to regulation as medical devices and radiation-emitting devices in the United States under the FDCA, as implemented and enforced by the FDA, and under comparable regulatory schemes in foreign jurisdictions.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">FDA Regulation of Medical Devices</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The FDA regulates the development, design, non-clinical and clinical research, manufacturing, safety, efficacy, labeling, packaging, storage, installation, servicing, recordkeeping, premarket clearance or approval, adverse event reporting, advertising, promotion, marketing and distribution, and import and export of medical devices to ensure that medical devices distributed within the United States are safe and effective for their intended uses and otherwise meet the requirements of the FDCA.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">FDA Premarket Clearance and Approval Requirements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Subject to certain exceptions, each medical device commercially distributed in the United States requires either FDA clearance of a 510(k) premarket notification, or approval of a PMA application. Under the FDCA, medical devices are classified into one of three classes&#8212;Class&#160;I, Class&#160;II or Class&#160;III&#8212;depending on the degree of risk associated with each medical device and the extent of manufacturer and regulatory control needed to ensure its safety and effectiveness. Class&#160;I includes devices with the lowest risk to the patient and are those for which safety and effectiveness can be assured by adherence to the FDA&#8217;s General Controls for medical devices, which include compliance with the applicable portions of QSR, facility registration and product listing, reporting of adverse medical events and truthful and non-misleading labeling, advertising and promotional materials. Class&#160;II devices are subject to the FDA&#8217;s General Controls, and special controls as deemed necessary by the FDA to ensure the safety and effectiveness of the device. These special controls can include performance standards, post-market surveillance, patient registries and FDA guidance documents. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">While most Class&#160;I devices are exempt from the 510(k) premarket notification requirement, manufacturers of most Class&#160;II devices are required to submit to the FDA a premarket notification under Section 510(k) of the FDCA requesting permission to commercially distribute the device. The FDA&#8217;s permission to commercially distribute a device subject to a 510(k) premarket notification is generally known as 510(k) clearance. Devices deemed by the FDA to pose the greatest risks, such as life sustaining, life supporting or some implantable devices, or devices that have a new intended use, or use advanced technology that is not substantially equivalent to that of a legally marketed device, are placed in Class&#160;III, requiring approval of a PMA. Some pre-amendment devices are unclassified, but are subject to the FDA&#8217;s premarket notification and clearance process in order to be commercially distributed. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">510(k) Clearance Marketing Pathway</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We expect the Nanox.ARC will be a Class II device subject to premarket notification and clearance under section 510(k) of the FDCA. To obtain 510(k) clearance, we must submit to the FDA a premarket notification submission demonstrating that the proposed device is &#8220;substantially equivalent&#8221; to a predicate device already on the market. A predicate device is a legally marketed device that is not subject to premarket approval, i.e., a device that was legally marketed prior to May&#160;28, 1976 (pre-amendments device), and for which a PMA is not required, a device that has been reclassified from Class&#160;III to Class&#160;II or I, or a device that was found substantially equivalent through the 510(k) process. The FDA&#8217;s 510(k) clearance process usually takes from three to twelve months, but often takes longer. The FDA may require additional information, including clinical data, to </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">97<br></div></div></div>
<!--End Page 103-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 104-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">make a determination regarding substantial equivalence. In addition, the FDA collects user fees for certain medical device submissions and annual fees and for medical device establishments. For fiscal year 2020, the standard user fee for a 510(k) premarket notification application is $11,594. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If the FDA agrees that the device is substantially equivalent to a predicate device currently on the market, it will grant 510(k) clearance to commercially market the device. If the FDA determines that the device is &#8220;not substantially equivalent&#8221; to a previously cleared device, the device is automatically designated as a Class&#160;III device. The device sponsor must then fulfill more rigorous PMA requirements, or can request a risk-based classification determination for the device in accordance with the &#8220;<font style="font-style: italic;">de novo</font>&#8221; process, which is a route to market for novel medical devices that are low to moderate risk and are not substantially equivalent to a predicate device. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">After a device receives 510(k) marketing clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change or modification in its intended use, will require a new 510(k) clearance or, depending on the modification, PMA approval or <font style="font-style: italic;">de novo</font> reclassification. The FDA requires each manufacturer to determine whether the proposed change requires submission of a 510(k), a <font style="font-style: italic;">de novo</font> request or a PMA in the first instance, but the FDA can review any such decision and disagree with a manufacturer&#8217;s determination. If the FDA disagrees with a manufacturer&#8217;s determination, the FDA can require the manufacturer to cease marketing and/or request the recall of the modified device until 510(k) marketing clearance or until PMA approval is obtained or a <font style="font-style: italic;">de novo</font> request is granted. Also, in these circumstances, the manufacturer may be subject to significant regulatory fines or penalties. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Over the last several years, the FDA has proposed reforms to its 510(k) clearance process, and such proposals could include increased requirements for clinical data and a longer review period, or could make it more difficult for manufacturers to utilize the 510(k) clearance process for their products. For example, in November 2018, the FDA officials announced forthcoming steps that the FDA intends to take to modernize the premarket notification pathway under Section 510(k) of the FDCA. Among other things, the FDA announced that it planned to develop proposals to drive manufacturers utilizing the 510(k) pathway toward the use of newer predicates. These proposals included plans to potentially sunset certain older devices that were used as predicates under the 510(k) clearance pathway, and to potentially publish a list of devices that have been cleared on the basis of demonstrated substantial equivalence to predicate devices that are more than 10&#160;years old. In May 2019, the FDA solicited public feedback on these proposals. The FDA requested public feedback on whether it should consider certain actions that might require new authority, such as whether to sunset certain older devices that were used as predicates under the 510(k) clearance pathway. These proposals have not yet been finalized or adopted, and the FDA may work with Congress to implement such proposals through legislation. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">More recently, in September 2019, the FDA finalized guidance describing an optional &#8220;safety and performance based&#8221; premarket review pathway for manufacturers of &#8220;certain, well-understood device types&#8221; to demonstrate substantial equivalence under the 510(k) clearance pathway by showing that such device meets objective safety and performance criteria established by the FDA, thereby obviating the need for manufacturers to compare the safety and performance of their medical devices to specific predicate devices in the clearance process. The FDA intends to develop and maintain a list of device types appropriate for the &#8220;safety and performance based&#8221; pathway and will continue to develop product-specific guidance documents that identify the performance criteria for each such device type, as well as the testing methods recommended in the guidance documents, where feasible. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20pt; margin-left: 0pt; text-align: left;">PMA Approval Pathway</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Class&#160;III devices require PMA approval before they can be marketed, although some pre-amendment Class&#160;III devices for which the FDA has not yet required a PMA are cleared through the 510(k) process. The&#160;PMA process is more demanding than the 510(k) premarket notification process. In a PMA, the manufacturer must demonstrate that the device is safe and effective, and the PMA must be supported by extensive data, including data from preclinical studies and human clinical trials. The PMA must also contain a full description of the device and its components, a full description of the methods, facilities and controls used for manufacturing and proposed labeling. Following receipt of a PMA, the FDA determines whether the application is sufficiently complete to permit a substantive review. If the FDA accepts the application for review, it has 180 days under the FDCA to complete its review of a PMA, although in practice, the FDA&#8217;s review often takes significantly longer, and can take up to several years. An advisory panel of experts from outside the FDA may be convened to review and evaluate the application and provide recommendations to the FDA as to the </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">98<br></div></div></div>
<!--End Page 104-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 105-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">approvability of the device. The FDA may or may not accept the panel&#8217;s recommendation. In addition, the FDA will generally conduct a pre-approval inspection of the applicant or its third-party manufacturers&#8217; or suppliers&#8217; manufacturing facility or facilities to ensure compliance with the QSR. PMA devices are also subject to the payment of user fees, which for fiscal year 2020 includes a standard application fee of $340,995 and an annual establishment registration fee of $5,236. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The FDA will approve the new device for commercial distribution if it determines that the data and information in the PMA constitute valid scientific evidence and that there is reasonable assurance that the device is safe and effective for its intended use(s). The FDA may approve a PMA with post-approval conditions intended to ensure the safety and effectiveness of the device, including, among other things, restrictions on labeling, promotion, sale and distribution and collection of long-term follow-up data from patients in the clinical study that supported PMA approval or requirements to conduct additional clinical studies post-approval. The FDA may condition PMA approval on some form of post-market surveillance when deemed necessary to protect the public health or to provide additional safety and efficacy data for the device in a larger population or for a longer period of use. In such cases, the manufacturer might be required to follow certain patient groups for a number of years and to make periodic reports to the FDA on the clinical status of those patients. Failure to comply with the conditions of approval can result in material adverse enforcement action, including withdrawal of the approval.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Certain changes to an approved device, such as changes in manufacturing facilities, methods or quality control procedures, or changes in the design performance specifications, which affect the safety or effectiveness of the device, require submission of a PMA supplement. PMA supplements often require submission of the same type of information as a PMA, except that the supplement is limited to information needed to support any changes from the device covered by the original PMA and may not require as extensive clinical data or the convening of an advisory panel. Certain other changes to an approved device require the submission of a new PMA, such as when the design change causes a different intended use, mode of operation, and technical basis of operation, or when the design change is so significant that a new generation of the device will be developed, and the data that were submitted with the original PMA are not applicable for the change in demonstrating a reasonable assurance of safety and effectiveness. We do not expect any of our products to be marketed pursuant to a PMA. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Clinical Trials</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Clinical trials are almost always required to support a PMA and are sometimes required to support a 510(k)&#160;submission. All clinical investigations of devices to determine safety and effectiveness must be conducted in accordance with the FDA&#8217;s investigational device exemption (&#8220;IDE&#8221;) regulations which govern investigational device labeling, prohibit promotion of the investigational device and specify an array of recordkeeping, reporting and monitoring responsibilities of study sponsors and study investigators. If the device presents a &#8220;significant risk&#8221; to human health, as defined by the FDA, the FDA requires the device sponsor to submit an IDE application to the FDA, which must become effective prior to commencing human clinical trials. If the device under evaluation does not present a significant risk to human health, then the device sponsor is not required to submit an IDE application to the FDA before initiating human clinical trials, but must still comply with abbreviated IDE&#160;requirements when conducting such trials. A significant risk device is one that presents a potential for serious risk to the health, safety or welfare of a patient and either is implanted, used in supporting or sustaining human life, substantially important in diagnosing, curing, mitigating or treating disease or otherwise preventing impairment of human health, or otherwise presents a potential for serious risk to a subject. An IDE application must be supported by appropriate data, such as animal and laboratory test results, showing that it is safe to test the device in humans and that the testing protocol is scientifically sound. The IDE will automatically become effective 30 days after receipt by the FDA unless the FDA notifies the company that the investigation may not begin. If the FDA determines that there are deficiencies or other concerns with an IDE for which it requires modification, the FDA may permit a clinical trial to proceed under a conditional approval. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Regardless of the degree of risk presented by the medical device, clinical studies must be approved by, and conducted under the oversight of, an Institutional Review Board (&#8220;IRB&#8221;) for each clinical site. The IRB is responsible for the initial and continuing review of the IDE, and may pose additional requirements for the conduct of the study. If an IDE application is approved by the FDA and one or more IRBs, human clinical trials may begin at a specific number of investigational sites with a specific number of patients, as approved by the FDA. If the device presents a non-significant risk to the patient, a sponsor may begin the clinical trial after </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">99<br></div></div></div>
<!--End Page 105-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 106-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">obtaining approval for the trial by one or more IRBs without separate approval from the FDA, but must still follow abbreviated IDE requirements, such as monitoring the investigation, ensuring that the investigators obtain informed consent and labeling and record-keeping requirements. Acceptance of an IDE application for review does not guarantee that the FDA will allow the IDE to become effective and, if it does become effective, the FDA may or may not determine that the data derived from the trials support the safety and effectiveness of the device or warrant the continuation of clinical trials. An IDE supplement must be submitted to, and approved by, the FDA before a sponsor or investigator may make a change to the investigational plan that may affect its scientific soundness, study plan or the rights, safety or welfare of human subjects.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During a study, the sponsor is required to comply with the applicable FDA requirements, including, for example, trial monitoring, selecting clinical investigators and providing them with the investigational plan, ensuring IRB review, adverse event reporting, record keeping and prohibitions on the promotion of investigational devices or on making safety or effectiveness claims for them. The clinical investigators in the clinical study are also subject to FDA regulations and must obtain patient informed consent, rigorously follow the investigational plan and study protocol, control the disposition of the investigational device and comply with all reporting and recordkeeping requirements. Additionally, after a trial begins, we, the FDA or the IRB could suspend or terminate a clinical trial at any time for various reasons, including a belief that the risks to study subjects outweigh the anticipated benefits. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Post-market Regulation</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">After a device is cleared or approved for marketing, numerous and pervasive regulatory requirements continue to apply. These include:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">establishment registration and device listing with the FDA;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">QSR requirements, which require manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation and other quality assurance procedures during all aspects of the design and manufacturing process;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">labeling regulations and FDA prohibitions against the promotion of investigational products, or the promotion of &#8220;off-label&#8221; uses of cleared or approved products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">requirements related to promotional activities;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">clearance or approval of product modifications to 510(k)-cleared devices that could significantly affect safety or effectiveness or that would constitute a major change in intended use of one of our cleared devices, or approval of certain modifications to PMA-approved devices;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">medical device reporting regulations, which require that a manufacturer report to the FDA if a device it markets may have caused or contributed to a death or serious injury, or has malfunctioned and the device or a similar device that it markets would be likely to cause or contribute to a death or serious injury, if the malfunction were to recur;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">correction, removal and recall reporting regulations, which require that manufacturers report to the FDA field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to health;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the FDA&#8217;s recall authority, whereby the agency can order device manufacturers to recall from the market a product that is in violation of governing laws and regulations; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">post-market surveillance activities and regulations, which apply when deemed by the FDA to be necessary to protect the public health or to provide additional safety and effectiveness data for the device.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our manufacturing processes are required to comply with the applicable portions of the QSR, which cover the methods and the facilities and controls for the design, manufacture, testing, production, processes, controls, quality assurance, labeling, packaging, distribution, installation and servicing of finished devices intended for human use. The QSR also requires, among other things, maintenance of a device master file, device history file and complaint files. As a manufacturer, we will be subject to periodic scheduled or unscheduled inspections by the FDA. Our failure to maintain compliance with the QSR requirements could result in the shut-down of, or restrictions on, our manufacturing operations and the recall or seizure of our products, which would have a material adverse effect on our business. The discovery of previously unknown problems with any of our </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">100<br></div></div></div>
<!--End Page 106-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 107-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">products, including unanticipated adverse events or adverse events of increasing severity or frequency, whether resulting from the use of the device within the scope of its clearance or off-label by a physician in the practice of medicine, could result in restrictions on the device, including the removal of the product from the market or voluntary or mandatory device recalls.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The FDA has broad regulatory compliance and enforcement powers. If the FDA determines that we failed to comply with applicable regulatory requirements, it can take a variety of compliance or enforcement actions, which may result in any of the following sanctions:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">warning letters, untitled letters, fines, injunctions, consent decrees and civil penalties;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">recalls, withdrawals or administrative detention or seizure of our products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">operating restrictions or partial suspension or total shutdown of production;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">refusing or delaying requests for 510(k) marketing clearance or PMA approvals of new products or modified products;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">withdrawing 510(k) clearances or PMA approvals that have already been granted;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">refusal to grant export approvals for our products; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">criminal prosecution.</div></td></tr></table><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Radiological Devices </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We and our products will also be regulated by the FDA under the Electronic Product Radiation Control provisions of the FDCA because the Nanox.ARC contains radiation emitting components, and because we assemble these components during manufacturing and service activities. The Electronic Product Radiation Control provisions require radiation-producing products to comply with certain regulations and applicable performance standards. Manufacturers are required to certify in product labeling and reports to the FDA that their products comply with all necessary standards as well as maintain manufacturing, testing and sales records for their products. The Electronic Product Radiation Control provisions also require manufacturers to report product defects and affix appropriate labeling to covered products. Failure to comply with these requirements could result in enforcement action by the FDA, which can include any of the sanctions described above.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Healthcare Regulatory Laws </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Within the United States, our products and our customers will be subject to extensive regulation by a wide range of federal and state agencies that govern business practices in the medical device industry. These laws include federal and state anti-kickback, fraud and abuse, false claims, transparency and anti-corruption statutes and regulations. Internationally, other governments also impose regulations in connection with their healthcare reimbursement programs and the delivery of healthcare items and services. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">U.S. federal healthcare fraud and abuse laws will generally apply to our activities, among other reasons because we expect that our products will be covered under federal healthcare programs such as Medicare and Medicaid. The Anti-Kickback Statute is particularly relevant because of its broad applicability. Specifically, the Anti-Kickback Statute prohibits persons from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in exchange for, or to induce, either the referral of an individual, or the furnishing, arranging for or recommending a good or service for which payment may be made in whole or part under federal healthcare programs, such as the Medicare and Medicaid programs. Almost any financial interaction with a healthcare provider, patient or customer will implicate the Anti-Kickback Statute. Statutory exceptions and regulatory safe harbors protect certain interactions if specific requirements are met. However, only those interactions that represent fair market value exchanges generally are protected by a safe harbor or exception. The government can exercise enforcement discretion in taking action against unprotected activities. Further, a person or entity does not need to have actual knowledge of the Anti-Kickback Statute or specific intent to violate it in order to have committed a violation. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal False Claims Act or federal civil money penalties statute. Penalties for </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">101<br></div></div></div>
<!--End Page 107-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 108-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Anti-Kickback Statute violations may include both criminal penalties such as imprisonment and civil sanctions such as fines, imprisonment and possible exclusion from Medicare, Medicaid and other federal healthcare programs. Exclusion would mean that diagnostic tests using our products would no longer be eligible for reimbursement under federal healthcare programs. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Many states have adopted laws similar to the Anti-Kickback Statute. Some of these state prohibitions apply to referral of patients for healthcare items or services reimbursed by any payor, not only federal healthcare programs. Insurance companies may also bring a private cause of action for treble damages against a manufacturer for a pattern of causing false claims to be filed under the federal Racketeer Influenced and Corrupt Organizations Act. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Another development affecting the healthcare industry is the increased use of the federal Civil False Claims Act and, in particular, actions brought pursuant to the False Claims Act&#8217;s &#8220;whistleblower&#8221; or &#8220;qui tam&#8221; provisions. The False Claims Act imposes liability on any person or entity that, among other things, knowingly presents, or causes to be presented, a false or fraudulent claim for payment by a federal healthcare program. The qui tam provisions of the False Claims Act allow a private individual to bring actions on behalf of the federal government alleging that the defendant has submitted a false claim to the federal government, and to share in any monetary recovery. In recent years, the number of suits brought against healthcare providers by private individuals has increased dramatically. In addition, various states have enacted false claim laws analogous to the Civil False Claims Act, although many of these state laws apply where a claim is submitted to any third-party payor and not merely a federal healthcare program.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, among other things, created two new federal crimes: healthcare fraud and false statements relating to healthcare matters. The HIPAA healthcare fraud statute prohibits, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private payors. A violation of this statute is a felony and may result in fines, imprisonment and/or exclusion from government-sponsored programs. The HIPAA false statements statute prohibits, among other things, knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement or representation in connection with the delivery of or payment for healthcare benefits, items or services. A violation of this statute is a felony and may result in fines and/or imprisonment. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statutes or specific intent to violate them in order to have committed a violation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Laws and regulations have also been enacted by the federal government and various states to regulate the sales and marketing practices of medical device and pharmaceutical manufacturers. The laws and regulations generally limit financial interactions between manufacturers and healthcare providers, require pharmaceutical and medical device companies to comply with voluntary compliance standards issued by industry associations and the relevant compliance guidance promulgated by the U.S. federal government and/or require disclosure to the government and/or public of financial interactions (so-called &#8220;sunshine laws&#8221;). Many of these laws and regulations contain ambiguous requirements or require administrative guidance for implementation. Manufacturers must adopt reasonable interpretations of requirements if there is ambiguity and those interpretations could be challenged. Given the lack of clarity in laws and their implementation, our activities could be subject to the penalty provisions of the pertinent federal and state laws and regulations.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Coverage and Reimbursement</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Over the past few years, the growth rate of advanced imaging volumes has slowed in part due to additional patient-related cost-sharing programs and an increasing trend of third-party payors intensifying their utilization management efforts, for example, through benefit managers who require prior authorizations to control the growth rate of imaging services generally. We expect that these trends will continue. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">By way of example, in the United States, the Protecting Access to Medicare Act of 2014 required CMS, in conjunction with medical specialty societies, to adopt appropriate use criteria (&#8220;AUC&#8221;) for certain advanced diagnostic imaging services, including MRI, CT, nuclear medicine (including position emission tomography). Beginning in 2020, payment will be made to the furnishing professional for an applicable advanced diagnostic imaging service only if the claim indicates that the ordering professional consulted a qualified clinical decision support mechanism, as identified by HHS, as to whether the ordered service adheres to the applicable AUC. Applicable settings include physician offices, hospital outpatient departments, including emergency departments, </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">102<br></div></div></div>
<!--End Page 108-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 109-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">ambulatory surgical centers and independent diagnostic testing facilities. Advanced imaging services ordered by certain physicians identified as having outlier-ordering partners will be subject to prior authorization for applicable imaging services provided to Medicare beneficiaries. The outlier methodology used by CMS will be subject to future notice and comment rulemaking before the prior authorization component is implemented. We cannot predict the full impact of this project.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Third-party payors may impose limits on coverage or reimbursement for diagnostic imaging services, including denying reimbursement for tests that do not follow recommended diagnostic procedures or can only be billed using an unlisted or miscellaneous code. To the extent our customers will depend on third-party payors, unfavorable coding, coverage and reimbursement policies may constrict the profit margins of our provider customers, which may force us to lower our fees to attract and retain customers. If we are required to request new billing codes that more precisely identify and describe our imaging services, coverage is limited or reimbursement rates are inadequate, a healthcare provider might find it financially unattractive to own diagnostic imaging systems. It is possible that third-party payor coding, coverage and reimbursement policies will affect the need or prices for our products in the future, which could significantly affect our financial performance and our ability to conduct our business.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Healthcare Reform</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In the United States and certain foreign jurisdictions, there have been, and we expect there will continue to be, a number of legislative and regulatory changes to the healthcare system. In March 2010, the ACA was signed into law and substantially changed the way healthcare is financed by both governmental and private insurers in the United States. The ACA contains a number of provisions, including those governing enrollment in federal healthcare programs, reimbursement adjustments and fraud and abuse changes. Additionally, the ACA imposed, among other things, a new federal excise tax on the sale of certain medical devices, which, through a series of legislative amendments, was suspended, effective January 1, 2016, and subsequently repealed altogether on December 20, 2019, provided incentives to programs that increase the federal government&#8217;s comparative effectiveness research and implemented payment system reforms including a national pilot program on payment bundling to encourage hospitals, physicians and other providers to improve the coordination, quality and efficiency of certain healthcare services through bundled payment models. Since its enactment, there have been judicial and Congressional challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Since its enactment, there have been judicial and Congressional challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future. By way of example, in 2017, Congress enacted the TCJA, which eliminated the tax-based shared responsibility payment imposed by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#8220;individual mandate.&#8221; On December 14, 2018, a Texas U.S. District Court Judge ruled that the individual mandate is a critical and inseverable feature of the ACA, and therefore, because it was repealed as part of the TCJA, the remaining provisions of the ACA are invalid as well. On December 18, 2019, the U.S. Court of Appeals for the 5th Circuit ruled that the individual mandate was unconstitutional and remanded the case back to the District Court to determine whether the remaining provisions of the ACA are invalid as well. It is unclear how these decisions, future decisions, subsequent appeals, and other efforts to repeal and replace the ACA will impact the ACA.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Other legislative changes have been proposed and adopted in the United States since the ACA was enacted, including aggregate reductions of Medicare payments to providers of 2% per fiscal year and reduced payments to several types of Medicare providers. We believe the overall escalating cost of medical products and services being paid for by the government and private health insurance has led to, and will continue to lead to, increased pressures on the healthcare and medical device industry to reduce the costs of products and services. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Data Privacy and Security</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Medical device companies may be subject to U.S. federal and state and foreign health information privacy, security and data breach notification laws, which may govern the collection, use, disclosure and protection of health-related and other personal information. In the United States, HIPAA imposes privacy, security and breach reporting obligations with respect to individually identifiable health information upon &#8220;covered entities&#8221; (health plans, health care clearinghouses and certain health care providers), and their respective business associates, </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">103<br></div></div></div>
<!--End Page 109-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 110-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">individuals or entities that create, receive, maintain or transmit protected health information in connection with providing a service for or on behalf of a covered entity. HIPAA and its respective implementing regulations, including the final omnibus rule published on January&#160;25, 2013, imposes specified requirements relating to the privacy, security and transmission of individually identifiable health information. HIPAA mandates the reporting of certain breaches of health information to HHS, affected individuals and if the breach is large enough, the&#160;media. Entities that are found to be in violation of HIPAA as the result of a breach of unsecured protected health information (&#8220;PHI&#8221;), a complaint about privacy practices or an audit by HHS, may be subject to significant civil, criminal and administrative fines and penalties and/or additional reporting and oversight obligations if required to enter into a resolution agreement and corrective action plan with HHS to settle allegations of HIPAA non-compliance. The Health Information Technology and Clinical Health Act also increased the civil and criminal penalties that may be imposed against covered entities, business associates and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorney&#8217;s fees and costs associated with pursuing federal civil actions.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Even when HIPAA does not apply, according to the Federal Trade Commission or the FTC, failing to take appropriate steps to keep consumers&#8217; personal information secure constitutes unfair acts or practices in or affecting commerce in violation of Section 5(a) of the Federal Trade Commission Act, 15 U.S.C &#167; 45(a). The FTC expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. Individually identifiable health information is considered sensitive data that merits stronger safeguards. The FTC&#8217;s guidance for appropriately securing consumers&#8217; personal information is similar to what is required by the HIPAA Security Rule.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, certain state and non-U.S. laws, such as the GDPR, govern the privacy and security of health information in certain circumstances, some of which are more stringent than HIPAA and many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. Further, &#8220;business associates,&#8221; defined as independent contractors or agents of covered entities that create, receive, maintain or transmit protected health information in connection with providing a service for or on behalf of a covered entity, are also subject to certain HIPAA privacy and security standards. Failure to comply with these laws, where applicable, can result in the imposition of significant civil and/or criminal penalties and private litigation. For example, California recently enacted legislation, the California Consumer Privacy Act (&#8220;CCPA&#8221;), which went into effect January&#160;1, 2020. The CCPA, among other things, creates new data privacy obligations for covered companies and provides new privacy rights to California residents, including the right to opt out of certain disclosures of their information. The CCPA also creates a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. Although the law includes limited exceptions, including for PHI maintained by a covered entity or business associate, it may regulate or impact our expected processing of personal information depending on the context. In Europe, the&#160;GDPR went into effect in May 2018 and introduces strict requirements for processing the personal data of European Union data subjects. Companies that must comply with the GDPR face increased compliance obligations and risk, including more robust regulatory enforcement of data protection requirements and potential fines for noncompliance of up to &#8364;20&#160;million or 4% of the annual global revenues of the noncompliant company, whichever is greater. The State of Israel has also implemented data protection laws and regulations, including the Israeli Protection of Privacy Law of 1981. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Foreign Regulation</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As we plan to market and deploy our Nanox System broadly across the globe, we will be subject to regulations applicable to medical and radiation-emitting devices in the jurisdictions in which we operate, which regulations vary among countries. While some countries&#8217; regulations may not impose barriers to marketing and selling our products or only require certain notification, others may require that we obtain the clearance, registration or approval of a specified regulatory body. Process for obtaining such clearance, registration or approvals may involve additional testing and time. Furthermore, complying with foreign regulatory requirements can be expensive and time-consuming, and we will need to seek for regulatory clearances or approvals in each country in which we plan to market our products.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">104<br></div></div></div>
<!--End Page 110-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 111-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_107-bus_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, depending on the country, if we modify our products, we may need to apply for additional regulatory clearances or approvals before we are permitted to sell the modified product. Also, for maintaining our authorizations in a particular country, we will need to continue meeting quality and safety standards required in such country. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Finally, while regulatory clearance or approval by the FDA does not ensure registration, clearance or approval by regulatory authorities in other countries, registration or regulatory clearance or approval in one country, or denial thereof, may have effects on the regulatory process in others. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Employees</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of June&#160;30, 2020, we had 21 employees based in Israel and six employees based in Japan. We have never experienced any employment-related work stoppages and believe our relationship with our employees is good.</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Area of Activity </div></td><td class="gutter" style="width: 3.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.22%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">As of <br>June&#160;30,<br>2020</div></td></tr><tr><td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and Administrative <font style="padding-left: 4.99pt;"></font></div></td><td class="gutter" style="width: 3.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.22%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">11</div></td></tr><tr><td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research, Development and Quality Assurance <font style="padding-left: 0.3pt;"></font></div></td><td class="gutter" style="width: 3.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.22%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">15</div></td></tr><tr><td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sales and Marketing<font style="padding-left: 1.64pt;"></font></div></td><td class="gutter" style="width: 3.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.3%; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td style="width: 6.22%; text-align: center; vertical-align: bottom; border-bottom: 3pt double #000000; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">1</div></td></tr><tr><td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 0.09pt;"></font></div></td><td class="gutter" style="width: 3.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt;">&#8203;</td><td class="gutter" style="width: 3.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt;">&#8203;</td><td style="width: 6.22%; text-align: center; vertical-align: bottom; padding-top: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">27</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Facilities</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our principal executive offices are located in a leased facility in Neve Ilan, Israel. We lease approximately 550 square meters (approximately 5,920 square feet) of office space and warehouses. The lease expires in December 2021, and we have the option to extend our lease for an additional 24 months so long as we meet the terms of the original lease agreement. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We also lease approximately 620 square meters (approximately 6,670 square feet) of office space in Neve Ilan, Israel that may be used for offices and technical development. The lease expires in June 2023.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, Nanox Japan (predecessor) leases additional facilities of approximately 740 square feet of lab space and approximately 190 square feet of space in a clean room at the premises of the University of Tokyo for research and development activities. The lease automatically renews on a semi-annual basis.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We believe this office space will be sufficient to meet our needs for the next 12-18 months and that suitable additional space will be available as and when needed.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Legal Proceedings</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. We are currently not subject to any material legal proceedings.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">105<br></div></div></div>
<!--End Page 111-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 112-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tM"><!--Anchor--></a>MANAGEMENT</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Executive Officers and Directors</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table sets forth information concerning our executive officers and directors, including their ages as of August 13, 2020:</div><table cellspacing="0" cellpadding="0" class="txttab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 41.03%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name </div></td><td class="gutter" style="width: 1.92%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.92%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Age </div></td><td class="gutter" style="width: 1.92%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.92%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 46.15%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Position </div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Executive Officers</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Ran Poliakine</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">52</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Founder, Chief Executive Officer and Director*</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Itzhak Maayan</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">55 </div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Financial Officer</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Tal Shank</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">42 </div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vice President Corporate Development</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Yoel Raab</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">65 </div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Technology Officer</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Anat Kaphan</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">50 </div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vice President Product Marketing</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Shirly Kaufman-Kirshenbaum</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">46</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vice President Human Resources</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-Employee Directors**</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Onn Fenig </div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">45 </div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Floyd Katske</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">69</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Erez Meltzer</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">63</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td></tr><tr><td style="width: 41.03%; text-align: left; vertical-align: top; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Richard Stone</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: center; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">77</div></td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.92%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This individual will occupy the position of Chairman of the board of directors upon the closing of this offering.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">**<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">We entered into an amended investor rights agreement with SKT that grants SKT the right to appoint Mr. Jung Ho Park (or another person designated by SKT and reasonably acceptable to us) as a director for a term of three years. We expect that Mr. Park will be appointed to our board of directors following the effectiveness of the registration statement of which this prospectus forms a part. Mr. Park has served as the CEO of SK Telecom since March 2017. Mr. Park also serves as the chairman of the board of directors of SK Group Global growth committee and SK Hynix Inc. and serves on the board of directors of SK Telecom, Global System for Mobile Communications Association (GSMA), SK China, ADT Caps Co. Ltd, Life &amp; Security Holdings and SK S.E. Asia Pte. Ltd. The appointment of Mr. Park as a director will be subject to our amended and restated articles of association and the Nasdaq corporate governance rules.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, we expect to propose for appointment by our shareholders two external directors within three months following this offering as required by the Companies Law. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Executive Officers</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Ran Poliakine<font style="font-weight: normal;">, our founder, has served as a member of our board of directors since our inception</font><font style="font-weight: normal;"> and will </font><font style="font-weight: normal;">serve as the Chairman of t</font><font style="font-weight: normal;">h</font><font style="font-weight: normal;">e Board of Directors upon the </font><font style="font-weight: normal;">closing of this offering</font><font style="font-weight: normal;">. Mr.&#160;Poliakine has served as </font><font style="font-weight: normal;">our Chief Executive Officer since September 2019, and served as Chief Executive Officer of Nanox Gibraltar </font><font style="font-weight: normal;">since August 2018. Prior to that, he served as Chief Strategy Officer in Nanox Gibraltar from June 2015 to </font><font style="font-weight: normal;">August 2018. Mr. Poliakine is a serial entrepreneur and has founded numerous companies over the past two </font><font style="font-weight: normal;">decades, including </font><font style="font-weight: normal;">SixAI Ltd. and its controlled subsidiary (51%) Musashi Ai Ltd. (&#8220;Musashi&#8221;), </font><font style="font-weight: normal;">Powermat </font><font style="font-weight: normal;">Technologies</font><font style="font-weight: normal;"> Ltd.</font><font style="font-weight: normal;">, Wellsense Technologies Ltd., Tap Systems, Inc.</font><font style="font-weight: normal;"> and</font><font style="font-weight: normal;"> Illumigyn, Ltd.</font><font style="font-weight: normal;"> (&#8220;Illumigyn&#8221;)</font><font style="font-weight: normal;">.</font><font style="font-weight: normal;"> Mr. </font><font style="font-weight: normal;">Poliakine is a member of the board of directors of </font><font style="font-weight: normal;">SixAI Ltd., </font><font style="font-weight: normal;">Powermat Technologies</font><font style="font-weight: normal;"> </font><font style="font-weight: normal;">Ltd.,</font><font style="font-weight: normal;"> Musashi </font><font style="font-weight: normal;">and </font><font style="font-weight: normal;">CLKIM Ltd</font><font style="font-weight: normal;">. In addition, Mr. Poliakine currently serves as a member of senior management of Illumigyn.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Itzhak Maayan<font style="font-weight: normal;"> has served as our Chief Financial Officer since November 2019. Prior to joining us, </font><font style="font-weight: normal;">Mr.</font><font style="font-weight: normal;"> Maayan served in different finance leadership roles in Perrigo Company from 2007 to 2019, including </font><font style="font-weight: normal;">Vice </font><font style="font-weight: normal;">President, Financial Services and European Investor Relations, Vice President, International Finance, and Vice </font><font style="font-weight: normal;">President and Chief Financial Officer, Perrigo Israel</font><font style="font-weight: normal;">. Prior to Perrigo Company, Mr. Maayan held various finance </font><font style="font-weight: normal;">leadership roles at Cisco Systems </font><font style="font-weight: normal;">Israel </font><font style="font-weight: normal;">from </font><font style="font-weight: normal;">2003</font><font style="font-weight: normal;"> to 2007, Xtivia</font><font style="font-weight: normal;">, Inc.</font><font style="font-weight: normal;"> from </font><font style="font-weight: normal;">1999</font><font style="font-weight: normal;"> to </font><font style="font-weight: normal;">2003</font><font style="font-weight: normal;">, Kulick &amp; Soffa from </font><font style="font-weight: normal;">1995</font><font style="font-weight: normal;"> to </font><font style="font-weight: normal;">1999</font><font style="font-weight: normal;"> and Elscint </font><font style="font-weight: normal;">Ltd. </font><font style="font-weight: normal;">from 1993 to </font><font style="font-weight: normal;">1995</font><font style="font-weight: normal;">. Mr. Maayan received his bachelor&#8217;s degree in </font><font style="font-weight: normal;">e</font><font style="font-weight: normal;">conomics and </font><font style="font-weight: normal;">a</font><font style="font-weight: normal;">ccounting from </font><font style="font-weight: normal;">Haifa University</font><font style="font-weight: normal;">, and is a Certified Public Accountant in Israel.</font><font style="font-weight: normal;"> </font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Tal Shank<font style="font-weight: normal;"> has served as our Vice President of Corporate Development since September 2019. Mr.&#160;Shank </font><font style="font-weight: normal;">has served as Head of Corporate Development at Illumigyn</font><font style="font-weight: normal;"> from 2017 to date. From 2016 to 2017, Mr.&#160;Shank </font><font style="font-weight: normal;">was responsible </font><font style="font-weight: normal;">for</font><font style="font-weight: normal;"> the corporate and governance aspects of Head Start, a company supplier of services to </font><font style="font-weight: normal;">technology portfolio companies related to Ran Poliakine. Prior to that, Mr.&#160;Shank served as Deputy CEO &amp; </font></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">106<br></div></div></div>
<!--End Page 112-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 113-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Legal Counsel of Speech Modules Holdings Ltd. from 2014 to 2015. From 2009 to 2014, Mr. Shank worked at Guy, Bachar &amp; Co. Law Firm, where he started as an associate and became partner in 2011. Mr.&#160;Shank has practiced corporate and securities law in Israel since 2003, and he holds an M.B.A. and a LL.M. from Tel Aviv University.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Yoel Raab<font style="font-weight: normal;"> has served as our Chief Technology Officer since </font><font style="font-weight: normal;">September 2019</font><font style="font-weight: normal;">. </font><font style="font-weight: normal;">Mr.&#160;Raab serves as Chief </font><font style="font-weight: normal;">Technology Officer of Six-Eye Interactive Ltd. (&#8220;Six-Eye&#8221;), of which Ran Poliakine is the sole owner, and </font><font style="font-weight: normal;">served as Vice President of Research and Development of Wellsense from 2014 to 2018. </font><font style="font-weight: normal;">Prior to that, Mr.&#160;Raab </font><font style="font-weight: normal;">served as </font><font style="font-weight: normal;">R&amp;D manager and</font><font style="font-weight: normal;"> Chief Technology Officer of Powermat Technologies</font><font style="font-weight: normal;"> from 2007 to 2014. Mr.&#160;Raab </font><font style="font-weight: normal;">also served as Vice President of Research &amp; Development at Magink</font><font style="font-weight: normal;"> </font><font style="font-weight: normal;">from 2006 to 2007. From 2003 to 2006, </font><font style="font-weight: normal;">Mr.&#160;Raab served as a consultant and managed the gamma detectors department at Orbotech Medical. </font><font style="font-weight: normal;">From 2011 </font><font style="font-weight: normal;">to 2013</font><font style="font-weight: normal;">, he served as Vice President of Research &amp; Development at Phone-Or</font><font style="font-weight: normal;">. Prior to that, Mr.&#160;Raab worked at </font><font style="font-weight: normal;">Intel as a process engineer and served in various development and engineering positions from 1982 to </font><font style="font-weight: normal;">2001</font><font style="font-weight: normal;">. </font><font style="font-weight: normal;">From 1996 to 2001, Mr.&#160;Raab managed the Yield department at the Intel Fab in Qiryat Gat, Israel. Mr.&#160;Raab </font><font style="font-weight: normal;">received his bachelor&#8217;s degree and his master&#8217;s degree in </font><font style="font-weight: normal;">A</font><font style="font-weight: normal;">pplied </font><font style="font-weight: normal;">P</font><font style="font-weight: normal;">hysics, </font><font style="font-weight: normal;">M</font><font style="font-weight: normal;">icroelectronics from the Hebrew </font><font style="font-weight: normal;">University in Jerusalem.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Anat Kaphan<font style="font-weight: normal;"> has served as our Vice President of Product Marketing since </font><font style="font-weight: normal;">September</font><font style="font-weight: normal;"> </font><font style="font-weight: normal;">2019. Prior to </font><font style="font-weight: normal;">joining us, Ms.&#160;Kaphan served as Vice President of </font><font style="font-weight: normal;">Product and Marketing</font><font style="font-weight: normal;"> at Mazor Robotics Ltd. from 2015 to </font><font style="font-weight: normal;">2018, and </font><font style="font-weight: normal;">General Manager</font><font style="font-weight: normal;"> at Essence Group from 2014 to 201</font><font style="font-weight: normal;">5</font><font style="font-weight: normal;">. She also served as Marketing Director at </font><font style="font-weight: normal;">Phillips from 201</font><font style="font-weight: normal;">1</font><font style="font-weight: normal;"> to 2014. </font><font style="font-weight: normal;">Prior to that, Ms. Kaphan </font><font style="font-weight: normal;">served as Business Development Director at Lumenis from </font><font style="font-weight: normal;">2001 to 2011 and Product Manager at Elscint Ltd. from 1991 to 2001. </font><font style="font-weight: normal;">Ms.&#160;Kaphan holds an </font><font style="font-weight: normal;">M.B.A.</font><font style="font-weight: normal;"> in </font><font style="font-weight: normal;">International </font><font style="font-weight: normal;">m</font><font style="font-weight: normal;">arketing from Tel Aviv University and </font><font style="font-weight: normal;">received her bachelor&#8217;s degree</font><font style="font-weight: normal;"> in </font><font style="font-weight: normal;">E</font><font style="font-weight: normal;">conomics and</font><font style="font-weight: normal;"> </font><font style="font-weight: normal;">A</font><font style="font-weight: normal;">ccounting from Haifa University.</font><font style="font-weight: normal;"> </font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Shirly Kaufman-Kirshenbaum<font style="font-weight: normal;"> has served as our Vice President Human Resources since April 2020. Prior </font><font style="font-weight: normal;">to joining us, Ms. Kaufman-Kirshenbaum served as Human Resources Director of Isreali-American Council </font><font style="font-weight: normal;">(IAC) from December 2017 to April 2020, and as Regional Human Resources Director and HRB</font><font style="font-weight: normal;">P</font><font style="font-weight: normal;"> </font><font style="font-weight: normal;">of</font><font style="font-weight: normal;"> EMEA and</font><font style="font-weight: normal;"> </font><font style="font-weight: normal;">Canada at ZIM Integrated Shipping Services Ltd. </font><font style="font-weight: normal;">from September 2010 to August 2016. </font><font style="font-weight: normal;">Ms. </font><font style="font-weight: normal;">Kaufman-Kirshenbaum has her bachelor&#8217;s degree in Human Resources from Haifa University.</font><font style="font-weight: normal;"> </font></div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Directors</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Onn Fenig<font style="font-weight: normal;"> has served as a member of our board of directors since November&#160;2019. Mr.&#160;Fenig has served </font><font style="font-weight: normal;">as the chairman of the board of directors of &#8220;Beit Meitar&#8221; Waldorf Education Association since 2018. </font><font style="font-weight: normal;">Mr.</font><font style="font-weight: normal;"> Fenig </font><font style="font-weight: normal;">is a member of the board of directors of SixAI Ltd. and manages the operations of Musashi.</font><font style="font-weight: normal;"> Mr.&#160;Fenig has </font><font style="font-weight: normal;">served as Chief Executive Officer and a member of the board of directors of Rioglass Solar systems Ltd. since </font><font style="font-weight: normal;">2014, and as Chief Executive Officer of Rioglass Solar Receivers BU from 2016 to 2018. Prior to that, </font><font style="font-weight: normal;">Mr.&#160;Fenig co-founded and served as a member of the board of directors of DUTYFREEBEE LTD from 2013 to </font><font style="font-weight: normal;">2015. From 2011 to 2014, Mr.&#160;Fenig served as Commercial Director, Project Acquisition Finance at Siemens, </font><font style="font-weight: normal;">where he managed finance and commercial matters relating to engineering procurement and construction projects. </font><font style="font-weight: normal;">Prior to joining Siemens, Mr. Fenig served as Finance Manager, Inside Sales European Markets at Cisco Systems </font><font style="font-weight: normal;">from 2008 to 2010, Service Fulfilment Delivery Manager at Amdocs UK from 2006 to 2008, and Systems </font><font style="font-weight: normal;">Analyst, Cyber Security Department at Israeli Ministry of the Prime Minister from 2001 to 2005. Mr.&#160;Fenig </font><font style="font-weight: normal;">received his bachelor&#8217;s degree in </font><font style="font-weight: normal;">C</font><font style="font-weight: normal;">omputer </font><font style="font-weight: normal;">S</font><font style="font-weight: normal;">cience from</font><font style="font-weight: normal;"> the Interdisciplinary Center Herzliya in Herzliya, Israel, </font><font style="font-weight: normal;">and holds an M.B.A. from the University of Chicago Booth School of Business in Chicago, Illinois.</font><font style="font-weight: normal;"> </font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Floyd Katske<font style="font-weight: normal;"> has served as a member of our board of directors since February 2020. Mr.</font><font style="font-weight: normal;"> Katske serves on </font><font style="font-weight: normal;">the board of directors of Floyd A. Katske, M.D., a professional corporation, and Triurol Inc. Since 1983, </font><font style="font-weight: normal;">Mr.</font><font style="font-weight: normal;"> Katske has served as President of Floyd A. Katske, M.D. and since 1999, he has served as President of </font><font style="font-weight: normal;">Triurol, Inc. From 2009 to 2011, Mr. Katske served as the President of the Santa Clarita Valley Medical Society </font><font style="font-weight: normal;">and from 1997 to 1999, Mr. Katske served as the President of the California Urologic Association. Mr. Katske is </font><font style="font-weight: normal;">a member of the Medical Board of California and has worked as a professor and as Chief of Staff, Chief of </font><font style="font-weight: normal;">Surgery and Chief of Urology in various hospitals. Mr. Katske received his bachelor&#8217;s degree from Rutgers </font><font style="font-weight: normal;">University, and received his medical degree from The George Washington University.</font><font style="font-weight: normal;"> </font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Erez Meltzer<font style="font-weight: normal;"> has served as a member of our board of directors since December 2019. Mr. Meltzer serves </font><font style="font-weight: normal;">as the Executive Chairman of the board of directors of Hadassah Medical and University Center. Since 2008, </font><font style="font-weight: normal;">Mr.&#160;Meltzer has served as a teaching professor at the Tel Aviv Faculty of Medicine in the area of crisis </font></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">107<br></div></div></div>
<!--End Page 113-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 114-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">management. Meltzer served as Executive Vice Chairman and Chief Executive Officer of Gadot Chemicals &amp; Shipping Group from 2008 to 2013. Prior to that, he served as Chief Executive Officer of Africa-Israel Ltd from 2006 to 2008 and President and Chief Executive Officer of Netafim Ltd from 2001 to 2006. Mr.&#160;Meltzer also served as Chief Executive Officer of Creo Scitex from 1996 to 2001. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Richard Stone <font style="font-weight: normal;">has served as a member of our board of directors since </font><font style="font-weight: normal;">November&#160;2019</font><font style="font-weight: normal;">. </font><font style="font-weight: normal;">Professor&#160;Stone has </font><font style="font-weight: normal;">taught at Columbia University Law School since 1974, and became Professor&#160;Emeritus in 2018. Professor&#160;Stone </font><font style="font-weight: normal;">has taught courses in several fields of business law, specializing in federal income taxation. From 1969 to 1973, </font><font style="font-weight: normal;">Professor Stone served in the United States Justice Department as Assistant to the Solicitor General of the United </font><font style="font-weight: normal;">States. Beginning in 1981, Professor Stone began providing consulting to private and public technology start-ups, </font><font style="font-weight: normal;">primarily in the biotechnology field. Professor Stone co-founded several biotechnology companies, including </font><font style="font-weight: normal;">Lev&#160;Pharmaceuticals, Siga Technologies and OptMed. In 2007, Professor Stone began working primarily with </font><font style="font-weight: normal;">Israeli technology companies, mostly in the medical space. He is a member of the board of directors of </font><font style="font-weight: normal;">Wellsense, Cardiologics, Quality In Flow, Dario Health and Illumigyn. </font><font style="font-weight: normal;">Professor Stone received his bachelor&#8217;s </font><font style="font-weight: normal;">degree, Magna Cum Laude</font><font style="font-weight: normal;">,</font><font style="font-weight: normal;"> from Harvard College, and his Juris Doctor degree, Magna Cum Laude, from </font><font style="font-weight: normal;">Harvard Law School.</font><font style="font-weight: normal;"> </font></div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Compensation of Executive Officers and Directors</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For so long as we qualify as a foreign private issuer, we are not required to comply with the proxy rules applicable to U.S. domestic companies, including the requirement applicable to emerging growth companies to disclose the compensation of our chief executive officer and other two most highly compensated executive officers on an individual, rather than an aggregate, basis. The aggregate compensation, including share-based compensation, paid by us to our executive officers and directors for the year ended December&#160;31, 2019 was approximately $25.5&#160;million. This amount includes approximately $170,000 set aside or accrued to provide pension, severance, retirement or similar benefits or expenses, but does not include business travel, relocation, professional and business association dues, meals and expenses reimbursed to officers, and other benefits commonly reimbursed or paid by companies in Israel, on the same basis for all full-time employees generally. The aggregate compensation to our executive officers and directors include payments from Nanox Gibraltar, including through Six-Eye. See &#8220;&#8212;Equity Incentive Plan&#8221; for a discussion of our 2019 Equity Incentive Plan and grants to our executive officers and directors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On August&#160;2, 2020, we paid bonuses in the gross amount of $100,000 and $50,000 to Mr.&#160;Maayan and Mr.&#160;Shank, respectively, less applicable taxes and social security payments and withholdings, in recognition of their efforts in connection with the consummation of this offering. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Corporate Governance Practices and Foreign Private Issuer</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Foreign Private Issuer </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Companies incorporated under the laws of the State of Israel, whose shares are publicly traded, including companies with shares listed on the Nasdaq, are considered public companies under the Companies Law and are required to comply with various corporate governance requirements relating to such matters as the composition and responsibilities of the audit committee and the compensation committee, and a requirement to have an internal auditor. This is the case even if our ordinary shares are not listed on the Tel Aviv Stock Exchange, which our ordinary shares are not expected to be. These requirements are in addition to the corporate governance requirements imposed by Nasdaq rules and other applicable provisions of U.S. securities laws to which we will become subject (as a foreign private issuer) upon the closing of this offering and the listing of our ordinary shares on the Nasdaq.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">After the consummation of this offering, we will be a &#8220;foreign private issuer&#8221; under the U.S. securities laws and the Nasdaq corporate governance rules. As a foreign private issuer, we will be exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal shareholders will be exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. Also, we are not required to comply with Regulation FD, which restricts the selective disclosure of material information. However, we will file with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required by the SEC, an annual report on Form 20-F containing financial statements audited by an independent registered public accounting firm, and will submit to the SEC from time to time, on Form 6-K, reports of information that would likely be material to an investment decision in our ordinary shares.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">108<br></div></div></div>
<!--End Page 114-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 115-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As a foreign private issuer, we are permitted to follow certain Israeli corporate governance practices instead of the Nasdaq corporate governance rules, provided that we disclose which requirements we are not following and the equivalent Israeli requirement. Pursuant to the &#8220;foreign private issuer exemption&#8221;:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we intend to follow Israeli corporate governance practices instead of the Nasdaq requirements with regard to, among other things, the nomination committee and director nomination procedures.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we intend to comply with Israeli law, which permits a company to determine in its articles of association the number of shareholders and percentage of holdings required for such a quorum. Our&#160;amended and restated articles of association provide that a quorum of two or more shareholders holding at least 25% of the voting rights in person or by proxy is required for commencement of business at a general shareholders meeting. The quorum set forth in our amended and restated articles of association with respect to an adjourned meeting shall, subject to a limited exception, consist of one or more shareholders present in person or by proxy (including by voting deed), regardless of the number or percentage of our outstanding shares held by them;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">with the exception of our external directors and directors elected by our board of directors due to a vacancy, in accordance with the staggered nomination as described under &#8220;&#8212;Board of Directors and Officers,&#8221; we intend to elect our directors to hold office until the annual general meeting of our shareholders that occurs in the third year following his or her election and until his or her successor shall be elected and qualified. The nominations for directors, which are presented to our shareholders by our board of directors, are generally made by the board of directors itself, in accordance with the provisions of our amended and restated articles of association and the Companies Law;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we intend to adopt and approve material changes to equity incentive plans in accordance with the Companies Law, which does not impose a requirement of shareholder approval for such actions. In&#160;addition, we intend to follow Israeli corporate governance practice, which requires shareholder approval prior to an issuance of securities in connection with equity-based compensation of officers, directors, employees or consultants only under certain circumstances, in lieu of Nasdaq Marketplace Rule 5635(c);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">as opposed to making periodic reports to shareholders and proxy solicitation materials available to shareholders in the manner specified by the Nasdaq corporate governance rules, the Companies Law does not require us to distribute periodic reports directly to shareholders, and the generally accepted business practice in Israel is not to distribute such reports to shareholders but to make such reports available through a public website. We will only mail such reports to shareholders upon request. As a foreign private issuer, we are generally exempt from the SEC&#8217;s proxy solicitation rules; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we will follow Israeli corporate governance practices instead of Nasdaq requirements to obtain shareholder approval for all corporate actions requiring such approval under the requirements of the Companies Law such as (i)&#160;transactions with directors concerning the terms of their service or indemnification, exemption and insurance for their service (or for any other position that they may hold at our company), (ii)&#160;extraordinary transactions with controlling shareholders, (iii)&#160;terms of employment or other engagement of the controlling shareholder of the company or such controlling shareholder&#8217;s relative, (iv)&#160;private placements that will result in a change of control, (v)&#160;certain transactions, other than a public offering, involving issuances of a 20% or greater interest in us and (vi)&#160;certain acquisitions of the stock or assets of another company. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Otherwise, we intend to comply with the rules generally applicable to U.S. domestic companies listed on the Nasdaq. We may in the future decide to use the foreign private issuer exemption with respect to some or all of the other Nasdaq corporate governance rules. Following the closing of this offering, we also intend to comply with Israeli corporate governance requirements under the Companies Law applicable to us.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Board of Directors and Officers</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, the management of our business is vested in our board of directors. Our board of directors may exercise all powers and may take all actions that are not specifically granted to our shareholders or to management. Our executive officers are responsible for our day-to-day management and have individual responsibilities that are established by our board of directors, subject to the terms of their respective employment agreements.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">109<br></div></div></div>
<!--End Page 115-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 116-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Upon the closing of this offering, our board of directors will consist of&#8201;at least five directors. In addition, we intend to propose for appointment by our shareholders two external directors within three months following this offering, who are intended to qualify as external directors and whose appointment fulfills the requirements of the Companies Law for the company to have two external directors (see &#8220;&#8212;External Directors&#8221;). These two directors, as well as three additional directors, are expected to qualify as independent directors under the corporate governance standards of the Nasdaq corporate governance rules and the independence requirements of Rule 10A-3 of the Exchange Act.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under our amended and restated articles of association, which will become effective immediately prior to the closing of this offering, the number of directors on our board of directors will be no less than five and no more than ten and must include, if required by the Companies Law, at least two external directors who must be nominated within three months of the closing of this offering. The minimum and maximum number of directors may be changed, at any time and from time to time, by vote of our shareholders.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Other than external directors, for whom special election requirements apply under the Companies Law, as detailed below, our directors are divided into three classes with staggered three-year terms. Each class of directors consists, as nearly as possible, of one-third of the total number of directors constituting the entire board of directors (other than the external directors). At each annual general meeting of our shareholders, the election or re-election of directors following the expiration of the term of office of the directors of that class of directors will be for a term of office that expires on the third annual general meeting following such election or re-election, such that from 2021 and after, at each annual general meeting, the term of office of only one class of directors will expire. Each director holds office until the third annual general meeting of our shareholders and until his or her successor is duly appointed, unless the tenure of such director expires earlier pursuant to the Companies Law or unless removed from office as described below, except that our external directors have a term of office of three years under Israeli law (see &#8220;&#8212;External Directors&#8212;Election and Dismissal of External Directors&#8221;).</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Upon the closing of this offering, our directors will be divided among three classes as follows: the Class&#160;I directors, consisting of Erez Meltzer and Richard Stone, will hold office until our annual general meeting of shareholders to be held in 2021; the Class&#160;II directors, consisting of Onn Fenig and Floyd Katske, will hold office until our annual general meeting of shareholders to be held in 2022; and the Class&#160;III director, consisting of Ran Poliakine, will hold office until our annual general meeting of shareholders to be held in 2023.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under our amended and restated articles of association, which will become effective immediately prior to the closing of this offering, our board of directors may appoint directors to fill vacancies on our board of directors, including if the number of directors is below the maximum number of directors who may serve as provided in our amended and restated articles, for a term of office equal to the remaining period of the term of office of the director(s) whose office(s) has been vacated. External directors are elected for an initial term of three years and may be elected for up to two additional three-year terms under the circumstances described below. External directors may be removed from office only under the limited circumstances set forth in the Companies Law. See &#8220;&#8212; External Directors.&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under Israeli law, the chief executive officer or a relative of the chief executive officer of a public company may not serve as the chairman of the board of directors of the company and the chairman or a relative of the chairman may not be vested with the authority of the chief executive officer, in each case, unless approved by a special majority of our shareholders as required under the Companies Law. The shareholders&#8217; approval can be provided for a period of five years following an initial public offering, and subsequently, for additional periods of up to three years. In addition, a person who is subordinated, directly or indirectly, to the chief executive officer may not serve as the chairman of the board of directors; the chairman of the board of directors may not be vested with authorities that are granted to persons who are subordinated to the chief executive officer; and the chairman of the board of directors may not serve in any other position in the company or in a controlled subsidiary, but he or she may serve as a director or chairman of a controlled subsidiary. Prior to this offering, we obtained our shareholders&#8217; approval that Mr. Ran Poliakine may serve as both our chairman of the board of directors and chief executive officer for a period of up to five years from the closing of this offering. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, under the Companies Law, our board of directors must determine the minimum number of directors who are required to have financial and accounting expertise. Under applicable regulations, a director with financial and accounting expertise is a director who, by reason of his or her education, professional </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">110<br></div></div></div>
<!--End Page 116-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 117-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">experience and skill, has a high level of proficiency in and understanding of business accounting matters and financial statements. See &#8220;&#8212;External Directors&#8212;Qualifications of External Directors.&#8221; He or she must be able to thoroughly comprehend the financial statements of the company and initiate debate regarding the manner in which financial information is presented. In determining the number of directors required to have such expertise, the board of directors must consider, among other things, the type and size of the company and the scope and complexity of its operations. Our board of directors has determined that we require at least one director with the requisite financial and accounting expertise and that Erez Meltzer has such expertise.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">There are no family relationships among any of our office holders (including directors). </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">External Directors</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Qualifications of External Directors</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, companies incorporated under the laws of the State of Israel, whose shares are publicly traded, including companies with shares listed on the Nasdaq, are required to appoint at least two&#160;external directors who meet the qualification requirements set forth in the Companies Law, subject to certain exceptions that are not currently available to us. We intend to propose for appointment by our shareholders two external directors within three months following this offering as required by the Companies Law. Both of these external directors are expected to be independent in accordance with the corporate governance standards of the Nasdaq corporate governance rules and the independence requirements of Rule 10A-3 of the Exchange Act. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A person may not be appointed as an external director if the person is a relative of a controlling shareholder or if on the date of the person&#8217;s appointment or within the preceding two years the person or his or her relatives, partners, employers or anyone to whom that person is subordinate, whether directly or indirectly, or entities under the person&#8217;s control have or had any affiliation with any of&#8201; (each an &#8220;Affiliated Party&#8221;): (1) us; (2) any person or entity controlling us on the date of such appointment; (3) any relative of a controlling shareholder; or (4) any entity controlled, on the date of such appointment or within the preceding two years, by us or by a controlling shareholder. If there is no controlling shareholder or any shareholder holding 25% or more of voting rights in the company, a person may not be appointed as an external director if the person has any affiliation to the chairman of the board of directors, the general manager (chief executive officer), any shareholder holding 5% or more of the company&#8217;s shares or voting rights or the senior financial officer as of the date of the person&#8217;s appointment.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">The term affiliation includes:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an employment relationship;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a business or professional relationship maintained on a regular basis;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">control; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">service as an office holder, excluding service as a director in a private company prior to the first offering of its shares to the public if such director was appointed as a director of the private company in order to serve as an external director following the initial public offering.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The term &#8220;relative&#8221; is defined as a spouse, sibling, parent, grandparent, descendant, spouse&#8217;s descendant, sibling and parent and the spouse of each of the foregoing.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A person may not serve as an external director if that person or that person&#8217;s relative, partner, employer, a person to whom such person is subordinate (directly or indirectly) or any entity under the person&#8217;s control has a business or professional relationship with any entity that has an affiliation or other prohibited relationship with any Affiliated Party, even if such relationship is intermittent (excluding insignificant relationships). Additionally, any person who has received compensation intermittently (excluding insignificant relationships) other than compensation permitted under the Companies Law may not continue to serve as an external director. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">No person can serve as an external director if the person&#8217;s position or other affairs create, or may create, a conflict of interest with the person&#8217;s responsibilities as a director or may otherwise interfere with the person&#8217;s ability to serve as an external director or if such a person is an employee of the Israel Securities Authority or of an Israeli stock exchange. If at the time an external director is appointed all current members of the board of directors, who are not controlling shareholders or relatives of controlling shareholders, are of the same gender, then the external director to be appointed must be of the other gender. In addition, a person who is a director of </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">111<br></div></div></div>
<!--End Page 117-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 118-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">a company may not be elected as an external director of another company if, at that time, a director of the other company is acting as an external director of the first company.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Companies Law provides that an external director must meet certain &#8220;professional qualifications&#8221; or have &#8220;financial and accounting expertise&#8221; and that at least one external director must have &#8220;financial and accounting expertise.&#8221; However, if at least one of our other directors (1) meets the independence requirements of the Exchange Act, (2) meets the standards of the Nasdaq corporate governance rules for membership on the audit committee and (3) has &#8220;financial and accounting expertise&#8221; as defined in the Companies Law and applicable regulations, then none of our external directors is required to possess financial and accounting expertise as long as they possess other requisite professional qualifications. The determination of whether a director possesses &#8220;financial and accounting expertise&#8221; is made by the board of directors. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The regulations promulgated under the Companies Law define an external director with requisite professional qualifications as a director who satisfies one of the following requirements: (1) the director holds an academic degree in either economics, business administration, accounting, law or public administration, (2) the director either holds an academic degree in any other field or has completed another form of higher education in the company&#8217;s primary field of business or in an area which is relevant to his or her office as an external director in the company, or (3) the director has at least five years of experience serving in any one of the following, or at least five years of cumulative experience serving in two or more of the following capacities: (a) a senior business management position in a company with a substantial scope of business, (b) a senior position in the company&#8217;s primary field of business or (c) a senior position in public administration. The determination of whether a director possesses the requisite &#8220;professional qualifications&#8221; is made by the board of directors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Until the lapse of a two-year period from the date that an external director of a company ceases to act in such capacity, the company in which such external director served, and its controlling shareholder (as defined below) or any entity under control of such controlling shareholder, may not, directly or indirectly, grant such former external director, or his or her spouse or child, any benefit, including via (i)&#160;the appointment of such former director or his or her spouse or his child as an officer in the company or in an entity controlled by the company&#8217;s controlling shareholder, (ii)&#160;the employment of such person, and (iii)&#160;the engagement, directly or indirectly, of such person as a provider of professional services for compensation, directly or indirectly, including via an entity under his or her control. With respect to a relative who is not a spouse or a child, such limitations shall only apply for one year from the date such external director ceased to be engaged in such capacity.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The term &#8220;controlling shareholder&#8221; means a shareholder with the ability to direct the activities of the company, other than by virtue of being an office holder. A shareholder is presumed to have &#8220;control&#8221; of the company and thus to be a controlling shareholder of the company if the shareholder holds 50% or more of the &#8220;means of control&#8221; of the company. &#8220;Means of control&#8221; is defined as (1) the right to vote at a general meeting of a company or a corresponding body of another corporation; or (2) the right to appoint directors of the corporation or its general manager. For the purpose of approving certain related-party transactions, the term also includes any shareholder that holds 25% or more of the voting rights of the company if the company has no shareholder that owns more than 50% of its voting rights. For the purpose of determining the holding percentage stated above, two or more shareholders who have a personal interest in a transaction that is brought for the company&#8217;s approval are deemed as joint holders. The term &#8220;office holder&#8221; is defined as a chief executive officer (referred to in the Companies Law as a general manager), chief business manager, deputy general manager, vice general manager, director or manager directly subordinate to the general manager or any other person assuming the responsibilities of any of the foregoing positions, without regard to such person&#8217;s title.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Election and Dismissal of External Directors</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under Israeli law, external directors are elected by a majority vote at a shareholders&#8217; meeting; provided that either:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the majority of the shares voted at the meeting in favor of the election of the external director, excluding abstentions, include at least a majority of the votes of shareholders who are not controlling shareholders and do not have a personal interest in the appointment (excluding a personal interest that did not result from the shareholder&#8217;s relationship with the controlling shareholder); or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the total number of shares held by non-controlling shareholders or any one on their behalf that are voted against the election of the external director does not exceed 2% of the aggregate voting rights in the company.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">112<br></div></div></div>
<!--End Page 118-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 119-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under Israeli law, the initial term of an external director of an Israeli public company is three years. The&#160;external director may be re-elected, subject to certain circumstances and conditions, for up to two consecutive additional terms of three years each, and thereafter, the term, may be extended for additional three-year terms; provided that the external director is reelected subject to the same shareholder vote requirements as if elected for the first time (as described above). Each re-election is subject to one of the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">his or her service for each such additional term is recommended by one or more shareholders holding at least 1% of the company&#8217;s voting rights and is approved at a shareholders meeting by a disinterested majority, where the total number of shares held by non-controlling, disinterested shareholders voting for such reelection exceeds 2% of the aggregate voting rights in the company and subject to additional restrictions set forth in the Companies Law with respect to the affiliation of the external director nominee;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the external director proposed his or her own nomination, and such nomination was approved in accordance with the requirements described in the paragraph above; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">his or her service for each such additional term is recommended by the board of directors and is approved at a meeting of shareholders by the same majority required for the initial election of an external director (as described above).</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">An external director may be removed by the same special majority of the shareholders required for his or her election, if he or she ceases to meet the statutory qualifications for appointment or if he or she violates his or her duty of loyalty to the company. An external director may also be removed by order of an Israeli court if the court finds that the external director is unable to exercise his or her office, has ceased to meet the statutory qualifications for his or her appointment, has violated his or her duty of loyalty to the company, or has been convicted by a court outside Israel of certain offenses detailed in the Companies Law.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If the vacancy of an external directorship causes a company to have fewer than two external directors, the company&#8217;s board of directors is required under the Companies Law to call a special general meeting of the company&#8217;s shareholders as soon as possible to appoint such number of new external directors so that the company thereafter has at least two external directors.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">Additional Provisions</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, each committee authorized to exercise any of the powers of the board of directors is required to include at least one external director and its audit and compensation committees are required to include all of the external directors.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">An external director is entitled to compensation and reimbursement of expenses in accordance with regulations promulgated under the Companies Law and is prohibited from receiving any other compensation, directly or indirectly, in connection with serving as a director except for certain exculpation, indemnification and insurance provided by the company, as specifically allowed by the Companies Law.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Audit Committee</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Companies Law Requirements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, the board of directors of a public company must also appoint an audit committee comprised of at least three directors, including all of the external directors. The audit committee may not include:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the chairman of the board of directors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a controlling shareholder or a relative of a controlling shareholder;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any director employed by the company or by one of its controlling shareholders or by an entity controlled by one of its controlling shareholders (other than as a member of the board of directors);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any director who regularly provides services to the company, to one of its controlling shareholders or to an entity controlled by one of its controlling shareholders; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a director who derives most of his or her income from a controlling shareholder.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">According to the Companies Law, the majority of the members of the audit committee, as well as the majority of members present at audit committee meetings, will be required to be &#8220;independent&#8221; (as defined </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">113<br></div></div></div>
<!--End Page 119-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 120-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">below) and the chairman of the audit committee will be required to be an external director. Any persons not qualified from serving as a member of the audit committee may not be present at the audit committee meetings, unless the chairman of the audit committee has determined that such person is required to be present at the meeting or if such person qualifies under one of the exemptions of the Companies Law.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The term &#8220;independent director&#8221; is defined under the Companies Law as an external director or a director who meets the following conditions and who is appointed or classified as such according to the Companies Law: (1) he or she meets the qualifications for being appointed as an external director, except for (i)&#160;the requirement that the director be an Israeli resident (which does not apply to companies such as ours whose securities have been offered outside of Israel or are listed outside of Israel); and (ii)&#160;the requirement for &#8220;financial and accounting expertise&#8221; or professional qualifications, and the audit committee approves the director having met such conditions and (2) he or she has not served as a director of the company for over nine consecutive years with any interruption of up to two years of his or her service not being deemed a disruption to the continuity of his or her service.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Nasdaq Listing Requirements </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Nasdaq corporate governance rules, we are required to maintain an audit committee consisting of at least three independent directors, all of whom are financially literate and one of whom has accounting or related financial management expertise. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In accordance with U.S. law and Nasdaq requirements, our audit committee is also responsible for the appointment, compensation and oversight of the work of our independent auditors and for assisting our board of directors in monitoring our financial statements, the effectiveness of our internal controls and our compliance with legal and regulatory requirements. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our audit committee will consist of Floyd Katzke, Erez Meltzer and Richard Stone. Erez Meltzer will serve as the chairman of the audit committee. The two external directors will become members of the audit committee and replace Floyd Katske and Richard Stone upon their appointment to the board of directors following the closing of this offering, and they are expected to meet the requirements under the applicable rules and regulations of the SEC and the Nasdaq corporate governance rules. Our board of directors has determined, in its business judgment, that Erez Meltzer is an audit committee financial expert as defined by the SEC rules and has the requisite financial experience as defined by the Nasdaq corporate governance rules.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Each of the members of the audit committee is required to be &#8220;independent&#8221; as such term is defined in Rule 10A-3(b)(1) under the Exchange Act.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Approval of Transactions with Related Parties</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The approval of the audit committee is required to effect specified actions and transactions with office holders and controlling shareholders and their relatives, or in which they have a personal interest. See &#8220;&#8212;Fiduciary Duties and Approval of Specified Related Party Transactions and Compensation under Israeli Law.&#8221; The audit committee may not approve an action or a transaction with a controlling shareholder or with an office holder unless, among other things, at the time of approval the audit committee meets the composition requirements under the Companies Law.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Audit Committee Role</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our board of directors plans to adopt an audit committee charter, which will become effective upon the listing of our ordinary shares on the Nasdaq, setting forth the responsibilities of the audit committee consistent with the rules of the SEC and the Nasdaq corporate governance rules, as well as the requirements for such committee under the Companies Law, which include:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">recommending the retention and termination of our independent registered public accounting firm to the board of directors in accordance with Israeli law;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">recommending to the board of directors in accordance with Israeli law the appointment, compensation, retention and oversight of any accounting firm engaged for the purpose of preparing or issuing an audit report or performing other audit services;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">recommending the terms of audit and non-audit services to be provided by the independent registered public accounting firm for pre-approval by our board of directors;</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">114<br></div></div></div>
<!--End Page 120-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 121-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">recommending the engagement or termination of the person filling the office of our internal auditor;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reviewing with management and our independent directors our financial statements prior to their submission to the SEC; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">approval of certain transactions with office holders and controlling shareholders, as described below, and other related party transactions.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Additionally, under the Companies Law, the role of the audit committee includes the identification of irregularities in our business management, among other things, by consulting with the internal auditor or our independent auditors and suggesting an appropriate course of action to the board of directors. The audit committee is also required to adopt procedures with respect to processing of employees&#8217; complaints in connection with deficiencies in the management of the company, and the appropriate means of protection afforded to such employees. In addition, the audit committee or the board of directors, as set forth in the articles of association of the company, is required to approve the yearly or periodic work plan proposed by the internal auditor, and where the board of directors approves such work plan, to examine such work plan before its submission to the board of directors and propose amendments thereto. The audit committee is required to assess the company&#8217;s internal audit system and the performance of its internal auditor. The Companies Law also requires that the audit committee assess the scope of the work and compensation of the company&#8217;s external auditor. In addition, the audit committee is required to determine whether certain related party actions and transactions are &#8220;material&#8221; or &#8220;extraordinary&#8221; for the purpose of the requisite approval procedures under the Companies Law and whether certain transactions with a controlling shareholder will be subject to a competitive procedure.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The audit committee charter shall state that in fulfilling its role the committee is empowered to conduct or authorize investigations into any matters within its scope of responsibilities.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Compensation Committee</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, public companies are required to appoint a compensation committee in accordance with the guidelines set forth thereunder.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our compensation committee must consist of at least three members. All of the external directors must serve on the committee and constitute a majority of its members. The chairman of the compensation committee must be an external director. The remaining members are not required to be external directors, but must be directors who would qualify to serve as members of the audit committee (as described above).</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The compensation committee will consist of Floyd Katske, Erez Meltzer and Richard Stone, and will assist the board of directors in determining compensation for our directors and officers. Erez Meltzer will serve as the chairman of the compensation committee. The two external directors will become members of the compensation committee and replace Floyd Katske and Richard Stone upon their appointment to the board of directors following the closing of this offering.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In accordance with the Companies Law, the roles of the compensation committee are, among others, as follows:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to recommend to the board of directors the compensation policy for directors and officers, and, once every three years, or five years from a company&#8217;s initial public offering, to recommend to the board of directors, whether the compensation policy that had been approved should be extended for a longer period of time;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to recommend to the board of directors updates to the compensation policy, from time to time, and examine its implementation;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to decide whether to approve the terms of office and employment of directors and officers that require approval of the compensation committee; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to decide whether the compensation terms of the chief executive officer, which were determined pursuant to the compensation policy, will be exempted from approval by the shareholders because such approval would harm the ability to engage the chief executive officer.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition to the roles mentioned above, our compensation committee may also make recommendations to our board of directors regarding the awarding of employee equity grants.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">115<br></div></div></div>
<!--End Page 121-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 122-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In general, under the Companies Law, a public company must have a compensation policy approved by the board of directors after receiving and considering the recommendations of the compensation committee. In addition, the compensation policy requires the approval of the general meeting of the shareholders. In public companies such as our company, shareholder approval by a majority vote of the ordinary shares present and voting at a meeting of shareholders called for such purpose is required, provided that either: (i)&#160;such majority includes the majority of the votes of those shareholders who are non-controlling shareholders and do not have a personal interest in the approval of the compensation policy, who voted at the meeting (excluding abstentions) or (ii)&#160;the total number of votes against the proposal among the shareholders mentioned in paragraph (i)&#160;does exceed 2% of the voting rights in the company. Under special circumstances, the board of directors may approve the compensation policy despite the objection of the shareholders on the condition that the compensation committee and then the board of directors decide, on the basis of detailed arguments and after discussing again the compensation policy, that approval of the compensation policy, despite the objection of the meeting of shareholders, is in the best interests of the company.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">However, if a company initially offering its securities to the public, adopts a compensation policy in advance of its initial public offering, and describes the compensation policy in the prospectus relating to the offering, or adopts a compensation policy within nine months from the date the company becomes a public company, then the compensation policy is deemed a validly adopted policy in accordance with the Companies Law requirements described above and will be valid for a term of five years from the date such company becomes a public company.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The compensation policy must be based on certain considerations, include certain provisions and needs to reference certain matters as set forth in the Companies Law.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The compensation policy must serve as the basis for decisions concerning the financial terms of employment or engagement of office holders, including exculpation, insurance, indemnification or any monetary payment or obligation of payment in respect of employment or engagement. The compensation policy must relate to certain factors, including advancement of the company&#8217;s objectives, business plan and long-term strategy, and creation of appropriate incentives for office holders. It must also consider, among other things, the company&#8217;s risk management, size and the nature of its operations. The compensation policy must furthermore consider the following additional factors:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the education, skills, experience, expertise and accomplishments of the relevant office holder;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the office holder&#8217;s position, responsibilities and prior compensation agreements with him or her;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the ratio between the cost of the terms of employment of an office holder and the cost of the employment of other employees of the company, including employees employed through contractors who provide services to the company, in particular the ratio between such cost, the average and median salary of the employees of the company, as well as the impact of such disparities on the work relationships in the company;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the terms of employment include variable components &#8212; the possibility of reducing variable components at the discretion of the board of directors and the possibility of setting a limit on the exercise value of non-cash variable equity-based components; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the terms of employment include severance compensation &#8212; the term of employment or office of the office holder, the terms of his or her compensation during such period, the company&#8217;s performance during the such period, his or her individual contribution to the achievement of the company goals and the maximization of its profits and the circumstances under which the office holder is leaving the company.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">The compensation policy must also include, among others:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">with regard to variable components:</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><font style="font-size: 10pt;">with the exception of office holders </font><font style="font-size: 10pt;">who are subordinate</font><font style="font-size: 10pt;"> to the chief executive officer, determining </font><font style="font-size: 10pt;">the variable components on long-term performance basis and on measurable criteria; however, the </font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">116<br></div></div></div>
<!--End Page 122-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 123-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="ebl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 60pt; text-align: left;">company may determine that an immaterial part of the variable components of the compensation package of an office holder shall be awarded based on non-measurable criteria, if such amount is not higher than three monthly salaries per annum while taking into account the office holder&#8217;s contribution to the company;</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><font style="font-size: 10pt;">the ratio between variable and fixed components, as well as the limit of the values of variable </font><font style="font-size: 10pt;">components at the time of their grant.</font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a condition under which the office holder will return to the company, according to conditions to be set forth in the compensation policy, any amounts paid as part of his or her terms of employment, if such amounts were paid based on information later to be discovered to be wrong, and such information was than re-presented in the company&#8217;s financial statements;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the minimum holding or vesting period of variable equity-based components, while taking into consideration long-term incentives; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a limit to retirement grants.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We intend to adopt a compensation policy following the closing of this offering, which will be designed to promote retention and motivation of directors and executive officers, incentivize superior individual excellence, align the interests of our directors and executive officers with our long-term performance and provide a risk management tool. The compensation policy will be submitted to our shareholders for approval in accordance with the Companies Law. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Code of Ethics and Conduct</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On the closing of this offering, we will adopt a code of ethics and conduct, which is applicable to all of our directors, officers and employees. We will make our code of ethics publicly available on our website.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Internal Auditor</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, the board of directors of a public company must appoint an internal auditor based on the recommendation of the audit committee. The role of the internal auditor is, among other things, to examine whether a company&#8217;s actions comply with applicable law and orderly business procedure. Under the Companies Law, the internal auditor may not be an interested party or an office holder or a relative of an interested party or of an office holder, nor may the internal auditor be the company&#8217;s independent auditor or the representative of the same.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">An &#8220;interested party&#8221; is defined in the Companies Law as (i)&#160;a holder of 5% or more of the issued share capital or voting power in a company, (ii)&#160;any person or entity who has the right to designate one or more directors or to designate the chief executive officer of the company, or (iii)&#160;any person who serves as a director or as a chief executive officer of the company. As of the date of this prospectus, we have not yet appointed our internal auditor, but we intend to appoint an internal auditor following the closing of this offering.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Fiduciary Duties and Approval of Specified Related Party Transactions and Compensation Under Israeli&#160;Law</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Fiduciary Duties of Office Holders</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Companies Law imposes a duty of care and a duty of loyalty on all office holders of a company. The duty of care of an office holder is based on the duty of care set forth in connection with the tort of negligence under the Israeli Torts Ordinance (New Version) 5728-1968. This duty of care requires an office holder to act with the degree of proficiency with which a reasonable office holder in the same position would have acted under the same circumstances. The duty of care includes, among other things, a duty to use reasonable means, in light of the circumstances, to obtain:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">information on the business advisability of a given action brought for his or her approval or performed by virtue of his or her position; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">all other important information pertaining to such action.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">117<br></div></div></div>
<!--End Page 123-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 124-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The duty of loyalty incumbent on an office holder requires him or her to act in good faith and for the benefit of the company, and includes, among other things, the duty to:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">refrain from any act involving a conflict of interest between the performance of his or her duties in the company and his or her other duties or personal affairs;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">refrain from any activity that is competitive with the business of the company;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">refrain from exploiting any business opportunity of the company for the purpose of gaining a personal advantage for himself or herself or others; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disclose to the company any information or documents relating to the company&#8217;s affairs which the office holder received as a result of his or her position as an office holder.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, a company may approve an act specified above which would otherwise constitute a breach of the office holder&#8217;s fiduciary duty; provided that the office holder acted in good faith, the act or its approval does not harm the company, and the office holder discloses his or her personal interest a sufficient time before the approval of such act. Any such approval is subject to the terms of the Companies Law, setting forth, among other things, the appropriate parties of the company entitled to provide such approval, and the methods of obtaining such approval.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Disclosure of Personal Interests of an Office Holder and Approval of Certain Transactions</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Companies Law requires that an office holder promptly disclose to the company any direct or indirect personal interest that he or she may have and all related material information or documents known to him or her relating to any existing or proposed transaction by the company. An interested office holder&#8217;s disclosure must be made promptly and in any event no later than the first meeting of the board of directors at which the transaction is considered. An office holder is not obliged to disclose such information if the personal interest of the office holder derives solely from the personal interest of his or her relative in a transaction that is not considered an extraordinary transaction.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, once an office holder has complied with the above disclosure requirement, a company may approve a transaction between the company and the office holder or a third party in which the office holder has a personal interest. However, a company may not approve a transaction or action that is not to the company&#8217;s benefit or that is not performed by the office holder in good faith.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If the transaction is an extraordinary transaction, the office holder must also disclose any personal interest held by:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the office holder&#8217;s relatives (spouse, siblings, parents, grandparents, descendants, spouse&#8217;s descendants and the spouses of any of these people); or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any company in which the office holder or his or her relatives holds 5% or more of the shares or voting rights, serves as a director or general manager or has the right to appoint at least one director or the general manager.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, unless the articles of association of a company provide otherwise, a transaction with an office holder or with a third party in which the office holder has a personal interest, which is not an extraordinary transaction, requires approval by the board of directors. Our amended and restated articles of association provide that such a transaction, which is not an extraordinary transaction, shall be approved by the board of directors or a committee of the board of directors or such person the board deems appropriate. If the transaction considered is an extraordinary transaction with an office holder or third party in which the office holder has a personal interest, then audit committee approval is required prior to approval by the board of directors. Under specific circumstances, shareholder approval may also be required. For the approval of compensation arrangements with directors and executive officers, see &#8220;&#8212;Rules Applicable to Compensation of Directors and Executive Officers.&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Any persons who have a personal interest in the approval of a transaction that is brought before a meeting of the board of directors or the audit committee may not be present at the meeting or vote on the matter. However, if the chairman of the board of directors or the chairman of the audit committee, as applicable, has determined that the presence of an office holder with a personal interest is required for the purpose of presenting the matter, such office holder may be present at the meeting. Notwithstanding the foregoing, a director who has a </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">118<br></div></div></div>
<!--End Page 124-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 125-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">personal interest may be present at the meeting and vote on the matter if a majority of the directors or members of the audit committee, as applicable, have a personal interest in the approval of such transaction. If a majority of the directors at a board of directors meeting or members of the audit committee, as applicable, have a personal interest in the transaction, such transaction also requires approval of the shareholders of the company.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A &#8220;personal interest&#8221; is defined under the Companies Law as the personal interest of a person in an action or in a transaction of the company, including the personal interest of such person&#8217;s relative or the interest of any other corporate body in which the person and/or such person&#8217;s relative is a director or general manager, a 5%&#160;shareholder or holds 5% or more of the voting rights, or has the right to appoint at least one director or the general manager, but excluding a personal interest stemming solely from the fact of holding shares in the company. A personal interest also includes (1) a personal interest of a person who votes according to a proxy of another person, including in the event that the other person has no personal interest, and (2) a personal interest of a person who gave a proxy to another person to vote on his or her behalf regardless of whether the discretion of how to vote lies with the person voting or not.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">An &#8220;extraordinary transaction&#8221; is defined under the Companies Law as any of the following:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a transaction other than in the ordinary course of business;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a transaction that is not on market terms; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a transaction that may have a material impact on the company&#8217;s profitability, assets or liabilities.</div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Disclosure of Personal Interests of a Controlling Shareholder and Approval of Certain Transactions</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Companies Law also requires that a controlling shareholder promptly disclose to the company any personal interest that he or she may have and all related material information or documents relating to any existing or proposed transaction by the company. A controlling shareholder&#8217;s disclosure must be made promptly and in any event no later than the first meeting of the board of directors at which the transaction is considered. For the purpose of approving transactions with controlling shareholders, the term also includes any shareholder that holds 25% or more of the voting rights of the company if the company has no shareholder that owns more than 50% of its voting rights. For the purpose of determining the holding percentage stated above, two or more shareholders who have a personal interest in a transaction that is brought for the company&#8217;s approval are deemed as joint holders. Extraordinary transactions with a controlling shareholder or in which a controlling shareholder has a personal interest, including a private placement in which a controlling shareholder has a personal interest, and the terms of engagement of the company, directly or indirectly, with a controlling shareholder or a controlling shareholder&#8217;s relative (including through a corporation controlled by a controlling shareholder), regarding the company&#8217;s receipt of services from the controlling shareholder, and if such controlling shareholder is also an office holder or employee of the company, regarding his or her terms of employment, require the approval of each of (i)&#160;the audit committee or the compensation committee with respect to the terms of the engagement as an office holder or employee, including insurance, indemnification and compensation, (ii)&#160;the board of directors and (iii)&#160;the shareholders, in that order. In addition, the shareholder approval must fulfill one of the following requirements:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a majority of the shares held by shareholders who have no personal interest in the transaction and are voting at the meeting must be voted in favor of approving the transaction, excluding abstentions; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the shares voted by shareholders who have no personal interest in the transaction who vote against the transaction represent no more than 2% of the voting rights in the company.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, any extraordinary transaction with a controlling shareholder or in which a controlling shareholder has a personal interest, and an engagement of the company, directly or indirectly, with a controlling shareholder or a controlling shareholder&#8217;s relative (including through a corporation controlled by a controlling shareholder), regarding the company&#8217;s receipt of services from the controlling shareholder, and if such controlling shareholder is also an office holder or employee of the company, regarding his or her terms of employment, in each case, with a term of more than three years requires the abovementioned approval every three years, however, such transactions not involving the receipt of services or compensation can be approved for a longer term, provided that the audit committee determines that such longer term is reasonable under the circumstances. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">119<br></div></div></div>
<!--End Page 125-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 126-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">In addition, transactions with a controlling shareholder or a controlling shareholder&#8217;s relative who serves as an officer in a company, directly or indirectly (including through a corporation under his or her control), involving the receipt of services by a company or their compensation can have a term of five years from the company&#8217;s initial public offering under certain circumstances.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Companies Law requires that every shareholder that participates, in person, by proxy or by voting instrument, in a vote regarding a transaction with a controlling shareholder, must indicate in advance or in the ballot whether or not that shareholder has a personal interest in the vote in question. Failure to so indicate will generally result in the invalidation of that shareholder&#8217;s vote.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Disclosure of Compensation of Executive Officers</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For so long as we qualify as a foreign private issuer, we are not required to comply with the proxy rules applicable to U.S. domestic companies, including the requirement applicable to emerging growth companies to disclose the compensation of our chief executive officer and other two most highly compensated executive officers on an individual, rather than an aggregate, basis. Nevertheless, regulations promulgated under the Companies Law will require us, after we become a public company, to disclose the annual compensation of our five most highly compensated office holders on an individual basis, rather than on an aggregate basis. This disclosure will not be as extensive as that required of a U.S. domestic issuer. We intend to commence providing such disclosure, at the latest, in the proxy statement for our first annual general meeting of shareholders following this offering, which will be furnished under cover of a Form 6-K and we may provide such information at an earlier date.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Rules Applicable to Compensation of Directors and Executive Officers</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Directors<font style="font-style: normal;">. Under the Companies Law, the compensation of our directors requires the approval of our </font><font style="font-style: normal;">compensation committee, the subsequent approval of the board of directors and, unless exempted under the </font><font style="font-style: normal;">regulations promulgated under the Companies Law, the approval of the shareholders at a general meeting. If the </font><font style="font-style: normal;">compensation of our directors is inconsistent with our stated compensation policy, then, the compensation </font><font style="font-style: normal;">committee and the board of directors may approve such compensation, provided that those provisions that must </font><font style="font-style: normal;">be included in the compensation policy according to the Companies Law have been considered by the </font><font style="font-style: normal;">compensation committee and board of directors. Furthermore, shareholder approval will also be required, </font><font style="font-style: normal;">provided that:</font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">at least a majority of the shares held by all shareholders who are not controlling shareholders and do not have a personal interest in such matter, present and voting at such meeting, are voted in favor of the compensation package, excluding abstentions; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the total number of shares of non-controlling shareholders and shareholders who do not have a personal interest in such matter voting against the compensation package does not exceed 2% of the aggregate voting rights in the company.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Executive officers other than the chief executive officer<font style="font-style: normal;">. The Companies Law requires the approval of the </font><font style="font-style: normal;">compensation of a public company&#8217;s executive officers (other than the chief executive officer) in the following </font><font style="font-style: normal;">order: (i)&#160;the compensation committee, (ii)&#160;the company&#8217;s board of directors, and (iii)&#160;if such compensation </font><font style="font-style: normal;">arrangement is inconsistent with the company&#8217;s stated compensation policy, the company&#8217;s shareholders (by a </font><font style="font-style: normal;">special majority vote as discussed above with respect to the approval of director compensation). However, if the </font><font style="font-style: normal;">shareholders of the company do not approve a compensation arrangement with an executive officer that is </font><font style="font-style: normal;">inconsistent with the company&#8217;s stated compensation policy, the compensation committee and board of directors </font><font style="font-style: normal;">may override the shareholders&#8217; decision if each of the compensation committee and the board of directors </font><font style="font-style: normal;">provide detailed reasons for their decision.</font></div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Chief executive officer<font style="font-style: normal;">. Under the Companies Law, the compensation of a public company&#8217;s chief executive </font><font style="font-style: normal;">officer is required to be approved by: (i)&#160;the company&#8217;s compensation committee; (ii)&#160;the company&#8217;s board of </font><font style="font-style: normal;">directors, and (iii)&#160;the company&#8217;s shareholders (by a special majority vote as discussed above with respect to the </font><font style="font-style: normal;">approval of director compensation). However, if the shareholders of the company do not approve the </font><font style="font-style: normal;">compensation arrangement with the chief executive officer, the compensation committee and board of directors </font><font style="font-style: normal;">may override the shareholders&#8217; decision if each of the compensation committee and the board of directors </font><font style="font-style: normal;">provide </font><font style="font-style: normal;">detailed </font><font style="font-style: normal;">reasons</font><font style="font-style: normal;"> for their decision. The approval of each of the compensation committee and the board of </font></div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">120<br></div></div></div>
<!--End Page 126-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 127-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">directors should be in accordance with the company&#8217;s stated compensation policy; however, in special circumstances, they may approve compensation terms of a chief executive officer that are inconsistent with such policy provided that they have considered those provisions that must be included in the compensation policy according to the Companies Law and that shareholder approval was obtained (by a special majority vote as discussed above with respect to the approval of director compensation). In addition, the compensation committee may waive the shareholder approval requirement with regards to the approval of the engagement terms of a candidate for the chief executive officer position, if they determine that the compensation arrangement is consistent with the company&#8217;s stated compensation policy, and that the chief executive officer did not have a prior business relationship with the company or a controlling shareholder of the company and that subjecting the approval of the engagement to a shareholder vote would impede the company&#8217;s ability to employ the chief executive officer candidate.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Duties of Shareholders</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, a shareholder has a duty to refrain from abusing its power in the company and to act in good faith and in an acceptable manner in exercising its rights and performing its obligations to the company and other shareholders, including, among other things, when voting at meetings of shareholders on the following matters:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an amendment to the articles of association;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an increase in the company&#8217;s authorized share capital;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a merger; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the approval of related party transactions and acts of office holders that require shareholder approval.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">A shareholder also has a general duty to refrain from discriminating against other shareholders.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The remedies generally available upon a breach of contract will also apply to a breach of the shareholder duties mentioned above, and in the event of discrimination against other shareholders, additional remedies may be available to the injured shareholder.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, any controlling shareholder, any shareholder that knows that its vote can determine the outcome of a shareholder vote and any shareholder that, under a company&#8217;s articles of association, has the power to appoint or prevent the appointment of an office holder, or any other power with respect to a company, is under a duty to act with fairness towards the company. The Companies Law does not describe the substance of this duty except to state that the remedies generally available upon a breach of contract will also apply in the event of a breach of the duty to act with fairness, taking the shareholder&#8217;s position in the company into account.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Approval of Private Placements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law and the regulations promulgated thereunder, a private placement of securities of an Israeli public company whose shares are traded solely outside of Israel, like we will be upon completion of this offering, does not require approval at a general meeting of the shareholders of a company; provided, however, that in special circumstances, such as a private placement completed in lieu of a special tender offer (see &#8220;Description of Share Capital&#8212;Acquisitions Under Israeli Law&#8221;) or a private placement which qualifies as a related party transaction, as discussed above, approval at a general meeting of the shareholders of a company is required. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Exculpation, Insurance and Indemnification of Directors and Officers</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, a company may not exculpate an office holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an office holder in advance from liability to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care but only if a provision authorizing such exculpation is included in its articles of association. Our amended and restated articles of association, which will become effective immediately prior to the closing of this offering, include such a provision. The company may not exculpate in advance a director from liability arising from a breach of his or her duty of care in connection with a prohibited dividend or distribution to shareholders.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law and the Israeli Securities Law, 5728-1968 (the &#8220;Securities Law&#8221;), our amended and restated articles of association, which will become effective immediately prior to the closing of this offering, </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">121<br></div></div></div>
<!--End Page 127-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 128-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">provide that we may indemnify an office holder in respect of the following liabilities, payments and expenses incurred for acts performed by him or her as an office holder, either in advance of an event or following an event, provided its articles of association include a provision authorizing such indemnification:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a monetary liability incurred by or imposed on the office holder in favor of another person pursuant to a court judgment, including pursuant to a settlement confirmed as judgment or arbitrator&#8217;s decision approved by a competent court. However, if an undertaking to indemnify an office holder with respect to such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company&#8217;s activities when the undertaking to indemnify is given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned foreseen events and amount or criteria;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reasonable litigation expenses, including reasonable attorneys&#8217; fees, which were incurred by the office holder (i)&#160;as a result of an investigation or proceeding filed against the office holder by an authority authorized to conduct such investigation or proceeding; provided that such investigation or proceeding was either (a)&#160;concluded without the filing of an indictment against such office holder and without the imposition on him of any monetary obligation in lieu of a criminal proceeding; (b)&#160;concluded without the filing of an indictment against the office holder but with the imposition of a monetary obligation on the office holder in lieu of criminal proceedings for an offense that does not require proof of criminal intent; or (ii)&#160;in connection with a monetary sanction;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a monetary liability imposed on the office holder in favor of an injured party at an Administrative Procedure (as defined below) as set forth in Section 52(54)(a)(1)(a) to the Securities Law; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">expenses expended by the office holder with respect to an Administrative Procedure under the Securities Law, including reasonable litigation expenses and reasonable attorneys&#8217; fees;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office holder or which were imposed on the office holder by a court (i)&#160;in a proceeding instituted against him or her by the company, on its behalf, or by a third party, (ii)&#160;in connection with criminal indictment of which the office holder was acquitted, or (iii)&#160;in connection with a criminal indictment which the office holder was convicted of an offense that does not require proof of criminal intent; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any other obligation or expense in respect of which it is permitted or will be permitted under applicable law to indemnify an office holder.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">An &#8220;Administrative Procedure&#8221; is defined as a procedure pursuant to chapters H3 (Monetary Sanction by the Israeli Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement Committee) or I1 (Arrangement to prevent Procedures or Interruption of procedures subject to conditions) of the Securities Law.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As permitted under the Companies Law and the Securities Law, our amended and restated articles of association, which will become effective immediately prior to the closing of this offering, provide that we may insure an office holder against the following liabilities incurred for acts performed by him or her as an office holder if and to the extent provided in the company&#8217;s articles of association:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a breach of the duty of loyalty to the company, provided that the office holder acted in good faith and had a reasonable basis to believe that the act would not harm the company;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a breach of duty of care to the company or to a third party, to the extent such a breach arises out of the negligent conduct of the office holder;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a monetary liability imposed on the office holder in favor of a third party;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a monetary liability imposed on the office holder in favor of an injured party at an Administrative Procedure pursuant to Section 52(54)(a)(1)(a) of the Securities Law; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">expenses incurred by an office holder in connection with an Administrative Procedure, including reasonable litigation expenses and reasonable attorneys&#8217; fees.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">122<br></div></div></div>
<!--End Page 128-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 129-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, a company may not indemnify, exculpate or insure an office holder against any of the following:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a breach of the duty of loyalty, except for indemnification and insurance for a breach of the duty of loyalty to the company to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a breach of duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an act or omission committed with intent to derive illegal personal benefit; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a fine or forfeit levied against the office holder.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, exculpation, indemnification and insurance of office holders must be approved by the compensation committee and the board of directors and, with respect to directors or controlling shareholders, their relatives and third parties in which such controlling shareholders have a personal interest, also by the shareholders.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our amended and restated articles of association permit us to exculpate, indemnify and insure our office holders to the fullest extent permitted or to be permitted by law. Our office holders are currently covered by a directors&#8217; and officers&#8217; liability insurance policy. As of the date of this prospectus, no claims for directors&#8217; and officers&#8217; liability insurance have been filed under this policy and we are not aware of any pending or threatened litigation or proceeding involving any of our office holders, including our directors, in which indemnification is sought.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Employment Agreements with Executive Officers</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have entered into written employment agreements with certain of our executive officers, including our Chief Executive Officer. See &#8220;Certain Relationships and Related Party Transactions&#8212;Employment Agreements&#8221; for additional information.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Director&#8217;s Service Contract</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have entered into an employment agreement with Ran Poliakine, our founder, director and Chief Executive Officer. Pursuant to the agreement, if the Company terminates Ran Poliakine&#8217;s employment and waives his obligation to perform services during the notice period of 180 days, Ran Poliakine will be entitled to receive payments of his base salary and social benefits in lieu of notice for the waived period, up to the full notice period for an immediate termination. The agreement provides Ran Poliakine with a gross monthly base salary equal to $40,000 which will be increased to $60,000 upon the consummation of this offering.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;"><a name="tPGEIP"><!--Anchor--></a>Equity Incentive Plans</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On September&#160;3, 2019, we adopted the 2019 Equity Incentive Plan and its U.S. sub-Plan (the &#8220;2019 Equity Incentive Plan&#8221; or &#8220;Plan&#8221;). The 2019 Equity Incentive Plan is intended to afford an incentive to any of our affiliates&#8217; employees, directors, officers, consultants, advisors and any other person or entity who provides services to us, to continue as service providers, to increase their efforts on our and our affiliates&#8217; behalf and to promote our success, by providing such persons with opportunities to acquire a proprietary interest in us. The U.S. sub-Plan applies to our and any of our affiliates&#8217; employees, directors, officers, consultants, advisors and any other person or entity who provides services to the Company who are in the United States.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We may issue under the 2019 Equity Incentive Plan and its U.S. sub-Plan up to 8,041,936 of our ordinary shares, subject to adjustment if particular capital changes affect our share capital or such other number as our board of directors may determine from time to time. Any awards that are scheduled to vest over a period of more than one calendar year shall be applied pro rata for purposes of the foregoing limit based on the number of years over which such awards are scheduled to vest. Ordinary shares subject to outstanding awards under the 2019 Equity Incentive Plan and its U.S. sub-Plan that subsequently expire, or are cancelled, forfeited or terminated for any reason before being exercised will be automatically, and without any further action, returned to the share reserve under the Plan and will again be available for grant.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A share option is the right to purchase a specified number of ordinary shares in the future at a specified exercise price and subject to the other terms and conditions specified in the option agreement and the applicable </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">123<br></div></div></div>
<!--End Page 129-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 130-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">equity incentive plan. The exercise price of each option granted under the 2019 Equity Incentive Plan will be determined in accordance with the limitation set forth under such equity incentive plan. The exercise price of any share options granted under the Plan may be paid in cash, through the surrender of ordinary shares by the option holder or any other method that may be approved by our compensation committee, which may include procedures for cashless exercise.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our compensation committee may also grant, or recommend that our board of directors grant, other forms of equity incentive awards under the 2019 Equity Incentive Plan, such as restricted shares, restricted share units (&#8220;RSUs&#8221;), which represent the right to receive shares of our ordinary shares in the future, and other forms of share-based compensation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Israeli participants in the 2019 Equity Incentive Plan may be granted options or other equity awards subject to Section 102 of the Israeli Income Tax Ordinance (New Version), 1961 (the &#8220;Israeli Tax Ordinance&#8221;). Section&#160;102 of the Israeli Tax Ordinance allows employees, directors and officers who are not controlling shareholders and are considered Israeli residents to receive favorable tax treatment for compensation in the form of shares or options. Our Israeli non-employee service providers and controlling shareholders, for these purposes under the Israeli Tax Ordinance, may only be granted options or other equity awards under another section of the Israeli Tax Ordinance, which does not provide for similar tax benefits. Section 102 includes two alternatives for tax treatment involving the issuance of options or shares to a trustee for the benefit of the grantees and also includes an additional alternative for the issuance of options or shares directly to the grantee. The most favorable tax treatment for the grantees is under Section&#160;102(b)(2) of the Israeli Tax Ordinance, the issuance to a trustee under the &#8220;capital gain track.&#8221; However, under this track we are not allowed to deduct an expense with respect to the issuance of the options or shares to our employees. Any options granted under the 2019 Equity Incentive Plan to participants in the United States will be either &#8220;incentive stock options,&#8221; which may be eligible for special tax treatment under the Internal Revenue Code of 1986, as amended, or options other than incentive stock options (referred to as &#8220;nonqualified stock options&#8221;), as determined by our compensation committee or our board of directors and stated in the option agreement.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">All awards, amounts or benefits received or outstanding under the 2019 Equity Incentive Plan and the U.S. sub-Plan will be subject to clawback, cancellation, recoupment, rescission, payback, reduction or other similar action in accordance with the terms of any clawback or similar policy that we adopt or any applicable law related to such actions, as may be in effect from time to time. A participant&#8217;s acceptance of an award under the 2019 Equity Incentive Plan and the U.S. sub-Plan will be deemed to constitute the participant&#8217;s acknowledgement of and consent to our application, implementation and enforcement of any applicable clawback or similar policy that may apply to the participant, and any provision of applicable law relating to clawback, cancellation, recoupment, rescission, payback or reduction of compensation, and the participant&#8217;s agreement that we may take such actions as may be necessary to effectuate any such policy or applicable law, without further consideration or action.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The 2019 Equity Incentive Plan and the U.S. sub-Plan have been designed to include a number of provisions that promote best practices by reinforcing the alignment between equity compensation arrangements for eligible employees and non-employee directors and shareholders&#8217; interests. These provisions include, but are not limited to, the following:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic;">Forfeiture </font><font style="font-style: italic;">U</font><font style="font-style: italic;">pon Cause Termination</font>. All awards held by a participant will be forfeited upon the participant&#8217;s termination for cause.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic;">No Repricing </font><font style="font-style: italic;">W</font><font style="font-style: italic;">ithout Shareholder Approval</font>. Without prior shareholder approval, we will not (i)&#160;reduce the exercise price of a stock option, (ii)&#160;take any other action that is treated as repricing under U.S.&#160;GAAP or (ii)&#160;repurchase for cash or cancel a stock option when its exercise price is greater than the fair market value of the underlying shares in exchange for another, unless the cancellation and exchange occurs in connection with a change in capitalization or a similar change.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic;">No Transferability</font>. Awards generally may not be transferred, except by will or the laws of descent and distribution, unless otherwise determined by the compensation committee. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic;">No Automatic Grants</font>. The Plan does not provide for automatic grants to any participant.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic;">No Tax Gross-Ups</font>. The Plan does not provide for any tax gross-ups.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">124<br></div></div></div>
<!--End Page 130-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 131-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our compensation committee will administer the 2019 Equity Incentive Plan and the U.S. sub-Plan, or if determined otherwise by our board of directors, the equity incentive plans will be administered by our board of directors or other designated committee on its behalf. Even if the compensation committee or any other committee was appointed by our board of directors in order to administer the equity incentive plans, our board of directors may, subject to any legal limitations, exercise any powers or duties of the compensation committee or any other committee concerning the equity incentive plans. The compensation committee will, among others, select which eligible persons will receive options or other awards under the equity incentive plans and will determine, or recommend to our board of directors, the number of ordinary shares covered by those options or other awards, the terms under which such options or other awards may be exercised (however, options generally may not be exercised later than ten years from the grant date of an option) or may be settled or paid, and the other terms and conditions of such options and other awards under the equity incentive plans. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">To the extent permitted under applicable law, our compensation committee will have the authority to accelerate the vesting of any outstanding options, restricted shares and RSUs at such time and under such circumstances as it, in its sole discretion, deems appropriate. In the event of a merger or sale, as defined in the Plan, any award then outstanding shall be assumed or an equivalent award shall be substituted by the successor corporation of the merger or sale or any parent or affiliate thereof as determined by our board of directors. In the event that the awards are not assumed or substituted, our compensation committee may, in its discretion, accelerate the vesting or exercisability of the outstanding award, or provide for the cancellation of such award and payment of cash consideration, as determined to be fair in the circumstances.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Subject to particular limitations specified in the 2019 Equity Incentive Plan and the U.S. sub-Plan and under applicable law, our board of directors may amend or terminate each of the equity incentive plans, and the compensation committee may amend awards outstanding under the Plan. The Plan will continue in effect until all ordinary shares available under the Plan are delivered and all restrictions on those shares have lapsed, unless the 2019 Equity Incentive Plan is terminated earlier by our board of directors. No awards may be granted under the 2019 Equity Incentive Plan and the U.S. sub-Plan, on or after the tenth anniversary of the date of adoption.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Any equity award to an office holder, director or controlling shareholder, whether under the 2019 Equity Incentive Plan and the U.S. sub-Plan or otherwise, may be subject to further approvals in addition to the approval of the compensation committee as described above. As of December&#160;31, 2019, there were 3,654,464 ordinary shares issuable upon the exercise of options to purchase ordinary shares outstanding under our 2019 Equity Incentive Plan, at an average exercise price of $2.21 per share.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">125<br></div></div></div>
<!--End Page 131-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 132-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table sets forth, as of December&#160;31, 2019, the total number of ordinary shares issuable upon exercise of the options granted to each of our executive officers and our non-employee directors as a group, the exercise price of such options, the grant date and the expiration date. We discuss grants made since December&#160;31, 2019 immediately below the table.</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 30.77%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name</div></td><td class="gutter" style="width: 2.47%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.47%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br>Options</div></td><td class="gutter" style="width: 2.47%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.47%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br>Price</div></td><td class="gutter" style="width: 2.47%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.47%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Date of<br>Grant</div></td><td class="gutter" style="width: 2.47%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.47%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Expiration<br>Date</div></td></tr><tr><td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Ran Poliakine <font style="padding-left: 0.96pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">1,206,290 </div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.14%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.12pt; text-align: left;">$2.21</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November 25, 2019</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November&#160;25, 2029</div></td></tr><tr><td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Onn Fenig <font style="padding-left: 4.85pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">40,234 </font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.14%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.12pt; text-align: left;">$2.21</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November 25, 2019</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November&#160;25, 2029 </div></td></tr><tr><td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Floyd Katske<font style="padding-left: 2.07pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 35pt;">0</font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.14%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.12pt; text-align: left;"><font style="padding-left: 5.28pt;">N/A</font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 17.39%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">N/A</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 17.39%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">N/A</div></td></tr><tr><td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Erez Meltzer<font style="padding-left: 3.76pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 35pt;">0</font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.14%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.12pt; text-align: left;"><font style="padding-left: 5.28pt;">N/A</font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 17.39%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">N/A</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 17.39%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">N/A</div></td></tr><tr><td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Richard Stone <font style="padding-left: 0.41pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">100,584 </font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.14%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.12pt; text-align: left;">$2.21</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November 25, 2019 </div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November&#160;25, 2029 </div></td></tr><tr><td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Itzhak Maayan<font style="padding-left: 0.97pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">161,107</font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.14%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.12pt; text-align: left;">$2.21</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November 25, 2019</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November&#160;25, 2029 </div></td></tr><tr><td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Anat Kaphan<font style="padding-left: 2.63pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.87pt;">112,754</font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.14%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.12pt; text-align: left;">$2.21</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November 25, 2019</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November&#160;25, 2029 </div></td></tr><tr><td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Yoel Raab<font style="padding-left: 4.18pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">1</font>52,754</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.14%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.12pt; text-align: left;">$2.21</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November 25, 2019</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November&#160;25, 2029 </div></td></tr><tr><td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Tal Shank<font style="padding-left: 0.54pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">74,362 </font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.14%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.12pt; text-align: left;">$2.21</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November 25, 2019</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 17.39%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">November&#160;25, 2029 </div></td></tr><tr><td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Shirly Kaufman-Kirshenbaum<font style="padding-left: 4.32pt;"></font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 8.55%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 35pt;">0</font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 6.14%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.12pt; text-align: left;"><font style="padding-left: 5.28pt;">N/A</font></div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 17.39%; text-align: right; vertical-align: top; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">N/A</div></td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 2.47%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 17.39%; text-align: right; vertical-align: top; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">N/A</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In February 2020, we approved the grant of options to Erez Meltzer in respect of 40,234&#160;ordinary shares with an exercise price of $2.21 per ordinary share. In April 2020, we approved the grant of options to Floyd Katske in respect of 40,234 ordinary shares with an exercise price of $16.00 per ordinary share. In April 2020, we approved the grant of options to Shirly Kaufman-Kirshenbaum in respect of 50,000 ordinary shares with an exercise price of $16.00 per ordinary share. All grants of options were issued pursuant to the 2019 Equity Incentive Plan. All options held by our directors will be fully accelerated upon a &#8220;Deemed Liquidation&#8221; as defined in the 2019 Equity Incentive Plan. In connection with the Private Placement investment with SKT, we agreed to grant options to Mr. Park (or another person designated by SKT) in respect of 100,000 ordinary shares with an exercise price of $16.00 per ordinary share as soon as practicable after such person&#8217;s appointment. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">126<br></div></div></div>
<!--End Page 132-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 133-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPS"><!--Anchor--></a>PRINCIPAL SHAREHOLDERS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table sets forth information with respect to the beneficial ownership of our ordinary shares as of August 13, 2020 by:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each person or entity known by us to own beneficially more than 5% of our outstanding ordinary shares;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each of our directors and executive officers; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">all of our directors and executive officers as a group.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The beneficial ownership of our ordinary shares is determined in accordance with the rules of the SEC. Under these rules, a person is deemed to be a beneficial owner of a security if that person has or shares voting power, which includes the power to vote or to direct the voting of the security, or investment power, which includes the power to dispose of or to direct the disposition of the security. Certain of our existing investors and their affiliated entities, including Yozma, SKT, JJFIHC and iA, and certain other investors have indicated an interest in purchasing an aggregate of up to approximately $80 million of our ordinary shares in this offering at the initial public offering price. However, because indications of interest are not binding agreements or commitments to purchase, these entities may determine to purchase fewer shares than they indicate an interest in purchasing or to not purchase any shares in this offering. It is also possible that these entities could indicate an interest in purchasing more of our ordinary shares. In addition, the underwriters could determine to sell fewer shares to any of these entities than the entities indicate an interest in purchasing or to not sell any shares to these entities. In determining beneficial ownership percentages, we deem ordinary shares that a shareholder has the right to acquire, including the ordinary shares issuable pursuant to options or warrants that are currently exercisable or exercisable within 60 days of August&#160;13, 2020, if any, to be outstanding and to be beneficially owned by the person with such right to acquire additional ordinary shares for the purposes of computing the percentage ownership of that person, but we do not treat them as outstanding for the purpose of computing the percentage ownership of any other person. The percentage of ordinary shares beneficially owned prior to the offering is based on 35,570,380 ordinary shares outstanding as of August&#160;13, 2020, after giving effect to the Transactions. The percentage of ordinary shares beneficially owned after the offering is based on 35,570,380 ordinary shares outstanding as of August 13, 2020, after giving effect to the Transactions, plus the ordinary shares that we are selling in this offering. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The percentages of ordinary shares beneficially owned after the offering assume that the underwriters will not exercise their option to purchase additional ordinary shares in the offering. Except where otherwise indicated, we believe, based on information furnished to us by such owners, that the beneficial owners of the ordinary shares listed below have sole investment and voting power with respect to such shares.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Upon the closing of this offering, none of our shareholders will have different voting rights from other shareholders. To the best of our knowledge, we are not owned or controlled, directly or indirectly, by another corporation or by any foreign government. We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our company. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">127<br></div></div></div>
<!--End Page 133-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 134-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Unless otherwise noted below, the address for each beneficial owner is c/o Communications Center, Neve Ilan, Israel 9085000.</div> <table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 5.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.44%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares Beneficially Owned <br>Prior to the Offering</div></td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.44%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares Beneficially Owned <br>After the Offering</div></td></tr><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name of Beneficial Owner</div></td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.52%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number</div></td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Percentage</div></td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.52%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number</div></td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.46%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Percentage</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">5% or greater shareholders<br></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Ran Poliakine<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 1.55pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">4,774,727 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">13.19 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">4,774,727</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">10.61 </div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Moshe Moalem<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="padding-left: 4.89pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">4,067,420 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 0.37pt;">11.</font>43 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">4,067,420</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 5pt;">9.16</font> </div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">SK Telecom TMT Investment Corp and Affiliates<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup><font style="padding-left: 0.24pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">5,774,886 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">16.24 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">5,774,886 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">13.01 </div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Asia Beam Limited<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup><font style="padding-left: 3.78pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">2,684,248 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 5pt;">7.3</font>8 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">2,684,248</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 5pt;">5.94</font> </div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Yozma Group Korea<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup><font style="padding-left: 4.24pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">2,512,000</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 5pt;">7.</font>06 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">2,512,000</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 5pt;">5.66</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Directors and executive officers<br></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Ran Poliakine<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 1.55pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">4,774,727 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">13.19 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">4,774,727 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">10.61 </div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Onn Fenig<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup><font style="padding-left: 0.43pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 17.5pt;">7,544</font> </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 17.5pt;">7,544</font> </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Floyd Katske<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup> <font style="padding-left: 1pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 17.5pt;">2,515 </font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 17.5pt;">2,515 </font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Erez Meltzer<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup><font style="padding-left: 1.01pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 17.5pt;">5,029</font> </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 17.5pt;">5,029</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Richard Stone<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup><font style="padding-left: 0.99pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">2,741,340 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 5pt;">7.70</font> </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">2,741,340 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 5pt;">6.17</font> </div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Itzhak Maayan<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(10)</sup><font style="padding-left: 4.48pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 12.5pt;">36,920</font> </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 12.5pt;">36,920</font> </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Yoel Raab<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(11)</sup><font style="padding-left: 2.97pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 12.5pt;">70,393</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 12.5pt;">70,393</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Anat Kaphan<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(12)</sup><font style="padding-left: 1.14pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 12.5pt;">69,492</font> </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 12.5pt;">69,492</font> </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Tal Shank<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(13)</sup><font style="padding-left: 4.05pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 12.5pt;">37,181</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 12.5pt;">37,181</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Shirly Kaufman-Kirshenbaum<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(14)</sup><font style="padding-left: 2.82pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 12.87pt;">11,719</font> </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;"><font style="padding-left: 12.87pt;">11,719</font> </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 22.5pt;">*</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">All directors and executive officers as a group (10 persons)<font style="font-style: normal; font-weight: normal; padding-left: 0.86pt;"></font></div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">7,756,860</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">21.28 </div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.28pt; text-align: left;">7,756,860</div></td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">17.13</div></td></tr></table> <div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Amount represents less than 1% of outstanding ordinary shares.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents (a) 3,572,212 ordinary shares of the Company held by Ran Poliakine, (b) 118,750 ordinary shares of the Company held in trust by Shay Zuckerman &amp; Co. Law Firm (&#8220;Shay Zuckerman&#8221;), pursuant to an Escrow Agreement, dated February 3, 2020 (the &#8220;Escrow Agreement&#8221;), between Ran Poliakine, Moshe Moalem and Shay Zuckerman, as trustee, (c) warrants to purchase 452,489 ordinary shares held by Ran Poliakine and (d) options to purchase 628,276 ordinary shares exercisable within 60 days of August 13, 2020. The ordinary shares held by Shay Zuckerman are held in trust for the benefit of Ran Poliakine. Ran Poliakine has voting power of all the ordinary shares held in trust by Shay Zuckerman. Ran Poliakine and Moshe Moalem may be deemed to share the dispositive power over the ordinary shares held in trust by Shay Zuckerman as such ordinary shares may not be disposed of until a final settlement between Ran Poliakine and Moshe Moalem is reached with respect thereto. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents (a) 3,948,670 ordinary shares of the Company held by Moshe Moalem and (b) 118,750 ordinary shares of the Company held in trust by Shay Zuckerman pursuant to the Escrow Agreement. Ran Poliakine and Moshe Moalem may be deemed to share the dispositive power over the ordinary shares held in trust by Shay Zuckerman as such ordinary shares may not be disposed of until a final settlement between Ran Poliakine and Moshe Moalem is reached with respect thereto. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents 2,607,466 ordinary shares held by SKT, 49,773 ordinary shares held by Pureun Partners Asset Management Co., Ltd. (&#8220;Pureun&#8221;), 855,204 ordinary shares held by EBEST-PPAM Fund No. 9 (&#8220;EBEST&#8221;), and warrants held by SKT to purchase 2,262,443 ordinary shares. SKT has the voting and dispositive power of the shares held by Pureun and EBEST pursuant to a proxy.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents 1,875,000 ordinary shares held by Asia Beam Limited (assuming the sale of such shares to Asia Beam Limited is closed on August 13, 2020) and 809,248 ordinary shares that Asia Beam has the right to acquire within 60 days of August 13, 2020. See &#8220;Prospectus Summary-Recent Developments&#8221; and &#8220;The Offering.&#8221; The voting and dispositive power over such ordinary shares is ultimately held by Kasudjono Harianto. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents 887,000 ordinary shares held by Yozma Global AI Fund No.2 (&#8220;Yozma Fund No.2&#8221;) and 1,625,000 ordinary shares held by Yozma Global AI Fund No.3 (&#8220;Yozma Fund No.3&#8221;). Yozma Group Korea is the general partner of each of Yozma Fund No.2 and Yozma Fund No.3. Wonjae Lee is the Chief Executive Officer and controlling shareholder of Yozma Group Korea and is deemed to have voting and dispositive power over the shares held by Yozma Fund No.2 and Yozma Fund No.3. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents options to purchase 7,544 ordinary shares exercisable within 60 days of August 13, 2020. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents options to purchase 2,515 ordinary shares exercisable within 60 days of August 13, 2020.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(8)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents options to purchase 5,029 ordinary shares exercisable within 60 days of August 13, 2020. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(9)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of (a) 287,894 ordinary shares, options to purchase 18,860 ordinary shares exercisable within 60 days of August 13, 2020, and warrants to purchase 410,216 ordinary shares held by Richard Stone, (b) 696,196 ordinary shares and warrants to purchase 298,642 ordinary shares held by Stone Isra Ventures LLC, (c) 221,719 ordinary shares and warrants to purchase 443,438 ordinary shares held by Adhoc Investors LLC, (d) 118,750 ordinary shares held by Ajax Partners, (e) 89,375 ordinary shares held by Frostop Securities and (f) 156,250 ordinary shares held by Patience LLC. Richard Stone is a minority holder of each of Stone Isra Ventures LLC, Adhoc Investors LLC, Ajax Partners, Frostop Securities and Patience LLC, and is the sole manager of Stone Isra Ventures LLC and Adhoc Investors LLC. Richard Stone is deemed to have voting and dispositive power of the ordinary shares held by Stone Isra Ventures LLC, Adhoc Investors LLC, Ajax Partners, Frostop Securities and Patience LLC.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">128<br></div></div></div>
<!--End Page 134-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 135-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_108-manage_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.25pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(10)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents options to purchase 36,920 ordinary shares exercisable within 60 days of August 13, 2020.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(11)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents options to purchase 70,393 ordinary shares exercisable within 60 days of August 13, 2020.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(12)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents options to purchase 69,492 ordinary shares exercisable within 60 days of August 13, 2020. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(13)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents options to purchase 37,181 ordinary shares exercisable within 60 days of August 13, 2020. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(14)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents options to purchase 11,719 ordinary shares exercisable within 60 days of August 13, 2020. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of August&#160;13, 2020, approximately 8,947,397 of our outstanding ordinary shares are held by 86 record holders in the United States.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">None of our shareholders has different voting rights from other shareholders after the closing of this offering. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">129<br></div></div></div>
<!--End Page 135-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 136-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_109-certain_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCR"><!--Anchor--></a>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our policy is to enter into transactions with related parties on terms that, on the whole, are no more favorable, or no less favorable, than those available from unaffiliated third parties. Based on our experience in the business sectors in which we operate and the terms of our transactions with unaffiliated third parties, we believe that all of the transactions described below met this policy standard at the time they occurred. The following is a description of material transactions, or series of related material transactions, since January&#160;1, 2017, to which we were or will be a party and in which the other parties included or will include our directors, executive officers, holders of more than 5% of our voting securities or any member of the immediate family of any of the foregoing persons.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Asset Purchase by the Company From Nanox Gibraltar</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company (NANO-X IMAGING LTD), an Israeli limited liability company, was formed on December&#160;20, 2018. Pursuant to the Asset Purchase Agreement, as amended on December 3, 2019 and December&#160;31, 2019, substantially all of the assets of Nanox Gibraltar, including all patents, patent applications and all other intellectual property rights, but not including the shares of Nanox Japan (predecessor), were sold to the Company for an aggregate consideration of $13.3 million, reflecting the fair market value of the transferred assets, which was estimated to be $6.1 million (excluding cash) based on an independent valuation report, plus the cash balance less $200,000, which totaled $7.2 million as of the date of the Asset Purchase Agreement. Following the Asset Purchase, substantially all the employees of Nanox Japan (predecessor) dedicated to the Company&#8217;s business have become employees of Nanox Imaging, Inc., our wholly owned Japanese subsidiary incorporated on September&#160;19, 2019, in December 2019.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the terms of the Asset Purchase Agreement, the consideration for the transferred assets will be paid only on the occurrence of one of the following events: (a) the closing of a transaction involving the sale of all or substantially all of the Company&#8217;s assets; (b) the acquisition of the Company by, or the merger of the Company with, another entity, consolidation, reorganization, recapitalization, sale, assignment or disposal by the Company of all or substantially all of the issued and outstanding shares of the Company; (c) the transfer, sale, lease, grant or other disposition of or the grant of an exclusive license over all or substantially all of Company&#8217;s assets, including, but not limited to, intellectual property, with the same economic effect to that of a sale and/or cessation of its business; (d) any other transaction, except for a financing round, following which the shareholders of the Company prior to the closing of such transaction own, directly or indirectly, less than 50% of the voting power of the surviving entity; (e) the closing of the first underwritten public offering of the Company pursuant to a registration statement under the Securities Act or the Israeli Securities Law, 5728-1968, as amended (or under equivalent securities law of another jurisdiction) or any other securities laws world-wide with the same effects and results; (f) an equity financing of the Company at a minimum pre-money valuation of $100.0 million, with proceeds to the Company of at least $30.0 million. In the events of (e) or (f) above, the Company will have the option to pay the consideration in cash or by the issuance to Nanox Gibraltar of the Company&#8217;s securities of the same series to be issued upon such event, in an amount reflecting a 25% discount on the price per share to be determined in connection with (e) and (f) above. If the Company elects to pay such consideration in cash, Nanox Gibraltar will have the right, at its sole discretion and in good faith, to reject such payment in cash, and require that the Company pay such consideration in the form of the Company&#8217;s securities in such amount and with such discount described above.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In January 2020, the board of directors of the Company and the board of directors and shareholders of Nanox Gibraltar approved the issuance of shares in accordance with the terms of the Asset Purchase Agreement described above. As a result, 1,109,245&#160;of the Company&#8217;s ordinary shares were issued to Nanox Gibraltar, representing an aggregate consideration of approximately $17.8&#160;million at the date of issuance that reflects a 25% discount on the price per share received in the Private Placement, and the Company has no further obligations to Nanox Gibraltar under the Asset Purchase Agreement.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Relationship With SKT</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left; line-height: 11.5pt;">On June&#160;17, 2019, Nanox Gibraltar entered into a Strategic Share Purchase Agreement with SKT, Pureun Partners Asset Management Co., Ltd. and EBEST-PPAM Fund No. 9 (collectively, the &#8220;SKT Entities&#8221;), pursuant to which Nanox Gibraltar sold 2,262,443 ordinary shares to the SKT&#160;Entities for an aggregate purchase price of approximately $5.0&#160;million. In connection with such transaction, Nanox Gibraltar also issued a warrant to SKT to acquire 2,262,443 ordinary shares at an exercise price of $20.87 per share (the &#8220;Warrant&#8221;). </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">130<br></div></div></div>
<!--End Page 136-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 137-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_109-certain_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left; line-height: 12pt;">In connection with the transactions described above, Nanox Gibraltar also entered into an investor rights agreement with the SKT Entities (the &#8220;Investor Rights Agreement&#8221;). The agreement provides for the rights to nominate a member of our board of directors, as well as certain registration rights. Pursuant to the Investor Rights Agreement, so long as the SKT Entities hold at least 5% of Nanox Gibraltar&#8217;s outstanding shares or any SKT Entity is otherwise deemed an affiliate of Nanox Gibraltar under Rule 144 of the Securities Act, it shall be entitled to the same piggyback registration rights as the most favorable registration rights that Nanox Gibraltar has provided to any of its current shareholders or provides to future shareholders, and shall be made a party to any investor rights agreement or registration rights agreement that Nanox Gibraltar thereafter enters into. SKT also has preemptive rights with respect to the issuances of any ordinary shares, warrants and other securities convertible into or exercisable for our ordinary shares (subject to certain exceptions, including the ordinary shares issued to the public in this offering) prior to the closing of this offering. The rights under the Investor Rights Agreement will terminate upon the closing of this offering. The SKT Entities are expected to become parties to the Registration Rights Agreement (as defined below) prior to the closing of this offering so long as they meet the requirements described above. See &#8220;Description of Share Capital&#8212;Registration Rights&#8221; for detailed description of the registration rights. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On June 4, 2020, in connection with the Private Placement, we entered into a Share Purchase Agreement with SKT, pursuant to which we sold 1,250,000 ordinary shares to SKT for an aggregate purchase price of $20.0&#160;million. In connection with such agreement, we amended the Warrant to extend the exercise period to the earlier of June&#160;17, 2025 or an exit event, which event does not include an initial public offering, and we amended the Investor Rights Agreement which grants SKT the right to appoint Mr.&#160;Jung Ho Park (or another person designated by SKT) as a director for a term of three years and certain pre-emptive rights to participate in any issuance of new securities by us until the closing of an initial public offering. In addition, we undertook to grant Mr.&#160;Park options to purchase 100,000 of our ordinary shares, contingent on him becoming a director, vesting in equal quarterly installments over a period of four years, at an exercise price of $16.00 per ordinary share. In the event that SKT nominates any replacement director, any such director may receive options with the same terms, but the aggregate number of options granted to all such directors together shall not exceed 100,000.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Furthermore, on June&#160;4, 2020, we entered into a collaboration agreement with SK Telecom, pursuant to which we and SK Telecom will further explore and engage in good faith to develop a definitive agreement within six months of the date of the agreement for the deployment of 2,500 Nanox Systems in South Korea and Vietnam, and we will use commercially reasonable efforts to establish a wholly-owned subsidiary in South Korea with the support of SK Telecom for the purpose of manufacturing MEMs X-ray chips for the Nanox.ARC. The collaboration agreement will be in effect until the earlier of December 31, 2021 or the execution of a definitive agreement, and may be extended upon the mutual agreement of the parties. The agreement may be terminated by mutual notice or by notice of the non-breaching party in case of a material breach of a party&#8217;s material obligations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, we signed an agreement with a President of SK Telecom, Dr. Ilung Kim, dated December 16, 2019, for the provision of consulting services to us. Under the agreement, we granted Dr. Kim options to purchase 1,206,290 of our ordinary shares at an exercise price of $2.21 per ordinary share. 301,572 of the options vested as of the grant date and the remaining 904,718 options will vest in equal monthly installments over a period of three years from the vesting commencement date. In case of an initial public offering or certain other events, all unvested options will fully accelerate immediately prior to the closing of the initial public offering. The vested options are exercisable until the earlier of (a) the second anniversary of termination of the engagement between us and Dr. Kim or (b) the tenth anniversary from the date of grant.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Agreements With Directors and Officers</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 0pt; text-align: left;">Relationship With Six-Eye Interactive Ltd.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On June 1, 2015, Nanox Gibraltar entered into a consulting agreement (the &#8220;Consulting Agreement&#8221;) with Six-Eye, pursuant to which Ran Poliakine, the sole owner of Six-Eye, agreed to provide services as Chief Strategy Officer and a member of the Executive Committee to Nanox Gibraltar. The Consulting Agreement was terminated and on September 1, 2019, Ran Poliakine executed an employment agreement with the Company.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left; line-height: 11.5pt;">On May&#160;1, 2017, Nanox Gibraltar entered into a services agreement with Six-Eye, of which Ran Poliakine is the sole owner, pursuant to which Six-Eye agreed to provide certain services to Nanox Gibraltar, including </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">131<br></div></div></div>
<!--End Page 137-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 138-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_109-certain_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">research and development, equipped facilities, management and administration, operational and supply and financial and accounting services (the &#8220;Original Services Agreement&#8221;). Following the Asset Purchase, all of the terms of the Original Services Agreement were terminated.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December 31, 2018 and 2019, the total expenses paid to Six-Eye under the Consulting Agreement and Original Services Agreement were $1.4 million and $0.7 million, respectively. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Relationship With Illumigyn, Ltd.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Since November 1, 2019, Illumigyn has sub-leased approximately 1,800 square feet of private office space, including access to shared public spaces, from us in Neve Ilan, Israel. Illumigyn pays approximately $12,000 per month and during year ended December 31, 2019, the total payment received from Illumigyn was approximately $12,000. Mr. Poliakine currently serves as a member of senior management of Illumigyn and is a significant shareholder primarily through indirect holdings, and he served as a member of the board of directors of Illumigyn until August 2019. In addition, Mr. Richard Stone is a significant shareholder in, and serves as a member of the board of directors of Illumigyn, and Anat Kaphan, our Vice President of Product Marketing, also serves as a consultant to Illumigyn.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Relationship with SixAI Ltd.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On April&#160;16, 2020, we entered into a service agreement (the &#8220;Service Agreement&#8221;) with SixAI Ltd. (&#8220;SixAI&#8221;), pursuant to which SixAI shall provide Nanox with certain software development and mechanical engineering services. The Service Agreement is effective as of March 1, 2020 for a term of six months, which may be extended by mutual agreement of the parties. In consideration for the services provided, we will pay SixAI monthly fee based on the number of hours invested by the applicable individuals in rendering the services during each month up to $195,000. As of June&#160;30, 2020, we have paid $150,000 to SixAI. Mr. Poliakine and Mr. Fenig currently serve as members of the board of directors of SixAI and Mr. Poliakine is a controlling shareholder of SixAI. In addition, Mr. Poliakine is a director of Musashi which is a controlled subsidiary (51%) of SixAI and Mr. Fenig manages Musashi&#8217;s operations.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Directorship Agreements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have entered into directorship agreements with each of our directors, pursuant to which such directors will serve on our board of directors. Pursuant to these agreements, each director was granted options under our 2019 Equity Incentive Plan in the number and terms set out under &#8220;Management&#8212;Equity Incentive Plans.&#8221; </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Employment Agreements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have entered into written employment agreements with certain of our executive officers. These agreements provide for notice periods of varying duration for termination of the agreement by us or by the relevant executive officer, during which time the executive officer will continue to receive base salary and benefits. These agreements also contain customary provisions regarding non-competition, confidentiality of information and assignment of inventions. However, the enforceability of the non-competition provisions may be limited under applicable law. See &#8220;Risk Factors&#8212;Risks Relating to Employee Matters&#8212;Under applicable employment laws, we may not be able to enforce covenants not to compete and therefore may be unable to prevent our competitors from benefitting from the expertise of some of our former employees&#8221; for a further description of the enforceability of non-competition clauses. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Equity Incentive Plans</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For a description of our equity incentive plans with members of our board of directors and executive officers, see &#8220;Management&#8212;Equity Incentive Plans.&#8221;</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Directors and Officers Insurance Policy and Indemnification Agreements</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our amended and restated articles of association, which will become effective upon completion of this offering, permit us to exculpate, indemnify and insure each of our directors and officers to the fullest extent permitted by the Companies Law. We have obtained directors and officers insurance for each of our executive officers and directors. For further information, see &#8220;Management&#8212;Exculpation, Insurance and Indemnification of Directors and Officers.&#8221;</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">132<br></div></div></div>
<!--End Page 138-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 139-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_109-certain_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have entered into agreements with each of our current directors and officers exculpating them from a breach of their duty of care to us to the fullest extent permitted by law, and undertaking to indemnify them to the fullest extent permitted by law including, with respect to liabilities resulting from this offering, to the extent that these liabilities are not covered by insurance, all subject to limited exceptions. This indemnification is limited, with respect to any monetary liability imposed in favor of a third party, to events determined as foreseeable by the board of directors based on our current or expected activities. The maximum aggregate amount of indemnification that we may pay to our directors and officers based on such indemnification agreement shall not exceed the greater of (i)&#160;in relation to indemnity in connection with an offering to the public of our securities, the aggregate amount of proceeds from the sale by us and/or any of our shareholders in connection with such public offering, (ii) 25% of our total shareholders&#8217; equity pursuant to our most recent financial statements as of the time of the actual payment of indemnification, and (iii) $50&#160;million (in each case as may be increased from time to time by shareholders&#8217; approval). Such indemnification amounts are in addition to any insurance amounts. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">However, in the opinion of the SEC, indemnification of office holders for liabilities arising under the Securities Act is against public policy and therefore unenforceable.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Participation in this offering </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Certain of our existing investors and their affiliated entities, including Yozma, SKT, JJFIHC and iA, and certain other investors have indicated an interest in purchasing an aggregate of up to approximately $80 million of our ordinary shares in this offering at the initial public offering price. However, because indications of interest are not binding agreements or commitments to purchase, these entities may determine to purchase fewer shares than they indicate an interest in purchasing or to not purchase any shares in this offering. It is also possible that these entities could indicate an interest in purchasing more of our ordinary shares. In addition, the underwriters could determine to sell fewer shares to any of these entities than the entities indicate an interest in purchasing or to not sell any shares to these entities.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">133<br></div></div></div>
<!--End Page 139-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 140-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_110-descrip_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDS"><!--Anchor--></a>DESCRIPTION OF SHARE CAPITAL</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following description of our share capital and provisions of our amended and restated articles of association are summaries and are qualified in their entirety by reference to the amended and restated articles of association, which will become effective immediately prior to the closing of this offering. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">General</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Upon the closing of this offering, our authorized share capital will consist of 100,000,000 ordinary shares, par value NIS 0.01 per share, of which, effective upon closing of this offering, 44,393,910 ordinary shares will be issued and outstanding (assuming that the underwriters do not exercise their option to purchase additional ordinary shares). </div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">All of our outstanding ordinary shares will be validly issued, fully paid and non-assessable. Our ordinary shares are not redeemable and do not have any preemptive rights. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Warrants to Purchase Ordinary Shares </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of August&#160;13, 2020, warrants to purchase a total of 5,195,749 shares of our ordinary shares were outstanding with exercise prices ranging from $0.01 per share to $20.87 per share. These warrants are exercisable immediately and expire on various dates. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The warrants were issued to certain persons in connection with certain corporate, financing and consulting transactions. Collectively, we refer to these warrants as the &#8220;ordinary shares warrants.&#8221; Some of the ordinary shares warrants provide that, unless earlier exercised, they will be expired or exercised, on a cash or cashless basis, immediately prior to the closing of this offering, so long as the fair market value of our ordinary shares at the closing of this offering exceeds the exercise price of the applicable warrant. The fair market value in connection with any cashless exercise prior to the consummation of this offering shall be the initial public offering price of our ordinary shares. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Assuming the closing of this offering occurs, the fair market value of one share of our ordinary shares in connection with any cashless exercise shall be the closing price or last sale price per share of our ordinary shares on the Nasdaq Global Market or other public trading market on which our ordinary shares are traded on the business day immediately prior to the date such holder elects to exercise such warrant on a cashless basis. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Registration Number and Purposes of the Company </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our registration number with the Israeli Registrar of Companies is 515942076. Following the closing of this offering, our registration number may be changed by the Israeli Registrar of Companies to indicate that we are a public company. Our purpose as set forth in our amended and restated articles of association is to engage in any lawful activity.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Transfer of Shares </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our fully paid ordinary shares are issued in registered form and may be freely transferred under our amended and restated articles of association, unless the transfer is restricted or prohibited by another instrument, applicable law or the rules of a stock exchange on which the shares are listed for trade. The ownership or voting of our ordinary shares by non-residents of Israel is not restricted in any way by our amended and restated articles of association or the laws of the State of Israel, except for ownership by nationals of some countries that are, or have been, in a state of war with Israel. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Election of Directors </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our ordinary shares do not have cumulative voting rights for the election of directors. As a result, the holders of a majority of the voting power represented at a shareholders meeting have the power to elect all of our directors, subject to the special approval requirements for external directors under the Companies Law described under &#8220;Management&#8212;External Directors.&#8221; </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under our amended and restated articles of association, which will become effective immediately prior to the closing of this offering, our board of directors must consist of a minimum of five directors, and a maximum 10 directors, including two external directors to the extent required by the Companies Law. Pursuant to our </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">134<br></div></div></div>
<!--End Page 140-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 141-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_110-descrip_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">amended and restated articles of association, other than the external directors, for whom special election requirements apply under the Companies Law, the vote required to appoint a director is a simple majority vote of holders of our voting shares participating and voting at the relevant meeting. In addition, our amended and restated articles of association allow our board of directors to appoint new directors to fill vacancies on the board of directors, including if the number of directors falls below the maximum number provided in our amended and restated articles. Furthermore, under our amended and restated articles of association, our directors, other than external directors, are divided into three&#160;classes with staggered three-year terms. Each class of directors consists, as nearly as possible, of 1/3 of the total number of directors constituting the entire board of directors (other than the external directors). The shareholders holding at least a two-thirds majority of the voting power represented at the meeting in person or by proxy and voting thereon shall be entitled to remove any director(s) from office and to elect director(s) in place of the director(s) so removed. For a more detailed description on the composition of our board of directors and election procedures of our directors, other than our external directors see &#8220;Management&#8212;Board of Directors and Officers.&#8221; External directors are elected for an initial term of three years, may be elected for additional terms of three years each under certain circumstances, and may be removed from office only pursuant to the terms of the Companies Law. For further information on the election and removal of external directors see &#8220;Management &#8212; External Directors&#8212;Election and Dismissal of External Directors.&#8221;</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Dividend and Liquidation Rights </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 20pt; text-align: left;">We have never declared or paid any cash dividends on our ordinary shares.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We may declare a dividend to be paid to the holders of our ordinary shares in proportion to their respective shareholdings. See &#8220;Dividend Policy&#8221; for more information with respect to the requirements under Israeli law for the declaration and payment of dividends to our shareholders. Under the Companies Law, dividend distributions are determined by the board of directors and do not require the approval of the shareholders of a company unless the company&#8217;s articles of association provide otherwise. Our amended and restated articles of association, which will become effective immediately prior to the closing of this offering, do not require shareholder approval of a dividend distribution and provide that dividend distributions may be determined by our board of directors. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to the Companies Law, the distribution amount is limited to the greater of retained earnings or earnings generated over the previous two years, according to our then last reviewed or audited financial statements, provided that the date of the financial statements is not more than six months prior to the date of the distribution, or we may distribute dividends that do not meet such criteria only with court approval. In each case, we are only permitted to distribute a dividend if our board of directors and the court, if applicable, determines that there is no reasonable concern that payment of the dividend will prevent us from satisfying our existing and foreseeable obligations as they become due. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In the event of our liquidation, after satisfaction of liabilities to creditors and other payments due as per applicable law, our assets will be distributed to the holders of our ordinary shares in proportion to their shareholdings. This right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to the holders of a class of shares with preferential rights that may be authorized in the future. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Exchange Controls </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">There are currently no Israeli currency control restrictions on remittances of dividends on our ordinary shares, proceeds from the sale of the shares or interest or other payments to non-residents of Israel, except for shareholders who are subjects of certain countries that have been, or are considered to be, in a state of war with Israel. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Shareholder Meetings </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under Israeli law, we are required to hold an annual general meeting of our shareholders once every calendar year that must be held no later than 15 months after the date of the previous annual general meeting. All general meetings other than the annual meeting of shareholders are referred to in our amended and restated articles of association as special meetings. Our board of directors may call special meetings whenever it sees fit, at such time and place, within or outside of Israel, as it may determine. In addition, the Companies Law provides that our board of directors is required to convene a special general meeting upon the written request of (i)&#160;any </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">135<br></div></div></div>
<!--End Page 141-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 142-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_110-descrip_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">two or more of our directors or one-quarter or more of the members of our board of directors or (ii)&#160;one or more shareholders holding, in the aggregate, either (a) 5% or more of our outstanding issued shares and 1% or more of our outstanding voting power or (b) 5% or more of our outstanding voting power. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under Israeli law, one or more shareholders holding at least 1% of the voting rights at the general meeting may request that the board of directors include a matter in the agenda of a general meeting to be convened in the future, provided that it is appropriate to discuss such a matter at the general meeting. Our amended and restated articles of association contain procedural guidelines and disclosure items with respect to the submission of shareholder proposals for shareholder meetings.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Subject to the provisions of the Companies Law and the regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings are the shareholders of record on a date to be decided by the board of directors, which may be between four and 40 days prior to the date of the meeting. Furthermore, the Companies Law requires that resolutions regarding, among other things, the following matters must be passed at a general meeting of our shareholders:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">amendments to our amended and restated articles of association;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">appointment or termination of our auditors;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">election of directors, including external directors (if applicable);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">approval of certain related party transactions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">increases or reductions of our authorized share capital;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">mergers; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the exercise of our board of director&#8217;s powers by a general meeting, if our board of directors is unable to exercise its powers and the exercise of any of its powers is required for our proper management.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under our amended and restated articles of association, we are required to give notice to our registered shareholders not less than 21 days prior to the meeting. The Companies Law requires that a notice of any annual general meeting or special general meeting be provided to shareholders at least 21 days prior to the meeting and if the agenda of the meeting includes the appointment or removal of directors, the approval of transactions with office holders or interested or related parties, or an approval of a merger, or as otherwise required under applicable law, notice must be provided at least 35 days prior to the meeting. Under the Companies Law, shareholders of a public company are not permitted to take action by written consent in lieu of a meeting. Under&#160;Companies Law, whenever we cannot convene or conduct a general meeting in the manner prescribed under the law or our articles of association, the court may, upon our, shareholders&#8217; or directors&#8217; request, order that we convene and conduct a general meeting in the manner the court deems appropriate.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Voting Rights </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Upon the closing of this offering, all of our ordinary shares will have identical voting and other rights in all respects.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Quorum Requirements </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to our amended and restated articles of association, which will become effective immediately prior to the closing of this offering, holders of our ordinary shares have one vote for each ordinary share held on all matters submitted to a vote before the shareholders at a general meeting. In any meeting of shareholders, we will follow the quorum requirements for general meetings as set forth in our amended and restated articles of association, instead of one-third of the issued share capital as required under the Nasdaq Marketplace Rules. Pursuant to our amended and restated articles of association, the quorum required for our general meetings of shareholders will consist of at least two shareholders present in person or by proxy (including by voting deed) and holding shares conferring in the aggregate at least 25% of the voting power of the Company. A meeting adjourned for lack of a quorum will generally be adjourned to the same day of the following week at the same time and place, or to such other day, time or place as indicated by our board of directors if so specified in the notice of the meeting. At the reconvened meeting, subject to a limited exception, any number of shareholders present in person or by proxy shall constitute a lawful quorum. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">136<br></div></div></div>
<!--End Page 142-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 143-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_110-descrip_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Vote Requirements </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our amended and restated articles of association provide that all resolutions of our shareholders require a simple majority vote, unless otherwise required by the Companies Law or by our amended and restated articles of association. Pursuant to our amended and restated articles of association, an amendment to our amended and restated articles of association regarding any change of the composition or election procedures of our directors will require a special shareholders majority of at least two-thirds of the voting power represented at the meeting in person or by proxy and voting thereon. Under the Companies Law, among others, each of&#8201; (i)&#160;the approval of an extraordinary transaction with a controlling shareholder and (ii)&#160;the terms of employment or other engagement of the controlling shareholder of the company or such controlling shareholder&#8217;s relative (even if such terms are not extraordinary) requires the approval described above under &#8220;Management&#8212;Fiduciary duties and approval of specified related party transactions and compensation under Israeli law&#8212;Disclosure of personal interests of a controlling shareholder and approval of certain transactions.&#8221; Certain transactions with respect to remuneration of our office holders and directors, the approval and extension of a compensation policy and certain deviations therefrom require further approvals described above under &#8220;Management&#8212;Fiduciary duties and approval of specified related party transactions and compensation under Israeli law&#8212;Rules Applicable to Compensation of directors and executive officers.&#8221; Under our amended and restated articles of association, any change to the rights and privileges of the holders of any class of our shares requires a simple majority of the class so affected (or such other percentage of the relevant class that may be set forth in the governing documents relevant to such class), in addition to the ordinary majority vote of all classes of shares voting together as a single class at a shareholder meeting. Another exception to the simple majority vote requirement is a resolution for the voluntary winding up, or an approval of a scheme of arrangement or reorganization, of the company pursuant to Section&#160;350 of the Companies Law, that governs the settlement of debts and reorganization of a company, which requires the approval of holders of 75% of the voting rights represented at the meeting, in person, by proxy or by voting deed and voting on the resolution.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Access to Corporate Records </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, shareholders generally have the right to review minutes of our general meetings, our shareholders register and principal shareholders register, our amended and restated articles of association, our annual audited financial statements and any document that we are required by law to file publicly with the Israeli Registrar of Companies or the Israel Securities Authority. In addition, shareholders may request to be provided with any document related to an action or transaction requiring shareholder approval under the related party transaction provisions of the Companies Law. We may deny this request if we believe it has not been made in good faith or if such denial is necessary to protect our interests or protect a trade secret or patent. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Modification of Class Rights </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law and our amended and restated articles of association, the rights attached to any class of share, such as voting, liquidation and dividend rights, may be amended by adoption of a resolution by the holders of a majority of the shares of that class present at a separate class meeting, or otherwise in accordance with the rights attached to such class of shares, as set forth in our amended and restated articles of association, in addition to the ordinary majority vote of all classes of voting shares voting together as a single class. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Registration Rights</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Prior to the closing of this offering, we intend to enter into a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;) with holders of approximately 11,186,011 of our ordinary shares. Under the terms of such registration rights agreement, and subject to the limitations specified therein, if we register our ordinary shares under the Securities Act for sale to the public, either for our own account or for the account of other security holders or both, the holders of registrable securities are entitled to notice of the intended registration and to include any or all of their registrable securities in the registration. The right of holders of registrable securities to include shares in an underwritten offering is subject to the right of the underwriters to limit the number of shares included in such offering. Holders of registrable securities are generally required to pay all expenses of registration, including the fees and disbursements of its counsel and all underwriting discounts and commissions. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, holders of warrants to purchase an aggregate of 2,438,725 ordinary shares, 85,256 of which are assumed to be exercised prior to the closing of this offering, are entitled to piggyback registration rights under the terms of such warrants substantially similar to the registration rights described in the preceding paragraph. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">137<br></div></div></div>
<!--End Page 143-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 144-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_110-descrip_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Acquisitions Under Israeli Law </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Full Tender Offer </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A person wishing to acquire shares of an Israeli public company and who would as a result hold over 90% of the target company&#8217;s issued and outstanding share capital is required by the Companies Law to make a tender offer to all of the company&#8217;s shareholders for the purchase of all of the issued and outstanding shares of the company. A person wishing to acquire shares of a public Israeli company and who would as a result hold over 90% of the issued and outstanding share capital of a certain class of shares is required to make a tender offer to all of the shareholders who hold shares of the relevant class for the purchase of all of the issued and outstanding shares of that class. If the shareholders who do not accept the offer hold less than 5% of the issued and outstanding share capital of the company or of the applicable class, and more than half of the shareholders who do not have a personal interest in the offer accept the offer, all of the shares that the acquirer offered to purchase will be transferred to the acquirer by operation of law. However, a tender offer will also be accepted if the shareholders who do not accept the offer hold less than 2% of the issued and outstanding share capital of the company or of the applicable class of shares. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Upon a successful completion of such a full tender offer, any shareholder that was an offeree in such tender offer, whether such shareholder accepted the tender offer or not, may, within six months from the date of acceptance of the tender offer, petition an Israeli court to determine whether the tender offer was for less than fair value and that the fair value should be paid as determined by the court. However, under certain conditions, the offeror may include in the terms of the tender offer that an offeree who accepted the offer will not be entitled to petition the Israeli court as described above. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If (a) the shareholders who did not respond or accept the tender offer hold at least 5% of the issued and outstanding share capital of the company or of the applicable class or the shareholders who accept the offer constitute less than a majority of the offerees that do not have a personal interest in the acceptance of the tender offer, or (b) the shareholders who did not accept the tender offer hold 2% or more of the issued and outstanding share capital of the company (or of the applicable class), the acquirer may not acquire shares of the company that will increase its holdings to more than 90% of the company&#8217;s issued and outstanding share capital or of the applicable class from shareholders who accepted the tender offer. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Special Tender Offer </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Companies Law provides that an acquisition of shares of an Israeli public company must be made by means of a special tender offer if as a result of the acquisition the purchaser would become a holder of 25% or more of the voting rights in the company. This requirement does not apply if there is already another holder of at least 25% of the voting rights in the company. Similarly, the Companies Law provides that an acquisition of shares in a public company must be made by means of a special tender offer if as a result of the acquisition the purchaser would become a holder of more than 45% of the voting rights in the company, if there is no other shareholder of the company who holds more than 45% of the voting rights in the company, subject to certain exceptions. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A special tender offer must be extended to all shareholders of a company but the offeror is not required to purchase shares representing more than 5% of the voting power attached to the company&#8217;s outstanding shares, regardless of how many shares are tendered by shareholders. A special tender offer may be consummated only if (i)&#160;at least 5% of the voting power attached to the company&#8217;s outstanding shares will be acquired by the offeror and (ii)&#160;the number of shares tendered by shareholders who accept the offer exceeds the number of shares whose holders objected to the offer (excluding the purchaser and its controlling shareholders, holders of 25% or more of the voting rights in the company or any person having a personal interest in the acceptance of the tender offer or any other person acting on their behalf, including relatives and entities under such person&#8217;s control). If a special tender offer is accepted, then the purchaser or any person or entity controlling it or under common control with the purchaser or such controlling person or entity may not make a subsequent tender offer for the purchase of shares of the target company and may not enter into a merger with the target company for a period of one year from the date of the offer, unless the purchaser or such person or entity undertook to effect such an offer or merger in the initial special tender offer. Shares purchased in contradiction to the tender offer rules under the Companies Law, will have no rights and will become dormant shares.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">138<br></div></div></div>
<!--End Page 144-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 145-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_110-descrip_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Merger </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Companies Law permits merger transactions if approved by each party&#8217;s board of directors and, unless certain requirements described under the Companies Law are met, by a majority vote of each party&#8217;s shares, and, in the case of the target company, a majority vote of each class of its shares voted on the proposed merger at a shareholders meeting. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For purposes of the shareholder vote, unless a court rules otherwise, the merger will not be deemed approved if a majority of the votes of the shares represented at the shareholders meeting that are held by parties other than the other party to the merger, or by any person (or group of persons acting in concert) who holds (or hold, as the case may be) 25% or more of the voting rights or the right to appoint 25% or more of the directors of the other party, vote against the merger. If, however, the merger involves a merger with a company&#8217;s own controlling shareholder or if the controlling shareholder has a personal interest in the merger, then the merger is instead subject to the same special majority approval that governs all extraordinary transactions with controlling shareholders (as described under &#8220;Management&#8212;Fiduciary Duties and Approval of Specified Related Party Transactions and Compensation Under Israeli Law&#8212;Disclosure of Personal Interests of a Controlling Shareholder and Approval of Certain Transactions&#8221;). </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If the transaction would have been approved by the shareholders of a merging company but for the separate approval of each class or the exclusion of the votes of certain shareholders as provided above, a court may still approve the merger upon the request of holders of at least 25% of the voting rights of a company, if the court holds that the merger is fair and reasonable, taking into account the value to the parties to the merger and the consideration offered to the shareholders of the target company. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Upon the request of a creditor of either party to the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable concern that, as a result of the merger, the surviving company will be unable to satisfy the obligations of the merging entities, and may further give instructions to secure the rights of creditors. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, a merger may not be consummated unless at least 50 days have passed from the date on which a proposal for approval of the merger was filed by each party with the Israeli Registrar of Companies and at least 30 days have passed from the date on which the merger was approved by the shareholders of each party. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Israeli tax law treats some acquisitions, such as share for share exchanges between an Israeli company and a foreign company, less favorably than U.S. tax laws. For example, Israeli tax law may, under certain circumstances, subject a shareholder who exchanges his ordinary shares for shares in another corporation to taxation prior to the sale of the shares received in such share-for-share swap.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Anti-Takeover Measures Under Israeli Law </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Companies Law allows us to create and issue shares having rights different from those attached to our ordinary shares, including shares providing certain preferred rights with respect to voting, distributions or other matters and shares having preemptive rights. As of the closing of this offering, no preferred shares will be authorized under our amended and restated articles of association. In the future, if we do authorize, create and issue a specific class of preferred shares, such class of shares, depending on the specific rights that may be attached to it, may have the ability to frustrate or prevent a takeover or otherwise prevent our shareholders from realizing a potential premium over the market value of their ordinary shares. The authorization and designation of a class of preferred shares will require an amendment to our amended and restated articles of association, which requires the prior approval of the holders of a majority of the voting power attaching to our issued and outstanding shares at a general meeting. The convening of the meeting, the shareholders entitled to participate and the majority vote required to be obtained at such a meeting will be subject to the requirements set forth in the Companies Law as described above in &#8220;&#8212;Voting Rights.&#8221; </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Borrowing Powers </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to the Companies Law and our amended and restated articles of association, our board of directors may exercise all powers and take all actions that are not required under law or under our amended and restated articles of association to be exercised or taken by our shareholders, including the power to borrow money for company purposes. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">139<br></div></div></div>
<!--End Page 145-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 146-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_110-descrip_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Changes in Capital </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our amended and restated articles of association enable us to increase or reduce our share capital. Any such changes are subject to the provisions of the Companies Law and must be approved by a resolution duly adopted by our shareholders at a general meeting. In addition, transactions that have the effect of reducing capital, such as the declaration and payment of dividends in the absence of sufficient retained earnings or profits, require the approval of both our board of directors and an Israeli court. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Choice of Forum</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our amended and restated articles of association will provide that the federal district courts of the United States of America will, to the fullest extent permitted by law, be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. While there can be no assurance that U.S. federal or state courts or Israeli courts will follow the holding of the Delaware Supreme Court which recently found that such provisions are facially valid under Delaware law or determine that the Federal Forum Provision should be enforced in a particular case, application of the Federal Forum Provision means that suits brought by our shareholders to enforce any duty or liability created by the Securities Act must be brought in federal court and cannot be brought in state court. The Federal Forum Provision does not apply to suits brought to enforce any duty or liability created by the Exchange Act. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all claims brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Accordingly, actions by our shareholders to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder also must be brought in federal court. Our shareholders will not be deemed to have waived our compliance with the federal securities laws and the regulations promulgated thereunder. Any person or entity purchasing or otherwise acquiring or holding any interest in any of our securities shall be deemed to have notice of and consented to the Federal Forum Provision. This provision may limit a shareholder&#8217;s ability to bring a claim in a judicial forum of their choosing for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Establishment </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We were incorporated under the laws of the State of Israel on December&#160;20, 2018. We are registered with the Israeli Registrar of Companies in Jerusalem. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Transfer Agent and Registrar </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">The transfer agent and registrar for our ordinary shares is Continental Stock Transfer &amp; Trust Co. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Listing </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">We have applied to list our ordinary shares on The Nasdaq Global Market under the symbol &#8220;NNOX.&#8221; </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">140<br></div></div></div>
<!--End Page 146-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 147-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_110-descrip_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSE"><!--Anchor--></a>SHARES ELIGIBLE FOR FUTURE SALE</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Prior to this offering, no public market existed for our ordinary shares. Sales of substantial amounts of our ordinary shares following this offering, including shares issued upon the exercise of outstanding options or warrants, or the perception that these sales could occur, could adversely affect prevailing market prices of our ordinary shares and could impair our future ability to obtain capital, especially through an offering of equity securities. Assuming that the underwriters do not exercise their option to purchase additional ordinary shares in this offering, we will have an aggregate of 44,393,910 ordinary shares outstanding upon the closing of this offering. Of&#160;these shares, the ordinary shares sold in this offering will be freely tradable without restriction or further registration under the Securities Act, unless purchased by &#8220;affiliates&#8221; (as that term is defined under Rule 144 of the Securities Act (&#8220;Rule 144&#8221;)), who may sell only the volume of shares described below and whose sales would be subject to additional restrictions described below. </div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The remaining 33,207,899 ordinary shares will be held by our existing shareholders and will be deemed to be &#8220;restricted securities&#8221; (as that term is defined under Rule 144). Subject to certain contractual restrictions, including the lock-up agreements described below, restricted securities may only be sold in the public market pursuant to an effective registration statement under the Securities Act or pursuant to an exemption from registration such as under Rule 144 under the Securities Act. These rules are summarized below. </div> <div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Lock-up Agreements </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our officers, directors and a substantial majority of holders of our outstanding share capital and equity securities have signed lock-up agreements pursuant to which, subject to certain exceptions, such persons have agreed not to sell or otherwise dispose of ordinary shares or any securities convertible into or exchangeable for ordinary shares for a period of 180 days after the date of this prospectus without the prior written consent of Cantor Fitzgerald &amp; Co. Cantor Fitzgerald &amp; Co. may, at any time without prior notice, release all or any portion of the ordinary shares from the restrictions in any such agreement. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Rule 144 </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Shares Held for Six Months </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In general, under Rule 144 under the Securities Act, as currently in effect, and subject to the terms of any lock-up agreement, commencing 90 days following the closing of this offering, a person, including an affiliate, who has beneficially owned our ordinary shares for six months or more, including the holding period of any prior owner other than one of our affiliates (i.e., commencing when the shares were acquired from us or from an affiliate of us as restricted securities), is entitled to sell our shares, subject to the availability of current public information about us (which information will be deemed to be available as long as we continue to file required reports with the SEC). In the case of an affiliate shareholder, the right to sell is also subject to the fulfillment of certain additional conditions, including manner of sale provisions, notice requirements, and a volume limitation that limits the number of shares that may be sold thereby, within any three-month period, to the greater of:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">1% of the number of ordinary shares then outstanding; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the greater of 1% or the average weekly trading volume of our ordinary shares on the Nasdaq during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Rule 144 under the Securities Act also provides that affiliates that sell our ordinary shares that are not restricted securities must nonetheless comply with the same restrictions applicable to restricted securities, other than the holding period requirement. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Shares Held by Non-Affiliates for One Year </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under Rule 144 as currently in effect, a person who is not considered to have been one of our affiliates at any time during the three months preceding a sale and who has beneficially owned the shares proposed to be sold for at least one year, including the holding period of any prior owner other than one of our affiliates, is entitled to sell his, her or its shares under Rule 144 without complying with the provisions relating to the availability of current public information or with any other conditions under Rule 144. Therefore, unless subject to a lock-up agreement or otherwise restricted, such shares may be sold immediately upon the closing of this offering. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">141<br></div></div></div>
<!--End Page 147-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 148-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_110-descrip_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Rule 701 </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In general, under Rule 701 as currently in effect, each of our employees, consultants or advisors who purchases our ordinary shares from us in connection with a compensatory stock plan or other written agreement executed prior to the closing of this offering is eligible to resell such ordinary shares in reliance on Rule 144, but without compliance with some of the restrictions, as described below. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Rule 701 will apply to the options granted under our 2019 Equity Incentive Plan prior to the closing of this offering, along with the shares acquired upon exercise of these options, including exercises or vesting following the closing of this offering. Securities issued in reliance on Rule 701 are restricted securities and, subject to any contractual restrictions, including the lock-up agreements described above, may be sold beginning 90 days following the closing of this offering in reliance on Rule 144 by:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons other than affiliates, without restriction; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">affiliates, subject to the manner-of-sale, current public information and filing requirements of Rule 144, in each case, without compliance with the six-month holding period requirement of Rule 144.</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Form S-8 Registration Statements </div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Following the closing of this offering, we intend to file one or more registration statements on Form S-8 under the Securities Act to register, in the aggregate, 4,359,604 ordinary shares that are issuable under our 2019 Equity Incentive Plan. The registration statement on Form S-8 will become effective automatically upon filing. Ordinary shares issued upon exercise of a share option or other award and registered pursuant to the Form&#160;S-8 registration statement will, subject to vesting provisions and Rule 144 volume limitations applicable to our affiliates, be available for sale in the open market immediately unless they are subject to the 180-day lock-up. </div> <div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Registration Rights</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Prior to the closing of this offering, we intend to enter into the Registration Rights Agreement that will entitle holders of approximately 11,186,011 of our ordinary shares to certain piggyback registration rights following the closing of this offering. In addition, holders of warrants to purchase an aggregate of 2,438,725 ordinary shares, 85,256 of which are assumed to be exercised prior to the closing of this offering, are entitled to piggyback registration rights under the terms of such warrants substantially similar to the registration rights provided in the Registration Rights Agreement. See &#8220;Description of Share Capital&#8212;Registration Rights.&#8221;</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">142<br></div></div></div>
<!--End Page 148-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 149-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_111-material_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tMT"><!--Anchor--></a>MATERIAL TAX CONSIDERATIONS </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following description is not intended to constitute a complete analysis of all tax considerations relating to the acquisition, ownership and disposition of our ordinary shares. You should consult your own tax advisor concerning the tax considerations of your particular situation, as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing jurisdiction. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Israeli Tax Considerations and Government Programs</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following is a summary of the material Israeli tax laws applicable to us, and some Israeli Government programs benefiting us. This section also contains a discussion of some Israeli tax consequences to persons owning our ordinary shares. This summary does not discuss all the aspects of Israeli tax law that may be relevant to a particular investor in light of his or her personal investment circumstances or to some types of investors subject to special treatment under Israeli law. Examples of this kind of investor include traders in securities or persons that own, directly or indirectly, 10% or more of our outstanding voting capital, all of whom are subject to special tax regimes not covered in this discussion. Some parts of this discussion are based on tax legislation which has not been subject to judicial or administrative interpretation. The discussion should not be construed as legal or professional tax advice and does not cover all possible tax considerations. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">YOU ARE URGED TO CONSULT YOUR OWN TAX ADVISORS AS TO THE ISRAELI OR OTHER TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR ORDINARY SHARES, INCLUDING, IN PARTICULAR, THE EFFECT OF ANY FOREIGN, STATE OR LOCAL TAXES. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">General Corporate Tax Structure in Israel </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Israeli resident companies are generally subject to corporate tax, currently at the rate of 23% of a company&#8217;s taxable income. However, the effective tax rate payable by a company that derives income from a Benefited Enterprise, a Preferred Enterprise, or a Preferred Technological Enterprise (as discussed below) may be considerably less. Capital gains derived by an Israeli resident company are subject to tax at the regular corporate tax rate. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under Israeli tax legislation, a corporation will be considered as an &#8220;Israeli resident company&#8221; if it meets one of the following: (i) it was incorporated in Israel; or (ii) the control and management of its business are exercised in Israel. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Law for the Encouragement of Industry (Taxes), 5729-1969 </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Law for the Encouragement of Industry (Taxes), 5729-1969, generally referred to as the Industry Encouragement Law, provides several tax benefits for &#8220;Industrial Companies.&#8221; </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Industry Encouragement Law defines an &#8220;Industrial Company&#8221; as a company resident in Israel and which was incorporated in Israel, of which 90% or more of its income in any tax year, other than income from defense loans, is derived from an &#8220;Industrial Enterprise&#8221; owned by it and located in Israel or in the &#8220;Area,&#8221; as such terms are defined in the Israeli Income Tax Ordinance (New Version) 1961, or the Ordinance. An &#8220;Industrial Enterprise&#8221; is defined as an enterprise which is held by an Industrial Company whose principal activity in a given tax year is industrial production. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">The following corporate tax benefits, among others, are available to Industrial Companies: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Amortization over an eight-year period of the cost of purchased know-how and patents and rights to use a patent and know-how which are used for the development or advancement of the Industrial Enterprise, commencing from the tax year where the Industrial Enterprise began to use them.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Under limited conditions, an election to file consolidated tax returns with related Israeli Industrial Companies; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Expenses related to a public offering are deductible in equal amounts from income attributed to the Industrial Enterprise over three years commencing in the year of the offering. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Although, as of the date of this prospectus, we do not have industrial production activities, we may qualify as an Industrial Company in the future and may be eligible for the benefits described above. However, we cannot assure that we will qualify as an Industrial Company or that the benefits described above will be available to us.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">143<br></div></div></div>
<!--End Page 149-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 150-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_111-material_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Tax Benefits and Grants for Research and Development </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Israeli tax law allows, under certain conditions, a tax deduction for expenditures related to scientific research and development projects, including capital expenditures, for the year in which they are incurred. Expenditures are deemed related to scientific research and development projects, if:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The expenditures are approved by the relevant Israeli government ministry, determined by the field of research; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The research and development is for the promotion of the company and is carried out by or on behalf of the company seeking such tax deduction. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The amount of such deductible expenses is reduced by the sum of any funds received through government grants for the financing of such scientific research and development projects. No deduction under these research and development deduction rules is allowed if such deduction is related to an expense invested in an asset depreciable under the general depreciation rules of the Ordinance. Expenditures not so approved are deductible in equal amounts over three years. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From time to time, we may apply to the Israeli Innovation Authority, or the IIA, for approval to allow a tax deduction for research and development expenses during the year incurred. There can be no assurance that such application will be accepted. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Law for the Encouragement of Capital Investments, 5719-1959 </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Law for the Encouragement of Capital Investments, 5719-1959 (the &#8220;Investment Law&#8221;), provides certain incentives for capital investments in production facilities (or other eligible assets) by &#8220;Industrial Enterprises&#8221; (as defined under the Investment Law). The benefits available under the Investment Law are subject to the fulfillment of conditions stipulated therein. If a company does not meet these conditions, it may be required to refund the amount of tax benefits, as adjusted by the Israeli consumer price index, and interest, or other monetary penalties.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Tax Benefits Subsequent to the 2005 Amendment </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">An amendment to the Investment Law, which became effective as of April 1, 2005, or the 2005 Amendment, changed certain provisions of the Investment Law. An eligible investment program under the 2005 Amendment qualifies for benefits as a &#8220;Benefited Enterprise.&#8221; Prior to the 2005 Amendment, investment programs under the Investment Law were called &#8220;Approved Enterprises.&#8221; The extent of the tax benefits available under the 2005 Amendment to qualifying income of a Benefited Enterprise depend on, among other things, the geographic location of the Benefited Enterprise in Israel. The location will also determine the period for which tax benefits are available. Such tax benefits include an exemption from corporate tax on undistributed income for a period of between two to ten years, depending on the geographic location of the Benefited Enterprise in Israel, and a reduced corporate tax rate of between 10% and the applicable corporate tax rate for the remainder of the benefits period, depending on the level of foreign investment in the company in each year during the benefits period. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">We are not entitled to tax benefits under the 2005 Amendment.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Tax Benefits Under the 2011 Amendment </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Investment Law was significantly amended as of January 1, 2011, or the 2011 Amendment. The 2011 Amendment introduced new benefits to replace those granted in accordance with the provisions of the Investment Law in effect prior to the 2011 Amendment. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The 2011 Amendment introduced new tax benefits for income generated by a &#8220;Preferred Company&#8221; through its &#8220;Preferred Enterprise,&#8221; in accordance with the definition of such terms in the Investment Law. The definition of a Preferred Company, includes, <font style="font-style: italic;">inter alia</font>, a company incorporated in Israel that (1) is not wholly owned by a government entity, (2) owns a Preferred Enterprise and (3) is controlled and managed from Israel and is subject to further conditions set forth in the Investment Law. Moreover, a Preferred Company needs to meet certain conditions stipulated in the Investment Law such as being an industrial company (including a minimum threshold of 25% export). </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">144<br></div></div></div>
<!--End Page 150-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 151-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_111-material_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A Preferred Company is entitled to a reduced corporate tax rate of 16% with respect to the income attributed to its Preferred Enterprise, unless the Preferred Enterprise is located in development area &#8220;A,&#8221; in which case the rate will be 7.5%. Our operations are currently not located in development area &#8220;A.&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Dividends distributed from income which is attributed to a &#8220;Preferred Enterprise&#8221; will be subject to withholding tax at the following rates: (i) Israeli resident individuals &#8212; 20% (iii) non-Israeli residents &#8212; 20%, subject to a reduced tax rate under the provisions of an applicable double tax treaty and subject to the receipt in advance of valid certificate from the Israeli Tax Authority, or the ITA. If such dividends are paid to an Israeli company, no tax is required to be withheld. However, if such dividends are subsequently distributed by such Israeli company to individuals or a non-Israeli company, withholding tax at a rate of 20% or such lower rate as may be provided in an applicable tax treaty will apply.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The provisions of the 2011 Amendment do not apply to existing &#8220;Benefited Enterprises&#8221; or &#8220;Approved Enterprises,&#8221; which will continue to be entitled to the tax benefits under the Investment Law, as in effect prior to the 2011 Amendment, unless the company owning such enterprises had made an election to apply the provisions of the 2011 Amendment (such election cannot be later rescinded), which is to be filed with the ITA, not later than the date prescribed for the filing of the company&#8217;s annual Israeli tax return for the respective year.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">We are currently not entitled to tax benefits under the 2011 Amendment.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Tax Benefits Under the 2017 Amendment</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Additional amendments to the Investment Law became effective in January 2017, or the 2017 Amendment. The 2017 Amendment provides new tax benefits for two types of &#8220;Technological Enterprises,&#8221; as described below, and is in addition to the other existing tax benefit programs under the Investment Law.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The 2017 Amendment provides that a technological company satisfying certain conditions may qualify as a &#8220;Preferred Technological Enterprise&#8221; and thereby enjoy a reduced corporate tax rate of 12% on income that qualifies as &#8220;Preferred Technological Income,&#8221; as defined in the Investment Law. The tax rate is further reduced to 7.5% for a Preferred Technological Enterprise located in development area &#8220;A.&#8221; In addition, a Preferred Technological Company will enjoy a reduced corporate tax rate of 12% on capital gain derived from the sale of certain &#8220;Benefited Intangible Assets&#8221; (as defined in the Investment Law) to a related foreign company if the Benefited Intangible Assets were acquired from a foreign company on or after January 1, 2017, for at least NIS 200 million, and the sale receives prior approval from the IIA. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The 2017 Amendment further provides that a technological company satisfying certain conditions may qualify as a &#8220;Special Preferred Technological Enterprise&#8221; and thereby enjoy a reduced corporate tax rate of 6% on &#8220;Preferred Technological Income&#8221; regardless of the company&#8217;s geographic location within Israel. In addition, a Special Preferred Technological Enterprise will enjoy a reduced corporate tax rate of 6% on capital gain derived from the sale of certain &#8220;Benefited Intangible Assets&#8221; to a related foreign company if the Benefited Intangible Assets were either developed by an Israeli company or acquired from a foreign company on or after January 1, 2017, and the sale received prior approval from the IIA. A Special Preferred Technological Enterprise that acquires Benefited Intangible Assets from a foreign company for more than NIS 500 million may be eligible for these benefits for a period of at least ten years, subject to certain approvals as specified in the Investment Law.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Dividends distributed by a Preferred Technological Enterprise or a Special Preferred Technological Enterprise, paid out of Preferred Technological Income or income attributed to production are generally subject to withholding tax at the rate of 20% or such lower rate, as may be provided in an applicable tax treaty (subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate). However, if such dividends are paid to an Israeli company, no tax is required to be withheld. However, if such dividends are subsequently distributed by such Israeli company to individuals or a non-Israeli company, withholding tax at a rate of 20% or such lower rate as may be provided in an applicable tax treaty will apply. If dividends paid out of Preferred Technological Income are distributed to a foreign company and other conditions are met, the withholding tax rate will be 4% (or a lower rate under a tax treaty, if applicable, subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate).</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">We are currently not entitled to tax benefits under the 2017 Amendment.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">145<br></div></div></div>
<!--End Page 151-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 152-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_111-material_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Taxation of Our Shareholders </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Capital Gains </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Capital gain tax is imposed on the disposition of capital assets by an Israeli resident for tax purposes, and on the disposition of such assets by a non-Israeli resident for tax purposes if those assets are (i) located in Israel; (ii) are shares or a right to a share in an Israeli resident corporation, or (iii) represent, directly or indirectly, rights to assets located in Israel. The Ordinance distinguishes between &#8220;Real Capital Gain&#8221; and the &#8220;Inflationary Surplus.&#8221; Real Capital Gain is the excess of the total capital gain over Inflationary Surplus computed generally on the basis of the increase in the Israeli consumer price index or, in certain circumstances, a foreign currency exchange rate, between the date of purchase and the date of disposition. Inflationary Surplus is not currently subject to tax in Israel. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Real Capital Gain accrued by individuals on the sale of our ordinary shares will be taxed at the rate of 25%. However, if the individual shareholder is a &#8220;Controlling Shareholder&#8221; (i.e., a person who holds, directly or indirectly, alone or together with another, 10% or more of one of the Israeli resident company&#8217;s &#8220;means of control,&#8221; which includes, among other things, the right to receive profits of the company, voting rights, the rights to receive proceeds upon the company&#8217;s liquidation and the right to appoint a director) at the time of sale or at any time during the preceding 12-month period, such capital gain will be taxed at the rate of 30%. Furthermore, where an individual claimed real interest expenses and linkage differentials on securities, the capital gain on the sale of the securities will taxed at a rate of 30%.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Real Capital Gain derived by corporations will be generally subject to the corporate tax rate (23% in 2018 and thereafter). </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Individual and corporate shareholder dealing in securities in Israel are taxed at the tax rates applicable to business income &#8212; 23% for corporations in 2018 and thereafter and a marginal tax rate of up to 47% in 2019 for individuals, not including excess tax (described below). Notwithstanding the foregoing, Real Capital Gain derived from the sale of our ordinary shares by a non-Israeli shareholder may be exempt under the Ordinance from Israeli taxation provided that the following cumulative conditions are met: (i) the shares were purchased upon or after the registration of the shares on the stock exchange, (ii) the seller does not have a permanent establishment in Israel to which the derived capital gain is attributable, (iii) if the seller is a corporation, no more than 25% of its means of control are held, directly and indirectly, by Israeli residents, and (iv) if the seller is a corporation, there is no Israeli resident that is entitled to 25% or more of the revenues or profits of the corporation, directly or indirectly. In addition, such exemption would not be available to a person whose capital gains from selling or otherwise disposing of the securities are deemed to be business income. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, the sale of shares may be exempt from Israeli capital gain tax under the provisions of an applicable tax treaty. For example, the Convention between the Government of the United States and the Government of the State of Israel with respect to Taxes of Income, as amended, or the U.S.-Israel Double Tax Treaty, exempts U.S. residents for the purposes of the treaty from Israeli capital gain tax in connection with such sale, provided (i) the U.S. resident owned, directly or indirectly, less than 10% of the Israeli resident company&#8217;s voting power at any time within the 12-month period preceding such sale; (ii) the seller, being an individual, is present in Israel for a period or periods of less than 183 days during the taxable year; and (iii) the capital gain from the sale was not derived through a permanent establishment of the U.S. resident in Israel. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Shareholders may be liable for Israeli tax on the sale of their ordinary shares and the payment of the consideration may be subject to withholding of Israeli tax. Shareholders may be required to demonstrate that they are exempt from tax on their capital gains in order to avoid withholding at the time of sale. For example, in transactions involving a sale of all of the shares of an Israeli resident company, in the form of a merger or otherwise, the ITA may require from shareholders who are not liable for Israeli tax to sign declarations in forms specified by this authority or obtain a specific exemption from the ITA to confirm their status as a non-Israeli resident, and, in the absence of such declarations or exemptions, may require the purchaser of the shares to withhold taxes.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The purchaser, the Israeli stockbrokers or financial institutions through which the shares are held is obligated, subject to the above mentioned exemptions, to withhold tax on the amount of consideration paid upon the sale of the shares (or on the Real Capital Gain on the sale, if known) at the rate of 25% in respect of an individual and 23% in respect of a corporation. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">146<br></div></div></div>
<!--End Page 152-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 153-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_111-material_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Upon the sale of securities traded on a stock exchange, a detailed return, including a computation of the tax due, must be filed and an advanced payment must be paid on January 31 and July 31 of every calendar year in respect of sales of securities made within the previous six months. However, if all tax due was withheld according to applicable provisions of the Ordinance and regulations promulgated thereunder the aforementioned return need not be filed and no advance payment must be paid. Capital gain is also reportable on the annual income tax return. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Dividends </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have never paid cash dividends. A distribution of dividend by our company from income attributed to a Preferred Enterprise to Israeli residents will generally be subject to withholding tax in Israel at the following tax rates: Israeli resident individuals &#8212; 20%; Israeli resident companies &#8212; 0% (although, if such dividends are subsequently distributed to individuals or a non-Israeli company, withholding tax at a rate of 20% or such lower rate as may be provided if an applicable tax treaty will apply (subject to the receipt in advance of a valid tax certificate from the ITA allowing for a reduced tax rate)). A distribution of dividends from income, which is not attributed to a Preferred Enterprise to an Israeli resident individual, will generally be subject to withholding tax at a rate of 25% or 30% if the dividend recipient is a &#8220;Controlling Shareholder&#8221; (as defined above) at the time of distribution or at any time during the preceding 12-month period. If the recipient of the dividend is an Israeli resident corporation, such dividend will be exempt from income tax provided the income from which such dividend is distributed was derived or accrued within Israel (although, if such dividends are subsequently distributed to individuals or a non-Israeli company, withholding tax at a rate of 25% or such lower rate as may be provided if an applicable tax treaty will apply (subject to the receipt in advance of a valid tax certificate from the ITA allowing for a reduced tax rate)). </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A non-Israeli resident (either individual or corporation) is generally subject to Israeli withholding tax on the receipt of dividends at the rate of 25% (30% if the dividends recipient is a &#8220;Controlling Shareholder&#8221; (as defined above), at the time of distribution or at any time during the preceding 12-month period); those rates are subject to a reduced tax rate under the provisions of an applicable double tax treaty (subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate). Under the U.S.-Israel Double Tax Treaty, the following withholding rates will apply in respect of dividends distributed by an Israeli resident company to a U.S. resident: (i) if the U.S. resident is a corporation which holds during that portion of the taxable year which precedes the date of payment of the dividend and during the whole of its prior taxable year (if any), at least 10% of the outstanding voting shares of the Israeli resident paying corporation and not more than 25% of the gross income of the Israeli resident paying corporation for such prior taxable year (if any) consists of certain type of interest or dividends &#8212; the tax rate is 12.5%, (ii) if both the conditions mentioned in (i) above are met and the dividend is paid from an Israeli resident company&#8217;s income which was entitled to a reduced tax rate applicable to an Approved Enterprise, Benefited Enterprise or Preferred Enterprise &#8212; the tax rate is 15% if a certificate for a reduced withholding tax rate would be provided in advance from the ITA and (iii) in all other cases, the tax rate is 25%. The aforementioned rates under the U.S.-Israel Double Tax Treaty will not apply if the dividend income was derived through a permanent establishment of the U.S. resident in Israel. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A non-Israeli resident who receives dividends from which tax was withheld is generally exempt from the obligation to file tax returns in Israel with respect to such income, provided that (i) such income was not generated from business conducted in Israel by the taxpayer and (ii) the taxpayer has no other taxable sources of income in Israel with respect to which a tax return is required to be filed.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Excess Tax </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Individuals who are subject to tax in Israel (whether such individual is an Israeli resident or non-Israeli resident) are also subject to an additional tax on annual income exceeding a certain threshold (NIS 651,600, for 2020), which amount is linked to the Israeli consumer price index, at a rate of 3%, including, but not limited to, income derived from dividends, interest and capital gains. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Foreign Exchange Regulations </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Non-residents of Israel who hold our ordinary shares are able to receive any dividends, and any amounts payable upon the dissolution, liquidation and winding up of our affairs, repayable in non-Israeli currency at the rate of exchange prevailing at the time of conversion. However, Israeli income tax is generally required to have been paid or withheld on these amounts. In addition, the statutory framework for the potential imposition of currency exchange control has not been eliminated, and may be restored at any time by administrative action. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">147<br></div></div></div>
<!--End Page 153-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 154-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_111-material_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Estate and Gift Tax </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">Israeli law presently does not impose estate or gift taxes. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">U.S. Federal Income Tax Considerations </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following discussion is a summary of U.S. federal income tax considerations generally applicable to the ownership and disposition of our ordinary shares by a U.S. Holder (as defined below) that acquires our ordinary shares in this offering and holds them as &#8220;capital assets&#8221; (generally, property held for investment) under the U.S.&#160;Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). This discussion is based upon existing U.S.&#160;federal tax law, which is subject to differing interpretations or change, possibly with retroactive effect. No ruling has been sought from the Internal Revenue Service, or the IRS, with respect to any U.S. federal income tax considerations described below, and there can be no assurance that the IRS or a court will not take a contrary position. This discussion, moreover, does not address the U.S. federal estate, gift, alternative minimum tax considerations, the Medicare tax on certain net investment income, any withholding or information reporting requirements, or any state, local and non-U.S. tax considerations relating to the ownership or disposition of our ordinary shares. The following summary does not address all aspects of U.S. federal income taxation that may be important to particular investors in light of their individual circumstances or to persons in special tax situations such as:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">banks and other financial institutions;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">insurance companies;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">pension plans;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">cooperatives;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulated investment companies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">real estate investment trusts; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">broker-dealers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">traders that elect to use a mark-to-market method of accounting; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">certain former U.S. citizens or long-term residents; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">tax-exempt entities (including private foundations); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">holders who acquire our ordinary shares pursuant to any employee share option or otherwise as compensation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">investors that will hold our ordinary shares as part of a straddle, hedge, conversion, constructive sale or other integrated transaction for U.S. federal income tax purposes; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons holding our ordinary shares in connection with a trade or business outside the United States; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons that actually or constructively own 10% or more of our stock (by vote or value); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">investors that have a functional currency other than the U.S. dollar; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">partnerships or other entities taxable as partnerships for U.S. federal income tax purposes, or persons holding our ordinary shares through such entities, all of whom may be subject to tax rules that differ significantly from those discussed below. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">INVESTORS ARE URGED TO CONSULT THEIR TAX ADVISORS ABOUT THE APPLICATION OF THE U.S. FEDERAL TAX RULES TO THEIR PARTICULAR CIRCUMSTANCES AS WELL AS THE STATE, LOCAL, NON-U.S. AND OTHER TAX CONSEQUENCES TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR ORDINARY SHARES. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">148<br></div></div></div>
<!--End Page 154-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 155-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_111-material_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">General </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For purposes of this discussion, a &#8220;U.S. Holder&#8221; is a beneficial owner of our ordinary shares that is, for U.S. federal income tax purposes:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an individual who is a citizen or resident of the United States; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created in, or organized under the law of, the United States or any state thereof or the District of Columbia;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a trust (A) the administration of which is subject to the primary supervision of a U.S. court and which has one or more U.S. persons who have the authority to control all substantial decisions of the trust or (B) that has otherwise validly elected to be treated as a U.S. person under the Code. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If a partnership (or other entity treated as a partnership for U.S. federal income tax purposes) is a beneficial owner of our ordinary shares, the tax treatment of a partner in the partnership will generally depend upon the status of the partner and the activities of the partnership. Partnerships holding our ordinary shares and their partners are urged to consult their tax advisors regarding an investment in our ordinary shares. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Passive Foreign Investment Company Considerations </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A non-U.S. corporation, such as our company, will be classified as a PFIC for U.S. federal income tax purposes for any taxable year, if either (i) 75% or more of its gross income for such year consists of certain types of passive income or (ii) 50% or more of the value of its assets (generally determined on the basis of a quarterly average) during such year is attributable to assets that produce or are held for the production of passive income. For this purpose, cash and assets readily convertible into cash are generally classified as passive assets and goodwill and other unbooked intangibles associated with active business activities may generally be classified as non-passive assets. Passive income generally includes, among other things, dividends, interest, royalties and rents (other than certain royalties and rents derived in the active conduct of a trade or business and not derived from a related person), and gains from the disposition of passive assets. We will be treated as owning a proportionate share of the assets and earning a proportionate share of the income of any other corporation in which we own, directly or indirectly, at least 25% (by value) of the stock.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Whether we are, or will be, classified as a PFIC is a factual determination made annually that will depend, in part, upon the composition of our income and assets. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Based upon our current and projected income and assets (including goodwill and taking into account our cash balances, including the anticipated proceeds from this offering) and the anticipated market price of the ordinary shares in this offering, it is likely that we will be classified as a PFIC for the current taxable and future taxable years at least until we start generating a substantial amount of active revenue. Accordingly, prospective investors should be willing to assume the risks of investing in a PFIC. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If we are classified as a PFIC for any year during which a U.S. Holder holds our ordinary shares, the PFIC&#160;rules discussed below under &#8220;&#8212;Passive Foreign Investment Company Rules&#8221; generally will apply to such U.S. Holder for such taxable year, and unless the U.S. Holder makes certain elections, will apply in future years even if we cease to be classified as a PFIC. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Because it is likely that we will be classified as a PFIC for the current and future taxable years, at least until we start generating a substantial amount of active revenue, U.S. Holders should not assume that any dividends will qualify for the lower tax rate described under &#8220;&#8212;Dividends&#8221; below. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Furthermore, because there are uncertainties in the application of the relevant rules, it is possible that the IRS may challenge our classification of certain income or assets as non-passive, or our valuation of our goodwill and other unbooked intangibles, each of which may increase the likelihood of us becoming classified as a PFIC for the current or subsequent taxable years. If we are classified as a PFIC for any taxable year during which a U.S. Holder holds our ordinary shares, we generally will continue to be treated as a PFIC with respect to such U.S. Holder for all succeeding years during which the holder holds our ordinary shares. However, if we cease to be classified as a PFIC, provided that the U.S. Holder has not made a mark-to-market election, as described below under &#8220;&#8212;Passive Foreign Investment Company Rules,&#8221; such holder may avoid some of the adverse </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">149<br></div></div></div>
<!--End Page 155-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 156-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_111-material_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">effects of the PFIC regime by making a &#8220;deemed sale&#8221; election with respect to the ordinary shares. If such election is made, the U.S. Holder will be deemed to have sold our ordinary shares it holds on the last day of the last taxable year in which we were classified as a PFIC at their fair market value and any gain from such deemed sale would be subject to the rules described below under &#8220;&#8212;Passive Foreign Investment Company Rules.&#8221; After the deemed sale election, so long as we do not become classified as a PFIC in a subsequent taxable year, the ordinary shares with respect to which such election was made will not be treated as shares in a PFIC and the U.S. Holder will not be subject to the rules described below under &#8220;&#8212;Passive Foreign Investment Company Rules&#8221; with respect to any &#8220;excess distribution&#8221; received from us or any gain from an actual sale or other disposition of the ordinary shares. The rules dealing with deemed sale elections are very complex. Investors are strongly urged to consult their tax advisors as to the possibility and consequences of making a deemed sale election if we cease to be classified as a PFIC and such election becomes available to holders of ordinary shares.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Dividends </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Subject to the discussion below under &#8220;&#8212;Passive Foreign Investment Company Rules,&#8221; any cash distributions (including the amount of any Israeli tax withheld) paid on our ordinary shares out of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles, will generally be includible in the gross income of a U.S. Holder as dividend income on the day actually or constructively received by the U.S.&#160;Holder. Because we do not intend to determine our earnings and profits on the basis of U.S. federal income tax principles, any distribution we pay will generally be treated as a &#8220;dividend&#8221; for U.S.&#160;federal income tax purposes. Dividends received on our ordinary shares will not be eligible for the dividends received deduction allowed to corporations in respect of dividends received from U.S. corporations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Individuals and other non-corporate U.S. Holders may be subject to tax at the lower capital gains tax rate applicable to &#8220;qualified dividend income,&#8221; provided that certain conditions are satisfied, including that (1) the ordinary shares on which the dividends are paid are readily tradable on an established securities market in the United States, or we are eligible for the benefit of the U.S.-Israel Double Tax Treaty, (2) we are neither classified as a PFIC nor treated as such with respect to a U.S. Holder (as discussed above and below) for the taxable year in which the dividend is paid or the preceding taxable year, and (3) certain holding period and other requirements are met. Our ordinary shares have been approved for listing on the Nasdaq Global Market. Provided this listing is approved, we believe that our ordinary shares will generally be considered to be readily tradable on an established securities market in the United States. There can be no assurance that the ordinary shares will continue to be considered readily tradable on an established securities market in later years. U.S.&#160;Holders are urged to consult their tax advisors regarding the availability of the lower rate for dividends paid with respect to our ordinary shares. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For U.S. foreign tax credit purposes, dividends paid on our ordinary shares generally will be treated as income from foreign sources and generally will constitute passive category income. A U.S. Holder may be subject to Israeli withholding taxes on dividends paid on our ordinary shares (see &#8220;Material Tax Considerations&#8212;Israeli Tax Considerations and Government Programs&#8212;Taxation of Our Shareholders&#8212;Dividends&#8221;). Depending on the U.S. Holder&#8217;s particular facts and circumstances and subject to a number of complex conditions and limitations, Israeli withholding taxes on dividends not in excess of any applicable rate under the U.S.-Israel Double Tax Treaty may be treated as foreign taxes eligible for credit against a U.S. Holder&#8217;s U.S. federal income tax liability. A U.S. Holder who does not elect to claim a foreign tax credit for foreign tax withheld may instead claim a deduction for U.S. federal income tax purposes in respect of such withholding, but only for a year in which such holder elects to do so for all creditable foreign income taxes. The rules governing the foreign tax credit are complex and each U.S. Holder is urged to consult its tax advisor regarding the availability of the foreign tax credit under its particular circumstances. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Sale or Other Disposition </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A U.S. Holder will generally recognize gain or loss upon the sale or other disposition of our ordinary shares in an amount equal to the difference between the amount realized upon the disposition and the U.S. Holder&#8217;s adjusted tax basis in such ordinary shares. Subject to the discussion under &#8220;&#8212;Passive Foreign Investment Company Rules,&#8221; the gain or loss will generally be capital gain or loss and individuals and other non-corporate U.S. Holders who have held the ordinary shares for more than one year will generally be eligible for reduced tax rates. However, as described above under &#8220;&#8212;Passive Foreign Investment Company Considerations,&#8221; it is likely that we will be classified as a PFIC for the current and future taxable years, at least until we start generating a </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">150<br></div></div></div>
<!--End Page 156-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 157-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_111-material_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">substantial amount of active revenue, in which case gains will be taxed as described in &#8220;&#8212;Passive Foreign Investment Company Rules.&#8221; The deductibility of a capital loss may be subject to limitations. Any such gain or loss that the U.S. Holder recognizes will generally be treated as U.S. source income or loss for foreign tax credit limitation purposes, such that the U.S. Holder may not be able to use the foreign tax credit arising from any Israeli tax imposed on the disposition of our ordinary shares unless such credit can be applied (subject to applicable limitations) against U.S. federal income tax due on other income derived from foreign sources in the same income category (generally, the passive category). Each U.S. Holder is urged to consult its tax advisor regarding the tax consequences if a foreign tax is imposed on a disposition of our ordinary shares, including the availability of the foreign tax credit under its particular circumstances. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Passive Foreign Investment Company Rules </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If we are classified as a PFIC for any taxable year during which a U.S. Holder holds our ordinary shares, unless the U.S. Holder makes a mark-to-market election (as described below), the U.S. Holder will generally be subject to special tax rules on (i)&#160;any excess distribution that we make to the U.S. Holder (which generally means any distribution paid during a taxable year to a U.S. Holder that is greater than 125% of the average annual distributions paid in the three preceding taxable years or, if shorter, the U.S. Holder&#8217;s holding period for the ordinary shares), and (ii)&#160;any gain realized on the sale or other disposition of our ordinary shares. Under the PFIC rules:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the excess distribution or gain will be allocated ratably over the U.S. Holder&#8217;s holding period for the ordinary shares; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the amount allocated to the taxable year of the excess distribution, sale or other disposition and to any taxable years in the U.S. Holder&#8217;s holding period prior to the first taxable year in which we are classified as a PFIC (each, a &#8220;pre-PFIC year&#8221;), will be taxable as ordinary income; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the amount allocated to each prior taxable year, other than a pre-PFIC year, will be subject to tax at the highest tax rate in effect for individuals or corporations, as appropriate, for that year; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the interest charge generally applicable to underpayments of tax will be imposed on the tax attributable to each prior taxable year, other than a pre-PFIC year. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If we are classified as a PFIC for any year during which a U.S. Holder holds our ordinary shares, we will generally continue to be treated as a PFIC with respect to the U.S. Holder for all succeeding years during which the U.S. Holder owns the ordinary shares even if we cease to meet the threshold requirements for PFIC status unless the U.S. Holder makes a &#8220;deemed sale&#8221; election as discussed above under &#8220;&#8212;Passive Foreign Investment Company Considerations&#8221; in which case any gain on the deemed sale will be taxed under the PFIC rules described above. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If we are classified as a PFIC for any taxable year during which a U.S. Holder holds our ordinary shares and any subsidiary we own is also classified as a PFIC, such U.S. Holder would be treated as owning a proportionate amount (by value) of the shares of the lower-tier PFIC for purposes of the application of these rules. As a result, such U.S. Holder may incur liability for the deferred tax and interest charge described above if either (1) we receive any excess distribution from, or dispose of all or part of our interest in, the lower-tier PFIC or (2) the U.S. Holder disposes of all or part of our ordinary shares. It is possible that any subsidiary we own would be a PFIC for the current taxable year or future taxable years. U.S. Holders are urged to consult their tax advisors regarding the application of the PFIC rules to any subsidiary we own. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As an alternative to the foregoing rules, a U.S. Holder of &#8220;marketable stock&#8221; (as defined below) in a PFIC may make a mark-to-market election with respect to such stock. If a U.S. Holder makes this election with respect to our ordinary shares, the holder will generally (i)&#160;include as ordinary income for each taxable year that we are classified as a PFIC the excess, if any, of the fair market value of the ordinary shares held at the end of the taxable year over the adjusted tax basis of such ordinary shares and (ii)&#160;deduct as an ordinary loss in each such taxable year the excess, if any, of the adjusted tax basis of the ordinary shares over the fair market value of such ordinary shares held at the end of the taxable year, but such deduction will only be allowed to the extent of the amount previously included in income as a result of the mark-to-market election. The U.S. Holder&#8217;s adjusted tax basis in the ordinary shares would be adjusted to reflect any income or loss resulting from the mark-to-market election. If a U.S. Holder makes a mark-to-market election in respect of our ordinary shares and we cease to be classified as a PFIC, the holder will not be required to take into account the gain or loss described above during </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">151<br></div></div></div>
<!--End Page 157-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 158-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_111-material_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">any period that we are not classified as a PFIC. If a U.S. Holder makes a mark-to-market election, any gain such U.S. Holder recognizes upon the sale or other disposition of our ordinary shares in a year when we are classified as a PFIC will be treated as ordinary income and any loss will be treated as ordinary loss, but such loss will only be treated as ordinary loss to the extent of the net amount previously included in income as a result of the mark-to-market election. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The mark-to-market election is available only for &#8220;marketable stock,&#8221; which is stock that is regularly traded on a qualified exchange or other market, as defined in applicable U.S. Treasury regulations. Our ordinary shares will be treated as traded on a qualified exchange or other market upon their listing on the Nasdaq Global Market. We anticipate that our ordinary shares should qualify as being regularly traded, but no assurances may be given in this regard. If any subsidiary we own is, or becomes, classified as a PFIC, the mark-to-market election will likely not be available with respect to the shares of such subsidiary that are treated as owned by a U.S. Holder. Consequently, a U.S. Holder could be subject to the PFIC rules with respect to income of a lower-tier PFIC the value of which had already been taken into account indirectly via mark-to-market adjustments. U.S. Holders are urged to consult their tax advisors as to the availability and desirability of a mark-to-market election, as well as the impact of such election on interests in any lower-tier PFIC. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We do not intend to provide information necessary for U.S. Holders to make qualified electing fund elections, which, if available, would result in tax treatment different from (and generally less adverse than) the general tax treatment for PFICs described above.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If a U.S. Holder owns our ordinary shares during any taxable year that we are classified as a PFIC, the holder must generally file an annual IRS Form 8621 regarding distributions received on, and any gain realized on the disposition of, our ordinary shares. U.S. Holders are urged to consult their tax advisor regarding our PFIC status and the U.S. federal income tax consequences of owning and disposing of our ordinary shares if we are, or become, classified as a PFIC, including the possibility of making a mark-to-market or deemed sale election. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">THE SUMMARY OF U.S. FEDERAL INCOME TAX CONSEQUENCES SET OUT ABOVE IS FOR GENERAL INFORMATIONAL PURPOSES ONLY. INVESTORS ARE URGED TO CONSULT THEIR TAX ADVISORS ABOUT THE APPLICATION OF THE U.S. FEDERAL TAX RULES TO THEIR PARTICULAR CIRCUMSTANCES AS WELL AS THE STATE, LOCAL, NON-U.S. AND OTHER TAX CONSEQUENCES TO THEM OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR ORDINARY SHARES. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">152<br></div></div></div>
<!--End Page 158-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 159-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_112-under_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tU"><!--Anchor--></a>UNDERWRITING</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We are offering the ordinary shares described in this prospectus through the underwriters. Cantor Fitzgerald &amp; Co. is acting as representative of the underwriters. We have entered into an underwriting agreement with the underwriters.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriters, and each underwriter has severally agreed to purchase, at the public offering price less the underwriting discounts and commissions set forth on the cover page of this prospectus, the number of ordinary shares listed next to its name in the following table:</div> <table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 5.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 82.05%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name </div></td><td class="gutter" style="width: 2.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 13.23%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of shares</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cantor Fitzgerald &amp; Co. <font style="padding-left: 3.48pt;"></font></div></td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 13.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Oppenheimer &amp; Co. Inc. <font style="padding-left: 1.54pt;"></font></div></td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 13.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Berenberg Capital Markets, LLC <font style="padding-left: 3.68pt;"></font></div></td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 13.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CIBC World Markets Corp.<font style="padding-left: 3.35pt;"></font></div></td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 13.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">National Securities Corporation<font style="padding-left: 2.65pt;"></font></div></td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 13.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 13.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.95pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">&#8199;&#8201;&#8199;&#8199;&#8199;&#8201;&#8199;&#8199;&#8199;</font></div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 1.09pt;"></font></div></td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 13.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.95pt; text-align: left;">8,823,530</div></td></tr></table> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The underwriters are committed to purchase all the ordinary shares offered by us if they purchase any shares. The underwriting agreement also provides that if an underwriter defaults, the purchase commitments of non-defaulting underwriters may also be increased or the offering may be terminated.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Certain of our existing investors and their affiliated entities, including Yozma, SKT, JJFIHC and iA, and certain other investors have indicated an interest in purchasing an aggregate of up to approximately $80 million of our ordinary shares in this offering at the initial public offering price. However, because indications of interest are not binding agreements or commitments to purchase, these entities may determine to purchase fewer shares than they indicate an interest in purchasing or to not purchase any shares in this offering. It is also possible that these entities could indicate an interest in purchasing more of our ordinary shares. In addition, the underwriters could determine to sell fewer shares to any of these entities than the entities indicate an interest in purchasing or to not sell any shares to these entities.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The underwriters propose to offer the ordinary shares directly to the public at the initial public offering price set forth on the cover page of this prospectus and to certain dealers at that price less a concession not in excess of $&#8195;&#8195;&#8195; per share. Any such dealers may resell shares to certain other brokers or dealers at a discount of up to $ &#8195;&#8195;per share from the initial public offering price. After the initial offering of the shares to the public, if all of the ordinary shares are not sold at the initial public offering price, the underwriters may change the offering price and the other selling terms. The offering of the shares by the underwriters is subject to receipt and acceptance and subject to the underwriters&#8217; right to reject any order in whole or in part. Sales of shares made outside of the United States may be made by affiliates of the underwriters.</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The underwriters have an option to buy up to 1,323,529 additional ordinary shares from us to cover sales of shares by the underwriters which exceed the number of shares specified in the table above. The underwriters have 30 days from the date of this prospectus to exercise this option to purchase additional shares. If any shares are purchased with this option to purchase additional shares, the underwriters will purchase shares in approximately the same proportion as shown in the table above. If any additional ordinary shares are purchased, the underwriters will offer the additional shares on the same terms as those on which the shares are being offered.</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The underwriting fee is equal to the public offering price per ordinary share less the amount paid by the underwriters to us per ordinary shares. The underwriting fee is $&#8195;&#8195;&#8195; per share. The following table shows the per share and total underwriting discounts and commissions to be paid to the underwriters assuming both no exercise and full exercise of the underwriters&#8217; option to purchase additional shares.</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.32%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.32%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 14.59%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Without option to <br>purchase additional <br>shares exercise</div></td><td class="gutter" style="width: 2.32%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 2.32%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 14.59%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">With full option to <br>purchase additional <br>shares exercise</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Per Share<font style="padding-left: 1.08pt;"></font></div></td><td class="gutter" style="width: 2.32%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.32%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 14.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.65pt; text-align: left;">$&#8195;&#8195;&#8195;&#8195;&#8195;</div></td><td class="gutter" style="width: 2.32%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.32%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 14.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.65pt; text-align: left;">$&#8195;&#8195;&#8195;&#8195;&#8195;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 0.09pt;"></font></div></td><td class="gutter" style="width: 2.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 2.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 14.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.65pt; text-align: left;">$</div></td><td class="gutter" style="width: 2.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 2.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 14.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.65pt; text-align: left;">$</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">153<br></div></div></div>
<!--End Page 159-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 160-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_112-under_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We estimate that the total expenses of this offering, including registration, filing and listing fees, printing fees, legal and accounting expenses and the fees payable to A-Labs, but excluding the estimated underwriting discounts and commissions, will be approximately $6,873,808. We have also agreed to reimburse the underwriters for certain of their expenses in an amount up to $150,000.</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The expenses set forth above include fees of approximately $600,000 payable by us to Israeli broker-dealer Rosario Underwriting Services (A.S.) Ltd. (&#8220;Rosario&#8221;) for services they are providing to us in connection with this offering, including identifying potential investors in Israel. Rosario is not a U.S. registered broker-dealer. All sales of our ordinary shares in the United States will be made by U.S. registered broker-dealers.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">A prospectus in electronic format may be made available on the web sites maintained by one or more underwriters, or selling group members, if any, participating in the offering. The underwriters may agree to allocate a number of shares to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the representatives to underwriters and selling group members that may make internet distributions on the same basis as other allocations.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our officers, directors and a substantial majority of holders of our outstanding share capital and equity securities have agreed, subject to specified exceptions, not to directly or indirectly:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any of our ordinary shares or any securities convertible into or exercisable or exchangeable for our ordinary shares (including, without limitation, ordinary shares or such other securities which may be deemed to be beneficially owned by the such persons in accordance with the rules and regulations of the SEC and securities which may be issued upon exercise of a share option or warrant); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">enter into any hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership of our ordinary shares or such other securities; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">make any demand for or exercise any right with respect to the registration of any of our ordinary shares or any security convertible into or exercisable or exchangeable for our ordinary shares, or publicly disclose the intention to do any of the foregoing.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">This restriction terminates after the close of business on and including the 180th day after the date of this prospectus. Cantor Fitzgerald &amp; Co. may, in its sole discretion and at any time or from time to time before the termination of the 180-day period, release all or any portion of the securities subject to lock-up agreements. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, we have agreed, for the 180 days after the date of this prospectus and subject to specified exceptions, not to:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the SEC a registration statement under the Securities Act relating to, any of our ordinary shares or any securities convertible into or exercisable or exchangeable for our ordinary shares, or publicly disclose the intention to undertake any of the foregoing; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of our ordinary shares or any such other securities, without the prior written consent of Cantor Fitzgerald &amp; Co.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have also agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act, or contribute to payments the underwriters may be required to make in respect of these liabilities.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have applied to have our ordinary shares approved for listing on The Nasdaq Global Market under the symbol &#8220;NNOX.&#8221;</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In connection with this offering, the underwriters may engage in stabilizing transactions, which involves making bids for, purchasing and selling ordinary shares in the open market for the purpose of preventing or retarding a decline in the market price of the ordinary shares while this offering is in progress. These stabilizing transactions may include making short sales of the ordinary shares, which involves the sale by the underwriters </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">154<br></div></div></div>
<!--End Page 160-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 161-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_112-under_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">of a greater number of ordinary shares than they are required to purchase in this offering, and purchasing ordinary shares on the open market to cover positions created by short sales. Short sales may be &#8220;covered&#8221; shorts, which are short positions in an amount not greater than the underwriters&#8217; option to purchase additional shares referred to above, or may be &#8220;naked&#8221; shorts, which are short positions in excess of that amount. The underwriters may close out any covered short position either by exercising their option to purchase additional shares, in whole or in part, or by purchasing shares in the open market. In making this determination, the underwriters will consider, among other things, the price of shares available for purchase in the open market compared to the price at which the underwriters may purchase shares through the option to purchase additional shares. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the ordinary shares in the open market that could adversely affect investors who purchase in this offering. To the extent that the underwriters create a naked short position, they will purchase shares in the open market to cover the position.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The underwriters have advised us that, pursuant to Regulation M of the Securities Act, they may also engage in other activities that stabilize, maintain or otherwise affect the price of the ordinary shares, including the imposition of penalty bids. This means that if the representatives of the underwriters purchase ordinary shares in the open market in stabilizing transactions or to cover short sales, the representatives can require the underwriters that sold those shares as part of this offering to repay the underwriting discount received by them.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">These activities may have the effect of raising or maintaining the market price of the ordinary shares or preventing or retarding a decline in the market price of the ordinary shares, and, as a result, the price of the ordinary shares may be higher than the price that otherwise might exist in the open market. If the underwriters commence these activities, they may discontinue them at any time. The underwriters may carry out these transactions on The Nasdaq Global Market, in the over-the-counter market or otherwise.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Prior to this offering, there has been no public market for our ordinary shares. The initial public offering price will be determined by negotiations between us and the representative of the underwriters. In determining the initial public offering price, we and the representative of the underwriters expect to consider a number of factors, including:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the information set forth in this prospectus and otherwise available to the representative;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our prospects and the history and prospects for the industry in which we compete;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an assessment of our management;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our prospects for future earnings;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the general condition of the securities markets at the time of this offering;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the recent market prices of, and demand for, publicly traded equity securities of generally comparable companies; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">other factors deemed relevant by the underwriters and us.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Neither we nor the underwriters can assure investors that an active trading market will develop for our ordinary shares, or that our ordinary shares will trade in the public market at or above the initial public offering price.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Other Relationships</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Certain of the underwriters and their affiliates have provided in the past to us and our affiliates and may provide from time to time in the future certain commercial banking, financial advisory, investment banking and other services for us and such affiliates in the ordinary course of their business, for which they have received and may continue to receive customary fees and commissions. In addition, from time to time, certain of the underwriters and their affiliates may effect transactions for their own account or the account of customers, and actively trade or hold on behalf of themselves or their customers, long or short positions in our debt or equity securities (or relative derivatives or other financial instruments) or loans, and may do so in the future. The underwriters and their affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long or short positions in such securities or instruments.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">155<br></div></div></div>
<!--End Page 161-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 162-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_112-under_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Selling Restrictions</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Other than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Notice to prospective investors in Israel</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">This document does not constitute a prospectus under the Israeli Securities Law, 5728-1968, or the Securities Law, and has not been filed with or approved by the Israel Securities Authority. In the State of Israel, this document is being distributed only to, and is directed only at, and any offer of the securities offered hereby is directed only at, (i)&#160;a limited number of persons in accordance with the Securities Law and (ii)&#160;investors listed in the first addendum (the &#8220;Addendum&#8221;), to the Israeli Securities Law, consisting primarily of joint investment in trust funds, provident funds, insurance companies, banks, portfolio managers, investment advisors, members of the Tel Aviv Stock Exchange, underwriters, venture capital funds, entities with equity in excess of NIS 50&#160;million and &#8220;qualified individuals,&#8221; each as defined in the Addendum (as it may be amended from time to time), collectively referred to as qualified investors (in each case purchasing for their own account or, where permitted under the Addendum, for the accounts of their clients who are investors listed in the Addendum). Qualified investors will be required to submit written confirmation that they fall within the scope of the Addendum, are aware of the meaning of same and agree to it.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Notice to prospective investors in the European Economic Area and the United Kingdom</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In relation to each Member State of the European Economic Area and the United Kingdom (each a &#8220;Relevant State&#8221;), no ordinary shares have been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the ordinary shares which has been approved by the competent authority in that Relevant State or, where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that offers of ordinary shares may be made to the public in that Relevant State at any time under the following exemptions under the Prospectus Regulation:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to any legal entity which is a qualified investor as defined under the Prospectus Regulation;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior consent of the underwriters for any such offer; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">in any other circumstances falling within Article&#160;1(4) of the Prospectus Regulation,</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">provided that no such offer of ordinary shares shall require the Issuer or any Manager to publish a prospectus pursuant to Article&#160;3 of the Prospectus Regulation or supplement a prospectus pursuant to Article&#160;23 of the Prospectus Regulation.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to any ordinary shares in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any ordinary shares to be offered so as to enable an investor to decide to purchase or subscribe for any ordinary shares, and the expression &#8220;Prospectus Regulation&#8221; means Regulation (EU) 2017/1129.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Notice to prospective investors in the United Kingdom</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, and any offer subsequently made may only be directed at, persons who are &#8220;qualified investors&#8221; (as defined in the Prospectus Directive) (1) who have professional experience in matters relating to investments falling within </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">156<br></div></div></div>
<!--End Page 162-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 163-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_112-under_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended, or the Order, and/or (2) who are high net worth companies (or persons to whom it may otherwise be lawfully communicated) falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as relevant persons) or otherwise in circumstances which have not resulted and will not result in an offer to the public of the shares in the United Kingdom within the meaning of the Financial Services and Markets Act 2000.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Any person in the United Kingdom that is not a relevant person should not act or rely on the information included in this document or use it as basis for taking any action. In the United Kingdom, any investment or investment activity that this document relates to may be made or taken exclusively by relevant persons.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Notice to prospective investors in Canada</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s province or territory for particulars of these rights or consult with a legal advisor.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts, or NI 33-105, the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Notice to prospective investors in Japan</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The shares have not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial Instruments and Exchange Act. Accordingly, none of the shares nor any interest therein may be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any &#8220;resident&#8221; of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organized under the laws of Japan), or to others for re-offering or resale, directly or indirectly, in Japan or to or for the benefit of a resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and Exchange Act and any other applicable laws, regulations and ministerial guidelines of Japan in effect at the relevant time.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Notice to prospective investors in Hong Kong</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The shares have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than (1) to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance (Cap.&#160;571) of Hong Kong and any rules made under that Ordinance or (2) in other circumstances which do not result in the document being a &#8220;prospectus&#8221; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) of Hong Kong or which do not constitute an offer to the public within the meaning of that Ordinance. No advertisement, invitation or document relating to the shares has been or may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance and any rules made under that Ordinance.</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Notice to prospective investors in Singapore</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of shares may not be circulated or distributed, nor may the shares be </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">157<br></div></div></div>
<!--End Page 163-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 164-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_112-under_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (1) to an institutional investor under Section 274 of the Securities and Futures Act, Chapter 289 of Singapore, or the SFA, (2) to a relevant person pursuant to Section 275(1), or any person pursuant to Section 275(1A), and in accordance with the conditions specified in Section 275 of the SFA, or (3) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. Where the shares are subscribed or purchased under Section 275 of the SFA by a relevant person which is:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, securities (as defined in Section 239(1) of the SFA) of that corporation or the beneficiaries&#8217; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the shares pursuant to an offer made under Section 275 of the SFA except:</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">to an institutional investor or to a relevant person defined in Section 275(2) of the SFA, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(i)(B) of the SFA;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">where no consideration is or will be given for the transfer;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">where the transfer is by operation of law;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">as specified in Section 276(7) of the SFA; or</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(e)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures) Regulations 2005 of Singapore.</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Solely for the purposes of its obligations pursuant to Section 309B of the SFA, we have determined, and hereby notify all relevant persons (as defined in the CMP Regulations 2018), that the shares are &#8220;prescribed capital markets products&#8221; (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment Products).</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">158<br></div></div></div>
<!--End Page 164-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 165-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_112-under_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tER"><!--Anchor--></a>EXPENSES RELATED TO OFFERING</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table sets forth the costs and expenses, including the fees payable to A-Labs, other than underwriting discounts and commissions, payable by us in connection with the offer and sale of ordinary shares in this offering. All amounts listed below are estimates except the SEC registration fee, Nasdaq listing fee and the FINRA filing fee. </div> <table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 82.05%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Itemized expense </div></td><td class="gutter" style="width: 4.17%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 4.17%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">SEC registration fee <font style="padding-left: 0.43pt;"></font></div></td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 12.5pt;">&#8203;</font>23,708</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">FINRA filing fee <font style="padding-left: 3.19pt;"></font></div></td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">27,897</font> </div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Nasdaq listing fee <font style="padding-left: 4.32pt;"></font></div></td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">235,000</font></div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Printing and engraving expenses <font style="padding-left: 0.44pt;"></font></div></td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">150,000</font></div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Legal fees and expenses <font style="padding-left: 3.78pt;"></font></div></td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">1,766,203</font></div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Transfer agent and registrar fees <font style="padding-left: 0.83pt;"></font></div></td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">5,000</font></div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accounting fees and expenses <font style="padding-left: 4.89pt;"></font></div></td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">316,000</font></div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fees payable to A-Labs<font style="padding-left: 4.87pt;"></font></div></td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">3,750,000</font></div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fees payable to Rosario<font style="padding-left: 3.21pt;"></font></div></td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">600,000</font></div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total <font style="padding-left: 2.76pt;"></font></div></td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$</font><font style="border-bottom: 3pt double #000000;">6,873,808</font></div></td></tr></table> </div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">159<br></div></div></div>
<!--End Page 165-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 166-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_112-under_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tLM"><!--Anchor--></a>LEGAL MATTERS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The validity of the ordinary shares being offered by this prospectus and other legal matters concerning this offering relating to Israeli law will be passed upon for us by Amit, Pollak, Matalon &amp; Co., Tel Aviv, Israel. Certain legal matters in connection with this offering relating to U.S. law will be passed upon for us by Skadden, Arps, Slate, Meagher &amp; Flom LLP, New York, New York. Certain legal matters concerning this offering will be passed upon for the underwriters by Gornitzky &amp; Co., Tel Aviv, Israel, relating to Israeli law, and by Latham and Watkins LLP, relating to U.S. law.</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tE"><!--Anchor--></a>EXPERTS</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The consolidated financial statements as of December&#160;31, 2019 and 2018 and for the years ended December&#160;31, 2019 and 2018 included in this prospectus have been so included in reliance on the report (which contains an explanatory paragraph relating to the removal of substantial doubt about the Company&#8217;s ability to continue as a going concern as described in Note 1d to the consolidated financial statements) of Kesselman &amp; Kesselman, a member firm of PricewaterhouseCoopers International Limited (PwC Israel), an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting. The offices of PwC Israel are located at Hamered 25 Tel-Aviv. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">160<br></div></div></div>
<!--End Page 166-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 167-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_112-under_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tEC"><!--Anchor--></a>ENFORCEABILITY OF CIVIL LIABILITIES</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We are incorporated under the laws of the State of Israel. Service of process upon us and upon our directors and officers and the Israeli experts named in this prospectus, many of whom reside outside of the United States, may be difficult to obtain within the United States. Furthermore, because substantially all of our assets and substantially all of our directors and officers are located outside the United States, any judgment obtained in the United States against us or any of our directors and officers may be difficult to collect within the United States. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have irrevocably appointed CT Corporation System as our agent to receive service of process in any action against us in any U.S. federal or state court arising out of this offering or any purchase or sale of securities in connection with this offering. The address of our agent is 28 Liberty Street, New York, NY 10005. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have been informed by our legal counsel in Israel, Amit, Pollak, Matalon &amp; Co., that it may be difficult to initiate an action with respect to U.S. securities laws in Israel. Israeli courts may refuse to hear a claim based on an alleged violation of U.S. securities laws on the basis that Israel is not the most appropriate forum in which to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. There is little binding case law in Israel addressing these matters. If U.S. law is found to be applicable, the content of applicable U.S. law must be proved as a fact by expert witnesses which can be a time-consuming and costly process. Certain matters of procedure may also be governed by Israeli law. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Subject to certain time limitations and legal procedures, Israeli courts may enforce a U.S. judgment in a civil matter which, subject to certain exceptions, is non-appealable, including judgments based upon the civil liability provisions of the Securities Act and the Exchange Act and including a monetary or compensatory judgment in a non-civil matter, provided that, among other things: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the judgment was rendered by a court which was, according to the laws of the state of the court, competent to render the judgment; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the obligation imposed by the judgment is enforceable according to the rules relating to the enforceability of judgments in Israel and the substance of the judgment is not contrary to public policy; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the judgment is executory in the state in which it was given. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">Even if these conditions are met, an Israeli court will not declare a foreign civil judgment enforceable if: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the judgment was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the enforcement of the judgment is likely to prejudice the sovereignty or security of the State of Israel; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the judgment was obtained by fraud; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the opportunity given to the defendant to bring its arguments and evidence before the court was not reasonable in the opinion of the Israeli court; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the judgment was rendered by a court not competent to render it according to the laws of private international law as they apply in Israel; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the judgment is contradictory to another judgment that was given in the same matter between the same parties and that is still valid; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">at the time the action was brought in the foreign court, a lawsuit in the same matter and between the same parties was pending before a court or tribunal in Israel. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If a foreign judgment is enforced by an Israeli court, it generally will be payable in Israeli currency, which can then be converted into non-Israeli currency and transferred out of Israel. Under existing Israeli law, a foreign judgment payable in foreign currency may be paid in Israeli currency at the rate of exchange in force on the date of the payment. Current Israeli exchange control regulations also permit a judgment debtor to make payment in foreign currency. Pending collection, the amount of the judgment of an Israeli court stated in Israeli currency ordinarily will be linked to the Israeli consumer price index plus interest at the annual statutory rate set by Israeli regulations prevailing at the time. Judgment creditors must bear the risk of unfavorable exchange rates.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">161<br></div></div></div>
<!--End Page 167-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 168-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_112-under_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tWY"><!--Anchor--></a>WHERE YOU CAN FIND ADDITIONAL INFORMATION</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have filed with the SEC a registration statement on Form F-1 under the Securities Act relating to this offering of our ordinary shares. This prospectus does not contain all of the information contained in the registration statement. The rules and regulations of the SEC allow us to omit certain information from this prospectus that is included in the registration statement. Statements made in this prospectus concerning the contents of any contract, agreement or other document are summaries of all material information about the documents summarized, but are not complete descriptions of all terms of these documents. If we filed any of these documents as an exhibit to the registration statement, you may read the document itself for a complete description of its terms. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">You may read and copy the registration statement, including the related exhibits and schedules, and any document we file with the SEC at its web site at: http://www.sec.gov. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We are not currently subject to the informational requirements of the Exchange Act. Upon completion of this offering, we will become subject to the information reporting requirements of the Exchange Act applicable to foreign private issuers and will fulfill the obligations of those requirements by filing reports with the SEC. As a foreign private issuer, we will be exempt from the rules under the Exchange Act relating to the furnishing and content of proxy statements, and our officers, directors and principal shareholders will be exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. However, we intend to file with the SEC, within 120 days after the end of our fiscal year, or such applicable time as required by the SEC, an annual report on Form 20-F containing financial statements which will be audited and reported on, with an opinion expressed, by an independent registered public accounting firm. We also intend to file with the SEC reports on Form 6-K containing unaudited financial information for the first three quarters of each fiscal year. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We maintain a corporate website at: http://www.nanox.vision. Information contained on, or that can be accessed through our website does not constitute a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">162<br></div></div></div>
<!--End Page 168-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 169-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_200-fintoc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tIC"><!--Anchor--></a>NANO-X IMAGING LTD<br>&#8195; <br><font style="font-weight: normal;">CONSOLIDATED FINANCIAL STATEMENTS</font><br><font style="font-weight: normal;">&#8195; </font><br><font style="font-weight: normal;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2019 AND 2018</font><br><font style="font-weight: normal;">&#8195;</font><br><font style="font-weight: normal;">U.S</font><font style="font-weight: normal;">.</font><font style="font-weight: normal;"> DOLLARS</font></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; text-align: center;">&#8195;</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">INDEX</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.83%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 4.04%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page </div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consolidated Financial Statements<br></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fROI">Report of Independent Registered Public Accounting Firm <font style="font-weight: normal; padding-left: 1.44pt;"></font></a></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fROI"><font style="padding-left: 5pt;">F-</font>2 </a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fCBS">Consolidated Balance Sheet <font style="font-weight: normal; padding-left: 1.2pt;"></font></a></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fCBS"><font style="padding-left: 5pt;">F-</font>3 </a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fCSO">Consolidated Statement of Operations <font style="font-weight: normal; padding-left: 0.67pt;"></font></a></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fCSO"><font style="padding-left: 5pt;">F-</font>4 </a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fCSOC">Consolidated Statement of Changes in Shareholders' Equity <font style="font-weight: normal; padding-left: 4.76pt;"></font></a></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fCSOC"><font style="padding-left: 5pt;">F-</font>5 </a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fCSCF">Consolidated Statement of Cash Flows <font style="font-weight: normal; padding-left: 3.45pt;"></font></a></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fCSCF"><font style="padding-left: 5pt;">F-</font>6 </a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fNOTES">Notes to the Consolidated Financial Statements <font style="font-weight: normal; padding-left: 0.69pt;"></font></a></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fNOTES"><font style="padding-left: 5pt;">F-</font>7 </a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unaudited Condensed Consolidated Financial Statements<br></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fCBS2">Consolidated Balance Sheets<font style="font-weight: normal;"> </font><font style="font-weight: normal; padding-left: 2.32pt;"></font></a></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fCBS2">F-23 </a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fCSO2">Consolidated Statements of Operations<font style="font-weight: normal;"> </font><font style="font-weight: normal; padding-left: 1.78pt;"></font></a></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fCSO2">F-24 </a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fCSOC2">Consolidated Statements of Changes in Shareholders&#8217; Equity (Capital Deficiency) <font style="font-weight: normal; padding-left: 2.21pt;"></font></a></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fCSOC2">F-25 </a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fCSCF2">Consolidated Statements of Cash Flows<font style="font-weight: normal;"> </font><font style="font-weight: normal; padding-left: 4.57pt;"></font></a></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fCSCF2">F-27 </a></div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#fNOTES2">Notes to the Consolidated Financial Statements <font style="font-weight: normal; padding-left: 0.69pt;"></font></a></div></td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 4.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><a href="#fNOTES2">F-33</a></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-1<br></div></div></div>
<!--End Page 169-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 170-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_201-fintab01_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><img style="height: 58px; width: 76px;" src="logo_pwc.jpg"><br>&#8201;</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><a name="fROI"><!--Anchor--></a>Report of Independent Registered Public Accounting Firm </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">To the Board of Directors and Shareholders of Nano-X Imaging Ltd</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">Opinion on the Financial Statements</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We have audited the accompanying consolidated balance sheets of Nano-X Imaging Ltd and its subsidiary (the &#8220;Company&#8221;) as of December 31, 2019 and 2018, and the related consolidated statements of operations, of changes in shareholders&#8217; deficit and of cash flows for the years then ended, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">Basis for Opinion</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United&#160;States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S.&#160;federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">We conducted our audits of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">Substantial Doubt About the Company&#8217;s Ability to Continue as a Going Concern Has Been Removed</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Management and we previously concluded there was substantial doubt about the Company&#8217;s ability to continue as a going concern. As discussed in Note 1d, management has subsequently taken certain actions, which management and we have concluded remove that substantial doubt.</div><table cellspacing="0" cellpadding="0" class="txttab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr><td style="width: 71.79%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Kesselman &amp; Kesselman</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Certified Public Accountants (Isr.)</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">A member firm of PricewaterhouseCoopers International Limited</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Tel Aviv, Israel</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 71.79%; text-align: left; vertical-align: top; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">February 18, 2020, except with respect to the matters which have removed the substantial doubt about the Company&#8217;s ability to continue as a going concern discussed in Note 1d and Note 12(d), (e), (f), (g) as to which the date is July&#160;30, 2020</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-align: left;">We have served as the Company&#8217;s auditor since 2019</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-2<br></div></div></div>
<!--End Page 170-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 171-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_201-fintab01_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br>&#8195;<br><a name="fCBS"><!--Anchor--></a><font style="font-weight: normal;">CONSOLIDATED BALANCE SHEETS</font></div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 10.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December 31,</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019 (*)</div></td><td class="gutter" style="width: 1.37%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.37%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018 (*)</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">U.S. Dollars in thousands</div></td></tr><tr><td style="width: 76.92%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Assets<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CURRENT ASSETS:<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 4.77pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt;">8,072</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 25.83pt;">5</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Prepaid expenses and other current assets<font style="padding-left: 2.59pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt;">1,564</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Related party prepaid expenses<font style="padding-left: 0.34pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000;">&#8212;</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000;">1,694</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total current assets<font style="font-weight: normal; padding-left: 2.53pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000;">9,636</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000;">1,699</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">NON-CURRENT ASSETS:<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Restricted cash<font style="padding-left: 0.86pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 15.83pt;">145</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, net<font style="padding-left: 1.7pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 15.83pt;">228</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 15.83pt;">156</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred offering costs<font style="padding-left: 3.29pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt;">1,197</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease right-of-use asset<font style="padding-left: 0.91pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 15.83pt;">526</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other non-current assets<font style="padding-left: 3.11pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000;">139</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total non-current assets<font style="font-weight: normal; padding-left: 3.09pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000;">2,235</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000;">156</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total assets<font style="font-weight: normal; padding-left: 2.88pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 3.7pt; border-bottom: 3pt double #000000;">11,871</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000;">1,855</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Liabilities and Capital Deficiency<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CURRENT LIABILITIES:<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts payable<font style="padding-left: 0.31pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 15.83pt;">475</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt;">82</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accrued expenses and other liabilities<font style="padding-left: 2.01pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt;">1,828</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Related party liability<font style="padding-left: 3.64pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 3.33pt;">17,820</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt;">8,157</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Current maturities of operating leases<font style="padding-left: 3.68pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000;">140</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total current liabilities<font style="font-weight: normal; padding-left: 3.07pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000;">20,263</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000;">8,239</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">NON-CURRENT LIABILITIES:<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Non-current operating leases<font style="padding-left: 0.34pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 15.83pt;">386</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total non-current liabilities<font style="font-weight: normal; padding-left: 3.63pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000;">386</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total liabilities<font style="font-weight: normal; padding-left: 3.43pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000;">20,649</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000;">8,239</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">COMMITMENTS<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">SHAREHOLDERS' DEFICIT:<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Ordinary Shares, par value NIS 0.01 per share, 40,000,000 and 30,000,000 shares authorized at December 31, 2019 and 2018, respectively; 27,150,080 and 21,924,208 issued and outstanding at December 31, 2019 and 2018, respectively<font style="padding-left: 2.05pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt;">75</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 20.83pt;">58</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Additional paid-in capital<font style="padding-left: 3.09pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 3.33pt;">31,748</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 3.7pt;">11,596</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accumulated deficit<font style="padding-left: 0.31pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">(40,601</font>)</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">(18,038</font>)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TOTAL SHAREHOLDERS' DEFICIT<font style="font-weight: normal; padding-left: 3.99pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">(8,778</font>)</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">(6,384</font>)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT<font style="font-weight: normal; padding-left: 4.57pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 3.7pt; border-bottom: 3pt double #000000;">11,871</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.2pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000;">1,855</font></div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(*)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The consolidated financial statements as of and for the years ended December 31, 2019 and 2018 reflect a retrospective application of a transaction under common control - see note 1c </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these consolidated financial statements <br></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-3<br></div></div></div>
<!--End Page 171-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 172-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_201-fintab01_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br>&#8195;<br><a name="fCSO"><!--Anchor--></a><font style="font-weight: normal;">CONSOLIDATED STATEMENTS OF OPERATIONS </font></div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 10.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December 31,</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.15%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019 (*)</div></td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018 (*)</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">U.S. Dollars in thousands</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">OPERATING EXPENSES:<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Research and development<font style="padding-left: 3.1pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 8.33pt;">2,717</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.23pt; text-align: left;"><font style="padding-left: 12.5pt;">672</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Marketing<font style="padding-left: 0.85pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 8.33pt;">1,556</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.23pt; text-align: left;"><font style="padding-left: 12.5pt;">209</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<font style="padding-left: 2.55pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000;">18,298</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.23pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">1,023</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TOTAL OPERATING EXPENSES<font style="font-weight: normal; padding-left: 0.84pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000;">22,571</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.23pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">1,904</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">OPERATING LOSS<font style="font-weight: normal; padding-left: 3.8pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">(22,571</font>)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.23pt; text-align: left;"><font style="padding-left: 1.67pt; border-bottom: 1pt solid #000000;">(1,904</font>)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">FINANCIAL (INCOME) EXPENSES<font style="font-weight: normal;">, net</font><font style="font-weight: normal; padding-left: 1.16pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000;">(8</font>)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.23pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000;">5</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">NET LOSS<font style="font-weight: normal; padding-left: 3.24pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">(22,563</font>)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.23pt; text-align: left;"><font style="padding-left: 1.67pt; border-bottom: 3pt double #000000;">(1,909</font>)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">BASIC AND DILUTED LOSS PER SHARE<font style="font-weight: normal; padding-left: 3.65pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 3pt double #000000;">(0.90</font>)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.23pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 3pt double #000000;">(0.09</font>)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">THE WEIGHTED AVERAGE OF THE NUMBER OF ORDINARY SHARES<font style="font-weight: normal;"> </font><br><font style="font-weight: normal;">(in thousands)</font><font style="font-weight: normal; padding-left: 4.74pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000;">25,181</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.23pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">20,793</font></div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 9.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(*)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The consolidated financial statements as of and for the years ended December 31, 2019 and 2018 reflect a retrospective application of a transaction under common control - see note 1c </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these consolidated financial statements <br></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-4<br></div></div></div>
<!--End Page 172-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 173-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_201-fintab01_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br>&#8195;<br><a name="fCSOC"><!--Anchor--></a><font style="font-weight: normal;">CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' DEFICIT (*)</font></div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 10.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.68%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 18.95%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Ordinary shares </div></td><td class="gutter" style="width: 1.68%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.68%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Additional <br>paid-in <br>capital </div></td><td class="gutter" style="width: 1.68%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.68%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br>deficit</div></td><td class="gutter" style="width: 1.68%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.68%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.59%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div></td></tr><tr class="header"><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.68%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number <br>of shares</div></td><td class="gutter" style="width: 1.68%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.68%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td class="gutter" style="width: 1.68%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.68%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 30.76%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">U.S. Dollars in thousands</div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">BALANCE AT JANUARY 1, 2018<font style="font-weight: normal; padding-left: 1.79pt;"></font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">20,257,434</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.99pt; text-align: left;">41</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.81pt; text-align: left;"><font style="padding-left: 8.33pt;">7,814</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;">(16,129)</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">(8,274)</font></div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CHANGES DURING 2018:<br></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Issuance of ordinary shares<font style="padding-left: 4.9pt;"></font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">1,666,774</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.99pt; text-align: left;">17</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.81pt; text-align: left;"><font style="padding-left: 8.33pt;">3,667</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">3,684</font></div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Share-based compensation<font style="padding-left: 3.76pt;"></font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.81pt; text-align: left;"><font style="padding-left: 16.2pt;">115</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 16.2pt;">115</font></div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss for the year<font style="padding-left: 2.11pt;"></font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30pt; border-bottom: 1pt solid #000000;">&#8199;&#8199;&#8199;</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.99pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">&#8199;&#8199;</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.81pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000;">&#8199;&#8199;&#8199;</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">(1,909</font>)</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">(1,909</font>)</div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">BALANCE AT DECEMBER 31, 2018<font style="font-weight: normal; padding-left: 1.62pt;"></font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,924,208</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.99pt; text-align: left;">58</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.81pt; text-align: left;"><font style="padding-left: 3.7pt;">11,596</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;">(18,038)</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">(6,384)</font></div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CHANGES DURING 2019:<br></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Issuance of ordinary shares and warrants, net of issuance costs<font style="padding-left: 2.65pt;"></font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">4,762,656</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.99pt; text-align: left;">16</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.81pt; text-align: left;"><font style="padding-left: 3.33pt;">14,022</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 3.33pt;">14,038</font></div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Issuance of ordinary shares upon exercise of warrants<font style="padding-left: 2.08pt;"></font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">454,166</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.99pt; text-align: left;"><font style="padding-left: 5pt;">1</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.81pt; text-align: left;"><font style="padding-left: 15.83pt;">136</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.83pt;">137</font></div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Issuance of ordinary shares to investors upon exercise of warrants<font style="padding-left: 4.33pt;"></font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">9,050</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.99pt; text-align: left;"><font style="padding-left: 10pt;">**</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.81pt; text-align: left;"><font style="padding-left: 20.83pt;">25</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 20.83pt;">25</font></div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Share-based compensation<font style="padding-left: 3.76pt;"></font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.81pt; text-align: left;"><font style="padding-left: 3.33pt;">16,245</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 3.33pt;">16,245</font></div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Additional consideration with respect to an assets purchase agreement, see note 1c and note 6<font style="padding-left: 0.95pt;"></font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.81pt; text-align: left;">(10,276)</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(10,276)</div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss for the year<font style="padding-left: 2.11pt;"></font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30pt; border-bottom: 1pt solid #000000;">&#8199;&#8199;&#8199;</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.99pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">&#8199;&#8199;</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.81pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000;">&#8199;&#8199;&#8199;</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">(22,563</font>)</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">(22,563</font>)</div></td></tr><tr><td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">BALANCE AT DECEMBER 31, 2019<font style="font-weight: normal; padding-left: 1.62pt;"></font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">27,150,080</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">75</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 7.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.81pt; text-align: left;"><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000;">31,748</font></div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">(40,601</font>)</div></td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 1.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 3pt double #000000;">(8,778</font>)</div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 9.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(*)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The consolidated financial statements as of and for the years ended December 31, 2019 and 2018 reflect a retrospective application of a transaction under common control - see note 1c </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(**)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Less than 1 thousand US dollars. </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these consolidated financial statements <br></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-5<br></div></div></div>
<!--End Page 173-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 174-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_201-fintab01_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br>&#8195;<br><a name="fCSCF"><!--Anchor--></a><font style="font-weight: normal;">CONSOLIDATED STATEMENTS OF CASH FLOWS </font></div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 10.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December 31,</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.15%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019 (*)</div></td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018 (*)</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">U.S. Dollars in thousands</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CASH FLOWS FROM OPERATING ACTIVITIES:<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss for the year<font style="padding-left: 3.11pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;">(22,563)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;">(1,909)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Adjustments required to reconcile net loss to net cash used in operating activities:<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Share-based compensation<font style="padding-left: 4.76pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 3.33pt;">16,245</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 11.2pt;">115</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Depreciation<font style="padding-left: 0.86pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 20.83pt;">53</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 15.83pt;">35</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Changes in operating assets and liabilities:<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Prepaid expenses and other current assets<font style="padding-left: 2.59pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 5pt;">(1,564)</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 15.83pt;">66</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Related party prepaid expenses<font style="padding-left: 0.34pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 8.33pt;">1,081</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;">(1,844)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Other non-current assets<font style="padding-left: 3.11pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 12.5pt;">(139)</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Accounts payable<font style="padding-left: 0.31pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 15.83pt;">39</font>3</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 7.5pt;">(134)</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Operating lease<font style="padding-left: 4.2pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 30.83pt; position: relative; top: -4.25pt;">**</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Accrued expenses and other liabilities<font style="padding-left: 2.01pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000;">97</font><font style="border-bottom: 1pt solid #000000;">0</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net cash used in operating activities<font style="padding-left: 3.68pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">(5,524</font>)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">(3,671</font>)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CASH FLOWS FROM INVESTING ACTIVITIES:<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Purchase of property and equipment<font style="padding-left: 4.22pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000;">(125</font>)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000;">(73</font>)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net cash used in investing activities<font style="padding-left: 4.78pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000;">(125</font>)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000;">(73</font>)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CASH FLOWS FROM FINANCING ACTIVITIES:<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from issuance of ordinary shares and warrants , net of issuance costs<font style="padding-left: 0.18pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 3.33pt;">14,038</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 3.33pt;">3,684</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from issuance of ordinary shares upon exercise of warrants<font style="padding-left: 0.43pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 15.83pt;">162</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred offering costs<font style="padding-left: 3.29pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000;">(339</font>)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net cash provided by financing activities<font style="padding-left: 4.23pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000;">13,861</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000;">3,684</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">NET CHANGE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH<font style="font-weight: normal; padding-left: 4.73pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 8.33pt;">8,212</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 12.5pt;">(60)</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF THE YEAR<font style="font-weight: normal; padding-left: 3.43pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000;">5</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000;">65</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF THE YEAR<font style="font-weight: normal; padding-left: 0.1pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000;">8,217</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 3pt double #000000;">5</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">SUPPLEMENTARY INFORMATION ON ACTIVITIES NOT INVOLVING CASH FLOWS<br></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Unpaid offering costs<font style="padding-left: 4.38pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 3pt double #000000;">858</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 3pt double #000000;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Recognition of operating lease right-of-use asset against operating lease liabilities<font style="padding-left: 2.64pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 3pt double #000000;">548</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 3pt double #000000;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Additional consideration with respect to an assets purchase agreement, see note 1c<font style="padding-left: 3.49pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">(10,276</font>)</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.07pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 3pt double #000000;">&#8212;</font></div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(*)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The consolidated financial statements as of and for the years ended December 31, 2019 and </div></td></tr></table><div class="ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 4.5pt; margin-left: 0pt; text-align: left;">2018, reflects a retrospective application of transaction under common control - see note 1c</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(**)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Less than 1 thousand US dollars.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these consolidated financial statements <br></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-6<br></div></div></div>
<!--End Page 174-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 175-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="fNOTES"><!--Anchor--></a>NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal;"> </font><br></div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">NOTE 1 - GENERAL:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">Nano-X Imaging Ltd</font><font style="font-weight: normal;">, an Israeli company (hereinafter &#8220;the Company&#8221; or &#8220;Nanox IL&#8221; or &#8220;the Successor </font><font style="font-weight: normal;">Company&#8221;), was incorporated on December&#160;20, 2018 and commenced its operations on September&#160;3, 2019. </font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">On September&#160;19, 2019, Nanox IL established Nanox Imaging Inc. (hereinafter &#8220;Nanox Inc.&#8221;), a wholly owned subsidiary in Japan. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">Nanox Imaging PLC is a public limited company incorporated in Gibraltar in 2012 (hereinafter &#8220;Nanox </font><font style="font-weight: normal;">PLC&#8221; or &#8220;the predecessor company&#8221;). </font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Nanox PLC developed certain technological capabilities aimed to design and build various applications for x-ray based imaging. Nanox PLC has been a development-stage company since its inception. Nanox PLC has a wholly owned subsidiary, Nanox Japan Inc. (hereinafter &#8220;Nanox Japan&#8221;). Nanox Japan primarily provides research and development services to Nanox PLC.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">On September&#160;3, 2019 (hereinafter &#8220;Transaction Date&#8221;), Nanox IL signed an Assets Purchase Agreement which was later amended on December&#160;3, 2019 and December&#160;31, 2019 (hereinafter &#8220;the APA&#8221;) with Nanox PLC. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Under the terms of the APA, Nanox IL purchased from Nanox PLC patents, patent applications and all other intellectual property rights, as well as all cash of Nanox PLC (less an amount of $200 thousand), with an exclusion of certain assets as defined in the APA (hereinafter &#8220;Acquired Assets&#8221;). </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Under the terms of the APA, Nanox IL shall pay Nanox PLC $6.127&#160;million as consideration for the purchase of the Acquired Assets, which reflects the fair value of the Acquired Assets (excluding cash) plus the cash balance as of the date of the APA, less $200 thousand. The purchase price shall be due and payable upon the closing of one of the following events: (a) an M&amp;A event of Nanox IL, (b) an IPO of Nanox IL, or (c) a qualified equity financing of Nanox IL at a minimum company pre-money valuation of $100&#160;million, with proceeds totaling at least $30&#160;million. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">In the event of an IPO or a qualified equity financing, Nanox IL has the option to pay for the Acquired Assets in cash or by the issuance of Nanox IL shares of the same series to be issued upon such event, in an amount reflecting a 25% discount on the per share price to be determined in such IPO or qualified equity financing. If Nanox IL chooses to pay for the Acquired Assets in cash in any of the events described above, then Nanox PLC has the right, at its sole discretion and in good faith, to reject such payment in cash, and require Nanox IL to pay for the Acquired Assets by the issuance of securities of the same series to be issued upon such equity financing events, in such amount which shall reflect a 25% discount on the per share price to be determined in such equity financing events. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">In November 2019, Nanox PLC transferred to Nanox IL an amount of $7.2&#160;million, which reflects the cash consideration under the APA. The total consideration of the purchase of the Acquired Assets is $13.3&#160;million. The outstanding balance of $17.8&#160;million reflects the related party liability of the expected future payment using the Company's shares, refer to note 6. For the settlement of the related party liability refer to note 12a. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">c.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">As of September 3 2019, Nanox IL and Nanox PLC had the same shareholders and, therefore, the </font><font style="font-weight: normal;">transaction was treated as a transaction under common control for accounting purposes. </font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The financial statements of the Company prior to the Transaction Date are the historical financial statements of Nanox PLC, which have been adjusted to reflect the fact that:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">only the net assets that were transferred in the transaction according to the APA. Net assets which were not transferred in the transaction are not reflected in these consolidated financial statements.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">no interests of Nanox Japan were transferred under the APA. The consolidated statements of operation include the costs incurred for services provided by Nanox Japan to Nanox PLC. </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-7<br></div></div></div>
<!--End Page 175-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 176-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the consideration in the transaction (the &#8220;Related Party Liability&#8221;) was recorded at the beginning of the earliest period presented against a decrease in shareholders' equity, with the exception of the cash consideration that was received by Nanox PLC from its equity financing activities in 2019, and which was recorded in 2019 (refer to note 8a).</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">all of the share-related information reflect the share information of Nanox IL.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">d.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">In accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, Presentation of Financial </font><font style="font-weight: normal;">Statements&#8211;Going Concern (Subtopic 205-40): Disclosure of Uncertainties About an Entity&#8217;s Ability to </font><font style="font-weight: normal;">Continue as a Going Concern, management is required to perform a two-step analysis of its ability to </font><font style="font-weight: normal;">continue as a going concern. Management must first evaluate whether there are conditions and events that </font><font style="font-weight: normal;">raise substantial doubt about the Company&#8217;s ability to continue as a going concern (step 1). If management </font><font style="font-weight: normal;">concludes that substantial doubt is raised, management is also required to consider whether its plans </font><font style="font-weight: normal;">alleviate that doubt (step 2).</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">In order to complete its technology development program, the Company will require significant funding. Moreover, the Company has experienced net losses and negative cash flows from operations since its inception and has relied on its ability to fund its operations primarily through equity financings. As of December&#160;31, 2019 and 2018, the Company had an accumulated deficit of $40.6&#160;million and $18&#160;million, respectively, and cash and cash equivalents of $8.1&#160;million and $5&#160;thousand, respectively, and negative cash flow from operating activity of $5.6&#160;million and $3.7&#160;million for the years ended December&#160;31, 2019 and 2018, respectively. The Company anticipates such losses will continue until its product candidates reach commercial profitability. If the Company is unable to successfully commercialize its product candidates and reach profitability, or obtain sufficient future financing from its shareholders or other investors, it will be required to delay some of its planned research and development programs as well as curtail, discontinue or, in the extreme case, cease operations. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Based on the actions the Company has taken as described below management&#8217;s assessment, the Company has alleviated the substantial doubt as previously disclosed and has sufficient liquidity to satisfy its obligations over the next twelve months. Accordingly, the consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The following is a summary of significant financings in 2020. During the first half of 2020, the Company entered into share purchase agreements with certain investors (together, the &#8220;Investors&#8221;), under which the Company issued an aggregate of 2,368,250 ordinary shares to the Investors, at a price per ordinary share of $16.00, for an aggregate purchase price of approximately $37.9&#160;million. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES:</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). The significant accounting policies used in the preparation of the consolidated financial statements are as follows:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Use of estimates in the preparation of financial statements</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates and such differences may have a material impact on the Company&#8217;s consolidated financial statements. As applicable to these consolidated financial statements, the most significant estimates relate to fair value of share-based payments and the fair value of the liability to related party.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Functional currency</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The U.S. dollar is the currency of the primary economic environment in which the operations of the Company and its subsidiary is conducted. A substantial portion of the operational costs are denominated in U.S. dollars. Accordingly, the functional currency of the Company is the U.S. dollar (&#8220;primary currency&#8221;). </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-8<br></div></div></div>
<!--End Page 176-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 177-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">Foreign currency assets and liabilities are translated into the primary currency using the exchange rates in effect on the consolidated balance sheet date. Equity accounts are translated at historical rates, except for the change in accumulated deficit during the year, which is the result of the income statement translation process. Expense accounts are translated using the weighted average exchange rate during the period. Currency transaction gains and losses are presented in financial income and expenses, net. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">c.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Statement of Cash Flows</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">As of January&#160;1, 2018, the Company adopted ASU 2016-18 &#8220;Statement of Cash Flows (Topic 230): Restricted Cash&#8221;, which requires companies to include amounts generally described as restricted cash and restricted cash equivalents in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the statement of cash flows. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">d.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Cash and cash equivalents</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The Company considers as cash equivalents all short-term, highly liquid investments, which include short-term bank deposits with original maturities of three months or less from the date of purchase that are not restricted as to withdrawal or use and are readily convertible to known amounts of cash.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">e.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Restricted Cash</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">As of December 31, 2019, the Company&#8217;s restricted cash consisted of a bank deposit that was denominated in New Israeli Shekel. Restricted deposit is presented at cost including accrued interest. This bank deposit is used as security for credit card use. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">f.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Property and equipment, net</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated on a straight-line basis over the following estimated useful lives:</div><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 88.39%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.2%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 3.2%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.21%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">%</div></td></tr><tr><td style="width: 88.39%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Computers<font style="padding-left: 4.62pt;"></font></div></td><td class="gutter" style="width: 3.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">10-33</div></td></tr><tr><td style="width: 88.39%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Office furniture and lab equipment<font style="padding-left: 0.96pt;"></font></div></td><td class="gutter" style="width: 3.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 3.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">10-20</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">g.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Impairment of long-lived assets<font style="font-weight: normal;"> </font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The Company tests long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. Recoverability of long-lived assets is measured by comparing the carrying amount of the long-lived asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the sum of the expected undiscounted cash flow is less than the carrying amount of the asset, the Company recognizes an impairment loss, which is the excess of the carrying amount over the fair value of the asset, using the expected future discounted cash flows.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">For the years ended December&#160;31, 2019 and 2018, the Company did not recognize an impairment loss on its long-lived assets.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">h.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Severance pay</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Israeli labor law generally requires severance pay be granted upon dismissal of an employee or upon termination of employment under certain other circumstances. Pursuant to Section 14 of the Severance Compensation Act, 1963 (&#8220;Section 14&#8221;), all of the Company&#8217;s employees in Israel are entitled to monthly deposits, at a rate of 8.33% of their monthly salary, made in their name with insurance companies. Payments under Section 14 relieve the Company from any future severance payment obligation with respect to those employees and, as such, the Company may only utilize the insurance policies for the purpose of disbursement of severance pay. As a result, the Company does not recognize an asset nor liability for these employees.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">In 2019, all of the Company&#8217;s employees in Israel are subject to Section 14.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-9<br></div></div></div>
<!--End Page 177-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 178-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">i.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Legal and other contingencies</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Certain conditions, such as legal proceedings, may exist as of the date the consolidated financial statements are issued that may result in a loss to the Company, but that will only be resolved when one or more future events occur or fail to occur. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company&#8217;s management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought. Such assessment inherently involves an exercise of judgment. Legal fees are expensed as incurred.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Management applies the guidance in ASC 450-20-25 when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss would be incurred and the amount of the liability can be estimated, then the Company records an accrued expense in the Company&#8217;s consolidated financial statements based on its best estimate. Loss contingencies considered to be remote by management are generally not disclosed unless material. The Company is currently not a party to any material legal proceedings and is not aware of any material pending or threatened material legal proceedings against the Company.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">j.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Research and development expenses</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Research and development expenses are charged to the statement of operations as incurred and consist primarily of personnel, materials and supplies for research and development activities.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">k.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Marketing expenses</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Marketing expenses consist primarily of marketing campaigns and business development expenses. Marketing expenses are charged to the statement of operations, as incurred. Marketing expenses for the years ended December 31, 2019 and 2018, amounted to $209 thousand and $1,556 thousand, respectively.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">l.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Income tax<font style="font-weight: normal;"> </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Company accounts for income taxes in accordance with ASC 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). ASC 740 prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value if it is more likely than not that a portion or all of the deferred tax assets will not be realized, based on the weight of available positive and negative evidence. Deferred tax liabilities and assets are classified as non-current in accordance with ASU 2015-17.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Taxes that would apply in the event of disposal of investments in foreign subsidiaries have not been taken into account in computing the deferred income taxes, as it is the Company&#8217;s intent and ability to hold these investments.</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The Company accounts for uncertain tax positions in accordance with ASC 740-10. ASC 740-10 contains a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative probability) likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits under taxes on income (tax benefit).</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-10<br></div></div></div>
<!--End Page 178-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 179-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">m.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Share-based compensation</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The Company accounts for share-based compensation under ASC 718, &#8220;Compensation - Stock Compensation,&#8221; which requires the measurement and recognition of compensation expense based on estimated fair values for all share-based payment awards made to non-employees, employees, officers and directors.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant. The Company uses the Black-Scholes-Merton option-pricing model as part of such estimation.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Prior to the adoption of ASU 2018-07, warrants issued to consultants and other non-employees, as compensation for services provided to the Company, were accounted for based upon the fair value of the warrants. The fair value of the warrants granted was measured on a final basis at the end of the related service period and was recognized over the related service period using the straight line method. After the adoption of ASU 2018-07, the measurement date for non-employee awards is the date of the grant. The compensation expense for non-employees is recognized without changes in the fair value of the award, over the requisite service period, which is the vesting period of the respective award using the straight line. The Company adopted ASU 2018-07 as of January&#160;1, 2019 with no impact on its consolidated financial statements as all of the Company's awards were fully vested at the adoption date. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">n.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Loss per share</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Basic earnings per share is computed by dividing net income (loss) attributable to holders of ordinary shares of the Company by the weighted average number of ordinary shares outstanding for each reporting period.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">In computing the Company&#8217;s diluted earnings per share, the denominator for diluted earnings per share is a computation of the weighted-average number of ordinary shares and the potential dilutive ordinary shares outstanding during the period. Potential dilutive ordinary shares outstanding include the dilutive effect of in-the-money options using the treasury stock method.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The Company did not take into account any dilutive instruments, such as share-based payments, since their effect, on a fully diluted basis, is anti-dilutive.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">o.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Fair value measurement</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Fair value is based on the price that would be received from the sale of an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair value measurements, the guidance establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described as follows: </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Level 1:&#8195;Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Level 2:&#8195;Observable prices that are based on inputs not quoted on active markets, but corroborated by market data. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Level 3:&#8195;Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and considers counterparty credit risk in its assessment of fair value.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">p.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Deferred Offering Costs<font style="font-weight: normal;"> </font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Deferred offering costs directly relating to the Company&#8217;s planned initial public offering, are capitalized. No amounts were capitalized as of December&#160;31, 2018. As of December&#160;31, 2019, the Company capitalized $1,197 thousand of deferred offering costs on the consolidated balance sheet.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-11<br></div></div></div>
<!--End Page 179-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 180-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">q.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Newly issued and recently adopted accounting pronouncements:</div></td></tr></table><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Accounting Pronouncements Adopted in Current year</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which supersedes the </font><font style="font-weight: normal;">existing guidance for lease accounting, Leases (Topic 840). The guidance, along with amendments </font><font style="font-weight: normal;">that were adopted thereafter, requires entities to record lease assets and lease liabilities on the </font><font style="font-weight: normal;">balance sheet for all leases </font><font style="font-weight: normal;">(unless an exception is applied) </font><font style="font-weight: normal;">and disclose key information about </font><font style="font-weight: normal;">leasing arrangements. The Company adopted the new lease standard on January&#160;1, 2019 and used </font><font style="font-weight: normal;">the effective date as the Company's date of initial application.</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">In 2018, the FASB also approved an amendment that would permit the option to adopt the new standard prospectively as of the effective date, without adjusting comparative periods presented. The Company has elected to apply the modified retrospective approach with no restatement of comparative information since the Company had, as of January 1 2019, only short term leases to which it applied the short lease exemption &#8211; see Note 5. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The Company adopted the new standard and all the related amendments as of January&#160;1, 2019. Upon adoption, the Company chose to apply the following permitted practical expedients:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 60pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Not reassess whether any existing contracts are or contain a lease; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 60pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Not reassess the classification of leases that commenced before the effective date (for example, all existing leases that were classified as operating leases in accordance with Topic&#160;840 will continue to be classified as operating leases, and all existing leases that were classified as capital leases in accordance with Topic 840 will continue to be classified as finance leases);</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 60pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Exclude initial direct costs from measurement of the right of use asset at the date of initial application.</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The Company also elected to apply the practical expedient which allows the Company not to separate lease and non-lease components for leases of real estate in transactions where the Company serves as the lessee.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The new lease standard also provide practical expedients for an entity's ongoing accounting. The Company elected the practical expedient (for a lessee) regarding the recognition and measurement of short-term leases, for leases for a period of up to 12 months from the commencement date. Instead, the Company will continue to recognize the lease payments for those leases in statement of operations on a straight-line basis over the lease term.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">See note</font><font style="font-weight: normal;"> 2(m)</font><font style="font-weight: normal;"> for other accounting pronouncement adopted during the year ended December&#160;31, </font><font style="font-weight: normal;">2019.</font></div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">NOTE 3 - PROPERTY AND EQUIPMENT, NET:</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 20pt; text-align: left;">Composition of property and equipment grouped by major classifications is as follows:</div><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 22.29%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 22.29%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(U.S. Dollars in thousands)</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Office furniture and lab equipment<font style="padding-left: 0.96pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.44pt; text-align: left;">325</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.44pt; text-align: left;">217</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Computers<font style="padding-left: 4.62pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.44pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">39</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.44pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">22</font></div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.44pt; text-align: left;">364</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.44pt; text-align: left;">239</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: accumulated depreciation<font style="padding-left: 0.78pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.44pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">136</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.44pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">83</font></div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total property and equipment, net<font style="padding-left: 4.52pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.44pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">228</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.44pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">156</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Total depreciation in respect of property and equipment were approximately $53 thousand and $35 thousand for the years ended December&#160;31, 2019 and 2018, respectively.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-12<br></div></div></div>
<!--End Page 180-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 181-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8pt; margin-left: 0pt; text-align: left;">NOTE 4 - CASH, CASH EQUIVALENTS AND RESTRICTED CASH: </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The following table provides a reconciliation of cash, cash equivalents and restricted cash reported on the consolidated balance sheet that sum to the same total amount as shown in the consolidated statement of cash flows.</div><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 22.29%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.52%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.07%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 22.29%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(U.S. Dollars in thousands)</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 0.77pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.32pt; text-align: left;">8,072</div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.07%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.32pt; text-align: left;"><font style="padding-left: 5pt;">5</font></div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted bank deposit<font style="padding-left: 2.98pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 10.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.32pt; text-align: left;"><font style="padding-left: 7.5pt; border-bottom: 1pt solid #000000;">145</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.07%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.32pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">&#8212;</font></div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Total cash, cash equivalents and restricted <br>cash shown in the statement of cash flows<font style="padding-left: 4.69pt;"></font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.32pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">8,217</font></div></td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.07%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.32pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 3pt double #000000;">5</font></div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">NOTE 5 - LEASES </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">As of December&#160;31, 2019, the Company had one operating lease for its facilities that it entered into the fourth quarter of 2019. The agreement is through December&#160;31, 2021 with an option by the Company to extend the period for an additional 24 months. The monthly rent is approximately $11 thousand.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;">The table below presents the effects on the amounts relating to the Company's total lease costs:</div><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended <br>December&#160;31,</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(U.S. Dollars in thousands)</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease cost:<br></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fixed payments<font style="padding-left: 4.07pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;"><font style="padding-left: 5pt;">25</font></div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Short-term lease cost<font style="padding-left: 2.43pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;"><font style="padding-left: 0.37pt; border-bottom: 1pt solid #000000;">112</font></div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total operating lease cost<font style="padding-left: 4.24pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">137</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 20pt; text-align: left;">The table below presents supplemental cash flow information related to operating leases:</div><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended <br>December&#160;31,</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(U.S. Dollars in thousands)</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash paid for amounts included in the measurement of lease liabilities:<br></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating cash flows from operating leases<font style="padding-left: 0.81pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 3pt double #000000;">25</font></div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right-of-use assets obtained in exchange for lease obligations (non-cash):<br></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating leases<font style="padding-left: 1.31pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">548</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 20pt; text-align: left;">The table below presents supplemental balance sheet information related to operating leases:</div><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(U.S. Dollars in thousands)</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating leases:<br></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease right-of-use assets<font style="padding-left: 3.02pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;">526</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current maturities of operating leases<font style="padding-left: 4.68pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;">140</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-current operating leases<font style="padding-left: 1.34pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">386</font></div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total operating lease liabilities<font style="padding-left: 3.13pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">526</font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-13<br></div></div></div>
<!--End Page 181-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 182-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 4.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 7.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 7.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.53%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 7.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 7.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.53%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average remaining lease term<br></div></td><td class="gutter" style="width: 7.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 7.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.53%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating leases<font style="padding-left: 1.31pt;"></font></div></td><td class="gutter" style="width: 7.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 7.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.53%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3.96&#160;years</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 7.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 7.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.53%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average discount rate<br></div></td><td class="gutter" style="width: 7.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 7.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.53%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating leases<font style="padding-left: 1.31pt;"></font></div></td><td class="gutter" style="width: 7.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 7.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.53%; text-align: center; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">5.6%</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The table below presents maturities of operating lease liabilities:<br></div><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr class="header"><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(U.S. Dollars in thousands)</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2020<font style="padding-left: 3.5pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;">146</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2021<font style="padding-left: 3.5pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;">146</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2022<font style="padding-left: 3.5pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;">146</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2023<font style="padding-left: 3.5pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;">145</div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024 and thereafter<font style="padding-left: 4.09pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">&#8212;</font></div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total operating lease payments<font style="padding-left: 2.03pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">583</font></div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: imputed interest<font style="padding-left: 3.53pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000;">57</font></div></td></tr><tr><td style="width: 75%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Present value of lease liabilities<font style="padding-left: 3.56pt;"></font></div></td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 2.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 20.93%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 39.38pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">526</font></div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">NOTE 6 - RELATED PARTY LIABILITY</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">According to ASC 480, &#8220;Distinguishing Liabilities From Equity,&#8221; a financial instrument that embodies an unconditional obligation, or a financial instrument other than an outstanding share that embodies a conditional obligation, that the issuer must or may settle by issuing a variable number of its equity shares shall be classified as a liability if, at inception, the monetary value of the obligation is based solely or predominantly on a fixed monetary amount known at inception. These liabilities are measured subsequently at fair value with changes in fair value recognized in earnings.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The Company analyzed the instrument's provisions and concluded that it meets the above ASC 480 criteria and therefore accounted the expected future payment under the APA in accordance with ASC 480. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">As of December&#160;31, 2018, the outstanding balance of $6,127 thousand retrospectively reflected the amount to be paid in accordance with the APA for the Acquired Assets. The outstanding balance reflected the expected future payment of such liability using the Company's shares. The Company recorded a Related Party Liability in an amount of $8,157 thousand as of December&#160;31, 2018.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">During November 2019, Nanox PLC transferred to Nanox IL an amount of $7.2&#160;million, which reflects the cash consideration under the APA. In accordance with the APA, the total consideration of the purchase of the Acquired Assets was $13.3&#160;million, which reflects the total consideration in accordance with the APA. The outstanding balance reflects the expected future payment of such liability using the Company's securities. As of December&#160;31, 2019, the Company recorded a Related Party Liability in an amount of $17.8&#160;million. For the settlement of the related party liability refer to note 12a. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">NOTE 7 - COMMITMENTS:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">Nanox Japan has been using two rooms and one clean room at the premises of the University of Tokyo </font><font style="font-weight: normal;">since 2012. The total annual payments in 2019 were approximately $76 thousand. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">As to the agreements for services with Six-Eye Interactive Ltd. (&#8220;Six-Eye&#8221;) &#8211; refer to note 10c.</font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">c.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">Nanox IL entered into an advisory agreement with A-Labs Finance and Advisory Ltd. (&#8220;A-Labs&#8221;), effective </font><font style="font-weight: normal;">February&#160;1, 2019, as amended on October&#160;18, 2019, pursuant to which A-Labs will provide the Company </font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-14<br></div></div></div>
<!--End Page 182-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 183-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">consulting services through December&#160;31, 2020 regarding an initial public offering, a private placement transaction and/or a merger and acquisition transaction. In consideration for providing these services, the Company agreed to pay A-Labs an advance payment of $1&#160;million in addition to 1.5% of all amounts actually received by the Company or its shareholders in connection with a &#8220;Transaction&#8221; (as defined therein); however in the event that (a) the fundraising is more than $150&#160;million with (b) a Company pre-money valuation of $400&#160;million, then such percentage shall increase to 2.5% (collectively, the &#8220;Transaction Fee&#8221;). All payments made to A-Labs prior to the date of the amendment shall be deducted from the Transaction Fee. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">In addition, upon consummation of a Transaction A-Labs will be granted options to purchase shares of the Company equal to 2.5% of all the shares actually issued by the Company to the investors in the Transaction, exercisable at the price per share set forth in the Transaction and exercisable until the earlier of (a) a period of five years or (b) an M&amp;A Event (as defined therein, and shall not include an IPO).</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">d.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">During September 2019, the Company entered into a Service Agreement with RMD AP Limited, a company </font><font style="font-weight: normal;">registered under the laws of Hong Kong (RMD). RMD undertook to provide the Company with services </font><font style="font-weight: normal;">related to the Asia Pacific region, including, among others, operational and business development related </font><font style="font-weight: normal;">matters. The agreement is for a period of one year and the agreed commitment for the services is </font><font style="font-weight: normal;">$800&#160;thousand. RMD will bear all costs and expenses incurred beyond such agreed upon amount.</font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">e.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">During September 2019, Nanox IL entered into a Collaboration Agreement with Hadasit Medical Research </font><font style="font-weight: normal;">Services and Development Ltd. (&#8220;Hadasit&#8221;), a wholly owned subsidiary of the Hadassah Medical </font><font style="font-weight: normal;">Organization. The parties agreed to collaborate with respect to the Company's medical imaging technology </font><font style="font-weight: normal;">and resulting medical images devices (the &#8220;Company Products&#8221;), by way of (a) joint research and </font><font style="font-weight: normal;">development projects (each, a &#8220;Research Project&#8221;), and (b) the provision by Hadasit of services in </font><font style="font-weight: normal;">connection with the Company Products, such as testing and consulting work, where no innovative research </font><font style="font-weight: normal;">will be carried out (each, a &#8220;Service&#8221;). Each Research Project and Service shall be rendered under a </font><font style="font-weight: normal;">separate project agreement concluded between the parties in writing from time to time (collectively, the </font><font style="font-weight: normal;">&#8220;Project Agreements&#8221;). The parties envisage the collaboration to continue over a period of five years, </font><font style="font-weight: normal;">unless an extension is agreed by the parties in writing. Under such agreement, the Company paid Hadasit a </font><font style="font-weight: normal;">non-refundable advance payment for the Research Projects and Services, in the amount of $ 250 thousand, </font><font style="font-weight: normal;">which shall be credited against payments due from time to time to Hadasit under the Project Agreements. </font><font style="font-weight: normal;">Nanox IL has no obligation to enter into Project Agreements with Hadasit in excess of such advanced </font><font style="font-weight: normal;">payment.</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Nanox IL also granted Hadasit an option to purchase 23,957 ordinary shares at a price of $20.87 per share and for a total exercise price of $500 thousand (&#8220;Hadasit Options&#8221;). The Hadasit Options shall vest in three equal installments over a two-year period commencing on September&#160;8, 2019 (the &#8220;Hadasit Effective Date&#8221;), as follows: (a) 7,986 of Hadasit Options shall be fully vested upon grant, (b) an additional 7,986 of Hadasit Options shall vest on the first anniversary of the Hadasit Effective Date; and (c) the remaining 7,985 of Hadasit Options shall vest on the second anniversary of the Hadasit Effective Date. In the event of an IPO, all unvested options shall be fully accelerated immediately prior to the consummation of the IPO. The Hadasit Options shall be exercisable until the earlier of (a) the consummation of an Exit Event (as defined therein, which includes an IPO), or (b) the sixth (6th) anniversary of the Hadasit Effective Date. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">f.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">On December&#160;16, 2019, Nanox IL signed an agreement with Dr. Ilung Kim for provision of services to the </font><font style="font-weight: normal;">Company. Dr. Kim will not receive any cash compensation, but will be granted options to purchase </font><font style="font-weight: normal;">1,206,290 ordinary shares with an exercise price of $2.21 per ordinary share. 301,572 of the options vested </font><font style="font-weight: normal;">as of the grant date and the remaining 904,718 options will vest in equal monthly installments over a period </font><font style="font-weight: normal;">of three years from the vesting commencement date. In the event of an IPO or Deemed Liquidation (as </font><font style="font-weight: normal;">defined therein), all unvested options shall fully accelerate immediately prior to the consummation of the </font><font style="font-weight: normal;">IPO. The vested options shall be exercisable until the earlier of (a) the second anniversary of termination of </font><font style="font-weight: normal;">the engagement by and among the Company and Dr. Ilung Kim, or (b) the tenth anniversary from the date </font><font style="font-weight: normal;">of grant.</font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-15<br></div></div></div>
<!--End Page 183-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 184-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">Share-based compensation expenses in an amount of $5,440 thousand included in the Company&#8217;s consolidated statements of operations for the year ended December&#160;31, 2019 were recorded as general and administrative expenses for the abovementioned awards. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">NOTE 8 - SHAREHOLDERS' EQUITY:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Share capital</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Each holder of the Company&#8217;s ordinary shares is entitled to one vote. The holders of ordinary shares are also entitled to receive dividends whenever funds are legally available, and declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). Since inception, the Company has not declared any dividends.</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Ordinary Share issuances prior to the APA</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">During the year ended December&#160;31, 2018, Nanox PLC entered into several agreements with third party investors, pursuant to which it raised an aggregate amount of $3,684 thousand at a purchase price of $2.21&#160;per share. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">On June&#160;17, 2019, Nanox PLC issued 2,262,443 ordinary shares to third party investors for an aggregate purchase price of approximately $5&#160;million. Certain investors were also granted warrants to acquire 2,262,443 of ordinary shares at an exercise price of $20.87 per share.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Additionally during 2019, Nanox PLC entered into several agreements with certain third party investors, pursuant to which it raised an aggregate amount of $4,038 thousand, net of issuance costs, at a purchase price of $2.21 per share. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Ordinary Share issuances after the APA</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">On December 31 2019, the Company issued 312,500 ordinary shares to a third party investor for an aggregate purchase price of approximately $5&#160;million. For additional investments after the balance sheet date please refer to note 12b.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Share based compensation<font style="font-weight: normal;"> </font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">On September&#160;3, 2019, the Company&#8217;s Board resolved to adopt an equity incentive plan (the &#8220;Plan&#8221;). Based on such Plan, each option will be exercisable for one ordinary share of the Company and will become exercisable at such terms and during such periods, as the Board shall determine. Pursuant to the Plan (and further increase of option pool approved by the Board), 8,041,936 ordinary shares of NIS 0.01 par value of the Company are reserved for issuance upon the exercise of the same amount of awards to be granted to some of the Company&#8217;s employees, directors and consultants. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The Board also approved the Plan for the purpose of selecting the capital gains tax track, under Section&#160;102 of the Israeli Income Tax Ordinance, for options granted to the Company's Israeli employees.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Share-based compensation to non-employees : </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-16<br></div></div></div>
<!--End Page 184-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 185-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">Changes in the number of share-based payments to non-employees are as followed: </div><table cellspacing="0" cellpadding="0" class="fintab" align="40" style="margin-top: 11.25pt; border-collapse: collapse; width: 428pt; margin-left: 40pt;"><tr class="header"><td style="width: 33.65%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 27.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December&#160;31,</div></td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 25.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December&#160;31,</div></td></tr><tr class="header"><td style="width: 33.65%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 27.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 25.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 33.65%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 13.39%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br>share-based <br>payment awards </div></td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br>average <br>exercise<br>price </div></td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.64%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br>share-based <br>payment <br>awards </div></td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 3.26%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.7%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted<br>average <br>payment <br>exercise <br>price </div></td></tr><tr><td style="width: 33.65%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding at beginning of year<font style="padding-left: 1.55pt;"></font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 13.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;">1,592,874</div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$1.32</div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.77pt; text-align: left;">1,751,140</div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;">$1.40</div></td></tr><tr><td style="width: 33.65%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the year:<br></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 33.65%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted<font style="padding-left: 4.29pt;"></font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 13.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;">2,271,698</div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.77</div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.77pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;"><font style="padding-left: 12.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 33.65%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised<font style="padding-left: 2.07pt;"></font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 13.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;"><font style="padding-left: 4.17pt;">(454,166)</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$<font style="padding-left: 5pt;">0.3</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.77pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;"><font style="padding-left: 12.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 33.65%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited<font style="padding-left: 4.85pt;"></font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 13.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><font style="padding-left: 12.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.77pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;"><font style="padding-left: 12.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 33.65%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired<font style="padding-left: 4.84pt;"></font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 13.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><font style="padding-left: 12.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.77pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;"><font style="padding-left: 12.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 33.65%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cancelled<font style="padding-left: 1.51pt;"></font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 13.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;"><font style="padding-left: 30pt; border-bottom: 1pt solid #000000;">&#8212;</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000;">&#8212;</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.77pt; text-align: left;"><font style="padding-left: 4.17pt; border-bottom: 1pt solid #000000;">(158,266</font>)</div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$2.21</font></div></td></tr><tr><td style="width: 33.65%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding at end of year<font style="padding-left: 2.1pt;"></font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 13.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">3,410,406</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$1.89</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 10.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.77pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">1,592,874</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 8.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$1.32</font></div></td></tr><tr><td style="width: 33.65%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercisable at end of year<font style="padding-left: 4.34pt;"></font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 13.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">1,830,809</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$3.79</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.77pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">1,592,874</font></div></td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 3.26%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$1.32</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The fair value of each granted award is estimated at the date of grant using the Black-Scholes option-pricing model. The assumptions used for the years ended December&#160;31, 2019 and 2018 are as follows:</div><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 61.61%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.62%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.91%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 61.61%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fair value of one ordinary share<font style="padding-left: 1.34pt;"></font></div></td><td class="gutter" style="width: 1.62%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td style="width: 15.91%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">16</div></td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td style="width: 15.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">2.21</div></td></tr><tr><td style="width: 61.61%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dividend yield<font style="padding-left: 2.96pt;"></font></div></td><td class="gutter" style="width: 1.62%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.91%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">0</div></td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">0</div></td></tr><tr><td style="width: 61.61%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility<font style="padding-left: 1.85pt;"></font></div></td><td class="gutter" style="width: 1.62%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td style="width: 15.91%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">41.11% - 50.59%</div></td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td style="width: 15.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">51.97% - 72.25%</div></td></tr><tr><td style="width: 61.61%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate<font style="padding-left: 0.22pt;"></font></div></td><td class="gutter" style="width: 1.62%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.91%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">1.55%-1.76%</div></td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">1.52%-2.94%</div></td></tr><tr><td style="width: 61.61%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Contractual term (years)<font style="padding-left: 4.11pt;"></font></div></td><td class="gutter" style="width: 1.62%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td style="width: 15.91%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">0.50 &#8211; 10.00</div></td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.62%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td style="width: 15.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">1.05 &#8211; 6.00</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 20pt; text-align: left;">The expected volatility is based on the historical volatility of comparable companies. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The risk-free interest rate assumption is based on observed interest rates appropriate for the expected term of the awards granted in dollar terms. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. Accordingly, as to ordinary course options granted, the expected term was determined using the simplified method, which takes into consideration the option&#8217;s contractual life and the vesting periods (for non-employees, the expected term is equal to the option&#8217;s contractual life).</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-17<br></div></div></div>
<!--End Page 185-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 186-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">The following table summarizes information concerning outstanding and exercisable awards as of December&#160;31, 2019 and 2018:</div><table cellspacing="0" cellpadding="0" class="fintab" align="40" style="margin-top: 11.25pt; border-collapse: collapse; width: 428pt; margin-left: 40pt;"><tr class="header"><td style="width: 50.47%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="10" style="width: 46.28%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2018 </div></td></tr><tr class="header"><td rowspan="2" style="width: 50.47%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercise price </div></td><td class="gutter" rowspan="2" style="width: 1.63%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.63%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.84%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Awards outstanding</div></td><td class="gutter" style="width: 1.63%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.63%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.18%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Awards exercisable </div></td></tr><tr class="header"><td class="gutter" style="width: 1.63%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.45%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of<br>awards<br>outstanding<br>at end of<br>year </div></td><td class="gutter" style="width: 1.63%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.63%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br>average<br>remaining<br>contractual<br>life (years)</div></td><td class="gutter" style="width: 1.63%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.63%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br>awards <br>exercisable<br>at end of <br>year</div></td><td class="gutter" style="width: 1.63%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.63%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br>average<br>remaining<br>contractual<br>life (years)</div></td></tr><tr><td style="width: 50.47%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$0.01<font style="padding-left: 1pt;"></font></div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.45%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;">186,815</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">2.33</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.56pt; text-align: left;">186,815</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">2.33</div></td></tr><tr><td style="width: 50.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$0.30<font style="padding-left: 1pt;"></font></div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.45%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;">454,166</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">0.77</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.56pt; text-align: left;">454,166</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">0.77</div></td></tr><tr><td style="width: 50.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1.92<font style="padding-left: 1pt;"></font></div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.45%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;">472,606</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">2.81</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.56pt; text-align: left;">472,606</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">2.81</div></td></tr><tr><td style="width: 50.47%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$2.21<font style="padding-left: 1pt;"></font></div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.45%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;">479,287</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">3.37</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 8.79%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.56pt; text-align: left;">479,287</div></td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">3.37</div></td></tr></table><table cellspacing="0" cellpadding="0" class="fintab" align="40" style="margin-top: 6pt; border-collapse: collapse; width: 428pt; margin-left: 40pt;"><tr class="header"><td style="width: 50.47%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="10" style="width: 46.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2019 </div></td></tr><tr class="header"><td rowspan="2" style="width: 50.47%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercise price </div></td><td class="gutter" rowspan="2" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.7%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Awards outstanding</div></td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Awards exercisable </div></td></tr><tr class="header"><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.45%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of<br>awards<br>outstanding<br>at end of<br>year </div></td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br>average<br>remaining<br>contractual<br>life (years)</div></td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br>awards <br>exercisable<br>at end of <br>year</div></td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br>average<br>remaining<br>contractual<br>life (years) </div></td></tr><tr><td style="width: 50.47%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$0.01<font style="padding-left: 1pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.45%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.23pt; text-align: left;"><font style="padding-left: 7.5pt;">186,815</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">1.33</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">186,815</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">1.33</div></td></tr><tr><td style="width: 50.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1.92<font style="padding-left: 1pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.45%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.23pt; text-align: left;"><font style="padding-left: 7.5pt;">472,606</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">1.81</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">472,606</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">1.81</div></td></tr><tr><td style="width: 50.47%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$2.21<font style="padding-left: 1pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.45%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.23pt; text-align: left;">2,727,028</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">5.27</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">1,163,402</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">5.27</div></td></tr><tr><td style="width: 50.47%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$20.87<font style="padding-left: 1pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.45%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.23pt; text-align: left;"><font style="padding-left: 12.5pt;">23,957</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">5.69</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">7,986</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">5.69</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Share-based compensation to employees, officers and directors </div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">During 2019, the Company granted to certain employees, officers and directors awards to purchase 1,667,267 of the Company&#8217;s ordinary shares for an exercise price of $2.21. For the awards granted to the Company's CEO refer to note&#160;10e. </div><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 4.04%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 27.64%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December&#160;31,<br>2019 </div></td></tr><tr class="header"><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 4.04%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.09%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of<br>share-based<br>payment <br>awards </div></td><td class="gutter" style="width: 4.04%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 4.04%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br>average <br>exercise price </div></td></tr><tr><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding at beginning of year<font style="padding-left: 0.55pt;"></font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.09%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.48%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the year:<br></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted<font style="padding-left: 3.29pt;"></font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.09%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;">1,667,267</div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.48%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;">2.21</div></td></tr><tr><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised<font style="padding-left: 1.07pt;"></font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.09%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.48%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited<font style="padding-left: 3.85pt;"></font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.09%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.48%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired<font style="padding-left: 3.84pt;"></font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.09%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.48%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cancelled<font style="padding-left: 0.51pt;"></font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.09%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 30pt; border-bottom: 1pt solid #000000;">&#8212;</font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.48%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;"><font style="padding-left: 7.5pt; border-bottom: 1pt solid #000000;">&#8212;</font></div></td></tr><tr><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding at end of year<font style="padding-left: 1.1pt;"></font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 9.09%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">1,667,267</font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 10.48%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">2.21</font></div></td></tr><tr><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercisable at end of year<font style="padding-left: 3.34pt;"></font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.09%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 7.5pt; border-bottom: 3pt double #000000;">450,557</font></div></td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.04%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.48%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">2.21</font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-18<br></div></div></div>
<!--End Page 186-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 187-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">The fair value of each granted award is estimated at the date of grant using the Black-Scholes option-pricing model. The assumptions used as of December&#160;31, 2019 are as follows:</div><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 80.36%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 2.38%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 14.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 80.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fair value of one ordinary share<font style="padding-left: 0.34pt;"></font></div></td><td class="gutter" style="width: 2.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td style="width: 14.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">16</div></td></tr><tr><td style="width: 80.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dividend yield<font style="padding-left: 1.96pt;"></font></div></td><td class="gutter" style="width: 2.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 14.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">0</div></td></tr><tr><td style="width: 80.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility<font style="padding-left: 0.85pt;"></font></div></td><td class="gutter" style="width: 2.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td style="width: 14.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">46.1% - 50.65%</div></td></tr><tr><td style="width: 80.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate<font style="padding-left: 4.22pt;"></font></div></td><td class="gutter" style="width: 2.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 2.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 14.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">1.65% - 1.68%</div></td></tr><tr><td style="width: 80.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Contractual term (years)<font style="padding-left: 3.11pt;"></font></div></td><td class="gutter" style="width: 2.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 2.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF; border-bottom: 1px solid #CCEEFF;">&#8203;</td><td style="width: 14.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 1.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">5.75 - 6.23</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The expected volatility is based on the historical volatility of comparable companies. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The risk-free interest rate assumption is based on observed interest rates appropriate for the expected term of the awards granted in dollar terms. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. Accordingly, as to ordinary course options granted, the expected term was determined using the simplified method, which takes into consideration the option&#8217;s contractual life and the vesting periods. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The following table summarizes information concerning outstanding and exercisable awards as of December&#160;31, 2019: </div><table cellspacing="0" cellpadding="0" class="fintab" align="40" style="margin-top: 5.25pt; border-collapse: collapse; width: 428pt; margin-left: 40pt;"><tr class="header"><td colspan="13" style="width: 100%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2019 </div></td></tr><tr class="header"><td colspan="7" style="width: 59.44%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.5pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Awards outstanding</div></td><td class="gutter" style="width: 0.7%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.7%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 39.16%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.5pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Awards exercisable </div></td></tr><tr class="header"><td style="width: 18.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.5pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise price</div></td><td class="gutter" style="width: 0.7%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.7%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 18.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.5pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of<br>awards<br>outstanding<br>at end of<br>year </div></td><td class="gutter" style="width: 0.7%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.7%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 18.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.5pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br>average<br>remaining<br>contractual<br>life (years)</div></td><td class="gutter" style="width: 0.7%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.7%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 18.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.5pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br>awards <br>exercisable<br>at end of <br>year</div></td><td class="gutter" style="width: 0.7%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.7%; font-size: 2pt; padding-top: 3.5pt; padding-bottom: 3.5pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 18.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.5pt; padding-bottom: 3.5pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br>average<br>remaining<br>contractual<br>life (years) </div></td></tr><tr><td style="width: 18.88%; text-align: center; vertical-align: bottom; padding-top: 3.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">$2.21</div></td><td class="gutter" style="width: 0.7%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.7%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 18.88%; text-align: center; vertical-align: bottom; padding-top: 3.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">1,667,267</div></td><td class="gutter" style="width: 0.7%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.7%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 18.88%; text-align: center; vertical-align: bottom; padding-top: 3.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">9.90</div></td><td class="gutter" style="width: 0.7%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.7%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 18.88%; text-align: center; vertical-align: bottom; padding-top: 3.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">450,557</div></td><td class="gutter" style="width: 0.7%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.7%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 18.88%; text-align: center; vertical-align: bottom; padding-top: 3.5pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">9.90</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">(i)&#160;Share-based compensation expenses for awards granted to non-employees, employees, officers and directors in the amount of $661 thousand included in the Company&#8217;s consolidated statements of operations for the year ended December&#160;31, 2019 were recorded as research and development expenses.</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 60pt; text-align: left;">(ii)&#160;Share-based compensation expenses for awards granted to non-employees, employees, officers and directors in the amount of $617 thousand included in the Company&#8217;s consolidated statements of operations for the year ended December 31, 2019 were recorded as marketing expenses. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 60pt; text-align: left;">(iii) Share-based compensation expenses for awards granted to non-employees, employees, officers and directors in the amount of $14,967 thousand and $115 thousand included in the Company&#8217;s consolidated statements of operations for the years ended December&#160;31, 2019 and 2018, respectively, were recorded as general and administrative expenses.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">NOTE 9 - INCOME TAX:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Basis of taxation</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Current tax is calculated with reference to the profit of the Company and its subsidiary in their respective countries of operation. Set out below are details in respect of the significant jurisdictions where the Company and its subsidiary operates and the factors that influenced the current and deferred taxation in those jurisdictions:</div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;">Israel</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The Company is taxed under the laws of the State of Israel at a corporate tax rate of 23%. In 2019 and 2018, the Company was at a loss position and therefore had no corporate tax liability.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-19<br></div></div></div>
<!--End Page 187-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 188-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 8pt; margin-left: 0pt; text-align: left;">Gibraltar</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Gibraltar companies are subject to a corporate tax rate of 10%. In 2019 and 2018, Nanox PLC was at a loss position and therefore had no corporate tax liability. </div><div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Japan</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Nanox Japan and Nanox Inc. are subject to national corporate income tax, inhabitants&#8217; tax, and enterprise tax in Japan, which, in the aggregate, resulted in effective tax rate of approximately 33.80% for the year ended December&#160;31, 2018. Amendments to the Japanese tax regulations were enacted into law in March 2019. As a result, the effective tax rate is scheduled to be reduced to approximately 33.59% effective from the year ending December&#160;31, 2019.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Under Japanese tax law and regulations, every company is required to submit an annual tax return to tax authorities. The statute of limitations to request a correction of prior year tax liabilities is five years from when the original tax return was filed. After filling of tax return, the tax authorities may conduct tax inspections on an irregular basis.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Tax assessments</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">Nanox IL. Nanox PLC, Nanox Japan and Nanox Inc. have not been assessed since inception. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">c.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Deferred tax assets<font style="font-weight: normal;"> </font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Nanox IL's deferred tax asset as of December&#160;31, 2019 was related to tax losses accumulated since September&#160;3, 2019 and carryforward. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">A full valuation allowance was created against deferred tax assets arisen from the carryforward tax losses, since the realization of any future benefit from the carryforward tax losses cannot be sufficiently assured as of December&#160;31, 2019.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">The reconciling item between the statutory tax rate of the Company and the effective tax rate is the change in valuation allowance in respect of tax benefits from carried forward tax losses due to uncertainty of the realization of such tax benefits. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">Change in valuation allowance for the year ended December&#160;31, 2019 was $522 thousands. </div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">NOTE 10 - RELATED PARTIES - TRANSACTIONS AND BALANCES:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Balances with related parties:</div></td></tr></table><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 64.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 4.03%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 27.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div></td></tr><tr class="header"><td style="width: 64.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 4.03%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 4.03%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 4.03%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.24%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 64.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 4.03%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 27.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(U.S. Dollars in thousands)</div></td></tr><tr><td style="width: 64.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Related party prepaid expenses &#8211; See d below<font style="padding-left: 1.14pt;"></font></div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.44pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 3pt double #000000;">&#8212;</font></div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.44pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">1,694</font></div></td></tr><tr><td style="width: 64.28%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Related party liability, refer to note 6<font style="padding-left: 2.6pt;"></font></div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.44pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">17,820</font></div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.44pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">8,157</font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Related parties transactions:</div></td></tr></table><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 64.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 4.03%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 27.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December&#160;31,</div></td></tr><tr class="header"><td style="width: 64.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 4.03%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.52%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 4.03%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 4.03%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.07%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr class="header"><td style="width: 64.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 4.03%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 27.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(U.S. Dollars in thousands)</div></td></tr><tr><td style="width: 64.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development<font style="padding-left: 1.1pt;"></font></div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.32pt; text-align: left;"><font style="padding-left: 7.5pt; border-bottom: 3pt double #000000;">154</font></div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.07%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.82pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">542</font></div></td></tr><tr><td style="width: 64.28%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative<font style="padding-left: 0.55pt;"></font></div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 10.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.32pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">5,824</font></div></td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt;">&#8203;</td><td class="gutter" style="width: 4.03%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt;">&#8203;</td><td style="width: 9.07%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.82pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">892</font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">c.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Six-Eye agreements for services<font style="font-weight: normal;"> </font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">On June 1 2015, Nanox PLC entered into a consulting agreement with Six-Eye, a company owned by Ran Poliakine, the Company's CEO and one of its major shareholders, pursuant to which Ran Poliakine agreed </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-20<br></div></div></div>
<!--End Page 188-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 189-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-align: left;">to provide services as Chief Strategy Officer and a member of the Executive Committee to Nanox PLC. On May&#160;1, 2017, Nanox PLC entered into a services agreement with Six-Eye for the supply of ongoing services which include research and development services, general and financial management (including accountancy), office management services and operational and supply services. According to the agreement between the parties, Nanox PLC reimburses Six-Eye for its actual direct expenses plus a 12% surplus charge. During the years ended December 31 2019 and 2018, the total expenses to Six-Eye were $679 thousand and $1,434 thousand, respectively. In addition to the services provided by Six-Eye during 2019, Six-Eye also paid directly to third party consultants and suppliers on behalf of the Company in the amount of approximately $1,015 thousand prior to the completion of the Company&#8217;s equity financing. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">d.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">The related party prepaid expenses reflect funds raised during 2018 (refer to note 8a) in an amount of </font><font style="font-weight: normal;">$&#160;3,684 thousand from third party investors, less amounts payable in accordance with Six-Eye service </font><font style="font-weight: normal;">agreement (see c above). The funds were received directly by Six-Eye (these funds were not received by the </font><font style="font-weight: normal;">Company nor remitted from the Company to Six-Eye) less amounts payable in accordance with Six-Eye </font><font style="font-weight: normal;">service agreement (see c above). </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">e.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">Effective from September 2019, Nanox IL signed an executive employment agreement with Ran Poliakine </font><font style="font-weight: normal;">(&#8220;the CEO&#8221;) to serve as the Company&#8217;s CEO (&#8220;the CEO agreement&#8221;). According to the CEO agreement, </font><font style="font-weight: normal;">the CEO will be entitled to a monthly gross salary of $40 thousand, which will be increased to $60 </font><font style="font-weight: normal;">thousand upon the Company's consummation of an IPO. The CEO will be entitled to other benefits as </font><font style="font-weight: normal;">described in the CEO agreement including an annual bonus subject to performance criteria. The CEO was </font><font style="font-weight: normal;">granted options to purchase 1,206,290 ordinary shares with an exercise price of $2.21 per ordinary share. </font><font style="font-weight: normal;">301,572 of the options were vested as of the grant date and the remaining 904,718 options will be vested in </font><font style="font-weight: normal;">equal monthly installments over a period of three years from the vesting commencement date. Share-based </font><font style="font-weight: normal;">compensation expenses in an amount of $5,299 thousand included in the Company&#8217;s consolidated statements </font><font style="font-weight: normal;">of operations for the year ended December&#160;31, 2019 were recorded as </font><font style="font-weight: normal;">general and administrative expenses </font><font style="font-weight: normal;">for the abovementioned awards. </font></div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">NOTE 11 - LOSS PER SHARE:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Basic</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Basic loss per share is calculated by dividing the loss attributable to the Company&#8217;s owners by the weighted average number of ordinary shares in issue.</div><table cellspacing="0" cellpadding="0" class="fintab" align="20" style="margin-top: 11.25pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;"><tr class="header"><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 4.31%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 27.09%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December&#160;31,</div></td></tr><tr class="header"><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 4.31%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 4.31%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 4.31%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.87%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2018</div></td></tr><tr><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss attributable to Company&#8217;s owners<font style="padding-left: 1.11pt;"></font></div></td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.6pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$(22,563</font>)</div></td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.87%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.61pt; text-align: left;"><font style="border-bottom: 1pt solid #000000;">$</font><font style="padding-left: 1.67pt; border-bottom: 1pt solid #000000;">(1,909</font>)</div></td></tr><tr><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">The weighted average of the number of ordinary shares (in thousands)<font style="padding-left: 2.18pt;"></font></div></td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 9.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.6pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000;">25,181</font></div></td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td><td style="width: 8.87%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.61pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 3pt double #000000;">20,793</font></div></td></tr><tr><td style="width: 64.29%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Basic and diluted loss per share<font style="padding-left: 0.01pt;"></font></div></td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.6pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$</font><font style="padding-left: 10pt; border-bottom: 3pt double #000000;">(0.90</font>)</div></td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 4.31%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.87%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.61pt; text-align: left;"><font style="border-bottom: 3pt double #000000;">$</font><font style="padding-left: 6.67pt; border-bottom: 3pt double #000000;">(0.09</font>)</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">For the calculation of loss per share, the Company used the net loss attributable to Company&#8217;s owners divided by the weighted average number of the Company's ordinary shares for the years ended December&#160;31, 2019 and 2018. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Diluted</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">When calculating the diluted loss per share for the years ended December&#160;31, 2019 and 2018, the Company did not take into account any dilutive instruments, such as share-based payments, since their effect, on a fully diluted basis, is anti-dilutive.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">As of December&#160;31, 2019 and 2018, the Company had 9,203,124 and 3,377,180, respectively, investor warrants and employees and non-employees option awards outstanding. These warrants and awards were not taken into account when calculating diluted loss per share since their effect, on a fully diluted basis, is anti-dilutive.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-21<br></div></div></div>
<!--End Page 189-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 190-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_202-finnote01_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br><font style="font-weight: normal;">NOTES TO THE FINANCIAL STATEMENTS</font><font style="font-weight: normal; padding-left: 4pt;">(continued) </font><br></div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8pt; margin-left: 0pt; text-align: left;">NOTE 12 - SUBSEQUENT EVENTS: </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Subsequent events disclosed until February&#160;18, 2020:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">During January 2020, subject to entering into a share purchase agreement in the aggregate amount of at </font><font style="font-weight: normal;">least $6&#160;million, and a pre-money valuation of more than $100&#160;million, the Nanox IL&#8217;s Board approved the </font><font style="font-weight: normal;">issuance and allotment of 1,109,245 ordinary shares to Nanox PLC with the purchase price of $12.00 per </font><font style="font-weight: normal;">share, which reflects a discount of 25% from the price of the last financing round of the Company. As a </font><font style="font-weight: normal;">result, on January&#160;30, 2020 the related party liability was settled into equity at a price per share reflecting a </font><font style="font-weight: normal;">discount of 25% from the price of the last financing round. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">During January and February 2020 Nanox IL issued additional </font><font style="font-weight: normal;">257,723</font><font style="font-weight: normal;"> ordinary shares to other investors </font><font style="font-weight: normal;">for an aggregate purchase price of approximately </font><font style="font-weight: normal;">$3.4 </font><font style="font-weight: normal;">million at a </font><font style="font-weight: normal;">$16 </font><font style="font-weight: normal;">per ordinary share.</font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">c.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">In February 2020, the Company granted a total of </font><font style="font-weight: normal;">407,868</font><font style="font-weight: normal;"> </font><font style="font-weight: normal;">awards with an exercise price of $</font><font style="font-weight: normal;">2.21</font><font style="font-weight: normal;"> per share </font><font style="font-weight: normal;">to employees and service providers.</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">Subsequent events disclosed after February&#160;18, 2020: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">d.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">During the first half of 2020, the Company entered into share purchase agreements with certain investors </font><font style="font-weight: normal;">(together, the &#8220;Investors&#8221;), under which the Company issued an aggregate of 2,368,250 ordinary shares to </font><font style="font-weight: normal;">the Investors, at a price per share of $16.00, for an aggregate purchase price of approximately $37.9&#160;million.</font><font style="font-weight: normal;"> </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">e.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">In July 2020, the Company issued 625,000 ordinary shares to one of its investors, as part of their </font><font style="font-weight: normal;">$20</font><font style="font-weight: normal;"> million equity investment at a price per share of $16.00, for a purchase price of $10 million, received in </font><font style="font-weight: normal;">July 2020, which reflects the second portion of the investor&#8217;s $20 million investment.</font><font style="font-weight: normal;"> </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">f.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">In July 2020, the Company entered into additional share purchase agreements with certain investors for the </font><font style="font-weight: normal;">issuance of 3,500,000 ordinary shares at a price per share of $16.00, for an aggregate purchase price of </font><font style="font-weight: normal;">approximately $56 million. As of the date of the issuance of these financial statements, the funds were not </font><font style="font-weight: normal;">received yet.</font><font style="font-weight: normal;"> </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">g.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">The Company has evaluated subsequent events through </font><font style="font-weight: normal;">July&#160;</font><font style="font-weight: normal;">30</font><font style="font-weight: normal;">, 2020, the date on which the consolidated </font><font style="font-weight: normal;">financial statements were available to be issued.</font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-22<br></div></div></div>
<!--End Page 190-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 191-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_203-fintab02_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; text-align: center;"><a name="fCBS2"><!--Anchor--></a>UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 10.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.06%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June 30, <br>2020</div></td><td class="gutter" style="width: 1.37%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.37%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br>2019 </div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.37%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">U.S. Dollars in thousands</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CURRENT ASSETS:<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 4.77pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 3.33pt;">39,524</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 8.33pt;">8,072</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Related party prepaid expenses<font style="padding-left: 0.34pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 20.83pt;">35</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 20.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Prepaid expenses and other current assets<font style="padding-left: 2.59pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 15.83pt;">890</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 8.33pt;">1,564</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TOTAL CURRENT ASSETS<font style="font-weight: normal; padding-left: 1.38pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 3.33pt;">40,449</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 8.33pt;">9,636</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">NON-CURRENT ASSETS:<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted cash<font style="padding-left: 0.86pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 15.83pt;">192</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 15.83pt;">145</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Property and equipment, net<font style="padding-left: 1.7pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 15.83pt;">439</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 15.83pt;">228</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred offering costs<font style="padding-left: 3.29pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 8.33pt;">1,469</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 8.33pt;">1,197</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease right-of-use asset<font style="padding-left: 0.91pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 15.83pt;">934</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 15.83pt;">526</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current assets<font style="padding-left: 3.11pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 20.83pt;">98</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 15.83pt;">139</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TOTAL NON-CURRENT ASSETS<font style="font-weight: normal; padding-left: 0.84pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 8.33pt;">3,132</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 8.33pt;">2,235</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TOTAL ASSETS<font style="font-weight: normal; padding-left: 3.96pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 3.33pt;">43,581</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 3.88pt;">11,871</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Liabilities and Shareholders' Equity (Capital Deficiency)<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CURRENT LIABILITIES:<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accounts payable<font style="padding-left: 0.31pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 15.83pt;">406</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 15.83pt;">475</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accrued expenses and other liabilities<font style="padding-left: 2.01pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 8.33pt;">1,690</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 8.33pt;">1,828</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Related party accrued liabilities<font style="padding-left: 3.11pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 15.83pt;">192</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 20.83pt;">72</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Related party liability<font style="padding-left: 3.64pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 20.83pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 3.33pt;">17,748</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current maturities of operating leases<font style="padding-left: 3.68pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 15.83pt;">315</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 15.83pt;">140</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TOTAL CURRENT LIABILITIES<font style="font-weight: normal; padding-left: 1.4pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 8.33pt;">2,603</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 3.33pt;">20,263</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">NON-CURRENT LIABILITIES:<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-current operating leases<font style="padding-left: 0.34pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 15.83pt;">619</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 15.83pt;">386</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TOTAL NON-CURRENT LIABILITIES<font style="font-weight: normal; padding-left: 0.85pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 15.83pt;">619</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 15.83pt;">386</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TOTAL LIABILITIES<font style="font-weight: normal; padding-left: 3.98pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 8.33pt;">3,222</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 3.33pt;">20,649</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">COMMITMENTS SHAREHOLDERS' EQUITY (CAPITAL DEFICIENCY):<br></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Ordinary Shares, par value NIS 0.01 per share, 40,000,000 authorized at June&#160;30, 2020 and December 2019, respectively; 30,679,965 and 27,150,080 issued and outstanding at June&#160;30, 2020 and December&#160;31, 2019, respectively<font style="padding-left: 3.98pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 20.83pt;">85</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 20.83pt;">75</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Additional paid-in capital<font style="padding-left: 3.09pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 3.33pt;">94,661</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 3.33pt;">31,748</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated deficit<font style="padding-left: 0.31pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">(54,387)</div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;">(40,601)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TOTAL SHAREHOLDERS&#8217; EQUITY (CAPITAL DEFICIENCY)<font style="font-weight: normal; padding-left: 1.99pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 3.33pt;">40,359</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 5pt;">(8,778)</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (CAPITAL DEFICIENCY)<font style="font-weight: normal; padding-left: 0.86pt;"></font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;"><font style="padding-left: 3.33pt;">43,581</font></div></td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 10.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.28pt; text-align: left;"><font style="padding-left: 3.7pt;">11,871</font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. <br></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-23<br></div></div></div>
<!--End Page 191-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 192-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_203-fintab02_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; text-align: center;"><a name="fCSO2"><!--Anchor--></a>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 10.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30,</div></td><td class="gutter" style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 23.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td></tr><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.01%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.01%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.01%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.28%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.01%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.01%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.67%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.01%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.01%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.67%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.01%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="10" style="width: 46.69%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(U.S. dollars in thousands, except for per share data)</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">OPERATING EXPENSES:<br></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development<font style="padding-left: 3.1pt;"></font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 8.33pt;">4,152</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 12.5pt;">340</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.22pt; text-align: left;"><font style="padding-left: 5pt;">1,786</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.21pt; text-align: left;"><font style="padding-left: 12.5pt;">172</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketing<font style="padding-left: 0.85pt;"></font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 8.33pt;">1,745</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 12.5pt;">242</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.22pt; text-align: left;"><font style="padding-left: 12.5pt;">772</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.21pt; text-align: left;"><font style="padding-left: 12.5pt;">122</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative<font style="padding-left: 2.55pt;"></font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 8.33pt;">7,903</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 5pt;">1,079</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.22pt; text-align: left;"><font style="padding-left: 5pt;">3,871</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.21pt; text-align: left;"><font style="padding-left: 12.5pt;">659</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">OPERATING LOSS<font style="padding-left: 4.18pt;"></font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;">(13,800)</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 1.67pt;">(1,661)</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.22pt; text-align: left;"><font style="padding-left: 1.67pt;">(6,429)</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.21pt; text-align: left;"><font style="padding-left: 9.17pt;">(953)</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">FINANCIAL EXPENSES (INCOME), NET<font style="padding-left: 1.54pt;"></font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 17.5pt;">(14)</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 17.5pt;">14</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.22pt; text-align: left;"><font style="padding-left: 14.17pt;">(65)</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.21pt; text-align: left;"><font style="padding-left: 17.87pt;">11</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">NET LOSS<font style="padding-left: 0.47pt;"></font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;">(13,786)</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 1.67pt;">(1,675)</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.22pt; text-align: left;"><font style="padding-left: 1.67pt;">(6,364)</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.21pt; text-align: left;"><font style="padding-left: 9.17pt;">(964)</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">BASIC AND DILUTED LOSS PER SHARE<font style="padding-left: 1.43pt;"></font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 10pt;">(0.47)</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 6.67pt;">(0.07)</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.22pt; text-align: left;"><font style="padding-left: 6.67pt;">(0.21)</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.21pt; text-align: left;"><font style="padding-left: 6.67pt;">(0.04)</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">WEIGHTED AVERAGE NUMBER OF<font style="padding-left: 3.28pt;"></font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">ORDINARY SHARES (in thousands)<font style="padding-left: 2.91pt;"></font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;"><font style="padding-left: 3.33pt;">29,273</font></div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.28%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.97pt; text-align: left;">23,452</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.22pt; text-align: left;">29,628</div></td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.21pt; text-align: left;">24,456</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. <br></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-24<br></div></div></div>
<!--End Page 192-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 193-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_203-fintab02_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; text-align: center;"><a name="fCSOC2"><!--Anchor--></a>UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (CAPITAL DEFICIENCY) </div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 10.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 17.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Ordinary shares</div></td><td class="gutter" style="width: 1.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 10.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Additional <br>paid-in capital</div></td><td class="gutter" rowspan="2" style="width: 1.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 9.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated<br>deficit</div></td><td class="gutter" rowspan="2" style="width: 1.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 6.59%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div></td></tr><tr class="header"><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br>shares</div></td><td class="gutter" style="width: 1.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td class="gutter" style="width: 1.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td></tr><tr class="header"><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 5.98%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td colspan="7" style="width: 31.5%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 0pt; text-align: center;">U.S. Dollars in thousands</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">BALANCE AT JANUARY 1, 2020<font style="padding-left: 3.24pt;"></font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">27,150,080</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9pt; text-align: left;">75</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;">31,748</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;">(40,601)</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(8,778)</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">CHANGES DURING SIX MONTHS ENDED JUNE 30, 2020<font style="padding-left: 4.91pt;"></font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Issuance of ordinary shares, net of issuance costs<font style="padding-left: 1.67pt;"></font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">2,368,250</font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9pt; text-align: left;">10</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;">36,690</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.33pt;">36,700</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Conversion of related party liability to shareholders' equity<font style="padding-left: 3.5pt;"></font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">1,109,245</font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;">17,748</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.33pt;">17,748</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Issuance of ordinary shares to employees and non-employees upon exercise of warrants<font style="padding-left: 3.58pt;"></font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">29,766</font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;"><font style="padding-left: 17.5pt;">66</font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">66</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Issuance of ordinary shares to investors upon exercise of warrants<font style="padding-left: 1.33pt;"></font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">22,624</font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;"><font style="padding-left: 17.5pt;">62</font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">62</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Share-based compensation<font style="padding-left: 0.76pt;"></font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;"><font style="padding-left: 5pt;">8,347</font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">8,347</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 0.18pt;"></font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;">(13,786)</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(13,786)</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">BALANCE AT JUNE 30, 2020<font style="padding-left: 4.54pt;"></font></div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">30,679,965</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9pt; text-align: left;">85</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;">94,661</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;">(54,387)</div></td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.33pt;">40,359</font></div></td></tr></table><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 6pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 18.06%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Ordinary shares</div></td><td class="gutter" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 10.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Additional <br>paid-in capital</div></td><td class="gutter" rowspan="2" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 9.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated<br>deficit</div></td><td class="gutter" rowspan="2" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 5.52%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div></td></tr><tr class="header"><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.23%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br>shares</div></td><td class="gutter" style="width: 1.23%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.23%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td class="gutter" style="width: 1.23%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td></tr><tr class="header"><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 5.98%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td colspan="7" style="width: 30.86%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 0pt; text-align: center;">U.S. Dollars in thousands</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">BALANCE AT JANUARY 1, 2019<font style="padding-left: 3.24pt;"></font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">21,924,208</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9pt; text-align: left;">58</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;"><font style="padding-left: 0.37pt;">11,596</font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;">(18,038)</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(6,384)</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">CHANGES DURING SIX MONTHS ENDED JUNE 30, 2019<font style="padding-left: 4.91pt;"></font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Issuance of ordinary shares and warrants, net of issuance costs<font style="padding-left: 1.31pt;"></font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">4,450,146</font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9pt; text-align: left;">13</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;"><font style="padding-left: 5pt;">9,251</font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.33pt;">9,264</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Additional consideration for an asset purchase agreement<font style="padding-left: 1.85pt;"></font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;"><font style="padding-left: 12.5pt;">174</font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10.83pt;">174</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 0.18pt;"></font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;"><font style="padding-left: 5pt;">(1,675)</font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(1,675)</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">BALANCE AT JUNE 30, 2019<font style="padding-left: 4.54pt;"></font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">26,374,354</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9pt; text-align: left;">71</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;">21,021</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;">(19,713)</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 5.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.33pt;">1,379</font></div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 9.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(*)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Less than 1 thousand US dollars.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. <br></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-25<br></div></div></div>
<!--End Page 193-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 194-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_203-fintab02_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; text-align: center;">UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (CAPITAL DEFICIENCY)</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 10.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.2%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 17.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Ordinary shares</div></td><td class="gutter" style="width: 1.2%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.2%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 10.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Additional <br>paid-in capital</div></td><td class="gutter" rowspan="2" style="width: 1.2%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.2%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 9.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated<br>deficit</div></td><td class="gutter" rowspan="2" style="width: 1.2%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.2%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div></td></tr><tr class="header"><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.2%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br>shares</div></td><td class="gutter" style="width: 1.2%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.2%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td class="gutter" style="width: 1.2%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td></tr><tr class="header"><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 5.98%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td colspan="7" style="width: 31.07%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 0pt; text-align: center;">U.S. Dollars in thousands</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">BALANCE AT APRIL 1, 2020<font style="padding-left: 1.01pt;"></font></div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">29,261,215</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.99pt; text-align: left;">81</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.35pt; text-align: left;">68,912</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;">(48,023)</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">20,970</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">CHANGES DURING THREE MONTHS ENDED JUNE 30, 2020<font style="padding-left: 4.91pt;"></font></div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Issuance of ordinary shares, net of issuance costs<font style="padding-left: 1.67pt;"></font></div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">1,418,750</font></div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.99pt; text-align: left;"><font style="padding-left: 5pt;">4</font></div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.35pt; text-align: left;">22,252</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">22,256</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Share-based compensation<font style="padding-left: 0.76pt;"></font></div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.35pt; text-align: left;"><font style="padding-left: 5pt;">3,497</font></div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">3,497</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 0.18pt;"></font></div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;"><font style="padding-left: 5pt;">(6,364)</font></div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 1.67pt;">(6,364)</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">BALANCE AT JUNE 30, 2020<font style="padding-left: 4.54pt;"></font></div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">30,679,965</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.99pt; text-align: left;">85</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.35pt; text-align: left;">94,661</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;">(54,387)</div></td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.2%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">40,359</div></td></tr></table><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 6pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 18.06%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Ordinary shares</div></td><td class="gutter" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 10.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Additional <br>paid-in capital</div></td><td class="gutter" rowspan="2" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 9.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated<br>deficit</div></td><td class="gutter" rowspan="2" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 1.23%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td rowspan="2" style="width: 5.52%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div></td></tr><tr class="header"><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.23%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br>shares</div></td><td class="gutter" style="width: 1.23%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.23%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td class="gutter" style="width: 1.23%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td></tr><tr class="header"><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 9.62%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 5.98%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td colspan="7" style="width: 30.86%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 0pt; text-align: center;">U.S. Dollars in thousands</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">BALANCE AT APRIL 1, 2019<font style="padding-left: 1.01pt;"></font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">22,250,688</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9pt; text-align: left;">59</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;"><font style="padding-left: 0.37pt;">11,908</font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;">(18,749)</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">(6,782)</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">CHANGES DURING THREE MONTHS ENDED JUNE 30, 2019<font style="padding-left: 4.91pt;"></font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Issuance of ordinary shares and warrants, net of issuance costs<font style="padding-left: 1.31pt;"></font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">4,123,666</font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9pt; text-align: left;">12</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;"><font style="padding-left: 5pt;">9,103</font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.7pt;">9,115</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Additional consideration for an asset purchase agreement<font style="padding-left: 1.85pt;"></font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;"><font style="padding-left: 17.5pt;">10</font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">10</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 0.18pt;"></font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;"><font style="padding-left: 12.5pt;">(964)</font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.5pt;">(964)</font></div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">BALANCE AT JUNE 30, 2019<font style="padding-left: 4.54pt;"></font></div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">26,374,354</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 5.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9pt; text-align: left;">71</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 10.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.36pt; text-align: left;">21,021</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 9.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.24pt; text-align: left;">(19,713)</div></td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.23%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 5.52%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.33pt;">1,379</font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. <br></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-26<br></div></div></div>
<!--End Page 194-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 195-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_203-fintab02_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; text-align: center;"><a name="fCSCF2"><!--Anchor--></a>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 10.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 19.96%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 19.96%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30,</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.96%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr class="header"><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td colspan="4" style="width: 19.96%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 0pt; text-align: center;">U.S. Dollars in thousands</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CASH FLOWS FROM OPERATING ACTIVITIES:<br></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 4.18pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;">(13,786)</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;">(1,675)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adjustments required to reconcile net loss to net cash used in operating activities:<font style="padding-left: 0.97pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Share-based compensation<font style="padding-left: 4.76pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 8.33pt;">8,347</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Depreciation<font style="padding-left: 0.86pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 20.83pt;">33</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">24</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes in operating assets and liabilities:<font style="padding-left: 3.12pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Prepaid expenses and other current assets<font style="padding-left: 2.59pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">782</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Related party prepaid expenses<font style="padding-left: 0.34pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 17.5pt;">(35)</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 10.83pt;">654</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current assets<font style="padding-left: 3.11pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 20.83pt;">41</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accounts payable<font style="padding-left: 0.31pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 17.5pt;">(69)</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 12.5pt;">(63)</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating leases<font style="padding-left: 0.31pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 30.83pt;">*</font> </div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accrued expenses and other liabilities<font style="padding-left: 2.01pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 17.5pt;">(51)</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash used in operating activities<font style="padding-left: 3.68pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 5pt;">(4,738)</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;">(1,060)</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CASH FLOWS FROM INVESTING ACTIVITIES:<br></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Purchase of property and equipment<font style="padding-left: 4.22pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 12.5pt;">(244)</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 12.5pt;">(80)</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash used in investing activities<font style="padding-left: 4.78pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 12.5pt;">(244)</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 12.5pt;">(80)</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CASH FLOWS FROM FINANCING ACTIVITIES:<br></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Proceeds from issuance of ordinary shares and warrants, net of issuance costs<font style="padding-left: 3.51pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 3.33pt;">37,237</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 3.33pt;">9,264</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Proceeds from issuance of ordinary shares upon exercise of warrants<font style="padding-left: 0.43pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">128</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred offering costs<font style="padding-left: 3.29pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 12.5pt;">(884)</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash provided by financing activities<font style="padding-left: 4.23pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 3.33pt;">36,481</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 3.33pt;">9,264</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">NET CHANGE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH<font style="padding-left: 0.18pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 3.33pt;">31,499</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 3.33pt;">8,124</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF THE PERIOD<font style="padding-left: 2.7pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 8.33pt;">8,217</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 20.83pt;">5</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF THE PERIOD<font style="padding-left: 1.4pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 3.33pt;">39,716</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 3.33pt;">8,129</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">SUPPLEMENTARY INFORMATION ON ACTIVITIES NOT INVOLVING CASH FLOWS:<font style="padding-left: 0.84pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unpaid offering costs<font style="padding-left: 4.38pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">138</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Conversion of related party liability to shareholders' equity<font style="padding-left: 4.26pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 3.33pt;">17,748</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Additional consideration for an asset purchase agreement<font style="padding-left: 3.16pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 20.83pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 10.83pt;">174</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities arising from obtaining operating right-of-use assets <font style="padding-left: 2.63pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">486</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr><tr><td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Issuance costs<font style="padding-left: 4.76pt;"></font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.96%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">537</font></div></td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.56pt; text-align: left;"><font style="padding-left: 15.83pt;">&#8212;</font></div></td></tr></table><div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(*)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Less than 1 thousand US dollars.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. <br></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-27<br></div></div></div>
<!--End Page 195-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 196-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_204-finnote02_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="fNOTES2"><!--Anchor--></a>NANO-X IMAGING LTD<br>&#8195;<br>NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">NOTE 1 &#8211; GENERAL:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">Nano-X Imaging Ltd</font><font style="font-weight: normal;">, an Israeli&#160;Company (hereinafter &#8220;the Company&#8221; or &#8220;Nanox IL&#8221; or &#8220;the Successor </font><font style="font-weight: normal;">Company&#8221;), was incorporated on December&#160;20, 2018 and commenced its operations on September&#160;3, 2019. </font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">On September&#160;19, 2019, Nanox IL established Nanox Imaging Inc. (hereinafter &#8220;Nanox Inc.&#8221;), a wholly owned subsidiary in Japan. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Nanox Imaging PLC is a public limited company incorporated in Gibraltar in 2012 (hereinafter &#8220;Nanox PLC&#8221; or &#8220;the predecessor company&#8221;). Nanox PLC developed certain technological capabilities aimed to design and build various applications for x-ray based imaging. Nanox PLC has been a development-stage company since its inception. Nanox PLC has a wholly owned subsidiary, Nanox Japan Inc. (hereinafter &#8220;Nanox Japan&#8221;). Nanox Japan primarily provided research and development services to Nanox PLC.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">The Company's solution, referred to as the Nanox System, has two integrated components &#8211; &#8220;Nanox.ARC&#8221; </font><font style="font-weight: normal;">and &#8220;Nanox.CLOUD&#8221;. Nanox.ARC is a medical imaging system incorporating the Company&#8217;s novel digital </font><font style="font-weight: normal;">X-ray source. Nanox.CLOUD is a cloud-based system designed to provide end-to-end medical imaging </font><font style="font-weight: normal;">services, including services such as image repository, radiologist matching, online and offline diagnostics </font><font style="font-weight: normal;">review and annotation, connectivity to diagnostic assistive AI systems, billing and reporting. </font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">In January 2020, the Company submitted a 510(k) application for a single-source version of the Nanox. ARC to an accredited Review Organization under the FDA&#8217;s 510(k) third party review program. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">c.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">In order to complete its technology development program, the Company will require significant funding. </font><font style="font-weight: normal;">Moreover, the Company has experienced net losses and negative cash flows from operations since its </font><font style="font-weight: normal;">inception and has relied on its ability to fund its operations primarily through equity financings. As of </font><font style="font-weight: normal;">June&#160;30, 2020, the Company had an accumulated deficit and negative cash flows from operations. The </font><font style="font-weight: normal;">Company anticipates such losses will continue until its product candidates reach commercial profitability.</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">If the Company is unable to successfully commercialize its product candidates and reach profitability, or obtain sufficient future financing from its shareholders or other investors, it will be required to delay some of its planned research and development programs as well as curtail, discontinue or, in the extreme case, cease operations. Based on the Company's financing activities during the six months ended June&#160;30, 2020, the Company has sufficient funds for its plans for the next twelve months from the issuance of these financial statements.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">d.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Current Impact of COVID-19</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Following the December 2019 outbreak of Coronavirus (COVID-19) in China, it has spread into most countries across the world, including Israel, Japan and all 50 states within the U.S. The COVID-19 pandemic is evolving, and to date has led to the implementation of various responses, including government-imposed quarantines, travel restrictions and other public health safety measures. The COVID-19 pandemic has adversely impacted the Company's operations in various ways. For example, the Company's engineers are unable to make work-related trips to Korea or Israel to test and optimize the Nanox.ARC or to begin development of x-ray chip manufacturing in Korea. The potential business partners are unable to make on-site visits to the Company's facilities or attend industry conferences and meetings to experience the Nanox.ARC, which has negatively impacted the Company's business development and deployment activities. The external labs the Company works with have also been affected by COVID-19, resulting in delays in the Company's timelines for obtaining regulatory approval. COVID-19 has also caused shutdowns or disruptions of business for our manufactures and suppliers. The continued spread of COVID-19 globally could adversely impact the Company's development, manufacture or deployment of the Nanox Systems, which could adversely affect the Company's ability to obtain regulatory approval for and to commercialize the Nanox Systems, increase the operating expenses and have a material adverse effect on the Company&#8217;s financial results.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-28<br></div></div></div>
<!--End Page 196-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 197-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_204-finnote02_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br>&#8195;<br>NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br></div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8pt; margin-left: 0pt; text-align: left;">NOTE&#160;2 &#8211; SIGNIFICANT ACCOUNTING POLICIES:</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Basis of presentation</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;). Accordingly, they do not include all of the information and notes required by U.S. GAAP for annual financial statements. The information included in these condensed interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in the Company&#8217;s annual financial statements. In the opinion of management, these unaudited condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary for a fair statement of results for the interim period. The results for the interim periods are not necessarily indicative of the results to be expected for the full year.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Use of Estimates</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of income and expenses during the reporting periods. Actual results could differ from those estimates.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Accounting Pronouncements Adopted in the Current Period</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments. This guidance replaces the current incurred loss impairment methodology. Under the new guidance, on initial recognition and at each reporting period, an entity is required to recognize an allowance that reflects its current estimate of credit losses expected to be incurred over the life of the financial instrument based on historical experience, current conditions and reasonable and supportable forecasts. In November 2018, the FASB issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments - Credit Losses. ASU 2018-19 clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments.</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The guidance became effective on January&#160;1, 2020, including interim periods within that year and requires a modified retrospective transition approach through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. Under the modified retrospective method of adoption, prior year reported results are not restated. The Company has performed its analysis of the impact on its financial instruments that are within the scope of this guidance and has concluded that there is no material impact to its consolidated financial statements.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">NOTE&#160;3 &#8211; SHAREHOLDER'S EQUITY</div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Issuance of Equity</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">During the first half of 2020, the Company issued an aggregate of 2,368,250 ordinary shares to the certain investors, at a price per share of $16.00, for an aggregate purchase price of approximately $37.9&#160;million. As part of the share issuance, the Company also paid issuance costs of approximately $661 thousand and accrued issuance costs of approximately $537 thousand. </div><div class="h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Settlement of Related Party Liability</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">Pursuant to the Asset Purchase Agreement between Nanox IL and Nanox PLC, as more fully described in the Company's annual financial statements, in January 2020, the Company issued 1,109,245 ordinary shares to Nanox PLC with a purchase price of $12.00 per share, which reflected a discount of 25% from the price of the last financing round of the Company. As a result, the related party liability was settled into shareholders' equity.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-29<br></div></div></div>
<!--End Page 197-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 198-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_204-finnote02_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br>&#8195;<br>NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br></div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">NOTE&#160;4 &#8211; SHARE-BASED COMPENSATION </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">a) The following table summarizes share-based awards to non-employees for the six months ended June&#160;30, 2020 and 2019: </div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.53%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six months ended June&#160;30,</div></td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.53%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six months ended June&#160;30,</div></td></tr><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.53%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 21.53%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr class="header"><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.24%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of<br>share-based<br>payment<br>Awards</div></td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.47%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted<br>average<br>exercise<br>price</div></td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.24%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of<br>share-based <br>payment <br>awards</div></td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.47%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted<br>average <br>exercise <br>price </div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding, at beginning of period<font style="padding-left: 1.71pt;"></font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;">3,410,406</div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;">$<font style="padding-left: 5pt;">1.89</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;">1,592,874</div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;">$<font style="padding-left: 5pt;">1.32</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the period:<font style="padding-left: 1.42pt;"></font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted<font style="padding-left: 0.29pt;"></font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"><font style="padding-left: 7.5pt;">121,840</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;">$<font style="padding-left: 5pt;">8.91</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised<font style="padding-left: 3.07pt;"></font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"><font style="padding-left: 9.17pt;">(29,766)</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;">$<font style="padding-left: 5pt;">2.21</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited<font style="padding-left: 0.85pt;"></font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired<font style="padding-left: 0.84pt;"></font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cancelled <font style="padding-left: 4.18pt;"></font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding at end of period <font style="padding-left: 1.43pt;"></font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;">3,502,480</div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;">$<font style="padding-left: 5pt;">2.07</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;">1,592,874</div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;">$<font style="padding-left: 5pt;">1.32</font></div></td></tr><tr><td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercisable at end of period<font style="padding-left: 2pt;"></font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;">2,168,033</div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;">$<font style="padding-left: 5pt;">2.40</font></div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.95pt; text-align: left;">1,592,874</div></td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.06pt; text-align: left;">$<font style="padding-left: 5pt;">1.32</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The fair value of each granted award is estimated at the date of grant using the Black-Scholes option-pricing model. The assumptions used for the six-months ended June&#160;30, 2020 are as follows:</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.32%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six months ended <br>June&#160;30,<br>2020</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fair value of one ordinary share<font style="padding-left: 4.34pt;"></font></div></td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 15.31%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">16</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dividend yield<font style="padding-left: 0.96pt;"></font></div></td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.31%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">0</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility <font style="padding-left: 1.52pt;"></font></div></td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 15.31%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">44.40% - 57.34%</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate <font style="padding-left: 4.89pt;"></font></div></td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.31%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">0.34%-1.61%</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Contractual term (years)<font style="padding-left: 2.11pt;"></font></div></td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.32%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 15.31%; text-align: center; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">5.00-10.00</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The expected volatility is based on the historical volatility of comparable companies. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected term of the awards granted in dollar terms. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The following table summarizes information concerning outstanding and exercisable awards as of June&#160;30, 2020 and 2019:</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 470.63pt; margin-left: 0pt;"><tr class="header"><td style="width: 61.19%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">June&#160;30, 2020<br>Awards outstanding</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.59%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 18.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Awards exercisable</div></td></tr><tr class="header"><td style="width: 61.19%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercise Price</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.59%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of<br>Awards<br>outstanding<br>at end of<br>period</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted<br>average<br>remaining<br>contractual<br>life (years)</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of<br>Award<br>exercisable<br>at end of<br>Period</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted<br>average<br>remaining<br>contractual<br>life (years)</div></td></tr><tr><td style="width: 61.19%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$0.01<font style="padding-left: 3pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 7.5pt;">186,815</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">0.83</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.5pt;">186,815</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">0.83</div></td></tr><tr><td style="width: 61.19%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1.92<font style="padding-left: 3pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 7.5pt;">472,606</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">1.31</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.5pt;">472,606</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">1.31</div></td></tr><tr><td style="width: 61.19%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$2.21<font style="padding-left: 3pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;">2,759,896</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">5.25</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,441,420</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">5.25</div></td></tr><tr><td style="width: 61.19%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$16<font style="padding-left: 0.5pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 12.5pt;">59,206</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">4.96</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">59,206</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">4.96</div></td></tr><tr><td style="width: 61.19%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$20.87<font style="padding-left: 3pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 12.5pt;">23,957</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">5.19</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">7,986</font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.31%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">5.19</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-30<br></div></div></div>
<!--End Page 198-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 199-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_204-finnote02_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br>&#8195;<br>NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: left;">NOTE 4 &#8211; SHARE-BASED COMPENSATION<font style="padding-left: 4pt;">(continued) </font><br></div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 3.25pt; border-collapse: collapse; width: 468.25pt; margin-left: 0pt;"><tr class="header"><td style="width: 61.51%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">June&#160;30, 2019<br>Awards outstanding</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.64%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 8.35%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 17.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Awards exercisable</div></td></tr><tr class="header"><td style="width: 61.51%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.64%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of<br>Awards<br>outstanding<br>at end of<br>period</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted<br>average<br>remaining<br>contractual<br>life (years)</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of<br>Award<br>exercisable<br>at end of<br>Period</div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted<br>average<br>remaining<br>contractual<br>life (years) </div></td></tr><tr><td style="width: 61.51%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$0.01<font style="padding-left: 3pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.64%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;">186,815</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">1.83</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.03%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.56pt; text-align: left;">186,815</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">1.83</div></td></tr><tr><td style="width: 61.51%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$0.30<font style="padding-left: 3pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.64%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;">454,166</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">0.27</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.03%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.56pt; text-align: left;">454,166</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">0.27</div></td></tr><tr><td style="width: 61.51%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1.92<font style="padding-left: 3pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.64%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;">472,606</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">2.31</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.03%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.56pt; text-align: left;">472,606</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">2.31</div></td></tr><tr><td style="width: 61.51%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$2.21<font style="padding-left: 3pt;"></font></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 8.64%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;">479,287</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 8.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.8pt; text-align: left;">2.87</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 8.03%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.56pt; text-align: left;">479,287</div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 8.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">2.87</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">b) The following table summarizes share-based awards to employees, officers and directors for the six months ended June&#160;30, 2020:</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.31%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="7" style="width: 35.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six months ended June&#160;30, 2020</div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.31%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 12.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of<br>share-based<br>payment awards </div></td><td class="gutter" style="width: 1.31%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.31%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 10.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted<br>average<br>exercise price</div></td><td class="gutter" style="width: 1.31%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.31%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 8.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted<br>average<br>remaining <br>contractual <br>life (years)</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding at beginning of period<font style="padding-left: 2.21pt;"></font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 12.25%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;">1,667,267</div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;">2.21</div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">9.90</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the period:<font style="padding-left: 4.42pt;"></font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.25%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted<font style="padding-left: 3.29pt;"></font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 12.25%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;"><font style="padding-left: 7.5pt;">295,234</font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;">2.21</div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">9.60</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised<font style="padding-left: 1.07pt;"></font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.25%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited<font style="padding-left: 3.85pt;"></font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 12.25%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired<font style="padding-left: 3.84pt;"></font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.25%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;"><font style="padding-left: 30pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cancelled <font style="padding-left: 2.18pt;"></font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 12.25%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;"><font style="padding-left: 14.17pt;">(9,375)</font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;">2.21</div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding at end of period <font style="padding-left: 4.43pt;"></font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 12.25%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;">1,953,126</div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;">2.21</div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 8.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">9.55</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercisable at end of period</div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 12.25%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.66pt; text-align: left;"><font style="padding-left: 7.5pt;">726,880</font></div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;">2.21</div></td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.31%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 8.35%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.79pt; text-align: left;">9.55</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">During the six&#160;months ended June&#160;30, 2019 the Company did not grant options to employees, officers or directors. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The fair value of each granted award is estimated at the date of grant using the Black-Scholes option-pricing model. The assumptions used for the six-month period ended June&#160;30, 2020 is as follows:</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.23%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fair value of one ordinary share<font style="padding-left: 4.34pt;"></font></div></td><td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 15.23%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$16</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dividend yield<font style="padding-left: 0.96pt;"></font></div></td><td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.23%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">0</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility <font style="padding-left: 1.52pt;"></font></div></td><td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 15.23%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">45.11% - 50.65%</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate <font style="padding-left: 4.89pt;"></font></div></td><td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.23%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1.45% - 1.61%</div></td></tr><tr><td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Contractual term (years)<font style="padding-left: 2.11pt;"></font></div></td><td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 15.23%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">10</div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;">The expected volatility is based on the historical volatility of comparable companies. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected term of the awards granted in dollar terms. </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-31<br></div></div></div>
<!--End Page 199-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 200-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_204-finnote02_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br>&#8195;<br>NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: left;">NOTE 4 &#8211; SHARE-BASED COMPENSATION<font style="padding-left: 4pt;">(continued) </font><br></div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;">c)&#160;Share-based compensation expenses </div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 3.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 15.34%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended <br>June&#160;30,</div></td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 17.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br>June&#160;30,</div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.97%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td colspan="10" style="width: 35.6%; text-align: center; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 0pt; text-align: center;">(U.S. dollars in thousands)</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development<font style="padding-left: 1.1pt;"></font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;">1,917</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.55%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.98pt; text-align: left;">&#8212;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.38pt; text-align: left;"><font style="padding-left: 7.5pt;">240</font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.58%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.39pt; text-align: left;">&#8212;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketing <font style="padding-left: 0.52pt;"></font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;"><font style="padding-left: 7.5pt;">644</font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 5.55%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.98pt; text-align: left;">&#8212;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 7.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.38pt; text-align: left;"><font style="padding-left: 7.5pt;">322</font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;">&#8203;</td><td style="width: 6.58%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.39pt; text-align: left;">&#8212;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative<font style="padding-left: 0.55pt;"></font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;">5,786</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.55%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.98pt; text-align: left;">&#8212;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.38pt; text-align: left;">2,935</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.58%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.39pt; text-align: left;">&#8212;</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;">8,347</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td style="width: 5.55%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.98pt; text-align: left;">&#8212;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td style="width: 7.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.38pt; text-align: left;">3,497</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td style="width: 6.58%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.39pt; text-align: left;">&#8212;</div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">NOTE 5 &#8211; COMMITMENTS:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">On June&#160;4, 2020, the Company signed a supplemental lease agreement to expand its facilities in Israel, </font><font style="font-weight: normal;">which expires in June 2023 (&#8220;Supplemental Lease Agreement&#8221;). The monthly rate for the Supplemental </font><font style="font-weight: normal;">Lease Agreement is approximately $14 thousand per month.</font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">For services with SixAI Ltd. (&#8220;SixAI&#8221;), see Note 6c.</font></div></td></tr></table><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">NOTE 6 &#8211; RELATED PARTIES &#8211; TRANSACTIONS AND BALANCES:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">Related parties transactions:</font></div></td></tr></table><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 3.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 15.34%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended <br>June&#160;30,</div></td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 17.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br>June&#160;30,</div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.24%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.24%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt;">&#8203;</td><td colspan="10" style="width: 35.6%; text-align: center; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 3.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; margin-top: 0pt; text-align: center;">(U.S. Dollars in thousands)</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development<font style="padding-left: 1.1pt;"></font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.24%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.29pt; text-align: left;">115</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.11pt; text-align: left;"><font style="padding-left: 5pt;">99</font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.01pt; text-align: left;">90</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.52pt; text-align: left;"><font style="padding-left: 5pt;">50</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative<font style="padding-left: 0.55pt;"></font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td style="width: 6.24%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.29pt; text-align: left;"><font style="padding-left: 4.63pt;">&#8212;</font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td style="width: 6.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.11pt; text-align: left;">278</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.01pt; text-align: left;">&#8212;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 2pt;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.52pt; text-align: left;">148</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">Six-Eye Interactive agreements for services </font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">On June 1 2015, Nanox PLC entered into a consulting agreement with Six-Eye, a Company owned by Ran Poliakine, the Company's CEO and one of its major shareholders, pursuant to which Ran Poliakine agreed to provide services as Chief Strategy Officer and a member of the Executive Committee to Nanox PLC. On May&#160;1, 2017, Nanox PLC entered into a services agreement with Six-Eye for the supply of ongoing services, which include research and development services, general and financial management (including accountancy), office management services and operational and supply services. According to the agreement between the parties, Nanox PLC reimbursed Six-Eye for its actual direct expenses plus a 12% surplus charge. The agreement was terminated in September 2019. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">During the six and three months ended June&#160;30, 2019, the Company recorded an expense of $377 thousand and $198 thousand, respectively. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">c.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">SixAI Ltd. Service agreement</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">On April&#160;16, 2020, the Company entered into a service agreement with SixAI for certain software development and mechanical engineering services. The service agreement is effective as of March&#160;1, 2020 for a term of six months for a total amount of $195 thousand. During the six and three months ended June&#160;30, 2020, the Company recorded an expense of $115 thousand and $90 thousand, respectively. Mr.&#160;Poliakine currently serves as a member of the board of directors of SixAI and Mr.&#160;Poliakine is a significant shareholder of SixAI. </div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">As of June&#160;30, 2020, the Company has a prepaid balance of $35 thousand with respect to its agreement with SixAI.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">d.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">Pursuant to the Asset Purchase Agreement between Nanox IL and Nanox PLC, as more fully described in </font><font style="font-weight: normal;">the Company's annual financial statements, as of June&#160;30, 2020, the Company has a related party liability </font><font style="font-weight: normal;">balance of $192 thousand.</font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-32<br></div></div></div>
<!--End Page 200-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 201-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_204-finnote02_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">NANO-X IMAGING LTD<br>&#8195;<br>NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS<br></div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8pt; margin-left: 0pt; text-align: left;">NOTE 7 &#8211; LOSS PER SHARE:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">Basic</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">Basic&#160;loss per share is calculated by dividing the net loss by the weighted average number of ordinary shares for the period.</div><table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 15.34%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended <br>June&#160;30,</div></td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 17.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br>June&#160;30,</div></td></tr><tr class="header"><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 6.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 5.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div></td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.43%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2019</div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss <font style="padding-left: 3.85pt;"></font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.02pt; text-align: left;">(13,786)</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.02pt; text-align: left;"><font style="padding-left: 1.67pt;">(1,675)</font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.76pt; text-align: left;">$<font style="padding-left: 1.67pt;">(6,364)</font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.77pt; text-align: left;">$<font style="padding-left: 9.17pt;">(964)</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average number of ordinary shares (in thousands)<font style="padding-left: 0.86pt;"></font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 6.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.02pt; text-align: left;"><font style="padding-left: 3.33pt;">29,273</font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.02pt; text-align: left;">23,452</div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.76pt; text-align: left;"><font style="padding-left: 5pt;">29,628</font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.77pt; text-align: left;"><font style="padding-left: 5pt;">24,456</font></div></td></tr><tr><td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Basic and diluted loss per share <font style="padding-left: 1.68pt;"></font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 6.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.02pt; text-align: left;"><font style="padding-left: 10pt;">(0.47)</font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 5.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.02pt; text-align: left;"><font style="padding-left: 6.67pt;">(0.07)</font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.76pt; text-align: left;">$<font style="padding-left: 6.67pt;">(0.21)</font></div></td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 1.43%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.77pt; text-align: left;">$<font style="padding-left: 6.67pt;">(0.04)</font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">Diluted</font></div></td></tr></table><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;">As of June&#160;30, 2020 and 2019, the Company had 9,627,014 and 3,377,180 investor warrants and employees and non-employees option awards, respectively. These warrants and awards were not taken into account when calculating diluted loss per share since their effect, on a fully diluted basis, is anti-dilutive.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">NOTE 8 &#8211; FAIR VALUE</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">As of June&#160;30, 2020, the Company's assets and liabilities have fair values that approximate their carrying values.</div><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">NOTE 9 &#8211; SUBSEQUENT EVENTS:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">In July 2020, the Company issued 625,000 ordinary shares to one of its investors, at a price per share of </font><font style="font-weight: normal;">$16.00, for a purchase price of $10&#160;million, received in July 2020, which reflects the second portion of the </font><font style="font-weight: normal;">investor&#8217;s $20&#160;million investment.</font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">In July 2020, the Company entered into additional share purchase agreements with certain investors for the </font><font style="font-weight: normal;">issuance of 3,500,000 ordinary shares at a price per share of $16.00, for an aggregate purchase price of </font><font style="font-weight: normal;">approximately $56&#160;million. As of the date of the issuance of these financial statements, the funds were not </font><font style="font-weight: normal;">received yet. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">c.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">The Company has evaluated subsequent events through July&#160;</font><font style="font-weight: normal;">30</font><font style="font-weight: normal;">, 2020, the date on which the consolidated </font><font style="font-weight: normal;">financial statements were available to be issued. </font></div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">F-33<br></div></div></div>
<!--End Page 201-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 202-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 456pt;"><a name="nt10006151x14_f1a_300-bcv_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="block-frill" style="width: 456pt; margin-left: 0pt;"><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div><div class="page-content"><div class="block-main" style="width: 456pt; margin-left: 0pt;"> <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 45.5pt; text-align: center;">8,823,530 SHARES</div> <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13pt; font-weight: bold; margin-top: 100.5pt; text-align: center;">NANO-X IMAGING LTD</div><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; text-align: center;"><img style="height: 55px; width: 225px;" src="logo_nanox2.jpg"><br>&#8201;</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; text-align: center;">ORDINARY SHARES</div><div><div class="rule-partial" style="height: 0pt; width: 192pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 55.75pt;"> </div></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 6.5pt; text-align: center;">PRELIMINARY PROSPECTUS</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 4.5pt; text-align: center;">&#8195;&#8195;&#8195;&#8195;, 2020</div><div><div class="rule-partial" style="height: 0pt; width: 192pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 13.75pt;"> </div></div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 60pt; text-align: center;">Cantor <br>&#8195;<br>Oppenheimer &amp; Co. <br>&#8195;<br>Berenberg<br>&#8195; <br>&#8195;CIBC Capital Markets<br>&#8195;<br>National Securities Corporation</div><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 124.5pt; text-align: center;">&#8195;&#8195;&#8195;&#8195;&#8195;</div></div></div><div class="block-frill" style="width: 456pt; margin-top: 12pt; margin-left: 0pt;"><div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div></div>
<!--End Page 202-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 203-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_301-part2_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">PART II <br>INFORMATION NOT REQUIRED IN PROSPECTUS</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 6.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Exculpation, Insurance and Indemnification of Office Holders (Including Directors and Officers).</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, a company may not exculpate an office holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an office holder in advance from liability to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care but only if a provision authorizing such exculpation is included in its articles of association. Our amended and restated articles of association, that will become effective immediately prior to the completion of the offering, include such a provision. The company may not exculpate a director in advance from liability arising out of a breach of his or her duty of care in connection with a prohibited dividend or distribution to shareholders. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As permitted under the Companies Law and the Securities Law, and provided its articles of association include a provision authorizing such indemnification, a company may indemnify an office holder in respect of the following liabilities, payments and expenses incurred for acts performed by him or her as an office holder, either in advance of an event or following an event: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a monetary liability incurred by or imposed on the office holder in favor of another person pursuant to a court judgment, including pursuant to a settlement confirmed as judgment or arbitrator&#8217;s decision approved by a competent court. However, if an undertaking to indemnify an office holder with respect to such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company&#8217;s activities when the undertaking to indemnify is given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned foreseen events and amount or criteria; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reasonable litigation expenses, including reasonable attorneys&#8217; fees, which were incurred by the office holder (i)&#160;as a result of an investigation or proceeding filed against the office holder by an authority authorized to conduct such investigation or proceeding, provided that such investigation or proceeding; was either (a)&#160;concluded without the filing of an indictment against such office holder and without the imposition on him of any monetary obligation in lieu of a criminal proceeding; (b)&#160;concluded without the filing of an indictment against the office holder but with the imposition of a monetary obligation on the office holder in lieu of criminal proceedings for an offense that does not require proof of criminal intent; or (ii)&#160;in connection with a monetary sanction; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a monetary liability imposed on the office holder in favor of an injured party at an Administrative Procedure (as defined below) as set forth in Section 52(54)(a)(1)(a) to the Securities Law; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">expenses expended by the office holder with respect to an Administrative Procedure under the Securities Law, including reasonable litigation expenses and reasonable attorneys&#8217; fees;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reasonable litigation expenses, including attorneys&#8217; fees, incurred by the office holder or which were imposed on the office holder by a court (i)&#160;in a proceeding instituted against him or her by the company, on its behalf, or by a third party, (ii)&#160;in connection with criminal indictment of which the office holder was acquitted, or (iii)&#160;in connection with a criminal indictment which the office holder was convicted of an offense that does not require proof of criminal intent; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Any other obligation or expense in respect of which it is permitted or will be permitted under applicable law to indemnify an office holder. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">An &#8220;Administrative Procedure&#8221; is defined as a procedure pursuant to chapters H3 (Monetary Sanction by the Israeli Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement Committee) or I1 (Arrangement to prevent Procedures or Interruption of procedures subject to conditions) of the Securities Law.</div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As permitted under the Companies Law and the Securities Law, our amended and restated articles of association, which will become effective immediately prior to the closing of this offering, provide that we may insure an office holder against the following liabilities incurred for acts performed by him or her as an office holder if and to the extent provided in the company&#8217;s articles of association: </div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-1<br></div></div></div>
<!--End Page 203-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 204-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_301-part2_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a breach of the duty of loyalty to the company, provided that the office holder acted in good faith and had a reasonable basis to believe that the act would not harm the company; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a breach of duty of care to the company or to a third party, to the extent such a breach arises out of the negligent conduct of the office holder; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a monetary liability imposed on the office holder in favor of a third party; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a monetary liability imposed on the office holder in favor of an injured party at an Administrative Procedure pursuant to Section 52(54)(a)(1)(a) of the Securities Law; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">expenses incurred by an office holder in connection with an Administrative Procedure, including reasonable litigation expenses and reasonable attorneys&#8217; fees. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, a company may not indemnify, exculpate or insure an office holder against any of the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a breach of the duty of loyalty, except for indemnification and insurance for a breach of the duty of loyalty to the company to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a breach of duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an act or omission committed with intent to derive illegal personal benefit; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a fine or forfeit levied against the office holder. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Under the Companies Law, exculpation, indemnification and insurance of office holders in a public company must be approved by the compensation committee and the board of directors and, with respect to directors or controlling shareholders, their relatives and third parties in which such controlling shareholders have a personal interest, also by the shareholders. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our amended and restated articles of association permit us to exculpate, indemnify and insure our office holders to the fullest extent permitted or to be permitted by law. Our office holders are currently covered by a directors&#8217; and officers&#8217; liability insurance policy. As of the date of this registration statement, no claims for directors&#8217; and officers&#8217; liability insurance have been filed under this policy and we are not aware of any pending or threatened litigation or proceeding involving any of our office holders, including our directors, in which indemnification is sought. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have entered into agreements with each of our current office holders exculpating them from a breach of their duty of care to us to the fullest extent permitted by law, and undertaking to indemnify them to the fullest extent permitted by law, subject to limited exceptions, including, with respect to liabilities resulting from this offering, to the extent that these liabilities are not covered by insurance. This indemnification is limited, with respect to any monetary liability imposed in favor of a third party, to events determined as foreseeable by the board of directors based on our activities. The maximum aggregate amount of indemnification that we may pay to our office holders based on such indemnification agreement shall not exceed the greatest of (i)&#160;in relation to indemnity in connection with an offering to the public of the Company&#8217;s securities, the aggregate amount of proceeds from the sale by the Company and/or any shareholder of the Company in connection with such public offering; (ii) 25% of the Company&#8217;s total shareholders&#8217; equity pursuant to the Company&#8217;s most recent financial statements as of the time of the actual payment of indemnification, and (iii) $50&#160;million (in each case, as may be increased from time to time by shareholders&#8217; approval). Such indemnification amounts are in addition to any insurance amounts. Each office holder who agrees to receive this letter of indemnification also gives his approval to the termination of all previous letters of indemnification that we have provided to him or her in the past, if any. However, in the opinion of the SEC, indemnification of office holders for liabilities arising under the Securities Act is against public policy and therefore unenforceable.</div></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-2<br></div></div></div>
<!--End Page 204-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 205-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_301-part2_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 7.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Recent Sales of Unregistered Securities. </div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following is a summary of transactions during the preceding three years involving sales of our securities and securities of Nanox Gibraltar, our predecessor company, that were not registered under the Securities Act. </div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From January&#160;1, 2017 to August&#160;13, 2020, we have granted share options to employees, directors and consultants under our predecessor share option plans covering an aggregate of 4,928,769 ordinary shares, with a weighted average exercise price of $4.18 per share. As of the date of this registration statement, none of these options have been exercised or forfeited and canceled without being exercised.</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In December 2018, in connection with our formation, we issued 100 ordinary shares to Ran Poliakine for no cash consideration. In addition, on September&#160;2, 2019, we issued 26,851,154 ordinary shares and 59 warrants to purchase 5,437,422 ordinary shares to the then existing shareholders of Nanox Gibraltar for no consideration.</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In May 2019, Nanox Gibraltar issued 1,583,710 ordinary shares to FUJIFILM Corporation for an aggregate purchase price of approximately $3.5&#160;million. In June 2019, Nanox Gibraltar issued 2,262,443 ordinary shares to the SKT Entities for an aggregate purchase price of approximately $5.0&#160;million, as well as a warrant to SK Telecom TMT Investment Corp. to acquire 2,262,443 ordinary shares at an exercise price of $20.87 per share. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From December 2019 through August 2020, we issued 6,812,000 ordinary shares to certain investors in a private placement for an aggregate purchase price of approximately $109&#160;million (including the 1,850,000 ordinary shares expected to be issued to Asia Beam Limited prior to the closing of this offering). </div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition to the above, from January&#160;1, 2017 to August&#160;13, 2020, we have issued 1,353,720 ordinary shares to certain investors, for an aggregate purchase price of $13.7 million, as well as warrants to certain investors, employees, consultants, finders and collaborators to purchase 182,425 ordinary shares at a weighted average exercise price of $2.75.</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">No underwriter or underwriting discount or commission was involved in any of the transactions set forth in Item 7. </div><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">All of the foregoing issuances were made outside of the U.S. pursuant to Regulation S or to U.S. entities pursuant to Section 4(a)(2) of the Securities Act.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 8.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Exhibits and Financial Statement Schedules.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Exhibits</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The exhibits of the registration statement are listed in the Exhibit Index to this registration statement and are incorporated herein by reference.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Financial Statement Schedules</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the consolidated financial statements or the notes thereto.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 9.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Undertakings. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-3<br></div></div></div>
<!--End Page 205-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 206-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_301-part2_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The undersigned registrant hereby undertakes that: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-4<br></div></div></div>
<!--End Page 206-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 207-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_301-part2_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Exhibit Index </div> <table cellspacing="0" cellpadding="0" class="fintab" align="center" style="margin-top: 10.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 7.69%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exhibit No. </div></td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 91.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Description</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120018404/nt10006151x9_ex1-1.htm">1.1</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120018404/nt10006151x9_ex1-1.htm">&#8224;</a> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form of Underwriting Agreement</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120003529/filename2.htm">2.1</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120003529/filename2.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Asset Purchase Agreement, dated September&#160;3, 2019, by and between the Registrant and Nanox Imaging PLC</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120003529/filename3.htm">2.2</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120003529/filename3.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amendment to the Asset Purchase Agreement, dated December 3, 2019, by and between the Registrant and Nanox Imaging PLC</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120003529/filename4.htm">2.3</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120003529/filename4.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amendment to the Asset Purchase Agreement, dated December 31, 2019, by and between the Registrant and Nanox Imaging PLC</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120003529/filename5.htm">3.1</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120003529/filename5.htm">&#8224;</a> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Articles of Association of the Registrant</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120018404/nt10006151x9_ex3-2.htm">3.2</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120018404/nt10006151x9_ex3-2.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form of Amended and Restated Articles of Association of the Registrant to become effective immediately prior to the closing of the offering</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4.1 </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">[Reserved]</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex4-2.htm">4.2</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex4-2.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form of warrants to purchase ordinary shares, dated September 2, 2019, in connection with the warrants originally issued to certain investors by Nanox Imaging PLC in 2016</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex4-3.htm">4.3</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex4-3.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form of warrants to purchase ordinary shares, dated September 2, 2019, in connection with the warrants originally issued to certain finders by Nanox Imaging PLC in 2015</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex4-4.htm">4.4</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex4-4.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form of warrants to purchase ordinary shares, dated September 2, 2019, in connection with the warrants originally issued to certain finders and employee by Nanox Imaging PLC in 2014 and 2015</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex4-5.htm">4.5</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex4-5.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form of warrants to purchase ordinary shares issued to A-Labs Finance and Advisory Ltd.</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex4-6.htm">4.6</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex4-6.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Warrant to purchase ordinary shares, dated September 2, 2019, issued to SK Telecom TMT Investment Corp.</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex4-7.htm">4.7</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex4-7.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amendment to Warrant to purchase ordinary shares, dated June 4, 2020, issued to SK Telecom TMT Investment Corp.</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="nt10006151x14_ex5-1.htm">5.1</a> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Opinion of Amit, Pollak, Matalon &amp; Co., counsel to the Registrant, as to the validity of the ordinary shares (including consent) </div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex10-1.htm">10.1</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex10-1.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Contract Manufacturing Agreement, dated May 26, 2020, by and between the Registrant and FoxSemicon Integrated Technology, Inc.</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120018404/nt10006151x9_ex10-2.htm">10.2</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120018404/nt10006151x9_ex10-2.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Registration Rights Agreement by and among the Registrant and the certain shareholders named therein</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex10-3.htm">10.</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex10-3.htm">3</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex10-3.htm">&#8224;</a> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2019 Equity Incentive Plan</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex10-4.htm">10.4</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_ex10-4.htm">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">U.S. Sub-Plan</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120018404/nt10006151x9_ex10-5.htm">10.</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120018404/nt10006151x9_ex10-5.htm">5</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120018404/nt10006151x9_ex10-5.htm">&#8224;</a> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form of Indemnification Agreement between the Registrant and each director and executive officer</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120003529/filename6.htm">21.1</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120003529/filename6.htm">&#8224;</a> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">List of subsidiaries of the Registrant</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="nt10006151x14_ex23-1.htm">23.1</a> </div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of PricewaterhouseCoopers International Limited, an independent registered public accounting firm</div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="nt10006151x14_ex5-1.htm">23.2</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Amit, Pollak, Matalon &amp; Co. (included in Exhibit 5.1) </div></td></tr><tr><td style="width: 7.69%; text-align: left; vertical-align: top; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_f1.htm#tPOA">24.1</a><a href="https://www.sec.gov/Archives/edgar/data/1795251/000114036120017084/nt10006151x8_f1.htm#tPOA">&#8224;</a></div></td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td class="gutter" style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;">&#8203;</td><td style="width: 91.03%; text-align: left; vertical-align: top; padding-top: 3pt; background-color: #CCEEFF;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Power of Attorney (included in signature page to Registration Statement)</div></td></tr></table> <div><div class="rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">To be filed by amendment.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#8224;<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Previously filed. </div></td></tr></table></div></div><div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-5<br></div></div></div>
<!--End Page 207-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 208-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_302-sig_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">SIGNATURES </div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Neve Ilan, State of Israel on August 20, 2020. </div> <table cellspacing="0" cellpadding="0" class="txttab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td colspan="4" style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">NANO-X IMAGING LTD</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">By </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Ran Poliakine</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name: Ran Poliakine </div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Title: Chief Executive Officer</div></td></tr></table><div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated. </div> <table cellspacing="0" cellpadding="0" class="txttab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr class="header"><td style="width: 25.64%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Signatures</div></td><td class="gutter" style="width: 0.53%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.53%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 56.84%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Title</div></td><td class="gutter" style="width: 0.53%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 0.53%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 15.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Date</div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 56.84%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.38%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Ran Poliakine</div></td><td class="gutter" style="width: 0.53%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 56.84%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director and Chief Executive Officer <br>(Principal Executive Officer)</div></td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 15.38%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">August 20, 2020</div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Ran Poliakine</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 56.84%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.38%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Itzhak Maayan</div></td><td class="gutter" style="width: 0.53%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 56.84%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Financial Officer <br>(Principal Financial Officer and Principal Accounting Officer)</div></td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 15.38%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">August 20, 2020</div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Itzhak Maayan</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 56.84%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.38%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">*</div></td><td class="gutter" style="width: 0.53%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 56.84%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director </div></td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 15.38%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">August 20, 2020 </div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Onn Fenig </div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 56.84%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.38%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">*</div></td><td class="gutter" style="width: 0.53%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 56.84%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 15.38%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">August 20, 2020</div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Floyd Katske<br></div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 56.84%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.38%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">*</div></td><td class="gutter" style="width: 0.53%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 56.84%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 15.38%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">August 20, 2020</div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Erez Meltzer<br></div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 56.84%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 15.38%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">*</div></td><td class="gutter" style="width: 0.53%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 56.84%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" rowspan="2" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td rowspan="2" style="width: 15.38%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">August 20, 2020</div></td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Richard Stone <br></div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td></tr><tr><td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 56.84%; text-align: left; vertical-align: top; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 0.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 15.38%; text-align: right; vertical-align: top; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr></table> <table cellspacing="0" cellpadding="0" class="txttab" align="center" style="margin-top: 6pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr><td style="width: 5.13%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">* By:</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Ran Poliakine </div></td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 5.13%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Ran Poliakine</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 5.13%; text-align: left; vertical-align: top; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Attorney-in-fact</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr></table></div></div></div>
<!--End Page 208-->
<div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div id="DSPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 209-->
<div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a name="nt10006151x14_f1a_302-sig_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="page-content"><div class="block-main" style="width: 468pt; margin-left: 0pt;"><div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</div> <div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant&#8217;s duly authorized representative has signed this registration statement on Form F-1 in on this 20<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day of August, 2020.</div> <table cellspacing="0" cellpadding="0" class="txttab" align="center" style="margin-top: 11.25pt; border-collapse: collapse; width: 468pt; margin-left: 0pt;"><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">By:</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;">&#8203;</td><td colspan="4" style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">AUTHORIZED REPRESENTATIVE </div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">By:</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td><td class="gutter" style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td><td colspan="4" style="width: 46.15%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Richard Stone</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name: </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td><td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Richard Stone</div></td></tr><tr><td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Title: </div></td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td class="gutter" style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt;">&#8203;</td><td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 3pt;"><div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td></tr></table></div></div></div>
<!--End Page 209-->
</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>nt10006151x14_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.1.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
      <div><font style="font-weight: bold;">Exhibit 5.1</font><br>
      </div>
    </div>
    <div style="text-align: right;"> <br>
    </div>
    <div style="text-align: right;">August 20, 2020</div>
    <div style="font-weight: bold;">Nano-X Imaging Ltd.</div>
    <div style="font-weight: bold;">The Communication Center,</div>
    <div style="font-weight: bold;">Neve Ilan, Israel</div>
    <div><br>
    </div>
    <div style="text-align: center;">Re: <font style="font-weight: bold;"><u>Nano-X Imaging Ltd</u></font><font style="font-size: 12pt; font-weight: bold;"><u>.</u></font></div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Ladies and Gentlemen<font style="font-size: 12pt;">:</font></div>
    <div style="font-weight: bold;"><font style="font-size: 12pt;"> <br>
      </font></div>
    <div style="text-align: justify;">We have acted as Israeli counsel for Nano-X Imaging Ltd., an Israeli company (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), in connection with the underwritten initial public offering by the Company,
      contemplating (i) the issuance and sale by the Company of an aggregate of 8,823,530 Ordinary Shares, par value NIS 0.01&#160; (&#8220;<font style="font-weight: bold;">Ordinary Shares</font>&#8221;) of the Company (the &#8220;<font style="font-weight: bold;">Offering Shares</font>&#8221;)



      and (ii) the potential issuance and sale by the Company of up to an additional 1,323,529 Ordinary Shares (the &#8220;<font style="font-weight: bold;">Additional Shares</font>&#8221; and, collectively with the Offering Shares, the &#8220;<font style="font-weight: bold;">Shares</font>&#8221;), that are subject to an option to purchase additional shares proposed to be granted by the Company to the underwriters of the offering (the &#8220;<font style="font-weight: bold;">Offering</font>&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: justify;">This opinion letter is rendered pursuant to Item 8(a) of Form F-1 promulgated by the United States Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">SEC</font>&#8221;) and Items 601(b)(5) and (b)(23)
      of the SEC&#8217;s Regulation S-K promulgated under the United States Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold;">Securities Act</font>&#8221;).</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="text-align: justify;">In connection herewith, we have examined the originals, or photocopies or copies, certified or otherwise identified to our satisfaction, of: (i) the form of the registration statement on Form F-1 (File No. 333- 240209)
      filed by the Company with the SEC under the Securities Act (as amended through the date hereof, the &#8220;<font style="font-weight: bold;">Registration Statement</font>&#8221;) and to which this opinion is attached as an exhibit; (ii) a copy of the articles of
      association of the Company, as currently in effect; (iii) a draft of the amended articles of association of the Company, to be in effect immediately prior to the closing of the Offering (the &#8220;<font style="font-weight: bold;">Amended Articles</font>&#8221;);


      (iv) resolutions of the board of directors (the &#8220;<font style="font-weight: bold;">Board</font>&#8221;) of the Company and its shareholders which have heretofore been approved and, in each case, which relate to the Registration Statement and other actions
      to be taken in connection with the Offering (the &#8220;<font style="font-weight: bold;">Resolutions</font>&#8221;); and (v) such other corporate records, agreements, documents and other instruments, and such certificates or comparable documents of public
      officials and of officers of the Company as we have deemed relevant and necessary as a basis for the opinions hereafter set forth. We have also made inquiries of such officers as we have deemed relevant and necessary as a basis for the opinions
      hereafter set forth<font style="font-size: 12pt;">.</font></div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="text-align: justify;">In such examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of
      all documents submitted to us as certified, confirmed as photostatic copies and the authenticity of the originals of such latter documents.&#160; As to all questions of fact material to these opinions that have not been independently established, we have
      relied upon certificates or comparable documents of officers and representatives of the Company<font style="font-size: 12pt;">.</font></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: justify;">Based upon and subject to the foregoing, we are of the opinion that following effectiveness of the Amended Articles and upon payment to the Company of the consideration per Share in such amount and form as shall be
      determined by the Board or an authorized committee thereof, the Shares, when issued and sold in the Offering as described in the Registration Statement, will be duly authorized, validly issued, fully paid and non-assessable<font style="font-size: 12pt;">.</font></div>
    <div style="text-align: justify;"><font style="font-size: 12pt;"> <br>
      </font></div>
    <div style="text-align: justify;">Members of our firm are admitted to the Bar in the State of Israel, and we do not express any opinion as to the laws of any other jurisdiction.&#160; This opinion is limited to the matters stated herein and no opinion is
      implied or may be inferred beyond the matters expressly stated<font style="font-size: 12pt;">.</font></div>
    <div style="text-align: justify;"><font style="font-size: 12pt;"> <br>
      </font></div>
    <div style="text-align: justify;">We consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to our firm appearing under the caption &#8220;Legal Matters&#8221; and &#8220;Enforceability of Civil Liabilities&#8221; in the
      prospectus forming part of the Registration Statement. In giving this consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act, the rules and regulations of the SEC
      promulgated thereunder or Item 509 of the SEC&#8217;s Regulation S-K promulgated under the Securities Act<font style="font-size: 12pt;">.</font></div>
    <div style="text-align: justify;"><font style="font-size: 12pt;"> <br>
      </font></div>
    <div style="text-align: justify;">This opinion letter is rendered as of the date hereof and we disclaim any obligation to advise you of facts, circumstances, events or developments that may be brought to our attention after the effective date of the
      Registration Statement that may alter, affect or modify the opinions expressed herein<font style="font-size: 12pt;">.</font></div>
    <div style="text-align: justify;"><font style="font-size: 12pt;"> <br>
      </font></div>
    <div style="text-align: justify;">
      <table id="zb105b0b1fd96488da0acc7dc8768bad8" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 70%;">
              <div>&#160;</div>
            </td>
            <td style="width: 30%;">
              <div style="text-indent: 9pt;">
                <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-weight: bold; text-indent: -9pt; margin-left: 9pt;">Very truly yours<font style="font-size: 12pt;">,</font></div>
              </div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 70%;">&#160;</td>
            <td rowspan="1" style="width: 30%; font-weight: bold;">/s/ Amit, Pollak, Matalon &amp; Co. <br>
            </td>
          </tr>
          <tr>
            <td style="width: 70%;">
              <div>&#160;</div>
            </td>
            <td style="width: 30%; font-weight: bold;">
              <div>Amit, Pollak, Matalon &amp; Co.</div>
            </td>
          </tr>

      </table>
      <font style="font-size: 12pt;"> </font></div>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>nt10006151x14_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 7.1.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 23.1</font><font style="font-weight: bold;"><br>
      </font></div>
    <div><font style="font-weight: bold;">&#160; </font><br>
    </div>
    <div><br>
      <img src="nt10006151x14_ex23-1image1.jpg"></div>
    <div><font style="font-weight: bold;"> <br>
      </font></div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-weight: bold;"><u>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</u></div>
      <div style="font-family: 'Times New Roman', Times, serif;">&#160; <br>
      </div>
      <div style="font-family: 'Times New Roman', Times, serif;">We hereby consent to the use in this Registration Statement on Form F-1 of Nano-X Imaging Ltd of our report dated February 18, 2020, except with respect to the matters which have removed the
        substantial doubt about the Company&#8217;s ability to continue as a going concern discussed in Note 1d and Note 12(d),(e), (f),(g) as to which the date is July 30, 2020 relating to the financial statements of Nano-X Imaging Ltd, which appears in this
        Registration Statement. We also consent to the reference to us under the heading &#8220;Experts&#8221; in such Registration Statement.&#160;</div>
      <div><br>
      </div>
      <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf4af6c8d39ec4504b48a5e0b5f9f0f8e" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 32.35%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', Times, serif;">Tel-Aviv, Israel</div>
            </td>
            <td style="width: 67.65%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', Times, serif;">/s/Kesselman &amp; Kesselman</div>
            </td>
          </tr>
          <tr>
            <td style="width: 32.35%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', Times, serif;">August 20, 2020</div>
            </td>
            <td style="width: 67.65%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', Times, serif;">Certified Public Accountants (Isr.)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 32.35%; vertical-align: top;">&#160;</td>
            <td style="width: 67.65%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', Times, serif;">A member firm of PricewaterhouseCoopers International Limited</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
      <div><br>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo_nanox2.jpg
<TEXT>
begin 644 logo_nanox2.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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MMD^S:-X>\*Z7H]GNCA1IOL=C!]HN#+=7'FW4\\TF9_P_,_X*W_\ 1^7QU_\
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M?C%XR:_\+_"#3KN&Y!:&\TU+?QO\2-!U"W4S:?X@^&^E3*4=HV'^FU7X"?\
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MC^V'^RY\"/VG? YM8M ^-7PU\->-CIEK?QZHOAK7K^R6'Q=X,NK^)(X[C5/
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M^$=8TJ[\F"X^RZEIGB#3[VQN?L]U%/:S^1=012^3<PS02[=DT4D;,A_UK_\
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M*WTSSOAW\6=1$EQ<WLC_ !$\.6=S;:QJEZT3ZM\0?"?C^XM;>&Q2U6OY;/\
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M0W?I^J _:JBBBM0"BBB@#_-R_P"#PS_E)C\#?^S%OAG_ .K^_:;H_P"#//\
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M6A?#W1=.TCP/I=Q9W T[6)]$U+Q9;VEE<^)KZ&LX^]*[Z:_Y+^NP'\Z.N?\
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M)N]9N+*PFBTZWU+7-)LI;IHTN=1M(BTR?S?^&/\ @\!_X)<:]K%KIFJ_#?\
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M:*XBBG@ECG@GC2:&:%UDBFBD4/'+%(A9)(Y$8.CHQ5U(9200:_R9_P#@O_\
MM,^)OVW?^"C?[3_QF\.6FHZQ\"?V<?&?A#]COP9XH@BMKG0M,_X1:/XC7%K;
M+J]C//9WD'Q)\?\ A#X\^/\ P;<*_F7_ (7B<E0=/>O]-O\ X)Z_$O4/C+^P
M7^Q9\5]9OI-3U[XA_LJ_ #Q=XCOII9YY[CQ-K?PK\+7WB5KBXN0)[BX779=0
MCGN)-QGE1Y@\BN'84KR:Z=/U!2NVON_)_P# /L&JM]?66F65YJ6I7EKI^G:?
M:W%]?W]]<16EE8V5I$\]U>7EU.\<%M:VT$<DUQ<32)%#$CR2.J*S"U7X+_\
M!R+^V4?V0?\ @EK\9+30M3;3_B/^TS/;?LR> S"$DN(;7XBZ=JL_Q-U-D66.
MYM(+3X2:-XXL+/6;?G2O%&K^&&WI-<VX=MV3?8;=DWV+O_!,+_@OG^S5_P %
M1OVA_BU^SM\+OAQ\1/AWX@^'_@_5_B'X2UCQS=Z%+9_$KP1H?B[3?"FIZE86
M>ES23Z%JUO\ \)%X6U;^P+R6]NGL-3U!TF9-"O97_=NO\H7X"^ _B?\ \$4O
MVI?^"/7[>'C:;4X_A_\ M(_"_P ._'7Q9?Q6,5Y80?#3XD^)O$_@OXG^"]'M
M4DA_M76M*_9H\=_#KQZD5ZP:P\6^.=,,4D;Z;;-!_JZ6US;7MM;WEG<07=I=
MP17-K=6TL<]M<VT\:RP7%O/$SQ3031.LD4L;-')&RNC%2"5%MK7=?D]4*+;6
MNZM]S6C)J\0_:)_:1^!O[)GPE\4_'/\ :*^)7AKX4_"[P=:/<:QXG\37;1)-
M<>3/-::)H6F6T=SK'B?Q1JYMY;?0?"GARPU3Q'K]Z%L='TN]NW6$^WU_G>_\
M%GM=^(7_  56_P"#@3X.?\$S[GQA/I'P-^$WC;X>_"72/^$39[JXTR'Q?X$\
M*_%W]H_XAB&:UU:UD^(6FZ*-3\'VGVNT;P_I\'PWT!;^VLEE\2:A>-NR\V[+
MU&W9>;=EZGZM:U_P>._\$_K'QF-)TC]GC]K77/ \4D\-SXQ70_A-INK3-%*D
M<5SI/A"[^*1%UI]RGG3Q2:IXBT/4$B6!9]+BFEEBMOZ//V.OVV/V:OV]/@YI
M7QS_ &8/B5I/Q"\%WTS:?JUI$?L'BWP3X@A!-UX6\?>$[IEUGPEXBMTVW,=A
MJMO$FIZ9/9:[HMQJ>@ZEINJ7GQ)XG_X)S_\ !%+]E7]G;1O@1\8O@;^Q5\+_
M (3>(;(>%X/$7QY;X8^&/''CO6M.L;QI-9N/C+X[N])\?Z[\0+*VU*_O+;Q%
MI_BI?$/AV"\>/09]&TV*UMH/D+_@C#^PO_P3)_X)U?$GXF6'[,O_  49\'?M
M*?%O]H26\T"U\ VG[17P<U.PN?!_AG6=<\6^#M-T?X1^ /$=[=>+?'W@[PR]
M];:Q\0+YM2N9;1?%.I>&?#_@#0_$/B#1)DN9/5JWW/HOS_I:(2YD]6K?<^B_
M/^EHC^D2O@/_ (*/?\%&?@C_ ,$P/@'I'[1?Q]\+?%3Q=X)UGXE>'OA9:Z7\
M(-$\):_XIC\0>)="\5>(+&\N+'QIXX^'^DIHT5GX1U**[N(]<EO8[J>Q2'3Y
MXI;B:V^_*_E@_P"#OK_E%IX#_P"SQ?A/_P"JS^-].3LF_P"MQR=DW_6Y^_G[
M%O[6WPX_;K_9C^%?[5WPCT7QMX=^'?Q>L/$.H^&M&^(VFZ%I'C2Q@\-^,?$7
M@F^77-.\,^)/%^AVTLNJ^&;^XM%L/$>II)I\UI+,\%S)-:6_U'7XF_\ !N=_
MRA?_ &'_ /L5_BO_ .M _%JOVRH6J7H@6J7HC\+_ (@_\%ZOV8OA!_P5.U+_
M ()>?%OP9XP\!>(H-:^'WA+3?CWJ>K:!)\,;GQE\4/A=X*^)7@K1-7LA+#KF
M@6FLS^-=/\$Q:W,EW96OB:2RFU-=/\/W5[K.E?NA7^7-_P %R/V>O'W[5W_!
MQ3^TG^SQ\*TTV?XD?%/4O@!X?\$66KWL6F:?JGB6']B[X-:MI6C3ZE.5M=..
MMW6G1Z3!?WKQ6%E<7L5S?SP6<4\R?U0?\&ZO_!6[Q'^U?\/->_84_:VO=>T/
M]N3]E2TOO#.H+X_CN[#QC\6/A_X,OQX8O+_Q!%JRPZP?BY\+M3AB\(_%73M;
MA&O:HJZ/XTNKK6-9U#QP/#TJ6K3[NS_02E=M/NTOET_4^^/V2/\ @M=^RO\
MMF?MN_&[]@CX7^ ?V@-!^,'P$_X6W_PF'B3Q[X5^'6E_#74O^%,_$72?AEXH
M_P"$:UCP]\5?%/BB\^WZ]K%M=Z#_ &IX.T;[5I$<]QJ/]EWJQV$O[ U_G^_\
M$%_^5D[_ (*3?]WZ?^M<^!:_T J<6VKOO_D$6VKOO_D? ?\ P4>_X*,_!'_@
MF!\ ](_:+^/OA;XJ>+O!.L_$KP]\++72_A!HGA+7_%,?B#Q+H7BKQ!8WEQ8^
M-/''P_TE-&BL_".I17=Q'KDM['=3V*0Z?/%+<36WX:?\1C7_  3)_P"B&?MV
M_P#ALOV?_P#Z)ZNH_P"#OK_E%IX#_P"SQ?A/_P"JS^-]?BK_ ,$J?^"B_P#P
M;_\ P(_8)^ _PI_;;_92^$WQ*_:>\*_\+0_X6;XU\3?L0_#+XOZWK7]N?&;X
MB>)/!GVWXB>(?#E_K'B'^SOA]K'A/2;;[9=R_P!DVEA;Z';^7:Z9!&B<GS-7
M22MO\OZ_JZ3D^9JZ27?Y?\'^M5_?A\!/C'X8_:*^!?P6_:"\$V.O:7X,^.OP
MF^'/QC\(Z9XIM=/LO$^G>&/B=X/T;QMH-CXCLM)U36]*M->M-*UNTM]7M=,U
MK5]/M]0CN(K+5-0MDCNYO6:\D^ /B#X8^+/@1\%/%/P3T'3O"WP:\2_"3X;^
M(/A)X8T?PY9>#](\.?#'6?!VC:CX"T'2_"6FPVVG>%M.TCPK<Z5I]CX<T^WM
M[+1+:WBTRUAB@M8T7UNK+/YA?C)_P=B_\$Z/@?\ &3XJ?!#Q?\&_VTKSQ3\(
M/B;XX^%7BC5- ^'/P/O/#=UK_P /_%6J>$=;U#1;J^_:+TS5KK1)]1TFYN--
MGO-&T_49[!H9+C3+2Y9[2/\ 2_\ X)__ /!9/]@K_@I3?ZMX7_9P^*=Y#\3=
M"TFVUW5?@_\ $O1'\"?$M-(F1VNM2T;1[NZO=+\8V.BRI]F\1WO@?6_$MIX>
MFFL&UB>S@U?1Y[_^/#_@C[\!_@E^T9_P<-_\%*/AU\?OA%\-OC5X";4_VZ-;
M'@[XI^"O#OCSPW%K>G_M:>#X+#6K?2/$VG:E96VL6,%[>PV>J6\,5_:PWEW%
M!<1QW,ROO?\ !QE_P2T^$/\ P2XU_P#9>_;X_P""?FFZY^SV+SXT-X=US1O#
MGB;6=1TCP/\ &'2[";XE_"WQE\.T\0W.L:CX>:]A\(^.3K&@C4I_"]J=%T*#
M0]$TNSDU&UNLU*5N;2R=FMNVV_\ 7X9J3MS.UD]5UZ;??U_X;_0\HK\%?V</
M^"\O[+'C?]GGX#>-/B]\0_ 6B?%GQ?\ !CX7>*/BAHVDZG>:=I6D?$37_ ^A
MZMXUTS3-/N;+4KFQT^P\2W>IVEE9W&HW\]K;11P2WMU(C3R%7S+NOO+NN_\
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MS^%[CP+!X:U?7M)\2V$=UH#^#?#Z0/K.C:S:W4-FT&H6=W%/*C<;_P $WO\
M@G)\%O\ @E_\!=;_ &=?@-XR^+?C7P-K?Q-\0?%1[_XRZWX,U_Q-I^M^)/#W
MA'P[J&E:=?>!_ 7P[TQ= 2'P?9ZA;6]YHU[J<>I:CJSR:M-926-EI[4;-/\
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..V7W%V7;^M/\ )?<?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>logo_pwc.jpg
<TEXT>
begin 644 logo_pwc.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M7QK\4:CJM]?-;S_"W6[)/LFFW<TGG2>+/!,Z[E=(@$V6TF6#$AMHQSD?B_\
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M[Q_!_P#Y)+\+O^R=>"?_ %&M,HH^#_\ R27X7?\ 9.O!/_J-:917_5]X=_\
M)O\ @7_LCN&/_5)@3_)3B#_D?9W_ -C?,O\ U-K'HM%%%?8GD!1110 4444
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MSXC^+-/M?BM/K*Z;/8IJ4WARX\!>&/$5K,)Y?!T%G>);+J_L ?\ !R_^W?\
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MV7S-2N[V&WL[>V /[(Z*_CV_X-E_^"KW[4_[6.L_'W]GC]K+QYJ?Q6T?X/\
MPPTOXK>#OC3XPATVWUKPQHMGXACT#Q+X5^(/C1(+-_$@U!=8LO$/AW6O%$US
MKUG9^'_%L=_K6H:9%IUOHWS?_P %2?\ @ZG\3VGB7Q#\%O\ @FA::3IVFZ)>
M:KH>O_M2^./#NE>);G6=1T_4S;QWWP/\&:K-J?A<^&Y(K-I+?QA\1M$UU_$%
MGJ<BV'@;018V/B#4P#^YFBO\V/X9>'_^#A#]J3]D_P",O_!2&\_;G^/7PO\
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M10 4444 ?QT?\'BG_)M?[''_ &7'QY_Z@4-?S2?\&]'_ "F-_8I_[&;XI_\
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MBA\3/'GQ$NH[R=+J[CN/&OBG5?$LR75S'#;I<7*2:FRSSI;P)-*&D6&(,$4
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M:WHEFB10Q^&]-\4:A=>&-._LZ&+1;"\T/5/#>F1P)X>FM+;[P_9+\/?M'_\
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MC@M[>"-(8842.-%154?YD7_!7W_@FY_P4!^+'_!3']LCXC_#']C#]IGQ_P"
M?%WQAU+5O"WC+PC\&?'>O^&O$.ER:3I$4>H:/K.FZ+<6.H6;R12QK<6LTD1>
M-U#94@?Z<]% '\X__!N9_P $K+[]@K]F:_\ C9\;?!]QX?\ VK?VDK6TOO$^
MC^(-*2S\2_"3X4V%RUSX/^%\T=R9;_2-;UJ=5\<_$.Q(TJY.JW/A?PKX@T@:
MI\.8+N7\T_\ @ZA_8U_:R_:<^/W[*NN_LZ_LW_&KXWZ+X8^#WC/2?$>J_"WX
M<^*?&UAH>J7GC2*\M=/U6Z\/Z;?0V-Y<6@-S#;W#QRR0@R*I49K^V2B@#_-4
M_P""0?\ P;Z?M$_M(?M.V&J?MQ? ;XN? K]F?X3_ -E^+?&^C?$GPKXD^&^N
M_&C4'NICH7PP\+2:M:Z9JYT35;BQFN/B'XAT+9>:-X6ADTC3M5T#Q+XH\.ZW
M8?Z3.C:-H_AS1]*\/>'M*TW0M T+3;'1M#T/1K&UTO1]&T?2[6*QTS2M*TRQ
MB@LM.TW3K*""SL;&S@AM;2UABM[>*.*-$&E10!@>*_"OAKQWX6\2^"/&>A:5
MXH\'^,M UGPKXK\,Z[90:EHGB+PUXATZYTC7="UC3KI)+:_TK5]+O+K3]0LK
MB.2"ZM+B:"9&CD93_G(?\%+/^#97]K[]GCXA^+?''[&7@[4_VF_V<]4U'6-<
M\/>'_"MQ;3?&;X9Z3<7LEQ8^#=>\&:CJ/]M?$3^R;6X@TS2O%'@7^WM5\0)8
MSZAKOACPQ-)%#<_Z1U% '^2=^SM\#O\ @MO^R]XIOD_9F^!/_!2SX*>(-2O-
M(O\ Q#HOPZ^#?[1_A.PUZ72WWZ1+XW\,V?A>VT+Q%IUD-08Q1^+M,U#2XK:^
ME$D8MKJ42?I'X?\ ^"5'_!Q%_P %)VL=%_:8\7?'#PS\+-0U(ZU<7'[87QU\
M0Z-X%T?4U_XF<=S;? VUU7Q+XNLM45;UH-*>Q^%-E864RII$NIZ1!8LEG_I'
M44 ?.7['_P "KS]F#]E7]G3]G/4?$=MXOU#X'?!CX<_"R^\4V6G2Z19^(+SP
M1X6TSP_=:O::9/=WT]C;7T]B]Q!;37EQ+%$Z+)(7R!]&T44 %%%% !1110!_
MFT_%?_@F1\)OBE\0/%'C3XC_ !H_:9\=^*]6UC49M0\0^,/B-X:\3ZW<DWDY
M1)M6U[P#J&I31Q [(5GNI/+C 4' KSL?\$AOV;%(9?''QR# @@CQ+X"!!!R"
M"/AID$'D$<@T44 ?V:?\$(_A<WP>_8W\7^!H_B1\5OB7I>G?'SQ7)H5[\6_&
M!\9:MX9TF3X=_"J.+PGX;N5T_3+?1O"5G=PWFK66A6=HEM;ZOK6N7ZDR:C*!
G^TU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>nt10006151x14_cov001.jpg
<TEXT>
begin 644 nt10006151x14_cov001.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBHV;G 88XS@\X]?\
MZW/3ZT .+=0,CMNXP#C/&>"?;Z^E0L5&TL<!F_O8#-@@#C&1WZD'UQQ39)
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MMKK^KO=V[72M;\M.KTV=K_IU3L[%J!7L%6YDQ]HSFT21@,,<YG9/O%%&5C#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&,9!(VYZDDLFLC$WS2Q?,&90KY+ $CC(&#QE@0-O(ZC%:L%TEU&EM>S$G?\
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MC>H!QD'%1&*WD++YQ3& ,[709Y&&&W!)/"XZG!' (9LB8J\<HBP=VUUR%P2
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M9];]=5HM7?2R\GKHVGN?HQ1112- HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>_$:J9@J,;@K)*1N\N<$,BR1;0I0.R22'..21@8&:TUS'(4Q\I10"=J*K8!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M98NP.3A$Z*J[L1@J%4E\(-Y+8F)@5$FF1@Z2(7*B)<$2*3&5)9MJ\,S*H9G
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M[3D*XR-PXW$Y/H\+R#C><G )!S[$%@,'^(GJ,^O JD.3Y@0$!7VG<&)^8*0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMC1&=09)BF2"K#.T)E<YZ\)N.068D)4=W+),0Z@,\/!<A=KJ <$*4 &U",@
ML>#D8K-EN98D)BPTRC:%<[$9U=2"JDJO VA6/0EB<M@++%<%U<B/$K;E"R$
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M*?F3S) IR2C*51MN 2R8/7-.]NG:>*>$#8=WR9("ECN<,"51=Q)9PJY4Y"D
M"JTUV\QC=G+ QN-V 7+!LN,+D<$$Y.2>#2?R::CNGMIMLK7:>EO05TF]7WMI
MUY?EO?\ %WZNN)66WGFE+$M+LC88ROWO-49X"C*J./O,0IY8B-)9'57+/ART
M98X1^0%"C/#J02O&XJ <@4Z<I+& "5* .W&T,5W 87DOO+,W)!&3G VY@=VD
MB61I02G[M4+XV1X(*K&%PBY)88 !QDDG@)Z:*5U;NOZ7HFR&^NM[+7I?3R]+
MWOK9:Z,68HK*4C*% 4^;)._H,C)R"P!P>1N.00!3!(Q4 @%3\N6RF&X^4*,
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MZY.*65R-B@9S&A('\+ !3@#(!P 2/<9SFE>ZZMK;71+^K?UNTNUGY7WV>O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)Y;A0LD9>.-SL692I&?)5% (JM)>!V9 T:.)7*,QPQ";FVQE\EPV-P0[D8Y
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MA;;HM=-+;/3=K:VC7O>35GWM=+I?3:ZZ6NGK<RID NC"[.TSK$(^2H1V8!5
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M,YV\#'7CD_ACM0_Z[[+S?Y]QQOJKV\OFK_-6\GV:U) 2RN<$@ #(X!8D<DX
M  5CG'8GC)I4\M<#:TDF<'!.U2>, #[Q)/ODCM3&;(VC  !9N?O$GCG^+ Q@
M=/RH!V ,."PZ@_,,9&5.,@D>F.V32_K^OZ_S!+32ZYNB:O:R>M[=+O3NK]B_
M'A,[W!==S;4 "HP0E2[<,68C&"2,\8/)JH9!D<%BW(#$G[Q(YQC.<@@8]\=*
M 3@83.=I8DCDGN1GC"\#)/)W'DT]HRV##()  ,Y3RV#'@QC=D-D@X //4J!3
MOVMI^.V]]_3;<-VNVB2OULNR>]O+Y,E,:+$)6("22-& ,EBR*I(P"1\N],YQ
MN]1S26X2&591@^6&8?*6.\8" HQQDL>@#C(//:HV+&$12X7RY"X'!8!@$<%0
M.2-JD9( )Y]!&DC>82AVD'<O3EAD$C@@9SG/08';H72::Z6MKU5F[_TEV$M%
M=7LG[W9[:=GN]/Q:+BIOD*LI9UPC$@<=VWG."Q!;()PP.!CFH9'\QFP<;=J*
M!D@;<@-R<_/CY@>F<=>3;@=1!)\Q#%F^9OO%R@&3GJ5&0.!@=<G-4XG7[K!7
MC\P%F(()&UP6!4;B!DM[$9QDFG:]M=7H^O5:/S5_+;[V]$O.SVVT25^CO9W[
MO7R$A?)7=(57<"P)[*,$E0,D-DKCD<@\G-(P7)XRA.U,'[J_7&?;GG Y(Y)0
M':7 1&7;E"1AB 0 X[!B #CH"1D$XJ,$*""IW*01DG//.<\<'GISSC!Y-2*S
MZ=UU3M>WXWLKI?,=E=V$R"2!N7[ON#C.0<XZ8Y]LT>8W)!Z$#&!G())(QD<#
M(Z]0#WQ3F0DA20&')QC )QQSSA1U!!YR, #%1%0"V#R#_P !'&3SC&1@<  \
M$<T; K/=]O/JMWI9?/Y]WJSLZ98MN )(P/NJ2PX'4 >QR,YYIS@+M:,DKM(
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MR",[V<\9.-N4/3AO45#G*9!B<J<[22"03C)R1D@]".GIVJ-Q\S*6SC81AN.
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M;KX?A\1:I<:?=/I/AJ\U.VUO5[=!/IEC=HPH ^NZ*** "BBB@ HHHH ****
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M1/PW\;Z7\3/AYX"^)&AY&B_$'P7X6\;Z1N8.W]E^*]#L=>T_+@ ,?LE_#E@
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M?^">NM>&_P!IG]F>+48?V9OBGXJN/#.M>"-0NYM2N/@]X_O8+O5].TK3=2N
M;J\\#^([.UU!?#JWTMWJ.BW6ESZ7?7MU%/IL\HX-:I[?U?KZC<6M8O;Y/3KO
M\[']2W_!"C_@MKHG_!37P'J7PG^,,.B>$/VO/AAHD6I^)M+TSRK'0OBMX2BF
MBLG^(7A#36D+V%Y8W,]I:^,O#T7F6^F7E[9ZEICC2]1^Q:3_ $+U_C'_ + W
M[5GB;]B;]L#X!_M,>&;F\C'PT^(.AZAXIT^SN);9O$7P_O;N/3/'_AB:2+=F
M+7_"5WJVG#S(YHXYYH9V@F\D1M_LE^#/%WA_X@>#_"GCSPGJ$.K^%O&WAK0O
M%WAK5;<Y@U/P_P")-+M=9T;4(#WAO=.O;:YC/=)5JXNZ]-/7^NQ47=>:_JYT
MM%%%44%%%% !5>[N[33[2ZO[^ZM[*QLK>:[O;V[FCMK2TM+:-IKBZNKB9DAM
M[>WA1Y9II72.*-&DD954D6*_GS_X.8/VM-?_ &7O^"9'C?0O!FISZ-XT_:1\
M6Z%\"-.U:SN9K2_TWPYK5MJ/B/Q[-8RP@GSM1\(^'=2\-R@O$4L]?N9XI!/#
M$" W;5G\P/\ P6Z_X.%_BU^U1X\\:?LW?L;>.M:^&W[*?A^ZOO#.M>./"MX^
MD^,/C[/ 6M-3U.;7+-QJ.B_#:>43P:#H6F75I/XCTTKJWB5I%O;;1-)_E:=V
M=F=V+.[%G=V)9V)RS,QR68DDDDDDG)/.:LV%C=ZG?6>FV$#W5]J%W;V-E;1X
M\RXN[N9+>V@CW%5WRS2)&NX@;F&2!S7^GM_P2/\ ^" '[*G['GP5\#^./VB/
MA-X&^._[5/BSP_IGB'QMK'Q/\,Z/XS\-_#/4M7L;2]D\$> _#&O6NHZ%93^&
M68Z;?^+GL[C7M5U*/4+BROM/TFY@TR')7FW=V6FG^7W7_P S))S;;=E]^NFB
M_/\ /4_R_P"BO]KX?LP_LU  #]GGX&@   #X3> 0 !P  - P !T%+_PS%^S7
M_P!&]? [_P --X"_^4%/D\U]S_S_ *N_*S]FOYG_ . _\'U_IZ?XH%)G\/3/
M>O\ ; _X9B_9K_Z-Z^!W_AIO 7_R@K@OB1^PE^Q9\7?"NI^"OB/^RE^SYXJ\
M.:M;2VMU97WPD\#Q7$*S(4-SIFJ66BVNK:+J,6=]KJNCWUCJ5G*%FM+N&55<
M/D]/N?\ \E_5_0/9KO\ A_P?7^GI_D7_ +'_ .V_^TU^PG\4=.^+/[-'Q0UW
MP#KMO<VKZWHL4[7O@[QKIMO*KRZ%XU\*W+/I'B'2KJ,/"RW=O]LL]_VK2[RQ
MOHX+J+_4F_X)&_\ !4KX:?\ !4K]F^'XEZ'9V?@[XP>!9M/\-?''X7)>"X?P
MOXHGLA/;ZYH1E=KR[\#^*Q%=W7AJ_N5^T0O:ZCHUZTE[I4\\_P#!5_P7[_X)
M#Z)_P3&^.O@_Q/\ !NZU74/V9_CVFN7O@"RUNZ_M#6/A[XI\/FQD\2> +_5'
MV3ZOI\,&IV>K>&-3N(OMCZ3/)IFHS7E]I,NI:ASG_!N/^UEKW[,7_!4/X)>'
MEU2ZMO /[2=Y)\ _'VEI)(;._F\7(Y^'U]/;#,1N-)^(4'A[R[UU$EEIU]JR
MK(D%S=)(HW3Y6U^&[MUT_4(W3Y7Y6WZV2MW]#_50HHHK0T"BBB@ K^7_ /X.
M#O\ @N%J?_!/[0;#]F']F/5=,?\ :P^(.@1:YKWBN6"SU:#X'>"-0=H]-U4:
M==1W.GW7COQ0(+DZ#8:I;S6^D:0G]OW=G,;W13)_3;K6KV/A_1M6U[4Y1!IN
MB:9?ZOJ$YY$-CIMK+>7<I&1D1V\,C]1]WK7^,'^VM^T5XL_:S_:Q_: _:(\9
M7LUWJOQ2^*/B[Q%:02W4MY%HWAR35[BV\)^&[":;Y_[+\->&;?2]#TY0$'V2
MPA;8&9JF3LO-[$R=EYO;_/S_ .#\GX-XU\;^,?B1XKUWQU\0?%.O^-?&?B?4
M)M5\1^*O%.K7VN>(-;U*?'G7NJ:MJ4UQ>WMPX55,L\SL$1(U(1%4<O7]>_\
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MM0\/:Q#)+I_B/PIK/D,4BUGPQKUIJ&B:E&0F;BR:9$$,L1/TC7^=?_P:P?\
M!34_ 7X\ZA^PA\6/$#0?"G]HS6(]0^$=WJ5TYL_"/QQ$,5G!H5J)'V6MC\4;
M&*#2O+C5E;Q9IOAY8TB.J:A<-_HH5:=U?[_4I--77_#/JOZ]0HHHIC/G']KC
M]I[X;?L:_LY?%K]I3XKZA'9>#_A7X1U+Q!+:":.*^\1:PD1@\.^$=&60@3:W
MXJUR6PT+2XON+=7J3W#16L,\T?\ CS?M7?M-?$G]L#]HWXL?M+_%/4GN_''Q
M4\8ZEXGNDA>46N@V#S"'P]X9T8.[RV^C>%-$M].T'18FEDEBT_3;;S)I9M\K
M_P!,?_!U)_P4T/QR^.6F_L$?"CQ T_PM_9ZU>/6?C'=:=<NUCXM^-LEDR0:'
M*\+B"[L?AGI-_/I\T;"01>+=3UN"4+/H\)'\[O[ 7[&/Q"_;[_:N^$_[,7P[
M2:UN_'>N"3Q1XE%OY]GX)\":/$VI>,/%^H9*1B'2-&M[AK."1U;4=5ET_2[<
M275]!&^<G=\J]/OM_P -Z-F<G=\J]&_N^ZUM?G?8_ON_X->?BU^WK\;/V0O%
MWC']J;QY?^./@7I6O6G@O]FG5/&^G7-W\1]3M/#[WT7C2[;QI<2PW?B+P-I%
M_):>'-"DUB/6K]-4T[6--M-7LM/T)-/F_IXKRSX(?!CX=_L[?"+X=_ [X3:!
M;^&/AQ\+O"NE>#_".B6X3%KI6E0")9KF5(XA=:EJ$YFU'5K]T$VHZI=WE]/F
M>XD8^IU:5DEV-%LNH4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KY7^+%R)K]U:&2&82QER[O'O3[/;F*95;)DAW03Q
MA]N5D*?-\[1CZHKY)^*Z.FNWT4HD&V426I8$H;>=#+*$9F)!BFD9BHPI$K=
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ME:LIO5>2O^+,ZG3Y_H?[2/[$4,5O^QA^R+!"BQ11?LP_ 1(XT&%15^%7A0
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MWF19(I[>?XG^%XIH98V!5XY8W9'1@596*D$$U_M/5_BT?L5_\GD?LE_]G,_
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M3: "\LG[2/QA+R.>K,>!DY(4*H^50!^W%?B9_P &Y_\ RAC_ &*?^P-\:/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%?+_ ,5X_M=_]I"1GR(E ._(QYDD4B3(#OBE4Q^6#P<Q[OXE#?3DKA(I') V
MJ3STSC _7%?,OQ)7=J<2 ,?M!.75E1?WD926-B#N8AE69"<*S/(@"L68W#=^
MGZK^K"EMZM+\?Z_X<\+VDD @$$D'CD-D#D^W.6&#D CG%=/H4;07B/C:R 2;
MBZH.'X*MN]3@G:6&<?3/CL\3A2I(0G*C!)Y^Z22/]PY&%)(.,8KH],A#73%%
MWED=EC6-03C)'EF0X*Y*E^,RD84DY8M*WF[KY:QT=KVOKUZ:$1BU?[EOUM=Z
M:JZZKYVL=<KO%(PFE?RDC5DCWR$A%0B-4.&,6=SE2"RYD)^4G)H2W:$+^\.Y
MY/,VK'Y9"*41 6+%"<L<AL!BK2,=V-NLL#^4P8>4Y(\P*!N4!E.U0X,L9&&$
MC'&U21\Y8)7/W44 D(^=LL40J J8&T@9+ 9W H')&<, 6SBK;:6BO_P=%_7X
ME7VU\WU[/IY/SM>Z5E=*9W= "TY1W)V/(TB[B"NXN03&4!&WG<QQR. %%T6!
M3!PL2L[EF=V!(VMYFXC9P5((&2 !SBLF21EE>*(EWW%'!V.SKPS988 4,=I0
M!GR5 ()(IAN#\I$1AX!3RV#8.!N.&.4'(//)SVQFL^9ZWU?RU5E?H]-+NSZW
MVV5GHKNUK+=?-[:]+6:76[3NVZ1FS&2$DF_>22*20 @5W96/RDNR+&N,  ';
MRN!21=DKQH2@BD@5]N6R5<1D$D9",2SMT)W* I .+D\C1QO(%PV$4X4=3DHK
M1X;&XL=V#C!+<9JJLS11-&"'N'!E+.5ZD*V5)"G<QXC0C"C&<@+E1O;2^OG9
M*UKM_+JG?R&EML[:7U>ZBK_=^%MKLZZWD(P ZKN5AO;&TE2 5P#CY,]6P0Q*
MD9!%6 5*8;EEW9&[*LN2?,,C,I3&650<G=@9)-<E#YTJP;2_,BEB"'*K\S[G
M(P!E@'; #,S8.3D5T\,@5%!=7*[02Z9R6'S8 'R[R2>00>GR\D:)MMZ;:7TO
M?2ZM_EH&RM?M:]O+3_@^96N(_,=225C0'#[\E9 <@*PP-NUF!!..H(/>)V90
M%9EDRI(;<F]@!V ^]\A.0>,KP1D&K:[0I)W#)5CT()"[MQ .-R9!P%!) R#U
MJO(A!)#99E''RJ,$C)##)5B'SC"KC"GN ?)Z_.RTT:;ZKLM-;><VW?>RTW3=
MFK-=%?35+1+L9&5QM*L'  +-&<$%B O. ,8[Y(],]*KM)AESN&> 2%&T[<(<
M\-AATQE3^ JS-YD<D@&50MMD4H6559>J 'Y3G<PVG[W  (JG-C)<2.Z[2?F.
M-RMDY ;G)*<D*,<?> .<U9/?73H]'=?\'^F6N_?5?<ON]",N&W+D@X.\$8W<
M'(7NC+SE^Q/'!R8)5903PQ4G:K$Y(YR,G(..@*D8+#DDBI#(KONQL?*DG (8
MA2.><<\$DCYCN((!%1E<DC@GKC#8!XR&(^7!&#G(PP(. >+2M9]=FFM>UT^R
MOOKI\DC?^OZZK[T4'8,^6VY9&*DCJP9=P;@8..>S#:0,[JB\PA2KHI&YG5
M<.>3DG!*MP?7@@C)JU-$7#,H VJ6P.K;"-P8#G!3=P!T/&2 *J!Q(Q.!\H"_
M+P"/NL>3DY.!_P"/9Y(HU76]VO+7W=//9KLM;MO;-K6VB[;N][*W6UK==GMW
M*TCQM'(C( Y=95<D[BI.V1&8\%?NR*""0P. -Y!8&X)R6VXX!SG:057 P> .
M3D$CN<YJ0Q, S$KA<@ _,SA@02 .P!PV0 >N?2NI(8*JC<#QGT! SMX'8$8R
M>A&<9J.W39]?OW>NK[;=]"7?K_P>BV^[I=[ZCG+NXD+Y) P3D@@#  [#&>%S
MTX X(IN!N_VB<@D]\8)VCC@8 R>#VZBE?<K,-ZXS\JK@$DD8.!R..>A!'&#R
M*;(I'EJHR[(=Q&<DB1QDY[\8'H  ,&E;>W_#^777_(=I=7;3\-+W>]EY]K('
M;RV" 84*&QC&6< ]CD<$#GD $8[%&<NBX)  (P,+\Q(V\#MW/X<YYIA1FVYP
M&QMQU)QT.!GL>>_'2K<=F5C\Z9E5"?W:9)>4XP2 %(50&!+'!XPOS="U]OZ_
MK_-[(K3>]VK7Z[63Z?-/OKTTI].!DCN0#DYQQSTP,GCC)_&F X.:ML6).TH%
M&5POR@9QRV1E^<@EB=P]#G%5AM)&0?<?C^1]0,CWXI#BT[K1_?KHK[KO^'2R
M'[C@!0002^ "0.1@'T&!GN.1TR2) @$;,?E)VKC@D[AR>"N <# SU)X %1'<
M@7G#,-V<\[>BC],X],#%.#%AG[K+_$. V>S#^\>?F R><CO1^?\ 7]; U975
MDKWO=W>OIKY-WTU++!5PR%RS[UP<'"*%!+8&"'.1Z]0.<5795]^5! Z,2<Y#
M?+V8<L3_  CUIK,02!QQ@C&/J,'/ Z#IZTX'Y$W<J"P.!R<X(!SCG.>ASWYY
MH)2:L^^BL]==OO\ 5>J'9^X?O8P"HP02#R#SP& QE> >IIX=T9W7"AU,:H6&
M CC:2!UXXP<<'WP0(8HV!ZMCB)^4W]BY'&!U"D9)&"<'%1,&)+.<CKD8ZD_=
MX]^PQZ]L4]O7=;>7W^G3[Q)?E?56;3MMWOLM==>Y82U,BJOF1@KG<N\9(^8A
ME[<CL1D_+U)-,D#\.ZD , &7A5  QMQE2.,'G+$CG<2*C+[E.<#:!EE]L!1S
MS@]R1VZ&IH9& +/@QYW>7M'SXQEF4@KL! Y/.2 #UIIIJVJVNUMT6J_X.[#7
MKI9Z]'[UO+>U_EOT(KB,(5"]%50><X+*&(X[ DCG!!&#DC)6T8I."#@A)>>0
M1F)U(SVZ]>OX<4CN')Y4,V22!\I+'E3UQ[=>QR*C =74D<D<9P0PQ@@X."#R
MI/USSFDM_*_772_4I/W;;-:KHVM]+[WU_P F2@';AN?EZXQ@@8()R.1^9 R.
ME.5D1?N*ZMC.=W;C<!GVR1GIUYQ3"RNQC4';D $Y/&"3GWXX/MUP*>JD?Q$X
M/\0R<#^[S@#CDD'.1QZFS_X'Z/\ 7\"-5O=7U:V\UY=_2Q)Y:,-PD,6T88<'
M*]MNT#:<X'S8QD8) &9H0TH9V#NJ1N%!9G8RL" -H(+ 9W 8YR.<<B!,(Y;8
M6R"" Q&[.>" 0"/J/3'(R+_VQ(@(Q P/1F4J0/0H 0PP, \X'/0BJ5K)NUMG
M>[;>_;;K^;8U;J[6UVUOIY.__ Z&5PC,0WF,"!\N,'..^,D\8)4=<\\YIQ?<
M<;0C=<;VQCN,@DCH#@YY)%2M"!^_B8-"7VL>%*DD8RG) R.2/EZ<@\55DC=7
MDC/WD8C;Z@G)*\?0D@Y(/I4V^[:_X^=G_P %=QZ-ZZ:)W?R2M:RM?KVZK<1]
MXR2" >,'D >F?QJ+W_\ UU*Q950$G)4GU^5N ,?1?U(I@P<<'/3TSD\9/Y_X
M^B+C>VR\K?GKWMH[ZW0 %V"J"68X50"22>@ ZDD\>M/;$:E,'S#PYY&P<@QX
M('S9^^>Q&T=#3"2CY'!5LC'8@Y&,=,=L=.U37&&G9NF\JQ_WF +8_$GK^O=]
M_P"OZ>WXCWMVM?[K6N_G\^_=@4J YX!!89_BY(P,YSR.3@@#K0N&8!4 X.<Y
M;C')Z=<#@=,_6B5F9L'HH"J.N !@?3IR.A//O35)4!E/S!N.G08Z>I.<$#MG
MCN$3JU?JUIO9)Z*_>U[O0N?;YW5(V90J85'VC>J@YP7ZMG/5B0.V.E6HY5O<
M12IYIC((,?R,5[DGG[O.6P!CIG&*R&(R2O ZCV[_ *'@>PJ]:2E=ZHTBLT+J
M=@(#'CCCDGC&>G'/08I/57NU?;N_GH#TLU?:W>VW2SUVMYKU.I2W@_=117*F
MVS&8T8\!VPIRXZ\ A02!@[L<Y.A]C$KS3/&JQ1N4C>(AT=8^&5ER>68'/ (S
M@ X-<TD^[R\,(R2JB/&?,.."F.0P/))]#BM#^T)'TV6UCW03P3K*Q5A^\ ;&
MW;QCGECG@DD]:NUNK[=M?=6ZO^37SU!/1-/H]/1+:_IL];-OS/NRBBBLBPHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH _'C_@OY_RA[_;B_[)UX4_]6MX
M K_)6K_6I_X+^?\ *'O]N+_LG7A3_P!6MX K_)6K*>Z]/U9G4Z?/]#_:5_8H
M_P"3-/V2?^S9/@+_ .JK\*5]-U\R?L4?\F:?LD_]FR? 7_U5?A2OINM([+T7
MY&LMWZO\PHHHIB"OQ#_X.._^4+_[:G_8/^!?_K3?P6K]O*_$/_@X[_Y0O_MJ
M?]@_X%_^M-_!:@#_ "BZ_P!EW_@FU_RCK_8'_P"S+/V6?_5&^!:_QHJ_V7?^
M";7_ "CK_8'_ .S+/V6?_5&^!:SI]?E^IG3Z_+]3[3HHHK0T"BBD) !)(  )
M))P  ,DDGH .3[4 ?QP_\'=W[: \#? CX,?L1>%M52'Q#\:M>'Q9^)=O:W*B
M\@^&_@2ZGL/"NEWT*DNEAXI\;RSZC&S"-IY? CQ([P_:HW_A"^!OP?\ &'[0
M7QD^%_P.^']F;_QK\6/'7AGP#X9M@CNIU;Q/JUMI5M-,L89_LUJ;@W5TR@E+
M:&5\?+7W-_P6(_;,D_;K_P""A/[0/QPT[49+[X?P>)O^%>_"6/SI);6#X:_#
M^,>'= O+1&)6(>))K2^\6W219C^W:_<A'>,(Q_8G_@TQ_8T'QA_;+\=_M8^)
MM,$_A+]EKPDUGX3GGCCDAN?BS\3;+4]!T]HED1P6T'P6GBJ^DE5HY;:^U#19
M(M^Z0Q9/WI^7Z+?[^GJ9OWIVZ+?Y;^E^GR/] W]GWX)>#/V;?@?\*/@'\/;=
MK;P7\(O ?AOP%X?$B1QSW-EX=TR"P.HWBPA8OM^JW$4VIZ@T2K&][=W#HJJP
M ^*?^"N7[>GBK_@F[^QEXF_:@\&_#_P_\2]=T/QKX&\*0>%O$VK:CHVDS0^+
M-4DL;B\FO=*AGO!+:11EX8D54DD8;VVKM;]-J_$3_@X1_9K^.?[6'_!-KQM\
M'_V=_ASK7Q3^)>H?$WX7:W9>$= FTN#4KG2]$UR:?5;R-]7O]-LS'90R++*I
MN1(4)9$8*V-30_!']G__ (.W?V@?C%\>/@G\(M3_ &0O@YHVF_%3XN?#?X<:
MAJ]AX_\ &L]]I5CXX\9:-X9N]2LX+BP\B:[L8-4DNK>*?]S)-$B2_(6K^ZFO
M\L7]DG_@B)_P58\"_M5_LR^-_%W[%GQ0T+PIX-_:#^#'BKQ/K=Y?^!_LFC^'
MO#WQ'\-ZOK6JW0A\62S&VT_3;.YNYQ#%++Y4+;(W?"G_ %.JF+DT[_+2S_K_
M (),6VM=[]K=C^;;_@Z$_8M;]IG_ ()X:E\9/#&CO?\ Q(_9(UYOBI:RVL,\
M]W/\+[^V&D_%33_*@#$VUCIPTCQI<W,B,ME:^$+IV>&WFNI1_F3:7JFI:)J6
MG:UH][<Z;J^D7UGJFEZC9RO;W>GZE87$=W97MK.A$D-S:W444\$J$/'+&CJ0
MRBO]OWQGX1\/_$#P?XK\!^+=.@UCPKXV\-:[X1\3:3<HLEMJGA_Q)I=UHVLZ
M=<1NKH\%[IU[<VTJ.K*R2L&4@D'_ !J_V\?V7=?_ &+_ -L#]H']F?Q EPQ^
M%?Q(\0:+X?O[B!K=]<\$7-TVJ> _$0A9G*+KW@^^T75=BR2I&]T\:RRA!(TS
M6S^_]"9K9]O7Y'^L9_P3/_:^T_\ ;K_8>_9]_:7AN+*37_'/@N"R^(-E9-"H
MTGXE^%KF?PSX[L);.$G^SUD\0Z7>:GI]G(J'^QM1TRYB#6US!+)]VU_!_P#\
M&@?[:)TWQ5\>OV$/%>J?Z+XELA\>?A';7,[*(=8T6.R\/_$S1+%'+)))J6E2
M^&?$,5M$8WB30=;NPDZRSO;_ -X%7%W2?]?U_6Y:=TGW"BBBF,*_C@_X/(/^
M38?V.?\ LO/C;_U7K5_8_7\<'_!Y!_R;#^QS_P!EY\;?^J]:IG\+^7YH4MGZ
M/\C^(?\ 8K_Y/(_9+_[.9^ __JT_"M?[2]?XM'[%?_)Y'[)?_9S/P'_]6GX5
MK_:7I0V?K^B)AL_7]$%%%%66%%%% '\EW_!X'_R8-\ /^SJ=&_\ 57_$BOX=
MO^";G_*0']B__LYKX,?^IYHE?W$_\'@?_)@WP _[.IT;_P!5?\2*_AV_X)N?
M\I ?V+_^SFO@Q_ZGFB5G+XX_+\V0_P")#UC_ .E'^RU1116A84444 >-_M%_
M\F^?';_LC?Q/_P#4)URO\3.O]M7X_6D^H? CXUV%K&\UU>_"3XCVEM%&I9Y9
M[GP=K,,,:*.6=Y'554<DD 5_B73PRV\TUO.C1302R0S1L,-'+$[1R(P/(9'4
MJP/0C\*SJ=/G^A%3:/K+\HG^KS_P;G_\H8_V*?\ L#?&C_UI#XQ5^V=?AM_P
M;=ZYI6L_\$:?V0;?3KV"ZN/#Z?&O0]9@BD5Y-.U5/V@OBGJ@LKI5),4[Z9JF
MFZ@D;88VE_;2D 2"OW)JX[+T7Y%+9>B_(****8PKY;_;D_Y,I_;!_P"S6_V@
M?_53>+:^I*^2?V^]8TW0?V&/VR-5U>\@L-/MOV7/CTDUU<R+%"CW7PO\46EL
MC.Y"AI[J>&",$C=)*BCDB@:W7JOS/\86O]2G_@V&_P"4/WP+_P"Q[^-O_JSO
M$%?Y:U?ZGG_!LSI%[I/_  1^_9[^VQ-%_:?BCXQZO:;E(\VRO/B?XE$$JY^\
MK&)P&'!*G'3%90W?I^J,8;OT_5'[Z4445J:A1110 5R'C_Q[X/\ A9X'\6_$
MGX@Z_I_A7P/X$\.ZOXK\6>(]5F$&G:+H&AV4VH:GJ%U(03Y=O:P2.(XU>:9P
ML,,<DTB(W7U_%!_P=??\%-F\+^&=#_X)N_"/Q T>N^,;31_'G[2M[IMRZR6'
MA'SXM3\"?#6XE@==D_B&\M8?%WB*RE.X:-:>&XI(WMM:F 3=E=] ;2U>R/X_
M?^"B'[5!_;:_;9_:-_:DCL+G2M,^+?Q#NM5\-Z9>A!?:=X-T33=-\)>"+*_$
M;/']OM?"'A_1(+XHQ0W:3%,*0!_49_P:I_LE:_\ %C]G3_@IGXKN)Y?#FB_'
M3X<V_P"RKX7\5W.G27EG9ZKJW@SQK<^*;Z")9K8:E_82>-?"-Y?6,=Q Y#VL
M?G1&Y#K_ ![_  0^#7C_ /:'^+_PV^!WPMT6;Q#\0OBKXQT'P1X3TF':HN-7
MU_4(;"WENIW*Q6>GV8E:]U._N'CMK#3[>YO+F6.""1U_V#?^"?/[&'@+]@+]
MDKX1_LQ^ 8X9T\$Z!!<^-/$4<2QS>-?B3K$,-YXY\87/[N.3&L:X9_[-@F\R
M73M#M]*THRRI8(YB"NW)^?WLS@G?F\]/7=_=?\3^0W_B#2\;_P#1]/A7/_9%
M=7_G_P )Y_2N-_X.>OV*]<_9\_9!_P""54\%Z?&-E^SG\(+']D#QIXWM-.FT
M^TO[[P=\/_ J>#]7^P-->'3;7Q)+X5\;7D=M<7<IM'2WL_M%S+*&K^_2OC?]
MOO\ 8R^'G[?G[*7Q7_9@^(PAL[+QYHHD\+^)S9Q7E]X&\>:/*NH^$/&.F*X$
MBSZ1J\,*WT5O+!)J6B7.JZ,\R6VI3AJY59I:7M^&Q?*M4E:ZM?7RWU[J_J?Y
M-'_!.[]JJ3]B;]M7]G;]IM[*ZU/1_A=\1-)U+Q;I=BZ)?:GX'U,2Z%XTL;%I
M 8S?3>&=3U0V*2%(Y+Q8(Y9(XG=Q_L5_#CXA>#_BU\/_  3\4?A[KEEXF\"_
M$3PKH/C3PAX@TZ9)[+6/#GB73+;5]'U"WDC9E*7-C=PR%=VZ-F:-PKHRC_%8
M^.7P7^(7[.GQ@^(WP,^*^A3>&_B+\+/%FK>#O%FCS$-]FU32;AHFFMI1\ESI
M]_ 8=0TR]CS#>Z==6MW"6BG0G^W7_@U _P""FI\1>'M>_P"";OQ<\0-)K7A>
M#6?'_P"S7?ZI<L\U_P"&LF_\=?"^T>5R2WA^4W/C3P]:JA(TR[\4Q>:L&FV%
ML(@[:=]O7^OR\R(/[+[MKUZ_DC^V:BBBM30**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#.U.4QVS $Y;.,8[8/4@A?J
M1QR>U?-WBRYC$YGV132J2"0X=89I"S-)$5+J[(6 *M@N[2,V&+&O>O$%ZL%O
M<,Q(6&-LE<DERI"\#IAB "0.N<XS7S/KLS3/(\C1B(&5EC5AM0L5P 5)W'KQ
M@88;@RAL"XZ)NUW=>O3R_KRM<3Z/SV]6K?=^&_D^0MS^\D^]O(Y9L",,#E\[
MBC8 W<%F);\,=C8']V99)$",BE<J,N5<88LI4ED#*X&6P?NC868<1'LS@MD,
M0'=B<C)RP122#N&03R6Z$KEZ].\+:7>:Q+''9VL<@2/,DDI!01% H20 (H0\
MD_O0TF54!]E-74G=K97?_@.^OZ^=M0O=KYV:U[?GU^75HAT_0->OFFF@BN;B
MWCW"-X@5BCCR#Y FW!I9 =QVK%((U.Y\LI*TKJ&Y25HKQ'AN(66)Q@+G*A^&
M555@ZKO1\ NJDLKD/CVJ?0[Z&W18=?OK"YBC46WE+$-,6Y13(_VJV.^61KDI
M)O>5RNU=H*80'BM7FN+DQ:?XFM4L;SREAAU>W1C;W+,V%BFVQOLF$B%D5R8S
MEO+=HYB27N^FZ?5:Z6;^=EY;M.UQ-:):K^KV:Z^BZ)I61XU.YCFD$LA)"$9.
M6(93O^4YR"V-V_G!)Q@@U%"\3L%\V1!_RS!SA.5/W]RDJ3SR" <XYYIVK6=W
MIUT(;I8R2=JRPJ%C?"_,"A.5?)(;((R"5)4@#(:1"0"R$'G!8C) (VE@""!G
M/(QSNP#DT^RVVU[.T;=EY=6UHNPN9+6ZZ]'J[*^S:L[^E]==S9DGEP 9 R)R
M"@W%@"#\W]T <;B"3@C&,TY/L\HPTA(V, )!^\W.V6E# 8 VC()7^)@ < 5G
M1R)'\JAU)()!)*D'C@8''7A2,9P >M/>4R,F)&C4#(*C:-N/F7;DD@G))W!F
M^88^;!3MI]^EKJ_+9[*WKIZ]"KI^O6VMFFKK_/RU\S6C*(Y,<CA4V[8WVJ5
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M1R<C: O )R".0W=N]1:R\G;MK:W7IN[/Y,GMZZ?@-=9%^](H((S@AF!!SG"
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M175M[[]?^'_$@D(+#!!&!C&>,DG!SW&?;W&<TSM]3T[\?ISG]#^*\?=ZGH"
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M]G,_ ?\ ]6GX5K_:7K_%H_8K_P"3R/V2S_U<S\!__5I^%?7^M?[2]*&S]?\
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MV7;9]EIU\MGI9Z+6YU ?>#&P<D H1P-PP-P8#A1@AE/#8RI&5(-9I3C8QP5
MQ(3NW(#R1D8/!&\9#9!XR 0GF%68>8RMLS&Z@$;@2!ALAMK+\K#&"<'J*@D/
M!<#<W*N<_<Y V[2<XY&,'!!PI%9[NSW=DM/2W7]'\RU%+\_3T]?ZTT44J;BV
MUE7'7@#('0$^H&0>IR<X'44V+@'D;<'*Y';(! /\0('08XW8%6Y8G4[3@.-K
M8!Q@%1MR02"<<Y#'C(.TXJJ5.XCDL.O7..X[]#CG&",=21MU5K6WV>GRWM?K
MK_P$'GOY[_=ZZ:+\]Z<A*@Y*/D8&<C@G)/ QQR,YX_'B'9NB*DA5&%4D=^G/
ML,[N,%2>.3Q-)]XC'WU; SG /!'H,8^4'&?;!JN%*!)9&^3S,&/^)VP2%7JN
M "&9OX1V)(!6S:ZW7W.R;U[]KO7N96M;JK6TNNTGW;6M^_I9 56!"H9]TR8V
MXQMB#*&(R02'(P. 0F[ .X&H>1TP<<@-S@^A##KTR0#WXHED:20L>#\PVYX&
M"H"CT4<  =,@8(JOYN2 <CG_ ($HR#@DCE>ORXX'?!(&:=NG;NMGJM^OX/IV
M6^B7R_K_ (+V5V*Q(.TJCEAU'R'&1@9!QM)'0CKP"<\PDE6S@$ D ,,@<#@J
M2<$9^GID"I7*@''!/)R3[X'![D' /W3S@$YJ'EOJ?7K@ 8YX!!]O3GCFD7'O
MLDG?IV=_N^^UWN/69PV00.<\*H SQR-N,<@?2G[Y"3NP<'@%?F.23G P>3G&
M[@;N.!4/W>O+$ KW SG/X^G7UJ7:"JR$D X#<'EEQUY[C!![_-WQ3UU^]_?_
M )L))=%IMHNKL]%Z=5OMV9(6CC RN9&!!.<B//\ $H/?)) / ZX)"U58@MP"
M!P.3D_4\XS_GWIS%3G:&9B>I[>_!Y//)/ [ "@D)POWN,Y'W<9R/=O4]!D@<
M\A#2M;3WFMM%VWW:^>]GU>IL"_>88YX&2Q[CCMGW(^OHN\!B5488 <X.1QD$
MY &>I.,YP>"<B(_G]:*!\M][O3Y=.UOZ^1, >,,,#GK]S.<D#/) Y]>,=> *
M"N0Y &<@_>RPY&!Z,"?F(P">3GBF9(488\]5Y''(QVR.N<''/K1NW  \E>%]
M3GC'X<$?0CO0+E?757[:^NJMO=O39O5W%+!L$@8Z!?XC_P "QT_J2 O<2JPC
M20 'E=F[/4MP1] -RYY!)S3"0">#YA!R>@5L=?3/4DYP#R!36RN ?8\8Q@ *
M"/<X/T['!H!:\MM%O9^37]7>K^XCIX'R@\'#-\N>3PO./0=ST/2F#\OI_D4\
MX*@\ C@C')Y//ZX/T[]@I_GI_7;U&5(C%<L#@J 5X'WLX!SZC.1WX]!4=% -
M7_JY(0&!8$ C[PP<'GJ#ZGCCZ_2E!P,MP54A2>X/& ,?P\^N,D=*:N5) P3R
M".2"._IQZYP>G3FI<+MSN;D8*@C;U/0L?Y#CGZ4$O2RW3:MZ:+7RM==;W\B$
M@G!Y/8D],@>N>P'0]JG1LJ=H.5"\=<J"20#@'/)]N@&<G,)(QC!'.?O \8QC
MIU]3U]J%8@\$J"<D]3^F"?TZGWH!JZVM;;\+[/KLDNWF7K:Q:XN8H3)&BNW#
M,P^[@MGIR, <G@9 R>:C:-8BZE!(4)7>3E"!W0#!(YSDD\ X Z5<@-O(($,C
M*49F5]N#CO%QR0"=V.<YP"0:CCMF.6A991\ZE0?F)8,$RA'7N<'/./0"N7JM
M?FF^GR>O9;;^2?,TO+MO]G?=W3;3Z[Z:E%I25PIYXZ>F,DC^O3&/QJ')Y.3D
MYR<]<]<_7O4D@48&-K G<O/!. !T&.G3'?O47^?I4E12MI?7O_2NA1[]/89/
M]/YT''8D^N1C^I_I244%"C&1GIGFKUU$87C@/WT17W@$EB^7.?[V!@ ^H/8\
MT/\ /^>E:%Q)YT5O-C]Y&HB;U98\*K?AP,<X#8[4UU]/U7]="9?CLO5M>7WZ
M[7T>I%*0%4$Y!.[Y"/E/'/L>> ".IY&<FZL91$OD9SYA\D!""3.%&\$<Y!0Y
M((.XD]>]1U)!4D!L9X/!ZX'.>#D<CJ>XXJY!< V[01 !XP)@QY#R_=8J,<'9
MWQT'>FG=]MK;O72VGDKV6W38S6VG1^?>+\E?3357V6KN:5G+ F&2$I?.0%B)
MSA5P2X4D;68YR.@!).!FGW-VTC+"JE&?K(IWQK@_,@< [>F2Q(Y.,>N9,TD?
M[M.;EU#2SH06PP!\D,#E0!]YC^.".;ME>BU%NCQB2VN PE!'S-,&"L&;N#\I
M';.3CJ:?RUNFG=OKKJKI].GX[VFM5?9=-.WR3;=GJK=+'WQ1114%A1110 44
M44 %%%% !1110 4444 %%%% !1110!B^(_#7ASQAHFH>&O%N@:)XI\.:M"MO
MJN@>(]*L=;T34[=98YU@U#2M3@NK"]A6:**98KF"5!+''(%#HI'B_P#PR7^R
MK_T;-^S[_P"&9^'/_P S=?05%%EV'=K9M?,K65E9Z;9VFG:=:6UAI]A;065C
M8V4$5K9V5G:Q)!:VEI:P)'!;6UM!&D,$$*)%#$B1QHJ* +-%% @HHHH *P?$
M_A7POXWT*_\ "_C/PWH'B[PSJJP)JGAWQ/H^G:_H6I):W4%];+?Z1JMO=Z?>
M+;WMM;7D"W%O((;JW@N(PLL4;KO44 ?/O_#)?[*O_1LW[/O_ (9GX<__ #-U
M[II>EZ9HFFZ?HNBZ=8Z1H^D6-II>DZ3I=I;V&F:7IMA;QVEAIVG6%I'%:V5C
M96L,5M:6EM%%;VUO%'##&D:*HO44#;;W;?J%%%% @HHHH XWQI\.OA]\2-/A
MTGXB>!?!OCW2[:;[3;Z;XT\,:)XIT^"XQM\^&SURQOK>*;;\OFI&KXXW8K<T
M+0-"\+:/IWAWPSHND^'?#^CVL=CI.AZ%IUGI&CZ790C$-GIVF:?#;V5C:Q#B
M.WMH(HD'"H!6M10 4444 %%%% !7F_C;X-_"#XF7UAJ?Q'^%7PW^(&I:5;O:
M:7J'C;P-X8\5WVFVKR_:'MK"[U[2[^>SMWG_ 'SPV\D<;2_O"I?YJ](HH"[6
MSL5+#3[#2K*UTW2[&STW3K&".VLK"PMH;.RL[:)0L5O:VMND<%O!&H"QQ11I
M&B@!5 XJW110 4444 %<1XX^&7PV^)UG9:=\2OA]X'^(6GZ;=/>Z=8>./">@
M^++/3[R2)H)+NRM=?L-0@M;IX&:%[B!(Y6B9HRY0D5V]% 'A.G_LM_LR:3?V
M6JZ5^SI\"=,U33+RVU#3=2T_X1?#^SO]/O[.9+FSOK*\MO#T=Q:7EI<1QSVU
MS!)'-!-&DL3HZ*P]VHHH&VWNV_4****!!1110!QOC;X<_#WXEZ;;Z-\1_ G@
MWX@:/9WBZC::3XV\+Z)XKTVUU!(9K=+ZWL==L;^U@O$@N)X%NHHEG6&>:(.$
MD=6\_P!*_9A_9JT'4[#6]#_9Y^!NC:SI5W!?Z7J^E?";P#IVIZ;?6LBS6U[8
M7]GH$-U9W=M*BRP7-O+'-#(JO&ZL 1[E10.[[O[PHHHH$%%%% !1110 UE5U
M9'571U*NC ,K*P(964@AE8$@@@@@D$8KQ'5OV8_V;->OI]4UW]GOX'ZUJ=T[
M2W.HZM\)_ 6HWUQ(Y+/)/=WF@37$SLQ+,\DC,Q))))KW"B@+M;.Q\^_\,E_L
MJ_\ 1LW[/O\ X9GX<_\ S-T?\,E_LJ_]&S?L^_\ AF?AS_\ ,W7T%12LNR_K
M_AE]P[ON_O9X#%^R?^RU!(DT/[-7P AEC8/'+%\'/AU')&ZG*LCIX<#*P/(9
M2"#T->W:7I.E:'86VE:)IFGZ/I=E$L-GINEV=MI]A:0KPL5M9VD<-O!$HX6.
M*-%'8"M"BF#;>[;]0HHHH$%%%% !1110 5G_ -DZ7_:G]N?V;I_]MFP_LHZQ
M]CMO[4.EBX^UC3?[0\O[7]@^U_Z5]C\[[/\ :/W_ )?F_-6A10 4444 %%%%
M !6?_9&E#53KHTS3QKC:>ND-K/V*V_M4Z4MRUXNF'4?*^V'3UO'>Z6R,WV87
M+M.(A*Q8Z%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+I>__#0HZKIM]RY?FG=_IZ^Z:-\0-18)9:J6B9A(RW]RI!NH50RA1O2-(E5
M0C1*-[!(XU4')[NV\06UR%E6<IA0B&X5&4 A<!(X[F(R(#AF9OF('("X#?/6
MNFPCF:&&6_>3:I47C1--'&T:NK&6*YFCC1B20BR.8HQQN=F<YVG:U/IZ-$Y,
MUN3N)'4,!D+&6S\N0!SNPH)&&8U7NIV:T5M=--M[='W?5Z^3OKKOLK)];::]
MNNJTMUV^B[R6"8;A<.VX$^8[10K+(,!I(U+CR]Q*JN KX1<'+%AS%U%OW!4"
MA]P7'W(60L2YQOW2@$M-&KXR'&T[R1QMGXFBC(:,I(K<SJ5.\<8*#<NT.%R
MR@KGJ"IQ6];ZM%=[D41O&<&)-JLT8&2(\PX;[O&4CPV.2I S::>U]$M[WU[_
M .?Z#6BT?56OV32:_KO\S%OK994-O(696.X'#EHID8AF1S_%&2#N<,S1OO#8
M)SSTBK=+)8WC!+J!MUO,N71T!;,B$ ;D8Y#A &&YMR!DS7:73QLIQYD2C#A7
M5U",,?*JR*6!R%P=S%^P&37*ZA;--DQQ2K<PEGBFC# 8(!>(H 65"#O5,DH)
M"1NVX,RT=UN[+KW6]D[[>6FFI+C>RW[>FBT=[Z7;2>FNS.3F1PK1R)B2-F5U
MR" ^>6##"E<8P5RC\$ $C-/&.#Q@XQC],<8.3_G-;[/%=1L9<PW41VR!CQ*I
MX8$@%F*ALJQ#;H\@XQ@8TR?,6'(Z-DC@D# X.>G4<@_[N,IK:W3>_DHI=FUZ
M:Z]'H*2>_P NO;?5OT?FNY$,$X)P>OL1[GMT/(R>G3)J4.H Y*].%4'G/7G.
M.N>.V<U".,#/Y_\ U_\ .*E5MO4 XZ]#GIQW(_A /(X..E$'I:U[;:[ZZ[Z:
M;_Y7UC^OZL(P/!SST..05Y&[(Z GKG;P<],TJR,A"% P88SG ([ ]02">"<8
MQUY&!<D_(%&X=R?EQU^;J <=SCJ.E2HH;=NP%#8PH! .!].OTR2._&*MHKW3
M5KO3^[?\M_)WTLA_CV^7KOZ>:]#0ADD5(PQ+%1\N=X(!'/ Z#&<XP<<YXR)?
M-;A6"M@9'RC)51SDXW$%1GKT.1U(-&)GC.QB< DI(#@@$8(##D '# 8P 3CG
MI:49 +$9 ZC.3MP2". 1C'&5^[Z$4:7T6VCVNNJ?G=Z_\$UC>RNWKY?\/\F]
MUTN.W28 +,RD-M!8';GC'KP,$=.1[8H96.&SC<%W'/4'@;L8VC(P>3@CD9R*
M8<@/DE<Y P.O&X8.3@Y&..0,]02*0R,0%;!1=Q0 #*@D$X/<$X(!SMYQR:>B
MV2W[6ZKTU_/1J^P=E]WRL_-_EV[,A<85^23@DX7DJ#SCISU&>.O3&#5*3E8U
M4DE &RW W, S#D\X&$'L.F,"KI&-V._0D\G/3D 9'&#QGWZU2DP#ACP1E& .
M >,*<\8/.,9(Y^E2_N=MO2SLGU?;1J]^MVXGZW^6OV=_.WE?IL]*KLN0>S X
M..C*1ACGOTYQU X.:A4L7Z@,N<#&02"01QT')^G/3-3.F<^H#'IGC !)'+94
MX.5[@$TP [@X&,J V.23GGZG@9/&#C.>AS::W$FDO.S6JOU7RU3M\O,8>6/0
MYRW.,9 P#VR&(Z$=Q[TU2=XY"X)R<9 ')(/J.#P<BGMNSG&!CY@N<@98_,>#
MV]<'L.U+][H!@X4'AOE(ZG))&, '/?U/!0[M+H[JU[WL[)>E[=$MNKU&,ROE
MB K<D@?=([ =P1VZ@#OVIRE>4R-L@'?[K#E<D]#V)Z'-0MU]L8'&./\ ]>>O
M/J<TH4L#CDCMW/7IZ].G7OZX"[*VK:717M:]K7]'KY>@I+;CG.1UXZ'.2<#.
M.>XQZ]:0J<GJ1S@CO@9SSSCU/OWIRMZ@MP<DGOR1[Y/ Y//3!XI6!.%!PH53
M]<C.<>N2?K@<#B@5VK;*V_:VFUG?T76XFU3N8?= P">I;MCD9)QD\8 )X'%1
MT]R=QX"XSA<#@'^OK^F, !H&?;\,_P"?UH*6VO\ GT[K?O\ ,4DX49SD=,=.
M2,?IGUYI1\HS_$?NCN,'[Q_IZ]<<"E520, L><#H#ZDG^ZO?H,G&>N$?&X\A
MO4CIGIQP.!V]J!:/1;=;>73Y_BKKT903GK2XX)^GZ_\ ZC0%+' _,]!W)/H,
M?_6H'=?=I^7_  !T:;VQG "LS'T502?Y8'N1]*"N1E>1R=O\2@>H]/?OZ#I4
M@8+&^T<MA-W0D'#-[@?*  1T)[G @Z_Y_P#UT=OZ_K_AA:MMWM;1*WDG=]?3
M:WWC@2,C@YQD<$'OCCGTY!&/RIVU67*_>R<J>P.,$$G& <@YYZ=<Y$J@L3Y@
M&2!C( R1PO7DYZ'(SCH1S3"@!)=M@;!VA>2I.>G\(X!&>3UQUH_X/]?CIZ"Y
MK^3TU6JOI=66^E_2V_9.%P%&3_$2<@\=#D 8!)SD <'GC(:6)R/EQUX4 9XY
M_P D@^^:=F-<A0S9R/F (P.A X_,]*;B/ ^9@<<@C//MTH!)7NT[Z:V;OHGK
MO9_\'6XC8)R!@8''7';_ #ZY]\4W_/\ GZ?_ *^,BGJ54'D[B"!@#'(Y#9Z_
MJ.^,TW([ _G_ /6%!2?D[>?_  =?GZ^5[,!#$)P#O! YQSQU!^@(/4<'.>-C
M^SY/+%P6\I4;)8'*M(<D,"H.T9('(X)YK'@1W.04Q'E]I(5CMY [9!)]>>F<
MU=CGGMX6WM*(Y,K@$LFX]V&>HX(XR1C\;CMKM?1WMU5UZ*]_57,W;F::OY*^
ME[>6[TV[V]&W,33#<=LD@X62+;APH'^L&0=Q/1CVSG)S5%HL$*3M?'*MUSR3
MDCIVX.3SZ"M-[?;"ES#*DT95C,L8Q+&V,\CNI&"6(X (ZXJ@[^8 '"L1N*,!
M@L,]"0.6XSG'.2/I+UU:MIIZZ???Y[J[L',UO=?C?1;/RW\^KOJX I7YQM.T
M\C.2#VSCCCKP?QIP,<F XV-_?&<,<_Q+V_WA]2*=GY]AQY;$9( ( 8YW C!X
M_'O[5'*GENR9SM8C=C&X<;3CMD<^^>:12UW>MEJNVC_/?36^FFS2"NX$<@CG
M/3\.^?Y59CE<",*,[3("  0 V">3D' QC).2,$YQ2)&9(G8G&S8"2."&/&/?
M&03[<\9J$M@%5&!GD]VQTSVQ[=*>J^?^?^:%?FNO/7>W3S6F]DNMO-N?:J*L
MI.XJ I0$XR1\N6YP,<C/H/Q?;SQ13HYBW)N!^9B.HP>AP<9P>Q[@5!N*A$!'
M.&)ZCKA3C@\#GD=3D'O36.2RL<;3\O''7! X) /4#)''XT:^EM?RU^=E^@1Z
M7UWL[]$UY;)]]E?38N%@)9B599 >&RV#O(P<9P"5)P1P<DU(SEH5;S>$GRK#
M@HY7!R,')X!.,Y!!'K4+'S65I&QOB $@ .-G ##WV\]/7'>MAK6&'2[+:RFX
MGN9'=B 4"A/D3)(QZLQ]>3GK2UT>VC[/HMOFKW\[/J3?JFUHO72V_EVZ?D??
M-%%%0;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:;=;75G;;[F[BK;:]];]%MIJK?UVKGLJKV.02"<$X5@1D9/0D 9QZ5"$)Y'
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M# ;NH'KSC'/4$8'2MB-5D&%WJ5!("AER,GYG)RCEB00N<@<8':PT",BXSM)
M.0-W8 $YQNY4+_<*Y&2.4I2:TT]%TNMEUM_P]M!W47_3MMJ^U[]-_4P1 "K
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MF^W5V7;2R2\A22&(ZG  ;.6QUR,X YSGC(/?I23,QD<,6)'RX;D@* %&<]
M,8/;ISRA5N<%0",D!N"/ZXS@=AV]3),J@*Q/S-&AVJ2QSL'+'H.F, Y'4YI]
M/ZM_P_\ P=K K776^GG]EW=WTMTT17') ]P,=>_2GD<,,8.[/3&%Y'7TR148
M..1UI<G^A]^<\_CS^O6D6U?K_5T_T_$<?F.0<G ZX&<#G Z<8QCDGK[4RBB@
M%I_7^7]?HN>,<<'/3G\Z2BB@8X$@9'0$?@3D?KS2$8/3'?'L>1^AIPPN2>I
M*J>AS@@D]Q[$<]Z.78DXZ9)Z  8&?\YY[4$WU;Z6W[[6ZZ]=;>2ZW  %W'N<
M*/7!^8\>G3GU]<4T@@X/!J7> . !@$)QD]>ISQ@D^A.1VQ41)/4D]^3W]: 5
MW>ZLO/?I;TTWUWN36[E7QQAE=3N.!@J3S_/)!Y '8TT,-N#@D'/(R#QP,\8Q
MTZX]*(Y"C+D KD9!&1W'X]3QW[5-&L1+QO\ NV.YBY^8(J@M@+C)+].#T/UR
MUK9:;_F)Z/5=4T[Z:65WVZ)Z?YC5 *!6_AR0H()ZYR,GC.",#@]>.TA'SK&#
MGG.01C.TM@GU!SG!&#Q[U5SAB5XY.">P/'MV]N.WK5B('Y,XZ'YF[!PW?G)'
MIVR,@YP!:M7ZM(B2:U[ZVVWWTU]-[B0*IPS=SM08R&9AC<V3SCJ/?/&.EB?#
MCR8$9Q&Y0Y!8LV.9,C&W+9P>F/0"H%*IY9)SM/ &%!?KR1^&?RZBGI=O$CQK
MA3)Q*R@YV'&5R>?F/)/4 X!R31LO7_@/?7];6V5V-.\F[>>E^CO;L[O>^[\R
MM(I! QP!P0!SZDX].GT'%-3AL]0HR1[?Y-2 D/Y88D$C&[!'(SS[<]L>M272
M)#)MB),3*C!O[QP-V#Z9Y [ C(H\_P"NE_S*5VN7R6J_E^?7IMOVW*[  [AC
M:>1QGCH>O&1W'7G/O0XPQQT/(/.#D ]3]>::,9YZ?YQ^O6I923L) !P>G(X.
M![8_#ZTA[-+R:_R]=M?7I=(55!,)W ;LJ>O&"1S]<\<\#'THC<1.21G!QC^$
MD'&?PY(_7)I8\!59E)VL9%]"%QD9^H' P>^,<T2L))!(J!?,);;R0",YP?3O
MZ]":?73R^_Y^9.]T[]5Y:-M:N_339V/T8HHHI&@4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@D8 )J]!"JJ) S-&"5=3U4G!!*[@=K9*AI/+"L"!G&VJZ%3SNQR<\C.1R%+
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MV>M[;(^9[E4#[D/48PH(./XL@D\#/S-N(/X8%/H3G [_ "^G)Y'3..#C/ '
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M'IW(''7ITS5>G!B""O'\LXP>.G?]:7?S_P T_P!!N-W?\_FK7332=_ZV%!3
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR9"J[E8EP^YMI) .>7Z/G'?3D#;<.V2JL<G=P?O$ +O/8\#=PW(VK6EE]W_
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M0@0A#C=GHI9DR"?X5XZ@9 ],&LVX=H^ ."  0O0EF+$ALXRIY+'<Q(QP.=/
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M?AFE8G &".N3S\W/OV!'3&!SW-..0JL!PR[2".NTD9'X 9/KD=J0 -G&<@Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR 58DG<"H'&W9E2,'('.#55F8@IDY&& VC=C/"G*YQN!(Y SCZU#:^Y;-/\
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M1Q[L0"2><_\ UL#O48Y]OK3B,G YYP"!U_#./0=<8 [4X@!/NDDX!8Y !ZX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTB&07)"F0@@,1R P8$< YQM18XRJMP0<8&"H/)![$YX'U/6LVWB8B/S&W/\
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MAHGBCP_;S:UX>FCM]8L1IWC#0_#VM(]E--&C2R::MO+N!MYI5!( /HBBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM>Q^;:7$> =T+C!Z$[21G)'
M<>M6:* /E368GBFG/'WMS!%?: #@)N;YMQS@!=O=B N&KB)'?Y^'P'8A5P1@
M[4VEQM((8$*!G:JX.2>?4_'NG2:?J%PQW>4\CSJB.Q=TD^88+;5&"1D L3D
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M;C<%;)W$ 8*@OU6O0-,B10R;HP"2Q:,R*Z2;77*CY0$P<' Y)4@@\!2=D_\
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MNP10N3A<*X",,[?E(+C(ZK@X!QNHI6VOWZ^9*N]?R^7?1]5?:VJWTMW%T5D
M654 !<D@AN<DJP'KR5 7G#,'/&*$M]\R*TH8#IE,#&2#ELDGY6"@L5/7<.N<
MMYBSAF8EB Z$$,2IP45F;:,+P!P< 8Z'!K>:P7&T*O)Z$LP<JI(;D%1QPO\
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M0>!_GUQ^%,HV$H:.^[_#_@^FA:DD>11(1RH\IO8\X.>_'Y'H>34#,2%!&,*
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MGZD@&8>>H8GTR#D<GOAN1GW%0COUZ?U'7V_KBG$$ ]@0N1C&<Y(&,=L$]<8
M]A3*'K^'X*PEUUW=]K;I/\OZOM^D%%%%!04444 %%%% !1110 4444 %%%%
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MOJL?A_39 UGHT>IZ@FG0VRWMR)?0:**LH**** "BBB@ HHHH **** "BBB@
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M;OQ;+>1>!-/U^\/B33[:RUIH$C\"W?@1%_=6A.ZO:WDP6JVMY!1113&%%%%
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MK* SRRA@K#;A?EB)+L5.' 1@R*#F%%OT[@W;^G;LE\S1>Z+%RIC01DJKS!F
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M6LNSTM=:M^[\VD]K+YET2$#!9F^^5&!A02N3@X Q\W!YX&2>S&8DCDA3PI&
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MH,=<G Z4DDM7OJMDM+=5KKH_35H5UW_K3_-:>9.)%QM!)W!MQ<YVX"@,#P,
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MC'<Q(')/'OD\?I@>]31_*I<'C!7'4!B0.F>_7\_:IE3<HQA)"R@?+ZD$DD<
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MU&RETK4]7^'_ (ZT?4?#]_.MI):#7_#DE[I[LD=K<'^5+_@BS\'_ (2>)_\
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M'@CQ/I^B>,_"=Q?1VUS+IJ^(=!TY=5@MI[G3'O+:)YA^:?\ P:A?\HB?!_\
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MLOO8[Z)OLMO/L?:/[;O_  7._P"":W[ ^K:OX,^,/QZL_%_Q:T25[;4O@O\
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MV;=?\0W7C'3/!TFLW=W+;6EBE_=V-W=NGA<7[_!'XBZ[=WWBKPMXR\,#P?\
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M%WN-TZ!B2\2@E'PP#;<AUW,0/X1A=H!"#>5;D*<;-Q+/ B^4N[?( \C$#8K
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M,$G\3GG';'4CID=ATJU(N^(.C<*/G ')&1M(/7V./7&,"JH8;64@ 8)'KO'
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M_P#]BO\ %?\ ]:!^+5?B]_P='?\ !1O1_B;\(]6_X)M_LG^(+3XL^+[>:_\
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M_P -@ZEO,9C\H:)_PN[]C[RQ=AAYID-_YO\ 9QB81A1J@G!8VY7^O.O\T/\
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M'C7_ "C)^!?_ &?;\,O_ %G_ /:>K]_O^"BU]K^F?\$^?V[-2\*2S0>*-/\
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M>PL+RTGC>UL]&L8?LG_@JW_P5/\ @7_P2Q_9WU/XH?$.^T_Q+\7/%5GJND_
M/X(VU^D?B3XG^-+>V4)/<PQ,UUHOP[\,3W-E?>/_ !I-&+/1]/EMM*T[^TO%
M^O>%_#VM>F_\$R/C-^UA^T+^Q3\$_C7^VA\./ WPJ^-GQ)\/KXJF\)>!/[;M
M;0>#-5*W/@C7=?\ #^O76J7?A#Q1XFT![;7M4\)IKNM#1HM0LXKV71M8DU/P
MKX?:2O:[;2OJ[VV7X_UT!)7W;:75MVVW]=[?\ _ _P#X,Y++PHW[ ?[27B"U
ME^T_$#5_VP?$%IXQN;CG4)-$T[X0?"2[\(K+(9YI+FS-_K/C&Y@NIQ!-)?W.
MK0M$R6\=Q/\ USU_$!\)_'=Q_P &XG_!7SXP?"OXW7(T/_@F=_P45UC7/B/\
M+_B/#I>IOH/PG\1:7JE_JFD6<MGIUEK=T#\+=1\83?"CQYI^FN)K[P-XD^&/
MQ5U>6SM]/B\.1_VQ^&?$_AOQKX<T+QAX-\0Z'XM\)>*=(T[Q!X9\4^&=6L->
M\.>(]!U>TBO])UO0M;TJXN],U?2-4L9X+W3M2T^ZN+*]M)HKBVFEAD1R1VM:
MS6C7Z_,([6V:T:_KON;E%>'_ +17[27P._9,^$GBOXY?M$?$KPS\+/ACX-L)
M[W5O$GB:_2V%S/%;3W-MH7A_38_,U3Q1XKUC[/):^'O"?AVRU/Q'XAU Q:=H
MVF7M[+' WF'[!7[7GA[]O+]E'X7?M9>$?".L>!O"?Q=G^(5WX7\->(;VSOO$
M%IX<\)?%#QKX!T.]UU].!T^TUK7-+\*VNO:KI%A<ZI9:%?ZG<:)::YKUOI\>
MM7]7UMUW*OK;KN?S4?\ !#S_ )3S_P#!=S_LIWQ%_P#6C?%%?U/_ +4O_)L?
M[1G_ &0CXO?^J^\0U_+!_P $//\ E//_ ,%W/^RG?$7_ -:-\45_4_\ M2_\
MFQ_M&?\ 9"/B]_ZK[Q#40V?K^B)A\*^?YL_"7_@U"_Y1$^#_ /LN_P ;O_3U
MIE?'WQG>\\1_\'A'[+UI\4));'2O"/[+NH)\"8# +JU\06:? 7X^ZU+'=27*
M:<--BLO&6O?%?4;2>S;73)J_A^PMM\3W]S#H_P!@_P#!J%_RB)\'_P#9=_C=
M_P"GK3*\L_X.+/V4OC[X'\9_LS_\%EOV/--FU;XX?L#!1\6=!@@U#4I=<^ >
MDZWJ/BF/5[G2K"XANKOP=X-F\2?$73?BK9Z<$O9OAM\1=?\ $-U?Z7H_@O4;
MU#[*>NG*]/*P?93[<K^ZUS^J2BOA;]@#_@HC^S/_ ,%'O@?H/QD_9[\=Z)JU
M_P#V-H,WQ,^&$FIQ-\0?@YXKU6S>2\\(>.=!GAL=4M6M=2M-6T_1O$RZ<GAK
MQG!I5SK/A/4=4TLBX7[EFFBMXI9YY8X(((WFFFF=8XH8HU+R2RR.52..-%+N
M[L%1068@ FKW*/Q?_P"#B#3O"NI?\$:?VX8O&%PUKIEOX)^'^HV$\<0ED'BK
M3?C3\-;WP5;KF"X*+?\ B^#1-.GE5$*6UW.3/;KNGC]V_P""-5_XHU'_ ()3
M_P#!/NY\7Q)#JZ_LJ_"&SME2<7 ?PSIOA6QT[P5.T@N[[$ESX-M=!N)H3,C6
M\LKV[VE@\36%M_.[_P %B/VS-6_X+'_M%?!K_@B[_P $W_%NC?%+P'XG\7:)
MX^_;#^/W@;_BJ/A_X7\,>"_$%I<M;)XHAN[/PQJ_@;X8@6OCWQ5J^E:C?V'C
M3X@S?"SX;^"/$#>,#J7AK6O[&?AG\._"7P@^&_P^^$W@'3$T3P)\+_!'A3X=
M^"M&1VD32/"7@G0;#PUX<TQ)&^:1+#1],L[17;YF$08\DU*UDVMDK?/<E:R;
M6R5OGN?RA?\ !H+X-TNQ_9M_;E^(4*H-;\4?M@7'@W4'%O"LC:7X$\!:%K>C
MJUTH^T3(EW\1M<,=O*QAMF>22 *]W<%OZ]*_DY_X-$O^3,/VP?\ L^[Q_P#^
MJI^$5?UC4X[+T''9>B/Y$?VG/^5P'_@G9_V9SXW_ /5+_MTU_7=7\B/[3G_*
MX#_P3L_[,Y\;_P#JE_VZ:_KNH6\O7]$"WEZ_H@HHHIC"BBB@ HHHH **** "
MBBB@ HHHH **** "BBHS*@)&<D9Z<].H&.IXZ#)_&@"2N5U]5O!]GZH@^;G
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M?F]MDM?DKZ+[GT[VTO=#NK))OLMK]-.BOK;MNWJB?+ /G*Y  3'8@@\Y!)&
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MAK6HVMH3:VU_JMKH45]>6]L3;PW$\D<),:J:]HHI65[];6^0!1113 *_ /\
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MV,E];I#XM\;>.=5,MXTD>M0V<9TZ3;\/?\&Q.B?%+Q%X;UG_ (*)_P#!2?\
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MYXI\0^-O#>G::(EDM-)\-WECXX^&GQ5M+.+58X=3GC\2_%CQ>DK*T%E'IO\
MH\UMS>C?\&O^N_%CQ=H.I?\ !0S_ (*K_MB?MS> O#NHG6K+X<>(+SQ7X1LK
MK55DT\(EYKGCSXQ_'>]L=)O+"UN-+U>+PI;>%_$%Q93VJZ3XGT.2P1Y_ZP**
M7*NW^7W;=$+E7;_+[MNB/QH_:9_X(G_LU_';Q#_P3CG^'^JW?[.'@#_@FK\0
M=3\>_"3X6?"[PMH3>%?$;ZMXW^$?CR^TS7Y=2D.H13:AK?PHBO=:\0B:^\0>
M(M6\4Z_X@UV^U#6[F:]N/V7HHIVM_7R_0=K?U\OT/S(_8$_X)D^!?V!?BU^V
MY\6O"'Q.\6>/]1_;;^-!^-'BG2/$FD:/IEEX(U,^)?B5XE_L70)],9I]1L//
M^)5];?:-1"W'E:9:/C?--C]-Z**226B _,C_ (=D^!?^'H__  ]&_P"%G>+?
M^$]_X4O_ ,*8_P"%6_V1H_\ PB']F?V/_8_]M?VSO_MG[?Y7[[[/L^S^9\N=
MM?IO110DE>W5W^8'Q;_P4;'P!/[!G[7C?M26CWWP!B_9_P#B9<?$RTM&TN/7
M)]%MO#-_<6J>#9=85K"'XA?VQ%II^'$\@,\'CP>'9K'%\EL1_/O_ ,&CG[#P
M^"O[&7CS]L?Q=I*P>._VMO%)TWP3-<I ]SIWP/\ A1J.K:!I<MN)+:/4-)G\
M8_$23QMJ.J6PG>RUS0/#OP^UB-65+>2NI_X.1OBEXT_:+\7_ +$W_!&'X%ZO
M<6WQ,_;>^+7A3QG\8+BPBO+T^%/@7X0\1RQZ+JGB/2H;0C4O"K>)]&\3_%/5
M);&^CO=*M?V?;MKF$6VI0N_].?PI^&/@SX*?"_X<_!SX<Z2N@_#[X4^!?"?P
MX\#Z(LTMS_9/A+P3H5AX;\.Z<UU<,]Q=/::3IMI!)=7$DEQ<R(T\\CRR.Q6\
MK]E:_6[_ $2_,G>5^RM?K=_HE^9WU%%%44%%%% 'X[_\%'/^"&_["O\ P4NU
MF+XB_%CPUXJ^&GQ[LM/L=.L?CY\&-:M/"WCN\L]'AG31;#Q?I^IZ9KOA#QK9
MZ?(]HD5_K?AYO&%GI>G6>B:#XNT/38UA7\L3_P &WW[<PTR3P?#_ ,' O[;D
M?PSDL_[.;P&VE?%Y]/;319FU33VC7]L*/06LAB-6M/\ A&A;/:1K:^4"J3Q_
MUK44N5=ONT_(32?3]/R]#\5?V)?^"#G[#_["7@;XJV'PQL?&7CGXT?&/P%XQ
M\ >+?VDOB[?Z1XN^*5AH_CC0K[1]<L_!J66CZ'X;\(:7<2ZC=7MU%I&D1:[X
M@!M[+Q?XE\206%@;;ZG_ ."9G_!/SP?_ ,$S?V6]*_9<\#?$'Q+\3=!TKQIX
MP\:1^*?%FEZ7I&KRW7C"\M[NYLGLM'9[);>S:W5()%;S)%8F3! K] Z*$DME
M_6G^2"R5O+0\O^,_P5^$_P"T1\,O%OP:^.'P_P##'Q0^%_CK3)-(\5>"_%VF
MQ:GH^J6C,LL$H1]L]AJ>G7<<&HZ+K6FSV>LZ%JUK9ZOHU_8ZG9VMW#_,;XP_
MX-9?#_P]\;ZKXM_X)Z_\%(?VMOV$=.UZ[N;_ %'PKX>U'Q!XWL;"9]0AN["P
M\/Z]X.^)WP.\7)HNDP1"VLHO&&O^-M>:6.UO+OQ)<30.L_\ 6%10TGNO\_OW
M!I/=?Y_?N?RX^#?^#8SP9\0_%GAGQ3_P4:_X*$_MC_\ !1"U\'WLNH:)X*^(
MOC;Q?X2\&R3W5OI=OJ%O?R:U\1OBIX]L['48]/\ *NE\%^//!FI26T>DVS:H
MT>EDWO\ 2Y\//AWX%^$O@;PK\,_ACX1\/^ OA]X'T2P\-^$/!OA72[71?#WA
MW0M,A6"QTS2M,LHXK:UMH(U^ZB;I)&>:5I)I))&[*BA)+8$DMC\R/^"KG_!,
MGP+_ ,%6OV=_!G[/'Q!^)WBSX4:-X-^-'AWXSVWB+P=H^CZUJ=[J?AWP/\1?
M \.BSVNMNEK'87-K\1;V^EN(R;A+C3K6-!Y<LI'Z;T4465V^^_R&?#?[=O\
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M;\->%O#4NBV<&C,\$]A!!X6M[F.XG(N&ENID8!$2OTWHHHV#8_+?XB?\$N/
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M552IRBC:%R) G(&U1\IZ#DL<HP-/EVWWU[J[5NF^N^W;8+O7;R\]KO2^E_\
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M6";ASE23G! '3GG&<]O?'85 =X&>W4G/WB>N#CZ],?B30S';M)!'&=OX8YZ
MD]>.O)R<53L_DTN_:_RZ/YBN]O3]+?@M]?QN(2 ,CDG(+=.3G/ XY'IP 1WR
M*0X /!Z<=2,_Q'!YR.@]Q2$YSQG/(('8$Y[YYZ\Y[Y[4T\<8[G.3V_+M^M)M
M+2^[\M'=>7G=W^0AW/.!]1GIGL2.N,>XSU[TTDDDD=AT [<>WIGZD\^A^/\
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M_F%K?F%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM6=8XP1&YE/F+YB[5*@E@^V-HV<1@&6,N &=E)SPHTHM3BN-JKF52#E9(5B
M9AO2.$X7>J-L)9LEV;Y58;5/G,E^)3YMM;SQ6AB4V]V;1K=&MQE5D*;=SK\B
M R[,2L"21SM2WO4<J&D=EY*!6=45E.2&"G<V\##X '(9LCBJTNNZO;]?T%I]
M[3W=NG5[[JWX6>W?FZE+JR2>4JMA$=5+8!)<%V1LDJ-O&'C3@..<QSWTD>0-
MK.22TQES*D:D%! V5!.YMKN 5<D@-C%<\UT%"J74N47#E7#E%W9P0&4!0 &
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ME0<GBJ\DI).&8C"DY.T9 &453DJ 23TP2<]3Q4EF!W%\@!FYP<!2RN450.6
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M^O'6D_I3L=/7KCT'4$Y]?Y8ZYH#^O^'^[?Y>JAAQ@;?<$[B?Q)ZG'&.O>E8
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **:S*@R[*H+*H+$*"SL$1<D@;G=E11U9F"@$D"G4 %%%
M% !1110 4444 %%%% !1110!^:^K_P#!4O\ 9^T7_@I1X6_X):77@_XQR?M
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M&\5:EH_@Z*;PQXEM#=7WA?X31^!/"OA"X\+V4GBC3=4^[/\ @Y^_Y0O?M/\
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ML*3:'%\*_@3H]Q);R26\*7<(\2Z3XAA:X@DNXEGBGM6N%GMIK6V\._X)7?\
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M_J4/@&QM-"U"ZWQZ9!JO[.7Q!N[=#-J1DN/ZS:_ER_X.3_@SXW^$VA_LF_\
M!7KX":;$_P :/^">OQA\(W'CA4?[$GBOX'^,/%FFV\>D^([RWGCU2^\/Z;X[
MNK3PG>:-IL4C-X5^,/C_ %&[>*SLYG7]<?VD/^"COPD^#G_!,OQ=_P %)?#%
MY:Z_\/[C]GW0OB[\*++4UDB'BCQ-\2])TFW^$?@W6K>TF6\TZZUGQQXG\->&
M?$]M'(M]X>:75C=)%-IEPJ"TNNVJOV_X&P+2Z[:J_;_@;'X/?'U8_P#@KG_P
M<5_"3]G>'R_$/[)W_!);PY<?%'XJQ@0W?A_Q-\>$U7P]J]_H$L[Z;=Z=?O)\
M0X_A5X U_P &Z\A^T:+\*/C$-.N56^N%7Z9_X.1/VI_C)HG@']E7_@FU^S7K
MD/A?XS?\%-OBTGP2U3Q<]Y<6R^'/A7=:YX-\$Z]H]Y-IR3:KH]C\0?$7Q(\/
MZ5K.M6]M>1_\(!H?Q%TDV<LNHQW%GW'_  ;1_L@^)_@=^PQJ?[4_QBDU#5_V
MC/\ @H7XTN/VEOB-XGUUC+XCU'P1J]QJMU\)TU:\COKJTU)_$=CKWB;XQIJ*
MV]C?F7XO7&EZI!YVDQ+'^9O_  <+_ CQ-\8_^"S/_!([PA>?&7QQ\!/"7QLT
M"7X/^"_BO\/]0N-#\7^!?B-!\4+U;_5/!NM6]W82V_B;4YO'_P -M%M5@O+>
M99KFQ02*;I,K[+?65ON;22O;M^(:\M^K:>GFTK+;I^)_3-_P3U_X)P_LT_\
M!-OX'>'/A%\!_!.@0>(DT#1K'XG_ !CF\.Z79?$KXS>(]/6XN+KQ'XWU^);C
M5;FT.JZAJMUX<\+2:I=Z'X,L+]M(T&*&W666X^Y-;T31?$VC:MX<\1Z1I?B#
MP]K^FWVC:[H.MV%IJNC:UH^IVTMEJ6E:MI=_%<6.HZ;J%G--:7UC>036MW;3
M2P7$4D4CH?YF_P#B'7^-/_2;K_@IY_X=WQ7_ /-]1_Q#K_&G_I-U_P %//\
MP[OBO_YOJ:;7V7]Z\O/U_IZ-7TT[=?3_ (/W>9\6_'_X :;_ ,$%_P#@L?\
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M:+I<^M:EJ\DX/E_8[;2[::\>8-L\E"X.WFOYA?\ @[Z_Y1:> _\ L\7X3_\
MJL_C?7[<?MJ^'?$/B_\ X)H_M:>$_",%U<^*_%'[#'QX\.^&+:QA>XO;CQ#K
M?P"\5:;HL%G;H"\]U+J5S;1V\* O+*R(H)84+XI?+\A+XI?+\C^<'_@BY^S'
MI?\ P5X_:*_:._X+5?MV^"=,^)-CXA^*.M?"G]D/X%?$71[3Q3\._AOX+\"1
M:1+9>);31=6L&\.>)!X+M;VS\#^%;U-.BL3\0],^*OQ"UC2KCQSJ>CZ[I/\
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MT:ZL-5&LQ^#FUZ^\6^%]-76X'BO^"_X-[/V]?%?[=?\ P3=\&>*OBYJ=]?\
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M)GJPURWW*WDK+)& 8Y&3YU P2IY*.I8HV0JCRUC)"\U;_P"$D5 %2#>9<9,
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M=/L?$%E!%=2Y\+"36C<>*KJX%E=Q6&G^'(=4U#4KF![/3[6ZN\0G^>CX _\
M!2+]K+_@KK_P52\ /_P3]\7^.OA!_P $Q/V1X]=D^.WQ=U[X=*-+_:?UZXOK
M#[9X+@L/%FFWMK8-XNTY?#]O\.-'OX?"_P 1_ /@N]\<_%/7(].\0ZAX<\#:
M?[1\+O\ @U+_ ."1?P\U*/4?$?@GXW?&@0W2W46G_%'XSZO;::ACDM)(X)+?
MX5:7\+Y+JU5K60-!>S7*3QWUW'<^=&+1;7^@GX7_  I^&/P1\#:%\,O@Y\/?
M!?PL^'7AB"2V\/>!_A]X:T?PCX5T:*>>2ZN1I^A:%9V.G6TEY=S3WM[-';B:
M]O9[B\NY)KF>65U[SWLEO9;^C>WK;T#5VZ+=V=WZ;?>?*/\ P5)_Y1D_\%%_
M^S$OVNO_ %G_ .(5?"7_  ;/_P#*$G]BK_NX_P#]:V^/-?L_\4OAGX(^-/PR
M^(WP<^)FB?\ "2_#?XL^!/%_PS^('AS^TM7T;^W_  1X\\/ZAX6\5Z)_:_A^
M_P!*U[2O[5T'5;^Q_M+1-4TW5['S_M6FW]G>10W$?"?LS_LS_!']CSX(^"OV
M<_V<_!7_  KOX-?#O_A)/^$.\'?\))XM\7?V/_PEWBW7O'7B'_BH?'6O>)_%
M6H?VAXJ\3ZYJG_$TUR^^R?;OL-C]FTZVL[.W?5/R?XV_R#JGY/\ &W^1[M7\
M=/\ P2N_Y6=_^"Q/_9,?&O\ ZM']GVO[%J^.OA7^P%^R1\$_VGOC%^V5\,?A
M-_PC/[27Q^TN]T;XM_$?_A._B9K/_"6:;J.J>']:O+;_ (1#Q!XRU;P'H/G:
MGX5T&Y\[PSX7T:XC^P>3%*EO=7D5PFFW%]G_ ) U>WDTSY@_X+J_\HB?V]O^
MR$ZK_P"GO0Z\Q_X-SO\ E"_^P_\ ]BO\5_\ UH'XM5^K/QU^!OPM_:6^$/C[
MX#_&SPO_ ,)K\*?B?H,OAGQSX5_MOQ%X<_MS1)YX+F6R_MSPEJ^@^)-,W36T
M#_:='UC3[M=FU;@(SJV9^SG^SI\&_P!DOX+^!_V>OV??!W_" ?!_X;VNK67@
MOPA_PD/BKQ5_8UMKGB#5O%.J1?V_XVUSQ)XHU'[5KVNZK?[]6UN^D@^U?9;=
MX;."VMX7;WK^5OQ#JGY/\;?Y'\TO_!W;_P F8?L??]GW> /_ %5/Q=K^L:OD
M[]KO]AO]EO\ ;P\%^#_A[^U;\+_^%J>#_ /CS3_B9X2TC_A-?B)X'_LGQOI>
ME:OHEAK?]H?#?Q;X/U2_\C2]>U6U_LW4[V\TB7[5YTUA)<06TT/UC0EJWWM^
M"!+5OO;\$>9?&KX1^"?C]\'_ (H_ WXDZ>^J_#_XP?#_ ,7?#7QGI\,HM[FX
M\->-=!OO#VL"RNMDC66H1V.H32Z=?QH9K"^CM[R K-!&P_S9OA-\/_VOOV@/
MBA^SY_P;-_%&#4[7X??LU_MZ?%KQW\5_&VF?;=&>\_9_\.6S>+#<:(\V@?;;
M'PY/I&N?&;XE_#K5_$K76F^,=>^,WPHL#:Z8- T::Y_TYJ^/?"_[$'P,\(_M
MO?%/]OO2- BM_CK\6O@;X"^!7B/48K6TAMSH?@S7]3U>_P!?:6*(7=[XA\6:
M;;?#;POJUU=RR);^'_A+X/LK%85^W>>I*]OQ]-&_R0I*]OQ]-&_R1]7Z+HND
M>&]&TGP[X?TRQT70=!TRPT71-&TNUALM,TG2-+M8K'3=,TZRMTCM[2QL+."&
MUM+6"-(;>WBCBB1415'XG_\ !>;_ ()R>-OV^/V3]"\4_ "[N=$_;!_9(\7G
MX[_LUZYI-[<:3XBU/6-)AMKOQ1\/- UVW=9="UOQ<FB>']<\(ZC&;;;\1_!'
M@2WO-6T31KC5M4MOW#HIM75GU&U=-=S^=+_@F#_P<+?LF_M/_"_1OAW^U_\
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M*=+B_M_P3KGAOQ1IWV77M"TJ_P!^DZW8R3_9?LMP\UG/<V\W3_"'X3_#_P"
M_P +/AY\%?A1H'_"*_#/X4^#?#W@#P#X:_M76M<_L'PCX5TRVT;0-)_MGQ)J
M6L>(-4^P:;:6]M]OUK5=1U.Z\OSKV]N)W>5JM[U_*WXCM[U_*WXG\OW[>?\
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M]Y::/S=_+=:Z_,/>\GYWM]ZLS^0;_@O;^V=\3_\ @J5XSOOVQ/AIX7\2Z?\
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M!\Q Z@#G )Z$^IZ#'%2\@$XX+DY/WB.O0'G.-N>^ .]1* 2<C)]2#U/4,O?
MZ @\\]!22]%VM\MNR=M5U[@^B]+KK>RLK6>RVNN_H+@,/N_>)Q@Y!V@#D]ES
MQDC! ],5&^SG:>2W5B1@ '\N>@.3^E*2H! 9E.3CU//0D<YZ'D]/K1R%R0=O
M7=TRV>>G4GMG@ G!!%/>W_#KIKY^3_703^5]]/R\NMUWV20BCY.1R3@D\9!_
M4^V>F,+WR<;25)QGC/8D# +'.0 .,]3[\E%)5#@DC\<CKWQU&">O7\,N*A4!
M(., CIR2".N3GU[XP!R.I=:+[EOM;UO;37_(7Z";VR&R<@[<G@A>#QP, CKD
M=\]Z4!=QRQ! &. 2><YQ@Y. !C'IUH*MR202P/&3\H/(['EN, \D9/O3=I3#
M<''.& Z>HR3G/&.,_D:'TLU^&UU?^O/T#^OZM_5]QXX"C&&)Z@]2<\'KC(ZX
MQ[<4N< EAN8C[P.-OWL 9). -PSP#D@\C%)N!!RK< 8Y& >"3C^@'7.*0E3G
M:<G'&1CG!!(^O8YX'7'<_#1]>]GH[_UTLAWZ]5]VRZ-;^=^GH.67=E2.@"C@
M \G 'L"1U()SSFHWXX!)XP#@CGH5P>0,= ./KV<BE3PI)]<_+@9Z#'7MU.#R
M,U&>&)XW*3G@]>^.,8'/?! /N*$O+HKZW=[+]+=O3J&ME\^GIUZ_\, #@@CY
M2.A.0,@=.<9/J.YI2Y['NW.0%/7/4$Y/<GITQUIQ.>5Y/5BQSDX[=^#GC@C
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI&8*"3T'^<4 03GY2IR%
M_B([]P/ZG&>V1CKB73!MVTA50<8 (R3RP'(W<< XX_&K]Q*%4\_.??DD]#@
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MBG*Q'J><CU/KGGMCCW!&>M-:K77;7OL[_P!=OD!,,$ ,!C=CI@9Y/7KR.3]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS^7]2.>__P!>B^]];]P%_P XHHHI !SV_P _Y_EFCGOR>_\ D ?R%'^?\_\
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MW7:I,AR<Q"-C'Q\C$L.3FN3U:ZN+S4K^ZN99)I[BZFEEEE;=([,['+L0,D#
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MD_SV_I5<B>NJOTT_/7]7U;N!^B%%%%9'0%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0V5PX<DL&P20%V@X!R,J"& P<@@@ 9(4S8+EN0%&TNN"L9Z[@">2>!G^\"2
M*7.K_P!>5UT[>>O5+96;5^Z2Z;::Z?Y:+=]',)0ZM]TMAL MDJ0K*3E<[@2
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MZ <<]^A;'J-Q&#D#([@Z[+\>EK^NFS[V5KV(7>[:TU;]/75/6W9=4)@G)(X
M)Z94$XR<]3C)]R0,#.*9@$Y!/?&XE1T&!MX[ <=_<G(63<>-S*6S@#&-I P"
M>Y)QSV]>,U "PP6.[@9&>.".AQUX&<@;ASG-)66M^BUM96TTUMO;3M<3ULOO
M\[V[;Z6\V]]1S[C]Y5)(SCG.>^6R03CG'!'(SZQG).&;A1DGV[YYX.WC&>G
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M05=DME8!**D">I_*G!0/?ZT 1 $G IP0D>GM[?X^U2X Z#%% #-@]S_G_/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5P'B[P5:Z]!(\"+%<D-DHH#,6
M.2P/&3D ["0I^8C#,<]_133:U0'P]KWAN\TN9D>-BNXHK8?EE&Y@P*@@@[OE
M['G&,9Y62-D !7[O)89Y).,9SC Z#IGDGV^Z];\.V.M1,)D1)\<3"-6W<$ 2
MJ1\X ) .0RY.#C@_//BKX>W-A(WEJ KEBK\F*0$YPA"XRIP IPP'!##;FTU)
M6>_X]-KWWZ_KN1*-]5Z>7]+Y]#Q6FDXZD8P?;IC\L'/?TK5O--GM)&25"A!(
MYYW$$Y/&0O';)/'3.16:R$<-QD=01R#Z'GKCCO\ C4.+[7_/INNFZ,GH,SZ=
M\G!!ZC'7 _GU. #R*0M@CC@C((Y_3@X'4GT_'#N<]O;UQ@?GSUZ<8[\U"X;.
M[/0XP"?7().>N>" "0.@]$']:_U^>A+O7&<XX!YQQWP>O/'/^-(6XSUSC'!'
M!Z'\LD_3 &:C5@, _,PZ]  .-N!D#/3H#]"0*"3M.,C 49/''\.T<X.#C@$Y
M)[@&@=M;=_U)2W';ID\].G'U/;UI0<]/Y?I]?7K4(.W!;KQP!EA@D#.#CICH
M>O!7.*3<?F^8+^0.?[QSR<CGKQ]TGCD"W];]4NE^_P#6A8'\N#29P,GW/;GO
MQZ^WMUJ+=USE-Q.<CL .>1W^F2 >1UHW''+<9^]P./0=\D'ANF>X- B7/';G
M'?U_+G'3O3=XR ._ /)Y!P1@=/7/3'/(!Q'NSU'0DC/+9ZX) ^4'CL>/EZ4W
M+<\D@Y)  (&0&P"V1GG/8_C@4#MK:Z_3[U<L9_\ K<]?QZ9/8?\ U\' S^)_
MQQ^/\^*@#=,$YY.<9/UZC !!PH [#H<E-S9SG).<;3\NT=L'(ZG@?AG&:!6=
M[;>NGYDC.!QD9ZCC@X;&/KP?<$<9I W8'N0< $G&,,N1SP<=P%YZ#F,GMCMC
M)Z[ESVZ8+9P#R3^.6]\@Y SSG&>,G (XS@XR,9['@4%J-TMU?S373[KO2VK^
MXE8LV,#@8.".#V)/3@<\' .""*9D<@YR1DX(QR> !GGC"@X& >.HINXG/!/8
M#DCG)/0CGZ#)]>#E"03WQVSU/&/?KQ@D<#WY(-1>B>ENW?W=;_?Z6=MAV_UR
M< $=.HZ$Y/Y;>QZ4N[D,3QU/3DGJ<#@Y& 3@X)'0\5&>A&<CC'KT^AZ#/< 4
MN<'' _ARO/X]3GGOZ9]L <O9=NFZ]WIT>_1]4^P%B,C YSD'G'7C/XYR.^/0
M4 G@GH!P?09P>.AYX)QU.3DXIN?8?D/P^OOW/0TH(!''3Z>G7/!///;_  "K
M:;>?S\_-ZKJN]]A0Y&=IQUX'?)/7MP/\.1T.F2#D^O8X')&1SCGG//?K@LHH
M'RK^M>W5ZO;O^EI 0>N,@#GCL..<'OCKTX'K3<]@H_GP0,<=,].<<G'T+:*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG'K3JAS[+[_^']1E<0'NW/L,_KD?RJ58U7& ,CO3Z*F\I=W^ !1115*#ZO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %075K;WL$MK=PI/;S+LEBD&Y'
M7K@CV(!!!!! ((-3T4 >#>,OA<JI)>^'HW,9#-<6.3(Z]V>'=F252,YC#%U.
M2F0<+X%=:?+;NZR*R,A967:R,K*<%2D@#JR_Q J>>_6OO:O-/&_@"#Q"C7VG
M+%;:J!B0\(EV@R<,0,+/V60X##AR/O52D[_KI?HMWV5]^^NXFKV_KJOE;37\
M#Y%,8!R!SW^OY<9/7D=>1Z-P>G3Z\?SK;U#3KBUN98'C9)(2ZR(WWD9&(9&&
M%.\'(P1GUX%91CXR<@@ \]>3T [8!'3.,CD\U:EM?LVW==+/56TWM;_AR)15
MK]79)6MKIW^>_P#P\%%3!%SGGV!__5_AT_"G 8XH<UT7WB4'U?\ 7]?\,0A"
M3^&<]1_^NG[!ZG_#_']*?14.;?E_7]?EWO2@EY_U_5A H'3\^]+3@I/;\33P
MF,YYSQ_]?GO0HREW]7_7]?>-RC'MZ+^OS(NM.V-]/Q_PS4H '04M6H+K^&W]
M?<2Y]E]Y'Y?O^E/"@=*6BJ44ME^OYDWE+35_UU_X(=****8U!^2"BBE ). ,
MF@M0BO/U$HJ80MW('/3K@>O7]*E6%5Z_,<8YQCZ@?_7J7.*ZW]/ZL450">@)
M^G-2"%R<' Z9/U[#U(_+WJT%48P ,# XZ#Z]>>_K2U+F^BMZ_P!?Y@0K"HSG
MYOPP!^IJ4*%Z #Z4M%*TY=[/Y+[O\D 4444U3[O[OZ]?S\@"BG;&]/U'^-*$
M/<X_6G[B[?F_EU 92A2<X'3K4H4#MR/7_.*=2=3LOO\ \O\ @@1!"1G('.,'
M^OMZ8SFG[ ">=V#P>WY>]2!6;. 3CKBI%A8]?E'OU/\ A^/Y&I<Y/K;T$VEN
MQJ' (&./F48SAAZ#!Y()'MC/&*1@?E;KOR?QSSV]?K_*K"PJI!))(QGICWP/
M?ZGZU,1@!<#Y<@8]_P#/^-3W_K^NOW$.:3NE=]7WT^_MT*BQ,0"<#KUSGD8Z
M8_K4BPJ.I+?H/RY/ZU/@GH"?PIP0GKQ_/\::3>R)<Y/K;T(E55Z #W[GZFG
M9X%3!0/?^6>,G]*=5J'=_=_G_P .20A&/;'U_P YI^P>II]%/EC'?\?\OZ^X
M:3>R$  Z 4M%%#FELNGIK_PW^12@^NGE_3"BE )Z _Y]Z>(SW/Y5-YO;_+MU
M?W]]2K06_P#6W3^MWTVCH SP*F"*/?ZT[ '08I\C>K?KU?\ 7]:B<TME^EOZ
M^1]@4445F:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!YKX\\%0ZW:S:A81!=4B7>ZH"#>QHIRI ZS* -C 9<#RVSE2ORU>6
MSV\\D#HR-&S*ZMD'<I);())!&,$$!@ >,YS]WUX1\3/":QROK=I!F"YR+U4
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M%B4#! 8YZD8_#K4P4GH/Z?SIX3U/U'_UZ:BWLF2YR?6WI_5R,  8' %* 3G
MSC^O^?PJ7:H[>GZ4ZK4.[^XDC$?J?R_Q_P#K4X( <\GZ\TZE((Q[@'\Z?NKM
MHD[[O7K^6W?I?5J+=O._W::^FHE%%%)S[+[_ /@?YEJ#T;=OZ_KN%%/",3CI
M^53-$!SDGI[# '_UO;GI1[[ZM;>7J_Z\[=A^['5:VZZ-K9+[]7_2*U* 3T!_
MS[U,% XP#]<'_/X4M"AW?W"<^R^__)$?E^_/^?S_ $IVU1V_K_.I=C'T'^?:
MG;!^GYGUJU%+9?K^8O???\OZ1$!Z#\J<%)[8^O\ A4V .@Q13&H=W]PP(!UY
M_3^M.P!V'I2CCW^M%!2BET/KBBBBN<H**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+W)/'TY]?_K?J:FHJ.:3T7X;]/U_.P#0BCH.A)&>V>N/RIU%%/DDWKIY[_J
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ME8**<%)]L>O7I3P@XSGW]/Y4#(J<%)[?GQ4H4#H*< 3T_P _6@"+R_?]*<%
M[9^O-3!/4_EWIP0#KR?\]LT 1 $]!3@A[\?K4OTIP4GMCZ\4!=+=D00#KS_*
MG\=@!_G^M2>7UY^G]<C_ .O3@H&..1WH(<TO/^OZ\_(B"D]!_3^=/\L^HJ7!
M/0$_A2A"?;ZT$N;Z:?B?3U%%%<YJ%%%% !1110 4444 %%%% !1110 4444
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M0HCC10OW< 9';C\.*;FW?I=WT[=O^#^@K;ZMWZ/5?<1V]E;6V?)C"YZGJ?\
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M%/Y\?KGVK4CO;27'EW$+9 ( D7.#R#C/^?RKSQM-T$/LDO;BU<\[)E!X[88
M@Y]<GIVYJ.Y30K QF"6:_D(S\LK1!/?<  #G\AVZFERJ^G-\U_FUZ>OR%?\
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M=Z<_F,'\,8]*.1^0'JI( ))  Y))P /4D]*K37MK!&TDMQ"J*.3YB_H 23^
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MI*@>BDX4G\<>I% &31SG!Y).  .?ICDD\5ZM9^%]+M0I>-KF13DO.=P)Z_<
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MS:OG;/#)'QU!93M8>X;!'N*^9-1@$$KQB+8$=T;(.XR!F!5L] O0YR6(/(R
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MO'-!/,N_6Q$L74D_0K@GKU&<8&1UQ]".2'A.<$'/0D]Q]<=>#U'('6G^6V<
M@9.?O#'7VXS].?0<9,@3'.2?4'V.>>..I''X \X"7+2Z:UV75;:/\?7IY1X
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M7\A4H1 00H!'0TZBE:;W=O73MV_K?K<#WBBBBH **** "BBB@ HHHH ****
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MEOO>[%LK??\ \/K^/;L<A-KVJ2EC]LD52#\L85!@Y. %!(&,# )Z"FPZYJD
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M_P"[Y=N@"T4F1ZC\Q2T^:7?\@"BBBCGE_2 ****?.^R_'_, HHHI^T\OQ_X
M!1113YUY_P!?, HHHI\T7U^_^OZ^0!1113NNZ[;]>P!1113 **** "BBB@ I
M<GU/YTE% #PY'O\ 7UP!_P#7Q^M+YA[@?R_QJ.B@";>OK_G_ #_G%(7 ]ZBH
MH >7/T_S_G_"FDDG)I** "BBB@ JY!J%[;#$%S-&/0.2/R.1_GVJG119/=7
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M^  4444U!+S_ " ****L HIP4GV[\^^?\*<(_4_E_C_]:@#W2BBBN< HHHH
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M8KA)&6ZMB,CADF_> <CE7!&3BNOLKJ]?*W!LYAQMD@=T,G<;HWR%R/[KL,X
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M+I^0'H%%%%9@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M21L1R\LA?'T50H^N3TK@IYGN)I9Y-N^9VD?:-J[G))P.PR>E:+FZI?U_7_
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M3Z'!(X(YXK4L]&LK.5[@1F:ZD&'NK@^=<,/0R,,JOHJA57D 8K+3_AO^"O\
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M<[BK2EB@[C;GU -=FEC;>0JO9VJ%8\!%C0K&=N,*<'&,=0>W6FYKM^*_X/Z
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M0 >,]S^F#/+I.IPC,MA<QKP2WELRCCC)7=CO@G'?FO<(S;](S%P<$*RG!],
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MW/? !X+=2'QNT3!D)5@05<'!5O8CDGCCD;3D^E6HK:60 QPR/G@>6C,J\=B
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MUOWL59VW2?DM%Z:_UV/*M*T*_P!5D001LL!8[[EE(B50?F(.,R/C. N>0?F
M&:]ATO1K/2X52WA7>% DN&&Z:0]V9SDX.<[5PJC@#UU(;:."-8HECBC0;51%
MP N#P!V'T').3SDU950"0=S=, CMZCIC!QSG^M7I%?C]UE_5WIWLM!*WKWTO
MWZ'+^)K 7>EO(J>9)9NMTJ@$EQ$<RQJ .=\>X>Y  Q5G1ULKB..>Q5[5C&ID
MM3N0;B!@O"W ;N&'7!)!Z5M7<\*0.)9%A20;%=V4;6.<  Y!]<8Y],5Q6F>*
MHXKN2RU41;H9FABOHHPL<B;CM:4+G:><9Z9.>,G"N[7M9[)/SMUZ>GETL/\
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M^U='::+IME@PVR;Q_P M'&]_?YFSUY_,UJT47_K_ #[_ # 0 #H /H,4M%%
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MS?3+;VD$D\K=%1<X'=F)PJJ.Y)%!'-)Z+\"M6]H?AZ\UR0^2RPVT;!9;EQD
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M.??\.OK1S6=GK\]GU6S>FO5Z:#(@K=>.F,$]NW'IGMU^G6GA.!DGCJ&Z=L8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5YKX]TJW,0U=KATF01VZQ$;DEW,=H X*,!N;(SD Y]*]*KB_'<MHFANERP\V
M26+[*@/S-,K@D@9^Z(]^X^AQWIQ=FO5(&KZ,\2S['&"?P!QQ]:87],<C\?\
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M/7L,?A24TN![_2@!X) ([&@DGK]*B+GC'XYIA8G@F@";(!P3CO32X'3GU_\
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MWS245H N>ON,?J#_ $H))Q[=*2B@!02.AI**0D#K]* %HHI"P&,GKTH 6D)
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MJ&XN(;6&2XGD6.*)"\CL<!4498_@.PY/2O-[_P"(T44K)861N(UZ3RN8P_\
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M!?HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@!&&58#J00/Q%?-^L:!JVG2W,UU8S);^=(1<*F^$JSDJ2ZY"@@C[VW'0
MXP:^D:BF@BN(I(9HTDCD5D='4,KJP(*L"#D'/-5&3C\P/E/&,D=^W&,_X_7K
M^51L3QR0<8/;GUX->G^)O L6G6UWJ=A=,MO IF:TE7>47< PCE!!*J#D!ER
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MQ66#DD>@_P#U_GQCKQ6PN9:+OIZ/S^_^D>O?#"]7_B9:>Q&_,5U&.,E<&*0
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M$H2"&0X)R#@<GOBO1:KM:6[SQW30HT\2E4E*C>H/7#8R,_6FG9-6W_3;^OQ
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MP'7-%U:]].X6=[6U'44@8-G&>/6D+ =<T75KWT[A9WM;7L.HI P;.,\>M(6
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MJ[^Y;JG]VN_XV^8'H-%%%0!SVH0>7,65?DE!;CH#_&,=N>>?[V!TK.*@G/\
M7\A[>O SGG/KT][%YD#<99/G'T'WA_WSDX]0*YL@@\^N/Y?XB@!@4#I^/O\
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MC\J1XSQM.0?8@$'//0=#U]?0=!$YDBC=D,;.BL4;JI(R5/T/%9^H1?=E_P"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYFQPN1A1G'7-<X3@'V&?YTQF]">_MUZ?E^?OWJ.M4K:(S<^UO6WDN_IK=?\
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M 4444 %%%% !1110 4444 %%%% $<D44NWS(T?8P9=R@[6'0C/0CL:D^E%%
M'S)XUU"[OM?O!=Q^2;5_LD4//RQ1\K)D\GSBQER."& &0,GDO\]<_P J]Z\?
M^$9-5B_M738@]_;H1/"N UU O(V^LT0!\L<;U.SJ%SX.RLC,CJR.I*LC*596
M'!5E;!!!X(/3WK2+N_2.GX+_ #^_S(E>S]?OVVM;;SOM?HAM%%%7;6_]=/\
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M#3M3N[2\O?-6!IEB,G[L^7\[(X4 NK $C.,'''4TUVO;733K=:_GZ6\[,?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT$=V]W:KM4V=XQFC"*" L4AQ+%@< AR.VTBN*5MQQC'&>O\ ]:E)X)_^MU_
MX_+%.S3MUTT_+R ^DO#/Q+M=<OX]-N[(V%S<9%LZR^=!-(!GRMQ5&CD8<H"&
M#@8!SC/I]?'_ (3@FN?$^AQ0 EQ?PR''&$B;S9&)_NB-6R?P]!7V!1V_K^K_
M '=GT0%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \O^*&FP3Z3!J&Z-+FRG4*S,%>2"8XFC7D%B&V2
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M"T1= QC8C@LF=IP!R#P.E<EI4'A;Q.HU*#14#03 I/=::+25I%YW*'C1Y I
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR:KV;^[?1Z;>7GIM?[[-2][EFG2?:I[KZ='Y.Y_ID^)?VU/V5/"&\>(?CO\
M#?3FC^\DGB;36<$<D82=N1CD?AUKQ;5_^"IO[#&DNT9^/G@R\=>HLM0BN<XZ
MA3&S _7./PYK_-?O/'.I7/-[JM[<NQ.//NKB<L>@),CL3D\$GJ<GUK2T"P\<
M^+;E+?PYH^L:M*YVJMC;7$X)/;=&-HYYR2<8S@\D=>&P%7$OW*=5*ZM-P?*U
MIJG9+1._IT6E_(S+/LKRV$G7QN&C5C:])UJ:FKJZYES75UJDTFUL?Z)>H_\
M!8G]B&Q)$?Q)2^PP&;.V,JG@G@B0=NGK6&?^"SO[&3,1!XEUNZ'9H-(DD!_
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M!844T."<8XYYS[>F/\^U*3@9IV=TK:O;Y@&1D#N>1^O^!H.<''7M_DTTN,]
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MJ.N/KFH9?"S$$PLD@Z"/(&W//N#UQS@CL.,UVNHK9:;"TU]=0V\0&6:215
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<8)_G^/ J*B@T44NGW_U^0H.#D4G6C/^?\^E(3@$XS1N4+1D#.>@S488EN2
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MUZ.VF[M]S"4:<%4E.4E"G!R512L[Q2:2MM?_ #O?KX,]T9&9-A:08  &3N.
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MM<<XYS[=.>OKGI[#&",8J(V[;><X/]>1CD<Y/UZ9'%=0]NN#P#R,=,?CP/\
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M@<D8XS_]=NG3;O*,&G]E[7=O/[K) TIIQE&,HJ-N5Q5K+172MTZN[^9U$-X
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MS^83'9E^ORVR8WJ#@ 3.V>I4'BO4(8(H(TBA18XXU"1QHH1$4# 5$4!5
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA# 8ZKOSZ9'3T^S-!T.P\/:;!INGQ[(8QO=V):2:9POFS2,>KR%03C '
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MM7DOB3Q5X@\7ZQJ'B/Q/K6I:]K6I3&XOM5U:[N+Z_NY6_CGN;EWED.<D<X4
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M0X3.6E? ,C8X 7%2YK6SN_ZZVL']?U_P3N;"U@LK*UM;:-8H(((XHHP,!$1
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MGJ5P6GN[EV9BJ*B+V8:CSI5)JR:32[ON^OE\M.YE*33^ZVOH^CNNBM_PQE?
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M]9_L@>+UTSQG?>%;R4):>(K1VMPQ"_Z?9(\B[<D$L\!E0XRQ*CH.*^12VT9
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MABIZO=TDTXZ/^Z]NEK>GH4<A*@@\'@C'';TZXSTSQBK"3!0??&>2#G';'O\
M_7R*YZ"ZWXVYQ[^N>Y[8_7UYJ[YYR%R.G('7WY/?O_7O7F*$M5==G^#[>CT^
M_O\ 4^6YV6FWI ,9(/7@GZ'MWS_//TZ""16#QR9 ?@$=L\AN@_B (.1@<8KS
MF"9U=2IZ%>GH?;W]./?M78V=TLB*20< #ID@^_IUZ@9]\8HA"I&M"I!Q7(TV
ME=[-65NN_?:US)PNWKHW=ZZ]-NVNWY]_OC]C_P >-+::]\/KZ<E]-E;6M##L
MH/V"[E*WUI&O!(M;PB7 'RQW*#  !K[C5P>N![]J_%WX>>+YO 'Q%\)>+!+L
ML(]5M].UG+$*='U>:*QOF< C*P%[>YR00/()(!Z?LG#,LD<<L;!HY421"#D,
MCJ&5@?0J00?I7V."Q"Q%"+;]^"49KS2T:?5-:>J:Z7(:LVGNG_P5^#1JJ^.#
MS[]__KU*#W'X5123@>GZC_$?Y[8J=3@Y'_ZQ78!;5^Q_/_'_ !__ %U)58$'
MI4BMC@YQV]O_ *W^<4 2U(K]C^?^-1T4 6**8K9X/7L?7Z_Y_P#KOH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHK"\2F[71-0EL'V7D%N]Q;G^$O#^\VM_L
MLJLI^M &G>7MK86\MU>31V]O!&TLLTK!41%&22Q[G& !DD\ $UYTWQ;\*J6
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MQRQ\$'()5@20Z-C:Z-D,HQP237T?X,\=6VOVIAOWM[34K<+YB&18X[E"#B>
M.PQE@1)$"WEG&"0W'S%O'/KCCCCI^?TX'\J57YX)![$?3G!X^GT_*L^5]4[>
MGI_7W^8'JGQ5O+>?7+9+=XY&AL$29XV5QF621U4E20"B^_\ $<UY>KE>HR"
M",D=,XY!XQG_ .M322>I)^O-)4@>P_"C6)8=2N=(=P8+R![F-2?N7$!7<5Y(
M!EA8LX'4H".AKW^OC#2M1N=)O[74+1]L]K*LJ DA7 R'B<#ADE0E&!(R#7UW
MHNJ0:SIEGJ5O_J[F)7*$Y:.3I)$W^U'(&0_2@#4HHHH **** "BBB@ HHHH
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MG6>[;NGN+F67JPE*4Y.5:+44[)-6O>S7R[_/7>V/-'K9WV[:/?\ JW>YZ?\
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M6IR[A9:%X?T]Y8Y=5UJ_E5DM[. C #S3O#!')*O6?'KXX_#G]G'X8>,/B_\
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M.P]?\CW]J3?GV[=_/^NVHFTK7:5W97$=^AQQG'Y]3T]J@DD^0C!QG /ZG _
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M?KR 1UQ0!."",CD&BJULLZ(1.RD@_+CL.._YX[_3O9H **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P"?\]ZC!R,^M.4X8?E^= $U%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\W?&3
M1DM=4L=8B*@:A"UO.@ !\ZUQMEZ#)>*15;J<H#T-?2-<?XU\+P^*M'DLRPBN
MX"9[&<C_ %=P%QM?C)BE7]W(!S@AN2H!J+L_+J)JZM^9\;T4^2-HI'B<;7C=
MHW7T9&*L/P((IE;& 4?Y_P __7S110/F??S_ *_K0****#526FO]:;]M_33<
M*7/7OGU_G]:2B@HF+ @@=2#Q^'\Z8N0P['_ZV:92@X.:5M&EUOOW?Z 7 _\
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M/]9%G,;@XX-=91@=<<^M% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\&WIT.'\ ?#)--:UUK7D$FI)LFM;')\JP;(97FQ@2W8X;!^2%L@;V&X>V48
MZ#%%)ZCM;^M_,**** "D)P,GM2U&YYQZ<GZ_Y_G0!&>23ZTA. 3Z4M1.V3CL
M/YT ,)ZD_C4#L#D]@/\ /ZT]V[#\?\/\_P!:JR/CCT_4^GX?YZ4 1R.3QZ\'
MZ>G]:KL<#W/3_&G$]2?J:@9LY)[4 ,9L#W/3_&JLC[0?4^^/U/\ D<FI';JQ
M_P _Y[_B:^=OVG/C'IOP,^"WCOXCZE<)!_8>B7;V.]MOFW\L9CM8U[EFD8$
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MA3XDZH88O+LM:4:O:[5(3-R[F=%X RDXDX'9ADY %?J9$@*C8>F,8[GTS_\
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MVO&TV#Q!XC0(\FI7Z"54E7G,4;\ !NF1T ]Z^T(1';QK# $BB0!4CC"JBJ
M JC    &!5/S?=?S_P#KTOF$],'_ #]:W45%622]$E?UL;I**LE9=E^?KHM=
MS0$K]GS^1IWG/Z@_4"LWS#W _E_C3A)CL1]#_P#JIC-(7#CKC'MD?UQZ<X_
MU^9O[>7PJMI[:Q^)=A9C<%.F:\L:Y$D3X%O/(0/X7;:QQT)YK](1+SU;\>1_
M6N!^*7A2V\=^ _$GAFX19?[0TZX6#<.5N40O"RY& =Z\'U]>E*45).+ZDSCS
M1<=KK1[6>Z=_)G\L,%[<>$O%4EF3LLKN?*]D,<C':W/]W. >!U'4$5ZE<7TK
M+O0G8ZY!QQRO&.><YX&>0.1BN6^-/AVYTNY+R0M#>Z/?7&GW2A1N0PR-L+8
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MT/P3P;B\JS/C3(*[E3K0XEQ^+PU!\L7# SQ525!I+5I49T%S6M:RT:L>Y+(
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MX_I69!)V['Z?X^^?IGVJ^AZC\1_G_/>IFNOR?Z/[M/5,F+Z?I]ZVZ/\ !HN
M]"/8BK<;9'UY_H:HH>,>G]?\FK$38./3G\.XJ"S10Y'TXJPIR![<?E_]:JB'
MDCU'^?ZU90\D?C_G_/:@"9#\P]^/\_C4U5ZL#D ^M !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 & >HI-JDY(!/N/\^E+10 8'X^O?\Z*** # ]**** "BBB@
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M8O*<]T7J:^F*'?KV7S[7^0!1112 **** "BBB@ HHHH **** "BBB@ HHHH
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MH 5510%50      , 8INW2^VO]?B"OU_#;I^M[>0^BBBD,**** "BBB@!"<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MB_%_@RW\7):I<WUQ:"T,C1"%493)( I:17^]@*, %>]=I10G;5 ?$_B;P]=^
M&=5FTV[(<*!);W"J52Y@;[DJ@]"""CKD[74@FN?KZ+^,VDSW%AINJP0!X[&2
M:&ZD1<O%%<"-HW?'/E"1&!)^5"X/&21\Z]_UY_R<_K6T7=?@Q>7I]WSWV?\
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MHHHH **** "D)P"?2EJ-ST'XG_/^>E $?6FL<#W/'_UZ=4+G)^G'^/\ GVH
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MJ.W]?YT[Z5L/VBZ+^OQ(=C>GZBG"/U/Y5-M8]OZ?SI=A]O\ /X4"<V_+T(P
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M^7Y<YZ8X[5=1C]X<8[ ]>V/Q/KQW]JYZPN7> 9.2 /3W]O3'85?\]^WTZ#'
M/H!R.N>O\ZU2]Z*6U]>UM%:VJWM;T?FC:#4*B:]Y77KI9[^?6S^ZQI1W#V\T
M%T!\UO<1S#!/RF)U<?CQU[#\J_;W]E[Q$UUKV@R>=Y<.KZ+&Z@. LCM:+*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$_C_ "'3_/\ ]>JSG QZ_P O\_UH C9LDD]/Z55=L MT_P _T%2N>WXG_/\
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MS_\ 7->L45A'_LD^Y[_R!J41^^/8#_/\JL"/U/X#_/\ 2I!%_L_G_P#7_H*
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M7*0-]WU!_GQ_/.?ZUT5L^0/7^>/\<G\*]/=>J_,R3^%]U:_G_29TD+ ,/?\
MS_(Y_"MNV?.,Y_IZ_P P>>V>]<]"^55OP/TZ?R_SUK:MF]_<_P"'Z$?SJ'\*
M?\K7X.S_ "+.BA.5QZ?Y_EBKJ'A3Z?T__56;;G/XC^6<G]!6@AX(]#_/_)J9
M[_A^3_4B+W75?HDOT_$N \@^X-74. /8_P!<U04Y4?3'Y<5<B.1]1GV]#4%E
M]/O?7_\ 7_2IAP0?2JZG[I/L:L4 6**0=!]!2T %%%% !1110 4444 %%%%
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M&>?U_E_/ZD5ILDEN]%OMU?WW^5GT(CJV_P#+K;\E9?-^A0N).H!_SZ\'\?\
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M^E6+33Q(N#N905..@(Z]1CMTYX..M?9_[.OPME^(GCO1-'EM]^B6$L>I:XX
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MC^@'_P"NK*6^>6Y_1?Q/4_I],4#*BKV53^ _K4RPL>OR],=R<^P/\\5H)!T
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MY8^W'^?QS0 VH&.23V_PJ5C@'\A5=S@?7C_&@"!VZGN>G^?8528Y)_(58E;
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M]E#Q)80SF*\\7WD.AQ;6(=HYE<R@8Y(P<'@C&..AK^.N$!@,^GZ]^W'7!_\
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MWL*DG@2A69L''21 <@@C/XU^Y/@;41J7A[2;U7#-+90EP#D;_+56SWX(.<]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX^U_ /0)4W#*QZW*C;>IY,)Y_#'3\?2M _X.9K1G1?$?[.TT:$CS)-/\2JQ
MXSM1[7GOU/2I=.2W7XC]K3_F_"7^1_6%17\]_P ./^#B?]DOQ+)!;^-O#?C+
MP7/,R*9#9_VC:Q%B 2\D*@[1G.0IXR:_2[X1_P#!1S]COXTQVP\&_&CPLU]=
M!/+TS4KL:=?!G4,$:*Y$8W\X(!/-)QDMT_ZM_FBE.,MI)^5]?N>I]Q45E:9K
MFC:U"EQI.J6&HP2*&26SNH;A&!Y!#1.P.?:M4G')J2A&. 34%.9LGCH/\YIA
M. 3Z4 1N><>G]?\ (JO(>?H#_P#7_P ^M2L<9)_R?2JDC<<]\D_AR: *TAR?
MS)_'_#^M5G/./3K_ )_SUJ4GJ3[DU79NI_+^@_SVH A<\D]AQ^7_ ->LNX?K
MSU^A^GKW_' J]*V%/J?S_P _7]:Q;A\9_P \$<?CC^?X5IM'SVMMJ[?BE:UO
M/Y0K.7IZ=&K;:[W?GHS.N9.O_P"KT_I@'ZGK6+<OA=O][K[_ .>OX"K\[9;]
M?Y_US^E8ES)DL<].GT_IP,_6K2LDM-%KZ_\ !=W?R+V/YPO^"Y_Q%+W?PP^&
MUO.2H6ZUJ]@4@[6'R0L0#GD'C(QZ5_/7 !^9'Y$^X] *_3+_ (*P^/?^$V_:
MS\46$<YDM/"MA8Z5"H8LL<@A22<#)PK;L9V\=.:_-.% !U/ 7_/^/]*N.JLW
M>[VL]KKR[+Y?>>3C&W5U_EB[:Z72WOYW_IDX4$CCN.?T'_ZJL@8'T%0D88 =
MBO\ 2IQW^G]16C271?=W:3_-',FUJM.G3U_R$H]?U_,?UQ4I13ZCZ4H0#/4^
MN<>H]O7%+G5M/+3[K_K;T!MMW;NQB@-G//3N?>G[5].ON?\ &G;=I(Q@_P"?
MZ4H[_3^HJ')MZ72TTOM;_@B&;5]*BZ$CMT/T![?E5EOO'_/:J_&XY['_ -F
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MWNO3K^@X[+RT^XWK8].>G_V5;D!R#^8_S^-8%J>F.^/Z?XUO6_3\!_2EM?\
MQ+\;?H["F[-?ULT_T+Z'@>W].E6UZCZC^=4TZ'Z_T%6U/0_0UB6:$9^[^7\Q
M5Q._X?Y_6J,9Z9[-^G!JZG4_3^HH L)U/T_J*EJ%/O#WS4U !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-=5:[2\KG0:[XDUWQ-J$FJ^(M8U+6]1D)8W>J7LU[<#. =KSNP1<<!4"@8X
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M?\ K:/V/*ZW[17]>7S/*Q.LX_P"%=]W&+:_'[BT%Q@]<<=O3\\>W3-.I3U_
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M@W^OR.0EMO;_ #Q]?Z_A67/;=?\ #/\ G_#UZUVLMLK9V\'G(/\ +_\ 7^!
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ6&74-5E1@1&D:(LC#:C.2*_GV_:@_X*^ZYXIO[ZT\'Z[JWQ0U+S'6'7]?\
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M./0<_A7SS\5'GU758;:,,8K"(@@'_EH^"V >IP #QUSFID[)^G?7>VUMO/\
MX<NRY4];\S5]'I9:+L[.]_+<\AM8P2-W;!XYSZ?X^_<=J](\)V8ENE>0$QQ
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M?\5\NG]=&<CE9NWW[W^^_P AS$'H#^/USZ].3[^]-HHJ26[ZL**** "BBB@
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M]OG'\T:R?>'X_P JM1]_P_K55/O#\?Y&K4??\/ZUG/XG\OR01V7HOR+D'?\
M'^E7X^B_7^M4(._X_P!*OQ]%^O\ 6I&6:L57JQ0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@Z!ILU]\9/$5YX8\*2PR3^$_@/X:OROC#QP\8S#/XRN;.1EM-)F;"2:>\MO
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M110 4444 %%%% "$@=2!]:,CU'YBHWZ_A_C3* )PP)P#S7N/PY.-)GR#Q<'
MZ#IGG^8X_,=/"5!#C. ,?CW_ ,^M>[_#XXT:8]FN6VG&0<(H/_Z^G\JTK-OE
M6UDK/YKSW]'U')24;ZJ]GI?:Z[:_EL^IZ"GWL8SD8Q[<?_J_&GMN!.2 ,=3@
M$]?7\>X'TYJK&V&![ CWZ'/T!&#U]#7L?PB^"GC;XW7FK6OA(Z?$ND0I)<3:
MC*T<1>0LL40*JQ+OM;&!@<D\]>K+,%F.88B5'!858B,8MR:A*3CHG)N*U2C9
M>3OZ'BYYQ#D?#6%CC\[K>RHRJ1I04Y*,)2E:T8N5ES2NK*^OY>7)DCGITP?_
M -9]#P./3O5P<9![C\?7/YXS]>*]1\5_ ;XP^ IKB/Q%X-OY+.W#,=5TJ%M1
ML"B\ES+;!C&N#G,BKU/H0?+9(W5]CH\;+D$,I5AC.00V"O.>HZD\#FEC<%F6
M#K3AC,*Z-)?PYJ$HQ;7*I:M6;5]MU>SV3*RC/\AS["QQN48[#U:4I*,J4:].
M;IR=K)Q4VT]].O384G)S_A_0"D#8)P1D\=C]>/PJ+ABPW8(&>F3QZC(Z#V]>
MO<X!/(.!CD$D>H .._'4<=AT'GOF2MRJR7573271WUL]M[K\?9<9*,9Z<D[J
M,KJTG&U^5;NU]>Q(S=SC)Z?Y].Y_Q-4V<ECSTSZ=L\_F>G]>:G8_+U  ( ],
MX.<'OS_CGFL?4KH6EK<W!("PQ2RDYX^12W/X#(['KVS4N[?2T5NM59>KU>VG
MWBMK:Z?IMJ?&GQ-OVU/Q;JDH;?'%*+:,^H@4(2,=L@].,^O-><D$<&MK5+A[
MF\NIV)W23R.2.<[G9B>2<=1^'ITK(8,23C]1_GWJ#<CJCJ<J0:?=322I"B1G
M=([A%520"2Q("YS@$\9/4=:O$8./2O(?C/J!M_",EA')LEU.Y@@4 G++$XGD
MX'&,1J#GKD C&#2;LF^WR&M6NFJ_/H<Y=7.D7[21P:E;3MOQ)Y4\<FWG&,QL
M?<'&?0GM5O0+9+G55DW%X;",M&0,[FY ]L#KVSV(&,>%>'K8PA<LP8$ L"0#
MDY.,=NPS[?A]%>%+;R=(EN.C3,$4G += <=SDGC&3D>O64T]'>ZUWVZ:/Y[.
M^]F5;6[;:NUK>^BN].F]F]/PT]\^'%D$M+^^8'?<7&%;&#MB4@ -Z9)[DCKZ
M5Z\-9:33K;3_ "S'Y#/+O!&"S$$'J!G  !XZ]1VXOPS:C3M T^V=0)3%YDQ[
M[Y2TA#<9X# #D]/J*UL YP5QP.>O'4]@?Y'U%;TX<Z;U3V:OI;1KIO\ +R*:
MOJM=EHTEM&]M.ZM>^ZOW/Z$_V!OV\/ 4W@;1_A3\5=<M_#NNZ BV.D:QJ,J1
MV&HV6[$,4UPQ BFCW*O(VD9QCBOV8\.:_P"'O$5K#>Z#K6EZO:S*&AGT^^MK
MM&1@#N'DR/C(.?7!-?PJ!FC<-'(RLI#*RL5*L#P0RG((X.1S7L/@3X^_%OX;
MW$%SX/\ '/B+26@*LD4&IW9@.W&%,+2% N,@X[9[5-3#M:Q5EZZ=-GOUV_);
M7&HXV4EHM+WN^F]NOW?Y_P!PUK%G' Q_GV_$_3(KI;2#IP>W^??U_7IQ7\Q/
MP/\ ^"O_ ,4O",UGIWQ1T:S\9:2ACCEO85-KJJQ[E#2&7+"5@N2 0<GH><U^
MT'P0_P""B7[,GQ<M+4Q^-;3PIK,B()-(\2$V3I,5&Y(YF7RG"L2 <AB>WKA*
MG..KB[=UJOP-8U(2^TE?O9?A^GW'W];08VH!R<%B!^G'8=!SZXKJK&VQM !]
M..,^H''?KGU^M<?X:\1>&]?MXKS1M=TK5()E#QRV5];SJRGD8V2,>>.,#/'0
M@UZ;90#"D<YQM/MW(ZY]!_7K4%M]=E^7]=31LX.F!P#P,9W'///'3IWR.M=+
M;0=.W<GV]?J>@_J.E.UAP!QP.!QU/?\ /C'H,8-=+9V^2!]"W7CZ=L#IZYY&
M,5HE9;:NR_+J^J_.^EHF?Q-R>RZ/Y6^_Y]%K=%JSMN Q' ^Z._'KZ8Z__6 -
M;L46,<9)_P C\NW\LFHX8N!Q[ ?Y_7_]=;%O!WQ^8_S^ ^H]<U%6UZO^KO\
MX/3S;N]]9;=%W[+S_5Z[),(;?.,C/]>F/S/;G/ZUHI"!U&/R_P#U#^=2Q1=
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M)!'9>B_(N0=_Q_I5^/HOU_K5"#O^/]*OQ]%^O]:D99JQ5>K% !1110 4444
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MS-_HOR"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^M2,LU8JN.2!ZU8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO;MKNOD>7T5L7N@:K8R,L]I)L4D>8HW+@#.<C(.1]/>LK;AMI!R, C!R#_M
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M4YQ_!C!Z'(SVR>PKZA\ 1%IM3OSC=+*(%/ &U,G S^''T[UX#X"M5VSSM_#
M^T\9_B)Q[\?EP:^EO ]J(/#<=PV3)-<7#X]O-*K[_=7/0<<X.!51?G?_ (:/
M?7N]--3.4I0YK-JTM+-K33MOL^O<ZA<Y<$Y)))(QU_#C_P#5WZ!"Y!('TI5Z
M%L8SDX]>I_KC\*BZUT0^';=M[?BNFM]EV,KR<6[MZZN^MK*W]?\ !#K1115$
M!1110 4HQD9Z=^O]*2B@$[-/L[BG'8#_ ,>X_/'^?U<".^WD8_BSSU]?\]Z9
M15<W]V/W&GM'VCTV33TML[[NWG^+&LQ4@COGU_GGWIN58<\=SC/)[\8QW]S^
M%$G;\?Z5'6T9.R=]^WK_ ,#\^[O<9-Q5VW_P['[\<+D#_P#4>_3!_7FGQ3RQ
M.'25XV!R&0E6!]01@C\/YU#14N$&^9Q3;W=MWIOZVU*N]KZ;6W/H3X6_M2_'
MCX-:A;WWP]^)7B706MW1U@BU":2U?RV5@CP2LZ%#CD8 QGI7[*_L^_\ !P!\
M?/ @L=*^+N@:=\0-*A"12WT(6SU+RP,&1F"[9)  .H!)Z'FOYYJ7<WJ?\^_6
MN:M&*:M&*NM=.S7:W;K<AU)P:<6TKWMT>U[J[73>R_,_O4^!7_!:_P#9!^+L
M=I9Z_P"(I?AYK4YC1[7Q'Y5O;"5SMPEPT@4J&(&XXSD''2OTP\)?&#X7?$*S
M@U#P9X\\+^(+:X421-IVLV,[LC#=GRUG+=,=J_R_EE=2"I(8<A@2&!SG.X$'
M.><Y^E>D^#?C7\5_AY<QW?@KX@^+/#D\.#&VEZW?VZ*1T C6?RR #TV[<$@\
M9K*,'M%-_*_9=+6VZ]=36.*EKS04O\-U_F?Z=]PRLJLC*P/&Y2&'52.02.Y(
MK&NNC?0_TK^#7X1_\%D_VT/A?]FM[GQQ_P )KI]N4W6OB9)+N22-2,J;@R%\
ME1M!.>I[G!_3?X6_\'#_ )J06GQ8^%)CD"HMQJ.@W1D#-@;I%MV *@D?=)/;
M@#J^244ERNWJGV?EWZ)Z:FT:T9VNI1::?O*RW[ZK:[W^;/Z=)_NMC^]_CG]*
MYB_'S2?7/_H)K\A-!_X+E?L@:U:)+J%QXAT:9@I>"ZL7+*Q/(RB,,#\SU'OY
MY\6_^"W7[/EGH.HVGPPL=:\4>+KR"2#2(6MGAM([J5=D<UP[*I58LB0@'G;C
MKFLVFY)I-I>36SUWLNWX%\\;M\RMKU[J/3?H]/)]CQ3_ (*Y_M%KJ>HV7P3\
M-Z@K0::5O/$A@E5E-Q(A:.V<H3]Q2-RGNPXXY_#/3KM+52%10S'EB &/;KG)
M.>0,D#'2NT\:>(/&_P 7/%>K^*-1$M[K.N7DNH:C<3R;4#SL2(D:5@%C0848
M) 5<8.!5"'X6^*IHWGDN=)LXH5,DC3ZC$ %09)8+D C'0GN<5I"-K+S3;>FN
ME_TM^6IYDJU2=1\LI*.RBF_A32VVOU[K7KJ^5\0?$RU\"Z+J'B#4[LI%9P.8
M8@X#W-T58P6T0((:2:1509)VJ&8@@5^:.N_$O6/$^OZGK>J32RW>IW<MR[EV
M8Q([EHH$.1B.%&$:J. HXZ"O6OB]H7C_ .(FN&ST2YT?4-"TN62*UMM/UJSD
M::X1BDEW/$L^7D8@H@PP13\OWB3\]ZI\/O'7AQ_^)QX<U.WCQ\MRML]Q;,!Z
M3P&2/\RI&<]Z).[>EDF[>>VOS\M'OUN;17+:^KZWU[:7O=K:_6YZ)HWC2:TD
M$AN7CR1QN)SSWY[8SQ^1YQ[5H_Q7NX8HD65WX7^/&3UZ<9'3CG(KXQ\^5259
M7W*<8P<J<_Q#Z\<@?7FNOTB;4K@1I$DF<_(2",8.>IQV . <>_>IO9VOKT[Z
M6_'KT+Y7)-VNM--UT75ORWT\S]$?#7QKOX&MD\Z2%RZ#*ODD$@$L 1DY)XQD
M XSP17]$_P"P_P#&F/X6>"K/4+VZ,.O^(5MKN63>H*VC1*UK V2",*[NYSC<
M>YK^7[X _#O6O&'B2/4-9Q%H&B217-]*[$"ZE1EDALX@?O%RH,S8*I&"#EF
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBB@!YSE?]T?C]?SY^O/6O9/ABXDMM23HR21/U!X97 (X/<8/3ICMBO'-QRH
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MFI@:\LXH++_KL\%&%7#8:OR4<4J:PL\.G4JT'.-.:Y?9U9*I)5$G3?\ /?\
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M2O962>VOJNW87.%[=,D#WYZ<\?\ ZZAJ<_=)'3''X@X_E4%=<HJ*27];?/\
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MY+",AY">GSL1@GIC%8=QKJSV5[$L\V^:WE7#23#?OC9=I^?DDD#GL<YKCZF
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M7: <9/4$D#U_!#]K#X7WWPE^*GB&V%O(/#&O:C>ZQX;O0K-!):W4[SO8M)C
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M<$Y&<Q!PK#O@[NF/:OMWX<?M_>(]-^SV^LZA8>(H"5!CO@UK?,.#@SH=N_C
M+1MT/7LJW"^"G!U,ES.&,HO5QG%0FIZ65DY*_2[Y?E:ZTH^*F-RY0CQKPOFV
M2P32>8TZ+QF7Q3M9SJTXQJ4T]^5TY-6:N[GR_P#&W_@@M92"[U/X%?%5[65E
M=K?PUX]M!<09ZK%'KVEHLT8., W&FR<G)?K7Y#_&W_@F5^UK\'VNF\3?"+5?
M%.A0!V;7/ UO+XKTXQ(3^]D&FP27UL@P&;[39Q,HQGG./Z^_!G[8_P -/$\4
M0U9I?#UPVW(G/GQ%N[+-$H; XZJOXBOHOP[X\\$^,$;^P];T_5!L!,8*;@#@
M'*/L<@C&1C)&>_%?.8O+,QP+7UC 8F5.6TZ,.>G#;WI->['>_P 5VK]T?H&4
M<4<+9_3C++,_R[$3J).C1C74<1.3M92HSY*D7VYH)]6FKL_S:M>^%:V5S-#<
M6%[I-[&Q22UN89K::)\X*R03HCH01AE*AEQR,UYKJG@75K5RUN1=1X/16# \
MXZY!]\'@GUP:_P!'GXL_LF_LZ?&ZWF@^(GPB\'^()YPR?VI)HUI::O$6#*7A
MUFPCMM2B< EE87/!R<$CC\GOC3_P0I^$WB![S4/@W\0=?\#7DGFR0:)K\47B
M70@[$NL4=PHLM6MX^54;YKQ@JC@G)/)3A*,^9RIJ-OAYY*INOLN#BNJ=IMM=
M>A]%]5J4K+$U\/AG)?NW4E*<9[6LZ4)2C?9N44DW9O=G\75Q87UHQ6YM)HP"
M<DQL$'(YW8 &??ISTZU5(XZ$<XY _0^V/QS[XK]T/C?_ ,$DOVO?A1]MNHOA
MY!\2_#EN)7DU;P+<P:M,($#.9)-#E,&LH"HR?+LY0"54,S#)_,#Q?\*I-$O9
MM)\0:%JWAC58)'CFL-3L+C3;F*12597M[J*.12'! !"D8(QTK;D4M4XKNG+5
MWMLFN^U[:Z,5*E4<9O$8;$J*?NU\-%5:#;^%SJMKD3=GUTOK>]_FUE/! XP.
M1W]__K__ *J0*3T%>@W_ ,/=0M]S64PN8QD[#]X8^F1D#@<X.#WKDKG1]2LB
M1<6DR8_V<@XY![\>^,@].]-TXI-N73I_P5O_ ,-H1:*;36BLM9+ROLG=[];?
M(RR".#25...,$$=0V0>?7/K[4$$C .#VYQ^?M7,YJ]K:7WO_ ,#_ (<5X](O
M[]]NEG^?4@HIS#'^?R(Y/4=?0_44T_=)]OZ'_"KW)=KZ*WEN'2H,GU/YT<GU
M./J<4E !1110 4444 %%%% !1110 445')V_'^E TKM+N2[AU!!X _$8Z>_'
MOGW!KT7X7S8UZXB! $MG(0&[E&4@>^T9'?N1C->8KVY/WC_,_P NU=O\/YO*
M\1V/)!D:6+CCEXFP,]<<9QQ_456=HI]M>KV:_KNSH<N:,4DMNO7;1^6B?6S_
M !^AYRR@G/7V['IVX^G?Z9K+:.3S(I8+B:TN(9!+%<V\C131NI!#QNK!T8-R
M"",'!S6S>1[<#&!@'ITQD$'W'0]!@^YK%F.W(!//H>,Y/Z'%8TJN)P]6.)PM
M>5"M!IQG%/2UDK>GX?,Y\5A<!FF'G@LRPD,;@:BY9X:HDX3323OHT[^5GM:W
M7Z>\ _MB?'[X<+'90>,&\5:2NQ5LO$\":D8XUVY1+U@+V,;05V_:& !Y' Q]
M6Z9_P4TU"UTF;^V/AM%<:\+5H[6>PU5DL1<NNU99(IHI)4C#,69!(W V^]?E
M9E@>I&./?\>,Y';T_E"V<^H)&2>YZ#).!GMP1G/)S7UF&XZXEH1C3J8Z=:%D
MJL:EG[7U=FUIU3U/S+&>"WA[BL13Q-#**N!G2JQJPIX7$U(46N>,I4YTD_9R
MB]5?E4E?1ILV/$>OW7B/6]5\1:@G^F:Q?W5_=!<<37<KS/CH<*6*C)'0Y%8,
MQ7' ZC//'7H/;TQ[CN.7R<#.[D^G^/N/ITQTXK/<D;CZ<?KC_/;VKY&K*=7%
M8C%.5GBIN<X*]N>][[I=>V_8_583JT9RHT_90P?L:%*GAU0@ITE0C&*<:RUL
MUHXZ6]"O(<-^IQSQ@]<>_J1Z^]?-/C'!UV_(Y_?OR/J<_KUKZ2E)#/@D8''_
M 'R#^G;VP*^;?%(']L:B>_VB0_F<_7O_ "J3?V?+3F[WNHOT2:_.^R7S.5J
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MN(T!R2J22D=!G@5]A>$?C+\+O'!B;P]XRT:[GF566QEO(;34$+#<$:RNFBN
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MQ<4];NZ9_5QX<^*_@+Q8JKHNMZ==O+@^1)<0I<KNXPT,A$@Z]LG.1FL[XD_
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M8Y'7M_CV%;7Q;0GQ<Z\#9;0@8/J6_'/?UX^@K/\ "]J\UQ"N"3O7IWY!QW[
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'K7BV7.D]%9O?_#W_'YG11DO9;N_,HV\TDGY;]5VTZGG[6TXDF1(\_*2RG@
M9XQ]00??-97D/<YMDMY%DW%5(3(XXX/OWX],^M>XVWPUU-G%UJ$K6Z-R\"\R
M$<85N?EXP,#GV[U/=Z!;V)"6T2G .6(^8\8)W$<DXZ\>@X-6DGY]E=;:=G;3
M;SZ;%.45;9WM:[2OK;JT_P#AMSPNQ\+W$,C-=,"C$G;D[O7DG Z8YY^N<9Z$
M:5;6\99 58#/!R,GCV]>OU]:[&\ACVL 0'4XP.<8X.!^A_QXK&E@D9&4 @GU
M'Z'Z?7']'&*6MG=.RO:ZV^7G= YPV<DK[J_EULWW_P C%2))8PKJ2JM^!(Y
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M7'!N)!N2$'L,L_7Y>A'R=XO^)_B;Q67AFO'LM-+,%T^SD>*-D)) N&!#3G
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M2,0ZQI9N%VY .ZYM;4*&RQZX^\O#/C/PGXQT^'5_"FOZ1KNFSJ#%>:3?6U[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ8J(USX@U2(7$YF!#$Q"3(55;[H"JHP>#DD_=JJJ*J(JHB@*JJ JJHX 50
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ME1U)*CY<GL:_6GX6_M@_LW_&2UM[KX??%WP3KGVA8V2WCUW3X[O]X 54V[W
MD#<X(V\'CM7^6YG&!D$8)/4G^9ZY[X%=#H'C3Q7X5O([[PUXFUSP_=P,&BN-
M)U2\L9$8'<I!MYD&[(R#@X].:R^JR:O>VVROV3LE?OWOMW-85:FO,HO56M?;
MY)Z^=DO+O_K(P7=M<H)+>:*>-N1)!*DT9!&00\;,#GVS5@$'H1_7\J_S<O@C
M_P %;?VVO@;-:KHOQ;UGQ/IENT>=+\6W$^KP/&A4^6'GD+HI"[>">#^7[/\
MP(_X.4KU%M-/^.OPJCD"B..XUGPS.VYR%P\IM9.A)^; )'8G.:SEAYQ5]&EN
MU\ORZ]/,W52+[KY/^OGL?UWT5^6?P*_X+ ?L3_'%+*VT[XG6?A;6;O8O]D^)
M5>PDCED( C,TB"#.2.0_\CC](?#?C?PGXOLHM1\,>(M'UZRF4/'<:9?V]TCJ
MP# @QNQY!'51UK"S6Z+3OJ=713 X[\?K3\@]"#0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK<S5I7;M:[5MTNEM%M]VQ^>]YX &\JD&[D< 'V]CC''Z<@<U6/P]B 7SXXT
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ME^_Z?_7JWY?^R?UI/*]F_+_ZU 7AV?X_Y_U;T*FP^H_7_"DV-Z?J*M^6/?\
MS^%)Y?O^G_UZ ]SN_P"K>7]:VZ%78WI^H_QI,$=C^56_+/8_T_QI-C>U <L'
MM+[_ .D5**LE3W&?UII5>X_I0')?9I_UY7*Y /4 _49IAB0]B/H?_P!=62@[
M$C]:;L/M_G\*!.,ETOZ%4P^C<>A';GN#[GL.IK!USPOHGB.U>RU[1].U>TD!
M#P7MM%<(01@C$B[AQ@<'H!Z"NFP1V/Y4E!)\O:Q^S!X(+M<^$+[7O =X,LD>
MBWTLFD[S\P\S1KTSV+*3U"Q+QD# .*\^U'X:?&KPKN:S.@_$'38SN#P.=!UW
MR\XP+5_-T^XEQDGRVM@2>,*<U]Q4PQH?X0/IQ_*G"3IRYHI*6U[*[7:]KV:T
M>NVAG[&ES^T]G#G>\U&*EHT[\UKW5M&[_=H?GO\ \)]::;.-/\8:1K?@Z\9@
M@'B'39K.V9V.,+J2B73V!. ,W*9'(P 372PMIVH1I<VE]!<PLH97@FCEB<
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M_P"8S_A2&(>WY8_E0!E&$]LC]?Y4PQGIP?8UJF+V_$'_ !/]*88R/Z9']?\
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M5D=$'4^@S7[!?"/]M;]F/XW6UM/\/?C#X-U::Y1'33Y=:L+745W@$*]I/.)
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M>] &0MLOI^I)_(<&I5M@.BCGV /ZG^E; M_;KUS_ /7.?T_"I1;GTR/QZ>V
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M"!2;O1[M;A0 -^Q'_>?-U & W!/ZUZ!IVJ7FJ:79:WH]W<PBXM8C(8)7PLP
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MY_R>M9224FE=I;7W(>_];]?Q*:+N8=2 >>_'T_#^=7<#T'Y"G",$C@KUR<8
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MRKG;CJ?H/YUT<_1O;_"N=N1R?7_#!JR7O/S2?X-',7_4?[@_F]<G>C*D#_/
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M?YX_G72DEHDEZ&B22LOQ=_(R# .S<>XS^N1_*G+;YZDGZ#'YDY_I6IY+>O\
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M5(.TL<X!YR1C/3U'/3!QGR;2?VBO VN%8;V:;P_>%,-#JT.R#>1@JMY")("
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M5W[Z'=@O$_AG$66/EB,JJ-I3>/I.C",O=YVYQYH)1=[N4UM]WY#?$G_@E_\
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M$C_@ES^S-\1!=7FAZ3J?PZUBX1FCG\)7HATQ9F#;)'T6^BNK3:& W16KV@8
MJ"I.X?G-\5_^"/?QH\-O<7OPW\0>'_B%I:^8T5E.Z^'M= Y(C,5Y+)IT[[=O
MS1WT>XDC8N!43J82,%-8RC4>B=.":G&W\RLM^ZO?JUU]*=*$:?M%4523VP].
M,E4DO=M4BY14'&[>B=U:[5FF?@&L$FY@Z-$0<D,#QT&#D#H.>#G.*M" !1SN
MX]_PQ_\ 7_ 5]G_$W]FSXF_#&[>Q^(WPX\2>&) 6VW&J:5/;VDNW^*WU"-)+
M.X4X)#0SNI!![#/A5]X(B!!MGDMRW\,B[HSZ>C <XZGC)QR*S4_=C)TZB4_A
M>EGINM$[/^GJ1"CB%3<ZN$JTHQ5TZB47--JUK-JRV5[777OY.(V'&>..I'7I
MV_3_ .O4BQDGK[_YS75W?A35;;+*BW*+U\LD,0<]FS[Y )]B*QOLTT1*R0/&
MRY&UU(S@8R<\=ASQSGG!K?V;4/:)^;\MO/U_RW'"$ITG4C&T8NUI?%=V5UUO
M_6VU)(]ISV]R.W3I4W6I&C<9R.G7T']>/QIJ*68!>HYR.V._;]:R,1YA<8Z'
M/IGW]O;_ #UI@R&  Y!Z'U'8^WK[5?VGT/Y'_/\ GO28YZ<]#Z\=OPYH#3O_
M %I_P5\@HJ78/4_I_A1L'J?T_P *"K1_F_!D5/3J?7'^?Z4[8/4_I_A3E4+G
M'?UH$TNDK^5FA:**,_YP#_.@04S8.>H]._\ G\ZDSVX_(?SQFDS_ )P#_.@:
M;6S(PG/4X_#^>>WTI^0./R _P%+2$ ]?3'4]*J*N[/;KW!MNUW^"_P" )N7U
M_G3&VDYW?H3^52!0.@HP/0?E6GLX=Y?<O\RTDMI:OT\O7^OQBPO/)'ID?X?_
M %JD!  YX]<$9]__ *_2EP/0?E1@?3Z<?RI>SCT;O\@EM\5_+37[OO\ ^&N0
M45-L7T_4T;%]/U/^-='.DDM79+MV]04TDEKHK=/\QJ8P3W_I_G^524Y$'/IW
M]^O?-2;%]/U/]36<G=M_UL#CS7DM+[7^2\_/^F0T4HY('J14NQ?3]3_C2)46
M]=-[$-%3;5]/YT;%]/U/^- ^1]T*H&!QV%+14B@$=/8__6].M!;?*EUM9?\
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MX(]>/R)QG^?X4!J^[^]]O^!^!S(LQCG/Y_\ UQCZ4\67L?Q _P#KFNJ6P/?
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MVX[#Z5Q%_!M9@![#CCVYZ YZD9]A7,E[SU3WOZ:6M\]/)?(R?]6.$NH&YST
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M2_;KWV(4KIW6M[Z7L]EK:_S5K/U/R3U#X ?$]=W_ !(7)7/W98W#=L*0V#Z
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MU^.'PT_;^^&>KO;P^+[#4?#,S,B>?'$=2L0Y(4L[6^;A$ P26A; K]-OA?\
M$7P%XZL(K[PKXITG6$=%D,=G>PRS(K+D"6U++<1. <LKQ@@\8STZ,'CLYP?*
MWF4JZA;EBY2=DK-*TM&M+---Z;HX<SR7"9M!0QV!R.M!045;#TU4:M'23Y;M
MK17W9[Q;6OV-XYM*FFM+F(AEGMI9(W# Y!!4C!R/3MD]#7O_ (-^._Q+\+K!
M"-;;4K>';BWU,"Y&T8^42$++QT&6/4'GFO!K*1B<Q['7(ZGG&0<CC...3U]<
M]*Z>TD@.&F4-C'&.2<X]QGIT'X#BOHZ?&,JD:=#-<)'%THIIP7+S6;6[DM-'
M\KWZN_YKC_"C)88BMCN&\9B\ES:M).K*-24,MA-)*$Z5&$DE"ZO..SLK]#]
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MF?1Y"68LRM8KGD9'&/C/P9^T-\0?"C0O8>*;VZMXL*=/U,O=VYVD?*!*Q<#
M !5QC/' VU]B>!OVUV*PP>+O#X&[:&NM+E#IC!!;R)<E2,9P'/&5/'%5+@W$
MM5*V6XZEFM!I2]C2FH>QB^7EE*-64;MIO2#G;[[]N$\7\MP]2%/B#+\SX=Q]
M6?L:WU^A*OAZK27-&,\*ZRY5;_EY"GJUZ'YL_&#_ ((C>-]*BN=5^"_Q!T?Q
M= ?,ECT/Q5;_ -@ZJ(@,K%%J<#76G7,O 0&6.Q#'GY17Y<?%W]B?]H'X2I/-
M\0_A'XJL-.@<HVLVNDSZIHAPP <:QIJ75FJ.V"&>5,@C)Z8_LP\&?'GX8>+E
MA2Q\1VUG<R@ VE\_V297)^[B3:I.>F&P<]^M>WV\.G:M"49;+4K.>,J498;F
M&9' R&0AXW4]P01@C@"O Q> QN#<H8G#5:4'I=PDWNMFDNR:2N_(_2<%GV4Y
MOA8U\MS+!8FG/E<HT*]*4FW:R]FIN<=?LM)IZ6OH_P#.FU'P#9L70++:2@XP
M$)".3_&&VG'4D$ X_$'B[OP1J%F[-"5N$ ZH#N(!SRN3@D=NA]S7]]GQ;_8"
M_93^-$=RWBOX3:!I6JW.YF\0^$[6+PQK0E8?ZU[C2XXK>Y;(!(N[2Y7()(Y.
M?R\^,'_!#/394NK_ .!_Q2DC<EF@\/\ C^S1U'S9$::[I$*$84X4S:6<D#<_
M6O,E4I+3FL[7=XRBTM/YM^K=[6[WO?T53DK.5H1E]NJU3A%63OS2:C;7OWOV
M/Y.KBPO+8XFMY$ZG)5L8'?D=/\FJ8C5NC+N.>,G(ZY_$>F/3&:_7[XU?\$X?
MVI/@W'=WGB;X6WNOZ';JV[7_  B8?$VG"-1\TDBZ=YE];(!DYNK.'  )Z5\!
MZQ\.;5;F6"ZL9],O8F9986B:"6*0$966*0(RL"2""H(QSR.';2Z::=M5=[VU
MT5[:K9 Z;C%2;3BVDJJE%T'>UK54W"6CN[2=K]TSY\(9<<9[9/7V/N!GG\QW
MI<8Z]#^'\Z])OOA[J*N3:/%*J\[68*W SCDG/TZ<XX[\C>:-J%J[)-:2J(R0
M[;20",C.1Z>W')Z\8J47&*<DDGL[Z]/-KR^=_1RI2CUA)].6<97TOI9WTZZ:
M:WL8E'^?\_Y_I4CIL;!RO'1L_P!!_P#J]:!$S?=&1_3\L4XTY22:6C_K]2?9
MS_E?_#C%&3C.*?Y8[D_R_P :<J$'U(S_ /7_ ,@_CSBG5,HN+LR7%Q=FK/<A
M8 ' ]*;4Q4,<].,<?Y_S[4FQ?<_4_P"&*D1%2]A]3_):DV#U/Z?X4;!P"3UX
M^I_#VX_^O5TU>5EV_5 ,5=V><8IWE^_Z4Y5VYYZTZM36,%;5*_S_ !Z?H1^7
M[_I1Y?O^G_UZDHH'RQ[?F1^6.Q_S^E'E^_Z?_7JP(_4X_#_Z]-92OXT"2@W9
M;_/_ (9C H'2EIRKN]O\_6G>6.Y_I_C0.\5IM\O\D0! #G]/>GCD@>M2&,=B
M?QY_PI=@!!R>*!*45MZ[=>W]:">7[_I_]>CR_?\ 3_Z]244$<\N_X+_(C\OW
M_3_Z]/ P,4M% G)O=A1110(**** "BBB@ HHHH **4#)Q4@0=^?TQ0!%12L-
MIQUI* "BBGJH()/Z4+7R]1I7=OS&45+L'J?T_P *-@]3^G^%.WFOO]/\_P '
MV'R^<?O]/Z^3(J*EV#U/Z?X4;!ZG]/\ "BWFOQ\O+SZ]F'+YQ^\BJ0)D9)//
M^?>EV#U/Z?X4\< #THV[?U9_U\Q-6OJF_+56_JVWF1L@ )Y_R?I357=GGIBI
M2,C![TBKMI"TU]-/6Z_2XTQCL3^//^%*$ P>>*?10.^EM/N5_O"BBB@04444
M %%%% !1110 4444 %'OSU[=?P]_Y<9IP0D$Y'^?U_2K5I:2WMQ!9P1R37%Q
M(D4,,*-)+--*P2.&)$RSRR,RHB*-S,R@9IP7/+DCK+31;ZV_1W_X<KET;;M;
MYO[M-KJ_:]M[V]%^#GPI\5_&OXB^%OASX.L'OM:\4ZM;:;;XCD:WM())$%YJ
MEZ\:N8-.TVV\R[O+EQY<4,99CD@'^PSX8_"_P?\ LW?"#PW\+?!T,<-IX>TU
M%U#4%4)-K.NSQH^LZY>$$E[C4+L._)Q' L4"[4A45\H?\$]/V0(_V7OAU<>/
M/'NF6P^,7CFP1[L3K#/<^#/#LRK);>'+:8*_D7]X-ESKDMO* \@@L6^6U<2>
MZ_$SQG*_GVT<QR7?>%;/()PO3/! XQD]#CFO8H16#I2K8B"A%6]YM;62U_%V
MW[ZZ+&NW.U*+3J;I:IM63MW>SO\ --*[M+X)^(4NG?%[P;>13LKKX@L8O,4C
M<1-<(G8GJVT[2#]TXQ7]+>FW*W>GV5TC9$]I;S9'K+"CGTY^;FOYHOV<OAZ_
MBCQ/+XSU>)O[(\-LMQ"S [9;V-A*FW/41!6=\'C(_#^B[X=:A_:7@GPU?!L_
M:M'T^8'/)#VL3+WS@*1CVQ7S>(S"EC\14=*7,J=HW6VJV6EM+:^;MT/3PL*E
M.E&-2/([7L]UHEKZ]-MM=SOPY[\_S_P_E4@(/2J@?U_/_P"M_GZ5(#Z'\JR.
MDL45&']?SJ0$'D4 2!_7\_\ '_ZU2 YY%5Z4$CI_GZT 3T4T,#['T_P]:=0
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M>HXKR\F:GA%7M:51I-65THK1-[M^]=WZGH5%:I*SNK*VSU:U_K8ZA9 >O/\
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M^B:U;1WNDWEAJ%G.H>*ZLYH;B&16Y#+- TB.#D'<&[G!/:U+'-&0(U4I_"<
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MA8D _05^8&H1K>:CX-T]QE;WQIX5B(/(.->T^49[''EDCZ<=*_3V)UVJN>@
M'3H!C_\ 417U.2J^ I]^:WX1WTTUVW7>UT56O&J[WUZ>MNG6ST[]D:"L1]/3
M_"I001D535\<'IZ^G^-3 D<@_P"!KU&K:,E.^J+2OCKGCICJ*M*V?K_/_/\
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MWH'!)9XB"R]L$KS@5W?PF\:0>--$B%QA=5L EI?P' 8RH@ G"9!*2;21WRK
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M*B,C# #*47'MBO\ 2A272=0MPT<]E=P2CY2CQR(X8=,C.\'IC&#@#@8KYO\
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M'GRQ@8&"&'7L3]?V_P"X18HP(HD4* %  4+M"C X 'I[#BJL<$%NBI#&J(H
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MY+T>M[2TMTOHOQ7]=N7N8=RD8&><9]/K^/'///M7.W$7)..1]X=R/7ZCH?\
MZU=E+'G/JN?;_/J?7^>-<V^[+*.>01UY/'3I]?Z<5#5GY?II_P ,_*SU:8D[
M/E?7\^C^>]UM*_J<A-#U(Y'KCZ]?;DY_/ID#)EM^25XZY'^'K[?AU[=7-#U(
M'U7U]U_P_+GBLZ2 -DC_ .O_ /KZ<]_2EOM?2VVK2TT:^U'L];^?5-.+NGOO
MV?KT3[WM>]TUL<I) &.6!'7IC&?4@@]S[$Y.:J/:>F#V]\?C_CQVKJ7MP<Y
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M_P![_P""MM%:.C5P2=TY/^O);7TZ7OV3*$-MG'R_11T_$]\9Z#/'MTVH+0
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M++<32I##'&C222S3,$CCBB0,\C.Q"A54LS$  G&/V=_8W_X)/>+?B2FG>/\
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MTM(L EYY-H,EU=3.3)/=7#R7$TI9I96+#'C7BSXAO<>>D;L0Q;'SXQ\Q YR
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MMOI]YB);#ODY]!@?B<?UJ[%:,<87;ZY!'ZGG^G;-;"6JCH@R.YY/Y_AWJTL
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M],XZUCRQ[&/'RGMZ'N/\/4?2NJGBZ\?YQ_G'<C(-8\\/4$9!_4=OQ';U_#%
M&!(GI]1_A_GVJC(F<^_7V/\ G_/-:[H02I_ _P B/\^HJDZ=>.G7W]Q_7./6
M@#AM<\'>&/$431:UH6FZ@#G+3VL9E!/=9D"RJV>0RN#GD'G-8EOX5\1^'K9(
M/AU\5/BA\-O(;?:P>&O&.K'2X'!R!_8^HW%YIS1[L$QF )@8VXKT>1/3\/?V
M)]?\]^*K+GD=>X]?_K_S^O690A-6G&,D^Z3+BUK%[.W?7;33IV/$O$O[5/\
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M_#([GW]JC@D2=Y8&0C:QP3P",=!SSTXX[U?OB"T'R$JS@OGH,_CSG P.<>V
M#1DC$ETP5O*< ;-OS*R]O0 #&>?7 XS7G/=W?7KIK>+LO6U[-)OIIJ2VVVV]
M6_ETZ*W;Y._SK"WD>>6W0[E)4JI&,>I__5CUYQQ%? V;);.H+R#&%(X![D_I
MR1C@#KFGW3W"G:@*O%(I,J<,ZG)(/KC'//!].:H72)-+]H$C,Z;0ZL2?48.3
MQUZ=?2HEZ:6LKW\GIUOT?DM[[;P:Y$]^OE:_WK4IS6,4LPF7#&!&5BK9P.#M
M)'0\="2.3SW.5-)$8I#:KS&QWKDC//.>OXG//3//.@9!$)UBB,2S-ND89RP/
M4@Y_^N3[$8H2S6MK#((8Y)9)B,XSCEADGT]>H]^!4ZZ)6:]+OH[=^K\K[7%*
M?*U%I.^OF_+:]O\ @O;4BC4O"7$9)QD\@\C/?.>#@#./QXIL5A)< W,\GV<1
M?ZM"N6..I.>F<],YY'0'%551@Y;S7A51N*;AR".G<<8)/OV]/T"_8O\ V$/B
M5^U)K\>KWL-QX?\ AK9NIO-=NT9!=J,,T=DK%3*[C'0$?,,M6U.$Y-\\N6-M
M[;7=NC=WZ=1TY<S2Y6]'MKIU;>FBOO?KZ'RA\(/@_P"/_C=XML_#7@K0K_6;
MF>9(1+;6TSV]L)'53+.\:%450V268 8YXS7]0/[%G_!-_P %_ ;3M/\ %7CR
MUM?$/CR2.*Y9)T\RWTN5T5C&JG"M-$S%2<#!!X'!K[)^ ?[,?PG_ &=/#EOH
M7@#P[9VURL:K>ZY-;POJM]*!\[R7.S>BLW(16  _&OH6M8TU&W6WW7T^73MU
MV6ITI12VN[W3>MMM$GY[Z?>-15151%5$4!555"JH'0    #T']*=116@'#^*
M_AKX$\<6YMO%/A;2-70@XDGM52X0D?>CNH/+N$<?PLL@*GD$5XE=_LVW.B22
M7'PT^(7B'PPI!":%K;KXH\/ #.$CAU)I+ZT4#"C[+>184#:, @_4M%)Q3W2?
MJD_S$TG\23Z:[V[)]-#XZND^-'@Z!QK_ (,A\5V<'+:MX'NQ=7,J@C]X^@ZD
M8;I#CK'!=W#$Y"C) JIH_P 6/!M_=?V9J5^_AS6 2K:1XEMY] U#> <QI!JB
MVZS' (/V>252!D%L#/VA7,^(?!GA+Q;;26GB7PYH^MP2 AEU&PMKEAZ%9)(S
M(I'7*,ISWK&=!2=^=KT2VTLMEUN];[OH91PV&BW+V34FV[JI/=]6I2DO_ 4N
MSWNO'HGT^Z4&#RYB<;'1N.1\I)'!SP00>>F>12?99 Y*M@C)VD9!)[=>,#IC
MT_ 5M2_9QTNTF6\\ ^,/%?@F>#)M],AU!]7\-9Z[)-%U/SXUB)_AMY(64?<9
M3@CG;G2OC?X.,C3^'=%\>Z>FYGO/#E\=+U4JI.TC1=5DD@E<@9(@OXE)/RA<
M#&'L\70J.>&JR6UK3<7I;3>RZ[:O=*ZLQJK236$5"A[3W:TO8QJ3FM%=WCJ[
M=[N^KOTWYK&</YC_ "$'(,099%Q]TA@0<CMGKR<]<=#I7B/7;)1'%?M)$APD
M5V#(  ?NJYPX!X&=Q /'.21Y%!\9?#$5U%8>*EO_  ;J<SK&+'Q5I]UHSEG(
M0(MW<1-IDNYB K17K=0>,YKU*%=,U&&*:SNX94D42*\$L;HX(W*5DC9T8'U!
M(/&"0*]7"\29WELH_P"WXB&TE2=24J,GIK*#ERRT[IOIMM\MFO!_#V=TITLQ
MR? XN,W>K+$8>#JNJU'FJ0JQC&=)OHE:VGE;USPY\9]?\/RQRHU_ITJD9NM,
MN9%. <[BBO&<=SG=G'?-?6W@#]LWQQ911PMXA@UZV7:OV?4UACO8Q@90R*$D
M)4 @%U<DX.XU^>LU@0@4L<X)X/IG&3G^@QVK&6Q>&5F1Y 23AE8KCCKD$8]S
MSCVR*^QPGB+]>2PN?99@<TH*/^SU$GAZM"<G'FDZD(MR32^!VWO=:W_-,1X.
MT\HJ5,5PGQ1Q!P_5K-R^IT,1]9P$K6Y(?5YR47%7?Q.:1^[O@G]LGPGJDT-K
MXKMY]*9R T\9%U K' W$J!(HYW XP,=*^I/#7Q(\"^+(\Z#XDTJ]R1F"*\MQ
M,K'L\#.) 0,@@KD]^1BOYF;"_P!>TUV>VU"1TSGRYF=U'L0S?*.G(..<^I/:
MZ+\4=?TNX5@D\,T9#"ZL;EX9$93PP =#D<D$-QSQSD>BL'PCF<55^NO+*DXW
MA3@E646[-)IN,FME\2:5M&CAIYMXM<+0J?6N'J7%> IR47BJ*>'Q\H75IPA#
MVD&TMXQI-O\ FZK^E75-"T/Q#97&G:II^GZI87D317-K>V]M>VD\<B%'26WF
M22"1'4D%61@P)!&.OY]?&;_@E?\ LB?&!;BY;X?1>!-<F>28:W\/YY- F,TA
M8L\VF#[3HD^7<N0^G*S'A7& !\H> /VQ/B+HLL-M%XC34HHV13::X'G.P'F-
M9)'60';E05<D9'6OM/P?^W'H=TUO#XKT*YMF=462\TR1;N$.<!F\IRD@4DY
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M4*?>'X_R-34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P _G5NFE ?8T 4&C'<8/\_Z'KS59XL<C_ZQ_7BM-E(X(X-0LGIR.XZ__K%
M&8RYX(_Q'TJ%DQUY'^>OI6@\8(XZ#\Q],_Y_I6*D<'_ZQH H.GMD?R_K^-49
MH>"1]1_4'_//;TK79<?3^7_UO\_6LZ8SQP?T_P ^O]:J,FG^&O\ 6WY;KJG+
M75;WOI^?;U[]>C7-SP=<#Z]^O^/Z_7KD2Q%23CCN._/T]NM=9-#Z=_\ ./\
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M>RUUW5M_GIJC.DDF(CAW9B=0>F=N1G&1G/4^N._MFZA>6]C9[))%B429\Q\
M$G'RDDXR>F.I[5I-(J20H,R22R+#;Q("\TLCG;'%%&H+,[$@!5!R>*_6C]B_
M_@F5JGQ=GT;XB_&BQNM*\&13QZCI^A7">5/JP"AX1/$X+"'#*WSH,C  [F/9
MRW<;.]M5JMNO6V]VFMMMRH4Y3>S4;J\NRTUWU]%WLUN?#O[-'[&OQB_:?UF%
M/#6B7>D>$?.C6]\6ZE;S6UBL9<"1[,.@$Y"Y92" 2IZCFOZ7?V6OV _@U^S9
MI=I=6^DP>)_&ICC>^\2ZM$+B9;G:/,-K'*66)0V0I R!@   8^Q_!O@?PSX"
MT*R\-^$M&L=#T>PA2&WM+&WB@0*@P"PC5-S'J6(YR3U//6! .O/^?3_'-:QA
M%6NM?/7U_'[[ON=M.FXQ273[3W>ST[?)=-R%4  55  &  , #T Z >W0 >U2
M!#WX_P ^U2@>@_(4\(3UX_G_ )_&K-.6*^)_+^M2'RQW)_E_C2A5';\^:G"#
MW/\ G_/>I!&>R@?E^O>@.:*VCY_/3O?_ (?[RN%/8?D./\*78WI^H_QJT(R?
M_K G_"GB'/K^.!_2@7.^B13V'U%+Y?O^G_UZN^3CL/U/\Q3O*'M^5 <[[_AZ
M>:\_ZVH>7[_I_P#7H\OW_3_Z]7_*'M_WR/\ &CRA[?\ ?(_QH#G??MT]+]?7
M_@=,_P L]B/Y?XT;&]C_ )]\5?,7LO\ +^0I/)^GYG_"@.=^OJO\BAL;T_4?
MXTTJ.ZC\15\PGW_0_H*88F'_ -<$?XT!SOJE_7]?U;6AL7W'^??-)Y8['^O^
M%7C&?0'WX_K49C [$?Y_6@+Q>\;:]-NG:WW?YE/8WI^HI"".M6_+/8C\>/\
M&F%2.WX]J Y8O:5O6WY:%:D*AA@@'_/KUJ<HI[8^G^<4TQGL?SH$X27GZ%&:
MSM[A&CEC26-@08Y466-@000R.&!!!P<YXKQGQ+\ /AOX@N'U%=%;0=89B_\
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MUU[U2*>W+V_IZT+Q;X:\2P++I&M6%^LJY013PR@@].C9YY&,=NO%9/C+X9^
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M^O\ K4ZJ![G^7TIX4G@#C]!4BH!R>3_*@!%3N?R_Q_PJ0#L!^ HJ55QR>O\
M+_/^?< %7')Z_P O\_Y]WT4 9X% "J,G'Y_2I^E(HP/?O2T %%%% !1110 4
M444 %%%% !1110 A&1@]ZA(P<5/36&1[]O\ /O0!#4##!]NU3TUAD>XZ?X4
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MQD;=P]1SG\.OZ5 8QSV]CT_'O70O;^WOSP?\?YU4>W!S\O/<XQ^.0/Y_CZ4
M8C1>WY<_I_ABH6CSV!_0_P"?QK7>W8=#^?\ B.,_E5=HR/O+^/\ ]<?6@#*:
M+_)']>WY5"T1'3C]1^?;\:UC&#_@1G_/ZU$T7MCKTY'Y>GY4 9)C]1GW'^<U
M&8_0X]C_ )X_6M5HL]@??H?Q_P#UFH6B'Y=B,T#4FNNGW_A_PQF[&^OX_P".
M*85!ZC!_(_Y^M:)A[_R/^(_E49C8?3W!']*"N?ND^_X?+O\ /MUH;!ZG]/\
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MBKQ#'\4-=T#2[J2"&\U*\EO)D8AGCEE.%#CHN"V['/K7PGX'U36_#OC*QN/
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MX)_WN!^0'^/\J LWLKF&EJQQD_@.3^0_^*JRMF,?=)^N!_/G]36ZEL,>G^Z
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M-\,&K-= X+ >7!*^<@8& N./T[_GUY9BBC0-R3\S>N3N[8(R3]<XSTK]5_\
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MBDP?0_D: (O+]_TH\OW_ $_^O4I!'4$?6DH C\OW_3_Z]'E^_P"G_P!>I**
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M?3V/J#W'0]1STR9X"N01]#V__5Z'J#^O4S0]?\./?Z?3J#TXK-EB'1AD=O\
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MOD#]/:B4@YY],?Y].OXU1+$<YQU.?KU_S^5&]GL[?=>U^WSZ]@)6D4DD=_\
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MC3].ME_=V=E;IA(HHQCJ[EG9C7FDD<@3>K!BN.O(QR1SGZ__ *N*: X) &,
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M.NWIW/MTSS_+/7M6A'89 ^4GV []:Z2.R.!A!SW;!/MQQ^!Q5Y++/7)Z9P,
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M\]/KU)Z53DM3CE<_K[=1R.OI_P#6[B6Q(R<9 Z$<_F?;TXZ]^M4)+,\\>_\
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M\/G)?U^1U%B,E/J<_F?Z"NJ@X5?][^>*YG3URR^P+?\ H7]3^5=1;C.T>O\
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MO^2HK?\ 8'@__3;/]N/H)?\ )@<N_P"RHXE_]2:(4445\"?V0%%%% !1110
M5^S'_!#?_D[+XA?]F[^+/_5E?"2OQGK]F/\ @AO_ ,G9?$+_ +-W\6?^K*^$
ME?2\'?\ )3Y+_P!AL/\ TF9^#_2>_P"3 ^*?_9+XC_U)PQ_511117]1G_/N%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!"PP?8]/\*;4[#(Q^50$8X- $;KW'XU$1D$>M6:B9<<
MCIW'I_G_ #[ %5EQD'G^HJM(GI^!_H?\_P!:OD ]:A9<>X]>QH SR".#43)W
M'Y?X?X?E5YX_R_4?_6_SZ56((ZT 5&4'Z^O^-0,F>".?\_F*O,N>G!_G]:B9
M>H/^?<4T[?K_ %^NZ$TGN9,L'7C],_\ Z_;N./>J$L&>W]?_ -?3IU':M]DQ
MUY%5GA!Z?D?\\_B?KGI5IJ7?2VOVE]RU7G]ZZDW<?2_RMHM&WIZ/3LT<Q+;G
MG@]3]"1[CZ'I@\]#5%XB,@C(]^?4'M_@0,\5T\D'J/K_ /K_ ,>1BJ$EOUP/
MT]N^?PX/YT[M?%JM+-:^E_\ /\V4FGZ]5L_N.9DM@W*G!]#T]N>O'OU]15"6
MWQD,,?AZGW]?;CZUTTEOC/'3_/\ G.1SP:J/%V89'TY_#O\ B#5+R=U^/W_H
M]>[&U?1G*2V@.3CUY SZ_KTZ8/TZUGR6Q&01D?\ U^GMTZ?G7726P()3\C_G
M'\OKZT9+?&<K[9QU'TX(]>..?>B]_7L]_P"O-:$V:_O+L]_O_P ^QR,D /0
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M.,D _7/KCZCGV[4P@8[>F.O;K@^O/88QGWI)3M..GIZ<8].Q[$<].F*13O)
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MJBBBBOZC/^?<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"?Y?GP :NQVGJ!CVYY]\\=/QJDDK7Z6UV[>K_"-O*XDY/I9?CT[_ .3,6*S
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MOEK;7K=^=LE)I63=EM]ZW?\ G?>VNXC,0,XSST[#^?3I3EW$;AP.O7V!(/\
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M8_U-9M6BO1O[W$AZS6O;3[W_ )??Y%I/O#VS5J/[V/7'\Q_C5=!R3[8_/_\
M55F+K^*_UJ#0OQ]_P_K5I/NC\?YFJR#@GWQ^7_ZZM+T'T_GS0!^-O_!<3_DT
MSX>_]G$^$_\ U6OQ:K^5JOZIO^"XO_)IGP\_[.(\)_\ JMOBW7\K-?SKXE?\
ME16_[ \'_P"FV?[<?02_Y,#EW_94<2_^I-$****^!/[("BBB@ HHHH *_9C_
M ((;_P#)V7Q"_P"S=_%G_JROA)7XSU^S'_!#?_D[+XA?]F[^+/\ U97PDKZ7
M@[_DI\E_[#8?^DS/P?Z3W_)@?%/_ +)?$?\ J3AC^JBBBBOZC/\ GW"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "FLH//0_YZTZB@" @C@TE3D ]:C9,<CD?R_P : (R
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MF>V]A].?\GGV_'BJ<EMUXZ?XCO\ _7']*$TNCC?[O\O5V11SCVS#)V[A[?\
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MU_+^O2X^5=;OUV^Y:&?':MW&T>_?^OYX^O%6TMT'&-QQ_G_))_E5Y+<GK_\
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M_+CN?3ZYZ'ZTVD_Z_KL*W1QMYQ^73JM.J>QR4MFIR2O7DD?AU&<?2LZ:Q/\
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MY#T'T/\ .LRRXG0_7^@JV. !Z557[H_SUYJU0!^-W_!<;_DTSX>?]G#^$O\
MU6OQ:K^5BOZI_P#@N-_R:9\._P#LX?PE_P"JU^+5?RL5_.OB5_R5%;_L#P?_
M *;9_MQ]!+_DP.7?]E1Q+_ZDT0HHHKX$_L@**** "BBB@ K]F/\ @AO_ ,G9
M?$+_ +-W\6?^K*^$E?C/7[,?\$-_^3LOB%_V;OXL_P#5E?"2OI>#O^2GR7_L
M-A_Z3,_!_I/?\F!\4_\ LE\1_P"I.&/ZJ****_J,_P"?<**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!"H/7\^]1E".G/\_R_P#UU+10!7HJ<@'J*C*'MS_G
M_/I0!$4!Z<?Y]/\ ]51E6';/TYJ;!'48HH JE0?KZTPH?J/\]JN%0>HJ,H>W
M/Z4 460'/;VQQ^50M%CIQ].1_B*T"H/!'3\*84]#^?\ G_"@#-*D=OQ%1E0>
MWXBM)D]1CW'^/3\ZA:('IR?R/^'YT 4"A[<_S_P_E494=QS_ )[]ZNF-A_\
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M?]7?3]5T20U%+SV\D[>2W^=R 1^I_+_'_P"M3MB^Y^I_PQ4X0=^?\^U.  Z
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M )]%K+A&6SSQ_P#K_H/SK;MT']/P]?KU[?X5#U45W:;Z>;O^91JVX_E^O?\
MG5]!QGU_I_DU5A&%_P ^Y_K5Q!PH]?Z__KJ9[_>_R7Z$06[]/79-Z^K_  +"
M]!]/Y\U<BZ?@O\JJ = /8"KT8Z>[?X#^E066T'*CZ?I4XY('K4*?>'X_RJ=>
MH^H_G0!^-W_!<C_DTWX>_P#9Q'A/_P!5K\6Z_E7K^JC_ (+D?\FF_#W_ +.(
M\)_^JU^+=?RKU_.OB5_R5%;_ + \'_Z;9_MQ]!+_ ),#EW_94<2_^I-$****
M^!/[("BBB@ HHHH *_9C_@AO_P G9?$+_LW?Q9_ZLKX25^,]?LQ_P0W_ .3L
MOB%_V;OXL_\ 5E?"2OI>#O\ DI\E_P"PV'_I,S\'^D]_R8'Q3_[)?$?^I.&/
MZJ****_J,_Y]PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,
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M';'\O_K?G5_:P['^?\J:57N/Z4 9QB(]1^1_ETJ,HP[9^G^<UI&/T/Y_X_\
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MJXK]'^*M?79O7O971$M;1[ZOT7^?2^AKVD73ISA1^?.>.A.!_.NKMDV@>BC
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M8/T)'XC'T[].?7&:^??C!9+J%Y\*M/=#(EY\7_ (= ,[A;:W;W?..RM ')]
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M!6@L"HJHD:JB *BH JJH&  !C  &!P !3UB/8 ?J?PZ_SK38[$DDDMDK%-(
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M.!R?PZ_T R.X]*V85).?0_X=O?@53@3:H]6[=O\ )Z_3'2M>WCZ?A_\ 6/\
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MW_LXCPG_ .JU^+=?RKU_.OB5_P E16_[ \'_ .FV?[<?02_Y,#EW_94<2_\
MJ31"BBBO@3^R HHHH **** "OV8_X(;_ /)V7Q"_[-W\6?\ JROA)7XSU^S'
M_!#?_D[+XA?]F[^+/_5E?"2OI>#O^2GR7_L-A_Z3,_!_I/?\F!\4_P#LE\1_
MZDX8_JHHHHK^HS_GW"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M? G]D!1110 4444 %?LQ_P $-_\ D[+XA?\ 9N_BS_U97PDK\9Z_9C_@AO\
M\G9?$+_LW?Q9_P"K*^$E?2\'?\E/DO\ V&P_])F?@_TGO^3 ^*?_ &2^(_\
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M& S#Z#MCZ8Z?CS].NE%$6(./I[?Y_(=^:=%"2<G_ #^/]?J!GMJ0P=!C_/\
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MG/\ GL"/Y5O3@Y/^>AS_ "-8EP.H[]/QY%:?:OWCOWU7Z6".R]#%NONK^/\
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MKW-*  /YGUI: "E )X% &3C_ "*F  '\SZT  &!BEHHH **** /QG_X+D?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
-10 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>nt10006151x14_ex23-1image1.jpg
<TEXT>
begin 644 nt10006151x14_ex23-1image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !: '$# 2(  A$! Q$!_\0
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:%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>nt10006151x14_graphic2.jpg
<TEXT>
begin 644 nt10006151x14_graphic2.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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MOF_ZZR]SWD8]S[]OJ<DDF*NE4FTO>[?8I_GR=OZZF7,OY7_X$_ZZ+[C\+_\
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M_A[M_P %"/\ I!]^V/\ ^'!^%_\ \JZ_=&BCV7][_P DI_\ R']>0<R_E?\
MX$_ZZ+[C\+_^'NW_  4([_\ !#W]LC_PX7PN'_N+-)_P]V_X*$?](/?VQ_\
MPX7PN_\ E77[HT4>R_O?^4Z?_P @',OY7_X$_P"NB^X_"[_A[M_P4(_Z0??M
MC_\ AP?A?_\ *NE_X>[?\%"/^D'O[9&?^RA?"[^7]E_UK]T**/9?WO\ R2G_
M /(!S+^5_P#@3_KHON/PN_X>[?\ !0C_ *0??MC_ /AP?A?_ /*NC_A[M_P4
M([_\$/?VQ_\ PX7PN'_N+-?NC11[+^]_Y)3_ /D YE_*_P#P)_UT7W'X7?\
M#W;_ (*$=O\ @A[^V/\ ^'"^%Q_]Q8H_X>[?\%".<_\ !#[]L89XR?B%\+QC
MW_Y!GH#_ $YK]T:*/9/^;_R2G_\ (!S+^5_^!/\ KHON/Q/C_P""MW_!0$HA
M_P"'$G[9[?*OS?\ "R_AH-W ^8#^S"/FZCGOUIW_  ]N_P""@/\ T@B_;0_\
M.7\,_P#Y6U^^,'^HA_ZY1_\ H"U+7)9]W^'^1NFK+W=[/=^6GY[Z_=K^!/\
MP]N_X* _]((OVT/Q^)?PS_\ E:?Y4?\ #VW_ (* _P#2"+]L_P##XE_#3^NF
M"OWVHHL^[_#_ ""Z[?*[_P"'[]>W9W_ G_A[=_P4!_Z01?MH?^'+^&?_ ,K:
M/^'MO_!0'_I!'^V?^/Q+^&G]-+-?OM119]W^'^077;\7Y=[^?]+7\"?^'MW_
M  4!_P"D$7[:'_AR_AG_ /*VC_A[=_P4!_Z01?MH?^'+^&?_ ,K:_?:BBS[O
M\/\ (=U_*OO?^?K_ $M?P)_X>V_\% ?^D$7[9_X?$OX:?UTP4?\ #V[_ (*
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M $@C_;/_  ^)?PT_KI8K]]J*+/N_P_R"Z[?B]=O7S^_RU_ G_A[=_P % ?\
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M8/Y5^^U%%GW?X?Y!==OE=^7S[]>OD?@3_P /;O\ @H#_ -((OVT/_#E_#/\
M^5M'_#VW_@H#_P!((OVS_P#PY?PTS_Z;,?K7[[446?=_A_D%UV_%_P!=_P .
MVOX$_P##V[_@H#_T@B_;0_\ #E_#/_Y6T?\ #VW_ (* _P#2"+]M#\?B7\,_
MZ:8?Y5^^U%%GW?X?Y!=?R_B_Z[_AVU_ G_A[;_P4!_Z01?MG_A\2_AI_73!1
M_P /;O\ @H#_ -((OVT/_#E_#/\ ^5M?OM119]W^'^077\OXOR_X/]+7\"?^
M'MO_  4!_P"D$7[9_P"/Q+^&F?TTPC]:/^'MW_!0'_I!%^VA_P"'+^&?_P K
M:_?:BBS[O\/\@NNU_F_Z[[WZ=M?P)_X>W?\ !0'_ *01?MH?^'+^&?\ \K31
M_P /;?\ @H#_ -((OVS_ ,/B7\-/ZZ8*_?:BBS[O\/\ (+KM^+UV_P"#_2U_
M G_A[=_P4!_Z01?MH?\ AR_AG_\ *VC_ (>V_P#!0'_I!%^V?^/Q+^&G]-,-
M?OM119]W^'^077;\7Y=[^?\ 2U_ G_A[=_P4!_Z01?MH?^'+^&?_ ,K:/^'M
MW_!0'_I!%^VA_P"'+^&?_P K:_?:BBS[O\/\@NOY?Q?E_P '^EK^!/\ P]M_
MX* _]((_VS_P^)?PT_KI8H_X>W?\% ?^D$7[:'_AR_AG_P#*VOWVHHL^[_#_
M "!-=K_-^7;Y_?Y:_@3_ ,/;?^"@/_2"+]L_\?B7\-/Z:8:/^'MW_!0'_I!%
M^VA_X<OX9_\ RM%?OM119]W^'^077;Y7?E\^_7KY'X$_\/;O^"@/_2"+]M#_
M ,.7\,__ )6T?\/;?^"@/_2"/]L__P .7\-,_P#IKQ^OYU^^U%%GW?X?Y!==
MOQ>NWKY_?Y:_@3_P]N_X* _]((OVT/\ PY?PS_\ E;1_P]N_X* _]((OVS_Q
M^)?PT_IIA_E7[[446?=_A_D%UV_%^7>_G_2U_ G_ (>V_P#!0'_I!%^VA^'Q
M+^&?]=,'\J/^'MW_  4!_P"D$7[:'_AR_AG_ /*VOWVHHL^[_#_(+K^7\7Y?
M\'^EK^!/_#VW_@H#_P!((_VS_P#PY?PTS_Z:\?K^5'_#V[_@H#_T@B_;0_\
M#E_#/_Y6U^^U%%GW?X?Y!==OQ?E_P?Z6OX$_\/;O^"@/_2"+]M#\?B7\,_\
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M?:BBS[O\/\@NNWXO7;U\_O\ +7\"?^'MW_!0'_I!%^VA_P"'+^&?_P K:/\
MA[;_ ,% ?^D$7[9_X_$OX:?TTPU^^U%%GW?X?Y!==OQ?EWOY_P!+7\"?^'MW
M_!0'_I!%^VA_X<OX9_\ RM%'_#V[_@H#_P!((OVT/_#E_#/_ .5M?OM119]W
M^'^077\OXOR_X/\ 2U_ G_A[;_P4!_Z01?MG_P#AR_AIG_TV ?K1_P /;O\
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MX[+T7Y!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** //)_P#7S?\
M763_ -#:HJEG_P!?-_UUD_\ 0VJC>7EGIUK<7VH75M8V5I$]Q=7EY/%;6MM!
M&I:2:XN)W2&&*-06>21U1%!+, *[X[+T7Y'.6:*Y32_'G@;7+M-/T3QGX4UB
M_D5FCL=*\1:1J%XZH,NR6UI>33,%'+%4('?%=7[=\ X]CR#]"""/K3NGL[@%
M%%% !117D/Q$_:!^!?PB\0>#_"GQ3^,'PU^'7B;X@7?V'P/H'C7QIX?\-:OX
MKN_/AM?)T&PU>_M+G4F-U<06JFVCD5KJ:*W5C-(B$;2W=O4#UZBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HK\B?^"FW_!9+]GC_ ()9>(O@_P"&_C?X
M$^*OC*]^,^D^+=8\.R?#C3_#5[!I]MX.O=!L-0356U_Q'H3QS3S>(+1K06J7
M"M''.9'1E1#^JOA+Q'9^,?"OAKQ=IT5Q!IWBGP_HOB.PANT1+N*SUS3;;4[:
M*Y2.26-9XX;I$F6.1T$@8+(ZX-2I1;<4[N.Z[#L[7Z'0T4?AG_Z_]?3WK\;-
M*_X+9?LV:M_P4F;_ ()B6_@'XNI\:5\9ZWX&'B^?3/"W_"O&U;0? FI^/KF?
M[6GB5]<^Q2:9I=Q:PNVBK(;QHQ+'' QE0E)1M=VOHGYWM;O<$F]C]DZ*/S_'
M&?QQ@9^G%%4(**** "BBB@ HHHH **** "BBB@#T.#_40_\ 7*/_ - 6I:B@
M_P!1#_URC_\ 0%J6O/-X[+T7Y!1110,**** "BBN:TGQIX.U^]FTW0O%GAK6
MM1MTDEGL-)UW2]2O8(XI%BEDFM;.ZFGC2.5ECD=XU5)&5&(8@$ Z6BL36_$O
MASPS##<>(_$&B>'[>XD:&WGUO5;#2H9Y57>T4,M_/;I+(J?,R(S,%^8C'-:=
MI=VM_:V]]8W-O>V5Y!%<VEY:31W%K=6TZ++!<6]Q"SQ3P31LLD4L3M'(C*Z,
M5() +%%%?,W[7W[7'P1_8<^ 7C?]I#]H+Q*_AKX=>"(;1+AK.TDU'6]>UO5;
ME;+0O"_AK2H2LNJ:]K=](EM9VP:*W@C%QJ.HW5EI=E?7UL ?3-%?B#_P2N_X
M+H? #_@J[\2?BK\,?A)\)/BW\-M9^%GA6R\:W=[\0_\ A$I=.UKP_?:W!H,1
MLV\.:]JL]KJ2WES$\MG<Q&%;<F07C2!H5_;Z@ HHHH **** "BBB@ HKBKWX
MD_#K3;NXL-1\?>"K"^M)I+:[LKWQ3H5K=VMQ"Q2:"XMI[^.:&:)P5DBD171@
M590016GHGB_PGXEDGB\.>*/#OB"6U1)+F/1-;TW59+=)"RQO.EA<W#0I(R.J
M-(%#%6"DE3@ Z*BBB@ HHHH **** "BBB@ HK)UG7M#\.68U#Q#K6DZ%8&9+
M<7VLZC9Z79FXD5VC@%S?300F:18Y&2(/O98W*J0K$4=%\9>$/$LLL'AWQ5X;
MU^>!!)/#HNN:9JLL,9)4/+'8W4[QH2" SJ%)! .: .DHH_IUHH **** "BBJ
M.I:IIFBV,^IZQJ-CI.FVH0W.H:E=V]A8VXDE2&,SW=U)%!"))I(XD,DBAY9$
MC7+LH(!>HKE-(\>>!_$%TMCH/C/PIK=ZZ&5+/2/$6D:E=/&OWI%M[.\FF9%P
M<N$*C')KJLCU]_Y?XB@!:*** "BBB@ HKQ7XI_M(_L\_ V[TG3_C1\=/A#\)
MK_7HVGT2Q^(_Q&\(^"[W5K=)3!)=:=:>(M7T^XN[2.<&&6Z@C>WBE!CDE5^*
M]1\/^(O#_BW1=-\2>%==T?Q-X=UFSAU#1]>\/ZG9:SHNK6%RN^WOM-U73I[F
MQO[2=,/#<VL\L,JD,CL"#0!LT444 %%%% !1110 4444 %%%% !1110 445S
MNN>,/"7AF2"+Q)XH\.^'I;I'DMH]<UO3-)DN8XR%DD@2_NK=IDC8A7>,,JD@
M,02* .BHK)T;7]"\16K7OA_6](UVR60Q-=Z-J5GJ=JLJ_>C:XLIIXA(.Z%]P
M[BM:@ HHHH **** "BBOR1_X*C_\%B?V?/\ @E"?@NOQT\"_%/QHWQP_X3K_
M (1G_A6NG^&[T:?_ ,(#_P (H-4_M@^(/$.A>7]J/B_3_L0M/M.X077G&'$1
MD/Z\OF^@'ZW45Q7PV\=:3\4?AUX!^)F@0WMMH7Q$\%>%?'6BV^I1QPZC!I/B
M[0K#Q!IT-_##+/#%>Q6>H0I=1Q3S1I.LBI+(H#GM: "BBB@ HHHH **** "B
MBB@ HHHH **\=U+]H?X#:-\5-.^!FK?&;X8:9\9]7BMI]*^%-_XX\.6GQ"U&
M&\LYM0M)++PC/J*:[=)=6-O/>6[0V+B:VADFCW1HS#V$D $D@  DDG  ')))
MX  ZF@!:*\?^%O[0GP(^.%UXEL?@U\8_AE\5+SP9/:VOBVU^'WC;P[XNG\-7
M-[)>Q6<&N1:%J%\^F2W4NG7\<"7@B:5[.Y5 3"X'L% !117CT7[0GP(G^+LO
MP!A^,?PSE^.$&G'5I_A)'XU\//\ $2+3A8C5#=2>$5U ZXD:Z6RZFP:R#KIK
M+?LHM&$Q /8:*** "BC_ #^76CKTH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH \\G_U\W_763_T-J_.?_@KAD?\ !,G]N8@D$?LV_$P@
MC@\:#<=Q7Z,3_P"OF_ZZR?\ H;5^<_\ P5P_Y1D_MS_]FV?$W_TP7%=LOX;_
M ,#_ /23&'Q1_P 2_-'^:W^QW_P31G_:K_8/_;@_;/T?XPKX#\2?L6+H6OP>
M"]0T9)-+\<:1)H6I>(=2CA\5IJ]I=^'?$5O'I;1^'HDTS4X]7U)[;3B]E),M
MTG]KG_!L1^US\4_CQ_P3J\9']H+QSJ?B./\ 9_\ BYKO@30/B)XYU-/]'^',
M'@[POXEL='UGQ/J<X>^_X1"XU'5%?4=7NF>QT2^TBSEG%O:1L/XZ/^":/_!,
M']NC_@HK^SE^TU%^RW\<='\*_#KP+XA\+)\0_@3XB^)'Q \):-\8/%#Z%JVM
M>%6'A[1-+OO .NZI8IIT]AI=]XWN+!-.N[R+R;NW@>:9/TM_X(X_MNWR?\$]
M/^"F?_!-_P 4^ _"OANY\"?LO_M$?&;PMXL\/V+V&M^(];BTF'PMX_TCQW*+
MJ>WU[6K6)O#YT+68(;>2'0]!ETNY::&TTXIR4_<G%I.*<9)/6TY+[UIMM;RO
MJ5:Z2OJ[=+VORZOSWU>]V?Z!W@_XF?#?XA66H:GX"^(/@GQOIFD.L6KZEX1\
M4Z%XEL=*E:%KA8M1N]%O[VWLI&MT>=([F2)WA4R*I4'$'@WXK?"_XBW&I6GP
M^^)'@+QW=:.L3ZO;>#?&'A[Q1/I4<[RQP/J46AZC?26*S203I$;M81(T,JQE
MC&P'\;/_  :98_X8N_X*,;L?\C5HI ."<GX2^*"#CU)Z=R1QR*_/[_@W#M?B
M_?VO_!7RQ^ CZ@GQIO/V4+JW^%S:5<M9ZN/&\VL^-X_#YT6[6:W-KK9OVB&C
M7*SP-#J?V6194VDUK[9OV=E\:=]=5;73IJNZ6HN7L^J7WI:Z7TU_%;]?[X?^
M&MOV4V\?R_"8?M-?L^'XIPWJZ9-\-%^-'PW/Q AU%Y3;KI\O@T>)3XBBOFF!
MB6TDTU;AI/W:QE_EK\'_ /@LQ_P1L^"G_!0?]J3X*_&?Q_\ MM>%?V;=4T3P
M+H_@'7/ OBJ;PW/J7B+PIIGBS7-<L]:\"1ZUXU\.3V.MW5YKVHZ1/.]AJ%E+
M+!8W"2//9M93?Q.?L+6W_!/'P[\3]<^'G_!4#PA^T]X(\96OQ7\(W5M\2_ 6
MMQZ?'X%MM#UB%_%_A+XJ?#[5=&D\6&#6IC(VK>)]!N[CQ/HUJI;2M+6\C,EW
M^Q?_  = ZEX-UC]M7_@GUJ_PYO\ 3M4^'NJ_LT_#C4? FIZ/<M>:3J7@R^^)
M&I7/A>_TR\=G>[T^\T.6QGLKAW=I[9XI6<E\U#J>T@W*,6KQ5E)W5VEKHNU[
MZ]AJ-GHW_P #W7\GKHGO;73?^^_5_B]\(/!NN67@?Q-\5?A[X=\621:;#9^&
M/$OCSPWIOBJ[6^ ATUETG5M6@U>\EU%PJVLBV\KWTA9HFD;<:Y7P'^U)^S-\
M4_%=_P" _AC^T3\"OB/XYTLS+J?@SP'\7/ 'B_Q9IS6RL]RM]X<\/>(-1UBT
M:VC5I)UN+.-H45FD"JK$?Y]W_!P;\+;[XY?\%\? 'P3TS5CH&I?&&+]D/X6:
M?KH#LVB7_P 0=3TOPE::NHCDB<MIMQJ\=Z DL;$P !U."/#O^"L7[#GAO_@A
M_P#MV?LJZO\ LK?%#XH7YG\)^%OC!I>M^,M4TEO%NF>*_#7C>]TG7+6+4?#&
MB^&;.30=;CL(C'IDVGO)#9W=[IM[>ZE$PG-.O)-VBG&,^2]]];:65O/MKZ"Y
M5M?6R>_=1>UN\NZ]>I_I@?$3XH?#3X0^&[CQE\6/B)X%^&'@^TD6*Z\5_$3Q
M=X?\$^&K>9T=TAFUWQ)J.FZ7%*Z12NB272,T:-(!L5V7F/A/^T+\ OCU:7^H
M? OXX?"#XT6&E.B:I??";XE>#?B+9Z:\F?*2_NO"&LZQ!9O)M(1+J2)G(8(&
MVMC_ #H?^"^_[6=W^T1_P5Y\0?!#XVZ]\4=1_92_9N\9^"?A\?AW\+9$E\02
MZ;#H&@Z_\4M9\*Z!K%Y!X;D^(>N:MJ>N:)8^(]2AE-MI5AHZO]HL+"*R;YE^
M&'[2_P )_P!D?_@HG\!?V@O^"9O@[]K'X4_!^WUKP5H_Q0^'OQT9-0GU[3+_
M %TZ7XWT#4+[PE>WMKXD\%ZUX=N5U"WLM<C-]HNO1-?Z=*)+73IK0^L-2M9.
M*ERO6TGJDVEMIKU_ %&_];/32V^EW=^7W_Z=WQ4_:3_9U^!=UI-E\;?CY\%O
M@[>:_C^P;3XJ?%+P-\/;K6LS&!1I5OXNUW2)=1+2 Q@62SYDQ$,N<#T71?&?
M@_Q'X8M_&OA_Q7X;UWP;=V#ZK:>+-&US3-4\,W6EQH99-2MM?L;J?29]/2-7
MD:]BNWM@D<CM*JH2?\S+_@L-9W'@C_@MC\9_%O\ P4<^&GQG\??L\Z[XTNCX
M/TWP+XE;P?JNM?!,>&8=-^'EU\+?$^M6&J>'W3PNLFG7OB#0[<6T-[XCL]?T
MK4;O2[Z]N+^/]H?B%HWP<\4_\&WWQ2\&?\$==<^+7Q!\(V/Q(TV[^.^E:_\
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M5;57^$WQ1\#_ !&33%=@B'4&\(:YK'V(,Y$8-QY8,A"CUK^$WP3_ ,K?#_\
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M$?$MH\VJ7-]87LVIPB'4;6/0_OS_ (*_?M._$W]K;_@G;_P1U^*?QCN-4O\
MXI:?X,_:8^&_C+7-;CO(];\2ZE\-/%WP^\'VOB;6WU!FN[O6]=TG2]/U+6-2
MN&+ZMJES=ZDQ#W3*KYM&[:V3M?>]NMMU>[0:]7]UO+75=-;Z6MV/],C1OVG/
MV;?$7Q0?X(>'_P!H/X(:[\:(K:XO9?A%HWQ7\!ZG\3XK.SLSJ%W=R> ;+7Y_
M%:6UK8*;VXF;21'#9@W4C+ #(/1/'OB<^"O WC3QDNG7>KMX2\)^(O$XTFPC
M,M]JAT'1[S51IUE$.9+N]-I]FMXQR\TJ*.37\2GP%_X(U?'G_@F'^S!\,/\
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M/B^ZT'4K73?$NO:=XL\*7=KK,4,LUQ+;V]Z8);/4]"$#Q23?Z.W[$_[2K_M
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M84444 %%%% !1144\R6\$T\C!8X(I)G9B%54B0NS,QX "J22> .30!_E5_\
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MDN%C25H$USPOJ6J:8TRQ2QR-$MT7$<B.5VNI/"?$;]JS]EWX/>*=/\#?%O\
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M_P"/'QU^#?P4L=59TTR]^+?Q/\$?#>TU%HR%D6PN?&6N:+#>-&Q =;=Y&4D
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MG9_?JK"<M+673\+?G;[M/,_S9?VK?V?O^"X__!4SQ#\"O@O^T'^P-)H7Q/\
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MW[/6@77[,'C+6OB=IFG+_8>F>&_ .MP6GB_5;N*::+48X=#N+*XCNHC:"<E
MT44B/&[_ -Q1ABR"$CZELA%ZD$'JN<D<$]QP32>3'P#'&1L*<QK]TGE3Q]T]
M2HX.:X)8?&M22Q%%7<I*^$FWSM0Y&[8J*=I<W,K14KPV:N^=_6EJJM'9VO1;
MUM#E;7MH[.]]$FK)+1N7\07_  65_9,_:,_:#_X+,_LN?'OX0?"#QEX[^$7@
M/4_V3K+Q?X]TFSC&A:!=VGQ+;Q5<PW\MU-#,C0Z#*NHN4A=$A5U9O,5E'C?_
M  4T_P"">?[8W[+G_!1N_P#^"E/_  3%&M^.[GQU\1_'/C^XT#PGH<VL^./
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MV<C5]S_\%"?^"&_[3_P9_P""-7[%_P"R!^SY\+_$7[0_QO\ #_[3?B3XY?M
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M._P[^ /['7@#]F[XF?LW7WPEN/"WAZ^_: C^'NJ_#/5?%&D>%=-&@Z0WQ/\
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M;VFH16\UQ%'/)IVH65V$69RL=P@;:^Y1^H5%-))W\K>73_(/Z_/_ #"BBBF
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M;2=)9WGEN)OTUI)>ZEMU=K7OH]_D)+;Y;=;):^E_R70_S//VT?AI_P ')?\
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MX&\$6/CNRLH;CQ+X>BD\::MXS%O;P7EXLEA;72^%H9_/54F>Y*("L<@K@_\
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M11"25_MRHH4;.]V[.^OJGK\T.V^^Z?S7Z;Z=W<_B6_X)9_\ !//]M/X-?\'
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M:7:37']EZ2(M)M+J?2["SN-3$^IRW=Q+[M113'_7]?GU"BBB@ HHHH ****
M//)_]?-_UUD_]#:HJEG_ -?-_P!=9/\ T-JBKOCLO1?D<X4444P"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH ]#@_U$/_7*/_T!:EJ*#_40_P#7*/\ ] 6I:\\W
MCLO1?D%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!" 2#Z<CD^XZ=.YSZ]^@I?\_Y]/PH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "@C/6BB@ HHHH **** #_/\ G_//>BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _!?QG^P=_P5AUGQAXKU?PW_P7!\4^$?#N
MJ^)-<U+0/"D?_!/_ /9HUJ/PSHM]JEU=:7X?36+_ %R.^U9-%L98--74[R..
MZOQ;"ZN(TEE<5S?_  [\_P""O?\ TGB\6?\ BNS]E[_Y?U^Y,_\ KYO^NLG_
M *&U15V*$;+6>R_Y>5/_ )(PN_+[E_D?AW_P[\_X*]_])XO%G_BNS]E[_P"7
M]'_#OS_@KW_TGB\6?^*[/V7O_E_7[B44_9Q[S_\ !E3_ .2"[\ON7^1^'?\
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M]Q**/9Q[S_\ !E3_ .2"[\ON7^1^'?\ P[\_X*]_])XO%G_BNS]E[_Y?T?\
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M^RS_ /-#7[KT4?-_^!/R\_)?<%EV_K3_ "1^%'_#O#_@L3_TGU\7_P#BN/\
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M_I/KXO\ _%<?[+/_ ,T-'_#O#_@L3_TGU\7_ /BN/]EG_P":&OW7HH^;_P#
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MY>?DON"R[?UI_DC\*/\ AWA_P6)_Z3Z^+_\ Q7'^RS_\T-'_  [P_P""Q/\
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M .:&OW7HI6\Y?^!2_P _)?<%EV_K3_)'X4?\.\/^"Q/_ $GU\7_^*X_V6?\
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M3_TGU\7_ /BN/]EG_P":&C_AWA_P6)_Z3Z^+_P#Q7'^RS_\ -#7[KT4?-_\
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M67;^M/\ )'X4?\.\/^"Q/_2?7Q?_ .*X_P!EG_YH:/\ AWA_P6)_Z3Z^+_\
MQ7'^RS_\T-?NO11\W_X$_+S\E]P67;^M/\D?A1_P[P_X+$_])]?%_P#XKC_9
M9_\ FAH_X=X?\%B?^D^OB_\ \5Q_LL__ #0U^Z]%*WG+_P "E_GY+[@LNW]:
M?Y(_"C_AWA_P6)_Z3Z^+_P#Q7'^RS_\ -#1_P[P_X+$_])]?%_\ XKC_ &6?
M_FAK]UZ*?S?_ ($_+S\E]P67;;_@?Y(_"C_AWA_P6)_Z3Z^+_P#Q7'^RS_\
M-#1_P[P_X+$_])]?%_\ XKC_ &6?_FAK]UZ*/F__  )^7GY+[@LNW]:?Y(_"
MC_AWA_P6)_Z3Z^+_ /Q7'^RS_P#-#1_P[P_X+$_])]?%_P#XKC_99_\ FAK]
MUZ*/F_\ P)^7GY+[@LNW]:?Y(_"C_AWA_P %B?\ I/KXO_\ %<?[+/\ \T-'
M_#O#_@L3_P!)]?%__BN/]EG_ .:&OW7HH^;_ / GY>?DON"R[?UI_DC\*/\
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M+T7Y'.%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /0X/\ 40_]<H__ $!:
MEJ*#_40_]<H__0%J6O/-X[+T7Y!1110,**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW_!37]DJ;]I#Q7\.="^%^JP_%'QC\/3X:\.ZQ?ZWI[6WABRT"[BU(7FI0P7
MFN3K3I+#M9$$",A_>$+^J-$9*24EL]AM6=GT"BBBF(**** "BOSR^,'_  52
M_86^ _[4W@C]C/XH_&[3_#?[0'CZ\\*Z;H_A1O#_ (GO].L-5\=7-O:>"M+\
M1>)[#2+CP]H%]XGN+JU738M1U&%(X[NSN-1DL+6[MYY/T-Z^V>WI['IR.YP,
M^@Z4DTVTFFT[-)[/S"W]?U_7WA110>A_S_A_,4P"BOSO_:-_X*K?L)_LG_M
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M\GMZT +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !12 @XP0<],'KCKBEH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBC(]10 449&,Y&/7M29&,Y&/7/'YT!==
M_P"OZ:%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** //)_P#7S?\
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MX?;PU;^+=43PWJ"W6M&_M=2OULK=?[I_V-/V2OV)?^"'?[(?Q<\<6OQ0N?\
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M'!7_  2.T'P;JGC8?M=^&=:T_2=3TW2)M(T#PGX^U'Q5=W>IPWEQ"^F^&/\
MA%X=8U&QMX;&=M1U*UMI-/TUFM8;VY@N+^QBN>-O_P#@CA^PC^Q1X$^/G[0'
M[,WPVUWX9>.]%_8O_:-^%6I16WC/6M=T/Q7H?B;P,=0O-3\26?B6;6+J;Q#;
M7/ABT-I?:/?:/;A+S4$O+&\1K8V_\C__  ;8_P#!,+]FG_@H3\1/VC_$O[4?
MAS4_''@[X+^'O EGX;\%6>O:IX>T[4?$7CN[\2_:-5UJYT6>RU*YATC3O#AB
MT^RAOK>%[S4C<W D%I#&].I63C%*'-)/O;2UF_QNK=0M'1ZVO^"M=NR>]_\
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M75M(ED2>[T+Q!8;8=8T6[8*HD>TN7+03%$^U64MK=B.-;@1K_#$O!.#ST&.
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M_P"UZOK^JW,L]K86,\(LOZDSR<_7IQU)/;KU./0<#  H_J,'W&2>?7D_H!T
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M<\0O9:#I.D^!_$EG<V%MX;O=.M=-,^KVTDEQ$\$L<$:+._\ 5Y^?7/4]12$
M]ATQTQ[=NF>YZGO5>PARN.KYK7;?O.ST7;_)^3LES/\ +YVMO?T7]7/Y8?\
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MHKZD_$PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFN^'='^(?A:/0M$F7PUXWTW2+^SM/%&@"6>:7^R-;AOM/\R1Y#!N))_<//\
MD\4=_+_)/]0>EKM:J_XV"BBOQ'_89^+?Q4\8?\%<O^"PWPT\6?$CQWXE^'/P
MPB_8_/PU\!:_XLUW5_!WP_/B7X;^)KWQ(?!?AJ_OI]&\,'Q!>6UO>:U_8ME9
M?VI=0Q7-\9YD5P ?MQ11FB@+KOY?/L%%074ZVMM<73X*6T$MPX+Q1@I#&TC#
MS)I(H8\JI&^:6.)/O2.J D?S0?L2?\'$^@_MA?\ !1/6/V)+?]GR]\)Z9J6H
M3>'O"GB:3XB?#J_O-!USP/X<\:7WQ.GUW4[#Q??>'_B!IT_B'0] TOP-!\,/
M[3U"^TS5-1UN\CEM=*E# ?UT_K^O2_\ 3-17Y*?\$U_VSOC5^T#\:?\ @HM^
MSE^T?#X7MOBQ^Q]^U!)X4T1?".CRZ'HM]\$/'VB'6_A'J%M;7-S>7MU/=:;I
M&IWUY?7UY<WLRZC9R7#0)-;VL'ZUT"3O_7Y=T%%%% PHHHH \\G_ -?-_P!=
M9/\ T-JBJ6?_ %\W_763_P!#:HJ[X[+T7Y'.%%%%, HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /0X/]1#_ -<H_P#T!:EJ*#_40_\ 7*/_ - 6I:\\WCLO1?D%
M%%% PHHHH SM8DN8M(U26R!-Y%IU[):!1EC<QVTKP #:W)E"@?*3SP":_E]_
MX(S_ +2_P]_8P_X(-?$;]J?QZT+Z1\+_ (F?M7>-?$%HUTEK<^(_&!^+VMZ)
MX8\-BYD$K)JGBC5Y?"_ANQ<Q32[K^T=()OEC?^I.OY>OV4/^"16J_$7P+^V=
M^PE^UCX<^+_@S]DCX<?\%)]<_:>_9VNO!WB3POHOACX[> /%L5MXMTKX<^)[
M+6/#GB:^UKX=>$KC^S&UN'38/#W]H^*K[5+:VUN.[T6YM+-=?D_QM_EW$_\
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MS_8/D_:T^)_QGU[]D;0_V;/B3^S]^U/=ZN^E?&;PKX<^+WC_ ,'KJ?PP\?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQJ5QX,\,0:B=(-E;)<:5%?0:>JVL&HWUU>MX;K/PN_:R^+G[=W@#_@C=>?\
M!1#]H7P9\&OV;_V5[S]H7XB_&K0-6M?#G[2/[2USXO\ B9JVD>$/"5WXWNI]
M4OFTSX?>'M5T31]4NM.GDT_5)-!UVXN]"MITTI=#_7C]L/\ X)-_!?\ :O\
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M:G!%#8^*?@GKNB^$-+?PC_PC8CD.A)K<'BN[\J\U"RUB^U?3KV>S;S_X7?\
M!#[X$>%/%/COXA?&+]H_]L3]J_XG>*_@G\1?V>O"_P 0OVC?C%;^.]?^$7PR
M^)_A+6/!'BJW^&$,OAJ#2-'\17_A_7-0@EUK5=.UJWEN)Y[IM)#WE^+M_P#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$O\ XK6_93_^:*OW5HHLO/[W_F%O7[W_ %T_/NS\*O\ AWM_P62_Z3[^)?\
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M)?\ Q6M^RG_\T5?NK119>?WO_,+>OWO^NGY]V?A5_P .]O\ @LE_TGW\2_\
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ME_TGW\2_^*UOV4__ )HJ/^'>W_!9+_I/OXE_\5K?LI__ #15^ZM%%EY_>_\
M,=OZN_Z_KS9^%7_#O;_@LE_TGW\2_P#BM;]E/_YHJ/\ AWM_P62_Z3[^)?\
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ME_TGW\2_^*UOV4__ )HJ/^'>W_!9+_I/OXE_\5K?LI__ #15^ZM%%EY_>_\
M,+>OWO\ KI^?=GX5?\.]O^"R7_2??Q+_ .*UOV4__FBH_P"'>W_!9+_I/OXE
M_P#%:W[*?_S15^ZM%%EY_>_\PMZ_>_ZZ?GW9^%7_  [V_P""R7_2??Q+_P"*
MUOV4_P#YHJ/^'>W_  62_P"D^_B7_P 5K?LI_P#S15^ZM%%EY_>_\PMZ_>_Z
MZ?GW9^%7_#O;_@LE_P!)]_$O_BM;]E/_ .:*C_AWM_P62_Z3[^)?_%:W[*?_
M ,T5?NK119>?WO\ S"WK][_KI^?=GX5?\.]O^"R7_2??Q+_XK6_93_\ FBH_
MX=[?\%DO^D^_B7_Q6M^RG_\ -%7[JT467G][_P QV_J[_K^O-GX5?\.]O^"R
M7_2??Q+_ .*UOV4__FBH_P"'>W_!9+_I/OXE_P#%:W[*?_S15^ZM%%EY_>_\
MQ6]?O?\ 73\^[/PJ_P"'>W_!9+_I/OXE_P#%:W[*?_S14?\ #O;_ (+)?])]
M_$O_ (K6_93_ /FBK]U:*++S^]_YA;U^]_UT_/NS\*O^'>W_  62_P"D^_B7
M_P 5K?LI_P#S14?\.]O^"R7_ $GW\2_^*UOV4_\ YHJ_=6BBR\_O?^8[?U=G
MX5?\.]O^"R7_ $GW\2_^*UOV4_\ YHJ/^'>W_!9+_I/OXE_\5K?LI_\ S15^
MZM%%EY_>_P#,5O7[W_73\^[/PJ_X=[?\%DO^D^_B7_Q6M^RG_P#-%1_P[V_X
M+)?])]_$O_BM;]E/_P":*OW5HHLO/[W_ )CM_5V?A5_P[V_X+)?])]_$O_BM
M;]E/_P":*C_AWM_P62_Z3[^)?_%:W[*?_P T5?NK119>?WO_ #%;U^]_UT_/
MNS\*O^'>W_!9+_I/OXE_\5K?LI__ #14?\.]O^"R7_2??Q+_ .*UOV4__FBK
M]U:*++S^]_YA;U^]_P!=/S[L_"K_ (=[?\%DO^D^_B7_ ,5K?LI__-%1_P .
M]O\ @LE_TGW\2_\ BM;]E/\ ^:*OW5HHLO/[W_F%O7[W_73\^[/PJ_X=[?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZU&3QW\.F71;C5=5O+UY+B^O?%'A]-!\7W%_/+-++-K\B3SR74-SC^0C7/\
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP7B_X*RR_%7]M_X3?M=>,_"MSX+\2ZE9>';_ %SXL^)OA_H'BGQI96L.N3^
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M"_-5OOS*_K9D3Z>B_P#2(!111700%%%% !1110 4444 %%%% !1110 4444
M%%%% 'H<'^HA_P"N4?\ Z M2U%!_J(?^N4?_ * M2UYYO'9>B_(****!A111
M0 4444 %%%% !1110 4444 %%%,\R/=LWINX.W<,\].,YY[4"NENTNF_7>WW
M:CZ*3(]1^=(&4G:&!;&<9&<>N*!W7??8=1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[HSKM;E-I&SJ 6^:K-%%.P!1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBBB@#T.#_40_]<H__0%J6HH/]1#_ -<H_P#T!:EKSS>.R]%^04444#"BBB@
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M\0?!^A>%8+N*:_L_!,^H:_K>IVT;J9+."?4=+TBRT]IT#(MY(;W[/O$@LIG
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M0\*^&? FH>$;C3+O5?B+KFIV$5I;:?J%MIVBZ?!J"R:GJUK%<17(^B_VO/\
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MVE/"NK>$]<T#XJW6M^,[?6+#5O HMU\)7PTNQ\2VWAJ:;1%M+9;<7&B31RK
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MK3UOJ--;J^B6^FJY=M7O;\>ES^J?_P"L/R  ]>@&.?2BC)))/4\G..O_  $
M9/4D 9))QS1789A1110 4444 %%%% !1110 4444 %%%% !1110 4444 >AP
M?ZB'_KE'_P"@+4M10?ZB'_KE'_Z M2UYYO'9>B_(****!A1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^\:?[*7]-?%?M_13Y(]Y_P#@RI_\D*_I]R_KI^?=GX@_\,$_\%BO^D\>L?\
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M(_[QI_LI?UU\TO\ PP3_ ,%B_P#I/)K)^O\ P33_ &4OZ>(!7[?44<D>\_\
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M1\W][\O/R067;^M/\D?A?_P[_P#^"S7_ $GWUK_Q6/\ LE?_ "_H_P"'?_\
MP6:_Z3[ZU_XK'_9*_P#E_7[H44?-_>_+S\D%EV_K3_)'X7_\._\ _@LU_P!)
M]]:_\5C_ +)7_P OZ/\ AW__ ,%FO^D^^M?^*Q_V2O\ Y?U^Z%%'S?WOR\_)
M!9=OZT_R1^%__#O_ /X+-?\ 2??6O_%8_P"R5_\ +^C_ (=__P#!9K_I/OK7
M_BL?]DK_ .7]?NA11\W][\O/R067;^M/\D?A?_P[_P#^"S7_ $GWUK_Q6/\
MLE?_ "_H_P"'?_\ P6:_Z3[ZU_XK'_9*_P#E_7[H44?-_>_+S\D%EV_K3_)'
MX7_\._\ _@LU_P!)]]:_\5C_ +)7_P OZ/\ AW__ ,%FO^D^^M?^*Q_V2O\
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M2O\ Y?U^Z%%'S?WOR\_)!9=OZT_R1^%__#O_ /X+-?\ 2??6O_%8_P"R5_\
M+^C_ (=__P#!9K_I/OK7_BL?]DK_ .7]?NA11\W][\O/R067;^M/\D?A?_P[
M_P#^"S7_ $GWUK_Q6/\ LE?_ "_H_P"'?_\ P6:_Z3[ZU_XK'_9*_P#E_7[H
M44?-_>_+S\D%EV_K3_)'X7_\._\ _@LU_P!)]]:_\5C_ +)7_P OZ/\ AW__
M ,%FO^D^^M?^*Q_V2O\ Y?U^Z%%'S?WOR\_)!9=OZT_R1^%__#O_ /X+-?\
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M_P"'?_\ P6:_Z3[ZU_XK'_9*_P#E_7[H44?-_>_+S\D%EV_K3_)'X7_\._\
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M_7[H44?-_>_+S\D%EV_K3_)'X7_\._\ _@LU_P!)]]:_\5C_ +)7_P OZ/\
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M1_\ H"U+44'^HA_ZY1_^@+4M>>;QV7HOR"BBB@84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT.#_ %$/_7*/_P! 6I:B@_U$/_7*/_T!:EKSS>.R]%^04444#"BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3^9_,THT81Y=7=2YFV]7+N_Q^_<'*_1:*R\O/??0_E._X),?\$8/VN_V)O\
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MDX)&. ,?0 ?TI*.G2KA34')K[3;=^[M>WEIL[OS$VW_7HK_@@HHHJQ!1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /0X/]1#_ -<H_P#T!:EJ*#_40_\
M7*/_ - 6I:\\WCLO1?D%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH \\G_U\W_763_T-JBJ6?_7S?]=9/_0VJ*N^.R]%^1SA1113 **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#T.#_ %$/_7*/_P! 6I:B@_U$/_7*/_T!:EKSS>.R
M]%^04444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#SR?\ U\W_ %UD
M_P#0VJ*I9_\ 7S?]=9/_ $-JBKOCLO1?D<X4444P"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_B*FF_\ S>T>UI_SQ^_^NZ^\.67\LON?]=5]Y^X=%?AY_P /EOB=_P!(9?\
M@L7_ .(J:;_\WM'_  ^6^)W_ $AE_P""Q?\ XBIIO_S>T>UI_P \?O\ Z[K[
MPY9?RR^Y_P!=5]Y^X=%?AY_P^6^)W_2&7_@L7_XBIIO_ ,WM'_#Y;XG?](9?
M^"Q?_B*FF_\ S>T>UI_SQ^_^NZ^\.67\LON?]=5]Y^X=%?AY_P /EOB=_P!(
M9?\ @L7_ .(J:;_\WM'_  ^6^)W_ $AE_P""Q?\ XBIIO_S>T>UI_P \?O\
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MY^X=%?AY_P /EOB=_P!(9?\ @L7_ .(J:;_\WM'_  ^6^)W_ $AE_P""Q?\
MXBIIO_S>T>UI_P \?O\ Z[K[PY9?RR^Y_P!=5]Y^X=%?AY_P^6^)W_2&7_@L
M7_XBIIO_ ,WM'_#Y;XG?](9?^"Q?_B*FF_\ S>T>UI_SQ^_^NZ^\.67\LON?
M]=5]Y^X=%?AY_P /EOB=_P!(9?\ @L7_ .(J:;_\WM'_  ^6^)W_ $AE_P""
MQ?\ XBIIO_S>T>UI_P \?O\ Z[K[PY9?RR^Y_P!=5]Y^X=%?AY_P^6^)W_2&
M7_@L7_XBIIO_ ,WM'_#Y;XG?](9?^"Q?M_QBIIOZG_A/>/K2]K3_ )U_7_#K
M[T'++^5_<_ZZK[S^@:#_ %$/_7*/_P! 6I:_!N/_ (+9_$>..-#_ ,$7_P#@
ML@2B(I(_95TH@E5 ./\ BO\ VI__  ^U^(W_ $A?_P""R/\ XBII/_S?UQW7
M?^OZ:^\V2:25GLEL_+_-'[PT5^#_ /P^T^(_7_AR_P#\%D/_ !%72?Y?\)_F
MD_X?:_$;_I"__P %D?\ Q%32?_F_I77=?U_PZ^\?R?W/R\O-'[PT5^#W_#[7
MXC?](7_^"R/_ (BKI/\ \W]'_#[7XC#_ )PO_P#!9'_Q%723_+Q_1==U_7_#
MK[P^3^Y^7EYH_>&BOP>_X?:_$;_I"_\ \%D?_$5-)_\ F_I?^'VGQ'Z_\.7_
M /@LA_XBKI/\O^$_S1==U_7_  Z^\/D_N?EY>:/W@HK\'O\ A]K\1O\ I"__
M ,%D?_$5-)_^;^C_ (?:_$;_ *0O_P#!9'_Q%72?_F_HNNZ_K_AU]X?)_<_+
MR\T?O#17X/G_ (+:_$8?\X7_ /@LC_XBKI)_EX_I/^'VOQ&_Z0O_ /!9'_Q%
M32?_ )OZ+KNOZ_X=?>'R?W/R\O-'[PT5^#__  ^T^(Y_YPO_ /!9#_Q%721_
M/Q_2?\/M?B-_TA?_ ."R/_B*FD__ #?T77=?U_PZ^\/D_N?EY>:/WAHK\'O^
M'VOQ&_Z0O_\ !9'_ ,14TG_YOZ7_ (?:?$<?\X7_ /@LA_XBKI)_EX_HNNZ_
MK_AU]X?)_<_+R\T?O!17X/?\/M?B-_TA?_X+(_\ B*FD_P#S?TO_  ^U^(Q_
MYPO_ /!9'\?V5=)'\_']%UW7]?\ #K[P^3^Y^7EYH_>"BOP>_P"'VOQ&_P"D
M+_\ P61_\15TG_YOZ/\ A]K\1O\ I"__ ,%D?_$5-)_^;^BZ[K^O^'7WA\G]
MS\O+S1^\-%?@_P#\/M/B/U_X<O\ _!9#_P 15TG^7_"?YI/^'VOQ&_Z0O_\
M!9'_ ,14TG_YOZ+KNOZ_X=?>'R?W/R\O-'[PT5^#W_#[7XC'_G"__P %D?\
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M?W/R\O-'[P45^#W_  ^U^(W_ $A?_P""R/\ XBII/_S?T?\ #[7XC'_G"_\
M\%D?_$5=)'\_']%UW7]?\.OO#Y/[GY>7FC]X:*_![_A]K\1O^D+_ /P61_\
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M_P#X+(_^(J:3_P#-_1==U_7_  Z^\/D_N?EY>:/WAHK\'_\ A]I\1Q_SA?\
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$4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>nt10006151x14_graphic3.jpg
<TEXT>
begin 644 nt10006151x14_graphic3.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %_7?^O4^C**^=/^&=++_HJGQC_\+>Y_^1Z0_LZV><?\+3^,A![CQQ/@?^0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_(_O=/\ P=U_L:Y(_P"%"_&\ ' )_P"$?P3G X^V#&?0GK4[?\'=/['61L^
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M:DWFWI%;7^)6Z;>]]RZZK6[9_?4W_!X'^QV"?^,>?C@ /5_#X/\ Z5#'0_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUC5+31[73H]2O5M)@["TCU$26NT,3@VD<H$.9%5MKH&/W@,;<Q7TT%W<O/%
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M&/@?\(!_U3/P/_ZC>FT#Z+U?Y1/6:***!!1110 4444 %%%% !1110 4444
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MSG>APK>7IODK( I4JH!SM& :+CQ%XMBNI#+JGA99VD"R$:9X>1599 Q9D&G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-\">/@G\(@.G_"M?!'_J-Z=3Z7]?PM_F.^EO-O[[?Y'JU%%% @HHHH ****
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M_7'Q>^-&K^'/^">/[+7A/3X(X;RYL=7^RS20"[6S@AO9Q<:@ID#QK>7$DVR
MR B$1XC3<F:_(_4-7U35Y99]3U74-3GGD,L\E_>W%T\KY)^8S2.>AQQRJ\#
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MZC]]73? G_DB?PB_[)KX(_\ 4;TZGT7J_P HB/5J***0!1110 4444 %%%%
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MU$8J^G*O-I>5UJGZ:>8K-VO?I]I+M;:6UOP3/R,/_!LW_P $DOX?@/K ]?\
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MHRP2ZI=O>WCM=W;R3R&6>1F^9CC.!Q7T/7SO_P )[^T">GP,T@^N?B-IJ_\
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M\MM- HHHKSCJ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC/\ RSC7\P2>W0'CGOU["MVOP#$-NK*_E^*O^I^B8=)4HV5@HHHK W"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **:S;>Q/T_S_G%.'/\ G_"E=7:ZK</Z_K[PHHHI@%%%% !1110 4444 %%%
M% !1110 4444 %%%% !6)K./*8G&1&2,G'/[RMNL#7,F)D'!:-2#Z89^OMTS
MR#[UOA_XT/\ $O\ TI&5>_LIVWY?U1_'+_P6LO/+_:K@C4Y,?A+2UQQQEISW
M[DMCCI@8'(K\>6OOD'.#@8YZ'!'KZ9^O?FOUF_X+7,Q_:X;+$!O".CL.P W7
M QSG.<'/;UZ9/X[EI,]1U..O0YZXX_R.:^EJ58\\(RDK0A35M;_PX7U5^J=M
M&F&"A'V.JUGLNO177K9VLK[=SYF^-4V[Q';DN2!8IP#WW>P)X..V#GM7ZZ?\
M&]]P&_;>E0< ^ ]=8C)))_=(,DCH">@QTYZXK\=_C2[#Q';#G!L5())P?<<]
M#C!Y]><5^NG_  ;Q/_QG+<;@6SX UP8]/GA'&<XR<=CWK]VC-U. ZMVFO[-=
MUM>HE+339VMIHK6OJ?C.*<(\8U4G9+$05NJ?-%V\W[R]?+4_O_T90(%YZQKC
MUYR>GT'?IT%;=8FD<1 9ZP@Y'8<8XQVYYSSBMNOYBK_Q9^OZ(_9:&E.*ZVO\
MFDU]Z"BBBLC8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%N-.NXKA".54XD3V>,X93^&/0FM.@-PHJ.66*!#)-(D4:XR[L%49.!DG Y/
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MBLK:/4)4GO$B5;B6-2J/(.I ))Z8R>,G)P*BN-6LK<$F57(95.T@ %\[<LQ
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MIG%;RNC$JKJS+C<%8$KGID Y&>V:S:L)-/;^O4=1110,**** "BBB@ HHHH
M**** "BBB@ HHHH *QM;UVQT&WCN;XRB.67RE,<;28.TMEMH( P._4FMFL?6
M]5TS2+,7.K,JVSRK$-\)G4R,"5!0*W]T\XXZ] ::5VE9O79;L3OTWZ?Y?/8Q
M8/'_ (4G*J-42-F8+MFCECP3C&XE"H&3R<X'7IS6Y;Z]HUT<6^J64I]!<1@G
M/IN(STKR/7]1TO4KB*70F\+RP[ LT5_ D4I?)'RN3'@8/4_=ZX.!CG9(D/\
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M5 %4'&0% QCVQBOS)_;9^"<NDV3_ !D\%6KQ7.E,P\4Z=:0!1>V9D5WU'8@
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MP/,4G'., D>_?KWXJS#XLD9@3)D=MKGVY^4]NQ^M?&,7Q(9'R6DC"@(3)&2
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M7M-T/1K"V%C;6$"6Z,D@1R\V9$4!'8,65I% ^5B#MX .W(.??:E#&Y02*H&
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MSFURPER02NK1M'71Z<S5WY6Z*QYA=?#S2K2RGN5BN]:OX8M\$-W<R".:16!
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M$G\C$MI)<R36ZNX^;B0Y..!A@1D'C/-=J %Z #)R< #GUX[TM%<LI.3NW?\
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M"^4NINS$  #&XDXS@XYQR0>"!:;]K#_@I\1M3XN?%..,/E6;56WL >RE22V
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M-#Q%J^M_"#1[;Q'/=MXBTW3/L6K)?(1,)UNP\;D@'>OE_=8# "GD]:_39?F
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MMVQD\GOFOY!;'_@J%\<)%\S5?AMXU$V#O:*XMG!7(R K-D\#/3< /K70P_\
M!3GQP_S7GPY^(3R$*-JQ6#<Y'4M=H3TSG:.N ,5PSS/.H6<<BQLVW9JU[;=M
MMEI^![]'ACA>W,^+LK:=K74H._N[-KRUNO79G]8,_C3P\-HCN(&PWR!I!N!)
MZ@!67J1COZXZ'-D^(>D1S*JS0C&58EF]^F%Q@#\B>>@-?RRI_P %._$<+*\G
MPS^(9/RX7R-/.,8YQ]K!SD=\#&/7-,E_X*B>))?FB^%?Q#D*-@_N-. ]>3]M
M.3^?;KSGSZN9\3SO;A[$N*?NOD3DE=;IK[W=O7S.J'#7!\;.7%>5U'9<T(5/
M>N[;)IWMI>_2_34_JA/Q TIHRPGM^,_==AW']T'N!P0,]CVH'Q0TF! 3<PH5
MQT=]S =#@KWQ]X@=O7-?RHS_ /!4KQIL(M_A%\0V=OX)ETZ%..^[SI,]3GY1
MC/4URFL?\%1/BT\,D>F_!3Q6S,F"US?6: .1R0RJP.#Z*/J!FN*>-XJE\/#^
M)BG9*4X+32.K\EJNMEMV>SR;@BEK6XFPBBDI2M*;=E9O57Z;I)ZO9G];$?QF
MT6%R9;J+@C&R8MN].P5>2,@GZ]ZWX?CAX4*A9;^!3M_Y[P[L\@@C=NR",9 ^
MASD#^(/QI_P4<_:^U>V>W\*?#&?2-Q8"XU"XDNRNY,941X4;6.0-N-V"03D'
MY?UC]JS_ (*$:W/-+-KWB/25D/[F#2K=8(XPO0;G5&.<G<<$=@Q[>IEN"XSQ
M:;^JT<,FO@JJ#NDE[UU)I.]UKKI?J>+C<5X>X9\M/,\5BIQ5XO#4&Z<K=7*K
M&G=ONKK5+T_O_P!3^-7@])"_VZT.$(+><?O-T+'@@<'OCOT%>7>)OC;X;6*0
M#4K4#[RMYS!<E6"C^Z>N< ]L]N/X)?\ A??_  4$=GDG\:>-RPW%!YJ$!1C/
M&3UX_+GMCJ=&_:A_;QL8MM_<ZAJ\:KE#J5JLDK'('S2,W7KZ9Z@#%:8SA_CF
MI3Y:*P+DMU*4J=KI6U@U?5NZ>U]W<UROB'P[I5(RK3S>*3C>4L'3GIIK97>R
M=M^E[69_8_XJ^-FG(6,.HP$%E8N)V"!7[ 8V]<#@]3D$DUY<G[05LEXZB[.Q
M6VY\SY6))Y4LA(P?O%3SV]1_*6?VMOVUW5UF\,QSJ. #:2%F'^R5XQT;Y21V
M]:H#]JK]M!I@Z>$(8T0DD-9R9+'.,<=3ZD@ YR<YKYFIP=QU-_\ ,/%MW]VM
M.2N[7TJ2<>7\58^TH\=^%<$XK$9C*5FK+!Q33]W7E=/2W57W=VK']>6F_M!Z
M=(@9K]%;DD;T8E5."!YN,$_[/7N3U'3K\:=(N8B4O82&X^9I#DGOG;T]^A]^
M*_CZL_VN/VU;?:!X,MWP2<O \>.<XRN[/KD].@%=-%^VM^VE!'L@^'UCO3(W
M.DJA6Y&< #(Y) (Q_7)<)<?PE;EH2@K+WJD8Q:LKW<9\RW>R3NNV\OC'PNJI
MR6*Q_M-W&>%:MM97A3YE=6M;S[G]4^K_ !@ALY6F$YN(LNP"E2JAS\JKPS$<
M_+GD#KBJUC\?;)WVSRO#LV[3N R.-O"@-TXX7\S@G^3G4/VQ?V[+]G7_ (1^
MWA\QS_J].\WRVQC:OF*JLHSRV>>H.>O(:E^T;^W9=#:IO;.8G.^STR*W(R,K
MR'/W1C.1R1QQQ6BX/X\G*+M@H1;Y7#V]63Y;Q3:;DT^R3=D^RO;GEXA>&,7[
M.5+,:DXV2<**<7;EMK4BIWOO;;IJ?VI>%?C)I=PRG[3$RN>6\Q]P8J&(8$9(
M*XX&>_')KW31OB/9W*(T=Q'L;&U,S'^0!''(Z<>M?P0+^T/_ ,% X@K0^*?%
M4$N,*EO'"K!02 5;)(  /'0'IUXT+;]I[_@H_ 3'#\1OB+;1QC=&(I(E'<'H
M@)Z<#MGOFOI\OX,XA@DL9C*5-2:M&$6_9I:O77GWM>UK][Z_,9EQMP?4FYX/
M+L=*][1F^5=.[32_S\C^][7O%,5Y9N%D:5IT\N..,.6+'Y0#N4''0D]>.G%<
M7::SX/\ A!<0>-_%GAOQA\0==20MIGA7P;X>DU;["6"%;BZN)9+>T:8@J443
M8CS_ '@PK^&!/VJO^"E+3JTGQ5^)B*  JK<Q[>.F24."<?GSCK2_\-6?\%,7
MD<'XP?%51NP-NHG:1C(P0H.!C& 1@X'(X/Z!P[P;P[A<;2S/B&>(S/$X5\N&
MHQYE1A!N[<8RO%25D[N[OM8^#XCXZSS&8*67</4J.68>M&U6M5:J56K+W>:+
MO9WU?5*SZI_UR?M>_%*?]LSP[=?"?QWX%_:S^'WPBOBCZYI/PY\):5;:WXJ6
M-U>.SUC5;K57,&FPE0HM+"!6F8DS3A %/YSP?\$QO^":$>GI8_\ #+W[<NH:
M@(1$=6FLM-,WFXP)_)>_CCP#DA1D<D=N?PWE_:M_X*9A55?BY\47&1EO[2D!
MQW!Y!]Q@$#)P<YS%_P -6?\ !312J_\ "V_BLV[.775),J!P!QD=">O&#^%?
MISQG TY6J99F$YQT7[YV25KJ/O62U=DT[-[ZZ_DTZ/&=6/)/.<*J<9N<*,<+
M1C#F=E*3G%JI?9W>DFDF[;?J%\2_^"3'[-<MM=3_  A\'_ME:!?1K)]FT_Q#
M\.M"U6RN)&(9$DN+;6;.[BC7 !8&3;C< QP*_/CQ;_P2Y_:S NK'PU\._']U
MH0:06TUSX<>UNIX6)9/M$#SO(CKA49B2,]&8C-<&?VL/^"F0R@^*_P 6'4C_
M %AU%E;K_L[>!VY/\\O3]K'_ (*9(N#\5_BN<Y7)U*0GU'!!&>_'L<US5'P+
M5E=99CXWLK>UDUI9/NK-._5*]_3HP]3C:@U'^T\)."M9.G%7VOJFGNDM]K[:
MI<'?_P#!*K]NRTO]^F_!+QA=0F%H@#9.K'*D98"0_?/\L8]<6Z_X)-_MV3KF
M7X#^+_,)+#_10"A[#]XX.![#Z'L/54_:P_X*:H2R_%KXL=R&.HL ,<C<< X'
M'.!@#TIQ_:Q_X*:$%G^+GQ28Y[:E(V ?P[G_ #Z*$.!X?\R['/L_;-679::)
MI;>?2UEO*OQ?-/FQF"UZ>S=M>6]WSW\W_P !G@+_ /!*?]O:W;Y?V>_&3P@;
MC(L$484#OB65..^!G'/'->3^./V/_P!H#X:W]O:?%3P1K?@A7*#[=K=C<M:A
M2 %S=0H\#2* %\LRAB?O>I^PM1_:;_X*0ZI#):W_ ,5?BE<0RC:\;:I,@(/4
M':R<-W!_3BKOPX^/O[8?A75Y?^$^T?4_B]X%U8/%XF\"^-8VU33]3LY 1++;
M7#E[G3]0A0L]O?6S+)$R@@%<J3#8;@O$XVC1JX;'X>A5;4JDJUU#1:NRO%+6
MSTUT9RXS%\6X/"2K4*V JXBFG*,/8R;DTE9*TM=K6Z>3W_,_7OAQ<V-\+-=5
MCEBP62X-M<PQ< %M@_>!BQ)("N6(&>,E1H:!X;\,Z3+)_:^GQZG.WRK-<&X\
MF X&9!%$BER?]O=C&,YR*_7;XD?LHZ-\3_!=Q\5?@1IVL-I"QO=>*_A-KT)/
MC/P1=1!7NI=-51MUC0(!YC)>1;)88@GVF/S=V/S%\0>&]2T)I6DA>2UCD:(S
M/&4,;[CM2:,J2CKC#J2<''8FJXD\/XX+#+,,KJ_7,JJ2Y_:4:T74IQ^)*HU*
M_,E9-N+YK73L<O#_ !WB,=.&#S?#4L/G--JZJ4Y1I3M;WJ:ES+M:R]U:;V/Z
M!?\ @EW_ ,%:?@7_ ,$[/@-X\\+'1?B5XQ^(GC/Q!;ZFFGZ'':Z'X6L[:WLQ
M!'%%+?27++*"TC/<"US,=BE2=N/TA\%?\'2'A]-4NFUSX5^+)M/$B&WL+FYT
MVXN&B8@R#[0L-DZ."0 S0L.3DY()_BO(G(1^<AQ@=@">2" #SQWXQU[5N6$;
M+=1R[1G: <,&)P#U[\D@CJ,@?C\=3@J-.-*%W&"LN;WI:V;N^MI::^2:V2^@
MQ<U7Q%2K6@O:3Y7+E^&ZA%)QLU:Z2O9*^I_K'?L*?MH^"_VZ_@?8?&SP1H6J
M>&].N-7O]$NM(UAX7O+:]T_;YA#P%D>*0,&0Y#8(R.#7VA7\Z?\ P;3S79_8
M>UVUN_,_=_$K6+B$N6*F&:VMU^3)./F7D'OG'%?T653W^2?WI,X)64GR[7TW
M_74*:R*V-RJV.FX!L'U&<X/OUIU%(DX'Q)X+M-2>\U1#=S7OD$P6:7#QP/*@
M.U<!U50['DD<<X(/->.W^FS:9*L.I:7I5G.RAXXKS43*XSCYRB,ZA2V/F(((
MZC/3Z@K UG0M/U%9+J33;2]U"*!UMC<QAP2!E(R6. I8#GJ,UK"HTTI7:T2U
MVVM\D+735Z?\#_+UUW/G=;J-/]5-X:MF4 %HK-KAP1SC!C<OP1EMH'ZUMVGB
M2^C-NO\ PE$\,,3A_LNGZ2XBF5&+/$ L<84R9 ))Y]S2WVKZAIEU+97%AX4T
MV>(@%3!'*Z \@,@&23C(SGCGGBHU\4ZB F-<\.6@R0/)TJ1Y!VSE;8'/IC!Z
MGM71\27NKHU=KRUO9_CK9#LVKVNG\UTZ7>_3^K^A?\+,T\*BQZ1K=RVU1E;*
M5-S8 /+)M&3SG)'/!-/7QUJ]QC[%X-U>7.1^\Q%C&>N4/7'0=N<UYV?$VHR[
MMOC"5!R"+'2)%#'D$@R1J#GMELYP<9KV+PIX@MM:M/)A:[EFLXHUN+BYMS!Y
MSG*AQG@LP7<P' SQQBL9P4$WR)KOS2TV5WLM7?\ X;0&FM_GIZ>>G]=C4T._
MOM1L5N=1TV72KDNRFUE;<P0!2K;L#.<D'CJ,]ZV***P **** "BBO/KS0_&\
MMU<26OB>W@MGFD:"%X'9HHBQ*(2J$':,#CM[TTK];;?G;\-Q-VZ-_P##K_._
MR9W[MM5FP3M4M@=3@$X'N<5\[:YK5U=ZE=S)=^([6(RE(X$MH9HE"Y5E3S 2
M%+ L,$9W8;UKO9/#OCQED#^*X-C1L&V6\N<8.=N-IW8)QP>W/IXW=6@@GEBF
M\27TDJ2R!\6=]PP.&'S;N,]  .IR3QC>C%7O>[MHET[I^OZ=&.-FXWT>NZVT
MUW7R3[[%LWETY.;[4WPI&9=,CD)7N"H1R.@R< =N^*KO+,1N-S<*!SAM(@(_
M%#'D#GT]Q500J_'_  D&IG SC[->'V[@>N..?:F-"1C;K&IMMR%*V%Z2?<$D
MJQ_X#V['FNAWL[;VT]35W2WUL^M[_"KMZ?EYGMGPYTR%[.75'$4LCR[(9#9K
M;R($'S8^53ALC../;BO4:X;X>R(_AV%4EGFV32[GN(7AD)8@@%'"L % _A'K
MDYX[FN*HVY._]:+H8IMI7O?S"BBBH&%%%% 'DWQ@^!/P>_: \,KX-^-'P[\+
M_$GPNES%>)HGBK3H]2L$NH6#17"0R8"RHP!5@01]*^5O^'5/_!.C"K_PQY\#
M@%SC'@ZS!^8Y/.<U^@5%.[VN[=KCNULVOF?GY_PZH_X)T9R/V//@=GU/@ZS(
M_$9&?SKJ/#__  3=_83\+:C9:MX?_98^#6E:CITRSV5W:^#]/$MM,A!62)G5
MPK @8.,\8SBOMNBM:.(KX>7-0K5:,OYJ524'VWBT]M/0SJTJ=:*C6A"K%.ZC
M4BII-;.TDU='SMJO[)/[-.N7<NH:S\$_AYJM],09+N_\-V%S.V%5 /,DB8@!
M550!P  !C K.7]C/]E< @_ 7X8,"<X/A/3#]/O0MG'KUKZ:HK.<IU)NK.4IU
M)?%.4G*3[7;;>G^9</W:4:=X);*+:M]Q\T?\,:_LK#@? /X7@#H/^$3TO _\
M@?C]:4?L;?LKJI4? +X7 '/_ #*>EYY_[88';MV%?2U%2&[<G=M[MMMN[OU\
MSYG/[&O[*Q^]\ _A@W^]X5TP_P#M&E_X8V_97[_ /X8-[-X5TT_E^Y&/K7TO
M2$@=: /FK_AC?]E;M\ OA>/;_A%-,_K":3_AC;]E;_H@7PN[_P#,IZ7W_P"V
M-?2A=0,D_P"?Y?K3?.3&>>_IGC\:->G]/H"\K_UM\SYL;]C3]E5A@_ +X7=0
M?^13TOM_VPIZ_L;_ +*RC:/@#\+L=\^$],R?K^YKZ/\ /CQG)QG';_&D^TP_
MWQ^8_P :;YG:]WVO=]MOP_ =WW?]6M^2_ ^;S^QK^RL>OP#^%^,DX_X1/2\<
MY_Z89[^M)_PQK^RN.!\!?AB!V7_A%-,V_D(0??KUKZ/^U0^I_0?S(IPN(C_$
M/ID?XT6?9_<3RKS^]]_7O^)\V_\ #&G[*Q()^ 7POR.X\*:9GCIUA)&/K3A^
MQM^RP.OP$^&+?[WA33#_ .T!7TC]HC]3^G^-'GQ?WJ+/L_N!1M9JZ[:OR\^U
MOP/F[_AC7]E8#"_ /X8*<]5\*:9GZ<PD8[]/QI/^&-/V5S][X"?#%AZ-X4TL
MC_T0.G;WKZ2\^+^]3O-3&=PI?+\/1[_=_3!I/5W^]_Y^2/FH_L9_LJG_ )H%
M\,!CT\*:8/\ VC0/V-/V5QT^ OPR'T\+:;_\9KZ5\U"<<]O3G/IS2[QZ']/\
M:/Z_R#E79_>_*W7R7X'S2/V,_P!E49'_  H'X7<]?^*3TOGV_P!14O\ PQQ^
MROC;_P *"^%V.G'A331_*(5]([QZ']/\:>.0#ZT E;:Z^;\O/R1\SC]C7]E5
M3D? +X7YZ_\ (JZ;_P#&N/PJE??L<?LN1PO)%\!_AHA7!RGA;31W.>D/IQWQ
MFOJ,N <<_P"?QK.U%LP'&>00!G&2 >N/8X[]:TI.4:D'%N+YHV:=K:KJ347[
MN:2W3T77_/YGY4?&SX4?#[X::YH:^ O!F@>$K2[L+U;B#0K"*QBN#',ICDD6
M$!694.P?*",<=:\; 0)]T9#<>G4DXQP,Y[5]<?M1(C7OAN8@AB^H(,\'!BC9
M5X]<9(Z>F#Q7RE%"JHQP23U)QQTR1Z?T_$BEFD^7%4H\VKHJ4[[^\H/\;O7K
MT.O+G%X=1;6TE:]GI)_>EJFG:^J1\;_'A!-XPBPA4#3X%X(.1SZ<Y/H?PKZO
M_84^$_@'XB0>*H/'GA'0O%=M:W=J;2WU[3;?4(87DB"N8EG1@C-N(W Y&<U\
MV?&/3VN?%T0X ^PP9/8=<9SSU."/4GFOO_\ X)_6*Z;I'B>[?:OFZG J-C&Y
M5@53USP3G'^UVQU_J?.<0X>%F$@IM3GEV!A[K:?QT[QOIND_-J_F?S5EE-?\
M1-S"7+=0QF(G!O;X(KFZ7M^;[Z'V=:?L>_LNO&)9/@/\,GE)P6?PKIDC$D'^
M)H"?4#K^'-6F_8T_959MQ^ 7PNW>O_")Z6?YP&O>+34(%C0>8O.#@YSD>O)Y
M(_3\,W#K%@ 3YP&#CD?RY'\Z_ENK&;J2OS.]M[[.VFOF_P!3^B8>]"+=[:VU
M:U35[K2SVMZ=-CY]_P"&-_V6.WP$^& .<@KX4TP,#G.0PAR#GG(.<\]0*V[7
M]EW]GZQ"BS^$_@ZV"C:HATQ8]JCH%VN  .P QZ@GFO7Y-?L(QDRJ/<L,?B,\
M?]]<>IZ&N?%.EA26F (!Z98=3C[H(/TW?7%92I.H[SCSNUO>M)VT5O>O;HK'
M33KUZ:<:56M!:)J$YI/;5J+UZ7;/);C]EK]GR\;S+OX2^#+B3.=\^E1RG/J"
M[$@_CZ^M9,G['?[+LKM)-\"OAO,[L69YO#5A*[$]26>-FY^OTKVO_A+-+[3@
MCU\N3_Z](?%VDC_EX3\59?RR1GW_  I1PZA\%*,;?RQBGWW6I4L1B9Z3K8B2
MLE:4ZK5M.[]/Z3/$1^QK^RL#D? /X8 ^O_"*:9G\S#GGODG/?M2']C/]E4MN
M/P"^&!;GD^%-,/Z>3C]/K7N \6Z6>/-'U) !^F32_P#"6:5G!G4'..$9A^:D
M@_A5\E2_PRNMO*W9_E_P#-RJ6LW.ST:O)K7R_,\//[&G[*Q '_"@_A?QC_F5
M-,[>PA _3MTI?^&-OV6/^B"?##_PD]+_ /C%>Y_\)/IO:XB_'*G\B<X]Z$\4
M:6Q*FXCSGLV,<=^OT^M/EJO7W_+WGW3Z/R1'+?[+^<7V7=::6T/##^QM^RSV
M^ WPR'_<J:8?YP\?4?3H33/^&,OV5B<GX!_"\G.2?^$3TS)/N?)_.O>CXDTQ
M?O3QXSQAT/\ (G]0*3_A)]*_Y[J?HV3^0!-'[W=.IT>CEY/^OGV8XRG'X7-?
MX6UU2Z/S1X0?V-/V56.3\ ?A<3_V*>F<_P#D&@?L:_LK#I\ _A>/IX3TK_Y'
MKW?_ (2?2C_RW4?4X/Y$ T?\)-I7_/PG_?0H7MOYJOSE+R[OR7X]%HW.H]).
MHUIHVVNGFUU1X6/V./V61_S03X8'Z^$]+/\ [0_S^5./['7[+1X_X4+\,,>G
M_"):3Q]/]'_#Z5[<OB?3FZ3Q'Z,!^I//X>HIW_"2V!Z2I@$C)92./^!?YZ>E
M/]]U<_FW;HNKL^B_ 2NFFKIJS3M9K9KS6MCPP_L<?LLD\_ 7X7X]/^$3TO\
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MWG][ZV_S7W^H*4TFDYI/=+F2Z=-NJ?JSY\7]C']E12"/@%\+]WJ/"FFCZ_\
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M][_KHON/F?\ X8V_99_Z(+\+_P#PDM+_ /C-'_#&W[+/?X"_"_'_ &*6E_\
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MOYNJ5Y2FVDKI[V\K;=-C^A*3E&G&*LDM5U=I6>_R/$[GPOJK)E9"> ,$'/8
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M67&6''0#MVQQCCOTY[\\5>HJ>>7?\$/88B[5Q[G_ #^-/HHJ0"BBB@ HHHH
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MM%5FNX(H$N+B1+5&0.?M#K&4R,D,6( ([\T6E[:7\0GL[B*YA)*B6%PZ$KU
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M]1$JI@X^98F))8]2 Q!  )YS7KC(CC#HK@$$!E# $=#@@C(['J*<  , 8 X
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M-X'3- RS12$@#)( '4DX _$TH((R""#T(Y!_&@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI"0!DD #J2< ?B:
M %HHZ]*K27EK%/':R7$27$JEXX6=5D=5X)52>>?S[4!_7WEFBD) !)X !)/L
M.36-I?B#2M8>>.PNDEEMY&CDB/RR?*?OJA.YD(Y#8Z=0,4"NOOV-JBD.0"0,
MD X&<9/89[9]:X>S\<6C:C-I>KVLVC72RR+;FZ(\BXB4X659L*HW]0,8/&#R
M,M)N]E>P-I;NQW-%<]X@GUV.QCN/#L5K=3JX>6*=PHE@QDB)L$;SU!]JQM'\
M=6%Y.-/U6";1=5!"&VO!B.1CQNAFP$8,>@/7(P31RMJZU\NOW!?U_JW^?X.Y
MW7^?\_F*BFGAMT#SRQPH6"AI&"+N/098@9/85P&I6/B_3+ZXU31;R+5+.YE\
MZ72K@D-&H4?\>TA++R%Q@'KC%11ZKI'C:)M!U:RN]/U!,2F"565T= W[V"5<
M CCN,$';UZ-+K>ZTO;==]/\ *^PK^5GIOYV]7U[>MCTA65@&4AE(R&4@@@]"
M"."/<5S-MXPT&YOI].^VK#>03M;M%.K1;Y%.#Y3. '&>,@XZ>M<J-!\6^&,O
MH.I?VQ8C).FW[$3(!D_NI&W*,*, ;ASC  K9CT/3_%>G17.N:(MC?;F#!2$G
MC=<#S$DCP2&Z@D'GD9IVCNW=/9K1K;H_^#IT"[]'V^Y[V[75^YV,[RFVE>T$
M<DWE.T 9OW;R!3L!9<_*6P"1FO.D\<:KI<C0>)M!N+4*W_'[9+)-:F,G 8G#
M#=C!(##(Z=:LV/A77-$O[<Z5KCS:5Y@-Q:7^]V2/^)("N1GN-V/3/8^@/&DB
M[9$5U/4.JL".X(8$8/?BC16O:2?;1]/N\O\ APU=KZ/?KU[_ (Z:M::]_,KB
M6ZUV[;5?"_BJ&.01H/[,G"E%;@;6C<JRY .[*\=3TS6?J&KZRL(L?&GA<:A:
M*VX7>GDRH74'#E5)52R].02>.>:ZC5?A_H.HR-<0Q/IUV26$]DWD_-V+(FT'
M!QR"&&.#6?I^D>,]%NK>W74[?6=',JI)]K#?;(8#DD@LK!\9QU) [U7-%[=$
MDN9*+2T^U&U^O2]AZ+II=?>[6?\ P=]#*TWPQ;ZA91ZIX-UO4M)AD)<6TX=H
M3(#]UHI "B]B%)XXXZ5KV>G>)I[V&P\2V&D:MIVQBVII$@F1B#A=C?/DG 9B
MHZD@D5Z''''$H2-%1!DA44*HR<G &!3ZAR=]EIM?6VWXZ"4;)?UU3MTOLE?_
M (8X&[^'FC/(+C39KS2+H$D2V4[*F<\9B/R''0>U=E;68BLX;6X87A2)8Y99
MT1C.0 "TBD%26QSG.>]7**3;>C=_Z[[CLKW\K?+^NQ3M-/L;#S?L5I;VGG,'
ME^SQ)$)&7.&<( &(W'!/3)]:N444AB$ C! (/4$9!_ TR.&*(N8XHXS(0SE$
M52[ 8!;:!N('<_UJ2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *8D<<98HB(7.YBJ
MA=Q]3@<FGT4 %%%% !42V\"RM.L4:S. 'E"@.P'0%L9.*EHH AN;>*[MYK:=
M2T,\;12*"5)1P0<,""#SP0<@\UGZ5H>E:+%Y.G6<5NO)+ ;I&).27D;+MSSR
M>.U:U% '.^(M 'B&VAM)+VZM(4E#S);OL%P@!_=N<9 W8.0>F<@\5>TK1=-T
M6W6VTZUBMT &YE4>9(W.6D<Y9B23U.!G K4HIW=K=%_PXK*[??[NG3;IZGFV
ML>+;^^O9-!\+6SW%ZKF&[OV3-O9'&&^;<H+KD?Q<>QK3\/\ @RVTN1M0U&5M
M5UB8B26[N!O6)R"2L"L6VJK$X8G/ (Q76V]G:VF_[-;PP>:[22&*-4,CL<LS
MD#+$GN2:LTV]+*Z777?;_+_AM@2ZMW_K?^O+=JYQWBF3Q+*]KIF@0I$MXK_:
MM4D.5LXP=K*J<9=E8LI!)! P,U<\.^&K/P_"QC+3WUPH^V7DC,7G?=N)P20J
M[CP .F,UTM%*^EM%Z=?4+*]WKK=>6B7Z'FNNSZ[XCU.3P]IL,VGZ;"RC4=3=
M2C, 0_EP$=G *Y'.2,'!-=W;06^DZ>D(>0V]G!S)*S22%(URS,22Q) )P/H!
M5[ !)  )QDXY..F3WQVS00",'IW'!!!!!!!!R#GD4-WLNBZ+KY^H)6ZW]>VF
MGX?,\TTN^UGQ9K::C"T^F^']-=DA4-M?4)0<,TJL.8\@C  &W&#WKN-9U:UT
M33KG4KLD0VZ%B%&2S'[JCW8\5HQQQQ*$C1(U'144*H_!0!WJ*YM;:]A:WNX8
M[B%B"T4JAD)4Y4D'C(/(IMW:TLET_/[PL[>;W_!:?)=>IR?@ZZUW4H;S5M5/
ME6M_-YFF63*4>"V'",_&?WBXZY/'3CGLV(52S' 4%B?0 $DGZ"D1$C18T4(B
M*%15 "JJC   X  X K!\3V^JW>D7%KH[(EW<%8C(QVE(6)\PQG@!\8 )( !/
M4XI;OHKM+R2V_ $K+J^_77K;K_7J96A^(KW7-<U&*VAC&AV""(71.9)[HDY$
M?RJ=JX^8<@#J<D5UE[=PV-I<7D[!(;:&2:0G^[&I8@#(R3C &1DD"J&@Z/!H
M>F6]A .47?/(<%Y9W^:61V'WB7)QG.!@59U/3;35[.6PO4,EM, )$#%2<'(Y
M&#P><=#T((IR<7+16BK+S:6[?FPMH[;^;O9V\^AE>%=8NM=TS^T;FV%LLT\P
MMEYR]LKE8Y#ECRV#TP/08J3Q+KJ>'M-:^,8FE,L4,,!)!E>1PN 1Z Y_*MFV
MMH+.WAM;:-8H((UBBC7HJ*, #^9/<Y-9FK:%8ZTUFUZ'864PGC0,0C.""-Z]
M&&0.M+1O717_ *TUW]=!:J.F^G;[K[;>1JP.\L$,DB>6\D4;O'G.QF4,R9[[
M22,^U<]J?B--/UO2M%6U>YFU,,Q:,X\A%."[@CE1U./>NF  & , < #H!Z5B
MR:%9RZW;Z\YE-Y;6SVL2E@85CD#!L(1PQ)SG.<\CK0K==1V=M]>_?_@=S:KF
M]+\0IJ>K:KIB6[)_9;K$\VX,KR-DE0!TPN/QSTZ5TE8FFZ#9Z7?:IJ$!D:;5
MIUN+C>V55U4+A!V!Q^I'>A6L_33[T#OI;]+?/KZ6^9MUSUWX@CM-?T_0FMW+
MZA!+,EQN C7RL@H1C)8G;CGN<XKH:\_\165])XL\+7=K;R200_:4NY44LD2L
M4V%R 0HX)R2.F!WRXI-N_;_+]+^2W>@-VMZI??W\OZN>@5S>C^(4U74M9TPV
MSVT^D7'DMO.?.C.-LR\#Y6R/SQUXKI*Q+70;&TUB]UJ$2"[OXTBG&\^40F"&
M"= Q(Y/6EIK^'W_Y7!WNK/U_J_\ 7I<OZA<26EC=74,0FD@@DE2(L5#E%+;2
M0"1D#L,GI6?X=UJ/7]+AU%$$3.7CFB5BPCEC.'0$@$@'H2*VV4.K*PRK JP/
M0@C!!^H.*R=&T2RT.":WL0ZQSW$ERRNQ8!Y/O;<DX'\^_2C2S[]'^GZ_UJ:W
M7:SOK^GR_'[\WQ7KMWX?M+6]@M!=0-=Q0WAP28(78 RDAU 4#.<CJ ,C-=';
MSQW,$-Q$P:*:-)8V'(*NH93^1J.^LK?4;2>RNXQ+;W$;1RHPZJPP<>A'4$<@
M]*2QLK?3K2"RM5*6]N@CB1F+E4'0;F)) Z#VHTMY_FOO_0-;^7Y;?GJ<GJ'B
M2\TCQ-:Z?J$,::1J$>RTNDX9+D$#;,3G.YN !C&02<=>WZ]*SM1TJPU:..*_
MMTG6*5)H]PPR.C!@58?,,D8(!Y'!K0 "@*!@   >@ P!^5#MI96=M?\ /_,%
M?7MI;OYW.(\7WVMZ0]AJ]A^_TVU9EU*S5?G,;\?:-Q^\(USA1C!))XSGJ-,U
M*UU>Q@O[.0/!<(&4@Y*,0"R-CHRDX/3L>]7)8HYXWAE19(I%9)$8 JRL,%2#
MP01U%<AX>\-W6@:IJ/V>Z!T2Y EM[(DGR;AC\Y09PJA0J\ $]R:>C79K;SOW
M].@M4[[IOSZ\N_W/T[ZF#=ZCJ_@_7'DOGN-1\/:M<C9,Y,DFGRMM58@!]V/+
M9P5)(48)[=]J=A%K.F3V32S11W<(VS0N8Y4SAT96'(YQD$<C(J_)%%,H26-)
M5#*P615=0RG*MA@1D'H>HJ3ITI-[/9K]+6_K]-$[;]G:VKOZZ];ZW7J]3S?P
M]=Z_HFJ1^&M8@GOK25-VFZLI+J(XPQ,=P>2N O&XAL^Q K<\2^%;77UCG$DE
MIJ=H,V5["[!D;!.R5<;6C)[$D9P>O!ZS ].G3VHHYG>ZT?7S^_\ J^H)6TOI
MTU=]EUZ=3D_"\WB#R9['7[7:]FWEPWX(V7T>?E8("2"JX#$\-T]:HZ]X,CO)
MUU319CI.LPJ=D\&(XILD$K-&H"'=SEMI^@ZUW5%%];K3RZ?TP2M\MO3^EKW]
M-#/TK^T/L%O_ &IY?V[9^_,6-A;L1CVZCGG/)J#5]#TS7+<V^H6R2C'R2XVS
M1'LT<JX=2/8X]JUZ*+N]UIZ?UL%EL]?74\I%CXJ\&2A]/>7Q#H);#6,@W7EL
MC' *2$[FV\ $L4QG*$DD]K>:)I'B*UMIM3TX,[QQ2J),QW$).V0*70A@RD#O
MVKH:*?,[IK1KJM&]M_ZMY E:_5>G:WRZ=B.&)((HX8@5CB18T!)8A4 502Q)
M)P.I))[TW[-!YPN?)C\\*4$VQ?,VMU7?C.#W!-345(]@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
-BB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>nt10006151x14_graphic5.jpg
<TEXT>
begin 644 nt10006151x14_graphic5.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M7LUW>7<TEN"\MU)<33S27+.&,LLDAW8.&/?[>M)"Z')R1C&0 =O;...N??\
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MG(_'3]J7]I&Q^*6I+IGQM^+6E:=)+(L=K9^.O$UI9H&E+(([>WU1(BHXQO
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M^(_CVW2-SXZ\3QJBB1]NNZKR%Q][]_VSG'O^%>7:]\9?B9JDS_V=\0/%\,<
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MG!+!ACYB>03C'4D<Y].+#1Q-.K>57EA&%%?.UV_=5DVFE^-^VDW#V<;V;O\
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M8# C'4$<^O/'Y$CG@T%A'R449X^7KZ]U7(]>>M>5P>*KC(/FJ<<@'/;G'?\
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M:/O*.EG=/?5=K(]S)LTJY=6E!N2H8A<E6#=KQEI>STV?S[['EGPJ\;:=\2/
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MO?<N-,V3M(QGCCM2><_M^54_.^GY-0LV2  .3CD<<\=S19=E]R,XJ^[MMO\
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M1-#'*F]=K L2"K+U.  0<C&,8 R"RUL--O[&WG>SM2\D66S$Q#K_ !;3P6(
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M (XII!)R&.#Z?_KI2 O4!<^O&:7=@9W8 ]^!5F\)QD[:Q=KWOI?3R[ZZC"N
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MO:A\/O!$[/-<> _"<SV5Q=6EU'S:3QB" JD/,;&2Y<D LO# #]K_ ( ?L??
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MZ%XK"=^HZ2-G.<\<],]^#QQ4>JWN%?KG/1> ,<<9YY]QD'VZ<'+?G[6O!P)
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M[L1 R* K$]#G<.Y&?ESR/>OCCPMIU]KUS!';HN)/E(*,2P)"Y!!X''.02<@
MC'/W%X&\$6V@6,4UTD;7+HF J#$9..>06W=<G/N.:Z*$*KIQ;;2L[M;[[/\
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M%22P\PKN'RD8;())./IRUU>/4K&.[C,<R-#'*1'()(OF&[*NF!(,./G#;67
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M&<Z+I74C/''IQ7S'#;)&K2C <D@@DE-O4X''S9 QQTSR._T_^V9_R<=\1?\
MK\TWH,_\P72^W\_:OF NQ7:,#O\ <8'@=SDCWZ=:^=Q=*F\7B6[W=63>OIT]
M6>_@_P"!3=KM1C;I_+^OK^!7N6&P+L4_,&.1V'&>YS^0QG-<^\>U@J(<2;7^
M4?*'WW 4GOC@$G''/'KN.%;<'9L]!@X&#C.>OT_P%0+A%( #&14C@+#/[PM<
M%M^.2N.1C:?7WY:M*,(*4;WOK=Z6\M/OU.J3<TE*+M9;7TV_IK\=#X%GT%+S
M1?BK<Q>:;^2ZDAW^9E%&923Y9^79V!'S=,]36W\$_ .JWNE:=>2V]HS92*0Q
MVZ$&-9UVDD@9<MC=VQDACWZ[_A'DC\$?%+5XYT4M?2+CDL7)FCVG!SM/MZ@C
M&*]._9@MHY/!=K/*[K+)Y6T212NC2&1Y'5"&!&1'A3N8C/S$]^5+5>C[;75O
MEZ:*^G0$[)>X]/+:UM=ET7X+Y?J;^R=I3:5X;FM@L49$$(8*NS.8V !501M!
M^F.O)KZ]$I3@L#G!ZCLH4]1GJI^HQ7R[^SLR1V-ZFR6"0;(U20YW+'N56^Z,
M CJ.O3CM7TB9&/?G)!X'7)_*NQ2Y::=^U]+]M.G3U/)Q*DZLE&RE9-7[)+HV
MN_2Z]&:@<-SD<^X^E+5!67:,N0>XSC^E3!@#U).1CICK]!G\^V:J$G*][6TM
M;S77\_F8PC/F2G;622LK>OY_U<G+@$C)!]1_D_RJ:%QN^9R4Q\P.,Y[8!P#W
MSD^E5^" QSR<$#\1_3UHW* < CZ]._7FM#N45%6M=>>O;3\$322$,<,,=AC/
M'..X[?A_*H?,8_\ /,@^H//U^4C]3]34#GS%)R1Z@''0C^F.Y]JBR@&/08^\
M.WMB@M.W1:>2VT_X;Y^A,3)CK'^ .?P^04PEQTY_ C_V6A64D ,Q/ID?XU(V
M,<DCGM2D[)OL.-175E%OM;?;_@_TF(!N!+#G/IV^O7K2E$VL_9?O #D?AD9X
M]/YU6D<*1@YXZM]>W2D\P[1)P3'G;UV^IR,X/)[YJ:%1.7OM6Y7LM;ODLM?5
M^K:]%E6CS+56UZ*UM/\ AOO,WQ/=0Q^'-1DCG9I1!(\,6WY,K<0^:3D@XV\
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M(F5QM9)8+>&(HH.2)2X1.6=6&16CI_BJ*U"BZO@[.P#*0>,\?+ENHQQG(Y/
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M22?03PQH!DBG%A:/L/F1F:)69&] -IPHYZNQS5-+J1@K2"3S%&UP2&P021C
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M6/[/$3P_ #X&0R(D<D7P=^&43QQ@+'&\?@K1$9$4<*BL"J@<!0 .*]AKPO\
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M'4"0YKZ_2SM0\DD:!#*%\W  W;%*(IP,%0K'"CCGCJ:J7FIV=A;,\CHL:A5
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MG_5NJZ'&?"C]D_3=8;5K7XC^+]2T5H4A2Q;35A E1Q\TDCR*[,1P&RH8DCG
M.?5+_P#8^\(^&] U"_T#XN:G)=11R-:17$5K(S'#%8W1;*:3YN!D-'QCD_P^
M@^=;S_,ES).R[2UW!E$E$@+>6"#@[2"2!C!'X5!?30RHB%K@#D',C88\'+#
MSCI[#M652E4<':*?PZI.^CC?5;?-^NFA4;75]O/_ (/]=3Y6\,_#?Q]%+<QS
MZK9S1+*0DLT>)9$#$*Y0QIC(YY3IGKFO2;+P-XCBN@9+O2V^7)R#PP&20N"!
MW..1DXXKUNWMXHUP@"J1N#+]\YP<D=>O'T[@4U[6W0F7?+YI;EB[8P3S\O3'
M7Y1QVQZ\_L:MOX<^_P +?9[ZW_RV-+PV]V_IZ=_77L>0:GX?\3P%U2&WNB0!
MO@12#N8 \$;3GH2>F01R,5YWK'_";:6!#:Z9-;)&R2R"58W3RB?WCF0'"C'/
M7MTZY^J[0*KATG9'SE2,J01R<G!(R,_PG/MGC8 %V6\WRISL*-'*BRQR(WRX
M=6C ( /&#GM@]:F4)0^*,H]?>OMIKJ-.+?3R[WTU]=ON^[SGX<?"[XD>+]#A
M\2Z=+X<^R@-&;;4KD^;(S/\ ),XDE"@INPF0<*N0><5F?$+P7K_PXUBUO=>M
MK:/4KBTC1+C1;Y H1G^8NOFJ6D92"%W%BA!Z&O;+33K:***TM4-O'D!H;<31
MP2[FR 0&"I\V3C&W.T@]J^/OVD]?NXO%>G6!O+B"?3X;;R-DSLA9W*DRI(S(
M55,*"< U-TTK=?ZVM?U[=1V].G372W^7Y=M?V$_9]NWD^&FARS23O+<(DI,K
M.5"?9I'(!;NS .1DC=SR17J=S,OG(2%#;U.3@$X/J <Y)['G/2O)/V>(V'PD
M\#R2RF9+K0[&5GR/]:8)%D(QR,+W!'('/>O6/+2>9LG/ED[/<C_#'4__ %Q<
MDE2>BOR]CDO[^_\ ELOU_)%TN7D( ( VDCZYZ_ES5N(+\I('?D@>^/\ ZU5E
M!R6/4@ _1<X_G3XVS+L[8'XY]L?YQ7(:/^OZ_,OD+DX QGC@=*DC(P<$<'MC
MC&/RI513\H_A&._&/S_#^M211(!AE//7@_S^OO\ CTPG)1W=K^=NJ_6WX";]
M59J_X-_AOT&$(RG=M90 2I<J6R0N%V]6P<@'CC/4"OE7]K7Q[_P@GP<\<W%Q
MIMZ^AC0K^U=X7!O[GSX@3!:&$&YC<ECY;*R$'@5]27&822GW@/E#+N1LD#9*
M/O%,\G;ALC@@9KXW_:WU.6'P<MLK>4+^1[>5)#BS!=5VM#&Z.X 8<[@QSTXX
MK2E)N3:;LE:ZUWM?3RTZ].EA))MNRU5]>C2VM;1_-ZK4_(3X?>(_A[XF\#+H
M&F>&=:TGP]<R7>HWMOXFTSQ%J%UJ&KE%>(*O[R-8!(S1!0 LJ L/OFO@[]JO
M7-%N?BC\+O"VC:)9:1X@CU6&WN[*TL+W3?/M7O;#%P@O4!5)8C&&"E5561>!
MBOWB^ D<]T^K3:A=#48[)D2RBD*R_9AM0K+;G[*HW1D[E69?E.0I*J,_BG^W
M4?\ A*O^"A/@C1WEDEM;4P6]R8Y%\U-R>'B?NI$(Y YR2HPC$E1@<^]3;Y::
M<F](:7OTC_DEY6\P2716^7IU:3T_K8_57X,I-'XI^':Q)B<2V%NT1F$Y"P&W
M4 ;21M1=RC:<#) P#7[J%VCLT))63R=-#@$@9\A>.O!QCCC(Q@U^,WP'TF;4
M?BMX4A2WBBM+.&*79 @PGV1X56(L.,N$$DDG_+1AL[U^T31B=H(G7:TL$&]3
MRN^W38",>RC!Z]<XZ5.(2YI2:5M-7:UM;];=8_@_,3DTMWOING96VMULEVWM
M=6L6UF&2 !C(R?4[5Z^Y_P .M+YT??;_ )_"JS(-S9ZDG)SWZ<=N@'8#VI-B
MCC'\_P#ZW\J\>=^=VM;2UG96NK_/O^MK!&W=MVZWTV?73>S^XE$RY&",]L,,
MY]L5<2X7:-Q&?4GD_7KS^GI6=M4<XQCGOVYI^#C/8TDGU?R^[^GYMZZEZ=-"
M_P":&>,C!"L"PSD$ J<$>G'^'(IFJWXM],U34R<^7:7GS CATB<19/!#9!V#
M.[.<<G)J*Q7)''!&?K_/Z5S?C2_ATOP9XCNB0OV?2+Z\8L<HSPQ32+N7C'!
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M2Z;6CITUT>GE8SH[RU^S%+[M?Q_4]8LH\0PDC("8SC@''K]#^O%=A;9$:#D
MH..F?P[]3^9KG;0)M@B7/"D]/;CD\9Z?X]ZWB64H#_"#CG'!'&".V.W'ZU\[
M*2C7D[V2:2=^W*_TOZFSNVM/=[^EGM^'=;E*4N)&P6 R>F<=3Z>U5)LE23R>
M>3UZ&IWF)=LG'.,8S_0_Y[5!(P8$ \GVQV/M6W/#^:/WK^NOY]F4E9)=M/N+
MMMNPOWL$\]<'@9SV-60I,A&#@ G&./O?Y_"J$,Y3:H(QWX/I]/QZ?G5U9&89
M&,?Y_P!FA3BWI)7\GZ?YE0^*.J6M[NW3KJ:"C@=,XQR0#QVYQ^G%0N-K9X&.
M01CCU((Z<]:@%S)'P ISSS_^H4BW+R2E6C!!C;!&.2 ?7@=<$G]*H[Z*N].5
MOEOHE?==5ND.DG; %NR-,0 /-.(LG@,S$XVEC@D?J>*_-W]JO]G+X:_$676)
MM;NGTN\\7QZ?:^)+=7DD758(?-#Q1*N"Z[V8A26X<@##8K[P\6R/;^&=5N;<
M2QWIA>V@E#L$0MN' '1@""&[D YZ5\?7NHWEM#+)KOE:P%#"$7DB-/'C)+0J
M2S"11\T;8P'4'D#FE1]NFFG))^;M?KOOIV-^22<7%6Z.ZOV[I[=]+=&?,'PD
M^!'PZ_9VT?5++X8^&[?2M-U"1DG>2VCCNIUM2@A=CM5OEY\I2"50DCCFNQN+
M^%Y4-HH:[N@RE3T9LC]VXSRJY+*#]TEB!DFI-?\ $MQJ]T+2%[V*TGC$ ,DX
MBE5 Q;]X\*%)=N.X#8ZDBMWP=X7@2[66:^MR82618(%BE(P@ F=W=')9\>8,
M2,"0  JDZT\%)1BH\R2>NZZI]7V[W_,IJ;UEJ_2_;2VOGO;;:YYS\;M8_P"$
M>\(0VD,HBEU*W3[0LH*?- OF,OS8W*20, 9YQR!7PO:^)]/\6"33C!)<7:%;
M%&LU(C98B.595(903RP; ZYZ&OK_ .-7AV3QKXBM=(%Y%:6EG<F.Y^R+)'/)
M@[92UPK.<A0,$( <#'K6SX+^#W@7X?V<K:;8KJ>H7A6]GNM5'V^>.<#+BV=P
MC6PVCY2 1D A3@BO5IQLXK6\5!*[T5DDO/O?_@F$O9I._LF];JUFGI?7375]
M[-7TU.%\,6"?"KPA<76OZ5,EC?VK7,3PY=\,,+PH)5SG!8X."<]>?E'Q?X\;
MQ=/=W/V_3]-N;>Y^QZ;87-RD4GV%6)@DP6!83$/@XVAHSCD&OT4U/2FUSP_=
MV5[:F>T"DA95,OD(AWA(E(X3 ;N.<#'.*_)GXV?L]Z5XVU2\UK2M:\6:5J5C
M'+!'%9:Y);6Z21S2/'Y5JL8^7#9."<$GH>O7=)W>BWUVW6G35O:^[;U1YTFK
MV6K=K)?HNVBTM>Z\K/\ MR_96\S_ (9@_9P\UE>7_A0OP?\ ,93E6D_X5[X=
MWLI/)4MD@]P17O5?-O[&EC<:7^R!^RGIEW-/<76G?LV_ RQN;BZD,MU/<6GP
MP\+V\TUS*P!EGEDC9YI" 7D9F(R:^DJ]".R]%^1YTMWZO\PHHHIB"BBB@ K_
M #>?^"_,[O\ \%6?VKX%!_=1? W<XVED7_AG#X/RX4=2"6YR1CKSQ7^D-7^8
MW_P<"W^M)_P61_;&@MI&6SB/[/JCY6*[9/V6O@B\@XX.7=B>A'8^OB9]1]O@
MZ<4TN7$PGKY4ZT=//WKKT-\.TINZ;3BUITUB[_AUT[GY;7;H;8RQM(OF+^_1
M>/,(7Y0_H5Z8.<G(KA]7(M+*[NBS[A;3-&,!6#>6<8Y)^7/(QV[9R+,FOW5H
M@3RX9HH^69L@;EY*L3VR,'.>XY-<3XK\807\8@0VZ,4*R!6+A02,@*NTD$ C
M)SUR>AKYW"X1QG:U[M/KTMO>U_NMZ[&TYJ*\^GX:Z[]]+]CR*R@?63>7$[%C
M#))(3(V%;8^XESMYX7"C.&/MUT&U,>9!<VV+:YM5+1/;L4D9F>4<D9.1O ^4
MK]P="2!JVM]"UA+I\%DLGFOODGB95<H#NP!M+8'/5CQQ3)K&QB%K=6,4L=QN
MVF&Z(>.3/=&''!SQ@<\D],_2>XJ+IN#4I/W=?<7D[.ZO_AMJS!25KIMNZN^M
M]%MY:;7Z?/\ OM_X-ROV^-7^,GPUO_A%\1]?CF\5^$((=/TNW>6-;NXTPA$M
MIEB)9W2U2)48Y9@&SP*_IB^,GQT^&7P(^'VL_$/XG>*K+P[X;T.RFDE;4;F*
M!KJ2VWE8+6*0HTUQ.4"Q1Q!F=RJJ2>O^5#_P3\_:@\:_L:?'KPS\8/#T=UJE
MMIAD&JZ/;SO&EQ:RSQQR+<*/O*4+*N[(3@I@@&OV0\6?$+]L[_@M9\<+3PUI
MUSK.E?#A;VW$&EVAO8_#FG:2MS'Y=]>&S:2&>X)<NQW)*WW5=5.*QRFABJ3K
M4^1NDJC]G)-VC3E:26NMH/2VUDK/4ZYQP]6$&ZD8-07/??FBH[:-6>G:SN>Z
M?M>_\%%_VBO^"GWQ>N/V>OV<=$\3V?PUO=6-MIUO; QW&K))/L-QJ;0>8B63
MQH[&-W!561PP9,-^^_\ P3H_X(]?"S]F+PWH'C3XG^&K'QC\7)K=+R:>Y2XE
MBT>XFQ=-#$9IBCO$\P0L5?.W.$Z'Z@_X)_\ _!-/X0_L/> +"WT>PM=<^)%_
M:0/XD\8WEO%)=?:VA56ATXB-1;V\1++MQYA)#%F8&OTN\A3'&AD.8PI\U2$=
ML?WF7:3PHZDD]Z[W@\-&JJ]:"KU(])I.*NDEOU5WY)[6,88FK2CR4*THPM9W
M;C=-)/9]5YW?5;W;:6<-M"([6-8-JHJP8PD"(H58XU4;0$ Q@#^E,O5N%@8P
MMND49VGINYR?7@Y., =>@&*OPXYVL0I/4X)..,DDY.3G'/X>CV)SC;D'@MQR
M/4?H<#VYK2I0IU(M*]._2*LD]-K7V_K1F$9R4DVU-K5Z/\4]_5M[=+GS/XUT
MGQEJEW(]L76!5VJJL0K'.=V -ISU&<<D8[ U/">@:U8JKWL#,RN220>Y&3T)
M/0].O&?2OILVZ2MAP"#[<\<CIC^OITXH>QB*X50#^//'?)//3G_ 5\OC.&*>
M.DYRK5+1E>,4W\2:=V[:::;_ )GL4LV5."BZ$;WW=E;9=.K:;Z6:]#S6'6H(
M04NR8PI &X%>0!T !XST/4\^F:T8M>5B6CDR@(Y4\8P",'(SQP>@!R.>:T-7
M\.QW*%?E0MGY@HR3S@#/3G!)'3MQC'S'\0-3O_!<Q,AE$05I1,%;R40#(W[2
M 0.02 #GUQ7SF94,TRB+E2E5=*-K.-V[*RU?;6_X6?3JH0PV-D[<L92U<7MK
M9:6UMMT_,^CF\3PPQF4N>,Y)*X&!P2,Y///.._;IDS?$32XD8W,JJ%."3M[X
MQD@Y_(8Z>M?GUKWQ\@B@$2W<2F1C'NW,<%_E! )/3.1GT->!>)/CI-*MY']N
M :'+-MDD'F(6^4X0JPQV"D9[CIGGI9[C_9Z59MN.SL]TM_>MO?SNMNIZ*R.A
M)[QU2L[[:QZ*^_W_ ''[!0?$'1[Q2;.Y$K!3E%."3D# W8XR#SR..17PE^W3
MI/AOXO\ PVU;X;^(KR9;#4K>.4G3G3[1E;NWD(ERLH.S9]P("Q/+5\=Z1\;]
M4LG2.+492URNY"&F.P.?DSN;Y>X SR.#D@@Y?BGXJWNM"475[']I4>5)<*#N
M<@J^UMP8@_*A)7;GC(SFM(8S,<9'DYW[UKQ7-L[;)==-&F5]1P>":J<L9R6W
M/\/2[UOM;S_)GQSIG[)'P,T35=1U-?#5MK%S#=VRQ2ZQ&3<L(X/-E9"?LX\I
MB"IB&%'4')P/8-,\,:%X>\O^RK"STRWAC,-LL4<:O'&YS(L>Y69#(0,E9!C%
M07VM"\EN);J0NLH<+.6)V3,IB9@HXP4XQR!G(&3D?//Q8_:L^#GP5L+F;QYX
MNL[>>)91';1*NI3M(JDCS+6W?SH<#J<28YRO!-?19?'&0BHU&TXN+BY:*_7E
M>K:LEVZ>AY&.GAZDXJG&G2DE)Z:7NH[M*[V_%^1]EV.KVT4D,"I<K;%MS3!7
M\JV)4AI7D("$,2 <-N)(QD9QU4OB_1?#6EW6H:E>0W5E:KYAED)50K,,N&8[
M0B+RQ[,!GKQ_.9\0?^"G^O\ B/7]!TKX626A\-7FI7$&J&4-<7$]H9;5;.15
M1U>S$L<DK;GB"*=JMEB@KUGXC?&KXC>*?"^C6>FW%Q9V-]IUM<WQ4S%95?>L
MR^:K")@X&W;MP/0$FOL,+A%B(QE4Y5)V3;;O:RL[>G>WJ?$9EG3PDY4DY-I)
M)I^:76VSZW7S2/>OVIO^"BFJ>&(]2T/X7:="-4::XM+;5)D$P="@19;*1',:
M-ACAL,0<YS@FOQ;\:Z_\9_B]=7>N^/\ 6]7U);A6N(;2>2Z,#*S'=!"(7C4B
M,GY^5"L"%./FKW33_A]XI^(7B"*TTG3;F[M+>\C2_O-0CW+;A\/(UM)&%)PI
M(&XG:,#@C-?9GB3P#X(^&/PXEO;A8+_4#8?9F^UK&MOI]Q,N[=&Y!D5^<'>6
M/4MELUZT<#&"BE.,K**M%7VMWBKW_/T9\K7SB=>\E)MO[-U=7MHNB=WW3[LD
M_P"":GAN:S\/W>NZO92:CI27[6OD863[(9+N*-R^\&6-(]HRQGY7@YY5OWZ\
M->'?"'A&S_MK3[>#4H+E?MSQB&&6(RS# CG)C#/'!@G8)2!@D=J_&K_@D%KV
MG^)X/BGX3-LNIWE_J<D%GI8"/N$]^J1RVLK$11E"PE+,""J< G&?WM\.?";2
M_ ^NVOAWXHW$MIH5_!]JL#;SQS0VLV?W=E>W4:M#&Q))PR+G."S XKHI1FJB
M;C**3U>FBMZ]7IHSBC3KU$OWDDF[.[U3OIMW2OK?6_0\ \:ZUK'C_2[72/#6
MAS7/B"6[*^&6TRUC2UWJ0"\C>7D0!Q+&06R2IP1FOSR_:7^'/B>_AN+7X@#2
M+#4]!2T>?2+?[1;2,TLA6.XD9IG$P,BE9=C+LX.*_H?TCPAX,\+O+J6@S:39
MIHUC)=Z?;J\,2J2'E$\]S*[HT3^9D!)(\L&&Q5VEORJ_;+^ 'B7QAH^L?$33
M-:\/13V EUS5I;N]L[&[U>TB@ENQ86"/<R&YP=FW:X!P.F=M:U:T=(^^W>]]
M&K+3:[MO;TUZW">&JJ*DJTVW9<J=KK36R6]U=Z^3/ ?V<-!O_#OAJWC\):[K
M'AJXU6U59YK>>23:GV=IC\QCEC!)&U1L4@88YP17TOIWQM^*OP#MYM4UC48_
M'?@^:YBM=2M]2CF::1F$;R(DVZVBVE9" Q 4D?= Z?.?[.GCI;[P5IMEX;T^
M\U'5B('U*5C);V^B2Y,"B68H$N752<6\?E>;RN_<0U?<6M^';'QSX)T_1M<T
M?2[AM.L3+K6H6Y5)9[N)"QBACC:26:2W41;U.#)G]XY'54YQDI1::5];6OTM
M;5].K:]-+&\,35I>R<9RDE&]VWY:+I;36W^5NVU+]M[X#Z;X9TS6/%-K%\/[
MS4+875E->7%LFFS!2ZFPB$9:-);@["N^=F<K\H&UB>Q^%OQ]U'XL0K?^%K:Y
M7P])@0:A X^Q>63B/SX49Y27!!W+N5@1M.1Q^$/CW]E'Q9XO\<6^N?&'QJ\7
MPOCNOM7A'P_ON$M!<6UP3IMM<Z2+@8$Z-,9'(4?(,JP V_9'@CQ7<? N6UU/
MX;:O+::+IL.^Y\/ZE<_:?#FHQPHOFFWMXHT^S2$C]WYMR6!&'^Z"?)Q^3X?%
MR<HSG'F2YE:RNHQ71N^SO=)GTF7\2.DE&5HI6C:;7.M5=N*;5GJ]WH^]S][?
M!/PUN]6BM]4UZ8,N\R"SA61(Y5;YEE>$D,2XPV6*$Y)*J>*^A;/3XK6)%1R8
MX4""(9^5!D!64GG'Y\8X%?A+\*_^"P?@?5O$]GX#U#0[RQ\4/?16ES"UW;R6
MQB<@)- L0)CB8#=&@9MJX!9B,U^Y^@:[:^)-%TS5K%D\O4K6&Z#D ?NYT+@'
M')!!YS@>N037'2R:EE]N1)\S3<E=-Z)WE=*W5=E^?T/UWZS%3A)2YDFE?ND]
M-=K/O>VUB[+.PD46]Q&P!YC0DX&<$$CG.<<=1V][J/#(5.<2 8.1TSZ X/7O
M[>M5AI]NI,L7S29W,1]TD=N/4XXR1QG /-1RQ2J?-#(HZD-G<.W\CD<]>N#6
M\HP?+%)MMI;+?1:]MT[?/UB+J7O)1M:][MK9*VMUY_EW+\VY2H4]3R<=.^.?
M;W]N>E9E]$);:10,R/N7ISSP"!W'IZ$ =AG4MYEDCP6&Y>&_$]0#DD'OP>_3
MH)/+[C;W(/U.<]#W.>*YZ]"$XRIR6K5KV6BV]>FFFVGF:Q;YD[I6TU]5:VEM
M/E^9\VCPQX@M_$,EU:&1(FG)SDX(R0>"3C()]!@?E[;8+<1HGF@,Q5=Q(Y8]
M/<<<G.!UYQVW&MD>0-M7W/()Z^A&.._7''L93"B\%1S[G^?6O#H9-+#5I5H5
M+7ES*,7):W3N[K>VNCWM;<[)8IU::I-)VZO=^GEUL^K\BFRJR_,5V'.02 1G
M^ZQ!(/4'DA@?NCJ?YZ_^"QW_  2M^%_[3GA>Z^,7@[3(/#'QN\- ZC::]I]N
MJ2^(&L(FGM+2<Q(8S-Y@8!WV,0<D$9%?T&7Z#R9-C;& )&.6(7)( .0<] ,'
M/(]QX-X[N+3Q!HVJZ+J**UI,"L43H'DCE6V<;EC8%7)^]A\CU'&1RY_CHPP$
M\-7J6<HVBT]8R5M6^][=[K1^Z['9DU)T\;3KTDDX23DGLTN71IIJUGHM-=;W
ML?!O_!/OXK:S/\&_!FE^,;=M,\7Z#I]EX?\ $&ENP6WB.@Q/IEG);0J6$9G5
MC,Q,C"-P%&X-N'ZRZ5JMM?P),C F1$PW')(SMR">>I/&?;(K\2)K?6/ /B:?
M2M,BB@L[RXGN8;Q=L#)&M^,+?,% W].2< =L<U]M?"'XNX6ST_7)VAN3A4#D
MM'/MVA3&_"88'( '(Z8'3\[R+C#ZAB(Y<XJ=&+4%4DME'EU>MT[7^?1)GVV?
M9 \70CF&'BISG[THP>J5E?2VMMEVM;S/OI55CN('3C&<\XZ=ST]Z9M)<\8![
M#H<CD#MCU/\ ^NN/TOQ797@1!-M9@,(YC4MW^3<5) !&<9[9([]0E]&W[Q75
MHB0GF!D;#\#:<9S[X)Z=.M?L>#S+#XZG&I2E&;:6BWT4=>MO/]#\WJ86K0E*
M,X3@[W][1)W6EU]ZV^9HJ,*!V Q[8Z8^F/6FR9V\ DY XQGD@'KZCTIRYP,\
MG SVYQZ4V0D# .">A(SC'/3(S_D^U=SMRMM66CLNNJ]/S.<^-/VZ_BG8?"K]
MG;QYJ-S=+9W6HZ3<V&GEBN]IGB:4;%)7DF/8<9(#$]L'^*/QEX1_LCQ)JVMV
MLF;;5+V>_9 0ZAKJ9YCL09 V,3WSG.0*_>#_ (+S_%62QT7X9_#"PUF&SN+V
M=]:U/$S9-BL-_ RS1H0PCDD:(9SP< !3C/\ .7'\=M+TNU2VUAS?O$61V"*8
MF^=RI1GR[#:0<\]>,<5Y->:E-I;1T7K97]/QTMZFL4U%/7>]K+;1=?);W6AT
M6H^&;G6X9)+:"6:X2+]V2&;=+N++U .58DCC..F0*^??%_AGXFV1E$,-U%#&
M#@F.1,Y4\]/;(Y/?WKUR/]J/0M&5GLM.60A3*BF)"%8=#R"<Y[<J<<]\^3^.
MOVIKS7891;V<4(9L99MOWL $8 '?@8P3C@UE>*:>UK??IO>RNW?5;]C6,VHV
M:=TDEVV5];W_ *TTV^?-6_X2:P>:;4;F4L0_RR%@I8 Y'.1G(X/)[=J\YO\
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M\"Y1C\R'P]JDP/WY)<]BP>2W<<\D8!P/7KCL,GP]"9;@!4W$.0X]%9OF.>V
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MMOD5U\3V6CO>RTO?\UUM^*WC?Q-J%CJ%W'NN%CM[Z=8C\R[@ <A<D;1C.&;
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M8#*J4;2]Z.FEG%/I:]X;/Y.W57/EL;G,I7BFY-VNDG=6ZZMK:W?H?L3\</\
M@I7XF^(&@Z]9_"OSO#UG>Z?<V2W8$J7-OO<^9(?*C$H7&!N*!6ZINS7Y%>+O
M'GC/Q??M+XDU"XO[MG+OJ>HW,=V9TQC)MW<&'Z1AG)X"\U0\*Z]+I<MO(R17
M$$4JK+:3 3I=(,;XWMGW QO_ '5  'KDX?XHTQ+(K>:7/%?Z5?3"]CO)%)2U
MOT(W:>[!F=(UZ[-OS'& ,5[+I1@Z:3<M_BLG=<FUDMWWZ;=3Y[$XZJE&5-24
MWI[^TM(KHXN_6]UH]39\!:P^D:]:RI#'%();,W5RVY8IPCJL>V+ PQ#=%!=
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MWT,9X>HX\TH\KOHE;EMHM;ZK6Z]>EM3S/XH>%M9^)VJ7&F>"[$ZC8VJ&._\
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M6)R/I_Q=\=OBU<RQ6\_Q3\72Z?=:=87EHVE7DVGF))HO//F+:RJ L@_=^86
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M4^^/V>/V\?B+XGTWQ"OBC6=3TS74L;E]+N[;3KF^U!;V1D<*;ZV:.39-&OE
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M(<D[\A3N;Q'X7?M1_'#2-:M8]!^*?CNSM+/[ +&2#Q%.9U,;,^1AV,B/&5+
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MK(4-($#QK$Q SMD#'OMP,U]E>$?@1X2\/0"2ZTB;6;TQA72_VSVQ=0K I%#
MK 9[F93[X )_1:T\/^![&%)(X#,K<J3'''&"JX$:(O&W@'.!GI56_FTFT5I+
M"QLXR05V20C!Y.6)((/'&XX/&>":]"GAU"-FTI):VVU>UKM_=Y:6L<CJ-O;3
M[NB^73>VUMK'R$FF7$,"1V/ABUL/(4+$MM T<6P$8#*9),YSGAV/)Z<@;6B:
M1%J2LVHV?D7$1VP3PJ4F6/)W([, I!R2>3DXZ8KUS6=3G*N(XK5>>/+'R#@?
M=.S]#^'K7#B:[>8- K$YR\('S8'7<H XX/..E:62MUTU]V]]%Z[/^M#ICB8Q
MC9)-V2;L]TDOR79?B)_PCMDD,D>[<A!W>:-S,N"/O*,9Y_J*X^W\-"U:5K>:
M9;=I68QJ1MP"3TZ\YX^4$?G7I\LSF&,,D:N<%DQE^G.1U('<_P"-9$\JJF"@
M!(<[5'3:5/)'J2,>N*4WRQ;23M;2V]VE;\C6E4YHM\J]%I?;HG_G8^X?!*[/
M!GA%,D[/#&@+D]3MTJT&3[G'-=/7-^#2&\(>%2!@'PWH9 ] =+M3C\*Z2O1C
M\,?\*_(\>?Q2_P 3_-A1115$A1110 5_F$_\'(N@Z=-_P5=_:UU9'-WJ,;_
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MR^6<J QDP<CFM:LY/GIV;:2[:+2Z]=M=W=KM>;)ROKT?Y6?SU^:U['P0EX\
MBC5'3]X5M)$8[7@2&!'D?LK!T50O4#)%>S^!_C/K/@R>VC:[GCMTV+#)#*\I
MWAAG<O( P!UX 'OD>0ZEX0\0^'YI[;Q#I>L:?<*>8FMIA%&<X ^=!L#!3GD9
MQD\@"LW[#<C9&L,NTX<MM;@9(RV. <#)'T]ZX)*2FVDT]-;-=%8NR>CM\]N_
M];G[0?"+]ILZQ#%'<ZD&9EC4B7YF:9?E$<6YT+E@H)X^4DCH,U]='XBZ-!I?
M]J:O>65I;R1M@W4\09&V'+[<ACM;G8#DXP#DBOYVO#^H:GHC0S65P\;0RK+S
MGY&C(=1G'5R< _\  2<5]-Z-\2+#QGH[Z/XJU2\AGBB<KM8JK#8?E/(QG)^8
M#Z#U7,[W;=[W=V[MI_GYO7S%:VVUEIOVUOZ:?=V/L[XA?M3?#O2YY;.RNQ?3
M%I6*6\'FQHBY498R$_.<X/OP.E?G%^T'^TG;W5E/-8V+)'.X$8$?E'Y2N"22
MVX'=GG& ,"N"UG1M+B\1R+ICRW-LDK'SF>9PX))922NP@<'DX'.!FOECXXZG
M$^JV^D6Z-&\*JTF3@=]IV@^QSGV]L<=3$3K5XP=TFFF]5I9]=UKIT:OT8:15
M^MM+ZN^BU];;?>C]H_\ @W8^(>K^)?\ @KI\";>4I'9W/@_XU!X"X#$K\-=<
ME## '.Y%( ^]SDG-?Z75?Y@?_!ME 7_X*\_L_P#!_=>"_C5(21UV_#/Q!R,]
MN<9]_4\?Z?8Z#/7 S7M9:DJ#2VYWY]%K]R,6V]6[Z'\S/[=O[7GQ ^'O[37Q
M4\$Z'IOA%=/T"]TQ(KR[?46U,-=^'=%N$,T:74-N,%FQL1B!@8QT^ M3_;Q^
M+<K2P#Q+X<L796$<5J+UI@PR0(E=9(D8*&^=W9!C!Y88X[_@JJH;]O7X\!O,
M?&K^'B%=V"#_ (I/0P,9. !V(R><>U?G<\LRMY8FE2-SLV*21\PP,MGOP![G
M Y(-<M6-JM2T;WE>ZW;T;O;UMM?ST.JFWRKFGIHDFUV75^=]._W'W5XK_;/^
M)&L6$ES_ ,+&NK6]MU976W++*5.Y6C+1((]Q&"&3&!U [_8_PK_:&T+P=\ /
M"GQ!^)/BN6==6O4M7NKH%9R]YJ&H1-)&K1[BT;[@QR<LN>,U^&\L5O%9R;8Q
MG,C;O,)W_N;S! SUROM\RYZBOV+^!WPI\%?&7]FKP7X>\;6;7.GV-Q=7-K&D
MNS;/%J%[(N2"#M4G< >%R37%B8RY+J&MGK9^2N^_]:&L9=%)O7:^VW1;=-E<
MQ++Q7X3U_0_B;/X5U>/5[+7(OML,SRQB4"1I!GRC&.27!S\I)SSGD?:_[+9)
M^$VD1QB.&S\N,7+WB;AO8NS&)2"2#(JXQPG!&,5\ :;\,]+\$?\ "TET"-K7
M3M/4V%C"SM) D*&3=*S9R<[1P,=/?G[\_9A$4WPUTA;J;RBL3W,D<L$ES%A&
MPHC\H@6R,#G$G\)QR6-?.:<S4NL9:/3=;:ZK:[[ZNW0WEJDV^S3LV[W71WU=
METNCZD\)V.HW%_J:>&O"NH>*3YJ221V<D42,%0$M&\TT4:&(@NHS@D= <U>\
M;^ /'GCKPEKGA.;1-$L?#_BJTGTC6K?7=1L8+H130M$ZW<S:@L6^-)F A$9V
MXWY);"_#?[4_B[XA^#=(T:\\!?$A/AM;ZW<*\TZ:Y::3+));2A6C@^T(V%N
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M!\/K;Q%XIO+-1%/+=V5U*]G+=#:TK81.5,<:$%RQ4=.*^?=9\0>*KK3 PO\
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MJO)SDKGKGIG(Q^->4? W34T[X6>$[9<.L>FJPD;AG:3R&"@?Q'8&?N JD@X
MKUQ2-HVC=C .WM]< X_'KVKQ\2GI9.]EK9Z:J_?_ (;IJ=D6HMV22LM$DK[+
MRWW^0^4EP6.,JH "@*/O 9P !G!Z]3Q5='3+AX?.W$@@?>'IM/)![_B<8P*E
M,F$/'?J,'L/I_D?@<Z65AG:"#WVY!)ZY)Z_CGGMQDUY]1R45J_B\^VUGV^XB
MH[J]]+K3K;2]NGG\M31 EF("%8%R/E8  Y(/..?;USW[4-<0V4Z1R7$"^<0B
M?;)X$)G3AS!'))&[$DC8!G@G .01GS7MNB,9))5&T\J%#=,@*6;;N) QGVK\
M@/VY/#?[;'Q&^(NG>(?@=830^"_A]:6NLS_V>@47EU801WICNH%#O<N\EOY,
MBH?F,FW'S',1J.,&W>]UHM>BN^K23];DJ.N]D[:IV72W36_=;ZZ(_:&*(LZ)
M(T<5TV1,TDP:012%?(.S: JOEM@RW .W'?\ "K_@J#-<7?QF^#_AUGWOIUY?
MR@@AI ?L\);:,<*PY*YP1@X]/,_"/_!5WXL>(O'_ (#^&>N>#&3XFKJUIX>U
MVS@MS%IC6D!42S?9U!G6X57N%EWXV.J[>G%;]M_QVGBW]JWP0(HA<B&V606D
M:LLMF\T5N&BD9F;#>8'4%@&('(KT\'*,TDUK?>22>^EVWNUIK=?-Z$[0C%W^
MR];ZZ271>2LO3JV?8/P"M5G\5^!K>)<>7LE7Y<%6B@7!(_A. 0R]_P"?Z]2I
M(9K?><B*1D7'&%6S7"YZ\%V/K@C@<X_*G]F2V6^^('AS="Z+;6JRNH)<)YD6
MPKN'W@KDQANA(.#TS^JE]<1YO/+SFWDA^S')P>4BD!(Y+!,J>>PSFGCI24&H
M2:ULK/;;2R"DU*4;M2WMU_EM;YD$_P"Z(*]FSSSU+9Q_]>I;BZW6DB@C#*@?
MIG.[@@XROY]N:ISNSA&)4Y7H,9!_SS]3[TS"OLB9@JR$*S9' &"><XQTR?IR
M!FM\!&/(FTN;E5M%?I<VJI*$FDNGYK^M+%/7[G,NE6ZX_>10IT'0"XZ=><\E
MNIKM_"$&VQML_=C5MN#R1C+9)&3\N0#C\CQ7G6N[9-4LE##;;^6J,,C("@<'
MH?FW =/F+>N#ZCH:+;VEL"P!.XE>@Y.<8STQCCCT[5QXZ4E))2=M[7_P/9-=
M=%IK=:VU%03=]W9*W=+7\-K7_+?LHG5HY$R,8(Y Z<\]\<^N.<=ZK*B*NT#@
M$]\GG'4_@#@],T[S<1$A<9QTQR/<CJ.W'X],U26X!+' QQC!P._H?IU]O4UP
M]E)]-5;=II[;WUVMKV1U0BTFW%6<GNM>GYZO7R2MK::55&3[8Z]_SZ<_SJ6U
M^7!!&2.<=N#_ ($?3TJ#<TH(&,#J<YQ^/) [_AGM5Z!;=2$>1A*!EE ST_N^
MWN?TJU1G-)QEH[65]=+>:\G_ ,$Y*BM.6K^*]EMZ>EM.BZ^1=\D>WYFCRRI!
M4$MG@*3ECV'XU);N\F%)5D8,R%>96"XW&15P% /!X_F12O</$ ZQ,DBR!=K@
M<IAB6QZ9 YQD9Z]J[X4(2E%*G'5](IOIY>GW^>N>V\GH^NWV7OY^??UON6.F
MR'9++&J C/(PPXYW'O\ R';TK0NKS2M*MQ'!;0RWLLDDKN$0L=P$;-(Q4LQ$
M:*JEF(4* N,5@-XEO)+8Q(B$8*EU4;\]/EQR<#.0 ,?7%<_]CO+Z0SR-*D7)
M,; I*ZCAL# .!@XP<8Y[C'IT*2IST5URVU6B;Y;OMW73KYBE)\MKNR>U[[7U
MMO?3MU^Z35O$%M;EYIY)"TOFE8XE#9\T#YF"XZ;5)SC SCVS6UE1;BX669=P
M#)G<H!7#9))]1T[_ )"LO6Y;"RA92IWMD+N.65<=3DDD+WZYZ$UYKK7B#[#I
M^R*1]QW;"0,8/ (R<#(Z8^O85T*<E=+W;[VTUT7Z"@KZ[--=?O5E]W;ML>CV
MOQ.U&UEDB,TD@#\-*6(SD#"D9XP.G08ZGK74V_Q5G< 3!7SQ@'(P,=F&<YW=
M.>1[U\J0:G<7GEM'-N(.95 ((R?53USCKU'O7<00S&!)L$X49R/3DXSV_+C/
M/6CFEW;]=7][+Y8]OT_(]\'Q MKD[&3RCSR<;??'!P.?UXP.E:[\865LLD_F
MPQ3A@I92 [CK@L2<Y'4X]L&OGR_U^/3XBA4M*Y(P!S[8Y&."#_CQ7#_VI<WD
MQ\^>4@L-@P0FXG:,]B.F>ISTZFCF;W?X+3S7F9J%Y_#UTNGKKIK;\7]Y]?67
MB?3KPB0WD0=NI)4N >IY_A'4YP/>G7NIZ>S_ "WJN6#!G1@ 1QTV\<8//7/X
M5XAI-Q9VMHCW,;;C&5##*Y)/'/&1@8(SR>*U8+V"5C''A6X(0L 3NZ$ \X..
M/7/UH<G9\MNF_757;7GN[W>]F=].$E-))I:[K?39[+I^6]VC]5_!+*W@WPDR
M'<C>&-!96Z[E.E6A4Y[Y!!KIZY'X?_\ (A^"?^Q1\-_^F:RKKJ]2'PQ_PK\D
M>1/XY?XI?FPHHHJB0HHHH *_SR_^"ZOC?7HO^"GG[4W@Z+4;\:"LGP/U&[TM
M+B8:?)+_ ,,\_"-S<S6[2/;R2JIPB^2BD#YB268_Z&E?YQ'_  < 75QIW_!3
MO]KF\$BVB%?@:D<[C;YB#]G#X0%T20$G!?<K#;G@X(X-9U4W&R[Z[[6=]C:A
M\;_PO\T?F#\4OCU-:_#M_ ^EWLMR=06*&.U=1,EC:1+-#),D1F5$CF>3&Q5*
MHPV@;>O[(?\ !OE_P3$?]H[XN1?M+_$O33<_#+X;7EK/I!NQ((O$_B*V=@L$
M!:$)';Z;/)#>LD3GS3 L$JB.1C7X=?LG?L\>./VO/C[X.^%_A&VNKV?Q-J]E
M8W<]K"TC6.E3RB.YN)"RO';VT/-P996YC4MP<8_U/_V2OV;/!O[*7P*^'WP@
M\'Z;!9:=X9T>T^VF(*#>ZY/:HVJ7DPB15:62<2$N[%2"P5<E2,X1T;DUI:R?
M6R3M\G:_?\]:DVDE'>6WDNKW]+:76I]'V]O8:;8Q6\*QQ6=M%'!!&HV11) H
MBCCB4D!550JJ JCCIT%?(?[1/QALO!VB7F^[0S!"D4+X!B'FJ 3M?+%<DG.,
M@C/M[5\4O&]EX=TJ=I[B.#R4:9F+;$QP5Z9!(;C Q[YK^>_]JGX\77B?7M2L
M+*]:2*,72;Q)^[=A-$=N2_)"E2!_#NZDFO&S#$32<*:3OI=Z.^FKZVW2VZI,
M(4Y:75E:[N]KZI?CZV/F_P".'Q0NO%_B.^NIYVN?+NK@Q2\'"R7$F/E\S##@
M=5!(Z U\OW]RTI>:Y8?O$(*L2"<]0<;@.#C(([@5JZS-->/<2-(5N)G/ /)V
M2,1GYCDG.3T^BGIQU\\T4:Q3!9"YVAN?EW<9!R>!D]L?E2PD7R152_-**ZI[
MJ/H[?\&QVUIIQA%?9BEZ-*-[ZW>U^Q5,UKYA,:)D'9P2>3R,9XZCKZCCJ<;.
ME6"))+J%US;H@D5&;"G!Z$_WCD!0,@_-D@=:VEZ:L^692$ZE@1E",X/S!BPW
M#) SZBK=U(%MT2.0-;)(+>=R?W8GPS_.F/,,:^7SA@0&(SR"-Y4:=-.2OS*W
MXN,6W=O1[;==K+3BYFE?3LG9Z[:*UFEWZ;]]*VO>+X-'T[4;^>;R+:T@>X;>
MJ[=L"$B,D-C!''!)/<<5^,7[3/[9_C+5;^ZT'P?J_P#9=J)S#'%;Q1N,[R-^
MYMI&%&1AQ@@X;C(]X_;?^/<OAU[_ ,%Z!/& L*#4+JWN,+%YY",'53G8RME5
M.Y@>I(YK\4;SQ.^J7-S-=.2;69I+>ZD*LLY5BJ@#8#M(.=N2?[Q(%5'FBN91
M;32NT[M;6OV_#[B77G%/75[7Z;7WM;RT/2];U_7/&M@+C5-2O+_5+556_FNI
MGE2:.)Y&;R8;CSTB!##B"23/0G;\U>=*THW2V[;(Y%,<2!6 #;@")!O,:@X/
M*1Y!QS@D58T75GLIQ-*4$6I 0SMDN DGR^;Y?F80LQ4*8P@W$9RN5,FL026V
MH"PM0SPI%]MC;;L+(OS_ #,Q",2V!\@7@\<]"%2+FH)W;W[=FF]OEOK<X9*<
MM9=-+;Z:6TW[]7UN6-)U2XTB\T^ZC1Q'+<>3>PCE7W-Y9;!/   )R5^7! K?
M\0Z=)#?R75KLAM-0A,XQ@J9(!F17<CY%EC7:F"<L<' PU<'#<RRB6YF5HAF-
M([=UR_FW&]1L0'[X=04?)4+U#8S7T5H^@V.E:#HMSXIEBN#J'E2/I\LBFXEM
MS$&80Q %Y&ZCAD  "D$@L=I8>#=VTI/=W]++S5O)=;NYS2HQDVWKKKI_P;?-
M+O:QXS"DAMSJ4/VJ.2^CVI'#:QR*J#*-R'.UU&6+8..",GBO>].\,0:;X,LM
M:U^Y@NM,UVZ18=$_=?:XV!13*C+*D\;.Q!9E!(]#@"HM-TOX3>,/%5OH]NGB
M72S+<*((H+>*/3[=0%5DDG^VQLJ,>6!V%1G,BD$CJ?$WACP_XJUW3-/T;QII
MB-HEO_9>D:7/=[FB=>/M%S&B20B<L/FDDE<*!PN>:Y:D'&,GI:S:U5UMYN^G
MIOIJ<\*]2-2.CMS+O:R:T>ZTT?\ 2-7PBWPIU;Q%!:P>%'L]5T2)5_LVXN[V
MXEU%B/ED$LA\R-8RN[Y(I 1(-VT $^K?%MO#WB_2=*L]>U_0/!>HZ9);V.C0
MVC6ESY"!UDBDF)6UEAND=B#,6,@P@(7 SX[HXL? FKZOJ&OK;>*-8>%-(L+O
M00'D@O+QUMX?,VB!FPPXEB9T!7+J!@'SZ\\ ?$:[\1_V;J>D:N;V_6>ZB2.W
M4D0//(L,\T[X\H+&G,VYLD%1@CCR9TI*HJETH1T3;5V[*^E_3H>?B<+*6*CB
M9R2M9IR:T;LU?3:[:7EM<_=?]DG]K[PUX,^&.L_#[XC^*HM8OO"86\\/:IHM
MR=0U;4X(K-;7^SWBDNHLJ^W?&L;R*0QRP-<U\=/VT?VB?'%Y!X(^!?@V]TC3
M=:C=4\6W*M.8(98E6>1XY8Q!;[!(' BE=Q@D@=_RJ\2W]S\.-'\(:;IMM:S7
MRLMQX@O(A]J*RQS" 6TL\J.ZD@$2JLQW/G80O%3?#?5?%FG>/M-OM U[7+WP
MSK9:;4[;[3*J*&AB69+*>/<B@HS!4A^SOD_ZP=#TUO=PZFKN45=*]KIJ+2]7
M;3?7Y7]JGF-26'5%.,E%<N][)K2]K6NKM)=++H>G?&ZR\>>!/!EH=<UJ_P#%
MGC*;4Y9_%NLF,W-M8*98&62"4%TMFD1) )%52IVJ6&\FO O",&OIXR\/Z[X:
MU34;SPYJ]NKZFG]I:BGV;#2R7;W%P)I %V+*&C6%ES\J@J21]97GQ#\<?$75
MI/AQ\'?AHNI:7:WWE:QK.IVUS>PWC_:AFUOYY[>[>U,;H&DW>8GRG,T?"-^A
M?P7_ &$;2>33_$OQ3;3['5;NU3R]!\.S&2PB4.'^SS;C$(C(A9&%O  06SA@
M*X,OKXJM6M5@XQ4K+6_NM)>]%)VMNKNS[6>FV6U'A*BJI2;Y^;3HURVO^JZI
M]S\Z_#DGQS^-VLOX&^#O@8-H4=WY4VKZA9(^C72+Y2&YDOI;>0[4=9!(VW)8
M'<N[@?I9HW[#>HQ^%[C6?$VH17OQ%M]%WMI?AM3'IJ31J!Y4<VGFV8NC+Y;J
M\6T@8^<')_2#PY\/_"G@*RL=/\/:':>'88;(&+3M-MV"ZE:!RK27VHDF>#+9
M(RY8*?ER*[:.S4L!I<:VTH1%EM8YYY[ O(04'VV:42>9M.0A/,@R#CBO<E\<
ME%W7,TF^JO9/K;:Z[:,]/&8V6:ITG33LE"\K+:RNNNZOH_/:Q_,U\2-1^%>E
M_$'P=:ZOX.\9^&_$F@:O9:=KD]E:WU\KRQ:C%;FZVO/&L+.QR9,DH"6;&#7]
MF'AW7/AEJ'[.7P@TJX\42^"M.N/#^EW5M<ZA';RS7F8U5;W5)[JYD:WBGQY;
M%1\K' 8\"OY\/VU_V9-/US6=$^+7AG2C<+X?U1I?&&F:="DDE^]C<P[ERY1Q
M]\S7!$DN4C8_*,YNV?BOQQX]\,Q>,;QM83P]X3M!H6E:=93W$L.FZ?:&(VMC
M<VZ7*6B[96+,R03RCH4"@FKITI1E=U7)-6Y;[JRN[:6MMW2/D\5">#G&DX2L
MWJTKQ2C9O5[*UE9+=G[+>/=.\-^$-5TDGQ_HFNIXH!2PET"\AU:"R-PTD%O#
M<P,ZI;F5H#(9$9V42C]V, GB7FE40PW<<$'V:[,<<-O=+<1R+&Q4W#R.4E\Y
MB"PC*;%!";@!7YR>#/C%8^%?A?\ %;QK\4- N;_["C:?X0:VN]4,MIK3VT8T
M^X2%KF.$_9C&LTS)'Y;>:RJ@Q7KW[,7[0^A?&GPM9VEW=1WNM6B".]A5HDFC
MD6)<9$:0R+M?+S2XE3RV"\.&<[\B[?*[\K_D_P"MO2P%1;OK'HM-7%:O;II^
M"U/K/4]._M$RVTR^;97 *NHEE8Q,ZD>8"DPVE<Y!5U8=B.WO7[/'QGUGP?K>
MD?"S5=:O#IX>&/PYJ5Y<S@V4LL@E?3GG-P9 Q4!4?S9$CR@&X$D?/D(-HLV)
M&BA5SO#,)(C XPADD!W*I)P[C&%W8 Q575H+?5IK>YA6YTZ]\.#S+&=5*W-Y
MJBH2M[&RD[[9/,0H[?(FWYTD!Q5IM-=_\FO2ZU_R1T8F$*D5=-V5GI?3_@-V
M_P" F?L_\6?B[_P@&DZ):R:C8V^K/;>:]A</!>R2W$B&6&-KAV:226=)PPB.
M[!3 )[^&27GBO]H_3M1TG51;^#-(M[+[9'J-[9QVVL:BL<6&DL1)'$T-N[J5
M9X;@MAAL0\U\W? +XI>!/$.@:GI'Q<L;OQ-\2[67R;34KDN[B&)66/4;-FFC
ML99K2%(U4-;D LWRN&X^[? <'P^O_"^KZGI=W<"!;9K2XUW59([=M.,Z?)"J
M0SRP!'93_JK=&)[=JN[D]9>Z]7&_1):/36VMK:;GSM>CRS;=^7W5JF]+))/=
M7[?=H?E#XJ30/"TFI>$I'>'78;R:V@DN'>:[NXHY7CCG^VSL98(7"AQ%&9"@
M8H,XS6K\#?AYIEE<W^IPV;0ZG/+Y]_.L)DN[M21<(D1E)N8POEC(CEC+8V'*
MDBO:_B]^SAIWC^RU/Q7H_P 1?#KW/AB5M1O\WH%R\4;-_HTLR6[RF=C]V,1*
MX)(<Y)(XSX4^(=2UBUN](\'PP/JFF2"QU;496C"QFV^0S2BZCFB9R<30R)*8
MG*A=N3D8.+N_1V5]]K=>[N_-:[G&\/&,N>R?*KQ]U7NFNCU37=?@>N>/KG3_
M  AX2G\:6NM)I%[%#(SV^L+#933%^!#;1,#.Q8J&P7W[59@K ;E_'W]HSXY0
M:KIVJZO*\=D4A*SRW=PSW-QM1E$VGQ2*ZM [C#F-AA<@C=Q7[)V?A'P;IY;5
M_%NM#Q-XHEC82ZAXBG@M[989,![2TTV.5;-@G&R8VJX"GYQNVM\=_&K]D;X!
M>+=:_P"$QMK^"P@>XCFUS1DNUF^V02929X+<3&)$1CN;R!&@4']SN!>E3BX5
M%.6UFM-[M)7MYO3?M?8SE[6:Y8)\U[ZKEO:STELNRVZ]3^?+]GOQ!\7/B#\7
M8=*\.-J<VBW>LQD20K<0K;1?;+?-Q;S1JH1T;( (13$H&<_+7]C6D^ /B1X!
M^%GAW6=7\12>)+632P\UM*P6YLB@7?$US&3<RQF+Y'$BJNW.7 )-?#G@33?V
M1_@K9+>>"(] M[BUMI$O]4RK2K<!@&+/-YA8*T8&$48*L,G(Q]"_"O\ ;6M_
MB3K-S\*_#^C'Q#H=T)89-<2:0V5DQ3RU*RR'"+N8,4<2+MRH3'%=-3"TL5"4
M:U]O=6Z3TO=:?C?Y:6]W+<VQ%*4:$GNXI136B6BY7ITUV2M;K<PM:\0W%R#-
M<W$6UWD$0%TP6!CGC(&[*CLR@,1]*XB&&[U*X^ROMNI[EPJ2I&0X1B-K"15(
MD#=%)(Z$GBO2/C'\/M8^'.KK)):V=]I>MR/<*8,M';QB2+!=BH0NJR$N1M!Q
MPHQBO4?V;?AU;^(M;@O[N%9DMKI47<6:)4^^O&=I4 _*.S9/.*^/S'!PP,XT
MHJTJTTG9-JTK*[^7>]M.A][AVYT?:*VBYM]>B];W[VOT/I/]G7X.)::?;W^L
MV2S#9%+$)<%@9%3!''4%26!((X.2.OW+::?%;(L4:*(T V(H "\ =AV&!DGG
MO46DZ?;6-M;VUO&B1QQ(F(U" ; V   ./4G.2>O05L'Y$.WL"1GW.?;UKWLM
MRFAAZ<9*,6VKWLGO:R]+:]?5;'CXC$2E)W;:OL[[[+3UZ;]^EG%1@\#\J@F
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MU]JR^%M'U/P5JNCP^%M.T^3QEI-SIVJ6MBA2&9K:![Q5ECC;#D2*"1()%(.
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M_CKE_P""1/[9^B^*[JQG^'PA\'RZS*)/%)^2P^QI=L6=9A;M%"3 J,RJVTG
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M?;9]DUILMC5^'_PBTVZ\/:5K7BMOMGB*:U61FA93964C>67";<*4RN.$R1V
MS5GXG>&]"TWP)XN$=N MOX?U.[\U54*[V=A=3[AEAT"$#@<GL.GH-E=216,:
M(55A&J@<X/ X.6+<X)Z\GTYS\Z?M.>);K0?@U\2M3$KQ_P!G>%-8<E =I$MA
M+!M?G=@BX8X5E.0F3@%6ZJ*BI+1-ORZV3\F]/3MW$TTVO3;T6C[_ -6V1_"A
M\6/)N_'/C*]B03B77-;:=P3CY-1\C!]QL&.>0,YR<5^]W[$GAV*W^"GA("-(
MX]1$F\$C.Z29G4'/0$*1ZY8?4?SYZHTNI>(M>#RLO]HZYJDH8E0 DNH^:A/!
M^]N!/(R">E?T ?LN/+9^$OASH$4[E;B>R5U5C\NYV)9,8 !)SR&R/0G)]B-6
MI&*2=DHVWW5EIKM^FO2P65]5?57]$[^1_3CX'LX](\&:!:$-&(;"VB3D%3(D
M$:L5'+;7W?)QD8^8+R:ZV+S$!4C9NP5#, 3[@9XS^'UQ6'H]NEAH6AON^U2G
M3[-C%C_5[[:-GVYZ;=O\6X[<CDD&KNIZYH&D-#=:Y=&TBN#&AE<%DMU8C#,!
MD\DD#G P/6O&Q6*:3E)I137-S-*VJW?=OYZG93@ZDE9.5WLKMM/MUZK\;[%N
M1IHP0T;8ZY&T@]ASN]N_Y"J#S.N2649/0XR,\\\X_6N]@\.6>NZ8;[PYK,%_
M;%!(0" Y0JIW \!>3C:1G(SDYKC[O0;BV^2Z@D9Q)L++G,G ^9>#GKC..G&,
MUYLL53J:*<';5:K^ZM&KWU>GITZ[SPE1).,).\DK6LUI=:;_ -;;'*:C(%4#
MS) 5&=R.%(R/O!N=ISQG:<9Z5X+XKT_Q#XADU70]/\0ZUHUI=6TL$KZ+J%WI
M[W(F4J=\D%S$'D .-Y3@\[:^F;C2$*?\>4LF0>55F49&"3P20![COT%8,/@<
M27!N/(D5!ERK+AA@CY@1MP5Z GMP03@'.%6E.5E4@ME9RU=]59/U]-DG:]\U
MAJ_6G+Y+T^=K/RO^!\(_!#]ACP!\._$^H?$G^Q9=4\97KW3QZYK-V]]J=O)B
M:4RQW<BR.KRDG&2=P7EN,'\D_C%?SZI^VSXOE@DD\S3WCB484*MR+F-'0*S
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M 3'83M0D\$G)X/7IU^G .:CM(9EC4N"<E>3[XZXP3[D>AZ8XV-+T234KK,\
M$49;:7!QC8V-I)Q]['/S<XZ\U!<5R^M[_/RO^IN>#]#WQ[V4MD?,6Q@A<,6
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M,%#%2PSW)+C[]DELT]ENFGHG^/;S6HX8*@I)\JV>UK[)7;6NOK?[KG[UV/\
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MFWRMMZ-MV2T37IW7?4_971;&&.(!898^ -J[EQM'3:   /0 =\]:Z:*WD\P
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M7UDU;5W^5M/OLS@:IZI-+1V:;O'1=G\^G2ZU.ZMO%!M+S3[J9%+-*%0!AY;
MDJ%,?0?-A@".2,]ZZSXC:[9W=_HMO<111121"2XN B;E9H<#82,E@2"2&..>
M1FOCK6_$4L5E-*ES*SV.V6-<E<NA&5'/+<D[<=LYXYZJ[\2'QIX9T+5;>1I;
MG39E.JVNXFXGM%1047:Q*A7R2V0<]<\ 7%QC?W4^MG;7O;3S7RZZ'+44>3W7
MU7W.VNZ7Y>NFG>ZC\/+V!QJEC<?;!>O$L#ID+&KR9S+&I*O@#YB<G(((SS7I
M=M\/[:VMXO[0NYI)XU#DH[)$Q(#%@-PSLSP.>@ J?PCKMM+IE@MK-:26+P(L
MT,C!G@D7*[.<LFPKAF)]6QSFNGF*,&)9E4Y^7S-^5.3W(PI' /H<X%6X0E9\
MJ>BW;\M=M7IULUHCGYI+;K9/Y:+H_P!/,Y>SATB"1K=XH&FB<")VCC9CC@%F
M(+$\9.3S]:DUR(7$$JDHAV#"KM52"#T P.,#.!P/6LO4(K>VG:>.&9L$%V7&
M,YZYSV/&3V_.F37\#0C>I+M&3@N20,9'?@YX/4_H3BZ4'?1)I)/;WOO[:>;M
MWT!2DK/5]._:^_X]3A?(AB$C^?&)%)"*P5ER.<[CD;@>HY(XZYQ4ZZCJ%M;"
M:._90@ \I'9>G]Y5P#QZC'I7,ZM*&E8K'*@\P\)DJ,GN>,Y Y[9_3,U*\@AL
MSNE=&P,Y< GC!!Y[$8Y]>?6B*Y4DM$E9 W=W:^7D;UYX]\20J8XM9F*QJ1D*
M"=I(&%PPXQVZ>QKBM0\7:E=AQ<:G)/C),+@*IX.1C=C!. 5Q@_>Z@5PFI:I'
M&<(9<MPQ+?*>_KT.?0]?PK .H*YW1Y4D[6);(VMZD9YSCC'/3Z.[VOZ:]-/U
ML6E9IOY[Z7M;YZZKM^-^_O[B_NCN57W$8+KD+MZ8R..O'0"K]AILSO&SB,IG
M<#\K-G/([GKT''UQ4%K;%F27&[O@@X/0\E1QSCZ ]1TK;?4UMDW&,1A>,X(4
M8XXXSSCGCCD<T%N6UE^.SLNOG?3[EN79$MXO*A;."Q4G^[UXW<8Z87Z8&,5T
M]IJ-O9VP2%ED; X)#,"W' R2",]\=.*\NNO$$;NNXQC$@R"=I8;N2">W.<Y'
M!/X<O=^/M#M3?.;B%TLQ(;H>>4$03.6=R, 1D;N,D[<8%*Z6[7WBN^W;:[3[
M]-/+6WGHSW2\U^VT^PGO)YXHC"&9II)%41@#<RON8;OE^ZK'.<8 .#7@U]K&
MJ^/+B6>)S;>'K9OW[R!A+>Q!CS"K=GSM!7.<$].:X31?B#!\1-5EMEROAZS8
MQ.8G+C4 W&^-AC<H&=Q;:<^O2O3[JZMK:&'2=/A66S:,+$ELH$D<BLQ192,;
M@H.YB&/!QBDG?R7GHV]/PUMYO3UI7^>GI?3O_P  33K6R,3V=A&+'3$_?3SN
M%9T"\-N< ;?F#$[CG( ."*\\U$W'CS7+?3(5DDTC2EF2=PS>5<HJD+"Q'[MP
MQ!5 2>6R.PK9\3:AJ4L%OX4T9L75^ZM=7=H@8P*5!>-WRG4GL2,Y[UU^GPV'
M@K3+9;F2!9;2#-T[!?.N7<'!(3))!QN)P1D=:'K[O16OZ]%Y=]/0>W372WX-
M;:NYMZ3IUIX=TD6D(CA!08C0JL@'.-N,'U!P.U5=5U)X+.1\^5$54QR$8)X(
M8LQ'<XVDG!YZ;36'9ZU:ZM=O<:GJ-MIEM&^^,W$RHCIM)4@#<=I!YR!GTQ7$
M>,O$,=S>1:=9S">VDACVR1O^Y9 SAF5\\DY&<@<8SST=TK;=+?A;Y:KR-J%O
M:1OJM;VZZ+JO^#Z=_P"@OX/2&;X2?"V4G<9?ASX(D+==Q?PSIC9SSG.<]37H
MU>8?!$@_!CX1$=#\,/ )'T/A322.O->GUZ\/AC_A7Y(\J?QR_P 4OS844451
M(4444 %?F1\%/V3++P]_P4(_;?\ VJ];T^.34/B)K7P@TCPM>SHLDL>B^'?V
M=OA'X7U!+(LF85;6-#O3(R,294;D$D#]-ZH2(5>Y9456D(96  +_ +F.-BY
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MJ6H!R95EC)A20'Y1'O)W8?C/W>.XJIK^KS7L 33PEOHHY:S(^9F/5L# R6)
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M2&'4D^9F&,RV5&5*C5M>.M[IM/MTOY)]'IJT;TH\J36DGJWVLU^/5=/0^?\
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M=/&Q5FDWJ[Z_=IMUTZ]/.PW?;;1:VZORO^.W70^K[&Y%O;W-P'+/'!,V2H.
M(W++M.,[@"#Q@\G'I\ ?#)SJ?[0VEE%4H/$%ZJ]L/()<9QT'') &.WM]L1WL
MR:=J3.-OEV\QR ,JHB8^F.,^E?#WP&$MU^T7"J(&C@\W59SG[EU(TZ-#G/W0
MBAL_[6!WKRZ5X5(.+M[R^^Z[E1LW%;W>W6S:O^GX'L/_  5(U:/2/V/O']T
MN^YL+?3 Y4?.RSZ>S)MP00.-I()QSVQ7:_\ !$[P)+%^QAX8U5[:0KJU\MXF
M/NRQRVLL)?/JA3C&1DXXXKY__P""P'B-K?\ 9&N]/A: RZGXCM[::%00Z0&*
MU<(N207=UW G)RI)X->@?\$U_P!J#5/@C^Q-\.=-E\-B\L=.T6"X4"(M=W'F
M1SY4L<J&1VW2<  ;0,=:]^/-4H[O7R3VTZ*V[[:>6YKRV?NV3U6]UNO7HGL?
MNU:^'+B:ZMH$M6\M%!4;\!3@85F;T''<]JZN0>%_#UM?R^)=7T[1K-K:2*6X
MF>%YUE[O$IWGY3G!VG(!]*^';?\ :=N]:^#FL_%C7M<TCPK9V\<UU;:=-#)!
M<F-2&0"0N=[88#&,,1D CI^)VB?M[-\<?BSJO@3Q%XL:P2747BT?4$\Q+6ZM
M@YC6W(W*%N)&*KN&,DX'4 <$:#YI7@V]+7;MN^WGW>J>X6;W?W=[KN[:6OMM
MI;4_<GQ?\7_A5H+K::5XM?Q-J,UTRV\.PHA+2$1A<1JK':3CGIT!ZC\RO^"O
M'BR.#]E=@&*)KFMZ;&8B""!/ P*$#C(QE0,@YYQ6IINCZI=ZGX>NK[2=5@AM
M=0M+87NHVMU:17T227 %Q K Q2;T5<2I)N*9VJ02P^<_^"TNOS6/[/\ \/-'
M0Q107^KZ3<,#S(ZQ*XD=<YX)PIST)X]*JEA'[1-*R5M5>VMM%?=[][F<MWZ+
MRZ+?^D?S^?!NT6\\6>&[:,8$E[9G#8X,LKJ5 SR!L!P>WI7]+O[".G"?XX^#
M9P!C2='O"S*V"C--II=B<@D#[*%"MD89O2OYK/V?O,O?''A\LFW=<Q2J23E?
M)&8$XP"'!$G3[TAY' ']+'_!.V::X^+\Z7"&-[73+[]Z8V\K:TUO@!MWW@.,
MYP6Y&<5[U.#<8I*^T7NWT7331Z_+L<KQ,*$TZJ4DY:)NVCDFMFMTO/SU;/WP
M<H)9 @"1AF=,'&7;JV#TX)]L'CVI2?,Y(; !!Y/7&<?EZ=NAS5"YU[0["#[1
MJFHVNEV09H_MM]<K'EU!W!8L9('&,$]>2>E NK2X$5Q87*:E93QB6&[MD*P-
M$W1P^[#$GDCY>.F"V:\['82K1BYMM--/3?5I+9;ZZ6?W7L>@L13Q'P1M%VNE
M=KH[)[W\M]+EUI=GRLX/<9.?7\/7J#[U')>E4,8VE6Z]NF<],8Z^V,#/J<EY
MU._;('VN0""?E'!V'N2.Y]\=ZKRSL4!"9X_/GTSWP>?ISZ>#5:LF[M^3?^?I
MK_3M1=DDK+3I9KX>[OI;^NET7>UU4D<_+N/4*>HXX_'J,<=ZG.H2L;(O(DD<
M:RH5.0NR16C).TJ,@,,#.">W6L,C<<]^Q]^WH/2AIE=(XP ,+(.!@EL$]1SU
MZ<@?6E2FVG?37\-++;7S?IMI:N6W5O3SW]5MT[JRUN?*?[?OB=- _9B\5S^3
M#'-.EPD<R*?,C1HH82J9?:S., !@W)XQBOPJ_9%\4ZIX3TS0M=L(+J.=+>!D
M#[3^[FNW9N%" D*3R1G/WCD U^K7_!4G4GM/V:UMWG93<ZO80NH)#2QR7UI%
M(N!@$8D&[.#Z'/(_)?X'Q_9/#OA>-9Y!,!:6[HV 26$;@],8W/D<=6/N#ZF%
M<KQ5]%?HNKT5[7UO?5^?8S:7>^WX)6_KR\S]I?B'KD5WX/\ #OC,I<Z;K5[8
MP36UZ,I')<+<N(YI53*C8AP,'D$Y]*[[X=_MEQ:?H5KX0\>@ZC(%CM;/5K9%
M1]P7:B>:"&VAL%F.25R#D$U[UX3\(:!K?PR\)Z+J]I:7=LFBZ;$T4JQQ2K-(
M%D)5W1B5!R,Y#$<DU\S?%K]F>P>RGD\.VRVJLS7+.CB18$5@Q\N1=NW(&%/<
MD ]<C2=6LYQDYMV:Z1LK-65DDGJET=[:]S2'+*G-25[*5M7I:Z\MW_7?Z<LO
M$5EXGTQGLP)]Z_(T<B,661<C<H)Y //?I@\UQ>@_$L?#[Q%/9:U'<C3I&6#"
M!@KB1SO##& 47!PO P./7X&\,^(OB;\'+^&6P2Y\0Z';L6DMYXY&N JN-R*Y
M8*Z!5( P3SU(''IOB;]I;P1XTMK<ZM$NDZQ QD:U:/8UO*4"-)<C^*$_=VY+
M9!((QFO1IMRI<SNY)JVG=JZ=MM-[OR>IAHFUV2W;\MNBW6M[]D?JKI7BS3+1
MK77M)DFETZYV$00M^[C\P?>=2WEX/+-T +>PKV6V\<:3);174UT2SH3AF&X
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M?+M(8#(JY)9#S.1GMT(S^.>>_7IR/IHVMIL]\XP-O3!(X_#'0#'H32_K^O\
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M#IJ*<NEU=RMMJK7=]-M;:V[G\^'@7]G:";4;C6_&7CVR/AG37,]NNF2RW/\
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MKKIWLM-UYW4RC?KLM%KJE_6VO3N?S/\ [,/_  1/U_XCZMI'Q(_:+OQX2TN
M65U'X)M;9EN[J)XR_DSI'.J0++G85,(VA=RJI;-?TI_ G]F'X6_ /PS9Z1\-
M_!NA^&(KBR+)=6UG -4U )"CRO<3V\:.KD+A3<#C:'!YWGU72;<M(@5XXO,
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M#[PW)8:K;$_VCKJK<VUK]N9+GSK<VXD7+;))'\N11N&X)NVX"^9>#_"7]O\
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M  9L/AO\/I+V#2;74M(U2*UN"MI?VMI#'*)_,EE>#&Y'+NQ<2<@D<=!7F?\
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M5>/^$F\*9&3S_P 4#X8< >^^1R?3..< 5^-(5AR$(P#SG/8CI[Y_SUK]I/\
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M6H75C;JAO$%O(ZAVCB0W,0SU*R19(QCE');OTZ\MJVIZ?-!BTF=6QU>WEC'
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MNUF_UW>I^OV@_MNW6HZB; ^%,74D:RPRVTL>V+*@LTIVCKU.<CNN.VSXJ_:
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M_@9H7P[\1V7B*$7MDMS_ &>?,DM'$\[2;D6:;F(;2?.&X^;QD!@/M_XWW?\
M9'P'M-/M[&Z$]AI-M+<H&S)&8D6(ND:-L(=%RZE3L!!&#@U\U^&/^">/PJ_9
M=U/P[XA\=>(+_P 8^-EFADE<22-%9SR'(PK-Y>T,#DH-Q"D'/%?0WQ.UY/&F
MBG1-.$TD5R?LIB1,J(Y(S#$QXR0,*#ZD?C75*G2Y5:<=-?A6NU]+W[=7MUU0
MKN^O7HM;?"OUO]^^Y^37[2S7&L?#WX;^.H$GN?-*V-S;P1/*T4C7;%'/EB;'
M7IL12>J5Z3^QS\*WLK'7_B3K6CW%M>2VZV^GI>(9YF@E&&GB9XX0N=V1B,@
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M-*2, ]>,].YX]/?C@#;]WOIY:V6FRZZM>FJZ"TZ6WVO;HO+KMIMJ:DDL,Y:
MH#$K.%\O]Y+@$@%MVXY;V/ ([<5<^SV>GV,L]J3%.J0E'G&W#.P&2I(4XR,@
MJ0,9QCKSRZ;J-AF:ZE"(0&RQ P!UR<Y)ZXX['BN>UO7E%O+'+<K/"7 ,:-EU
M&#GICL3CGTQDTN;3;72VG32VOWWTUN6M]>B3>G3W?7I\WUW&:WK.]ECWB5ON
MGR\%#DG."!]#V_/ KBY6ECF:3#!3RH!(''WNN<]1]!5F7Q;H,*&,1,TBKAF(
MP%'<D8X.<8'/)P, \8AUA[V072F'RVRJJYQM51\I4<<,">" >.<]IU>F[?\
MP-;_ "^2-:<H1G'YVW5M+>N]N^NNES^JW]GH[O@%\#F]?@_\-#^?@O1#7L%>
M._L\-O\ V?\ X&.<9;X._#)C@Y'S>"M$/![CG@^E>Q5[L/@C_AC^2/*G\<K;
M<TOS844451(4444 %?G[^U]?M#]OM]^%:VB^7ZV,!_4\Y.0.]?H%7YC_ +:-
MX4\0SVN&P\%L %)YW:=9]>H[D8'7'UKS\R@YX=16_M(_^DS.W .U=Z7]QZ>D
MH/IZ?>?E!JUJ?M5R0 VZ0-ANH#-DXZ] >3QC!]*P/L1)<,,;@0"/;)[]1TZ=
M?:O1[JQ5WD9@=T@VD<=>1QP2"2.<_CTK'DTUE8;<\>H'((QR, _2O PN$C3<
MY-.[:>[?;?RVZ'JUJDG:-E%-.^B?;]--^VUCB%T[!8%N<]<GW_GU'&,8P:L0
MZ<"^,@X&2>?? Z?7_P"O74C3B"2Q)) '9>GX'V_KS4T-CMDR(G?C&000.N<\
M<'IUX]LXKT5&Z5O\NJ\NFOZ7MKS*BY>\DW?OMO;JK:=KO3H<_'9!<'(QV'/]
M?TZ_EQ5M(!(@51C:<DD\8[?KU...W2M]+4;BA@?CW&><G^[4L=D(^ ."#G)!
M)X^G_P!;Z=GR/TUMU?;567Y^>UKC>'FTW?9:7=EIV5E]YR,D&QB2/4=P?7^G
M/Y]^8_+!Z _AS_C727=F>H'?CH/7_/?H<=JQ949,Y)&.F.,\CK_D8]ZGE:U:
M=NO]?UKH<\H3BKM6M:[]6E]^ORZE0)M;/8=CUJ];##*2<#(//'H?7V_7I52K
M$$@S@\]!C].<]P3_ )["T:?9HCEE*R6[6MN^FWX_\.>C:!J/V,BV5D<.WFCC
M.%)W8Z?>..?X>@SQSZ5ILH>02 '<[9^Z=N.^.#@Y.<=?0UXG8S(DR21D))M
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M->!D#/K7ZN:=\)/!GA#18_AEI6BZ?<I!IT0FN4B61I;I6)PL^!,2QP K.>N
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M]FM S1&\#9#K&RD[21NSP0#7Z<^'_$?P^GL([SPUJ_A:XT\JKV]SI.IVK-+
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MI*Z5VFK;;+M>]K_NW/IW[(>K3^;?7&C3R'G"+)"Y')PBI AXP.G3(Y&:TY?
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M#P_X^\.6MOJ4-D]ZC-/;R/J%H@M88P[D2XN5VX81@'#@L5&TY)7^2/\ :6\
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MOTVOI:^NNNF_G<UO\]5LEJ[*V[\]]-K7[^=V/C/QI>6-C+:P6-A:E2L&H1N
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MWIGGCO77BGS0O'^5MVV2LG]Z6CO^9O'9>B_(XV[L#;RC$)D24?.RQAR$QT)
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M/3? WC>(VD4H2[40%7\P*-[ DE>,@$YP3GD5]Q?!'R+GP)X96&,FT2PCDF(
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MRWG6:X=WW32.2>\D1 .0&R2N,CG/J.:[;PYJEA;SS1:IIFFW4<P(-O/9*T2
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MLLLES;?.=R1QRA(EEF"MY81>@%>\SF3!78L4Q *&!A^_MV .04.71E/S!=R
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M7N^_W&4;RE:-VTK_ )6M?31=/^"?5T%TODR,=H+,>6V\#@;"#T"@ !<8&,=
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M'NCIEO-<7\T<4=LTD%[+/(D<D2#]X+II9!';FWBBRQ829&"!N)(/P?\ %_\
M;9^"'[-VDQWWQ!\6VKZK>2BR_P"$;TZ>"YU*ZU$@I"C0C(MK;R602R,Q"[G(
M/&#^&G[4O[;OQ'_:0M/%OA,_%6S^$?A"R\B/P[IWV_[+>^(;2]AWHSW$3JDC
M@;,Q$C<QV=>OGRK*C&\;R<+\J3_EM:[VZ7\G>R2/23C)KWK7>VM[Z)+3_AGJ
M^A^EG[7?_!47X6_#>YN_ 'PFN]-^(WQ&DU.32 L#+-8Z/(UR+5WU%I&A3<C
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MT5G??>SMH]5?2_X]O%_&O[/GQ8\7>++22YT+4!-'.L5YY4+G3#\[NT]BJ(0
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MK^FV]O+;MK^NMM3Z?_;J_P""R'C;XH7.M?#S]G^>3P]X4F\^"X\3AHHM6\B
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M:'%;P0P1#R[3(6*#+-)&IP2&D.YW7.3\S,<D^F*Z^/2XIW$YCGLFC*1)97"
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M:/E^%'P&O-5T[XA_!3Q->K'XKN],76M(LKR"V_L^WC+)=B5!\A;EC+&5SC.
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M+?V\]<^&7PZ\.PZ<+_XC^,/!VFP6X\1RS'1] MC'"\,+OI"EK;5&8D.Q)W.
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M.DD>RMMN,O(=VPG)']X+GD$_7->K^%?AKI%O:07MY9N;P2QNMS+(LPFA90P
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M171^GZK^NGKT/Z2$N2RI%OP'2%I<CA3)"5P/;)X]3U.,U^6__!8_7#8?L_\
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ML['?%C:>_-:_U2DK.S5KW^5O/3M=/=7N=.#<J<^=V479^=]-+[/7?39>6O\
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MCYR_94N;.62PMI'\P"ZEEW,2</LA55!(Q]U0>#U/;!Q^H'AQQ)K&F0\+BZB
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M;..2*<Q8Y=2CDEP3D]^W6N/T36?#FKN9?$&GWL^N;G>&?6OM#QF3=P &=%4
M$R*Y5B6<J1\H):3T;L_1)VV2LU:UM7=:+[C&RL[6L[+5^CMIU>M^BMV1]1ZQ
M^U-8>";*V\'_  $\)S7^JSVZ:<E_K$ \N<;1"UYOA:Z0&(CS@,Y9F/&0PJ7X
M1Z1XXU[QA9:Q\0O$]MJ6JZ@]W</I<3_:(-)5HC*CM&T;[2(P9& &>"",\5XE
MX9LF\2:U'9^'8S/<SM]C$EK&!';7) PL,LDDJ!0<9(106![D9^SO#OASP_\
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M%>5_)=V[>1HM6O/=;=4^U^OHM#]6_P!C+X>+X:\'/JTT2"74/+9"8UW%659
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MY\&?%SPS\16FE\2:;%%J-PC6,]YJTPEN;]+@&(F.=F,I;#$*B.JL>"IKX#\
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MA4%FN&N5CA4A"%)8QH3V"J&&XD<'!QQMKXEU=VD_L^U>23S'5@@!<H2=C[5
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MZ?\ #*/[.V.W'_"H?!^.*^KJ[H?!'_#'\D9!1115 %%%% !7.>)+"+5=,O\
M3Y$:3S[6<!<X&XQ84[CQP>GOG'-='5.3:SR[R L3J>>A1HE!!/IN.3Z_E6=5
M-QLNZ_7^NI479Z^G]:_YG\[W[2W@,>'O%^M7#P>2);A!')MR"=OR@GCG. 3G
M Y)'2O K'2Y);9-RJV2,MN Z$$8&2V <#T&#[@_KI^V=\/$N$FUBWL]L$NPN
M5CPK,%PQ! YP<G(Z$Y[5^:]IH&R41^6$V2*JC.%VL<$,.23@M@D#!YXKY]*I
M2G4C'E2E)7N[=MM/^&Z6=CVJ;]M0232E>.[MJDM4U>_ZO[REH.E>5*H>1D&
M 0<\G@@D>AP!CU)YZ5ZI9:>@B58W,LPPO(QM0'<&.1Q@NW3/(X-5=,T$1N&*
M@_, ""<#C/(]<\_7%=]!8")%^7:Q&<C ..F.<<<'MZ^M=5-R<4Y-<W7RMLM%
M_7I8ZE9**YUI9;JUE;K:^NO]:"0;TB W88C!(&.G'U'3\_6J\]QL1@SG;M.2
M#R!WK1:((@ZY /?T//MCG-<U?R)#D$]5(P3G.1P.W7H3VZ9],VHM_$]7;KW5
ME>^OKVO;<MS@HK5WM;39M)+6SM_6NAS&N7"$L48LS)C'7 [G'IQ[#U.1@>1Z
MWJ<:L4YR64'<1P5XXXQSSD\@=^U=QKNIM$';:, %1M'/0]#G'4=^>G&.:\'U
MK5/,F9WR/W@'/7DDD@#\^#U^N:SG0IOO?KNUTU?9=M]?F<LJB:=I2OI967=7
MOT>E_P#,R=:OUWR+G!#]<@CN.3C!P><GM7GVJ7 DR-^,;CU!!)SR, #GM[G-
M6M<OBV_8^26.%Z,1SSD=,^PY)..F1PM[>N !M<8';G!Q@]NOKCN :S5",91<
M4DT[N_;2S5UWL^W4PFTU%MV2?;K9=?TMHM-K"W%TL0*2$[\84YX_'/'0>O<#
M&,8RK>Y9G89P"=P)/&"WX8X[<C YZ<U9YEF5M_7KNYSG/J1^&/3IS5>VD7&,
MG@]SSU[G&/\ /)%=,VG:SOI9WOW;O^/;N82=VVMOZ_4]6T.7E"6&/+4$=L9/
M7KP<@<>E?0?@NZQ-  =S'Y=@_AWQA1R1@XQGJ.N.>:^9M$GR ,@_(%'YGWY/
MOW_#->Y>&+PQ-"Z'!5X\''4$#.X\$_3CM6D*BC;?:STWZ77]='Y(Q<&Y-Z6O
MWZZ=%_GK=W6J/NCP^;2_L+:SO=/ANU-A<P3V3A6MIX9XWBF$^<AU,;-M08*O
MSD'BOYO/VM?^"9WP-T'QYXW\02:M;>&$N/M>M:!;2W=M817D\BO/<+';,\;7
M4D4KED.]F(PJ@MU_H3\':V\3V;QY>)%V2Y4L [G[VT$$XSG')(P/I^=O_!7'
MX*CQ[\+?"?Q.\-V^H77B#PEJ%K"VF6(<FXMY=DDAFC16'S/W93A<K[UY6<8>
MKB<%.-!N,U>TE)Q>J6S6J>SW[+J3%.$TWHKI_=OZM^7SL?FI\"= ^./P+^$7
MC+XF>%?$^BS:<UO)I.C)_9T=S>IIMM#)8/- Y(VS#[0)""^]AC&"N6\8^-OA
MRV^(/PA\*?$[1);K7/&.M7*^'O$ELL(ENDE$ZRWE[>VX=YK:&0@1PN> 7/.5
M;/SM\8=6_:U^'&@:;X%O;V[TSPQKR1ZS;:)'/<D6\#Q?;@L\494!F)3(*@,H
MV[3BL+]G3]IW7++Q)/H?Q*TV9?!>JZ=-X;CN+*$^;#K0@GN[:=1%%&YN'OI;
M8!B2PB&PELYKX6EE>)I5%4G.24+.23NU?E^SII>_R3>NAUJO!7WU5K6UUMOJ
MMNOZGRO^T9INGWOC_P /> [#18M,O],TU8[^= UQ)=RDK<%'P&=1R4"E%;<.
MG4#@O#OP"\4_%'QMH?@/X5^%]3UG59;BWMKNUAAEFLH9?W9>\EU!08HSALE'
M*A, D@9%?JQ^RK_P33_:%^/'Q4U/QU\38IO!O@ZVU\FV\3ZLH-_JD<T7GPI%
M'.(I/*>$1,&+MU())QG^EWX!?LL_";]F72FL?AUX>L8O$U\SG5O$]_8V[76H
M,D?E3RQNZN(HYA@PA&&TY.XU[OMYT(TH4INHHP?-*6SD[:VNVVN:UM+=[WOQ
MR2E)R[M6[JUM.O6_WGYN?L"?\$I]*^ .CW.I?':YM?'%]XD-M=KX:OUAN])T
M&XB(N(F\F/\ =3W.21N0X"^8&4EN/V7L+.RL;.&WL8K6P@TF);?3EM[810BU
MB7RA:6]G%MCMHC'M0%5.6"LV2,U:9EC'E2D.X)ESMRJMD@E", $EC@>GI51G
M+.7& W3<.O'8]AUYX^N>M>97K574E)VYG9MO=R5NJBK6[?+J)RC'2VR6U_S?
M7\-^IIQW VJJPI;KM&R(R[_+!Y\Q6./FESYC9'#L1P!6C;S\_,Z[@1RS+R>.
M3CJ3S^.>_3EQ-B4@P*YX.XMUXYXSGVS]:NI(XP1;QA3SC<.A],CKZ<]>]3&M
MM=7=DGTUTZ]M7T7RV>,I2N[;-]WHKKUM\G_D=2)\D#S8^:229E VNKY/.S&1
M^?8USJW"[A_H_K_&/0^U3"=2?]4$]]V[/Y+Q6G,UKRJW?;M_7W6NEK+G-:N]
MO\3\OZ_K71\Q^^3_ -\_XU'(7&6'/J. 1^)X_P _7%3SE_SG_"E$X4Y'ZD_X
M=.]"DWHDMNM_+^O^&U2J2>BO_P"!/_(M@.2,D<D9_P X_K5S&YD(.-H[]_I6
M0)@2,#DD8Z\9/T_+)^N:OQ,<@]R"/Y_X5K%._=[KI;;SU^?<VIN33OWTUO\
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M)XKQ3]GCQ=X=GUC7+CQ:=-65XDBT^WU5T1)98KQ(B(WF601(P)#N(W"@ERI
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ML*1R6\L*S/%$C,4!N)!)F,[P<;-Y*\')S7Z4_"?5= \5>"M*;Q?X@FL=32V
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M1!G &!7S=X+GE @#%3AF^4L5!P^[;N ) .>H!(X R*^H?#US&NV40>?.]O\
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M*]WT)'4C%O"<*,-\N 3D\$#CD\\]>M>!:*<ZD&#@.",*20&'Y8Y[Y..O'K]
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M54-L9L$L%'&#D D9/\/WN.M=CHWA+3KE&N+RW22X>4N)2H+O&1D+C!. >.I
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M264 YP"M?1WPW^!NA^#]*CT30M,EENIGC\V64O>3-<,<[M[*[JQ!VI(I!QD
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MB ^2OW5 6(#!DD82%B,9&">17ET.@V>NO(EM-J6GK:2/</>+&#')!(0BP\*
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MU84.IE5^2<A@>O7.,3Q'X/T+5M.>^DL;"R@B@EG^UW#06UO<PKGS&AD),CR
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M=EH6=1_:"\40W5JUA>7UEI=G<B*_A/G2321QG:,%HV:)00<<X+989)./F?\
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MB$FXA5/]%7PDUK7O%7PS\&:WXITNXT?7[[PQH]YJ^G7D9CO;+4[FU66]M[I
M[Q12QRDAH8VVIG'K7A8VO&$^6,4FHIK2[2;O;KLTVKW^;U/T'#TINC"4HJFV
MDW%/=Z:O5ZMWMKTT[/=:)23YIVKC [,6R?4$8QCMSD\]!5-[+:3,[[X0.(U/
MS'C( !Z\?[/>NBO+"&6)#N(+ML#=E9,,?F[$AN1Z8//&='0O#5YXIU>TT;1K
M=[FZ+P+MCRN03A@^,?>/![$'H>M<^%YJJ3:YG)Z):[VLDETW[WWZCE:+\EOU
MV^>NEE^1L?#SP3J/CWQ!::/IUL[6QN(Y;BXSG"-(H2/<% RX)R,<_P .!FOV
M7^'_ ((TWP7X?M-'L84CDMXU$^#\K.P5F *@$KU!SDYQSR:\X^"WPCL?AYH,
M4LUJK:Q>);/<LZ(PM9[?J4;&Y02><=> 0:]NU?6-/T+3+W6=0GAM-.T^W:ZN
M+EW5=D:#?.Y+G "Q!F.[G +?=&1^A99@51IQE-)U'9W=M-K);7O>][=.UT<T
MI7?Y=_-_UY=7KXQ^TG\=O!W[.?PN\1?$_P :W<%MIGARPN+JVMI)E2?5+P1[
M8+&UCVL7F=R2@*N,KG! (K^'3]H_XJ>.?VA_'WB3XH^)=5@/B#QC=W0T;399
M=\OA_P ,.=C1QCRBL6[9'(O]TLVX$\C[/_X*??M[6'[2'QFF\ Z/=SS_  +^
M'I;^T;NREW)KFN6<LT3AHXW6&:(%'CRRL&4_*=JXK\F?$6JPWD4WB;2IA^]L
MY8+87ETZ36U@W");P(VQOE"EE?"EASG/'L5*E+#TIUY\MJ$)5-7V6G77?2^_
MS)<_9KF?6RW>^CTM;:W3YVU.0T[4O!7PY\9:$/&T\SQZ7?VVHL]JTK07-Q;R
M,T,JAC;J2P8J2?-!4_Q<EOW3\ ?\%&_A_K.C:1%:ZE96@TC2;'3AIT][% ZV
MML0L,BYW9+[P"J)G_94;L?S&^(?[2UC4KY]2O4O40_Z.;E0K6X5N& 0LJ,5!
MSM(5CG&017$7%M")EEMKZY6X@)(,,[PQJ2,84*R]C@X'')/I7XIG_%DJ^(G*
MG.<;348*,79)6[-::J[_ #V-J6,C0]Y3Z\S22=]G?I=]ONMW_L"M_P!N/X0Z
MC-&NJ:U;VYD8'?)=82-\?PO@(4P3U7)SU(Q5K4_VVO@;:[(CX\T*)% V/_:,
M:L!DX5MVX9&,9P!CC@BOXX[_ %+6+Y#!>:K<>4H"[!<W D"],[U?DCT.<9ZU
MYWJ?@X:FTQ_M358U#;@4U*[P5QGIO(YSU]<_0ZX/B5RHPA.NXQM=W@YVNU=-
M-K=]$WOH=5+/(RGJG9:6::2:2UUO;YZ]'=Z']N&F?M@_!_5$+VWC;P]?0%E6
M=1?0%@,8X+<L2 .5QCICBM*Z\>_#7QO%)>>'_%NDQ3LKK"%U&.,@8(W.@.Y@
MIZA>64' R:_A/;PIXDM9 ?#_ (LURU\HYVK?WDF,=<_O57&2<'L,>AJ4ZU\>
M-!82Z5X]\0(\8+)LU&1&PO(&UGVD' RI&".#U(KVL-FD*J5\30FI6LIJI"23
MM:^DELUI?R[V[_[;TM::]U):Q>]E9>5O+S=]#^O_ .*&I^*M/CGECDM-1TN5
M76WECF><X3C=@*2-^05!QZYSG'YU?$+QA);74KSIJ$<A;.2B+ "#GY=KEF'.
M3O5,#;MR2<?A'_PTI^TSH40MS\0M8=0,,KS0S.0.BL2&! '!%85_^U5\=K\"
MWU7Q3<WD8# +-;6AZXSE@BMSQ][/.2.13JT*U?6$J4HM/55%VWU5_75KYD_V
MA%M.3::[I::+?7_@NUT?UD_\$;_'B:S_ ,%%_A;I(O&D:X\(_%'$9"#'D>"=
M6G&.ISE,MUR,8 /-?VVU_FH?\&[/Q1\8^)?^"M?P+T[6;YI[6Z\&?&<R0[%*
M,R?#779E<E> RL@(XPIR1G/'^E<"" 1T]^OXYKZ_(,.\-@%3:BG[1R]UW5W&
M-SRL165:IS+9*U^^WRV:[?Y?RW_MZLJ_M3_%U"Y&[5=-;!(QE/#>A@#M@$9)
MSGU! R*_,SQ).POV<$/""58KDL,Y!P<@#OV/..HXK])/^"@61^U3\62./^)G
M89/3C_A&M%Z^W3KQTK\SM3(^VW R-I)R.-I.X?AG Z>V:\C%?[UB%WJ2_!+_
M #.G#I.%VNOZ1?\ 7J[GJEOJ2RV4+HKJ'2,.5^ZL9C1"RY&0<*N <C)8D$'
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MF$SQ$*C')#*0 P /'3&<'&2/2G["\KN3MVT7;R_5O[S5U$ERW=]%IZ+:VO\
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M$?LJ^.M+T?4;7PA(C">[N/.;N&"R1NC J2H"?*0. ",X../MKX[:A:6/P_\
MM4<HC%QJ-O CR#<K"289VK_%OW,,C())^AQG&*A*RU35GY77WJS6N^NNFK;E
M>*=][;;WT;L_^!V^?PKK[VMY%I]NWFN!YBRJQ4J)'6$E5^7.W)X!)/(],U_3
M/^R=H-II_P !OAZ8B89IM$LLX!^7S(XU8 #' "#;DG@$'J#7\R4UREY/HL4$
M&_[1?B!B#@R.Q@4MMZD@@\ 9[<@<?U4?!);7PU\$?AY;72JKV_AK1Y)5& RJ
MULGF%N. '8!V(X<C/)%>;BN:T4KZMW_!KT,SUNVEMMDZR1QXT]9+@R32JC2F
M,%ML:'9G)  ^8=>=P!4\7X<_;I^'VE:E=>'?%/@ZXM(M,GEMFU;2;5I-0 @!
M"N\D5LI:-R,,$F)[\9S7@WQ6_:5T+PW97FF:/-;7=XR21/"ABGG!W;2J!$!W
M DCYBO3N>OYT7W_"6>(M1N+N2>;1=)NYGN99YG999#,Q?#%#N8;&VJO. -O7
M(J*&$5:#FXZ\[C]RB^WGULK_ #:3=O3OTZ=?G_P=&?H-^TY^W1??$RS_ .$%
M^$]M>66@L0LU_+O@N'+IM99&^SAHR2 &66<L5P>#\Q^ +3P]&\T]YKUQ)_:K
M='.^;>YY.QPY'!YY8@$'(SFK-G'#IT3"(H;<OM:Y9<;V4*3(%(! !.X<=3GG
M-=SX;\(:MXQFBM])M9GB:7$FKDG[,N[)^9<8 5CM((P2">_/6J48)1LFHZ+3
MT?X:?\,"MOWM_P #^NYRNFVER;B*"&*-[B2=TB55\V5E0C#,$ZDGKD8.<''6
MOK/X=?"'4-0:UU3Q&EOIMO+M*03E8Y;E1]UHXP _0=.2,].]>A>!?A7I7@ZV
M2^D@M]9\0VUM,V3#'+"S"-B#&"I(;( W]CR#QFNAT31M3\2:CI^L:U?S6$MN
MZ&+387RH$,)8+%&[! 7('F[0"6//6LOK;D^5/?39>5DVGZ?Y= MY=MO+;]?E
MIKL>IZ/8V6CZ<(M/L;:/3[<BW^U%0'DD7?NW39W(\F1C*MOV\ %23P?CB2WT
M'3KG5M6NH-/TYXFD$=[+'9-.2X4);R2 _:""PRJHI((^85>\:_%+P+\*_!MQ
MXC\27EO_ &UB:YT_16<C#QLHBGF1LQYXSN&=I9LD;L'\-_BY^U_KW[0?QCT/
MPI;ZBT>G7FJI;&TTU&EM[*%),OYJ,_EQ0G8-SQ]SS@XJ%S*7.HIRLKN^OGZ>
MM_/<'YI;]?EKZZNVFO='ZC:Q=V<%KYD1:>VND5HO+(:-8W&Z, $-CA@,;CGO
MWKDTM75EAE:,1'][&<,"IX.U2<C;QT*D].2.*M6EM-::(EBK+=QVEG;%Y2"Y
M(6)!\F0#MXRH.W'3' JLPC+%VD:3RERH8EE53['H,=,8'X@5HYU].6',UJ]W
M;9I;[O=Z)?F3?1WT7337I;;Y>>NEK&HQD(\]I"T,2A#$3DOZ=AA<C)Q@X'6J
MXO+..>)KH&5F8!57<53<3MVD[L;>A#%B3G.  !6-S)(A6$L3R. Q& "6&02%
M.,\^O'>LC7=8TOPQI#Z[JEQ:Z;I%L&F>6_8-)(\2G>J*<D*3CG'O@=1O3G6Y
M+R3@];Q[17+9^O3J'NW[W_/31I::[]KWT.%^-1L;JSM;;7/%LWAK0KJ[LC=1
M64K?:[Q,-$+91;3Q21[DB3[X*DMN8$,*^<_$'Q$L[72[7PW\&P+"VMYQ8ZE)
M'>13ZIJDS --+-9VK?:I?,&Y,-*I:0E78,<CF?&/CW2OBYKJP^$1?742R&,W
MD,23V$=S!T,[RG]S;B AE91PS-@YR:32)M)\.K:VF@2^$_$?C-KZ* WL;75G
M-89$P_L_3H8+:WBU+41*%C#WLABBN@A:3;ESISU&UK*SMW>FG7LE]VWIA;5W
M=[N]M'OUZ_?L>I>%_"'AKX>:=:>(_'M[-K_B*\@-]8^&K1'ETYY6;SH[C6$\
MQXH4A<[FCE5I/-545U?:X992>.OCIK,L3Q2RZ'83L(GD@"Z3H<,8# VDS1M%
M%Y*C&S*,%50788QQ4N@0Z-*-;U32->BU)K74HKE+:]_M+3M*=YE9+F0-<222
MRR.Q5+1%>".1EVG )KK=*\<ZOX7\+ZIH%OXKT*[M?$GV%FTN_B?1+]8[N!6^
MV276G6GVF-XW&(H(Y#)<R,RR#BNGHM[76O7I:]TNN_\ P]IWUU;TU[6L]$M+
M:K5NSW7GZ#KGB;PYX%TV?PEX2*WFJV<(76?$ 99+V)1SOTXAGE6$S-*/+B<#
M?O*QH6W/5\+?#A?LTOC_ ,<:A<P>'DCFN[6>[D>#4=7NHE60P2)<>5(UO(#B
M((ZG(.96Z5S6A"'PK9R>+?%_A"&2>X4)I&F:->S7FH0O@10:KX@2_F$D%K=-
M&S0K;KYA*DNBDG-7Q5X]A\6Q6OB3Q%JU[HDLDL>G6>C:C"8K:.SLYT%WJ4-E
M!'+%]FB@QM:?!(#,Q()K2%K[;=-K/3O;OI^C$D^E^EVM>UTK;6OTW.IU'7?$
M'CZ]LM"\):=/#I]W+]FM-"TN&22S^P A8[EIHW6":<[LN"B;AD!4ZUZ(=-\-
M_"V"2T@B@U+QE);1QW*$Q2);7"A2Z3X55MR"RE&<R%=C ECQ4EOXC\%^ ?"M
MK#\/M4@\1Z]K]BDMU>6S*DME$R-ON["4B!(+>('S&4H8R%!92,XXBRT4W2?\
M)QXXU6Y;PY'<6,5[XD""*:^6*YCQI\"6ADCN9I(6F$\GE&4&%2Q 8YT[-V;[
M[JVB=O5:[675V%>^E^R2ZMZ*[Z?>W;\3-_X1>Y\4QZEXMU:XNDB@%V7GA:2X
MA:2UB:8VUA A5KVX1 RFV@7,FY>F.?+]9\::Q=W-I#X<FU'P)X2TV/[1]GN=
M-GM)]1ND48UJ:ZQ9-IER6+,B$$1JP5C*WS'K?%/B1?',YTRS'AU?">AZE?RZ
M+96VOZKI5_HUC<D0IJ.IK:K!%=7FIQ)M2W?=,DD" HH8;O/KU;AI;/1/#<_B
MC0K.TC O)M;T_3M=LKZTMES,;VXU"2=\D99!(OG;"FY1C%92D[NS=M-M+M\K
MTU7GN][Z,I+H^R=K)V^&^B5[M=TK>>XMS\0_%^O'2Y+3[#?PZ7)Y_P#PDE]X
M@@\0QZP43$=QJEFZA[ 2A?M$9DED\QW 4MD4W4_'=_XWUVQT[Q1I%QJ]Y8VZ
MO>7EMIC>$]/ATME8--=3N98+NUA!\Q)R\1DE5%15=E(Y_4Y(]1U&'P[H<'A_
M4[355,J0PM<:/?W;K\TD]\NFPVUG9V$+YDM-K [ BLB]!5U^.71-/D\-^'(?
M$5I]LN94O]:LDM=;;4=0,,37.DE=3N&6WT"U*Q3)<(K><1/$/GD.*N[*[[]G
M?:VFNM[77;SO>XI7CHMUKHM-+]GUMM]QU5WXJ\#OI[>'?!5I9VD#7#P7-_%>
MQ7%]=1!BUPI=0LHAW*'1F.UE3;DD@C(\,>%/ MWJJV][XCU-G,[SV5M]EFAT
MZ6X5=S-+)-,T"E%^7S&BVD*".N*\ZO+BQTF*'34_L+5=5O+,?VIJ)2XTXM)$
MZA=*MOL\+".0'#S/:(%")(OF8)#9US/<:2!;06>H+JEY;*+J;0)&U.WTV!B7
M6UM6U"X$0E:-@TLJH'*.(S]TJ%>^CMHUKT2T6BT_!VWMT:WY(]O\^G^5OOV/
M:_#WA'5?$'Q!T6=-9T6[TS2M9 TV"UO8I9P\$-X2AB282-*2K$-Q&!@*NP!1
M^VVB_%'XE>&8+4KX2DUW3(K:&/[:+,RPQ,D:JB,T,%SL P!([G@;B" -P_&K
M]DN:UL?CCX#M]1N9-2N-1N9)+Z*YT^UCL-+L5M-42#[6UNFU+ZY*Q1O+ NXE
M@C'S,U_1'K7]NZG:V-AX6TFT\/6UP$<;Y7:RN'3 5_/9/.)D(R(WC93G&UAE
M3M1=DUW:Z>GX+K?R]"7%;=DGZ]-K[Z:6ZO5]Y?@I\7[CQ#J]X=?DDT::W@ED
MMM+>*6.S>=)?*CW;I47;SNXMP2P&UU!KC_%:^(M:\3:MK1L3Y7F3)&($5XV"
MLQ\PD E%.05;/(SD&MBR\'>*-!T_6O%/B6&Q)CTX&SDM 0LC;R[!9/L4*F1\
M[F'F@D#.&X%;G@/XS>&X2FEZMI<;2W P7F51M5U P"00Q)YP3^AQ6K5]'=6U
MO>ZV6[W_ "OON2G\VUY7Z/L];I[W;\M+_.^L6=S)<6&H2;%F@6>(^27*A7QG
MS><"5,?+T !&01P"U\31P7MM#=QQS12'8[3E8D; X+%U;<<=2  >F.*^W-2^
M'7ASQ=9"^T>:VM6GC<^4=I EF!*MD@,#T Z8]NA^8_%'PFUO1[J1Q'%+#AF3
MY0R;@<!EXP&.,]/0D]*YY:2::TV3ULM5HWVNM+Z_)W':6Z6ED]6O*[?K;?1]
M2I/<^&_(-\%ALR\;*T-K"9&D8C&]HX2BLYSW4+C^$G&/#?$MU::',U_H;WT6
MIK<+<03P^:C%-LA>)H%8%5<8+%CM &#U!'37Z:C:3F-R6V]2(G(0]\C:=N".
MG7D8..G-W\:W#[DG#W*#)C8$*I(((;.<'G!!&""<=#2C%+6]]5IZVL]5?_/;
MN%V[+M;S=]/)]=U\MSB-9^(WB#69K.Z\1Z=!=0Q/MBCV)YCQJP$7G,Q8A0 >
M'R3SR.:H?%?Q3H7ASX->)_$^HPPQR%-D&FZ<X=X)75A$[Q1 '[@#G)X!P233
MY[2W_M2,7H126"CA=B@-P!GY1[#'(Z 'D?/W[8OBW1/#7@.T\,:21=:IXA;-
M[!@ 11)\@8D8RX0#')QTQTQ3:5MU;HEYI^7EVU[ZH45=[7OOZ77Y>O\ D_FW
MP#I6F>.TL?$<UE+=6<CB:86J[[B"4H/GG0$2(!G.UG7:<AB0./TF^'OA+2[S
M1=.T[5)+?4+1S$^F);R^?=6;!0B?:UBCE$")C<RNY)Q@OV/YD_L\:'XCTR8W
MWAB=;]I$AN)M*+L J0A"RRH3M*D EE8'>,G!K]3?!FB:%\3-+BL+?5Y_ OQ!
M&P*(F^RZ?+*2(TCX41!)#D,IR<$G@\TEM?5-VZ7VLE;3S6]^MNY33<NZ3V[;
M='IK]S+&L^$KC3;^>"^6(11'$5TD?R20;?D7B0MD#!.44<>HS7G6J^!O[3E"
MZ*C_ &B9MJ2/$S1EU^9MQ)4;2K+M'8[B6(.!]%:EX0^*WAG1QHWB'1/^$HC5
M2NFZSID<EPCQ1C8\ETR3*H7S!A6*D$<=,UY9?MXZLK28R&VTU8$\Q8_+8.L:
MDY!*@;'X(+9.!C+<4*^E[/35;]4KV>M]_)-:VU$U:UT^UNNC6_==%;3;J>5-
M+/X1N;."]@99;*6>XG8QHL8 @<H1R&#F6/Y<DC81P6(-?B;^T7XEO/B#\7=:
MFG1'M5NFC)DM1<QPVMH [RO;,Y\B&1$(,NYE R:_83XBS7EYH^J7UW9SB9;8
M.9Q<!HY&P464_.=N5RJDDG!..#7YBZS\/=%\4Z_=7%C'>PDV\,-[<6K^8T@9
MBN$5V1F49R"3@#OC.5/5)=6_QVT^_K]_>H+=]=4_PZWL_N/D*33WN+F.R:_^
MSV\FV6S5=2:WLA;&%9# EJ@9=@;<8T.6Y.6-9+1K/>F2UMM.D2WVQHBZ ;AQ
M$I</(\L95I-Q7]VS\<.0.37U9J/P%TG2I;J73/&-Q')IT*K;65_86+N\Q1L)
MND@D<[2ZH%,@4C@M7GG_  I;Q?(XOI-/CN)XH/(F+7EYIS.%9V3=;6D@ARZO
MD^6H. -P&146?9E;[6W5_.VN_P"6ZZ'^I1_P3GQ_P[X_82PH0?\ #&O[,.%6
M,PJH_P"%)>!\*(3S$%Z",\Q@;>U?95?'W_!/2SFT_P#8#_8<L+B,0SV/['W[
M-%G/"'>0136WP7\%0R1B23+N$=&7>YWMC<W)-?8-=T=EZ+\C ****8!1110
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M7TY/->0ZD9-N^[>MGK_EVMIML8<R;OKNTFDWU7KOTU?KJ=3EO^>H_P"^E_\
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M?8V4+;($A!D 655+$X5R,EB23RG=>8^'/PCU/Q]?J=/0V5HA4^>^YH@4 R0
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MR,-]T<<CGT'T]6GC)U7&#5^:UTYN_P!E]E>V[MO]Z>\/WFNR:OKKIITT5_\
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MQ:0J4V^61@Y?:A+5Q_ASQ+HWB;3(-:\*O%JEE<3>5!*)E>Q14<;WAAA)B$N
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M'4?ASX[5=<ABM803HTMY)*XMX8T2(! RMD;5(7')(R?PQMY[I%M&FC5X_+9
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MX-[HZ"!9+BW*W*H#  &+#TVL#P2>>0>3R/5+A5;2U@DMVD8\$G&X9X)8@$L
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M[1-J<[I.)&ED4>8W)7?\YQ('..,D>OCW[6OQ0L_C[X;\&_"SX?ZW:7.G>/\
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MQ!I7B[&>2_B_521R3P-Q'?IP#@9'%;$?_!.;]FZ(@KIWBTX[-XLU,@_4%O\
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M"_B*%E*671BFKVQ$W?;HZ>]K+ITZB^JUNM:/3[+\O)]/R??7^#TZS#J<!-Q
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M*1M(5(4@E>2:_P!$@_\ !K/_ ,$U EPD.K?M$6S7!7=-!\1]!298U!_<QN/
M_P"[C;<=P7G@<UJZ7_P;"?\ !.G2KJRN(=<_:&GAT_RV@T^Z^)&A26,DL9W+
M)<1#P,&E96P=Y;<Y R%ZT<C\OZZ$I-6OK^/;];VZVVZG^?/I7AOP?8"QU;5)
M-1T.YN!E?#\JOY2,H&^ZU%&(G:($G+(1#D?(,8QZ_HWA?QG?AM0TKQSIUWHZ
MR&6X:$)_I46Y=NCZ5;WL!B5<96XG<L^TMSOVU_?MXA_X-P?^">WB=[R;5IOC
M5)<W]G]AGN8O'6E0RI;'^"WV^%=L( X 10 .PKC;W_@V-_X)TW2:/%;:O^T#
MI,.B1-'8Q:3\1-$LPDASBX=D\%[GFQP2>WO43I2=K6=K];/IZCM\O1^G^7]7
M9_"F=0N;SR](UCX.Q#2FNMNDPV;.$L;B,[9=;U=UF26=1&9GBC=FA*RML3:.
M.F\._P#"KV?7-$\,_$7Q#X.U+5+B.WU#6M0MKK9J]ZH5)-)T&(12);VRRXC1
MXCO8*&4XX/\ >'X9_P"#=?\ 87\,V\]O%XL_:(U1;J17N'U?XE:7=2R(N?W!
MDC\(P/\ 9V!^:#=L8A6ZJ*W[?_@WM_X)_P 'B;2?%#67Q2N9]$R]AI=WXOTV
M?1X[DY/VQK0^'%=KD-\P?SE ;^&I6'O9RM>ZO>]K=].JZ?I;4\O)Z^>GR_ _
MCF\$^&F^"6G6OB?XN^)[/Q[?WMJLWP[\'W=DUQ#:0&$Q1:CJ)-K$9+YYHWN(
MUO6E)+ +\@4#@;_Q9K'Q'UVVU+4]-77-6EO8X-(L](:XCOK:U#,QLVM)U73T
MA3? K(L)B5L$DJ :_M;O_P#@W]_8DU77;S7M3\1_'F^FNYTF6SN/B+9R:?:"
M-2B6]E;OX:9[>W5<!8Q.P7D+A< =+\-O^"$'[$/PP\67/C30S\5KS6;B"6W7
M^V?&EG?6MHLI0,]I"OAZW$<BJ@",Y<K@9SR2_JT=$K)+O?7;?M;=;KR$DEZ]
M^WDK6[]M=;G\L7AGPUX*_9L\+Q^+_'NH1ZO\3=;M+R6P\.:A:RM::)<7!BDT
MR[>:QB?S9[:)R\*H5B$T:F13'O%?+&OGQ=\1/% N+HWFJ^*M4G#K?Z=<0S%[
M:Y8/#9O'=N"@='"+##")0%.X$8S_ &?:O_P0A_8UU_7-<U[7/$OQXU:YUZ=I
MKBWO_B+:W%G9YZ1:= _APBUB7HB@MM4#'(S71?#3_@A_^Q7\+-4FUK0H_B=J
M.HRB7RY]?\8VVJ/92RH8UN+)CHEL(IH =UN[K)Y+A610023ZM'2]NGHWIOY:
M?+N[Z)II;[65G>VMNV^^SOV2T/Y3['38/V9O"LNH7-Y:WGQAURV@BTG^T(R8
M= M+P+'=&"38(1<11I&J_+YD,HW _=KYN34M:\5^(#':FZO=;UR^6!I('M[T
M7-[*[">[::Y\R29(PS*T+C8@+#;U)_LXU/\ X(>_L=Z]=ZA?^)-7^-/B:]U
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M#/)..I)Z9K=\*?\ !#?]BKP?K*ZWI;?%:6ZCQY27OC2SGMHV!!W)"-#BV/D
MAU96#'<,$"DZ"E\6RVUVT7;NUK\[+JQS5K+MOK^'73>[[>=S\M/AWJ-EIWA;
M1D2<AK;R"8 JL'40JK<'G.,@' &<8..GTKX9UF6&W>\T.1["XERS./EDR^>@
MX$9&"0.A)]A7ZAV/_!-C]G33X([>!?&YCBQL#^(XV(V]/F^PY_7'%=A!^PA\
M$H(%MXY?&8B0;4']OQ948QU%CR<=SFB.'BNV_3MIHW\O+_*XUW%<JOOY:_#=
M]6MFMS\@;""_@UJ?4]8U635)[G)7[:\>8PS$X610/DS_  9SGDCD5Z#;ZC;6
MD+.)(UD?YB#(H&3U"C<,#I@C_P#7^FC?L#?!"1P[7'C;CD?\5&.O/./L)]<=
M:6?]@;X)7"*CWOCI548 3Q&@[8Y)T\D\=SZ"L7@_>;3ZW6OFO*ZZ]_38OVT?
M/N[):/31>6_]6/S6MO%UG!IT]R]Y]FN%+PQ+&ZLF0&8$\] 1@\>E>#:K\9O$
MVG2W&HMJ2W&GP+<2I%Y<! \H/L+&4[#\HQZY(([M7[)7_P#P3U^!&HPBWFN_
M'<<0!^6#Q(D0)(P2P73QDX[Y'T[UR]U_P3%_9OO+&;3YY?'SP3QR1.6\31M(
MHD!!:-GTUPD@S@/M) R.A-+ZF]-;>C]-=4_/;\;:CK1Z7^:VV[?Y[^1_&5^T
M[\?;:VU7Q1XLU?1-/U6_UC4#9Q:=J<T44EQ 2R.UJL=Q$3*ZD"/<^.F!@$5\
MG^'?'GP4\5ZMI&F)X7^(?A35;EGDGBM+C09-'6Z,<1A>0^9-<?9W;]X%5@R[
MF!RP)K^Q;XK_ /!NY^P5\8YM+G\6:E\<('TFZ^VVW]C^/=)M,W'4-,TOA*X>
M8*?NABHQG*],<OX7_P"#;3]@?PIJCZI8^*_VCKIVE29;:^^)VFRV<3( "(K:
M'PC;JBN1N<*RY)+$9))<,':5VTU;2]F]T^BT>G_#@JT;.^^^B>OK]Q^+WP[T
MLR)H8TF_C98"I2X@B\XM$H3RQ+(F5$CJ%!QU<\ =!]P>'M9NM/2."]"72-&B
M22RJQ8 <X4 @E@0,8^Z0&QP<_LWX/_X)2_LQ>";"VTW1[GXE-;6BA8EO/&)N
M6.%"DL3IR#G&=J@*"?E50 *]%3_@GC\ 8U"JWC4@9 )\1*6'X_8,_P N.E.I
MA$VK2M?;?>Z\OPVTW?5*ORJR?;I>]K=WII?_ (&Y^,]CI-EJC*WVK4;B:<Y5
M8S$;5%9=H2;S6#AH^N5+28X  '-ZZ\1:;X#T]X[*ZN=0U:!TE%M823SS2+G$
MT&)<D.RHH78"O8-D''[*6?\ P3^^!EC(9+>[\=ID8*_\)*NP_A]@[_7^F+^E
M_L&? ?2;Z74+>W\3274Q+-)<:O#,P)&,J6L,CU^I/K7-/ 5^:].K&*=M'JUM
M?9;.WGU^=?6>Z?W1_KN?B'X=^.OQ$U:ZOI]9\+/8VZ",65W,DANHX%=A$'!4
M*T@C"E@N,?Q<TW2OA5\(?C9XZ-]\<-/L=36TA\S2]-N6\I;I),*XD=9(CYH&
M52/(7D@*1Q7[G:A^Q!\&-3CDBN&\5A)#\WEZS"A(P!C(L.,8Q]/T\K\2_P#!
M,?\ 9Y\2ZI9ZM-J7Q+TZYLL+&-)\9O91.@()$J#3I"Y/IN [9%3]5QJ5E4C)
M)6UTOHEJM;WMUO\ Y;+%T++FI2NDKR36LK*[MT=U\_N/AFZ_9)_9.N+*"VTW
MX1>$&TV,,<P&Z2278J;#+YEV6D;J 8_DSVSTS+'X%?LPZ%]HLK?X/Z!#"T#6
M^?L+3$AV5BS/+(_";2!@C)8]Q7Z?:)^PQ\)-!\H6FM?$.18555CNO%9G4A!M
M7<3IZL<@#/(!/8XKO;7]ECX:6D;1!O$$ZLQ;,VJ0NXSGC?\ 8E8CGN3CMC)K
MF6"QSM9P5[:*S7V>Z73>Z\WT-8XV@FKPD]UJ^C2U;UZZ[Z;'JOPGM-+T_P"%
MGPTL-#M([#1;+P!X-M-(L85"0V6EVWAW38=/M(D'"1VUHD,**.%5 .U=_6;H
MVEVNAZ1I6BV0<66CZ;8Z7:"5@\HM=/M8K2W$C@*'<10IO8*H9LG SBM*OH()
MJ$4]U&*?JDK_ (GER:<I-:)R;2[)NX44451(4444 %%%% !1110 4444 %%%
M!Z'M0 4A( R:;AAT;/USC^=(P8XR >O3)_/_ #ZU,I65TF_EYI>7?OT8TKM+
M:Y#)=QIW.?IG] 1W_P ^E9M2@7&68'H1M.,]^<< ?B:M%%Z%%QZ%1_+%,,"$
M'Y!@\_=&/_0>E8*<[WY;]-7Z-?UW\TRU!;MIK_.W4JRZO!$"3G Y)P>AX[9[
M\?SQ5!O$]C&3OWD <;(WSGWSD8ZCZU/)8"7Y3$B@]O-_7IZ\].V*S9-'6,EU
M126^4@L9 /?:P*KR!R,GJ._$NK**OR/3[[6CW]+=NVFVD80;L]-NO?YNW7U\
MNJ2>,]-CSA92>P92.OY9'IQ^G-4+GX@Z5!$S-%?LP!.+>RN9N>F,I$RG_@+'
M'1@""!6N]+R?FC@<E3C,:'OVRO'?C@=NE<[=:=,K%%MF,8C8X69E3/7*QJ-H
M[] "2"20<UPU,=)2>\;?-Z<N]GY*[]-MC;ZO3>G,MUL_2Z[OK^F]REJ_QT\/
MZ.F^6QUN7KP-,O,<=LB$8)Z98X&#D]ZY1OVK?AW&Q5DU?(SD-IURH0 <ABRX
M8[OE!7'<8/6I-6TV*>)HIK"6;<&1E:9B<,"IQUP"/0>OX^0ZQ\(/#NH1S+#;
M26+[6)*W;E]SY*^4>!& WWER,=AGBL7F&(;5HNS:O=-/I;5M;^G6QTK!4VK6
M=^C5O+R6NKV=_)'K2_M9?#0$F:6_AC'!=K"[ !/3.^%!@XQA2YSUQ@9B_P"&
MO/A.'*&_O 1P?] N#SZ@^AXQQUKXA\7?LU:I-#/-IFIW%T' #6+:I+;K(&/W
MFE#,RO$03'L&?F))!Q7QSX]^"7C[P[<'[-8ZS*@9AYJW]W*JB/+8+I)&91S_
M *UP6(P"Q"@":F8UJ:OR-VLM+>7G9[+6^^VVC_LZ*5Y-Q7][SL^S?H]$?M3)
M^US\)E1?+OM1DE< A%TRZ91GU=5P.?7&*SW_ &Q?A4APTNJKWR=*NB/T&>W7
MI7X#)XK\8^%#)97^EWJPQ9:22>224;9AE&Q)(TC1(GS9PQ7&%QSGJM.^+EA?
M,L6H2-;N#R7CV(>N<MUP.F>><9XK#^UVK<[47TNKIVY5I[W2VO=/03RU2LX2
M;2WY;7MI9V<;]U?UOT9^W[?MJ_"0@D3ZL%5MA_XE5UN+8)XZ#& >.N<8S6YH
M7[77PDUN]2R&KW&GF0 K/J5C-;6Q;./+\^21 CL<;1M?/)X')_$]?$>D:@JB
MRN[67(W,OF,) V,948![D#GN<U5?740-$(IMT9&UVB1E/7#1L3C>O4$X/((]
M:K^V$K?O8-::6Z:=;_UTU)_LR>ND]/3R\NM]M_4_HXLO%FEZG9K?Z9>6>H6S
M(KC[+<I-,0PR/W,7F/DCD#;D@C R:H-X\TB.8V\XG@N 2/(FAE@EP#C<%G5
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MO </Q#LI/$&J:.AB-_!8Z7?3ZAIJR1"5GO;"&)KF%8T.79X6"<Y'45YMI_\
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MI62VBOU\K:>FW3KI8*4ES6;UTMKI9>BW_K1G[JZ/_P %1?@IJSJB>'O'-J'
M<R:CX;U?3UC7GY93=V401P025R<!E.220.R7_@HQ\"OE>>;5(T/2*.UGN;MN
MO*6EM%),W7'SB,GT[5^8OP-_9FO/C!IMQJME?7$EE9WT5M<-=W\\;"62-B5B
M2Z,F-TK;5,3!-NS:-P)K[=\.?LJ^#M"B>UU/2K2]N8FMH99Y(K02!YK4Y,=R
M( \F& D#9&7&3SG/=A<77Q%)U%%*,;7NG>ZMM;39;-6W'+!TXV3J6>MTM;;:
M/?9;V_X)ZEK_ /P4E^!.BV+7^WQ!=VP1F'E:/>^:X49(6,1E\G_=.>V:\_\
M#G_!5_\ 9\\0V&L:G';ZYI-IHKQQ7,VL6=[9&1I"1F**XM49T!'56)S@=,D\
MIKG['G@.^OHI4U":*V5E,EE]D$T"*#\V+@DO-D C;("&&00<D5R/CW_@G_\
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M0^E?P0?L>VWQ7L/#>KZKXJ\,^()_#+;%TO598[][>> PPDO T%T8I [[@'9
M#AB,-DG[,LO%*+YLDLS0R>6ZQPW!4NR-E8P#O,JM&5=3YA)&0%Y+5YE;-,71
MERM4GHG=1;6_76WEIW.FGA:4X7=[W[OR=G^-_7R/ZS=<_P""_O[#>@KJ!NM&
M^/$ITZ&2:98? /AI&D6,$LMNMUX_MA*_&,;D&> >>..^#O\ P<8?L&_&^\\8
M:=X1\,?M%VM]X+T^YU/4[;6_ASX4AEN;6U+K(^GQ:7\2=7EF+%#Y8G2VP"/-
M,?S;?Y$?%6G-=E) BL][(OF?+N8Q.Y\W)(;<I4Y=2?F& V0*X;]D7X+_ !/B
M_:TTN]^'.G1SZ-X@:TTO6Q+*UMID,>HRR?:&OFE)1HYMY#1I&T0/"K@ 4Z69
M8RII>DGT]U^5[Z/HWVL]V9SH4XR:][1[M[_AZG]>'A'_ (.=/^"<OC'4M0T:
MPT#]I.SU33+I[2[M-5^&W@VQ<21L5<Q@?%"X#H"#R67/"C+$ _>W[.__  52
M^ /[3VIVVF_#/P%\>3'=#,>J:_\ #_2-.TH_/LYNK/QAJ90#(8N\8CVAOGR5
M!_GB^"/_  2M_93^"W[3/B[XP?M.^([5[F;R=1T?PIHTJ2Z-)<LD%P8Y4@@2
M*Z$C*4:-HLMRSAL$5]#?';_@K1\)O@"^H>$/V9_!/AW2Q9'[)&]C:VD07(DA
MC,7E102%E7<S12G[/'AB1D#/KJO-0ISGRI5'9*SOLKWU5M;I7L]5HW>W):[L
MEKO>^G3H[].S[G]#OQ1_;'^#'P<AO9O'NH:IH_V"TENYH98M(BGE6)%<I:)>
M:U9BYD() 6-L%\+N# BOS.UO_@XA_8'T&:_@N])^/LK:?=7-K-):?#_PO-"[
M6\TD1>%G^(<+/&Y3<C%5+*00O(K^-_\ :L_:Q_:;_:,U]-5\1Z[(-)N)08+.
M*]AAF1I<QYGBAD!>%>#Y09\X5U&,&OF/Q-H.N0Z?IGAV6;SM2O8_M%W+-YC2
M.]UY) #R.TC*QD:5.7SG.,EA6-3%SC;E2UDHKY^OI^([)<M_M.V_SOITTVUW
M1_I _L7?\%/?V</V\+OQ'9?!&S^(UI/X7B@FU,>.?#FC:$FRX#F(6K:9XIU[
M[0[%" N$(/RM@\U^@1U>U!*EB"B>8Y*\!"=H.=W'/'.2<=*_A[_X-\O%Q^'7
M[56O?#/4+V*(^)?#&E^3%.8(I)YX$UF3_1]BCG;&K21G!=(E!S@8_MDG&99$
M=5\J2WV;@ > _*D],J3D*<@ YP#7FU\XG3O9).,G&2EW]UK1:I6:3^;[FOL&
M[6=KZK?^N_E]QT2ZE$XW*0ZD J5'.#Z_,?T]Q]+"7D3XZCZC'Z'_ !YYQT-<
M]"\*?NU 55PBYQC@<XX'<]/K[9G*Y;=P<8&<Y Y/^/('0?6HH9O6JR3O!Q=D
MHJ][II-ORWMKKU5W<J5%0BKIMVNWLM;>:?RMVUW-YKB,*6ST^G^(JA+JL4:D
ML1A022H+# P<]1@?4'BHF="@!P2<9R !^>/QY].*YS4K::^1;>$B/S/,\QCG
MY5)& < ;@.F"2,=LFML=F.*ITTZ'(YVTC:]Y.UEYZM;>?:Y-*E&4ES:16LFW
MTZ[/39][+5^45U\1='LY/+DCOIC\P+6]D[H"N<_.753R.QSCMW'.WWQN\+:;
M?V=A>6NM12WK!8G.F/Y*DC.Z683,D8 [. 6/W<X-:D7ABQM;80>7'))('+R,
M@#,6SD*V,J?[O0 #J3C/P1^U?\'/BGJFD7'B'X?:VT$^GR"<6"[%;[/$C#8G
M5Y6D8JA6,J0I92/FP/D\=Q%Q%A*4JJH4*CCKRJ#=DK.2>NKMOV>NR/HLLRS)
ML94C2JUZE!RM%3E)<O,[6>S=KVO?Y]#]'--\8:5JL0FM'=HSCYFCP"&^[@AS
MUXZ Y]L5KMJL(QC))YSL)7'UW=>G\\=J_%O]CS]HCXA:WXGO_A7XV\.:A::S
MH$4\D][>1R0JYAMT"K'NE>66(ODHLI548'RP!@#[VU#XG7^E7S6M]&ZPQ%BS
MS*(CAF(4Y4Y('4$'![=JY\NXTS+&495IQH)1T<8TYJ2E%KF4N;33;SUZLVQG
M#"HXGV&&FZJ:4N9237*TK/ITM;3JO,^J9M;M8(O-?=C.,!02,9ZC<#V]OKZ\
MW>_$30M/1GN7E 4D';&.HYQEI #^!X[U\6>,/C=+IS[(9O-CEW"/R=T@;G.2
MS2*05 +'@XV\ 8KQ:[^+A\1/):/>/:!\PNS,4Y'\49WX+$_*,_,QX4YZ<6,X
M_P 90DDHTFVU!1:U;TU33OV>U[_,]'#\%/V2J8F<HN6L4K*T?=U:?FGLWMUL
M?HY%\:?!LDRPF:]WL<#;:C9R<8WBYQG(].A!QS77:9XUTC5KC[-9FX9\ @M
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M+/Q\CJA<B?PS;P_*K*I^]J^<Y<<8]?2MC_AM3X/D;EL_&SKW*Z#:87(Z,3K
MY[_3MW/K6K?!'X8:F@:;P?IP=I58FVMHK20'8XY9(E)7YN4'R[MO'R@5S-U^
MS'\);I"O]@-#D'.V[E7&?3 P,=NA%9R<TURN-M-U*_2^R?5V_'TI.+U][Y-/
M^OZ^?&K^VG\'F( MO&>?0Z'9 CZ_\3COVK0/[8'PH*[DMO%\@V[B4T2T;:,9
M.?\ B;#.!R0"?0<U4N/V1/AB[L+6*ZM.05;S9ISR 3\SL ?FS@ C' [8KF-1
M_8S\)7#'[/KNHPDYVAHVV*<'! ^4, <'!9LXQSGF5*IM>#U6U_[NWWN^GW%6
MA?=K3MY+U\^FOW'7S?MB?"6")998/%P# $#^Q;0,=V,$*VK>^>O&#7(ZC^WQ
M\#M.G6VDMO'DLQZQV_AFWG('8DKK*[0><'#9[XKA[[]C*1IO+T_Q5*3$/W7G
MV2F,$@D#;,2F&4$DE,# (VG!'E^O_L+>.[^=I[;Q!IL[ $J9(;"VP@.$=9O)
M<_,.O.<"M)J2B^6W-I;5/=]D[]QQC#F7-+3KHU;^NQ]*Q?MU?!:7RO\ 0O':
M>< 5W^'K)=N3@!\ZUP>,D8R!BN[LOVI?AM?VT-W!:^*3#/O\LMI=F#F/[X8#
M5" 1D=">O6OA8?L7?$S3O(=DT:],;+D'4TP4_O@K HW'!]3WW'I7H7_"F/&?
MA;12][9QPQ6HG>0)*;BU5#&-Y%R5+1N5!)$*AB% R:PYJJ2^%[*]GY?BUKUL
MKFDH459J3E=K1/;;NO/\=UT^M#^TM\/0"?LGBC@9XTJU)_ ?VE3[;]I'P%=%
MMFG^*T5<_-+I%LBD@]B-3;CZ@>YKXLTRSNKQ/,$=MY@N$#H93M5-PW!=P(Y&
M>"I'3/'%>@RP_84G$0MTQN!99+<L $!90-@(0$ GC:#C/.#4.M-6O975[VZ>
M>OS^_P!">2-NM^_3IY/S[?Y?5J?'3P6T7GM'K4,1QAI+")BV<X 6&[E(8XX#
M8)_A#<XQ+S]I/X=V2NTHUMM@^94T^$./4>7-?0N<?0 Y!4FOB>&]DU&X2TU!
MT%HMUN$B/$ "K':25V)D?PG&>3T)YH^.;2Q2V62UN$W$D$R;<D ?>#[@2?<$
MY//;G2%24HJ7N]5L[Z.WIKKNUML=%/#4Y1C)S:;OIIT=M[=ON]=OL*7]KSX5
M0DJ\'BL$$@G^QK<C(..,:G_^OK5=OVQOA&O#)XH4]R^D6JKVZL=4 'XGDX'6
MOS%U#[:TS+%/"Z@D*N8=SJ"<$@J6)QU+$MGJ23SSLR*78RE=P.0H*GDD9P-Q
M['/ _ 4^>?6WROY>7K_GVKZK3[R^]?Y?U?T/U=B_;$^$DK!$'B1F/0+I=HY_
M)=5)'IGIG [TEW^V)\*+, R6OB^0''^IT2T<@YQR#JRGCOC@9'/:OR8CV+/$
MRN5 D^;:2 >O!"^GWL=,BM>\O46,_9]LDV0.<+\GLQ&>O/&>>,<XH4Y>7]6\
MO7^ME]5AWE^'EY>OW^1^IJ_MD_"5HUD-OXN0-DX?1+8$ ,1R!JIQT]3^%/A_
M;&^$DX8K%XJ0KG ETBR0DC/"@ZOEB2.!\I.>W;\HDFGN"(N01C@<#GKZ>N/?
M^>I&B:?;GS(3+.X;<I(8*AR=P!Y&%'!P!G'&324Y:;=.C\KZ67G_ %M<,'2D
M]925K==[M7]+?\![GZ>?\-K?!OS#"8_%ID4E2%T:R(SV _XG'?GC/4?EH6W[
M87PHNU9X++QDRJQ4DZ+9+R.#P=7S_GZ5^2L%IONFN([4(?,!RT?')ZCCYF!.
M01WYSWKTS2HY8H"'B5"VUB"F""3@DYX)8E021DYZ]*?/+R_JWEZ_UM;P-%+^
M)+[XZ6MIM+5WZ];?/]*X_P!K/X7R$C[+XL3 Z/H]H&[X("ZJW!P1SCH3TI3^
MUG\+ 2#!XKR#C_D#VO\ \M*_.1EDQ(P1<A?F(487!/4CD#/&<'IVKF;R2\!/
MEM%]XG@ GGID@9(.>N.U95*U2FKNSOLK-=GY?\$2P*?PJ;6GO75K.WY^7W'Z
M>']KGX59P(/%9([#1[7GV!_M3K_GWIQ_:V^%BGY[?Q4@QG+Z1: 9R/E_Y"A.
M>IZ<@'TK\LH+B19RURBHR8)!&, 8 W@CY1G&<\=L\UJ372RX4*JL-A&U3G!=
M<@;0,Y!(VC/'/:CVU3R^Z_\ 7]>@_J"Z\R7>[=EI?:/9_C\C]1;?]JCX8W/,
M4/B8CO\ \2NT&,].NI^F<TD_[57PR@8J]MXJ.W RNDVC Y&1@_VH!WK\W].;
MHH.&\QQA6^8#(VY7J,>ASP?05K7^G^;#YN%4, #O 7&!M!)/.21D<X/88."I
M5JB2;2Z:*ZO>W7KO]_1:"6!IWUF[=;7\O+U_JQ]_-^UO\*DP&@\5 G^]I%HH
M_$G5,#W/X]*QKG]M+X16LSQ26WBXM&I=@FC63*5'4B4ZPJ */F.>H! .2 ?S
MHNK4(Q5ESM)VEE'('3&1CD=,<$Y '0UROB.W*VKNH8O)&0NP[7QC(!/&!T'!
M!Z $'KA6Q56%.3AR<RU3E=Z:>>_EY>:+C@:#:7-4;DTK*VFWEJM_/[C]>=)_
M:3^'FLZ9;:O:+KBV=W*L,!ETZ,RF1B %>.&[E*]>N<<]<\5ZGI7C/2M8M([V
MU6Y$,N=GFP['.#C)3<<#.1C.000:_(+X/ZC%>S:!HMPLX=7,@9G+,& W0G#,
M2,$;ATQCC'2OU*\+Z5]ATBUCD78^S>P^7(+@8QUP" &)]2>U?*UN(LQHSDK4
M)15K6C)2O:-[W=K)_K=[WTJY?AZ5KSEKK9.^FEEUUW\K?AZ*==M5R3O"G&,H
M01]?F/\ (52G\6:= RJ?-<L<?)$S#MW!XZ\YZ>E<_/;IMX=L^A).<^_3OVX/
M3C->3^+-0N-+N,MN*#DX+@#'48'ZXXZ=LD>)CN.,PP=W*G1:[I.RV7O>]YIO
MYFV RFCC*JI)U+RU5GK;ML_P7Z'OT?B6SD 81S@$<$QD#)Z<Y_3'\JL1ZY;R
M;L)( ,=4/?/H3Z?_ %S7RW9?$==OSQ!8\[5 .%PAY;JN&/!.>OKGBNTT_P >
M:?/M4-@OM4G.06/3#%B"<D@[3V&0*\REXEUY22J3PJB]VHR4NEK7:6Z[][[Z
M]N(X8K4[\E.HTGU=VTW'RZ)N_P GKL?1$;B2-)!TD17&>#AE##([<&GU1TR5
M9]-T^=3E9K&TE4^JR01N#WZ@BKU?LN&J>VP]"MO[6C2J7[^TA&7ZGR<XN$Y0
M>\92B_6+:?Y!1116Q(4444 %%%% !1110 4444 %%%% !1112L^MFO3_ (+
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MQ\;G,'3E*K%R:J)II2T4E:UKIM;6WV2MY^KERA6J^RFDDES76C>JNK[7[?\
M!N?UO:9JIN)%W J&^=0Y&3S@\9'' X_+H<=4)2^UER%QG[H '/4GO]1US7RG
MX+^)4.H-:Q,3'++$DAA:,+.HD=5*RA9" \;EQL5FQ@,P :OHW3=6BNK4S0.)
MHE+QL4+%E*N\>QPRJ1\RD9 /.<$XQ7AY9CY.4J=26J;?G=-::O2R>MKV6USJ
MQ^&4'SPOR]+O=:+3IJ];=W?:YTZSQM\C-R.^" ?H>O\ DD=:?%'$9=P(SG!.
MX$=<<@<D9XP<C&>G;"@N[>3<\:OM''0D;NXW$] <'UY XP<6+:_@-Q+:QE1-
M'&)I$&-R(TAC5V&<X;&1@'O]:^GPN,A5E>=GR2TTZ1:LG?TUZM>9Y,Z4H)='
M))65]6[=_7].YT<JKC"JHXX?G)P.%QVSQSG!QVK#O[9;F%H9D26,E<JR*<A2
M& (.01N'0XYZ5K17 . [Y!!P @'H/7G].>":LO&"C,%7+#CN<8.2,GC'],<=
M*]RI3H8[#5()14YQ?+M9))-MI/71::_+J81]I&I%J32OZ-/IM;3;IW[GRUXJ
M\%>&M \1GQO%IEE9:B4:*;4$ MM\!(:1&@BC2.9B0=SR2G'?'2J6JIX%^(>F
MRSPSPW%T[&%S#-L,+1G 5VA)VE77 .3[>_9_%'2M5UN*WTNSLI9H[V5+6XE@
M*C[/#<2&-Y&W%2" ,@H3C.3C-8W@[X*Z9X.TJX@MY)[VXO728L\DC>6<AU4;
MI0OR'&> 3U.,\?F4,-6I8C%TJ=&U-OWI-:2EHKJRU;W>KM?R1]=A\=RPP\Y8
MCEJPV<;72NM)/FN^^OG;8_+O]H7QY#\#]=L-%\0^0FEZE>Q"'5[AG>%8+H.8
M(4$B$LR-MCD8."%)<Y"D'<UGPSXBC\-V7B?1K+2[S2]3M!<V%Y'=3?ZR124F
MV)#A"#@IM)W$8P217U]\=_V<_ _Q;TPZ1XRTTZA]E139W#EEDBE574B*2-D=
M?]8V"KJ6(VM\K$'@H-#D^&_AVQ\.6NG?VYH.EVHAL[7,ER]BJ($2.5I)0Y.1
MO(W.(QT&#7@3PU.EBY/%1C.DFI4V[N46WK%JSNNW6WSM]15S*6(P]%TZTI55
M%*3O:#BM$MW[UV[WTU?8_*30_P!JKXA>#]5N!JOARVNX;6ZN(UM99)4 :*=T
M!9I4:17E15?:J%3Y@8')('U#X-_X*M:AX6B^Q7/PHMI8"ZA[J+4KH$<[)#M6
MQR2%7Y<,<GKD#GQKXL?!S5=5U?4;O3_#T\T=\[W=H(E=V9%2(,ZNSDM&LAD0
MG*@,I4#*U^9'BZXATCQ%J&BWIEMY;.ZF@N+8RW4;!HWN$V,JN% 9H01M')).
M3NS7WN1YUE^'C!*T-.6WNI7O%:-K6W9*UG\CX_-,'C,3.4^=M2E>RO97M=;K
M1?-65^]OZ&-(_P""O/P_F:%-=\#:Q8*ZXD:R\ZZV,?NLH9(F(&0?E93P,$&O
M4-(_X*L?LVZA\M])XJTXJN66;2H(U&!\V'?4XYFZ<#;\W\6._P#,/82*R":T
ML;<VS\%Q/=.<'AMR^:7P!U"@L?X03BMH79>2.%B^W:<);VL$H4C'47$)GP.,
MMG XY'-?=8;,8UK*-6C*4DE"/+JV[+3WFV[WT2O>ZW9X4L'"*;=.M&VE[R<4
M_/?3=[]O4_JMT3_@HM^RWKA00^.I;-B"Q_M"VM8?+ Z[R]\[ \'[@8G'/:O6
M=*_:]_9SU:*.>U^*GA;][@*DNIQ12'..6B8K@Y.#@,,CACBOX[MT$DC2*H,R
M$ISF(E1_SU"H^SD  H(3U!W8&VVM[+;E9!&T>U-O[FXO65<9 .3,#E3G&%"C
MMWKL=2M'62IV\E*][)]9>?\ 73EJ4.6*<;O5;ZK3U2UOY[WMT/[1++XZ?"74
M6C6P^(/A.Z,S*D2QZQ"7D9QE55=F2Q'\()]#UKO+3Q1X>OR!9ZQ87+'&$AN$
MD<Y.!A5))/L >.>E?Q'6VN^(H3%]GUO4D4O%,<7D^]-HX6%O-1X6 P-P<MQR
MW4UVEA\5?B9I4Q_LGQAK\,T2@RH=6U8M&H/WI-U^^WIP-ISSC-+V\NL>VS]+
M[W2Z]?-,Q]G4OMOKM?LM->O3NS^U-Y5.T[X@A/#.Y49P> <@$X[<]SVIZRQO
MD))&Y R=KJP_1B?\/Y_Q]:%^U+\=]+VR6OQ,UNW\Q1&OE7"WP5,JS+,+Q"T?
MS(I+^8Q4X&#N)'MOA/\ ;L^/U@1_Q<&ZO1$I5T>*T\UBF2VX/;>6>F2-YDP2
M55EQ5*JFDVFGKYK=:NSN]'WMHC2-&35]$^S;\NO;?;MM=G]2A+HQVA2)2,%#
MRN  3@DI@9Z@ '(R2:XGXD^+-+\&^"M<\0:Q>PV-E8V4AFN[APL:#[C'<NT!
M^>,%0&XW+C-?C%\,/VQOVG_%S6RZ#X=N_$SRW-K%/J<L*Q0^7*RGA5M42-4A
M9264D-@MSNI__!1#XF_'P?LXZOIVK:6EC%J&G.]U?Z>;F62"=W#+;RBV6%F&
M%4(K1M'(2079"33YO=<ES.WO6M:[LFEH_NMMLM05*7-%-Q5WWW^_3]/Q.V^$
MO[4=W\1_&6L3_#_Q=?3:!H]]#IDZRVJZC'+<HTWF7"F>X "D?NA'NSM8X!X-
M?K[X5N[N]T/3)[]B]U)8P"[+(4)N57$N$ *JAR&4AOF!S@#!K^?S_@F9\.;S
M3/AAX5O'TU;ZXUQ;75KYT6>1S<RB3,4;2LB).0-\D<P8J R@C((_=>#QO/8"
M*&\\,:S:D0QN8?+@+Q%@0%'ER.C+M4%1DOAN<5E1FY6O"JFVFG.[7336W>R2
M:6QI5A%72MLMFNB6G>RTNW^!Z>44C:>G8>@]/I7D/QF>\3P?/:Z<RPW-W=V]
MO%,^#&L<L;HQ;+#HQR..<>@YWV^(6D8)EMM2A^7!#0-\K<[E(7/S $$GZ8/K
M\T_'WQU#K=E;:)HCW;F?)^TVZONAN4 ,:3QG$H.<X95).2%-=KIW@G)M=/-Z
M>N^OJM?0Y5+WFELEKYNZT]/U.$M?@7XV@M_.@C>[CGBLKT2K<W$FQF<>;'&(
M@$.X= PX[]R*^M?#WXAP1RK!X=\0W*EGW!+9GC,97!"LS,Y!(X/"\_2OM'X5
MVU[I_@G0K6_GFN9A"5,\N[.!C8N<EL$\ MC.".<\>D,H88.,=P<\CTX(]O4>
MQK&5"F^DE;=<SUVWT77_ (!2G+KRMWWMI;1]^VOKZ(_*.;P'XZL52:3POJ\:
MO* L=S T:L_S$() &D5B,X55))QT*U@ZAX0\7:M'-"MI<65PX+"QFN)W:5?N
M")YY(S-$Q./DC3Y.BDU^M\ME;-@F"%F!++YBAD5^H<!E<*_HP&1CO7(:GX)T
M/4;P7U[;!IU)V>6H"ABX;):-8\G(!.<?C5QIQ45%2FDMM4];KROW=NFEM32-
M:2232^5_+:_S^_?J?B?XF\/ZYH%U-8:UIUSI][:L@:V6ZN;FW8/S',TES%'<
M*)5PZ[?E&[ !SBN#%]-YC>=%&R*6#MNNI"FQ2=VP1#+ @;><!L9R.O[O:YX-
M\,ZC QU+1-+O)'*!9KR)1,S6Z^5#NV!"\<$7R(&=@PP6W$DGS^'X%?#&_>22
MX\-V+M(69S;^:JL<=_+DC8 =<!AD=<J2K-THV;4G\[;Z=K]]>QK'$O1-=EIM
MTOV^7;NS\=;222XC6>)(VA8$?:[AWC9-I)(,44;(P SA9 A/!+CI5"4QDR&S
M2[9\.TMT+))8R$*AA&@D90IW+M9@&)&", "OU(\1_ +X8P7DODZ9,ZN^5L;7
M>K(0"1M N8LG "DR.R8/*D\C!T/X-Z/%?ZHA@ABT=M)N%AT]DA^VPS;X@69Y
M(S&,)M.!*QSGDUE[-^7]=?ZU.R,XRASZWZ>C:O\ UH?FM870D)3%TSJT@(E1
M(V!CD:-B5C;Y0S#*]>"/>M>XF!2VMYI)(S<RE;>V9@0K* ?-#EQ)G.#Y<A$;
M'Y6PI)KZY\0_LWZ$]W?W:ZM<V*O*Y2,+&I8-@$*Z!=VUMP. .01D]\/1_P!E
MB\OX+C4+;75-A9S,Z1W06.?E,'=($D;8P!).<#J<8I<DEI:_G_P[?X[ETZU.
M#;D][6TV?_ O_2U/%=+TM;>U$<\DIEGP$)6W3RU?'WRLKL(VZ,0,D?=.:WK6
MSC%K>"YDMW=9<1"SDGD1L30!?*5P [C!#!G !VA<9KNY?AOK]I( =1M7,8"(
MLPC82B%\(@/V< J3@%AR.Q.#C2T?X9>.+N]M6L=/BG1[F.25;%'8*OFQ2$;&
M)B&WRNNS!YW8P*TC3YE=I[]/ET?K_5M-/K-)WNW?=.Z6VFGW;K5V.*E\+Z@E
MG#.MG?"&X$LLSWEO!8P\S2X,,MM-++(Y &0Z;2 .YKAM8M;BT)>2S<[FSEGF
M;=SC.1&HQQC..>W2OVD\):!!9:!IMI?V4,EQ' OG)<6UJ621AN==J1J@P3C)
M&[U)& -:Y\*^'+S/VG1--ER>K6-JQ)^IB)[=21[GK6=2A&>C<K)Z<OR5[W^?
MW]CCECI*34;V\K+:W^7RL?@Q-=1,D1N#J5K&W,=Q)9+-:NYZ1)=W#1SB1S@*
MDBX(Y!R.='2Y%:01*DES<L<M9VL:-&7S\K7$F[S(B$W,VP,-F<9-?JI\7=#\
M">&-/M[]?AW::_J.H.L$,202P1Q>5M57G$3!@69N715=0,@XKPWP?+\.=0U^
MT\+>.?A[I_A;5]44OI^I6][=&*5G6<QH7FN"H=X(I$+%=V257&3B94XPU<FH
M]>G56ULU>_3R6J&L;*U^2;7GJMHZZNW7?;6_I\U:4=Z?O4T\"-]F(+R[G6/&
M=RHLMO&ISD9#2<,." -U=,T,4L+- LTIP1Y9MK:*W)/\8N$GEE9D(P,HNT@C
MMQ]^']G/X<S(!9:>;*-55$\B24X0*&0J6D"M]]F+LKE\@D\8K+N/V8_"S*PM
MM3U&+.<!Q$0N>OS)MR.X^0$9P2<9//.G5DTHJ+@WHW=/5)6>VO7\^MW]>76*
M^Y>3Z7_X=,_.#4X%M7+31SJ2"28XXY<D]3\SY.3D] 6ZX4\#E-4>UG1'CG?"
M!BZR6L.0@!+C89,[BF=I/1L'M7Z)ZS^R3:W0_P! \1W$18<Y0*<]\DL^\GUP
M,Y)(&2#YAJ7[&OBN"60Z?XEMYH)E8$2 ;U)7@$"V8 'H2&]\'MS8BAB?9NU/
MG\D]=O-JU]%?RVZ%T\;%R5[1VUM;JO+;\>W4\W_9K\)0:KXEBUF1W6UM% 17
M@B3>T-NVXEE=B<GG;\N!SGL?TE2YAE0+YJ;3&H4*RJ1C(VY' X'X ]N*^</A
MQ\&O&WPZM9;>"2"<S,VYT57)5EVMM(AX/O\ 3O7LD-CXH@"B2VF4X!.?*4'"
M@9 "#J%ZGG.01QBOA\=A\:ISM@ZS3>K46U>T=%I;KTV[L['*E7M.56,79)+F
M2T5ELTK:=>^YTDS;1NW_ " <<\8(]>,@G\.V<=?%O&U_!>K/&<>8@8< 9 P1
MD<@[L'((ZYQC)S7H6I1ZXMF[M%(2OWD &X8S_=ZG&"<=^Q&:\&73=;N=6OC<
M:?>1VVTND[@F+<,G +'GO_(<\U\'GF#QM:JJ3P==PE%[<SC=Q6]EMWZ=M3WL
M@^K4*SJU*T5[UEVM=6?3MNOR.?T;2(M>,UI!(L<L$CJ\;-NSA2X*XY97'"GL
M2W7%2ZAX8U?3E+VCR1;'0JH+NK?+G<N02H&X!@ 0Q'48Y\QOM=UOX>?$4W5O
M8RW=G/';P311Y>&WB(9?,E!PBG#$G)S@]\8'UQI'BCP_X@L+=F,*F>.,.ZLK
M;)"BJJX;J6V8)!(7N>@KX^CD%2M)PGAZM)Q;O*TTK*S5GRK5O2^ROON?28K.
M84,3!T_WU)J]UKK;5OIZ:)Z/H>\^#3*WA#PJTY)G;PWH9F)ZF4Z9:F0GWWYS
M725G:.B1Z3I<<9!CCTZQ2,KC!1;:)5(QQC:!C'&*T:_K++X\F P,/Y,'AHZ[
M^[1@M?N/R'$2Y\17GMSUJLK?XIR?ZA111788A1110 4F1ZC\Z6JSN!(R\<8[
M\C('4?C[5E5ERQ3_ +R7;HW^FGG8J*N[>5_Q18R/4?F*6JGF8/3H>H/ZCBGK
M)D@_,>O!R/Z8%9PK)Z7[=6WTV^__ (.CLY1M:VM_^!^K+%%-#9ZC [$]#^-.
MR#T.:VYU;3?LR6FMPHI,CID9],TM4G=>>EQ!1113 **** "BBB@ HHHH .M0
M,,$@5/4+')-95+:;:[_@E?\ (N%[OM;Y7T*[JPR5#'=UVD9'.>_UZYXQT)P:
MSY4<KR"".QQG'Y#K_3T/&M4$L8;)/KVST'3/^'ZUR5H+ELKZOIONM/ZUWU9J
M<Y*HP^>3D@_3N>N/;C^5<9JEJFXY"@$'.1@8((YQP/<D_6N[N(L/*HW$, H.
M#R0<]>?\Y(["L:XM2RLO*DJ?[H(X/J,=>:\^2[]';MU77[GI;6QHK-+R:TVN
MM+]EJ[;NYX?K.G0"$[$R55N%&"%8@G@<8]QT/:O*=<T.V>-@(T3>P+-,/E.0
M<\GD'L ,#GGC%?0NJ6<B*4,ZM)M*;@1@ MNVMN[Y7(.,<=LBO/-5M69G61A*
MA"C 88!'H<G/('3&.I-82<=G:VZOHT[*_P#E\[W>Y*E;>UKKY:I:6_I_.S^0
M_%'@FUFBE\N)0Q,CEA#&1N4DH?ND./0,".G>OFGQE\.Y)ED=BIE90=FQ5)S@
MEB$ V@]=@PHQC:-HQ^A&NZ4&1P/F/0@%>!@8!QSQP#UXSR"37B'BG1WB$IB8
MJGE*S(P)!D"X)! _O DX)ZYR,UA*FVKI.4;WTOI_5^YNF]&GOM;6]_S/R6^(
M_P (+>\$K7^A-=1JTF^6&"$':00&#LT6#G&,MSG R<*?A3XA_ 71K@O_ &/<
M/9O&"WD7:R;]Q)!1S!;R%5'53)*5!]^G[RZQI$4P=9D1G."N%8 D$$\[> <$
M$=P2!ST^?_&7P[T;57FEOM/10>!Y"OM)/!;;@D,1W("GKZY\W%TVM:;VM?2W
M5=?._K^)VX75)R6J=]=>D=?^&WW/PUM? 4O@^XFEGL+BZD$,P(M[F)E="8E#
M1QF8.1D2'! P-V5ZUROB?XC6?AU9(_\ A&M;N/)D9,BW94(#$C:5D*8 P,Y
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MV_PUM^9\[ZI-=QW;!8RP496/@9.?I[CC\?KN>'=,O=5U+2[.&)YIY;^R$Q4
ME(S=1,6;D%8U  9D^8<$<;JY#5OB9X'$CLD=_=?*W[Z2!UP<<'S @"X/0Y'7
MKGD]5\._VA?#'@\2:G;>!-5U64JT=M?R_9D(E2.1"L?FP^>8UD:,\OEN"<@<
M?6UL_@\(H<T$FG=*VD6DOZ\]]=O/A03E&45SM--[>6]_._EJ][)/[%^-O[/)
M_:0\):3\*KC5'T6![&.&34K8,[VX/F9>-OG4RH%.Q9L@9W#!(%<GH'_!,C2O
M#7PFU7X=:KXFN?%^FFQ<6?\ : B.H>9';O&%60QP()&=AM_>#& "3C%>?V7[
M;OC+2YICI?@2Y-W<2_Z.6GM8S#%)"K?Z^,,Z*3&Y(QSM )W8J:__ ."@GQ@D
MMX1:Z)HMO_J]XN8+Y9=O3G=.I) !!<J Q ) !K\_KO#8BK5K5(2;<K+EC=M;
M[:7TZO2Z2O>QZDHUXJ$*'*DHWLFM-8MWMW:\NNQ\(>"O^"(_@J^\0ZQJWBS3
M=9MK.'40+2UDN62:56D?:HS*R,%!(5HY&5B-R,00:_5OX.?\$POV9_ F@6T#
M>'#=W$:*DZW\X?,3?)*DC&7?AHV8$Y'WN>E?-_B+]O+XMMIT-GIL.@6UQ=W,
M,US<6\<L4T>9)O,57$\@?))PK8D<8;&>#RUI^U!\4M5 DG\0M',^TO%!<3Q,
M\98"9-Q;Y2T6]5/&<C'7%8TXX"E--TJG>\HVUNKMZ_C9]^X+Z\W&,Y\E^5+E
M;\MUUOH_O36I]HP? #X:Z)\8X/ &B^$-)_X0V30[2[U,S%ECCGO%F+1F..41
MRK<&&%"7!7C(P>OPC_P5A^'OP_\ A_X*^%6C^$_#VCZ5;ZIXPTJTNA:F3:T0
M>"28&.U);9E(UPQ*EDR1NYK6M?B[XZN]3EUB[U*5-0G@M+(70ED6:2.#S"@5
MO-);R$POS#:22<_-S\1_MT^.-4U=_@MIVJ:I=ZI)+XVTM LCO(P\Z&-EW$LS
M%28Y<$?*,8ZEJ[L1C,)3PKC3E!-W:ORIJ[3_ ,2MK96]+*S.N<*D%"<ZC5E9
MWNN9V6M_\[>=NO\ 1#\+_AYX&3X6^&[E=.TFWN]1\,V"7<D(+2OOLK=E,C-$
M?,WJD4C*^<'"MR*^2-;^ 7ABPU+43;G3('NK^3R)4M+)/,B:0,<@0G!5\!CM
M9F( ;.<5]V_"+3M*?X/>%9CY<I_X1VWD0HV-F+5."!]UL,GRX!7D"OG;QXB^
M8T]FC.8;B6+YSR#]LA,A7^$?+ZC([C%>#B?><&DFY)2T=VT[-O:^J=^WGIHL
M!+VDFW+FBW9M^\KK:W;YVN]KO5>,6GP1\#63)<WU_P"82ZL%ABMQ@K]]%"P(
M 7Y .<GZUU$?A?X9:="L46EOJ,A=V2XGAA:9<[<QNP"X5>"O )P<GO6-<7T@
M;RY1M'+#@=>,'@<'TSTQ]!66;\QLQ7N<D[<\CH?F!P3W[D]>U1&$)22C&$5_
M,TKK:]V[K7;;9^IZK2>_]?.U^_WORMZK::UX5T6$?8?#]D7"QHNZWB:2/!'S
M[VW$= <9X.3QFGZV- \7FWN-1T"UU"^> )"TXC,9,=\0ID[+Z@8..GO7E4=Q
M+<.N 1NY!P$#;.W0 ]??/%>L^&[16M8KN2)UBM-/FF?(^5G@NS),QP,?*HRV
M<%CRHQ6OL_=E9QFK;73MJO>VU>N_:VRO?*<8JS2N]_NMU];?CT/@?_@I'\&?
M!][^S5))X5\">'[#Q2+RSG2^M+:**Z$8;5A/$95B4E79(F93D,=C$<"OY8;W
MX:_%7]X9KJUM(K>X!\LQ3N"BQ)Q(RC9M+!5(P>1GTK^KS]HWXO:+XX\.WG@1
M[5MPO!+YF=P,5K<3QF%MO.%)&1WSR,"OS1O/A/X9FM[A7MF#,QE90I?'4#A%
MX&&QCJ..G?YG,ZZIMJ-E&R=K6U5ELEU_7NSNPD7[+WDK\S:5F]'RO[M>G:Q^
M*DG@+QN_F275[+ \C%MMML>W0=,QADW -U*D<'DG'2A-\._$3J?,UB]##)P-
MH$A(P00J@#C SV4 Y.>?U\N?A3X1MXC))"2%R!N##&.O4< $'/IC'TX/4O _
M@^U:1?L3NH1FW*&V[@=JJHV;CN8#E?E (SSS7DTZD90C)R7O7:VUU:T2W_$<
M\+"<V^75VT^2UV=K_AW/R$U/X1Z[J<%R8GNVBA8B\FA2:?R5[;DC@V=,[CR0
M3@$GFN>D_9]U"T66'4HYX;@;&.^%X[A5E3S(B8WB&86AS<(VX,2F&RN17[^_
M"?PEH,7@7Q9+;:38>8]Y';2?:8([EAYL,K L"0$PZMU& .G2O"_B'X<T^Z\1
M7]U<Z9:JSPV$<DEM%Y<:M;V4MN3L5F!!W*=O3OT!->Q3J.*C+FNERMJZLTK?
MA96>WSU.;ZL[OXM-+W;[?*UO/HEL[GA_P.\.0^ /V0?B+&DLD;:KXT\/V-FT
MB[)+A$\5?9T6//WBJ2NK!OX6(8D\U_8S_P $JF!_9&\.*-P,7B/58G#XW!TT
MO0<CC P,C'KU[XK^5+X@6MKX;_9YT7P_:K''%J?C_0?,VAF9&G\3V4AP I)R
M)5;)P 6)/6OZO/\ @F!";?\ 9;TZV88>V\8:W!)R"=\>E^'U.<$@'&,CJ.XS
M7TF15Y5,;R?8]A*2MJKW6^ZOYMW=CR\UH.GA>;FDTZJ5G>W3S]//3SN?(G_!
M:;QGX(\!6G[-7B7QDFBN+'6OB;+IT>M!?*8K!\/OMDL+<2*T,9B+,K*0",Y!
M%?R#?M]?M._LX:QJ!\0^&]9LM7\5:KIRP/IFDJGV?3IVR9[:)O)C8^6YW-N^
M0G@,W.?W._X.S;..[^'G[&>ZXO+>>'7_ (\O;&UE,(D+:=\(U<2,H=FVC[N%
MR S>N3_$'X;^%,^OW']H7YOI]+!+O*Y,K^8I!\HRLR*D+ 8<D@@="#C/T5=I
M59)KHNVNBMOVWUT/$I<W+IK?:][+7RW;O^79LDTB"+4M5L[R2TWPW+FWAAM)
M=T=R\CN8E3!#M(5/ER*K#<P '8#] OA_^S[K6CVVC^*(M)GM9M6DMF$4SR1R
M)%(I9YC#([2*"J1YWM@JJD<<'P#X'^&?!6D?&'X;IXR>*#P<-<LFOX;-I$6W
M7[3)<.C-.3$PDA0&4.>2X ?:M?KK\8_BOX?U[QO9V?@CPXMMI&GVEEI>G1Z;
M/;0VIAFMH8Y;R6WV2B2Y46]LR&)USYDN\GY<<_*FF]];)6O\_P _GU-;V?+U
M>[^2_P O+HSSUM)U#1GLAJL9,QAS;SE7&1CYV4-E<?=PS')ZBDM9(9XKD2OY
M;ER98B<F9"Q* .V&&..%*C/7->E_%[X@>'M0E\,>'$@2VU5=.C%U*98TGFE6
M.(;9V$CN3E2!P, \#%>3G*"9I4C:4W$HCPKD(JNV$WD#=M "ACPPP0!DUXN,
M<J53W%*'OJ]KJ^L7\U;[K&\=8IZWTWZ6M:U_17MU]-(1X)\)>(O$NEW>O016
M4%G/"[7ES&C0J/,X$8C1Y%WN50A5).XYP#D?L38_MC?L+^!_V9?%WP.^*VL:
M%;RW5G(=)N;&.![B^"64D,]O<6[!B)DN9(XU66!5*L69\@ _DC>6<&LZ!=V-
MV)+I7AD14GW.(E<8"QA&&1G&0#TSC)&*_,+XO_LYW<OC>]UB\N+N'0M1D\Z"
M>.1@]N8Q'%%;P)+YL:1NIE+*P5LKU # ^SA\5[2#CRQ<FK<UDVGILW9_<UK<
MYZJDHZWC:SL_=T;6^CO?[OU['XF?$CP;XX^)=Y%\(=2FB\$V,MV8C=226\3S
M,05=$C*J#'),V!'E"2>#W=>QW4;PZ7)XDC6W>W=)$DD!1"D/RDHV0S)P%D(W
M'@$[B2<7X9_"#P>(9M6;49S9Z7:7!FA8# ?Y3;IOBB"O-.Z.Q8<C''!%,ET_
MPE/?1*TNI3+>7=V\DDJMYT,#SB2*.,>7G:^"JD@#:1UZU:OOM=VWLDM'VVLO
MP7SRIRBTTVFU%[:ZW7?K;?S[$\D4%A81SS^(C(8IY;:YCC*^9);,J06DKD+E
M59Y7CXY"EB1T!^@_V2_C7;? +XW>!O&&E^)+H&UU.VB\01(\D4$]C-/\\H6W
M(9W/F&*8MD!?F(ZBO K_ $_PQ+?".VM+]K8M.DBA)-S)$A:"6;*J-\4F#&5!
M4%0Q]:E5=#AU6ZNK30F!M2TD4GEDR2DLC1L-A4[QM)5D)PWS '&*\W,<%#%8
M>5^7FC=6TO*]K675IO3N^K1IA:LZ6(4K2M=--;):73TLOQ]=V?Z&'AKQ-:^*
M_#'A+XC>&;[&E:YIEAJ%FUF4D2,O!'(_F-" @#F2,D8WDD;R2*^G/@]\49KY
M9?#6NLL$\#-/!.S$/<>7(TH#C()S)+M;@\D8!Y!_G_\ ^",G[5]M\5_AQJGP
M*\7F*T\4>%K80^&%NF$L4FFVZPE@&N7$C3DKA2,1(1@Y.,_K_J-A?Z#K$-]9
MS/<Q02O.8H'=3YD-TKEI1@(58!T^5V&$],"OS#,<-6RZK+$QI5(Q=G.*B[/2
M"?2SN]=&_6]SZR@XXBC&%N>Z;5]>J=_5;.]O+<_02+65:'YY([<-/&2H[B2Y
MV..>1\IXXS@\X JSIQ,6N7-RL_F%K*WB))^5$6Z? SG++@\L<G'&17RWH7CP
M7D$<=\DRREQ(-LB-&@^T!P%(QD!,$="".,=:]ZT+7XYE:Y_T0B2%H(]CN9_D
MN"\;.6D*D.AR?E/(Z#G.=#,VG&2DU;EE;57;L[6NK7UT6WKMR8C!MM));Z*R
M\DOP>JM_P/:(KE)HPR,K-QG:<X &,GICDC@9[<]16C%<D(06QQCTR.^1DXZ]
M.."*\[TS50 R;NK<D$'DG.#@^W0\_E6W-J4<408R %CC))ZGT !_#/4 XSR1
M]/A,^45K[KY;-/2Z26N^[T[Z]-T_-K8"<9:)M::WUZ:?C_P==+]U*4D#^7D!
M@VYL$HJ9R1G)QU/'KGW, U2WX_>93[PS]T@XVC<>W?D].U>>:_XCF594A8#>
MA17+!2"1M[XX)SUXQP/6O-I?$C6%ONNKLM(@ 8 G:,9!/ Z C.1GCUS7EU\X
M=2M.,+QB]==$[M:)K?OK9:^31[&%R&I*E"H[N^MNUK=]KM_U<]2\5:K:QVDZ
MF2/S) YC99(F=6R& *XW8) 7@\ [L\5\9>,?$%\U]'::/"+Z42(UPCY94DWC
MS6(& #&G(R<L![\5_%_Q0<S&..7<7N9(2 ZLJQD,JOG@ G(. 0RC!;Y0<_*W
MQ&_:'T[P%97RVD4EQKVH0SAO-!DB4@&*(J4==CK@,AR<$<J,5X..ISQLE4YN
M2*2BVF[[J6EN]UWTL?18/+XX>"I\T7)MR=VNJ2=WVLKNVG8]8^+7Q5TOX;:
MT5]<Z6_B*Z@>*&S$BF6T23]XS11J@8*R,K%"&4.6( .<_C=\7M'T'Q'?W&MW
M4"6^HZ@TEW-<0[4!;#36[2[LNK2RRM$0>,#*XX 3Q?X\UWQCXBN/$_BNZD>X
M#3&$2S.T15Q;HHN(G)9BB1D*R-MVA1UR1X+XG\:7.LWT^GZ?<R20M>AA).I^
MY#,QA@"QJWRL1A"<*$"98'->9"<L(^:=W&&D(R[^Z[OJI/777_/L^KQ@W&ZE
M*^K5FEHM$ULELNK[*SM]/?!32M">%HM0M89_(&7!4$[P<JP (C9AG*A\J6X8
M $BONCP%\*OAUXJ,O]I^'[*[5+:1DV*JNA$[*"YB9&#;<#@X['@8KXG^$6EM
MINEPW,\;&>]B::6-OW<:@1F4%%< E]@8K@'<V,')K]#/V>BNH-J#3#S%^RR(
MG;:IG9@&('7;SVSUZ\5]QP[C7.=&2?-:2:;U<=M=.O>ST\SP<XH04)N,HI:*
MT7HDTD[_ "?7U['CGBW]GOX9".^CC\/I;+)*[#RF9"<)(5&2W4$C&3P3UKR;
M5?V<O!3320V2S0QA(54%8W )AC9OF<EB<L1R>,'OS7V[XUL88[JYMTB4AI P
MW'^%2V[ &,YR"3QQC)]?*YY")6"HB@<   @X[_C^'&*_2Z5=U8*+V7O+>^EE
M^KT?W'QDX*,VU)2OI;FO_+=VM96MKU/D>[_9FT<$/:W;H1T.V,^XX,$F""!D
M#WP<8K)N/V7+]F6XL]7:5RZ^:J$HQ7(SN?;M(P3E6/3//:OL<N3QA>>QX'\^
M!_*I[=%@>XM7C@=+J$R2Q,04B63*-Y3,#EAGY00>>G6M+>OI?T[^GYBVU>G?
M\O+\3Y1^&'[&^K>+?&MEIGB2:Z@\)SM;R:KKD)C^RZ5%$+J>2]D>7<D1"PB(
M.R$G>1C!!/HOB/\ 9<TQ_C/X/T'P/>1>-? LNKVUK?7]I(DL=O;JJK(]U*@2
M K(@+,\:J5SC=Q7*?MD^.OVM/#WP.\4^%_V=;73H(I[.X?Q!K%E%=/XAFT9H
MT 2&9+GRH)T4"$[8#((G<KM7<*\H_P""+OC[Q9=>!?B)!\7]7U"TU?3M0N%G
M.MATO+-+:.-)S9W5T%?<65SR &SE00"3A.NX34.63ND[M-+5*ZNGV6NG6ST1
M<:3G%SYK6TMS:[K5JW7R5NMS^J;PSX$\+^#/ >G^'?#5AIEA':Z5:V\.U("2
MXMW!<NR.7+L"P))..0<\5\-_$;6-%\2^&?%?@/QM_9U[%"&B1KB2-W((=B@*
MNK9*#:J98 X&T=*_)'QW_P %<?\ A'O&6O?#/P[9ZU<Z?IDQT]=8M[V$3C[%
M)+9O*#-')&Q=0'&Q3@G\:VO@!\7-'^-6G:]>^(;W4H[I]0$S:EK5] &,(W^6
M(O(%JAGPC *P.6V[E.2*QGF#E+DBI=8M-/2[22[^CMZ-Z-W'"**YISBWI)6U
MEJD[ONW?7=OR/VL_8T\%>'?!/@Y+:V-C"@E9K&'*J44LX0Q ]-L#,O&20>^3
M7W*D6"I 1BW+R%%<,N25(^4X 4  @ $=.E?CS\.F\3K<6S:-?:@--TP^4D,,
MI$4FP;&E<(3$Q=""FV0L",E>#7Z#_#+QOKUR(;+43)=J^$,ER6,RH. HX&-O
M."2<@''%>IAY2G34&FG9:MMWV?5:^APUHJ]TT]=>_:WIVO\ \/\ 1?D0L!OB
MB;O_ *M<9/?!&<XX]_3TR;OPWH-ZV^[TNSN'R"K31"0JRY*E Q(4@Y(V@?E6
MVIR ?4 X],@<#@?Y]N*6NM-]VOG_ )'/9/=)OTZ$<4,4,:0Q1I'$@ 2-%"HH
M7H%4<#&!CTP,=*DH)P"?3FF9;:Q&W/)3J1C'R[@.>O4+VZ<T@VLK=.GY7'%0
MV,\X[4W8,8R?T_P]Z\)^+/[2'PH^"\4+>.O%.G:9-,PC6!ITWM(RAMJJ&+9
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MC-C$=W%/N4MV+(C9(..D8XY%>R:%^V[^S+XA>./3OBSX9D:;'EJ\S0DY /\
MRU>-^XY"8Z@'((%*FI;)-/HFM=NE^GZC]].UI+3S3]+;Z+7T/JE[>/!^1,'M
M@?X$>O\ ^NJG]F66&!@A/!XV#WZ9X)Z8Y'09KS33OCG\)-8(6P^(/AJ?/5/[
M1A!?K]WS+A3R!C&.O'>NUL?%WAC4"GV+Q%HMSN(($-_:N2,@\8NLY/0?*Q]
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M8*HFW%OE\NZ7??;;9:]&3"I/F3NW9KRZJW3_ (?[S[GM_P#@H[X?AOK*PM_
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M<2F>.&7*N(7 8AI"/N8P>O4XZD\_"7C;QQ$\LXOKK^T+EOGAVRF380"203@
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MT,Y4+.REIUT^?J[;*]W>ST/[?3J5F(1))J=J)$S@MY0&%<2$D>83@HK$CGY
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M6!!)V[>XX)&,C/8\9[9Q712G77O6C+7S:VB]TK]=.G?>Q#AA]&G)+2^OIO\
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ML;-(CVFH$M\P=85NB@QU^9PRHQ&2PPQ&.?1_AS%>OHZZ@U@%@CO?$LT)A=F
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M +&G[+_BF*2VO?AGX:C 9G4Z2EGI=X<%0Q:>SLXY@BG;E&<NQ/R 885XQ?\
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M +0.%21 C*H.22&*J6(I5:Z:]Z]FGJH[JUMK/IUZN['R4FDK--VU6_;KI?\
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MP!Y,[Y)Z\#(X!R1FNKMM5T^\56M+N"Y0G:)8)4EB+#DCS$8KD#KSQD9':O\
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MCM89?MMTUW<26-JKQR*+B5+=</LC91L,OE8 4D 5Y+\<;N8:<\L$*7,NGO\
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MPA]_JU_X;\.^)-,\0B.$ZAJFHZ;+9DQPW3;[0-+;F9N0@/G+,4+%0' !JO\
M#'XI>(/AT5TR^EFO-*\Q$M9)I7=%*OD)'([3KN"%,EF2,G@*&!+?AN/P&,R^
MK.4HU9RO:RLTET?39;J^C=EL?=83&86O0C!QC=66E[MZ=+]&M>FFRUO_ $,-
M\;= MHGNU>*U:,D<3"WDV$D@%E)CZ<@*2%S@_-NKR;Q1^U?I4MP;"S>.[5OW
M9\R8E?FXRZE0K#&<Y95;'49R/S2L=>\3?$>95E\1QP6DNYT@BEB1EC,BJH81
MNI)'F9^[C SVW'Z&\#_LZV<$2ZCJVJB:6XC$@625&Q&8C-O4.W/ (520S8P"
M3U\5QSBLFZ7/"#5W)MZ)M;)IKT^3OVZZ4,#=NI!/72UW?577G??YI]CUG7];
M\/>/=)OY[O2M,N,0L/M/EPR2O&59F!C,RG;&,E$5@2>0.]?(=E^Q/I/[0_C>
MST/PVMUIEE-*'O\ 5[(S>3;PG;YF+24$QE1@MAW#$XXV\^]>.5T#P!I[06UZ
MCWU]+)'%;(ZB/R6+6L+^7&[%?FWE@!NR1P,\_K'^QC\/--\/^"+/59TCAU+6
MQ'/#+(,3>5)"G ='7*2!79!EB"#NVG&>C!83$XK$0H5ZKJ)7=5RE9M*SC'F5
MK7:76^^YSX[&4<'AYSI4UO[D;.ZUBF]];=.COL?=?P3\"V_PO^#/PC^&EI<R
M7EK\._ACX"\"VUW*,2W5OX2\*Z3H$-S(.TD\>GK*X[,Q%>G56LABSM .@MH
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M U^3W[<ALK;X:ZUK$4L%I/"QMRD:I&^U;0Y(5<'#9.WG(..2#74^.OVQ]/\
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M#PWXV'49_'UG80)<- 1J%VK*X<@6]V98S]X$?NRN>,[%0G(-=E-MTTVU>_\
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M/R;]5^/'[67B?Q/%>Z+X92#0M)BEE4,D@M&:!FB9/+6*&*'S41F1@97D;?\
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MM+)%YA+.ZF:?#E!R1-(&X/HV1C&?K7PAX.$]AXKL=1BO&-A#;R--*5)PBF!
M92!L$9*D#:,Y!XQR?<]5^/OPJT?6)=-UCQ%;P7+2NOV7[7:H?-9VVB-'NTED
M#L0<(@()QC*FM(U(]6EKTOKZ.S[VTNKHB2;MHW\GIMUZ_-7WOH>Y_:=X+,^1
MDXSSD<\ <G_]8Z53ED0Y.6 P?X=O7![C@C';U_+#TK5;'5K&+5=-?[1I<Z12
MQ2(<J#-&[QF(\LV750<EN3DDC-2W#,I5@3AUR!G.0<X)]QGG'KCCBHY)/9?B
MG^I"T:O?=?GV)9GRL>UTC+-LW,P!&YT8D8!;D(1QZCGM76^%O'.GZ#ITEM<V
MM_=?9YY)2;.":53L>:9"8XHY&)"EEW <Y7 XS7#$2%K=O($^)@PCR "=IZEL
M'Y?0<\GG@UZ5\/+A)$U /)! H<AU6W>?:6BGRA\@K(  OWB2.N#G./$S.E.4
M&GI=KHNOW?GUMTL=E"2<TNG*]M.SUW[[&S;_ !#LM062>RTO5R&D(99;:YMR
M"<'*K<00LP]"N1Z9!J>;Q<;S3Y8SX:UB4HK(KDPHTCD';\Q7@;L9/;J>>O5^
M;&V'2=758HXXGBMY"ZNP^01M*TQ3GJ&4$>C5Q7C&YDM[2W\NYNHFDN[08ACE
M C\^5%<3.@5"X##*Q\<G PIS\Y1HNG4EJW=:Z12ZZZZ]?NU]=YQYK):W;ZWL
MO=?E:ZMM]W?HO#OPYLO$<.GZQ?\ @;5YI+=5>Z4W%MFX8JWF%78G]X&*E&9?
MG7)(R!C6NOA)H#)K!D\$:[#I]S8W(:,7%JTSAE"E)/W;0LH!P/E4[?0'(]X^
M$&I/+9O8321,T:J,')EW(Q1@V]3N9@F]22 55L&O<GM496.V-C(IC*D*5"/P
M20 -QP 0#GG@>E?38/#<RBUJ]-++>R:Z76^J>G>ZO;FE5J4GR[6U5I-]4VNO
M7>_;N?CKXU_9L^$GP/M=9^+7A7X2O#XACAN[Z\NPEO'>1*D2S.T,T:MM:6-E
M9RX*[F; VC%?A7^T;X:@^-GQ:_X6K]DU/3[@0Z3I\MO/=PRB)+0LR1J45(G$
MBA49F13CI\U?V2?$OPW!XE\#^+] :")VU?1-1L;<NH9EGEM'0.H (0(J?*9"
M!G&" ./XV/B;JEYX3\4^)?"UQ*(Y--\1-9EP"H5XWN0B\;@9#]G)(4,B$8V_
M-7TF"RJES<[BDI/FDDD_>TVLGO?6U[._FB(XNJ[R4KM/1OF?5/:][>?IKW^B
M/ ?Q1N/AY';Z3;Z&T]Q/IUJB3&YA6*V19(PN8]CNQ;&,AAC()XX/K)_:1UEI
M;13I4@2Y\G<T=Q"6CA8D.$W1, 7V[<')&<A<5^>>H^)X[?6=-FFOKC<VE63/
M@?>:68L 2(UQ\\: 88 \CK6G'XMBGNK"/SY=\48VJ&<,_E.508!QSNYW' ZX
M[G3%Y+@9PG45/EJ05XM+SC=[^;Z._1:L<<;5<U%V?1Z^6EO1_AT6J/TV\8?%
MW5?!_@WPWXGATSS[CQ')OAB)B<V=NMQ<0RFX9Q_I$C+!\N B,"%(!7)X?PW^
MTY/J>J66F7>CW$4FI7:PK]GN+;RDW3+"K3Q!?,8'*/Y",H7.WM7BGQA\0%O@
M1\/KN":X$\=VD&X%P0@U#5,H=S9+E44G:<$,/<5\:?##QCJ,_P 0/#32BYDS
MJH(B^9MZ&_B)94C4G(Y W$#!&.U>)6RC#RPM:I;VD5!I)V7O<M[[76B=TWMY
M:'90Q$I5$K.V[:?2ZZ]>B7KZM?M-J,\AOB[.03'#(B@<$2QF1%QZ!>. <?SB
M>_G520%+*N51@C!B2%"C>57U.<Y 'U%<MJNK3->6FY9()$L; 2Q.,,&FM"(I
M,\@C)7)& .XI/MDTJ@K(0X#@E=F NT^83O7@[-W( (;[I&<U^*U'3698C#TX
M>SE&M;E^R[VZZKR?GKNCZ&M+FH0<^D+*^NFEN]]/D]SPCXA_$+XE:)J%];>%
M_#NC21V\KQ+<O$9WD1&B*,@AF ^=KAL'!&5..^?-U^)_QFN84N[WP):B9"JJ
M[1Q$3(Y82G]Z4*EF (&" #@,QY&G\3+[4-+L?$UUHEY>,EOHESJ%AYJ%D!21
M7A#R2Q%F99%8J-Z#!P21C'X5M^U]^T5<7EQ$==C@MK>]OHHX[A5D#".YE0?Z
M.6+,5501E\'H N*ZZN7592YVIVDHMI3NE>,4DK:.VFB^:U/,6(Y':.RVTMN]
M=]=V]+?@C]I]5^.7Q1TE_(U#X51S!\DSV]S911+DG*M&^X,#R,DDUI_ _0_
MO[3/Q=C\.?$_X<?V;/-$D=TR75K+#]DMHYXUA"P?.%98W W&3[V#CM^"NN?M
M2_M'ZE>F%O$MBUJBY)?3@FUFQPZ!P58$<A#D$'! Q7Z'_P#!,3]I#5M&^->O
M:O\ &GQ+I=KI&GZ)]J6^:2ZM74W"ZN&*B>[D1S%';O+&KQL,@\;BIKT,OP3C
M4I.H_=4HN2=I:<RO=6[;ZIN_8TDVXMWU2[KY*[]=+=[^9^_B?\$X_P!D>(7<
M%O\ "S1[BUBGFB62>SBDG,EN$0R>>9D<Y2<JD04Y!+?P\1:O^RW\"?@?X=\:
M:S\.? &F:!JL]A>V37:Z:H=TV"; E(!5=R\D;@" >O%>F^&OVI/@;XKT_P#M
M'PKXR@U6":[OMQM+Q9]P$<$HDCC/)D;8!)&@W@G"E5)%4?B/\2_"WBSP9XE&
MG:CJTK.;D""6WN%#));E6+[I-L7S+@*VW(R<'(-?H=L*Z%/V;3FH*RLK15E?
M75?<K*W;1>/453G4FVXW[^:2\M?^'6Q^/_[*\^_Q=\1_)E>%#KR&YMSB7S9I
M&N&\P.5&T GY01\H 4D@ U]MB-63;(/,RA&'SD$KCYNF><9ZCCC'?XD_99<)
MKWQ'F6.'RF\20J#$T;,GF-,Q+*I$F<MECR > 37VBD@(R)"< $=@0/8G)'L<
M9S7/3G*$TX]7KK;TUL]/^!N-62UTT22MU=NVB^]_,@NM$^UB*>.40W$$J/N3
M=^]17&(W  .U<8Z#\0>/'/&_P0L_&WC!?%%YKVJV2'<MQIL%QML;F(K.OE/;
M[,,'67&&<8'OR/<5N@%(#8;U&/;KUZ^P_P *JRS$L@$A.XD8'."2.><=2>?Z
M]O83E-1YTV]][V5D][:J[>SU[NZ!5YT)J=-M-*UKV;N[/HKK5>7GJ>'> OV>
MOAW\-M7?6?"6D#3;Z23,D\&T,^Y4,C>8S,R;Y=[>6!M&=W5N/?.//$SSW3D?
M>0W#;6/ )92F,C'KZC&:CQG!.>@X/KZX]:4C/_UB1_+%+V=&6K;3=KKENEJN
MKDK];MVUMYMJOBJU9\TM9.U]=MM-]5_3V$$:@@@2@@Y!8C:/KSTJ.99P2WF*
M5(P /EPW8[@"<=<@#GCG-2_6J\LBD,FXC"EN"1TZ8Q[G/IW/'7GCAU=<NCZ-
M+72W=^G_  [%[>:ZI?TO/R7]6.>OQ(2ADYVL&7#9X4C=G(!P..?\CC-2N&5W
M\N1E.XGH .>?O9^O08/;!//57\ID< .6 W@$D]21G/Y?3T]^"OI7\QU*ENA)
MQD].G48&#_.HE%QDU*;OYM=EU?9/\?*YU8:52;O)VC;2S2>\5L]5I==_(H?:
M"TH>62YW# .UE(R.N"><'GDX]QFM:.V@-O/&_G,C1S7 5G! D$;.K$X'*D!P
M 0"0,X&36?% 9"N0 &4-G@X&-V3GGTY&,<D5TTEJ([4OYJ#S+.14)Z.S1,OR
M<#&68<-C([XZ88BG*=/EA[SYHO6VRMMLO-WW-:VDE[S:L[WMHU;JDNG=_B?"
M'P]DDMOB9XM,9S;+J&L7B-Y8:00N$=P"2,,&C)5>03@D@5Y)X1C$_P 9/'DS
M-^Z;PU+I[KDNZ3+?PRF1&SD?(=F?4$XYKZ!^&>GI-XN\<;PNZ&>]B\P$;D:1
MUC*S D+G+*$*D*5)P217E7PJT1[OXI?$B694D\F:\MMH.69!>Q 'K@8XX)[]
M>,5VT=*<5=-I)-K;3IU\O+OY>;5NJC]%^*BE?77\;ZV:V?RS^U:D=IX<UNSM
M0(K:\=[:X=QB6=I]0$J*9NH;9D 8R1C '?U_X8?%OX-?#[X<>#_#_B;QE::;
MJR:7#*ND7#!;FWD:-I84,T@50)0N.O(?%>/?MR"!;ZQT6V0QW#ZO;W%U;*Q5
MFACN64SA6.9 JA5Q$&!QR#BOSI^,/@J]\2?$FQDTZR\Y&M]!6..[NYHK-HUA
M19+A!+(+<&+YG*AMQ8?<XQ7F8S*Z6(<Y)7=2[DO.>_WMW;U[&\,3-1A%-V2B
MDG=:*R_+\O0_H?TC6_!=U%IMS;27-Y8ZFD%U9W$+"42)-'YN8A&I#C;QDL,C
MD=JN^,/$7A33O"GB9KW3Q'90:5?^9<:E:S,DR-9W$WE;U"&)ML#$-YI^8@L!
MCGY:^'?Q8^&G@#P7X4TO7==LIK[0M*L_MD-E,ERMHT%F4V+(LB@R+C)56.3Q
MR0:Y;XI_M-_#3Q)\-O%FE:!XAO-6UK5M,D73[(Q2KC[=#);(,;RJJAN-S$#*
ME$!^5N<\#P_3I3@VDI=G:UN5=;6V;WWUMMKI+$2G92>EU=ZOM;757\UO?H>7
M_P#!->ZL]5\7?'WQ;IJ6IT;4_$TK!;J>V1H+1=1TB=4A)FA<$QQXC>1)B^!&
M<AN-K]J&P_X*$7_Q+-M\!_&NHZ%\/;VWN;N!1K"V4L*%EMDMTF@U"VB(C*D1
MKMC$@_A'*UX9^R?X7^(GPZ_9H^-S^''TZ/QW=--J.G6-S<2K(D+ZGI%D\\47
MGQ;KEA,C1A"TBODA0!77_"_]E_\ X*#?%7P%)XH7XB+9ZA?7"V%EH<^K7<=Y
M$ID^T)';VEU<2S'+' =% ;&2,<'ZFEED(1@U%2;LGUTLNG_ \_(ARIM-SDU:
MS7+LVU'2ZL_Q^XL>$_AQ_P %#-0^'GCC3_''Q,U.?Q=$MM!X?U&368[A;>*5
M9W*V\@N6 2"0H2(WP#@$@8QY)X4^ /\ P5!DU/1KW6OCUK/]C07D<U[;W?C!
M(X9((&1Y0;$7HE+.L;9C )V[I,$*0<CXA? _]M_X>^&]<U;Q5XN^)QGT)9IK
MZ>R77I]$LU4RLR?:K9XK19'$63LWJ5'RC/3XYE\:?'R]M]/U:3XT>++.6^63
MRH+F_OHKB-O+5581F0S%F#M&H!+;"7V@KN'?4P+A!3E#W5'5^ZWOKI>Z[;;=
M]SRWBO?=-R;Y7[MN;162ULUNT][ZW[GZ)_%C]F#]N_Q5XAW^ /C+>^'] FL;
M2WU2ST_5+V&%KS</.N)#%.1<PSROE)24&&<*F&KZ0_98^ _[3/P@3X@^(OCQ
M\3[GQEIE[HOEZ5;3ZC-*/,)NV8RPWDY&7+< "/=U#$$-7YH?#+]JOXQ_"GX.
M_$GQ7J?CG6?$^K0:L-&MKGQ"EYJ$*R0WD20QBTO9<ND9PL<L;1_(?WFXX(@^
M /[>G[0/Q>\;R>%O&>N6U_H,NF^;<VFEV$NF;87FE@B:55NSYR0;T#+&,^6
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M*[2?V5\:>$[WQ3-X%D>%I-.\->--#D@9D817 L8[Z']^VW;ME\LEF10T8@B
MW!^/,?@Q\#=<_9]_9MFO+"(7_C?4XIM4U"-VA\UY8)I((O*2%WV%X;%6?A4W
ME@2!BOT*\*:!>:]^R7HOQ#6W2+5(]?BAN[65!+-;JK7H=T*,J!BP<%B"<<Y
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M43BVW+*KNKE\ %0057\FO^"A'Q/U;Q]\<_&F-5GU#PIH5Q#HFG6]NH32+?[
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MMY?2AR++>-17:%FD7:8<*H!P&[U\K?!?3/AS\4?B+JW@J7Q#?^$=*UVUO)O
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M+2Q/!!+<Q[AM)?$:I+\P.T$EN",8!&#T->5^(K>]T&]35;>3:QG8*-R\LHW
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M.<M;6MU=EOHE;NMAS=7W53DX[W5K[VMU]?Q$T'QEI_A[5M+F\7^*?"&B6:"
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M 4)^6-&_9Q^($NIZ?JM_X?66Z,EO++.EU 9(XEN8T#QJMY&2)$;S5/E996+
ML"&*IUJ4\NQ,7=W4M-;[??\ >MU\R*=!TI<S:=VDK<U[Z;WT>B\NA^^?@BYM
MX_A_X)N9GE:ZB\/Z5Y<?F_*Y^R-DAR%6,18#?>PQXW# -9/Q5\=>)O#W@75]
M?\'Z(=1\3>>L$=B"S3RF18#"Y =XPLF\KA7RZC(ZFNS^&OAB^C^'GAB%O*6X
MLM#L;<1W,UI+<+,;-UF*>5+)O< A8XFW!9-K;3G%7KGPK?6=O#>6T,$]Z+S3
MB+FXDAD;[]L6$D+M%&Y5<[1(&"$$@<@U^&U\OK5<RK./,H.IK&VJ2:UOOJNU
MM.M[,]J$W&FHK5/>[UNU;K;K;IYO9'P/\.H?VM8?B9<>-?$?PJN+2PU+2IY(
M@ZS0AHIGC2 Q(&?=G8Q) 0Y(Y;.5\@F_9\^-_P 1?&6J:E-X;GT9-1NKT3S^
M9(K/:O>2/(N02Y=.1@1Y'(!Y(K][_$.OZO>Z1%!%(?/@@$=N[/9C8(V< 1NM
MTKD%MQ)=\_<&,#%>-6>GZRGD1W.WR!=1@LT]L"K37#,5'DW+2_O2Y);?@ G/
M4&OK\/D,70I)J;;3;;NNJZ7TMWMV>MSSZE>,9R3C:2<6]7VB[IV:MJ[VVTZ[
M_"Z?#;P3\-/ ,VAZSH]C_P )!)INK:@M_J2JWF-8KON#&91(0\4H:/R"L9 R
MNU<#&?\ #;PWI'Q#UWX:1>5I.G)%KGAZ\OKJRL[40BQL;VRGMC-*$9(I$BSY
MB&YE)4$G<0*],_:/TKQ<&OVGT^"VMKC3;FUTZVQ$;IHWLD%W+;1F2X>073'S
M'<HKR9!9BQQ7Q]X:U.[UGP#<>&[SPUKMK+:1ZOI\5U/!=6<%JVDV48M-2M7A
MAB+YF5)BP8D!3USBO2P> 49)<B48M7MO9-=7ULNM_+SY/:3;2N[/3[VM-+7]
M>UVVM+?UE7/C/PGY<MJ/$NDQ67]F1JC6%Y8Q!R %"NZSQM&X>-<E8B!D /G(
MKY&^.>IZ=J/@[Q'IEA<6VJW45O<B:2"^$\Y41S%&9C,!.RJ<%%R.,\]:_@/U
M?Q=^TA-\4-:\(:3X]^*UYHVGZNMO+>M+K$MM;6.78Q1*MM"1Y,LRDYF=553F
M-CAD_HH_8M_9Y^)7PY\%>*_'GCGXWVWQ'LO$/APWFG^'(=;FU+4]%GE/G"2]
MM9&1[-P@,+'RIF3)RW %>Y5DG!6BUR*R?:]D]=4[Z/\ $S]GRIVOHUNM[-:K
MK^G;JC?^!.D1>)_#/Q:T&VU![.2\&H:4\EJH62U>:WF2!Y0%9B_VN;RV26-M
MH52A:/:3^2WAK_@C_P#'?1_C+9>-;_X@6D6E+XQ?Q L275P=2%E'=1WTTDBO
M#&NQ(8R-F[9E<;-N ?V2_9,N?M)\<K&?M-G-KX346F(V(\HE86OFE8S*T8"K
MN<APXP <#/V([0S" 3(\BP1HD4<DCLD:J -NTY#9 "ONW;AG/4US7Z62NMM.
MO+W[VOIJM;L2V76UK.S5FK6=O\TU;<9X=@?3]/T_3R9II;*R6V>YGWL[(8;7
M<4#.Z1QF:V4JZ85]Q4#)%7);C8QW')<J@W'@<D'\S@#K[C&*CAE2,1HF\"-#
M&N78G83NVG@9 /*YSM[8/-$C02$;P>"#PV.?<9![_7TZG*^:6J_#1:K3KKUT
M%?WEH_A[+2[^7;O^H^XES^Z0C"#:2N2#QGJ![]#[&I[90=NYSG&3C_Z^,$@=
MQ[8Q50^26.W(+'G+$9/3^]WP/?-/22,,<@G!YY/4<>Y_ETZUY>+M"3E%VDW=
MZW=[>>B7;7_,Z4DTUT:36VNWZ7\[[=#2/0U TN-R8"!02".23CIR??.>!D9X
MH\X'C!&>,YJO,!MSCG(R<^Q'3_ZWXUSN4E!MOMUTMI\OZTTL"A%/;MO_ ,&R
M\_\ @&1=2E'W Y!8H3LW*"5) ;J "%/#!L8(XQ66=]PL$3V1F-W=VSQR6H 2
M+:9562Y6-X%5,D+DK+TY6M#8'9E;. <[<G!.TJ2<$#(!./QJDT:A8]I=?);$
M6UV7:%D9QC:0!\Q/0=S]:VA-PIQG%VFY6;MTYONULO2VBU&G9^CNM[=/Z_X8
M_";]L+_@E1\6/VEOC#?^//"7CC28!K#6<9TJ:=XI+> JD-Q)&($=F6UFMS&P
M8H9U +(F,5]\?L.?LF7W['?[.GBWP?XQ\0QZ[K.HG5+E4MYI)+6&8M?NBPOY
M22!V9MHAV@?Q,RKN<?>VERNLS*&($*">-AE2)(YR1\RX9LLS,V3EFRQ/>L/X
MPZT;7X9^)1:.T$D.E2,K*06\R>VNI)'+G)W-(=I<DMM+*?E.*V6,KN-N=6:V
M:7X/H]7U_&PFES.;2YFK-]U9;].B/EWX.^(+KP_X,^(#RVAADN-%A6$S,QDN
M(XKB\/G)&LD@(7+ [FS\I^3(KV7_ ()1Z[HNE:G\0H=86VNI)=;N;B*,Q6LD
M@(S K-O42;CY6=P8_*<BODWP+M3X5:E=3O(LEQ%>V[2K(RNT3N&92V>QF?Y@
M. QP0:]F_P""4L(N?$'B2^ED5YIK>*ZW8!S)+YI>1\D*2S \X[8"\5A2DY5X
MIZJ]^V]O3^M-DD+VU2*<(RLK+HG?1/5]3]OM;^+?A#0P!<VU@EH\4:202VEN
MTH+M@@1[]TO4D -'A2 .G/ 77Q9\'*TC6":=!9M@O$;:WFFCD/*.%^>:/!(8
M"241KT?Y17S-\7YKJ+5YY<^88UA:(JB##_+G!"C.#_+!'6O"M7OQ<W=E/<6K
M/+';2$3Y"9(!Y(3",P/W2RLPXY  KZ'#U'+W&M(\J5T]$K)6?;1>3?XY\\N^
M_IOOVUZ_CU/T?T?XG>&Y)5DCFM=H;.Y;"U))[$;<\@]!TSUQ7JWA[Q?!KLWE
M6BVT@C(FCNAIUJLP<!C]\;L"/:!C'.XCFORQ\)W,[ZC"(3)'AAP'."K(<KSD
M<\ @^W&<U^B7P3TJ-(]0NI%"RP0FX:<Y.$>W5L.,XR"7'3@\#O75)OEULGII
MNMT[>>WG\R(M<R_POHK+31;7T\UU5[:'1^-[4Z_<6=UIIDOWM),:J88D"Q[<
MB4R!8X@FX%.0S $#OR/D?5=;DT6X^*X@O9K6.QC$VGO*Q'[]K+D*X=B0.@ R
M">,<U]Q^![BQF@\27-U(/L4TS1,N6"N7+]5STPISC P#TKX3_:)GT72K'Q;<
MZ,XMTO;DJJQ)G.;0 8WALC V@C)!'!Q7).I4BE*,>:^Z6EDK:Z:ZO;MIOHC;
MFM>.O17LMM&[Z:6]-.I\!Z3XY;QEXGNHM8TU"\@NO-O)5,,4RV3A+;:ZB/S&
M*%B6D5-V "2<FNAN];^'5C((+J\#RA@K6[EB-QR B,C2%2"002O(!4GYLURD
M#10W4EU&B03,JB:>)%$CI<J656QNSC&>/X<'!SDS-:Z;-(+J9/-D4[^8D!<J
M0=IP!_O#!YP#@BO-K5,2YQ<>:G[JNM7=WM?UUM;[[; HJVR=W?379JVMO+?U
M['?ZIXC\/:5X+U3Q.=,CETS1K::X%I$/,N;O[-&[MM+1ESOVY6V5H@6 (<\U
M^?OCWXR:1\:/ NF>)-(TF\TF*+5#IYTG4$"B_D3SR2L4DSO(T<,*RQJ8F\L,
M$YVDG[-&J6J6=Y C!$D5 ;65(W02F7.X(X=22,@X !!VG.<U\C?M#7<<<_AS
M3K2WL;6RLY9;Q(((8;1%NFCG#S%;>.+YVY(9F(*MC:<5KAI3EB<-[1WEWLE=
MJ2M]R2MY,APBX2AJHRLVN9[Z)^5M5ZZM;IK\@]+^!=O^U#\<_%'A>XU>\T&"
M[E\V*/[% X+1QZ<A=-T<H!Q<["I\L+A00,';]H7WP!7]G/P'%X0L=<U#7+C4
MO$>@10S-;V\1>VA89E98I-B ,OV=H@&5D<MG(Q7B?['-P1\:_B+KWDPF?3+3
M4VM)A/(#%()X K\2*&8&*,H'Y&Q1@$5]T_M(7UQK>L_#K39+>"*&ZU[1IY)4
M4EYK>.]M(PN?,<L,RON&W)W-T&#7HY_5<,-0FG9QJQ;=GTM?356=O/[S+*L)
M[2=2<H\SAS):VT5DETM9=6]-SG?B/_P3.\/?M$ZQH'Q#U?Q=?Z1>R>%/"]DM
MG]AM5*RV=C8:>)T6-P\RHJ%RSL<$%@":_JZ_X(=?LPZ/^R7^Q5=?"_1-?N/$
M=I>?&/QKXODO[E561+K6="\&6<UME6(94&DI*I."/.*8P@)_'[P-*MOHVC1_
M:)A):6FB6\1*$A('DTEFC')"J3(X(/)^8=,5_1!_P3R*'X!7(C8LJ^/_ !(H
M.W: %LM# "CTQ@_4FO-RG%.MB7"[:=*4KVLM&EI^5O7N[=F.HPIT.90Y7S)7
MWWM=;];:;[6[W^!_^"T_C+P]X'\4_L6:QXBLEO+7_A,OBHD09@H1Q9?#K<<X
M; *GDD9XZ$8K\K(_!7@']HO]K0>);'6=4ALO#-AIVIZ:NF:E+#Y%VS7,4OGQ
M)O>2)C=$F*3S4PH!3'!^S?\ @Y%N(['P=^REJ#+,9K77?C*+4P9WI<2Z;\.%
MC? ()*LHP<\$YK^=K]A3]K/4_AG\:=1M]6M;W5'\0:99VR/(LKS0RBZ4;9<H
MQ"#&XY( 3\:]>N[5&N_+;7_#I^+_ *9P492Y&OLIZ=-WK?NET\[G]Q_@3Q'X
M-\/^$[3PYJ%M;QP16]BTFH13)%)?W,%S;P"X#>9YI#JF)%4!5*G>7SQ_-[^W
MY\5?VH-;_;N^$">"0L/PYT^ZLK.W73XHXT6UEU6TC>XN#&P\Z8HNU1+URY5@
M0V>7^(__  4$^+%CXYLO!OAW34GM?M%M:P,;C]V"^JQ2% YAD,+!2=R J".>
M"H-<%^U7^T/\6?"*_"+XE7.AI;W<%SIE]%LGWP75Q%/<R1022/;NK([A@P.0
M&"L5  S,IMQ2=TE;ULK;V]+OU[W8X+DE[NK[6V>G?[[ORL]3^Q7X3_$K09/
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M28%AG5YW'FQS2CR3*"ZH<M&WRXKK_P#A$HA;212ZC;7D97"R1S)- _!(,;Q
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M?#VG7%GX1TJX>PO[^1I'N/(CF,CW\4[HLB-#(IPB$*P<E7C(+-U?QK^$&J:
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MWI7]2;??IKZ._1+_ "T6FY]R?#/]A77/!D^I7:^"H-+OM(O[AI-1\*VR6?\
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M"  !5 '0X_EJ_8[O=7T[]KKP[>6,T@?4->^T21%27:,Z_I3L1ABVR,,,#WP
M#BOW[_X*#^)FUJ76-!CFE:T33KQDN(0!N)2)S$5!=3@GRP44'(YK\K?V2OA/
MX6\(?$K2_CIXM\8Z79:?I>JM;Q>'XY8GO[F1=5T_C#@3Q@?96W^2&^?()#9%
M?E$,T6,XJK0]I:E1JJ/-=\J4;7>][.ZO9ZWTOK;U8494L.I3AR\T6T^]^5*U
MKOOT/Z^-(N))M(TNYD#>;<VMO*0,$AI$!)]>%R?;H>:^4?V[;G2;#]FGXC7V
MK>'K/Q'%;:+=2"QNHDF!>.U)R%D  D&/E&>><C/7Z<\):[I?B7P_HVLZ+)YU
MC?6%I+:DC:/*:T$@'& 3AE!(&#GBOG7]MW37U#]F;XHA%$L\'AZZN(PH& Z0
ME&/S<'CDCD'GBOUC%VG@:CTDO92=]TTHO77T_K1'BQ_B+77F6U[7YE=;>N_S
M;W/\PCX\WPN_&^NZQ)9I!IEQJE^EOH\*(D=NKWDNUECB)96MO==OSG'\5?-]
MJ1:ZPDHFDFS=!@TWRLR[#MP 6!"X 7G.!@] :^G_ -H.W2S\<:U# "MS_:NH
M"663!8NUTY>,(,((Y!@X &-G;-?,$[,U_:L/+C2.:4L 6P2(S@>NU64X!/4G
MZU^>*<983%1C)^^I*R>C7+HFO-Z*VU^G7T*?\2G:]U*+?2VN^^VO7KKUL?T;
M_L;:I'/X;TK]XPCELDC= #\Q"K&C#KC$@P".@QVK]R_V<=/UJ76+77/"UO;7
MM_X>AWFTF2WFD*BV#$QF<F8L6BD7:H!&%[<#^?S]AV_DN?#6EONA,R1)&HR0
MJA+H Y)/0@9.>V#7[Y_LEVVHZA\6-!73)+FU^T21C5!$)1:7$<C7J+^]CEB4
MJ$+;RD39X)QD5_(^982=3C&EAWAZDJE7$N,7!J,HR;@D[O16;YE>R:B]K'W3
MQ,:> ?OJW*^;F=]$HNSL_5>K[FQ\4OV@OB/K7B.]O-1UC5/#=SIDDT2Z/:O-
M%]JVL&58PJK%"YDB7]]@D+F,*0Y%5/AW^U3X^T>2ZTOQ_JUQKWA;Q;:O:W.G
MZA%'JDEI$I>27:\QBE5EA!53$"JN06&X"OVC\6?LX?"KQA:R'7?#6F?:=058
MY9XPD,[NK"13'*%:1'?RF)9&#;=XP=QK\TOVI%^&7[,6G7WA7X>^$+2;Q!K=
MM<,;W4EGU&2R:2,2 V8N96C:;+8#DQA(PRXK]1S7AO/<@ISQN8YA*G@9T(N*
MFY2<W.&L.2,FG=;I66KNK-GC4,1@<8^146ZMU'1)*RY=6VM++:R=_N/ASX6V
M'[-6H^.O%NO_ !1FO+3PC;2W3Z+;R^9']OEG#7%O;R+:L\YMUN3);%7565HS
M&?D KSWQA_P4?^(OPJUR?PS\"[7PSX-\#:1//#HJ75E8W$^J6\C1"$R37C*T
M*R.FQ) 3)N(9EX KU?X.VO@7XV>'?$_PE\;6%I9^,-4CNM1T;5)]D%T+J*.2
M<V\"^4-L;RW*G;YY"Y(C"KM4?!7CK]D7]H+1O%5QX2TSX9>(/$-N+E[.UOK'
M3FOK2>"(I%$PDN(6CMA(71A<1R;H@0Z'*J3\CE,\SP=2.+RN]6A4]I*=6A!Q
MJ0E.W[NK*4N;W=.51=GNDVCIJT\)&7+5DXNZ2A/HKJVFSW2>E[[:69ZY^T!X
MUA_;R^#$WQ)N+ZRT[XS?"ZVBDU+0YGBL;'5M+4>6[VX.ZUO)//;S5&Y3\I50
M6*FOB3]E7]DWXD^._$FB_%_4[2PT+X9Z%K,>J^(-<UNXCBL[.QLK>![JRBMK
MU5B2*1LO!)!,"RR9=P1BO3?C!\ =._9]\ 2:OXX^*26GC;4)HK67X?\ A^:W
M?7;-I&C>32M>2UFAF2*)"SR.\#[-FXL"-P\R\=^&OCSX6_9QT_6? /C#4M9^
M%'C"PL;37=!T>XDU=='N7L+&2:*_#-<2QCY0LBHL#Q2,IW-T'TN62JYAC(QQ
M,9>U7O5(S;YG*,;WD[7BWHI)I-V=VG(YZM"GI*$HM*UK+1*ZT2WMK^*6R/Z1
M]-_:&^ >KV!TG1?B%X/O;?1--M-.LY['Q):G,\%O8!E@"3E59'9HI$/(=&<,
M=^X_@M_P6F\9R76N?#O3+5DD\./IFK7"WMI.-3T^[GNKC2S;1_:@=ID@V2O,
MK,KC?PS@U^-%[?:OH]S%:VB^(+!;I9,6)DOT=KLGS0)54!H@&<',<BQ!@S<,
M9*]Y\7_%'XOZW\$=$\!?$3P2=1T22Z9_"7BO7IC'<PSM<(LEM923[VN"H &R
M9SD@ 9%?H%7-93HPR^I&,52:JK[+=O=6]]KV5GT7;3@K89QIR]G>3:T2M>UX
MMN^E];;>OI\D_#O0/$&L^,_"47A)=4U75'UNS9S86<HM[2#[5$5D#Q@KE#M=
M6!8C&>QQ_7EX6^!/PK\0_#SPF_Q,\':+KVOV'A^:;5]2%I:W>HW=XMG.TD=]
MR+MDS+'F)AAV4L<;:_ B[_:R\)_"CX(67P\^'_PQ;P1\48K>*/6O'&L:5%:R
M^5/;O)*NF*\ A9>0JO'*"K 8D4\U\?\ AK]J+XX>%/$^G^*;3X@^)[LFX@N]
M2LY[O4+A=:M!(6DA2![O9$&7@B&%B8U.&P"*G#U(SGSKEE&*2=U)*^DMG'72
MR6EEW:N13H5?94U*+C)+9M7[6TZ._5;V2T/:_P!K'X_^*M:\?>(_AOX5$?A+
MX>^$-6GL+'1=.TVSTK[9:V:B-HF\DM*5DP68R*Q)QC^(5ZK_ ,$Q+O7;_P#:
M1T#P38RR7OAGQ3+%IWBCP_(\IMKB"1FDE-U',HCD,,+MR"N_D9&:\I_:-N_A
M+\5?"^A_&7P-J6G:#XLUNY%MXA\*S73PSC539N]QJ>UC)<LCO'(9!)&$BR"2
M=PQ^C'['_P .OA%^Q*GA/]HSXK?$/3-:U#QQ8VT>EZ?HC6US<Z9-+\LD]R1+
M;)Y\978XEE0@L5^E.4)8JA.\>1./-+LHR@GS7\[JSZZ6%*+@[-6DME;=M+9_
M.Z\^W7]*_P!J_P#X)4?LQ^-O NJZ_IWA:;1M=M;ZWF$EE+=6VF))<W4TLQAM
M5,H:621R[QQE8T;[BD+S_,S^U7X0^%?['C7?@;P/X7LO$OB[Q';0QWD^LP_:
MS!]H%Q"!!]NVL)(U9FC8C"R*IZC-?U4ZE_P4F_9 ^)7@2XLSXUFTC4#<Q3R)
MJ1?2XXK@.TES</;P7EU#,DDLCA9"[QMG(++@G^1O_@IH]]X@^-USXKMYX]2\
M)W4:#PSXAT[-QI]]!&IEBEDNR4\F11,@\N,$-*H7&&-?=X993.-Z-2+GR\SC
M&3LII)IN*:6LEKUND]#S.6?+/F3OKZ_A:^J_70^$OAR?"&O7^M>!O'-I%9-K
MXN'LM7"*DNEW"@ND$,HVPJBS-@Q@Y4'*C .>)\5?!CQYX/U&YT8>'M1U'39%
MQI5^EHTPN["1A,;BU; <2R*ZJ)(P4W;L$MG'2^$/A%XT\5>)=*>TT&[M]-CN
MK:\O]3U#S+73[D&19C*+N56!#1J7'EE,@,"PK]Z_"WC7X9:AX>T725U_PKJW
MB#0=$@LHK29[2=!=VP"K !,H+,ACPSB52RD#8#@GU</)1BI*?NM)M:-<RMJN
MSZ[-V;NVF<_LW+22;7=Z;6?375^5M-M#\//#_P !M7T+0&\8?$#Q'%\.M.MX
M'.F6,UQ')K.J,L;/;PY=HKR)90K(RR*-K [,H$8R_"32?'6I6_BG7?A]XDET
MS4+1;YKV&.=UU*^L-HN(KN9YE:0I)$C",6Z%WQM4*6#5SG[0OB7Q'XC^*/C#
M^U_M+VMGJDA@TII'FMXVFGN&26R$WGA4CA9!"(@\:1J$P A T_V5K?5W^-/A
MB&TGOK&TU"<IJK1;YTGLX(P$AF$A\K)W<J4)P"!'@XK*?--N2DFTTTE&-K73
M2:>K=GN[ZV]4>PBFEVW=Y>2Z.SZ=M-;)6OXEJD^OV^M7MWJ1UB*[E:Y>]^UQ
M3R"6\1WC8EV"IM\W:RLOSJ.@SQ7J?PB^(_C[PUJ\<>DG7/&,&HV8.O:3+)=R
M65N\EO/%([(Z&)$C 4%PPD^1LXP*_H7U+X+?"35;B*X\2>!+"6R:2Y@F>U$:
MR,@5)6O#%';,OF,[ N6 523SZ_GO^V1>>%?V;K)='^%OAC2]$U/Q9<WUM/.[
M;KD6Q\V(W4#-",!TA)96*[9'8)P":Z9.3I\O+%RDDDKZ>3Z-=]]TM05""ZO7
MK?O;K?K;3_ACXC^$?Q"^'OA'XF^(O&7C_P $G4=$@9H)]&%G+=VEO=2- -[0
M_+#$$E8'SI"005.,DDYGQ3_:+\9^*?$6JMX1O[CPOX,EDD&BZ=H4CVIB2.U.
MWSFL-RJ4CP'7:"0.>Y'-?!WXI0^$/%5Q#XGM[+Q'X>\2!+#7UF@AN62&_6.X
MDNE5HI6::'(AA9P$1U8ME17JGCW]E3QY=:B_BKX8:+>Z]X)U\^;81V4*?VC9
M?:@(FV:?:H(9&7<I9EV(PRHQQ7-3CR59.HFM%9MN4=%'9-*ST[OT3WU5U%*+
MT3L[;VO?NTUMM>_GL6OAA\<H_&6FW/PN^-%W=:WHFL0K#I6NZM)-=2Z'>11E
M&9FNO*<PRLZ2@HQ/RDNI/!^:/'7A>U\&>(=2T'2=3AURPL+CSM/NU82)>Q-Y
ML9<-PJ*0Y:*,!F98R?EP0?H#PG^S-=>'88O%?QTNY/!.BP--)9Z'<11G6M3G
MCC3:TEC+.K6BR%1AU9VW$#&.:^8?$MUHT^MZXF@+>36J74@TFYOU*-9VPN2Z
ML@5V#EHBT9#9&7!7 4@ZQ2YFHOW;7:M[J=TEJG?;HEU?83^%.6]]-7?2SU5G
MJ]K]'TL[F+OD !VJPQ@-NY(';'95)PH] :,EL<88G##K]/TQG/%5E9AN[ L6
MQUY.-Q/'5B,G'!XQ0&<,3G'H>_3V_K[8JW\ME^GXZZ_,F_;HNK\DOSUT?;:Q
MHQ*V&'3@\Y]ASZ9'^>O-^WCD5>) <9  XSQC ]AR?3V[5DQ3'GL>F>HYX[GI
M_GG-:4#,!]X''7')_,'WSR>>1GUQJ_#NM^MOU_#U'%-W?E;7OI;\NFQT^FW,
MEMMD,@+Q$2 9Z>6<KNR!D<  8/I]/UM_9*^->JV%QX<UBSO/LFJ:*EO*9H9&
M686<,AWJ7 9=J%Y7,9P3O]Q7Y VN\/DR':XP1QAAZ'/ _#_]7OWP$\:2^'?%
MPL)'$&G7X-O/,\S#9&=A>)5.4 8$$'(;+$>E>6Z:55U6^7ELW+7;W;K3T].K
M[FD>;16>UO7:RM=OY/LMMC^@KXR?LY_$7XH^*?"/QT\)?%XV/A#5Q&GB6UDO
M_L8AL%82:DGE2L?.:3##JI+9^7;BOT*_X)WWGB#X!7'BCX?_ !-^-.G>(-*\
M5QKJOP]MFU.SN+J.V%CDQD3.%*R// &0L0GFX8*4./QWG\0ZKXU^$U_\/;;4
M;B/3S;R7VFK9W=Q:7$)C6,'R8[:2+[:\@ERJ-(PW\$8Z?%W@:P^/6C)I7BG3
M]/\ &,_C/X&^-=)OM7ORNIO::QX+O]8COGMI/M)N(1)'HD$=E&L6\^8AV*T)
M8G[/+L12J482C54O=4=F_>LE9>FRU\M$#71Z:I_)6_7TZ?/^S&R_;)^ =QJ.
MJ6UW\1=%-_X:U!-!U L\,,<>H17IM521(W:WFDANPT$LN[<"O*N,-7TUXN^-
M_@_P7X 3XB7CS:[H\UC%>?VOHC_:8[B$#]Q$DD!9"V7;Y&8 9W#H:_C9^.W[
M-7Q%OOBOH7CCP7\/_%^I> OVDO#%AXEEFT^"\6S\(^*7TQ=8N'E-N%MK9+B]
MOHX ;LJ_FKNC'EE2/VT_X)GVGQA\7_LJ>/?V=_C)X7\2:1K7@_5M0TC3-1OK
M/[5)J>G00VL=I]BCNG$$DOFK+<%HSL\G=DEA'G>K54>:DVO:36D5=ZJSU>W=
MVW\^^TO9633V>NRTE;L[Z;V^1_5?\(/$UMXU^$OPN\964,MO9^+?AUX)\36E
MO<<3P6VO>&M,U6"&8=I8HKM$D_VU:O1:\>_9XT>;P]\ /@;H%RMPEQH?P>^&
M>CSK=HL=TLVF>"]$LI5N43Y4N%>!A,B_*L@8#@"O8:[8?#'_  K\D>7+=^K_
M #"BBBJ$%%%% !7R_P#$5U3Q?KC H&7^SMP9E!?_ (E-B1M!.<@<9QGT%?4%
M?!WQP\3C2OB'X@ME<&14TL(I *HSZ'IC@.2P(W!L]N#U[CS<T<8X>#EM[:*W
MMKR5#OR[^/+_ *]2_P#2X$TNK6B+MD9(I&.P>8^0N[@.PP2R@G)4 DC@<FL"
M_P##]_XHB>*%$CCGS)"\EH+B,X7RS$ Z[8Y&'SKN'"]#G!KY^U[QDT:B2Y;-
MR?G# MY8CYR_?'S#  &>!U.!7!77QK\8V(@.G7G^BF97B>);9MX)*1LRLB.2
M>0,$+P>N:^=<X2G#[279Z[I:W\NVG9:6?LRIRE!RC96>_P#PZUVZ=/-(];_:
M,^".EO\  +XIZ99:///=W7AK4;E9I+.ZN#!>M!F2>U6) L+ABY5B=HSP,Y%?
MP;>*-,FT[Q!K^GP/"AT_5;^W4&*..0&*YDB?>8R)>65G8,P<,S' !%?VL:]\
M>_B9JGAG6-/GNY;BWU72[^WF2.VMYS''(KQ.-GFJ(V$:LS8W'.1CI7\8GQ<2
M2P^*7CM+LR+)-XGUJ4)(I1BAU"X490LP0%HV)"D 9SCM7L494HJG*511T:E&
MWO+WK7W:U335D[WWT/,G2E'FE*5]7Y]NKMV;[;];' 'PU=6.FS:DLDKS([RQ
M1MNF1I%C-S!'"LK.<-*@+@YRH*@U^T/_  1BUSQ+\<_CRMS\8M0T+3O!GA70
MH[&TTW7=%M;*.3;<E46.&[<Q;$1.%99<$X*$C _'*ZUJ%M-BA#,9(RTZP@E@
MY$J#+LO,9\L-@,,;-WK7],G[ EAX7D^ 'PN\3Z/X;L+#4]0T"&WU6]BLH=6F
MO;V#RG-U]HDAB>-BV697SN+-N+9-36Q6'@G^]4KW]W?>UD]%Y76N_:P-<T5:
MST2OI[KMKNM^_IU/M;]O3X/_  M\&>&;*^^&5M8V\^I7CI+;6;0^7=7DEU<Q
M V<<*J@S' P2&, 2#:1C@5^#_B;XM+HEQ>VUMIE]]JTIS'JLFL6\^D00+'++
M&SC[3;R@B(H/NMB52"#@D#[W_;&U/QM'XC\+_$+1M2NIM!\,PG0-4\/S73JE
MS=SSW%Z;]=/"&W$RI*L?FR,6V!4;(VA?QW^*'PWUKQKK^N>(=.M-6U*771)%
M,ESXEU;2+2QD*.XDDTVU5X&1&D 'D>6DAPLJDM'CQO;1]M>,6M[);6Y;-KN^
MOKUU5R-[)-N^_9Z6O_5^OE8^K/#'QJ\):W;LUYXBL)-2CC0QV]A*A578#!D,
M)Q(AZA748YR #7:Q:UINI>5="YMY3<C.Q+>,DL1ER(PIZDD@%2<<'OG\POA)
M^SUXO\"7EUXA\7ZH+6"YG9HH+N62. #>2H+R"8%2@SEHMQSEADU]HZ)XB\-V
MG]G+::SI%[=*VQK:UNO-="04.5,5L !EB"JMT.T$8J+/G<G;6^WJK?D4DE;T
M_P O^ /N_ .E1>/[;6)9;Z.&X6&_9+5)D3S#-,A+6\ MXBC;5,B/PPW 98BN
MQU#QQH-]I'B*WNTOXIY-+E2UU&RT^YB4$,\8MOLD,>6$Q5?,<3ID!@),G%>C
M:SX!\=Z/I/AC4?#OABQ?Q5XLTR!-"BU36KA;.ZCFO+A(;FT!LYD))63?'*A'
MEHQ7#88?G?X\^"'[6?P^US4]0^)F?#^E:EI]XD$VE ZS!"MS-*Q$D$JP1H/,
M 6&15#JH.W +5VT*:E!RZJ;2W6RB]UZB:3=V[::=/GKU6O3KIJCWSXFWFO6=
MGH=[:P:8FEI8"XDNKS4;1;R/[.EN2%CFF>6-2 "86D9PIV'D8KM_V;=(\)>*
M9-:U*VTO1[W57O@_VDV$#.#/?W!N&,L>6:)%E?83*<=> -H_-O1O&&J^//B!
M<?!'7[3Q EY'9SPZ7J-S+?6ME=2QQV[^9#&DZKB9MQ944PELJ2QS7Z^?LS_"
M9_@SX4?5+B\M[O4=:EOK5-,N)5:[MT7SY8[F6.5945" 7C4-EH]C<.Q [8KE
MBDNB23?=-/1]/^'[F4M)/?5W_!:OIYZ6]-SJ?BLY\&^'=7L],U&#2IH;.-;:
M73S);&/;>(K0R/:WD.X31LRD,K9#?,&%?G/I-Y/J7C8275X@6:=&,@$HFC$C
ME&CMK@RM*D);YRI=B6))<@XK]$/B%:PZMH]W;WC+>7>JM([IN;$0\Z(QKL(*
MQEE!*@#!QD *>/B/3?!;VGBP&:TV)'(H5R'*(IE."V ,<<;B,#Z"J6MEYZ^5
M[+T_K7H0W;5]M/PO\_ZTLSZ9TO6_#VEIIL5]/IDTWDFTM)=1L5O7-RX:2(L\
MBOO*&+:'DW85W ^]Q\[PZWK/@OXF^)+#0YRFGZO*+B:V@M6C@;S8)+F1H5V(
M(8_,E? CVD1[0"< G:^(FA::T>A37>I1V$-GJ5K=)/;2&1FO(H[DQP.ORK)"
MX9O-3S -P3=D8QY7KL.FS:_<W:>(KJT>[MEALKJ[A\IKB1K(CRX6CN[MR_F2
M;(PR!.8T(7.2VE?IO>S:U32;N_\ -N_3S2NUZ]5Y62;=]^ZZI6\C]?8_CWX?
M\$_"K3]=\3W-KH]C/I5K:I+/;R78U*YMVC@GACANG:,X4X\XAAP2QQ7Y^_%K
M]K+PYXU\/Q_V1X(U6XT^WF.RYLK!X9I&942WD1EMILQ (I832E2 5#!L&O/K
M'P]+J]_X$TKQ#XHN_$>@3<P:-*Z3VUK>1W,JS/>&&2&2))7V;XHQY9/<@9K[
M/U/P)X=M=)O[;3M-M$GLX(5@LUTZ!['RXKF0K^^):=_,*[',JE=K'M4K1J_=
M:[]GTWT_,KIM?3TOI^!^=NJ?'R\BT*75+3X6:Y-!HI73KNZO-0O;FQN+:*2)
MVE6R2P7[-N:0NC&0D;<*Q4,&[C3='^*?B#PUI7Q/\':GHVE:5I975;7PQ>16
M\D-W8QN6>!;QI8W-QN<J2\!P6*L&. <KXI>!/%6G>++/QCI^JN_ARYTJ'2O$
M'A*&WCF)NUE:2[EB6-6=P(S&$D:-=L4"KO&$6O7_ ("R6=IX!NM$L+B>_M('
MN+?45UEKFVELK:[N)Y'$*;[B6=[=2NV)3;QD&-2AR2JKSY*"D[O>UK=&KMO2
MZ_*VK$DD]%Y/\&K^?_#W/3OAU\5-#\?:#X)\07 _LG7;#6HK?Q+H(B=X9Y(K
MF1$N;6:0+:6,:,,NT(+2L2YY8UX'^U9_P3$\8?M$?$K5_C/HWQ \(>'_  W<
MZ9#/;Q7US82:O<266<0Q"YGCDB>.0GRYHF ,>"D?1:\TT3PU#X%^,&I3W/B/
M4(?"4PEU.SAD06\377F"2)6(N)ML1ERHS&"H/())S[7XA\;?M:_$[^V=%\+7
M/ACP[\/PEE:Z9<B>VEU:YC$DZO<Q)-IZ.[E%!=XW=1*=C,!@U\E5QM5S;A2J
M)Q;M*ZL];7UT_/3RVVYHVLT]EZ/;SNE9;I/T9\S^#O\ @D-\1?C&?"7A6'XP
MWNJ:7?:@(=>FGM]0:*WMC;W:O]DF^TR1.(FB11+&L8*9"@EE4_:L/_!MWX!M
M8K-Y?'+:E+%-!)-Y&H.8+@E&>0/'-*TB ,H#1O&-H#J=PK)_9Y^%G[4W@GX@
M>#]2U7QG-?Z182VDATVSU)[ .#+/)+)JLD2MO5%8R1QK&X,XC0[5)=?WY\/>
M)=7F?0X;JXWW%SIOVF;R+B2683-=7T+-&'94D:,>6&=XU^3.?2O0CF*H4X>U
MC52J6]]244MM6N[?G\E9%Q5HN-DWMM>UK/K9VLDW;JWYV_E!_:6_9>^ 7P0T
MK7/@1::YH/A#Q/I%ZNKZIKKI:YO9;2SMQ';AE\B56DCF8E3<!&<*VS();\Y]
M-_9F\-:@LMWI_P >=$4QETA:>.TN!'%O4Q*5DU":/>%2-2$&2P/ )K]//^"\
M'P@LO"/Q$T3QQ;SW4VI^.]%FO[@&XFC"/9_Z,X)27RC@0!G"1,HS@.3E5_"3
MX;Z+K&J03)86%S=&6[D@1(;F5C*]S-M\I5*HK2!I$VRJF1YF?O#=7H8'-L-6
MIN:GSVFZ2C=/]XEHW[WIMN]D9U:;DE[UG;F_+;1_UMU/M'0/V 8?%V-;O_C?
M:R:)I5S!=W\]E9&X3;-J<06.*6TNY(X9$^],QV[1SD8R/U]T/PY;'X:^&/ %
MI\8O$UOX>CMK-%NK;PYKC))!&L,C_P"G1WJ)L+Q$*0Q4D@!2,U\I?L^_"3XB
M:1^S]XWFU#P/KL;27J26%S>17,<DH-T&N61':8,HA#&)MR /@DJM?H9^SYX)
MUCXJ> =-\.VT^G6,NB6-HQ61(9)MY'[RV<W%K)*0CJY*PRF)2"6&[::\S,<S
MSN+KX:O##O+J[Y(N-.2JQ@[)IRO;1-O1WO9>2,)2YIOWTFI=4WM:SO\ YJ^B
M9W/@_P"._P ./A[X:N]&\0^+Y-=BL9"-/EU#PU=6NHVQ$D44+W6HRS'YE#SO
M SO&02^=V./8KGX]_"35/!>GSQ>.]*2_\57-KI&FW&I7<'E075W<^3$SBXGE
MA&R,&-W#0[&<,V 37YS?M=?L.?%KQ7X"U_7- UE- @\/Z)-JNM:N\DUK9306
M]VVTM/&QD:;:%&Z(1G8R;RWR[?R"^$VK6%K<^!?#GC#4[O58+'4C8:TPUR\9
M6\C4&,NH6+"2-U$"897ED"+E5W(Q K\FSCP.R#B?,*&?5<PKPQF%G[6BJ4JG
MLW+1VFKKFM*_R3\F=M:I.%2<$XN-HKFMK=PCM?SV\GOT/WC^)7P*\1>)?BA?
M:1I7BCP5<75SX76]AG'B2RF0K'I<321O+!)-#;RJ<JR$[4 RIV@&MJTTKQ!K
M'@U/#_BGQWI>C:UX5_LZVTYK?3HM3TZ>W5[>T:2*[CECBND2SLD5'?RPK*6Y
M88/Y5_M3):>"O!3^)?A1J?Q':SB72DFUV_U/4HYTCO2&U2)9FO;IA!&-T<2;
MU7R$5 @0 5^HW_!-_0?"7C/]F)?B1XUN[SQ!K,]KKMG:QWMU)J&Z;3]+22SG
MNI9W4JK74L 6-E(9IWXW-FOVK@;"OA+"O#5I<\K^XIIMM:62YMFT[)M6VL>-
M5PT9\S4IW:=O>TN^KNGHGK;7MT1\@?$W0_%EEKD]IIOQKT/4'EGF%OI-UJD%
MBA+G_1S':2ZG)Y4@;"H8D1P6PKKN*M]M?LU>,?B!?^'/'?A#QCJUOK-KX?T-
MY[>,F*:Z6_R5RU\X>2:(HQVKN*E".O)KO-&^&7PV\9:3>7?B?PKH":ZC7DVE
MWW]CV;^5=V]N+EH7WJ-S(T0,62V%#,%ZD?)7['&JW&N>/OVE+34=4,K:3)>P
M6T(;S)%@C1/+6.) BPPH!M 8L%W84XP#]%F.8/'3<U!03;=O=OTZ)?KW,L*G
MS-.-N2Z;MH]4M/G;HK:+='U#^RA+*^E^)[MDCMF.N3((K=0D*&-I@655RN]F
M9W=LM^\9B .5'UDGRA<$G:!@DY)QCDGC)/4GCFOD?]DD.=$\3IMDP-?N<(1S
M_K)"#@'9\ZX;(P2""1DU]<].,8QV]/;\*\Q^?E^6GX'<7$&4+GJ.>?Y]<X[Y
MQDU%YQ#8)&/PR>G'].!3(W*L#U !X/T/3W':H99<N/E]>V/3OV_KD]>#05>R
M5FT[O]/\C1782"#P1R >._./Q&?_ *PK1MVBSC)SC')R#^0'7Z?0]:Q%G4$+
MMQE<YQC YXXZC((__55F.X4-D <9]P/;U[]".W->95A+VLWR67,[.]D[I/\
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M])TG]F*P_L>[AG>34$,S7<?G0$!<?V5&YD0X(#3,R,OW\G)_/O\ :\^"&O?
M;2HM?N/AOJVBP:I=1B_FOK=SI\:7 =)(W>X64(Q54DQ'&&:,(P3H!M@Y\[YT
MG%26S?G%/731VZ>5^AG4E.5HQ4M+6:C>.MGND[I[7[]MWXGX M-'\2>&Y]5M
M=5&B>,7U2W9EDU14^V$QR^:PC<VR[I'0--M5Y2Q("EN*^DO!,4.H_':XENI[
M=)-)TZ," :G;RO=F"T1Y)5:20 ,SJ&961BI/(.,CXI\&2Z5+X:\*2W&C7EG;
MW-^+J3Q4\ES':K'F42&.=&6Y:*%Y%&]@L."JE028Z]^_9:U+PY=^.=<U*]OG
MN7C:[%E<7%[*TMR0UY!LMS"N9!(0K.L[J#$#C+;0;QT(..LE;E;:>G2_16UO
M:_7=^?1AWR-)Z\UD]'I=I7T:VZ^>A^FEQXK\/^&X/[8UD3Z?;,((&BDMQ<J\
M:7%N\9241K&_S("OE/)T/3K7]-W_  2(\6^'_&G[)L^L^&KA[G31\4_&-F&>
MV>V9)[?3?#)>+8Z)OVI+&WF*"AW;0Q*$#^5K6+#3O%VBWFEZI=7FV\CA6SCL
M[59O(,DJ+$X>2XAC0J#YC)-O!P0HSS7]'O\ P05^%UU\)?V)/$'AV[\0OXD:
M_P#V@/B/KT-W)&(I;2"]T3P1:II\D:Y5'@:P>4A69<3@ACFIRV5-5.2"U<'K
M?>UNG^797*S!1^KMK=2BK7=EKYZ]M[GQ]_P<B10-H'[($TL)E:/Q!\:U3KP#
MH_PYDZ#@_-&N,CK7\BOB'0M>\3>(5^S:/+'ID-Q-(9,;D:(KF,*F<IC@ OP*
M_K[_ .#C:]T?3_#?[)-]K%VEO!:Z_P#&5A$719)]^G?#:-O+#,"YCWIN558[
M9 >.#7\K4_Q"T:X^U0^'[*[B\P>0UW>&W6Q98XR^Y>?.VLG(\P!>F[C(KMKV
M=1WM?W?751V_X9^J5SRZ&S^7YORU>K\MN[/#/BMH.FZOX9@TZZ:*PO-,2.UT
M68K&)Y084<Y$()\PN[JTLJ,YX *\Y\I\"Z/_ &-JLT/C"YBM9=1WP6K^5'YI
M 2W6!P6C169%C)SO7.X\$CCW&ZTC1K>\AU?Q%K^C2W,A64J')C@)++'&8\)#
MN4$!R"3TX-87Q'\':7XLTK[3;^)=.NDL+998K:VF<2&2%7QADMU"D;UP6=CE
M3@C'S<[3OM9[6OVM97OV:[?>;G:"Q\,0F#/B>TP&!"M%&'8\#G$;#<",, 3S
M^=;MUJOA.Q%BT^L_:8X79E6W@A9 2,F.;:D>[9]T@,2NW!.:^6?!7A.U$^BV
M?B359H+6UN%F>>&16D\KDE'$D:HQ4$'YF.XCD\$U]0Q_#+X4RM="]\2ZQ-#.
MGFVVY;<@L_SXC,,;?. 3N"_.!PP!! <=5TZWOO:VK_.[:>Z6J6AU_K\RU+\5
MOAQ9W$*/+<&((K.?*M\!R,.$7S =H4D[0>1QDYQ4FK_&?X<20@S:/>75IL_T
M>58XR[1]RJ).&09P?+/7@]<"M[PC\'/@MJ89[^+5+RWLSO5I'B=7'H[B2W;)
M&,?NVR<# ZCT9]/_ &:]/1;2#P)K-[+ WEJ[-:-$9 #\WS7 <#CC^7-6G+JX
MZV^[[_3[]]A??KKU_6WS6_EN>*:?\5/ 4=K));Z!>^7+$WEK*DJ*R'(VR*LQ
M"@MR-P.:TK#X[Z-IB".S\(+/*B@!/+<!UZH!RH)"%5QW(SGCCV"VOOAKI[*]
MM\+8)(3)%Y9N64!E# X=4N264]\'&?IS(?&7A;4=55-,\"^%["*WE;S?-0J8
MT$FT99Y)\Y.%7]VO(P 0!DLUUV_NKRO\GOI;??0%;L^^KOZ:W>]WZJZV/&[S
MX\ZA>1?:K?P8T$UOY#H([9RZF:<1I&HVGSF4X>1AD"/AN*31_&7CK6=?-K+X
M?N4T^WC:X,J6LD8"+.N#@HS QJQ+,.8^^&P#]22_%OPWI@M[>/0?!\-Q;JR!
MKN"1XOF! QL.QCVY3Y@,%0#BO)O&7[1.L:5+;W&EZ9X=N;>YNK='73;*9\Q&
M$ELEX?E#R -(2Q8L!P6"USUEJKN^G1+R_3] 7DE:W?5>EKKTUZGKOPU^%OQA
M^+VL64?AKP]XD>WTN I"+5()(9Y?.1!,#<7'GS864YW1J%W<#YN/O6X_X)Y_
MM<:1\/KN>>+Q'>V,L<MXGA^6&R4&W3SYP(8Y P5DX(DCPP+'+G;QY?\ !+]L
M#XI>%](U"]\%:"YU>#0541VUF?*DO6DM90L'F1^=)LA&XJRD*%=EP 37WUX$
M_:N_;C^(YE#:->263>&]2D2 M' S71LY'LHP&N8X8PQDW,KH&GC"DC&!6U&W
M)&][ZI;6MS>M^G;IO8E];)6OJK:M>Z^B\W?R>Q\&^%OV1?VBM-NM'GO/!^J:
M;I<-Q:-+)//)&F[[6N]I K-(PM^DH164D_>QDCZA^(O[,?Q6\3QZ+!;)HR06
M<$,P75-4U6RACE=%CCCC_LY/WDL2 [U9/F.2=O&?6?!^B_MRZQXT\"S^(YS/
MI-TFK75Y+.MND>FPK8K/]D\F&203RHQ+D#+;MOS#/'GOQ=\#_M7>//$FLRZ1
MJVE^'[)?$,^GV\;W<@-YI\&H+YUTB17<R0F\MPQ4F5//.,,^,B[;.VVBZ=KV
M^7^6@[::O5VLT_-:]+:ZK>S=E>]B[\$/V/?$GA[7WUKQGJ&@12&V9;>.SU/4
M+A5,4EQYDBQWTF-LJ F.4!&4C:"-S"H_&O['>H>+?%EUKT7Q'T#3[.\N4DAM
M+FYW74"HZ(6VO;3QR;HXSY<;39;:Q& "*XSQ5\$_CK<:GKTUM\1=-T73X_#M
MMI6G6TFL3;(KR.]@W%T*[#)):B]DD+3,ZJ"=K$ CGO$O[-_BQG\%OJOQBTZS
MAT?0UDN]/&L3"5+[S&9[]I5#/) 4D,OW0@B&Y0P!-&Z3V?\ PVFWW_H+31/;
M2UG=-W2>[V3LK>I]5_#K]FSPEX5\':G::G\7;&-+V.:W=[86.)3<)Y31DM"T
M$<WE!6$<8CD8#+ L37/:#^S'^S_HVHO%K7QYL1BXM+L6+36!^TO-*X8*I@F*
M$A%PWFH9/X%!(QYVG[+WAG2/@3X=TS7OCM;Q/JGBJ'5KJ5-2GDFO"MU<.9+<
M^098TA@D195489 ,E=V3SWAWX!?LVPS7":[\=1?VM_J.EZ:ZB>XC:/489G)5
M3%"^%6;:JY4@ @[<9%7!Q3LVE?2[?=KS71_+2V@/5-=]M&^JOTNUUOUN?OS\
M+/A=X7T/P-HS^&]0@U'2Y=/M[J&Y$>P7"3KNS&RKAL^4GE\]2XY!8#ZFTJPM
M? 7P_O[\EXI+VREF!V#S4 BD6(;LC/!)X' XS@$#X7^$GQT^$.BZQX1_9J\(
M:P-6\2V]G9"&.,O*8=(A6+RY7ED6!VDDGC**GEG$;N>-S$?7?Q]U?^S/"^G:
M/:OB_NC% !_!Y6V2-C("<)RDA(P0-G'0FO'XQS&.5</8FM3DE6E"2C*#Y6KP
M27=W<MEU(P6%4\3&4GO)=[M:/HEZ;=]$?DK\>=3:>_U;5[Z:+498=TL-JS!F
MCL0XDN"K%58O,N8XT$G5&( )%?G-^T!^SOJ7B+4?!?Q1^!IU34-.NFC'B#P_
M'-NL[>ZN)[>:6:6.2::6%DE9]\:1[V8%E&U@*_1+XFZ?>:_9M;+93SS7X$=J
M]A"+AY@BRP2^:"RHL*LJLS %]T@( XS[99?"X?"/X>^!-.EL1:WFI11:C-"0
M6G\T);W!!-R)S&[EF9@L2 'A1C!/\_< QQV,Q^)QF+C.%-S52\U*]Y-.-I.Z
M?,NE];>2/I\R<:=*$$[VBHV3\E?MLNJZ]+Z'Z9?LN1:M%\#OAQ;ZY9FQO[+P
MSIEK+"Y^=IHK,([9R"054 $C/KA@:V_VB=)CUSX,^/\ 2Y#&$NO#>K M(&9$
M,=E-*KL%() * 8Z9SZUT'PGU""]\$>'V0@.+*'<K+M 9;<EU48!!0,-Y4#DG
M  .*U?B9:+?^ _%-HR@K-H6IHPS@$-93# .#QST.*_I6;YLMDK/7#M*W903M
MWU6A\C%_O$[=6[6[>7Y^9_E6_M.0BW^*/B1!(%4>)[JU57!4H3+=2,\J'!$4
M;;MP/)WP@'@U\AW#IY\1+%B&N<^N563J1P3QGM\K+R.<_;_[=NE)HG[07Q M
MRCB/_A)+TML.[!#G)XP%4Y&['7 .>*^";J95D@!,L23&=HY-@/RA&"X+,_WV
M(7_4GYR,LPXK\\PU&4J-=)[<S>[M%)M]-;=EKUO=G:[WCR[WC^E][+OW].I^
M\'[!&H&YT?3K=W4J)DCP3]T/=_-C!&#UQG/3//-?UP_L^^'OA;\"_!NB_%36
M?$B7VJW%JI320\;.SO8V]T-J$YC(:^E;>4C#J(E'$1S_ !U?\$Y?$-A!J6DB
M\CDOK&/4K>XO$=#)NL(+L"\5$"VZF0,#A5(QT!]?ZTM8_9JUWQIX7\-_$KX0
MI+/H^JZ-'-<:7*[R(D,FG6[C;"[J&V1>6D6,;2PYQQ7XGFN&E3S?&9CE^">,
MQ^%J*=&$>9N$XR]Z?(EJXVMRR3[6/H*4E4HQIUJJI0>[M=35E=7Z=^NKU1^A
MGA7]LSX/>(VMK:76[;2+J:9H$M[^4B?Y A!VQ><-I,S<Y!X )Z"ORF_;VCU[
M6/BTM]):3:OX9U/3W_X1Z[LHH94>62!#%Y)9X6EE9&RJKO;'&>*S(/V;?BX-
M1MK"#P6UE)YR3V\][YJQB>:-HYIKEUD#Q(D$C@.I.UWC'!(Q;\3Z-\6(/B;X
M4^'DFL:5X@N?"D$6K:9HZSM,FZ"(-Y<=S(4:9XTRKI)(SY  .*\7B;C[/,VR
MNC@,TRZK0JJK&G!N"C?E]Q*4'&+;:3?N[M1[FV%P5"A756A5C*%FVKW>ENNR
MUVNUHWKJ<G^S!^SMXFT3XBZ3\6/BE.O@/POX6E5K/5M5<6DES!<R)=(LD8;#
M%D90'<2[(553C:0OZR_'/XQ>"-3^"WCW5OAMKNG>)=;L]%O5M9O#PL;C4(IS
M;22--;BZB3?, BN"HV[MIR,<?@C^V!\>/BU\0;ZX\)^+5N?"T/A^-K1-.L0(
MGO&MV!W2QNTBQC.88V>1MRA3QG:/DCX2?'3Q)\'/&^C>*+9'O=,NS-I^N^'K
M^XNIGNM)E14OR]K"19M*T<D@Q@3>6V05'3KX>XIPN79;5PBPS4*R]G.M-*-7
MFDHQ<HPMRKEOLKM:6DVT5C<)4Q,U5<XQ:2:BDY*UT[7[ON]%?:VI\/?%#Q/K
M7BK5M8\2^)+VYUWQ%-K#3:C+J<UU)JD;327"YND)6TAD1@H7RE5$53D$ (?W
M7_X)#_#A=4^$'C75=?B74?#>NW<4=MI>M&*ZTKSI=+TUWGMX',Y23>"CRQPV
MJ,NW8[C&/SB\2Q_LW_%?]I&YN]4CN_#'P@UV5KOQ#'=QBW&D,?GD\C;;W,YD
M-T5%O#.RNBL)#M0%A]BV/_!3'X(?LM:@?A)\*O"UWXQ^&6F$"/6K=8(;Z>VC
MFGCAC4>=;VX0V:6S(\B$G&P* BU[W#-?"+-.:I)0A&;]YROJX\J?*DY<K>[:
M79ZZ'GXA5?92C&:;:6B33LI1ZWM=?YGZ1_&7]G#]GMO#6O>*K[X3^'K.\\/V
MT]W82F-DBW?:S'/(Z^<7500\J[T,(CEC*@MN _CP_:/^.OBOXD>-Y]/M'M]'
M\,^&=0N6T;1HK>&&PM;S3KIA#]D$-K'Y;WHC3S-V?- !4@X-?T0S_P#!2'X9
M_M;>%_$GP3\&66I^%_&_CO1KFPLKR[FMREJ7GC'E@M(L.];> DB-BHDS@@DY
M_G.TS]GCXK_$3XG:Y\-/#VB7.K>(K;5+E]23,4MM8C3YI([2[O)]\(;SS&TC
MB.1@5(&>,5]EG53+JF)HO"RA.HU%5.5)<T4]?=<4][)=7>][6)P?.G+VKEHG
M;F=[?#;57>U_P\CZ=TCX>V_[>'PLTZZ\)Z='I_QE^'MG#IU[IXL[6+3M7L+-
MC:P:@7A6(S/,NU03"YD)&U6KP72/^"?WQSM=8OC\0M.3X>Z/I:Q+=>(M:\NV
MM;JT5]ES/IC7(FCSY)80^6JDC. #FOT8_99\3_"[_@GY>:K;?&GQ#;P^-/$:
M6]M<V'AZ2.XGL%L9@TEI=*\=Q$0'P"R-\O;& :N?\%&/C/8?';]GZS\0? [6
MYM8T@:BUYXINK)V6;0[!S S!_G!>(117"Y2-8DE#HI7;SZ-&G@E@IJ-10K2D
MM'LMM[ZWMK)*][/9G1>TDNC6][ZM*VFGG:^[VOK?\C_BC+\#_"NO>%_#7PLE
MDUY-/#6?BOQ!?RR^3?74?VFUN%MUCE**LIED(9X8/-6,E2P4[?=/BE^S+X^G
MTCPUXR^#RZW\4?AIXFL[.[O(;=IKJU\,:FTJOY5NBW#,L7FF8<9! ) & *_.
MB*&=KN&YM+626-+F*2S$WFF:[MY&E59)'VE1(7D9W5L@I(GN3_9-_P $O/",
M?A7]E/P,;L)$VIE-0N[6\BMY3Y(DF CC6520 KAE)QG)P3FN"AD<L1*-ZLE*
M2ES2<DEHTD^6Z\MFG>[Z:\N(J*$Y-)M:?E"_Y75K._8_EPNOAQX]MGDT>_\
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M_$.D00P75] \K3S.9TC,,?VR*. *K*<+$T:], #!K\E++XE_&+X7?!;^Q-+
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M%\,KW:O;Y;.VW7;4E6V235[VMIT?^7Z;:?V>?#G6[3Q+\/? ?B/3Y$EL-?\
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M^8 -V1D..@)4<]QGAOA=XQD\5^"='O[B&:YEC%N#AW14C"S;!\CAI2",%E!
M/+8&2/CCXV_$RXU2YO;:2X>&0R36Q6;F/86MW9@>?G'^]C!Z5Z_^R_KD>I>!
M9X;C48)VTRY@AM882(V:'[/<2>9* R@OD$,0P7 Y#9KYO+YR]HY>R=2":YN7
M>VC:M9VOU3=WL>Y.LE!M-<M_>TN[NR6M]-+WM]Z/H^UU61DN;5],N=ES!J4<
M+K-=)M=[:[=2-\H#(1$^XJ20P48P:_F _:0MKC3/C9XWA-JD$:ZM<SHDN7D8
M75S,Z2,6\P[B90< X&,!<#)_J)M[&UWVBG?(98;N2(0RDDLUE>L5R9_EP"2
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MYJD_AC6M&O\ 0QX<O1<,YW"##+O.Y&#$Y!(5OEX[5_,?IGA[XR>%-<N=0M?
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MT.?\_C7R3^RC))-X3UV42"1#K=TL?"D'9+(G;&1E<< #\,5]91LS[0VW@ '
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MMY)=KI:6U['9_LU?$.*_U"U^#?B"!_$'A#Q)<Q6=F7!A.G:I<J^+HHX,S0)
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MH/[,7P$/B33+B)H;C3M?/PJ\*'6+">%\/%-9ZC]IMY8G :-XV5N0:^G:\_\
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M;LV[/3=Z/II=W[>?[<ZU^S)^SG<>(8O$]CX5TGPWJMO 9[A=-NG@A#1,JO.
M^Z%LY4Q@OE!NX.<5\)_M0^(M?^$_BC1;3X2WOB#Q;:ZIO^V:9I%_:-,D,<R+
M*KGS([:(")MN^0[F7[R]*^#OC9_P4<TOPIX,OO%^I:M=Z5*;624^';5I#$K$
MNJ+YD:2;5:5,$F>/(P?FP2/P/UG_ (*K_'&Z\4WOCWPIJ,^D6.J-<V,5N4,V
MVW>9@LH^UW%PL;@)L9HTW'=R!64XQI-PA!12:=XJU[I.]DO.]^MMM3JG\33G
M=JRBVWT4=59NW;HE?R/ZWO!G[0/Q>G\'ZUXFO-#\4>'-,TF)K2;3KF2"ZO\
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M]ALVLZ6$>XAC_P \HD&> 5C S@ 5^NGP;,EG^R5\)[06>YYM.LDD\LX"'[#
M 6SRN&R 7 !)!QR:_&;]N/4K(V'P^TN\U"XCFMH_"B""W)\G841L[3CG&"V.
M_P N.HK][?V<K+1M6_9U\!VDJM<11>';>6-YHRC%UA VGL<8 SZ=#7KY=S))
MR5EKJ_)K\/RUW'4Y/8QUC=MZ>5UT?KIZL_-'XNZ*=)U=Y664JX1N1M&#)N /
M!/"_*#GD#WKQ2"-_MZW:[N9%7"DY9=X^4@[?O 8QCKTZ<_?7Q8\%MK4\Z'"A
M&,<3;&9L)*V.>^$ ';L/7/@P^%EPD\*1Q22W#2A;<G9Q*""A(') 8@X W=!W
MK[S!XN-/#PYE%14(Q<M%;W8K5^OIYL^=J82<JDYKF]Z;D]=M;JR^:7HK::L]
M)_94M)[[XF07WE!X[&TN)!&&(#%?."+N7Y5#+G&_@D8/ Q6M\=/"/@?XN?'.
M'5M;\7ZUHEWH$K6UC'H6I6T:SK9W-V4>5%<21RGS=LK.%#(RA2>2/5OA_P"#
M/^%+^$M4\1W0)UFXMI;>&)4&]28790$)1B-T@ (Z Y]17X\3_%+Q(_[1)TV^
M2:Q77+IMT\AE4[4\X2X+LZY1DP,8#$E^01CYG,:D744HU(\GO7:>BNN6-WKK
MLO5K;0]C!0J<RTDFT[='=)-OK=/\F][G[_Z:VG:;\/?#^E0:E<WMY:30VULV
MI203/<*EN0F&BS.SK&%X7)8C"$D''FWQ[G,KQP$D8MXU898YX4$G?\Y.0>6Y
MZ9]:\FT+7KZV@\(6T][+>)"UG?S()!M4NKP1N,G+*?-B7/\ O8Z9'K_Q<T]-
M:T]+^U.Y5@(WKR28P-V0,YP=V<GKQCT\K#R]I&/*U*4:D=FVW'2[=U>SZM:6
MMO<]!QE&[E>UM+IV3TMH[_)ZNV_G^>6L2>==3M'N62"0Q,0&RQ .64GD^@9<
MKV'7-,T5;AKA2SL<$E@Y/'8MGC&T'/<$9K<O],F%XY>%E"R7$;E<M\P88&W&
M2".^?;'>M7P_H5Q<S;4B9@5?) VD C&<'.!DC&>1WZU],JZITX1TMRJZ>O:_
MDM;.VZU>^IYB@ZE:-Y2Z*R;2Z/\ X&VN_:WN/PRLQ-(#/%N+301X*[R2LJGY
M#@DE>I #$ YPHPP^[?B'J6G^"O@5XTU&Y:W0V>@3W%M%-/!!'ND5$"Q1D,9F
M9@<1[PV[H=O-?+OPL\.SK=V4ZV]YNL[JXN8S"=JB.2 1-NPDA.,'G(.#^-?
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M'((&*_S>O"WQ1_:"\#+96UAILH9KE)(_*4IM#SQ')031G.T<G)!YZ]_[NO\
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MHW)C<JE]L6.  *\QU&YN&U">%U\43RR%5+P^'M1M<NS*=S3!KD9((RS *>H
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MLEII:SVTT[L^S?V9-8\!2_!OQ1XK\#Z8VF^&-7U75=060N6-R3_H^]H6C@:
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MJRE=QX S^;?Q1^)WBO5;VZUR37-2MM8;S7W07URD5X%  $\/RI&B(\<81/E
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M*24>:35VY12?);K=O1)\6'Q$)WDVHIMV<VEKOY[-]^EK69]2_$7_ (*&^/\
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M9A5J3E&4Y;:<L[)N+Y976NJWOYW2M<P5E:W+MKJE?X6N_DM+I>73Z2_X)?\
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M?X?^.&T^VM1>L4M[;5[)&N(;>YD\MPT;R&)WW$7?F!^6C"DMY9J__!'[XJ:
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M?.MU;3HTVO/I:_8<%=M7T79;:+^EO;\K@)7D#) /'X53ED!+;L+Z8'?'T/;
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MV;2[7TO:VMS]$/\ @FAXLO\ Q!H'QPDGAN)?[!\/1!E%W<R1L4O="1$ )"*
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M^1O 1"6\\W();<< ?,> /YA+2ZN-0NDLS%</*[H@$EOYWSF:(;LNYV[>3G&
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MTO1=-BAO[K[(]P; "266./87\P#<203MQ7U+_P $J6U?XE^,/&/PK\5A-?\
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M4,5:,$NRHR$AG5F)SD#T;XO:]\,[KX=,;(&\OC<P"&1@51Y#>+C#[)7=E!1
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M$$@!6(112,^W8X>/#[<9(P?E_5_#TOQ2\2ZCXNEN3#HU]=0S6=NQ($N-\;,
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MXX&#-'*0T4,7RJ2#\JMC^6__ (* Z/<V^JZ-K*_9XS?JBO\ .@03,X5HY6/
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MDZ-K/C[6-!@GNO&]R]Q=7.CWIL[>:-]+:*ZF19$>-3*1;,#*[ELA@M9_P?\
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MTKJ[7/QK^)-[:/<I:3:[?V]W+&8I)403P!EC4[B%VLI&2'W%MQP 1[K\//\
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M;2N\QDY)QV_-WP;XNM+CQ%8V;V-@;:&4+$[%0$BW;K=$5U!,L>2H))/15(
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M5K7XGUO=:ZI-M-V3;5UTN]=M==M;7\]6<W,4MH[R8Q!)(XV0'&%;<1GGJ3N
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MHQ/&$4-G:H".@&ULD+EOF)SXI^V3H/A!O#^E:[I.FZ6#+I5VE]<QVQE58UG
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M^?  S^&/CWQ3XWT_4/ 'ARQ\.:: ^DQ:CK\T<4:%+C[*4F6XE#\)G]V<QQR
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MRE-5&WNY*-G'E6J5KW>NJ5NQFI)Z+I]SVNUJ^W_!M8^M_"_[;O[0UMXJM_%
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M,941;I(GEXF<*I"\497@J6*Q#E4:]VR5[+3W7O;;5ZZ[O<).ROIT/YL?&/\
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MJ9NH9F,<</EQN87R37PU=6QLU(F%P]T\4LL$-E,IM!82?O+6(L0R,[)B&0R
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M5MI;7PI::]<KH%LPCGUE+2 0322SP021/Y&Q(GD7<X\A<)&R[\'.?-/VX?\
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MP0/ER?ESGIDE<')S@5Q8I7I3?9QZ+O%[WULEVZG31_B4?7_Y MC_ (]F^O\
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MPKXC3QA;ZMIFE:G:R7L-_%<QQ/;Q/$D7D26\49=A"I^1E*G)/6O2OC]^R/\
MM,:IJGB"Z^&VMZ+8Z9J5N\&C10W>JQ-$K2R1D%%!(?:69&.<E-I(!(K^B+4M
M ^URM&T-D8(]C !)FC7RCE#DN"1D<[B=W Z9JC:^#]-F+274$)<' 2*)4C10
M2WF+YC;4P21B+:^'..,FOMZ6#P]##PBX0NEOIJ[*[LM-&_\ A[&-2I*K)2FI
M2<4DM%MOJEZO3S^2_C'U3]FS]H;X97$$'B'6-&76-7M?*U)Y;G4;:XN?+D<E
M9[BX6"VQ=-A2DLKA!ET R:^ ?B*;KP]KOB#1]>:2YN-):?98;H/L4MY:OL=;
M>ZTY59C^]S'-,WRH@"Y4ES_=I^T%^R;\+_V@_#]]H&O>';-M66QN8M/U6R5K
M/4$VV[1JT5P3]F$T(8RHSIEB"2Q.#7\,G[1'PVF^"/Q=^,7PVLM?N]13PYKV
MH6MI<W\JSR+ BVJHMT50/N <!NJG&1E2*]K Y=AL7@75C*,)TE+G>CO;6VKN
M]-[+HG<B.+Q$6X4J3:C:W:S2>FG=OIZ:/3FO!]IX>328K>ZEU&*0VTTQ5D0(
MNV<JQ#,'X8 DDEBHYW-6S+I&C7J6OV?5Q,]N;_8MPT D=A=0DJ=B9#1QA@,'
M) (/!KF(]8O8)M.TV^NUVRZ<\7FV@"$R,Q<LJRJ=P(SM0#YB,8ZFL/2X]35Y
M;8S23S1/=-' #B:3SI"YEDP 03'D$*0 !TP*^2DO:XJK&FW[.FI7LM^2UVNM
M[)^NHG7<DT^9.6EFY:-V\K=M^ECU%-.L#$HBGB>=Y(HU8$';NFB#;BR@#@]?
MQ]Z_ML_X-Z[%K#]@G4XFVDR?'OXB2_*05P?#_@2(<@ <^5D]3[FOX3S?:C';
M_9FLK@2+/"6;<Q('GQX(R<C<,D>F"3D$9_N<_P"#=2[EO/\ @GYJ+3!P\7Q_
M^(L.)"2<+X=\!2<$@<9D(Z8SFNC#M.HK7TC):_*W_!.:M?D>O5?TV]_ZW+O_
M  71\07_ (8^#WPRU72]0FLM2>]\;:;9)#+Y1FEU/_A#+17;][&Q2U\WS7*!
MCR%.U68U_-[XG\/>,;NS_9T^&]SXRU*ZU"PLK3Q5XNW75U"QM3HM]%%;P);W
M EE62YM0K^8B%7.2.<'^EW_@L1\'-8^,6I?LK:;;.)- T/Q%\3]7\16TDBI#
M-"EKX!:S%QO4@PQS0NP"D-N/ (R1^.FI?LS^(=0\9?$+QSJ7B#P]86G]G-H?
MA+4X[^*."W@%PZ/")#)Y@<K-)Y<(.U@=JIDBIKU(TZL^97ORM6OI9+>R>MG?
M7Y:(*3?LTDD]9?GUW[NUMG]Y^?\ I>KZ[:>"_P!J#XEIK\Z1Z_=Q^$?#7VB]
MO<VMPUKH,S-8H;@N7G339T?: T89GV,W*P?#WX=ZKJ?QH_9A^$PU+4=1;2;9
M?''B"&YO[YI)M1AU*#45#K]KC)MQ:WRI$)/*'#, Y=MOZ&7/[(VBOX6^&/P?
M'CG0["WTV\?QMXDL9)46;4M0$&H6<;7$8C8S-;6=RCQNW+1E&9O-9F/J?PO^
M"?PL\*^*/'WQ^\0_%+0UL;31F\.0^*(GB-OX:L;6"V@\M)_LI(NXKC2F\H$-
MGS,?,'.>=U:,MX2;:MJ[::._PZI7MW\M--5*2]+7V5T[)>?2^W_#_FG\4[[3
M];^+/Q[^*G]I2?V%X1T+_A"/"AMYKJ2.SO9=.ETL0W7VB>2%"9-/( B6=SDL
M_7-<IK7PDOY?@E\"OA6Y^V7GCSQ>OC/6WM8G21H5%IK:QEK9[>1A$W[AO-@Q
ME#AN]?H9I7P#^ MIIFF?#[4/B[IFJQ_$?Q3%XFT^*'R9KO6Q)>S7DL\T4EL5
M9'ANF*L I ). H&/7M7TO]D2W^(-[K>I_$==1?X1>&[?2M6M[95EL] :4#3)
MU@8VNY;M5B6UE7)CC<?N]I -4J]'1<KLK+=:JT=-NJ_+T2;E+OYK3JK6N_76
MW7UW_-KX=>&=*TKQO^T3\5C:RBU\"^$QX,T&>-&=VN;5(8F$3RKY1<M=E6 +
ME5&Y69A@^;>#_@[-XELO@1\,H=*U"XU'QAXU@\;>(/(2XEDO;6WU>^B07Z,4
MB,<<4IW,;0Y4<.5;:WZT:YXF_8I\$?!3PWIVH7%W-H_Q=\2SW>CQP0N=1UQY
M)T1KJY$*"5[;="3U*XMW*C(&/<?@E\2OV2M5^,6H>'O!_A/5[_QA\)/#=PT>
ML6EK:&TM[6+[!=B",SR[VPLSEC)$7WR*H?ELU3JTG:$(\O-9)]OA>R26V[N^
MFQ/--+7H[I)=4DEU_397:N?&'[7/B[X@:C\2-)\&_#?]L3PM\)-'TWPW86$_
MAJPCTF6_LM0M[#3[@6@M9]*N!%*)8DS&T@W8+$;G8UQ?P;^%_P >O&_C/PW:
M:Q^W=XO\5,FMP33>%-(T;0[:QU!(K^&34%OY+&ST]T-U$'4B:.9E5Q,N=P6N
M1\4_MQ?LSQ_&?Q1JJ?L9>._%NK"_O[>;5[NS=C/=0M%##<QQ_P!H?9T0,F 4
M\LD9PN17Z'_L-_M@6/QL\;W6BZ1^QEJOP]T_03J-Y;:_);A9+B:V>5Y6=Y]0
MEAV2+&S/MR25< #!*VDFUKK==W;:ZV7W/7?0:J3@FXZ:-;)Z-IZZ;W2;TV6C
MZ'C?_!070/#'CKXA^'_!LGQN^+?AY/!OA_2X=1T/P792S'[?-)-'-/-=0WEB
M)2T!50\L91%.XY"MCYQ^%?[&?@*_\;Z$K>(/VC=:N1JUO>C4+B76A:WT"7$*
M*UP(/$ 3!S\VR+"DY(V]/H_]H+_@H+\?]-^,7B_2/!'[$FA^+X=)N6LK?Q1J
MT:R27;6=W>)#B9-01&,400I&S!2I49VD$>S_ +'W[9O[;OQ=^,'AKPYXL_9F
M\$^!O",T2R-=P03^<EN&9Y,%[VX@697C4(=P 8@GI6D.5O1W]Y+1;ZJSO^E]
M=M['-5@W9M*Z7\S3^SV76WR>VQA?\%&OA_X+\>>)/A5\';GX7_%KQMIVF6%H
M)I- O];ALHA'&(]VHW-KJ]M-'( =TFZ1CU;().?CCP5^P3X3A\5>'[6/]E#Q
MQ+8'4M/,6L:IXH\8216\EO?1/%<-Y^O3(\;)$FT&(AF#*9"" /L3]LW]JS_@
MH%HWQ_US1_@GH7PCB\)Z:4AM]9U:XAEU&2%D7[2;G-P(@XG,BM'#&678,@+M
MS6_9Y^./_!2'Q?\ %'P'H7CKXJ_!\Z%<^(+!M2T+31Y]Y+;&XA:X@MXC995U
MB.PL2\0SN3!WYI\KGI?=)))6W6UI=-5;6WFM%BH6C==E?WF^W2W;TTMLCZH_
M;?\ @EK_ (M\*_";X>:+^S-9?$C0M!\/VT<5AK6IZM8-IUS:Z=%B7S5OY$AC
M'E@>;/EV"YRQ-?$ND?L/_%EKG2[/2?V1/A5H2++8N=129]8MQ%#,IBM9GOEO
M7,UKC&V:(K-R7"@5]"?MS_%[]I:X^-D>B> ?VN/"/P9T+2K""WUFVN#9-+.U
MQ;R*R0.-*OHO.0J04N$4+P,5\_\ @B7XH:KXB\(:3??\%$KG5KV]U^SNKJPM
M4M7_ +3^T2VS+!;@:)&;B*4[QDG;PQ]ZMVN[)V\G%;<JLK*W1K?TV0*GMJ[O
M72^OPOJ_/75]KGZJ_M'?!KXW:Y\$/AG\._ O@SX<Z?<:7$D6KP:Q;:>GA^&:
M!KZ,1VUO-ILT87*QN4$,49;#,V0%;X8TK]B7]JYX)(CKOP9\+E8625(M#\(W
M%NL$)FFDFGNKGPTS1B82,(/(.5"%MVX+GV3_ (*!WG@V+Q?\-_#_ (L_:?\
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MZ-_P5;_:,UGQ)J_C+2?B%J>FS:E?/>PVGVF&XAM(4EB:.WM8[RWE19-NV*.
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MM-\?V>KW5J_A^^26[L+:XN&M]2LDS.L*()\K$F8T8DB,F+Y4!9BW3^.OC;X
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M4^7T[=+]+/7:WW?D%XZ[]-$ET2?5+KO;1V/@[XKW'A#2OVA?@+\-(7TLZ?\
M CX766OZU:A))K>QO#-K%Q<[PTJM+>/!>VN'GV)$94D_Y9G/O?[".L7%Q\&?
MVF_CW9ZQX9\#ZCKVM:OH6B^-]:DG\Z:$6RK"D5P)-@6W>V8"-E6)BA$9<KQ[
MSJ?P[_X)[V/B#XX?&KQ9\:UU2/5;BX\(:S>M+,ZZ1,\>EW2:= ;?3Y)YE*72
M0JZY3#(N0N7'=?'6+]@#]G3]C;PWX%\<:IK^I?##QW*-7\//HT-X;S5(KR6X
M7,D-A9"558MYY\U!*/)(#)N.7RJW-[J6^Z[)?*^WYB;6BY7=V5U][=KI=O6]
M]V?C5>ZM^T$9+ZYUK]M'X9Z3;1:V6ADM8XW?R);VZ*K*4T^5FC92&/)^;!W'
M'/ZU_P#!/C^T/!/P\^+OQ9\9_M.)\0M'M-!U"*'4["$PV>BW[:-J\<US%LL8
M7F:'@Q[I  4"G!&!^;>C>-O^")&F/+<6OPC^)/C*]DN#J=Y#)I?BQXVNEFFN
M+6'=+90120//*J".-V$:@%YG(*G]=M$^,'['_P !?V+V\:?#S]G_ ,4-\._'
MU[=6=SX82UEN)KZ\N(+PWEE-&K7%\D8>\D@$LD2B(Q;$4JHR1233O&]KO63U
M5K;[]U^J!ZI+ENW;I%=4VM;;;7UO=Z;'XF^*/BW\&+KQ)XCU#5_VS_'FH+K.
MH:C.]EHFF7+2QSR,I9)OM%C*AC$6XR&*959>(G#$$?JC_P $N_$/P4\4>*O$
M_B#PA\4_B!XW/A#0+UKFV\1V\UM9+$DCO++:(MM _FLJMPDA5&VEL@FOC*#]
MLS]F* 6DO@G_ ()=WEQ,EU=0IJ-[H\RM)+ (_.DF:YO8F8-&Y<N(R[#)5 1M
M'Z[_ +(7[1\UO^S9\4/BCX2_8]T?X:7%A:7K:7X*^R0V-_XC<H;E8-_]H;Y$
M)78=QPX.U58UI2LWNM-;6>ENC7E?7Y[:WBJM+*.NR?NK>R\VK+JKW;OOM^"_
MQQ^*G[*>M_&WXA:O>:%\=M>UZ^UN\CBDM=Z6(E$TH:)%:T#"U3RV-L#,0XR<
M=:^W/^"<4/P&\:?M#Z5_PCOP3^,$.H:)I\=]/J/B,A=%GFMS;744K*5B?=*C
M 1XG^\-VT9+5S\__  4+_;.UZ_GETS_@G[\-M,M)]1=A->6%A!?RI$9+1#$+
MK7X6C+L1)+YJ%L@'(5@!^D?["/[0O[8_Q"@^(_B+Q_\  OP;\/M-\/>']2FT
M9]&&F$27FEV,MQ'#>O;ZC=JZ[K0H\?VF+:C$D8&6J-KI)];VC%NZ=O72WK;M
MHB)+W7:,5LM7:UTEOT>O=:Z]3\POVN/%6E^*OC]XYATK]C+X@>.;ZRU>[M)-
M=F@N(HKQ@]Q%:>0\=PW$+8RA8N$P649%>D?L9+XR\6?'CP+IL?[#=[X&\/07
M%NEQXQU^W>5[.&*VN#$MLD-R(G (!"2PX! RO%=+XQ_:A_X*.ZEXG\4PW&J?
M!GP=H-KJ5P]C')>>&K>\CMIKA\R3K<:EYIN2FW"GS K9YKZ^_82^)/[7OQ)^
M,=O_ ,+'^-/@35="T^QE;^S-%FL9FMYDM+Z-+HK#OD=GV%Q(R(H"G"UCHY/W
MG\5E9+6Z5U9M_+KOL82OKHE;K=Z>FB?D[=_)G#_M]:+^V7XB^.&OZ+\'_P!F
M+0/&/A][=[>R\4ZLWGS2#[=]LC02B>W>U!@EBA&P.JK*0Q"_,/#_ (,_ [_@
MIYJWCSPO;:]^SU\)O"GAZ34H)-2EDCN9GTK3X'C5X8Y(KQVFFE4;W.67=M",
M06V]Q^T7\4?V@E^,_BYT_;I\%>"?!XU6>WAT:*\#W%BQTZ.=@Z+9W(C/F%,L
M#E2%5<(SX[+]D2U^)WQ!^-'AF"+_ (*$1_$&[TVY2?4?"FE/<SG4+6)HI) '
MDT!(@K"01-Y9D)(R"!R>NC:2O9N[7:^_EI?3OV[$R;27DM+7Z<N_X6T[:7T7
MWS^W;\$/VY/B3I7PZT_]G>_^'NF3Z7I\5GXACU*SNV:V41Q"9K5W:9!)&XD,
M($9.W&.^/I;]A+X'_&[X.> +FW^//C&U\2^+-2<#%O''#!;QI/*PC55CMY&*
MJRA&=2[#DDY-?=%M#Y5K:V5RQG?R%229B0TTD:A6=P%B;=(1N)"KEB0%ZXN!
M77RPJQA$55"D-N4  $*<L,8&!].2>M;-K6RLW]W9V5NOGLOE;)-N*716Z:J_
M*UUMHNMEZ-:'YX_%?_@G?\*_BG\6-9^,.I7FJQ^)-3\)R^&V2VE@B$<<@G5X
MUD>)I8XMLFU0KKZ/E,UY9H__  3V^ 7P*_9 ^(/P&\3^+-4T[P;XHM]2O_$G
MBO4+C3HIXI9+.53!!--$RI$BN\.QL/)MR"4'/ZP3H3&RQD(TA4%R,A?F!)QD
M<D9 .1\Q!.>A_-[_ (*9_ +QI^T3^SOJ_@?P7-J$4]S<LM[;:;.+:2ZAG5K>
M65Y/-B(VK*7 SG*]",9SEU:C=V_/39?/;6RL5'=+LUJ[=+:KT^ZY\[7/['7[
M"6E>,?V?-+N_'FGMKOPT@N=5\ :1/>*SZM%'JUM?V]TX1P)$CO!G<K*O[Q^P
MQ7O7P#\"_L7^!M4^/7Q ^$^MZ5>:E<ZE<R_$_6K%VEFLKO39-5F5+G#21A(5
M2^='DB5 L2H23M+?$^C_ +#>J0_'SX)IK?A'Q)=6W@[P%>:=%XL,ZO#;7 DL
MIH;:4BX+>8LC3J9&C<'J#@$CTSX#?L!>+?@YX5_:]T#1(KTW'Q6_M6+0VNKM
M)(K^YU&U\0P?*Y96V^;J:/*9!R?E5U15)SDG*"4:<5))[[IV5O7T_P"'*LNL
M[WLUMM=)O[M7\MMCYA_;=\&_"K]H7X3:CKOPRU#3_&^C//K-JK[D6'3Y[!Q+
M)'"?LJ#&<,X)53DY/<>9?\$%_!%Y\-O'?Q+T:)+A],O=)CE\Z1%53J$>H70G
M(;8NY50(BA"V-OS$<8^E_A?^P9^T;X!_9L\.?#C3[73;#7K[QKK=]XE2 VQ:
M/1=5N8(4=96E(^6-6=B-Y'/#=*]R_9)^"?B3]F7X]Z_X>UJ&3^P]:MU^P7\D
M6+43O.RR);F%6W>=(YD^;HO!VX!/QT\OJQQ=&M&G*"52,I..D5JKZ:-K^K]#
M2ZM92VMUZ75_+R\_,_9B%-T<;,?G7RGSQD[4Y!&<X^<YZ9R,FOYG_P#@XY^,
MW_"$?L_Z;X$TZ&YM[_Q3'-$UW; (WD1W2-*KOP?+)[CIDDD=*_I>BE38J$E"
MRJ%!&&88Y;:"6XVY)( P5.>U?S#_ /!R1X(FUCX3>"=>MXB1;/-:O,%1HXOM
M,Z+APR;E9L9!R ,C QS7T..DU@HR>RE33?7=7^]_-]=!T+*JNUFU^G]?)G\
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M[;?FM/Z^:OU--KA<H2VXPG*;1P&QP ?]E=J@]!MSTZ:.FW3M,3!,S-E1.K$
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M$"=6X<$\=\9XJHM>GXZW6NJT6EWKZ6.>\XM-)N^_SM9:Z-M+_@K4JV=G+>7
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MJZ?^QYK-U)JFO_$?XC:E'-.KVNG6TVJV]K (,PG=!'#<.SJ<[0L21G'RQ*I
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M+76]5\6Z/IMM>232:4]J))TBCCDD$HWO)Y=M$YWGY06?<>NXBOB?XN?LGO\
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M?_ 9Y[3<W+:[;L[OR;_!+?5.[U/CNZ_81N=1M)=1TOQ%:SRW#AVAG*JT:R!
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M$2Q2/+)'&DDC[@8_DP",U:D_>?+':33LEIHNNW3]4<TH;)MOWE=/7;?\%O\
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M4-?\9ZI+XQ@CM/"^B>(9_,G^62>UC/DZ]%(\*.([:4PQ^6(O,617&[/Z:_\
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M"?U%^/MY\!?AM^S1JFG_ !BO;6S^"^G^&K'1+U);AU271C UO$(IE5[B%7M
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MI\6;CQ#\!38W":MX]?7KR2[>UD-L9Q+J:W<4Y2,H,,D@)!R?NU^ MQ\)/^"
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MZS(22[DE,L/D M/\P#;RJL!&7VG%?FG>?\$]_P#@H;+<W%SXG^/7A[21#)/
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MOS+U! K"<)-I^SHII6U3\MGWUU[7UVTZHU)3C=S:MI:+T>W>^S[;]==3]/\
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MM9NUM5ULMKZ'-.<E/D<:2;:3=G%KF<5=-Z:=_5V/V!^)&J? +XCVJZ?^T?\
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M]#\+:?%=74L]S=?:62>UFMXQ$8BBR%Y25,AVA0< 8 ['%>*_ *R>[^(FFM&
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M%OP\^.GA_P"'6@:%JDWB1?"M[IQL;&:WFABTDK]N$$J21$2 OM:%()<*=Y8
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M^[7IK\[_ +8+H-WI_P"R3X*O+."&:RTV"WDM$B>3SK43&[N\,Z$QOAH)<AI
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MA+PE-HNH:;>ZQIKSKJ%JM["EIYEF]GON(I@US$8W52VX@,%4C/\ GK7W@O\
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M:/;R2U>K_$YZL5[BYK62CIUVU?3^O,_-+X4ZY<_!;]B#X"FZL(]6O_C?\9;
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M_LI_&;]D6X\$Z1+\'/V1?$&BZ0MO!%9R:KH,L$CA(602>=>64<3A7(9G;<H
M)<%0QK];/A_XGM;SP)J>LP?#V;P_%;P7LKZ#'9B*74HH[=V2W4)"L),@^0,$
MQ@@C R3^(OA/_@O)^R=/):^'? 7P!\=[(XEDL["P\*:G;;%:%I<Q0KII5%4C
MF-LH1G=D5^NGP2_:OMOB[\$]4^+UG\._$?AZ+38+R9_#5Y87"ZM>R11$B&WM
MGM8YGD9 A4HJABV"AR,M-=T]GLDNCW\[6_X&I+3ZII72UDWIITVV>FNG3HSY
MD^!?Q[UOQ3\1/B)I?@3]CV^^'DVFW<Z7'BC59M.CMM9>.6V#.\*V:2_O5#L@
M,A)#G#8R*^G_  5\3/C?KWCF30=0^%MII/AA&:,ZS#+;QR6A%T&80JI,A#IG
M<Q=0W!"#%?G;J'_!5WXNZ9K^IV6F?L9?%'4;$:D;.*_L].U,-*@>-4N;B!=(
M**F(COYRBMR6^7'TM\-_VQOVB/'WBWPMILW[.NMZ/X8UEHGUC4KR.YMGTR.X
MF"H2\EK ^8_,"G<N 5/'8":6FZO9:>BO9)Z^>]KCMOIT[Z]&[.Z=M=+JV_1&
M)^W-\5?VP/!/C[P9HW[.G[/'ACXL:=?V\W]K>)=?BL;F;2BD8D>6V^VN#&UJ
MN5((+EL&+< &KR#4?&?_  5.U?0MOA[X3?#C2]5:V#0Q7%O8O#:$P.NT!;X*
M<%N,/G/TP?H3]MWX_?ME?">YT:/]F[X)6'Q&M9HE6]O;S[/+<VCS6:O($$JP
MP$*Y*MD$L 0>N*_/+5/VKO\ @M;K^DRW7A[]G?P=I8"M]ECGLM.EO)%DB8A9
M%NKQ2,$#DE?Q.,/FMIRW:2V=NVNBUZ+S[M/46O*[1[J^N[3>M[)K5/\ '4_6
M+X>V_P"UW<?LT>)K;QROAO3_ (^O931Z!+IL47]CPZ@XMC TL8N& 5 &#9D4
M8R0>*_$!OV=/^"]GB=]4.J?%WPKX7C:798#2UMT#6L90!9G@N7012H"S?,64
M\<<U^T_[/7BW]LGQ%^S=K&L?&WPQH'AGXUFUNH],TZS6VM[6.\>&-;22<+,\
M07?AG;S67("@=&7\0?BQ:_\ !9#0_#/Q#\;^*_B?X4\+6F@:9=WUM8:=J^B6
M;36YO?*M!%#%?RRJSQNI9G9'9E) &1N?-K?E;6CT;TT5T_NOVVZ,<6UT5U9?
M/2UO^#MTZL^D/V5OV.?^"J/@[X\>&_&GQL_:"TS6/!=C.AU/1(_-F6[52INE
MBB,X!64!X@Z9P,$=@/</C;_P3#UWXC_\% _#7[6FG>+M(L-'L_#XT^_\,B*0
M74M[_9T]H)O*^T!=I>4$2*-ZA2<9-?GG\'_V>O\ @N3%\0O /Q2\0?%JVUSP
M-G2/$.H>$7\1VICU[2)Y!>/8B[>Z(@$MBRKM02;682!@V53QS]J;]OC]HV?]
MO+]FFQL=7U_X7:-XI\3:]X/\7?#O3=>DU+39M5T"[BM6N9+RUPK&0D3%6CS&
M-V&?<Q6'*-DN2VNGK9*]].^UKV>[*U<KJR=K75[+R^Y=[:+1ZGZV_LW_ /!+
MX?!KXD_M9>([[XB:5J^F?'V#4[3[';2EKG1!?7EY,QO5%PS)$%W%%=5:-4.\
M\\?+O@__ ((L_#70OV6_C'\$-?\ CKH$^D^,-<FUN[UFVO+46^CVJ6M@L*N6
MN2(I(9(8<NY4 L0W!Y^0/V*OVB/CQJ__  5'_;(^%GB/QOXAU#P=<^"-?N])
MTO6+J^N-/T^ZANKN>.33X)G:**7R$EBC:(!I-V%PN6'PO^S_ /%/XK^*O@M_
MP4R\':CXX\:7&I>&+C7T\,6EYJ&JB>R^S1>'[69;4NI6VMT\J>9P63 W$%F8
M+7*Y0TO#^;J^EOS5_*VY24M;3WY7HKO9;_=KWOK9(_?7X_\ _!./]G'Q?^R?
M\!_A]XJ^,VE6?AOX/WMC=Z3XXEU*S"W;V/\ ;4Z;;P730.TK7UR@9#@E H.]
M& \]\4?L)?L>Z%^TQ\%?B5<?&/28/'.CZ586N@Z:^H10MXD33WT<6ILTDFB^
MU,\<2L1 7RS XZ"OQR^('BOQ=XV_X(6^'_$>H:MX@O->\&>,/LMQ/'>W.YK%
M#XH.&O59C+"#<P%5/F.)%.5 VEOEOX]^,/$!\2?\$[?B7#K&I,OV/3+.XENK
MF]BEFNVOO#X(<SB)2T/V=X?.2<C:Q.T<D.G)7?N+X8O>3_E7??TO>VKNA.+=
MES-6NM-TK7ZKT7;6VNQ^_P#\>?V:OV";#]L*S\?>,?&#:5\8=?LS;IH=W> -
M>P7=@/,>" 0QR1@QG"R%"I)SDXKS;X$?"?\ X)X^%?B/\??"?P[\0OJ/B36-
M.UN7XA:6TL2VZ6Z1W<MZ(((X6#@*I'F LP8C..:_-'_@KM<W>C_MB_LK^-(K
MBXN-1U_0_#@O7M)[FZ$;W%G$'&Z%)1)%G&]GG;YLKC)P/ OV;KFZ\&?\%,/'
MFEZB^[3?'?A.\D8I=R@AKS3[_<38Q[293D822W</_$X8 '9O7;K;RV3_ ,DK
M_P# (4&DFY/9?@TK[=;W\UI;J?>T%Q_P2]L_@S\6]"TS0=0U?P=I&MW<GB31
MWC3[9;7Z@YO8I19KB)I6>-2[8569NYSK?$_XO_\ !/JS_9-^'OQ1OOA\^N_"
M/PUK*:=X;L8UCDO])NI+TS0F0"W;$:+9SO,[ I(-H#@CC\7?!&GE/B5^V9\.
MI/.B=[?7+RTNY2D*2*9H'1#;2JJL@&0SI Y3/!%3^ ]*/CW_ ()<_&?1Y&S?
M^ /&]G<01(98A)!);>()2BE86W!6MB8UVHI4-T&-S4TE;EB[*5ODTOG?9=C:
M#2BDTI--7;;5U*SV7K;IMW/U^\;?ME?L0^ O''P \4+\(=(U#4_&-AIUIX7\
M1R"T=M%BOKK2H-+<7/E*%-M%-!:-%%F.$*?+<!5-=S^U/^VY\ O@S^TG\+]#
MUGX(Z'K6H^-M,L[^T\9&&T.VWU.*TNH46:2&9Y&"RQ*J+*K-(QSD%@W\U'Q1
MU)]0_9C_ &:?'<<3R7GA;Q/'872R-]CD1[?7[2=2SR")93Y>F^6R;VRTF_)*
M8K[:_P""F=V][X0_9"^+.F6\D['2? T%P9$A!MREEX>4(DBLT #*!(Q,PP".
M"_RG#E>KYVK6=DEL[/3T_P A7N[?XNFVJ_.U^KO9GZ=>'/\ @H]\.[+XY?$C
MX50_!GPSI\5QHKZL+B&QMK675VM3+*3>,8E>8ND<H*8 (",3\HSVO['W_!2
M_&+X4_&VPTCP#X6T#Q)\*K2ZDTKP]!91Q:?J+:=!<QS(86$<;MNEB)W.&SD9
M&0*_!GQ/K%QHW[7?PY\7JY6/QAX8$>H31F66W"2:=?3LEPZP^6RL;D@C#-A!
M@$+7K_\ P3VOQX)_;5^/OPKO(XQ8>+]&U][* H\<#L\\=L'MP+<AI\MN)*Y8
M[<CBJ2<97;;5^7IV5MDG\O+KH3*[2U>J6NUKVOKT6SO9Z[6/LGP=_P %;?C#
MXM^ _P 3M4T7PSX:MO%WPX\2".^TZ;3D\BULK7^U87D@MXKE5CE5BFSY=S!M
MP4A@6_>S]@O]I/5OVB/V;-(^+ABLKWQ@NAWY@LK6!X)!JMFDBR7,://,SJ9%
M2,*I4*%^\N#7\:7PK\,3Z)\5?VM?@]>(1%>+XHO[>UE$KI<R"6>W@=F,2;W0
MW89D&W;( HW84M^^_P#P;^>,]9O_ ((>*_ =Y<0VFK>&O$&L6ME)M=Q#;R7M
MQ;K:PK'%-M3%H&(DPAE=U8C)(3;;@NOO)][IQ7??^M!**5];[66VGN]]D^]U
MU>NI^:O[9OQ__P""KOBSXY^+D\*W.K>'_#FF:E)'IEI;>(M'T^V:-;N5(F<7
M%S$S[8XF+.KDH#C=N %?J1\+=;_;&^,O_!-?Q+H7B'Q/-HOQBT+28GM-0TKQ
M#:2W-Q#'9:4D*W6K6]S<101&20^9N>+&X@LP#;?S0_X*(?L ?ML>(OVC?%_B
MKPI\5X;/PUJZQWEE:7?C"U\/VUIF]N'>.."\OK0(Q28[E6,F7[O3@?9O_!+S
M]F#X_> /@Y\;?A/\4?BOI.N3^,= N;;1_L/B*S\2W>D.Z6D<,TD\=U.(8G\@
M(%4D*%?'3C%*2[OO[S[+KHM^S[K7=:Q;3:LG'=/3;HE;^F?A!J/PN_;ZGN9'
MU_XX6UB]O=RVTEM=_$;16MPCNZ2/*J:DBO)&P8 NX:0J#C&VO<?V1O _[47@
M+X]_#'Q9K'[2.D7MA9>(+&75](U#QK87%M=6#7X%Y9Q6C:L4GEG.55@QWG[N
M1@T[XC_\$F_&>A?$+Q+IOB/]JSP-IME=:Y<,5O/$.F/=0+]I4XFMO[6AFB:(
MS%2QMCRI&[(8#F=(_P"":WP_T'7!<ZC^V?X+%YHFH6EU&\&J0R%OLY^U"5"M
MV%5% "E</GG.>E+7:VJM;;39*[LOO3_#4F[NW9JSU]YOMT3?1[;+S/VY_P""
MG/[(7@?Q]8Z?\43\2G\*>)M>TVRFN7^U7)L'*V"F&2UGM6BCE^UD!R8#(5 S
M*JXS7X2Z3^QEX8U&SO)==_:5BGD$<Q\FS_M6X6WD6&4,"R7#$2Q,5P[XC8D!
M>H!_J7^(OP_^ /C3]C3POJ?Q)^)6B7GACP[X;M=+M?'UF8ITO6T^T>UO(Y[>
MUDO+=IX3'YFTR,[ >6/E7=7X5^'_  3_ ,$X_ ^H3WLG[3-UJMAJQF,=A;6U
MU;K&TD32)*P>:-(T#L3Y2[F"H$"?,62[)SC=)W?6Z=K+TZ[WUMZ:/N]>EM+V
MV;T=M_*]K.VNA]P?\$J?!OPXA\!_&?\ 9TU7]I5O%CZ_I2"RT81ZE<W=HHN+
M!IFC@$TDFXH)8VV1LJC!=EP,_D]^T-^S%^QUX2L?%NG:C\6O$,5UX9UV^N-8
MO-*L[Y+FSE5LFT>9[:56'ER(!'<6L77$;2*1(WW]^PWJ/_!-#X7?M2Z3XL^'
M/QW\4:EXZ\0WJ6FI:=>6E_#H,HN9HI7CB4@1S"X:W6%4-R%3>S,7!&/5/VX/
MAQ_P3P\"?$SQOX6\;0>,]8UCQO _BJ]M=(NKJTT6.WN8(K:2=VCMTMO.2YA9
MFB,L[2N6#,K+BE]5IN7.F^;5/5VU::MYZ+5=^MB>;IRZ65EO?KV[7OOJM^_\
MZ/A6U_8'\+>(+&YN/B5\0-;N],OK34+1_+N;2-6C+MM\QM/$8*$QY93&1@E0
MO0?O/^WF?V+_ (U?L>_!_P#:'\3VOC7Q/X<\-:-IOA>&+1;V%-86[M=+M;&'
MS[Z2QNXY8Y"KD22LG[LA5!EV*?R]U#QA_P $C_"4KV"_#GQ[K&K6=PX^?4[E
MDD#%F<,_]GN%56&T;2.,8P.:_:W]C3XX_L4?M#?LN_%/X;>&?A)=CPE\-M-?
M7Y?"^M^;JS:G<6]C<7*F.&[@D)!$.Z)TC3RW57 4@$3*E%-+FO?71W?NVZ]-
MWZ:@E?3M;33O'5J[^=DMM6C^9"T^+?["FEBY-I\"_&^J2+<R/:2:WK]E>NL2
M^7Y&[R]+AD1E()"O@ XQFOU!_P""8G[6?P"TCXW6_@7PA\"+_2+/QO#<:3J&
MI:E);W,$\=X\@"S8L@K@HR)Y:RHP51@#[Q\7\5_MO_L<^%-?U31_#'[#GA.1
M-+U#4+2YGU".S>YN+E)"B2'3Y;1I(HPP 8?:,'[P3G(A^'O_  5 \-^$_$ND
MZMX"_8T\!Z7J6GWRB&[T[0K.>[L09(P)XI(K83(P1^,$['3<#DD!)=$G96WM
M;=:;6UTZ[:[: K*VSN[66W39M]-.GDWU7,?\%!->\+?"']HKQKX4\+?LR>&K
MJVGN8]0BOG\.WESYRW9MI9! (W:/!/F%MI/SL3@$XKX\TOXW?$U[@-X<_9P\
M/Z9%<)'%:F/P7JKB)8H#%&4;Y=Y,I&,.#CE2#R/Z$_\ @I%^T%X[L_AG\'?B
M_P##KX+>'?$]UXVT.TGU[4-4\*1ZW-IUV\,#-81O-"LD+(\C1A& /RC;D5^*
M<O[6'[8>L.(]+^&ECX>A0%84TWP2UA'&3P"JPVB88$Y##?@] ::23Z735G>W
M:VET[[WT;OW&[[7:\M?[JWL]7KM=7_'Z;^)47Q#_ &D_V$+Z_P#'_AA= \4^
M M44:-:1Z;-ID5OI>GW,:O+;VEPK7",;.W),F]LXP@;/'YZG4W\9? SP%\08
M#,/$_P +]0@\/WL@7,S:;I9M7B9W;$T@=;HA%90$!8(&(?'Z4_L=_$3X^_$K
MQ3XD\)_&[3[F[\,>(_#U_9PV]Q;-9I'<20W#-<&TN"C0%"X!DV,<#(7-<G\(
M_P!AWQGX:3XN>$M?N;?_ (1G6;8WFBP/=1!5N7DD:%LG!+-'!"C';G!5C]W:
MW;33<X6UNFG?R3:>_?U[JY*T>NG3N^EM^J:[>BMJO]([]@;5UU_]A7]BS748
M.NM_LF?LY:NK@8#+J7P>\'7@8#C 83 XQQFOK.OD;_@G]X:N?!G[!O[$O@^]
ME$]YX4_9%_9M\-7<X&!-<Z%\&_!FESR@9; DEM7?&YL9ZGK7US3=[N^]]?4@
M****0!1110 5^-?[3G_!*KQ[\?\ ]H_X@?'KP[^UG+\,=,\>'PJ9_ "_!@^+
M([,>&_ OAKP7*DWB+_A;/AH7\6I_\(^VI/%_8-HD OC9,+G[.;NX**B=.%1*
M,US).Z5VM4FNC71O38J,G%WB[.UMD]/F<)H?_!%/2=+T/5[)OCY9:3XAU:*X
MAF\6^ ?@PG@S5)8[@+N6\6;XH>(OM*L5)F6&>S60,P00\$>;^!/^"#*_#NTU
MJ30/VKKI_$>L2RRMXBU/X*1WTT$DK.S3"V?XLJTEP"P/G"[B!903'M)6BBLO
MJM#_ )]_^33_ /DO(KVM3^;\%_D5-#_X(#Z5)K5_KGQ%_:>;Q[<7<ES<Q6\7
MP4/AVS^VS1.L5W?PGXNZV+]X)F6X58S9!G5@"F_*X^K?\$"/$7B3Q)97WB+]
MM.6]\(Z;-!]A\%6/[/S:;:0V=OL\JR:_/QPO Z#8,D:>B%B6\D,2244?5:'_
M #[_ /)I_P#R0>UG_-MIM'_+R%\:?\&_?_"2W8@T/]KB7PEX766:<>%[+X%F
MYMC+*WF>9)<Q?&;3A(XD"LS?95W@;?E!S65H7_!O]XVT 216G[=#R632R2II
MLW[.3-8 2 @QR0?\+ZS(F#@@/&2.,BBBK5&DDDHZ*R2YI=+6Z^0G4F]W>W=1
MZ?(NZA_P;R^%]?M4_P"$D_:0T^_U2,'9J.G_  %32H]YR/,>S;XPWQ=\$@DW
M0)SDY/)\9O?^#9*TE$_]G?MJWFFF82;2G[/AE$3.SLK($^.EO@Q@J%/#?+G<
M < HH]C3_E_&71W[]QJK43NI:^B_R_X<Z'3_ /@W%\3:9';6MM^WC='3X?+\
MVTF_9P\PW(3!(EG/Q[#D,03@JV,\EL<]UJO_  ;PZ+K\%M;:Y^T_87L5NQ;=
M#^S]':S2$]-\O_"Y9\X//*D$]A111[&G_+][D^W=^2^>H_;5?YOPC?IUMY(\
MYUK_ (-H]-N6+>'/VPQX9:6,Q7,D7[/)OI9TWAE!D7XY6(7:HV\H_.& !  U
M](_X-PKKP]X9/A[0_P!M:>QEN(WBU+4W_9Y6YFO4=F)"Q/\ '%6MR%9E!6XD
M()W*5:BBJ5."V5OF_+S\EKY#^L5?Y_/X8_\ R(1_\&WMO;Z4NE6W[7]K"'4K
M=W__  SHTFHW09@6S<M\=<J" HPRR\C/? Q=,_X-HK+09-1NM#_;,FM-1OU8
M&_NOV>Q>R1&5R\S!5^.-J&WY*IAD*+@;FQFBBCV</Y?Q?^>GJ+VU3^9?^ Q_
M^1_K7NR?2_\ @VLCL=034[S]LW^T[LAOM,MQ^SL0UR7C:-LF3XZSA$((/E@-
MTQN.<B?6_P#@VQM_$UW%+XA_;%CU*TC1(_LG_#.Q@;9&X8+%.GQU98E*C80(
M&..01SDHH]G#7W=]7J]?Q%[6I_-^$?\ (E\0?\&W<\MII^G>!/VV]3\!:=90
M&![.V^ DFJ0W)$IE61@OQRTL(PW2*V1)NWALC;@]SI?_  ;^^)K+PK'X:U+]
MM.T\1NHV2:AKG[-:7AFA!DQ ;<_'8,L>'"G_ $IB0N">F"BA0BNGEN_\P]K4
M_F_"/^11N?\ @V_^%6IVUO\ VK\<]-74X!=-]OT'X(G1H7GN+9($F:QF^+FJ
M*/*=7FV"?YS(5W*0'/C#_P#!L5JLNII)+^WI<MH,%Z]U::"O[-.W[/'+N62W
M6_/[0+91X]D9;[(HPF=GS8!12=*#^S^+_P _(/:U/YOPC_D:&M_\&R$>KR?9
MXOVUH[#1 0RZ1#^S6& <.'9OM:_'N$_/C#8MU)YYP2*Q+O\ X-?]0.GIINE?
MMY2Z5 9O-G*_LS&Y,JDG?",_M"0E(W7:I7+K\N=O/!11[*G_ "_B_P#,/:U/
MYOPC_D;VC?\ !LQ<Z'9-96?[;\9$I+3R3?LSK(\K,-K'YOC[E!@D*J,-HQR<
M9JL?^#8339+B.:;]L[>J.)6C7]G-D#3 ,#(&_P"%],5!)4A"& V@$G/!10J4
M%M'\7_F'MJG\WX+_ ")H_P#@V3>&_GNH/VW2D$W'V63]FP3;%^48$K?'L _(
M&7/DC[VX8(Y->_X-DY=9BT^T@_;>.G:?9W FFLX_V;#*MVH??Y;2#X^P&($D
M@L%<8Z****T)YI::[;'27/\ P;9BY\.IX2;]LBS/A\W$%W-9R?LVM)+)/$K*
MY2?_ (7VJQ)("/E,$A4AMS2 J$YGQ+_P:^^%=4M-.L_#W[8>I^%8[&VEA<6O
MP*-TES+-'L:=E3XU6#KM<M)%&\DWE;@J.-H-%%)I/=)VVNKV%=Z:[._S[OO\
MSJO"O_!N5XT\#:#/I?A']O\ U+1-1N!;A]6M_P!G(NI^R^6L9-E)\?22SQK(
MD[K=J\XE)D8E>?0)/^" /B/4='MM&\2_MA^&O$L1DGDU:ZU+]EE3=ZL;D,)
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MCG<F]W^"'Z1_P:M-IOV7SOV\/MHM595#?LO^3E65T(7_ (R'EV<.>1FC4O\
M@U:-]'(D?[=PMWD.3(W[,!N#QOP"'_:(0'!*'C'W.GS9!12W_3R].WR+56<5
MRJ5E>]K+>UNJOL3:Q_P:O_VEI\-E;?MV#3Y(C\T\?[, F612S,Z^0?VA8PN_
M<,_O&&1D@]*\DUS_ (-"8=5UB'6+/_@H1<:7,B*DJ+^RNTZW 5%7YRG[2=H
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M2DF6=/\ @N_\9XI%A6$%?V;M>/W510Y_XRW!,FV-1N)S\H/49HHHY8]OQ?\
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M;35Q?A_,-T+N#]J^.7SS)\_F;RP.2.3FBBERKSTVU>GXCN]-7IMJ]#Z U_\
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M\Q!)'%8^K_\ !I5\8->T_P ,:7JW_!6OQ1J-CX,</X8@O?V3[RX71R)8YO\
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M!7DXS@C]JOC@8&.G-%%')'M^+_S#?O\ >_+_ "7Y&OI/_!F7K.A:G:ZOI/\
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H?0FU;7FT6;Q+<:/)K,NDMKFLG3GO6LSJVHF'[9-[/113 **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>nt10006151x14_graphic6.jpg
<TEXT>
begin 644 nt10006151x14_graphic6.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)O@/P]X'A@\4^![VWU3P_9^(WU&/2OWT^GV,=[[#ILO[*GCW]L6T_9V^._\
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M>B8E4CLT_P -=O+R>W_ /Y,=;_9MUSPO_P $ZO\ @D1\3=/_ &I?VQQ\7O\
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MVB^-;GP#J4?PVO$\=&)?$EIKME<W4_A+QE)X5UV#P\]CK5Q:P+>+:1^;3?\
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M\;?#35]2TGQ?K.L^'O%>D7NLQV>FIK6BVFG>)9=+UR71+ZZM["*:[_3+]/\
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MLZ^#/ G_  2>^.GAO]B#_@DW^R_K?C/X1W?BK]A/]JKX9_''XQ:MIVL>-?\
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M?^'.E7U[I$DOAGX>?$'Q)KEG>SZ3?)X,7PKH^MZ#;:;)HOF,K[>:O^7GY_\
M!%R>?;IW^?W]OOM_8QK?PA^&7B3XD>!OC!K_ ('\.:O\3_AGIGBG1_A]XYO]
M-@G\2>#]+\;VMG9>+K'0=29?/L;;Q#:6%E;:I'$0+F*W1'X)!]&K^!2;XO\
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M^XN/#_C);*S&J:0UH&M;>2!XE8376_I\[>?E?:^]S]*J***#(**** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ[U2\WC3K!=!D+I?C^&_]?YB]G+NNR\WIV^=F][']8M%?A+X0_X*+?M&1_\
M!6KQ'^Q_\:'^"_P+^!6H7DVC_ GP[\1/ WQ6TWXF_M%Z2_P]M_$&F^.?@_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.TU;3YK6^MM5TG6M#O9H+N.PUG1-8L;+5--NFMIHX[FV1989H'FAD\A^'/\
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MO2=:BT^^L+I[/5+.UOOL5W:3B,P31.W]"5 3UY7Y?Y;A11109A1110 4444
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M]XJOH/#/ABPC5"+2SN]5L;>*&)8+"UVI'%7]&O[-O_!G!^T/XNL-/UC]J?\
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M\)/9V\+>.?A;K6M3N++1_B?Y(@LK?PQ:PK+(/B7LL=!A@MI!KZ:)<O:QW?\
M>)_P2W_9.^+W[%'[%WPC_9^^-WQLUSX[>/\ PEIK/J?B+591=:;X5@O%A>W^
M'?A"^NH8M9U#PAX/5#8:+>ZW-<7\Z>;Y,>G:8-/TC3W'FU36W7OMHOS_ #U$
MXIJ[T?JE?UNM&]?Z5W^AU%%%49A1110 4444 %%%% !1110 4444 %%%% !1
M110 445\3_\ !0G]MSX<?\$^/V4OB;^T[\1VCO+7P?I9L_"/A<726M[XZ\?:
MLLEMX3\'Z<[*[K-JFH#S;Z>**9]/TBTU+4F@DCLW0@TFW9?U_5B3]MC_ (*#
M_LH?\$^OAQ_PLK]I[XJ:5X)LKP74?ACPI:H^L_$#QS?6L>^33O!W@^R+:GJT
MJLT45S?R+::'IDD]LVL:MI\,R2-_(O\ M!_\'FMXFJWVF_LL_L<6<NBP3RII
M_B[X[>.[A=0U*W!Q%/<> _ EHL&EN0-SP+\0-3'.!*"*_D2_:G_:E_:-_P""
MB7[2>O?&'XLZIKGQ#^*?Q(UZVTOPWX8T>UO+ZWT:TN;I;/PYX$\">'K59FM=
M.L1+!8:;IME"T]Y<,]W<_:+^ZGN'_IE_8B_X-"_CG\7O!.A_$#]L3XVP?LZ'
M7[*WU*U^%7@_PW;>./B-IUG<IOBB\5ZE?:KIOAKPWJ9C:.273;4>([FS8M;W
MRVUVDUO%GS2E\*LN_P#6GRU9=DM%RM)_$^KLOPU?YZ,_(K_@IW_P7:_:^_X*
MD>"_!'PR^*>E> ?A9\-/!^K7/B*\\#_">/Q1I^D^,O$3((=-U7Q?+XC\2:]<
M:F?#]N;A-$LD>VLK6>]O+QH)KJ2&2#[$_P""!O\ P0;NO^"C>K2_M&_M''6?
M#?[(W@S79M*M=)TJXGTKQ+\;?%6F/&]_X?TG4E59-%\&:2TD</B;Q#:,=0NY
MF_L30GM;QKW5M(_8KQC_ ,&8/P@F2S?X??MO?$G3)H[B)KZ'QE\*?"^NP7-L
M)%\Z.VN-#\3>&Y;*8Q!S'));WR;V0,B@%J_KY_9K_9\^'?[*WP)^%W[/OPJT
MJ/2/ OPJ\(:5X3T2!8XXY[M;&$&^U;4#$%2;5=:U%[K5M4N,9N+^\GE)^88:
MBV[R^2_X;I^>H72U;3?1+5+1=/PWWU5[%GX%?LY_ K]F7P%I/PQ^ /PH\#_"
M7P-HUO%!:>'_  3H5GH]O,T42Q&]U.YA3[?K>JSJH:\UG6;J_P!6OI<SWEY/
M,S.?8IK6VN(I8)X(IX9D:.:&9%DBEC<;7CDC<,CHZDJZ,I5E)5@02*GHJR.9
M]W]Y_,S_ ,%@O^#=']G#]M?P1XN^+'[,/@OPG\!?VL=.M+O6]/N/#%E!X=^'
MGQ=NX(?.D\/>-_#VG1Q:5I.LZHT6VP\::19VEU'J$S2>(8M6MYC-9_YS7PH^
M*'[0'[ _[4.B>/?!UUKOPN^.W[/GQ#N+:^T^[CFLKO3]=\.:C+IGB3PIXDTY
MRIN]*U*.WOM$U[2KE7@OM/N+F)E"R*R_[93*&4J<X/IP:_S6_P#@[B_9.\._
M!;]N7X;?M">#](@T?3_VHOAQ<:GXM2SA6"VO?B9\.[^WT'7M8*1(L*W>K>'-
M1\(W%^X/F7=^EW?3%YYY998DOM+1JS_%6^:_KRI.Z\T^F]M$V[Z??V[']]7[
M!_[6W@W]N3]DSX)_M0>"HQ9:?\4O"-KJ6JZ(9?-E\-^+-/DETCQ=X<E<DNQT
M;Q%8:C9PRR!&N;6.WN]BK<**^NZ_S3?^" __  7Z^&?_  3?^&OB/]E_]IWP
MAX]U[X0^(OB+-XX\(^/_  4;37+OX<W.N:?8V'B*PU+PC>2V=WJ6@WESIUMJ
MXGT2_>_L[E[_ ,K1[Y[O?'_H6_LT?M5?L^?M@?#+3?B]^S?\5O"?Q9\!:FY@
M&K^&;\37.EWZHKS:-XCT>=(-8\-ZY:AA]JT?7+"PU"%2DKV_DR1R/2::W5^J
M_/3>VNX25_>6JW?=7U/H6BBBF0%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% '\9/_  =L?\%&?BK\"/!'PA_8B^#/B36/!$_QZ\-:
M_P#$#XU>)M$GGTW5]2^&UCJ8\,^'? .G:M;3I/;:7XIUBW\277C**W6"XO-.
MT31])-R^E:MK=E=?YY[.S$LS$DG)/J<YYQ[@?D/05_7A_P 'D,Y?]O?]F^WS
MD0_LG:7(!Z&?XM?$X'\Q"/RK^0VL9_$_1?BK_J4V]+-Z)=>Z3"BONO\ X)J_
ML9WG[?W[:WP)_94AU74_#^D_$SQ+>+XO\2Z/!;7&I^&?!'AS1=1\2^+=<L8;
MQ);22^M-&TJY33H[J-[>74)K:&8;'S7UC_P6Y_X)7Z7_ ,$IOVG/!?PC\&^,
M_%GQ&^&WQ&^%NF?$#PEXO\86&F6.M2:A%K6K:!XIT*Y&C6]MI<KZ3=V%C=QF
M&-)8[/6+(72 LDLBL[7MIM?[O\T"4FKI]NK\E^#LGV:L?C'2@D=#_G_)/YGU
MK^A7Q!_P21_9&TO_ ((LZ-_P4<LOVT-.NOV@KVRT[4)O@H=0\&-H5SKM[XYC
M\+WGPIL]+%TGC6/QQHNBROXBO;AUFB>*QNY1I<>CR0ZJO\]-#5K>:N$DXVN[
MW[-]+?\  ^[R/[[?^#1__@HO\6?BC)\6OV"?BQXHU?QIH?PT\!6OQ7^!VK:[
M=W.I:CX4\,6.OZ3X7\7?#];^Z::YE\/P7/B'0-7\,6#RK%HRIKMK;,+2:SMK
M;^WNO\T#_@T'NF@_X*;>/H <"\_98^(<3#!^81>-/AQ<#V&&B!YK_2_K6/PK
M^NH2=[7M>VKM:^K73R044451(4444 ?S=_\ !5CQ5:^ O^"L'_!*CQ[J'[.7
MBS]J*Q\%?"_]LOQ#=_#/X?>'M"\8_$""&#2/AK9#QKX*\'^(M0TK3_%'B#P9
M)>QZS%I,5[#JALH+V\T=GU2SM%/Q%>?L5_'/X_\ C76/CT_[%_COX4_L_P#[
M2'_!9;]@+XO67[+OC7P;I4'B'P[\$/@QIGBKPQ\;?CI\7OACI+:EHO@K2?BA
M=ZQ;:CXPTF_EN@]CIQN]7^UVE];W^H?T_>/_ -E'P#\1?VI_@!^UGK6J^)[;
MQ_\ LZ>#?B]X(\&:187>GQ^%]2TSXSV&@:?XDN-?M)=.GU&XO+"+P_:OI$EG
MJ5C#"\UP;N*Z7RU3F/V;OVN=)_:)^-7[9/P;L/ ^H>%[O]C_ .,'AGX1:MKM
MWK=OJ=OXXN_$GP[\/_$)-<L+&&QM)=#@M(]<32S93W6I2326K7@N8UF6WA7]
M+[EO^/EUW-E)):7>BYK6\M._1='KY'XU_%KP'XA_8P_X*&_MH?&_QU_P3=^)
MW[;WP:_:V^%_P<T?X$Z[\ _A?X"^*ES\+9_A[X$;PEX]^ _C/P?XAO-%B^'7
MA+X@^*IV\:7GB33+>]TG6'O1=:CIVLZM'JS6/Q-?_P#!(_\ ;W^'?[&/[('B
M7X F+X0?M6>*5^-7[)W[0?@;2]3AU_3/A;^Q+^VE\4?$?B&+PI-K5E?R'4F_
M9;OM>L/$]C<:8VI76C:CK_B'4+&^O;/PK8>=_9GY4?\ =_5O\:\A^)7Q\^"W
MP;\3?"CP;\4/B-X9\$^*/CKXU/PZ^$>AZ]>O!?\ CWQK_9UQJQ\/Z%$(Y1)>
M&SMB?,G:WM6NY]/T_P \ZAJ>FVMT_P"OQ_S_ ,M@Y[Z)2?\ EHOT^>GJ?SA?
MM5?\$Q?B]+\6_C!\ OV3O NO>%?A?:_\$([G]DWX2^/)(UT?PCK7Q)T;]I+2
MO%0^%VJ^+0D&G6OBGXC^%M.U%O$5Q,T3O;^)-3UJ[:.-Y)1Y%XT\%?%?]J[X
MA?\ !*/PM\(/^"8/[0?[(^H?LK^+;GPE\6/BWXY^%7ASP-X?^$7]J_!#Q#X3
MAT+P'K/AO7-4UKQG\.].\560\27/CBZT_2]*M;BW\*N%_P"$@\3W=I;_ -9_
MCCQKX/\ AMX,\6?$7QYKVG>%_!'@;P]K/BSQ=XEU:9H-+T'PYX?L+C5-9UB_
MF <I::=I]O<74SHCNL<;>6K-A37^'?CWP/\ %GP'X-^)_P -_$6F^+_ 'Q!\
M,:+XQ\&>*=(EDETSQ!X8\1Z=;ZMHNKV3RI%-]GO]/NX+B-)XH;B,2>7/%%*K
MQJ6_KT!3MNGNGLDKZ?-Z;7UU/XN/V*?V&?C?X3\0?L%?LX_$S]G?_@IQ)\4/
MV6?VI_"OQ,\;ZO>:O^R7X _8;^'I\"^,]0\0ZI\:O ?QGM/V?/$/Q3^*.E>-
M;1[0ZA\*_P#A+;;Q-XSL]6UOPWJ/CB&2QTZ^N/Z"/^"NWP)\:_'?PY^P5IO@
MKX8ZA\3X_ O_  4K_9=^(/C^RT_P_'X@B\/?"K0U\<P^-_$FOP2PS1V_A.QB
MO=.CU^:X4V?ESVRW:LFW'ZXB- <A>1[D_P R:<5#<'^9';'8CL2/QH6B2[$\
MZYD[.R[N_3M?;]-.A_([\;/V%OCAXQT_]K#P4O[-_B_6? 7C[_@N_P#LH?%?
M3?#4'@YY/#_B/]F+0-.^'&D>-/&MCIL40M+CX::)I-OJ6GZM=PP_V98VEK>6
MTBQQVLR1^N?\%??@K\6=!_:4^#_Q/_8G_93_ &CIOVEO#/PS\*^#/A7\2/A9
M\.?A#\2?V1/'6ER?&5?%>K_!?]H[X>>+Y(X/AUIOAV_N)?B+I/Q5MHM'N[/5
M)XKBSEGO-(M-9T#^H0QH>-OOP2.P'8^P_GUS1Y28QMXY[GOC)Z\$X'/^)I))
M?AOUML/VB;N[[)6Z:?.]^^I^/7_!./X!>/?AI^UQ_P %5?B1\1/A*O@8?%W]
MI/X;^(_ /BK_ (1]+#3/&>A'X#^ H?&%]X,UJ6U@N]6\-_\ "=VVJ1WEP"J7
M.M6]Q->(=16<KX1<_L1_$#XF_MW?\%J_&MU\-%\-WWQY_9E_9U^%?[,7QV\6
M>'0ND1>)Y/@!XL\-^(KWP9XGDL+ZZM6\(>/+7PA<^(+O14:^TZ_TO39T1[F"
MV!_=[Q3XG\-^!/#'B3QKXMU>Q\.^%/".@ZQXH\3Z_J<WV?3=$\/>']/N-6UK
M5]0N&RL%CIFFVES>W<Q&(K>"60\(:YWX5_%'X<_&_P"'?@[XM_";Q7I/CKX<
M?$+0;'Q1X-\7:'++-I/B#0=23S+/4;,SQPS".0!E>&X@AN+:9'@N(89XWC4M
M^;?WW_#47/JY)/ET\[/3;73RUZ]3^-;]CG]C#XJ1>)/V$_A?XU_90_X*E7?C
MG]CNS\27/Q$TGXA>(?V//@[^R=X#N]$\"ZWX:\4Z1\(/B7X9^!%OXW^-_AOX
MX:B\FC6WAZ3XB:#J&I:?XEC\1>)?B+?7=A?^*J^8/C'\,_VAOA=_P3O_ &]_
MA5IG[.7[0_PX_8CL_#_[$5MX#^'_ .V7X%^&_A/XO>&_C>/VV?A1!JWP*\&_
M%CP@L6L_&GX$:3X<O=2.D>-_%]BQT0ZA8V.F0VBS7]UK?]TWQN^/GP4_9O\
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M"/PV^*7[3/B7_@E]\%_A=_P2[^+O[$?C;]AGXI^ _'_Q]_: \?\ @KP-\/O
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M!@^N3Z8]<=.I[]>M*45B&(R1C')['/3.*?Z6739?U87/[U];6ZZN_P!_DO\
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M/B5["W;7+/1+Z^M[2]O-)M=3-S#IMU>6MO=7%FD,MQ#'*[H.G "# X YY/\
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M\)V'BC11=>4NH:=)/NM]5T+5HHGDC@UCP_J\%[HNJ0)))&E]8S>5))$T;M]
MU_&'_P &<7[27B+QE^S[^U+^S%KM[/>:7\%/'?@GXA^!5N)'E%CH_P 6;'Q'
M9>)-)MI"66"QL=;\#6^J+; )']L\17DT2R-),T?]GE6M4GW2(DM;K9I/TNE_
M7;ML%%%%,D**** /R!_X*S_\%AO@]_P25\+?"#6_B;\-O'?Q4UKXT^(O$>E>
M&?#O@JXTG2ULM)\'0:+<>*-:U76=9<VL4EJOB/1XM-TN&"6?4YIYM\UA!:R7
M#>Y?#G_@J3^QI\2OA]X&^(FD^//&&G:7X\\(>&_&6G:?J?P<^,+:E8V/B;1[
M/6K6SU!])\#:II3WUK!>I!=MIFIZEIS3QR-97]Y;&*YEYS_@J;\ O@K\=O@'
M\/\ 3_C)\,/!7Q+L]$_:@_93CT:+QAH%AK+:5%XQ_:0^%?@[Q5#ITUU"\]G!
MXA\*ZQJ>@:Q#!+''J&F7DEM=+*JQ[/T:TC0]&\/Z3I>@Z%I=AHNAZ)IUEI&C
M:/I5K#I^EZ3I6FVT5GIVF:;86B16MC86%G##:V=I;116]M;Q1PPQI&BJ#J^V
MEOU_K_AWI[EE=-][::JWY^GXW/CK_AXG^R)_T4CQ%_X9KXX?_.WH_P"'B?[(
MG_12/$7_ (9KXX?_ #MZ^UO*C_N_JW^-'E1_W?U;_&@5Z?\ +/[U_E_5WY6^
M*?\ AXG^R)_T4CQ%_P"&:^.'_P [>C_AXG^R)_T4CQ%_X9KXX?\ SMZ^UO*C
M_N_JW^-'E1_W?U;_ !H"]/\ EG]Z_P OZN_*WQ3_ ,/$_P!D3_HI'B+_ ,,U
M\</_ )V]'_#Q/]D3_HI'B+_PS7QP_P#G;U]K>5'_ '?U;_&CRH_[OZM_C0%Z
M?\L_O7^7]7?E;XI_X>)_LB?]%(\1?^&:^.'_ ,[>C_AXG^R)_P!%(\1?^&:^
M.'_SMZ^UO*C_ +OZM_C1Y4?]W]6_QH"]/^6?WK_+^KORM\4_\/$_V1/^BD>(
MO_#-?'#_ .=O1_P\3_9$_P"BD>(O_#-?'#_YV]?:WE1_W?U;_&CRH_[OZM_C
M0%Z?\L_O7^7]7?E;\B;#_@KW\$=#_:'\.? _XCVU[9Z!\8/%\?A;X ?%/PAX
M5^*-_I/B+5KQ0;+P=\1?"7B;X?\ AGQ7X,\5M)^[@U;0+7QMX%NK=EN]6\1^
M%75K-OUY4Y52>I )_$5X=X:_9P^$'ACXJ>*?C?;^%SK7Q;\6-)#=>/\ Q;JF
MJ>+?$6A:(ZJJ^$O!%WXAN]07P%X-3;YC>&/!T>B:3=W+/>W]M=WS&YKW+ITH
M%)Q=N56[^ME^MPHHHH)/\WO_ (/'/^4@_P"SV/\ JT7P\?Q/Q<^+(_D!^5?R
M-U_7+_P>. _\/!OV>S@X_P"&1?#PS@XR/BY\6<C/3C(S]17\C0Y/_P!?'ZUE
M4^)^D?\ TE#>K2[J/Y(_L@_X-$/@=I&G?%+]L7]N7QI'%;^%?V?/@ZO@?2M2
MN8CY=MJ7BX7?C3QCJ5M<./*AFT/PAX#CM;DKF7[+XH*L\4+NLWU9_P '"":?
M_P %#O\ @C+^Q)_P4R\)Z7 ^K^"M:TFY\9'3HA);Z1X;^+*'P+XTM7;#31VV
MC_%[PIX6TN%)7"Q&^G69/-PR_1G_  34^(OPI_X([?\ !NQH/[4/QR^&LWQ%
MC_:$\5:A\0_$OPKD32M/N?B)%\9_$$/P[\%^&WDU^POM.NM&U'X.>&M+\57<
M&IV-W9WVES:E;PPS07*%OJ3]F#]I/]FK_@N=_P $H/VWOV=_V=?V=;3]FW3/
M#OA3Q=\,_#OP6TT>%;31-"\9ZYX;G^(WPJ\7:1:>$-(T#0M/LM1^)FGR7T]I
M%IT1EU#1M1GN)I3?2^725X\M]7&]M=;NZ^Y^M]#:VB7=6>JTT7XJ^^WZ_P _
M?C/]@+]C^R_X-@O"'[:EE\"_"EM^U+?1Z1/>_&1+C7_^$EN1-^TEJ/@N='A;
M66T;;)X9CBTET72U3[.BR;?M&93_ "#U_=[\2(Y;'_@SH\%VES&]O=6YTFQN
M+>=62:&>+]KS5DFBD1MKI)')$R.K*"K JRJP('\(53)64=+.ROTZ*UU^O4SG
MM&^]M?P/ZG?^#0__ )2?^+_^S7OB3_ZE7P^K_3+K_,T_X-#_ /E)_P"+_P#L
MU[XD_P#J5?#ZO],NKA\*^?YLE[1]/U844450@HHHH _)3]M']J[]JVU_:\^
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MWUQ=7-P?U_F7:"Z+MM=IZ:]+[K?:^O1OY<^&O_!3?]I?7?VIOV]O@%^T=9_
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MEWWQ"\!Z;')+?^-O"%E%&A9GO/$FC6J+C.2TD][&BJH&3DY'/ME#LWT?]?\
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MZA:VZ:S!&/[!:VBK15_ZU')64;[V?^?ZA1115$A1110!\<?'7Q=XKT']I/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#XM_;U_Y(?X3_ .SHOV+_ /UK7X,U]I5\6_MZ
M_P#)#_"?_9T7[%__ *UK\&:^TJ!]%ZO\HA1110(**** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRS"1WT_KR??^M>JT.5J+2N[VOI^2W72_7R73T6BBBD9A1110 4444 ?S7_\
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MVB36))+XV T#^R [>6FGB#;%7]&7QR_X)/?\$_/VD?BYJ_QO^,W[-_AKQ?\
M$7Q+I]EIWB_5T\1>./#FG>-H-+M19:1+XW\->%?$^B>'/%U_I-LL<6G:IKVE
M7NHVZP6G^E,;"Q^S[NM?L)?L#>#M#70_$?PO\%>&=#\8_LZ^$_V"K:WUWQ[X
MNTF'7_@'8:EJFH^#_@9IUSJ/C*"6[N9=3U'5)M,N["=O'NJ3221C6KL01I$:
MZ_*SN^C3VZ;6W[=A<T;K1OJ[)7MI=:/O>^VKU[GXR?'[]L;]LKX-?'/]A[X_
M_%?XZ_%#P;^P=?? ?]D+4_BSX@^"'@;X+_$6PM_B]\6[RR@\8K^U9X'UJTMO
MB/X1\ ?%'^TM.T?P?X_^'1CL_"M\+G_A'=%O]?D%M'\8?#SPG_P42^&OP^_X
M*5>(_P!E?]IGXI^+]8D_X*__ !6\'_$KP+X-\/\ [/>@_&KQ)X-\+61\0?%#
MQU\!W\:>%_[%U[XQ^++2Y\+1S> HD%G+X?\ !URGA73[;4-0U$R_TH^/O^"5
M?_!/_P"*/Q2^&WQA\<?LX^%=?\=?"G0OA[X9\):A/K'C"'39M"^$Z6L?PUT_
MQ;X=MO$$/A_QZG@I;*TCT.7QOINOSQ06L%O<RW%O##$FK\4_^"87[#GQE\)>
M-O!'C[X"Z/JVA?$+XYZ[^TMXGEM_%'CG2=;E^.GB>T@T[Q#\0M(\2:5XGM-?
M\-:GK&G6\5C?:?X<U'2M"FM0T)TH([!C\/F_+Y;K:S]&QW2MTOKJDOEOJ]=5
MIYG7_P#!/;X_^'_VG_V-?@+\:?#OQ'\5_%JW\3^#AIVK?$'QYX&T;X9^-_$7
MBSPCJ>H>#O&=QXN\!>')KGPYX7\0P>*]!UBTU33/#UW>: ES \VBWMWIDUK<
MR_9E>6_!3X*_"[]G7X6>#/@K\%O!FC_#WX7_  ^TH:+X0\'Z$DXT[2+!KF>^
MN,2W<US>WMY?ZC=WFIZIJ>H7-UJ6JZI>WFI:C=7-[=3SR>I4&+W=MON_KS\P
MHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %-8X5CG& <'W[?K3JCE_P!6WX?^A"@:W7JOS*C.5#,>IY]S
MUY'^>G05BW%X<L-WRCH, <_CGK_3/IG1O6(5AGL![\__ %Z^9OV@/B9JOPS\
M)P:MIVBV>LV^HZB-(U(7=WJ-D;.WN;6XD22VN=*N;2^@GE>$QI<0RHT)P5='
M9#793C%1<I?#%:Z+175WY;_H9U)-R26CDTEV[);K^K>A[C+J(4D%B<= 0!QG
MN21_GIZU"FIKD'=C/ )"_7&/H">1_2OSETSXG>'M?TFTU5O#DMI)?QR2S6\G
MC?XBWJAQ+(CD/<>+CF-F4NH*D[3@\<5WGAGXQ> -+T7Q1HHM/L6L2:?;"-+G
MQ3XJF>^DBO1/Y5I<76MRZE9O$KABUG?PRM#B+>UN!&OJT\)*I&"IT)3E-)PC
M&<.9QY5)OE:3LDT]F]>NMN"I5]FG.==0@I*+;HRDDW)12?*W:[^T[))[GWG;
M7V[G<>/3'N,#C_\ 56[;SK*N#T_(C!SV_P X]NOR5X"^.\OB_P 0:=X<GT?2
M[1[M)RMW:2S"4?9+2>X*>5*\OF;TA.]V<GJV]B#GZ>L)>0,^F>#T/')]EY[?
MI7#B*#IJ\H.#ZQ=G=65W?JDVTWW3Z69U4JEY<M[Z+5:>2?EW23V?<Z2 DA@3
MP,8]LY)J>J\/#8'0IDY]0<9_4X]JL5YK5G8Z9;OSL_O2"BBBD(**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /YM_^#D+Q_P#\%%?!7P-_9S7]A7PU>ZUH>H?'?PG/\5=1
M\/\ AS1/%/BC3O&>A^./A]JG[.VGV^FZW;7B0Z/K7Q/ABCN[BVLYOM6LVN@:
M1?3V]EJ4EI?_ *7?"+QI_P %0K_X4?#*^^)/P/\ V3+;XB7GP_\ !MUX\M[C
MXY?$C1[B#QC<>'=.E\317&DZ/\$=?TC2YX]:>]2;3M*UW6M-L90]K8ZMJ-K%
M%>3>C?MZ(H^"/A-L<G]J+]C <\]?VM?@R3_GWQTK[4    X & /0"A:-O>]M
M'JE;MZ]2VU:-DGZKJK?G^/4^*/\ A*O^"AO_ $17]D;_ ,2#^+/_ -#W1_PE
M7_!0W_HBO[(W_B0?Q9_^A[K[7HIW\E]WI_E^+[DW_NQ_'_/R_/NSXH_X2K_@
MH;_T17]D;_Q(/XL__0]T?\)5_P %#?\ HBO[(W_B0?Q9_P#H>Z^UZ*+^2^[T
M_P OQ?<+_P!V/X_Y^7Y]V?%'_"5?\%#?^B*_LC?^)!_%G_Z'NC_A*O\ @H;_
M -$5_9&_\2#^+/\ ]#W7VO11?R7W>G^7XON%_P"['\?\_+\^[/BC_A*O^"AO
M_1%?V1O_ !(/XL__ $/='_"5?\%#?^B*_LC?^)!_%G_Z'NOM>BB_DON]/\OQ
M?<+_ -V/X_Y^7Y]V?%'_  E7_!0W_HBO[(W_ (D'\6?_ *'NC_A*O^"AO_1%
M?V1O_$@_BS_]#W7VO11?R7W>G^7XON%_[L?Q_P _+\^[/PB\'_$K_@I2W[;;
M>'OA3X,\!>)_A1<^,1%^U1IGB7XJ_%'Q=\'/AE(UK:O>R?![QKX\^#_@S7]/
M^('V<V\K?#WP%JGC?X<0S3EM6T'P=>W,^IO^[HS@9X..?K30BJ2P&"<DXZ$D
M@DD>O'7W.:=2')WZ)>BUV6_I;3\0HHHH).'^)7Q(\$?"'P%XQ^)WQ'\2:;X1
M\"> ?#NJ>*_%OB75YQ;:=HN@Z-:27VHW]S*RME8K>)]D4:23W$ICM[>.2XEC
MC;_/W_:;_P""Y7Q=_;E\>_M4?';PE<ZEX$_8R_8G^'B^(_@Q\*Y)/LX^+GQW
M\9>+=-^'/P.\:_&&*%FB\1#0/$NL3_%33/ %[]K\+V*>"+:QO;/4KN6\U"X_
M07_@[8_;.\7Z9X3_ &?_ /@G)\)+R]/BG]H?4K/XA?%*PTR1X[S4_"&G>((_
M#OPS\'2,D@62P\6>.X=5U:^MY$_UW@O2R["&X9)?X[=+^/OP'^"GPJ^*7[)4
M'@/7_BOX*^)OBKX?:M\8/BQIGC=_">N7WBCX6R^(QI)^$FEKH.I:5;>#],U+
MQ+JKK_PF4.MW7C1++3-4,'A)I$LK66[.VFW7N[67XZ]NIK&R2MU6K\W:ROV^
M^VY\4:+\5O'^A?$VS^,-EXGU*;XC6OBMO&K^*-3F_M34=0\1S:@^I7M_J[WX
MN%U8ZG<RSG58=0%Q!J4=S<Q7D<L5Q*C?W7_L;?"7_@@C^VQ^PQXQ_;^^-OP*
M\-_!CQ3\%-'>X_:W^'?P_P#B9\1/A[X1A\;VMJ)H;S1?ASX7\8:/HD^E?%&Z
M13X+T32-/LK:XU.]G\,VT;W%C))7\+GQ;^'MM\._%$-GHVL-XF\&^(]&TWQ=
MX!\5/9_V?)XB\(ZRLALKF\T\3W2Z=K6F7EOJ'A[Q-I<=W>0Z7XFT;6-.@O;V
M"UBO)^,L?%'B33-$UOPUIVO:O8>'O$CZ;)XAT.SU"ZM])UR31YI+G27U;3XI
M4M=0?3;B66>Q:ZBE-M-(\D)1V),1ERMW5[_GTU\^K6ZV8E)Q=G=W_/1:7WVM
M\E:Y],_ME_M&>'_VC?C-K7B'X:?##PQ\"_@AH,T^@?!?X+^#+&&QT3P+X&M9
MW33UOYXU^T^(?&&LQJFI^,/%NJS7>KZ[K,TLD]T;6"RM[?\ :[]A'_@IG^US
M\*/V4V_:%^"GBS7-:^,/[!_BGX<^"?BSX/U4ZEK?A#]H+]C/XAW.I:3X2TOX
MBZ2&=+O6_@1X^LH?"GA?QQ"T?BO1/!_Q+T?1[74HM&\,6MH/YG26)YZCCWZY
M'3Z\>V . *_I5_9^O_VPM3_9)_8RMO\ @EO\1?!W@OP_H.G^*D_;5TRP^(/P
MP\ ZW:_&\?$GQ)>'Q5^TC;>.]7T>]\0?!"X^$[>#+;PS<ZI'JOP]M;6S\3Z6
M\,6ORWL=V1;;D]=MEZI+RT\]"HN[N[Z[)7VTNUTMK?TOJ?Z#/_!.3_@H3\%O
M^"DG[-GAO]H+X179L+B5DT/XB?#^_NH9_$7PV\=6MO'+JGAK6%A6,S6Y$BWF
MAZLL44&LZ5-;W<<<$QN;2W^^*_S;_P#@F=_P4/\ AA^R3_P7>^)GA7X*ZYH<
M/['7[6'Q=/P=UVP\+,UC\-8_%6NW$%EX7^('@RQE,-OIWABQ^*-S?0^'Y_*C
M2V\ >(+N%8XX!$D7^DA_3K6B=_D[/^OZML1-)6MU_2W8****9 4444 >"77[
M3'P6L_VA_P#AE6]\;0:;\=I/A/)\;[/P3J.D:[8C4_AA!X@D\+W?B?2?$-WI
MD/A;5(]/UR)[+5-.T_6[K5],79=WVG6UFPN#Y&O_  4*_9%;X<_ +XK1_&71
M[GP/^T_\3[7X._ W5=.TK7]8E\>_$*ZUC6]#;1;'3]'T?4-0T^WL+_P[K UK
M6]7M;'0M MK*2]US4M/M'BE?XX_X+$?L$_&O]K7P3\)_B5^R3XFA^'G[5WPA
M\2ZQX*T+QJMW9Z9)=_ C]H+23\*/CYX?NKRZ,<<@TGPIK4?C_2?,E>]LKSPG
M=#PW WB'4[(/\'?!3_@@UXN^'OQV^/O@.Y^(6I0?L<_#W]G_ .*_A3]@C3=2
MU"#6M1^&/QF_; ^%B_#GX\^/9;%+D:A]J\$#P]=7FB17S0P._P 0_P"T-"O(
M]2M=8>$Z_P!>7_!O\K=4MH\EM;;+^7LDU]]WUMV>Y^J7PL_X+'_\$Y_C/\:=
M(^ OPZ_:0T76_'7B?Q%?>$?!5[<>%/'>C> OB#XKTV:2VO?#?@'XF:SX8T_P
M#XMU5+B,165OHOB*[76Y)8$T&?5&GB#^VI_P4"_9*?X0VWQV'Q;MS\++SXZQ
M?LV6_B@^%?&HC?XS3>/F^&$?@PZ:/#:ZTDA\; Z1_;3:>N@8 O\ ^U!II^UG
M\$]-_98_X*-_'']G;]B+_@FW\0/V#? W[/7@[]D_XJ?L^^(O'/[9&F_&?X6>
M)O -SX5_9VU>UOH/%GP-\ ^'KL?$NV^(/Q<M]+<:DNMZ;I<FERZYK,?B=K-=
M9>:RQ+7]B'_@H8/#^F?\$\IOV68T^">G?\%3H?VR9?VS_P#A;_PS;P+-\ ;?
MX[2_&Q=-B^'0UH_$L?$J6=D\.C1WT(VXN/\ 3'V:63J(5_SMM_5_7L%H>2VZ
MKI;\^_;1]&?3G["?[7/[/7[&?@G_ (*C?$W]HSX@V7@'PQJG_!:']LKPEX>C
M&EZ[XC\1>*_%>J:MX8DT[PSX3\)^%]-UKQ)XDUF[CM[B5;/2=,NFM[:&6[NY
M;:UADN%ZC_@F_P#M _"?]I[_ (*W_P#!3KXO_!;Q/)XJ\#ZU^SY^PEIT5W=Z
M'X@\+ZOIVM^'[3XW:/KVA>(/"_BO3-$\2^'M<T?5+*>TOM+UK2[&Y0JEQ%')
M97-M<3?+=Y_P3Z_;F^$OQDNOVP/"?[.>E?&37O@U_P %>?VZ?VHO#7[/-]\2
MOACI&J?&#]GS]IWPMX7\*>&_BEX*U_4?$MUX3\.^/O"']AR>(/#/AKQM>:!X
MEM[F23SM/L+Z*WMKK[W_ .">7P@_:XF_X*"?M_?MC_M%_LL6_P"RYX._:8^'
M/[+&B?#7PS+\3?A?\1?$]Y-\)=,^(GA_7F\=R_#GQ!JL5EXN^RWVAZE?;X'T
MF#3M6TO1=/US6[W1-5EA2O[JMM_\CU[:NUM_7HVU9VM=K1IWZ+;SVOK\KGU7
M^T7_ ,%5/V'OV6/B9XA^#'QD^,%]I/Q9\,:!X>\5:K\.?#GPT^*'CSQ2OACQ
M-;ZI>6'B"WL?!7@W7X[S1K6QT;4;W6]0MYVM]"MXX!JSV4^HZ;#=8_Q'_P""
MN?\ P3W^%OP^^"_Q2\2_M#Z5=^"_VB_#?B?Q/\$-2\)>$/B%XVN/B19>#[G3
MK'Q%9:+I?A7PGK.I6_B#2]1U:TTV\\-:U;:;KMKJ OK.YLH9=+U);/\ +SQG
M\3OV@_@Y_P %S/VV/'7P%_9#N/VN[EOV-?V8?#OB/P[X5^(_PZ^&_P 0O"J:
MKJGBV[T'4M)U+XFZCHV@:GX1U75-,&G>,;&RU9-:L2-$URWTW4[/2[Z&.A^Q
M%_P3%_:M^"O[07_!.3XM_%+X9>%-/L?!'BS_ (*/_&_XY>'O"?B[P9J'@S]F
MOQ3^U?%IU[\-_A3X0LI-8@U+Q-8Z0$GTV;4/ FDZWHFF:W+J]T^H1Z9)8ZE>
MT_3LNN^FOGH[O5?($HV5_=]W6[2YMGVZJ]KWW\S]'/$__!;?_@F?X)\9:1X&
M\3?M(6NDZQJ.G^#[[6;R;X>_$Z3PW\/V\>:?8ZIX6TKXI^*(/!TN@?#7Q!>6
MFI6W]I:%XQU'2-2\,R^=%XJM]%EBF\OZ0'_!0O\ 8_'@/]I3XG3_ !JT.U\$
M_LA:[?>&_P!H75KO2/$]I)X!U:TL[6_MX_[.NM$BU/Q+9Z]:WMG)X0U/PE9Z
M[IOC+[5!%X6N]8ED45^%VJ_LS_\ !1;]G_X2?\% _P!@OX;_ +!G@S]I?P;^
MVG\8_P!HOQWX!_:UO_C7\*_"7@C2= _:6D<WE_\ '?P/XINX_B)>>+?@W'?A
M]+DT+3M2773I6EV_ADM)I?FS[OQ%_P""&GQ'OOCY^Q1HNA^/9-4_9?U+X2_
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MJ)TUWMMT[V[+S_JVO]2V]/[R_F/\:"5QABH!R.2!G'!'X=_2OXY/V0_VHO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC&CZ;D@' (SC'/3IU(K\9?CGK$C^+;4;R=NCV[ $G'-Q=9P"=HSTS@<]/?\
M1^#L)AL\SZC@<:YO"X>A5Q-2G%\KJ_5W#EI.HKRC3E.<8SY5>SNM$?(<3XVO
MDV2U,9A5!XB=6CAZ=2?O*BZL92=10=HRE&,&XWDDVDF]D?Z1'[']A:V?[-WP
M(CM%$<4OPF\!7K*,_--J/AK3+^YDYYS+<W,LG.<;CW)-?8.FKP".QS[D8'4C
MC@=OKZ5\D?L@8D_9F_9\DXR_P4^%[9!SU\%Z(W;CG/05]>6!"H<#)QU_'KCZ
M8'X5\/G7+#%XF$(J,(5JBC&.T8QFTHIO5J*M%-ZNU^Y]'E%YX:E.3YISA%N3
MT<I.,;M]+O?2Z5^]S:CSL&>,Y/YDFGTU/N+_ +J_R%.KYT]9[OH%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM[MA1110(**** "BBB@#Y0_:I_8?_9;_ &U]%\):)^TM\)])^(T?@+6+K7O
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MCN+9'B#C#&.15D4?+(H*G'10_MA^#;F,217-\RMT8V=WMSQPQ"'&>G/?@\D
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MC2T@+<&)-1MH<C@X 62-F.1NY)(V]!Q7G^H>-? =S,TMSXBM[NZ_BEENA*_
M"@F5F8G:-JCYC\H&,!<5A/B;!T)QJ+V;46W>K7I03=M=.;2ZEU>EUU1KA^%\
M=5YFZ-=QE'EO##UFTVT[_!:]]5:[2T>Z1WGBWQQJ0NHX=#M+K4CX3LXX[&U2
M:)+>_P!?U*[S-=1-*Z121:7:SF8N9 IF40H&"FNTN?&MU<ZC;75M;W$D5XK7
M5^SLGF6\QACBBLP VV4)F:21T8Q,[8W,0M> )\0_!$#XBU&V(4#GS$.>F>6.
M,@YP0.W''%75^,'@^QYDU"S.T9_UL70X ZL.Y P!SD<8XK@K<>X>G*7^T9=3
M5OM55)QOK=WDKONEN>G2X*Q<U&,<'BI3LK?NW%R345I%QWOV]+:H[/QK::QK
M/B3PUXDLBMM::#!K<5Y;S@^==KJMBEO'Y>QBB+%*IED\QLL/E0C.1Y#:VVK6
M/B!]8NM1O]1NCK4.MF-[1+6W^T6FF7.F608-/<2.EF;N>ZA=63?<,C.&1=K=
MDG[0WPL5#'J'B#2H?[PDNX% ! R3F3''3'MP/7B==_:%^#D N3;>)-%+#+*/
MMEN @8$L!OD!Z\X QEN.37C8KC[#3@ZL<[PE-1=Y1IU*4+<J47IS7\O>T3?=
MZ^Y@>!\X<X4%D6,J.45!2="NY<K:DM'#57=U;?M9G23:-H\YO+F\%U<2ZH+%
MKT374@C9M/D>2UPL0A(VO*Y< XDX5]P K7CLM&,IO5M;9[H&25;IT5KA'N,&
M=EE?<T9FPHD*% RJ%P54 ?%/C+]J?P?9R2-8ZO8W$?/EF.YA8D!N=HWX)(S@
MCCC)YK!T?]K/PS<XCEOX06 '+AL =1E=P!QC\.,8Z_(UO$/!5JDH5,TE./\
M-[27LY.3O=2BTGKS/1VU31]G1\,<]A2C4CD]=/2Z=&7-%12TY90O&W9JZM9G
MW1/JT%FY V;1G'(P#D]!S@9YSC'MFK=KXA\^58A(H&Y2".R\8!;N.<9 'T&
M!\,:W^T/X=DMENK74+>885FC68*^W);@%AD@!LCO@J#D\U/#_P"TKX8DN(XS
M>+"=X0K*5!)4Y)ZD<]R>#W/()XO]<LJE44%C82;=O=O)O;7JVM%=RNUI?K?J
M_P"(?YY[/G_LZO'EOS1=-Q<4DMDXIV[Z6\T?I5;7"O")/,!;&>&+<_W<9P./
MI]*CNOB7IFA6%[I]]/"-Z.0I^\I7DL!SN!^[@^RC)/'S[X7^+NA:I;(T-RI1
MQR23C)&1@\\<]%/4^]<OJVH^&KGQ#:>*?%L^NS>%],OH9Y=(\->'M;\2:UKD
MB,KQVMKI^CV5R8++<%^U7]U)#&L0D6!9'):/WL+6SC.*F'PO#N"KYCB<3)0;
MH4JLX4:4W&$\35E",E"G2BY24YM<TXJ$6Y-7\&MEF49+3Q.-XFQ=++L'A(2J
M+VU2G&=>O3M*GA:$7*+G4JN*A9*2A%NI.T8LZW]L_P")?@#X9>$_ &N^+=1C
MT6_\6>&TG@8R*+BYO--LK W6^$?,YQ=VT<I W),'=F)9@?P#^(_[0^E^+]3N
M+NUUV"&WA\PP1^>%D8(""[-E&*OM)"G(XQCD5[O_ ,%)?V:]7_X*2?%+PUXF
M\2?&3XK? SX=_#30]2\/> /!G@[]F;Q_XQUZZ.L2V%SK.N^)-<N_%/A+3DN-
M2GTVRAM=-LM/6'2K:VBB:YO)[F>\G_(#QG_P1U^,G@!9[[X/_&;QK\39D\HP
M:=XI^$/Q3\ ZA="-S(%W,OBK1X\_>(GU**)F#*9U5\UZW%'@SQ5G6.KXVE2Q
M>%P\W!PPT,KJSGSQI4U5E4J0JW:J58SGI2LN=IM\MSBX6\9.%,@P&'P$XT,7
MB:47SX^>:0I4K3FYQA2I3PDDO94YQHW=>492ASQ:4TCZ27]K"#X5WMQJ=OXP
M70EO8_L^I+M2[M-3CC#JOV^SDREPT<<DHBE^6>*.>2-9521PWR#^T?\ ML:+
M\8?#=SX&T34["[>XN[.&Y:PL9[2"2+38KAM'LX#<7=RL5E9R3S?9K:SC@B6Y
ME$MP9Y(X2G@WBC_@FA_P4-U2^,=U\-M5U[3YHIOGCBU:!;9F,;(JK>:9!,WE
M,FS C<F/,8RC@GF=-_X)=?MQ^%[@:E)\(=5:")A//<&YCM4LDC;>9))-1%HF
MQ3QDNW&"<*<GWN#/"3-\HKX;$XK#9M.IAYPJ1ARXFGAH3BT^;V4Y*,7;>\'[
MU^YX7&_C'@<XP^)P.$KY72H8FFZ52JW1GC)4Y)/D5:FJC<;_ /3Q)Q5W&,KI
M?HI^S_\ #KQ]KG@CX?\ B_0O#-_K%G%;Z)?0W$29BN/[.2U#0>:0,,'M_*=B
M'.=V2Q )YSX]:'?^!Y?&FAV_P_\ &\WB3QYX<U-5FO;C4!IFG0>(]0?[1*[7
M'C'6([EK7R)O*C_LB-9F*R*UF5"I^XG_  3[\ ZSX(_95^'/AGQIH]KIWB;3
M!K*:E912VUXEN)]8O+JU"7%N\T+K]EEMR!'*RQG,1PRG&7^TKX;TB_\ '>E/
M-IUM*3X>L4SY2 X_M#4B!P >K 9)SCI@U^_^%.49;GG''U;-J=2=/ 8;&9E3
MY9\DHXS!XK!^QE+I*,95)N4'I)JVC3/YG\3LWS')N#WB,JJ4X5,9B,)@*CG#
MGA/"XJABE54=G&4HTXJ$EJKMJ][K]S/V%/AWX?\ A;^RE\!?!WAS3$TJTM?A
MEX5U6^@ S+/K_B+2;?7_ !%?73G+/<WVM:E?W,S$X#2"-0L<:(/N*Q_U<GX?
M^A5_-SIW_!>+]E/X(:['\&_&/A+XI1S?#^&V\(:EJ.G>&M/>(S:!#!I4LMA;
M_P!OSFZ@8PK/#)/)8>9 P#+%*/*/]$_@?Q)IOC'PGX=\7Z,\LFC^*] T;Q)I
M+SQB*=]-URPM]3L7FB#.(I6M;F)I(P[A')7<V,U\7GL>7%XE_9E5K<C[KG;6
MG2ZU2[;7/L,EFI82@K^_&G#G33TE:-UYZIJZZIH[E/N+_NK_ "%.I%!"J#U"
M@'Z@4M?.GK!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ?%O[>O_ "0_PG_V=%^Q
M?_ZUK\&:^TJ^"_\ @I'XM\-^ ?V98/'/C'6+/P]X2\'?M"?LC>)_$^O:@[1V
M&C:!H7[4WP@U/5]4O'17=;:PL+:>YF*([^7$VU&;"GPKX)?\%A_V3OC=KVK^
M(-.^)7PQ\#? F/395\&>/_B)\3-$\/\ COXDZR-1C@74M!^$L<%YK'AKP#]@
M@O)K;6_B#JWA3QAJ5V]J;;P!'H\Z:S*%*+<=.C?_ +;HO,_6FBOBS_AXS^PK
M_P!'5?!3_P +C2/_ (_1_P /&?V%?^CJO@I_X7&D?_'Z!<LNS_K_ (?\^S/M
M.BOBS_AXS^PK_P!'5?!3_P +C2/_ (_1_P /&?V%?^CJO@I_X7&D?_'Z Y9=
MG_7_  _Y]F?:=%?%G_#QG]A7_HZKX*?^%QI'_P ?H_X>,_L*_P#1U7P4_P#"
MXTC_ ./T!RR[/^O^'_/LS[3HKXL_X>,_L*_]'5?!3_PN-(_^/T?\/&?V%?\
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MT^Y@@\/JGP)_PM?P5\-?V+?^"H_P#^$?Q"TW]H:;6O@I\$_C_=_MT_!7Q_\
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M3-?F(W;2LTAE+L27_6WIY_UH+VFKT>J2U=[6:=_/M;31(_.7PQ\;/BI\7O\
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M?-?5MZG\:@_X-?OCOC'_  W5KV&&"O\ :GC(HBX_@1K<@$?PD!2HXSBIH?\
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M_7F-V)_=7_OD?X4;$_NK_P!\C_"G44"N^[_K_AE]PW8G]U?^^1_A1L3^ZO\
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MFEZ!;WWA?PIX_EO-+E66TUZ^F\/1ZA;>=+J[W>FQ7OJJ?\%>5E_9"TS]JD_
MEU74/V[(/V*V\$?\+%7=$)_C])\$#\11K_\ PA2[RL:GQ)_PBS:,F&QIAUW
M_M&O*_!G_!&GX\/IWP$^ WQU_P""@WB_XW?L,?LR>._ WCCX8_L]7'P1\'>#
M_'?B*#X4WZZC\)?!?Q6^->E^);O4_%OA3P!-::7&EO;>'-,D\01:=:"5=&>Q
MT][6&W_X(I_$"#XB6?@YOVR]0?\ 87L?VTO^&Z[;]EL_!7P\OB__ (6>GC5_
MB+#X'?XW#Q8=0?X;1^-7.M-8'PK]I>V#:7L6X*ZQ&?*^OX::^F_G>_2Q:Y.T
M7I?32WG_ )^>VA\I?LO?MO>(_P!E36/VTOA=\(O@K??M$_M*_M4?\%OOV]?
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M;PMKOQ"^!OC[Q)XDT74_AMXE\7:'96HU4"RU&.UUX/XFL+F.\BTVSTV[=_\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?YUO\
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MP0W,I!8_31_X/3= .,_\$]M7_P#$D[/ ]\#X+#/H?4$@\$BO[+O^&9/V;?\
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M "BBB@ I"JGJ ?J ?YTM% $?E1_W?U(_D:/*C_N_JW^-244#N^[^]C515Z*
M?7J?S.33J**!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
2444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>nt10006151x14_graphic7.jpg
<TEXT>
begin 644 nt10006151x14_graphic7.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M) R>?:E;^OZ]?ZLP):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@?3&<_A^OY^],"55VC&><Y_#CGKGT_/K2,NXYSCC'3_Z]2#&><].W7MZ]O\
MZU,.X'*\@=CCGK_];_Z_-&WY "KMSSG-.I3CUYYR/3TX[9_^MVHP><C& ".,
M=\<\#/?U[&@!C)D]<'&",=^?\]*D.,(P Y&3S[#C\_ZTPD^A/Y?U-*"?3D=
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MAZY_0C]:7M\O?')[?3.3_+W% #2VS Z\#GIV_&F*0#SZ?X4[83RQ.?\ ]?\
M^O\ I2NR[0!R?EY_X",_CG^9H#?^NVA&QR2?\]*2BB@!X.?FZ;1CZ\'\OUIK
M'<<XQQBE*E>O?MW]?R_^M3: 'E"!QS^'_P!>FXYP>/PZ?A1D^I_,T ;B>>G4
MG].?\_I0 F/7_(['\:*** "BBB@ HHHH **** "EP?0_E24N3TR<>F: %4@!
M@3C(Q_.FT4]R"1M&/E /N<>WY?A2_K[[?\.PZ/7MIW&444X' /J1@>U,!M*"
M!U&?QQ1P1R<8!QCKGKS[?E_.DH6O_! **4GMP?< ?7T!I*+_ (: &3ZFBBBB
MUO\ AV_S *4G./8 ?E24I!&/< C\:'Y^7YZ?B E?ZNW_  ;5?\H4/V+?^[C/
M_6LOCO7^437^KM_P;5?\H4/V+?\ NXS_ -:R^.]!<-WZ?JC_ "?26<C<#Q@=
M,<9YI\D0505!SG'KQS4RN&7<.V>/I34D#DC:>F3G&*PZ;:=7I?[-[?UU]2?E
MMOKKT_KKN )6($#D+W']*(W+ [L#!QZ=J>QVJ3C@#I4)'G<CY<<'/<^O%/=.
MZ7:]TOY5U\NNVHABKNDP0<$MZCL<<T,H5\*#C(]\>O/M[U,LH9@N#GGGC' )
MS^.*EI:=M_/_ "^>ZT#^M_Z^[H%0[W\S;C*YQT[?6IJ*7]?U_P "P!1110 '
MH:BC=V)W#IWP14M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?'>O\HFO]7;_ (-JO^4*'[%O_=QG_K67QWH+AN_3]4?Y04?RHP8A3EA@D#/
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M%2>9[?K_ /6J.@"55&!QR>??VY[<>E(IW$YY],_YX[4]>@^@_E3(^"3W&/\
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MHHH **** "BBB@ HHH]>/_K4 %&.OMUHI0>"/7'Z&@!YV[3C'MZ]?SJ.BB@
MIV1C&T9]>G\A_P#KIM% !1110 5_J[?\&U7_ "A0_8M_[N,_]:R^.]?Y1-?Z
MNW_!M5_RA0_8M_[N,_\ 6LOCO07#=^GZH_R>EZCZC^=69OE4%>#N'('L3_2J
MV"I'KGI@]C^N?:GL[L,-T/MCI6*=EYZ_CR]O3R^_0F^B[IM_?;_(41NPW@YS
MGG.#U(J:-"!\^">W? []:CC=\JO\/ Z?UJS2U2T>]]K^3?Z;?D(3 ]!^0I<
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M%(>I[TX 'IUZG/3% "$\8'0$X]_K24N#U[>M)0 4444 %%%% !1110 4444
M.49#8Z\?SI!P>1TZB@$CI026/N?2@!SD'&#Z_P!*$&23Z#/ZCI3<'T/Y&I@
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M,9.?Q)_G4W;/;\C^1Y[^E(P5L8W<>O']*!$>& SGC [GO2!2W.?;DG_/>I@
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M!S[]J4'&!D>S>G4'J/YC'.>^0F>,#IW^OY4 )1110 4444 %%%*.",\8(S0
MK+M[_P"?\]?2GA,%3D'CG@C''3GZ_I2.00,'/.?YT(S9P.<YZ]3W^O7_ #Z
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M.JM;TTNE\M[W&Y(&< D8R ?\1Z=,THQU)SGOC) [ 8QD#CWXIA!Z\YR&8X.
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MB"TG<&9H[FYMYW8Q0M1Z:_U_5PY%V_-=M-WOK_5CQ#;P"2,<<\]1SZ'N/?\
MK29SU]!^@Q3=P.1U/3YN,^_3\>GU%"D')R2 ><]/P]O7T]!09NUE;N^_DNO>
MUPVY8-D<#ICJ>W/M_3K2CIQQZ=\?T_#IVZ4@8$X')Z<]!SUSQ_/'KCJ#(]2<
MG!V]0/\ .30+^OZ_X(8/)Z'@9ZY'&3CMG'_ZJ4@@J,?*1_B1W]O?K1@\8)_'
MN/?/>D^4Y&>O49_'IGB@ / )P"1[=L]/\_E1D\A<<8ZG.>/Y_4T%,C ) SD@
M<Y_/-* %Z9.3R>_U/^?ZT#MUZ7M_7_## <G=W VX!X)8CKUY7K_P+\GD9_E3
M> P7!Y);/H?P_'@T[.<$'CG\?S]Z!!R,#!(Z9XXP._<D^P^N*806((;&TXQ@
M')!IQ;H.1U(]^.0/<8S]1@\=4Y [#UR2<^G3OCK[Y[<D :^3U4C!P.02<],8
MS^M(0 H/4GH!]1UX_P ^E.91P5'(.1SG\??K0H48_O<G!//4GI^M []]?^!Z
M>0PXS@=@,GUZ_P N:2GN N,8&2?Q/%,^[QUR??@G)([?KGZT""D=N=V/;&?U
M_3T[U(H7!W=<^^>W:F$'D,JXSC@GC/(SD^W4?_7H#^OZ^\0$$9(SUP.N/\\G
MI[8[T_HO^]^F#_7/M3<8&.H''L<<4$] 3ZXS^M UI?TT^>_X7&A^"""3D@$'
M@8Y. ?\ /I4;$$Y'I_C4A53SC/\ GVHVJ.WZG_&@1&%(&<@?W2<8S[_A^M#
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M?TP"BBBM "BBB@ HHHH?EJ 444N#@'L: #Y>Y(_+^9/]*4A>,$D'KG&1^O\
MA3:!V_\ U?\ ZJ25MOZ_K0!2!U&<=,^_7T_SZTE*01P?K247Z75^O_# %%%%
M, HHHH **** "BE&<C !]C3B2O.!NQ@+CC'7/<=>/UH : ,\\?A2L03QW]?\
M]/K0I&26QS^(!I&QDXZ?_6H "I'4?RIR9# ^_P"&<4A;*@<YSDD_C_C4IP=N
M.GT]C_\ 6ZT?U_5@%]??_ #^E%(2!UI=Q?C!  ],?7_/3Z=P/SZ#&;:< ?\
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M=E!X;_:1\;:?=P66O_#GQWHE[KNH7.EV-LC7?@T?#;X.ZCH^I:;:A8VO!;^
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M $L*\ME^"6L0VZ3_ -MZ9&DOR6XN;;5K(3. "8U:[L(D##.#N8<XY&<T6?\
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M%0.#S@Y/MG'7Z^G-']*4#.?89H&FT]-]AI5<YQCG/7/ZYQ[TN0.H)STZ_P!
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M"QV[+VU6YB3OS+;.\I&<A3M<D8R0:RYWT\M]==.[?7;_ #'S<UTKK;7\^O\
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MQTY_#!/MU_#-!/\ EK_P?P_ :<C@#:.N<=3]!D_4D?\ UV*H)()Y'<=#_/\
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MT_\ #/P%IX5)KFPT/4? ^K3> [1 ,B2>RGN;.YL7ZED@D'.*_ +_ (-=@/\
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M;]OC_<\;?^JG\25G_P#!4[_@H1_P3C^*'_!*?6OV8OV2?BGX?EN]-E^#.G>
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M#X0LO$/B70_A/KDGBC7M$L=)U/QU8:!#%X6>RU#6[07NG S6UIJ)AN9FE?\
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M>YG,=O#$K2S2QQH6 /5]W^)Y*H?/)SQV[>Y.!@?4]<"D&<GTXQ^/IZU_6/\
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MXE%* 3GC/T('\\^]!],$'W.?Y ?SIZNS5E%:]4[:7NOD%GV$HHHJK)KR=O\
M, I1U'U'\Z,<X]\>G?\ &@C!Z8_$'^53=:NVBTVUO=:^BT\_P"VE^@F0.ON/
MQ(HHHJ;RBTF[JZ=]]+K\K?UH 448Z^PS^H']:*T3NKH HHHIV_J[ **** "B
MG;CC&!TQT_SS3:._G_D@"BBB@ H ).!13MQ(QQC 'Y4!IU_.WZ,;1110 444
M4 %%%% !2Y/J?SH ).!U]R!_/%*5(ZX&?<'^6>G?_P#5D &5@ QY!'!_I_G_
M /7(#A<G)& 1C (SC'U%*<,.>0.?89]ZNV.EZGJ3^78:=?7^3M"V=G/<G/0
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MN^W_  WKW6U^YIMV79?HMCTJV\9_!OX:0^'-)^#O@RY^*7Q%N(Y8-<\8^+K
M7%II^K3;8(8_ V@VZS0RK'&6,%_JUO=.;D+<I;J$ &C/X,\'Z_XE\/:OX^N?
M$NN>.M;\1Z+I&J>$+/7DU:.TN[^_M+<R:KKMT'\HQQ2XN=)L0XLG>-9&BC#1
MIU%[!JFH?#HZK\/=7T_X2_#C6;K3[;QA;'P5XH/C#5?&-A8_88-/M=3M%\1W
M6K7VI:9<OK-AI]IJGAO1Y+>^U*\FM+&.*0ISUO\ $#Q!\+]2\.I\*--T/PKJ
M.EBW_P"*B\>:_P"%(?&VJ('CN=0CET2YU.:V\)VNLW"?Z1!,TFJ74?EQ76JO
M$#"'ZVMV^[:S3VMJ[7V>J$[NUFDOOOMWW]?-&9\4/BCX:TCQ(?!FI^#M,@N-
M U34;7Q'JGABVAM=7MYGO;D7V@)J-T[-J<EE]JN(;C4KI27EBBM+)(K2W0MQ
M&MVL6N?#>_M["#Q5XCN+GQW:W'@N_GU2:\L].T2YT^Z:]TZ;3'DD@LKE=J_:
MIXC'$K1;I#Y;*U?07QR^$EE\?-)\6_M'_#@:M#X]^Q)XI^/'PG/ANWM[GPUX
MCDE*>(O&WAQM%NY[;5?A_P"*&DM_$%CXBT[3[;2+#5[S6/#NJ0>'I3X/C\5?
M*VF>)?&L'P)UW0M/M[H^%8O'NGSZGJ,%C(#8WEQI=PEM;SZI'M\I;S;)&+23
M'G%6*@L,4G?KUU5MNWRV]=-044F_/;7II^I]+^)?''A?P'!\-?A7XKL/$&O^
M"=2\)VWC*YGG*:+_ &%X_P#$G@S3_!5AXF\+7,<<B7VFZ5!HT!OW+&+5]LD$
M<D1T^UFKY)\$Z3?Z+X\O-!U13:R6UMK^F:QCY_W26=TA=2C 2+/.L#0NI(D6
M5&3>&7/I7CC2+6&V\!Z#\2=5U'1[>Z^$FA>(_ _B.*'^WTC^W:=/<)H%[!#J
M4KQ:+<ZS]MMY7@ N]#U-9GDL4ADNDCY6#4[Z270O$,6ER:KJLUE%H%Y$NU6%
M[!!'#9RSO#%*+K3;ZTAAD+;7E%Q;W&^4I,HH?W?\,M>_Z:L+I[_9?7Y:Z=KO
MTO=HZ+QU\._BOK'@/X>>,=?T+5[71Y=.UG3M(O-;N#IU@VFZ7JSF)M*34[B*
M%;%5N8[=(K/]WYJ%0@9QNN:FAM_BM:>!+ORX@WPX\.^ BUNZSP"_U#P98ZBS
M0R1L4=)=8OY43RR4D:0-@EN;GQ(TV[TG1/#^E>,/C)X'U9YO#;23Z%X0U'Q!
MXWU33);KQ%/K1T_4('T;2-&\/ZK:O%!%)9+K+C[.@5I07>-?._BW=2P^.-$\
M6Z1?22C6/"G@;Q!IFHK:BQG$^F:!I^BRSBV5YHXIK?5M N@Z+/,JLIQ+)@DK
M\0:35GHWWM?I^MK_ /#'C]Q;3V=S<6ES&T5Q:S36]Q#(,-'/%(8IHV! QLD5
M@01VYKUS^R]6^(O@K3=1MH?MFM^$[ZT\,WUQ)+#&;C0;FTN;G1I;NYGDC5?[
M):SN;#[1/(%6TGLK?=^X052^,-K:_P#"9-JUG$D5MXJT;0O%*Q1[V6.77M.@
MN[J,*8E4[;EY=V&QO;&6'-2Z?J:R_"WQ?9V4/V*UM=1\+&38Q,NH7DES<K<7
M=T^!DXW1VT"@16]NNT*7::20(3Y79W]?DNG;;KT6FZ>?'H'@WP]"\GBC79]7
MU%#\F@^&#%-#&2.E[K-P!;J%8#>EJDK[L[9&&:^AO@U\:I=-O--TVTTRTT+X
M>^$KRTU74=./_$YUO5EU74[;2!8#5-0C=+2.XFU3=(T-J#;+&+B$F>")U^+2
M<G)."23]2>WH/;\L\U]-? OX)^.OB3874GABRBU$>(M1'AK3]/%XMI<RW>FI
M'XAN=2NIYT6QTW1-/^P0P3ZGJ%S%"UW=+#"LC6]R(FK]/ZU7ZV*C*[MY?Y?\
M$_1G]O;6/%OQ;^#GP#@T6'Q+XFUWQ=XH^)6J:K'.;N6WA\-^"-3MO!_A6YM'
MNW"Z?HAL[229[B[F6W>]FN)-ZN[9^./@/^RWJGQ7_:N^"7P,\5VMYI>C^+%\
M*3:C<VQBNI;KPY8>&+?Q/XM_L2:&>6TN;WRH]1M[>&.?:UXZ*Y4ON/Z>_'+P
M-X7\+_L]^"_!"76MW-OX(^)OB7PEXQ\0>+M>U'1?A5XA\1W&G:;JT\?AV+P=
MX2U/XJ>./!VC7,=SIUGIOA];+2[S58=1U)[A8[R(O](_L-?L-?'[QAX__9V\
M;Z]\/)_BO\,-*\;?%Y_#_P 7/V=-6\*WWAO1/">K?#OP-8:3X6U"QFET*Z\/
MS":;6#;^'/'L7@/Q?I%S9W]M=6[W<\>GSU:[7?W;JW3W4U9:K?1^NFFM/[MG
M?TMOKU_X'K\JZUHOB;]H+XD_M_\ @;PS;QKX6T.S^#?[/OPD\/V^HHVG^%_"
M^C_&#0/#&@Z5:6[R$I<6]I9WE]>E8TN;N=[Z]F,DK2$]K\>?B-X2^(?[1O[0
MGP,\1_#;PH/"&I^-O#'PY^&_B[4=3;4_$6J:_P#"?PSIOPFBM-+D\^YNM%T;
MQC9:!;HM_P"2=*.L6.GQSND5U?W,?[>P?L!>,/V?=6_X*"?'KX8^&?"WCOQY
MX]T;3OB=\,OA%X:U6^U3Q#H/Q)\+:EJMO=:Q):2:+$VJZ;:VMS+\0M-T#3%N
MM;O]2LGT."SN%DBN+C\&O^"0'[&NK_M2_P#!0;7/%'BCQ/<2Z9^SQIWB'XE>
M*]6\3^&O%%CIVE^/]-NK;2O UIK*ZY:V7G7<?C/4$\3WV@WDUKJ.JVOAS4HH
M83+<2>0TFFDMY.VUU:^VNZ?76^U[=2]]='KT^_9>7;=]M;>P?"KX2Z;\._VU
MOV:O@I:6L&N>$/V'8;GQM\:O!5A8:A-XHMKBZB/CWQGXNGTM7A7Q%/X>F.E^
M';B[T:::'9H<3Q)- Q8['[:'[$OC"_\ VL]4_;1_9'\%W?A'P#I>O>$?%NF^
M%-<\+^(-*U3Q9!;KJ5Y\8_$]]8:M:V.GSZ%8:1>Z ^MZ>+E)=?L/&D5EIEG<
M_8=6:#][]=N_V'/V1/!VL>&;']K[X'^"/VFQ:7>D>)?VC/VB8X?B'\9[KPYX
MFN3K.O6=EX>LO%7AB]T:PO[ZX^VZ!X<OYI=$LK)WC:SNK=Y+B:_H7_!3W_@G
MKI>I>-M'^*/[;VN_M1R?$;68K/PA\,_A]\"K8>%/#.BW&AOI47PU74[_ $<>
M'-6U+Q[<[4BUCQ3XAL8;V>2QM+&73[59KR>^5;-Q3W5FFT[+3?FZ;I?=>YG*
M5I72;NK6:MM;5:6T\VFVO/3^"[XL_LQ_&I-0^+/Q4O? ^H>&?!EEXH\0ZY;)
MXIO-.TGQ ^B:AKMXVG1PZ"UQ]NFN+:U>$7-O#;@VT<9<J(E#5\EZ=I]QJEY;
MV5J$\V=A\\CI'%%& 6DEEE?Y88X8PTDLK<(@)ZX!_L4\"_"+_@D]_P %4OB'
M\3? OP*\(?M(_LS>)]-M]6M=*\+77B;1O#45Y<P2RW&LW^C?#Z]A\7:#//:R
MJ9/$NB)K^C3PV\2F-8DC>2/\M/VG_P#@CUKOP(^('Q&^#OP)_:%^'_Q=^(VD
M6?AR;4_AMXPDT?X-?%>/PSK< U2/^S++Q+K][X+\4PZR+K0/LDOASQE-?:@^
MZRATX3-/ N;B]UJNMG?7^MEJRG'FL[VTOZ_+RTU_R1^2W@W19_#VJ:+XUT?6
M-.U73-.\0Z7H_B7[/!*/[-M-7N/[-D:[AN!MN+"\MGGB6Z 5#.T:/&K,I'V1
M^QK^T5^U=^R1^T;XM^'W[,?B:[T5_'NK3Z%XQ\-:E?-I'A?4_#.BR7.M-K'B
M2^9T3P]:>&-)BNM8N/$WFQ-I&G6]U.[M )$;7\%_\$UOV][/P1KVBV/[)/[0
M6K^)?B?J6G>%-$TO3_AOXIDT:QL])U&VU&]\1:YXB&D-X9L;-[A8+32;FYUJ
M"*5C<7YE^RVDC/\ OY^Q;_P3X_9Z^ UOX^\:_MS7_P -/BA^UCK/PL\.>&I_
MV/O!'Q!\&>(_B!<VVD7=OJ%]:/<_\)?X6\'R>//B99Z!IMI=^%-4\1QR2>'[
M?Q3;_8]?COY--N4HMO33OTMY7[V]=RDK;)]NK[+_ "_4[K]G_P"-;_MS>/-5
M^)UMX!CTGPYX&U#19M<^/-E>QV?@?Q]\9]1U&<?8/"?AS6XM*U7Q?<W]]=:>
MI=[F/3K.*66.73XC/!;W'JG[2*_#K]B[P3XW\.S>.FTO]H+QS\&_$?CZ=UT#
M1=3N[KP9XG\2Q^#QX/L;#4II8]-F\8^+-8^U7-Y:6C2Z9HFD2+! !>":/[K_
M &*_VA?A[\=_C5\+_P!EN+]DCXV_LW7'A[2+_P".Z>%/&7@;X6V'A+P;X*T_
M7?$6@:)X+OH[7X<Z7/I-U!K&D:?K^G76ARV^O377B.*Y'BV_@A19?S(_X*(_
M\%,/V./"'[9?Q*^'GQ2^&O[1<.J^$]=T_P"'\^LM^SY^SGXET^3P9H;QVNIV
M/@_5_'>GZ?X[NO"WB:<RZC)J-_K-W>19+Z++9I*F-=$KN5]>S2Z.W1]=FKVU
M>A+CS2OM:#6MM&WH]_+H?+-QXFTKPU^SA\)-)^(WC+PA\*?&/@WQ-KWPIU[X
M<> M8\6?"KQCXDU7QU<7_B.P\1>&]2T_4%T)M0NI6NM$U^?7[%]&TYH-.NDN
M+..^EC/SQ\!?BQ\,/A3?>/+G6?BM:_#FX^%'B.QUCX<?"?QYXECU>_AU"'4X
M)D?6]9\/VUQ8>-1)--/?:EJ>GO>)J\#7FGR0G<#7TGJ$-]\<?BM<Z%\.OV@+
M^\?P1XN6#7+G]H[_ ()C>$SX#TV.RU%4.KW/QK^%Y^)N@6>CZA9QPW,?BG7$
M\/6DFGS1W4C(%7=VOQ$L/V'/@;\88?&GQ\_;2_90NHM&"ZWI6B_LR?LH>$OB
M!XSU#19=7$FE6X^*</A37M"\)"RNY7L+G6=)\.ZGJ]I8H+[3XX;XJT:]+)+3
M6SZI;\W3L$8))7=W>][-6VMI\[6W>NA^/_Q;_P""<?Q7_:3^/WQ4\7? 7X8:
MWX&\+^-/B)X@\8:'9>(-';2/A=9^$?%>LRZII5[X,\;VL)TB^T@6.H6\VGZ(
ML,6J06\B6*V_VF P#US5_P#@EE\,OV=],O9/BMKEK\0_&6F:?9WMXFM^+-,^
M%WP_6^GQ_P 2S1X-6E3Q7XJ>$A@]REOI-LX5C&[(48_8?[4W_!<;XZ>,4O?!
M?[,>G? ?PW\(YX[VS:_\6?$SPA_:GB734N&A^T2Z-_PD6A:_H]Q<VJJ8+C5)
MH]819&N;6RTF[)5/P<UOX@&\U2[\2:GXG^"7@C4[B64W%QI,WCCXQ>)8[I@\
MS7FF_P!NW/C+2;6Y9R42[37=.,3$&.9 2U1[J>U^U_=73_/K96Z;#UN[O1=/
MNM?;5O5;]KGZ9>!_A/X8BU/P#H'ACPA\ =#UKXD^)],\.?#VPUJ[36Y];US5
M+Z'3[1-+T;2K35_%&I11S70C-Q<W=KI4QM\B^+;U/]O'[!_@#]DK]@'X?^&_
MA]J7CKP[XB^,?C75);'Q5\3K/P5_9UEKWB26WDO9/#V@WNG:8XT[POI$,,D%
M@EQ=&&7R3-<7#3RA%_BQ_P"" _PU\#_M#?\ !3?P3J>HWWQ"^(VH_#[P=XT^
M(.H>+?%\^G:38:;*EI8^%-,O[?PW;R>(+AY;34_%:2V<]SXBMX[>6"WN8;)+
MB!8Q_=9^T%^TIX%^"]K::1IVA:/;Z7;6\D4$=KIVGR0V7V2/!DA1H,%5"20M
MA@7 )8$&M(KFBV[))VMK;2VG2]]UVZV1+23]U6DUH]&M;+KILDNS/HSXJ_'G
MPIX<\/S:G-J$$NFRPM*EQ;W"MYZ%E=3!(CD.(R \N"579AN67/\ (W_P5!_X
M*PZKH5SK7@/P!K,OGWJ3037=J3Y@@95 6"=7D"2,"&*@9&#R 0M>*_M??\%?
M+*S^)6J^ KW1R/AWJLBZ9XD/A>:WTKQ+H]MJ<$;+XP\(PFX-A<7^D7*1S2Z#
M=B#3/$-A+=1/-IUZ%U"W_ [XOM->?$34M6\2>)K+Q#HLT7]K>&/$MLLATWQ/
MH.KB2XTO5-*@,I5;BXC'E7EE<%+O2KR&[L;^.&XMG2G*:M9>ZE:Z7R\NVU^O
MF8*+NVVWYWLW>WSTUZZZ'W%^QK^VI\7-(^))TOQ/\3?$.E?VQ<1#X7^(=2N)
M;K1O"_C1]474--\.:_;RW"0_\(AX\N9)O#VKS*1_PC\VIQ>(+=7EL3"_]9WC
M7X.:#_P4Y_9LM?B/X3M[OX<?M>_#WPGX@T/PEKEK.+'6;;6[."?2-?\ A_XD
MN RVM]!)?V[KI-]J$%Q'IUPUMJMF4AN26_@$T[XL6NFQ76FZ'H$EU%YBQW5S
M<+%<2^:@21);-T6..&-'_>"3@QE 0S;=U?T>_P#!/K_@IM\0]'\0_ ?P[I.I
M?V.FLWVM^$_BII-S9PS&[\2+8:;#X;\;VNJBU9[G^V= TZ&UNHG640ZC:2-L
MWS"6E!IZ/6]M.NEOO:?7KK8?PM26ZU>NZT3TUTMOUVZG\NGQO\,_%+1OB'XJ
MT7QGXT\5W/C'PYX@UCP[X@T[Q3K5RFLZ7J6D7<EK=6ERJ7;&.2&>.1$2*UB3
M.651GCY^UH^*9&$6N7NKWFT#:FH:A<WH . "OGS2D#@=0H&/6OZ)_P#@Y7_9
M-@^"G[6'@3]HGPZT3>'/VL/!$7C/5I+80Q6H^(GAU[33O&<D)MU5'.IQ7.D^
M(+IL_P#'[J]S&%18U5?YQ8M0OHT*I>7 5CEE\UB"0>,[N<C\/I6+5FUV-9M-
M1=K7UL_-+?S6BV*C0SH-S(ZJ#M#$,%)] 2 #C%0D'/S%@>HP?\&'X58GN;F9
MR99GDZ\.Q9=S=6P3@'TQC'\H?O'!4Y'4YQCDXXZ'\,\<^F43Z]-OP_3TV(SV
M R1G.3VP0??KVYIQ.2 .H4?IG^6/ZT'C(_\ K'_$9S_*A3M/'?U)/\S0)?GI
M^*?Z"?Y/_P!;_(^E)P,MCH1SC/;]1ZTY@0W;&,GV/IUZ4GU^48P">0W.2 .!
MGD\_3TH!JVY&1N)P0>?3&/R'3K[4PJ1UJ; "G']Y?UX_IZTUV;++@<$C@#./
M7/N.N?YT 1#J.].8J1P,<^@'\J<JY'().??)XJ/!'48[?B.HH 4 G.!TI**4
MDGK0&GS]?TM^H9)ZDG\:2E ).!0<=O3\S^9Q0 E%%% !1110 4444 %*<=L^
M^:2BC^OZ^X I<<9XZX]Z2@'!['ZT ..=HSMZ]L9_3M3:4#.<#@<GZ?Y__502
M#T&/QSTH_KU\P$HZ]>W3VHHH 7!P3V%?ZNO_  ;5?\H4?V+?^[C/_6LOCO7^
M47AL>P.3T_\ K'/U_*O]77_@VK.?^"*/[%QZ9_X:,_\ 6LOCO07#=^GZH_RA
MVZ'Z'^55X.K?04 39&<X[\KT[]ZG"*IR% -8=%ZO\D05_P#EM_P+^E6JA<H-
MQ&-_)'/.?\?:DCD&/G89]^O_ -?_ #Z4=/1M_DA]+=KO[[?Y$]%1,X8$(P+'
M&,'GKD]>.F:<F[;\W4<?_7]_K2_K_(0.X0 D9R<8I5.Y0?7FF2JS !1G!)[#
M^=.3Y4&>,#G/&* &R1ER""!@8YIHE"@+@D@ <>H&/YTKLS8\HY ZD<<^F20#
M[XZ?C3EC7 )49P,GW[]/>GIUW].FGFMEY?\  !5<,,],] >N/7Z4KL$'.<^G
MTZ_2O[._V,O^";_[%WP7_P""8/@?]L7XP?LF^._VVOB%\1?"VD>-O$'A;X?Z
M2?&'BK0O#?B345MF_P"$6\+_ -LV$*VG@_2P]_K.HZ<MWJI\N6[DBAL([JZL
MOYFOVOE_9P^*7[6>K:'^Q1\,O%_PQ^$^OZMX:\*>%?"?CRXO?^$B?Q3?R06&
MJW5YIEY>:I/X<MSJ]T;.+1O[0OA:0V3W1EC^TM;0:.FE:[U:3MY.WIH[]^JN
M4XZ:/RMUOI>W?5_\.?$ZR;B/E(![DC\/S[4KN$'0G/3'X?XU_;UXH_X)W?\
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MG3GW_EZU_4S^UC_P3S_9+^&W_!"_X,_M<^#_ (8Q:5\??%?PY_9LUW7/&_\
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M/5!HNE^#9=:MM,M?'GA[PI''H>@>(=6>6X:U\46NB6?V?2H-7@OR\HL(K>.
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M&/;Z4E! 44NTXSCBDH **** "BBB@!0Q'0_RI*** "EQ[@_G_4"DHH ***4
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ME;7-W<RMM2"U@EN9G;T2*%&=SWPH.!UKZ-\#_LK_ !0\6V<NLZM9VW@KPU9
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M-Y-M:VYF_1;_ ()5?$KP[?+8>(?%+2^+/$6O?%37O&WP[\,W=YI]EJ%SX/\
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M3@\'>#;;XCZSIVDV\^G:9%KWQ(ACUCP]]OM)E5KC7],\!MX:L-6O&DD$E_\
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MW_:=_8W,<.YUMWV.H=F]DW\A;6OI?;S]#\Y2/R[''6DK[ US]BCXN>&]"O\
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M@>X]?\_UXF_K]W]?@1-IO3M_F#*1R<<G_/:D'4?4?SJ3A\@9&.?Z?UIR<+C
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MMZ-I"O%I>DZA*9;/3X9GB>:&P0!39K*T*;A;F,'+'&XYKZ#?QEI>I>'?A_\
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MG?VGA'1H-:N-2U+3_A<^H7EM'8ZMI5G&+F817&D/9/J=I;0&754L988]T]O
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MQ%J:*-)UCP]I<UOJ-[H>H6FI):SS1>&FTN;4HD,4EQ%((;B'TOX<_LN_$/\
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MW$,2"H<L;^[=OK+M9-:6VU^?79&CY967/RVM=)N[M;>WX/RT?0_67X@>,OV
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MH34AQ@YQCOGI2TA 8$'H:2W5]NH#4V<[,>^/\^U.W*3MR,CM340(" 2<G/-
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MBV]6FM]=-/Z]4 4444E:6EWWMT6VGYI:?EJ!1115*-G>]]+?E_E_5@"BBBJ
M**** "BBB@ HHHH 4#/<#Z\4NW_:7\Z;10 $@8'?)&<]>IX_ &BEXR"1G'3_
M #_/U[TA.23ZG- "@X'0'ZC-)12X !!SN_3_ #_];WH_K^OZ_0!!U%+QVSG
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MV\-?\$P/'5]X1^)'Q9^.6G?M4>'M(LO"M_X$^&,=G\ _ACXQE@FOK=;--/\
MAKX/^$_Q4U_Q-I_AJQTIKB2"*\:U\/&9UFO[V6[WM)T.B?\ !*GQ3JO@?2?
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MD?&<@(.^Z37/@G=>"=%O-1>3$KW?B/PKXC65QB>WE4L#_=+^S)_P1'^'FE>
MY?%'_!1>+X6_%?Q_J^BQW&J_#KPMX3T'PUHGA@3VR2R0/XOT1?#^K:AJD&[]
M]/#%!9%X_P!T)1EFX_X\_P#!/#_@B]H'AJXTF[_9U\.^&H([.Z9=<\/^-O$&
MDZK;3P0LK2+J&J:K>0S^6X0?)9R1;GP9 Q J_9SLFVEU2;=^FEK/R5O+4SE.
M*:C=M.UWLNE]V^F]F_O9_#I%IW[(OCV\%GH^I?&+X&:A=+#!:#Q6?#_QB\(F
M\<$.+W7?#FE^ _%6E:>\S1JDL'@[Q)<PQ(7F\YB=OZG?LP?\$Z/'GPA\.O\
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MX9XV(!.#S6!10 ]F+'))/U[GDDXS@$D\\9/4FFAB.AI*7'&><=O<\9_KCZ4
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M8I-2N#HUR7;<ULT$0V^RZK\)_CA+8IK":?;_  ZOS$MS)XI^/?BZUUWXDW,
M $&I:-9>(+S^RM)(@R/(MT^U6;1@I-"X %)>3?\ 2]>_6RZ^1=DOOT\KV6CL
M[.W?=_<86@?#'Q'\-?"NO6WB;XX_"']F?PAXG.FVMYHW@;2=>^*OQ=\>7.E7
MJ7^C6?A>^LK.ZNM4:348T9+S2O''ASPE'?+ -4NK,/%7H7Q3^)'P"^ GA+PQ
M\+_"WA3]H?7?B)NU[3OB]-XT\<^&/ OBJ^74YU@=VU/P_P"'/B'J&AZ!?11_
M9+WPKX:U_3KZ.2UN;77O$/B!"HM_-;3X2_L^^$[>S\8?%S]HB?Q[\2]9U"[:
MYM=+U!I9;"*"ZM5M);;5-FNRWFIW?F.=]M=H^G+%&UL#*ZF/J/$?[5?P/^#W
MB2_O_@#\&-"\1>(-(T.:ST_QI\1],/BBV18DDTFXOOL&O2:BVJO<7:7UU)=W
M<-JIOIWO8O*8JJO9+5*Z[MVV>WGNOFGTM71=/ZV[''?#73)_'UIXEO?AW^P+
MX)\0V5Y>6%B-7\<^(_CS>Z':Z?'*]W/=ZUXO_P"%J^!O#5C$GV:S,<EU;V8G
M>YD,:H$51^FG@+P8NG?!VVTO5/AK\)_@_P")H?"_V*^U7X5^%M$\>Z!J?AG0
MM9UG4]8DUO7?VC;/Q%X;M#::5(]U:Z]X#\8?$&YAEL;/^SO"JF*1)_Q'\>_M
MK_M%_$72+>TU7XK^*M+6UO[J:VT[PM?MX5T:UL9X((%LK.QT46;I&GDR.5>:
M0,C*NW(J?1/'@GTSPII-M=ZAIWB4Z_X?-Y\3=9\3ZY<:G&^K6.L6&NZ9%#&\
MSC19XYV:Z41RW!>WR6:*0(R4DG?5[]$M[>OW7[;:D7CO:]F[?>KM:VZ[O\['
MZ&_%/]J_X0_"?7K?PQX>U[7OCOXRTB%6\/:^VO:ROA>W>X@CETM!X\\5>'M)
MU33+9XYY[9K#X.?"GX(W=A<F*.R\?3VVZ:N>_:__ &B?B%\1?A+=>*] O=2T
M*V\;^&_@O'J_A'0)8;7PJMII?A^-?%7C.TA%UJ&M>(]?OOB#X&GT#Q#KOB?4
M]:\0R6VB6E_J>M7/]N7-O;?G7J&G:)J%]X/N[CP[KU[IO@+7+#1?B1XG\/3R
M:O#JV@Q^(4CL-1MA);F'29YK(/I]M_:3+%/>"+S!O?8?=M5ETWQG\.?%GP_^
M&-OK$6N_!_XK7OBGX=IJDL-QJ^M? WQC=ZTTMGJFQ8;:[?POK>M#4;N*. QO
M;^(];FF6.&P8*7=FM[I)6[Z?IH#DK*3O^MWNMM>MV_EY9OP4NO#&DZ1:?%K7
M?#UI:^*;ZXU'PEX!T&^M=-O?".O^+)EB_M'QJVCWU[%]H7P\LUK-%HDUK+HV
MJ^(#$HN[;[))97'V3X#^&?PJ\6Z?XK\>_$SQ'+X7T&34SI'C;7KCXD:SX:\7
M+J6KII%I8KX8TB/P1JEKK=\MUHS;4O\ 5(K?1XXQ.;FZLX94K\[_ (J3^%];
M\56'@.3Q"GA63X<V,'ARS$EG)%X:N=1++>Z\P^RO--I]S/K4TRS7&)86:%6"
MJ!@>O>$;CXY?V8ECH'BCP-=^'%:^ALDU7QQX7O= T?3S8Q?9)&M_%-PMPJ"[
M25E(M2S2W5VH0F5Q0FMK77HF[Z7^_;[NMQMVM?=NR?K;STULM=7;3J?IC^S=
M^S)X9?\ :B^$9TG]J7XX_%;X)6OCWPM<7?@[PQX6N_'.O7$,>KV-W)H_BZ_T
M_6IO .E^%H[-WD\1ZKK$UC_Q+UNC::7<2G _J_T?Q)X-^&?AZ[CG\.:-I7@C
MP/X@\5>(--MH?"5Q?Z;KVOPZ9?2V,%W#X=TNXD9+.TL].U"*%K2YNA;_ &Z>
MVADN;BUMF_B:^#7C:;]G?4=#^,WQ%^+]BLU[KFFZ?X=\ ?![28_"EO\ $6XF
MO[>*]DU?Q7:65A>77A'1)09=5N;"W,>HS0?V;9W#B:::'^S3P9?Q3>#?$_A?
MQ-<1S+%\6;;6=+-W]^:QO;'5[1XHUE\LRK<PO8R*1&=K-&."@6M(M-:>5_NZ
M:OL*2E9<KUOK=_C\M[+TMKI_'M^VU^WW=?%+XK_';XB^!=0CO?!'BS5[/PW9
M6FFV"Z9X=^)G@](TMG?Q/HFH:)H_BBR;37C!TVZU::<IJ$4CVNFVL&T#YH_8
M9\2P>'?VL?A%X]\)ZJC:%XA\7MH&H6&O6]K=S_#CQOKVC:UX?^&_BF[@B2VL
MK_\ X13Q5J6EZ[X9U=+6"RFNK1=+U)(OM-S;S_)G[1VF3^!?C;\;/AS$9(]-
M\,?%?QUI%E!T\JVTWQ)J=O:QMD E$MPH08"\[AG(KD/@UXB;PS\3_ ^HO>W%
MA8#Q1H5OK4EM)*#)I$NK6IOH'2-U:4B$&:':0\4T44\)2>&*1<[MM-^7Y^J7
MY+YZE?FNOW7]+Z:?<?KCX,O_  %_P3U^,OAS]IWQ9X;U/Q'HOQF9-5\-?L^P
M:?=V7A?3?"&OS@^,5^(\^JVMQ#J&E^'=3^T3_#SPM97$NH:_I\.CZSJ>IZ(J
M-;S_ %?_ ,%)O@+XW_;)LOV>/BI\+_%5N?A?=:/XNU/6?&_Q"\=02^ O"ND>
M-O$=UXLT=/"E_9Z!I=A8^%+&RN9O#WAGX:6-MJ'Q!MM>TK5/"NF:'J\MC;W-
MWH^/O@+IW[1OQ<_:/\:?%&XL_"_[,/C3Q]XG\177B;Q]XLM/#.H_#SXA^#/$
MTOA[7O _@>^U79_:ETT$5OJ&C1:?8ZA;CPAJ'V,(;FR91\F_$VZ^ C^'-'^&
M'B/XS^/_ (F_!WP;K O?!/P5^#/F_#KX/:-)&;P'6;KQ3XU275]>\331RR/J
MGB#^Q#)++/,]H8K81Q![*WV79ZNVUF_7Y=+6UNA]UVW^^W];_=J9W[(OC+QE
MX._:1^!OP=_9/\,_$>3X;?#?XM>$/&'QL\>ZQ87'A76OB;J%EJEMIQU;Q3IA
MOH[#PGX T..YN;7P7X2U#4[B_GFO;C4]8FEU>]AT_3/[.H?A!^QI_P $Q/B=
M^T!^W3\6==\%7?[0_P"TWXH\0ZYX(BN8X-,UCPOX$UV9;AM)TRSGO;R$ZA=7
M927Q'XECLH7U%F@L(DD6(03_ ,V7["/Q^_9P\?:A8_!?6_V;O#/B;X8?"J+5
M?C3X@FU7Q?XJ\9^/-9U#P5:)-X1@U3Q4EWI5K/$FJ16&GZ99WD;:)I0OK^Z%
MG^\=Z^//VW/VNM0^-'Q9\;_&;XJ:Y%\5OB'<2SV>A^%K'41#\+/A5HUK,\>D
M^%="@$JQZK/I%LR)+=01F,SI+(AE:=YFJ+25]-TTUT=EI:VOJK[-OSRE)-<L
M7J]-N]KVUT2MJK:Z;Z'ZA?MR?\'"4,C7>C?"#3+;Q)KQ<FWU+46$FB:2SR%Q
M+::*C2B:XA;+1W&LW(>4 .+!%\O'\TGQJ_;,^/G[0&J7FK_$/XCZ_J$.HSW#
MMI5G>S6.EP>>V[RA:0%+>5!D!8Y%V)CY5!%?.WB?Q=JGBS5+RZFATC2HI;AV
M%GI5I;6Z(2<(D;!3*ZH" -S#(Y'>JFDVEH\T<=PX+B0,3([$96-B/E4DK\QY
M"D%B I('-1*3EN_Z\R+7:OJ]E>VFWHCH(/$&H*QA@)@:1(QYRB6:YFRJMYGG
M-,8EED+$9B4!7!; <MGL;+0-5UV:)0]X/),95[P"5U8+G[0)74Q(1NVA6C).
MT,G(!K;\/Z)I5NELMX8R8U+^?E7 "[61UW[8X5XD,:DLK E@"6!KT+4?B/X7
M\,VXM]&CMKV_AC58;B,+/M=N097)2,!%R,*AVDMR0HI?.W]?UO9>9:45I):W
M\]M.QVO@VY@^'EI=Z_J\UY.T<<M\EKI,%S-?7\4*QI>R.$FE6&VLL1EKJ5+5
M$,CJ4%L%9O,_BM^UW\4OB%I4O@:ROY/"_P /YD2VNO"/A]VMTU:"V97CFUS5
M$'VO59695D962.RA8 );N5#GSS1O%7CZT\73^*TU0R7#V.J:/-9962P:QUJU
MEMKNR2)B8I(Y(_+:;<I5Y K \*!2TGPC))<R7-]!&#.[W$A!,4@,CE$MQ' &
M2)'D(P6*;$P" #3NVDE?5V;UU;LM7^G;N$I1Y;1T2^R^BT;?Y?)^AM_#_P")
M7Q?\+6ZVWAOQ-J-Q9,@>72=9']NZ:ELYS$HL-1BNH[6.5HXP'MYH)I54 [0>
M/J/PO\<-(U@QK\6?V?-$UV:2WFLX-<\':Y)X=U(AW)^V1Z9J]KJMLK"0;MUK
M=6"M@J&0$UY1X:\++#<16<[Q 7"PN5$PB65H(WE0(Y W2J)8P6RZ1LK.N=HK
MUJ31WTN59IFC\PJD$I$$<CW,TB J?.3+NPW,V7EB0A. ,YIQYN^G6]FK:='Y
M7[WVL1RMKF:LG;5/7[UKOI\ON]N^&7A/]E77C<BXT[XP: );F)1J&L2>#186
MDLAS<Z9;R6&J7U[<B6Z^RP>>;21PKL-I+ K][_M-^"]=_9-_9<\/?&+P5\*-
M.^+'PCN[C3VFTCQ-=7%I>> =?2 'P[XMU& :?+?ZSI=VZR!F?[!+:7H^S&<6
MD\(K\ZOA;K>B>&O$.G7JZ>FJWFGR6=U9W.I&*2SMKI99!$$1B;6*=IM@_>K(
M$""8DG K^BGX6_$#P?\ M _ OQ7\-/B!-9:OI_B3P[<Z/JFF 12PI%/&D=L@
MEE3:+B.;;,)47$4Z[X@NQ<:)>[I9.VK5O+1[JUU_6A#LI*]VKKKL[KTV7=ZW
M]6?DE^S+XX\6_'S]F:?QS\0-<OM3UC6O&'BRXOYH(87,+3ZM+;65M907$;06
M=AI\*QVUI BB"&!+>$(HBW'Y=\7Z$GAK7F@?QIK!2VNBGV>YMM-BD2W$DDD:
ML]OI<[9<OYF]A*&"JKAEP1]U?LE?"C5?@WI/Q>^ ]V[SGP%\2=0F\/R/%OCU
M30?$-M9ZUH#8=7C\BZM[JY\U@K 2VTJ,5>$D?-/[1'ACQ%97L\MW'%87 N)6
MGN$A#)*!-+$GD^2HEEEC"%7 ^6-.%  %-7LKZM)7]?\ A^M^VNPVX<RY;J^Z
MV6UUW_1W/2?@-XUT+3M6TJ#^T=7OI9;B6-[G4KVYLX//B*_9WEATI+*553Y3
MN-BB2J%/S@8K^Q[_ ()K_$'4_$EG>6VH7\3V^HZ6]E::7IUC-'8Q""W6-V2Z
MOH89'D>4-*X6%HX?,VM(K86OXN/V6/#4^M>)])M+N:]EG@N!<VH\M$GE,\JH
MQM[>3S9F(E9=LC"-43(=P.!_79^Q;!;> 8M#U."[D6Y>W,CB:]EDDNKG8(;M
MWE\QFN$297+DK';H2$6//(I77*V^O?;:_5VW=]0BU%S6NJ72_5=/G9;VW/Y,
M?^#H2#4-/_X*/6T/F7$&G2?!+X>'3HO,=8DB6TGBNEBA41K$IOTN68*N'<M*
M=S.<_P \OA#PGXJ\>^(])\)^#M'U+Q%XGUNX6TT?1M-CDNM3U*[=<Q6ME;J3
M-<7,H&V*",-+(^(XT9F%?U'?\'&?A>R^)_\ P58_9C\(7MKJ>I6/C?X;_"#0
MM:M=%@GNM6N=/U?Q_JMAJ!L([6*::2Y73)9'C$<$K)L#;"JD'["^./\ P0:_
M97T"\\.Z]^S@/CI\/_'^K:Q$O@3QA?RIXZ^%W@?QQI/D7^B6_P 0EL=.@UW3
M=)UR[-M!'JT%M>6MG<2.;KR;=2PPE%N4[=)/\WL:-12C=VNE9)-WLE?O;O=]
M^R/<?^#?U_@+_P ,Y3P_#;PQ\:_A?\=?A/'JGP^_:X^&=X=5G\'?&N;Q7/<S
M>&O'-_I^K+<VNF:[X,-D;+1Y-(LM+U*">1]*U(7%I=PSVWLW[7GQ;@\?:/XG
M\&^%9=5AU?P[<W=O96]S:_8O$4(M+ET^TPZ?;R7]NERC1PM+$DK26Z*EQ)%%
MO;'UIXM^)7CGX$?L_P#A?4?C+!H?P_\ C;KN@W/ASQ9JG@>YTF]L/$WC?3((
MK9/$]U>:%9V]T$\07 22"^NH#<VN38O*JVT9KY1_9K\-0,OC+XK?$[Q%X"L$
MLK6Y2PUJ:[=]<O[_ ,2RW5C+<6NN>1=0VFHV< N=2FG$,FK2&R41@HIK5:12
MUTU:M;6RZ=UU\]C.I+FDMEI;1\UMG?YM>EM=C^:_]N"X\;_&71[3Q3K4%A/X
MTTRPTW1M:UJ[T'39M4U_2-) %OIMUK5NL6HOIADMTG5$D#?:2ZRB-&5#^-6F
M^%/%.CZHCW^DSQ6[:BD+7TD,\<=L9+F"+S'8J%DA*2E!OV$!<J6^\W]Y_P 9
M?V,?A1\2/#Y\8?"B?1M?M(H8F\366D>)-.UY=2."4F6);>RU+3;Z64 RPSV%
MO'/+(3'M9_FY'X _L+?!.YN/LOBKPOH\_F7$,LFCZG:PW%S!-"Z$_;8[E#(K
M0NOFK%L8+A 7Q4RBI6LVOZ]>]_E849--<RNKK5=KI=/O[NZ[IG\XOP!^*6H_
M";X)?M27U]:7[>'O&7[-OBGPKJ-VUE-'%8ZAXGU:ST[2+)?.\R+SKMTCQ*\J
M$11W*1*[@,OX3-$S X5]O&6V_*.1GY@0,CC('/(P,9(_U0_B'^R)^Q]HO[+7
MQ/7Q;\'?!'C/P]I%QINN#PK)#):V>KZW8K>)H"W\>CW%A<30KJ&I22NDDKQ*
MC3,(S)BOQPO?@)\%/@9XW\,_"W5/@%\';RX\::#-XZFL-7^&GA74=.71;Q;>
M6?4EO-1TZ[U&P\/VDL@T:VN&N]ES>[K2T,UT)S&I4WI=K96]/DK=[:OS9KST
MK=?N?6VVO9>27Y_PE.N%''S Y[ \=N_ZY[\U"TF<8X_ #^7^?SK]C/\ @JG^
MR]!X7^/UGKGP%_9E\5>!/A_XKT=9?,\"7&H?$/X?ZYXAM91!J=YX6ETS3I[C
MPPK2G-YX4U666]TV=U\MC:R0JOS]\ _^"4W_  4"_:4N;9/A9^R]\4+S3+D@
MGQ%XCT&?PAX?MXR/]?<:GXC33HQ"N0Q,*3-LRQ7:I-9V=[=1N+N^5:.UM5Y>
M9^>7)W#)X'.<C/KCU_SG%(!ZD >_KV'N3Z#GKQ7]17PD_P"#5#]N'Q:]I<?%
M7XB_"'X26#)'->0R:EJ7BO5DB)(D6*WT:T:W,R@$H&FV-SE@!FOT#T#_ (-E
M_P!B+X,Z$WB3]I#]JKQQXAMK&))M170U\.?#W2E ;]XW]JZO<7]S;P#GYWL]
MY5&+(.E4J<VK\NG=V7YO_AQ<O=I>GO/[E?\ S\C^(+3M+O\ 5KVUTS3+.XU"
M_O[B*TL;*U@DN+F\NKAQ'!;V\,(>2661R$1$4MN8  DU];_&C]@S]I[X#>!_
M!GQ$^('P^,7AKQM?W.AVDWAW5=*\476A>)+*SMM1N/"WBVPT"\U"\\+>)(]/
MN[>\_L?7(;*]:%G*1,T$ZQ?T _M*?##_ ()V?LU1:#=_L%>*M)D^(^CS20:M
MJVM6<_CWQ%%.A:--2T3Q/?VUOI.EWL1!5;C3M($XG43V]W&ZAJ]D_P""4?[0
M_P 4?!GQ=U'P[JOB;2X/A=XKM_%OC'QMIWC:VL-7MM4US2="N;6WUS2I]624
M67BJUGN8-1,T#I/=6-G=0E97=8W:IZV;MYK5?GK_ %KT"\+=>B[=$^KWU_3S
M/Y2?"W[+_P"T9XWF2W\'_ WXK^)[B0D)#H?@/Q)J4C$ -\JVVGR%AM8$D=!S
MR.:^EO#/_!+3]MO7A;SZK\'Y?AS97%O+(EW\6_$GA?X7Q/L(#8B\:ZQHUV[J
M2 (XK=Y6SA$)K^G+_@H)_P %7_BU\2/C'XN\%^&?$/A_X:? +P[K5YHVAV?A
M7Q'#<ZYXHT[3[J:Q'B*6;31::59MJ,4 O[;3@T[VD$T,5R[.&+?BO\4OB_\
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MK\+^%_!&GR32^8-@L= T33;8(H<EGD26YDV1JUPT<4:KSE[^R'\,]:U=?^$
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MCXA:/IW@GPG:%0&B>[\(Z!XB\3:GK\D,[.SPWGB73=.=HP+FUOX9#$F;\8_
M?B#X5>*1X*U_3-1L[9;*UU."RU 7#P0R7:^9=-H]W*D8N( <QO<6X,4CAU8N
MR;AF?"_X+?$?XT:\/#OPQ\,:EXGOHXDFU&2&,6^F:):,6WZAKFM7+1:5H]C$
MIW2W=_=6\("G!)&"?+7^NFWX=[D2O*RL[I[]/6^]MOEN<KXJ\<^)_&VO#Q'X
MDU.;4;]#"ML D=M9Z?;6IS;6&E6%LJ6>F:?:H%2VLK.*&W@10L:*!7^A7H^L
M7.N>$/@SXU>6*&?QMX"^$OB5E2%)I+B?Q-X!\#ZMYWVB20 3/?W4T2J(PJJS
M2;M[L#_)-\*?^"?7P3TQ#+\6OBGXM^,7BNWMOM-Q\+/V5_#K^,OLDZKN?3?$
MOQ0U$6WA'1&!!5[G3_[;575@D;[>?TZ\8?\ !4#Q;X"\%>&O &@?#GP)\,+'
MX8^"O#O@OPAI'CK7$\5_$6\M/"NB:7HVBOJ]OI*WEG]N6PTF!)[R:UTZ$<,M
MNDCBK@N]K.WGK?\ /79V=[$SD[**;4DU=WM>VCUWM\O\C\<_VM_V>O%_C3]L
M_P#:-D\Z/1+?6/CQXTTGP]:/INMZ_P"(_%.KS:Q([V'AGPOX<T[4M7U:2.69
M8YKD06]@DS+$;OS&"5^F'['_ /P13\->&KC0/B/^UK\4? VA:SX@O9HOA9\%
M?%(US2_[0U?1]%O?%VM7_P 3[;3W;5X[3PGX3TZ7Q5KGA;0[V&PTS2BMQX^\
M7>%1''X<UW$^!?\ P54T'PUXY^)_QL^(OP>^%>H_$Z[\,?8M(U71_"4L.K7O
MB/4M30-<3:A]MAC@MHH6N+F^L[.SM6UF=X+6^DEA,P'Q5^VM^W#\4?CY\=;_
M ,;:3/+\.-#M/ NO^!=+\/:2L>F1>#_AOXMTZ/2==TF(6S^3::[XZM;K5;[Q
M7=0;;B]&KRV!*VMM;Q0KW4^_9=K;WV^2L6III?+717V_I];'I_[6WQU_9G\<
M>.KC1[7XB_&/Q3"FMVFE:7\9-:O=-?1[B%Y6AU;Q+X2^$>D:!'IOAOP3IR!Q
MHWAZ#5;C5=5@CAD>YT:65HT[_P"$/@/]F?P_X)N_CMXCME\#_ 30=1N]+LOV
MA/VAM(T_XF_'#XV^)-,0?:=%_9G_ &9%U"V^&6ER&18X;_Q!XXF\<Z-X42X5
M]0\3WNH1G1U_"?5]2?4=1N1IJJJ!@B3IF."* (400*V I(+,[+PSDD* 0*ZZ
M[\1>*?$%CX=T_P 2>*-2UK3_  KI<6C>'+*_O9Y[/0]*6<2IINDVLS""SMI)
MGEGG2&-4FED::;?(2U2W=W:5_P"M'W7X^8G)+5):ZZZZZ/77\.]V?J-X^_X*
M-06-S>:5^SC\#_"7@/P[%;2:=:^-OBU;P?%WXF:UIDB*@FO+>_L=.^&'A=78
M%[?1?"W@33[&QC*P+<7./.?YNG_:3_:%\=6MU;:A\1+VUTB9I8;NQT70]"T;
M3YH;H&"6U72=!TC2;6RC*DD)YJHZ@!F56S7S+IL5JZ'[1-9I;QRYD6>-_*0.
M&<\JVZ4JI40[OER,'/-=I:^(+BU>YBTF03PY5(2L4X242K&F^X@!:'9&I$<9
M;(+.,A0:=V]+OLE?3M9ZZ?J2Y7DGK9=TKK5:*W1_IJ:=G\*]'A>6_P!7EMYK
M-))'N[B]N+/33Y;_ +UE-O#).RRH3M)CN%+/N"CJ:X;Q=/I,LW]E_#S2'E@5
M-FH:K+'(]LX'R-'9-+(TFS>0'F;!$A'EMC!KL!_9^H3+=>*+V:]Q*YDM//:&
MTMUC)$K"UPH5IF526 (/\.T=.XT:SGM]"L?%N@Z',GPU3Q5INC^./%?ATVVJ
M:GX8TZ>^MK6[O=2TY)VN=-MH[>5Y;"XNH8[*_D4V_P!I27HONU_#^O\ @=T-
M6E+31;OO??3?OY6['@=AX:L=#MYM1\:W>L7*6T$-Q)HVFWT4+I )DLX;B>7%
MP?L[7$@MU5%WJ[*#&%RP\^@\4VT>K2F&U2.QDE<6\%WY5Q+% S_*))HXX 75
M."RQYR3Q@D'Z,_:-^#_C'X$_%;Q[\)/%LMOJTHL8I/#WBBQ\RXTCQ9X3OWM=
M>\)>*?#MTYS/HOB"S%C>V<I8O&L\MM,JW$<H/Q])830K%),C(\WF(BC =@C%
M<ODY&2"2>WYTGV\^OJD_GV7?YCY-'KKIOLMM.O3L['O?A[78+F6 &WL]NVYV
MM)(TQC*R*401R-&HP@W!R)" <*,<5ZEIVJRL(Y8PR0SAI7GCB@,BN"#L>!RK
MM&=GE^9MPA(.>]?)>BZI]EF EXF"YC=&965<@D\$$'.,,"6XXPM>PZ'K08^;
M]H='$FT173-*DR/@DI*")$=FX?<SQA0"$S33Z?TF[;_U_P '-II^>GGVT_3\
MCZ.TI$8"[FLHO+BN&E.V6X2YDQY!:-9BCCR(Q&F8Q&NX2O#NP=X^B-*M5UW3
MHQ)91.DAB#P02S6RN[[5A%Q<"PN)9)47]XY B12&PPZU\W^#=0/VFQDMY(I0
MUQ%+=6LC+=1K#;MYGGLTD7VB)I=XBD"L,*K1CY>*^P/ NL->PQ".'RF*,=J:
M?(WFJ!EF)CD*E2"2A"K(!R""!BH)-OO;:W337] N^5V>B5[:]U_P]K'/2_#:
M_P!,L(G8,EM<W$[Q06K%#&VP*OEW4D0E$;2'YI6B,@= D,;"0D?>?[&OC:QT
M'Q/;V;)I\BW0:&[DFGU?4KJ01^65\DS6T5MM4A_,\G(R<;6(-?.5]J&NKI\J
M16D=JCQP30NGVUQ)Y<S0PM(GFR""1)070E$<L\NYMJ@5RNB>,O&/ABZ1[34M
M6L8-Z^9'9K)'+AV<2E7\M"(49=CQM*X?/0@\:D6<HN]KWT:?^7:]OZN_VS\6
MP:7#X\OO$M@+1)M;@M;>]N;*$V<DFGVD<YM8HHY")(K@37/V6U,B_NUN[E%<
M1A:^!_VF;?2+:]-SJ"6=F[>:HLHY)KC4G5HU=A<SRB*T22++ERP>;?DX)'/I
M/P-\6>,_B9J^E:#:Z)KOB7Q!K$MGI-E86GGR7NJ3WH86D%G86\DL]U<[K3S1
M<A$@MB0S^7%O9/V%M_\ @@7\3_C]X6'B+XC_ !8L/@UK6H6WVS2]"M-!B\4:
MND\ZJRIX@N7NX;>V:1>+A+83S6\I;:KD"AM+KT]+O>VK_JPZ,$W>5FMNM[WC
MKHO/?6Q_-Y\"?&MQH?BZULM!MA:6E[+ CW2;KF]FB,[*MHD]RXN;M6=_,>"V
MBA2)O+VNX %?UJ_L@?#_ ,<'2_#&J^+-.U"WB\2:##KVF6%P/(U74M _?Q6F
MHRVCG;I.CN]KOMWOI;.6:(+(EI%$5:7\VU_X))ZG_P $_(]4_:$_:A\1Z=XR
M^&GA;6+72]$'PJBU:_\ $.K7M[<%M/N?$%S<:=(OA300+4IJ5Y&DT[7$UM9P
M-#Y_VA/T"G_X*4?!>&_T[Q5JM]HN@6]Q'X=L=-LTU ^'[%]$T>Q,>@^'XVGV
M1P6B07$LS68??/=JI!;R/+5IK2^MO.ZW5^FO7[]$M;N<>5R;M[VD;7?9/\';
M2[TV=B]^T1XB_8?_ &:_VIXOVJOVB]=\.Z/\3=9M/#'P@\$>)_%%C/K\7AHZ
M3:6YGT#X9Z-I]A<ZA'J%[/=R7>O>*-1-E;(+TVYU2QT_R8)_1/#6M^"=9^V_
M$W6_&GC'2?#\>BS:/\,;O68;3P"GA9/$E[=P0>([-]2LK;5=/UCQ=97=A;6U
MAXCG\1Z%<"WTR^T6WMW)N;[YW7XQ_ 7XR^*=6/BKX+_"CX\:1XHU+4+_ $^7
MXB^'M#\6W7PXN]<O+*U*#3]7LM1NIM O;7%QJ6HZ*ZWEN;* 36TL0C(^[O\
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M54G) )]2 >E+6">UUM?\?SMOKZ$"*=P!QC(SBEHHI %%%% !112$A02>@HW
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M\/:+H0>?7M4U:2-FM])TW4WQ*F]H_P"FSX(_MM?!WX#>*KW]AS]N3]NOQO\
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M/K4A7:64YR"5.1@DC@YZ$'CG.#FC:HY!S[<\=^YQ^M8F1#N8\9Z\=!WIQ.S
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "C/;^@_GUHHHNUL[ %%%%4G\.OVMNWX_IW\[@XKM"GU!/7/?BF
MTN>@]/\ $FDH=G+^[=>5MK^@/_+\OU"B@_X?R_K10FE=6YO/;MI;U^\ HHHI
MRTY6M+KI\F'2_K^%O\P_S_\ K[?SHHHJE=O565M+]]-?7_@^8!1115@%%%%
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M0+I]<T&>UO9C(]Q:VT8*NJ2.(X9R)+*1R57R[J1222!7]CW_  2L_;M3XQ>
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MG]A7XZZ-XW_8F_:5U_Q ESX?D\'_ /"0Z=I6L>-=$FDGTJQFAU*1->LK^"Y
M>Z\+>)I/LMZ\'G0:U;7J00K^@_P,_P"$D_9ETOX2_LB?M&?&+P[XB_;L^,6G
MZS$/%Z>$;/4+CQE^R_\ "#Q.GB'Q-X%UOQ+-%!J,MSXLT+^T#I<LT\EZUSX8
MUU[G[.EC$FI^+_LP?\%AOV2/VX?C'XO\&:!\.++]FC]K+Q-X?U+P-\*OB1\1
MOA]X)\1W?B*ZNXF@T[1]<U+1M.M-9O%M;E8V'AG5-3M+2YM@]LDA9FM9O>?V
M9_"G[<7@W2O'%[^WU_PIF]_:7\">+/B3X:_8I^)?B231;?Q%\7[?QAX7U*#Q
M9'H6C:)]@O\ 3_#&C^&+.*47%O;0&ZT*.TTZ_P!//]A+/)*MNGS/;F2:22:W
M7>VVROU;-8MM7:Y7;X;^G;I?RTWTU/\ .Z^(?]GGX@>./[),9TL^,/$QTWRA
MM0Z?_;5[]C*)C*H;;RRHVX52!SUK[._9;_X)K?M-_M6>&[WXC>&="T;X<_!7
M27FCU;XW_%S4I/!GPYCDMT+W-MHE[-:7>K>+[^V#0K/8^$=*UF6V>:!;YK43
M(U?O-^Q)_P $7?!WQ@_;4_:V^.'Q]T V/[*'P ^-GBZ#0/!KR-96?Q(\1S7A
M\26'AB2XAD1T\,:+8:C9R:XMM(#<"6VTQ6B^T.\7BG_!9W]N7Q#K5U;_  /^
M'K6?@/X<^&=,B\/Z)X1\)V\.F>'+/0K)T@M;/3-.TV."UL+6%+2VC1(]Z%E+
M1I"[7#39J.G-+;IW?_ Z?KH1)QC*UKOJNBT7?3STUUV/Q/\ BQ^QQK/@5_%<
MWPW^*OPQ_: L/ 5K]N\9R?"^[\1'5/#^GQR&&YUB70O$VAZ'J6HZ%:3!8[O5
M=&CU*WL/,B;4A8I+&S>S_P#!)G]A*\_X*"?MF> ?@YJ"W=I\,- BN?B+\:-:
MMBT1L/AQX7EMY=1TZ"Z (MM3\5:A/I_A;2B%>:.XU5KQ(F2SE*>)_LK?$^^^
M$7Q2T7QR)_,*1W^CZO;R;)H=3TCQ)8RZ/JNE:A#*&2XTZ^L[N>*[A=761'^9
M2<FO[7/^#<']EOPY\$OA[^T3\<IEMXI?B_\ %:?1/#M]B"7['\*? %K+JMT%
M=$#PVTVLZAJB7,J2K OV&S)VF)78A%2DETOJO*U]_.S7^5QRDE!RLM.BMHV[
M;].C/H3_ (*(_!+X*W7@/X2?L3>!_ASX0\*^ =&L['QCXGT'1]/LK/3]&TW3
MM+>UTTW4:0O*UQ::/;R_;+F>=;J:1KB>XDDFE8M^07P;_9J_8,_;]\,^)/V'
M_&_PY\,_LX?&3P4-<OOV:?C%X TWRKJ_TZ:YDE_L?QK#)*K>)AY_EW=U'?R"
M:6QFDDT^\M)H%B?T+]O?]MY=6U_X]^-O#R7-G=^+=<O_  CX?O9WD\ZW\/RW
M4UM?RQ^1<Q@QW6FVK1VR3?\ 'M)<,-L@P[?@WX;_ &DM7\+^,?#_ ,0O!NLO
MHWCOPQJ/]JZ1J,<?ERJD#1_Z)<2)NBFM[Z.(V\XDS',CE)]V"#K)QOJDET6B
MTT^[2WYHP@WO?Y._2WX7>ORV/D#]N']A+X__ /!/_P",FH?!WX\^&#8W;&>]
M\&^--),MYX(^(GAI;B6&V\1^$=8:)%O+20(%N[*=8M4TFY#6FIVT$P&_XP(/
M.>O?\><\<?K7^AY\)!\'?^"\?["OC?X'_%2/3-$^.W@F*/5/"VNNL4NI>$_B
M%+9#^S_$&@W4YDU"/PSK=Q')9:]IS74D%S;SAF4R06[U_!5\?/@9\0OV;?C!
MX_\ @I\4M"N="\;_  _\0W_A[6["YC*'S;.X:&*\MRP GLKV(1W-I<1EDE@D
M1E8@@UE*-K-:Q>SZ^:>VORU1MR\VM[/2Z]4M=[Z^?6^O4\7HI6ZGZG^=)DCD
M=:@@**4DGK2<<YS[?_7H_K4!<D<'TQSGCW]J^KOV6?V)/VG/VSM>UG0?V=?A
M/XC^(+>&;,ZCXIUJQM3%X<\+:=M9_MFNZS/Y=I:J4CD>*U226^N C?9K69EQ
M7RDH+.HP2690!SDDD  8YR>@QSZ5^F_[._BSX\:-K?@\_#OXI^*_V=/"'PHL
M7N=.\0:'>:CX??6?B!JUG;ZI/:W:61A&K>(?$"RV]G:OJXEL[+2K2+<;>!G6
M1K5K>S^_7UV^[[BXQO9]G^JZ[=?P/HOX=_\ ! ']N?Q]IS>+'NO@SX6^%VES
M7P\;?%7Q)\0AIWA7P'!I\3S73ZU!<Z1!K-_<E8S%:6.AZ?J4]S<R0Q,8$8S1
M_'?[6?[-G[-WP#;1?#7PQ^.?BKXR>)D>2#Q3XL?P5;>%/ $5PH90/#EI<:CJ
M'B2^LGF5U@U#48["2=%++885L?HE\?/^"I/[2MAID_@?XD?$WQ1\9/!.N6]G
M!-H.JZZML]M<213-G6AI=M%I.L:@KP&\-V55VL[ZS\W<6<#\=_'5SXM^/?C&
MUU/1O",/AO3M3U.PTF"TMKB[N-.AU"["PPM=WUX[%9KDHY7[D8 V1* ,M344
MK*[=[=6_\G^>H->_HDDN5_BDU;OV_P ]_GF4!7*8!(ZN@/E$ D#:6 ;)Y.&
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MB@  8 P*6BD(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:H.@7'R]CG)/Z(>%-0TO]N[X:^'OA/XCNX+3]K;X5>'?[&^#GB6[:*%_CQX
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MT'Q-?1^&?%-JK$V]UI.HS*T%RVTA5EM;GR]B$$QR1J.$R*_:'_@Y4_86\/\
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M _-[;.W]?\/]XPY+9R,=#^!YSGWSS3QQ@GIUZ9R/;UI!Q^?\^?ZTN,[CGGC
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MHHHI %%0S,5"X)')J1"2JD\DCF@!U%%% !1110 4444 %%%% !1110 4444
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M 1R>1^GY\_R_K2J#QE!CU/7&>O7_ #TI<CD?</KQS_3]:!M>OKZI.W];BC@
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M\1?!KPGIVH7 6VT#1K6\6TG71&!N7O8]5^UW4][<K]FA@"R6\,96::1O0_\
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M#X6DM(\/M$L%^-290"/GB=D7'R[U!S7]-W[-G[!GQ$T3X9_ _P ??&_6-/\
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M E>YT1I8X]0\0>!DM3_;TQ8EENM6N+=I[F),1HLC0QJ(PH']A?QM_:M3Q/\
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MK#QIIM[%;74LFFK)!?VDMU"L\L%SI[S"XA:"5G@9W7#M&S+E2I+L[7MHNO\
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M<5.00<<]/S_QQUI>7Z?U<"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLX?%NUOWBVFRTK5XOB5\-=3B4+E81?:CXC\.),!]\65N2<1H!^?4,K0S>:F
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M_2G88C/UYX'^?ZTVE"D@D8^49/\ ]:@!*4'!S244 *QW'.,<8K_5U_X-JO\
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M@\C(!_/^GO0 X#=R>QQ@=*=N'J/S%+QV'U]_T_QJ./&2".,=L>HSVYH DR"
M 1D?>Z>N<=>N./6CU^G^?TS_ /JI"HS\O /+9ZD]CQZ4N<<CKZ^@[_G_ #%
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M#QCL(.J6T27I3+16VJP)LN[=3D^7&[#[1"C8_=.%3Y8\CQ:N&IK*_1WM]_\
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M_P"'$&.#[8_'K_\ 6I2V1T&>YQS3:*8!CZ?F*_U=O^#:K_E"A^Q;_P!W&?\
MK67QWK_*)K_5V_X-JO\ E"A^Q;_W<9_ZUE\=Z"X;OT_5'^433'W%?D.#_3_/
ML:?17.0(N<#=UQSCUI:** "D.<''7''UI:* (8_,W'>3C''IG/45-110 5$H
M?>V<[,G&?TQWQ^/IFI:8[%%R!GD?K0 ^BFHX<9''J.XILCE "!G)Y'M]>WY&
MBVMMO70"2BD4[E#=,C.*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BOWZ_X-^OA-^S+\7_B]^VCH/[6D6B0?!W3/V*O$VM:SXCUNUCF7PC.
MGQK^"&FQZ]97QL[ZZT29+;4+K3[G6-.@-]:Z;J-\L65D9&^E_A?\%)_VA/\
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M$DC;P, =3C/T[8XZTP!6R"&/';./Q^O;-/"@=!4:J",G/7_"I1[\4 %*#C/
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M3X:VFA^&/C7\:[33(GU>:VL?A'\/O%^I(T<6FZIXBMI[_P >:]X>@,T45O\
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M[-U86'B"]^#<_P */AO=>9.0OEGXA_$'PHPC7+*GF/ K>7MKY[\??$N/XR?
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M<>,O%GPF_P""HG_!-SP5X_U25#XX_P""8?A3P%!H]S=G['IFI6WAR75#I-N
MZK]IN)] GCO8F5I%NWGC.&0 ?R]_!G2[.UM?V'?A3>^6;/XC?%'Q#\?/&4<<
MD4K7-A!X@;X>^#+&X@&<-IMKX \6ZA!#.I!3Q0S [9BH_7CXN?%;7/$W[4W_
M  0L^.=U>2MK/BC1]%M;[4DVB:6#4/V@O'&D7-H=Q\L(NG:JUGY+'RXX"L('
MEX45'1I]4XORW6_WK8VDFX272R3U[N-_F]+^3]#] O\ @KEI<EUX;O-+TZ;^
MT+2VM)I;E+:,+!+:[7EM/,94&!/#;V,+1M(?,1)-A2-BM?Q0^-+4PZ[<AH5W
M27CL(E58E>,/@G8!E3O'3/3!R<U_H/\ _!0+X46^I_"CXCZQJ$"PQ'3;V&WN
M&2-_+$,\=D/+8#:S0PQRQXC"@.2P[5_ 9\4TMY/B)K-FBJOEWD@B1/NP6Z38
MM[<QC@.8PK$J?O,<>U5.GS_0P245ROXT[W6R6EOFK-/0V/!EM=6.@ZO>Q,8H
M9)8X=J@LK3LC&62-5*F1%A"*_P S*A*OA7(K0^&7C"_^'7Q,@U/3KR2*?3K[
M2]>M)8$'F2N'BDDB7*,[*P,FY!D$DD]36M9(-,\)2L7$?D+)-)%*(MRRW(9,
ME990XD3[/E8XXW.UT=>*\MN[F6R\8^'+MAYWVBU%N"N1E0FU(T<!"6B#Y)*A
M\KC!&*SO:S7W^O\ P?O\BDF[-I.%KK;IV];?KUNOL#]HFWT%OVM+CXB:"MG-
MX:U[0?#GQ0M].BD5+:WU76=+COM7TF-D;9$T?B#^T9%B8QALR#:NY17K'P _
M9:\ ?M3_  5_:Q_:9^(/Q.\2>$O%GPI\3^ /#?PJ\.:/I.GZK;^.O$?BR35&
M@T>9+B[LKFP@TZUTJ?49[JT-SY-K%<2RPERI/Q#XJU>:U\-)=7+0/=RPR:$T
M[RN\[VPNI+A!'(Y/^HB:16( $2J%&-W/4Q^,?$/@7X$_#3PGX4\5WEEJGC/Q
M?XC^(?B#1],F:W$%I;P)X8\,2W4R&.3S;N*37@D9)6*./S01YI%5?77O=J_Y
M>>[7]7:V=E:-KQ72[LD]=.E]=CZL_8F_:%UGX4_%?4?@_P"*O&NKM\//&VOV
M<%YK=A>7)N/ _CK0[_'PX^-WA:&2=VTCQE\.?$D5KJ-O>VA6YU?PZVL>%;Z2
M71]=O('];_X*!_#BP\2VGP[\?:'H^CZ)J7QJUS4M ^)?ACPS'!;:-X:^._@/
M7(M#^+"Z%96D<=K::'XHWV'Q T>Q@'V>RA\17%I;QI:6\2K^;_B2YM-/\3^"
M_B#I6E_V4]]>V>E:KI4[(,^(],TO1Y=3U.%(WW?9-0OKDWEL6(2.7=C@!1^B
M5Q\3+#Q1\)K^+6I6.I:5\<+/Q5HULRQN+*[O_AK<:-XAN'E8AE:=].TIKF6-
MF$MR(&D+OBFM59[_ /MK<6W^HU.UTW=62775N-]?OUUOYGA_B^_M_!UWI_V5
M;;9X*T::;1PBJD2:G9V(ATTLJX9G>[:UPQ<[;C&W!#%O</@?^T"GP[^ _B[]
MFOXG6VKZG^SY^T3J&CV=UJ5A<+_:_P *?C!HD/\ Q(O'^FP%6MKZSGL)!9>)
MM+,D1U'28XI8I8;S3HB/BSXH:U%J$&F!DEADU#6UCE*L1(4BG!)4.!YL0F2$
M,3E1C(.17WM\)_@%?_M _LM_$W0?"MDU_P",_"_Q-^">M:996T<DMZNG>)O%
M.M> ];V!5+8A76=/>9E*HK0$%P4!HZNW176[WLO7;3R\K(GGE=:WZ/TNK]/^
M#IH?1?QB^$7Q]N/V:O!7B+XG>$M6_MKX.M<^&?\ A,IX)I(?$'A'2+JVM?#O
MB^VG,:R77]FPWEMINJRO*573;_2[A@\%P\L/3_ 'X,_!#P;\"?BM^U=^T+\(
M)_BWX?\  OA73O%</A!FU2[6PN;R_M!HCK_9E]9!+6;4Y+>36+Z]FGM([6>X
M6YBN(99$/]&?_!3^S\*_LR_\$[],^$OB>&:YUS0- \%>!_#_ (BN-/?4+&?Q
M)J/@&\\&ZQ8Z[=1@R06>MPW-S;1WL@: :D=)-SQ&'7^0_P ;?M<'2?\ @GA\
M5OV?5OO%&B^+]6U[P=:Z/?:'%(+;5/ HU*X_M_P;XQF(#KIUJ&5K1T+K,UM:
M0.%4 M;]U6=G[J^^T>_:_P#P&]I;BW'E5ES/FMUMMK?KUM]_?\P/VH?VD_$7
M[3GQ'U#QMJ?AGPAX&T)))HO#/@7P+X>TGPWX;\-Z8\VZ&W@L])L[2&>Z*!#=
MWDT9GN)%'*HJ@>&^%O#MYXFU:+3K,.B-\]_<H&:*TLHB#-/.%&W:B@JN[DN0
MH(SSSW3GKZCUR,=_0D'\/QK]-_!?A_X6^$OV>_#LGA34M/U;QIXO6WU/Q=KF
M^.=["_EC<KX=C(026%OIB3K:S031MYUZ'N"TD<D3)DE=O797=^R^\MSOOUT2
MM?7I]R7Z[61YCX=6+PO)9W-G=K!;V4UK#;3HA4^0I55=80K'S&?)R3M8DD^H
M^T?#OB=_$%A&(_.6YD$0 FERSS- !*OF)O"DQ(656="LF5SP<_)]GHUM+HU_
M,) EY&]O'8J[1E043=(L</15+[O+9QM8 ^M?3/['_A'Q!\4/B'8>#M*TFYU+
M4-:N;2!(4@-Y (/,\RXNIHHMS1QQVJM*UP@ 4.XW!5%7%[+H[]5O9;]MK_,S
MTT;V6K[Z:]/F?=W[%_Q'^,/PSU3QIK/AG0]3\0VFB^!O%_B%[;3-,O=5O#)I
M.B7UU8,MC:KNO MS%:JX,,A7+.05!S_,3XIN]4U3Q'XAU+6!=)J=_K.HW>HI
M>B9+Q+RYO)9YQ<I./.6?S'8.)1YBL#G!!K_5(_9K^"/[(?[).E06UY/:>$/'
M3_#'2/%OB3Q?K%_ 56SO[K[))9VHO%*I!/?12$VD6))(XL8==P/\9'_!S%\%
M/@K\+_VY_ _CKX'V>@Z?H/Q\^!WASXGZ_!X72W@\/WOB;_A(/$OAJ]U_3K>T
M1+:+^W[71+&^NUA54DOOM=QM5YY :J1]U.ZTZ7N[-+7[]'YEI)WE%-+1K2RO
MI=W?W]C^=47$ZP26W+02LK-&6.U95!"SJ,[1( 2N['*,5Y%8DMK*#A"0!\V\
MCC@X(/YC_P#56J7(/&".OU_P]*;D%L,0 ,$#OD9SQR,$\_AUX%8-)[H5W>[U
MUOK_ %Y?Y&7'!(258,P'W\84$$9/<8X^OO6I91169\R("2<$E2P#+$2"%=<@
M98#)R>X!^@1@G')[G ''&!QZ#C\OK3TQSQCIGWZT));?TM/\@3:V=O\ @#&W
M'+.Q+NQ9CD_O&.2SMSR3UYY'0<4T\C!Y'I_GZ4XGJ/\ :)SWZTVF#?Z7_7\=
M0I,XW8/.#T/]*6F,OW2?EP<M@9)QSTZ^GZX- CTSX1?"/QW\<?'_ (<^&GPX
MT*Z\1>*_$MY'9V%E:QNX0-_KKNYDP$@M+6,-+<S2LL<<:LS-P!7Z8_%']A1?
MV6HK*T\81VVOZ^UA;7FI:U<0BXT^SN-ZFXM[&.X(M]MOAHTDDCE,I#.$'&?0
MO^"8?B?PU^SOX=N_C'?Q6TGBWQC?76E6$\D(DOM/\+:/,;:2"S<K(+?^WM5C
MN#<SA59X+&% WDO(&W/V^OVMF^+%Q/J;7>FLI9DCLHEC?;(R-)-&8QLR02%D
MW$(A!*#D"M%%*-Y=5]W:WF_/0J7-'ELM[W=E9V4?+N[ZZW[(_.KQ?XCTZXMU
MM)-3GELB\<4UM-,T,2VR&-D^RVT&VV2+/F(SM;JJEL*BGFO&F\2:-9I+9C1-
M'O+,SM(HN[.WD<85D4O+Y0NL G>&BN(AD\YXSY[K_B::]N7+3!C,WDD_*#'"
M&E8*JJQ")N<84<=QU-8BNTH&6)*@+G/!4=!C\1SZ=!ZYW3=NJMIZ)$JZZZO7
M1_+?HOGOJTM#WX?&O5X?#=WX9L8K.'0KY]-DUGPW)YEUI&L3:7*\UA?S6MXU
MPBWUA)+(;.:,^9;AYE!,4TL;Q:'XTFU.8+926]C(HD6.V6WBA)B*[0N+= K[
M<[2IB(*GD$UX3Y8X)SE2"""1^!QU!/7(Z<4^VN&L;J&Z@WPSAUD5XR<(RG*D
MD<#)P.V[..:=V]7KZE1>CC>W;MYKR3_KL_UL_8O_ &B]'^&_Q>\,VGC>/3M6
M\.ZCJ<6CZYINM16VK:1JFCZU_HEWI=W87@-K>6,L$DZW%LZ!)('>&1=F17FW
M_!3WX"_"'X/_ !TDUOX$PKI?PW\>F_U2Q\*+*)K;PMJ,0LKF\L=(=I'E/AZ<
M:A'/H\4[&:TC$MF7D6!7;X'O-8FN;V'50XM[R%X)%*Y"B:$HV4"Y P0-I(SN
ME*\ D5]??%/X<_M$?&_X*VG[15OX*\3>+?AQX"N[;PKXR\7Z3I=S?VGA>_NM
M+CO+)=>-I',=/L9;2-4AU&=8K9G5(7<2%07>ZL[M[I_G_6OX!'JEHG&UEKKH
MK_=OY:*SW^!Z.M'^?\/SHJ20HHHH *_U=O\ @VJ_Y0H?L6_]W&?^M9?'>O\
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MJ:VMYKNX@M;=0\]S-%;PH72,/+-(L4:EY&2- SLH+NZHH.YV502(: "BBB@
MHHHQ]/S%-)MV0!1112 ***,X_P#U$_RH .W^?Y44455[VOLETW_'Y )SE3Z9
MR.F?P_QI:.M%',]DM+]K/?RZZ %*.2!ZD4E*.OTR?R&:MJ\EK=I)OS2=_OOK
MV&MUUU0E%*.<_I_GZ9HP?;\Q_C3?O)-=[Z^5^PA**/;_ #Q_^NBFEN^KM?MI
MV ****$DKVZNX!11122L[+K=Z_(! K%LCIMZ>^>O7']:6E!(Z4E/;^M>EOP[
MZ[ 28V@Y(R1@=?3_ #_C4=%%/K?U_&W^0!1110 4N."?3&?QI.O&<9[^GO2]
M.W()'/0__7'M^M "$8.**** %((.#0,DX'&>.IY^O^?PHSQC]>_TSV%+T"D=
M3G]* 'A=ARQ SP.Y_'TZ>E,;[V<YSR#C/KUZ]/\ //%(23U-.495CC)!4#C/
M7.?Y4O\ A_N:_'L (P (/]:<Y!4'H>.,8'/]?P_I2*H(Y!SGOD<4Z0DJ!UP1
MCCV(I@" [ <'J0#QC'J?QXIV>V.O4]P.O'Z4B$A0.1UR.G^>/PI: ]-/^&U^
M\<HSR3@+P#GG!X&?_KY^O'"C.,;MV!@@ GG_ 'OUYI@([ DD]>2/P[?AGK^5
M2*0 2 !CDXX^F/IP/3TH'I9;7OOKHNS5M?Q$56!'4#J>>/TXS4F5!QWZCC/)
M_P#K]?7BFJ2V2.!C ]?J<\^M-"Y)SG@\'L2#_G]:!;?\%)_F2+&SR1JF2[L%
M"CD.QPJ@@\]6X ZYYS@8]<\0:+I.G^&/#4=WJUFJQRZB)X;"UFGOI[L&V-R'
M8(EH7A=_LY66Y3R?+;ABQ4^9:=>C3[I;M85EFB5Q;%QN2&X9"(YV7&&\KYGC
M!!'FB,G.*Z\)>7VA:/I-W)/(LZW]W82SR,MO:W,MTIE:1VQ'']KV8ED9P P5
MB1S0:16EUU]>EK>?>]KK>^BL=3\./$HL_$6E7MCX>T?6;7PF-5UM=$\26$6N
M:;J5DFFW$6I#4[*;R8+V>$.MS9(ZF*W<NT<;!-DO 75G#INM7-G)##<S_:V%
MI!C=9113$2VLQ*D&=%MY(Y(UWLN #*\@#9BBU&[\/L;.R9DG:>WEO9Q\ID$!
MD7[)%("6:QEWYF(RERR+D-& *[#QN@BN;76E0&-M(LM+AG09C^TVMA;0J2ZC
M8MS! 3;RQGYMUNS*2.:!6;;;T<>W5K[^W:WW'%>(=1;4+XH)VFMK2-+6W+90
M;(=Y=MBEEW33/+*Q&$!EPH"C PN.O.1TQC'IR#Q[Y[^_=,@'&2<G@G/.>^>G
M?\.]+TX]/QH);;=V&.G89Y..I(Y)]SU_#CO31D<[@1Z]",CL1V]33N<<''^?
M\"1^- ZC@ <#./EX['ZXY[4"?EY?EK^)<M+VZLC.;69X3>6TME.R##O:SE3/
M%N()1953RY,8+1L\;'8Y#?LW^P!^R#\/_B?^T7^SEK7QP\42^%?A1XMU/P=X
M+\)Z%96[7OBCXL>.])TO2M0UW0M&L+)I9M-\(:7JVI0V?BSQA?\ EV%DOVFR
MMFGU3=9Q?COX7T'4_%OB30?"^C65SJ6L>(M8TS0]*TZQ@>XO;Z_U6\AL;2TM
M((\R37$\\Z1Q1JK%I&50.:_M)_8VT3]G'X>P:\;U/!GBWXX_L0_"R7X=^+O%
MD?VP6OPZ\0^,?B+\2/BB- \'37,JZ#J>N:#X=UO7/!_CG7((?[4?Q7X8O(=&
MCETV."_>HJ[Z:6=GUUV^ZYK%I0OK\N]_/?\ +\4?$G_!;G7O#?QC^,6I_![P
M&;>WU7X&:/=Q:0^D:M=3Z3J'B+6XX9/&/A77-/+-9:3X@AB-O<>'KN9"-2L8
MI=)DG,MMI\2_S7ZM9-X?\.6VDZOI#P:WJ%Q=:BKWT-Q#=Z=907)TV"*W#2QH
MB75S9:JUR)(91)MMV0JP#MZA\2/CIXT\>?&/XR?%Z'Q'JEEK'COQ-K?B&>YM
M+J:+[0MYKPGL$NH@WE3I%;K#LBG214(SA2..I_:+\:S?$/X=?LX^*-;M[.3Q
MDWPYU73O$FMV=O;VKZQ;Z?\ $3QQI&A2ZE#:QQQ?VD+31YWNIS'&UR94EQSP
M.SN^WXJZ7R_KKJU)VCRO>R5[WNEU;WUUWZW[GR222!GG&!CKG/J>I [\]Z1?
ME ]<]N@ZG.2<^G_Z^0O?Z<>W/Z'Z]J.,>^<8Q^M29BX ]>W8<C@^_//KC\:]
MI_9PT:7Q#^T#\%=$B4-_:?Q1\#69!SGRY/$>GB5B01@+ )&)'3;G@#GQ4D@C
M(.,#''7V^G3K^>.GTU^R&IMOCGHWB9\I;^ O"7Q,^(LMP$#+:3>"/ASXH\0:
M;<2!OEV#6++3HSGJTB8.XY+6Z]>]OQZ>I2:O&UT[I-WWV7^?R/[VO^";]G\/
MOC;\7H_BD+>[C\2Z;\5/#_CO0M6@9;&YET+QYX3@OH+7Q&,)%J-M;V6JII]A
M!<123VWEJL$\*!HZ_C0FUC0]*_;$_:K^#FL:AIGA[X>_M(77Q2^$&J7LWD6F
MD^'?%,_BN/Q;\*-<N9-12=M,TW0_B[X6\&2:S<B:.6W\,W&OHMVL,TN?ZXO^
M"8WQ,^&&F?%GP]\)]+MC91Z]JWP)TG1)A<K+=Z_::;\#_!>JVFK:?+'\UMIE
MU<:=J<JV\KAW:*;<&<L!_';^U[K/[-S?M/\ QPFC\/\ CR1(_C!\18KNUCU&
MVM[](SK^JF&XMM4"-93-%>%=JRZ: ;<,#EP#5R?PO2_5:];7OY=UOJ:Z/5-Z
M/[[?FOZ[GQAJ-GXB\)Z=XL\ :O9W6GZW!XMM=)UC19P\=S;ZIH;WEM<VTEH4
MW&6"\5H>3]X@+N##/TC^V1JVH:%)\$?@#<.JP_ 7X0>'- U*TB01I#XS\5--
MXX\9/*H;Y[V#4]<_LJ625/,6#3+:W#&.WAV_6'PF\!_!3]J#5OAS\3M077_#
MGBSP997?B3XJ7VL:BNHZ5XLTSX+VMEK>IWVH-#9)%:ZWKOA&&")FD:234]1T
MZXGGF>>]85^8/QA^(%]\4_BIX_\ B'J4K37OC#Q3K6NNQ!&V&_O)GMHP"3M2
M&U,,2)V5,= *C;Y]OR^75 VHQ6NM[6\E9N]O^&=F>:G&6] ,_4<\=NP_6G(2
M&4@#)8 AN 5)P0Q'8J3D=.Q."::1DCYMO4Y[<>O'^>E.!(((.#V-(Q6Z]5^E
MS[<\(>,[?PW\;_V/O&-R531M'\(_#2SVSAH8$M].\3>(]!UHLRCYH)-334KJ
M:103*T\C$EV)/[:_M6_ G5=!_9(_X)_?&+P7XJM;WXA_L<77C;Q-XF^&L=K/
M!KUU\+?"G[0%]?I\1/#EPXC74]/TF\EMH=;L4"W5AIVH6.JN'LGN9;?^8F^\
M0:E?V7A^RFG(3PS:SV6DRJ2)K:VN-4N=7,:MG.V&^O+J>' &QIY,'))K^HCQ
M]\;/#?B:#_@BEXM&HR6FA?&+X=>/_@7\9UD;S8;JV^(WB"_^$7C![B.0;92V
MGZG9:RD<NX+?P0SGD T^_32*=_6*;_7S]6;Q=[K7[+>VEWMTWT>_D[=/Z"?^
M"P7Q$\.^$/V*]0\5Z1*JVWC+PUHNI0W<)$4VI6?B"WBU&(1H2 GFVVV;,3*[
MF5Y-S(Y8_P"<9-J-QK?B74]7>-YOM6I3S;"VU9%>=S'$C,[E'12%!!*J!@#D
M8_JV_P"#A;]I6[\!^'_AQ^Q_IU_-J#>"?"7@_0M2O9I5BDN8O"FAR:&+IX(V
M^0W8M_.4'D1/$",J17\GN@Q2/) 8I3&TLZA7<'8CF3Y2N"-IWE=S'HOL,U=1
MW?HOT7^1S)-7OW=O0],U?6Y;;PQ:0,8]VK74D$,1:9FC@MVC-\RK(Q781%%"
MN%!5P[(SMNSRGBBQEM(_"FH&5BL=_!&#$?*9(W9,/&58KA^C,IS)M+,<\'F[
MW4Y=7\0+:/-YEM8;K2!&  1GEDDG?(X42718EPV=IR3C%>A^,[:,:%II5$CN
M(;O3 L?WUC16V@1N'<,A)SSR>_K69<;W4==G[KV]7?MH_P#-E#Q].ZV&GVYD
MDCCB%Y&D!VF/?>31,9HV4YD<P&9"V>  >O(^[/VP_@=H?PQ^%W[&GCS3Y=M_
M\0/V??#5SX@T\J?)CU"/5-<U"TU&W9,.3<V.HP+=1R!@L\89'(+*OY^_$._,
MU[8V:!%CMX;B8QKG*F>5V&00 "1$0I ( ;@CI7Z<_MSZX?$OP3_8:U.&19K)
M?V=M L;=!(6476DW>H:-?*(@^%\FXTYU8X7>>V<TUM+T_5%N-U96T:\M.5?/
M[]?P/S \77]W)/9>9<2HLP#,(V\S:%=@9$5D CD,:QQC:V-HP3E0!]9>"O&6
MJ/\ !^+P=)J,-Q:W'B]]7M[9K/3C>VBG1HK6XN5U*2T.L-)<221[H)=3.GNM
MM'MMU>-7/R7XAA$NM^&;??"P\J&>1UQY6U)7=BZ'ABJ@*R8SS@Y.*][\,*UY
M+#;FWB*1R+)FU"[0@C=2[E641DJ7(3@#"X]*2>^ZZ>NWX?J2HM=$[]_EK;?R
M?S(O$<7_  D/C#P[X=TO3[K4;P6L=O%86D$\VHWVHWTFVTVV\?VN6:2;RD.R
MUM\DN)6S@M7]'?\ P0X\9Q_#G]HKQOX2\;:3>:)<S_"7Q'-JVE:_IK)?66K^
M$9K#Q);W?V*ZB$MK>V7V>?48C)"7DV&4H#R?+?\ @@[<?LW_  C^+W[7W[8_
M[25CI4]I^S5\)?!^K^"8M9CBNI-/O?&&KZSI%[JNCV\@8R:]+:Z';:-I4J8E
MM9=4D:*6)Y%E3JH_^"Q_[%WB?]N>/]J37?@/XL\->']+TO6/"$ND^$_$%O'<
M^-/#]_:WNEP77C'3[JWG@DU 6-Y/',MA<P?Z&\=L]U*T"N=(6BU)R2?9WVOO
M?U6OEMULY1VM9;W=TET22NO75Z?B?KU_P59\<?$YO^"?_P =_BO\1/%OP]\<
M_#3XDZ8/ ?@_POXLMFT?QH+^\CBO]!\6>"]=TRTEM-5NM#O(H=3ATS4K8RW-
MK!<O'?PRHEO)_#'X2^*UF='CTC4Y+6]28S?;X[F$I([E9(@D@8-;O!)&ZC*1
M+(Y!?<KY-?JS_P %3?\ @J[XO_;LT7P9\ O@_P"#[3P9\ /!NJ02^ _A[I-K
MYNKEH;:73K WET6:XED-C<SHT,86"'<6D+;?,K\.;SPOKR2RP7NCW>FWVB/<
M)=P2PM',)K>%G:(G 1QPS!@6!##:3D9*DKO1MV5KWWO:_P NWXD4XVNFK^FV
MZ[_\#JK,](\2?":'Q [:K\.E62.6(33^')966[BE&!*-+>X.Z[@\PDK&'\U.
M, @9-;X5QZ[X:U[6M!U:VU#1Y;JVM9)=-OH'MFGDM[Q#N:"Y1#E8Y)2LL?S-
M\P5\')\ZT?QYKFD!(X+E@JG[F^3;M&"\2Y.0"2"P!&[GIGC[!\ _M8ZS<Z?>
MV_BWX:^'_BG::99Q)-<^(-&:_FT>Q#06T+1:O:?9[^PB=@88HY+MH3*PV1Y
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M9QD1N 1C&2.!GIR>E:<U]D[;7ML_OMM]WF7O).*:5U?3S\M#HH79D(4G#IC
M)R <$DCG(( +*!GCD@X-?U ?\$KOVA;;P#^QOXF\'JNG3B\^,GAAM>T#4M.T
MV]TOQ=H&OZ-K.@ZYHFJZ;?&>TU73+FPAMXKNWU&+'E.S0-&X9Z_EITVXD95C
M.[S"6C! ./0$GH ,_,<],\_,*_1']G/Q+<V>B6&B6MQ?1:;I.L6_B'7GLC-!
MJ,+6,<R6MU;QQD)>Z>BW$RS(^UA*\01@P K6#5[]TM/6VXG?F:3LV[7]7U_K
M3L>1_MU_#+0OA'^U3\8O!WA31UT'PBGBNZUOP?I:9\FU\*>(536- CM@S,RV
MRZ=>0^2CLSK&44L=M?(U?8G[=?B2/Q7^T?XMU"UU1M7LH-+\*:;87<^_[7'8
M:;X;TVRM+*]+C<U[8PPBVN6/62,GN2?CPC!QZ?Y-2]VK:)O^M[BEOKOI>W>R
MOVZB444$$?F1^(ZT""O]7;_@VJ_Y0H?L6_\ =QG_ *UE\=Z_RB:_U=O^#:K_
M )0H?L6_]W&?^M9?'>@N&[]/U1_E$T445SD!44D9<C! P.XJ6B@"!G#YC4')
MXR>GR\DGJ><4]%*(0>HR>.]*%0'( S['GWI]4[+2W17Z7UO?=^7^0_\ +72W
MG_3(TDWYP",#GD=3V_G^524T*JYP ,]<4ZI_K^OZ^X04QUWJ1G'>GT9 ZG%
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M/]%^6H<#N!S^9/I_GZ4H[^@P#Z]S^/08]^O3AH)!/OP!C/ ]?KC//T[TOO\
M3@G(&.@ Y^G<=/Q!K5J_<^[_ -B#3[+P9=_%W]IO5YK>T;]G?X=:GK?@"XNH
MWDMI?C1XIAN= ^&:HAC*S76D7TE[XIMXFR!/H<#O\@R/TX^ FDZY\'/^":W[
M8_Q^U :EI_C+XLZAI&GI=7GVJX-_?ZA9Z5I%EXB@OI+A/[1.H:AXM\93:@UQ
M;M]DNTNXX7E\IIY?SV^'OPL\5>/?V8_AE\(? T 7Q+\:_BGXD\<ZO$<FXOM
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MXD?Q#:^*-1U#^WM9M(EACG\2VMEXEAD@CA:"."YL=>@OK&\@CA=HXX;F&2-
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MNW^ T*>X(P>?IZCUXZ_IFFG^'VY_,'I^8_G2D$=3UX R<@#'!['UZ<=J4'&
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MT\N_4/Z_K^M1:*** "BBB@ HHHH **** "BBB@ KTWX<_P#(/^*'_9,M3_\
M4F\)UYE7JGPPM;F]M_B7:V=O/=W4_P -=2C@MK:&2>XF<^)O"F$BAB5Y)'/9
M44D]A05#XE\_R9Y7177?\*_\>?\ 0D^+O_";UG_Y"H_X5_X\_P"A)\7?^$WK
M/_R%19]G_7_#K[R;/L_Z_P"'7WG(T5UW_"O_ !Y_T)/B[_PF]9_^0J/^%?\
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MIP.<C.,=CZXX_/\ SZ4A))SD;< 'VQ_D9YH#HM=^G8;LY!))P>.,G\\]N].
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MF131R0:?'N6'S(8?L\5P^\"2:7RMP,KEG)8Y.<FN&8*,_P![/';/O@<#OQV
MH5@!CG/)]O\ /X4"YK)I:WZO_+_@C*<&(&.W?UP>M(!G/L,TG6C^OZ^\D>P
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M .$K\4_]#+K_ /X.-1_^2:/^$K\4_P#0RZ__ .#C4?\ Y)K HH"[[O[V;_\
MPE?BG_H9=?\ _!QJ/_R31_PE?BG_ *&77_\ P<:C_P#)-8%% 7?=_>S?_P"$
MK\4_]#+K_P#X.-1_^2:/^$J\4GIXEU_/4?\ $YU'DCL?](Z>M8%*"1T)![$
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M^:!Y6(8LUO<3.8L9&Z;,J&/;D'!W;5P3F:G*7OKW D$?VNY*+(P9UW3N6+,
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MPE&T;WVTTMTLO\_PU[^XVMYO@^UW!_?6EJZB J8XI&G'D1B.1B MQ<)+Y?R
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MUI 0.#U)P">K?S_S^("\$@YR.N./S]>/Y_2@KG)SSQCVQ_C^E #220!@Y/7
MXQ]>?;]:3YL$YY7M_7W_ *TX.Q!& >,XY&&SCKD=N??TII'.1VY.1P?4?S'\
MSZ@].E_GZ?H[_@,QD@;L8Y/X^O\ G\JGMS"ES ;@%[=94,X7JT((,H7J"2@8
M 'J>.O%,* G(/4#C'3&<?I48(W=" I RP[],@>QZ=<'!H!?$M;ZH]D^/7BG6
M/&'Q'UJ]GE>2.2Y%CI$7S+';^'[&&.V\.:?:0 %8+>TTJ.S@MX(P%$:+M!5A
M7E>KZ'-H5T--OUVWR1Q2W,!VMY#SQ)<1QLXY,BPR(9 0I!.T@D&O>-(TN+4]
M'^'/C^X$4J1:[+X*UH3D%%OO#,.E7NEWC'YB@O- U"UMU#+F672;AB3AMNK^
MV'H=AH_Q[\576DQ1PZ3XFTWPMXLTZ*%MT<=OKGAW3IY$4  )LO%NE,8 ";0N
M.*+/6^M^_9KMUO;\?OJ4F^MO)=4UUZ?\.?,&5 *@@#(3&<#)Z ^F>*=DXQV]
M.U 52W/.48XZ<@_X?RI2>W89Q^-!!7/!(]_Y?Y[4#'?MSUZCT_S^7H\IDDYZ
MG/3_ .O36&TXZ\?XT -!(SCN,?A112X]>.#CCJ?2C^OZ^X!*7)'/<=/;VI**
M "O]7;_@VJ_Y0H?L6_\ =QG_ *UE\=Z_RB1U'>O]7?\ X-JSG_@BC^Q<0,?\
MG&<?]W9?'>@N&[]/U1_E$444F0>A!_&N<@A\MO-W#&W(/7VY_7_.*GHHH_K^
MON#^OZ^X***#P"?2@ P#U&:*BC=F)##W!QCCW[>G^>DN1TSSZ4?U_P 'Y@(0
M#U /UI:*A5G,A5N ,]!P?3D\T?IK^0$I&01Z@C\ZBC1@3OY&.,G/-349 ZG%
M--]/PW ****0!1110 4444 %%%% !1110 4444 ,$BLVT9SSV]*?3%C56+#.
M3GJ>!GT_^OFGT %%%% !1110 5ZS\*;^\TM/B1J-A,;>\M/AOJ,UM.JH[12K
MXF\*;7"R*\;$9/#(P]J\FKTWX<_\@_XH?]DRU/\ ]2;PG05#XE\_R8?\+D^)
M?_0TW/\ X!:5_P#(%'_"Y/B7_P!#3<_^ 6E?_(%>944[ON_O8KON_O9Z;_PN
M3XE_]#3<_P#@%I7_ ,@4?\+D^)?_ $--S_X!:5_\@5YE11=]W]["[[O[V>F_
M\+D^)?\ T--S_P" 6E?_ "!1_P +D^)?_0TW/_@%I7_R!7F5%%WW?WL+ON_O
M9Z;_ ,+D^)?_ $--S_X!:5_\@4?\+D^)?_0TW/\ X Z5_P#(%>944TY75FWY
M7?\ F%Y=W][/UW_X)X?M[+\&==O_ (<?$+0-5\6V'Q(\7:,^E:EHJ:>NIVWB
M'4I+;1X+2XM+B33K*XL+V:2W61C<VIMLO*6D'R#P[]NG]L'PU^U_\6?".JVG
MAK4_!OPV\$:=>:-IL"/%>>(KQ=4O(;C5]8GBFE:T@FG%G8QVVG)-+# ELQ:=
MWF9J\J_9:_9*^+?[2WB:U;P-I=W;^&=%UK25\2^+5O+?38]%M&O;=[J?3[JZ
MF@6XU>UM=]U9VEL[W+2QHRQD!F7QOXN_!_X@_ WQMJ'@#XE:!<Z!XCL%CG,$
MS1307=G.6\B_L+R!WMKZSG*.([FUDEA=D<*[8R?T'%YYQS+@G 97C*&+CPE[
M:$,'B*F ]G0Q'LJLJU+#/'*,75I4ZL93I0YDW*GRJ<E1C&'QF&R?A%<6XW-,
M-5PLN*70E+$T(XY5,10C4I0HSQ/U%U)>RJ5*,H4ZE5PMR5-4G6DZF*?#NAZK
MXD&C^%_$T,FG2P%[75O%L%OX4CDN%C,C6D^=0U6SM6+#R8;BXOHK>5CND>V4
M\9=SX6UZVU+5M)CLAJUWHB22ZD_AVXM/$ME!;P[!+=KJ>@3ZEIUQ9(9$5[VW
MNI;168*TP8[1SYR"#@'!'!!/(]ASUQGT'-:6D:WK.@7\6J:#JNI:)JEL=UMJ
M&C7UUIE];,3G=;WMI-#<PL<<O%*IZ#D#CX>]*27M(.%YWE*G+2-.33Y(PG>[
MB]G*I=I<KU?,OK[32=IJ34+)35G*:M9RE"R2:W2IZ/6.GNF>05.&!!]",'\0
M>1[^G0TF>GH>AR"IQG/S#CC'//%=CH?C.[TV_P!5O]7TK0_&;ZZ6?5E\96ES
MJL]W.TS7#W:ZQ:W=CXBL[V69V>>\T_6+2>ZW%;MYUP!'HLW@F2SU:+Q+:^(H
M-1E)ET?4- ET^XLK9@K_ .AWNC:C]FDGAED*;;V+6HIK5$;=:7KN&2(TZ4K<
MM:,6^>\:BE'EY6G%<RYE[Z?*KM)2NF[)29S25^:#:7+K!J5^;1M)\K]QZO36
M-G'6ZCR&X<XYQV'7_/-.Y[@CV/6NJLO#=CJ6@7^KIXHT.VO].+-+X?OI;JRU
M*XMPR@365S/ EA>.S,,6MO=M=A02;<*,K6D\)^)(?#UMXK?1;\>'+MG2WU?9
MYMH[I<R6CJTJDE"+J*2$>:J;G7:N21E.A.R<8.2Y/:-PM-*&B<I<KER)2:4N
M=Q<6[-=GS15KR2;ER)2]UN5KI1YK<S:3:Y;JRO<YWVQQG=U[_3U]_3CVK;O/
M$NOZC96>FZAJVH:A8V$@DL[6_NY;N&T^1(]MND\DGE1^7&B>3'MC"J,+Q6*<
MC'!Y..G^>*7:?KTZ<]1GCN?P![^E3&51)V=DTDTOM):I.VZ7]:E=G975[75[
M7T=NUSL-;\50>)+K29M1\/:!ID=B?+O%\,:;!H3ZE;EH=QN! LD+786-PMT8
MF8O*S2*PP*??V_@?4]?T^#P]<:QX9T2Z58[V[\53PZT]A.QDW2L^B:79R36@
M_=\1V4EPBEO]<PYXS:<9XXZ^WU]_;K33R#]#6CKS:;J*,W*49/FBKRY+:<\;
M32DKJ2C)76K=[,GD2246XJ,7&*3?*E*UWRN\7)-73<7;6VC:.T;P3?WOB9?"
M_A2_T[QW=RQB6SN/"RZH8=0/E^8T%C;ZUIVCZE-<IS&;8V(EED 6W6<%2W/:
MMH^K:!J5WHVN:9J&CZO83-;WVEZG9W-CJ-G.OWH+JRNHXKBWF4$%HIHT<9&0
M"16>C,JJ Q5E'+ D$GZCD_4GZYXKHO#?BS7?"6HMJFA75M#=36[VEW'J&F:5
MKMA?VDCQR26>H:3KMEJ>E7]M))#$[V]]93PLT:,T9**:M.B[7C*E>7,W"TXQ
MIM*T(4YR4G)-V4IXC5+J]6?O.DHSM!)*?N.4]%S2G%.,8M:M1HNW31'-CGUS
MZ$<_E_G!R#C!P<XS@X_SQ]:[+2/$&@?;]6O?%WA>'Q&NL-/.PTJ^3PC/IEW/
M,T[2Z/'IFGW&@V5N'8HFG_\ "/RV-O;[;>QM[-$39'I&G^$-1M=6.I>(;SPY
MJ$0FFTF&?2[C5;"\B5'DCL9[_3E:[@O)"!!'(^DK9L[++-<6L98(HTTU'EJ0
M;DYOEG)P<5'9RE-*DG-:J,:LKNZWLF<UK\T9*W+K%<ZDY;J*C>;47HW*,>^U
MVN1&3G@C'4'&?R_GZ=Z*Z[3_  9K&J^']1\16#Z;=6NE/<"^M%U2R&L6]M;Q
M03RWS:2\RWS:?LG"K>"$Q-)%<1JQ>WD Y^33-0BM(K^2RNX[&<E8;Q[:9;65
ME.&2.XV>2[@Y!5'9AW -1[*<>5\DDI1YDVG9PNDY)ZJREHG=J_7HGS1;:4DV
MGRO7:6]N][6?1V*8/!4G /?G/X8_S[U8CO;R.V:Q6\NOL+R"62T^TS&U>51A
M)6MBQA:1,G:YCW+V/)-5PK$$@$@=_P <<_YZ\4A!'4?Y_P BCT?W/=?+<>WX
M/;YIG7:QXX\0^(-,TG2-:O(]0LM%,:Z<LUI:1S0010B!;7[1;PQ3R6^P9\N5
MI#O.\L6YJ36=<\-:K+I/V3PC:^'$MMB:O+H^IZG<R:HI9/,F6'5;B[M;.8('
M\I+:)(-Q&^,@5QE*,=\_AC^M6ZDWS<TN=RY4Y349RM"W*E.2<HJR2?(XWC[K
MTT)4(JUER\MVE%N,;RWO&+497W]Y/75:ZG::GIO@ZXUS2[+PWXBO(M*U,V\=
M]J7BS2FL(]!GGNY(9/M+Z-)K,^H6-I;^1=3WMGIT5PP,T4.F221)YR77@776
M\26_A;04@\:ZI>112::G@LS>(/[1CD5F46MO9P&^^T *QEL[BTAO8<#SK= R
MYX[(P!G(!)QR".N.1_G/<"E1E4@@;2O0 \>O)RIQZ 'MCH1A\\')N5)).<9/
MV<Y0?)IS4US>T@D_BC*492C)O2<?=2Y9J*2J;0<8N<5)<VG+*7)R2=E9.*:4
MDK)QE>3NZIH^JZ'?7.EZUIU]H^IV<ABN].U.TGL;ZVD'5+BUN8XYX7'=9$4@
M<D8JEY;?KCH<>OIU[].A!S72Z%XOUSP_J8UJPN+::_\ (^R2?VSI>D^);&>U
M(0&WN]*\16.J:7>VQ6-%\B[LIX]JA0N%YOZ;XHT9]:U/5?%OA73_ !)#JYED
MN+/39$\&K8W$THE>XT*#0+--$TIA\T45J="NM+MXF*0:='M0JU&C+EM4E3;E
M*ZJ0;IPA:\6ZM/FJ2FW[KBL,DM'S;I%YJ]XJ45&-G"24Y3O[Z]G-*$8I6<9.
MLVVVFE:[XDJ0 >.<?AGUXX]Z;7::%;>!]0DU8:_J^M^'&8L^A?9M(M]>L@#Y
M["#6;Q+S3[Z(QC[/$+FPTB\,[F25K>U50K0:-X0NM<TO4=4M=7\-VPTT%I-/
MU/7M-TS5KI=A?.G:;>3Q7-^0 <K:K*P.!C) ,JG-\MN63E&<DHSBY*,/B<HI
M\T-FTI)-Q5]F-SBKWNK.*;DFE>=N5*32C+5I-Q;2EHW<Y*BME/#VN2:8=:CT
MJ_DTD.Z-J,=K-):(T;JCB2=$,<6UW1<RL@W,J@Y(!R=AQGMC/?D8SQD<U+C*
M-KQ:YDI1NFN:+VDK[I]&M&--.]FG9V=G>S6Z=MGJM'W&4IQV))^F!_CFEVGZ
M?7/^3Z\<8[T$!?O9YR!CK]>G3W^E3IH]/)^O;U&-HH^E%, IZ-MSR!GKD9SR
M"/I@C\>0:910&Q:BN98I(IHI9898&$D#Q2-&\,JE666)U(:.16565E*E64$$
M$"NDD\:>(;K5M+UO4]3EU?4-&\@:?+JH34-D=O,\Z0SK.&^TP^;([.DYDWAF
M5B0<5R:@$X/I_A0%&X@\=<?T_2FI2C\,I+52T;5Y1^&3M;WH]'TZ TGND]&M
M4GH]][[VU[G<3^+;/5/$%OKFM^%M O[:-(X[K0]/MYO#VFWWE[R99?['DMYT
MN)2Y::>)UD<A 20M$%[X,OO$<UUJ>B:GI'AR=6":9X=U+S[BPE8*%>*YUM+Z
M6Y@0[F:&9A))@(MQ%]X<8!CIG\:7GL2/I6GM973DH3]]U&YP@Y3DTD^>=N>4
M79>ZY.-[M)-MD\D5MS12BH)1G**BELXQORQDOYE&]M+V22[73]$\,ZOKNI6*
M>+;;PYHZ&5])U7Q+IVH8N4\Q5BCU"+0K;6)[21HR6=X+>\0%,!06X9HG@G5O
M$]_JMGH5_P"&KHZ4<M<ZCXI\/^&(+]#))%%)I(\6ZCH5QJ+3&/=';6T+WH#Q
M^;;1,ZJ>-PQYSD=R<9_F/Y5)&0,L3@$?+C;GUY)&?3D $<4*=/W5.ES)2DY.
MG.4)SYEHKR]I3BH-)KEI)M73;=FE*,U?EG9M145."E"-GK*T?9U).2OK*HTG
M9I)73VK#PSXCU6PO]5TW0M8U/2])>)-4U"PT^\O+'3GG69H%O;RWADM[5IU@
MG>$32H94AE:/<L;D895@0#WZ<\#_ "?2M/3M9U;1Y7GTC4]0TR9XG@DET^\N
M+*9X) 5D1Y;:2-GBE4X>)B593\PP,5MZ5XUUW2M'O_#]L^DR:3J0D^T6^I>&
MO#>M31/*JJ\^GW^L:1?:AI-T510+O2;JRN5 .V89.!*BU'FE5@^67.U&%6\E
M\'+%RH\L7M)N<Y1UDE+2 /VFMO9RO*/*I.4+1T4W*252\EJXVC%25DW'5G*_
M=PK<GTZY_'IQ[]/PIVTXSCY>!CI@#G/N"<#C^0KJK?Q'I4'AJ?19?!/AJZU*
M:222+Q=)<^*D\1VH<J8X(X8O$D?AB2WBPR*)O#DEP5=MUR2%*I)<>#9O#<21
M67B*T\5QR();E[S3KW0;R'<WF,MO]DLK[3G1"H1/-U)7;<3)&,"ER1M=5:;_
M '?.U:I%J5TG2]ZFE*:6MXOV;6BFVFAJ5]X5(^^XZ^S::W]HN6HVH/9)I3NG
M>*5F<OM. <<= >W''X5?TPVRW<3W)E98Y(7CAC7B:19$(CDD#HT<?&9&568J
M" <D$;>IZ3X<M] TW4M-\7VNHZK</;1WWAHZ3K5I?V3RVTTMU/\ ;I;'^Q;B
MSM9XH[93#J9NYWN4E2T$4<K1ZUUX'O-)TV'5Y=4\.W\=U9)+:0:+X@TO6+J&
MYNA&8;74;>PN9IM-G"2,'CNT1TE5HF D7%#I3BFVHM1C"4G"<)Q2G91NX2DD
M[M1:;4E+248O0J%2%TKM.3E&*DI0DW"][*45=:-W7,FK-75V6]/@GU35M(=R
MP'DZYKKK#%A;6"S6[=7C5EVD106)EC0_)A%7@DD^<W8Q<S;00/.D&"W( E8'
M=CC=QS[YR>U>R:/X4UV#7[?P[?65[:ZKJ/A76[6SMG,D=R9X=!DU:WC6*)R9
M8[Q$FME"G]^)G"]<'RG6+2>SU*^@NHQ',LY<>I28">,C'!#12H<@G/6H:<6T
MTTT[----/LT]4]5H-^\E*+YDU>ZLU;6VJ;TMU;?KIIF ?+QPP))/' SD #J3
MG@GL#U[4A.!@^F2P!_$ ]?PQ1Z\]<<?U]_\ ]6.](>00,X(*D9QG. 3G';\?
MTI"_K^OZ88&,<GC\_P >/\]:=P03GD<8_ X]?U[#J.*:, $#LO'X=/\ >SC&
M!]:=D=AC@9!YP0#GZCGCT]\F@<;75]CUN^<7_P %_#<S.YN-"\<:]INW;LCC
MM=2T_3-2@VNP4AI;AKD[<<,F[/.*_2_P=9W&D?M;:'XTO#;G2-(^'7PA\/:+
M<V=N(;:'4O#WA;P7X>\3Z!' S 0:KH]_!JPU*T4-)&L\%T@:.]MC)^=7PXTG
M_A*/!?B;P[LBEDA\:_#:ZC1TB:3R-4O]3T"^VA@9MC-=V"RJA4-A"V2%Q]X_
M /QSI5]\7OBM%XFL;K7?!GB;XZ:W<Z=8PZC+#JGAR;3Y=7L[76-"E9+RRAF%
MI>Z98:O'/IUY'J6CPM:PM:7D=EJ-G2W5^Z_#I^7H:MZ7]'JW;73UMZK=W]/+
M?VB?$/BGP;XJ^*/CC3[B^TG4M4^)VDR>&-;ADD2Z;_A'=;\17LL]I=1\!%GF
M@,\0()PB3 *Q%9=KX9\"?M>Z#>:CH%M;>!/VB-,LY+NZM+.WNQX(^)L=NC.U
MI<+!%-%X+\4&-6&G:K*8?#&K0H++4GTF\M([[4/6?V@/!?CJ\N/$VL^#['PA
M\4O!D&HG6O$OAG6([)-:T47O[L7L?AQ=2MO%&@Q+YZ^?K/AG4!9Q^9"E[>,_
M[I/'_A]\(-<M_$/ASQGX:\%_$WX7WF_2]1M[JU2[\7>#KN*\F(M9[+Q!I;V_
MB31;>6[LYEMDEMM;NH9T5FU%98%D([\S6KNU?:_W]-_QU&GI?35:O6VG;MYM
MZ[Z=OB#Q#X=U[PIK>I>'/$^CZAH&NZ/=36.J:/JEI-9:A87=L[1W%O<VLR++
M#+&ZL&#+M.-ZLRL#6*>I/K@\]>GJ.,<],5^RWQ<\*Z1\6/"&DZIKWA9O''CI
M+(_\)#XHT;6YIKWQ,FF62S:C/I3"QDO= \4^&;=XXM4TB]T^>UU>RMM[V0>&
M.ZA_,+Q=\)M:T&SBUO2Y/[:T2YC,NY89(-4TX)*T4D>I:>R^:5B9&B^WVGVC
M3IW#"*Z+Q2JHXM?UZ?+=VW_-&;UY6K.RU2=[>32MZ;+MIH>3$#/( &U?F)XR
M,'\P#V^M6;&VDO;RVLX49YKF>&")5P69YY4@55&<EB\B[0!DGIQS5;&W//7)
M)8?<.< $'.#[<@_R^H?V*?#6@^*OVL/@)I?BF..;PS#\2O#FO^)EFB$T+^'?
M"=PWB?6TN(W5E:UDTO2;J.X!0CR&<L" *D27O+1K57OT6GS_ *6Y_3I^U1?1
M>'OV-OV:+:6T72?#OP)\(^(OV2M0OVG==4UKXE>'C\+]1\8R:DC8(GL]6U7Q
M%HD$?G21PVFC6OD_* B_AQ\-/#[:#+^V#\-'=+N3XW>)O#_P)T^ZF90TM[?Z
MMJ?C?PG<QN\B@ >//#O@2>YWR /;))'N.]J_3_Q1\1[_ ,>?\$&K_P 4>*#;
M7?BSQ%^V-XT^*4$MQB2\$GB3Q5H?]MR6]Q*TER(9)[IH2 ZY"*"QX%?CW\8-
M?DT33?%>JZ.8K6]M_B'I?BN-(T+/9ZGH2_#G[%<.Y?Y_+EO;I &Z/(V&&\@V
MWHO[J2UZ\RUM\O+N:VLV]=;.S]%LOZ_$_/B2*2&22*9&CEB=XI8V&&CDC8I)
M&P[,C JP/((IG3\1QWYZ#Z#(Y_.O7?CQI-EI/Q;\<C2X7M](U;6I/%&CP/$L
M!ATCQ?;V_BK2XEA3,<<4-CK$$,:JQ 2-1VR?(3T/T-08M6?ETO\ BM--.HJD
M]&/3OU'.>@XY_EU^BJPW-TRO&,]-PRIZ<X[]::NXGE>XX!&<=^<$#'T]NM.X
M)Z>HST.!SSUR3T[\] .P&N]KI=]O1BG! '!P/7W]P,GC(^O .,U]P?L3?$P_
M!R^^-7Q%@>.+5-%^$FMV^@2'<)!KGB 2^&K!X752B26YUA[O#LA:.!BA.TX^
M'5W$YP%'7!//IC(P&/3(X&.]?K[X]^!\_P &/^">G@G2[FPM8/'GQ;N-,^/O
MC%FC9M4M? =[J<WA7P%I,T;!3;6_V:TO]?< [)O[4@<?PD-7W717_KTW*4>=
M._2VR2O:VGKM\MM-OD3XFSZ=HO[.WPS\#_V;H][XT\;?%#6OBMXI\2*&E\2/
M9W/ARQT?PYX;FN9-R1:=:1W.H:V\,+ SZAK<K7&\VD(3R?XF_#JU^&_C?2]'
MCN)+RTU'POX<\1RF26$R1OJ>FPWE["XB!53;2B2,1R?O#@;P-U>I^*M"UCQ3
MJO@/4%ADN-+.K7GA^W7<!(\]C%I5QJ!5MSK']B@U'3P"N-D<\2\%3CU_]IWP
M1/KEMIGCG0M):2S\,66D^%-;NQ<BX^Q+K'F6&ABZ>.(6YDDDM;E8GC8#;&V5
M=@S4[73?9+3RMK^5Q2NO=L^7O9[Z=M+7;W1\F^$"(8M9U6XC>2V97$B_=Q#:
M1&\9N6P$BE 23:" SI&!TKR;6-1DU?4;O49V#/=3,^!D!$&%B1?0)$$7 ]/>
MOHSXE^%;CP/X%9IE:%M=UE;&S55"*+1HI-1N_+99&9DE!MHY=RA7 4X48KYB
MP> 3D?PJ1T[<=NV/7IZ4GII_6O>__#=N[G57[/\ 3M]WWW =0#P">?R/3\<?
MADT8[D$#L3T/L/?MCCTI"/QQVXZ^O^?RS2[>FTC !) _0$XXY].M(#]5?^",
M/[,-A^U?^WG\._ WB.PU&]\!^%?#?Q"^(?C^33W>%K;0_#?A/48-,\RX7"QB
M^\6ZGX<TR-7=?/FO$A&-QQ^E/[97@%OA)^R_\3_A)XFN=7U_QO\ ##QQI<OP
MEDMM-EN=,O/AWXEUW4M5UGQ/I[VR.FE6RZT\DNO1321QV5Q>I&1Y<*L?IS_@
MVM^!J> _@%^U#^UMJ]OY%]XVOH?@QX)O) /,30/"VEW/B[Q9>6Z. 9H+OQ')
MX9MI2I7C0[A X9\I\&?\%"_C'KGBG6?$+^#M?N=)\=?!OQC'J-DUE=H9]9\&
MZ]9I;ZUI-W"8C#J$%KJEE;LD,ZW$,J7[1S1NT*,-8Z0OKK=Z;VTVU^=_S);?
M-:VB]=].WK\M^EC#^ 'Q3\%:EX$TWX;>/_%&I6_A.&P\-W5QXFTZX@N=3L+W
M2/$-G)JTVEV]Q_HZGRY)5LH+J2-99$09;S%>OUV_8RTGP;'^QK_P4_\ 'GA+
MQOIGB*T3X6:KX:_X1]9_[0UOP[;W+7M_I@U^\M[=+%KC4[*#%I%"ZS+/I6JM
M-;PHD?F?Q[:G\3O$/C35_%4FIII>FWFN:?<VU]'I&BV6C6T@CD0O(-,L(;>U
M2],3.6FAAB8RHLX42HK+_35_P2K@A\*_\$9/^"F]RUGY,LX\-W\DDET4>\L-
M1\*:U::<IC#Y62647MSEG+^1<0': ^VG&7,[=DW>^KLM-+?@OO&DX:I:-K1K
M3>.STT_X&Q^%G[-F9OAU^V/9)&"E[^S!KESYPDZ_V5X\\"7[Y& 6+_9@C\#:
MPXSV_.]1G&!R0?S7&03W//7I7Z!?LXRK;^ OVOKN* RK!^S-XBM6X/EVW]H>
M.? =IRS2[MQ\\HN0V7*\<D'\_CD$J<94GH>I(!;/7@$CIG![FLNB]6OR?ZLM
MI)*SN^OX?=U\PXXR,@G'X_\ UNM(1DCG'4=3T/7\N".M*."<=".AYP?5>.">
MY^GN:*1(#H>3UP/3 QG)ZYSS_/V:1NSD=.AZ]LDD=/Y\#M3QM.><=2 .QST^
MI]>/>@X49SDXZ8]1U!XY]/0_2@:U>NW4^K?@SI9D^#'QEU'<B-_:G@RQ@W.0
M7F:74;A5C!!5V"H6*DY(QP1FOIW]F%-.G_9[_;KCDC:*YG_9NU4V49SLGETS
MXB?#O474N -TEO'$[KE<JJ3<X  \I\*^%[CPW^Q?_P )'-B"X^(_Q;O1I+R0
MN99=.\':''!<SP9V@H+W4EB23D!@X!SN%>L?L3:8_BK1?VIO ._8_BW]F'XW
M1VJL2QNK_P ,^"+SQI"A +D-)=^'88@HPSNR@,2<"UNE;H_1W3=M?76__#U?
ME=EJOO>MKVMOMH?EF.05 Z<]1P!G&>A)Y_&FG/ XP3@Y..,'IZGH,?CVHY('
M+8)##( ' QCC.1^.>QZ4I (QW[>WO['IC\:@EZM]/Z_/OYB#'3T_R/TH&<G(
M&.,=\]<YH QW)QZ_Y]\>G'KS2C..F2<X ZC'3GH<_3C'6@0QL 9QCG' Y[YQ
MZ=^?_P!=//X=!T_SU]::#P&(Z@;N>GX?CSCZT9)Y"Y7UST]L$?U]/6@:]+^6
MMNG9_(:>$XX) P0.?QZ>_<_CTIK$G'Y#L"?;_/X"I" ?E]/\_P!:0*,YZC/R
M]>#W^E A%.W(;(]/3OG'^<4U@<;CT/;/(';^?^>:5QTY)S[C';I@4T$_7@#!
MY''^?\Y- ?AYGL&@_$..S^&J_#R>TAMTB^( \<_VMM+W$P?0H=#DT[:!A5BC
MA-Q$Y/+32+P<$XWQ3\>/\0_%$>M&(P6]EHNC:!8K(Q:8V>CVBVT4DS'K)*YD
MD(Q\JLJ\X)/G!/!;N,9.U<D9.!N(SC)/R@@<]*3CN ?K3N_R_#1#=KZ7MYV_
MK^MA2,=Q^!'KBF\Y&,=^"<9^E*QXZ#@< ?[//Z=Z8IW=0#CVX_S^-(6GR]?U
MM^A(1MVL"-P]^Y!^O;OCM[TAYZ]^N/\ ]0J-G.3P.#QP?<#&..GK3E)8$\>W
M;G\>O;IF@;?W=OZM^1$ 2<#_ #]:<5((4GC!/!R!Z\]!_GK2H,[LCV_Q_I3M
M@P0._<X_^MQ1_7]?U]XOZ_K^O^#$3G XXSC'^?\ />DIRH26R>AXQ_\ K/\
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MQBDMUT =14<9<@[\YSQD <?A4E#T_#\5< HHHH **** "BBB@ HHHH ****
M"O6?A3>?V>GQ(O1:V=Z;;X;:E*+34(!<V5P5\3>%,1W-N602Q-GYD+#/'/%>
M35Z;\.?^0?\ %#_LF6I_^I-X3H*A\2^?Y,/^%F-_T(/PR_\ "2C_ /DRC_A9
MC?\ 0@_#+_PDH_\ Y,KS*BB[[O\ K_AE]PKOO_6G^2/3?^%F-_T(/PR_\)*/
M_P"3*/\ A9C?]"#\,O\ PDH__DRO,J*+ON_Z_P"&7W!=]_ZT_P D>F_\+,;_
M *$'X9?^$E'_ /)E'_"S&_Z$'X9?^$E'_P#)E>9447?=_P!?\,ON"[[_ -:?
MY(]-_P"%F-_T(/PR_P#"2C_^3*0_$U@"?^$!^&7'/_(I1]O;[9SQVX^HKS.C
M&>/7]?\ /O33=UK^7ZZ=%;T0)O2S[6V\K?DON/W2_P""9O[<'PK^'>CZK\*/
MB';0>#=4\1>+K>^\+7_A_0YWTB_OM5>&S@TEK&P2ZNK>\>\,,5JYCF@E\T+(
MT*H7/R5_P4-_:M^'O[37Q\\-^*?"NARZKX)\$>'8/#37-VKZ)>>+F.I7>HZA
M=E;;$]E:"2X^SV+DB=E5YW6+SS;Q_+'[/WP7^*WQ>^(/AVQ^%NC>()K_ $[Q
M#H5Q=^)=$TVZOH_!X&JVAB\1W;V[1K$FD2;+\&2>%28542*6#+Y;XN\(^*?
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MES/V;DDX*/LY1YG=VDW&HX1BHWYK*I-N*:7O63XX[2P!('))!)&<<@^A]?\
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MMYJ52J*S46XOFY7%J3?+;F?NMVM>_31WMJBN:-[.237+?I;FV^+OTWVZF/\
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M.%CDQP<C\\AT'.3Z^H)_^M^)%?>/@&*ZA_9>_:UU2%Y8(I/^%.Z%<PR2F/\
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M@]/H>?UH(XR2>!R.QQR>/4T$\Y/!.><#KC@GMGK]>: 001U['_'\:!#<EP0
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MO,J*=WY?<O\ (7,_[O\ X#'_ "\OS[L]-_X2CX;_ /1+'_\ "YUO_P"0Z/\
MA*/AO_T2Q_\ PN=;_P#D.O,J*+OR^Y?Y!S/^[_X#'_+R_/NSTW_A*/AO_P!$
ML?\ \+G6_P#Y#H_X2CX;_P#1+'_\+G6__D.O,J*+OR^Y?Y!S/^[_ . Q_P O
M+\^[/3?^$H^&_P#T2Q__  N=;_\ D.@>*?AL",_"Q\'C_D>=;./0\6@X]:\R
MH_R>.WMZ'W[4T]5>UK]E_D/F?]W_ ,!CY>7E^?=G]"7_  2F_:+^ WAKPEXG
M^'6JW.C?#SQ5J7BQ-2T^PU?4G9?$-G=1QP6UG;:U=(CW%Y%*/L\-G*4FD>9!
M:B65M@^-?^"GGQ>^"WQT_:.\-/\ #36K:31?#WA:S\->*?&MK:&\L[O4VU&[
MN\VAC6WN-5M='M;A(#=-@O(TT5NTEM##))^=/PY37'^(7@2/PQ=V&G^)'\9>
M%X_#M_JF/[-L=<;7+$:5>:B&@N5:PMK[[/->*UM.I@CD+0RC]V>/<[BV<Y).
M2"1WSQW SZ<XXR*_0<?XAYEF'!V7\&UL)@(X+ RH+ZU"%18BO2PLW4H4Y04E
M2IR4VO:5:<8SJQBDW%RJ.?Q>#X(R[!<5XWBV&*QDL7C858O"RG!X:E4K4Z=.
MK./NJI)<L7[.E.3A3<I6O%04.PE\%WMUX@/AWPS?Z=XONGB,]K+HDKK'=QK&
M97C@34([*5[M$'S6D:22L_R0^<1FN;U+3-2T:_N]+U?3[W3-3L93#>:??VTU
MI>VDR_>AN;:=(Y8)5R"8Y41P",J.]2.26)U>*1HG0Y5XRR.IP1E'!WJ>>>2#
MZ5T?A[Q?KOAG4I]5TV:RGN;N"2VO(]:TK3/$-E?02.DCQ7^GZ[:ZA8WJ&2.-
M\7-O( R!E"D CX5/#R:YHSI^^VW"TXJF[6C&G/EE*47U=?79K>1]>U4BO=<)
MV@DE).#=1=95(II)]5&B[7NF]CF0"<8!)/0#DGZ8SUH_,$<$$8(/I78:-K/A
M/[5J]SXR\,:EK7]HF6>U;PSK]AX.;2[R1Y9#)!:GPSK^ER6(:1<Z;'I]F%BC
M$-K=V:MN5FBZ#HFL:;JUY=^--"\.:CIXDELM%UNS\1R3:U$L9=(M/U/1M"U/
M2X;O<K1,NLW&CVY(1DN"7,:'L8SC'V=2FY-3;C*?LY04$G[[JQA2<IQ4G"%*
MK5;^%+G:3;G:]X323BN91YXR<VE[JA*=3E@W:4ITZ:2]YMQ3:Y+KC/.W[N<8
M!/4XQDY[\_TP L%90<!L;@,@$!@V#SR-P##.<, P&0*Z6#P9XKN?#D_BZV\/
MZI=>&K29H+O7+:TEETRUF0J#%<W8'E0/EU 60C=D%2<BN8)(P2,*1D$@\\XQ
MC'&.^??IBLW&K#EYHN"E&,X\T>52@TK25TKQ:^TM':R;=BDU*_*U+EEROE:E
MRR5O==KV:OJGK??4ZO4?&?B'5]%T_P /ZC=V]UI>EE38QG3-,BNH54%1&VHP
M6<6H3QXP ES<S*H&% %2:YJWA754TF/2O#,GA>>'?'J]U%JUWJL%_N%N([B&
MVN8XS9.C+<,\$;M&P9,/D&N0!R,CCIR<8Y]""<C\N>,4N",8( [C&03^)]SV
M_*K]K4:;G)3YE!7G%3DHQLDE)^_!)67NRCI9;63E0BK67*DY-*+<8MRUDW%6
MBVWK>2=F[[G::MX<T5M6TS3O!_B:/Q)'JFU$GO['_A&S:W+,JB"Z_M"\EMHU
M)8[;E[J.$A2[^6N*R/$/AK6O"VI-I6M6D=O=B..91;WEGJ,$L,J[DFAN]-GN
M[2>)UY62&=T/=@>*PB"<<]#G)&3T[<X'MD''UYK6T;7M;\.ZI::UH.K7^CZO
M8EC9:EI]U-:WMH7C>%S;7,4BRP%HI9(CL<#8[J  3BE.C+>$J?-4C=TFW&$'
M922IU+N4NJO72Z-ZII6FEI)3M%KWURRE/2S<X>ZD]5)*D[7NMK/,(X!.5.,D
M,,?7CL1Z>^?6D4$\X&,@#D\@@<GH>_3_ .O7:0>,5NO$UUXC\7Z!I/C62^C\
MN\LM4FU328I76WBM5O8YO#.H:),FH1I$DHGE,\,]UNN+^UO6DF65-'LO!.MZ
MOJ:ZOK.J^!M/FW-H:0Z2?%MG!,\AV6^LWD-_I.HV]E$@.;[3]'UF\<A4&F/S
M+3C",^7DJ0<G*4%&H_8M)6:E.<^6C'FZ+VK=U;2ZN^9I.\):13;C&51-MI.,
M8PO4DXO=NFE;775+C=W)QW]>XQCG_P#7ZYSVV-,\0ZYHT=W#I&LZMI4-_ ]K
M?1:;J-W8QWUK*C1RVUXEM-$MS!+&S1R13!T=&96!!.=30O!&O>)X=6F\/+I^
MJ-I#$RVD>J6%MJEY %N'-SI>BWUQ:ZQJD*16[R7#6-C-]C5HQ=^2TL0?F?L=
MUY)N#!)Y ;89@CF+>.J>;MV;^^W=DCIFH4:T.6;4XQFFX37-&,DFHR<9:)I/
M1V=KW6['>,N:/NMQ:4XNS<6[.*DNC=DXIJ_5:'2V'B^YL= O_#C:/H%_97TE
MQ/%=:AIHGU73+FYBBADN--U!)898I D*;%F\^%&W,L09W)#=^#9O#@MY=,UJ
MW\51N/+OX+VVDTB[C9P6-W:SI]HAECC&$-JX5B<R<"N3*MQQQWR1D#MC!/?]
M/I0#@'IS@<J#QWZ]*KVLW9.SY8*FN:,9<L/=?+%O6+6R:LTKJ+Z!RJ]]5>2F
M[-KF:TNTFKW6COH^NJ.JO_#VDVWA^QUG3_%6FZC=SR107WA][>\L]8T^:6.5
MV=0T<MG=V,31>6UVMU"Y>6';;$.Q1FM^#/$GAVST_4-7TR6VL-6BCETZ_BDM
M[VPN_,A6<117UC-<VOVI(F5IK1I5NH/F6:&-T91RZX P<D9!ZG Q[<#IQQCC
MN*MB]ND$0CN9XQ;NLMN$D<+#(I!$D:EF6-P0#N0*<@<TOW;NW3<7RP4>2;LG
M&W-*49\SDY);*<$GTM=,2E=6DFKR<E):VM[J4H\J23W;4FTK;NY 8\''S GH
M".GL?KGC^M-(QQW[@\8/^?K^M=AK'CG7/$M]I6H>*9+7Q#/I06/.H6JPW&IV
MPD5VMM9U/3&T_6-25E01+//J)NK>)G6VG@WDB6[O/!6O^(K*X.E7W@/09T1=
M7AT%Y/%[VLH$C27.B:;K^JZ-<M Q\M%L-2\33RH \C:G(=L;7R4Y7Y*L7><8
M1C43IR:DE>4G>5&FHR=GSUKVULM;*\DES0?PN4G!JHERVT27+5E*2NU&-+RO
M??B*<&XQDC'0#IGW]<GK7:_\(E9:KXH/A_PGXCTG5+26-IK+6O$-YIW@:SE1
M+7[7)!>R^)-1MK"POH_FM1;_ -I7$=S=H(;">\\V%I,.^\/:MI^J7VCSV,\E
M_ITC1W<-ILOA&5 .]9;-IX9865E=)XI'B="&5V4@TI4YI<SBW%SE34H^]&4X
MVYE&4;QE9-.\6U9IIV=P4XMVYE?E4G%Z2497LY1=I1NTUJEJFMTS'#D C'48
M[=!TXQV//XGM72:'XP\1>'(+ZUT;5;FRM=3C\K4+,)!<V5VH1XU::SNXI[5Y
M8TDD$4YA\^'S'\J1-QSS;1E6*M\I!(*MPP(X(([$'((]0::1@X/:IC*4'S0D
MXRU5XMQ=FK-75GJM'W6FPVE)6DE)::-)K1W6CTT>J\]3K+#Q)I]MH-_HM[X7
MTC4)[GS)+/7";FVUFPG<*%(N(Y&AN;9-N1:R0*"2Q,IW8#E3P9)X9:3[7K]K
MXNAE8^3)!:SZ+>1&4*BP21M'=VLL4.7=YQ+')(-J* 37(4NXY![BJYVU9J$K
M0<%>"O%-IW35GS)KW9-MK;5:!RZMIR3<E)ZNS:TLT[KE?6*LF[/='6WWA(VG
MAZR\11>(?#FHQW;Q17&E6-_,^MZ9+.)#''?V-Q:6^"1&VZ2TENH4)17D4NHJ
MCJWA;Q+H5O87>NZ!K>D6NJV\=UIESJ6F7EC;ZC;RH)([BQGN8HXKN&2,ATFM
MVDC=3N5R#SB>82,$9'& >HQZ'/'X ?I5]M:U22WM[2:_O)[2UF2X@M9[B2:U
MCG1=BR+;REX@0@$8&S'EC9TH<J;3]R47RP47&5XJ2LIN49IR?.KNRG'E=[75
MDDE)->\I*[<DXV=G\*3323C>S;B[KSU>=LP0">O3'/;U_P#K?D:1EQV(/H>I
M'X=#[&NPU?QC+XCNM'EUS1O#WDZ8T*7">'M!T3PC<:G:1R(TD-[/H.F6L,EU
M+&K1_P!I3VES=AG,LS7##!DU,^!=8\0:;'H$&N>"O#]Q#;V^I2>)=8B\:3V%
MV9I5NK^*XT7PQX9FGL! ;=TLDTF6\A83H;B[)C8TZ<'?V=6+]^,81J1E3G-2
MM>;MST81AM+FK*U[^\KN*YI*W-"5^5N3A:<8M-6BOAJR<DVX\M)K1IV;5^)H
MKM6\%37WB3_A&_".KZ7XXFDB\VSO-"CU>PM[YA'YCV]M;^*-*\/ZFUTF"GV=
M]/1YI,+:_:,J3AZIH&LZ)J-]H^K:7?Z=JNF.T>HZ?>6TL-U9.FT,MS RB6$C
M<NX2*NT$$GD5,J<XIMQ;BIN'/'WX.:2;C&I#FA)V?-I)^[KL-3BVDFN9Q4^5
M^[-1;LFX2M**OI[R5I>Z[/0Q\_+M]P<_0$?UH!QD=CC/&3@<\9IY49QD#USQ
MZ] 3G'J3CVIN #C^+USP,]",<^E1I;I;;_@6^96S[?H2(W.03P,<X]^GZY]:
MW=(\6>(_#\5W;Z'KNL:3;WR^7?VVG:C=6EK?H%90E]:PRI;WB .P5+F.15!.
M!D\<]A@<-(",=D(Y^O4CW-!7 R.1UZ?Y_'_]>!-P]Z+DFD[--IZJS5T^J5GW
M!I26J35UH[/5--.SZII.Z5[J]SL-(\6OINBZAHKZ%X<U.&^\PI>ZIIKW.I:=
M+(H0S:?=QW-N89 H&WS5FC5LL(\G-.BN_"#^&I[>XTG5X_%<3;K/5;2^A;3+
MA&GC+1ZA8SH7B$=J94C>SD#O,L3R_)O%<BN-H]OY]?ZT_<3QC&!QTSSD>XQQ
MSZUI[26B=I)0=-<T8RY8MW?+S+1IZIJS6R=M">5;JZ?,INS:O)::V:NFKZ.Z
MOK:^IU=SHOAT>&[?5[/Q7#/KFY5U#PU-I5U:RVV^XDB1K+4?-FMM000+%<S'
MR[8QB8PJ)'B)9NK>"]?T;2=.UN[CTYM-U3'V2:SUK1]0GRRE@MS86-]/J%DY
M .%O;6W)((&2,5RV>&.,XZCT)QT'')[8IX9N0N=N0=H)&"!P>N#ST)![\#-)
MR@[WII/EBH\DY))JRE*2G[1MR5VXJ48INZLO=!*2M[UUS-RYHIOE>T8N/(O=
M>B;3;2LU?WG9FL;JQG-OJ%M/9SJ%)@N8I+>9-RAUW12JK@,C*Z$J-R,'&1S4
M#J,XY((P<#/'4<]NO;K71:GXR\5ZW!I%GK7B#5=9M-!8MI%AJ]Y)J5A8%A"K
MI;VMXTUND<JP0I+'Y121(TC<,BA1;U?Q/I_B#5])O]7\+:1IUM:O%_;%MX,S
MX8DUN)9@\L@62/6=%TF^:'=!#-IV@1V,65EETNZ92'IQI/FY:DHZP4?:0M=2
MMSMN#G;D=[>[><5=*,GR"3FK<T$W:7-R23LT_=2YE'XU\HRT;:]XY;9T&<''
M"XS[\\CMZX[]>*9C!^8\ \]L$'CO@CZ]^_IVEY#X)U7Q):Q:'=ZKX1\/7L<
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M.2I(4A22*QT///&,Y!!Y ZK\H9OF'RY4$Y.>!R)(2:DK]U^9^N'AG7#\%?\
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M^,_QI^)Z?#KPOHT)U8WDD5Q]JU'3[=8HD8^9<6AO+B*"]20(TPEMWD3RQ]_
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MG]78444QU++@$#)')ST!SQCO_GWH ?13$4JN"<G)YI] !1110 4444 %%%%
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MP]/\W]WF%H_S/[O^#_5GY7\OHKU#_A;&M_\ 0L?"W_PTOPY_^9JC_A;&M_\
M0L?"W_PTOPY_^9JBR[_AZ?YO[O,+1_F?W?\ !_JS\K^7T5ZA_P +8UO_ *%C
MX6_^&E^'/_S-4?\ "V-;_P"A8^%O_AI?AS_\S5%EW_#T_P W]WF%H_S/[O\
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MRH5VO6_@>:;2V\+WGB*P2Z;R]7M_%5K9S6^CL6A59K75]":6[UJV(>XDG/\
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M[T7Y:_>XK]/S*O%O31NR_);7MM?2VI\[?\%==)@TC_@HC^TQ%; +%?>,;'5
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MG 9('/L3CWR0!R/3!_KF@-6UWT2_)'IOP]^*FO\ @ WNG16^F^(?".MO;?\
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MW$QN%U?%'[!_BO3VAMO WQ-^&7Q(U&RNQH_BVVTC79])@\*^('FG@@TBYO\
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M:A/X)UG6[ :7INJ^#M$=(XM1DO=57Q5+#/\ -YMU 8-(T:0V_P!W9:?9I94
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MDY[?TI"YG:UVOGY)?UZ_,_4WPIXEN_B3^S'\(O'*6#RZ_P#LZ?$S2/!OQ#U
MA;BXO_A/K<.I6OAO6O*$'VB:+PS+KFO:%J=U/<-';V=_H5J%2*% /S=\>Z)-
MX;\:>*-#FB=&TW7-2MU211&ZPI=2FWRO0#R&C*[21MQ@U^IG[&7Q'\+^ OV2
M_C/X@\0QK;V&E_$3P'X5\33^6VIP:KX5\?3W46J>']?T/[1;M<^&=1ATDC4+
MZQ*:OIEREG<Z?,9T$,G$?M=?LS3W]O8?$?X5VVJ^,K)O#[:N[Z=I=_=7FN>
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MG/X8I]<_]?>0(QV@GT&::CAP2!C![TX@$8/(-1,&4@1@>I Z_P#ZJ:LUY_\
M!27Z].H$U%)G RW'3/M_DT9R,KSD<?TI +14,?F9._.,<9Z=:E) &3P!3UVU
M]/-^7]7 6BF>8G]X4/NVG;U_I1;57OK9?E^E@']>M11QE"22#D4L>0GS9&,\
MGTZ_6G!E;H0?I0U9M;Z+OI>W_#:@*3@$^@)_*FHX<$@8QZTX@$8/(- 4+T '
MTI::_P!=O^#N M%%% !1110 4444 %%%% !1110 4444 %%%% !1113CNO5#
MCNO5?F%>B> "?LGQ!Y_YI_JO_ITT7_ ?E7G=>F_#M%.G_$AF )7X=ZLR^H(U
M;0AGZ D?X5TPUDOG^";+JNT;ZM7BK+SDK?Y?,\=;HOT_H*^RO^"?,.D2_MC_
M +/K:]+%#IEK\0=)U"4S!_+>>P:2[LHR4BG<%KN* J5AD.0,(U?&K#(7Z=R!
MV'KC/X5] _LLW\FE?M!_"'4HI9(6L?'/ARY:2$@2B&/4K;SUB)#*)'@,B(2"
M S \C@\MU'5]&GZZ['1E\'4QV$A%M2GB*45;>\IQ2M\V?T9^*/@59^%]#U2U
M\,_#27Q?>_%#Q]\3?%7P\O\ XB%;K4-"^&WAF\\!:KXMOM&,=QIMS)XBU&X,
M!T34-:UW319:':Z])?VR+-+I]Q"O@/P/X<TZ\\=?"GXE^,?VDQ>I<^,O&WPY
M\=ZKJ5KIOAKPQ;Z=IPU+0=?ET^_TZ\U'QH=:N+G2K*2^D\0O92K!!-;7'V>X
MO;CV3]DG]L"+XF:3\0_V=-5TC0?B%K'A+P=XDN_ -_X^\11:)K_Q'?6];=Y?
M#GAV^:,$6M[X5&J-<QV\PO(IM+BT]X$2UF*I\+[[P7X,OOB7J4_@O4/%=MJ7
MQ(MM&T:PNK;4/#/A[P1X3U#4?^$W\3:]K>L2VEA=WMU:NEQ:VME)'_:^IF/3
M[.&Q#7"PG]HP=3!U\%A\3!WI4J/*I4XMN-H0C))7=W=6LU;1M;*WXOF,<71S
M3&Y?.C:O6Q4U4A6?)[5*K.H_:-IKWHN,HI-.T[-NY^4W_!3'P:WP@C\0V&A>
M$]0L/!OQIM/#GBFP@U.[2\N?# T\>%-3T?SFTTC3[:;2["\OM&MK34XH==AM
M?$MQ-<XANX%;\1022,\\XYYX-?K?_P %%OVL5_:(U7Q-JZW4SV%_JX\,^"[.
M2UDTZ:#PGHWB+5M9U&:]MA<20W,D5TOAG1;/41% UW#H\\+Q1FR5*_),)R.O
M!ST'_P 4:_,N(,33Q69U:E&;G34*=.+[N$;2:[IRN[[NY^C9'AJN%RS#TJT7
M&J^><HN[:YY7C%-W=HT^2*72QZ-H4"M\/?%=R02\?B/P7"I^THN%DA\3NX-K
MM,DNXHA$X8)"59&#-,I7GE."":ZG0%7_ (5KXP?<^\>)_ RE/*A,>TVWBPJQ
ME9Q.KA@0$2,QLN6D8,L8/-$ $8 ZKV^OY=.U><_@I?\ 7O[_ 'Y_U\CU$]9+
MS_\ ;8_YG3?#[XI^,OA%XIE\3>!=372M8:TEL7N7M;>['V::6":1$2YC=49F
M@CQ*FV5,-L=<YKT3Q7^U/\3O&,/AB#6X?!9/A.XEN-+N+#P/X7TFYF\^TFLI
M8=4DTW3K3^TX6AN)"PNQ)([B$M*PMK58?G>[_P"/N3Z<_7/>J3$[CS[?ACI4
M.M5A'EC.2CS7LF[;)^E]F]-;>13A!VDX0<EI=Q3=DDTFVK_+U/2M4^*OBW5K
M'5]/O;BS>+7;:TM-2DCTZRCGN+73YA-8P":.(/'%:L%2#85,<(,*XC9PWFA/
M'?GN>^../SYZ_A245E*<IN\I.3VNPT6B22TT6BT_X8*7!]#^5*H]<8X]..1U
M].,]>O:O8/@[\$_'7QP\3)X8\#Z8;F94:YU#4)G6VTS2[&(;I[S4;Z4I!:V\
M2ACOD=0QP@.6%71HU<14A1HPE4J3=HPBKMO_ "6[;T2U9E7KT<+1J8C$U84*
M%*/-4JU)*$(+3>4FE=WLDM9-I)-L\? )('N>WY_CT_05L:?HFK:I*(-,TV]U
M"<X BLK2:YD.XX4>7 DC8)R.@!/3/6OUL\-_#;_@G3^S5IEQ?_&CQCXK_:/^
M*]A:3(GPX\"PKHG@*SUKR2;>+6O%4S27.H6MI<X%[%IL!,X5XX[F+/F+]):'
M_P %A](^%<.C:?\ LD_L&_ 'X375K-*\FLZKX67XAZ[JLDNFW-A;+<WWB**]
M$*6=W<#4[46T<!%S!'N,D0*'U7E,:*<<1C*'MU:]"ASXB46[:2G2C*DI7?+R
MJ;=W:RW/.CFGMHJIAL)7E1=K5\4E@J<D]5*$:[A5DN76[A%6>_5?BAH7[.WQ
MU\3200:!\(/B+J\EPVV!;'PCKD[3/Q\L8CLCN)&.F?ZU?\6?LR?M ^![/^T/
M&'P:^)/ANR#*C7>K^#M<LH%)&0#)-9JO0=\#'.<5^UU]_P %F?\ @KOKUEK/
MB+2O&MKX<T#0&C.KP>$/ 7A71K72X;CYHE9;#28S&H08+??*Y+'DD^R_!#_@
MXG_;A^& M-"_:(\,>&_COX"O9$EO]'^)_@ZSG%YI=XR^9Y>J)IZ3K&T>_P"S
MRSI=PH6!\IT0(=)9,Z<5*M]9HIVLZV%JTJ:3LKRJJ,HI7T=[6;=[.Y*S>-27
M+16&Q#C)J<</BZ%6I&24)<KIQJJ3;C).T>:25GK<_F E@EBD:-T=)%8JR,C*
MRLIPRLI 92"!N4\C&#BJ[D@XR1QZGU-?V4_'S]CK]A'_ (+!_LR>._VJ?V!?
M#^C?!K]KSX;:'=^*/BK^SKH@6TTWQ3%I\+7&IW'AKP]%ERMPBN^G7^G6T,5Q
M*HM;JSM;J5<_QS:IIM[I>H7FG:E:S65]8W5Q:7=I<1M%/;W-O(T4T$L;A722
M*0,KJP!##GI7EXG#2P\DK\R>JE"SB]G9.+<7;1IIM--:Z'IT:\:\6X733M*+
M3B[]4XM)KEDG%J2BU)-<JW=OPUXDUCPEK6G^(=!O9-/UG2KA;O3[Z)(WEMKA
M%94E02JZ%UW':61MIP1R!CUC3OVC?BKI/COP]\2M,UVULO&/A>^N=4TC5+?1
MM)'EZG>V;6-[J%Q;/:26]W>75N[F2:X1R)3Y\0BE4.OA(Z\^X]?;/OCK7H_P
MV\+6GB_7[O2KJ18UB\.^*=51VN%MF$VB>&]3UB!(V<8E>26Q1!!R90S(N&(K
M.DZLI1ITY.+<DXZV2DM4_5='NC27+RRE-)QC%N5TG>.B:]&NGRMJ;7Q:^./Q
M+^.WB>+Q3\3O$#^(-9 2-9Q8V&G0(!#:VQ*6>FVUI:1LUM9VD#,D 8PVEM"2
M(X(HTX6L)5_TA1G_ ):?3]>W*GOWSQ6]Z^O]<_X4*3ES2DW)N6LGN]%JQV48
MJ,59+9)6232LDNFWIYV,2Z_U]QQ_RR7]/+Y_3BIM+A$UPH+JBA3RQ"C)('WB
M.3@D@>OTJ*Z ^T7.. (Q_P"A1C_Z];WA&WCN]1DAD<*ZV5U+;?)YF^YB3=#&
M4"DG<00H ))YI02=5)J_O:)]7?Y>8I-1C)OHM/)W7Z7.QM].M86:V=0K(%$A
M? <L>5#*1DJ3U8^@)^\"8M0TN+RI9DP&"9^3U P 6YR/X20>^*D8&^TZ*:5I
MQ?NT:R2H!F6:%Y_,C*9&'2$0$D[3@DX. :M:I ;*R\ZZG$4:11G8K$R3R.NX
M6Z)C(DZ>;G[@SSD@5[+4'3FW!*,8)J3=GK;3O=6UZ::'!>7M8+GESRDXN*V;
MBHN3B^L7>R:MMKU1Y+<.T4TJ)P"'.!\NU6(; Z' W'C].:]2EY^$FEYY_P"*
MON.2.3G3#GGJ<UY7+(9II9"H4NS'&>P)&.>@Z#'7/6O62 WPATDD<GQG=KCT
M TTX_3CIU'Y>/3O)U?.G*U_6/Z6N=[^*"NG[\>UMKV\]K:?D>8J!UP,Y;G Z
M;C_3%.J65%0C:  1S]23D\^M1GM[C^I']*:5E;^NQK/X4NS2_!B49/J>.GM1
M13,Q<GU_+C/UQU_&C)]3^9I** +-I=W5C=6]Y97,]G>6D\5S:W=M-);W-K<0
MR++#<6\\3)+#-#*JR1RQNKI(JNK!E!'8:EXWU7Q%KVG>(/%\.G^+)[%((+F/
M4+1-/EURWAFDF*ZYJ>@C2M6U6\D$K12ZQ>W]QK+PK# U\T5M;QQ\-2Y/J?SJ
MXU)Q7*I-0YE-P;O"4HN\92@[PDUTYHOMM=.7"+?,XKFY7%3M:<8RW49*THWZ
MV:[[V.V9O!6M^)%(@U'P1X>N8B"IG;Q8]E=^627+BUTFY;3VEP!$(+R\MHO^
M6E^_S$L?!=WK_B#4-!\(ZA9>)S:+++8W4'G:6-7BB,:[K"SUJ*POWF)D^6UE
MMXKAE21O+"KFN)R?4GOR32ACD84=^@QGU_Q^M-3BVN>":<W*3A^[DT[>XK7I
M0BM7&U)/6U[:!RM+W9-6BHI3]^-U]IWM4DVK)WJ:[[ME^[TZ^LY[ZUN+2>*?
M3IWM;U"A86L\4C1/%*R!HT99$9,EL%EPI)Y.?@^A_*NH\.>+O$7A.2ZDT'4S
M8F]A,%XGV>TNXYXB&&QXKR"XCRN]]KA/,4L2CJ3FK>C:YH%GI^JVFM^%+77+
MN]WR6>K-J-_IUWID[H5\R)+-UM[I ^)/L]S&T6[/'(%)*F^7WW!VES<\6XJW
MPJ,H<\I\VUY0@D]7I=IMR3=H\RO%1Y9+F>RDVI\JCRMWLIR=MM;)\8#C/7D'
M\#ZT9/J?S-==9:9X4N/#M[>7'B.\LO$MNTC6NB-HAN+#4(=R!=NLIJ$;6DV&
MD/ERV$L9V@>:A-$O@O7H_#,7BY4TR717D$,CVNN:)<ZC:NTQ@0WVBP:A)K6G
MPRS#9#<7=A#!,S+Y<C;@2*E-J\8N:5/VC]FU-0@VHWGRM\EFU\235UIJA<\5
MHWRMRY%S)QYI6O:/-;GNKM<MT[.S=G;DBV5 .3CUY'TYS4ZW-P(%MQ/*84F-
MPEN7=H!,55#-Y)/EB0HBH7V[F10I)7 $!1@H9@PR>"00#QG()Z__ *OQD7 P
M.A(S[_Y_SVK/MNG9;WNEIUO?MU^\H[;6/&4_BN\TJZ\1:1X?"6#^7<_\(KX=
M\.^"9M1M&\D/'=#P]HUMICW2+$WE:C+I4UR9)Y9+EKMCPZ]C\#ZQXALH-%EU
M+P9H-TJ)>7'B>ZD\3'2I?F#R-<^']$M+R_M1\H5H-#AGRV#;D#)XD<=./IQ2
M%0N3GDC&.21GM[GU!/Z5LZTY-NK:JY3C.<JB<IS<=+.I=55&2TDHS5U9WNDU
M"IQ22A>GRP<(J#M&*=K.--WI\R:NFX.VR]UR3[8>"M0O?$DGAOPQ<6OB^Y\C
M[7:W.A,\D%Y;"V%V\D2W2VT\<D,1(N+>XABN(9$>-HPZ[:Y6]L[S3KR>PO;:
M6UO+::2*XMKA#'+#(K8:.1",JP/)!'/WN^:J1R-&R.KE)$8,K*2K*P.5*D$$
M$<$$$$'WKJM!\::]H&IW6J6=U'<7-]$;?41JMK!JT=_ SH[17*WZ3NRN8TRZ
M.DN%P'"DBDO92:NIT[SE=IJ<5"5N6,82<'S)W3<JKNFK)-/F?[Q*R<96C'=.
M,G)-)RE-<R2:2TC37O+5N_N\L/EW \D[AQZYX/;\^M*IPWW221UXZ?Y/\_>N
MRT;5/"8EU5_$WA^;4%U$/):SZ/?OI4^D7#-+)_H=LRS64L#-(B>3=12".*(+
M$0W-1:1HN@:AIFJW5QXKM=$U6R\R:RTS4["\>WU.VCA:3RX-3L5N?*OY'4P1
M6\]BEN[E7DO(5)VBI\W+RS@VXRDXN7(X*-]).HH0<FE=1A*;>WQ: Y6YKQDD
MG&TDN;FYK;*'-))-I-RC%)W?PWD<NQ.,DG@@^YZC')'K2[R1NR>_4GMGKU_K
M740>#?$E]X<N?%5CH]Q?Z%8R2)?:AIYBO_[,,03,VJVUI)->:7:,9 D5YJ-O
M;VDSY2&61@0.4P0"2>"#P,XY[C/^''-3*$X\KE"4>:*E!R37-%[-72NFUNKQ
M?1WNDU*+ORR3<6U*SNXR5G9V>C2:=M'KJK6'$],<@DY.>F<DD_YZ_IHP:QJ]
MM876E0ZIJ,.E7TD4M]IL5[<QZ=>2PDF%[JR25;:X> DF)YHW9&8E"I)K,((
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M>*^R]^9%II)<RE:+3YX\LI2T<9.4+1BK732HMZIIMJSQL-_&"".?4X]?49Z
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MH-M#2.&.0)<C?NVKMJ'X@Z^I#-:Z+\LCR#_B16'WWE29O^67(,J A3\JKE5
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M/#_AQX-2\/7>GZ)K6JV$QU.[L)XO.NM,2[6"VM[F0K&%47EPTD:H6=MA+!4
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MQ!L\HP\^?D8B$G[HL?WG KP,)_O-'SFOU_JW78]VM_!J^<)'C8^6[('S?O\
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MG_A249_#UZ\_6@ HHH_S_G]: #K2D$=10<@^_'^-&2>I)_&@!!U]*7D'T/\
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MOX6UCQ#:7<VB2^&=&E$::G::%<&^*2Y??=Z?#J6%ACR8_P#0Y)I@B(VV5F<
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MS';:Q:Z?>W-UHM[*(V=;+5(;2Y9"KB'8ZL>5YY;)ZY.WT[GV R!R,9(YIZ,
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M>+$>L:$\S*^DZDT9>"U\3^')0VF>(-/$C&*\A,T)EM9X)GYY1:]'LU_77?\
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M  2>_P""<O[4W@W]I;Q#?W$=K<>#O UEJOA#XGVDE]#<Z_J'A/QKHMYI%Z=
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M8,#D_@,9'X_Y_E0 E-9B", 8 YX]SU[?Y[T_/(.!],<'@C_ _A2>OO\ I]*
MZ??I]WY_H-4[CQQ@$G/?V'ZG\*=QVXHSUX'/Z?2DQQC/X_\ ZL4 ,DZCZ8_+
M'ZGO4=/V'U'Z_P"%(#M)SU&0#Z'I^5  I"]0<_A_G-?ZNO\ P;5X_P"'*/[%
MV.!_QD9_ZUE\=Z_RB/J<GOVY_P _Y[U_J[?\&U7_ "A0_8M_[N,_]:R^.]&O
MR]/UO^A<-WZ?JC_*&PCG=PQ'&>O3GZ=Z?344(,#\3W-.KG_K_,@C/EAB25#
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M5/C9KEMJ7Q#\9:SXLOX_+LM+BU.]":?IENQ"0V6DZ>##IFCV$>0L=M9PVEI
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M+DCH<?AF@ /.,\XZ>V*".H/X\_CVI<$GCDGGG ]<XYYI!D^^/O'\,D_Y_.@
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MDII.*YH-3C>2O%>ZWJ]O7325XI*<797<6TVE).+M'XG:26B_+75:G+*PX4D
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M/3H]]--;'RF.O3@#+8(;DGC'&,'WX[#/. _*23@Y. .<@].GW1Z\$XYSVIP
MP?[Q0$_@><<],]./QIIYSG!R2><=3T'3I_7U[22(0",'H?7WZ?G2@8 _+\J3
M&1R.O^>OM3PP &0#]>P]!_GVQTH&DGN[?\/^(AZ 8P1U]\XQ_G_]5- Y)]<
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M+<'UX.3QU!^[VQ@=.E.)X'^UC&"._P!,\_YZ<TGL,C!R,C@X.<?0_P L]J"
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M8_AI9H]1\01>+8I5,^GSZ78MH$\#7 4?9=1BU%[U)TMV\UTN=.ACW)MCF=F
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M .F1C&.O^?\ )H ZD$G/<_Y''-1 @$\C./KD?AT^O?VYR"_K_A^@_P#AYSN
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M>3BF?\+0\*^68_\ A4'@,DVUU;^;]H\9"0-<W'V@7)(\5@?:+93]GM7VE$@
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M"V>P[<]^,?7K28!X/3W_ /K4$O1OU =AUP"><\@<G/\ +Z4=>N,_X=/Q _\
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MGMG.>*[[P?\ 9)6UVSGO[*P?4O#]Y9V\]]-Y%LT[W5C,D;S8*1ETAD(9R%)
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MTIQVR >F>#_G-)QG/ R1DGU[8'?()Z#C]"N.W(QR<GD$>F?<<#V[\T '^>H
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MDX..G^%1DDXSV_S_ )[TE);+T D;[Z_A_,T2=OQ_I4=%,!P"G .<GZ8I67!
M /3_ #_2D7[PJ:@!1CG/H<?6DR.F#G\<?R_K3V15Y Y)]O?\:90-JSMV$R 0
M#GGT_P _Y[T]E4#J23@CZ9R,_E_]:D &">ZXP?J::"2 3U(R?J: [>?^?_ ?
M];3+DCJ1CCC'^%,(48*LV?J1Q^6/ZTVG*<$>_'YT"'\8X&3T/&",CKTX_E0
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36_\ =QG_ *UE\=Z"X;OT_5'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>nt10006151x14_graphic8.jpg
<TEXT>
begin 644 nt10006151x14_graphic8.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
M                                                          !8
M65H@        ]M8  0    #3+71E>'0     0V]P>7)I9VAT($AE=VQE='0@
M4&%C:V%R9"P@,C P- !S9C,R       !#$0   7?___S)@  !Y0  /V/___[
MH?___:(   /;  # =?_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_  !$(!78"O@,!(@ "$0$#$0'_Q  ?   !!0$!
M 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T!
M @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F
M)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@J'Q+Y_DPHHHH)"BBB@ HH
MK\>_^"J__!73PW_P2\NO@%I.I_ 'QW\?O$/[0>M^(_#_ (4\.^ =;ATW6%U3
M03H<<-A:Z?\ \(]XBO=;U#6+G7;>UT^PL+47$DZ>7&LLDJ)1_7WNWYL:3D[+
M\TOQ=D?L)17\VWP*_P"#EO\ 9G\7_%KPO\&?VHOV>OVAOV(_%'C;4+;2_#&J
M_&[PS>VGA6:\O)HK>V&L:AJ.C>%]7T>TFN)XH%U$:#?6$#R))?W%E;;[B/\
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MD#1,P;+MG^@.C?;^O^!V[H;5G;?;\K_@%%5KV<VMG=W*@,;>UGG"GHQAB>0
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M_LFNH)K&2:.]BDMU_EA_8C_X*I_LP^#?^"]'[;OQ+\1^+_B&WP^_:0UGP?\
M!KX31Q>!O&=Z]QXXNO&.D^&8(M3T1+![CPYIW]I!E_M34K>UM5@;S_,\O<5^
M\_V-?!WA?X2?\'3_ /P45\"_#W0=+\*^#?&'[&?A/Q=JOA?1;.#3M"'B'6[+
M]F#Q!J^IP:9:I%:17&H:U>ZSJ-QLB53<ZYJ;JH^TN*YO_@GM\/? 5[_P<9_\
M%2]-O/!'A"[TWP]X1\+ZOH.GW/AK1I['1-636-'N4U32+26R>WTW44N6:X6]
MLXX+E9F,HE$A+4^L=.OGK9/STOKU>Z>FQ44ES6O9QNUY6=UOY=_D]G_74"&
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M3\2O#OAO6;:P,DEUIOPPTW7+07<UY#"5D^P:CK8M[J=T<2):^'KD%6BE;/\
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M%HVDK.ZOK=]/^#_7;UW_ (-^_P#E(9_P6_/K^TIIA_/Q1\2,?IBOZP*_D_\
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M/<?&U/A)?374M]8:;'JO@?Q]8:AI6EW#/)"D#6^E65W+#$V&F=IB,N2?8?\
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M^(-*\-G1[B]T:^UC1-#UJ?1WN3YD,][H&GWK0?,^GQR?NJ_.+_@G!_P2H_:
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M[^&D/['_ (-_:_\ V4M1^#.G:*/ ?AS]H74VU"/XI>'_ (>QVQTVSL[:_G\
MW7BVVU:QT?;:6=PUAKFLZ4RP6VE^,5AL[2]@_KKHI66G2RMIV[?U\M04VDUN
MGKKKKO?^OU9^=_\ P3%_X)^>&_\ @F]^S!HWP%TOQ_XD^*GBB_UW5?'?Q*^(
M?B2XNP_BCQ]XB2U&M7FCZ3<W=ZF@:#"MG;VNF:9'/-,88#>ZC<76IW=Y<R_H
MA113$VV[O5_TC\5O^#B;_E#'^W'_ -B=\-/_ %>WPMK[!_X)A?\ *.']@_\
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M!4D59HH)/Y;_ (Y_\$&OVC/V>OCSXH_:J_X(N_M9V_[)7C7QM=SZEX[^ /Q
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MVT+Q Z-9V>HS^+/!W@N]BU:,*?M4%MI]U9H<>5?3#IY=_P $NO\ @FO\;_\
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MHI[_ ,97NI?M>^$OAEH+MX+\'#]N+X3_  W^*MYX-\#?M&MX#O=.A\4.^G^
MM$\.>+P_A'[!IH_X3"?7M0ADTC6],C7Q/_@J5XG_ &(M>^)5[JGQ4_;A\=?L
MG_M1_LH?!CQ5XX^$5KH'C'4/AE?3W?CJP-Q9:KX(M=;TJRT[XW:GKUYHVE^&
MM4\%^"]1\37EPBQZ%J&EVEW<<_NE%X;\.PW&CW<.A:/#=>';&XTS0+F+3+..
MXT/3;N.UANM/TB9(1)IMC<Q6-E%<6EFT-O-':6R2QLL$07P_]I;Q]^SS\%?
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M:&8K%*F\Y^P>E'1=;7U[WL_TT\M-M G)NZ<;-M73Z66EO5/78****#,****
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M'KL5I#K6CR7EK%</IFKPV%YJ-C%J5BTAMKV.SO[VV2YCD6"[N(@LK;%?GO\
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M@M_P3G_:P_8D_97_ &)]4^ O[4WQ"^%_P"_:#^#5QXZTO]L#X7?&K6M%\/\
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M1H6E^(-/2YCSY=PEGJUK=VRSQY.R98Q(N3M89H&G9IG\N7[2OQI\)^-?&O\
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M*]W;88.'N+>'!=MWEM*A8#+':Q/ (*! P"E  P+1>RZ=_->;VOKIZ#Y%UO\
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M GRMS/)N49!;))9W#'!!E=0"O"MYAVL/Q;N6X-PZ %B0LH +')W#.$!;: 0
M0/XF8DM1R]+);=7?==+Z[VTTWMT#D72^NWW7UTTO\_T/[/V_X* ?LNJ&+>/G
M7:<,#I5X-IVJX!)7&2&& ">0V<;6QG2_\%$OV5H02_CJZZ!@%T:[+,I) *KD
M$C*GH/3L1G^,M_BU=O&L8O),A?E7>0$4J[!0IF=#N;&YP0^-P&"$*YLOQ2NY
M-V^[)VL2HWR8RV<EDED<+W8.,CID]P<KTT7IK?U:_JU^G0Y8I]6GMJO*VW>[
M^73J?V=2?\%(?V4(R ?'%^<E0NW0[MMQ8X^7#9./FW#JNQU(#J5JA+_P4Q_9
M*B8H_C750X&<?V!=#CGG)D [$\']:_C'E^)5P^3]HQN #89@=Q;EMJ'!((0%
M2 B[G8$$FLQ_B+,&*^<K,68.5>8' 79MW"0@+MSN)5LD#<3D[CD\UZ:^6_;?
M7M^3Y8KOTZ^FO]>=NA_;#X._X*,?LK>.?%_ACP-H/C747\1^,-=TGPUH-I<Z
M#>P17>LZW?6^G:;9FY'F0QM/>7,,.YV"*6RQ QG[FK^#S]COQE_:'[7G[+=K
M)*29OVA?@["O+!79_B#H( 500H4C:XWYR5(P"5 _O#J6K.Q$DE:WS^Y?YA11
M12)"OB7]L3_@H!^SW^PU#X(G^.MWXMME^(%SJ5MX?7PKX>77G:32HHY;MKQ6
MU"P^SQJLJ!&!D+,<$*!FOMJOY*/^#FS5A9>*_P!C'3Y"3%J;?%,!#DQM):V.
MDR@LJD$D*2!SQDY!'!.C^7XR2_4J"3E9[6;^Y/\ X=^5S]1K#_@NM^P?J*QM
M;ZE\5<2#*^9X C3C&<G_ (GQ & 2"3@X(!)P#U-O_P %I_V([D*8]6^)/SX(
M#^!MA"G^-@VKC:@/!+8.0>.,U_$!X8GB)MMNUMRQ@AN8X\;Y,* A.)$,JN"-
MNQRVY%&#[=HUPB*F%11@@KY4<F3@*1CR&.=P;]X^5R?E?&*M135]?Z2?KY==
M=?(OEC=JVVN[V^^W];:7?]D\/_!8[]BZ?.S6/B'PH8G_ (0B1@%/\19-3=54
M#+%F(4*"<],SI_P6&_8RD8*-9\?@D*PSX.!RK$@, FK,<9'ID9&1S7\A%O(R
M!0N=T0C.9&5]P+C>TL8@R[!0H"KA(N"NPC?'M03OY2IL0J"BM&Z&<%7!9RJE
M591D ,B(H5AM&*.5=[7M:]M?Z^7S#ECV7GJ]-OR]/N/ZX_\ A[]^QP<[-5^(
M4F"0VWP6RA0,Y+-)JD:J."!E@2?E +D*6-_P6"_8U0[6U;Q^'R04_P"$0CW@
MABGW?[8R?F!&%R<\$ \5_),LNX, L3C#R(BQ[86413O+(%,2@F)7RT;%"ZR/
M!(9598W8UP#OD'DCSFCD?Y+9L!%"+O'E%7<,BD&59 2QPJ@XI\BTU?ST[?Y^
MB[Z:G+'MVZOK_3?R^[^O?0/^"L?[(?B6VNKK2]8\<-%9WDEC<";PD(G2>-(I
M'^7^TVR@69#N!]3C )JQ?_\ !5K]DC3HIIKC6/&VV $RA/"@W(1,T)7Y]316
M(=6)V,P ')#$*?Y4OA-<Q_\ "-:P1(JFY\6WENT:I'%&4ELM* <[;4^4 \IV
M1*P19 KMD'8-'Q;=%+*]C#H"]U S07+RSA6++)'M?8W[S ,9PP@S]U0I#&+:
MVVUMK_PR_) HQ>MO37?1/O\ +<_ISNO^"Q/[&=H"9M5^(6 2,IX-C<=0!RNL
M8YW(W)&%D0MC) XC6/\ @N/^PMH<?F7^I?%)1YJ0JL7@*.1V=SA<)_;H8#'S
M$L%PI!QD@5_*QK4ZDKN5(<[2L9CD6/:)%WE1 826!!"OE0=^"Y=5-?,GQ'N0
ML5I&'\LS7):1 Y*9",ZE@P9)#*=SRX<E22JHBA06XZ7[6[;Z??OOY?,%&/\
M*_O?SOVM^/0_L+O_ /@X'_X)\:<':XU'XPX3/^K^',+EL8^Z/^$B&<DX[8(.
M[&,UY%XO_P"#G+_@F/X)FL(-:O?CSYFI>?\ 95M/A;8S9%L4$I;?XPAP 9%
M(W9YZ=_XM?$TJJ'P492I<'"MD(""2R;'5@7<87[IQ@@X(_/#]H6Y%QXP\+V8
M*E;31;BY*9!V/=7H3=G!X*6Y Z'AAGM4/KKYE<D+;:^K\M?Z?RMM_H:+_P '
M3O\ P2R;D7G[0?8?\DHT_J>@X\:'FG'_ (.F_P#@EF!G[;^T%CU_X5/88_\
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M._B'Q1J,.EZ4FI:A%XLO'L[-[NXC6:Y6UG,2$OY; &O\PED7& %R3CE  #D
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M,TC@@C!\QV"=5)<#>C[F4*JDGRU9B^TEEJ^NI %OF.. Q<L, 8WD!4 V;3@
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M<8\!.NG.#)_>XW'@XX(+$  J H&   NXDC!<-?8$$/A^@(9<G(R =V/EQD
M<#H.:KGEIKU[+^OR]>R45V_K^MV^[N['O8\5RG!\SD@G +  +ALY) 8*<CY2
M0?F]LA\62A1F8]1@AV(R-I&3TQ_O'(Y''%>!'7B3DN>@P%8E=JDDA0<Y "EB
MN NXL. $"G]NYY#$CC))/4D8;Y\Y!P .22?[IYI<\N_X=NGI_7<.5::;;?A9
M_@K'OA\6R%1^^.3QPZG=A>6[@?,,'E>N>N,QOXKE RTPP %!+;B1G@9R<DDD
MC&,XSTR*\&_MW!9<L3D$X8#A3G*@*N,DL2#)PR'Y0"26'7B2Q\PMWR3DYQD#
M[N2!V"O@')  (%"E+O\ ?\OZMZZ!RKHE\O\ +KZ??MI[R?%DBA_WO7&Y<DL.
MI4$8)8,64;02?O<X.:C_ .$K=6&9QG)/(SEB,$KQCGOG(!QSG(KP@ZX0&4,V
M<')W#&04/3>&R=Q3:S=2<+G<:;_;YZ"0@M\I 9CP>F2P'!X'"G."?>CFEW[=
M%TVZ#2[6^_O;?\-7_F>[GQ9*>MQ\JJV !R#C'R <X4!%..[ 8X!J(^*I" &F
M(^;:&8,I;D8SG!&!C'TP,<"O"FUTJ6 ?J#@!B<DCYLA<(>%Z <8+$':#3/[>
M/16P&&1DL?N'./O,>><8Z$8P3R5S/N][]^W^7IY"LNWX>5K'NG_"5RARWF'(
M.<[MO"G^,,<$Y/ )!]1E:K'Q6Y+ 3LR[WY!P1@E2 .OKD''MR<5X@->((+.P
M.X[?G8!2P!)(R#ELJ"%<<'(##<35;706*DL,,V/GR5RS'(R"#D\Y5LMSDC)-
M/F>FKT_K^KWL'*NB^Y>:[>=C]'?V%?$DD_[;'[(D!E#>=^TQ\#8W.X@N)/B7
MX6B[D#@D!@,DD@$8)K_1AK_,V_8 U@R_MV?L91;P1)^U/\ D)VD%O,^*?A3:
M,[2H(R2X5E)X!+ U_IDU+U_X)%3I\_T"BBB@S"OXZ_\ @ZFU#^R_%W[ -T9#
M''-XL^)6GS$8R8[S2-/3;D],N$[\U_8I7\7G_!W/>-IT7["FI*RJ;'QWXOG9
MF;:%CVZ,DI)XZ1LYR"",?B![/_MW_P!+B7#XEZ2_])?]>9^'7A2Z;:@4E24(
M!9 5.U693N." RAQGJ,#@*"3[=H]P2J%73;A>205*R!F!8#Y\_-Q@JHSG/.:
M^:O"-Z#'$P9L,L1RV#'(,OD.C[P %;*L%91LWL"5PWO.C3,Z*2J$DD[E."V2
M' P2BY.X$EV;:2 ,*-E:0V]'^J=O2]]7W?G:WNGIO;6W5^?:VEM;_CZM:W/R
M!MRG:""V\G:-X4A]K$*6.&')(0$%<M@[*2CE3+Y<@(C+"9&; 5,*SY8'S" J
ML<%%.#D9%<;;32,%52=Z@.@+Q#:B! VS:54R;F&T%F88VY$A4C9CN)GC82/(
M738%) ,C$A=Q!9E)4[258?,5+ K5+>_5K^NG^=UMH#VU[KNGNMK:Z7\];=4=
M#%.7+Q1$D;Y,E2 RYC+?NR2 JLRA9#M^90N>&Q2R32,[L/,PV=J*X("Y(!58
M@ O.!SM/ 95V\UC1S$!T)1@!N<2B0QL$WNJN'<HR@$9X7YH^#@L*0SJQ.TC=
M(B84HW!R$D*D/*BR;LJ27D4D-M0#  OQNK[ZV2^?5:/S3WN'9^6G5:M=;]/Q
MZ=E[9\(Y7E\,:M%YBHO_  EMPY\Q@T@#+I8#QG(=69X&&X L  <8;*WO%\[_
M -G [F\V2\@9@I6$ABCD9(>3*ME6?H0#P-I!7%^%4B1>")'1CO?7=2G:-$C*
M++%J3);Y:123OB@=MTT94LJ'8[K&%?XVFCCTVV!^;_2X5B<6TIV(D(*-T,65
M5A&<2, 5;Y0 F[-+5:==/E9O?I;:_P!X[ZVOTO\ BO+KM\]NWE6N3;!A7 4J
MN06WR *T+R X &P,C21[L,Y!###KGY@^(MSB[M4QR&N)%9F"J2N5W#HF6!)
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MQ@$9*DX/&">2#D=#U]P(BQ& P' 8\#((!!4L W Z#G8,8/ XI^6!'S(Q&[.
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MK^OEWW =N.,8&X'<3GC .!GGCKP ?[H'6H^@VO\ *  06#-\VT[B",X'H.N
M"1W*EOE"_*5VD#GD9)VJ5+.!G!.2"!C/!Z,=B"3@H2QZC=@#!";C@D[< ':3
MV(Y()M9W=EM9+ROJDUOH^_=ZI@$]1AB&!PRC.XGJ,8Z$9]".2#QDQL,;CVQD
M9!S@D?=VGJ<9.1V'7.2YB>C%2<[C@L2,C &"=F1QDL,X^5LC ,1&X+R.F%P,
M'/'4 XY((&YG(&#@BC1K>RVM9WO[NW7HFM_._0 Y8@X]<\Y[#H.HSTZC))&<
M](FY(SDGT & <\>N 0 >1C)]1DO.03G@9'5A[97&",8^\!N! Z*<5$<$X(!(
M&.QSC'.%W<C.<_=((!^[BDK-].GG?1:)O:]K6;ZVM<!I9< X/S8[XR<\]>HQ
MG:1QGUZ5&S$G(..!DX5B.6!('7OP< #H<8IV,$8( + %@!GD\C QC&!]WE>>
MN *A)8@8V],$<KR3DX!8 #G).S[PP!G<:>]]=K=?.+;Z.SWO?N^H"9QP3DGM
MD9.<G.3Z=\G/;-?H3_P23_Y2=_L$_P#9UGP6RO88\;Z2,],94]/;'T/YYM^'
M! .,'/4]/8CH#R.F3G'Z%_\ !)/!_P""GG[!.W!Q^U9\%QUWCCQKI(<*,#;R
M W.6&?7!H5]+=UJEI]E:;>:\E=6 _P!=BBBBM#G"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH*A\2^?Y,****"0HHHH *_SN_P!KOQ =&_X+9?M#
M+O(75?B)\2M&*YQN?^S-"U*->^<+I\I &"1G&>E?Z(E?YJ__  4-US^Q?^"T
MWQ6OBS!#^T_XBTF89V[DUOPW-I,:Y'3-Q=0%,]6"C!Z%=5Z/\U\_T[]#2G]K
MY?J?L'X0UC>D>'&XI&5<E3N8JK!./N (R\8RQ<@G<,#WK2-4\R* .RMDD* 5
M P!\AZX"LPP.1G/;.:^0O NI%[:V4EBHBC168 (N5D.W*IDLJX7;M7.!D[5W
M'Z)T6XR5(=58, H+IP.ZEBI!4'!P8PR#!!8X6J6C7]?H_P F:+\CVRVU+<H^
M9"[,!P4/WBRDDC^+=N9AC  C#8P:U!J9QD, 6^4D,&#$K@ 80D8##/(R !GC
M->>VEVVW*F0E2"Y#@'<V'=1YK,9 N"%*RA"<+L&PM)L1W? &[>N =RXDD!W$
M!MS&6,$9^;:N!M'S8!QI=.UM;6O?2]N77KK^-UI?9AUOV\Y)4D!RN-R@;5"L
M%' !5]@&T!< !UX 4+7L[\R^(?#T)D4AM6@\P/@L=L<LO ?& V,E>F,9R,US
MJSL Y!5268 %5)*D,) K(-AR09 67:0^58DLBRZ1(#XJ\/H A_XF!D3<V7S%
M#,_#,=F$PQWJ2<\ 'C*5W9ONEKZIIV[M-Z]M'?</Z^\^@;ZY!E@RA9560 %A
M\JB2:7E3D@EB$.X<EB0<+D^-ZI?E5N""8R9)F5<ACEG;YPJY4?*Q7#C;_=Y-
M>DZC+D(V48J96(W'<2&!^3< "H0G<"VY#N1&*D%O$=5N,6\K!X\%6 ;=P0Q#
M2(K$$%CDDX*] I8#YA4G:W_!VNF[=.G78#S7QIK MM,U&;&&CLKALIAQEUVX
MPH_UF]@%!"\EP"6RU?(GBS6O*M907()5<# 5F4* 5;'4#(R,9R"0<BO>/B3J
M#6NC72C,9::V@*EDP%DG53@%WR-B9("K'LP44+DU\8^.M6\N&0%A@EP6 "@!
M<@,-I&  1CYRJD9!SQ62NVOE]VW03[[VTMZV?X6N?ES^W#XF-UXA^%VAB57,
MNI>+]?= XY&FV.D:7;LW0C/]N7"(2.0' S@X^<+?4"L2*7Q^[3D_P@>AX/).
M,CH.?KN?M7:X-4^/&B::K%X]!^'UI<-DAO+N_$6N:O<RJ<D+O^R:9ISMDDD,
M &(&ZO-DNR$4XX Q@<,1M'/<J>,<,/?. *'N_E;?9)+6_4I:=+K_ ":=E^7H
M=B=3VX!;Y03R3P!C&#^O7D<<9()7^U#C)< <$'/"\<Y..3DGYAC\>M<?]JP2
M >-N"3R' "DY&5((!QV8G ^ZAIGVS /(SP.%&21TV_*22?7!X&3@X-(+^2>E
MOZ_SWWV>W8MJF/XQQM(SG&23U[==HX!Y/'(X:NK<8W."<_0D-D@XZ9!Z'\!V
MKCS=Y)..>BY* ].IPV68@'+< 8  R>6BZ8 !B,9 *@$DX !/WOO8Q@'@XSGG
MD"_==--_*W7HMOEN=H=6QR'QRP '<\@\Y[ $ 'H2<]1EHU7)!W8!8 #>2&YR
M,].@."!QGL.17&_:CD].=QX8 @=2 #@N"0,@GIGJ -P;HY W$+C)SLVY"YY(
M!SR<YR0<G'K0-R5[VM_2MKY6TT^^[.O.JE@,/M7G+9[G<>,C@X.!VW+@\'EI
MU4DCY\@X^;..G8#([\<Y/4@<"N0-T !ASE06 )4'/;;]XX ) QD%F+<'"JPW
M/4$K@<,-PR3D< X7[K'@$KG'H1D%?5=ET5_P[7[G8?VH2O+*Q QC)X&=P.#V
M^8#G /&,D\1_VKQ][D $ '/&#P>N>#DX!QUP*Y$W2L!EPHSPAP.A)7YFSD =
M/O,&'RDCK']J['J,'[R<\\@8=B, =%); /;B@=V[+2VB_+KTV5[-(Z_^UN&P
M<?P\$<,W /?.-W0]>>.F6MJ[ GYQN!Z@\Y'J<8.0>,G!S7'_ &O.XDNJG )8
M GDDGJ%)PWRC.5*XX_O1M<J." 2&R0F&+-QM)(4 8Z'/(()/7@$FU>VFG^2T
M\_\ @G8-JWW1O/<@,!['=CH/N]<X^Z<\55_M?J2S'&0<$@!NW0D],XP1GJ,B
MN6-V21@G!XZIG.02!C*D%5Y"X/!& #NJF;KMD8Z8)& >#@A0=S9!'0@G(8*,
MX N].EM5MY/KZ;W;?Y_>G_!/#5/-_;Z_8D3S"=_[6/[/*8)XQ)\6/"0XSCN.
MW\...:_U%Z_RO/\ @G+<E_\ @H+^Q I!&?VN/V=%R1&6(_X6UX2VY8DMMX;A
M<!>/]T_ZH=!E4^S\_P!%_7^04444&85_%1_P>$!CX1_8^*_>36?B)(O'\4=C
MICKSVY'XU_:O7\6?_!WXH?PQ^QXF 2VL_$8#.,<Z?IH()W+@'/;.<=*'L_\
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MY?N=S7VHWU\S8^^]W=S3EA]3)G(SR<\]_O3XE:NVGZ%XHU L@:S\/:O/$"2
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M(7[N/44>;MTWV=U'37M9ORWU "3D$@%<8R,XQP?3 7C!&>02#[,X( (ZDG!
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M'C/3)YYX_0O_ ())-G_@IY^P2!Q_QE9\%^,9Q_Q6^E9&?7'!.3P 1TR?SR)
M& %W8R3SZ9SQC)P.3D#GKC-?H5_P22;_ (V>?L$@@\_M6_!7'.2I_P"$VTGK
MT/.<XRR@@X., 4EHO*SWZI=M>UM;:WVZA_KN44459SA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444%0^)?/\ )A11102%%%% !7^7Y_P5NUK^PO\
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MYQ'&0=W#<;@&XVG)^88P1_#G)[U&9R!DE2=O7!Z^ASDDYZ$$>@P,"J6]L$@
ML3CY@X&,8.[A>C< #=D$%B  XB+_ "MAAD<X(.% P<;CSD\\  ]N<<FK_73;
M1:='^#^6P:+[M-O+UUUU6FBZW+HG.X$G).3R" QR,#@ L!DY!XY_&J?G_+GC
M P1D#)YZ<Y)]>,GW[4S>V< Y!'W@,C[H/.1D$Y Y /"X /)I%\^G8@8<@$8
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M/;^KV+@;/)(^\6P,CD CV^[G!.<[BU/#8R>1WP#WSG/3..@QD8]^:K*VXK@
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MC[!IG7@G'X?CC-)_#+T7_I42Z?Q?*7Y/^O7[U_&?\!;XV/Q.,&XHNJ^&M4A
MW8#R65U87D;'@X*0I<X&?XV[<U^G'A^YRL:[< QJ&4!<'&-C$\%@0/F(R",'
M&3S^3WPXO7T[XG>"I!Q]JO[_ $Y^0N4O-*NU"Y^8*6D6,8P0,<]Z_4CPY.[+
M&V6(:,E3A<?=)()8G&%)VKSCC W' :=MNEE]UGY^1MI;SN_T_P"">UV,X8 Y
M. ,,ID;E1&ZR#:05;[Q9<  #!SPV>KM9"!O8/RHD)8D]<Y.%R'&6(&0,<\97
MG@])G/[G!V*#DL490!M"XR"K8;S=S'(VHF5&#SU5GO*@, RM$&V)("02[,PS
MN+J"Q+8$2;@&.X*1G6+TZ??T7*O/?Y>7=9R6GDO5NUOZWTVN^ATT4API^0J5
M. O"QYVJ  <89G&UNRQLP;@,*;?RL+=T9F7<"%/7#8V!5()5 ?N*25RH5L@$
MU139M$>8P WF.1(?W2C=L+$EU&]L$,Z,6(<95MJFQ<%RB@8PT\(4[L95I4^8
M_*5'IU(7W &*O_7W;[6>NWSUV%KIN[V>OK'O=_TK*Q])>&<?V+:(P+#[' KM
MNVN&\J106RIWO$-K(BLJ$E 58L<TO&DJM;6_S0LXDC(#OO?:9'<!25&S8)2.
M&;)&<@';5OP^#%I]GY2J["T5F(9@1);RQ2,%PLSN[QMM+B,#8C-N7Y2U/Q@S
M2V4.T0RJ") Q#[C\R\RR;XD3JHW%02&4*,<E+>ZMUO\ .S3\_P!+I="K_IKM
M?:^[W\FKM+1GSSXUF\O1M>9QCR=*OY4V.65"MA<C*DG)+%MAQP-S'@*,?$FM
MS%;1Q@C=&5 #,5V9^7![COP,GJ>"!7V=\0@R^&O$LJHW.B:DA8L"5_T8X,1)
M!(4.N0^"5+."IP3\4:^V(96PW 9%W*=H7'RDNCF/E1PR\9SR2"!$]_E?^M?\
MOU*C?6[Z_A;;3=ZVT?7?>WP_\?)]VJ^$K3!"+'JUTP/)R\EG;JQ]L*^W/8$#
M'.?*8S^[4'K@\ @#&,'!QC!SSQGC@8.*] ^-\OF^,]$A_P"??08\JN=N9[^Y
M?N3M)54!R 2!G!KS^/E0.<8X4@$X]6(^Z,<\D@D]A6,K76WGKJM5;TO?ROW5
M@)<YQP., \;AG<.,YR1@8'/L!@TJGA@1P3D_*,K@YXR"0 <=.#WS32,#)R!G
MEOF(!! R,[ 3G..C<';NP<.'7U&"<9'!Y/(QDC)8@')(&<DC-+;796\]KIWO
MH^]EOV33 >0"K'J20 #G&,$9Y[Y)P.%YR.F*=D\L!C([*,@8S@<$*/FX (XV
MYX.*:N0<+C<0,-D9&"-V2"-GREL#&!D;@2 *4#GE?X?F!. #VR#\H QGAMS+
MZ8S1V5VGI:W:T5JN^EVM;==-0#)7:/N<'((.2 "VXC) ('W>AY)/!-*#QACG
M//13\IZ*<D,0#MV9''!]*0,0 =Q! .WA\<J0.!QC!)/!& -P898-Z$E1D<@E
MR <#@#DD'' RO3H0!R3;1=]GI?X;.VFJMLVF]]G8!0#@8(R <'&"I&XD_='0
M@8ZX)]R*0_/DC&<Y.><[CG(.0,'KP 3V'>E^8]!CD$9!.!@!F!*@@+M+' QG
MH":;R!Q\N"#R1NX. ,M\W _ \\#@E=;Z=+=+.T>E]MKVOML '!7DD  _*2<[
MMWWB/?H?IZ4C'YB=H8YPV,?,<GD=!G:,9 [$\YY"RMG@=<DNP7ISP.I)QD '
M))!Q3>.<\G@Y"\@8Z?,P.>?3D'/'."SMZ)>[_P" Z>=]---=K@)Q@<8'(P3D
MXQZ?Q>O!'3\*3CC!(&#WX.<# XX!ST&#T':@8XP,;<!<JIQR.3R<D?-P#C
M8@&FD9X[;%X)!*YSG)! &#GIGA>23@DUNU>UM5KVMOZK:[2OIU 0GH06P#@X
M_BQD8XY.1SD^O YJ-FZ]3STW?=&<\XSGG'J,# Z9I^2,@ X)YXX( R",D@C&
M3R01SDC&*B./E&3N(!4 >HR20&Z\?,?NCC!)R*>SYM;::K:WNVO;3NFON6P
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M*[6SN0[1,Q9FR1N3:N3R%"AW&<=@,YQDJ,C,@M4M_GH_G8ZU;DE/,+'<X+$
M*K/RY!"C"@E &.< 941\!:],^"K._B/Q5<%F*1Z5I4/7<R@W-S.HRJX.>#QG
MD\\<5X_'+O4%2[%7D/RH6SA(MC$ G:%0LX( 50.ZG<WL?P+4/+XNN<,8WNM+
M@+)&H3$$<Y957 ;))W@ D#^(*=JFH[K^OZ_/MJ/]?Z^1Z_XN)71+M');<MTY
MR68.$"JS$;NPP64KO+2<-M9E/RAXQE*VTBJ6*"*;.,[58L%51EL#"GY0J*,'
MCTKZL\8>2NB2ON?_ )?03B3=^\^Q(0P^:,*C%BRJ_*?=8,-I^1O',XM+"_N
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M6V@$8P5//H"!4#+R8;!'MD<  \@D<9Z=N"-H / Q.H!Z\]<'@\YP.!D=1Q@
M\GU-5$."3\N3EOX23@A0<C(;);.Y0%W-MW#YL7D_F"3T4],=3T!/&205P"1P
M:3T_3\.^BU[O7\"EKZ];[6NK>:[:=/F3K'P>"%ZE2H.>G )W-@,""1@@8&22
M:FV#^($YX& !C!YST&?3'.!C!I$'.2VT;CNW;3@#&T@#(ZDD%<ELCU"B<@X'
M4\<=]V 3V')./X>0>O H72^__ ^[Y;#V=]-_-+H_N739[;IV*^T=P#MX'R@\
M*>>H! W '(/#;5&!U0KGJ0,'("C/(SM.,8S[\YQZXS-MVGC/&%P 23E1U X^
M_P 8X'*@]J"G+'+=SP.?IC.#NP<X.1G@'-,2OMWW]-+6V7HKZ]K6*QZC"D@C
M^%0""6R"#U!P<$_Q8X[@,(;GCL0O7/)R5/7<!TQSZ>HJU@G &X@XQCDY+#:N
M5W-E"RDC=G'85$8P#GD#YNO)ZC)!^;AN2#D-Z9')5MOZ^[[M5_D.]W?=W6ME
MTMT5GOL][67>U1@3D89@ ,J<<')QU&,ID\9/?@<&HF7CIDD]N.W&<<D#CN.W
M< U=*= <87=C*E!D@8.<D$$\*,C+ \X4U&4.3QD\8(4A1V(.=H )ZD9Y&!W%
M%DON]6]M>_1;"UV75VMI:^G;3T?6S*95A_>R0"0,XR" ../FQPW8<G !X;L&
M",'Y>>@YQR0..2!TQC&>#QS89 N['.TEN,G(P"<$GC) )4 D8X ^;:-QNR!P
M.2H.1D#@@@N,DDD$#CGW!?\ KITZ_/3N))75_G;73^M^WX%4J LF&. &P5..
M&53@GD\'' )^Z<X/2N1D9.<=A@!N1UX R#UR<<]0<U=9=RNO0%,G*9P@8?,N
M,$YW-M.W##=R, U4*Y!!.,8R %). ",8)&,9! ;.2,\D98C[+_X)OY'_  4+
M_86SD_\ &7_[.!)/.,_%_P &K@#/')4Y'I\PY '^K=7^4G_P3>_Y2%_L, 9/
M_&7W[.)Z<8'Q?\'C@@MP$Z,=OS J?FQ7^K91_7J9U.GS_0****#,*_BV_P"#
MOC;_ ,(Y^QQG_H.?$0^V!8:9GN,]J_M)K^+;_@[X)'AO]CG&W/\ ;?Q$ZXSC
M^S]-SC/'3K^'TH?PR_[=U_[>B73^+Y2_)O\ X/R/XA-+NA8^*O!]\6VK:>*M
M%E=OND(VH0PR9 X \N0@GN"<GK7ZH^&I<JF3@;<G:VSYN%ZD'YC@D-M)/0^W
MY*ZE*88X9U+;K2YM[L<88-;7$,N?FYQE%]>V.HK]4O"MYYL4$BG>9(XW52H_
MC&\G+(?ER<+M!!'\0.<3';T?:S>BW_K_ #>W]?U_PW7T/=M,D=G5I1N8@$X8
MH7;+%2&3@L0H +[B0KJW##'96[;BA'WRJJ01ER 2-I;))7L I''));->?:9(
M6\M2 NT-)Q(S\+N.Z0J@P$8!B 1P&Y*_+7;VLF#"1Y>_>P9E="&<MG"N%4(,
M$L49L\$J<$5K#?\ KNEKY:I^JTZDM7ZV>O\ P_\ 71M=3IH)&B*DG8N1DY1V
M7!=]HP&("R%"K#!PJ+G&<605EN-/A0JWFWD>TB7Y@Y<.P4D;22/F/ 4D_,N#
MD9\!;*F-0K,_EKEE8G<,HK9#<J\8))(<1,Y(P0U:EBOFZKI<8V86ZBFDW!'1
M"(2T8,B+@+NW$ABF",LH&!6EWVOJO57MTU[ZWL9VM*]O/33:SM;O]Z;:6CU7
MT?HG-G;@MMC6W$3F5SA@8I?,!8* $8@!PH!^8D'>8G2KXMB$EA#(O*L[JLN\
MJH  PC,J@D*1]W)7' X(5=#0EG:TM5+1*KQG,FS+1_,2[-LCE5R6(V'<"RJP
MP%$F(/%2,-)4DIO2Z1'/%PTP,1/F$J#$'(1 QB(5G+#MS+OHNUNOIW6MGU2:
M[I.S5K5W76V_;1Z:^=GTOZ:_+?Q2:2/P?XCG !;[+!!O^7A+B_LK$9YPP"3.
MPP%X)P,9S\6>(WQ%-AB&RW(R"!D@=>Q&?;CCY>GVQ\6D1?!/BA_F4Q6FA9!Q
M&K*_B_P]&[>64#$J&.2-RHOF*ZQJV1\2>(,_9G _B0Y&U2"%)R, G@8'3[QW
M,3@9J);KR2_I?\'7Y6'!:.SO=MK?JEIVOKYNZ74^!/B_(9?B$5Z>3H^FH5.,
M!CYLGR]-V206R,')SGG/&)D <^H &,8QGDXSV'&?SQ72_%.3S/B1J?\ L6>D
MJ.HPOV1')PW?YCA<C!ZXZUS:Y."1@'D#CH22#@%L9Y(Y Z8SGC*6_79O?KHM
M-==UIIY-W:&./4+@9)XQU#8!SQSP <]^G>GDD]3U"@EOO XP3R"1CD$9.1VJ
M,X_(\C."" 2>.<$$@YQANY&1E^,[A\P(&W[I( )/?@!LYQR#['@!==]-&VNM
MFKMVT73?1:O2ZN#@!AP /N@Y+'@\ '.. P.,8ZC/&.'Y' !8YP!MY.<8!;GH
M!G X^Z  "#4:YZC[P&T8"@]N2IPRD#(+XP>W(-.X. ''7 (. -P&!EMI)/).
M.,C('-"[V72]WIJEJ[WVUUW=^NH <D#!QD =B3TSWR0V#D-A5SZT;NH +88$
M$X(VDG@*1UY]\D\GO3B IW%5(# 'D'G.0%"$GMR2.3E1P>6 <#.1CH,-P!@8
M!( )# @X!4YP#D8 WHWT5KVVWC][[:Z*VS 7<"#@A/O9QP2I'&XCGDJ!V7(!
M(XI,Y)!XS@DD#(8A0>>2#\H!P1P 3[K@?PJ=A)!R/8'&X]!GGD;>1P5&"S<>
M>H!V\D$$GW##=@>N.N!P.*/1MK2W=+W;[K?:R6VNV@"DG ^\><D D DD+@')
MSG@<YP3Z"FDL05R3SN.XX4\8R2",GZC'J<<$)P"3QCG(.1E2>^!C(.3QUQD@
M88!.,D, 2Q!^;=U/ VY))'?Y<'@?Q4+IUVU^:W[VNTM[6T2LP&G'7@C(/4]1
MG)R#U Z#IQ[DTC#!( SGNQ#'&!R3SG&!D\#/.,MB@DG@$]UR0 !W/RXR.F,$
M9 .,=J8SY)Z X('')Z$XP<G!Z],?=(XI*][Z=]-+K39::OS5G?T ;G@8R<;N
MY)'7@9(&<@<]1GC&*0\GT/S<$9!!VM[A?3(SC  YI6& <#@D #^(MN!X X''
M)R&P1S3&)P3R , #C@LGJ",D\C)ZY (S3;W[Z:7>^C32?2[V?GK;1 W)'W<8
MZDX!Z'G"X/08P#R3DBHB#RO(&YCC XY/'/S8#9]B<GKS4F0<YR.""2.N5P >
M?O'UR5R.W)J)B,\<G<V#NW<$G ZCITS@=.?<3VVO\TEHEUW>RTW7:X#&QSG.
M N",$>_&0<\GH1C P!Q49R#A<DG/.<X(STYP,<9ZYR3UIYR>6Z=R2 ,<GD'M
MWZCIP#TIC,,A@>O0$CIQW('.3@C.>F0".6MF^Z7;Y-VUNW=WOIU?8(B>^"_)
M&0 .V!U7@Y./;IQFOT,_X)(9_P"'GO[ ^,A1^U;\%QV' \<:3]X8SDDXY[C\
MOST)/\73#<85ESD'&X9& <D].1C'I^A7_!)#_E)]^P/P0!^U=\%N>,Y_X3G2
MADX/(X('89..:?;IM:VUDX_TO+I?0#_7DHHHJCG"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH*A\2^?Y,****"0HHHH *_RQ/^"P[@?\%._VU@.3
M_P +Q\2#CGDV]CURQR.P  *] !FO]3NO\KK_ (+$N%_X*>_ML@GI\<_$F0<8
M \BQ88(Y4]^>V<\'(75>C_-&E/K\OU/DG]F*_-E\;%0'Y=0\$ZS;$'C/V;5M
M%U# R "4^S/P!TSTP:_>#X=7XDMH 2'+;3ELX(VA2"#P2-P/S%<XZ%L8_GQ^
M!%[]F^.?@G<2%N]/\5V3CH"TF@:A<0C;DX)FMXSQU/Z_NI\,-15[6#+[5^4-
MN4A2VT'EC\P4E0&;!QR05(K2*O%I*UGVTUM>VU[?UKM;=GV6K?RM_771'VOH
MUUOC5S(-Q969B/+.268@A2RX'"J"2,%1E=F!WMC, 4(PHW(V5=59'52 S%0,
MXY(&2@., 8%>2Z!<K)&H!5@,8"L"<D$ A5<R ,"6)<J=I/&X@5Z+9,WR@@L&
M&-I5PK$K]UOD?H>21CMDCO']?U^(?BG9J_R_X==V^ECM(W)&#M;#"7)8E4*F
M,LJN9%.[YB%5579NSAMQ%>^_ 6 MHFLW+84SZY\Q5P %C! (Q&!\NXX+=&.[
M!P17SE"^(2R LFS).,*FX(QR#(I!7@>8V06&&;(VK]2_ >S=?!EO(RE?M-S)
M<!R,HS//,$*L 4?A0P&<[<L0!S51W_+IOI^5P_33[[?Y=#T/QB"/#UPYVX61
M0"=A !ADD;=N4.N^/REX;(VY/&Q!\2_%IS#X8\3NVT-#X;U^0%^=I@TJ[DW*
MR[2KL%"YR<D CYCNK[J\66Y.@79** 73 "Y+%DN@FU1O!50J9()0O&P+9!5_
M@KX^.8? OC&92%D;0M2B9%D1O*\Z%K:0. 3@DSD$$8).-Q(P'+1K5Z+=]_\
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M' !Y&"V54#@E=V[)X'3/3*Y)% =O5[V\N^_]:):N @8! P,E0.Y(.[&W/WN
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M=0%Y(!Z'!/'0?WCP#R13 ZV.\96!SC&2%#N,[B2V1N+ Y"G ((7C)! -PWS
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MCS2>!\7_  @P)4D@')SP%'SL00S8K_5QK_)__P"";4A_X>'_ +"@VX!_:_\
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MX'89QS@\'O\ E36)XX)R!_"1QR.HZY*_-\O)IV:2TZZVWUY7;>]^GX[NX 6
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M:7X):?UY%O;YKRV9^AG@NX#Q1@L-I!(&XL7(6-"65"/D 'RA"K C=(68$CZ
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MQ?:B?3W(QRORI@@',99>2>^>0  .." *_++]KC098M0\"^,8T_=)%>^%M1D
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M*!TPI)'!ZY&!UZX).,G'\6>AS8$N=H7G=SC&<?W3W_X%C/!ST% &LL^#D,Q
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M !SC/3(.<8Y./4'DCKC\Z - S-G(R-N",A2"3@9?MN )QPI Q\Q!I%=<DH,
MX(&"!D'.."V!SUR 2,X'(K/\T;MN2.,J=K'^_P -SR00/8C@GC%.WY#+@;%X
M& ?E! .<YQP<_-G@<TK_ '/K;?9+\UOV8%YY,1D'@AU&[@*HPY< ;1CD ,P!
MR  3C@P&0X^4@'YMNWK@'*@L0"0>.7+XZ<]35FEPJX_AD4L,'*AD?DX.5)W
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MDD1PRARIA:1AM(+!0PP556JW,#H6*V\K!R\8\PHK)YF65)8U9V/ V1O)M"8
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M%^@QVZ#%,(/&.."I!+;3R3D8V@9Y(RN!R,#&1(?F(&2<D'&,84$]\C&<C!)
MQ[5"PZ=<$?Q#TR5Q\V3D$$8P#DGGFFK66F]M-M5;H_30!AQC@_7W/N<\X['
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MDF%POX\G/.<X)QSUQW (P.]'IY?=Y=-K]->Z UTD 7(S\I+':O)SD$<\9)4
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M+!>",, >=IIK28/&0V>VX!5Q\P7C&03DEL-GDKBJ)D/)' P,DG.>A'&#T <
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M/Y[&E/K\OU/R^NOWDEK",[YKNVBQG.1)<0*W  S\QP ?0]P2/UD\#%8[E(P
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MV0 <^A)/!'0#!K\\3WY Z]QGD'WYX!_K7Z'?\$D,?\//_P!@;_LZWX+8Z_\
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M5OMCN&D4(H+,_+KORZF1;D#=-;!K9ES(7MYID;/RC)EC;:%4!?FDB<#@_(0
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M154A()6(4L7XM!4@>:V\3ZGYBM,?M46FV$0=V"[(Y)XI)50K)AI(C& Q*D,
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M1J%;8!G8.1D\Y! K>.RZ]_*UK;:>=M[MM:W)VNN[[^G=]=M-M-@56A+%8;E
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MM5U':@8G9=2!D5X]C,K%LXV QJA^8!Q@XW5,WVBY/^DZKJ-T3OWQM>W3!9"
M#MP\:*NW&0$&%+ 97&%R)VUW_K2^NG9Z_=JW==K:65[=5^'_  UG<^G+B\%[
M\2O" E6TFL+&ZT*SA)CN;653#;R32AY$D%L'@U%PVUHXW=P C[URW6:MJVGQ
M7MZVJKI0GN;F6XFMKZZLBX$UW<N&0Q3AU*JGR[G679C.$E&?D2-)HX5B@O\
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MC'(YQV_.[[W)['!YX_#MR2/?I@]*_1'_ ()($_\ #T#]@;C)_P"&KO@IR ,
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MI\Z_LKN/[+\<(=I=?$/A^0@G)"R:3?JI.!D F)L<'N1D5_0U_P $A2T_QO\
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MEU;RW*!I4^F/ -WJ.K6,FBZ[+87E[ID4,>DZ]<:D\%W-#$"HLKMI5=KSSHU
M60Q%TE3_ %F"P/S_ ']SX=N;,Z]?R),FFV\RM=M''%=6\<\+2/%&08_G::.
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M0E\Q(VV'\I?VC-01+[2[)EC2XN-+M8A'N D>-=0>2%B&9@-HM[CJ0!\P +'
M];?X@W=I!(_]C6B.(VDN;JYO)9%"H"QEE9HV>0(5+#>ZG/!(KXN\4>(]1\=>
M+-3\3:E*&$DOV73XD4I!;V%J/+MT@B)(165?/9LEG:4DMR:E_P"7X?/K^NUB
MM/Z_S^_33IO8J1 A!G&3TZ>ONP''7D#%?HG_ ,$CP#_P5 _8%8D<?M6_!4#D
M8S_PG&DYQ@]>IPW/4X/;\[^@!&3QZXXQSUS@'N!BOT0_X)'@'_@I_P#L#GT_
M:O\ @I@G_L>-(R./?J.G(]<TEKK;?[^B[;.WW6^2/]>NBBBF<X4444 %%%%
M!2-T/T/\J6D;H?H?Y4#CNO5?F?P\?M??\G-_'#_LHGB#'_@2<_GD?E7S?7TA
M^U]_R<W\</;XB:_^MR<_R%?-]?R#CO\ ?<9_V%8C_P!/3/\ H"X,_P"2/X4_
M[)K(O_57A/ZT/ZO/^".?_)H\?_8^>*/_ $?%7ZN5^4?_  1S_P"31X_^Q\\4
M?^CXJ_5ROZ=X3_Y)K)/^Q=AO_2$?XI^.O_)XO$G_ +*_.?\ U*F%%%%?0GY0
M%%%% !11105#XE\_R84444$A1110 5_DD_\ !:4X_P""J_[=A)Z?'[Q3C(_Z
M9V0X'?@YSD8Z#C-?ZVU? 'Q*_P""5O\ P3J^,?CWQ3\4/BC^Q[\$O''Q"\;:
MK-KGBSQ=K_A5+O6=?UBX5%GU'4;GST\ZZF$:>9)M!8J"<G)I6UOY-??;_(N$
MDKWOK;97_5'^1AX%\5_\(-XUT'Q)+N-A!+)8ZQ&N<OI-^OD79QCEH%*W*;AM
M5XE8?,,5^KGA36(%2WGANHKBUN8XI[>>%@T5S;2JLD4L;'ADDC(8 <X^4@-D
M5_H<M_P1@_X)5OP_["/[/3#T;P9&1^1N<5U^E?\ !)[_ ()OZ':06&D_L<?!
M&PLK8%;>V@\,;88%)+%(4-TPC3))")A 22%%-:)+L7SQ_O?<O_DC^ 7PQJNJ
M^&M?TWQM\/\ Q5X@\$^+].*R67B;PEJ][H>L6SKG;Y=[I\T-QM!,H*R[U^5I
M "N17U[9?MX?MD)H]QH.O?&&Z\;:7<1F*8^,-&T?4=8F@."89?$=O;6VORI(
MN04GU#:R\;@"0?[6(_\ @F%_P3\A.8OV2_@VAP!E?#0!P,@#/VCH,G [=JL#
M_@F;^P*IRO[*7P@7'8>'2!T(^Z+@ \$]J:?JMMGV_7MV8<\>\ON7E_>_X?0_
M@_\ %7Q'\8?$74[74O'.OOJ"6<21Z;I5O';Z7HFGQH'\O[/IT(BCGN/G+27D
MXFO).7GE;Y2,Z?QQ:V4.U;E$*AL!F5?KQGIC@]2V>"!Q7]YS_P#!,G]@-P0W
M[*/P@(.<X\/,N<G/.VY&1GD Y [8JH__  2[_P"">TO^L_9(^#;YY^;PXQY]
M<FYS5*5E:RZ;WW5O\M-K"YXOK->B7_R7XZ,_@,U+XKV\6_%VF0P; 9CDANQR
MVT#*C)W[^G(^8\5?_%QG+>5(\S*"<1*7^8G)V@8.#TSG!'KUK_0;?_@E3_P3
MHD^_^Q]\%6SU/_"-$$XZ#(N@<>V:RKK_ ()'?\$U;T%;K]C7X+3J>"DF@W13
M'IL&H!,>VVES/T]/E\^@<T/[VO=+\N8_SP=4^*NI(&9T6UB+#;)>RK;+M )"
MJ9WC' /W@2!@'(R!7"WGQ?8$^9K^AQ-W1M:TL$$YX8?;.<=QQGTXK_15E_X(
MO?\ !*FX<R3_ +"'[/$TC$EI)?!<<CL2<DEWN68Y//)ZDGN:B_X<K_\ !*+_
M *,*_9SYZX\#P#^4_P"E2VWOK^?]?UU'SP[->B]/[UO^&7R_SF#\5HI253Q'
MH9R -J:UI9( .0,B\P1D\Y]\Y[7[;QS>7!_T:_M[DD9Q;7-O<GMC AG=C@C&
M ,<9/%?Z+'_#E?\ X)1?]&%?LY_^$/!_\?I1_P $6/\ @E(IRO[!?[.@(Z$>
M"( 1[C_2.#[CF@/:1[2^Y>7GMOY^>NG^=Y%X^OK?_6[UV\$GS54@9(W%AU8X
M)P3GWKH]-^+,ELRE;PA@5)'F' *D<$(Q.<\#&[D^AK_0WMO^"//_  3"L@!9
M_L3? NU QA;?PU-"N <@;8[Y1C/.,8K0'_!([_@FD.?^&+_@;GU/A=B?S-V3
M^M >T@[W3VMLO+?WM>J\]S^!3PW^T-=V#(LMU#<Q+M!6=^6'S L78J1U8?>&
MXX*@G<!]8_#7]I[04O(W'B#_ (1R_DB:U>XN'5K2:WG7][;RR@%=C84_O8RJ
MX#;E/S#^T ?\$EO^";"C _8R^!P!_P"I7_QNOU^GH*E3_@DW_P $W8L^7^QO
M\$DSC@>&F XZ#'VO 'L.*=WUU]?E_D@YX?WON7_R1_+K8>+[K5[2TOY=6?5+
M"15E@OK2Z%YIHE$R2JT;PRR6C,A?*JS(Z-@%?W:D]S?^-9-<N5N-9U07+1QA
M(T9XX((8U4$"*S1E@4N,[L(K22.Q.\\U_4!X8_X)M?L)>#+AKKPK^R]\*]"E
M<;9!I^C3PPS+@J%GMOMAMIU ) $T3@9.!R<]O_PQ#^R-C'_#/'PLP?X?^$7L
MMO\ WSC _ 4E_6EQ.<7_ #?@OU^7H?RHV7C3^QW633M46S5&3;%YB" &5G<-
M';GY#,I$<AEV;D$6%<_O#3(/C#K=K#9:;I>M%8[>]N+I;>*"V9;Z]NKAKNXE
MU$$.;]Y)VWM]J+*RJHPH7(_JL?\ 8;_9"D&'_9W^%Q7^[_PC=L$Z8Y12%(]B
M,?G73^%_V3/V9/!=U]M\,? 7X4Z1>?\ /U#X*T*6X'TFNK.>1?P84].[_JWG
MZ_AL'.O/[EY>?WJQ_*?:>'?BOX^TNXU>P\+Z]K>@:;/=WEQKE_;7.G>"=)DE
M\R6[N[K5[E+30[15\YQ),UY''%""D<FU7)_*?]J7]OGX4?L[/JD$/Q-\.?$7
MXBVT,EKIO@CX2ZOI^H66F7<:L(5UKQ;IHU'3K.U@G^>[2.]N=2N40PQQJLIN
M8_[POBU_P3W_ &,/CS?/J'QG_9]\$_$V=D$21>,GUS6]/MH ,"VL=*O-7DTO
M3[102%M;&SM[9<G;$,G/A1_X(K_\$HCU_8*_9S/U\#P?_'Z3\OQ]?PT\_G8.
M>/\ >OUTNEM_>5_P_%G^679?MF>-/%'BS7O%?Q&\2>-=4U#Q%JESJ=]=SWTV
ML6[2W4S.8Q:I=Z1)## NU(E2YE58U"K",5Z1)^T=X6U.W>&S^)5AX8,J!998
M=)\86NJ;"#N0W @U&$,<X+1.3GA7(YK_ $[/^'*__!*,?\V$_LY>G_(C6_\
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MR7 P,8X)&0,G. :DOA75)%YT&<Y Y"0$\XQ]V1CW'\.?3(%?Z]@_X)-_\$V
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M HHHH,+ON_O_ *[+[@HHHH%=]W_7_#+[@HHHH"[[O^O^&7W!1110%WW?]?\
M#+[@HHHH"[[O^O\ AE]P4444!=]W_7_#+[@HHHH"[[O^O^&7W!1110%WW?\
M7_#+[@HHHH"[[O\ K_AE]P4444!=]W_7_#+[@HHHH"[[O^O^&7W!1110%WW?
M]?\ #+[@HHHH"[[O^O\ AE]P4444!=]W_7_#+[@HHHH"[[O^O^&7W!1110%W
MW?\ 7_#+[@HHHH"[[O\ K_AE]P4444!=]W_7_#+[@HHHH"[[O^O^&7W!1110
M%WW?]?\ #+[@HHHH"[[O^O\ AE]P4444!=]W_7_#+[@HHHH"[[O^O^&7W!11
M10%WW?\ 7_#+[@HHHH"[[O\ K_AE]P4444!=]W_7_#+[@HHHH"[[O^O^&7W!
M1110%WW?]?\ #+[@HHHH"[[O^O\ AE]P4444!=]W_7_#+[@HHHH"[[O^O^&7
MW!1110%WW?\ 7_#+[@HHHH"[[O\ K_AE]P4444!=]W_7_#+[@HHHH"[[O^O^
M&7W!1110%WW?]?\ #+[@HHHH"[[O^O\ AE]P4444!=]W_7_#+[@HHHH"[[O^
MO^&7W!1110%WW?\ 7_#+[@HHHH"[[O\ K_AE]P4444!=]W_7_#+[@HHHH"[[
MO^O^&7W!11105%OF6O?\O^ ON"BBB@D**** "BBOA[]JW_@H/^SU^QK\2?V;
MOA5\9KCQA#XK_:I\?1?#?X5IX:\/P:S8/XBEU/0M)4^(+J;5=/;2[ 7GB+3@
MUS##?R",S.+<^5A@:3>B/N&BBB@0445_*7JO_!63_@IY^U;^WS\8_@'_ ,$\
M/@-\,M9^ _[+?Q-T'P5\7_%/CF>#^WM?T[^WX--\1WUG-?74,-E.UO%J<FF6
M.G1FY6"V6:>5I&"A-V]7LEN_1=2HQ<KV:5E=M[?\#U=EW9_5I14%LTK6\#7"
MA+AH8C.B]$F,:M(HY/"L2!STQ4],D**^&OBU_P %#/V>/@M^V/\  G]A?QK<
M^,4^.O[1/AB7Q;\.X-,\/07OA1](BOO$VG$ZUKC:I;SZ?<O<^$M85(HM,O%V
MI SR()OE^Y:!M-6OUU045\,:/_P4._9WUS]N_P 6?\$Z;"X\9-^T9X,^'UG\
M2]:@E\/6Z>#%\-WVAZ!XB@%MXB&K-<S:A_9GB33)'MFTB.(2--$+AFC&_P"Y
MZ!--;]5?Y!1110 4444 %%%?BC_P2W_X*3_%C]N#]H?]O[X1?$3PAX.\.:)^
MRG\8F^'_ ()O_#(U%=0UG2%U/7+ 3Z]]MGFA>\V:7%(7M5BCW.Z[  */U&E=
M-]K?BS]KJ*^'/^"C/[;OA_\ X)V_LE?$+]K#Q/X$U;XE:/X U?P#I$_@_1-9
MM?#^HZE+X]\>>'? MM+%JM[8:G;VR:?<>(8]0F5[*4SQ6SP(8FE$J?3_ ,(?
MB%:_%SX3?"_XKV.G3Z/8_$[X=^"OB%9Z3=3QW-SI=IXT\-:9XDM].N;F)(XK
MB>QAU)+::>....62)I$1%8*#^OZ^\+.U^E[?/TW/1***_/S_ (*"?\%+OV:/
M^":'@KP)X]_:7G\<0Z%\1O$.I>&/#8\#>&K7Q+>OJ>E6,&HWGVR"[UG18[:W
M6WN8=D@GE=Y&VB/ +4"2N?H'17X-_ '_ (.2/^"5'[07C[0_AQI7QB\3?#;7
M_$MY;Z;HEW\7?![^$?#UYJEW)Y5K83^(K/5-<TK27FD*H+O6KC3=,B+KY]]$
M#D?O#')'-''+$Z212HLD<D;!TDC=0R.C*2K(ZD,K D$$$$@T)WV&TUOUV'T4
M5\+_ /!2[]I[QA^QE^PO^T7^T]X T?1=?\8_"'P?IVOZ#I'B(7+:)>W=[XL\
M.Z T>H+:217+0I;ZQ-,JQ2(QECC!8*30"5VEW:7WGW117R-^P/\ '[Q-^U3^
MQ;^S#^T?XSTS2M%\6?&OX,>!_B+XATG0Q.-'T_5O$NCP7][;::+EY+A;..:1
MA LTCR*F SL1D_7-&X@HHHH ***^)O\ @H9^VIH'_!/K]E3XA?M2^)O ^K?$
M72/ $FBQ3^$M%U>TT+4-2?6M2ATV(QZG>V6H6]LL#S>;(6M)F=5V*H)R $KN
MW?0^V:*\F^ _Q7L?CM\%_A;\9M-TBZT#3_BAX%\-^.+/1+VYBO+O2K?Q'IEO
MJ45A<W4,<,5Q-;+<")YHXHTD92RHH.!ZS0&P44C,JJS,P55!9F8@*J@9+,3@
M   DDG ')K\,/VL/^#B/_@FQ^RGXZU+X6W/C[Q=\<OB/H]S/I^K^&_@%X9B\
M>6^D:G;NT<^G:AX@?5-+T62ZMY4:&[CT:ZUB2RG1[>[2&XCDB4VW:7J[#2;V
M1^Z%%?@O^RI_P<<_\$V?VHOB)HWPDE\7>._@-\1?$-_::1H.C_'?PI'X/TO6
M=9U">."QTJT\1VFIZMIME=7;RJ+>3Q"="M)9,01W+SR013?O10#36ZL%%%%
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MXDUO1))"-B:_8^&K/5I=#9E8.%U1;4[#OQMYKU[_ (*!_&3Q#^SW^Q'^U/\
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MTNYHF^T1:7I]W#:SP^:[ ;M:_5I?UZ(23EHV[)-]^U[?+\C]U_@+_P %B_\
M@FC^TOX^M_A?\'?VN?A9XC\>W]S]CT?PU?ZA>>&+_P 079) MO#@\3V6D1:]
M.P4ND6E27;O&-Z@J03]H?'3]H'X+_LS?#Z]^*WQ\^)'A3X4_#K3;_3],OO%_
MC+5(-'T2VU#5)6AT^SDO+@K&+B[D1U@B&6<HQ PK$?B/_P %5?\ @B[^P=XV
M_8=^-WBSX7_ [P!^S_\ %KX ?"+QI\6/A5\3?A9H\'@O5M)USX6>&M0\9V=C
MKTVD-:1ZUIVKG0QI]]J.JK=:O8>>NI65_'/;LD_XZ_MD_M._$']K?_@U1^&'
MQ9^*M]>:Q\0[?Q_X&\ ^)O$=^S27?BB?X?\ C;Q+X9TWQ#=3ME[J_P!0T.RT
MLZM>.2]WK$>H7+$-*0"^MG;;IY6OH]M^[^6Q2C%V:NU?6]D_Z^_<_ISMO^"Q
MO_!,J\^,FE_ 2V_;&^#DWQ*UF[T_3M-TU/$&=%N=5U9(VT[1U\7>3_PBBZQ>
M230VT&EOK"WKWDT5GY/VEUB)\0O^"Q?_  3.^%?QC?X"^.OVP/A)HGQ.M]63
M0=2T5M9FO+#1-;>;[-_9&O\ B.QMKGP[H>HQW&(9[35-4M9K>1E6=8RPK^>S
M_@HI_P $L/V.O@S_ ,&\,WQ%\'_!SP?H_P ;?A=\)_@#\6;'XR6&F)#\0-7\
M5^+/&OPZT_Q4^N>(\_VEJFG:MHOBW6+(:5<SMI]E-]CNK&UMY;6,TZ^_X)B?
ML@:9_P &W$OQ=U/X-^#M7^/'B+]E_1_VC=0^-M_IRW?Q+G\>>+;JQ\6I=-XK
MN&DU06=OINKQZ*^FI.NGW,,/VJYM9KZ26Y<N[M66R:W_ !UOK9ARQ;LN;XN6
M^F^GEMO;KW/Z[_B9\;OA+\&_A7KGQP^)_P 0?"W@KX1^&M)L-=USXAZ[JUK:
M>%=.T?5+NRL--U&?5FD-J+2_O-2L+:TE5V6>:\MTC+&1<_"OQ8_X+-?\$Q/@
MI;^#KCQ_^V+\([(>/-!TGQ3X9@T75[CQ5>7GAO7+>.[TC7+FS\,VNK7.FZ9J
M-K*EQ:W>HQ6L4L3;U)7FOPX^(7CO7OB)_P &B.J^(/$M[<ZCJ\'[-/PZT.:_
MO)Y+FZNXM ^-_@72[66>:0EW?[+;1(,GY515' %?3?\ P10_X(\?L,6G_!.[
MX#_$_P"+?P1^'?Q\^*'[1'PPT3XA>-O&GQ'TF#QC/8Z?XHLEGT/PCX:&IF>/
MPY;>%M!-AI$DNE"VU-=3M[W-ZL,=K;6I=WZ?"I:^?32W3S5K/78.6*3;;TDX
MZ6>UOEW/Z"O@C\?O@M^TEX"TSXG_  '^)O@[XK> =7W+8^)_!6N66N:8\R &
M6UFELY9#:WL&<7%G<K%<P-\LL2FOG']JC_@IE^PI^Q3JUAX=_:7_ &DOAY\,
M_%.I0Q75IX1OM0GU;Q:UE-D17\WAK0;;4]:MK"0J0MY<645NQZ2<C/\ .C^P
M[X3TS_@F%_P7U_:6_8A^!]WJY_9@^,_[/.I_''3/AB-0N-2MO _BW1/#6D^-
M;-;&&YDGDC>VM)?$?A^S9V^U7VFW^A_;I;B2WB8<Q_P;U?L7_ __ (*(>'/V
MD?\ @IQ^VGX1\.?M%_&CXK?M#^-?"NE:-\1K6/Q3X8\$:=I>E>'?$5PEOX>U
M$SZ7,[0^+K+1='L[ZUGM=%T31;:.RA5[@2QEWHE9OKV5K7ZW>ZMM^ <B6K;M
M9-::ZV^772]OP/Z4/!O_  4^_P""?WQ L_@Y>>#_ -K+X,:Y_P +_P#&B?#C
MX0V=GXPT\ZKXV\>O>Z!IP\':9I+NFI1^(UOO%/AZUDTJ[M;>[CGU>Q1XP9TS
MZ-\=/VXOV1OV9O%FC>!?CY^T'\,/A/XP\1>'M4\5Z)X>\:^*-/T34]3\/:,&
M_M'5;2VNY4>6UMV1H]ZC,DJF*(/(-M?R/?\ !4[_ ()T_L\?L9_\%?\ _@C!
M\6?V<O#&F_#+P[\?OVW/A#9^*?A;X?DFM_"VF^+/ 7QM^"LD_BOP]HKS20:2
MGB#3O%=C97]G9I%9PSZ*C6Z1Q3I;P>J_\%KO@/X'_:7_ ."[_P#P2R^#'Q+T
MX:SX \8>&Q!XNT1W>.+6]"L_&CWU]I,[QLD@M[^.W\B;:P)C9ASFE=Z[:-+[
M[?YC4(NUKM63W\XI[+2W,[[[7ZG].7[,/[?_ .Q]^V3X5\<>-OV</CIX/^)'
MACX:W7V3QUJME->:5!X8;[++>K<ZL-=M=,DMM/DM()KB+463[#+##*Z3LL;D
M?.-G_P %N?\ @E7?_$]/A#:?MK?!J;QC)J?]C1.-:G7PM-JGFB 647C9K0>$
M9)S<'[.%762#.&BSO4@?C;_P<4^%/ W[&O[#'PW_ &8?V/\ P/X0_9P\/?MN
M?M.^%_!?Q:OOAYIL/A32]2\/V>D0P7MCJO\ 9XB6&SU>ZD\-G5?):&*YT?0[
MW3YXY;6^O(Y?UA\%_P#!"+_@F1X2_9NLOV<;K]F3P#XDLD\+Q:)J_P 3M9TF
M*3XL:QKGV$6]WXP/C=6_MG3=6N;XOJD=CIUW!HMK,RVT>GM:H8F>M[:;*^_7
MM]SWOZ$V@DG>5GMM?2U^RT=^O;U/M?PI^W)^R+XZTOXY:WX._:$^%_B71_V:
M=,U?6OCSJFC>*-.O[#X6Z3H6FZEK&KZCXMNK>5XM-L[#3-'U.]N+B1C$EO97
M$FXB-L?SJ?\ !O?_ ,%+M$^.?C;]L?X/_M#_ +8%]\4_B'X^_:=\51?LW>#/
MB5\3=5\4Z_JOPN5_%,Z6OPWM=:U"[GM_"Z:<MA);V>DFWLXX$A:")=BUXK_P
M;9?LY^#?"/Q?_P""QO[*_C 6WQ+^'NF>.]/^#7B.VUMWO[/QEX+F_P"$^\+Z
MGINJN)%>ZM=6T.>:PO-LJM)#+(JLN01K_P#!L5^R]^S[JGCG]O?XJ:A\)_"-
MW\0_@E^V)XK\*_"?Q;-92-J_@3PZ]WXPLFTG0)A.$M[3[);PP!9(Y66.-0KC
MG(FVUTWOKM9I7]=W_D4DDIK71*_?I:ST^U]R[O?]4?\ @GA\(?\ @D_^P9I_
M[;WQN_9>_:,3Q#X=C\<2:K^U'XG\8?%32?&&@?"'4]+O+^\7P[(^G:-HR:!I
MFG7>L7TGF:RVM:RXF$=WK,T-NB1_L;\'/C/\*_V@_AQX;^+OP4\>>&OB9\,_
M%\5]-X:\:^$=3M]7T#6(]-U*\T?4#9WULSQ2-9:II][87*9#PW-M+$ZJR$5_
M*Y_P;I^!?"OQ0D_X+&_#7QUH]KX@\%?$#]IOQCX+\7:%>KOM-9\->)]$UK1=
M<TRX7KY-]IM[<VSE2&59"R$, 1X;_P $P_VNX_\ @C%XE_X*>?\ !.G]I'7Y
M/[ _9<C\;?M%_LS7VNS>0?&OA*_M+=['1]*21\33>+-,N_!OB$:?8YCL=1@\
M:D@W(F4JZ26R37W/1_E?^MQQYF[?$FOFFE_P7_2/ZVO#7[6G[-OC+X[^+/V8
M_"GQF\!^(?C[X%TJ;6_&/PJTG7+6^\7^&]+MGL(KB[UC2X&>6QC@EU.PCE$^
MQHY+F-&4,2!\H?&__@LI_P $R_V=?B+=_"?XM?M>?"SP_P"/M,O3INM^'[*_
MO?$<WAW4%D\J2R\27/ARRU6RT&ZA;F>#5;BUEA4AI%53FOYB/V1M,^,O[,W_
M  1T_P""G/\ P62\2O?V?[5/[85CJ>H>!_%5TDG_  D'A+P/XZ^(ND?#S2=>
MTBY=?M%G>1ZEXWO_ !-8W,3*@FT?29I4=+1!7R)_P3E\5_L^_![]D_0=.^(_
M_!"_]HO]LGQ[\8-!F\4^/?VAO$5A!XBMO'4/BUI=3L+[X?W5_P"%]2N/#>C#
M3;RW>SU;2=037-2NGN=4O-5<W$-O:EWII:]GKV;5MNZ=UK_FA03O:[VVMY=[
M+KL[.^FY_H2_"OXN?##XX^!]%^)7P?\ 'OA7XD^ O$5N+K1?%O@W6K'7M#U"
M+)#>1?V$TT)DC8%)H69989%:.1%=2!Z)7\<G_!MSI'[0WP@_:C_;%^%,G[./
M[0/P"_8Z\=VD?Q1^#O@[XU6&HLO@+7X]=-E/X>LM;GLK*QO[R\T>_@BG>WMX
M)+J/2([J:(RF1V_L;JM_Z_X"_(B4>5V\D_Z_3N@HHHH)"BBB@ HHHH ****
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M^K?@?R7-I_\ P<>_\%*?%O@SP?\ %3X??"G_ ()G_LNV?BS0-8^)-QHWB/\
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MBBB@ HHHH **** "BBB@ HHHH ****"H?$OG^3"BBB@D**** "BBB@ HHHH
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M_8\^ _[:?[;/PVE^+,?P>^*WA3X#?!;QOHWQ"^"?BIKK4/&NG:G\3M2T+4/
MWC"PM+6V4Z-:K#HVI0?VHFKZ9J#Q7+VUJ+BVNKI0._E?_AK][7LOZ;OHIQ>C
M2LD[Z;I?#IM=.35NNE[+;L?V%OC]\?/VJ/AM\)/BIXF\5?"[2[#PIXL_:?\
M@]\;=+\(^'+_ %+0/C1XP^#GQ7U;X3^%_BG\$_%5QKV=)^'^HW/@_5_$5S!-
M9:ZE]_;Z:7;WD"Z3'=S_ #[_ ,%-/@K8_'GQ?9?$WP1^US\'/AOX_P#V$?AA
M\0/BGJ7PE\?>%?AM\4O#]K<^+="COX?$7Q=\'^+KB_FT'PMK.@>'XM,TO6)=
M(L[RUCGN]1T746N&"']-_"_[,O[/W@B[^$%]X.^#_@#PM<_ #POXF\%_!9M
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M:/I:^W6[OLUZ:L]$HI 00".00"#['I2T&84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '\U^H_M+>/\
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M3TNUU1Q.K>1);%HY(XVD5E;IYM[+9O5>=S7VB5K*[Y8K;[24;/N[._W];GX
MZS_P4(_;/\)VW[17[1@\<_L[ZA^S]^R_^WF_[)%[^S?8^#+V/XH^/?!6H_''
MPS\)-/DL/&<?B4OI'Q3M=,\86.L^#?#UKH$^FZ_;:.DNH64\.H2M%^\W@-_'
M7AK3/B-JOQ?^('@K7]/MO&_BK7?#>J:-H@\'Z=X)^%\5E87.E:!XLN;[6M3A
MOM9\/I!JEYK?B>6;2[6YM;F!VTZRBMB7_-C]C/\ X)W?LJR^*O&'[7OB/P)\
M OCC\1OB%^TQ\9/VB?@Q\;]"T8:_=Z3X9\>>.]9\2>!IQ?ZG86MI<^+_  A!
M?RPZ?KBVFH7?AR^0GPYK,*P03+^GG@/X2?#3X7V_C.T^'W@GP]X2M?B)XUU_
MXC>.+;1=/AM8/%'CGQ3!8VWB/Q1K$2@I>:MK4&F6$6HW,BDW*VT?F X.7;7?
MMY_UZ::W%-QV44FK7:27:^W6]]=>Q^!?AWPM/^RQ^VQ\!_C[X2^/7P6_:Q^'
M7_!2G]J_QVLWARV^'_PZUCQMX-CU#X:>,_%FG_%GX*?%K0FUCQ3>?#WX2Z9X
M$T?PUXVBNM4OO#FG:%K5O(LFF7]Y;2FE<:+)^SK^VC\&_P!K+X??'WX(?M9_
M#C_@H]^UGI^@IX<M_ /PW\4ZSX?TB70CX5\,^+O@E\7M"DUCQ)/IWPMTCPS!
M;>)+>WUI] :Z&J7=S;Z?>7$WE_KMX)_8U_86_92\2^/?VC? GP"^!_P5\2KH
M7B'6/&OQ0TKPOHOAZ70_#82XUKQ7/!J+(EIX2T2Z2.>_\00:"FDV%^(O-U"*
M<Q(5E^"7[%/[#_P[\=']I3X&?LY_!KPAX_\ 'VFR>(+?XD>$_!>E:=JES8^,
MH(]3O=2T-D@%OX>/B:&Z6ZU>;P_:Z5)K'VB1M1-R9I=YIVZWW>CMOY]=-K/;
M36O::==K:I:^5[Z>NKTV[?95%%%!B%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;'XH_LL?ME_M,_&;XC?MB?!?XE?M!_"OP+XZM]!U;XO_ +-7C?0?"GPS\;?
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MF*>&%T:^_P"2[)?B[ORZ=QJ=/K!/;6RZ6TW7G?N][H\\_P""8W[7'Q&_;?\
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M^_9,^"GP[\)>+-&\ ^+_ (L>&/#/Q+\.ZIXS\,^&VT31-,T/XP^*K7QCXZ\
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M)-"L=P:_AMOK^%^F]OQ8*4&TN5:O5M)?RZ];)KF]U=6O4]!_8.^-7Q8_:.^
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M,K$?,5Z'"G.3]T4C50AUYODX_JO\S_2&E_X+"_\ !-& D2_M=?#="#@@V?C
M\\>GAD],C/ID X-9\G_!9G_@F#$<2?MA?#53G'-CXT(ZXZCPL1C/&<XS@9R1
M7^9GK(X=0K#)<L')9R&)8]V _B &0??=RWF&I#C.3P"06.0,G!&3DDCC V\@
MG/0TM>Z^[_@AR0_O?^!+R_N^?X,_U$3_ ,%IO^"7"]?VR/AH.G/]G^-\<D@<
M_P#"*8/((P._6HC_ ,%K/^"6:DAOVR_AF"!DYT_QO@#.,D_\(ICKQUK_ "Q;
M@8)W D!MOS#.?E0@=-RGD A0%&,\MNQC3'.<@'KDJH..,D<,I!P3S[<@+P"[
MTLUJK[/R\_/\@Y(?WO\ P)?_ ")_JG'_ (+9_P#!*Y1D_MG?#+&<9_L_QP>?
M3CPF>>^.N.:;_P /M?\ @E8.O[9_PRZD?\@[QSVZY_XI+@>YX/:O\J*0_/D,
M?F)8!E((.1\QQ@9'*],#YN 0<U2,Y/&1D]SNSP,X!"GKU'X XPFVNW]6UWO;
M5^?YAR0_O?>O_D3_ %9_^'VW_!*P?\WG_#+U_P"0=XY^G_0I>W3K2'_@MO\
M\$JAC/[:/POYYXL?&Y/X@>%"1]" :_RDB,@GY=PSTQRHW$C<P."""?FR 01D
M9.6;,,1ST)Z9ZXZA2,]\[1SW)(S2YI>76^CTLD]==_UT]#DA_>_\"7_R)_JX
MC_@MM_P2K)P/VTOA=GI_QY>-?;_J5?<8]>W0TO\ P^U_X)5\_P#&:7PMXXYM
M/&@_+/A7G\*_RD0!UQG<!DG!YR"&5>@^\222Q7!P"""0(O7/.,!=N>,'(8X
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MO7^EK_K:_P##]#_@DQ_T>W\+NF?^09X]Z9Q_T)]'_#]#_@DQD+_PVW\+MQ.
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M^7_!_#S#DA_>_P# E_\ (G^LG_P_8_X))?\ 1[OPO_\ !3\0?_F-H_X?L?\
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MD7_?*TW[!:'/[N(^OR)W]>.]'];/IO\ \#]0Y(_WOO7_ ,CZ_P!;_P"M(O\
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MYPS#L6X/(SG$38P,GO@Y))(+#KD\YQ@$<_J"K;)VZ??IOLM5HNKT[70*!Q]
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M/<\#!X]O4^_MVY]> <\^W ^O//\ GM[T -V#U/Z?X4;!ZG]/\*?10 S8/?\
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M_!5O]J+]KOX>ZQ\,_BQH_P %H]&\1:G8:SJNL>$OA+X8\,^*;F\TR5KB%_\
MA(["+^T@LLQS=*9&-PH59"0 *_JL_P"#9Y&C_8,^*"L,?\98>.R/<'X0_ K!
MYY/<9.,XSC%?P8>'G+21;6!^5\$$DJ6 '1\ <GG! ).?EP,_WL?\&U!S^PA\
M3SDG_C*WQUSS@_\ %H_@9C!).1C XP,@C&0:!3=X:OY=EITZ?\ _H7HHHH,
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MW.L7&/[KSS/IUHASP762X0$' 8#)?YZ7M;]?^'ML!R+SA< D<')))!YW8_\
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MG[(G'_-;O&W.<8_XH-!^.>U?P2?"< ?%;X99W$#XA>#2 ".2/$-@P&&"Y&5
M& 2V1ANU?WN?\'>G_)MG[(N1D?\ "[O&QZXP1X#4CN,Y/09'./I4O:WG'\_Z
MW$]X>LOR77^K?,_@2G^\> !P,KD$@[NHR3^/'0'L,9[J!SC=QCJ#ZC(/4\]^
MG7KU.C.<$G'(QCGH1T& "2",C';.[.*H/[ \\=ACW. 2.W! Y.>.E*/X65K^
M26RZ:ZWU7X,96_R?J.WOUHIS#DYZG.1CMS_3N0#W]Z;_ )_SUJEIIKIIU\O\
M_*UNVP(3^9Z?Y[?YQFDZ<L?H!^F!W/O_ "I?Y?U_+]<_3UI:8"8SR>W0=0/<
M^_Z4M%% !112$^G4]/\ Z_M_D4 '7CGC!^O_ .KV_P ::YP,>O\ 3%.Z#D].
MYJ/!<GT^O;VX^N./K0 ]1@?7GZ4-P5^I'YTZF/T'U_QH =W/Y_T_I2TA."/?
MC\3T_E^M+0 A&1Z?_6YI,YP1WX/'U_D?YTZD[D>O/]#_ $_/\@!:*0<CTI:
M"BBC_/YT %'6DR.YZ>G;'KCI]._3F@D#J?T/7_)'Z_@G>VF_]?UKH X#KWQD
MD9XX_G^'X'FG@ G)Q_"?J3Q^1/.#CJ/QKM,B#EU48.<\=?7H2/Q].U7;*PU7
M4N=-TR_O0<9EAMY#;CDCYKIPENN.,%I0._3FB.B7IU]%_73T %.".>@)QGMU
MQ^)_7UJ4'(_$ ?D"?Q'T_*MF+P;XCD :9M%T\'&1>ZQ$[@9QEDTR/42N#U#8
M(!YP:MIX'U0D ^(/"P8\@&XUL@<9()_L,<CC.1@9&3FAJ_\ 6W6^ZV:7?;S
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M3D #!)"#IQ@@C#N6&T]\ELYST[,.#P23UZ]1Z4OZZ^3W[=^CV\@*$A!)(/'
M&1QQ@$#/N3@X]<&J;,  02<\G&03C!' QG@'(YQSCUJ>4\DY'4<Y#8/RX/&Y
M3ECQ\PS@G(J@[#CW8 %C\P&>A7 '!S]TD=!C!YA]WU[=WR;6;?FO\MP86/8$
M'E0",#J<#KD=\]<9P>E,+9 QG.><9 /X>_/.<G/0<4UCU& ?F)#'=S@E>1P,
M$[AD=-IJ L!C/0'Y<9'3'0D<8ZG)Z<CH#0M'?33167^%=-]VKV\[/1 2E^<D
MGH1R/08ZGG.,C'?\C2&0<CL0>!CGD?3IZ=.>.HS6)/( /09R!M^88P.Q;<.<
MC.5R#R132X&3TSCJ/3(STY)YX ) '7-'NK7=O96MOR[>>MU9V6RL!8WCJ>Y)
MYYXR!DCJ1D#.>.IY!IAD ))R2,8'3YL#!P,<9&#W]>:K;\$]#R3R!U. >21A
M< ^VXX'7(B:4#/3&,\@]/?.,?XX'>G;ROVO;;W?56TOM]S L-(222.1@#+=<
M@C /'&,YP><\YQBH3)QQUR#C XQCC/7'IWX[54>X521GG&3TP, @ #VQU!/!
M]L&F;Q6D$47F2S,0%BA1YIG/]U(HU=V;)X55SZ=:$GU5K;:]=&^^C]>Z] T6
MDQU[C(P>3@ ?CQGD9R2??%=Y02?[I''."&YP?ZD#K[XK3@\+^*+Q?,_LQ]-@
M.#]HUN:+255?E!(M[HC4)0<Y!@LI2P!*YP36DGA*PA ;5-=DO'!YM-#@:.$X
MSP=1O8S)(IS_ ,L["(XR5?O3M;MI;5]E:^EK;+Y67R#CI;N- 6=P/FQ\V!US
MZ\=CCCKCC&*T++1]=U4;[+3IUA<AOM=V!96NTX&[S;@)O4]2T*.,=,BNTADT
MG22&TG1K*"52P%W<"2_U#G@'S[LRO#TR4A\M03E%"Y%07.IW=RVZ>>27( "A
MC@!2,?+A<#!''RCOUH^6G>RM96U[?EHM-4!0A\'V,&&UK6VG91N>ST9/E. #
ML>]F'&3_ !Q1,!GMS6Q;3:'I9!TG1K*%P3B[O(_[0OFP3AO-N@R1MCG]U%&/
M3  QC&4-@Y;G (S]W/3IE1A@>2 ,$\' !B,P (!09.3C[P(R3T'&<<<].Z\T
MN:_=:JVVM[7Z=+K[]&!NWFKWEXYDNKB29N@WR,X #X 4,=JH%^5=J\9!Q\N3
MDRS\$'^+( Z@ 9  '. !Q@9R??FJ3S'(Y(QN/<8.0,'/&  21TQ@=N:DEP
M2?3!Z8(YZ\]6[<8SWI65]M-.E^UNKTTWVTE;H!H-.2$R<'UR 2,MUXX&0!C!
MQG/)((K&;!^7'!R>G1@202><9Z\8X-9$]^B9+,<9'0<CC! QU).<8'7;GJ*K
M+-<W#!(()G9SM12C9=FX^1?]8S'H%5"3Q@8)-/E\[)N]K+3;2]^NFW5;WW#;
M-P,G!V@Y [CG80!Z=,#N",\DFF&0'(P",YR,G^'J,>GIZ#N>:D3PGXODC$B:
M->,"H81_NTN&7@+MM)72[8D'"A826..#E:PUFDBED@N(I(9XF9)8ID:.6-PV
MUE>-@&1E889& P00<4[+;Y=+]+6>Z2WMW=^UPV-Y!)7D'!QQ]X8( /4 <GV&
M>>HJX-1D,!MKF.*]LVX:TNE$T!)7!*ARQC;G[\95@1D&L829X+<<#CJ< J0?
M3Y>>,C.,CG-+NSCKR.QZXZG^' ^N>AP1UI*VCN^GKK9*_ETTT^:N!/<^&H+V
MW6\T";RIRK!]*NI00SQYRME=$@Y(&Y89\'!4*Y/7E(Y6$DMK<1O#,K/#-'("
MKQOC&UE;D>H)X(((R#766LI421@G(:.9,8!R1Y;CGT(C[J,;CUX-N^M;77T\
MNX*6FJQ#%EJ(&T2D#"6]]C[\/&Q)3\T60RMMR*J_R]=.WWZNW9?+4//4)P1T
M*DJPQSG(4D].< \?XXJU;_\ 'PF<_P"J;U()V@#ZXYYX &._2E=)/97L]I=Q
MM!<QD&:%UR5;< 6!&5:.1E+(RDAD8,N0<U<M2//!!X$3  G(Z >I '4$XZ\@
M]:8'I7PGY^*GPUVCD>/_  =D\#D^(=.) P<Y X&>VX>@K^]O_@[UX_9K_9%/
M?_A=_C4#\? BY_09_"OX)OA+S\5OAFISG_A8'@[^(,>?$>G#&/3D=O7D$9']
M['_!WL<?LV?LA\XS\;O&P] ?^*#7_/\ A4RT3]5?SU5_733\!/>'K/\ )'\"
ML_+D#&..<G).??KGCCGKQUJBX)!&,#&21GC.!S\QSDX]<XR>:NS$$G'ID<CM
MSP>N!P#QGGK5%B><=O4XP"<\D@%N>2.W!S1'MY?DE?TM\];[=60$YSV.1^G7
M\R!Q[<TVE/7DC)/'(&>_X]>YSR!VQ2?X>N>GOW]C1JK7U\]>KC?LO16Z=[@(
M!SU)]OK_ )X]N*6C_/Y9_P ^W-%4 44A('U]!R?RI.3[#_Q[_ ?SH 4GM@G^
M7XG_  R?:@#'4Y]2?\\#_P"O1D*/3'05&6+<#CV]?\_Y[4 #,20!V.1[GU^G
M_P"LU(!@ ?G]:0*!CU]:=0 4C#((I:3(]1^8H 0'*YZD?S'(_/BG4T;1G!&.
MO44W=C@<^G/&.WY=,?K0!)2'L>X/_P!8_I^N*CWGV_(_XTQIE7DLHXQR1V_'
MMFE=?UO]VX$_0YR,'U/?V]L4;AZC\Q3H+'4KL9M-.NYD(R)3%Y-O[?Z3<-#;
MX/3)E'\ZTH_#]V,&\OM.LAQN1))-0N%R,_ZNV46QP.N+S ^HP1O\=KNW_!_
M#(,F.W'N>W]*B>91A21EB JCEF/HJ]3SV SVKITTC1HN9I=0U!ADX++86S<'
M^"$27(7IUNL\\ \5IPSP68(T^RM;(\@20PJTY!'&Z=PTSD9'S,[<Y)S1?T\O
M\M+Z]5IKTOJ!S-KHVLWH#0V3PQ<CS[UA9P@ =<2[9"".A6,@],G-;$'ANQB(
M.I:G).=N3!IT8CC.><&ZG!.1G[T<1![5<>YGF8M+*[MV+$MSG^[D+W! /8<#
MU86)&2<8P/F!!)R<],J"/N^ZCCTI75]]^GK;77;];]6!H6ZZ38C_ (E^DVB.
M#@7-T@O;DA<$$/<EXD<<G=''&3U' Q5R34+N<XEN)G _A=VVC;@   A5'. J
M@>G&,5B!U'09QDD8XPIXSD#)(  .5Z]Q4@DQEF.<\X!Z MG(4Y'.2>>1E>V5
M$W;U>VE[-KM;>R3]'K?1=0-(2."3N;@9P>0<GH ",#&01C..E6XYF(7)8_+R
M=Q'0XSQSR>H]L\ D5BF=0<]<YP"W.."2 2#G(P.^1UQS0+U%YR,=CN&XD<'.
M. <CG /'!QP*K16UOLNCU=K-/Y7M=[IV Z:&4\?,V1DYR,<XQUXP0"#Z <"N
M@L-5O+4LL%Q*BD!602%DD4<8DC8E71A\I!!!&0>V."@U*/?C<I!&"=W?@YX!
M(Z8!!_0UT5M,'4,"HR1MQGOM[#GO@XR!D!L,#D3[=.C;35[=+=/N2Z]@Z&[T
M/PQX@#&YL_[)U!^4U32HDA1G.,-=6(Q;S ')9D$3=2"3Q7,7NB:QX7\DWR1W
M6F2L(;76;0L]I*R95(YCC?;3M&R#R9L!F.59NW16[\H.=P).!T. " >1P .X
M()*@X!-=QH=\(XKC3KN*.[L+Z("XLKA1)#(H)RKH02&:-\JX56#1\-P,-J_D
M^C^[?H]?ZN!Y_93K- <'+*4E!QDX1N1T!!VENW.,'@5V&F./EZ$[@,XST4!1
MSGC/4=LC.<"LGQ#X5_X1:XMM5TQY[GPKJS>7&\A,DVD7<@._3;P@%BA8-]FN
M" '4;&/FH35C1IMPPQ 8'&!M^4J2" %!/WEZL"6Y8# P6![%X=8@<AL&3.T\
M#@#@#/'Z<BO[YO\ @VB_Y,,^)IR>?VK/')PV,C/PB^!G''Y^V<=J_@6\.,-L
M>3G,DA&2PZ$# W%<@<<D#C/&,FO[Z/\ @VBQ_P ,&?$W;D#_ (:L\=8!SQ_Q
M:+X&<<^GU/UST"9_"WZ:==S^ARBBB@Q"BBB@ HHHH **** "BBB@J'Q+Y_DP
MHHHH)"BBB@ K^(?_ (*FRD_M1_&]0[E5^(6N_(I&0X2Q#8'R]5P0"3DKGKFO
M[>*_AX_X*F2@?M4?'4816'Q%UWYV<%2!%:X)7)VMEMH!V'C<,YXJ/Q+^OZ\O
M,N&[]/U7]?EJ?B+XQ.99#GD[02& 'EJ",AOXL[L@D9Z@XR,?/^MM]_G@E\DG
M<K/M;:HW$CC(/ID'J3D^Z^+W#.^3RQD4J.%^8JV$)SD*2VX@8(+;2%49\$UA
M@"^0"N7QAL@'!.,8)QR!EL9Y YZR;+KZ?+=:/R].MCRW6F)&!N/ R3R,DL2I
M.< *J[B001NQZBO.]0;!.TE <<# !P>1P <#;W)QG/6N]U=^-I8+U"KC)R#A
M@3A0.68D<M@YR0QKSS4&Y;(((W#=T.> "%!&,'@\' Y/(Q0(Y6X*[FVGV4D8
M+<'=DC(].PZ C&:P[@]3D8QC@G.,$+@\8ZG'TZ'J=>=B-QZ'=@YQC<$(/NN.
M<DK@_7&<&Y;[P(7@ =CQM()/0<#)^4D\< '.9^=M'JWZ+;:VS_34"E,QP>3P
M.@)!/(8XQZG/;&-PSBLYVR< X&0!GIU)Y X.<D]/2K,SCJ   2,Y& 0%]#Q@
M9SC !SEB20,N695YW '/?&!@G)VY';ICD$<CBIW6RLK7M=Z:.VJZ^NBWZ,!S
ML1D9Q]WD<#C.,KQW.>.#D=<$FN[KV(Z<],GN/<_3V%1PM<7LAAT^UN+Z7H8K
M2VEN&4DM\S^4CA N>6D*J!@D\<;$7A36Y,->/8:5'P2+BZCN;E5[D6UBUQAN
MF$FFA.3@XZ@2?6RZ/KTCWNK[=M=;-;AB/*H'WNQ&,XZ#CZG .,\Y/KQ5:2\1
M.-X5FX R 23T& <G/8<_0UV4?AW1K9E-U<:AJCA1N7Y=.LR&&<[8GENNOR_\
M?:=#N&.FG#=65A\NGZ9969Y!DB@#3,OS?+)/,))7..=S-G(/-59+??3\U;1;
M:V27_! XFSTK7-1/^A:9=NN?];+']F@ Z!C)<&,%<GJNX$\=L':C\&3_ "MJ
MFMV5H. ;>P5]0N1G!PK#RK8,!D'=(0",<#)K5N-4N)<&29V'W@"Y*JNX," &
M'1@..,DG&>0*'VECR&S\V  >4 /'!RW0\Y '/?L77RTU2]+)JVE_RM;R"[;Z
M/X2LBI.GW>LR@9+ZK=O';DKNP?L=@;<J<C)5KB5#E001FM(:]);(8-.M[32;
M=>#'IEI;V08,"")7@C6:8^\CR$C!))KG#<<<$\DC)SM8A 2N,%AAAG'0@@D8
M90:4MRN6SDD'.,D@')/+<'CT&?0C-%W;9_XM++:[^_7L]T[(#1N+V29M\DCR
M$LS$LS'J(R"<D9#%3U)R5;C!-9TLYQ@DGI@\=.@ P<C@9ZYYSG.:I27:C(W
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M0,L?HHR2?H*Z*+3],B_UKRWTH )WN;>W!! )2*,K(P]!)(P/((&<5;2Y%O\
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MB!M,DD-Q87L::AHE^X/^FZ9([Q_-LP/M5K*C6]W&N<3 .OR2)GK-/E9D@D#
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M4OR3ULVK+6[2\U=?=^:"_#:7&IWB6=KM5\-)+*Y/EP0(RAI7;))4,<*HP6+
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MYS4-&N)X&MKF."^M2,&VO[>.\@<8 .8;A9$Y'MQVKZ0O-+7#$*/X^ ."!@]
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M].I)SMXP>HZY%,:X ''J<Y[>N/?/XX&..@[?_A6E^P)CMO%\O?:F@Z>AQC@
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M,&WKM,%N((G R3F9)3SR3S7'B_M@,"0=1T5L^O "D>A[9.1GBG+?[L!$E?N
M$<^G/ .>2<$9Z\X[.Z[K[PNNZ->.(E@\CF1SNZG+ #)(4<@<<!0-IR!P*T 0
M@5EXV/N]L<!L$\],@$_08K(A74I!N6RN2H!(*Q,5QCH3CC/;)R!@G:3R\7$J
MX62,KC.0XZ=>H!.,\9!(/..#33OL,[J-2$7).0%4;CQC*%2K'H,')Q]![3VX
M=A.RM(##"TBX." K*K'@C/&,Y.3T'(K)L[]9;>-FA!8#8Q1ROW"%+$,K<E &
MQGKZ\5L:9<P>=)YJ3 & JVU48X=@&)!=.PS@],Y'-39_=:SZ]/6R>MV[NVZ:
M [;P5YDGQ'^"VH,S,T?Q"\+Z7*Y.?E'B+3;ZT5L@C'S77&2<9ST%?Z>'_!<3
MPAK7B_X,_!FVT:YLK:2T^)&KS3M>M<(KI)X8N8T6-K>.1PQ;KE<8[U_F*?#F
M2WE\8> (0[^99?%'X=WBJ\;DH!XHL[&0!EW* T=X&.XD$@ '(%?ZJ/\ P5=T
M>XUGX7?#*&WADG:+QSJ$C+'&TI .@7(R54$XS]!ZD4XN[5M]';UV1+WAZR]-
ME_3/X\-=^$'C6&5P^H:.JA0'PFIL.>2-HLMQ0#S"V!R5 P>_FFH?#+Q,68C6
MM)8Y8,TL.KQ]\]18MN&<KQC(Y/%?J1KGPVUD!Y?[)OA$=N96@D6'8[?+N>1
M%4DDD9!'S*  03Y7J?@*X +2Z6@4DDR/<I#P><'=C:2-V"V.O]X &[WW;\[/
MTMOZ/YN_D-[WLO5]]-/FNJOZ'YPW/PL\2N#OUO1@K8 *1ZDQ7)P"Y:WCPPQU
M'(7(ZXKGKGX2^)""JZ[I+<Y^6TO@O Y);9S\QS@KD<#G&:^^-1\/Z/!O\T:>
MJESPVIVWRL"5,;X+MG<X4_*57>23QQPE^OAY&=%DM01E2D=QPNW.[! W'@C
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M7LKB;['=QG*\K):R/$^3T8\$<5_:;_P:]VDUG_P3S^(L<ZA9/^&M?B9"P4'
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ML_L^_%?XFW]U-+)<>(-'CTSXB6[S-EV^SW7AW6=9M[>( KY5O"D"Q)A3"F"
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M)/$VMZ=&+>RM[.[DY7P/_P $W_B7XAUZ.S^)'[17[,WPFBN;>3[!+:ZOXO\
MBG?W%\H=HK>YL_ _A.:TM+-TBDEDU :K.J(I989%(-;%_P#\$X?VAO">J^&Y
MO$/BKX?:_P#"2]\2KIWC'XH?"S6-*\;2>"O#WG*C>*=2\)V^HIKEGITH>.(2
M:G:67V.:5%U!8/F)5VVWUOVM_7JOS'^OFO+[OTV[GQ+\0?B3J7B37[CQG\0?
M$E]XC\27,*0'4-1\R6VTVPM4Q:Z1HMDN;?2M'LH5$-GINGPPP1(!M4RN[M\Z
MZE^U"Q3[)H.BL)%!4W6J3FW@4],I:V@>>48XQ)/"W0$"OU2UW]A'Q'J.N3Z#
MX ^(G@C6;VWEN[1M)^+F/A_)+?V<LD4UE%KT4&IZ%%<;HW5!JHTFU9QAKT,R
M*><'_!.+]J/3[A[Q_@C\,KMY0'6]T[QWX(U6VD!"[9(I+2[FA8.C;PP!5@25
MW$G T]-;;-];K]!:NVJMWWTT_"WKY'Y$:E\4OB+XG8J?$.K0Q.2!9^&[>YLH
M@&/"^;:JUW)Z;I+ASCMUK.A\+^-+P_;I?#?B?43@EKV[L=0NY2!U+33AI" #
MCDG(Z<=/VTM/V#_VG;:"*271/AEX?!)5[>SU^.>Y@7C+S#3M$$*!,A3MNG)R
M<9 J>/\ 95\3:%KL&B?$/XI>']/N;RTN;A4\#SS>(KC2W@"&+^U4N8[.#=.P
M(^Q6LYGCC4RRR)E$<M_6_P#70/Q_K]-O,_$!TUBU8K+HVKQLO!#:9>+CMSF#
M\,9QSTYJ[;IKTY40:+K$F3@;=+NR.QSGR>0?3.,DD]>?WWTS]E_P]HNEB3Q?
MXU\2ZS;:I=:1<6'B/1H4TR;1M'O=.-U.&T"^^TV^I743*CI))(D4L4\;!8\,
M19UG]E6&$-=^ OVB?#.NZ27/E6WB;P?XCT#7($*KE+A=+FU+3[B5<XW6CJCM
MR%C!R#EOK:_G;]0TZM+M?U7^9^%EAX2^(M\JFQ\(>(;A&(P4TRY&1GH-T?!'
MMR>]=.G@?XK6$?GW?@GQ';VXQND?39PO #$YV-G Y)//)R6SQ^WWA+X*^&K6
M>_TOQCXW\6:U?SV\*:+=^";.WTJ"'4I9XH0LD/B-KQKRWRX65Y$MV*D>6(V!
M:M?4O@,\^@^%-0T;Q/J&E74OA;[5X@;5+5KVWN]3L-7U71[R^LDBOH);878L
MX9?(WR1Q!M@!8/1RO9)JW1?)[?=?KJ&G=/3IY]_Z9^&UAJ=Y:RF#4+>XM9TP
MYAN8G@?"MG!5@L@!8 $CY<'C)XKWO2=3@G5)FCE42I')N0JR?O%,@;(,;L1G
M!PAY)Z[1G[@\:?L]:%XT\.ZV9]6>77-*TK5=3T_5;O3;:&%;C2K":\\D7<3&
MYVW!A\G9/)(@+A70G#5^?OALO&#$RD"%44KR=ORJPC!&>$211UZC=P,9&FMU
M;^OZ_'LQ)I[>A]%^%Y[<'2V68*P<??=HR26+( 'R 200."1GDX)%?W3?\&X&
MG_V=^P=\1X@FU)?VP?CY/$=P;?$4\&Q*WRDJN/*,>U0H^3('.3_";H$>^.T^
M4XC:U8@\M\QVD$X. =PZ]R/P_N*_X-J-R?L=_M.6Y=REG^W]\<K..)I&>.W^
MS_#GX'I/# K$B*(W7VB;RT"J99I)"N^1R0)_"[;67WZ7/Z)****# **** "B
MBB@ HHHH ****"H?$OG^3"BBB@D**** "OP_^-&F:E>>/?C!+8-IHD?XK>*K
M+RI[B>!IE9-,D5G\B.5EDBW.RR@[0XC)59"K#]P*_(+XAVRW'C;XJQ%,/-\6
M/%L:%4+&;S&TI9 QD 3$,&Z4!7P"%9AA0#4=WI?3:_FOZL]&7#=^GZH_-/Q=
MX6\19NI/[0T.-R\RQRI+JMT1#LCD"?9I--6']V1,597X,8  A=4/SYKG@F[=
M[B2XUR1_D3]W9Z3)!OB#?O$:XN[LHJ$?NL)99!VEE9N%^^O%=B@BN07C\J6!
M22%;9'\MME(Y%5F65+@W.&#,KPN)-Q4 GYTUZ" SR;7ES#L9HVC,FZ&.)@$W
M%=LL>\B1]F0WW5!)IS6M^_IT2[?U^;U/C/5_ 5G(6CE_MJ>4EH[E;B^LGCGB
M+,R*B6>CV!A.%$S,9IF90@=VD0FO/M2^&?AUR_F:9?2/(^U6_MG7$F#129VL
ML=\P.2#G#E0'95*  K]5:[,BB5HHE<".*$-]Y8XS+MCD!P=CEQ,%D8KG>5);
M;@^4:E>R(/GW*L>=TF[RY 68;077.<!0"JDKV)&<U-VMG877_/Y:7^YWUOKV
M/G^;X9>"$9S<^&[J=266'[7K7B$1"/S"2#%#JL:D,QERQD"LCQE0 0*GL?AU
MX!2V _X0?19$CGD,0NO[3OP'!4$?\3"^F\U@%4%92\>-V0QP5[W4-2WRS+')
M/L264(SR "1=D1'EQ%<>4H$@ 8%2Q;D,#BA;:F@A;<9&,4A_>(N25:,.!M.X
M$%OF8MCOD\<-MO\ SU[):].SU#;N]_/MU>NFO7OV17TVPTWP]YDVA>&/#7AQ
MF5B;KP_X8T?1[IT=55O,NK&SBFD&6,;"60[Y 9'&Y<GM+=I=3YFN[I971 7=
MF9F8;0"_'RHX[D% 2?E8XKB'UV%)%Q;[]^"WF,>@=FX 4!EE .05W%@Q"8Z=
MFNHV<;QR$?9D ,>U715VD1E5"L?F;/ !QR O I?A^3M^>OG8-_\ AMM%^C_'
MY'>: !8:BM^\D=Y"K6X=;@S0>6K2#!A-OA!(J,B2&2WDBE8;9 1+@?%FO:-8
M^#/VF=7TZ&XM+'2/&EIX@3PL9#++-;VT4L&I2:4!+';MYTZ([R*&83Q(Q&&(
M6OJ+_A(XHRXAD\R.8,Q&Q2%4^4Z@JJL/,?8A9N,A'"$E0U?.?[<_AW7;CX>>
M"_C-X>U06]SX&\;Z'IFHO9L'ETZ;Q#8WB:+JZ[2SK:S/I<UA>-(!$TCQ6TIS
M,@*_7_/_ ( )7:5[7?E=+33Y7_K<] \4Z/XHU7PAIFFZ(O\ ;^E>$_$MMXEU
MCP3<6-KK2:CH<%U:W]Q?>'H;^.22#4-'ELVNI],D>>TGM[^>XCM;::TDDN.6
M36/!K6=O%I-^A^TPQ7:2,89"(WEEBE@F@NGE>&=79)$BE3SH&5XFCW(M5?@!
M\98?&%MINKIJVF6?C6TL-9ENO#$-]'%JWVS2(Y)+FZM+221+FYL+RS,=_!<0
M+,D<:S6\Q$L4RB[XHTGP_IU[=>/HK2P@O)(XC?)<Q1'3-<O.%5+C1R[127LD
MV 6LXH99"X+[B<FE9/R=O36SL[WT3M?T?<%^7?RZOY_YG?>%];T_6(-+TRZU
MJ"_UN\NM.@M](T_[9]N0ZMJ$MMI#ZAJ9M%L+.2]O=*N$C2:\%TEM&+H>?$ZJ
M.Y\1^%+:[TSQ+IVE7O\ :US<6T?A#Q'KTGD)X>>ZT#Q*^M7VC^'=3U>]_P"*
ME.E31!-:;PM::C96]UB&69+C*)!\-/AUKZ6=GXX@\/VNE?\ "4:E_P )0UOJ
M\4%O=ZYH^GS7&E:&(;6&UDGTZQN;))+O3M%MY+9K:"81I)*_FSORUQK6F^%O
M#FO_  3FTW4_"TGPK\;6NO>"[35ENK*ZLO ?Q'T&7Q'J'@^&\G@2XFB\/Z_)
M-=)!?W3WTMGJH1)I55J5_P -5ZZ?G:VO_!'9:O6^G^7R\[+S>QX9KD^@Z%%K
M]AJ/B?1M!M+.P:XN[R?6=+BT4(DBJ(Y[KSQ]HN9( 72"V1KN241@M+*1$OSA
M<?M ?"#1+BX^R^,?$VH3,0C&/5?[$TX\YDFT^QM#X@UVYB8J"GVO2-'>7[Z*
MJ$%OLGQ=X+\)^//!E]X4U:QN7T_4]+N=&:WMKRYDAF_M"1Y&-K&K_9H8Y4>:
M6(B$-#/;QR+(&A8GX/U?]B/14W1_#;XJZ=I$D.8TT#XA:/=A4<'8(8]>T5)_
M+5&^3=<VK%2#E1@@.\G?KU>GIOY:?YB5NNE[;?+;6R[6U3[.]S8G_:W^&H'E
MOKGCTQRR[9(=,\/>)]1&"I7/VS5;[3?-YVE62S3)#LN060Y7_#4O[/\ <QA-
M4U'XKP2*'$DMQX7N[N$ELX800RLRY!Y_?DY+9<X&?-IOV(/VN;\2?\(Q\-O"
M_CF 22F.X\*_$[P.5=8P"S?9?$&L:!>)OB8':T 92'!^85SM[^P;^WLGFD?L
MK^,W* N3!KW@2\!0$C.ZQ\4SH5P<\N"<#C' .9^E]-%V\TOZV[%6[7?]+S?]
M>;/<A^TG^SU$(Y-%^)7B72KASND_MKP;XGTV%8TQO5[I8KI0=S[MH@D1C(ZL
M22&'?^%-7\"?%;4[&V\(?%;X5ZSJFH2""/3=3\>^&/#FJ7$KE?NVOBBYT64N
MH&YT,CN0&D C*,P^)+S]B?\ ;AL]K7G[+_CI2=KF(3Z#>2@>8HP\5EJMTZC*
MJH!7+,!C=DUR=[^PY^V'JY87?[+>NZ;;OY8^W^+]5\$>#--QD9*ZAXP\2:';
MD#DAE=BV!M!-',_7S?E;?N]-]_/822VM]VC^5MMNA^H^L>,/V=_@YI\VF?%#
M]H'PY:ZE9&YM+G1OAK86WC]S$9)&2""^GU31]!U.YC1WC=M!U'Q"L<Q#1H?+
M=1U?@OQ5X8^-?[/6G^//!WBC3(?#&K_%_P",OCG4Y=<\0:)8:IX+B:?PYX6T
M*/QMI\EU#-H.H7WA?PK::],'AEB U*-8I9'A<G\E=?\ ^"?O[77P]T"#Q1=_
M!&VUS1)[::ZO-5^&^I:9\4-(T2,#+0Z]KGPUG\56.D7D$+;YHM0DMC$JNR&1
M$,E?.^@_L^_%;XH>*-<\+^'_ (9VD6K>&?#R>*]=U/6[[3]$T2TT*2^&FVFH
M+J]^\<-Z;O4G%C;6]M'/>&[W036\4B2!)YG>[MZ:[Z*^EO2W7=^322TMT7K9
M6>F_3[M_7]<_%?[8O[(GPUM/[%T2W\<_M4?$;"/<0>#]=L/AA\%M$N]W-KJO
MQ!UG1]8\3^,9E5 UP/!_AS3]')D9+;Q)*$"5\G>,?^"GGQ(T6ZBMO!7AK]D?
MX*2)B6.>R\"/\9/&-L&#%$O]>^*^K^-],\X+@;+/PWIL8;Y_LZ*0!^</Q5^%
M'CCX9ZZOA+XB:2/#][?6J7EAY&HVNH:1JMB\:;YM,U33;F;3[T0LZ17,"R?:
M+61D2Z@A9T!\ U'X6WSOYFB7EA<1%VD6VNF:WF0D8*!\2)(BD J24QG!I.<M
MU^=NBO\ /KJ[Z7V5E+OT2?K_ %VO_DS]0]8_X*4_M):W'(FJ?M@P0P.V[[-X
M?^&WPJ\/+#M1TB6T;0/AG9RVZHDCHBPN%B3&!D8KQG5_VP_%]_=PWVN?M5_&
M'Q+=P,\D,&H>+?&^MZ5"SDDB#0=22;PW$N=K"*/3(H(R T4:[1C\^[OP5XMT
MX,T_AN:>)<$RVB"[4J-VX@0&1QZ@E ./RYZ2<VTGEW5D]K("!LGB>-QCU61%
M88[#'%3S6LV[/II+R]-G?\-=[J_?3:_NOLNOK_PW?[ UK]HJ1M5T[7M,\;?$
MR[U_0_$5AXOT;6-,UN\\-W6E^+-&D%QHWB73+O3KZRFT_P 0:7=-Y^G:U;6L
M>I64IWVUQ$S,:X+QI^T!X[^(OB*Z\5^,9=5\<>)[O8MQXD^(?B36/%^MSK$"
M$#W]]<QRA ?GV*2&=GE<&21V;P:*\MB20T8P2#D@'^'!&1T.<D]@.E7TFB/0
MK@\GD<G![]/?..A_"J5MT_6ST?K>_P#GYE=OTZ_GZGH,OQ,\92#; VEZ<G/R
M6MA; @G/*R2PS3*,G.?-SC)+' K)G\6>,KLXEUR^ )SLBN9TC ./^60G$8XZ
MXC&.F,<5@I(A  Q_$,9!+;NAYX.,XQV]*M(RGN.1Z>P],8!(/;'7GBF Y[C5
M+IBUS>W$C$DLY==W3'WA\Y//KT.,\C"QVT:G<WSMS\SY8YR><DGGCGC/K4XP
M1UZGL>A  (R"1V^OXBI,=<X[=2,YSS@D\=^>] #PF%( QQC@G^\H![8 &>@R
M,]..-^T^=)91C#B%B0W0[6W#')!!R,_4#C@8R@$=/3KGIQ^.3G/YDX K8TO/
MV608R4N-HP<':4+JO<$$[B<\'&,'LF]/2U[>5F_P ]5^%!(\=>!U!^:Z^(GP
MYM(P>%9V\9Z1<C@8PP6V8[LY(W!NVW_48_X*^^//"G@/X6?"6]\6ZC?Z9:7W
MC[5+:WGL=&U+6E,T?ARYE9+F#2[>YN8HBN,2!,%N,]17^6_\/)6M_B+\&+;D
M/>?%+PGJ+KT(AL-<LH(O0D//>2%3W92!TQ7^E=_P7QO8[+X)? QI#@2?$_6T
M W 9QX4N2>OH.>.11#HO1=.N[7^>SW0I?8]9_E$_$?6_CS\)KEEE7XHZ?9B4
MH0M[I.IPL-KB13(+BSBFLPI39MF17"X8%9%5EY"Y^+'PDNRY?XI^"[B5SNC8
M:K:0,^>B,MRR;&SG!8JRYP"O(KX7U;5[5W?*(3Z,%_AW#OC))P!U)W9![UPE
M[=:=*3NAA;C^*./:1SDCC/!QVK1QLKWMMH_E?[O05[MVO:VCT\G;5:?/_AOT
M0;7_  -J>_\ L[Q7IUZ3EE>RU33KT-N/!79>2 @@G:VT $CDJ36'>Z=HTK'R
MM4BW%F( N"20Y/  =U4E67!5<!0-O)S7YNWMIX?FSOTVR? !!:",YR=I_ASD
M$]R<\=NN%)#I=L6^R*]GN&=UG<SVI!]#]GFC[#L,],D\TE)KS7:_FO\ +\?4
M;5_+5?.W]?AU1^E,GA*21-\$]U(A&/E8E6 Q(K -"#@L '097D'(SD8ESX7\
ME]K7+QLV\E;B,8&"!D! < @ J< J#@KDY'YTOJ5]$?W'B'Q+!@X40^)M<C12
MP(("KJ &,]@.2>E(OC+Q?98-CXX\46SJ,;_[7FN2 .G-UYY/'<[L]^:?/=JZ
MVOMIO;^MU?\ ,MIO^']*_;16\S[^NM)CM1OFND= 6!>)I!N&W;MP2"&.TX *
MC'(^ZRG+:"&&;S"F],G&0PBP.0>0F[ Q\PX /&<XKX;_ .%N?%:W 1?'^IWL
M0!VPZM:Z9?PACWV&TC9B2.-S,><XR.+*?'WXHQH([U_#>KH!PDFFOIIYYR6L
M9L9X&> .HQC@'/MT[VMY:VV[_>"6G^6FUNW_  W0^R9]6CMY7\J&.1 1(WE(
M5DW _+&&#%=IXQN&&X# J2*IW5Q')&9O/@C# (8KFW@! (;C?&4!V$\?(#DC
M+,W-?),?QZU0F,W_ (=>!P"))=-NX+B#!;.5MYXTG;!Z SJ3D_,,59?XV:1<
MSCSS>V_R* ]W92Q)E,KRL#W0&[())) )SDCI7,KZ/>V_ROU[?E]Y9]%I]^]O
M)Z_/J[M.Q]*K_8"P7,LZK).D321R22RF&-Q&V6$;S,F%94("\,&*$*":][TV
MWTJXTZQB$MBH59_W[3R6ZJ?M<Q /EEG.5( 8[2V"/W9RH^!K?X@6NK)'%;:A
MITXGDBB\B.\A>X(FD2,#[+$[3X&X95HE(SR!UKW<^(42"P=I[)8G@M6:59LO
MOD5G;S(DQ*HWL3B1 P&%P<TU)-Z67>_IKZ6LE=Z>MD+6VOX7UU5M7Y]]][[G
MU]X2LXM/O;:2[875H;^(S+:'S4CMG<AXP1*TLQ"_.Q(!<#8<C=6Q\9+2SG^
MOQ3L);C3[^2QTK2O$=AYNE?:)HYM,U6&W\Y+F6XMI].O([6XN5FEC6;S%9UF
MBQ*&7YN\-_$J6Q@6SL;>"4[SYMZ68QD-)&@E2.,$H\1*NS';D X *FO81\2-
MEC%#K]O::IHNN:1JWAS6=.:ZVOK>GZC#,LMO;AO-;[99"Y2ZC><)S;C=(IR!
M#3O?2ZLE:RUTM^?X;)#2\]+[]NC[O=7?KNV?*7[/6I>%]1\)7?A358TF;3)=
M9\#:[86L-M%='2=12:.";:4,9NKG3;\W-A=RQMY-RD4AW26Y=?;M0LM>^$W@
MGPCX+\1V+ZWJD]]/I_@;6M-@,MMKGA31+."TL+Q[8QM)I^L:;826FEWVG?O)
MV-I%.[/OD*?&?PL+_!S]J3PY:ZYI]QXB\(_$FYM=,LIK.^C@62XB^TVVD:DX
M<O%)-IVH*L>HZ9<"*ZGAE2*-E$UO(WZ"?$N2[\8Z3?>(+Z[?3-/'B2U\.>"-
M,B)BEU*2\>0P7S&"4/9VUA;Q3W]]<1N;EYA,D>(QN"O>ST35K^=K6T6K\P_&
M_P#PWI\O4\O\ )=^)-8OK2ZBM]!TC37E:\UU[Z_UJ&]MP5=RVEZ!HUSJ5O+:
M<O)!&+Z<;5$<$KEHUZ4V_A[Q9\-I?%=LYTB+XL^"?"E_X?T:"/4-4U6X\/>!
MO&WC/6475UL-(FMM.U+5HI;&<Z'IM_J^HV+1QV=[B=Y;:PZ6^^'-Y\)QH-S\
M+;^VUA;FZN9-1N=<G2TET[5)8$CLM1T:>*W>ZEAU*X\^25I9<PB!C*6BG=AY
MUX&\9Z3XGBNO#^I6+1A/&7Q4\86UU;6[Q^'=.37/%^HF32[9+8I:FTG%C;ZQ
M8/;Y@DO=6NEC4I(#3NY/7;?IOHMNOH];::L?]?Y_UW/FOQWXO\ :!IMI)K^H
M:I]LNK:!_P#A"K*TN+/7X;>2/S8KG4TUNWTVUT2RE0!UN[SS)F5_-MK*Z:&1
M!YW8?M%> ]%6.31Y3X5=) S3P^*-6\17\3*S?ZI?#^C:?:'Y,#<'+;EP"HPH
M]]^.?PA\ _%G4-.G\:MJ^DO:6"6GAOQ9X>B0K;64<MQM@U+3V7[)J828LRK<
MJMPJ HL^, ?(.N_L@_&*SF9?A@GAOXRZ:R^;;KX=OK3P]XGV$'9'/X;\27%B
MTTY4@D:?>W0E<'RTP=M#YDTW]_?[K"5NF_5=M%;3RM_EU/HG3/VR?!L\ODZG
M\?OB=HT;8#2I<>+[>U&WC&+C4%PC@E2S2 A.,$<5TUI\2OA_XOFAO['XZ^%_
M'-\@40V/C+6Q)-"ID7:D;:_'Y2ONX5(KL,<%H\L0U?F_XL^$/[0_@MB_B_\
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M:5).A5@1)& 53\1[;]H#QV-N[3/",I&#N&G/$>.@)CF&3@C\NE;2_M#>.67
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MB#@*H/W 3E0*^:_$?[8GPNMC(MEJNLZL=SD/IF@W4R,6*@E9+LVP V]PH!'
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M75-*E9I([#7/#-\DMB;RW),4.IV,EN3 0LL,C#<>M^&_[4?AOXK?$S4/"O\
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M $MNK_?KZ70XO2S5WI=6UZ;.VOG;Y=3Y>U&[4[FRK8'+#?\ *"$"C(<!3C!
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M9[AXH5)*IYKD9&69FPD2L[-LC1<*,9+:)>=@'!'W1T.<#@#IC/X+CK5I4 R
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MPYZ-*G'3Z =>@&,EL=,#IC@GOBK)7KGN>WXX'3TSUQSCWINW.">,\@'H1DG
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M6XHXY DJ[@K,2S!0HQRQ?;@ #^+KQ7A6N_$*QM+F1([B&5U.&9VD.6QSY-M
M))Y%R#@S-;1L""LI&,<1\1?%>II]FT:U>2V2\B%S=S+D2RAF*I$KXR$506.,
M$NW/W:\PM[50H)))QD[B68Y[DG)/UST()YI-I?UYI?JA'J[_ !7O%?-O8O,!
MG]YL@M<^I$<WV]AWY\WG&,9Q4DGQ=U*= DFE$C@JW^AL0<$ C=;!>01\PQGT
MQ7FJ0@XP!@'MW'3IC Y_D,]:F6#Z_B>.V,<\ =?Z\8J5+:]UZV2\]?D_Q6FE
M@].L?BR]N0+C0XG0G+A[. DC//SV<]FP+<_,8YNIRI[^A:)\4?!-S<PW%S8W
MNBWT;!XKS3[E?-AE4J5E24#3+R%AU MTN7!R S'D_.JQ CH.HST]QC/J<G)_
MR1[=6R&3UX X'&,=^GUXXI\VJ3WZKMM]_P M-7VN!^H_@/\ :4\2VB0Z->>.
M-0^)?@>^:&#5_ _BG7&_M![,,!)-X=UG6;6[U7P]K-O&-UE?Q0:A8^8!%?6%
M]:/)"WU5X$_:-^%NGZW+<CP)XM\$:B^C3?V-K_B/Q5HOB3PW8:KX?N;+Q'HJ
M7$6B^%K#5ECUB\T.ST);,QS6EK+>QZA=:K%!;202?@@EK-#S%/-&, 821@AZ
M8#)G'/TYY[GGI]-\6^+M' &GZU>JD> (O.D$0P,_ZC<;<D9[Q$X!R.*?-I;5
MWULD_OUM]^FGJ&G;^M+]]_S^X_;<_$3X#3P6>I/\3/&]CXLD57OIM(^$FN+X
M;M)F8N%CUG^V;35ID1@-[0^'W0')BDN$(<R+=7VJ/<:[H>O6GC'P_#ID_P!I
MU"V2\NHKBWFF1;FVEL[VTANX+V(GRKBSU"TAGA\P$$QNDC_D9I/QV\6V6V/4
M["VU:,8#%H_(G91TS+;A !QG AX(&<U[1X;_ &AO#+Q/;7UKK>B?:E1;R.QO
MI4MYV3(4S6T<D NBH8[?-#8&0.E._P!Z=[]>GW]/F^X)+1>B_K7]?NOI^BWQ
M#^&/A:0>'=/TF]@\.2:5X9TSR+RUL&OS<G4X/[9F34;".YMW?R)=0^RI-!<Q
MRP1P@^7.H$2_)7Q<_9KDUWPEK?B_2-5\/:EK?AC3)]:U'[%9ZCI.I'3K)0]W
M(PGAD@U>TMH0[W#S-97EHBB6UCN8UF2H9_C?X%U5QJMWXLU WX@MH$E=+BVN
MH[>U@C@MX8HK618U6..-4 4#=C+9.37#^/?VF-2UGPWJ?A'POJ6IWJ:S:RZ=
MJ.J7%E%92C3[CBYMWN4<SW*S)^["810C%9&8=6[/IV^]6_X+];!_7HK=/ZT[
MGSMX:E\VW0LP?:JX)!QNR"!W+<#DH.V  <$^T>$;9);Q)I65(8Y8#/,<B-(8
M0\]S(Y ("HF"V6P0 . 6 \JT*R6WBB51C(48)QSP3R <[>I!'/XDUW>O7;Z9
MX=T_0+9L:OXRF9,*2KVF@K.L-[<CIL^W"$6ELQP67[4P/[G%+Y?\#R&G;\/P
M_+U-.34#KE\-2P5CU"_DU"W0@!4L44VFDB//S*&LH$E*'!1Y",8PH_OA_P"#
M9^,)^P7\3B,X?]JSQPP+'<2%^#_P)B!R>1Q&!@^G'& /X']/5#=QM&@\DG-N
MN, 6\2+;P$*, ;HD$FT8&]VYY-?WR_\ !M&,?L%_$H9_YNJ\=<$_=_XM+\#N
M,=O7';/I01/X7_75']#5%%%!B%%%% !1110 4444 %%%%!4/B7S_ "84444$
MA1110 5_$W_P503'[3OQG;+%F\?:UA=@10&AL@3OW;@V ?F3+29Y5 H)_MDK
M^*'_ (*J1J?VF_C(S$KCQSK!)51]WR[3N,9(5C@8+%N&."0:CNOZ_I]O,J"N
MWZ?JC\(_&:?OI/F+'+9!8,$9<*4;9GG&)-@Y1"O1]RUX!K0QYA.< ,P )8@$
M89V^;*A> %  /;'#5]"^-$82S98-ECDL-I4(H &S R,*_P P SGD%LX^?-97
M/FAL#D@?*,@%B Q&.2"<<$ X[=Y_X;?L;Q_3[W=;KMZZ>NQY'K2?-(#DE2V5
M^5<$'<=N6&0$*'*]/1E 6O.M07[V.F?5>0QS_?4_0@D9'3!('I.M+M,@!P<O
MR>!PP Z'DA7P-V2$ P>17G6H]R>,X^7!(.<=,GC !P?_ *] OZ_K^O\ @\5=
M<E\$G) !..A'&648.1NQ\P;L1DKG!N$&2<X #$=5'5L<9P2#SD<8YZ5T%T "
MP(&<G.<\,%=<*3GY5##H!SG!(/.%<C.X8YQU((P!Z$<]>I((R!@4K;^J?W6\
MO+S]>P8$R?-@*3GH0#@=\$G.2>6YY;C=R2#EO$4D6>!Y;>9"-DL<C1R(1C.&
M0@@Y[9(.<':"36Y*IR>!C)P.>",8)(P#\O5NHXQU).9(OJ%') ^H]B3Q^!S@
M]>M3:UNE[7>NKNGK>VM[^=GMO8+D'B:\B CU6T748N<W$6(=1522-S!L07.,
MXPPB<KSYF2!6Q#_9^JIYNF7(E( \R!E,5U"2<GS8&.Y0.?GC+QD<!B#FN.D7
M\,=^IY)'!QZ8QT.">!D51:,I(LT+O#,N3'-$Q25#P>&&#CU!X/\ $#0FFDNZ
M>]GM9VZZ/?OU2M:P=;/:,I*D#&W;G&#N! W #[V02"/8]PP&9) 03C_:Y(.
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M$X!R!P0,9V[K(+8P<;L]""3D#GK@#KM&<$G.163)R6Z,"WTXSP!@8 / QQT
M-2[Z:V?5;[M:VW:[?)6M=#,UQD_=;.!@8SC.<9YXR<'&XY)P< G%8CCI@@=
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MYR>AYR ,+N.<'V X!)['KT(/^!_7];",28=LX&2X^7.#\IY&21P/X@,DG;D
M5FR@'<0ISSRO Z<+CUSZXXYSTQK2A3Z<Y+<Y&"V.G &  ,=,$$ "J$@&2#M[
M@<=R 1D+@G/3I@$\]<U#>J7GKKTO%^6_;S:6B S'4'&,X/3=GJ"W7@D#@JO&
M6ZX&2#6*<_EP>2N>.>!C)'0\X(R*T&7&0..W4@9PQ(_\>Q@YZXY'%5V7YN,9
M/3/4?B?7ZTM[V\K=6G[OELE9/5VZ@4F13P<D<@\9YXXR,CUSG&.2*L:?J5[I
M$F;?$UJS S6,IS$V003&>3%)C[K#C/+*1Q3F08.."?3../8<=3@DYSQCH:C*
M'G [\?Y/IQ^?6GJN]KK?2[NM%IM:^B;LE9VU0';6SV&MPM/I\FV6,K]HL9L"
MZMR3@D1X"S1$LQ62,E2-^<!6:J,UFRG+#:RYSNX)X'7/ .3C[O/IU!Y01RQ2
MQW-M*]O<Q$&*>-L.#U/^\IS\RME6 P0179:7XBMK\K::PL=I>-\D=XHQ:W!.
MT 2J>()6]?N%LD8SBFK2U_7O9V?X;=M]T!B36BRJ0RM]W&1P0PQ@@?,<@$#*
MXPP.P'G'7:%X[U+19+>'5XKK4[:UPEMJ%E.+?7M/B'\$-S(K0W]LH'_'EJ"/
M$X&U7@^]3KS2I(V#;0%9=X<8VL/FZ<88$!3GG@8S@#&#-; %E(Y))"XQ@#NO
M."#D\COR.<TMKORT3MHDDGU^_O9:[ ?6WP_^+/B+34O-1\&>,-66QFN+6[UF
M3P_*UG?VLMNABMKCQ5X0N/,,D4*2R1#4H$U#2I%+*URH"JOVU\/OVI4DMX[#
MXP:"?$^B7*@6OQ$\ V=K;^(-*+;,7&M>$1/!H_B"S" "<Z2^CZL@W2*-1E"6
M[?C#%'=Z?>P:EIEU<Z?J5I(9;6]LIG@N8&7@F.1"&*L/D="=LBDI(K*S*?<O
M!'Q-FEG6VODAM-9=_P#2(4"P:;KQ/WI8(^(=/U@\LT,82UNV9BJ1NQ4VI=4[
M?ET_/3>U^U@/VY\1>!_A[\3?A_8W0O/#'Q-^'FJW<D6A>)-*DO(I=#UET?=8
MBZ$,&O>#_$485'OO#^L6EK>PK+%<36$L$L$LGQ?X^_8V\6^!;/[?K?A3Q=I&
MD:]/'8>%]='C'PIXXT=;ZZD9M/M+ZT\+6MUJ$/VV!2ZV&JQV&KF+,D<#RHT1
M\^\">*[[1+Z;Q+X&U(Z;?W"Q6FOZ3*"-.UVVA<,=)\3:42([O8Y9[69T6\L'
M<W6GW%NYW']"/A5^T'X9\3SS^&]3&G>!-/33-.O=>D\2ZY%9W%TUI(4>T\-Z
MR\@CA>6=T>748;!=4@TQ98();2:=YA3:>KW_ #V7?1[]+!:S[KR^6B^_Y/RV
M_#'Q=\(3<VB7[>']7\.WD]S>6EO)>Z7J.F:9JMY9,\5Y%I=[=VL5M)<Q.HDD
M@5V!1E,D2F02#YZN;2\T.]-C?+("K,D<CKL)*YRDL;9VS+GE<[6&'0NA#'^C
M+XK> OA_\1-)U/3]"@M+/0]1LAIEKKWA[5%O+&VU6WOX]1T^:UNX4N++4K"Q
MN$M9?[.O=FIA()(CJ2I>/M_(+XO_  FU6PO-9T/6[80^(=$N9;>"]MXV6PUN
M&W02QW5C*RJLQEA9)X_^6@!>"4!U85+C:VBMT_I>KOW] NG^JU[>??\ SV/E
MB/\ >#(R<X[8*C(X//7!XX]*DV CH.0" <].^>N/49SZ\BJ=MYD,CVMRI2:%
MF1@<@Y!X(Y[;=W7&2#VK8"Y&0,CJ1[<?-SG'.>@QGTQ6;5W;;S?_ &ZM'??K
M^&][!2*CG(.UN&QC*G#=SM& >",GY<D8J(KCT) &0<@D\<$G\.,$?AFK^P
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M./E&XDE>G05$1D],=?ER6(/OCJV!R,<]LGI.0>>G4CN<D8'&>2"3G!]/K49
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M'OW\K*UOE?0"EI?C;Q'HLD4JS//-"J)%>A_+O?*C#*D5P_,=]$@50BW,<I4
M;64@9]DT'XWZ/J1CL?%5@]I(2$74$@%S:$DC!N+=1)+%DCEH1,.<F*,"O#I+
M4D<XYR1R<8#'&1@<#(. >^#DCG.FL@^[@@@8/(SG"G.><G&<#!Q]<$G5*]]/
MGNE=_CTWW\FFUM_6M_T/T!\)>*-4\-&/7O &KP?8KGFYTZ.47WAK6XT<O):Z
MCIJDP$X9@;A5@O;.5EDC>.:)6'T%JFL_"/XQ_#WQ0VKZAHOP\\:Z+HEYK$%G
MXCUBRM0NM:5&;BTT_P /)+.-1UV/5&1K.Q-K;2W;-?>1?P.ML;V3\@=*U'6?
M#]REQHVJ:A8S.R*[VEP\9G3=AHY(P#%.I!)6*YCECSDLI -=?JGC/Q3J$,EM
M/XAO=L@=&-KI6F6<\B[2'2:[MXDDCQR&>W(#KP54<4^;IKZ76]EM=KH_\[!I
M>[6UEZI6T_K[CSSQA#;/XINGL2K1@L&,?W0YG?Y<MC 56"(0&)5 <#J**0L%
MSL;W)]R/E) Y.>,+T...:T9]/$,ZL5E99HPT;S'>S#[DB[B2&:.0 A>,+@D9
M89>(4/.U5 'W=JXZ@Y!(W%L@\ XR#S@9,NS:N_E]SM==7OI>^R:ZHS#&<$D@
MG:<C<HQU"]3VZ$[5SGZ9B,6T9XQEN#@$< ]R6QR""5 QD^U;0A=@H7@YW!<G
M;G#$@8 "[L%<?,-PS][FM2#1R8#?7KQ66GPJ6FO+R010Q]R=S#YWX&V-=[EB
M  >Q9][[:[]4[==EJM^K;L!RD=H\[KY:$GA> QR690N/ER3V' .=H !8 S:I
M>:;X7'DW86_UPJ&BTB-^+1F'R2ZJZG]P,%62UW?:9!@E8D*N:6K^-$B1['P?
M') &4QW/B.XC(O)P04==*MV!6Q1@,_:IE:Z P8%MFQ(>"CME5GD9FDED8R/,
M[%Y)9'8L[R.^YW=V.YW9BS,2<Y)IJ*7W6[/IV]/ZOH#[RXOM8NWOM4E::; 6
M-<;8;>,L1Y5O$H,<4:A<X7:S  DDX-($V@#&0"/;/([D]NAZXQ4VT'!ST]/4
M=>HX [8P.3[4N,8P.O4]#QT]S_G/6J CVD@^N"<=<C!ZC!.>>,#IR,DXI2/7
MICEB,8QZ<XQ],YS[4\C &,8'4>V"<#V!ZDCG@&DY/<#!(.>_ID< DYSQ@'/?
MLOO_ *M]W_#ONP$3F6'J2)T(QAL@8]1C/3CKQ]<V&!XSP0<9P?SR0,#/I]WI
M["!!^_@'&?.!_(9.#Q@<].PR?I8//3&?R/'/(&"23^0 XR*?7RT_6_Z =U\+
M0Q^*/PJ*Y _X6)X4XX/'_"0:6.!G.>>OZ>O]]'_!VW_R;[^Q_P#]EI\>?^H#
M']?Y&OX&?A;AOBG\+ 2.?B!X4/S<@?\ %0Z5G'.0>0._ (P<X/\ ?/\ \';0
M/_#/O['^!G_B]7CSOCKX!C[C)_SVI/\ 5?FA/>'K/\D?PAW@RQ.02"H^8,1A
MMQ.2#@ !3G@ 9XZ$5DRYR0=O#$<;>>>&'(8AADYY'?'2M>Z ))()P<=1QDE3
MV^;J!D@D9!R"H(R9"&+=#CI@#@9SSDDG(' !'4_4IO1O7IWTO;S7?K9^5AE,
M]R.X/ R&SD],@,O503@C'89!-=E&3P2%('S9.< #OTSV4<],=35AEY8 \XQD
M#Y<%C@$# R<@?,.G//-5WQD\G SD $$G/8< 8R1U)QCTJ5LK*^W7T;V:LU;J
MEM>]W9A X(R<9(+8*YZ@YZCC/))R?E&"0,8J,@C/3C ').3CDYP,KGN/0Y/<
MS$#GC! ;)P"0,' /)P,X!QR=V?X<5"1UZ<\9(./RR>V,^O7@DT*VEEK9/KT<
M>BN^FG3U ;P3GMNY.=I(.!P3C@#.,YP<$@DBF%?0D@GJ!D=, ]02/3V(Q[O.
M>O7 XSR<_EQU)QWZ8QG(0>#D\X]R1V&[J%!';.>I'%";5M=.B;M=:=5T3?W7
M7=((6QWSSD9!YR!G !YST)R3T.#CB@@X!."/NYY&2,Y'(STQCMC'3!-28QGV
MSC&,XX.,YW#IQCH><9P0SCDXSG@Y.>.<<<=!QQZ<CFA*Z_X9=O5ZZWDK/1]4
MD@9@#KQP,>O3'8\D=<<8^@.#IDE0.Y.>"0?4>ISG 'H!T%/  YYZ'=QT)4@$
M8YSVQG'.>M-(X ."<#G R!T Y!P#C/\ (XXH7K>R75^5K+K9K:W:]V @![#!
MS@=<C&2<%@ , =.,#GGBFD=#TP0!P3@#\\G/T(.![F0<' R#CHN1D9^8>N3T
MZCC/?)I"!C'<YYSW)).#R>@Y)'.3^ TK7V>BVMM96;:>_2]M'KH!7/?&/8\X
M]P3QT_\ UC')C(( SQ@\ ^_7(ZYSR1VSCGH+!'; )"\GD# !.,_G@CG/ P::
M5(_#(&#T.<D\<Y&<9/0' QQ0GHEHMNU[WCZI[W3Z[^;"LK7%M-#>6<TEK>6T
MBRV]S$VV2*0'@CGH1\K*<HX+*P8$BO6M'U:U\66[JR1VGB"UB,M]8(NR.^B0
M8?4-/7'*M@M=6P):W8ED+0$%/*@O/7'//)/&?P.><9]/K42M-!/!>6DSVUW;
M.L]O<1,%DBD7&&!]&Z,ARC*2K*0357Z;ZK\UO;JF]K=KVOJ'I5Q;,C%<'& .
MA&"2<]B.!S@YY[],X]S;JPQC@C.1C X R&'7# G@@$;<=#CI]&UJU\61-!,L
M=IX@A0M-:( L6H!< W5B#C#'AIK53NC8%ERF&JO<V;1,P*D$<D$$L < _,3D
M$8 /'3;U(R6_/RL_FM/F_P"M .P\ _$!M#DCL-3D7RLJF96PKJ1@.LIPD<Z@
M;2LG[N8<;U;D_8'@CXBZYX2-WJW@C4=-5=6MA;W<5]IUMJ-LZ*YDP([A?-L9
M]\A+O;/!*7VLQ9E0C\^9K9'SNCSGMP,@9R>F,\@'(QC)X-;'ASQ-K7A6ZWVL
MK3661YMK,6>)USPNW)8#'R@K\\?&T[?E(F[VM;L]7M;R_&^Z8>7]?UZ_Y'Z6
MP:W;?$O3-8L+NU/]LW5F]MJ.GF;?()[D[8M2TO>N^X@$VV6/<));2:$)(78Q
M&3XG^,?@J33(+-IDD,T$5O-:W$L?ERSZ=>).$68 ;8YK34;:>W9> R-YP&R=
M!77^'OB7I<EQ9ZO9:G%HNKV9;$-U+Y<<BNH2:$3;2LUO,GWXY$!!"EHRRK6-
M\8OBK:^-+;2;&VM[!)=/M;B">:QN9;K[4\URUR)))7B@0;)'&Q$C(C6-_P!X
MYEPC;OU\OQ[][_,/Z2^[[O\ AD?/-@=T2Y!Z@]#GCEN0<$;1QMSQC'/%:J+C
MD G@DXZ8X('&[@'.T_,<$@8QBJ]I!L4 \ 8R2<D@@G()&>@SSW&0 PR=!8_N
M\8[9SNP",8'IQZ9P!SSFH2>SN^^W2VEG^-K^;?0 *#D]O1>O)!Z]<#D9QMR,
MCUJRJ#DXS@X. >.-W0X."1P>=W&,TBQ'HN3TS@#DGC'<X)QQG\^36U::9YD;
MW5Q)':6D"F2XN[AQ';P1HO/F.Q !!SA5RY(( )ZTNCZV]+7M_EY@1V=C-=RQ
MPQQ22R.1&J*C9)<E0%&W)8Y&,<^Q-5-=\4V^A>9HN@2Q7>N#=!J&IH4EL]'8
M#;);6LJ[DNM3C.4FE7,%DX*!WN Z086N^-&G2;2/"S26MDZ&&\ULAHK_ %!&
M^62"SZ/964@RKR#;<SH2NZ.-V5^5L[5(455C&%.U< @8QG=T&2.O/K^%)R6U
MU_EJE^OX?<%VTM54N[N\DLI+R2/N>5W<@N[NW+.S?>+%LYY Z5T-LHSA<;5Z
M Y&202,9(!]"%XQC&#P,^)2>1RQQSTSCCDC./0<$YYR.VQ;*0V<D#K@DEL?+
MM.U@3W)&,9+'.<4]M/ROTLO/3OV^]@=/HZ'=,V>"D?(QD'YB.,]<<X Z?E7>
M:6F77.,X)  R054X)())()92#M!'<"N+TA1ME(!^_&"1@#[ASV&.N#VZ^H%=
MSIN5!8 #;$S'[QRP0!R"<\':PX ( R,9%,#NO"_$L&6)WH4)P01D;_3[V5X#
M<]CUQ7][G_!M> /V$/B=CI_PU1XY/0C@_"/X'$'!YY7!!_B!W D$&OX)] PA
MMFQ]QXVSP 4! ;LV>">A ]!TK^]K_@VQ7;^PE\4!C'_&57CKCMQ\(_@<..>G
M'^>I!2V_[>7YH_(C]K[_ ).;^.'_ &43Q!C_ ,"3G^E?-]?2'[7W_)S?QP]O
MB)X@_6Y/^%?-]?R#CO\ ?<9_V%8C_P!/3/\ ?S@O_DC^%/\ LFLB_P#55A#^
MKS_@CG_R:/'_ -CYXH_]'Q5^KE?E'_P1S_Y-'C_['SQ1_P"CXJ_5ROZ=X3_Y
M)K)/^Q=AO_2$?XI^.O\ R>+Q)_[*_.?_ %*F%%%%?0GY0%%%% !11105#XE\
M_P F%%%%!(4444 %?QA?\%5]H_:2^*S;@#_PF>K*RLP4$>3;N2"P4 H%8@9*
MN,#J<'^SVOXM_P#@JY<K!^TU\5(F($DGBS564^5O/ELD*@%SN!P5X5@4 9OE
MR0*J/Q+Y_DRH[OT_5?=Z[K=:GX3>-EVO.N21N7.%*J0%C!_AW!@[OD,H.=O&
M"H'SMKH*^9A3C!*_-C(!RRC!]LY*XP #AB,?1OC,AFF^5PI9BF67C" CH<'<
MK(2I' 12H' KY[UQ1E@0.-V?FZ]<8  QDX.3N).>.E)[O]-/R-X]GULM=;/\
M+^O^=CQK6_\ 63 \ LQZY4KD!=S#!R1RN<J3CYN<5YQJ .&RN1@#H N,^IYX
MQR"#SV'!KT[5UP\@QL!8CJ>%+%E4X& Q RR@Y&T!CG)KS?4%/.?4@XR5.0>H
M+9/<=<YY[4@Z?-_H<3<YS(,=PI]RP+ '(ST((."21GL<Y,O4D $9QG..3VR<
M#(((&3R>N,FMN=02W&,@'.2 H*MMX!.21@888..3R:R)A][.3N X^O Z8ZDC
M)ZGZTNO]=UTMY_Y^2,B13ZG[H8C))!(5L$8!SM&5ZX '7.#4< \D!03P<'GL
M!@#KZ\]NW;1D'H.Q!//]X#D]/F YQM"A3@ $@4G49 /;+?*H.X\@#GKR1[GT
MH?\ ETUW7],"JRX/!/&[&5(XR0,9 .1@@@'C W$=3$ZCC Y)!SC."2!RP!V]
M01G'/![&K3 Y)Y)8@[=HY.&+ @'T//)/.TC.:C?&!M./7GG.1GC&!],=O85#
MTM=?EO=.S?WZOH]WJ P(H&1P"?3IP"05ZC@D<@$GTR*"JG@@8//('7D9_3KU
MJ3"\?3&!SP!DXZE<'G' )+= *<0W)^8<\]N>^3T/U/.<'ZM)Z62\M[)>[9ZV
MNWN]MKK6Z8,\LD#@$ $MT/.5/53T.>G8\'J*:8\]<C!& 2,Y;IWPHP,D$G'K
MSBI\<X/4X !&,C)!QU&[=@\$#.2.#RS:. ?E4Y'0 <+[\\]_F&>F",4N6V]]
ME^:TV^[7]6!7,2D-U#<'&2IXW8'7.00,\YZGC !K2(!C&X$YX(VCIP<$_=;/
M)R&'H:OD8P2#P,C#'HO  V\8&>1WP<8(XJRJ<$A3D9+<D G&2P'S<]CE>V,9
MYHOKHDMG]UG?31K?JWV2U RIK:.12KY*D\_(-J@@ # W?-E20<X.  ,X%;6D
M^*M7T-4M9=NKZ6N1]BO&/G1)DC%I=$-)$>X1M\><<=*SG7[Q*X#<C&0/EVXY
M X^;L,$+@@Y -5I,D8QP1\QV[CP<C'\0S_%D^^<YIW:MY_*VD=+:Z^2[Z6U
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MD%1T(_A^@'UX!&<9 7&. 3AQZG!A6W*",@_,I;/;GH.O;.2>035V/5+<9^9
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MUX0\/ZK=S2-C=)+<7VG3S.[8&YF<L<<FN\HH#DDMFE\W_D>/R?L]? *7/F_
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M)T4679?U_P ,ON#EG_-^+_KHCYL_X8S_ &/_ /HU+]FS_P ,7\+_ /YEJ/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\+>(_"GQ$UC41;:?;:KI#17XNO"^EK;W37,D<,/VA#;NTJO'^.7P*\3^)/\
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MV/3;*RU"YM7U>NFFBTW2>O?73MIM<2T2M%2;>[^7;;JM6NNET?FK_P $=_\
M@HG\?/\ @I;_ ,$VOVR_C;^T(GA"+Q-X2\?_ !V^&7AN#P;X>F\.6=OX-TOX
M'^#?%&F6^HVLVK:P;G5H;WQ9J:7-ZEQ''+&($6!3$7D_ _\ X(AZY_P66^*W
M['?B[X1?\$Z=3^!WP9^&'PM^+WQ$\1>(_BK\6;$:MK/Q \;>*+J#4%\&^&K:
MZT[6K&SM-/L;.WANKF;25A%S<EKC6+4%(T_1'_@V'U.+6O\ @D;_ ,% -9@M
M8K&#5OVCOVD=3ALH1MALXK_]G3X574=K"O:*W2411CLB 5];_P#!J5:P1?\
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M<=19;G!E*YC1@P/X5?LH$_\ $3U^W>.,?\,Z>&#[_P"IT.OZDO#/_(N>'_\
ML":5_P"D%O7\MO[*&/\ B)Y_;O\ 7_AG3PQ^7DZ'^'6J?V>NN[WV9":?.[?9
MV2T6JU]#^JVBBJE^UZEC>/IL=O+J"VMPUA%=M(EK)>B)S:QW+Q*TJ6[S^6LS
MQJSI&6902 *9!_*M^V#_ ,$Q/^"@_P"QG^VI\8?^"E/_  2)\7Z#XGO_ (\W
MUWXF_:,_94\;+$VG>-M9O+^37M>U#1X+JZLK/Q#!JNNS:IXAM8(-2T;QCX>U
MC6-3LO#=SJ&E:U?V*?4__!.;_@N]X3_:@^,<?['_ .UC\&/%'[('[8]N9;&'
MP!XPCNX_#?C/5+*)GNK7PU?ZI;6-_9ZE*D,US!I&I6^9HP4L[R\*[F3_ ()F
M?\%R?"7[3/CW]HK]G;]MU?A=^R#^U5\$_BMX@\-Z?\-?$GB!O!NB>)?!6F"U
MTP)I.L>.M<==7\<:%X@L];3Q)I%O=VSW&CW6B:SH>GW-BNL/IOY9_P#!3KXI
M_!']NK_@M3_P36^&7[%.K>&/BM\7_@UX\L?$GQL^*GPNO+'7M"T7PGH6NVNN
MW.BZKXQT&6YTS45T+2[*_-[/#>W4&GRZM'I,TT=RTENL[6:VNKKU:^[1[;?K
MLE?W91])+1=.KLGYO76]UU7A_P"W0G_!4$_\'*WPI7X12? 8?M!-\!O'#?LF
MGQ#;RMX.7]F(3_M&K /B$G]L0,_CTZ8/B8TTJW5E']I.CE+(+L23].OVR/\
M@J9_P4$\5_M0> ?^"9'_  3R\"_#CQ%^UUH?PW\*:Y^T_P#%_P 16GV_X??#
M;Q1<>'M.O/%5OH=I=7R:;9:?I>H2S3-?ZS-J9,=U:Z99Z=>7;)(]']I#/_$6
MC^P#_P!H\_&A'M_HW[:H_I7SW^S;\9/ 7_!/K_@XK_;S\._M6ZUI7PVT7]L;
M0='USX+_ !4\<W5OHGA>Z2:71M1L-+N/$^I21Z780:F^GWFDQ2SW5M:Q:I!#
M97<T4TL4<@M&]7\2_)/Y:Z+RM:S8D^:WNQ;2NM/.UM]5=6M_>OH['*?MN?\
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MQXD\/WVJPZII6O:?<0O:0Z1+:_:K\FV?34NX;JUDF_GU_P"#<[XW>#OVD/\
M@I9_P5J^.?P]M#9^!_B7X@L?$GA5#;-9M<:'-XO:WT_4GM75)+>35H+==4DA
ME1)DDO&695E5P![QU>[WUOI^%NVVNB5AW=I+E4=/F[)K?K;RLM>UDOU:_P""
M>/\ P4&_:!_:9_X*8?\ !4?]E;XEMX)_X57^R1XMT'1?A(OA_P .W.E^(ELK
M[Q9XPT.Y_P"$EU:;5[Z+6)GL]#L6$D5C8!)Q*ZH$D$:_E;X>_P""G'_!9O\
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M/>Z%XJT6[UH^)IY#IEMX9MM%U6PUK34TZWN[K4X9I;M8[H2P8*O&AW5\V?\
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M\(/'[_%SQ3IWA>PAC+:G<ZEHD+>&+&ULXWEO=:W:0JO.OE#^A3_@A7_P4/\
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MX^5UHK7Z;[]-#^@SX*_\%O?VE/A9_P $I_B%_P %)?VS/#/@K6M5^*/Q7NO
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR^)GP6^".G:QX T?7O$7Q5^/?@3XB^(? T_C[QCXDN-'\'?#N'Q'X3L7\/\
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MM-+%E+&WW5X!_;K_ &2_BCX&L_B5X ^-7AWQ/X'O_B5HGP@L]?L-.\3)#/\
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M?!2YNO!T^K?$+6?AI\/O!OA^'3I_&FC> K3Q?X@OO$%YJESIEN;-9/A75O\
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M>_\ D>QT444$A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%UGI]OK5NVNW?AK^T+6:]\B-=(77K&[TR36IVBTF&YA(EO45XV?J-,_;D_9
MUKX6^)OC7I?[1?PJO?A5X-UM/#?B?QO%XJL1HVCZ],D$EKI-R[LEP;[4(;FW
MGTJWA@EDU>WFBGTP7<+JY!<LOY9;VV>_;U/JNBODM?V\/V-F^'LGQ87]I/X2
M-\.(?$EEX-E\8KXMT\Z+%XNU'0[_ ,26'A>2X#[D\0WFB:9?W]MHS(-1F2UD
MB2W-QMA/?_#O]IS]GSXM#0S\-?C#X!\9_P#"2^"M1^(VA+H7B"RNGU/P/H^M
MR>&M9\2VR;U=M-T;Q##+HFLNRK+I.J1O9:C%;7"L@ Y9?RO[F>ZT5R/@7Q]X
M,^)OAC3O&GP_\2:3XN\)ZN;H:7XAT.[COM*U$65U-8W+V=Y$3#<QQ7=O/ TL
M3/&9(G"L<&NNH$%%%% !1110 4444 %%%% !1110 4444 %%%%!<-WZ?J@HH
MHH("BBB@ KX1_:;_ &>/'OQ:_:A_8.^*WAN'0I_!G[/GCOXRZ]\24U6_-O?'
M2?'?POD\(Z,ND:>;6>/5GDU1O+OH'EMUAM6\TF1=RC[NHH[>33^YW0T^5W79
MK[TU^I_/+\>O^",_C.?]I[PKXS_9E^)4'P\_9K\2Z'^U%<^,?@Q>SR)HGP>^
M+GQP^ GCCX>GXC_":UB7S=-\,>-M>UC25\>^"-,D@M;6]SXATBW"RWUNGA6L
M_P#!./\ ;B^)^CZ;X<U?]F;]EWX'1?#/_@F[^UQ^QGI/B7X?_%A-=U;XO_$7
MXK_"G2_!/@7Q;J-M!\/?#K>&/!.IZG8_;YK/6[W5]?T2_P!0UR\O6D@GMHZ_
MJ/HI67]=+6V[;(OVL[6;3TM=WO\ FK_._P!^I_/!\=?^"5?QF\2^)8-8^$/A
M[X-:1HGA7]F7]ASPS;?#S7+V71_ 'Q:^)O[+/Q<\9^.O$W@#X@6NB:!<SQ^$
M?$WA[5M/TBU\536.HR/-,J7>G2VT$R'@_B?_ ,$U?VNOVH-5^,EQXJ^%'P(_
M9:\.?M5^,/@MI?C30O 7CVW^(&N_L^^!_@<D>KS?%3P5JMCX'\(:#K/Q\\>Z
MJD?ASPWJFD:1#I?@SPZU[?:M/J5_)!;+_2W11;^M_P []-/FP]K+LO+\/OV5
MNUDMKI_!7["GP2^-/[/O[&WAW]G#QAI'PS\%^._@SIGB;X6^ ?&OP]@6X\'?
M$#0-#26'P#\:M6\)O#%/X=\3^,(;FWUGXC>$;JYU$_\ "90^(KNTU*?3-5L/
M+_-Q/^">?[4?[5/QET[6?VM_A/\  #X':9IOP#^/7P(^.'QA^ 'CRYU3Q;^U
MO;_&7PR/!]AJDG@V'P+X8LO VB>&+'S?$UM9^*[_ ,2:K9>*9E73PUA&KK_0
MQ13^2_X;5?=_P'IH)3:;=E=]7OKOK>]K7T\_)'XJZ=H?_!83PM\$X?V1K/X<
M_LO>+=5TWPK'\,-#_;HOOC)XBT;29? =OIJ^'['QKXJ_9P;X=:GXI;XM)X>C
M634='T;QU<>";SQ4_P!N@UNTTG=:CA_A[^Q!^U5_P3O^(VE^,_V-O /PX_:H
M\+^)_P!GCP'\%_''ACXF_%B?X&>*=%\>>!;_ %/4X_B;9ZS_ ,(;XZT36/"O
MB34M:U&^U_PTD=KKVG/,(M(N+U$#']XJ*5OZ[?UYW#VCU5HV>ZMH];ZZ_+2Q
M_,5\2O\ @A_\6?BI\-OV,OAWXT\6^ ;SQ%\!?A;^V[XR\1_$+1VN_P"QO#/[
M4O[2'[0?@7]I#P?_ ,(MX;UBR:]\2?#O2O%J>,O"NI3ZO%9S7_A6W@EU#28)
M]5-C;_7WA#X&?\%!/V?_ (E#]JOX7?"GX'?$#Q;\</AC\/\ PK^U?^RO+\5)
M_ASI%K\2OAAI+>%_#_Q+^!/Q-3P7KWAR'2]4T2&)=5\'^*_#VEK:VLD4%AJC
M7$+8_;>BG_DOP5D]>J6GS>FH>T=FK1:=[JW=W>S7EYJVCN?A%^T!\$/^"@7Q
MC^)_[&G[2WCG]DG]ESXJ^*/@QJ7[3<7BK]G#_A?-SI?A;0?!OQ<\*>#M ^'5
MIJ?Q+\:_";Q#IWC/QQX?FTK5=0\4ZCHO@#2= >\2SM=#A2%6U-_V+^"G_"4#
MX5^"QXT^%OACX*>*%TIDU?X5^#/%-GXU\+^"YTO+I8]*T;Q3I_AGP;9:Q:M;
M"&\-Q;>&=(B2:ZEMU@D\G[1-ZE11\_ETT22?W*PG)M)622VM?YZ7MOKM?S"B
MBB@D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#\&=*_9S_X*8^"_$'[='P@^#/@C]GSP)X"_:R_:8^*OQ7TC]JCQK\8=>UO
MQ'\/O GQ-T[1= O1X>^ /AWX<&;7/B%IFEZ?/J&@2:]\3="\-PZJ\(U2.XMK
M<Q77R;^VM^P3)^RWX'N/$^E^(_ &C_ SX9^ _P!@_P"%7PVB^)]]KI\/?$CQ
M%\"/$VIV]SX1^,%UX;\,:[#X*\.>.'O8+BY\:ZII]SX8L?$<]G)JT5GI[-)%
M_4Q6'XE\,^&_&>@ZKX5\8>'M#\5^&-=LY-/UOPYXETFPUW0=9L)L>=8ZKH^J
M6]UI^H6<N!YEM=V\T+X&Y#@4?Y6UU^_N:*HT[V5KIM+K:W5W[+\=C^5KX1?"
M_P"*W[:/B_\ X*UZ)X)^&'P(^&'BKQUXN_X)GO:^%_A-\3M*^(7PPTJ\^#_C
MW0?B7XSTS4OBMX:\+:%X6UWQO;^"]'35=:LM T7R=.U'5]*T&YGFN1-?R?1E
MS_P3D_:<^%WQPUS]IOP7\'?@?\>=1L?VS?VD?BU:_ GQGXYM/!NG^+_AE\:_
MAI\-_"?AWQ79^+[[P9XET/1O'?A;7?#FO7<NE:[H]W;BQNWFL[TW5TZ-^^OP
MU^$WPK^#'AM/!OP?^&G@#X4^$([NXOX_"OPV\'>'? WAN.^NRINKQ-#\,:=I
M>F)=7)13/<+:B68JID=B!7H%)+OO_P %M?<WY7'[5W=EIV^44UOM9>JWN?S(
M?#S_ ():_M=V'PXBTWQ#X0^"O@[Q#?\ P>_X+"^&+SPCX#\:7,_@KPWXD_;A
MU[X4:I\%= \.75UX<TVX?P[:Q>$M:MM:O)--M3H,%O9E[2<W*QK],?#S]D;]
MN7X\Z#^Q[\._VI_"'P4^ OP)_8XTKX<ZO;>!_A_\5=:^,_Q"^./Q2^$_@>U\
M)>#=;\1:Q)\// 7A7P#X'M+I)]<?0M/?Q5KLUS)]BEU)80ER/W7HH22Z?UI_
MDOZ;%[67973NG9WVMW[==_,_FP^&W_!/;]L;]G.P^$'B/1/@#^SI^U+K5W^Q
M19?LF>-O GQ1^)P\*:=\'_%&E?$GX@>-[3Q[X<UR_P#A]XPM/$_P_P#$]EXZ
MCL/B%X=T;3-,\7W-SX=TB?2;B[B62WA^%=6^%_C;]A/2Q\)O'_A[]DWXJ?$Z
MS_X)?K\,?B%X'^,OQ-G^&FD_!ZVT77O&]V_Q!^$_B#Q7\/-;T#XK>']0.K);
MZWX*\%WNG>.DUJST*%T@MYENS_9S7E'Q*^ WP-^,]QH%W\8/@Q\*/BO=>%+H
MWOA>Z^)7PZ\(>.KCPW>ETE-WH$_BC1]4ET:Z,D4<AN-.:VEWQH^_<BD#6FFC
MM9>2TO\ EU_ :JN_O*_>V_E;M9WVMN?S3_ [_@FI\6?C3^Q%\;]:7P/\.Y_$
MW[0__!+7]FSX&_ 6X\33QV.J>'OB3X/L?BQJFJ-,=0TF:^\&:4U]XG\$7VG:
MM"S3W!M897C1]/2OHCXK?\$[OVL=;O/VE_@?X?\ A9^SWXR\$_M0_M&Z#\>H
M/VR/%OCV\L/B[\&M)CN?!%YJWA/_ (0!? NH:OXC\0^&'\(7.G?#O5="\;Z7
MHJ:7K4R:Q#92(YE_HCAAAMX8K>WBC@@@C2&""%%BAAAB4)'%%&@5(XXT541$
M4*B@*H  %246TMTM87M)+[^K>EK6V:[+R?8_EW^*'_!+K]M3QG<_\%'?"GA3
MP9\*?!7P^_:9^!?Q6\-Z=8R_&"^\9:)\9OCAXH^(?ACQ-X ^*-IH7B3P0-;^
M"-[::'I?B2;XFV \4:GX>UKQGK.FZEX>T9;>Q6^M?UK_ ."F7[(&M_M@_LLZ
M;^SYX'T3PQ+ILWQ5^%&KZYH6J7P\-Z,/A_X7U])O$MC82V5K*+:XCT5I(]-M
M;6*$^8J)!)"RH1^CM%.W3O\ J)U)-IZ)IW]79+6[=]%^9_+G\0/^"4/[7FD?
M#_X ?#GPMI?A?Q_X'_8C^-/QEN?A!I'@KXSS_L^^//C3\$OC+X4L--T#5]8\
M;V'@S7M,\+?&?X2:A:OH^HR:]HUYI'COPUJ&N31^([#4[B!I_HG]D3]@#]J7
M]DKQ+\)/BEHW@#X:^(=>\!_LZ_M/:/-\+Q\</%=[IT'Q)^-'QQ\-?$KPWX-D
M^)GBSPKJNHWT$>B6-[)XK\8V?A6PT-O%CZBVB>&8-+N[>8_T!T4K)?=;KY?H
MDNUEWNQNK)Z65NJUU[]=F]?^&5O$?BW9_'GQ'\ _%L'P9U;P7\-OVBM0\"?:
MO!5YXO@F\8> /#WQ%6R@O8M(U^2WL8;O5/"\FIQRZ%?:U9Z2;Z'3;B36K+2)
MKN&&P?\ -/\ 9@_9Y_:Q\+_M)?M+_MJ^,?V=?@A\"_&7Q#^!VE> =+_9W^'O
MQGG\56'QA^*VAZW+XGN/BI\1/B/9_#K1-&T!K^;=X9\.3#PUX@UZUTG5-3NM
M>:&58X)_V:HI_P!?U_7J2I635EKZ[73MOMI;NKNS5W?^?;]M/]@+]K3]L+]H
M/X<_M3IX#^ ?@+Q+^RQX5^&WB3X9_"/Q!KY\:Z/^T]X^L?$^@^._'7PZ^-OC
M"W\-:=_9'PW\*RZ;=:#\(KL:-J%WI_CFX'Q$OK2QL@NEK^J7[-OQ<UOXN>/?
MVD);SX+VOPUT7X>?$#PS\,[/QG+=1/KGQ0\2Z-X%T37O&[W4":+IYN=#^'^L
M>)XO!6A^(H-2U?3M>OK+Q"=.:UM[ &Z^MZ0 #.!C))/N3U-'?SW_ *Z?*P.;
M:LTK:6WTM;[_ )Z7;?I^/G[*_P#P3CM?@_\ ![]J.\\6_#+X6+^TK\8O'7[6
ME[X9^).GQV>H:Z_@SXPZOXCF\"Z;?^*I-.COM-0Z;J5G#JMG C"RB,EN[7"H
MRGY%N_\ @E+\<=+^#GPW\#>"?#'PM\.ZUIG_  2<\#?LB^.AINM0:7;:Q\?]
M#\9? KQ-K%[>75GHRG6-&FE\$>-;P>*[E7GN;RZB:2W4ZBS+_1]12M]UK6Z#
M522=_3O;2W2^VA^$FB_\$]?VA=/^(-GXDGB\%'3(?^"D/[-/[43M'XED:?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)DKDG]IGPZ ,Y/\ 9&O<8&3Q_9V<8![=J/FOO7EY^:#DG_++[F?K'17Y-?\
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M_!++C_C*+P[R2O\ R!?$749Z_P#$MX'RGD^WJ*C'_!>;_@E@<X_:C\.\=?\
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M'[57AS."?^0'XCX !//_ !+?:BZ[Q_\  E_GY_GV8<D_Y9?<S]EJ*_&C_B(
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M<P" 2-$\1GJ0!TTSN2/SI77>/_@2_P _/\^S#DG_ "R^YG['45^.!_X+[?\
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M'JI)4$55DESO8DG.3EAR2H)"^H&0< +P.FW.:-]OD_N?S3T_(![LPW*,!A(
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M6'0_CC'&>N <C^TD(Z_PD@AB1N .#RN>&((&2,Y (W9IAOU8Y+8(X'4G@YY
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MXX':BVM_Z_K_ #8V[_UZ;][V5_/4'<'G)P#P<,"P;;U+8^8^@/!W=.15"5E
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MTU5_3N-KS[;=M'_7],_.6R_9B^.5^ ]Y;>&?#T;<O_:WB*V>= "HPT-DMUG
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M%PN>)_K5[/2[_K]!GYYG2;7.T$#:PR=@/R!?,#= 5WECAF&,8)., 5S9V<0
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MD'!+ R!6P=P(&VO#7,NEW][IMW(IN+*:2"5X\^7,H8>7*A8$A)$(88VLOW6
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M_P#"/?##X0:$' D5M;N/%7BZZ5!'#%N=)]0T_2G=?).XBSA+X<.P1E1>:O\
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M!'AV)DAU%9/D1L!AL;<SY?: 4V[0<@GF<?L]")E2_P#B)IBL%8.-/TJXG 8
M8"M-(H;().#[,#UQ]!LS:Q%=R6&EPV]C!<2XO;PS[7.V0/';QPQB69@&&QFE
MA!)+J2(]C8.JZ/<:=;PWC:[96ZR /_I&F7$322-G"H5EN^9 4*KY),A!*>5@
MX3@NEW;?5*VW==GZ>8)M=GMTWVUZ_P!=EOY)%\#/!]MAKOQCKVHE(G7%I9VV
MGQ^8$!6/S6+L&+;@H"9))QGOHQ?"?X067EF>WUW5I@H4K<:BX0, $.Y;?:<$
MJ0&5C\N1CJ:75=3\8PKG2?A]K.KQF0EM0_M"RCAD"M'F=(;.2ZU!+<B)I DU
MO;%51E8H7W'BI+OXHW+21V_@Z^L<,&#1:/>W #G),F^\O!;(/G)'[I@21E6X
M!/=72^OGY:._75_@NH>]:S=NUK;:>;ZIZ/7T/2;7PO\ ##2N++X?Z?/,45&?
M4W-V ,G>2LX<#:"&!9@ 65CRN*TUU/3[")7T[1?#.APIG=)'9Z9;LJ^8=K22
MR$L"NT=0.,L.N*\9?PO\6-5#^;:ZU$K1D"./4M%TF,$["8WC%Y:21AMK!Y75
MY(P-X(X%4Q\)/%5ZH:Z&GK+DPE=0UBXOKAV1B2QDM;>^B=@Q(<J_#@@#/-+K
MI&UM-4M]+7TTOZ]=/-K3=K\^B^;U?7J[,]6N_B/X?A69=5\5V,DH9A'%;3/>
M1_( Q/EV=O<*"@"H [;6+9P!\PQK#XK^!X$N8TU?48I;M1OECL)XXR2N[;YW
MDNZHV-I(7:" QQC%<G#\';R/'VC4;&V<"2-TM=-EN<LZ AR]Q<6XVD@*!L38
M<AL<[;2?">QP3+J>L3X!WK']@M5926 (C2SN&1/,&W_6R ,=S^7RE.\^ROWZ
M]-]=+Z7VT]!<L4K7T;O:^C^'NOEUWVV+K>,=-NDG_LU_/1H][213Q7$D,C,P
M_>1MY3HS#YV^7H-@P6.?)/&WB"TMM$UC2-+N1?7VJ6_V)UM\-%8I.RF9VD^8
M2SF- BQQ;P'+;FP,'U"#X2:+EQ)::C=G:N!)J,JEMC2 DK90V;-L8PEL9<A,
M*&!R.CT+X::-!>1HFC'3X\.S3+ IOI% 9UC1[Y6N [D-O;$F&)Q'(I!,M2;U
M5V]%\GY?F]-0NNCOW]6M.]^GKZG!SZQ%?>']/;3;2]D73="M--TG0LK;ZA/]
MGLO)D8I<&*%3-<%Y6EDDW[2SJC-MSYDVB?%/686-GH7V*%N#86-[8'4)=H(5
M6W2^?(/+0 +$03M(!R0#]57F@>&K>>WF?2_-N%D18OMU_-<3!B'52=GV&W(C
M&&,,D))^4F-RP%9FK6QM]4M+>UC6WNU\LNT>R-[$! Z,7B<E%\MLA9#-)''C
MSU0-A3E?5ZV6G75I=;+\1GQM_P (AXKOX5F/AO7Y_,FGMEAD\T79FA(,F('G
M$S*KC:I*$. AC+ -GCM5TURLMIJ:ZO8Q*=DEM?17-D':-B S0R0Q&95P,,Y*
M$KQD#-?:\'B/4?$?BSQ9K>C6ZW&@FQM-#TF>.-O+GUNTELK>:_AD14,H1(+Q
M2L&"SRPL1E01RVM>)H=,E:TUG6[*PN5WH\,UV]Y?J_\ $39VZW=P,[BRLP97
MCP4$C%FI:7W_ %^[UZ?+4%_7_!/B:Y\/6#P"T75;]+*3YFM,R"R\QBYYM]WD
M$L5.3LR6<ECW'-#1M1@MX-%CNK^YTO[4;BTLU@FDLX;E^"\<)'D1R[6 <X 8
M@DDU]>7?C/PP[-C4]4NB2%>6/P[>&-L$\*]VMF_*G"CR5Y)"H023C1:GI.J$
M1Z=?6D4C@O\ 9KE9[6^)!=20ET$D8GAM\ F19!N.T8+(?]:?UI_GT/G6Z\.W
M.G"T&KKJ6EI>*YM1=Z9/;"]PQ4FT:6-1<CHNZ NH8A6.3DUY/#=H;MK*YN=5
M%_& USI[6DJ749"CS7-OY0DC49WY* 8^;/<^W_%+4+]IOA583ZW8WTFE+K_V
M;36N8;H64UU+:26-S<2,&\DRF-H%$A&6SY:J74UZ-X^UCQ-?>,)I+'3[2RN+
M^]-[#/:1*94MKW;=>3( ,.I#$!CY:YPH4*=BG]?U^(OZ_K\SY F\/>&X@4:Z
MU&9FD">6LS(QE9O+\I1Y18-&Q8E%7<Q^0#-<!?\ P_\ !>L:M-J&=412D<4W
MDWY8R,C=2H0E259?O<]CQC/V+X7L+3Q#^TQID%S-8V(\*_#WQ)XH6#2+1;8Z
MOXLTCPWJE]IZ7'EK,KW-G,T=U>R1H)1]F50N[+ISL7@#0-6N[G6;BR\0&ZO)
M9[JZM= NX_LTET6626>XM)K6::!)9"6G6VFMF#[V"?*11;Y:_P#!?_!]0/EB
M;X/>')P_]G:WJEDP/R+.L5RI?J$<NJ%?0\Y.,9'4\9J7PQ\5:9&T]I<6>K11
MLP:,%K6Z)!))5)-R.V,$8= !WR3G[!\<>%=-\.ZII-KHWF0F_P! M[_4;">Z
MDN;FRO7N)5VS>9(S0>?;".98@2RJQ)15.:Y"[!$$B,X:-8]WF'<&+%@6.3P'
M+,"00H9^AVX2EU]?Z_I^B';T_P MM=_/\_E\;PW=Q'</;W$4EM=0N$EAG39(
MN6P00<Y3L6^92I)!.!6HC!CC<!@#&#A5!Y(Y)W#DC"C) ''6O3?B;H5JWAZ+
MQ''&L=_87UM 9XP ;BSN6$4L<@"IEH9C$Z DG:6P>H/DELQQS_&I.YFX)^?=
M\K#!R<X^9F' W9 J6DFOG;U=EMN^_?ST0C37.9 P8,B@@,.@;Y23U!&/F &#
MGGC&1[=^RR-O[5W[-AW$Y^+O@(C'#<^(K#. -R@ Y3(!&%'&017B&X;< JHY
M(++TZ#&3E20Q!)(/R[LCIGVW]EM@O[5O[-Q7&!\7_ 0Z@9!\261(&U%9 2S$
M8!V@87<.2).UGIIZM:6VWU6O?IZM;KU7YG^RY1115G,%%%% !1110 4444 %
M%%% !11107#=^GZH****" HHHH *_*+Q$J?V]K+."/\ B=WY7&#R-0E*J "7
M& S,QSM_7'ZNU^5&O*G]OZWYC'8NL:B%R4<-(=0F?B-F7Y6VA"20Q4Y)VAB+
MAUTUTM^-^_S+AU^7Y[?/[^VN^&@0H,@L@6,OM;.Z019Y^51NBRB@E<?,<$D\
M+LPB!U("%I6*; 6D+K@  ;58A0 P.-Y7(SS3PH.6)9W:YD1<'9E8T(7Y"55
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MM&%'S';'$$.0"JC(#Y7Y+U:[KU_KULP^PQ^SY\.;AAY7[/VGW0PBJ(T\=.@
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MMH4.^H,#YKLS%I_"Y8",G8$C^7##YLR8)../Z)?'7_(D>,N"?^*5\0\#J?\
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M J7L_)/L_P //7[MF.-[KU7YK_/\C_9DHHHJCF"BBB@ HHHH **** "BBB@
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M^IKU?X%#6;IIY?+15-NLPF!\O:)9$;;YJJ,EHG23*$@9,62#P3QEP[%9 5.
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MB%BT<;'RZ^7S\2M)T^Z^P:VUQH=_ ^V2RU^SFTB^CD4D%1'?Q02>9&Q8 HQ
M.23VK]M/#OQ"UGPI-"WAWQ%K&C/)(0DEC>7?E.\9>5E,'[N$HI4 AEYCPZG9
M\P['5?BC8>,K1X?B%X&^'7Q%25C'(WC/P)X=U"X>*3@*=0DMA>8SF0R^>#NX
M+ $D-2M_PWIU3\NSV6_0_K^O^ ?AU!X[TBXC=HM2B 9H6!66%H7)%P79@SLI
M8B7*M@%03M(!!K.O_B#HT3P6L-W]IU"^N$M+.PM'%S=WUY/,(H;:UMX?WDD\
M\[I%'$JN23DX +#]A[KX=_LG:@6N;[]COX'W<LCG=+9Z?X@TQ)!"%&98M.U1
M846;<REA'$HD3JN\*EKPZGP+\$7T.J_#']FGX+>"]>M7%Q!X@M="OM8U"QG5
MF.ZSNM7NKD1W$>$*2B-63"@.':JYW;==.]^E^B7ROZ,5ETNM_P EJM7:VJ6Q
M^=>C?LT>+?$%@9O&'B2S\#ZG<A&LM%U"S6YE@@\QV0W\S7$#PO&9 'CC$S(
MP48KY3^*?P:C^'?B:'2?B/X0TMSJ'FR:+XEM[>*ZT77+?<V6L;PQ@Q3!<-):
MS;+E&!#+S7]!\7A[PCXMTN'QCX@T3PY<^)=6\]+E[M)Y&M;I[J=)6!FG-J3-
M''&T4*!)!$P:-T[^=>+/V?\ P3\2=/U+PIXOTV_7P7JA\R>W\.6HOM7TR^_U
M-OJV@"ZN96TR\M9&\U]ADMYB?+E5E)6E[VCT=[=%UM]U]/NOYA9??:]M-OR/
MP/;P#X)M$W:-;+HK&ZLM20V$K6\2ZIIH86.I?94/D27=I*6>UF,;RQ.TA20
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M(5XOP2#_ ,(OX@P0,D'^R;O! P<G/08.3VK^?#_@@'9QV?P^UU((VCA_L[Q
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M$[HXH9YO)0*T<DJ_:,K;P22O%XEO;?33;"8VZ.()I8(8[B!@TT<HVQQS0R-
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MXDEO-+G:VBU^PEF8S^;+,;^ J(U:2%B@^/)?$(!0AFC.'"_)P@9BOED!OFW
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MW_E!1;:-8ZE=9 A17+>>UGUT3MK:WY-].BN.S=OEI\U_6]N]SY1MYO#GQO\
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M,JI$Q9@ ,D$8SFI _O>_X(&;A\.]4(V>7)HVO-D%5=G75_"(+LB@ AE=5$F
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MXC:GR@D-)M_CK^OD)/2[?ET?;=KS]/3J?8\^B^);:U&;:\U>6-8%=M/OH;N
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M;L>8"J@DD-FLJ;4XT*JS$C:A8 ,H9E& I8@D#)RV1CY3M.#@3?\ #R6MNO\
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MV4VA1<:Y?23)"Z%7^87 Y.!C?AR& 7H2*L-[?07)EL]:UV%V2,M+%K&I8#*
MZD&24J&&,,<8W;L_=JN?RV_X%_OUW[WW2 ^S;E+Y$5IM/E@VB)BQ#*/*5G48
M&U2' /3<,!2 X;D9;W[1+AHV+$C<O5%R ^S;MPK*I(&TYXY(W9/S);^.O'5M
MY2P^-]=*H&4Q75X+Q-KD+&C"2*4<-(I&,H2X'WC@;%K\6/B'#&J3:GHNJ$1D
ME=3T>R<2EB,,TUJEO)E4<*LGF;B5))X%-3[K[E_F_P"OR36B]5IZ?+\NW0]]
M?4(WD*,FU!&[L=JLB;MJ22A< ;HX\L2R!@VT@LPYC?4()L' ^0A8U96+E=@
MPX<88#: S#+*,X Z^0P_&?51"\6J>"="O=R^6\^CWMSIL@V.LA+)*+I,N-R*
MIP9)'&T;3D=)'\7? %W)MUG1O$OA]W*":9;>VU6T3$8DS_H$OGE1)D96VW",
M@%00P#4HZ=/Z7E;\=$D)IW;OO:^EU;3I?:]WW[>?6W1A2*7S5#*52+&%9Y8V
M!+X!61B6)495-P*;BP*C&IJ6KR0"UD$ 4QV]LL8>V(956)5<J9%+YWJV6;@J
MRMCJH9H/BCPC-/9WWA_7=#\1JA!DTZ2:.QU>*"0&,E+74O)8S1B1V10S*Q !
MVC=C4U2Z@N'F6>%]UPY<FXMW27RMS>7F-D7AD(.]7>#;L_>LPS36]_QTZVW]
M='LK(5K6L[=[W:6VF]OQO9Z&$VO02EOM$4<H:6.<6^U0257&9M@3<.^WY=PP
MH.YAG,U:UM-=\$_$#2PSQS?\(EJEZEM+-&MJUW; W"LJR@DB.4*T0W!E+;58
M':HT-1L].?3S) D,B@8E,.2$\L!D7]WYCDML5MRJPY QDX'BGBZ_NK:]F\+Z
M:T]SJ^M6<5K)IEBCS7=MI][-)-:PW)R MSJLBE88P@E:S5I  &BS,G9)?+[K
M/K>_W^MQK?NM[M;Z='MNW]]EILSX,K>V_P ']3TX&3?H'C'3KFSNC<2@F]UJ
MPEGU%8MC(DA673H9""<1F=BIY&VQXXL/#OCN6&Z\3Z3-I.NQHL">+/#\2Q7$
MP13L74[;#0:@BJ-H9T:8*I D&6D?TG3M#?PSX2TGP2T<,E_;W-QJNHRQ;V0Z
MI<QJCQ.[1["+& +"WG,5602"-\G-9]WI6V &:<O,ML6'E M$IW>6IDR0/,5F
M\LL"1R02<T<KLMK]NFK3W_-KIHMA\ROY=^G3\[WU_*Q\K:A\,_$,,F[1-=T;
M6[;S"L0GF?2KQLD*OF13EH%)#D$"4X;:Q QSQNH^!/%\2RKJ!TG3X<*?-&H)
M>2-M?,C1PV:S;FR"&PB#DA=IP#]&ZMII\T.$F8!6;++DI*&YD#(K((SA0F0.
M%!W*:\[U:&<JTL&^-47SF$>74 Y+$$+P"6YP2OR]3D"H?W/M_7S_  &MDM^W
MG>W;N>.V?PJTZ^5[G5?$$\*22-' 8--@&^4X##,TZR+$O0N4!4C V[FQRWB/
MP;J7A'7;#PZ[1WDNK1-<V[F/RWAC6>-&DN8HSM41JZ['0[)%!'4<_1G@70KS
M6O$6G:?=VK-!+.UR5G2X#SQ0*]S*8SY>PF1$;:(SD@X 89%>>>!6G^,GQ+UO
M496CCCN-<U33K-(E=S8Z/X>1I'4H,O%YXMY+I_D'RRJ0"BG!9Z>;LO7^F%]N
MW7SVT[_G\NLZ?##0H]/:2YO[M[BY98;>]?='#'=*JN_^B*C!8?.V$%FD9DR6
M>/BO+-8T#6O#UQ/#JFDWL4 =_*U*VMI[C3KV+>H2:*Y@1H@90C.8I27C+F,@
M;<C[(N='BO-" M_)$R737+H1)*!%.60(B$)^\ 0  8!7+#@9'--?OI>FW%A%
M>2N+E6#6LEQ'+;@N596,"[U$Y#,R,0'7< 6!!4IZ?A^*N!\GVVB:[J]M<7=A
MH]R]I;D)++)&+8NR'=L2.=AO5QD QA1N)SNR17/:EINIZ<88[^VDL_-.8Q*5
M=6D18RZAP9!D)M?:6/7./E./HMK;SWNIY+R>-H8B^X%)HU7.-LJ E@N1D JH
M'S9[UQ'Q%:RB\":-#ND^W7'BM[FT+^2C7$1MI8[B5,DSBV4%EC 'EY*Y.> #
MT6^OE]S_ !7]:'B<EHDKE&V%)E6)MYW JP(^8;27W^A.,XV@"N$_9^T[^Q?V
MM_@9IJH42'XV?#B6 !RP2.?Q/ICJH8@_*K%U [ !0-RY'I3PI$"'QD810-S,
MC," 0"$ (XQDC;@Y&.3R?PKF@NOVT?@;);-F.+XN_"VWFVK\HN%\46$LBYVK
MN($JYPI(/' I/9^C_+ST_0%NO5?F?[)]%%%,Y@HHHH **** "BBB@ HHHH *
M***"X;OT_5!11100%%%% !7^1-^TIX1T34?CI\8[J2V,=Y#\5_B');WEN[6E
M]:21^+=9=9X+N!DGBD0KN62)E9< @]:_UV:_R3_C\3_PO'XRGDG_ (6M\0@I
M96/R_P#"8ZOGD9'*YP 3R0,4=?O_ $_KYFM/:7K'_P!N/*_#WQA^.?@%4@T3
MQU>>(M*ASLTKQI&=:9$7Y L>JYBU8$JHCW3WDZQ@<(1BO7M*_;B\<6*JGB+X
M?WK,JA9+SPWK"S(Q .&6WOH[=T0G)*>8Y7Y0K  @^$3L&:0*<9+2$DY ^9D;
M@'< 2.<\%EZ8'&8T8)! 'SYY ^\,G+ $8'!.!CDC('6G=KJ_O+LKI)=DMM]-
MO*^WR/LVP_;^T0Y%_:^+M-8J$,=QI%S<A=H'REK595R"0, %2 .I+&NA3_@H
MQX<T[8UO?>(Y=@^6*+0]61B<'H6B'.3D ,!NR0!U/P%-$G5DC!8!AE0,') 4
M[E+$A@0>O)XJJ88^1Y41.1M_=@@Y)X+;5P20%))X.!T.:+OO^'333\/^!O</
MTCL?^"L,.DLH;P9XPUQ,EF=+,V\I)*[MK7L\:J&5!D8(R22I)-=I8_\ !8+P
M.X\O6/@M\68EP2\]C/X;G7>1M+K%+>Q,%VLP**0,?*<KQ7Y3- G)$: MG=D*
M6ZGMTR%[9&2&SR#E?(1L@(N.0,JH+ K@$<9)P2.P'/-)N^H'Z[I_P5A^!=_L
M%UX>^*&A[MV]M3\.Q7/EN-F#_P 2N>[48_B*%6=QELX &A!_P49^!FKJHM?%
MT%B[ +G6[:_TR0$/NRZW$64<@!<AU )/3 -?C@UK&ZX=(SG@[U!))QG)('.0
MYZ9)Q@$ 9HR:5:2DB2&)P3T,$8]"RDE,$GT!X^H%']?U_P  #]J8_P!KWP/K
M()TSQOX2E60E@8]8M=SM(?,))N'4A@[$=V"D ;<<L?XY66HMNM_$'A^7YCC;
MK.F LN<E?EN4(W\C.0,\CYN3^']QX7TJ4D-I]H^U3@_9XR00 < !>F!][)SN
M(//3,;P;I/+1V,"G[Q*YC(&X  #M@?>)!Z]N#5J;LM%^/^8K:WNW]WEV2[(_
M<V3Q]=7W^JU/2'#*JDKK.F$,R\Y8K=C?DC/S;NK'KBJ[:Y?2AFDO-.#,,Y_M
M73W/(P6PUX5Z8(^7TP :_#-O"EJ% C$J%L,NRYN$*AB?1U 52& .?FQR 1M%
M6;PODD)<WF"H 4:A=!AQGIYW)&#@C([=12YWV[7Z]NK7EN[[^067G][OTO\
M?8_=!KZZ=F+7.G9<MQ_:FFLJL<[W4?:N"V%!QQC!QE155YKH\M/IY(!R4U2P
M !P0#\EP/FR!R<G/KS7X62^'&.TB[U *, ;KZ\!RP8[L^=TRR;>@POOFJA\/
M2@D_;]2 *YRNHWH120>.)L=LXSR,\C&:.=KT226WEK=I_=]W0$DNGZ_F?NJT
MEQR1-9D$D';?63;LM@9"W++@#(+'.[&X@D56=[ILJ#$PZ!1/"X<CC8S"8C'
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MX"<X>YU+5)CDE5!(618R%))P1^.:XC5OCQ\5M45H[:]T?0HV&#_9FGI)<KG
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M*EUHLS N<@C).X.F3M(  4<@A<95@K<$#FJ<NK,=P+[ES]YB0 HX4\A\<=
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MV0DVOA5U() >[U5=VYE&W>L=N#N &2-Q]R">#F\]MNMMONZ>HG;H_7>W3O\
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M4A_8:_8G/7]CW]EH].O[/OPF/3I_S*/;M7U+119=E_7_  R^X+ON_O9\M?\
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M_9__ ,$ZO^3-?@=_V*P_]*[BOMFOB;_@G5_R9K\#O^Q6'_I7<5]LU_6>1_\
M(ER?_L5Y?_ZB43_!7Q)_Y.)QY_V6/$O_ *N<:%%%%>H?%!1110 4444%PW?I
M^J"BBB@@**** "BBOSG^,/\ P4Z_9V^"?[8?PJ_8J\6P>/7^*OQ6M)Y=(;3?
M /C;4-.2YN+KPK:^'TL9['PW=6>O:9J@U[6)]5U[3-0;2O",/@[7V\136A2W
M$A_6KMY=1I-[*_4_1BBOR#\6_P#!5ZZ\'>/_ -H6VN?V0OC=XE^ O[,/QBU/
MX+_%W]H'P-J7AKQ+8>&]>T/PIX'\8Z[K%Q\/MUAXGDT'1]$\?Z'>ZA<V4][-
M%:FXG2"0PO$/U8\'>+_#7Q \)^&O'7@S6;+Q#X2\8:'I?B3PWKFG2>;9:MHF
MLV<-_IM_;/@,8KFTGBE"NJ2(6,<J)(K( '%JUUOYI_EU\MSI***\R\5?&/X<
M>"?B)\,OA3XG\2P:7X^^,<?C*7X;^'Y+34)IO$J> ++2-1\7&"ZMK2:PM/['
ML]=TJ>0:A=6C7"W06T$[QRJ@+^ONW/3:*** "BBB@ HKY8T/]H74M6_;6^)?
M[*C^'[&+2/ G[,GP9^/EMXI2XN#J5]J/Q0^)_P ;_ %YH,]HQ^RI9:9;?"BQ
MO[6XC GEGU6[CE)CBA ]9\$?%"R\<>+/B9X2MO"?CO0)_ACK]AX?O=8\5>'&
MT;P_XKFU#3(]374O NIF[N!XBT>V23[)>7RPVGD7RM;F-B-Y!\K_  4ODVE^
M;/3J**\K^./QB\%_L^?!_P")'QM^(=Z;#P9\,?"&L^+]=DC :ZN;?2;1YH-+
MTV$\W6KZS>?9M(T:R3,M]JM]9V<*M+.BD$E=V6[T1ZI17D?P#\:>.?B/\%/A
M9X_^)G@V#X=^/O&O@;P[XH\5>!+>\DU"/PCJ^N:=!J-QX?:\E5)+B?2Q<):7
M3LH_TJ.91E5!/KE ;!17&_$3X@^$/A1X%\6?$KQ_K$7A_P %>!]"U#Q+XHUR
M:WN[J+2M$TJ!KF_OI+:P@NKV=;>!&<Q6MO/.^-L<;L0#J^%_$NB^,_#7AWQA
MX:ODU/PYXKT+2/$N@:E''-"FH:+KNGV^J:5?)%<1PW$27=C=03K'/%%,@D"R
MQHX90!9VO;3:_2_8W:**CE<QQ2R 9,<;N >A*J6P?KC%&X$E%?!O[#_[:C_M
M:_#+X,>)]5^&?BSPCXB^)_[//A;X]W^KV6CSW/PFL8_$OBC7?"O_  A.E>-+
MF\:>\\9V-QH,NL7F@2V0EM_#]]INHM=R?:?+3[RH_77[QM.+LU9_UV"BO-OA
M/\7OAY\</!Y\>_"[Q'#XJ\)CQ/XY\&_VO!::A91GQ'\-_&>O?#[QGIP@U.UL
MKHMHWB[PSK>D//Y'V:Z>R:YLI;BSE@N)?.?B]^U/\*_@YKNL^"M8;Q5XL^)N
MD_"Z^^,5M\*_A_X7U'Q/X]\1> ]-UZ/PU=ZEX<T]%M-,U&ZCU=S;KIKZO;7K
MK%+.L1A0O0"3;LD[GT?15/3[Q=1L++4$@N;5+ZTMKQ;:]B\B\MUN84F6&[@+
M-Y-S$'"3Q;F\N563<VW)N4""BBO,?BW\9/AO\"_"</CCXJ>)8/"GA>X\2^%/
M!\.JW%IJ%[&_B+QOK]AX8\,::(-,M+VY#ZIKFIV5BDS0BW@,WG74T,"22J!O
ML>G45\I_LF?M%:C^TAH'QLUC4O#MEX<D^%'[4O[1?[/=K#8W,]RFJZ?\$?B;
MKG@.P\07!N"6AO=;M=*BOKRWC/D07$LB0 1A0/JR@&FG9A117FWQ8^)EE\)/
M!EUXUU#PKXX\9VUIJ>A:8VA?#OP\?%'BB9]?UFQT2&[M](%W9&6PTZ:_CO=7
MN/M"_8=,@NKPI(("C )-NRU;/2:*CBD$L4<H5T$D:2!)%VR('4-M=<G:ZYPR
MY.&!&34E !1110 44R1F1'95+LJ,RH" 78 D*"> 6(P">!G)K\>_BS_P4Z^.
M7P7^(OPX^'_C?_@G[\2+.;XO?%:#X5_#6\M?C%X"OKWQ5=SWLB/K]GH%GI$^
MHQZ-8:1&=>U>>4B+3+$JMS.)'CWG]?>[?FRHQ<KJ-FUTND_E=J_RV/V'HJ.%
MI'BB>6/R97C1I(@XD$4C*"\8D 4/L8E=X50V-P SBOE?]FC]HK4?CUXF_:AT
M"^\.V6@Q_L_?M$:U\$=/N+2ZGN'\06.E>!/ 7BY=;O%F^6WNII_&%Q:-!!B%
M8;.%@-[N2"2;3?16O\W;]3ZLHHHH$%%%% !1110 445\F?'/]I#4?A'\??V1
MO@U:>&['5[/]I7QE\1O"^I:S<W4\-UX:A\#> +OQE#=6,$7[JZDOI[=+.5+C
MY8XF9T^?!!_P/Q:2_%H:3;LM]?P5W^!]9T45X#^U1\9KS]GC]G7XP_&_3]&M
MO$5]\,O!&K>++71+R>6VM=3FTY4*6EQ<0?OHHI"_S/'\X XYH$DVTENW9>K/
M?J*_*SXZ_P#!0WQEX1^$G@G4?A/\&=3O?C!\2/C;^S!\ ?!\?Q5LM1\,?"/4
MO&/[2&CZ-XAM_$&D>)--NYM5\3^$?"VFWUY8ZG<6$=A=)KEL;$AA#*S^O_L9
M?M-_%[]ICQ3^TC/XM\">!_!_PZ^#/QF\0_ CPQ>:'K&K:EXJU_QG\/;+11X\
MU+6(+L#3[70I=2U=5\-BU5;LVD1^W%Y3O(4XM)MVT\U?^OZ9]Z4444$A1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6+XD_P"1=U[_ + N
MJ?\ I#/6U6+XD_Y%W7_^P+JO_I#/45/X=3_!+_TEF^%_WG#_ /7^C_Z<B?P4
M^-0!XN\4X_Z&371_Y5+HUS&>,8[YS_2NF\: CQ?XI[_\5)KG/O\ VI=FN9XQ
M[Y_2OX[E\4M;^\_Z_7YG_0Q@O]SPNEO]GH_^FX_GN?V??\$ZO^3-?@=_V*P_
M]*[BOMFOB;_@G5_R9K\#O^Q6'_I7<5]LU_6>1_\ (ER?_L5Y?_ZB43_!7Q)_
MY.)QY_V6/$O_ *N<:%%%%>H?%!1110 4444%PW?I^J"BBB@@**** "O"_%/[
M,G[/_C?XJ>'/C?XM^$?@;Q!\7/",FCR^&OB%JF@V=UXIT63P_%KT&C-8:K)&
M;BW.G1>)M<6VV, AOY&.6CA,?NE% 7:V=C^='1_B;\>O@UK7_!4OX ^#OV)_
MVH?BM\3/VFOVR?BSXM^#GB*+X2ZYH7[/&I^#_B3^S]\!OAII?B_Q+\<O$T>F
M> [+PYIVL^$_$LVJI9W^I7Y@TT10V<DMRBCY9^(?[.'[47[-G@CXJ_L<Z)X"
M^/OQ+\1_&SX _L3_  X^#WQ%^%G@KQMXB^%6F>-? GCKPJ_Q?_M[QMI$,NA?
M"W1O#D%KK=\]]XNO-"6_\,1VLL8EDN?(7^M2BE;ITM9>2_K]#55;7M'>S=WN
MU:WY?B?R%?"S]FO]L*R_X*0)XZ^($_Q^T[XVP_MY>-?%=_XY\-?LI_%37/!^
MN?LF3>+=0;P=H]Y^UEK7[5>B? B+X#2_!LZ#X5E^&=A\(YO'WA76(I]#A\,:
MYXBLI-:U']&/^"M_[+?QH^-WQU_94\>?L\^!-<U/XM^!/@E^W!:>#_B5I\.L
M0:/\._BC>?#'PDWP+N]7\1VLL&B^%]3N?&]SJK^$;[7)H+*;6(7ENH[RTTZ>
M&/\ =VBBR_%-_)I_CW%[1\T96V5K7>NEOEW]3^=3]@+X6)X>_:Q^!FN_LP?L
MZ?M:_LY?#S2/@9XYTW]NVY_:3T;XI>&-*^)?Q,N].T*/X?V)?XF75S8_%/XN
MZ-XV36O$.J?$[P##-HS>%K[4H)/$5U::Y8::OEW_  4J_8K^)OQW_:!_;0^)
MNG?#'XZ^(=9T#P-^Q3I?[.WB7P'=?$K38[:^U+XN^"= ^.C_  ^;PI>VEG?Z
MI!\,M3\5V_C2XLHKJXTG01>7MXUHEK]IB_I\HHMTZ=NWI;;OZW>X>T:ES6Z6
MU;N_>YM7^%NVA_*_X_\ V6O'?PG\/_$/X27WP,_:-\5?\$_? '_!3N+Q/XK^
M"/PULOB9X@\1>)?V;O$G['OP>U&TN_!.C:9=W'C'Q]\%_#W[4NJ>(=;\6>%_
M![:I$^J:?XFM88UFTS4[9?GWX;_ KQK::PVH_$[]EO\ ;EG_ .":3?M1_&S6
M;K]GV_\ !WQKU;XD)X>U+P;X2@^!7BSQ1\-+*:Z^*7BOX0Z%-;^+(;;P[86V
MKIX<U"\L9=8B4+%%!_9%13>O1>EM+::6[.UFNJ&JK2M:][W=[=M=.M[M/?[C
M^4'XZ_L.0_&#6OB]\5_AG^S1^U%X6T_X:?\ !*_X :5^R!H_C.V^*>G_ !(\
M&?%KP[^T9^U#XCL?#,42:WJ&J:E\4_!GA?4?"]Y9^&]<U#6_%/ACPKXJTRTU
M.VM6U9H9/0OBC^S1^T3\;_$VJ^%?B9\-/CEK'@;QW_P48_9&\3>-HX=/\=:3
M9:I\(M._9I^(UG\2M3NK_238R6W@)/%]SIFA^,+JWN(-'74KZ'2M1D6XN4@?
M^GRBCOY[^?J)5&NFBVU=UJGOONM?\]3^/3X__LL?M.Z;\+/A5\)9O!?QFL_V
M.?@_^W%_P4&T*;P'-\!/CE^TV++X3WOCF\N?V2M7N?A!\.OC#\'?BOX[^$VE
M:;>>+(O!'B>T\8:SH.A2ZAX:U2XL]0L+>SDB^L/V<?"'Q6^-F@?L5?\ !/?X
MFZO\3_$/AOX.J_[4G[39^+G@M? /C6#P'X:\9ZA<_LQ_!+Q?X6?XD?%S4-,@
MO]<BLO%O_"/^+/&^J^)[7PSX7\)6VLI%)%<1#^ENN>T_PCX5TG7]>\5Z7X;T
M+3O$_BE--C\3>(K'2;&UUOQ!'H]N;328]:U2"!+W4TTRU8V]@MY/,MI 3% $
M0XH5M^J22T[6]%TOL]6]-=&ZEUMJM4[W][3757OZ/>VA_+/^V_X=^&?C7_@H
M;^W]H/Q+_9__ &LOC[XCTC]FG]E*S_9L;]GS2OBCXE\/?##XOZWH'Q<;3KV^
MM?A]>1Z=X!\8:U?V>C7WAKQ]XJM8]%L]+\.>*[$ZKITEU);:MQ_Q2^!?[1-S
MIWQ-M_VQO@7^U_\ 'G]LS4_V>?@MI/[$/Q=^!=O\2=:\$?"_XMV'PSL;'4);
MGQKX)U6'P3\*_%V@?&!;?Q-\3O%GCI[:P\2:5:ZG?17NJ6%TEA=?U&>%?@CX
M#\&_&#XN_'+0[2_B\??&[1/A?X?\>W<U\TVGW>G?"&U\6V7@Q;&Q,:K936UO
MXUUQ+V599/MF^V)6/R!O]=HL/VMDDE>RCK=WT4=%V5T[KK^?\>/Q._9]_:1\
M1_&_]MS0-4^ G[0'QH\4_'7]ESXH^%OC/XN\=_##XH:';^$?&/A+X1?"FV\&
M1? /XG>%O&U[\'_CW\'/B_X^\*3#X?\ PWF\#6/Q8^&6K6FOW<CZ;8W&M6&H
M=WX6^#G[1/PGL++]D[PU\!_VD-,NOB1\6_\ @G#\2_A_KNB>!O'M_P#"KPGX
M#^%^C^&->^.=IXN^(ICE\/\ @*^T/5=,U6QUSPOX@U33]2O-1O(;2#3[E7"K
M_6G11_7];^OKY:"]J_Y5_3372VEET/Y"_P!H']A?XTGX0^,_BKI?PV^*UGJW
MQ*_X*D_M2ZO^U"S_  K^,7QP\7^*_P!DVV^,GQINO@@MO\#?!_Q2^$WC'Q_\
M#(=:E\ ^-9/#/@'Q-IHU?3[VU\:6]OK^FV=UIU_^T/\ P2)^'?Q-^&?[(%SX
M9^(5_P#%.ZL#\2OB#?\ PRTOXM_"?5_@GXA\/?#:\GM6\/Z+H?PV\3_%[XT^
M-/"_@J.Y74;GPKI/C?Q;#XGM+*Z:.]TBPM_L@?\ 5.BA:._7^OP)<VU9K1OO
MT5K?/3?MI8_CDM_V8?VP;?\ 8S?X?6/P9_: TO5F_P""/OP"^&">'-,\(^.-
M/U6W^+5C^UC\1M7\4>#K6PM;2&ZM?B!8>!K^QU/5M(@2/7K3P_=6EU<PQV<D
M3GV_0_\ @GQXK^!_[27B7Q[\%_@Y\=-%B^&__!0SX"Z9\&]7M]3^*FMZ+HW[
M-GB'P#XJ_P"%QS:!%JFJ7^EWOP]U3Q%)ID_C369(KNT.M/!)>7T=Q*X?^JRB
ME:UO*UOE_6OHBO:O73>]]>]ORL_DS^.?X=_L:0_!/0_A#!^TG^R1^U!XX_95
MU3Q7_P %$-6O/A-\'?!_Q@U_7] _:;UK]JW5K+X#?%7XB_#_ ,&747BZ[\/^
M(_V;]!TK0/@]XP>ROO"^@:A=GQ%*+2;Q:/$,OE_A7]B3]HN^^%^@^/+G]FW]
MI2R^)^E_L ?M#^'?#]WXPT#XB7WQ-T?QWJO[5_C&Z\%>$M9U%S+>7_CV?X7Z
MA:7,-FTEQ>:IIDPUFVCN()H[L_VT4466GDK?E;\K^KTL-5FNE]NKV6UNSMN^
MNES^47]H?X*?$[5/%_[3A^(O[/?[8WQ$_;F\0>)O 5Q_P3O^/7PKL_B?)\*_
MA?\ #^'X>^ ;'P!H^G^/_#^IVWPV^"LWPY^(=GXVU;X[6'C^#1;SQ3)J5QK,
MY\5V>K6D4'6Q?L>_'O3?C[XS_:=U#X;_ !BU']H6Q_X*A?"^VL_'.AP_$!-'
MNOV=;GX3VFG_ !)U;POH<DT/AW_A46L>(_-74]6_LR+1UNH;6*YNH)871?ZC
M:*=O\_GW]>GIMKJ)56E;E^]O1::+I;1:6M][/YFO^">WQ'U3]AZ__;N\??%3
MX1_M&6?P,DU/X?\ CB/XH_&OX6_$;P%^T'XT^-7CKXF^/_"\'P)O_"GB'Q]X
MJ^&7QK\7Z?\ V]X9&D_&?X*1>%M#\3:;KWAK1O%G]HW=IH\NE_HM_P %?_@3
MJ?[1_P"R#H_P_P!*^&_B+XEW;_M#?LW:_=>%?#VFZOJNJPZ%8?%;P[%XMU.:
MUT$O>1V.D^$[[7)=6O5;[/I]A]IOI)HEMUN(_P!*_%'@[PKXVLM/T[Q=X?TG
MQ)8:5X@\/>*]-L]8LH;ZWLO$GA/6+/Q#X9URVBG5TBU/0M<TZQU;2[M0);._
MM+>YA998E8=)1_6NI+G>496=T[O7=:67Y]-G:VA_*[X-_82^*?PH\90_'CX)
M_"7XJ>"?VB-?_P""N?[9.EOXM:#Q^MG9_LG^.=#_ &E+3PE?ZOHEQ=G0XO@M
MK>N1_#KQ%IWB.XL(M+N_$&HZ3K=IJQOM62>Y^"?@W^RA^VCIGP^^,D=EH_[5
MUM\:=8_9/^,_AO\ :(T6R_9*^,?PXM_B)\7=9FC.DOK/QJ\<?M1?$+3/CMXU
M;Q U]K7@3Q/\%/A1%:W.CRQO=VWANQ?^SK3^YBBBW]>??UZ?TBO:OM?6^K_!
M^7Y/8_C'_; _8*^+'@'XH6GA+PCX'^-VB?!^T_9B^%@_953X5_LR?'W]J#5O
M!/Q]U2_\2Z[\<)K'Q1X%_:@^"UA\$/CWKGCJ^T+Q,?B3\8M/\3:)JOABPTO2
M8O$F@:3X.U+P_J_[^_MM^"?CGK__  3PT+P?H-K\0/'GQNMG_953Q))H.C8\
M=ZWK&@_$_P"%=U\0];OM%\&:IXDM+.<VUCKVK^);;1=<US1]/M$U'R=9U#3(
M/M\OZ=T46_K^O0EU&W%O[+OZO3RZVU^_<_GY_8^\&_%#P3_P5S_:5\1Z;\(?
MCQJO@+XMZ'\5[CXD_%/XX_#_ .(?@8_##4/#GB+X<1?#OPQ\-_B-!X\UOX&?
M'SX1_$-+;6-0^&&F:9X1TKXK_"G1-,U.QU;5+;2KK6]-ON+_ &]-%_:+A^//
M[8OPK\$_"C]H;Q6W[6V@_L4Z=\#/'/P[\%>,?$/PS\-WWPP^)]KJ?Q6/B_QO
MHL,OA_X;+IVAP2WE_+KMYIG]J6C!(/M1<*?Z.J*._2]]M-]QJI:7-;HE9N^S
M33V\EO\ ??4_C&U3P/>>._B3^W):?#3X)?M8^,?V_M*_X*'^)="_91_:&\)6
M?Q3U+X0_"_3?#WCKP>VJ)=?$/3]23X7?#KP-X8A3Q-<?$_PCXP^Q7'BK2M?M
MMMKJMKJ.GG3/WI_X*9_L^ZK^TCJ_[%7PZNO!GC3QM\*Y_P!J+1;KXVZ9X4;Q
M+;Z7'\.X_"^N+=R^-=0\-36USIOA=[XVD5S<75Y:VIF:&%ILR!'^\/A)\#?
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M8WLBBBBNH\8**** "BBB@N&[]/U04444$!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !11107#=^GZH****" HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
9B@ HHHH **** "BBB@ HHHH+AN_3]4?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
